PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Sabini, RC; Nutini, DN				Sabini, Rosanna C.; Nutini, Dennis N.			Return-to-Play Guidelines in Concussion: A Closer Look at the Literature	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; traumatic brain injury; return-to-play; guidelines	SPORTS-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; RECURRENT CONCUSSION; SEX-DIFFERENCES; BRAIN-INJURY; PROFESSIONAL FOOTBALL; HEAD-INJURIES; SYMPTOMS; MANAGEMENT	Traumatic brain injuries that occur during sports have gained significant attention in the literature. Despite improved education and research on proper identification, risk management, and treatment, standardized methods for returning an athlete to play after a concussion are lacking in universal applicability. Current return-to-play guidelines are considered appropriate for the majority of athletes who recover within a few weeks. However, applicability of such guidelines becomes difficult when treating those athletes who experience prolonged symptoms or do not have the resources available to adequately manage complex presentations of concussions. Understanding the guidelines with consideration to special populations will assist the treating physician in providing an appropriate and individualized evaluation and treatment plan to safely return an athlete with a concussion back to play without compromising his or her health.	[Nutini, Dennis N.] Natl Rehabil Hosp, Bethesda, MD USA		Sabini, RC (corresponding author), 1437 31st Dr, Astoria, NY 11106 USA.	drsabini@gmail.com		Sabini, Rosanna/0000-0002-9273-3855			Alla S, BR J SPORTS MED; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bruce JM, 2004, NEUROLOGY, V63, P1516; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; d'Hemecourt P, 2011, CLIN SPORTS MED, V30, pviii; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fuller CW, 2007, CLIN J SPORT MED, V17, P197, DOI 10.1097/JSM.0b013e3180471b89; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell M, 2004, CLIN SPORTS MED, V23, pix; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Putukian Margot, 2006, Curr Sports Med Rep, V5, P15; Randazzo C, 2010, PEDIATRICS, V126, P727, DOI 10.1542/peds.2009-2497; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Sabini RC, 2010, PHYSICIAN SPORTSMED, V38, P139, DOI 10.3810/psm.2010.04.1771; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	66	5	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2011	39	3					23	30		10.3810/psm.2011.09.1917			8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	893VC	WOS:000300384000009	22030937				2022-02-06	
J	Vuille-Dit-Bille, RN; Ha-Huy, R; Tanner, M; Stover, JF				Vuille-Dit-Bille, R. N.; Ha-Huy, R.; Tanner, M.; Stover, J. F.			Changes in calculated arterio-jugular venous glutamate difference and SjvO(2) in patients with severe traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Critical care; Midazolam; Deep sedation	EXCITATORY AMINO-ACIDS; INTRACEREBRAL MICRODIALYSIS; CEREBROSPINAL-FLUID; HEAD-INJURIES; BLOOD; BARRIER; RELEASE; LACTATE; DISRUPTION; METABOLISM	Backgrounds. Cerebral metabolic impairment is feared to induce secondary brain damage following traumatic brain injury (TBI). The present study was designed to assess the temporal profile of calculated arterio-jugular venous differences in glutamate (AJVDglu) and SjvO(2) in patients subjected to continuous pharmacologic coma. Metabolic impairment was assumed to be reflected by increased jugular venous glutamate levels and decreased jugular venous oxygen saturation (SjvO(2)). Methods. Arterial and jugular venous blood was drawn once daily for up to 14 days from 14 patients to assess the temporal profile. Plasma glutamate was measured by high performance liquid chromatography. SjvO(2), lactate and paCO(2) were determined in routine blood gas analysis. Calculated AJVD indirectly reflects cerebral uptake (positive values) or cerebral release (negative values). Results. During pharmacologic coma an increase in ICP approaching 20 mmHg was associated with significantly reduced paCO(2) (4.7 +/- 0.5 kPa; mean +/- standard deviation), markedly decreased SjvO(2) (66.0 +/- 4.2%) without reaching ischemic values, and a trend to more negative AJVDglu values (-6.0 +/- 14.3 mu mol/L), suggesting cerebral glutamate release. Arterio-jugular venous lactate difference (AJVDlac) remained unchanged. Conclusion. During pharmacologic coma increased ICP was associated with significantly decreased SjvO(2) which coincided only with a trend to increased cerebral glutamate release. Calculated AJVDglu appears to be inferior in unmasking altered brain metabolism compared to SjvO(2) whenever ICP is increased. (Minerva Anestesiol 2011;77:870-6)	[Vuille-Dit-Bille, R. N.; Tanner, M.; Stover, J. F.] Univ Zurich Hosp, Div Surg Intens Care Med, Dept Surg, CH-8091 Zurich, Switzerland; [Ha-Huy, R.] Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Univ Zurich Hosp, Div Surg Intens Care Med, Dept Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	john.stover@access.unizh.ch		Vuille-dit-Bille, Raphael/0000-0002-0884-9493	SUVA Fonds; Swiss National Research Foundation (SNF)Swiss National Science Foundation (SNSF); Department of Surgical Research, University Hospital Zurich	The present study was supported financially by the SUVA Fonds to JFS, the Swiss National Research Foundation (SNF) to JFS and the Department of Surgical Research, University Hospital Zurich to JFS.	BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bechir M, 2010, MINERVA ANESTESIOL, V76, P896; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; D'Onofrio M, 2001, J NEUROCHEM, V78, P435, DOI 10.1046/j.1471-4159.2001.00435.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang H, 2001, CLIN CHEM, V47, P1458	31	5	5	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393			MINERVA ANESTESIOL	Minerva Anestesiol.	SEP	2011	77	9					870	876					7	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	829HJ	WOS:000295568900004	21878868				2022-02-06	
J	Kuo, JR; Lo, CJ; Wang, CC; Lu, CL; Lin, SC; Chen, CF				Kuo, Jinn-Rung; Lo, Chong-Jeh; Wang, Che-Chuan; Lu, Chin-Li; Lin, Shu-Chin; Chen, Chiao-Fang			Measuring brain temperature while maintaining brain normothermia in patients with severe traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Brain normothermia; Intracranial temperature; Rectal temperature; Superficial temporal artery temperature	HYPERTHERMIA; CARE	The aim of this study was to evaluate the relationship between superficial temporal artery temperature (Tt), rectal temperature (Tr) and intracranial temperature (ICT) when attempting to keep the brain in a normothermic condition in patients with severe traumatic brain injury (TBI). We also compared the incidence of temperature gradient reversal in patients who survived (survivors) and patients who did not (non-survivors) and the difference in temperature gradient reversal between survivors and non-survivors. Tr is normally lower than and and temperature gradient reversal, when Tr exceeds ICE, has been demonstrated to be an early sign of brain death. A total of 28 patients with severe TBI were enrolled retrospectively in our study between November 2008 and February 2010. Each patient's Tt. Tr and ICE was recorded every hour for 4 days. Our results show that the frequency of brain hyperthermia in our participants (ICT > 38 degrees C) was 17.7%. Using a paired t-test and Bland-Altman plots, it was shown that a significant temperature difference existed between Tt, Tr and ICE (p < 0.001). The use of Spearman's correlation method revealed that Tt, Tr and ICE were positively correlated (p < 0.001). Brain death occurred in five patients at a mean of 9.6 hours (range: 8-12 hours) after a temperature gradient reversal between Tt. Tr and ICE Fisher's exact test showed that there was a significant difference in the incidence of temperature gradient reversal between Tt, Tr and ICE in survivors and non-survivors (p < 0.001). We conclude that a significant temperature difference exists between Tt. Tr and ICE when maintaining brain normothermia. The daily practice of non-invasive Tt measurement may cause doctors to underestimate ICE; reversal of the ICT and Tt and/or Tr temperatures could be an early marker of a poor prognosis for patients with severe TBI. (C) 2011 Elsevier Ltd. All rights reserved.	[Lin, Shu-Chin; Chen, Chiao-Fang] Chi Mei Med Ctr, Dept Nursing, Yung Kong City, Tainan, Taiwan; [Kuo, Jinn-Rung; Lo, Chong-Jeh] Natl Cheng Kung Univ, Sch Med, Inst Clin Med, Tainan 70101, Taiwan; [Kuo, Jinn-Rung] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Yung Kong City, Tainan, Taiwan; [Lo, Chong-Jeh] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Trauma & Emergency Surg, Kaohsiung, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Inst Med Res, Yung Kong City, Tainan, Taiwan		Chen, CF (corresponding author), Chi Mei Med Ctr, Dept Nursing, 901 Chung Hwa Rd, Yung Kong City, Tainan, Taiwan.	kuo.ox@msa.hinet.net	Lin, Shu-Chin/AAG-3608-2019	Lu, Chin-Li/0000-0002-0818-4823			Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; FITCH W, 1994, ANESTHESIA NEUROSURG, P1; Forte LV, 2009, ARQ NEURO-PSIQUIAT, V67, P480, DOI 10.1590/S0004-282X2009000300019; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; Hebbar Kiran, 2005, Pediatr Crit Care Med, V6, P557, DOI 10.1097/01.PCC.0000163671.69197.16; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; MELLERGARD P, 1995, SURG NEUROL, V43, P91, DOI 10.1016/0090-3019(95)80049-M; OLSON DM, 2005, NURSING, V35; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	20	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2011	18	8					1059	1063		10.1016/j.jocn.2010.11.014			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	805YY	WOS:000293768200009	21723133				2022-02-06	
J	Andersson, HC; Anderson, MF; Porritt, MJ; Nodin, C; Blomstrand, F; Nilsson, M				Andersson, Helene C.; Anderson, Michelle F.; Porritt, Michelle J.; Nodin, Christina; Blomstrand, Fredrik; Nilsson, Michael			Trauma-induced reactive gliosis is reduced after treatment with octanol and carbenoxolone	NEUROLOGICAL RESEARCH			English	Article						Astrocyte; Gap junction; Microglia; NG2; Reactive gliosis	OLIGODENDROCYTE PRECURSOR CELLS; GAP-JUNCTIONS; GLIAL SCAR; EFFECTIVE REDUCTION; RODENT MODEL; AXON GROWTH; ASTROCYTES; BRAIN; INJURY; MICROGLIA	Background: Reactive gliosis and scar formation after brain injury can inhibit the recovery process. As many glial cells utilize gap junctions for intercellular signaling, this study investigated whether two commonly used gap junction blockers, octanol and carbenoxolone, could attenuate reactive gliosis following a minor traumatic brain injury. Methods: Octanol (710 mg/kg) or carbenoxolone (90 mg/kg) was administered 30 minutes before or after a needle track injury in adult male Sprague-Dawley rats. To mark dividing cells, animals were injected with bromodeoxyuridine (BrdU; 150 mg/kg) intraperitoneally two times per day, 8 hours apart and killed 2 days later. Immunohistochemistry for BrdU and markers for reactive glial cells [glial fibrillary acidic protein (GFAP), ED1, and NG2] were investigated using immunohistochemistry and western blot techniques. Results: Two days after injury, increased cellular proliferation, activated astrocytes and microglia, and upregulation of NG2 expression were observed surrounding the injury site. Octanol and carbenoxolone administrated prior to injury significantly decreased cell proliferation by 60 and 70% respectively. The distance of GFAP immunoreactive astrocytes from the wound margin was decreased by 32 and 18% when octanol was administrated prior to or post injury respectively. Treatment with octanol also decreased the number of reactive microglia by 55% and, when administrated prior to injury, octanol reduced the distance of NG2 expression from the wound by 48%. Conclusion: The present study demonstrates that two important components of reactive gliosis, cellular activation and proliferation, can be attenuated by octanol and carbenoxolone.	[Andersson, Helene C.; Anderson, Michelle F.; Porritt, Michelle J.; Nodin, Christina; Blomstrand, Fredrik; Nilsson, Michael] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, SE-40530 Gothenburg, Sweden		Nilsson, M (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Medicinaregatan 11,Box 432, SE-40530 Gothenburg, Sweden.	Michael.Nilsson@vgregion.se	NILSSON, MICHAEL/ABE-7821-2020	NILSSON, MICHAEL/0000-0002-8826-1621	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; Sahlgrenska University Hospital; Region of West Sweden; Sten A. Olssons Foundation for Culture and Science; Edit Jacobson's Foundation; Ulla and Rune Amlovs Foundation; John & Britt Wennerstrom's Foundation; Axel Linder's Foundation; Yngve Land's foundation	This work was funded by grants from: Swedish Medical Research Council, ALF-funding sources at Sahlgrenska University Hospital, Region of West Sweden, Sten A. Olssons Foundation for Culture and Science, Edit Jacobson's Foundation, Ulla and Rune Amlovs Foundation, John & Britt Wennerstrom's Foundation, Axel Linder's Foundation and Yngve Land's foundation. The technical support by Birgit Linder and Ann-Marie Alborn was highly appreciated.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Anderson MF, 2003, NEUROCHEM RES, V28, P293, DOI 10.1023/A:1022385402197; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Del Rio JA, 2007, CURR PHARM DESIGN, V13, P2485; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kurata Y, 1999, MOL PHARMACOL, V55, P1011, DOI 10.1124/mol.55.6.1011; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; MOUMDJIAN RA, 1991, BRAIN RES, V547, P223, DOI 10.1016/0006-8993(91)90965-X; Nodin C, 2005, J NEUROCHEM, V94, P1111, DOI 10.1111/j.1471-4159.2005.03241.x; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; SHAMLOO M, 2004, P ANN SOC NEUR M 200; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Velazquez JLP, 2003, NEUROSCIENTIST, V9, P5, DOI 10.1177/1073858402239586; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	31	5	5	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUL	2011	33	6					614	624		10.1179/1743132810Y.0000000020			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783ML	WOS:000292087300008	21708071				2022-02-06	
J	Smith, AM; Stuart, MJ; Greenwald, RM; Benson, BW; Dodick, DW; Emery, C; Finnoff, JT; Mihalik, JP; Roberts, WO; Sullivan, CA; Meeuwisse, WH				Smith, Aynsley M.; Stuart, Michael J.; Greenwald, Richard M.; Benson, Brian W.; Dodick, David W.; Emery, Carolyn; Finnoff, Jonathan T.; Mihalik, Jason P.; Roberts, William O.; Sullivan, Carol-Anne; Meeuwisse, Willem H.			Proceedings From the Ice Hockey Summit on Concussion: A Call to Action	PM&R			English	Article							SPORTS-RELATED CONCUSSION; NEURON-SPECIFIC ENOLASE; HIGH-SCHOOL; INJURY PREVENTION; BODY-CHECKING; RECURRENT CONCUSSION; NORTH-AMERICAN; HEAD-INJURIES; RISK-FACTORS; PLAYERS	Objective: The objective of this proceeding is to integrate the concussion in sport literature and sport science research on safety in ice hockey to develop an action plan to reduce the risk, incidence, severity, and consequences of concussion in ice hockey. Methods: A rationale paper outlining a collaborative action plan to address concussions in hockey was posted for review 2 months before the Ice Hockey Summit: Action on Concussion. Focused presentations devoted specifically to concussion in ice hockey were presented during the Summit, and breakout sessions were used to develop strategies to reduce concussion in the sport. This proceedings and a detailed scientific review (a matrix of solutions) were written to disseminate the evidence-based information and resulting concussion reduction strategies. The manuscripts were reviewed by the authors, advisers, and contributors to ensure that the opinions and recommendations reflect the current level of knowledge on concussion in hockey. Results: Six components of a potential solution were articulated in the Rationale paper and became the topics for breakout groups that followed the professional, scientific lectures. Topics that formed the core of the action plan were metrics and databases; recognizing, managing, and returning to play; hockey equipment and ice arenas; prevention and education; rules and regulations; and expedient communication of the outcomes. The attendees in breakout sessions identified action items for each section. The most highly ranked action items were brought to a vote in the open assembly by using an Audience Response System. The strategic planning process was conducted to assess the following: Where are we at? Where must we get to? What strategies are necessary to make progress on the prioritized action items? Conclusions: Three prioritized action items for each component of the solution and the percentage of the votes received are listed in the body of this proceeding. PM R 2011;3:605-612	[Smith, Aynsley M.; Stuart, Michael J.; Finnoff, Jonathan T.] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA; [Greenwald, Richard M.] Simbex LCC, Lebanon, NH USA; [Benson, Brian W.; Emery, Carolyn; Meeuwisse, Willem H.] Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; [Dodick, David W.] Mayo Clin, Dept Neurol, Coll Med, Scottsdale, AZ USA; [Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Roberts, William O.] Univ Minnesota, Dept Family Med & Community Hlth, St Paul, MN 55108 USA; [Sullivan, Carol-Anne] Ontario Neurotrauma Fdn, Toronto, ON, Canada		Smith, AM (corresponding author), Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA.	smith.aynsley@mayo.edu	Wiese-Bjornstal, Diane M./L-1408-2019; Emery, Carolyn/AAI-2761-2020	Wiese-Bjornstal, Diane M./0000-0003-4824-3311; Roberts, William O/0000-0003-4517-4330; Mihalik, Jason/0000-0001-6085-8322	Ice Hockey Summit: Action on Concussions: International Ice Hockey Federation, USA Hockey; Team Wendy and the Johannson-Gund Endowment; Hockey Equipment Certification Council; Ontario Neurotrauma Foundation	Joint Sponsors of the Ice Hockey Summit: Action on Concussions: International Ice Hockey Federation, USA Hockey. Partial Support by Team Wendy and the Johannson-Gund Endowment, Hockey Equipment Certification Council, Ontario Neurotrauma Foundation.	A St  John, 2009, POPULAR MECH; Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], FACTS PREV TIPS; [Anonymous], 2009, BRIT J SPORT MED, V43, pi85; Ashare A, 2009, J ASTM INT JAI; Ashare AB, 2000, J ASTM INT JAI; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2001, BRIT J SPORT MED, V36, P6, DOI DOI 10.1136/BJSM.36.1.6; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernard D, 2004, AM SOC TEST MATER, V1446, P152, DOI 10.1520/STP11616S; Bernstein R., 2006, CODE UNWRITTEN RULES; Bishop PJ, 2009, AM SOC TEST MATER, V1516, P3, DOI 10.1520/JAI101900; Bishop PJ, 2008, SAFETY ICE HOCKEY, V5, P171; Bloom GA, 2004, AM SOC TEST MATER, V1446, P12, DOI 10.1520/STP11605S; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Castaldi CR, 1989, J ASTM INT JAI; Castaldi CR, 1993, J ASTM INT JAI; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Ciavarro C, 2008, COMPUT HUM BEHAV, V24, P2862, DOI 10.1016/j.chb.2008.04.011; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Coulson NR, 2009, AM SOC TEST MATER, V1516, P141, DOI 10.1520/JAI101890; Crawford BJ, 2004, AM SOC TEST MATER, V1446, P26, DOI 10.1520/STP11606S; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; CUSIMANO M, 2002, CAN J NEUROL SCI, V29, pS23; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; Dorsch KD, 2007, PSYCHOL SPORT EXERC, V8, P585, DOI 10.1016/j.psychsport.2006.06.003; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Faught BE, 2009, J ASTM INT JAI, V6, P277; Ferrara Michael S., 2001, J Athl Train, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fraser K, 2010, FINAL CALL; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Gilbert WD, 2000, AM SOC TEST MATER, V1341, P291, DOI 10.1520/STP15246S; Gioia G., 2008, BRAIN INJURY PROFESS, V4, P14; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gladwell M., 2000, TIPPING POINT LITTLE; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Goodman D, 2004, ASTM SAFETY ICE HOCK, V4, P11; Gordon KE, 2010, CLIN J SPORT MED, V20, P405, DOI 10.1097/JSM.0b013e318202de6b; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead PD, 2000, AM SOC TEST MATER, V1341, P93, DOI 10.1520/STP15230S; Heads Up: Concussion in Youth Sports, 2009, HEADS CONCUSSION YOU; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; LaPrade RF, 2000, AM SOC TEST MATER, V1341, P124, DOI 10.1520/STP15234S; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Link A, 2007, HEP NEWSLETTER   NOV; Link A, 2008, RYHA NEWSLETTER  JAN, V1; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Marcotte G, 1993, SAFETY ICE HOCKEY, V2, P100; Mariconda J, 2004, AM SOC TEST MATER, V1446, P135, DOI 10.1520/STP11614S; Matheson GO, 2010, CLIN J SPORT MED, V20, P399, DOI 10.1097/JSM.0b013e318203114c; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McPherson MN, 2009, J ASTM INT JAI, V6, P7; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; *MN HOCK HEP, 2010, HOCK ED PROGR; Montelpare W, 2010, INT J SPORTS SCI COA, V5, P61; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; MUELLER F, 2002, 19 ANN REPORT NATL C; Pearsall DJ, 2004, J ASTM INT JAI; Pocket SCAT2, 2009, BR J SPORTS MED, V43, pi89; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Roberts William O, 2010, Clin J Sport Med, V20, P500, DOI 10.1097/JSM.0b013e3181fc94e6; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Rousseau P, 2008, J ASTM INT, V6, P152; Rudolph H, 1989, SAFETY ICE HOCKEY, V1, P35; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; SCAPINELLO R, 2006, LINES NOT SO TALL TA; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Smith A.C., 2010, P 2 ANN WORKSH SEC P, P1; Smith AM, 2000, AM SOC TEST MATER, V1341, P199, DOI 10.1520/STP15240S; Smith AM., 2009, J ASTM INT, V6, P1; SMITH AM, 1999, POWER PLAY MENTAL TO; SMITH MD, 1975, CAN REV SOC ANTHROP, V12, P72; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stuart MJ, 2009, AM SOC TEST MATER, V1516, P11, DOI 10.1520/JAI101778; Stuart MJ, 2009, CLIN J SPORT MED, V19, P494, DOI 10.1097/JSM.0b013e3181c0aaa4; Stuart MJ, 2004, AM SOC TEST MATER, V1446, P52, DOI 10.1520/STP11608S; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2000, AM SOC TEST MATER, V1341, P150, DOI 10.1520/STP15236S; Tegner Y, 2000, AM SOC TEST MATER, V1341, P165, DOI 10.1520/STP15237S; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Visek A, 2005, SPORT PSYCHOL, V19, P178, DOI 10.1123/tsp.19.2.178; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Watson RC, 1996, CLIN J SPORT MED, V6, P108, DOI 10.1097/00042752-199604000-00008; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2009, AM SOC TEST MATER, V1516, P211, DOI 10.1520/JAI101851; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	133	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUL	2011	3	7					605	612		10.1016/j.pmrj.2011.05.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961BC	WOS:000305437900002	21777858				2022-02-06	
J	van Dongen, R; Cohen, SP; van Kleef, M; Mekhail, N; Huygen, F				van Dongen, Robert; Cohen, Steven P.; van Kleef, Maarten; Mekhail, Nagy; Huygen, Frank			Traumatic Plexus Lesion	PAIN PRACTICE			English	Article						evidence-based medicine; traumatic plexus lesion; spinal cord stimulation; brain stimulation; surgery	ROOT ENTRY ZONE; TERM-FOLLOW-UP; BRACHIAL-PLEXUS; NEUROPATHIC PAIN; DEAFFERENTATION PAIN; MOTOR CORTEX; SPINAL-CORD; AVULSION; STIMULATION; GUIDELINES	Pain, motor, and sensory deficits characterize patients with a traumatic lesion of the brachial plexus. Frequently, more severe injuries co-exist that require immediate surgical attention. Early rehabilitation and physical therapy are the cornerstones of treatment. Pharmacological management can be difficult. Surgical reconstruction is frequently advised when nerves are disrupted. The results, mostly from small historical reports, vary greatly. Neurostimulation may have an additional beneficial effect, especially if the pathophysiology of nociception and neuropathic pain becomes evident in these complex patients.	[van Dongen, Robert] Radboud Univ Nijmegen Med Ctr, Dept Anesthesiol Pain & Palliat Med, Nijmegen, Netherlands; [Cohen, Steven P.] Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Pain Management Div, Baltimore, MD 21205 USA; [Cohen, Steven P.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [van Kleef, Maarten] Maastricht Univ Med Ctr, Dept Anesthesiol & Pain Management, Maastricht, Netherlands; [Mekhail, Nagy] Cleveland Clin, Dept Pain Management, Cleveland, OH 44106 USA; [Huygen, Frank] Erasmus MC, Dept Anesthesiol & Pain Management, Rotterdam, Netherlands		van Dongen, R (corresponding author), Radboud Univ Nijmegen Med Ctr, Huispost 550 Anesthesiol Palliatieve Zorg,Postbus, NL-6500 HB Nijmegen, Netherlands.	maarten.van.kleef@mumc.nl	van Dongen, Robert/L-4279-2015				Akita S, 2006, J BONE JOINT SURG BR, V88B, P637, DOI 10.1302/0301-620X.88B5.17175; Bennett MI, 2006, PAIN, V122, P289, DOI 10.1016/j.pain.2006.02.002; Brill S, 2008, PAIN PHYSICIAN, V11, P81; BRING G, 1991, Scandinavian Journal of Primary Health Care, V9, P135, DOI 10.3109/02813439109026597; Chen HJ, 2006, ACTA NEUROCHIR SUPPL, V99, P73, DOI 10.1007/978-3-211-35205-2_14; Chillemi C, 2008, J ORTHOP TRAUMATOL, V9, P217, DOI 10.1007/s10195-008-0028-0; Cohen SP, 2009, ANESTHESIOLOGY, V111, P416, DOI 10.1097/ALN.0b013e3181ac1c47; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gilron I, 2009, LANCET, V374, P1252, DOI 10.1016/S0140-6736(09)61081-3; Guenot M, 2002, J NEUROSURG, V97, P1402, DOI 10.3171/jns.2002.97.6.1402; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Kandenwein JA, 2005, J NEUROSURG, V103, P614, DOI 10.3171/jns.2005.103.4.0614; Kim Kwang-Kuk, 1996, Journal of Korean Medical Science, V11, P158; KUKS J, 2004, KLIN NEUROLOGIE; Lefaucheur JP, 2009, BRAIN, V132, P1463, DOI 10.1093/brain/awp035; Saitoh Y, 2007, ACTA NEUROCHIR SUPPL, V97, P51; Sindou MP, 2005, J NEUROSURG, V102, P1018, DOI 10.3171/jns.2005.102.6.1018; Tanaka M, 2008, EUR SPINE J, V17, pS263, DOI 10.1007/s00586-007-0537-1; Terzis JK, 1999, PLAST RECONSTR SURG, V104, P1221, DOI 10.1097/00006534-199910000-00001; THOMAS DGT, 1994, J NEUROL NEUROSUR PS, V57, P737, DOI 10.1136/jnnp.57.6.737; van Eijs F, 2011, PAIN PRACT, V11, P70, DOI 10.1111/j.1533-2500.2010.00388.x; van Kleef M, 2009, PAIN PRACT, V9, P247, DOI 10.1111/j.1533-2500.2009.00297.x; Wilberg M, 2009, LAKARTIDNINGEN, V106, P586; Yokota Hiroshi, 2007, Neurosurgery, V60, pE205, DOI 10.1227/01.NEU.0000249195.76527.61; Yoshikawa T, 2006, RADIOGRAPHICS, V26, pS133, DOI 10.1148/rg.26si065511	26	5	5	0	5	WILEY PERIODICALS, INC	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN, MA 02148-529 USA	1530-7085			PAIN PRACT	Pain Pract.	JUL-AUG	2011	11	4					414	420		10.1111/j.1533-2500.2011.00451.x			7	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	840US	WOS:000296467400012	21447077				2022-02-06	
J	Emeriaud, G; Pettersen, G; Ozanne, B				Emeriaud, Guillaume; Pettersen, Geraldine; Ozanne, Bruno			Pediatric traumatic brain injury: an update	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						brain monitoring; decompression surgery; head trauma; hyperoxygenation; hyperventilation; hypothermia; sedation	CEREBRAL-BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; TISSUE OXYGENATION; HYPERTONIC SALINE; ACUTE MANAGEMENT; CARBON-DIOXIDE; CHILDREN; HYPOTHERMIA; THERAPY	Purpose of review The developing brain is particularly vulnerable to traumatic brain injury (TBI), leading to frequent disability or death. This article is an update of the pediatric specificities of TBI management. Recent findings We review the evidences with regards to general management and therapeutic goals to prevent secondary injuries in pediatric TBI patients. Recent controversies in neurocritical care, such as multimodal neuromonitoring, hyperventilation, barbiturate coma, hypothermia, and decompressive surgery, are also highlighted. Summary Many therapeutic modalities in pediatric TBI have a low level of evidence. Further research is needed to establish clear resuscitation goals. Universal objectives may not be suitable for all patients; intensive neuromonitoring may help in identifying individual therapeutic goals and guiding the selection of treatments.	[Emeriaud, Guillaume; Pettersen, Geraldine; Ozanne, Bruno] Univ Montreal, CHU Sainte Justine, Pediat Intens Care Unit, Montreal, PQ H3T 1C5, Canada		Emeriaud, G (corresponding author), Univ Montreal, CHU Sainte Justine, Pediat Intens Care Unit, 3175 Chemin Cote Sainte Catherine, Montreal, PQ H3T 1C5, Canada.	guillaume.emeriaud@umontreal.ca		Emeriaud, Guillaume/0000-0001-6405-3054			Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; [Anonymous], 2011, CHILDS NERV SYST; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bauer DF, 2011, J TRAUMA; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Drummond JC, 2008, ANESTHESIOLOGY, V108, P225, DOI 10.1097/01.anes.0000299576.00302.4c; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2010, PEDIATR CRIT CARE ME, V11, P325, DOI 10.1097/PCC.0b013e3181b80a8e; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Fox JL, 2010, CAN J EMERG MED, V12, P355; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Javouhey E, 2009, PEDIATR CRIT CARE ME, V10, P472, DOI 10.1097/PCC.0b013e318198b1cb; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Martinon C, 2011, PEDIATR CRIT CARE ME, V12, P65, DOI 10.1097/PCC.0b013e3181e2a244; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Morrow SE, 2010, SEMIN PEDIATR SURG, V19, P279, DOI 10.1053/j.sempedsurg.2010.07.001; Murad A, 2008, ACT NEUR S, V102, P89, DOI 10.1007/978-3-211-85578-2_18; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ogawa Y, 2008, ANESTHESIOLOGY, V109, P642, DOI 10.1097/ALN.0b013e3181862a33; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Wang HK, 2011, INJURY IN PRESS; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040	81	5	5	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	JUN 11	2011	24	3					307	313		10.1097/ACO.0b013e3283466b6b			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	755XV	WOS:000289974800011	21494129				2022-02-06	
J	Bianco, M; Ferri, M; Fabiano, C; Giorgiano, F; Tavella, S; Manili, U; Faina, M; Palmieri, V; Zeppilli, P				Bianco, M.; Ferri, M.; Fabiano, C.; Giorgiano, F.; Tavella, S.; Manili, U.; Faina, M.; Palmieri, V.; Zeppilli, P.			Baseline simple and complex reaction times in female compared to male boxers	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Brain injuries; Neurological impairment; Executive function; Brain concussion	SEX-DIFFERENCES; FOOTBALL PLAYERS; MEDICAL ASPECTS; VERBAL MEMORY; CONCUSSION; PERFORMANCE; AMATEUR	Aim. The aim of the study was to compare baseline cognitive performance of female in respect to male amateur boxers. Methods. Study population included 28 female amateur boxers. Fifty-six male boxers, matched for age, employment and competitive level to female athletes, formed the control group. All boxers had no history of head concussions (except boxing). Each boxer was requested to: 1) fulfill a questionnaire collecting demographic data, level of education, occupational status, boxing record and number of head concussions during boxing; 2) undergo a baseline computerized neuropsychological (NP) test (Cog Sport) measuring simple and complex reaction times (RT). Results. Female were lighter than male boxers (56+/-7 vs. 73.1+/-9.8 kg, P<0.0001). No significant differences at Cog-Sport scores were observed between groups. Male boxers showed a longer simple-RT at the end of the NP battery than at the beginning (0.247+/-0.007 vs. 0.243+/-0.007 s, P=0.02), however, with a significant lower rate of mistakes (0.7+/-1.6 vs. 2.0+/-3.1%, P=0.005), observed also in the female group (0.5+/-1.1 vs. 2.2+/-3.0%, P=0.005). No boxing activity parameter (record, number of knock-outs, etc.) correlated with NP scores. Conclusion. Female and male Olympic-style boxers have no (or minimal) differences in baseline cognitive performance. Further research with larger series of female boxers is required to confirm these findings.	[Bianco, M.] Catholic Univ, Sports Med Dept, Internal Med & Geriatr Inst, I-00168 Rome, Italy; [Bianco, M.] Italian Boxing Federat, Med Commiss, Rome, Italy; [Tavella, S.; Manili, U.; Faina, M.] Natl Italian Olymp Comm, Sports Med & Sci Inst, Rome, Italy		Bianco, M (corresponding author), Catholic Univ, Sports Med Dept, Internal Med & Geriatr Inst, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	massimiliano.bianco@fastwebnet.it	Bianco, Massimiliano/M-9907-2019; Zeppilli, Paolo/AAA-8877-2019	Bianco, Massimiliano/0000-0002-0587-5899; Zeppilli, Paolo/0000-0002-5228-3634; TAVELLA, Sofia/0000-0002-2310-9944; Palmieri, Vincenzo/0000-0002-4478-4033			Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; BETTI O O, 1969, Acta Neurologica Latinoamericana, V15, P47; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Bianco M, 2008, PHYSICIAN SPORTSMED, V36, P95, DOI 10.3810/psm.2008.12.17; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brown CN, 2003, J ATHL TRAINING, V38, pS24; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Decreto del Ministero della Salute della Repubblica Italiana, 2005, GAZZETTA UFFICI 0824, V196, P196; Decreto del Ministero della Salute della Repubblica Italiana, 1982, GAZZETTA UFFICI 0305, V63, P62; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Kimura D, 2002, PSYCHOL REP, V91, P1137, DOI 10.2466/PR0.91.7.1137-1142; LEWIS RS, 1987, BRAIN COGNITION, V6, P142, DOI 10.1016/0278-2626(87)90115-1; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maki PM, 2001, AM J PSYCHIAT, V158, P227, DOI 10.1176/appi.ajp.158.2.227; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Massimiliano B, 2011, BRIT J SPORT MED, V45, P563, DOI 10.1136/bjsm.2009.061135; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; STEWART WF, 1995, BOXING MED, P33; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	31	5	5	1	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	JUN	2011	51	2					292	298					7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	816IY	WOS:000294593100016	21681165				2022-02-06	
J	Fahim, DK; Luo, L; Patel, AJ; Robertson, CS; Gopinath, SP				Fahim, Daniel K.; Luo, Lan; Patel, Akash J.; Robertson, Claudia S.; Gopinath, Shankar P.			Pulmonary Embolus from Acute Superior Sagittal Sinus Thrombosis Secondary to Skull Fracture: Case Report	NEUROSURGERY			English	Article						Pulmonary embolus; Traumatic superior sagittal sinus thrombosis	CEREBRAL VEIN-THROMBOSIS; HEAD-INJURY; TRAUMA; THROMBOEMBOLISM	BACKGROUND AND IMPORTANCE: Pulmonary embolus (PE) occurring concurrent with-and as a result of-traumatic superior sagittal sinus thrombosis (SSST) has never before been reported. We report the first case of a patient who presented with acute traumatic SSST and concomitant PE. CLINICAL PRESENTATION: A 30-year-old man presented with altered mental status after a motorcycle collision, and subsequently developed respiratory distress. Computed tomography (CT) scanning of the head revealed multiple calvarial and skull base fractures, contusions, and hemorrhages. Air was noted within the superior sagittal sinus, indicating a fracture involving the sinus and suggesting thrombus formation. A chest CT scan obtained at the time of presentation revealed a PE in the right pulmonary artery. The patient had no personal or family history of hypercoagulability, and all coagulation study results were within normal limits. Work-up revealed no evidence of long bone fractures or deep venous thrombosis. Initial intervention involved placement of an external ventricular drain, brain tissue oxygen saturation probe, internal jugular venous oxygen saturation monitor, arterial line, and central venous line with extensive treatment of all abnormal values according to established standards. Ultimately, pentobarbital coma was initiated for persistently elevated intracranial pressure (ICP) refractory to conservative measures. Aggressive pulmonary resuscitation was required to maintain adequate oxygenation. Anticoagulation was begun 3 weeks after admission. CONCLUSION: Our patient had good neurological recovery. This report highlights the possibility of acute PE in the setting of traumatic SSST.	[Fahim, Daniel K.; Luo, Lan; Patel, Akash J.; Robertson, Claudia S.; Gopinath, Shankar P.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Fahim, DK (corresponding author), Baylor Coll Med, Dept Neurosurg, 1709 Dryden Rd,Suite 750, Houston, TX 77030 USA.	fahim@bcm.edu		Luo, Lan/0000-0002-1314-4367			CRIMMINS TJ, 1984, J NEUROSURG, V60, P179, DOI 10.3171/jns.1984.60.1.0179; Daligic A, 2008, TURK NEUROSURG, V18, P70; DIAZ JM, 1992, ACTA NEUROL SCAND, V86, P390, DOI 10.1111/j.1600-0404.1992.tb05106.x; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Matsushige T, 2009, J TRAUMA, V66, P1599, DOI 10.1097/TA.0b013e3181a3a8e6; Page RB, 2004, NEUROSURGERY, V54, P143, DOI 10.1227/01.NEU.0000097514.60813.1B; SALVATI CA, 1990, HEADACHE, V30, P650, DOI 10.1111/j.1526-4610.1990.hed3010650.x; SCHELL CL, 1988, WESTERN J MED, V149, P304; Schultz DJ, 2004, J TRAUMA, V56, P727, DOI 10.1097/01.TA.0000119687.23542.EC; Sipahi T, 2004, J PEDIAT HEMATOL ONC, V26, P754, DOI 10.1097/00043426-200411000-00013; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Tamimi A, 2005, PEDIATR NEUROSURG, V41, P237, DOI 10.1159/000087480; Tanaka H, 2004, NEUROL SURG TOKYO, V32, P753; TuttleNewhall JE, 1997, J TRAUMA, V42, P90, DOI 10.1097/00005373-199701000-00016; VOGL TJ, 1994, AM J ROENTGENOL, V162, P1191, DOI 10.2214/ajr.162.5.8166009; WANG PY, 1995, NEURORADIOLOGY, V37, P447	19	5	6	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2011	68	6					E1756	E1760		10.1227/NEU.0b013e3182171439			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	760CK	WOS:000290299700013	21389895				2022-02-06	
J	Rimmele, T; Bishop, J; Simon, P; Carter, M; Kong, L; Lee, M; Singbartl, K; Kellum, JA				Rimmele, Thomas; Bishop, Jeffrey; Simon, Peter; Carter, Melinda; Kong, Lan; Lee, Minjae; Singbartl, Kai; Kellum, John A.			What Blood Temperature for an Ex Vivo Extracorporeal Circuit?	ARTIFICIAL ORGANS			English	Article						Blood temperature; Cytokines; Ex vivo extracorporeal circuit; Inflammation; Leukocyte surface markers	TRAUMATIC BRAIN-INJURY; STAGE RENAL-DISEASE; NF-KAPPA-B; CARDIOPULMONARY BYPASS; MODERATE HYPOTHERMIA; ACTIVATION; ADSORPTION; REMOVAL; MODEL; INFLAMMATION	Ex vivo circuits are commonly used to evaluate biomaterials or devices used for extracorporeal blood purification. However, various aspects of the ex vivo circuit, apart from the circuit materials, may affect inflammation and coagulation. One such aspect is temperature. The aim of this study was to evaluate the influence of different blood temperature conditions on inflammation parameters in an ex vivo circuit. Blood was collected from 20 healthy volunteers and run through three different experimental conditions for 4 h: a miniaturized ex vivo extracorporeal circuit equipped with a blood warmer set to 37 C, the same circuit without the warmer (23 C), and a tube placed in an incubator at 37 C (no circuit). We measured the granulocyte macrophage colony-stimulating factor, the tumor necrosis factor, and the interleukin (IL)-1 beta, IL-6, IL-8, and IL-10 concentrations at baseline, 15, 60, 120, and 240 min. Human leukocyte antigen (HLA)-DR, CD11b, CD11a, CD62L, tumor necrosis factor alpha converting enzyme, annexin V expression, and NFkB DNA binding were measured in monocytes and polymorphonuclear neutrophils (PMNs) using flow cytometry at baseline, 120 min, and 240 min. While cytokine production over time was very slight at room temperature, levels increased by more than 100-fold in the two heated conditions. Differences in the expression of some surface markers were also observed between the room temperature circuit and the two heated conditions (CD11b PMN, P < 0.0001; HLA-DR Mono, P = 0.0019; and CD11a PMN, P < 0.0001). Evolution of annexin V expression was also different over time between the three groups (P = 0.0178 for monocytes and P = 0.0011 for PMNs). A trend for a greater NFkB DNA binding was observed in the heated conditions. Thus, for ex vivo studies using extracorporeal circuits, heating blood to maintain body temperature results in significant activation of inflammatory cells while hypothermia (room temperature) seems to suppress the leukocyte response. Both strategies may lead to erroneous conclusions, possibly masking some specific effects of the device being studied. Investigators in this field must be aware of the fact that blood temperature is a crucial confounding parameter and the type of "background noise" they will face depending on the strategy adopted.	[Rimmele, Thomas; Bishop, Jeffrey; Simon, Peter; Carter, Melinda; Kong, Lan; Lee, Minjae; Singbartl, Kai; Kellum, John A.] Univ Pittsburgh, Med Ctr, CRISMA Lab, Dept Crit Care Med, Pittsburgh, PA 15261 USA		Kellum, JA (corresponding author), Univ Pittsburgh, Med Ctr, CRISMA Lab, Dept Crit Care Med, 604 Scaife Hall,3550Terrace St, Pittsburgh, PA 15261 USA.	Kellumja@ccm.upmc.edu	Kellum, John/AAP-3072-2020; Lee, MinJae/AAK-1972-2020	Kellum, John/0000-0003-1995-2653; Lee, MinJae/0000-0002-4329-506X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HL080926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL080926] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grant NHLBI #1R01HL080926.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aldea GS, 1998, ANN THORAC SURG, V65, P425, DOI 10.1016/S0003-4975(97)01347-7; Bouchard J, 2008, NEPHRON PHYSIOL, V109, pP85, DOI 10.1159/000142941; Clark WR, 2002, J AM SOC NEPHROL, V13, pS41; Cole L, 2004, INT J ARTIF ORGANS, V27, P388, DOI 10.1177/039139880402700507; Cole L, 2002, NEPHROL DIAL TRANSPL, V17, P1950, DOI 10.1093/ndt/17.11.1950; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Courtney JM, 1999, PERFUSION-UK, V14, P263, DOI 10.1177/026765919901400405; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; ELHABBAL MH, 1995, CARDIOVASC RES, V29, P102, DOI 10.1016/0008-6363(96)88553-1; Guillevin L, 2003, THER APHER DIAL, V7, P155, DOI 10.1046/j.1526-0968.2003.00036.x; Haase M, 2008, INT J ARTIF ORGANS, V31, P722, DOI 10.1177/039139880803100806; JANSEN PGM, 1995, J THORAC CARDIOV SUR, V110, P829, DOI 10.1016/S0022-5223(95)70117-6; Kato A, 2002, AM J PHYSIOL-GASTR L, V282, pG608, DOI 10.1152/ajpgi.00454.2001; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Straaten HMOV, 2007, CURR OPIN CRIT CARE, V13, P635, DOI 10.1097/MCC.0b013e3282f161b2; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tetta C, 1998, NEPHROL DIAL TRANSPL, V13, P1458, DOI 10.1093/ndt/13.6.1458; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2002, ASAIO J, V48, P650, DOI 10.1097/00002480-200211000-00013; Ueyama K, 2004, ASAIO J, V50, P369, DOI 10.1097/01.MAT.0000130679.55946.4D; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	27	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	JUN	2011	35	6					593	601		10.1111/j.1525-1594.2010.01147.x			9	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transplantation	781MM	WOS:000291936700007	21314837	Green Accepted			2022-02-06	
J	Gunther, SA; Stegmaier, J; Paul, AO; Biberthaler, P; Mutschler, W; Kanz, KG				Guenther, S. A.; Stegmaier, J.; Paul, A. O.; Biberthaler, P.; Mutschler, W.; Kanz, K. -G.			Mild traumatic brain injury with anticoagulation	NOTFALL & RETTUNGSMEDIZIN			German	Article						Minor head trauma; Traumatic brain injury; Anticoagulation; Complications; Outcome	PREINJURY WARFARIN USE; INTRACRANIAL HEMORRHAGE; HEAD-INJURY; ELDERLY-PATIENTS; MORTALITY; RISK; COMPLICATIONS; ANTIPLATELET; PROPHYLAXIS; ASPIRIN	Traumatic brain injury (TBI) with concomitant anticoagulation (AC) is a common presentation in emergency departments, especially as the average age of the population is rising entailing an increasing number of co-morbidities requiring AC. Although minor head trauma (MHT) under AC is a common entity the literature remains controversial with regard to imaging and treatment. An evidence-based review of the risk of intracranial bleeding (ICB) in MHT under AC was carried out. A systemic analysis of the current literature from 1992 to 2010 listed in Pubmed and Medline was performed using the keywords "minimal, minor or mild traumatic brain injury" in combination with "aspirin, clopidogrel, coumadin, warfarin or coagulopathy". Exclusion criteria comprised spontaneous, non-traumatic ICB and studies including less than 50 patients. A total of 18 studies met the inclusion criteria and revealed that elderly patients under AC suffer more frequently from mild head trauma due to falls. Of these 2 prospective studies dealt with the question of a control cranial computed tomography (CCT) if the initial CCT scan showed no signs of ICB. Regarding treatment 3 studies elaborated therapeutic approaches for patients suffering from ICB under AC. There were 10 studies where it was reported that AC entails an increased risk of developing ICB whereas 4 studies claimed that AC has no impact on ICB evolving after TBI. Due to the fact that the evidence is not consistent regarding the management of TBI under AC a coherent and generally applicable recommendation does not exist. We recommend that a CCT scan should be performed within 30 min after admission for every patient suffering from TBI under AC. Furthermore, patients should be admitted for observation over 48 h for neurological surveillance. It remains controversial if a control CCT needs to be accomplished in patients without neurological deficits before discharge.	[Guenther, S. A.; Stegmaier, J.; Paul, A. O.; Biberthaler, P.; Mutschler, W.; Kanz, K. -G.] Klinikum Univ Munchen, Chirurg Klin & Poliklin, D-80336 Munich, Germany		Gunther, SA (corresponding author), Klinikum Univ Munchen, Chirurg Klin & Poliklin, Campus Innenstadt,Nussbaumstr 20, D-80336 Munich, Germany.	julia.stegmaier@med.uni-muenchen.de					Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; MAEGELE M, 2008, INZIDENZ OUTCOME NAC, V10; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Rickels E, 2011, UNFALLCHIRURG, V114, P417, DOI 10.1007/s00113-010-1872-y; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	20	5	5	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	MAY	2011	14	4					268	274		10.1007/s10049-011-1423-2			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	771OT	WOS:000291171300004					2022-02-06	
J	Santos, SF; Rodrigues, F; Dias, A; Costa, JA; Coreia, A; Oliveira, G				Santos, Sara Figueiredo; Rodrigues, Fernanda; Dias, Andrea; Costa, Jose Augusto; Coreia, Alexandre; Oliveira, Guiomar			POST-TRAUMATIC MENINGITIS IN CHILDREN Eleven Years' Analysis	ACTA MEDICA PORTUGUESA			Portuguese	Article								Introduction: Traumatic brain injury is a frequent reason for admission at pediatric emergency services. In severe cases, with basilar skull fracture, bacterial meningitis is a serious and potentially fatal complication to be considered. Objective: To describe clinical and laboratory features, bacteriology and outcome of children with post-traumatic meningitis, and evaluate the proportion of meningitis in the population who suffered head trauma. Methods and materials: Retrospective review of medical records of children with this diagnosis admitted to a level 3 pediatric hospital in the Central Region of Portugal, contextualized in the evaluation of the number of head injuries, fractures and cerebrospinal fluid leakages, during a 11-year period (January 1999 to December 2009). Results: Four children were identified, corresponding to 0,7% of the children with skull fractures, 4,1% of children with basilar skull fractures and 13,8% of those with documented cerebrospinal fluid leakage. Three were boys, with a median age of 8 years (2-10 years). The median time between head trauma and meningitis was 1,1 years (3 days-3,4 years). In all cases a basilar skull fracture was identified and cerebrospinal fluid leakage documented. Two children required surgery. Streptococcus pneumoniae was the pathogen identified in two cases with positive cerebrospinal fluid culture. One child died and other has post-traumatic peripheral facial palsy. Conclusions: Bacterial meningitis is a complication to be considered in head injury with basilar skull fracture, particularly when associated with cerebrospinal fluid leakage, even though the injury occurred several years earlier, and is usually a serious condition. One of our children died. Similar to what is described, S. pneumoniae was the most common bacteria, and this fact supports that children with head trauma and cerebrospinal fluid leakage should receive pneumococcal vaccine. The follow-up of these children requires constant vigilance and should include a multidisciplinary approach.	[Santos, Sara Figueiredo; Rodrigues, Fernanda; Dias, Andrea; Costa, Jose Augusto; Coreia, Alexandre; Oliveira, Guiomar] Hosp Pediat Coimbra, Unidade Infecciol Pediat, Serv Neurochirurg, Ctr Desenvolvimento Crianca, Coimbra, Portugal		Santos, SF (corresponding author), Hosp Pediat Coimbra, Unidade Infecciol Pediat, Serv Neurochirurg, Ctr Desenvolvimento Crianca, Coimbra, Portugal.		Rodrigues, Fernanda/AAW-4615-2021; Oliveira, Guiomar/I-7255-2013	Dias, Andrea/0000-0001-5102-5388; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; Oliveira, Guiomar/0000-0002-7049-1277			[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1999, AM J HEALTH-SYST PH, V56, P1201; CAVINESS AC, SKULL FRACTURES CHIL; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Kallel H, 2006, NEUROCHIRURGIE, V52, P397, DOI 10.1016/S0028-3770(06)71238-3; Kendirli T, 2006, PEDIATR INT, V48, P91, DOI 10.1111/j.1442-200X.2006.02165.x; Kulkarni MS, 1999, CLIN PEDIAT EMERG ME, V1, P70; LAU YL, 1986, INJURY, V17, P407, DOI 10.1016/0020-1383(86)90082-3; Ragheb J., 2008, PRINCIPLES PRACTICE, P803; Saez-Llorens XM, 2008, PRINCIPLES PRACTICE, P284; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; WILSON NW, 1991, PEDIATR NEUROSURG, V16, P17, DOI 10.1159/000120497	12	5	6	0	8	ORDEM MEDICOS	LISBON	AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL	1646-0758			ACTA MEDICA PORT	Acta Medica Port.	MAY-JUN	2011	24	3					391	398					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889QL	WOS:000300088200002	22015025				2022-02-06	
J	Siranovic, M; Turkovic, TM; Gopcevic, A; Kelecic, M; Kovac, N; Kovac, J; Rode, B; Vucic, M				Siranovic, Mladen; Turkovic, Tihana Magdic; Gopcevic, Aleksandar; Kelecic, Mijo; Kovac, Natasa; Kovac, Josip; Rode, Bojan; Vucic, Marinko			Comparison of ultrasonographic measurement of optic nerve sheath diameter (ONSD) versus direct measurement of intracranial pressure (ICP) in traumatic brain injury patients	SIGNA VITAE			English	Article						ultrasound; ONSD; ICP	HEAD-INJURY; SONOGRAPHY	Aim. To compare ultrasonographic measurement of optic nerve sheath diameter (ONSD) with direct measurement of intracranial pressure (ICF) and evaluate the correlation between them in traumatic brain injury patients. Patients and methods. Twenty traumatic brain injury patients were enrolled in the study. Patients had a median Glasgow Coma Scale (GCS) score of 5. All patients underwent noninvasive measurement of ICP by ultrasonographic measurement of ONSD and invasive ICP measurement using an intra ventricular catheter. We used MedCalc to analyze data. Results. We compared the ONSD measurement in patients with ICP less than 20 cm H2O with patients with ICP greater than 20 cm H2O. The mean ONSD for 8 patients with ICP > 20 cmH2O was 7.6 +/- 0.8 mm, and for 18 patients with ICP < 20 cm H2O was 5.6 +/- 0.6 mm. Student t-test comparison between these two groups showed a statistically significant mean difference of 1.99 (95 % Cl = 1.4-2.6). The ROC curve showed that the optimal cutoff value of ONSD for predicting ICP > 20 cm H2O was 6.1, with sensitivity of 100 % and specificity of 83 %. (the area under the curve was 0.98, 95 % Cl = 0.825-0.990). In this study, the usually used cutoff of ONSD > 5 mm gives a sensitivity of 100 %, but a specificity of only 22 %. Conclusion. Ultrasonographic measurement of ONSD correlates with direct measurement of ICP This method has potential as a screening test for elevated ICP in traumatic brain injury.	[Siranovic, Mladen; Turkovic, Tihana Magdic; Gopcevic, Aleksandar; Kelecic, Mijo; Kovac, Natasa; Kovac, Josip; Rode, Bojan; Vucic, Marinko] Univ Hosp Sestre Milosrdnice, Dept Anesthesiol & Intens Care, Zagreb 10000, Croatia		Turkovic, TM (corresponding author), Univ Hosp Sestre Milosrdnice, Dept Anesthesiol & Intens Care, Vinogradska 29, Zagreb 10000, Croatia.	tihana.magdic@zg.t-com.hr	Kovac, Natasa/H-2008-2017	Kovac, Natasa/0000-0002-8269-6675			Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; GANGEMI M, 1987, NEUROCHIRURGIA, V30, P53; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040	10	5	5	0	2	PHARMAMED MADO LTD	ZAGREB	ZATISJE 8 G, ZAGREB, 10000, CROATIA	1334-5605			SIGNA VITAE	Signa Vitae	APR	2011	6	1					33	35		10.22514/SV61.042011.5			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	797RW	WOS:000293146700005		Green Published			2022-02-06	
J	Bergrath, S; Rortgen, D; Skorning, M; Fischermann, H; Beckers, SK; Mutscher, C; Brokmann, JC; Rossaint, R				Bergrath, S.; Roertgen, D.; Skorning, M.; Fischermann, H.; Beckers, S. K.; Mutscher, C.; Brokmann, J. C.; Rossaint, R.			Emergency mission documentation in simulated care. Video-based error analysis	ANAESTHESIST			German	Article						Documentation; Emergency medical services; Computer simulation; Video recording	MANAGEMENT; QUALITY; PERFORMANCE; SKILLS	Background. The aim of this study was to examine documentation quality in physician staffed emergency medical services (EMS). This study compared simulated on-site care with the associated patient records written by EMS physicians. Methods. For this study two standardized simulated case scenarios, ST segment elevation myocardial infarction (STEMI) and major trauma with traumatic brain injury were designed by an expert committee. Overall 29 EMS teams each consisting of 1 EMS physician and 2 paramedics ran through the scenarios on high fidelity patient simulators and each scenario was videotaped. The scenarios were stopped after 12 min for STEMI and after 14 min for major trauma independent of the actions carried out and each EMS physician then had 10 min to document this initial phase on standardized protocol sheets. The videotaped scenarios were analyzed by two independent investigators. Documentation of predefined contents and all drug dosages were checked against the simulated on-site care. The data were evaluated and classified as correct, incorrect or missing documentation although action performed. Results. Written consent for data analysis was provided by 28 teams. Overall 20 parameters and actions in the STEMI scenario and 16 in the major trauma scenario as well as all drug dosages were evaluated. For the scenario STEMI 469 actions were analyzed of which 271 (58%) were correct, 94 (20%) incorrect and 104 (22%) had missing documentation. A total of 140 medications were administered of which 31 (22%) were documented incorrectly and 14 (10%) were not documented. For major trauma 401 actions were analyzed of which 244 (61%) were correct, 101 (25%) incorrect and 56 (14%) had missing documentation. In this scenario the teams administered 138 medications of which 31 (22%) were documented incorrectly and 16 (12%) were not documented. Infused amounts of crystalloids and colloids were mostly documented correctly in this case (35 correct/6 incorrect/8 not documented). Documentation of several clinical parameters was carried out predominantly correctly, e. g. initial blood pressure (STEMI: 25/2/1, major trauma: 21/4/2) and initial ECG rhythm (STEMI: 27/0/1, major trauma: 26/0/1). Documentation of other clinically relevant parameters was often performed incorrectly: 12-lead ECG in STEMI (5/9/12) and capnometry in major trauma (9/4/7). No team used a pain scale to assess the level of pain in the STEMI scenario but 12 EMS physicians documented an accordant value (numerical rating scale) on the patient records. Furthermore some parameters could be identified where documentation was mostly missing although they were measured, e. g. onset of symptoms in STEMI (5/4/15) and reduced level of consciousness and bradypnea in major trauma (9/2/17). Conclusion. Patient safety can be reduced if relevant preclinical data are not transmitted correctly to the admitting hospital. Therefore there is a need to improve documentation quality in EMS. Electronic documentation, training of EMS staff and quality management programs might offer solutions. Because of the small sample size further studies are needed to evaluate the validity of these results.	[Bergrath, S.; Roertgen, D.; Skorning, M.; Fischermann, H.; Beckers, S. K.; Brokmann, J. C.; Rossaint, R.] Univ Klinikum Aachen, Rheinisch Westfal Tech Hsch RWTH, Lehrstuhl & Klin Anasthesiol, D-52074 Aachen, Germany; [Mutscher, C.] Univ Klinikum Aachen, Rheinisch Westfal Tech Hsch RWTH, Inst Med Stat, D-52074 Aachen, Germany; [Brokmann, J. C.] Berufsfeuerwehr Aachen, Aachen, Germany		Bergrath, S (corresponding author), Univ Klinikum Aachen, Rheinisch Westfal Tech Hsch RWTH, Lehrstuhl & Klin Anasthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sbergrath@ukaachen.de	Beckers, Stefan K/C-6776-2011; Fitzner, Christina/H-6431-2013; Beckers, Stefan K./O-2943-2019	Beckers, Stefan K/0000-0002-2896-7948; Beckers, Stefan K./0000-0002-2896-7948			Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Barsuk D, 2005, ANESTH ANALG, V100, P803, DOI 10.1213/01.ane.0000143390.11746.CF; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; *BUND, 1996, DTSCH ARZTEBL, V93, P2201; Eden KB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.004; Gordon JA, 2003, ACAD MED, V78, pS45, DOI 10.1097/00001888-200310001-00015; Grmec S, 2001, CRIT CARE, V5, P19; Helm M, 2007, ANAESTHESIST, V56, P877, DOI 10.1007/s00101-007-1215-8; Helm M, 2009, ANAESTHESIST, V58, P24, DOI 10.1007/s00101-008-1435-6; Marshall RL, 2001, J TRAUMA, V51, P17, DOI 10.1097/00005373-200107000-00003; MESSELKEN M, 2005, NOTFALL RETTUNGSMED, V8, P476; MESSELKEN M, 2001, NOTFALL RETTUNGSMED, V4, P408; MOECKE H, 2004, NOTFALL RETTUNGSMED, V7, P259; MOECKE HP, 1994, ANAESTHESIST, V43, P257, DOI 10.1007/s001010050056; Moore L, 2006, J TRAUMA, V61, P718, DOI 10.1097/01.ta.0000197906.28846.87; Murray DJ, 2007, ANESTHESIOLOGY, V107, P705, DOI 10.1097/01.anes.0000286926.01083.9d; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Rehn M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-1; ROHRIG R, 2010, ANASTH INTENSIVMED, V51, P119; Sandberg WS, 2008, ANESTH ANALG, V106, P192, DOI 10.1213/01.ane.0000289640.38523.bc; Skorning M, 2009, ANAESTHESIST, V58, P285, DOI 10.1007/s00101-008-1502-z; SKORNING M, 2009, NOTFALL RETTUNGSM S1, V12, P12; Th Schlechtriemen, 2003, NOTFALL RETTUNGSMED, V6, P175, DOI DOI 10.1007/S10049-003-0561-6; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Wik L, 2002, RESUSCITATION, V52, P273, DOI 10.1016/S0300-9572(01)00476-2	26	5	6	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	MAR	2011	60	3					221	229		10.1007/s00101-010-1790-y			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	746IM	WOS:000289238600004	20852833				2022-02-06	
J	Frohlich, S; Johnson, P; Moriarty, J				Frohlich, S.; Johnson, P.; Moriarty, J.			Prevalence, management and outcomes of traumatic brain injury patients admitted to an Irish intensive care unit	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Traumatic brain injury; Intracranial pressure monitoring; Neurosurgery; Outcomes	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; GUIDELINES	Traumatic brain injury is one of the leading causes of death and disability among young people. However outcomes from traumatic brain injury can be improved by use of parameters such as intracranial pressure monitoring (ICP) to guide treatment, early surgical intervention and management of these patients in a neurosurgical centre. To examine the incidence of traumatic brain injury, compliance with best practice guidelines and outcomes in patients admitted to an intensive care unit in a major teaching hospital in Ireland. Retrospective chart review. Forty-six patients were admitted over a 3-year period, half of whom had GCS < 8. Medical management was appropriate but only two patients were transferred to a neurosurgical centre and none received ICP monitoring. Overall mortality of 37% was higher than international norms. Irish patients with severe head injury do not currently receive care in accordance with international evidence-based guidelines.	[Frohlich, S.] Mater Misercordiae Hosp, Natl SpR Acad Fellowship Programme, Dublin 7, Ireland; [Johnson, P.] Our Ladies Hosp Sick Children, Dublin 12, Ireland; [Moriarty, J.] St James Univ Hosp, Dublin 8, Ireland		Frohlich, S (corresponding author), Mater Misercordiae Hosp, Natl SpR Acad Fellowship Programme, Dublin 7, Ireland.	frohlics@yahoo.co.uk					Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; HERSDORFFER DC, 2002, J TRAUMA, V52, P1202; Lu J, 2005, ACT NEUR S, V95, P281; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; PALMER S, 2001, J TRAUMA, V51, P369; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Royal College of Surgeons of England and the British Orthopaedic Society, 2000, BETT CAR SEV INJ; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	24	5	5	0	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAR	2011	180	2					423	427		10.1007/s11845-011-0674-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753SN	WOS:000289800100019	21312002				2022-02-06	
J	Graf, J; Kulke, H; Sous-Kulke, C; Schupp, W; Lautenbacher, S				Graf, Julia; Kulke, Hartwig; Sous-Kulke, Christa; Schupp, Wilfried; Lautenbacher, Stefan			Effects of an Attention Training on the Aphasic Symptomatology in Stroke Patients	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article						selective attention; neuroplasticity; aphasia; computer based training; rehabilitation	TRAUMATIC BRAIN-INJURY; EFNS TASK-FORCE; COGNITIVE REHABILITATION; MOTOR IMAGERY; DEFICITS; REORGANIZATION; PLASTICITY; GUIDELINES; DISORDERS; RECOVERY	Attention is a control-system of neuronal activity, which modulates neuroplasticity. Attempts to promote functional recovery after brain injury by improving attention have been infrequent. We tested this idea on aphasic patients. 15 stroke patients participated in a training of selective attention (PC programs CogniPlus and "Konzentration"; ca. 15 sessions over 3 weeks complementing standard therapy), whereas 13 further patients served as controls. Training effects were evaluated using the Go/Nogo test (2 versions; TAP) and the Kurze Aphasieprufung. The training did not produce group differences in attention and aphasia and appeared ineffective under the given circumstances. However, the patients, who showed most attentional improvement, exhibited - as trend - fewest aphasic symptoms, supporting partially the hypothesis of plasticity modulation by attention.	[Graf, Julia; Lautenbacher, Stefan] Otto Friedrich Univ Bamberg, Abt Physiol Psychol, DE-96049 Bamberg, Germany; [Graf, Julia] Neurol Rehabil Zentrum Quellenhof, Bad Wildbad, Germany; [Kulke, Hartwig; Sous-Kulke, Christa; Schupp, Wilfried] Fachklinink Herzogenaurach, Herzogenaurach, Germany		Lautenbacher, S (corresponding author), Otto Friedrich Univ Bamberg, Abt Physiol Psychol, Markuspl 3, DE-96049 Bamberg, Germany.	stefan.lautenbacher@uni-bamberg.de					Cantagallo, 2003, Z NEUROPSYCHOL, V14, P283, DOI [10.1024/1016-264X.14.4.283, DOI 10.1024/1016-264X.14.4.283]; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J, 1977, STAT POWER ANAL BEHA; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Demir SO, 2006, BRAIN INJURY, V20, P1383, DOI 10.1080/02699050601081844; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; LANG C, 2006, KURZE APHASIEPRUFUNG; Leclercq M, 2002, APPL NEUROPSYCHOLOGY; Marsh EB, 2006, PROG BRAIN RES, V157, P143, DOI 10.1016/S0079-6123(06)57009-8; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; Page S J, 2001, Top Stroke Rehabil, V8, P54; Paolucci S, 2005, CEREBROVASC DIS, V20, P400, DOI 10.1159/000088671; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; *PETR RIGL REH SER, 2008, SOFTW VERB KONZ AUGM; Plohmann AM, 1998, J NEUROL NEUROSUR PS, V64, P455, DOI 10.1136/jnnp.64.4.455; POGGEL D, 2002, EFFEKTIVE NEUROPSYCH, P67; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Poggel DA, 2006, BRAIN RES, V1097, P142, DOI 10.1016/j.brainres.2006.04.011; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Posner M.I., 1987, NEUROPSYCHOLOGICAL R, P182; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; Raymer AM, 2008, J SPEECH LANG HEAR R, V51, pS259, DOI 10.1044/1092-4388(2008/020); RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROBERTSON H, 1997, NEUROPSYCHOLOGY, V11, P290; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; *ROT LIST SERV GMB, 2009, ROT LIST 2009 ARZN D; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Stroop R. J., 1935, J EXP PSYCHOL, V18, P643, DOI [10.1037/h0054651, DOI 10.1037/H0054651]; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Sturm W, 1996, EUR REV APPL PSYCHOL, V46, P207; Sturm W., 2005, AUFMERKSAMKEITSSTORU; STURM W, 2007, COGNIPLUS VERSION 1; Sturm W., 1994, Z NEUROPSYCHOL, V5, P15; Sturm W, 2009, Z NEUROPSYCHOL, V20, P59, DOI 10.1024/1016-264X.20.1.59; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Zimmermann P, 2002, TESTBATTERIE AUFMERK	42	5	5	0	7	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X			Z NEUROPSYCHOL	Z. Neuropsychol.	MAR	2011	22	1					21	32		10.1024/1016-264X/a000027			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	756ZY	WOS:000290054600003					2022-02-06	
J	Kreipke, CW; Rafols, JA; Reynolds, CA; Schafer, S; Marinica, A; Bedford, C; Fronczak, M; Kuhn, D; Armstead, WM				Kreipke, Christian W.; Rafols, Jose A.; Reynolds, Christian A.; Schafer, Steven; Marinica, Alex; Bedford, Christopher; Fronczak, Michael; Kuhn, Donald; Armstead, William M.			RETRACTED: Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury (Retracted article. See vol. 39, pg. 472, 2017)	NEUROLOGICAL RESEARCH			English	Article; Retracted Publication						Drug therapy; Endothelin; Microcirculation	SUPEROXIDE GENERATION; RESPONSES; PHARMACOLOGY; MODEL	Objectives: The purpose of this study was to test the efficacy of a novel endothelin receptor A antagonist on blood flow and behavioral outcome given 30 minutes following traumatic brain injury. Methods: Male Sprague-Dawley rats (400-450 g) were used in this study. All animals were scanned for initial blood flow using arterial spin labeling magnetic resonance imaging (n=72 total). Half were subjected to traumatic brain injury using a weight acceleration impact device (n=36 total). Sham operated animals were used as control (n=36 total). Thirty minutes following traumatic brain injury, animals were given one intravenous injection of vehicle (0.9% saline) or 1.0 mg/kg clazosentan, a novel endothelin receptor A antagonist, for a total of four groups. At 4, 24, and 48 hours post-traumatic brain injury, blood flow determination continued. On the second day post-traumatic brain injury/sham operation, behavioral testing commenced using a radial arm maze to assess cognitive function. Results: Our results indicate that 1.0 mg/kg clazosentan was effective in ameliorating hypoperfusion seen after traumatic brain injury. Saline had no effect. Furthermore, clazosentan treatment was effective in significantly improving behavioral outcome following traumatic brain injury. Conclusion: Collectively, these results indicate that clazosentan, given at 30 minutes post-traumatic brain injury, is effective in improving outcome following injury.	[Kreipke, Christian W.; Rafols, Jose A.; Reynolds, Christian A.; Schafer, Steven; Marinica, Alex; Bedford, Christopher; Fronczak, Michael] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Kreipke, Christian W.; Rafols, Jose A.; Kuhn, Donald] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA; [Kuhn, Donald] Wayne State Univ, Sch Med, Dept Psychiat, Detroit, MI 48201 USA; [Armstead, William M.] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA		Kreipke, CW (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	ckreipke@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS064976]; Department of Veterans AffairsUS Department of Veterans Affairs [RX000224]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064976] Funding Source: NIH RePORTER	This work was supported by grants from National Institutes of Health (no. NINDS NS064976) and a Department of Veterans Affairs Rehabilitation Research & Development Merit Award (no. RX000224) to Christian Kreipke. The authors wish to thank Actelion for generously providing clazosentan. We would also like to thank Dr E. Mark Haacke and Dr Yimen Shen for their assistance in using arterial spin labeling-magnetic resonance imaging to measure blood flow.	Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 2001, J NEUROTRAUM, V18, P1039, DOI 10.1089/08977150152693737; Benigni A, 1999, LANCET, V353, P133, DOI 10.1016/S0140-6736(98)09423-9; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Dawson DA, 1999, NEUROCHEM RES, V24, P1499, DOI 10.1023/A:1021139713026; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GORLACH C, 2001, PFLUGERS ARCH, V44, P844; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; Kreipke CW, 2010, NEUROL RES, V32, P209, DOI 10.1179/174313209X414515; Krum Henry, 2003, Curr Opin Investig Drugs, V4, P298; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Luscher T F, 1995, Agents Actions Suppl, V45, P237; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; Povlishock JT, 2008, J NEUROTRAUM, V25, P717, DOI 10.1089/neu.2008.9964; Rafols JA, 2007, NEUROL RES, V29, P337, DOI 10.1179/016164107X204639; REYNOLDS CA, 2010, NEUROL RES IN PRESS; Roux S, 1997, J PHARMACOL EXP THER, V283, P1110; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Uhlmann D, 2006, CURR OPIN INVEST DR, V7, P272	25	5	5	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					208	213		10.1179/016164111X12881719352570			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600014	21801597				2022-02-06	
J	Reynolds, CA; Schafer, S; Pirooz, R; Marinica, A; Chbib, A; Bedford, C; Fronczak, M; Rafols, JA; Kuhn, D; Kreipke, CW				Reynolds, Christian A.; Schafer, Steven; Pirooz, Ryan; Marinica, Alex; Chbib, Ali; Bedford, Christopher; Fronczak, Michael; Rafols, Jose A.; Kuhn, Donald; Kreipke, Christian W.			Differential effects of endothelin receptor A and B antagonism on behavioral outcome following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Cognition; Microcirculation; Endothelin	RESPONSES	Objectives: Previously we have reported that endothelin receptor A and B antagonists elicit differential effects on cerebral blood flow and cellular damage. In summary, endothelin receptor A antagonists restore microcirculation and diminish cellular damage after injury, while endothelin receptor B antagonists had no effect on either parameter. However, what is not known is the effect of either antagonist on behavioral outcome. Therefore, this work was designed to test the effects of endothelin receptor A and B antagonism on behavioral outcome following traumatic brain injury (TBI). Methods: A total of 48 male Sprague-Dawley rats (400-450 g) were used in this study. Four groups (n=12 per group) were generated as follows: sham operation, trauma+vehicle (0.9% saline), trauma+40 nmol BQ-123 (a selective endothelin receptor A antagonist) and trauma +20 nmol BQ-788 (a selective endothelin receptor B antagonist). All treatments were delivered via intracerebroventricular injection. Trauma was induced using a weight acceleration impact device. Twenty-four hours post-injection animals were tested for 21 days on a radial arm maze task to determine cognitive outcome. Results: Our data indicated that endothelin receptor A antagonism significantly reduced the extent of behavioral deficits following TBI while endothelin receptor B and vehicle injection had no effect. Conclusion: The results suggest that endothelin receptor A, but not endothelin receptor B, antagonism improves behavioral outcome following TBI. Furthermore, these data provide a functional correlate to previously published findings in our laboratory showing that endothelin receptor A antagonism improves both blood flow and cellular outcome following TBI. In a broader sense, this work demonstrates that hypoperfusion following TBI likely contributes to poor outcome following head injury.	[Reynolds, Christian A.; Schafer, Steven; Pirooz, Ryan; Marinica, Alex; Chbib, Ali; Bedford, Christopher; Fronczak, Michael; Rafols, Jose A.; Kreipke, Christian W.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Rafols, Jose A.; Kuhn, Donald; Kreipke, Christian W.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA; [Kuhn, Donald] Wayne State Univ, Sch Med, Dept Psychiat, Detroit, MI 48201 USA		Kreipke, CW (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	ckreipke@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS064976]; VA Rehabilitation Research & Development Merit Award [RX000224]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064976] Funding Source: NIH RePORTER	This work was supported by grants from National Institutes of Health (no. NINDS NS064976) and a VA Rehabilitation Research & Development Merit Award (no. RX000224) to Christian Kreipke.	Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 2001, J NEUROTRAUM, V18, P1039, DOI 10.1089/08977150152693737; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Kallakuri S, 2007, NEUROL RES, V29, P362, DOI 10.1179/016164107X204675; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; Kreipke CW, 2010, NEUROL RES, V32, P209, DOI 10.1179/174313209X414515; Pollock DM, 2006, HYPERTENSION, V48, P211, DOI 10.1161/01.HYP.0000229908.62191.6e; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Uomoto JM, 2008, NEUROREHABILITATION, V23, P415	11	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					197	200		10.1179/016164111X12881719352499			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600012	21801595				2022-02-06	
J	Romesser, J; Shen, SY; Reblin, M; Kircher, J; Allen, S; Roberts, T; Marchand, WR				Romesser, Jennifer; Shen, Shuying; Reblin, Maija; Kircher, John; Allen, Steven; Roberts, Toni; Marchand, William R.			A Preliminary Study of the Effect of a Diagnosis of Concussion on PTSD Symptoms and Other Psychiatric Variables at the Time of Treatment Seeking Among Veterans	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; POSTCONCUSSIVE SYMPTOMS; MISSISSIPPI SCALE; SHORT-FORM; MILD; IRAQ; RELIABILITY; AFGHANISTAN	The aim of this study was to assess whether a diagnosis of concussion given at a Veterans Healthcare Administration secondary traumatic brain injury assessment impacted either posttraumatic stress disorder (PTSD) symptomatology or other variables at the time veterans sought treatment for PTSD. This retrospective study compared 61 male veterans with a history of military-related concussion and military-related PTSD to 83 male veterans with military-related PTSD but without a diagnosis of military-related concussion. There were no significant between-group differences in PTSD symptomatology. However, the cohort with a history of military concussion endorsed decreased ability to cope with PTSD symptoms, increased problems with physical health, and more pain complaints. If replicated, these results may guide the design of more effective interventions for veterans who receive diagnoses of PTSD and concussion.	[Romesser, Jennifer; Shen, Shuying; Reblin, Maija; Allen, Steven; Roberts, Toni; Marchand, William R.] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Romesser, Jennifer; Shen, Shuying; Kircher, John; Allen, Steven; Roberts, Toni; Marchand, William R.] Univ Utah, Salt Lake City, UT 84112 USA; [Marchand, William R.] Univ Utah, Inst Brain, Salt Lake City, UT 84108 USA		Romesser, J (corresponding author), George E Wahlen Vet Affairs Med Ctr, 500 Foothill, Salt Lake City, UT 84148 USA.			Reblin, Maija/0000-0003-3108-465X	Department of Veterans Affairs (Marchand)US Department of Veterans Affairs	This work was supported by a Department of Veterans Affairs Career Development Award (Marchand) and resources and the use of facilities at the VA Salt Lake City Health Care System.	BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Dirkzwager AJE, 2007, PSYCHOSOM MED, V69, P435, DOI 10.1097/PSY.0b013e318052e20a; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; FONTANA A, 1994, J TRAUMA STRESS, V7, P407, DOI 10.1002/jts.2490070306; Forcehimes AA, 2007, ADDICT BEHAV, V32, P1699, DOI 10.1016/j.addbeh.2006.11.009; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; HYER L, 1991, J CLIN PSYCHOL, V47, P510, DOI 10.1002/1097-4679(199107)47:4<510::AID-JCLP2270470407>3.0.CO;2-F; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LEHMAN AF, 1988, EVAL PROGRAM PLANN, V11, P51, DOI 10.1016/0149-7189(88)90033-X; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wichern DW., 2007, APPL MULTIVARIATE ST, V6	39	5	5	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2011	176	3					246	252		10.7205/MILMED-D-10-00056			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825BN	WOS:000295246000003	21456348	Bronze			2022-02-06	
J	Singer, AJ; Wang, E; Taira, BR; Steinhauff, N; Rooney, J; Zimmerman, T				Singer, Adam J.; Wang, Eric; Taira, Breena R.; Steinhauff, Nicole; Rooney, Jean; Zimmerman, Thomas			Controlled Mild Hypothermia Prolongs Survival in a Rat Model of Large Scald Burns	ACADEMIC EMERGENCY MEDICINE			English	Article							FIRST-AID TREATMENT; HOSPITAL CARDIAC-ARREST; EDEMA FORMATION; THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS; TRAUMA PATIENTS; INJURY; WATER; COAGULOPATHY; IMMEDIATE	Objectives: Early surface cooling of burns reduces pain and depth of injury and improves healing. However, there are concerns that cooling of large burns may result in hypothermia and worsen outcomes. In contrast, controlled mild hypothermia improves outcomes after cardiac arrest and traumatic brain injury. The authors hypothesized that controlled mild hypothermia would prolong survival in a rat model of large scald burns. Methods: Thirty-six Sprague-Dawley rats (250-300 g) were anesthetized with 40 mg/kg intramuscular ketamine and 5 mg/kg xylazine, with supplemental inhalational isoflurane as needed. A single full-thickness scald burn covering 40% of total body surface area was created on each of the rats using a Mason-Walker template placed in boiling water (100 degrees C) for a period of 10 seconds. The rats were then randomized to hypothermia (n = 18) or no hypothermia (n = 18). Core body temperature was continuously monitored with a rectal temperature probe. In the experimental group, mild hypothermia was induced by applying ice packs over the prone rats until their rectal temperature was reduced by 2 degrees C for a period of 2 hours. After 2 hours of hypothermia, the rats were rewarmed back to their baseline temperature with a heating pad. The control rats were not cooled. The rats were monitored until death or for a period of 7 days, whichever was greater. The primary outcome was time to death. The difference in survival between the groups was determined using Kaplan-Meier analysis and the log-rank test. Results: Hypothermia was induced in all experimental rats within a mean of 22 minutes (95% confidence interval [CI] = 17 to 27). The numbers of nonhypothermic and hypothermic rats that were dead at each time point were as follows: 2 hours, five versus none; 18 hours, 16 versus five; 24 hours, 18 versus eight; and 48 hours, 18 versus 13 (p = 0.05). There were no additional deaths after 48 hours. The mean time to survival of the hypothermic rats was significantly greater than that of the nonhypothermic rats (p < 0.001). Conclusions: Induction of brief, mild hypothermia prolongs survival and increases the survival rate in nonresuscitated rats with large scald burns. ACADEMIC EMERGENCY MEDICINE 2011; 18:1-5 (C) 2011 by the Society for Academic Emergency Medicine.	[Singer, Adam J.; Wang, Eric; Taira, Breena R.] SUNY Stony Brook, Dept Emergency Med, Stony Brook, NY 11794 USA; [Steinhauff, Nicole; Rooney, Jean; Zimmerman, Thomas] SUNY Stony Brook, Div Lab Anim Res, Stony Brook, NY 11794 USA		Singer, AJ (corresponding author), SUNY Stony Brook, Dept Emergency Med, Stony Brook, NY 11794 USA.	adam.singer@stonybrook.edu	Singer, Adam/ABG-4506-2021	Taira, Breena/0000-0002-2510-651X			BERBERIAN GM, 1960, SURGERY, V48, P391; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BLOMGREN I, 1982, BURNS, V9, P17, DOI 10.1016/0305-4179(82)90130-9; BLOMGREN I, 1985, BURNS INCL THERM INJ, V9, P161; Chinchilli, 1997, LINEAR NONLINEAR MOD; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; COURTICE FC, 1946, J PHYSIOL-LONDON, V104, P321, DOI 10.1113/jphysiol.1946.sp004125; Cuttle L, 2008, WOUND REPAIR REGEN, V16, P626, DOI 10.1111/j.1524-475X.2008.00413.x; DECAMARA DL, 1981, J TRAUMA, V21, P911, DOI 10.1097/00005373-198111000-00001; DEMLING RH, 1979, J TRAUMA, V19, P56, DOI 10.1097/00005373-197901000-00011; FERRARA A, 1990, AM J SURG, V160, P515, DOI 10.1016/S0002-9610(05)81018-9; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Grounds M, 1967, Med J Aust, V2, P846; JAKOBSSON OP, 1985, BURNS, V12, P8, DOI 10.1016/0305-4179(85)90177-9; Jandera V, 2000, BURNS, V26, P265, DOI 10.1016/S0305-4179(99)00133-3; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Kim K, 2010, J TRAUMA, V68, P373, DOI 10.1097/TA.0b013e3181a73eea; Kim K, 2010, RESUSCITATION, V81, P100, DOI 10.1016/j.resuscitation.2009.09.020; KING T C, 1962, Surg Forum, V13, P487; KING TC, 1965, ARCH SURG-CHICAGO, V91, P656; KING TC, 1963, JAMA-J AM MED ASSOC, V183, P677; KING TC, 1965, SURG GYNECOL OBSTETR, V120, P1271; KING TC, 1963, SURG FORUM, V6, P80; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; LANGOHR JL, 1949, ARCH SURG-CHICAGO, V59, P1031, DOI 10.1001/archsurg.1949.01240041041005; Li C, 1997, Zhonghua Yi Xue Za Zhi, V77, P586; MATHEWS RN, 1987, LANCET, V1, P1371; MILDE LN, 1992, J NEUROSURG ANESTH, V4, P211, DOI 10.1097/00008506-199207000-00012; MOORE DH, 1952, AM J PHYSIOL, V170, P616, DOI 10.1152/ajplegacy.1952.170.3.616; Moserova J, 1975, BURNS, V1, p267~8; National Research Council, 1996, GUID CAR US LAB AN; Nguyen NL, 2002, BURNS, V28, P173, DOI 10.1016/S0305-4179(01)00094-8; OFEIGSSON OJ, 1961, POSTGRAD MED, V30, P330, DOI 10.1080/00325481.1961.11694415; OFEIGSSON OJ, 1972, J PATHOL, V108, P145, DOI 10.1002/path.1711080208; OFEIGSSON OJ, 1965, SURGERY, V57, P391; OFEIGSSON OJ, 1959, BR J PLAST SURG, V12, P104; Peng RY, 1999, J AM COLL SURGEONS, V188, P685, DOI 10.1016/S1072-7515(99)00035-6; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; PURDUE GF, 1985, J TRAUMA, V25, P167, DOI 10.1097/00005373-198502000-00017; Raghupati N, 1968, Br J Plast Surg, V21, P68, DOI 10.1016/S0007-1226(68)80089-X; RAINE TJ, 1981, J TRAUMA, V21, P394, DOI 10.1097/00005373-198105000-00012; Rajan V, 2009, J BURN CARE RES, V30, P729, DOI 10.1097/BCR.0b013e3181ac059b; Rivard Andrew L, 2004, J Extra Corpor Technol, V36, P269; Rose HW, 1936, NW MED, V35, P267; Rutherford EJ, 1998, INJURY, V29, P605, DOI 10.1016/S0020-1383(98)00139-9; SALL DL, 1992, PROG CARDIOVASC DIS, V42, P185; SARANTO JR, 1983, J TRAUMA, V23, P927, DOI 10.1097/00005373-198310000-00015; Sawada Y, 1997, BURNS, V23, P55, DOI 10.1016/S0305-4179(96)00080-0; SHULMAN AG, 1960, JAMA-J AM MED ASSOC, V173, P1916, DOI 10.1001/jama.1960.03020350034007; SHULMAN AG, 1962, SURG GYNECOL OBSTET, V115, P557; Shupp JW, 2010, J BURN CARE RES, V31, P849, DOI 10.1097/BCR.0b013e3181f93571; WALKER HL, 1968, J TRAUM, V8, P1049, DOI 10.1097/00005373-196811000-00006; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; White CE, 2008, CRIT CARE MED, V36, pS318, DOI 10.1097/CCM.0b013e31817e2d64	56	5	5	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	MAR	2011	18	3					287	291		10.1111/j.1553-2712.2011.01016.x			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	734YM	WOS:000288379600013	21352400	Bronze			2022-02-06	
J	Combes, X; Jabre, P; Amathieu, R; Abdi, W; Luis, D; Sebbah, JL; Leroux, B; Dhonneur, G				Combes, X.; Jabre, P.; Amathieu, R.; Abdi, W.; Luis, D.; Sebbah, J. -L.; Leroux, B.; Dhonneur, G.			Cricothyrotomy in emergency context: Assessment of a cannot intubate cannot ventilate scenario	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Intubation; Emergency; Cricothyroidotomy; Simulation; Manikin	SURGICAL CRICOTHYROIDOTOMY; AIRWAY; MANAGEMENT	Objective. - The aim of this study was to assess airway management by emergency physicians in case of a simulated situation where intubation and ventilation were both impossible. Study design. - Observational manikin study. Methods. - A manikin (Airman (R); Laerdal) allowing simulating difficult airway situations was used. The scenario assessed concerned a patient needing tracheal intubation for severe traumatic brain injury. The manikin was settled to make tracheal intubation under direct laryngoscopy impossible at the first attempt and to make facemask ventilation impossible after the second attempt. Manikin could initially be ventilated through the intubating laryngeal mask Airway (ILMA) but became impossible few seconds after its insertion. With impossible ventilation through the ILMA, arterial oxygen saturation decreased during 2 minutes before an hypoxic cardiac arrest occurred. Physicians could use classic laryngoscope with Macinthosh blade, a Gum Elastic Bougie, an ILMA and a cricothyrotomy set. Adhesion to the national airway management algorithm was assessed. Time to cricothyroidotomy decision after ventilation through ILMA became impossible was measured. Results. - Twenty-five emergency physicians were assessed. For 14 of them, national expert conference algorithm was perfectly followed. For ten physicians, cricothyroidotomy decision was taken after hypoxic cardiac arrest occurred. Conclusion. - Simulation with a manikin is useful to assess the adhesion rate to difficult intubation algorithms. Our study shows that the decision making process for cricothyrotomy is too often delayed as soon as ventilation became impossible and oxygenation compromized. (C) 2010 Elsevier Masson SAS. All rights reserved.	[Combes, X.; Leroux, B.] Hop Henri Mondor, AP HP, Dept Anesthesie Reanimat Chirurg, F-94010 Creteil, France; [Jabre, P.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Jabre, P.] Ctr Rech Cardiovasc Paris, INSERM, U970, F-75015 Paris, France; [Amathieu, R.; Abdi, W.; Luis, D.; Dhonneur, G.] Hop Jean Verdier, AP HP, Dept Anesthesie Reanimat Chirurg, F-93140 Bondy, France; [Sebbah, J. -L.] Hop Gonesse, F-95500 Gonesse, France		Combes, X (corresponding author), Hop Henri Mondor, AP HP, Dept Anesthesie Reanimat Chirurg, Samu Smur 94,Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	xavier.combes@hmn.aphp.fr					Adnet F, 1998, CAN J ANAESTH, V45, P266, DOI 10.1007/BF03012914; Battefort F, 2007, ANN FR ANESTH, V26, P171, DOI 10.1016/j.annfar.2006.11.009; Chan TC, 1999, J EMERG MED, V17, P957, DOI 10.1016/S0736-4679(99)00123-7; Combes X, 2008, ANN FR ANESTH, V27, P33, DOI 10.1016/j.annfar.2007.10.029; Combes X, 2006, ACAD EMERG MED, V13, P828, DOI 10.1197/j.aem.2006.02.016; Eisenburger P, 2000, ANESTHESIOLOGY, V92, P687, DOI 10.1097/00000542-200003000-00012; Friedman Z, 2008, ANESTH ANALG, V107, P1663, DOI 10.1213/ane.0b013e3181841efe; Isaacs JH, 1997, AM SURGEON, V63, P346; Jacobson LE, 1996, J TRAUMA, V41, P15, DOI 10.1097/00005373-199607000-00004; John B, 2007, ANAESTHESIA, V62, P1029, DOI 10.1111/j.1365-2044.2007.05219.x; Langeron O, 2008, ANN FR ANESTH, V27, P41, DOI 10.1016/j.annfar.2007.10.025; Leibovici D, 1997, AM J EMERG MED, V15, P91, DOI 10.1016/S0735-6757(97)90059-0; Levitan RM, 2004, ANN EMERG MED, V44, P307, DOI 10.1016/j.annemergmed.2004.05.006; Nguyen L, 2009, ANN FR ANESTH, V28, P889, DOI 10.1016/j.annfar.2009.07.085; Schaumann N, 2005, ANESTHESIOLOGY, V102, P7, DOI 10.1097/00000542-200501000-00005; Wong DT, 2003, ANESTHESIOLOGY, V98, P349, DOI 10.1097/00000542-200302000-00013	16	5	5	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2011	30	2					113	116		10.1016/j.annfar.2010.11.016			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	741CC	WOS:000288839700003	21282035				2022-02-06	
J	Kobayashi, L; Inaba, K; Barmparas, G; Criscuoli, M; Lustenberger, T; Talving, P; Lam, L; Demetriades, D				Kobayashi, L.; Inaba, K.; Barmparas, G.; Criscuoli, M.; Lustenberger, T.; Talving, P.; Lam, L.; Demetriades, D.			Traumatic limb amputations at a level I trauma center	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Trauma; Injury; Amputations; Amputees; Epidemiology; Traumatic amputation; Complications	UNITED-STATES; INJURY; OUTCOMES; SALVAGE	The purpose of this study was to analyze the epidemiology and outcomes after traumatic amputation of the upper (UEA) and lower (LEA) extremities. The Los Angeles County + University of Southern California Medical Center trauma registry was utilized to identify all patients sustaining traumatic amputation during the years 1996-2007. The demographics, mechanism of injury, clinical characteristics, associated injuries, surgical procedures, complications, and outcomes were obtained for these patients. During the 12-year study period, 130 patients suffered limb amputation, accounting for 0.25% of all trauma admissions. Thirteen patients (10%) were excluded because they were transferred from another facility after amputation or died in the emergency department. Of the remaining 117 patients, mean age was 38.1 +/- A 16.4 years and 77.8% were male. The predominant mechanism of injury was automobile versus pedestrian (27.4%), followed by work-related accidents (23.9%). Patients struck by vehicles were more likely to suffer LEA (93.8% versus 6.2%, p < 0.001), while patients with work-related accidents were more likely to sustain UEA (81.5% versus 18.5%, p < 0.001). Only nine patients underwent reattachment, all of which were for UEA and unsuccessful. Overall, 24.8% developed a complication during their hospital course, 55.2% of which were extremity related. Overall mortality was 3.4%, primarily attributed to associated severe traumatic brain injuries and thoracic injuries. Patients with LEA had longer hospital and intensive care unit (ICU) length of stay; however, after adjusting for confounders, this difference did not reach statistical significance (adjusted mean difference: 2.1 and 1.2 days, p = 0.69 and 0.79, respectively). A higher percentage of patients with LEA required discharge to a skilled nursing facility or rehabilitation center when compared with patients with UEA (29.6% versus 4.8%, p = 0.001). Traumatic limb amputation is a rare consequence of civilian trauma. Amputation is rarely the primary cause of death; however, these devastating injuries are associated with significant intensive care unit and hospital lengths of stay. Although no mortality difference was detected, when compared with patients with upper extremity amputations, patients with lower extremity amputations were more severely injured, required revision extremity surgery more often, had a higher complication rate, and more frequently required discharge to a long-term facility.	[Kobayashi, L.; Inaba, K.; Barmparas, G.; Criscuoli, M.; Lustenberger, T.; Talving, P.; Lam, L.; Demetriades, D.] Univ So Calif, Div Trauma Surg & Surg Crit Care, LAC Med Ctr, Los Angeles, CA 90033 USA		Inaba, K (corresponding author), Univ So Calif, Div Trauma Surg & Surg Crit Care, LAC Med Ctr, 1200 N State St,Inpatient Tower C,Room C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	INABA, KENJI/AAC-8532-2020; Talving, Peep/G-8621-2015; Barmparas, Galinos/L-6530-2019	Talving, Peep/0000-0002-9741-2073; 			BARMPARAS G, AM SURG IN PRESS; Busse JW, 2007, J ORTHOP TRAUMA, V21, P70, DOI 10.1097/BOT.0b013e31802cbc43; CRAIG GR, 1983, INJURY, V15, P163, DOI 10.1016/0020-1383(83)90005-0; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Dillingham TR, 2002, SOUTH MED J, V95, P875; FELICIANO DV, 2008, TRAUMA, P871; Goldman Matthew W, 2005, J Orthop Trauma, V19, P529, DOI 10.1097/01.bot.0000161543.52643.ab; Jernigan MV, 2005, AM J EMERG MED, V23, P99, DOI 10.1016/j.ajem.2004.02.045; MacKenzie EJ, 2004, J BONE JOINT SURG AM, V86A, P1636, DOI 10.2106/00004623-200408000-00006; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; MacKenzie Ellen J, 2006, J Am Acad Orthop Surg, V14, pS205; MacKenzie EJ, 2007, J BONE JOINT SURG AM, V89A, P1685, DOI 10.2106/JBJS.F.01350; Mullenix PS, 2006, J VASC SURG, V44, P94, DOI 10.1016/j.jvs.2006.02.052; Tomaino M M, 2001, Am J Orthop (Belle Mead NJ), V30, P380; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	15	5	6	0	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2011	37	1					67	72		10.1007/s00068-010-0011-3			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	722TQ	WOS:000287458300012	26814753				2022-02-06	
J	Muller, MC; Burger, C; Wirtz, D; Weber, O				Mueller, M. C.; Burger, C.; Wirtz, D. C.; Weber, O.			Replacement of the comminuted radial head fracture by a bipolar radial head prosthesis	OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE			German	Article						Radius; Radial head fracture; Replacement arthroplasties; Judet prosthesis	VALGUS STABILITY; ELBOW; EXCISION; ARTHROPLASTY; RESECTION; JUDET	Radial head arthroplasty as a treatment of non-reconstructable, comminuted fractures of the radial head in order to achieve elbow stability and to prevent secondary complications, such as valgus elbow instability and radius proximalization. In acute trauma, a radial head fracture not suitable for internal fixation without (Mason grade III) and with (Mason grade IV) concomitant destabilizing injury, Essex-Lopresti injury, sequelae following radial head resection (e.g., elbow instability or wrist pain), failed reconstruction of the radial head, and tumor-associated radial head or neck resection. General medical contraindications for surgical intervention, cobalt-chromium allergy, and osteoporosis of the proximal radius. In supine position, a lateral or posterolateral approach at the elbow was used. The annular ligament was exposed and the radial neck identified just above the bicipital tuberosity. In pronation of the forearm in order to protect the radial nerve, the medullary canal was prepared using rasps. The size of the implant was determined using trial stems. A distance of 0.5 mm between the head of the prosthesis and the capitulum humeri was recommended. After using a small bone plug, the prosthesis was cemented with respect to the anatomical radial curvature. After reconstruction of the annular ligament, the stability of the elbow was verified. In case of instability, the medial collateral ligament was reconstructed and afterwards the wound closed. Early mobilization begins the day after surgery. In case of additional injuries, the elbow was supported by an above-elbow cast for 3-4 weeks. To prevent heterotopic ossification, nonsteroidal antiinflammatory drugs were used for up to 4 weeks with gastric protection. A total of 13 patients with 15 radial head prosthesis were analyzed at a mean follow-up of 29.5 +/- 20.8 months. In all patients, the elbow was stable. Subjectively, good and excellent results were found with one exception. Compared to the pretrauma status, the subjective rate was 78 +/- 12%. Based on the Radin and Riseborough score, 6 of the results were good and 9 were fair. According to the Broberg and Morrey score, 1 result was very good, 8 were good, and 6 were fair. The mean DASH score was 9.9 +/- 9.7 points. Two temporary nerve lesions were observed. Five patients were diagnosed with heterotopic ossification stage I, while 2 patients were classified with stage II on the Brooker scale.	[Mueller, M. C.; Burger, C.; Wirtz, D. C.; Weber, O.] Univ Klinikum Bonn, Klin & Poliklin Orthopadie & Unfallchirurg, D-53105 Bonn, Germany		Muller, MC (corresponding author), Univ Klinikum Bonn, Klin & Poliklin Orthopadie & Unfallchirurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	marcus.mueller@ukb.uni-bonn.de					Ambacher T, 2000, UNFALLCHIRURG, V103, P437, DOI 10.1007/s001130050563; AMIS AA, 1995, INJURY, V26, P163, DOI 10.1016/0020-1383(95)93494-3; Beingessner DM, 2004, J BONE JOINT SURG AM, V86A, P1730, DOI 10.2106/00004623-200408000-00018; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; ESSEXLOPRESTI P, 1951, J BONE JOINT SURG BR, V33, P244, DOI 10.1302/0301-620X.33B2.244; Frosch KH, 2003, UNFALLCHIRURG, V106, P367, DOI 10.1007/s00113-003-0573-1; Holmenschlager F, 2002, UNFALLCHIRURG, V105, P344, DOI 10.1007/s00113-001-0350-y; Janssen RPA, 1998, J BONE JOINT SURG BR, V80B, P231, DOI 10.1302/0301-620X.80B2.8255; Johnston G., 1962, ULSTER MED J, V31, P51; Judet T, 1996, J BONE JOINT SURG BR, V78B, P244, DOI 10.1302/0301-620X.78B2.0780244; KING GJ, 1999, CLIN ORTHOP RELAT R, V368, P114; Leppilahti J, 2000, INT ORTHOP, V24, P160, DOI 10.1007/s002640000134; MacDermid JC, 2000, J HAND SURG-AM, V25A, P330, DOI 10.1053/jhsu.2000.jhsu25a0330; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; MCKEE, 2004, OPERAT ORTHOP TRAUMA, V16, P238; MORREY BF, 1991, CLIN ORTHOP RELAT R, P187; MORREY BF, 1995, J BONE JOINT SURG AM, V77A, P316, DOI 10.2106/00004623-199502000-00019; Muller MC, 2008, Z ORTHOP UNFALLCHIR, V146, P218, DOI 10.1055/s-2008-1038333; Prokop A, 2002, CHIRURG, V73, P997, DOI 10.1007/s00104-002-0545-y; RADIN EL, 1966, J BONE JOINT SURG AM, VA 48, P1055, DOI 10.2106/00004623-196648060-00003; Ring D, 2004, HAND CLIN, V20, P415, DOI 10.1016/j.hcl.2004.06.001; ROLF O, 2002, OPERAT ORTHOP TRAUMA, V14, P74; VANDERWILDE RS, 1994, J BONE JOINT SURG BR, V76B, P78, DOI 10.1302/0301-620X.76B1.8300687; Wallenbock E, 1994, Unfallchirurgie, V20, P115, DOI 10.1007/BF02588152; [No title captured]	26	5	10	0	1	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0934-6694	1439-0981		OPER ORTHOP TRAUMATO	Oper. Orthopade Traumatol.	FEB	2011	23	1					37	45		10.1007/s00064-010-0004-8			9	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	726WS	WOS:000287758100006	21327953				2022-02-06	
J	Williams, G; Clark, R; Schache, A; Fini, NA; Moore, L; Morris, ME; McCrory, PR				Williams, Gavin; Clark, Ross; Schache, Anthony; Fini, Natalie A.; Moore, Liz; Morris, Meg E.; McCrory, Paul R.			Training Conditions Influence Walking Kinematics and Self-Selected Walking Speed in Patients with Neurological Impairments	JOURNAL OF NEUROTRAUMA			English	Article						locomotor function; rehabilitation; traumatic brain injury; treadmill training	BODY-WEIGHT SUPPORT; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; STROKE REHABILITATION; HEMIPARETIC PATIENTS; HEMIPLEGIC GAIT; CONTROLLED-TRIAL; OVERGROUND GAIT; SINGLE-BLIND; BALANCE	Gait training is a major focus of rehabilitation for many people with neurological disorders, yet systematic reviews have failed to identify the most effective form of gait training. The main objective of this study was to compare conditions for gait training for people with acquired brain injury (ABI). Seventeen people who had sustained an ABI and were unable to walk without assistance were recruited as a sample. Each participant was exposed to seven alternative gait training conditions in a randomized order. These were: (1) therapist manual facilitation; (2) the use of a gait-assistive device; (3) unsupported treadmill walking; and (4) four variations of body weight support treadmill training (BWSTT). Quantitative gait analysis was performed and Gait Profile Scores (GPS) were generated for each participant to determine which condition most closely resembled normal walking. BWSTT without additional therapist or self-support of the upper limbs was associated with more severe gait abnormality [Wilks' lambda=0.20, F(6, 6)=3.99, p=0.047]. With the exception of therapist facilitation, the gait training conditions that achieved the closest approximation of normal walking required self-support of the upper limbs. When participants held on to a stable handrail, self-selected gait speeds were up to three times higher than the speeds obtained for over-ground walking [Wilks' lambda 0.17, F(6, 7)=5.85, p<0.05]. The provision of stable upper-limb support was associated with high self-selected gait speeds that were not sustained when walking over ground. BWSTT protocols may need to prioritize reduction in self-support of the upper limbs, instead of increasing treadmill speed and reducing body weight support, in order to improve training outcomes.	[Williams, Gavin; Moore, Liz] Epworth Med Fdn, Melbourne, Vic, Australia; [McCrory, Paul R.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Sch Physiotherapy, Melbourne, Vic, Australia; [Schache, Anthony] Univ Melbourne, Sch Mech Engn, Melbourne, Vic, Australia; [Fini, Natalie A.] Alfred Healthcare, Caulfield Hosp, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	McCrory, Paul/Q-8688-2019; Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019; Schache, Anthony G/F-4482-2016	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Schache, Anthony G/0000-0002-1041-5213; Morris, Meg/0000-0002-0114-4175; Fini, Natalie/0000-0001-5474-6404; Williams, Gavin/0000-0003-2758-7473; McCrory, Paul/0000-0003-4850-0568	Royal Automobile Club of Victoria (RACV)	This study was supported by a grant from the Royal Automobile Club of Victoria (RACV).	Ada L, 2010, J PHYSIOTHER, V56, P153, DOI 10.1016/S1836-9553(10)70020-5; Ada L, 2010, STROKE, V41, P1237, DOI 10.1161/STROKEAHA.109.569483; Allet L, 2009, ARCH PHYS MED REHAB, V90, P1408, DOI 10.1016/j.apmr.2009.02.010; Bacik B, 2006, INT J REHABIL RES, V29, P255, DOI 10.1097/01.mrr.0000230064.52043.de; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bernhardt J, 2008, STROKE, V39, P2059, DOI 10.1161/STROKEAHA.107.507160; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; da Cunha IT, 2002, ARCH PHYS MED REHAB, V83, P1258, DOI 10.1053/apmr.2002.34267; Dickstein R, 2008, NEUROREHAB NEURAL RE, V22, P649, DOI [10.1177/15459683080220060201, 10.1177/1545968308315997]; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Franceschini M, 2009, STROKE, V40, P3079, DOI 10.1161/STROKEAHA.109.555540; Hamzat TK, 2008, EUR J PHYS REHAB MED, V44, P121; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Harris Jocelyn E, 2004, Physiother Can, V56, P171, DOI 10.2310/6640.2004.00017; Hesse S, 1998, ELECTROMYOGR MOTOR C, V109, P515, DOI 10.1016/S1388-2457(98)00033-9; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HESSE SA, 1994, STROKE, V25, P1999, DOI 10.1161/01.STR.25.10.1999; Hesse S, 2008, NEUROREHABILITATION, V23, P55; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Jutai J, 2007, ARCH PHYS MED REHAB, V88, P1268, DOI 10.1016/j.apmr.2007.06.773; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kuan TS, 1999, ARCH PHYS MED REHAB, V80, P777, DOI 10.1016/S0003-9993(99)90227-7; Laufer Y, 2002, CLIN REHABIL, V16, P141, DOI 10.1191/0269215502cr481oa; Lennon S, 2001, PHYS THER REHABIL J, V81, P924, DOI 10.1093/ptj/81.3.924; Maguire C, 2010, CLIN REHABIL, V24, P37, DOI 10.1177/0269215509342335; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; McCain KJ, 2008, ARCH PHYS MED REHAB, V89, P684, DOI 10.1016/j.apmr.2007.09.050; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Moseley A, 2005, AUST J PHYSIOTHER, V51, P192, DOI 10.1016/S0004-9514(05)70029-5; Moseley AM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.cd002840.pub2; Mulroy SJ, 2010, PHYS THER, V90, P209, DOI 10.2522/ptj.20090141; NIGG BM, 1994, GAIT POSTURE, V2, P213, DOI DOI 10.1016/0966-6362(94)90106-6; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Peurala SH, 2009, J REHABIL MED, V41, P166, DOI 10.2340/16501977-0304; Pohl M, 2007, CLIN REHABIL, V21, P17, DOI 10.1177/0269215506071281; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sousa CO, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-43; States RA, 2009, J NEUROL PHYS THER, V33, P179, DOI 10.1097/NPT.0b013e3181c29a8c; Swinnen E, 2010, J REHABIL MED, V42, P520, DOI 10.2340/16501977-0538; Teasell RW, 2008, ARCH PHYS MED REHAB, V89, P575, DOI 10.1016/j.apmr.2007.08.164; Tong RK, 2006, ARCH PHYS MED REHAB, V87, P1298, DOI 10.1016/j.apmr.2006.06.016; Tyson Sarah F., 1994, Physiotherapy Theory and Practice, V10, P77, DOI 10.3109/09593989409047444; Tyson SF, 2009, ARCH PHYS MED REHAB, V90, P475, DOI 10.1016/j.apmr.2008.09.563; Tyson SF, 1999, CLIN REHABIL, V13, P295, DOI 10.1191/026921599666307333; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Wessels M, 2010, J REHABIL MED, V42, P513, DOI 10.2340/16501977-0525; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925	51	5	5	0	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2011	28	2					281	287		10.1089/neu.2010.1649			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	719UE	WOS:000287234700011	21174634	Green Submitted			2022-02-06	
J	Aadal, L; Kirkevold, M				Aadal, Lena; Kirkevold, Marit			A Model for Neurorehabilitation After Severe Traumatic Brain Injury Facilitating Patient Participation and Learning	ADVANCES IN NURSING SCIENCE			English	Article						action research; everyday activities; model; neurorehabilitation; patient participation; situated learning; traumatic brain injury	QUALITY-OF-LIFE; REHABILITATION; BODY	Background: During intensive neurorehabilitation, it is a professional challenge that patients with severe traumatic brain injury may have changed abilities to learn. Purpose: To develop, initially test, and evaluate a model for neurorehabilitation aimed at systematizing and facilitating professionals' efforts of promoting patients' participation and learning. Methods: Qualitative study inspired by action research. Empirical data were analyzed by a theoretical framework of "didactic relation model," "situated learning theory," and neurophysiologic/neuropsychological categories of learning premises. Findings: Our findings indicate that the model for neurorehabilitation expands and systematizes the professional's reflections and interventions aimed at facilitating learning among patients with traumatic brain injury.	[Aadal, Lena] Hammel Neurorehabil & Res Ctr, Res Unit, DK-8450 Hammel, Denmark; [Kirkevold, Marit] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Kirkevold, Marit] Univ Aarhus, Dept Nursing Sci, Aarhus, Denmark		Aadal, L (corresponding author), Hammel Neurorehabil & Res Ctr, Res Unit, Voldbyvej 15, DK-8450 Hammel, Denmark.	lena.aadal@hammel.rm.dk	Aadal, Lena/R-3444-2019; Aadal, Lena/U-9172-2017	Aadal, Lena/0000-0001-7365-3916; Aadal, Lena/0000-0001-7365-3916			Aadal L, 2010, INTENSIV NEUROREHABI; [Anonymous], 2006, MEDITERR J PHYS REHA, V42, P290; [Anonymous], 2004, HVIDB REH; Antelius E, 2009, HEALTH, V13, P361, DOI 10.1177/1363459308101808; Arntzen C, 2008, JEG FAR IKKE HENDERN; Bazeleley P, 2007, QUALITATIVE DATA ANA; Borg T, 2003, THESIS AARHUS U I FI, V2; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Forchhammer HB, 2004, UGESKRIFT LAEGER, V166, P2372; FOWLES GP, 1995, CLIN NEUROPSYCHOL, V9, P251, DOI 10.1080/13854049508400490; Freeman T, 2006, J ADV NURS, V56, P491, DOI 10.1111/j.1365-2648.2006.04043.x; FUGELMEYER AR, 1988, SCAND J REHABIL MED, P51; Fuhrer MJ, 1998, AM J PHYS MED REHAB, V77, P557, DOI 10.1097/00002060-199811000-00022; Gadamer Hans-Georg., 2004, SANDHED METODE; Greenwood PJ, 1998, INTRO ACTION RES SOC; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HALKIER B, 2003, FOKUSGRUPPER; Hammersley M, 2004, GRUNNLAGET FELTARBEI; Hansen HP, 2001, HUMANISTISK FORSKNIN, P116; Hastrup K., 2003, IND VERDEN GRUNDBOG; Hiim H., 2007, LAERING GENNEM OPLEV; Hiim H, 2004, LAERING GENNEM OPLEV; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kirkevold M, 2010, ADV NURS SCI, V33, pE27, DOI 10.1097/ANS.0b013e3181cd837f; Kvale S., 2008, INTERVIEW INTRO HAND; Kvale S, 2003, INTERVIEW INTRO KVAL; Lave J., 1991, LEGITIMATE PERIPHERA; LAVE J, 1997, NORDISK PEDAGOGIK, V17, P140; Lave J, 2008, UNDERSTANDING PRACTI, P3; Ledoux J, 1999, WILD THINGS ARE EMOT, P225; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mattingly C, 2006, NEW LITERARY HIST, V37, P563, DOI 10.1353/nlh.2006.0050; McLafferty I, 2004, J ADV NURS, V48, P187, DOI 10.1111/j.1365-2648.2004.03186.x; Nielsen B, 2010, KVALITATIVE METODER, P97; Northern Nurses' Federation, 2003, ETH GUID NURS RES NO; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Pryor J, 2009, J CLIN NURS, V18, P1766, DOI 10.1111/j.1365-2702.2008.02322.x; Sandelowski M., 2002, INT J QUAL METHODS, V1, P74, DOI DOI 10.1177/160940690200100107; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Standal OF, 2008, ADAPT PHYS ACT Q, V25, P208, DOI 10.1123/apaq.25.3.208; Uniform Data System for Medical Rehabilitation (Adult FIM), 1993, AD FIM SVENSK UDG FI; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Wenger E., 2009, COMMUNITIES PRACTICE; WENGER E, 2008, COMMUNITIES PRACTICE; Whitehead L, 2004, J ADV NURS, V45, P512, DOI 10.1046/j.1365-2648.2003.02934.x; WHO rGSTD, 2003, ICF INT KLASS FUNKT	50	5	5	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	JAN-MAR	2011	34	1					E1	E17		10.1097/ANS.0b013e318209b01a			17	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	718MF	WOS:000287126100001	21304277				2022-02-06	
J	Di Paola, M; Moscatelli, A; Bigler, ED; Caltagirone, C; Carlesimo, GA				Di Paola, M.; Moscatelli, A.; Bigler, E. D.; Caltagirone, C.; Carlesimo, G. A.			White matter changes in patients with hypoxic amnesia	NEUROCASE			English	Article						Hypoxia; Limbic system; White matter; Memory; Voxel based morphometry	VOXEL-BASED MORPHOMETRY; TRAUMATIC BRAIN-INJURY; CARBON-MONOXIDE INTOXICATION; ENDURING MEMORY IMPAIRMENT; MEDIAL TEMPORAL-LOBE; FORNIX TRANSECTION; HUMAN HIPPOCAMPUS; CEREBRAL ANOXIA; NORMATIVE DATA; ATROPHY	A deficit of declarative memory is a common sequela after a hypoxic episode. While the role of gray matter changes (i.e., atrophy of hippocampal formation) as mainly responsible for memory loss has been emphasized, the role of the white matter damage has so far been neglected. The present study was aimed at evaluating whether white matter damage, within the neural circuitry responsible for declarative memory functioning, is present in anoxic patients. We assessed, by means of voxel-based morphometry, the integrity of white matter regions in five patients with hypoxic amnesia. When anoxic patients were compared to healthy controls, significantly less white matter density was detected in the fornix, anterior portion of the cingulum bundle and uncinate fasciculus bilaterally. We conclude that cerebral hypoxia may alter, together with the hippocampi, the integrity of white matter fibers throughout the memory-limbic system.	[Di Paola, M.] IRCCS, Fdn Santa Lucia, Dept Radiol, I-00179 Rome, Italy; [Di Paola, M.] Univ Aquila, Dept Internal Med & Publ Hlth, I-67010 Laquila, Italy; [Moscatelli, A.] IRCCS Santa Lucia Fdn, Dept Neuromotor Physiol, I-00179 Rome, Italy; [Bigler, E. D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, E. D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Caltagirone, C.; Carlesimo, G. A.] Univ Roma Tor Vergata, Dept Neurol Sci, Rome, Italy		Di Paola, M (corresponding author), IRCCS, Fdn Santa Lucia, Dept Radiol, Via Ardeatina 306, I-00179 Rome, Italy.	m.dipaola@hsantalucia.it	Caltagirone, Carlo/B-4930-2013; Di Paola, Margherita/A-8480-2010; Moscatelli, Alessandro/L-1391-2018	Moscatelli, Alessandro/0000-0001-6269-4536			Aggleton JP, 2000, BRAIN, V123, P800, DOI 10.1093/brain/123.4.800; Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Ammermann H, 2007, J NEUROL SCI, V260, P65, DOI 10.1016/j.jns.2007.03.026; Arbelaez A, 1999, AM J NEURORADIOL, V20, P999; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bergouignan L, 2009, NEUROIMAGE, V45, P29, DOI 10.1016/j.neuroimage.2008.11.006; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P383, DOI 10.1016/0887-6177(88)90052-2; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; CARLESIMO A, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; DESPOSITO M, 1995, NEUROLOGY, V45, P1546, DOI 10.1212/WNL.45.8.1546; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; Duvernoy HM., 2005, HUMAN HIPPOCAMPUS FU; Fink F, 2010, MULT SCLER J, V16, P332, DOI 10.1177/1352458509356367; GAFFAN D, 1992, EUR J NEUROSCI, V4, P381, DOI 10.1111/j.1460-9568.1992.tb00886.x; GINSBERG MD, 1985, J TOXICOL-CLIN TOXIC, V23, P281, DOI 10.3109/15563658508990635; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Gold JJ, 2006, LEARN MEMORY, V13, P699, DOI 10.1101/lm.357406; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Henke K, 1999, J COGNITIVE NEUROSCI, V11, P682, DOI 10.1162/089892999563643; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; HOPKINS RO, 2008, HYPOXIC ANOXIC CONDI, P521; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Kesler SR, 2001, J INT NEUROPSYCH SOC, V7, P640, DOI 10.1017/S1355617701005112; Koenigkam-Santos M, 2008, AM J NEURORADIOL, V29, P1799, DOI 10.3174/ajnr.A1202; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Milner B, 2005, PSYCHIAT CLIN N AM, V28, P599, DOI 10.1016/j.psc.2005.06.002; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Nakada T, 2005, NEUROLOGY, V64, P1170, DOI 10.1212/01.WNL.0000156158.48587.EA; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nestor PG, 2008, NEUROPSYCHOLOGY, V22, P246, DOI 10.1037/0894-4105.22.2.246; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nocentini U., 2002, NUOVA RIV NEUROLOGIA, V12, P13, DOI DOI 10.1080/00336297.2015.1051236; Offiah C, 2008, CLIN RADIOL, V63, P146, DOI 10.1016/j.crad.2007.07.021; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Porter SS, 2002, ARCH CLIN NEUROPSYCH, V17, P195, DOI 10.1016/S0887-6177(00)00110-4; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Raven J. C, 1947, PROGR MATRICES SETS; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rey A, 1968, REATTIVO FIGURA COMP; Rusch N, 2007, SCHIZOPHR RES, V93, P79, DOI 10.1016/j.schres.2007.01.029; Salo R, 2009, BIOL PSYCHIAT, V65, P122, DOI 10.1016/j.biopsych.2008.08.004; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Spinnler H, 1987, ITAL J NEUROL SCI S8, V6, P1; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilke M, 2004, PSYCHIAT RES-NEUROIM, V131, P57, DOI 10.1016/j.pscychresns.2004.01.004; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	62	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2011	17	1					46	56	PII 928663690	10.1080/13554794.2010.497155			11	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	714OQ	WOS:000286819300005	20981620				2022-02-06	
B	Fuhrmann, T; Gerardo-Nava, J; Brook, GA		Pallua, N; Suschek, CV		Fuehrmann, T.; Gerardo-Nava, J.; Brook, G. A.			Central Nervous System	TISSUE ENGINEERING: FROM LAB TO CLINIC			English	Article; Book Chapter							SPINAL-CORD-INJURY; OLFACTORY-ENSHEATHING GLIA; PEPTIDE NANOFIBER SCAFFOLD; NEURITE GROWTH-INHIBITORS; SCHWANN-CELL GRAFTS; CHONDROITIN SULFATE PROTEOGLYCANS; MONOCLONAL-ANTIBODY IN-1; NEGATIVE SURFACE-CHARGES; TRAUMATIC BRAIN-INJURY; ADULT-RAT		[Fuehrmann, T.; Gerardo-Nava, J.; Brook, G. A.] Rhein Westfal TH Aachen, Inst Neuropathol, Fac Med, D-52074 Aachen, Germany		Brook, GA (corresponding author), Rhein Westfal TH Aachen, Inst Neuropathol, Fac Med, Pauwelsstr 30, D-52074 Aachen, Germany.	gbrook@ukaachen.de	Fuhrmann, Tobias/D-3880-2014; Hasan, Mohd Shahnaz/B-9124-2010; Stupp, Roger/L-3303-2019; Chung, Caroline/AAM-5504-2021	Fuhrmann, Tobias/0000-0003-1857-4806; Hasan, Mohd Shahnaz/0000-0002-7493-7416; 			Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Avitabile T, 2001, BIOMATERIALS, V22, P195, DOI 10.1016/S0142-9612(00)00169-1; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Bhandari PS, 2007, INDIAN J NEUROTRAUM, V4, P21, DOI 10.1016/S0973-0508(07)80006-2; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Borgens RB, 2002, J EXP BIOL, V205, P1; Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.3.CO;2-4; Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116; Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brook GA, 2000, EUR J NEUROSCI, V12, P3224, DOI 10.1046/j.1460-9568.2000.00228.x; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; Brynda E, 2009, J MATER SCI-MATER M, V20, P909, DOI 10.1007/s10856-008-3625-9; Bunge MB, 2002, PROG BRAIN RES, V137, P275; Bunge R P, 1997, Adv Neurol, V72, P305; BUNGE RP, 1993, ADV NEUROL, V59, P75; CARBONETTO S, 1983, J NEUROSCI, V3, P2324; Chen AQ, 1996, EXP NEUROL, V138, P261, DOI 10.1006/exnr.1996.0065; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Dalton PD, 2009, FRONT BIOSCI-LANDMRK, V14, P769, DOI 10.2741/3277; Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5; Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051; DELATORRE JC, 1982, BRAIN RES BULL, V9, P545, DOI 10.1016/0361-9230(82)90162-9; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DOU CL, 1994, J NEUROSCI, V14, P7616; DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; FeraboliLohnherr D, 1997, EXP BRAIN RES, V113, P443, DOI 10.1007/PL00005597; Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.3.CO;2-B; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Giannetti S, 2001, NEUROL RES, V23, P405, DOI 10.1179/016164101101198622; Gonzenbach RR, 2008, CELL MOL LIFE SCI, V65, P161, DOI 10.1007/s00018-007-7170-3; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Grimpe B, 2002, PROG BRAIN RES, V137, P333; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; GUTH L, 1985, EXP NEUROL, V88, P1, DOI 10.1016/0014-4886(85)90109-8; Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]; He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255; Hejcl A, 2009, J MATER SCI-MATER M, V20, P1571, DOI 10.1007/s10856-009-3714-4; Hejcl A, 2008, PHYSIOL RES, V57, pS121, DOI 10.33549/physiolres.931606; Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067; Hennink WE, 2012, ADV DRUG DELIVER REV, V64, P223, DOI 10.1016/j.addr.2012.09.009; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9; Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867; HUANG TK, 1988, J BIOMECH, V14, P269; Hudson TW, 1999, CLIN PLAST SURG, V26, P617; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Iannotti C, 2003, EXP NEUROL, V183, P379, DOI 10.1016/S0014-4886(03)00188-2; Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407; KAKULAS B, 1992, HDB CLIN NEUROLOGY A; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Khoueir P, 2007, NEUROSURGERY, V61, P963, DOI 10.1227/01.neu.0000303192.64802.c6; King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5; Klinkhammer K, 2009, TISSUE ENG PART C-ME, V15, P77, DOI 10.1089/ten.tec.2008.0324; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; Lesny P, 2006, J MATER SCI-MATER M, V17, P829, DOI 10.1007/s10856-006-9842-1; Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X; Li SX, 2003, J NEUROSCI, V23, P4219; Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063; Li Y, 1998, J NEUROSCI, V18, P10514; Liang HF, 2004, BIOMACROMOLECULES, V5, P1917, DOI 10.1021/bm049813w; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Liu S, 2001, NEUROSURGERY, V49, P143, DOI 10.1097/00006123-200107000-00022; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; Luo J, 2004, J NEUROTRAUM, V21, P994, DOI 10.1089/0897715041651097; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4; MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; MOELLERS S, 2004, RESTOR NEUROL NEUROS, P23; Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078; Niederost B, 2002, J NEUROSCI, V22, P10368; Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496; Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16; Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180; Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/01.NEU.0000219859.35349.EF; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033; Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X; PAINO CL, 1994, J NEUROCYTOL, V23, P433, DOI 10.1007/BF01207115; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterials.2003.09.052; Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020; Pradny M, 2005, J MATER SCI-MATER M, V16, P767, DOI 10.1007/s10856-005-2615-4; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576; Ramon y Cajal, 1928, DEGENERATION REGENER; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; REIER P, 1983, SPINAL CORD RECONSTR, P151; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0; Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131; ROGERS SL, 1987, J CELL BIOL, V105, P1435, DOI 10.1083/jcb.105.3.1435; Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007; Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shoichet MS, 1996, BIOMATERIALS, V17, P285, DOI 10.1016/0142-9612(96)85566-9; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041; Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777; Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023; Suzuki K, 1999, NEUROREPORT, V10, P2891, DOI 10.1097/00001756-199909290-00003; Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X; Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9612(03)00497-6; Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; THOMPSON JM, 1982, DEV NEUROSCI-BASEL, V5, P447, DOI 10.1159/000112705; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Vavrek R, 2007, J NEUROTRAUM, V24, P1667, DOI 10.1089/neu.2007.0290; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang KK, 1998, MICROSURG, V18, P270, DOI 10.1002/(SICI)1098-2752(1998)18:4<270::AID-MICR11>3.0.CO;2-V; Wang ZH, 1996, ACTA NEUROPATHOL, V91, P180, DOI 10.1007/s004010050411; Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520; WOERLY S, 1994, J NEURAL TRANSP PLAS, V5, P245, DOI 10.1155/NP.1994.245; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774; Woerly S, 2001, J NEUROSCI RES, V66, P1187; Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091; Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9; Woerly S, 2001, INT J DEV NEUROSCI, V19, P63, DOI 10.1016/S0736-5748(00)00064-2; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Wu SF, 2001, NEUROSCI LETT, V312, P173, DOI 10.1016/S0304-3940(01)02219-4; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0; Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16; Yoshii S, 2001, BRAIN RES, V888, P158, DOI 10.1016/S0006-8993(00)03025-0; Yu XJ, 2001, J NEUROSCI RES, V66, P303, DOI 10.1002/jnr.1225; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744; Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887; Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870	198	5	5	0	2	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY			978-3-642-02823-6				2011							221	244		10.1007/978-3-642-02824-3_12	10.1007/978-3-642-02824-3		24	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical	Book Citation Index – Science (BKCI-S)	Cell Biology; Engineering	BUN32	WOS:000289825800012					2022-02-06	
J	Glick, RP; Ksendzovsky, A; Greesh, J; Raksin, P				Glick, Roberta P.; Ksendzovsky, Alexander; Greesh, John; Raksin, Patti			Initial Observations of Combination Barbiturate Coma and Decompressive Craniectomy for the Management of Severe Pediatric Traumatic Brain Injury	PEDIATRIC NEUROSURGERY			English	Article						Glasgow Coma Scale; Head injury; Traumatic brain injury; Intracranial hypertension; Barbiturate coma; Craniectomy	SEVERE HEAD-INJURY; ELEVATED INTRACRANIAL-PRESSURE; PUPIL REACTIVITY; SCALE SCORE; CHILDREN; HYPERTENSION; SODIUM; SIZE	Objective: In the pediatric population, treatment of severely injured children presenting with low Glasgow Coma Score (GCS) and fixed and dilated pupils is controversial. The combination of barbiturate coma and decompressive craniectomy as an aggressive means of controlling intracranial pressure is limited to few studies. In the present series, we report our experience with aggressive combination therapy resulting in good outcomes in pediatric patients with severe traumatic brain injury (TBI). Patients and Methods: Six TBI patients, aged <18 years, either presented with or deteriorated to a GCS <5 with fixed and dilated pupils and CT evidence of surgical lesions with brain edema. Despite hyperventilation, anesthesia, and mannitol, intracranial pressures remained elevated and all patients underwent decompressive craniectomy and external ventricular drainage and were subsequently placed into barbiturate coma for 72 h. Results: One patient died and 1 patient remained vegetative. Two patients had excellent recoveries (GOS 5/Rankin 1 or 0, no cognitive deficits) and 2 patients had good recoveries (GOS 4/Rankin 1, mild cognitive deficits). Conclusions: Combination of barbiturate coma with decompressive craniectomy and external ventricular drainage led to good outcomes in a small group of pediatric patients with severe TBI. Based on this series we recommend further investigation into aggressive combination management. Copyright (C) 2011 S. Karger AG, Basel	[Glick, Roberta P.] Univ Illinois, Coll Med, Dept Neurosurg, Mt Sinai Hosp,Rush Med Coll, Chicago, IL USA; [Glick, Roberta P.] Univ Illinois, Coll Med, Dept Anat, Mt Sinai Hosp,Rush Med Coll, Chicago, IL USA; [Glick, Roberta P.] Univ Illinois, Coll Med, Dept Cell Biol, Mt Sinai Hosp,Rush Med Coll, Chicago, IL USA; [Greesh, John; Raksin, Patti] Stroger Cook Cty Hosp, Chicago, IL USA; [Ksendzovsky, Alexander] Chicago Med Sch, N Chicago, IL USA		Glick, RP (corresponding author), Mt Sinai Hosp, Dept Surg, 1500 S Calif Ave, Chicago, IL 60608 USA.	rpglick@hotmail.com					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Capizzani AR, 2010, J PEDIATR SURG, V45, P903, DOI 10.1016/j.jpedsurg.2010.02.014; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; JENNETT B, 1976, LANCET, V1, P1031; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Pryor JP, 2003, J TRAUMA, V55, P442; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237	26	5	6	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2011	47	2					152	157		10.1159/000330709			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	842BP	WOS:000296561900013	21934277				2022-02-06	
J	Hellwig, TR; Onisk, ML; Chapman, BA				Hellwig, Thaddaus R.; Onisk, Mallory L.; Chapman, Bret A.			Potential Interaction Between Valproic Acid and Doripenem	CURRENT DRUG SAFETY			English	Article						Valproic acid; doripenem; drug interaction; blood concentrations; anticonvulsants; antibiotics; epilepsy; seizure		A potential interaction between valproate (VPA) and doripenem leading to decreased valproic acid concentrations in two patients is described. In the first patient case, a 54-year-old female presented to the emergency department following a seizure episode after stopping her medications a few days prior. She was given a 1500 mg (23 mg/kg) intravenous (IV) bolus dose of valproate and restarted on her home regimen of divalproex sodium 750 mg daily which quickly resulted in valproic acid blood concentrations within the reference range. The patient was later started on doripenem 500 mg IV every 8 hours and subsequent valproic acid concentrations decreased by 62%. The second patient was a 54-year-old female transferred from an outlying facility following a motor vehicle accident. The patient was receiving valproate 1250 mg IV every 8 hours for seizure prophylaxis following a traumatic brain injury. She developed pneumonia and was started on doripenem 500mg IV every 8 hours. Valproic acid concentrations decreased by 69% within two days. This case report describes two patients receiving concomitant valproate and doripenem resulting in a 62% and 69% reduction in valproic acid concentration.	[Hellwig, Thaddaus R.; Onisk, Mallory L.; Chapman, Bret A.] South Dakota State Univ, Coll Pharm, Dept Pharm Practice, Brookings, SD USA; [Hellwig, Thaddaus R.] Sanford USD Med Ctr, 1305 W 18th St, Sioux Falls, SD 57117 USA		Hellwig, TR (corresponding author), Sanford USD Med Ctr, 1305 W 18th St, Sioux Falls, SD 57117 USA.	Thaddaus.hellwig@sanfordhealth.org					[Anonymous], 2010, PROD INF DEP; Clause D, 2005, INTENS CARE MED, V31, P1293, DOI 10.1007/s00134-005-2695-0; Coves-Orts FJ, 2005, ANN PHARMACOTHER, V39, P533, DOI 10.1345/aph.1E358; De Turck BJG, 1998, J ANTIMICROB CHEMOTH, V42, P563, DOI 10.1093/jac/42.4.563; Fudio S, 2006, J CLIN PHARM THER, V31, P393, DOI 10.1111/j.1365-2710.2006.00743.x; Gu J, 2009, AM J GERIATR PHARMAC, V7, P26, DOI 10.1016/j.amjopharm.2009.02.005; Haroutiunian S, 2009, J CLIN PHARMACOL, V49, P1363, DOI 10.1177/0091270009334377; Horn JR, 2007, ANN PHARMACOTHER, V41, P674, DOI 10.1345/aph.1H423; Ketter TA, 1999, CELL MOL NEUROBIOL, V19, P511, DOI 10.1023/A:1006990925122; Lunde JL, 2007, PHARMACOTHERAPY, V27, P1202, DOI 10.1592/phco.27.8.1202; Matthews SJ, 2009, CLIN THER, V31, P42, DOI 10.1016/j.clinthera.2009.01.013; Nacarkucuk E, 2004, PEDIATR NEUROL, V31, P232, DOI 10.1016/j.pediatrneurol.2004.03.014; Nagai K, 1997, J ANTIMICROB CHEMOTH, V39, P295, DOI 10.1093/jac/39.2.295; Nakajima Y, 2004, DRUG METAB DISPOS, V32, P1383, DOI 10.1124/dmd.104.000661; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Santucci M, 2005, J CHILD NEUROL, V20, P456, DOI 10.1177/08830738050200051401; Spriet I, 2007, AM J HEALTH-SYST PH, V64, P54, DOI 10.2146/ajhp050512; Suzuki E, 2010, DRUG METAB DISPOS; Tobin Jennifer K., 2009, Drug Metabolism and Drug Interactions, V24, P153, DOI 10.1515/DMDI.2009.24.2-4.153; Torii M, 2002, INT J PHARM, V233, P253, DOI 10.1016/S0378-5173(01)00916-4; Torii M, 2001, J PHARM PHARMACOL, V53, P823, DOI 10.1211/0022357011776171; Yamagata T, 1998, THER DRUG MONIT, V20, P396, DOI 10.1097/00007691-199808000-00008; Yamamura N, 2000, DRUG METAB DISPOS, V28, P1484; ZACCARA G, 1988, CLIN PHARMACOKINET, V15, P367, DOI 10.2165/00003088-198815060-00002	24	5	10	0	2	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1574-8863	2212-3911		CURR DRUG SAF	Curr. Drug Saf.		2011	6	1					54	58		10.2174/157488611794480007			5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	V3I3Z	WOS:000218283800013	21241241				2022-02-06	
J	Hildebrandt, H; Gehrmann, A; Modden, C; Eling, P				Hildebrandt, Helmut; Gehrmann, Annika; Moedden, Claudia; Eling, Paul			Enhancing memory performance after organic brain disease relies on retrieval processes rather than encoding or consolidation	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory rehabilitation; Encoding; Consolidation; Retrieval; Novelty detection	CLOSED-HEAD INJURY; COGNITIVE REHABILITATION; STROKE; PATTERNS; DEFICITS; AMNESIA	Neuropsychological rehabilitation of memory performance is still a controversial topic, and rehabilitation studies have not analyzed to which stage of memory processing (encoding, consolidation, or retrieval) enhancement may be attributed. We first examined the efficacy of a computer training program for stroke patients, based on a previous study (Hildebrandt, Clausing, Janssen, Modden, 2007a) for memory-impaired patients of a rehabilitation unit and compared it with the standard group treatment. In a second randomized controlled experiment, we trained two groups of 15 patients with mild to moderate memory disorders, caused by organic brain lesions, with the same two treatment approaches. We used several standard tests to analyze improvement of memory functions, focusing on separate parameters for encoding, consolidation, and retrieval. We developed for that purpose a new word-list learning test, which allowed assessment of response to novelty and a systematic comparison of free recall after learning of semantically structured and nonstructured word lists. The first treatment experiment showed significant improvement of verbal learning for patients treated with the computer software program. The second experiment showed that memory improvement was based exclusively on retrieval processes, whereas no specific change was found for encoding and consolidation. However, the two groups of the second experiment showed no significant differences for the treatment, although the absolute scores pointed in the same direction as in the first experiment.	[Hildebrandt, Helmut] Klinikum Bremen Ost, Dept Neurol, D-28325 Bremen, Germany; [Hildebrandt, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Psychol, D-2900 Oldenburg, Germany; [Gehrmann, Annika; Moedden, Claudia] Rehabil Ctr Oldenburg, Neurol Rehabil Unit, Oldenburg, Germany; [Eling, Paul] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands		Hildebrandt, H (corresponding author), Klinikum Bremen Ost, Dept Neurol, Zuricher Str 40, D-28325 Bremen, Germany.	helmut.hildebrandt@uni-oldenburg.de	Eling, Paul/D-5786-2012				Baumler G., 1974, TEST LEARNING MEMORY; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BUSSMANNMORK BA, 2000, NEUROL REHABIL, V6, P195; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; Deisinger K., 1991, PSYCHOLOGISCHE RUNDS, V2, P55; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; Desgranges A, 2002, NEUROIMAGE, V17, P1658, DOI 10.1006/nimg.2002.1289; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Godefroy O, 2009, EUR NEUROL, V61, P223, DOI 10.1159/000197107; Goldstein G, 1996, CLIN NEUROPSYCHOL, V10, P66, DOI 10.1080/13854049608406664; Habib R, 2008, CEREB CORTEX, V18, P1720, DOI 10.1093/cercor/bhm201; Hildebrandt H, 1998, J CLIN EXP NEUROPSYC, V20, P673, DOI 10.1076/jcen.20.5.673.1119; Hildebrandt H., 2006, J NEUROL, V253, P631; HILDEBRANDT H, 2007, NEUROLOGIE REHABILIT, V13, P135; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; Horn W., 1983, SYSTEM ASSESMENT PER; Jennings JM, 2003, NEUROPSYCHOL REHABIL, V13, P417, DOI 10.1080/09602010244000390; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Lehrl S., 1991, MEHRFACHWAHL WORTSCH; Markowitsch H. J., 2003, NEUROPSYCHOLOGY, P448; Mayes AR, 1997, MEMORY, V5, P3, DOI 10.1080/741941147; McCarthy E. A., 1990, COGNITIVE NEUROPSYCH; Milders M. V., 1996, NEUROPSYCHOL REHABIL, V5, P223; Niemann H., 2002, DEUTSCHE NORMIERUNG; Park H, 2008, CEREB CORTEX, V18, P868, DOI 10.1093/cercor/bhm130; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Roediger HL, 2002, MEMORY, V10, P319, DOI 10.1080/09658210224000144; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Stark CEL, 2003, J NEUROSCI, V23, P6748; Thone A. I. T, 1999, NEURO REHABILITATION, P293; Thone-Otto A. I. T., 2010, NEUROLOGIE  REHABILI, V16, P63; WARRINGTON EK, 1982, NEUROPSYCHOLOGIA, V20, P233, DOI 10.1016/0028-3932(82)90099-9; Wechsler D, 1987, WECHSLER MEMORY SCAL; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; WILSON B, 1992, RIVERMEAD BEHAV MEMO; WILSON BA, 1995, HDB MEMORY DISORDERS, P451; Zimmermann P., 1992, TESTBATTERIE AUFMERK; Zola S.M., 2000, OXFORD HDB MEMORY, P485	47	5	6	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	2					257	270	PII 927575846	10.1080/13803395.2010.511471			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	715OV	WOS:000286894700012	20924913				2022-02-06	
J	Kesikburun, S; Omac, OK; Yasar, E; Hazneci, B; Alaca, R				Kesikburun, Serdar; Omac, Ozlem Koroglu; Yasar, Evren; Hazneci, Bulent; Alaca, Ridvan			Severe heterotopic ossification in the non-affected limbs of a hemiplegic patient with traumatic brain injury	BRAIN INJURY			English	Article						Heterotopic ossification; traumatic brain injury; complications		Background/objective: Heterotopic ossification characterized by new bone formation in the periarticular regions of large joints in patients with neurologic injury most commonly occurs on the neurologically involved side. This study presents a very rare localization of heterotopic ossification that developed in the non-paretic limbs of a hemiplegic patient with traumatic brain injury (TBI). Case report: A 25-year-old left hemiplegic male with TBI due to a gunshot wound was admitted to the rehabilitation centre after a 2.5-month period of coma in the intensive care unit. He had limited range of motion accompanied by pain in the bilateral hip, bilateral elbow and right knee joints. Neurological examination revealed upper motor neuron lesions only on the left side in neurological exam. Plain radiographs of the involved joints revealed bilateral heterotopic ossification, which was more severe on the non-paretic side. Discussion: Clinicians should keep in mind that heterotopic ossification can occur in non-hemiplegic extremities as well as hemiplegic extremities in patients with TBI in whom the extent of neurologic damage cannot be definitely established.	[Kesikburun, Serdar; Omac, Ozlem Koroglu; Yasar, Evren; Hazneci, Bulent; Alaca, Ridvan] Gulhane Mil Med Acad, Dept Phys Med & Rehabil, Turkish Armed Forces Rehabil Ctr, Ankara, Turkey		Kesikburun, S (corresponding author), TSK Rehabil Merkezi, TR-06530 Ankara, Turkey.	serdarkb@gmail.com	kesikburun, serdar/AAO-1445-2020	kesikburun, serdar/0000-0001-9400-4683			BAIRD EO, 2009, J ORTHOPAEDIC SURG R, V20, P4; Chan KT, 2005, AM J PHYS MED REHAB, V84, P145, DOI 10.1097/01.PHM.0000151939.59660.B1; Cifu DX, 2007, PHYS MED REHABILITAT, P1133; Cullen N, 2009, J HEAD TRAUMA REHAB, V24, P69, DOI 10.1097/HTR.0b013e31819a8fcc; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Kocaaga Z, 2007, J REHABIL MED, V39, P500, DOI 10.2340/16501977-0086; Safaz I, 2008, AM J PHYS MED REHAB, V87, P65, DOI 10.1097/PHM.0b013e31815b5b4d; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235	10	5	6	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2011	25	1					127	129		10.3109/02699052.2010.536198			3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700013	21142825				2022-02-06	
J	Lewis, FM; Murdoch, BE				Lewis, Fiona M.; Murdoch, Bruce E.			Language function in a child following mild traumatic brain injury: Evidence from pre- and post-injury language testing	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Mild traumatic brain injury; general language skills; high level language skills; pre- and post-injury performance	HEAD-INJURY; COMPREHENSION; PREDICTORS; DEFICITS	Objective: Pre- and post-injury language performance scores following mild traumatic brain injury (mTBI) were investigated through a replication and subsequent extension of a previous case study where a trend for declining language scores was described based on pre- and post-injury data. Methods: Test norms were used to descriptively analyze pre- and post-morbid language performance and performance score changes. Score changes were subsequently statistically analyzed using data obtained from a group of age-matched non-brain-injured control children. Results: Descriptive analysis identified a trend for declining skill on general and high-level language skills. Statistical analysis failed to differentiate the mTBI case from the control group on language score changes. Conclusions: While supporting the earlier identified trends in language decline following mTBI, subsequent statistical analysis undertaken to extend the earlier findings failed to detect statistically significant changes in language outcomes following mild injury. The need for monitoring of yet-to-emerge higher-level adolescent language skills, however, is highlighted.	[Lewis, Fiona M.; Murdoch, Bruce E.] Univ Queensland, Sch Hlth & Rehabil Sci, Ctr Neurogen Commun Disorders Res, Brisbane, Qld 4072, Australia		Lewis, FM (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Ctr Neurogen Commun Disorders Res, Brisbane, Qld 4072, Australia.	f.lewis@uq.edu.au	LEWIS, Fiona/F-9076-2010; Murdoch, Bruce E/C-1397-2012	LEWIS, Fiona/0000-0002-2181-1983; 	Motor Accident Insurance Commission of Queensland	This research was supported by a grant from the Motor Accident Insurance Commission of Queensland.	Aarsen FK, 2009, J CLIN ONCOL, V27, P3526, DOI 10.1200/JCO.2008.19.6303; AGRESTI A, 1997, STAT METHODS SOCIAL; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2007, DEV NEUROPSYCHOL, V32, P619, DOI 10.1080/87565640701375823; Bowers L., 2005, TEST PROBLEM SOLVING, V3; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Crawford JR, 2004, CORTEX, V40, P533, DOI 10.1016/S0010-9452(08)70145-X; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Didus E, 1999, Pediatr Rehabil, V3, P177; Docking K, 1999, BRAIN INJURY, V13, P953; Docking KM, 2007, BRAIN LANG, V103, P236, DOI 10.1016/j.bandl.2007.07.021; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Gennarelli T. A., 1987, HEAD INJURY, P108; Hammond-Tooke GD, 2010, J CLIN NEUROSCI, V17, P315, DOI 10.1016/j.jocn.2009.06.026; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; Katz D.I., 2007, BRAIN INJURY MED PRI, P3; Kennedy MRT, 2002, J MED SPEECH-LANG PA, V10, pIX; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lenneberg E.H., 1967, BIOL FDN LANGUAGE; Lillis KA, 1997, PEDIATR EMERG CARE, V13, P149, DOI 10.1097/00006565-199704000-00016; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Murdoch B. E., 2011, HDB ACQUIRED SPEECH; Napolitano E, 2007, BRAIN INJURY MED PRI, P57; Nippold M. A., 2007, LATER LANGUAGE DEV S; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Semel E., 2003, CLIN EVALUATION LANG; Wiig EH, 1989, TEST LANGUAGE CCOMPE; World Health Organization, 2008, HELM ROAD SAF MAN; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	40	5	5	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2011	14	6					348	354		10.3109/17518423.2011.620576			7	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	855UC	WOS:000297589600003	22136119	Green Submitted			2022-02-06	
J	Lupi, A; Bertagnoni, G; Borghero, A; Salgarello, M; Zanco, P				Lupi, Andrea; Bertagnoni, Giannettore; Borghero, Anna; Salgarello, Matteo; Zanco, Pierluigi			Relative Hypermetabolism of Vermis Cerebelli in Traumatic Brain Injured Patients Studied with 18FDG PET: A Descriptor of Brain Damage and a Possible Predictor of Outcome	CURRENT RADIOPHARMACEUTICALS			English	Article						Brain trauma; imaging; prognosis; vermis cerebelli		Purpose: The almost constant presence of apparent metabolic hypermetabolism of cerebellar vermis seen on 18FDG PET in a population of injured brains has been reported in a previous paper. Aim of this paper is to determine a) whether there is a correlation between the entity of this sign, semi quantitatively determined, and the severity of the trauma at its onset, and b) whether the entity of the relative enhancement correlates with the medium and long term clinical outcome. Methods: A group of 45 consecutive patients admitted to the Acquired Brain Injury Unit of our Hospital for recent, major head trauma, underwent a basal 18FDG PET/CT scan of the brain; the presence of relative hypermetabolism of the vermis cerebelli was visually assessed and semi quantitatively determined (vermis/cerebellum ratio: V/C); the median V/C value was used as a divide between low V/C ratios (group A) and high V/C ratios (group B). During one year after trauma, every patient from both groups received an extensive testing to evaluate cognitive and behavioral performances and evolution: Disability Rating Scale (DRS) and Levels of Cognitive Function (LCF) were administered monthly from month 1 to month 6, and at 12 months from the trauma; Glasgow Outcome Scale (GOS) was administered at 3, 6 and 12 months from the head trauma. Numerical scores from each of these performance-testing protocols were cross-matched with values derived from the V/C 18FDG PET/CT determinations. A relative risk estimate via Chi-square testing was performed on the results of both groups for LCF and DRS scales at 1, 6 and 12 months from trauma. Results: At one month after trauma, overall LCF (LCF1) values ranged from 2 to 8, avg. 3.77, SD +/- 2.10; the average value in group A was 5.21, SD +/- 2.09, in B group 2.47, SD +/- 0.98 (F= 17.5, P = 0). At this time, overall average DRS (DRS1) was 6.7, SD +/- 2.05, ranging from 2 to 9; the average value was 5.52, SD +/- 0.47 in group A, and 7.72, SD +/- 0.30 in group B (F= 6.3, P = 0.01). Relative risk estimates for patients with higher V/C ratios for poor performance in DRS scale were: 2.46 at 1 month (confidence boundaries 1.66 - 3.64), 3.75 (c. b. 1.64 - 8.64) at 6 months, 5.17 (c. b. 1.76 15.16) at one year. Relative risk estimates for LCF scale were: 3.20 (c. b. 1.74 - 5.90) at 1 month, 6.909 (c. b. 1.03 - 46.15) at 6 months, 4.22 (c. b. 0.65 - 27.10) at 12 months. Conclusions: A) there is a strong correlation between the semi quantitatively determined values of vermian relative hypermetabolism and the severity of trauma as determined by standard cognitive and performance testings; the V/C ratio may therefore be considered a reliable, although non- specific, index of brain suffering. B) there is a good statistical correlation between the semi quantitative vermian/cerebellar ratio determined shortly after the trauma, and the clinical outcome of the patients, evaluated by standard clinical performance tests and relative risk estimates.	[Lupi, Andrea; Salgarello, Matteo; Zanco, Pierluigi] Osped S Bortolo, Div Nucl Med, Via M Rodolfi, I-36100 Vicenza, Italy; [Bertagnoni, Giannettore; Borghero, Anna] Osped S Bortolo, Acquired Brain Injury Unit, Vicenza, Italy		Lupi, A (corresponding author), Osped S Bortolo, Div Nucl Med, Via M Rodolfi, I-36100 Vicenza, Italy.	andrea.lupi@ulssvicenza.it	Lupi, Andrea/AAI-8661-2020				Alavi A, 1997, J NUCL MED, V38, P1717; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Hattori N, 2003, J NUCL MED, V44, P1709; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S., 2004, ARCO GIANO, V41, P85; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	14	5	6	0	1	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1874-4710	1874-4729		CURR RADIOPHARM	Curr. Radiopharm.		2011	4	2					167	175		10.2174/1874471011104020167			9	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging	V21BJ	WOS:000214929400012	22191657				2022-02-06	
J	Pachalska, M; Ziolkowska, M				Pachalska, Maria; Ziolkowska, Marta			INDIVIDUAL HAPPINESS IN TERMS OF PROCESS NEUROPSYCHOLOGY	ACTA NEUROPSYCHOLOGICA			English	Article						traumatic brain injury (TBI); spinal cord injury (SCI); quality of life (QOL)		Background: The aim of this work was to discover what happiness means to a sample of healthy persons as compared to persons with brain and spinal injury resulting from an automobile accident. Material/Methods: Altogether 800 participants were examined; 300 (group A) were students, another 200 (group B) were persons randomly met by the authors in different social situations, and another 300 (group C) were patients with traumatic brain injury (TBI) or spinal cord injury (SCI). The Individual Happiness Scale was used in the study. Results: The great majority of participants found themselves generally happy, with healthy participants marking higher scores and disabled participants lower scores. Total happiness was most often understood as having a goal in life, a feeling of achieving the goal, and a close relationship. Losing a close partner was the main reason for unhappiness, along with loneliness, lack of love, lack of friends, loss of house or job, or being expelled from university. In group C, sickness, disability, pain and a feeling of insecurity (anxiety) related to death or dependence on others were listed as causes of unhappiness more often than in other groups. Conclusions: Disabled people feel subjectively less happy than students and random adults. Happiness can be understood as the fuel for human development (ontogenetic view) and evolution (phylogenetic view), whereas unhappiness supports the pro cess of disorganization, entropy and involution.	[Pachalska, Maria] Andrzej Frycz Modrzewski Cracow Univ, Neuropsychol, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY 10075 USA; [Ziolkowska, Marta] Psychol & Pedag Dispensary, Wroclaw, Poland		Pachalska, M (corresponding author), Andrzej Frycz Modrzewski Cracow Univ, Neuropsychol, Krakow, Poland.	neuropsychologia23@o2.pl					Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown J.W., 1988, LIFE OF THE MIND; BROWN JW, 2000, MIND NATURE; Dodge R., 1930, HIST PSYCHOL AUTOBIO; Owczarek K, 2010, ACTA NEUROPSYCHOL, V8, P297; Owczarek K, 2010, ACTA NEUROPSYCHOL, V8, P207; Pachalska M, 2001, Ortop Traumatol Rehabil, V3, P75; Pachalska M., 2003, NEUROPSYCHOLOGICZNE, P51; Pachalska M., 2000, 3 INT S EXP SPIN COR, P41; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Stabryla S., 1975, ANTOLOGIA TRAGEDI GR; Whitehead A.N., 1985, PROCESS REALITY	12	5	5	0	0	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	JAN-MAR	2011	9	1					19	30					12	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	V1K4H	WOS:000216984600002					2022-02-06	
J	Rabiu, TB				Rabiu, Taopheeq Bamidele			Revisiting the eye opening response of the Glasgow Coma Scale	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Eye closure response; eye opening response; Glasgow Coma Scale; traumatic brain injury		The Glasgow Coma Scale (GCS), introduced by Teasdale and Jenneth in 1974, has received tremendous acclaim from clinicians and has been extensively used in clinical practice for the evaluation of the level of consciousness. The author notes that some traumatic brain injury patients close eyes in response to painful stimuli as opposed to the eye opening response to pain of the GCS. A revision of the eye opening response subsection of the GCS is suggested.	[Rabiu, Taopheeq Bamidele] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria		Rabiu, TB (corresponding author), Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria.	eshohealth@gmail.com		Rabiu, Taopheeq/0000-0001-7138-875X			CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; JENNETT B, 1975, LANCET, V1, P480; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; TEASDALE G, 1974, LANCET, V2, P81; Wilson S F, 1988, J Neurosci Nurs, V20, P189	7	5	5	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JAN-MAR	2011	15	1					58	59		10.4103/0972-5229.78231			2	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3D3B	WOS:000218151400013	21633551	Green Published			2022-02-06	
J	Sorokina, EG; Vol'pina, OM; Semenova, ZB; Karaseva, OV; Koroev, DO; Kamynina, AV; Reutov, VP; Salykina, MA; Panova, AV; Goryunova, AV; Pinelis, VG; Roshal, LM				Sorokina, E. G.; Vol'pina, O. M.; Semenova, Zh. B.; Karaseva, O. V.; Koroev, D. O.; Kamynina, A. V.; Reutov, V. P.; Salykina, M. A.; Panova, A. V.; Goryunova, A. V.; Pinelis, V. G.; Roshal, L. M.			Autoantibodies to alpha 7-subunit of neuronal acetylcholine receptor in children with traumatic brain injury	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						traumatic brain injury; autoantibodies (aAB) to neuronal acetylcholine receptor (alpha 7-ACR)	CULTURED CORTICAL ASTROCYTES; INTRACELLULAR CA2+ INCREASE; PROTEINS; DISEASES	An objective of the study was to search for new biologically significant markers of brain damage. Levels of blood serum autoantibodies (aAB) to different fragments of alpha 7-subunit of acetylcholine receptor (ACR) were studied in children with traumatic brain injury of different severity. The more severe was trauma, the higher was the level of aAB to fragments of alpha 7-subunit of ACR in the first week after trauma. The data obtained suggest that alpha 7-subunits of ACR and aAB to them are involved in the pathogenesis of traumatic brain lesions and, probably, play a significant role in the course of post traumatic period.	[Sorokina, E. G.] Russian Acad Med Sci, Sci Ctr Childrens Hlth, Moscow 109801, Russia; Russian Acad Sci, MM Shemyakin Bioorgan Chem Inst, Moscow 117901, Russia; Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow 117901, Russia		Sorokina, EG (corresponding author), Russian Acad Med Sci, Sci Ctr Childrens Hlth, Moscow 109801, Russia.	sorokelena@mail.ru	Semenova, Zhanna/ABB-9352-2020; Kamynina, Anna/R-6461-2016; Reutov, Valentin P/O-2033-2013; Volpina, Olga/P-7454-2017; Pinelis, Vsevood/K-5564-2017	Karaseva, Olga/0000-0001-9418-4418; Pinelis, Vsevood/0000-0001-8579-605X; Volpina, Olga/0000-0003-0740-6110; Kamynina, Anna/0000-0002-9107-3891			Archelos JJ, 2000, TRENDS NEUROSCI, V23, P317, DOI 10.1016/S0166-2236(00)01575-7; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; GANNUSHKINA IV, 1974, IMMUNOLOGICHESKIE AS, P200; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Kamynina AV, 2010, J ALZHEIMERS DIS, V21, P249, DOI 10.3233/JAD-2010-091474; KHAITOV RM, 2002, IMMUNOLOGIYA, P534; Koller H, 2001, EUR J NEUROSCI, V14, P1793, DOI 10.1046/j.0953-816x.2001.01808.x; Koller H, 2001, BRAIN RES, V893, P237, DOI 10.1016/S0006-8993(00)03318-7; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; PINELIS VG, 2008, VESTNIK RAMN, V12, P44; Pleasure D, 2008, ARCH NEUROL-CHICAGO, V65, P589, DOI 10.1001/archneur.65.5.589; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Scott DA, 2006, WORLD J GASTROENTERO, V12, P7451, DOI 10.3748/wjg.v12.i46.7451; SOROKINA YEG, 2010, ZHURN NEVROL PSIKHIA, V208, P67; SOROKINA YEG, 2006, BYUL EKSP BIOL, V7, P59; SOROKINA YEG, 2008, ZHURN NEVROL PSIKHIA, V208, P67; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Vol'pina O M, 2006, Bioorg Khim, V32, P169; Vol'pina O M, 2008, Bioorg Khim, V34, P50; Whitney KD, 2000, J NEUROSCI, V20, P7307	25	5	9	0	4	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2011	111	4					56	60					5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	779KG	WOS:000291775900010	21512503				2022-02-06	
J	Doll, H; Maegele, M; Bohl, J; Storkel, S; Kipfmueller, F; Schaefer, U; Angelov, D; Wirth, S; Truebel, H				Doll, Hinnerk; Maegele, Marc; Bohl, Juergen; Stoerkel, Stephan; Kipfmueller, Florian; Schaefer, Ute; Angelov, Doychin; Wirth, Stefan; Truebel, Hubert			Pharyngeal Selective Brain Cooling Is Associated with Reduced CNS Cortical Lesion after Experimental Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						body weight modulation; immunochemistry; selective brain cooling; therapeutic hypothermia; traumatic brain injury	FLUID-PERCUSSION MODEL; THERAPEUTIC HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CARDIAC-ARREST; BEHAVIORAL DEFICITS; TEMPERATURE; PROTECTION; IMPACT; NEUROPROTECTION	Therapeutic hypothermia (TH) is still being explored as a therapeutic option after traumatic brain injury (TBI) but clinical data has not supported its efficacy. Experimental approaches were promising, but clinical data did not support its efficacy in the treatment of TBI. A novel approach of pharyngeal selective brain cooling (pSBC), recently introduced by our group, has been accompanied by superior neurofunctional, sensorimotor, and cognitive outcomes. This work is now extended by data on histomorphological and physical outcomes after pSBC in a model of experimental TBI. Male Sprague-Dawley rats were subjected to lateral fluid-percussion (LFP) brain injury, and randomized to the following experimental groups: (1) TBI with pSBC, (2) TBI without pSBC, and (3) sham animals. On day post-injury (DPI) 14, the animals were sacrificed and their brains were harvested for immunohistochemistry using the following antibodies: (1) glial fibrillary acidic protein (GFAP), (2) neurofilament (NF), and (3) synaptophysin (SY). In pSBC animals brain temperature was selectively lowered to 33 +/- 0.5 degrees C within 15 min post-injury, and maintained for 180 min after induction, while keeping rectal temperatures at physiological levels. Animals that had undergone pSBC showed a significantly faster recovery of body weight starting on DPI 3, and had gained substantially more weight than TBI-only animals on DPI 14 (p<0.001), indicating superior physical recovery. Areas of cortical damage were significantly smaller in pSBC animals compared to TBI-only animals (p<0.01). pSBC was associated with preservation of cortical tissue ipsilateral to the lesion, and superior physical recovery after experimental TBI. These results complement earlier reports in which pSBC was associated with superior neurofunctional and cognitive outcomes using the same experimental model.	[Doll, Hinnerk; Kipfmueller, Florian; Wirth, Stefan; Truebel, Hubert] Univ Witten Herdecke, Helios Klinikum Wuppertal, Dept Pediat, D-42283 Wuppertal, Germany; [Stoerkel, Stephan] Univ Witten Herdecke, Helios Klinikum Wuppertal, Inst Pathol, D-42283 Wuppertal, Germany; [Doll, Hinnerk; Maegele, Marc; Kipfmueller, Florian] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Maegele, Marc] Univ Witten Herdecke, Cologne Merheim Med Ctr CMMC, Dept Traumatol & Orthoped Surg, Cologne, Germany; [Truebel, Hubert] Yale Univ, Dept Pediat, Sect Appl Physiol & Pediat Crit Care, New Haven, CT 06520 USA; [Bohl, Juergen] Univ Med Mainz, Dept Pathol, Mainz, Germany; [Schaefer, Ute] Med Univ Graz, Univ Hosp Neurosurg, Graz, Austria; [Angelov, Doychin] Univ Cologne, Inst Anat, Cologne, Germany; [Truebel, Hubert] Bayer HealthCare, Global Drug Dev, Cardiol Res, Vasc Dis, Wuppertal, Germany		Doll, H (corresponding author), Univ Witten Herdecke, Helios Klinikum Wuppertal, Dept Pediat, Heusnerstr 40, D-42283 Wuppertal, Germany.	hinnerk.doll@uni-wh.de			Witten/Herdecke University, Cologne, Germany	The illustrations by Lukas Kretschmer, the extraordinary histological preparations done by Silvia Vogel, MTA, and the technical assistance by Rainer Kobrich, Ph.D. (Marquet (R)) are greatly appreciated. This study was supported by a staff position (Rotationsstelle 2006) at the Witten/Herdecke University, Cologne, Germany.	Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biagas Katherine V., 1998, Current Opinion in Pediatrics, V10, P271, DOI 10.1097/00008480-199806000-00009; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1998, PEDIATRICS, V102, P1098, DOI 10.1542/peds.102.5.1098; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Gunn TR, 1999, PEDIATRICS, V103, P1079, DOI 10.1542/peds.103.5.1079; Harris BA, 2007, BRIT J ANAESTH, V98, P93, DOI 10.1093/bja/ael308; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horn AR, 2006, SAMJ S AFR MED J, V96, P976; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kinoshita K, 2003, ACTA NEUROCHIR SUPPL, V86, P377; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Polderman KH, 2002, INTENS CARE MED, V28, pS103; Polderman KH, 2002, CRIT CARE MED, V30, P1932, DOI 10.1097/00003246-200208000-00058; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Reynolds JC, 2007, RESUSCITATION, V74, P13, DOI 10.1016/j.resuscitation.2006.10.032; Schafer S, 2008, DRUG DISCOV TODAY, V13, P913, DOI 10.1016/j.drudis.2008.03.026; Thoresen M, 2001, PEDIATR RES, V49, P594, DOI 10.1203/00006450-200104000-00024; Tooley JR, 2005, ARCH DIS CHILD-FETAL, V90, P262, DOI 10.1136/adc.2003.044305; Trubel H, 2004, INTENS CARE MED, V30, P1829, DOI 10.1007/s00134-004-2350-1; Trubel H, 2003, BIOMED TECH, V48, P298, DOI 10.1515/bmte.2003.48.11.298; Trubel HKF, 2003, J APPL PHYSIOL, V94, P1641, DOI 10.1152/japplphysiol.00841.2002; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	50	5	5	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2010	27	12					2245	2254		10.1089/neu.2010.1505			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	691PN	WOS:000285093400013	20939694				2022-02-06	
J	Schliemann, B; Schildhauer, TA; Seybold, D				Schliemann, B.; Schildhauer, T. A.; Seybold, D.			Posterior dislocation of the shoulder. Diagnosis and treatment strategies	OBERE EXTREMITAET-SCHULTER-ELLENBOGEN-HAND-UPPER EXTREMITY-SHOULDER ELBOW HAND			German	Article						Shoulder dislocation; Locked shoulder dislocation; McLaughlin procedure; Shoulder instability; Grafting, bone		Posterior dislocation of the shoulder is a rare injury and is often misdiagnosed at initial presentation. Shoulder function improves over the course of time with the joint still in locked dislocation. Misdiagnosis is due to a lack of clear clinical signs compared to anterior dislocation; thus, appropriate x-rays (i.e., true anterior-posterior and axial views) are indispensible. However, posterior dislocation frequently becomes chronic and closed reduction is not successful any more. In contrast to anterior dislocations, the humeral head defect accounts for recurrent instability. Depending on the size of the defect and the duration of the dislocation, there are different treatment options, including elevation of the defect, bone grafting, McLaughlin procedure, rotation osteotomy, and arthroplasty. The patient's outcome strongly depends on the size of the humeral head defect and the interval between trauma and definite diagnosis. The smaller the defect and the quicker the diagnosis is made, the better the results. Recurrent dislocations rarely occur in comparison to traumatic anterior instability.	[Schliemann, B.] Uniklin Munster, Klin & Poliklin Unfall Hand & Wiederherstellungsc, Munster, Germany; [Schildhauer, T. A.; Seybold, D.] Berufsgenossenschaftliches Univ Klinikum Bergmann, Chirurg Klin & Poliklin, Burkle de la Camp Pl 1, D-44789 Bochum, Germany		Seybold, D (corresponding author), Berufsgenossenschaftliches Univ Klinikum Bergmann, Chirurg Klin & Poliklin, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	dseybold@mac.com					BLASIER RB, 1988, CLIN ORTHOP RELAT R, P197; BROWN RJ, 1984, INJURY, V15, P267, DOI 10.1016/0020-1383(84)90012-3; Cautilli R A, 1978, Am J Sports Med, V6, P397, DOI 10.1177/036354657800600616; Charalambous CP, 2009, ARCH ORTHOP TRAUM SU, V129, P753, DOI 10.1007/s00402-008-0721-8; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; Cicak N, 2004, J BONE JOINT SURG BR, V86B, P324, DOI 10.1302/0301-620X.86B3.14985; Cooper A., 1839, GUYS HOSP REP, V4, P265; Delcogliano A, 2005, KNEE SURG SPORT TR A, V13, P151, DOI 10.1007/s00167-004-0524-6; Dervin GF, 2002, J BONE JOINT SURG AM, V84A, P804, DOI 10.2106/00004623-200205000-00018; Diklic ID, 2010, J BONE JOINT SURG BR, V92B, P71, DOI 10.1302/0301-620X.92B1.22142; DORGAN JA, 1955, AM J SURG, V89, P890, DOI 10.1016/0002-9610(55)90159-8; Duralde XA, 2006, J SHOULDER ELB SURG, V15, P701, DOI 10.1016/j.jse.2006.04.003; ENGELHARDT MB, 1978, SOUTHERN MED J, V71, P425, DOI 10.1097/00007611-197804000-00024; Gavriilidis I, 2010, INT ORTHOP, V34, P79, DOI 10.1007/s00264-009-0762-9; Gerber C, 2002, CLIN ORTHOP RELAT R, P65; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; HELLER KD, 1994, ARCH ORTHOP TRAUM SU, V113, P228, DOI 10.1007/BF00441838; HILL N A, 1963, J Trauma, V3, P225, DOI 10.1097/00005373-196305000-00004; Hughes M, 1975, Phys Ther, V55, P850; Itoi E, 2003, J SHOULDER ELB SURG, V12, P413, DOI 10.1016/S1058-2746(03)00171-X; Itoi E, 2001, J BONE JOINT SURG AM, V83A, P661, DOI 10.2106/00004623-200105000-00003; Itoi E, 2007, J BONE JOINT SURG AM, V89A, P2124, DOI 10.2106/JBJS.F.00654; Jensen KL, 2009, SHOULDER, P177; KELLY JP, 1954, J BONE JOINT SURG BR, V36, P70, DOI 10.1302/0301-620X.36B1.70; KEPPLER P, 1994, J ORTHOP TRAUMA, V8, P286, DOI 10.1097/00005131-199408000-00003; Khayal T, 2009, ARCH ORTHOP TRAUM SU, V129, P515, DOI 10.1007/s00402-008-0762-z; Kirchhoff C, 2007, UNFALLCHIRURG, V110, P1059, DOI 10.1007/s00113-007-1285-8; Levigne C, 2008, SHOULDER CONCEPTS 20, P121; Matsen FA, 2009, SHOULDER, P617; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; MCLAUGHLIN HL, 1963, SURG CLIN N AM, V43, P1615; MESTDAGH H, 1994, ANN CHIR, V48, P355; Modi Chetan S, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-43; MOELLER JC, 1975, J BONE JOINT SURG AM, V57, P1006, DOI 10.2106/00004623-197557070-00029; OCONNOR SJ, 1955, J BONE JOINT SURG AM, V37, P1122; Petersen SA, 2000, ORTHOP CLIN N AM, V31, P263, DOI 10.1016/S0030-5898(05)70146-2; Purchase RJ, 2008, ARTHROSCOPY, V24, P723, DOI 10.1016/j.arthro.2008.03.015; Randelli M, 2001, SURG TECHNIQUES ORTH; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; Schliemann B, 2009, SPORTVERLETZ SPORTSC, V23, P100, DOI 10.1055/s-0028-1109418; Schliemann B, 2010, J SHOULDER ELB UNPUB; Schoenfeld AJ, 2007, J ORTHOP TRAUMA, V21, P150, DOI 10.1097/BOT.0b013e318032c4a9; Seybold D, 2006, CHIRURG, V77, P821, DOI 10.1007/s00104-006-1181-8; SEYBOLD D, 2007, C GERM ASS SHOULD EL; Spencer EE, 2005, J SHOULDER ELB SURG, V14, P650, DOI 10.1016/j.jse.2004.11.008; Sperling JW, 2004, J SHOULDER ELB SURG, V13, P522, DOI 10.1016/j.jse.2004.02.012; Steinitz DK, 2003, AM J SPORT MED, V31, P1010, DOI 10.1177/03635465030310060301; Tibone JE, 1997, OPERATIVE TECHNIQUES, P273; WEBER BG, 1984, J BONE JOINT SURG AM, V66A, P1443, DOI 10.2106/00004623-198466090-00019; Wiedemann E, 2010, SCHULTERCHIRURGIE, P437; WIRTH MA, 1994, CLIN ORTHOP RELAT R, P98	52	5	5	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1862-6599	1862-6602		OBERE EXTREMITAET-SC	Obere Extremitaet-Schulter-Ellenbogen-Hand	DEC	2010	5	4					216	224		10.1007/s11678-010-0092-y			9	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V6F8F	WOS:000420244800004					2022-02-06	
J	Schultz, IZ				Schultz, Izabela Z.			Neurocognitive Disorders in DSM-V: Forensic Perspective	PSYCHOLOGICAL INJURY & LAW			English	Article						Neurocognitive disorders; DSM-V; Forensic; Validity; Neuropsychological testing	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL INJURY; DISABILITY QUAGMIRE; META-STRUCTURE; DEPRESSION; MEMORY; SCHIZOPHRENIA; DEMENTIA; NEUROPATHOLOGY	Although determination of diagnosis of cognitive impairments constitutes one of the core objectives of forensic neuropsychological assessment, the diagnostic criteria for cognitive disorders provided by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR, American Psychiatric Association 2000) have been of low internal and external validity and limited utility. This paper reviews the evolution of diagnosis of cognitive disorders from current DSM-IV-TR to the proposed DSM-V (American Psychiatric Association 2010). The conceptual framework is tracked, along with the body of literature associated with the DSM-V proposal on Minor and Major Neurocognitive Disorders. The quality of evidence for internal and external validity is reviewed, as well as the fairness and utility of newly proposed diagnoses from both clinical and forensic perspectives. Significant conceptual, evidentiary, psychometric, assessment, and practical questions are raised related to the new classification, and recommendations are offered for improvement to the proposal of the DSM-V Work Group on Neurocognitive Disorders.	[Schultz, Izabela Z.] Univ British Columbia, Fac Educ, Dept Educ & Counselling Psychol & Special Educ, 2125 Main Mall, Vancouver, BC V6T 1Z4, Canada		Schultz, IZ (corresponding author), Univ British Columbia, Fac Educ, Dept Educ & Counselling Psychol & Special Educ, 2125 Main Mall, Vancouver, BC V6T 1Z4, Canada.	ischultz@telus.net					AERA, 1999, STAND ED PSYCH TEST; American Medical Association, 1993, GUIDES EVALUATION PE; American Medical Association, 2008, GUIDES EVALUATION PE, V6; American Medical Association, 2000, GUIDES EVALUATION PE; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 2010, PROP DRAFT REV DSM D; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychological Association, 2010, GUID ASS INT I UNPUB; Andrews G, 2009, PSYCHOL MED, V39, P1993, DOI 10.1017/S0033291709990250; Antepohl W, 2003, NEUROREHABILITATION, V18, P307; Aycicegi-Dinn A, 2009, INT J NEUROSCI, V119, P600, DOI 10.1080/00207450802543783; Barth JT, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P271, DOI 10.1007/0-387-25610-5_15; Belanger H. G., 2007, J INT NEUROPSYCH SOC, V13, P723; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Beutler L. E., 2003, INTERGRATIVE ASSESSM; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Bucci P, 2007, ACTA PSYCHIAT SCAND, V115, P380, DOI 10.1111/j.1600-0447.2006.00911.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen-Mansfield J, 1998, AGING MENT HEALTH, V2, P313, DOI 10.1080/13607869856560; Collie A, 2002, AUST NZ J PSYCHIAT, V36, P133, DOI 10.1046/j.1440-1614.2002.00972.x; Delaloye C, 2008, EUR NEUROL, V60, P149, DOI 10.1159/000144086; First MB, 2009, PSYCHOL MED, V39, P2091, DOI 10.1017/S0033291709991152; FLETCHER JM, 1985, NEUROPSYCHOLOGY LEAR, P00187; Frances A., 2010, REOPENING PANDORAS B; Frances A., 2010, RENORMALITY IS ENDAN; Frances A, 2010, J AM ACAD PSYCHIATRY, V38, P11; Gordeev S A, 2008, Neurosci Behav Physiol, V38, P707, DOI 10.1007/s11055-008-9036-z; Grisart J, 2002, J CLIN EXP NEUROPSYC, V24, P994, DOI 10.1076/jcen.24.8.994.8380; Gualtieri CT, 2008, J CLIN PSYCHIAT, V69, P1122, DOI 10.4088/JCP.v69n0712; Guilmette TJ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P303, DOI 10.1007/0-387-28919-4_16; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heaton RK, 1991, COMPREHENSIVE NORMS; HEATON RK, 1996, NEUROPSYCHOLOGICAL A; Hoge CW, 2010, ARCH PHYS MED REHAB, V91, P963, DOI 10.1016/j.apmr.2010.02.005; Hwang TJ, 2004, ALZ DIS ASSOC DIS, V18, P17, DOI 10.1097/00002093-200401000-00004; Iverson G. I., 2008, MOTOR VEHICLE COLLIS, P243; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Jelinek L, 2006, J CLIN EXP NEUROPSYC, V28, P940, DOI 10.1080/13803390591004347; Jeste D, 2010, NEUROCOGNITIVE DISOR; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KENDELL RE, 1989, PSYCHOL MED, V19, P45, DOI 10.1017/S0033291700011016; Kurz AF, 2010, INT PSYCHOGERIATR, V22, P37, DOI 10.1017/S1041610209991013; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Levin RL, 2007, COGNITIVE THER RES, V31, P211, DOI 10.1007/s10608-007-9128-z; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Loewenstein DA, 2009, DEMENT GERIATR COGN, V27, P418, DOI 10.1159/000211803; Luis CA, 2003, NEUROLOGY, V61, P438, DOI 10.1212/01.WNL.0000080366.90234.7F; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; McClintock SM, 2010, CNS SPECTRUMS, V15, P304, DOI 10.1017/S109285290002753X; MELTON GB, 2007, PSYCHOL EVALUATIONS; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Monzon S, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-48; Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; PENNINGTON BF, 2002, DEV PSYCHOPATHOLOGY; Perneczky R, 2006, AGE AGEING, V35, P240, DOI 10.1093/ageing/afj054; Petersen RC, 2006, J GERIATR PSYCH NEUR, V19, P147, DOI 10.1177/0891988706291085; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Robins E., 1970, AM J PSYCHIAT, V127, P107, DOI DOI 10.1176/AJP.126.7.983; Rockwood K, 2007, CAN J NEUROL SCI, V34, pS90, DOI 10.1017/S0317167100005643; Ropacki SA, 2005, AM J PSYCHIAT, V162, P2022, DOI 10.1176/appi.ajp.162.11.2022; Royall D, 2003, J AM GERIATR SOC, V51, P277, DOI 10.1046/j.1532-5415.2003.51072.x; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Ruff RM, 1999, BRAIN INJURY, V13, P943; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sachdev P, 2009, PSYCHOL MED, V39, P2001, DOI 10.1017/S0033291709990262; Sachs-Ericsson N, 2008, AGING MENT HEALTH, V12, P183, DOI 10.1080/13607860801951739; Sbordone R. J., 2000, NEUROPSYCHOLOGICAL A, P94; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; Scherer MJ, 1998, DESIGNING AND USING ASSISTIVE TECHNOLOGY, P99; Schultz I. Z., 2000, DETERMINATION UNPUB; Schultz I. Z., 2003, PSYCHOL INJURIES TRI; Schultz IZ, 2008, PSYCHOL INJ LAW, V1, P103, DOI 10.1007/s12207-008-9007-2; Schultz IZ, 2008, PSYCHOL INJ LAW, V1, P94, DOI 10.1007/s12207-008-9011-6; Simeonsson RJ, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P1; Skelley SL, 2008, SCHIZOPHR RES, V105, P78, DOI 10.1016/j.schres.2008.05.027; Sonn U, 1999, SCAND J OCCUP THER, V6, P11, DOI DOI 10.1080/110381299443807; Tan HY, 2009, ANN ACAD MED SINGAP, V38, P420; Tan Hao-Yang, 2009, Cogn Neuropsychiatry, V14, P277, DOI 10.1080/13546800903091665; TORNQUIST K, 1994, SCAND J OCCUP THER, V1, P6976, DOI DOI 10.3109/11038129409106665; VANDERMERWE R, 2000, CUEDFINFENGTR380, P1; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vane J. R., 1987, PSYCHOL EVALUATION D, P19; VISSER PJ, 2006, PRINCIPLES PRACTICE; Walsh ND, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-69; Weickert TW, 2010, BIOL PSYCHIAT, V67, P948, DOI 10.1016/j.biopsych.2009.12.027; Weiner DK, 2006, RELATIONSHIP PAIN NE; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Young G., 2007, CAUSALITY PSYCHOL IN	99	5	5	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2010	3	4					271	288		10.1007/s12207-010-9090-z			18	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3ZG	WOS:000415451700003					2022-02-06	
J	Neese, SL; Clough, RW; Banz, WJ; Smith, DC				Neese, Steven L.; Clough, Rich W.; Banz, William J.; Smith, Douglas C.			Z-Bisdehydrodoisynolic acid (Z-BDDA): An estrogenic seco-steroid that enhances behavioral recovery following moderate fluid percussion brain injury in male rats	BRAIN RESEARCH			English	Article						Estrogen; Traumatic Brain Injury; Fluid Percussion Injury; Behavioral Recovery; Neuroprotection; Rats	(+)-Z-BISDEHYDRODOISYNOLIC ACID; HORMONE REPLACEMENT; RECEPTOR MODULATOR; WATER-MAZE; ESTRADIOL; PROGESTERONE; TAMOXIFEN; NEUROPROTECTION; STIMULATION; ACQUISITION	Several lines of research suggest that estrogens (and estrogenic compounds) are neuroprotective following experimental traumatic brain injury. However, therapeutic use of estrogens in this and other regards remains controversial. Therefore, analysis of estrogen-like compounds without potential problems similar to estrogens seems warranted. (+/-) Z-Bisdehydrodoisynolic acid (Z-BDDA) is a seco-steroid that has potent estrogenic as well as antioxidant activities in vitro and in vivo. We evaluated the therapeutic potential of Z-BDDA (300 mu g/0.1 cc./100 g body weight, sc) to promote the recovery of behavioral function following lateral fluid percussion injury (FPI) to the brain in male rats. Two hours subsequent to FPI, treatment with Z-BDDA began with a bolus subcutaneous (sc) injection followed by booster treatments given 24 and 48 h later. Behavioral testing was initiated on the second day after FPI and results of Z-BDDA treatments were compared to treatment with vehicle only and to sham FPI surgery. Z-BDDA effectively enhanced recovery of coordinated limb movement assessed by locomotor placing performance across the duration of the study. Z-BDDA treated animals also performed better on a spatial memory task in the Morris water maze, showing improved learning curves across days of testing. Vestibulomotor function, measured by beam walk performance, appeared to improve in Z-BDDA treated animals, however these results did not reach statistical significance (p > 0.05). Following cessation of the behavioral testing, all animals underwent assessments of gross neuroanatomical pathology. Cortical lesion size and cell death analysis with Fluoro-jade B failed to reveal Z-BDDA enhanced neuroprotection. These findings support our hypothesis that Z-BDDA can facilitate behavioral recovery following FPI in adult male rats although the mechanism(s) of these effects remain to be determined. (C) 2010 Elsevier B.V. All rights reserved.	[Clough, Rich W.] So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA; [Neese, Steven L.; Smith, Douglas C.] So Illinois Univ, Brain & Cognit Sci Program, Dept Psychol, Carbondale, IL 62901 USA; [Banz, William J.] So Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA		Clough, RW (corresponding author), So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA.	rclough@siumed.edu			National Institute of Neurological Stroke and DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 41551]	The authors would like to thank Bryce James, Melissa Swisher, Luke Sherrill and Arlene Tan for their technical assistance in surgeries and with collection of the behavioral and anatomical data. Supported in part by a National Institute of Neurological Stroke and Disorders grant NS 41551 to D.C.S.	Adler M, 2006, ENDOCRINOLOGY, V147, P3952, DOI 10.1210/en.2006-0316; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Auriat A, 2005, J CEREBR BLOOD F MET, V25, P247, DOI 10.1038/sj.jcbfm.9600026; Azcoitia I, 2002, NEUROTOX RES, V4, P235, DOI 10.1080/10298420290033232; Banz WJ, 2008, FASEB J, V22; Banz WJ, 2005, OBES RES, V13, P1915, DOI 10.1038/oby.2005.236; Banz WJ, 1998, HORM METAB RES, V30, P730, DOI 10.1055/s-2007-978968; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Chesler EJ, 2000, HORM BEHAV, V38, P234, DOI 10.1006/hbeh.2000.1626; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; CLOUGH RW, 1983, AM J ANAT, V167, P205, DOI 10.1002/aja.1001670206; Clough RW, 2005, FASEB J, V19, pA796; Conti AC, 1998, J NEUROSCI, V18, P5663; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Daniel JM, 2004, NEUROBIOL LEARN MEM, V82, P142, DOI 10.1016/j.nlm.2004.06.001; DonCarlos Lydia L, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS113, DOI 10.1016/j.psyneuen.2009.04.012; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Green P S, 2000, Novartis Found Symp, V230, P202, DOI 10.1002/0470870818.ch15; Gresack JE, 2006, PHARMACOL BIOCHEM BE, V84, P112, DOI 10.1016/j.pbb.2006.04.013; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Henry N, 2001, BIOL REPROD, V64, P227; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Markham JA, 2002, HORM BEHAV, V42, P284, DOI 10.1006/hbeh.2002.1819; MATSUMOTO A, 1977, BRAIN RES, V129, P375, DOI 10.1016/0006-8993(77)90019-1; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; MEYERS CY, 1988, J STEROID BIOCHEM, V31, P393, DOI 10.1016/0022-4731(88)90307-X; Meyers CY, 2002, J STEROID BIOCHEM, V82, P33, DOI 10.1016/S0960-0760(02)00150-4; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Morey AK, 1998, BIOCHEM J, V330, P1097; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neese SL, 2007, J HISTOTECHNOL, V30, P109, DOI 10.1179/his.2007.30.2.109; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rustemeyer J, 2007, BRIT J ORAL MAX SURG, V45, P556, DOI 10.1016/j.bjoms.2007.01.003; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; TERENIUS L, 1967, ACTA PHARMACOL TOX, V25, P313; VANBUREN GA, 1992, AM J OBSTET GYNECOL, V167, P828, DOI 10.1016/S0002-9378(11)91597-X; Wilson T, 2002, LIFE SCI, V70, P2287, DOI 10.1016/S0024-3205(02)01483-2; Wise PM, 2003, ENDOCRINE, V21, P11, DOI 10.1385/ENDO:21:1:11; Wise PM, 2001, BRAIN RES REV, V37, P313, DOI 10.1016/S0165-0173(01)00136-9; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Yang Xiao-feng, 2005, Chin J Traumatol, V8, P96; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	59	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 29	2010	1362						93	101		10.1016/j.brainres.2010.09.055			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	685ZU	WOS:000284667400010	20869954				2022-02-06	
J	Jha, S; Ansari, MK				Jha, Sanjeev; Ansari, M. K.			Partial Kluver-Bucy syndrome in a patient with acute disseminated encephalomyelitis	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Acute disseminated encephalomyelitis; Herpes simplex encephalitis; Hypermetamorphosis; Hyperorality; Hypersexuality; Kluver-Bucy; Visual agnosia	MULTIPLE-SCLEROSIS	The symptoms of Kluver-Bucy syndrome (KBS) include hyperorality, hypersexuality, visual agnosia, hypermetamorphosis and decreased motor or vocal reaction to fear- or anger-provoking stimuli. This syndrome has been associated with a wide variety of neurodegenerative disorders, as well as traumatic, non-traumatic and infectious brain injuries. We report an 11-year-old boy who developed a fairly classical presentation of KBS, presumably in the setting of post-infectious acute disseminated encephalomyelitis (ADEM). This patient's presentation is a reminder of this rare syndrome and extends the clinical manifestations of ADEM, which is a relatively more common condition. (c) 2010 Elsevier Ltd. All rights reserved.	[Jha, Sanjeev; Ansari, M. K.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Lucknow 226014, Uttar Pradesh, India		Jha, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Raebareli Rd, Lucknow 226014, Uttar Pradesh, India.	sjha@sgpgi.ac.in					Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Duggal H. S., 2000, Indian Journal of Pediatrics, V67, P74; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Habek M, 2006, CLIN NEUROL NEUROSUR, V108, P290, DOI 10.1016/j.clineuro.2005.11.024; Hahn CD, 2003, PEDIATR NEUROL, V29, P117, DOI 10.1016/S0887-8994(03)00143-7; HOREL JA, 1969, BRAIN RES, V16, P281, DOI 10.1016/0006-8993(69)90103-6; Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308; Kluver H, 1938, J PSYCHOL, V5, P33; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; LANSKA DJ, 1994, J CHILD NEUROL, V9, P67, DOI 10.1177/088307389400900117; Leake JAD, 2004, PEDIATR INFECT DIS J, V23, P756, DOI 10.1097/01.inf.0000133048.75452.dd; Madan S, 2005, INDIAN PEDIATR, V42, P367; MARLOWE W B, 1975, Cortex, V11, P53; Menge T, 2005, ARCH NEUROL-CHICAGO, V62, P1673, DOI 10.1001/archneur.62.11.1673; MISRA UK, 1994, NEUROL INDIA, V42, P29; Muhammad A., 2004, PROFESSIONAL, V11, P416; Pitt C, PEDIAT NEUROL, P73; Pradhan S, 1998, CLIN NEUROL NEUROSUR, V100, P254, DOI 10.1016/S0303-8467(98)00055-9; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; SHRABERG D, 1978, J NERV MENT DIS, V166, P130, DOI 10.1097/00005053-197802000-00008; Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f; Yilmaz C, 2008, J EMERG MED, V35, P210, DOI 10.1016/j.jemermed.2007.05.051	22	5	5	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2010	17	11					1436	1438		10.1016/j.jocn.2010.03.015			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705JF	WOS:000286124000020	20638284				2022-02-06	
J	Eberl, R; Saxena, A; Fruhmann, J; Hollwarth, ME; Weinberg, AM				Eberl, R.; Saxena, A.; Fruhmann, J.; Hoellwarth, M. E.; Weinberg, A. M.			Treatment of pediatric radial neck fractures. Consideration of patient age and fracture dislocation	CHIRURG			German	Article						Radial neck fracture; Age; Dislocation; Treatment	CLOSED REDUCTION; PROXIMAL RADIUS; PROGNOSIS; CHILDREN	Fractures of the radial neck represent approximately 5-10% of all injuries of the elbow in children. Depending on the degree of radial head displacement, either an operative intervention or conservative treatment is recommended. The medical records of 168 children treated between 1999 and 2008 were analyzed and fractures were classified according to the Judet classification system. The fractures were treated according to an algorithm depending on age and fracture dislocation and 103 type I, 21 type II, 30 type III and 14 type VI fractures were found. Conservative treatment was possible in 124 patients and 44 were treated operatively. The overall outcome was good.	[Eberl, R.; Saxena, A.; Fruhmann, J.; Hoellwarth, M. E.; Weinberg, A. M.] Univ Klinikum Graz, Univ Klin Kinder & Jugendchirurg, A-8036 Graz, Austria		Eberl, R (corresponding author), Univ Klinikum Graz, Univ Klin Kinder & Jugendchirurg, Auenbruggerpl 34, A-8036 Graz, Austria.	robert.eberl@meduni-graz.at	Saxena, Amulya K/AAM-5872-2020	Saxena, Amulya K/0000-0002-7635-7490			Chambers HG, 1996, FRACTURES CHILDREN, P586; Dunlop J, 1935, J BONE JOINT SURG, V17, P584; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; JUDET J, 1962, Ann Chir, V16, P1377; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66, DOI 10.1302/0301-620X.71B1.2915009; LAER L, 1997, ELLBOGEN ORTHOPADE, V26, P1030; LAER L, 1984, SKELETT TRAUMATA WAC; LINSCHEI.RL, 1965, J AMER MED ASSOC, V194, P1171, DOI 10.1001/jama.194.11.1171; Metaizeau JP, 2005, INJURY, V36, pA75, DOI 10.1016/j.injury.2004.12.016; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; ODGEN JA, 1982, SKELETAL INJURY CHIL; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; TACHDJIAN MO, 1990, PEDIAT ORTHOPEDICS, P3136; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; Ursei Monica, 2006, Acta Orthop Belg, V72, P131; VAHVANEN V, 1978, ACTA ORTHOP SCAND, V49, P32, DOI 10.3109/17453677809005720; Vocke AK, 1998, UNFALLCHIRURG, V101, P287, DOI 10.1007/s001130050270; Vocke AK, 1998, J PEDIATR ORTHOP B, V7, P217, DOI 10.1097/01202412-199807000-00007; Weinberg AM, 2006, UNFALLCHIRURGIE KIND	21	5	5	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-4722	1433-0385		CHIRURG	Chirurg	OCT	2010	81	10					915	921		10.1007/s00104-010-1915-5			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	667DJ	WOS:000283172500008	20237746				2022-02-06	
J	Anschutz, JR; Luther-Krug, M; Seel, RT				Anschutz, John R.; Luther-Krug, Michelle; Seel, Ronald T.			A Verbal Cuing Device for Persons With Brain Injury: Development and Proof-of-Concept Case Study	TOPICS IN STROKE REHABILITATION			English	Article						assistive technology; driving; rehabilitation; stroke; traumatic brain injury	FOLLOW-UP; RETURN; REHABILITATION; POSTINJURY; DRIVERS; RISK; TBI	The ability to successfully return to driving following neurologic injury is one of the most critical factors in re-establishing independence and the most notable safety concern of health providers and family members. This assistive technology study describes the development of a verbal cuing device called the Electronic Driving Coach used as an adjunct to driver training following brain injury. We review literature on rates of return to driving following brain injury and factors associated with predicting return to driving and driving ability. We then address critical factors to return to driving addressed by this emerging technology and describe how the verbal cuing device called the Electronic Driving Coach was designed. We provide a proof-of-concept case study that evaluates use of the verbal cuing device with a person who has experienced a traumatic brain injury. Last, we discuss practical considerations for developing and using assistive driving devices in persons with cognitive impairments, including drivers who have experienced a stroke.	[Anschutz, John R.] Shepherd Ctr, Assist Technol Ctr, Atlanta, GA USA		Anschutz, JR (corresponding author), Shepherd Ctr, Assist Technol Ctr, Atlanta, GA USA.						Bouska MJ, 1990, NEUROLOGICAL REHABIL; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; Finestone HM, 2010, PM&R, V2, P497, DOI 10.1016/j.pmrj.2010.03.030; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Galski T, 1997, AM J OCCUP THER, V51, P352, DOI 10.5014/ajot.51.5.352; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kreutzer JS, 2009, PM&R, V1, P723, DOI 10.1016/j.pmrj.2009.07.005; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; PIASETSKY E, 1982, COGNITIVE REHABILITA; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	30	5	5	0	5	THOMAS LAND PUBLISHERS, INC	ST LOUIS	255 JEFFERSON RD, ST LOUIS, MO 63119 USA	1074-9357			TOP STROKE REHABIL	Top. Stroke Rehabil.	SEP-OCT	2010	17	5					337	344		10.1310/tsr1705-337			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	699MD	WOS:000285666600003	21131258				2022-02-06	
J	Hirsch, N; Taylor, C				Hirsch, Nicholas; Taylor, Christopher			Pharmacological and pathological modulation of cerebral physiology	ANAESTHESIA AND INTENSIVE CARE MEDICINE			English	Article						Autoregulation; cerebral blood flow; cerebral ischaemia; cerebral metabolic rate; neuroanaesthesia; subarachnoid haemorrhage; traumatic brain injury		Anaesthesia for neurosurgery aims to provide optimal surgical conditions whilst maintaining adequate cerebral blood flow in order to supply the brain with appropriate amounts of oxygen and glucose. Most anaesthetic drugs influence the normal cerebral physiology either directly or indirectly. They can cause changes in cerebral blood flow by influencing cerebral blood vessel calibre, by interfering with autoregulatory processes and by modifying cerebral metabolism. The brain's limited ability to store oxygen and glucose means that its supply must be continuous if neuronal damage is to be avoided. Ischaemic cerebral damage is the most important pathological mechanism in patients with stroke, subarachnoid haemorrhage and traumatic brain injury. Significant traumatic brain injury causes widespread derangement of cerebral physiology, including changes in cerebral blood flow, autoregulation and cerebral energy dynamics. This article outlines the effect of anaesthesia on cerebral physiology and reviews the pathophysiology of traumatic brain injury and subarachnoid haemorrhage.	[Hirsch, Nicholas; Taylor, Christopher] Natl Hosp Neurol & Neurosurg, London, England; [Hirsch, Nicholas] Inst Neurol, London, England		Hirsch, N (corresponding author), Natl Hosp Neurol & Neurosurg, London, England.						Priebe HJ, 2007, BRIT J ANAESTH, V99, P102, DOI 10.1093/bja/aem119; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	3	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1472-0299	1878-7584		ANAEST INTENS CARE M	Anaesth. Intensiv. Care Med.	SEP	2010	11	9					349	354		10.1016/j.mpaic.2010.05.011			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V08RV	WOS:000214093400004					2022-02-06	
J	Wong, MN; Murdoch, BE; Whelan, BM				Wong, Min Ney; Murdoch, Bruce E.; Whelan, Brooke-Mai			Tongue Function in Nondysarthric Speakers with Parkinson's Disease: An Electromagnetic Articulography Investigation	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; KINEMATIC ANALYSIS; ARTICULATORY FUNCTION; DYSARTHRIC SUBJECTS; SPEECH PRODUCTION; MOVEMENTS; PATTERNS; STRENGTH; ADULTS; SYSTEM	Articulatory imprecision in Parkinson's disease (PD) has been attributed to reduced range of movement, rigidity, and abnormal speed of movement of the articulatory structures Previous studies provided acoustic and kinematic evidence of lip muscle rigidity, reduced amplitude, and velocity of lip and jaw movement, mainly based on nonspeech measures Very limited studies have documented the effects of PD on lingual kinematics during speech production. The present study aimed to investigate lingual kinematics during sentence production in a group of 7 nondysarthric speakers with PD using the electromagnetic articulograph (AG-200 EMA) Tongue-tip and tongue-back movements were recorded by the EMA system during sentence production. Seven non-neurologically impaired participants matched for age and sex served as a control group Results revealed no significant difference on the distance of tongue movement However, the PD group did show significantly reduced maximum velocity, maximum acceleration, maximum deceleration, and significantly longer duration of tongue movement. Rates of sentence production were also slower for the PD group The subclinical differences in tongue kinematics of the nondysarthric speakers with PD documented in this study support that limitations in the range of tongue movement leading to articulatory undershoot may be a major contributor to articulatory impairment in dysarthric speakers with PD	[Wong, Min Ney; Murdoch, Bruce E.; Whelan, Brooke-Mai] Univ Queensland, Ctr Neurogenic Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia		Wong, MN (corresponding author), Univ Queensland, Ctr Neurogenic Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	min.wong@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Whelan, Brooke-Mai/0000-0002-7909-3160; Wong, Min Ney/0000-0003-0585-3566	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [456017]	This project was supported by a grant from the National Health and Medical Research Council of Australia (Grant No. 456017). The authors would like to acknowledge the participants for their contribution to the research project	ACKERMANN H, 1993, FOLIA PHONIATR, V45, P84, DOI 10.1159/000266222; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Bartle-Meyer CJ, 2009, CLIN LINGUIST PHONET, V23, P93, DOI 10.1080/02699200802564284; Brown J.R., 1975, MOTOR SPEECH DISORDE; Chen JF, 2008, CORP GOV, V16, P32, DOI 10.1111/j.1467-8683.2008.00660.x; Cheng HY, 2005, J MED SPEECH-LANG PA, V13, P15; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Duffy J. R., 2005, MOTOR SPEECH DISORDE, P187; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; Field A., 2017, DISCOVERING STAT USI, V5th; FORREST K, 1989, J ACOUST SOC AM, V85, P2608, DOI 10.1121/1.397755; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; HIROSE H, 1982, FOLIA PHONIATR, V34, P210, DOI 10.1159/000265651; HUNKER CJ, 1982, NEUROLOGY, V32, P749, DOI 10.1212/WNL.32.7.749; KATZ W, 1990, BRAIN LANG, V38, P555, DOI 10.1016/0093-934X(90)90137-6; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; Kuruvilla M, 2007, BRAIN INJURY, V21, P601, DOI 10.1080/02699050701427525; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P1, DOI 10.1080/02699200400001044; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P19, DOI 10.1080/0269-9200400001069; McAuliffe MJ, 2005, J MED SPEECH-LANG PA, V13, P149; MCAULIFFE MJ, 2007, ADV SPEECH LANGUAGE, V9, P13; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; SHAWKER TH, 1984, J CLIN ULTRASOUND, V12, P125, DOI 10.1002/jcu.1870120303; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; Solomon NP, 1995, J MED SPEECH-LANG PA, V3, P13; STONE M, 1983, J PHONETICS, V11, P207, DOI 10.1016/S0095-4470(19)30822-8; [No title captured]	30	5	5	0	5	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2010	18	3					24	33					10	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	646VI	WOS:000281570900004					2022-02-06	
J	Baird, LC; Newman, CB; Volk, H; Svinth, JR; Conklin, J; Levy, ML				Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Svinth, Joseph R.; Conklin, Jordan; Levy, Michael L.			RETRACTED: Mortality Resulting From Head Injury in Professional Boxing: Case Report (Retracted article. See vol. 67, pg. E1475, 2010)	NEUROSURGERY			English	Article; Retracted Publication						Boxing; Head trauma; Mortality	MEDICAL ASPECTS; BRAIN-INJURY; BIOMECHANICS; CONCUSSION; FATALITIES; FOOTBALL; PUNCH	BACKGROUND: The majority of boxing-related fatalities result from traumatic brain injury. Biomechanical forces in boxing result in rotational acceleration with resultant subdural hematoma and diffuse axonal injury. OBJECTIVE: Given the inherent risk and the ongoing criticism boxing has received, we evaluated mortalities associated with professional boxing. METHODS: We used the Velazquez Fatality Collection of boxing injuries and supplementary sources to analyze mortality from 1950 to 2007. Variables evaluated included age at time of death, association with knockout or other outcome of match, rounds fought, weight class, location of fight, and location of preterminal event. RESULTS: There were 339 mortalities between 1950 and 2007 (mean age, 24 +/- 3.8 years); 64% were associated with knockout and 15% with technical knockout. A higher percentage occurred in the lower weight classes. The preterminal event occurred in the ring (61%), in the locker room (17%), and outside the arena (22%). We evaluated for significant changes after 1983 when championship bouts were reduced from 15 to 12 rounds. CONCLUSION: There was a significant decline in mortality after 1983. We found no significant variables to support that this decline is related to a reduction in rounds. Rather, we hypothesize the decline to be the result of a reduction in exposure to repetitive head trauma (shorter careers and fewer fights), along with increased medical oversight and stricter safety regulations. Increased efforts should be made to improve medical supervision of boxers. Mandatory central nervous system imaging after a knockout could lead to a significant reduction in associated mortality.	[Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Levy, Michael L.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA; [Svinth, Joseph R.; Conklin, Jordan] Rady Childrens Hosp San Diego, San Diego, CA USA		Levy, ML (corresponding author), 8010 Frost St,Ste 502, San Diego, CA 92123 USA.	mlevy@chsd.org	Levy, Michael/AAL-4647-2020				ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BORGES R, 25 YEARS IS LONG TIM; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; COHEN L, 1984, CAN MED ASSOC J, V130, P767; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6; GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012; Hodgson V. R., 1972, P 16 STAPP CAR CRASH; Joch W, 1981, BIOMECHANICS A, P343; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING AI, 1995, BIOMEDICAL ENG HDB, P357; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; MCCOWN IA, 1959, AM J SURG, V98, P509, DOI 10.1016/0002-9610(59)90545-8; Miele VJ, 2007, NEUROSURGERY, V60, P307, DOI 10.1227/01.NEU.0000249247.48299.5B; Miele Vincent J, 2006, Neurosurg Focus, V21, pE8; Moore M, 1980, Phys Sportsmed, V8, P101, DOI 10.1080/00913847.1980.11710972; MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PINCEMAILLE Y, 1989, P 33 STAPP CAR CRASH; POLIN AW, 1996, NEUROLOGY TRAUMA, P166; REFSHAUGE JG, 1963, MED J AUSTRALIA, V1, P611, DOI 10.5694/j.1326-5377.1963.tb25567.x; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; SERCL M., 1962, WORLD NEUROL, V3, P351; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; SUGAR BR, 1981, RING RECORD BOOK BOX; Svinth J., 2007, J COMBATIVE SPORT; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77; VIANO D, 1988, P 32 STAPP CAR CRASH; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207	40	5	6	1	17	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2010	67	2					E519	U378		10.1227/01.NEU.0000373207.04297.13			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	628HI	WOS:000280105800080	20644386				2022-02-06	
J	Golubovic, Z; Stanic, V; Trenkic, S; Stojiljkovic, P; Stevanovic, G; Lesic, A; Golubovic, I; Milic, D; Visnjic, A; Najman, S				Golubovic, Zoran; Stanic, Vojkan; Trenkic, Srbobran; Stojiljkovic, Predrag; Stevanovic, Goran; Lesic, Aleksandar; Golubovic, Ivan; Milic, Dragan; Visnjic, Aleksandar; Najman, Stevo			Penetrating injury of the lungs and multiple injuries of lower extremities caused by aircraft bombs splinters	VOJNOSANITETSKI PREGLED			Serbian	Article						explosions; aircraft; war; multiple trauma; thoracic injuries; wounds, penetrating; leg injuries; surgical procedures, operative; treatment outcome; amputation; skin transplantation	MISSILE INJURIES; WAR INJURIES; WOUNDS; FOOT; PRINCIPLES; BALLISTICS; MANAGEMENT; RESECTION; TRAUMA	Introduction. injuries caused by aircraft bombs cause severe damages to the human body. They are characterized by massive destruction of injured tissues and organs, primary contamination by polymorph bacterial flora and modified reactivity of the body. Upon being wounded by aircraft bombs projectiles a victim simultaneously sustains severe damages of many organs and organ systems due to the fact that a large number of projectiles at the same time injure the chest, stomach, head and extremities. Case report. We presented a patient, 41 years of age, injured by aircraft bomb with hemo-pneumothorax and destruction of the bone and soft tissue structures of the foot, as well as the treatment result of such heavy injuries. After receiving thoracocentesis and short reanimation, the patient underwent surgical procedure. The team performed thoracotomy, primary treatment of the wound and atypical resection of the left lung. Thoracic drains were placed. The wounds on the lower leg and feet were treated primarily. Due to massive destruction of bone tissue of the right foot by cluster bomb splinters, and impossibility of reconstruction of the foot, guillotine amputation of the right lower leg was performed. Twelve days after the wounding caused by cluster bomb splinters, soft tissue of the left lower leg was covered by Tirsch free transplantant and the defect in the area of the left foot was covered by dorsalis pedis flap. The transplant and flap were accepted and the donor sites were epithelized. Twenty-six days following the wounding reamputation was performed and amputation stump of the right lower leg was closed. The patient was given a lower leg prosthesis with which he could move. Conclusion. Upon being wounded by aircraft bomb splinters, the injured person sustains severe wounds of multiple organs and organ systems due to simultaneous injuries caused by a large number of projectiles. It is necessary to take care of the vital organs first because they directly threaten the life of the wounded patient. Despite adequate surgical treatment of war wounds of the feet, because of massive defect of bone and soft tissue, amputation may be the only rational solution of the treatment. The resection of the lung may be succesfull method for the severe destruction of the lung.	[Stanic, Vojkan] Vojnomed Akad, Klin Grudnu Hururgiju, Belgrade 11000, Serbia; [Golubovic, Zoran; Stojiljkovic, Predrag; Golubovic, Ivan; Visnjic, Aleksandar; Najman, Stevo] Klin Ctr Nis, Klin Ortopediju & Traumatol, Nish, Serbia; [Trenkic, Srbobran; Stevanovic, Goran; Milic, Dragan] Klin Ctr Nis, Hirurska Klin, Nish, Serbia; [Lesic, Aleksandar] Klin Ctr Srbije, Klin Ortopediju & Tramatol, Beograd, Serbia		Stanic, V (corresponding author), Vojnomed Akad, Klin Grudnu Hururgiju, Crnotravska 17, Belgrade 11000, Serbia.		Visnjic, Aleksandar/AAA-3869-2019; Visnjic, Aleksandar/AAD-6872-2019; Najman, Stevo J/E-7160-2019; Milic, Dragan/AAI-5513-2021	Visnjic, Aleksandar/0000-0002-6463-9706; Najman, Stevo J/0000-0002-2411-9802; Stevanovic, Goran/0000-0001-9619-8696			Asensio JA, 2008, CURRENT THERAPY TRAU, P282; Celikoz B, 2005, MICROSURG, V25, P3, DOI 10.1002/micr.20049; Cothren C, 2002, J TRAUMA, V53, P483, DOI 10.1097/00005373-200209000-00015; Davila S, 2001, MIL MED, V166, P705, DOI 10.1093/milmed/166.8.705; Demetriades D, 2002, Scand J Surg, V91, P41; DUFOUR D, 1993, VICTIMO WAR SURG, P15; Ebrahimzadeh MH, 2009, DISABIL REHABIL, V31, P1873, DOI 10.1080/09638280902810968; FISCHER RP, 1974, J TRAUMA, V14, P293, DOI 10.1097/00005373-197404000-00004; Has B, 2001, CROAT MED J, V42, P630; Johnson Brent A, 2005, J Foot Ankle Surg, V44, P177, DOI 10.1053/j.jfas.2005.02.007; KATARGIN NG, 2003, REGIONAL CIRCULATION, P73; Khan MT, 2002, INJURY, V33, P167, DOI 10.1016/S0020-1383(01)00092-4; Maricevic A, 2004, MIL MED, V169, P147, DOI 10.7205/MILMED.169.2.147; McNamara J J, 1970, Ann Thorac Surg, V10, P389; MIRONOV G, 1988, VOENNO-MED ZH, V11, P28; MITKOVIC M, 2000, FACTA U, V7, P86; Nikolic D, 2000, INJURY, V31, P193, DOI 10.1016/S0020-1383(99)00271-5; PISCEVIC S, 1980, EXPERIENCES WORK M 1; POPOVIC Z, 1998, URGENT WAR SURG, P809; POPOVIC Z, 1996, THESIS MILITARY MED; RICH NM, 1968, MIL MED, V133, P9, DOI 10.1093/milmed/133.1.9; RICH NM, 1980, AM J SURG, V139, P414, DOI 10.1016/0002-9610(80)90304-9; Santic V, 2000, MIL MED, V165, P18, DOI 10.1093/milmed/165.1.18; Stanic V, 1998, Vojnosanit Pregl, V55, P583; SWAN KG, 1987, MIL MED, V152, P29; SWAN KG, 1991, SURG CLIN N AM, V71, P221; Tanaka Akihiko, 2006, Kyobu Geka, V59, P1018; TOMINAGA GT, 1993, AM SURGEON, V59, P834; Ullman EA, 2003, EMERG MED CLIN N AM, V21, P291, DOI 10.1016/S0733-8627(03)00016-6; ZAKHARIA AT, 1985, ANN THORAC SURG, V40, P209, DOI 10.1016/S0003-4975(10)60029-X	30	5	5	0	4	MILITARY MEDICAL ACAD-INI	BELGRADE	CRNOTRAVSKA 17, PO BOX 33-35, BELGRADE, 11040, SERBIA	0042-8450	2406-0720		VOJNOSANIT PREGL	Vojnosanit. Pregl.	AUG	2010	67	8					688	693		10.2298/VSP1008688G			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647YW	WOS:000281657800015	20845675	gold, Green Submitted			2022-02-06	
J	Kim, JH; Chung, YJ; Shin, HK				Kim, Jung-Hee; Chung, Yi-Jung; Shin, Hwa-Kyung			Effects of Balance Training on Patients with Spinal Cord Injury	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Balance; Spinal cord injury; Unstable surface	REHABILITATION; STROKE; STABILITY; REGENERATION; RELIABILITY; PERFORMANCE; ACTIVATION; INTENSITY; EXERCISES; RECOVERY	[Purpose] This study examined the effect of balance training on an unstable surface on patients with spinal cord injury (SCI). [Methods] Twelve inpatients, 7 in the experimental group and 5 in the control, at a rehabilitation hospital in Seoul were enrolled as subjects. The experimental group was treated with conventional physical therapy, and allowed to exercise on an unstable surface for 4 weeks (30 minutes a day, 5 times a week. reaching forward, to the right and left, and over the head holding a ball with both hands. The following variables were measured before and after training; Modified Functional Reach Test (MFRT), sway area, and sway velocity using a Balance Performance Monitor (BPM). [Results] There was a significant increase in the MFRT distance in the experimental group. The experimental group also showed a significant decrease in sway area with both opened and closed eyes after training. The experimental group showed a significant difference before and after training compared to the control, as shown by MFRT distance and swaying area. [Conclusion] Exercise on an unstable surface improves the sitting balance of patients with a spinal cord injury. This treatment can be recommended as an effective treatment program for patients with spinal cord injury.	[Kim, Jung-Hee] Sahmyook Univ, Grad Sch, Dept Phys Therapy, Seoul 130650, South Korea; [Chung, Yi-Jung] Sahmyook Univ, Coll Hlth Wealfare, Dept Phys Therapy, Seoul 130650, South Korea; [Shin, Hwa-Kyung] Catholic Univ Daegu, Coll Med Sci, Dept Phys Therapy, Taegu, South Korea		Kim, JH (corresponding author), Sahmyook Univ, Grad Sch, Dept Phys Therapy, Seoul 130650, South Korea.	yijung36@syu.ac.kr		Chung, Yijung/0000-0002-2431-8895	Sahmyook University	The paper was supported by Sahmyook University Research Fund in 2009.	Bayouk JF, 2006, INT J REHABIL RES, V29, P51, DOI 10.1097/01.mrr.0000192100.67425.84; Betker AL, 2007, PHYS THER, V87, P1389, DOI 10.2522/ptj.20060229; Bjerkefors A, 2007, SCAND J MED SCI SPOR, V17, P672, DOI 10.1111/j.1600-0838.2006.00621.x; Bjerkefors A, 2009, J REHABIL MED, V41, P390, DOI 10.2340/16501977-0336; Cressey EM, 2007, J STRENGTH COND RES, V21, P561, DOI 10.1519/R-19845.1; de Groot PCE, 2003, SPINAL CORD, V41, P673, DOI 10.1038/sj.sc.3101534; Dean C, 1999, GAIT POSTURE, V10, P135, DOI 10.1016/S0966-6362(99)00026-0; Douglas J, 2005, DIABETES SELF MANAG, V22, P55; Douglas J, 2005, DIABETES SELF MANAG, V22, P51; Douglas Jean, 2005, Diabetes Self Manag, V22, P47; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Haas B M, 2000, Physiother Res Int, V5, P19, DOI 10.1002/pri.181; Haas B M, 1998, Physiother Res Int, V3, P135, DOI 10.1002/pri.132; HOBSON DA, 1992, SPINE, V17, P293, DOI 10.1097/00007632-199203000-00009; Kamper D, 1999, J REHABIL RES DEV, V36, P121; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Lim PAC, 2007, ANN ACAD MED SINGAP, V36, P49; Lynch SM, 1998, PHYS THER, V78, P128, DOI 10.1093/ptj/78.2.128; Marshall PWM, 2006, J MANIP PHYSIOL THER, V29, P550, DOI 10.1016/j.jmpt.2006.06.025; Matjacic Z, 2007, J REHABIL MED, V39, P91, DOI 10.2340/16501977-0019; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Mudie MH, 2002, CLIN REHABIL, V16, P582, DOI 10.1191/0269215502cr527oa; Potten YJM, 1999, ERGONOMICS, V42, P1200, DOI 10.1080/001401399185081; Ryerson Susan, 2008, J Neurol Phys Ther, V32, P14, DOI 10.1097/NPT.0b013e3181660f0c; Sackley CM, 2005, CLIN REHABIL, V19, P746, DOI 10.1191/0269215505cr863oa; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Seelen HAM, 1998, ERGONOMICS, V41, P302, DOI 10.1080/001401398187053; Smania N, 2008, NEUROL SCI, V29, P313, DOI 10.1007/s10072-008-0988-0; Takayanagi K, 1995, J PHYS THER SCI, V7, P77, DOI DOI 10.1589/JPTS.7.77; Taube W, 2007, ACTA PHYSIOL, V189, P347, DOI 10.1111/j.1748-1716.2007.01665.x; Tsang WWN, 2004, MED SCI SPORT EXER, V36, P658, DOI 10.1249/01.MSS.0000122077.87090.2E	32	5	5	0	11	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	AUG	2010	22	3					311	316		10.1589/jpts.22.311			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	649DI	WOS:000281747200015		Bronze			2022-02-06	
J	Lee, JS; Jwa, CS; Yi, HJ; Chun, HJ				Lee, Jeong-Shik; Jwa, Cheol-Su; Yi, Hyeong-Joong; Chun, Hyoung-Joon			Impact of Early Enteral Nutrition on In-Hospital Mortality in Patients with Hypertensive Intracerebral Hemorrhage	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Enteral nutrition; Intracerebral hemorrhage; Mortality	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; MULTIPLE-ORGAN-FAILURE; INFLAMMATORY RESPONSES; ALKALINE-PHOSPHATASE; CRITICAL ILLNESS; GUT FUNCTION; RISK-FACTOR; PNEUMONIA; GLUTAMINE	Objective : We conducted this study to evaluate the clinical impact of early enteral nutrition (EN) on in-hospital mortality and outcome in patients with critical hypertensive intracerebral hemorrhage (ICH). Methods : We retrospectively analyzed 123 ICH patients with Glasgow. Coma Scale (GCS) score of 3-12. We divided the subjects into two groups : early EN group (< 48 hours, n = 89) and delayed EN group (>= 48 hours, n = 34). Body weight, total intake and output, serum albumin, C-reactive protein, infectious complications, morbidity at discharge and in-hospital mortality were compared with statistical analysis. Results: The incidence of nosocomial pneumonia and length of intensive care unit stay were significantly lower in the early EN group than in the delayed EN group (p < 0.05). In-hospital mortality was less in the early EN group than in the delayed EN group (10.1% vs. 35.3%, respectively: p = 0.001). By multivariate analysis, early EN [odds ratio (OR) 0.229, 95% Cl : 0.066-0.793], nosocomial pneumonia (OR = 5.381, 95% Cl : 1.621-17.865) and initial GCS score (OR = 1.482 95% Cl : 1.160-1.893) were independent predictors of in-hospital mortality in patients with critical hypertensive ICH. Conclusion: These findings indicate that early EN is an important predictor of outcome in patients with critical hypertensive ICH.	[Lee, Jeong-Shik; Jwa, Cheol-Su] Natl Med Ctr, Dept Neurosurg, Seoul 100799, South Korea; [Yi, Hyeong-Joong; Chun, Hyoung-Joon] Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul 133791, South Korea		Jwa, CS (corresponding author), Natl Med Ctr, Dept Neurosurg, 243 Eulji Ro, Seoul 100799, South Korea.	chsjwa@hanmail.net	Yi, Hyeong-Joong/AAR-2685-2020				Adam S, 1997, INTENS CARE MED, V23, P261, DOI 10.1007/s001340050326; Alexander JW, 1996, ARCH SURG-CHICAGO, V131, P1264; Balk RA, 2000, CRIT CARE CLIN, V16, P337, DOI 10.1016/S0749-0704(05)70113-5; Barr J, 2004, CHEST, V125, P1446, DOI 10.1378/chest.125.4.1446; Braga M, 1996, ARCH SURG-CHICAGO, V131, P1257; Caparros T, 2001, JPEN-PARENTER ENTER, V25, P299, DOI 10.1177/0148607101025006299; Caparros T, 2001, JPEN J PARENTER ENTE, V25, P308; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; CHIARELLI A, 1990, AM J CLIN NUTR, V51, P1035, DOI 10.1093/ajcn/51.6.1035; Chuntrasakul Chomchark, 1996, Journal of the Medical Association of Thailand, V79, P21; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Field CJ, 2000, MED SCI SPORT EXER, V32, pS377, DOI 10.1097/00005768-200007001-00002; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Gamrin L, 1997, METABOLISM, V46, P756, DOI 10.1016/S0026-0495(97)90119-0; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; JACOBS S, 1990, JPEN-PARENTER ENTER, V14, P353, DOI 10.1177/0148607190014004353; Kattelmann KK, 2006, J AM DIET ASSOC, V106, P1226, DOI 10.1016/j.jada.2006.05.320; KEARNEY PA, 1994, CURR OPIN ANAESTH, V7, P305; Klodell CT, 2000, AM J SURG, V179, P168, DOI 10.1016/S0002-9610(00)00297-X; Kompan L, 2004, CLIN NUTR, V23, P527, DOI 10.1016/j.clnu.2003.09.013; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; Kudsk KA, 1998, NUTRITION, V14, P541, DOI 10.1016/S0899-9007(98)00047-1; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Montejo JC, 2002, CRIT CARE MED, V30, P796, DOI 10.1097/00003246-200204000-00013; MOORE EE, 1994, JCCC, V1, P15; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Nguyen NQ, 2008, CRIT CARE MED, V36, P1469, DOI 10.1097/CCM.0b013e31816fc457; O'Flaherty L, 1999, P NUTR SOC, V58, P831, DOI 10.1017/S0029665199001123; Pachler C, 2008, INTENS CARE MED, V34, P1224, DOI 10.1007/s00134-008-1033-8; PINGLETON SK, 1989, EUR J CLIN MICROBIOL, V8, P51, DOI 10.1007/BF01964120; Pupelis G, 2001, NUTRITION, V17, P91, DOI 10.1016/S0899-9007(00)00508-6; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Zhang Jian-jun, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P552; 1988, BR MED J CLIN RES ED, V296, P316	40	5	9	2	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	AUG	2010	48	2					99	104		10.3340/jkns.2010.48.2.99			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	650WX	WOS:000281886100001	20856655	gold, Green Published			2022-02-06	
J	Wang, YT; Green, JR; Nip, ISB; Kent, RD; Kent, JF; Ullman, C				Wang, Yu-Tsai; Green, Jordan R.; Nip, Ignatius S. B.; Kent, Ray D.; Kent, Jane Finley; Ullman, Cara			Accuracy of perceptually based and acoustically based inspiratory loci in reading	BEHAVIOR RESEARCH METHODS			English	Article							TRAUMATIC BRAIN-INJURY; SPEECH PRODUCTION; BREATH-GROUP; CHEST WALL; RIB CAGE; DYSARTHRIA; PATTERNS; CHILDREN; LUNG; ADOLESCENTS	Investigations of speech often involve the identification of inspiratory loci in continuous recordings of speech. The present study investigates the accuracy of perceptually determined and acoustically determined inspiratory loci. While wearing a circumferentially vented mask connected to a pneumotach, 16 participants read two passages. The perceptually determined and acoustically determined inspiratory loci were compared with the actual loci of inspiration, which were determined aerodynamically. The results showed that (1) agreement across all three judges was the most accurate of the approaches considered here for detecting inspiratory loci based on listening; (2) the most accurate pause duration threshold for detecting inspiratory loci was 250 msec; and (3) the perceptually based breath-group determination was more accurate than the acoustically based determination of pause duration. Inconsistencies among perceptually determined, acoustically determined, and aerodynamically determined inspiratory loci are not negligible and, therefore, need to be considered when researchers design experiments on breath groups in speech.	[Wang, Yu-Tsai] Natl Yang Ming Univ, Sch Dent, Taipei 11221, Taiwan; [Green, Jordan R.; Ullman, Cara] Univ Nebraska, Lincoln, NE USA; [Nip, Ignatius S. B.] San Diego State Univ, San Diego, CA 92182 USA; [Kent, Ray D.; Kent, Jane Finley] Univ Wisconsin, Madison, WI USA		Wang, YT (corresponding author), Natl Yang Ming Univ, Sch Dent, Rm 411,155,Sec 2,Li Nong St, Taipei 11221, Taiwan.	yutsaiwang@ym.edu.tw	Green, Jordan/N-3585-2019; Kent, Raymond D/AAI-1928-2020; Green, Jordan/A-7159-2008	Green, Jordan/0000-0002-1464-1373; Green, Jordan/0000-0002-1464-1373; Nip, Ignatius/0000-0002-6972-6737	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000319, R01DC006463, R01DC009890] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC006463, R01 DC00319, R01 DC000319, R01 DC009890] Funding Source: Medline		Brown J.R., 1975, MOTOR SPEECH DISORDE; Bunton K, 2000, CLIN LINGUIST PHONET, V14, P13, DOI 10.1080/026992000298922; Bunton K, 2005, J COMMUN DISORD, V38, P331, DOI 10.1016/j.jcomdis.2005.01.001; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Collyer S, 2006, J SPEECH LANG HEAR R, V49, P412, DOI 10.1044/1092-4388(2006/032); FORNER LL, 1977, J SPEECH HEAR RES, V20, P373, DOI 10.1044/jshr.2002.373; Green JR, 2004, J MED SPEECH-LANG PA, V12, P149; Hammen VL, 1994, J MED SPEECH-LANG PA, V2, P253; HIXON TJ, 1976, J SPEECH HEAR RES, V19, P297, DOI 10.1044/jshr.1902.297; HIXON TJ, 1973, J SPEECH HEAR RES, V16, P78, DOI 10.1044/jshr.1601.78; HOIT JD, 1987, J SPEECH HEAR RES, V30, P351, DOI 10.1044/jshr.3003.351; HOIT JD, 1990, J SPEECH HEAR RES, V33, P51, DOI 10.1044/jshr.3301.51; Kent R.D., 2002, ACOUSTIC ANAL SPEECH, V2nd ed.; Macmillan NA., 1991, DETECTION THEORY USE; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Milenkovic P. H., 2001, TIME FREQUENCY ANAL; Mitchell HL, 1996, J SPEECH HEAR RES, V39, P93, DOI 10.1044/jshr.3901.93; OLLER DK, 1977, J ACOUST SOC AM, V62, P994, DOI 10.1121/1.381594; SCHLENCK KJ, 1993, CLIN LINGUIST PHONET, V7, P119, DOI 10.3109/02699209308985549; WALKER JF, 1992, J SPEECH HEAR RES, V35, P4, DOI 10.1044/jshr.3501.04; Wang Y.-T., 2010, FOLIA PHONIATR LOGO, V62, P301; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; WINKWORTH AL, 1994, J SPEECH HEAR RES, V37, P535, DOI 10.1044/jshr.3703.535; WINKWORTH AL, 1995, J SPEECH HEAR RES, V38, P124, DOI 10.1044/jshr.3801.124; Wozniak RJ, 1999, BRAIN INJURY, V13, P191, DOI 10.1080/026990599121700; Yunusova Y, 2005, J SPEECH LANG HEAR R, V48, P1294, DOI 10.1044/1092-4388(2005/090)	26	5	5	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	AUG	2010	42	3					791	797		10.3758/BRM.42.3.791			7	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	702UD	WOS:000285920500019	20805602	Green Published, Green Accepted, Bronze			2022-02-06	
J	Coskun, F; Sezer, EA; Karamercan, MA; Akinci, E; Vural, K				Coskun, Figen; Sezer, Ebru Akcapinar; Karamercan, Mehmet Akif; Akinci, Emine; Vural, Kubilay			An assessment on the use of infrascanner for the diagnosis of the brain hemotoma by using support vector machine	SCIENTIFIC RESEARCH AND ESSAYS			English	Article						Brain hematoma; Infrascanner; CT; support vector machine	HEAD TRAUMA; CHILDREN	Diagnosis of the brain hematoma injuries is critical for patients and requires exhaustive processes. For this reason, the practical methods may be attractive for medical applications to reduce time and cost. The purpose of this study is to discuss the applicability of the InfraScanner for the diagnosis of the brain hematoma and to determine the most important factors affecting the positive brain hematoma cases by support vector machine approach. For the purpose of the study, the data of 92 adult and 161 pediatric patients (253 in total) with traumatic brain injury were collected and assessed. The analyses applied in this study gave encouraging results about the use of near Infrared Scanner (NIRS) on practical diagnosis of brain hematoma. When making a comparison between the adult and pediatric patients, it is obvious that the use of NIRS exhibited better results in pediatric patients than adult patients.	[Sezer, Ebru Akcapinar] Hacettepe Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [Coskun, Figen; Karamercan, Mehmet Akif; Akinci, Emine; Vural, Kubilay] Ankara Educ & Res Hosp, Dept Emergency Med, TR-06340 Ankara, Turkey		Sezer, EA (corresponding author), Hacettepe Univ, Dept Comp Engn, TR-06800 Ankara, Turkey.	ebru@hacettepe.edu.tr	Sezer, Ebru Akcapinar/H-5566-2011; Karamercan, Mehmet Akif/AAG-5512-2019	Sezer, Ebru Akcapinar/0000-0002-9287-2679; Karamercan, Mehmet Akif/0000-0002-3895-7989			GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; JAGODE AS, 2009, J EMERG NURS, V35, P35; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Liu JW, 2007, PATTERN RECOGN LETT, V28, P912, DOI 10.1016/j.patrec.2006.12.007; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988; Zhao ZD, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-6, P1188, DOI 10.1109/ICMLC.2009.5212365	9	5	5	0	5	ACADEMIC JOURNALS	VICTORIA ISLAND	P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA	1992-2248			SCI RES ESSAYS	Sci. Res. Essays	JUL 18	2010	5	14					1911	1915					5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648YN	WOS:000281731600019					2022-02-06	
J	Cambra, FJ; Palomeque, A; Munoz-Santanach, D; Matute, SS; Balbuena, RN; Fructuoso, GG				Cambra, F. J.; Palomeque, A.; Munoz-Santanach, D.; Segura Matute, S.; Navarro Balbuena, R.; Garcia Fructuoso, G.			Use of decompressive craniectomy in the management of refractory intracranial hypertension in paediatric patients	ANALES DE PEDIATRIA			Spanish	Article						Traumatic brain injury; Intracranial hypertension; Decompressive craniectomy	TRAUMATIC BRAIN-INJURY; BARBITURATE COMA; CHILDREN; THERAPY; COMPLICATIONS; PRESSURE	Introduction and objective: Intracranial hypertension (ICH) is the main cause of morbidity and mortality in patients with severe traumatic head injuries. Decompressive craniectomy (DC) is a surgical technique that allows to reduce intracranial pressure (ICP) and to improve cerebral blood flow. Objective: To present our experience on DC for the treatment of ICH. Patients and methods: Retrospective review of patients admitted from January 2005 to December 2008 who had a traumatic brain injury (TBI) and uncontrollable intracranial hypertension despite optimal medical treatment and who needed DC. Results: Fourteen patients with severe TBI were included in this series. Mean age was 14.2 years (4-20 years). The more frequent damages detected in cranial computerized tomography were diffuse brain lesions types II and III. Indication for DC was made if ICP levels were above 25 mmHg for more than 30 min despite optimal medical treatment. Clinical outcome was favourable in all patients apart from two. Neurological outcome was correct in 78.8% of patients (Glasgow Outcome Score 4 and 5) six months after PICU discharge. Conclusion: DC is an alternative for the management of refractory intracranial hypertension in children and adolescents with severe TBI. It could be used simultaneously with the barbiturate coma or as an alternative, particularly in haemodynamically unstable patients. (C) 2009 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L. All rights reserved.	[Cambra, F. J.; Palomeque, A.; Munoz-Santanach, D.; Segura Matute, S.] Unidad Cuidados Intens Pediat, Barcelona, Spain; [Navarro Balbuena, R.; Garcia Fructuoso, G.] Univ Barcelona, Serv Neurocirugia, Hosp St Joan de Deu, Barcelona, Spain		Cambra, FJ (corresponding author), Unidad Cuidados Intens Pediat, Barcelona, Spain.	fjcambra@hsjdbcn.org		Cambra Lasaosa, Francisco Jose/0000-0002-3818-8032			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adelstein David J, 2003, Curr Treat Options Oncol, V4, P3, DOI 10.1007/s11864-003-0027-6; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Citerio G, 2007, INTENS CARE MED, V33, P45, DOI 10.1007/s00134-006-0381-5; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Lee H. L., 1994, Tropical Biomedicine, V11, P31; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; PIATT JH, 1984, NEUROSURGERY, V15, P427, DOI 10.1227/00006123-198409000-00023; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Raffelsieper B, 2002, ANASTH INTENSIV NOTF, V37, P157, DOI 10.1055/s-2002-21800; ROBERTS I, 2007, TRATAMIENTO CON BARB; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2005, J NEUROL NEUROSUR PS, V76, P1181, DOI 10.1136/jnnp.2004.058537; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	31	5	5	0	3	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	1695-4033	1696-4608		AN PEDIATR	An. Pediatr.	JUL	2010	73	1					12	18		10.1016/j.anpedi.2010.02.011			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	630YZ	WOS:000280314200003	20466606				2022-02-06	
J	Coltro, PS; Goldenberg, DC; Aldunate, JLCB; Alessi, MS; Chang, AJBA; Alonso, N; Ferreira, MC				Coltro, Pedro Soler; Goldenberg, Dov Charles; Conduta Borda Aldunate, Johnny Leandro; Alessi, Mariana Sisto; Bok Audi Chang, Alexandre Jin; Alonso, Nivaldo; Ferreira, Marcus Castro			Facial Palsy After Blunt Trauma and Without Facial Bone Fracture	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Facial paralysis; facial nerve injuries; head injuries; closed-skull fractures	NERVE PARALYSIS; HEAD-INJURY; MANAGEMENT	A 14-year-old patient had a low-energy facial blunt trauma that evolved to right facial paralysis caused by parotid hematoma with parotid salivary gland lesion. Computed tomography and angiography demonstrated intraparotid collection without pseudoaneurysm and without radiologic signs of fracture in the face. The patient was treated with serial punctures for hematoma deflation, resolving with regression and complete remission of facial paralysis, with no late sequela. The authors discuss the relationship between facial nerve traumatic injuries associated or not with the presence of facial fractures, emphasizing the importance of early recognition and appropriate treatment of such cases.	[Coltro, Pedro Soler; Goldenberg, Dov Charles; Conduta Borda Aldunate, Johnny Leandro; Alessi, Mariana Sisto; Bok Audi Chang, Alexandre Jin; Alonso, Nivaldo; Ferreira, Marcus Castro] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil		Coltro, PS (corresponding author), Alameda Jauaperi 943 Apto 172, Sao Paulo, Brazil.	pscoltro@hotmail.com	Alonso, Nivaldo/AAB-4570-2021; Alonso, Nivaldo/D-2711-2012; Coltro, Pedro/M-1808-2019; Coltro, Pedro S/P-5349-2014	Alonso, Nivaldo/0000-0003-1532-9610; Coltro, Pedro/0000-0002-0164-4508; Coltro, Pedro S/0000-0002-0164-4508; Goldenberg, Dov Charles/0000-0001-5953-2448			ADOUR KK, 1977, LARYNGOSCOPE, V87, P380, DOI 10.1288/00005537-197703000-00011; Chan EH, 2005, ANN ACAD MED SINGAP, V34, P322; Chang CYJ, 1999, AM J OTOL, V20, P96; Darrouzet V, 2001, OTOLARYNG HEAD NECK, V125, P77, DOI 10.1067/mhn.2001.116182; Davis R E, 1995, J Craniomaxillofac Trauma, V1, P30; Frijters E, 2008, ANN PLAS SURG, V61, P181, DOI 10.1097/SAP.0b013e3181591e27; GREER JA, 1974, ANN OTO RHINOL LARYN, V83, P582, DOI 10.1177/000348947408300503; Guerrissi JO, 1997, J CRANIOFAC SURG, V8, P431, DOI 10.1097/00001665-199708050-00018; Leitch EF, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2004.016477; Li J, 2004, BRAIN INJURY, V18, P315, DOI 10.1080/0269905031000149489; Odebode TO, 2006, J TRAUMA, V61, P388, DOI 10.1097/01.ta.0000224140.26660.5c; PAREKH D, 1989, ANN SURG, V209, P105, DOI 10.1097/00000658-198901000-00015; ROSENBERG JJ, 1966, ARCHIV OTOLARYNGOL, V84, P337; Simo R, 1996, J TRAUMA, V40, P306, DOI 10.1097/00005373-199602000-00026; Smith OD, 2001, EMERG MED J, V18, P402, DOI 10.1136/emj.18.5.402; Vasconcelos Belmiro Cavalcanti do Egito, 2006, Med Oral Patol Oral Cir Bucal, V11, pE175; WILLIAMS M J, 1991, Journal of Emergency Medicine, V9, P27, DOI 10.1016/0736-4679(91)90583-2	17	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2010	21	4					1162	1164		10.1097/SCS.0b013e3181e571f9			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	628UV	WOS:000280149100049	20613585				2022-02-06	
J	Ozan, F; Yildiz, H; Bora, OA; Pekedis, M; Coskun, GA; Gore, O				Ozan, Firat; Yildiz, Hasan; Bora, Osman Arslan; Pekedis, Mahmut; Coskun, Gulnihal Ay; Gore, Oya			The effect of head trauma on fracture healing: biomechanical testing and finite element analysis	ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA			English	Article						Biomechanics; femur; finite element analysis; fracture healing; head trauma; 4-point bend test; rat	DIFFUSE BRAIN INJURY; MECHANICAL-PROPERTIES; HETEROTOPIC OSSIFICATION; FEMORAL FRACTURES; CALLUS FORMATION; BONE TORSION; RAT FEMORA; MODEL; ADULTS	Objectives: We aimed to evaluate the effect of head trauma on fracture healing with biomechanical testing, to compare the results obtained from a femur model created by finite element analysis with experimental data, and to develop a finite element model that can be employed in femoral fractures. Methods: Twenty-two Wistar albino rats were randomized into two groups. The control group was subjected to femoral fracture followed by intramedullary fixation, whereas the head trauma group was subjected to femoral fracture followed by intramedullary fixation along with closed blunt head trauma. Bone sections obtained with computed tomography from rat femurs were transferred into a computer and a 3D mathematical model of femur was created. At the end of week 4, femurs were examined by biomechanical testing and finite element analysis. Results: The mean maximum fracture load was significantly higher in the head trauma group than in control group (p < 0.05). Maximum strain values were also significantly high in the head trauma group (p < 0.05). There was no significant difference between the groups with regard to maximum deformation (p > 0.05). The head trauma group had significantly higher mean bending rigidity than the control group (p < 0.05). The head trauma group showed no significant difference from the control group in terms of strain energy and elasticity module (p > 0.05). There was no significant difference between experimental biomechanical test and finite element analysis (p > 0.05). Conclusion: Noninvasive methods such as finite element analysis are useful in examination of the mechanical structure of bones. Experimental biomechanical test and finite element analysis methods suggest that head trauma contributes to fracture healing.	[Ozan, Firat] Izmir Bozyaka Training & Res Hosp, Dept Orthoped & Traumatol, Izmir, Turkey; [Yildiz, Hasan; Pekedis, Mahmut] Ege Univ, Fac Engn, Dept Mech Engn, Izmir, Turkey; [Bora, Osman Arslan] Ataturk Training & Res Hosp, Dept Orthoped & Traumatol, Izmir, Turkey; [Coskun, Gulnihal Ay; Gore, Oya] Izmir Buca Govt Hosp, Dept Pathol, Izmir, Turkey		Ozan, F (corresponding author), 9110-2 Sok,3-5, TR-35160 Izmir, Turkey.	firatozan9@gmail.com	OZAN, FIRAT/AAZ-1170-2021; YILDIZ, HASAN/AAA-1191-2021; OZAN, FIRAT/ABA-8872-2021	OZAN, FIRAT/0000-0002-2417-8343; YILDIZ, HASAN/0000-0002-3432-2249; OZAN, FIRAT/0000-0002-2417-8343			BEER FP, 2006, MECH MATER, P735; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BOULET M, 1961, ARCH BIOCHEM BIOPHYS, V93, P157, DOI 10.1016/0003-9861(61)90329-0; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Comelekoglu Ulku, 2007, Acta Orthop Traumatol Turc, V41, P53; EINHORN TA, 1988, J ORTHOPAED RES, V6, P317, DOI 10.1002/jor.1100060303; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; EKELAND A, 1981, ACTA ORTHOP SCAND, V52, P605, DOI 10.3109/17453678108992155; ENGESAETER LB, 1978, ACTA ORTHOP SCAND, V49, P512, DOI 10.3109/17453677808993231; Ersozlu Salim, 2006, Acta Orthop Traumatol Turc, V40, P158; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GARLAND DE, 1983, CLIN ORTHOP RELAT R, P190; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P219; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; HOU JCH, 1993, J ORTHOP RES, V11, P263, DOI 10.1002/jor.1100110214; KELLER TS, 1986, J ORTHOP RES, V4, P57, DOI 10.1002/jor.1100040107; KENNEDY JG, 1985, J BIOMECH ENG-T ASME, V107, P183, DOI 10.1115/1.3138539; Khare G N, 1995, Indian J Med Sci, V49, P281; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; LEVENSTON ME, 1994, J BONE MINER RES, V9, P1459; MAHY PR, 1988, CLIN ORTHOP RELAT R, P236; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Rockwood CA, 2006, ROCKWOOD GREENS FRAC, V6th, P297; SMITH R, 1987, J BONE JOINT SURG BR, V69, P518, DOI 10.1302/0301-620X.69B4.3611149; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; TURK CY, 1992, ACTA ORTHOP TRAUMATO, V26, P248; Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; WAISMAN M, 1979, CLIN ORTHOP RELAT R, P244; Zhong ZC, 2006, MED ENG PHYS, V28, P90, DOI 10.1016/j.medengphy.2005.03.007	36	5	6	0	14	TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY	ISTANBUL	SEHREMINI MAH KOYUNCU SK CIGDEM APT NO 4 D 5 FATIH, ISTANBUL, 00000, TURKEY	1017-995X			ACTA ORTHOP TRAUMATO	Acta Orthop. Traumatol. Turc.	JUL-AUG	2010	44	4					313	321		10.3944/AOTT.2010.2277			9	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	729IP	WOS:000287942400010	21252609	gold, Green Submitted			2022-02-06	
J	Barratt, J; Ogle, V				Barratt, Joanne; Ogle, Victoria			Recorded incidence and management of dysphagia in an outpatient paediatric neurodevelopmental clinic	SOUTH AFRICAN JOURNAL OF CHILD HEALTH			English	Article								In recent years there has been an increase in the number of children diagnosed with neurodevelopmental disorders. Dysphagia is believed to be a co-morbid condition in up to 90% of children with neurodevelopmental disorders, and is potentially life threatening. Objectives. To describe the medical diagnoses of children attending a state outpatient neurodevelopmental clinic; to determine the involvement of allied health professionals in the management of children with neurodevelopmental impairments; and to compare the reported incidence of feeding difficulties with the number of referrals made for feeding assessments. Setting. State hospital outpatient neurodevelopmental dinic in South Africa. Subjects and methods. Retrospective audit of a systematic sample of 100 files from 1472 patients aged 0 -14 years attending the clinic between June 2008 and April 2009. Data were tabulated and analysed quantitatively using descriptive statistics. Results. Diagnoses recorded in the files included developmental delay (32%), genetic syndrome (24%), cerebral palsy (19%), autism spectrum disorder (15%), learning disability (4%), microcephaly (1%), hydrocephalus (1%), dysmorphic features (1%), neuropathy (1%), traumatic brain injury (1%) and specific language impairment (1%). Of the sample 79% had been referred for at least one type of therapeutic intervention including speech and language therapy. Feeding difficulties were mentioned in only 29% of files, and less than half of these children (14% of the total sample) had been referred for a feeding assessment. Conclusion. A minority of children with neurodevelopmental disorders and recorded feeding difficulties are referred for feeding assessments. This supports the suggestion of mandatory dysphagia screening in clinics and regular follow-up feeding assessments, as well as improved multidisciplinary teamwork.	[Barratt, Joanne; Ogle, Victoria] Univ Witwatersrand, Dept Speech Pathol, Sch Human & Community Dev, Johannesburg, South Africa		Barratt, J (corresponding author), Univ Witwatersrand, Dept Speech Pathol, Sch Human & Community Dev, Johannesburg, South Africa.	joanne.barratt@wits.ac.za					ASHA, 2008, COMM FACTS SPEC POP; Boesch RP, 2006, EUR RESPIR J, V28, P847, DOI 10.1183/09031936.06.00138305; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Gerek M, 2005, BRIT J DEV DISABIL, V51, P57, DOI 10.1179/096979505799103849; Grimwade K, 2003, PEDIATR INFECT DIS J, V22, P1057, DOI 10.1097/01.inf.0000101188.95433.60; Kosim MS, 2008, ARCH DIS CHILD, V93, P296; Lefton-Greif MA, 2008, LANG SPEECH HEAR SER, V39, P237, DOI 10.1044/0161-1461(2008/023); Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Rogers B, 2004, J PEDIATR-US, V145, pS28, DOI 10.1016/j.jpeds.2004.05.019; Rosnow R, 2005, BEGINNING BEHAV RES, P221; Schwarz SM, 2003, INFANT YOUNG CHILD, V16, P317, DOI 10.1097/00001163-200310000-00005	11	5	5	0	0	HEALTH & MEDICAL PUBLISHING GROUP	CAPE TOWN	PRIVATE BAG X1, PINELANDS, CAPE TOWN, 7430, SOUTH AFRICA	1994-3032	1999-7671		S AFR J CHILD HEALTH	S. Afr. J. Child Health	JUN	2010	4	2					38	41					4	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VD5OJ	WOS:000437025700004					2022-02-06	
J	Llompart-Pou, JA; Perez, G; Perez-Barcena, J; Brell, M; Ibanez, J; Riesco, M; Abadal, JM; Homar, J; Marse, P; Ibanez, J; Burguera, B; Raurich, JM				Llompart-Pou, J. A.; Perez, G.; Perez-Barcena, J.; Brell, M.; Ibanez, J.; Riesco, M.; Abadal, J. M.; Homar, J.; Marse, P.; Ibanez, J.; Burguera, B.; Raurich, J. M.			Correlation between brain interstitial and total serum cortisol levels in traumatic brain injury. A preliminary study	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Brain interstitial cortisol; cerebral microdialysis; total serum cortisol; traumatic brain injury	ADRENAL INSUFFICIENCY; EXTRACELLULAR FLUID; HEAD-INJURY; MICRODIALYSIS; TISSUE; HYPOPITUITARISM; TESTS; COMA; CARE	Introduction: Brain cortisol availability has never been evaluated in patients with traumatic brain injury (TBI). Cerebral microdialysis is a well-established technique for monitoring brain metabolism in neurocritically ill patients, which may be used to measure interstitial cortisol. The objective of this preliminary study was to measure brain interstitial cortisol and its correlation with total serum cortisol in patients with TBI. Methods: We prospectively studied 6 patients with severe TBI admitted to the Intensive Care Unit of our tertiary University Hospital in which multimodal neuromonitoring including cerebral microdialysis with a high cut-off of 100 k-Da and 20-mm long membrane was used. Serum and brain interstitial cortisol microdialysis samples were obtained every 8 h and analyzed afterwards. Results: Linear regression analysis of total serum cortisol and brain interstitial cortisol in the whole population showed a moderate correlation (R-2=0.538, p<0.001, no.=118). However, intra-individual correlation showed a great variability, with correlation coefficients ranging from a R-2=0.091 to R-2=0.680. Conclusion: Our prospective and preliminary study showed a moderate correlation of brain interstitial cortisol and total serum cortisol values in patients with diffuse TBI. However, intra-individual analysis showed a great variability. These results suggest that total serum cortisol may not reflect brain cortisol availability in half of TBI patients. (J. Endocrinol. Invest. 33: 368-372, 2010) (C)2010, Editrice Kurtis	[Llompart-Pou, J. A.; Perez-Barcena, J.; Abadal, J. M.; Homar, J.; Marse, P.; Ibanez, J.; Raurich, J. M.] Son Dureta Univ Hosp, Intens Care Med Serv, Palma De Mallorca 07014, Illes Balears, Spain		Llompart-Pou, JA (corresponding author), Son Dureta Univ Hosp, Serv Med Intens, Andrea Doria 55, Palma De Mallorca 07014, Illes Balears, Spain.	juanantonio.llompart@ssib.es		Ibanez, Javier/0000-0003-3735-8332	Spanish governmentSpanish GovernmentEuropean Commission [FIS PI070307]	This research was supported by a public grant from the Spanish government: Fondo de Investigacion Sanitaria (FIS PI070307) awarded to Dr J. Perez Barcena. This public institution will not gain or lose financially from the publication of this manuscript in any way.	Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bratton S L, 2007, J NEUROTRAUMA S1, V24, pS71, DOI DOI 10.1089/NEU.2007.9985; Caricato A, 2006, INTENS CARE MED, V32, P325, DOI 10.1007/s00134-005-0015-3; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cohen J, 2009, CRIT CARE RESUSC, V11, P287; Cohen J, 2009, CRIT CARE, V13, DOI 10.1186/cc8184; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Doczy EJ, 2009, IMMUNOL ALLERGY CLIN, V29, P265, DOI 10.1016/j.iac.2009.02.003; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; JENNETT B, 1975, LANCET, V1, P480; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; Llompart-Pou JA, 2008, NEUROCRIT CARE, V9, P230, DOI 10.1007/s12028-008-9115-6; Llompart-Pou JA, 2007, J TRAUMA, V62, P1457, DOI 10.1097/01.ta.0000219143.69483.71; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nieman L K, 2003, J Endocrinol Invest, V26, P74; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Sandeep TC, 2005, DIABETES, V54, P872, DOI 10.2337/diabetes.54.3.872; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; TEASDALE G, 1974, LANCET, V2, P81; Tisdall M, 2006, BRIT J NEUROSURG, V20, P285, DOI 10.1080/02688690600999786; Wijesurendra RS, 2009, NEUROCRIT CARE, V11, P158, DOI 10.1007/s12028-009-9217-9	28	5	5	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	JUN	2010	33	6					368	372		10.1007/BF03346605			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	628ZK	WOS:000280163500002	20631492				2022-02-06	
J	Manso, Y; Serra, M; Comes, G; Giralt, M; Carrasco, J; Cols, N; Vasak, M; Gonzalez-Duarte, P; Hidalgo, J				Manso, Yasmina; Serra, Montserrat; Comes, Gemma; Giralt, Mercedes; Carrasco, Javier; Cols, Neus; Vasak, Milan; Gonzalez-Duarte, Pilar; Hidalgo, Juan			The Comparison of Mouse Full Metallothionein-1 Versus alpha and beta Domains and Metallothionein-1-to-3 Mutation Following Traumatic Brain Injury Reveals Different Biological Motifs	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						Traumatic brain injury; full MT-1; MT-1 domains; MT-1-to-MT-3 mutation	CENTRAL-NERVOUS-SYSTEM; II-DEFICIENT MICE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ASTROCYTE-TARGETED EXPRESSION; AMYOTROPHIC-LATERAL-SCLEROSIS; GROWTH-INHIBITORY FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRANSGENIC MICE; PLUS II; EXTRACELLULAR METALLOTHIONEINS	Traumatic injury to the brain is one of the leading causes of injury-related death or disability, but current therapies are limited. Previously it has been shown that the antioxidant proteins metallothioneins (MTs) are potent neuroprotective factors in animal models of brain injury. The exogenous administration of MTs causes effects consistent with the roles proposed from studies in knock-out mice. We herewith report the results comparing full mouse MT-1 with the independent alpha and beta domains, alone or together, in a cryoinjury model. The lesion of the cortex caused the mice to perform worse in the horizontal ladder beam and the rota-rod tests; all the proteins showed a modest effect in the former test, while only full MT-1 improved the performance of animals in the rota-rod, and the alpha domain showed a rather detrimental effect. Gene expression analysis by RNA protection assay demonstrated that all proteins may alter the expression of host-response genes such as GFAP, Mac1 and ICAM, in some cases being the beta domain more effective than the alpha domain or even the full MT-1. A MT-1-to-MT-3 mutation blunted some but not all the effects caused by the normal MT-1, and in some cases increased its potency. Thus, splitting the two MT-1 domains do not seem to eliminate all MT functions but certainly modifies them, and different motifs seem to be present in the protein underlying such functions. (C) 2010 Wiley-Liss, Inc.	[Manso, Yasmina; Comes, Gemma; Giralt, Mercedes; Carrasco, Javier; Hidalgo, Juan] Autonomous Univ Barcelona, Fac Biosci, Inst Neurosci, Barcelona, Spain; [Manso, Yasmina; Comes, Gemma; Giralt, Mercedes; Carrasco, Javier; Hidalgo, Juan] Autonomous Univ Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Anim Physiol Unit, Barcelona, Spain; [Serra, Montserrat; Gonzalez-Duarte, Pilar] Autonomous Univ Barcelona, Fac Sci, Dept Chem, Barcelona, Spain; [Cols, Neus] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Vasak, Milan] Univ Zurich, Inst Biochem, CH-8006 Zurich, Switzerland		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Dept Biol Celular Fisiol & Inmunol, Unidad Fisiol Anim, E-08193 Barcelona, Spain.	Juan.Hidalgo@uab.es	Hidalgo, Juan/C-9082-2011; Carrasco, Javier/C-9732-2011; Giralt, Mercedes/K-1626-2014	Hidalgo, Juan/0000-0003-0921-1122; Carrasco, Javier/0000-0001-6436-0863; Giralt, Mercedes/0000-0002-1806-1528; Manso Sanz, Yasmina/0000-0002-5788-4180	FP6 Integrated Project Exgenesis [LSHM-CT-2004-005272]; RETICS [REEM, RD07/0060/0002]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [3100A0-100246]; DURSI [SGR2009-68]; Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [SAF2008-00435]	Contract grant sponsor: FP6 Integrated Project Exgenesis; Contract grant number: LSHM-CT-2004-005272; Contract grant sponsor: RETICS; Contract grant number: REEM; Contract grant number:RD07/0060/0002 (to J.H.); Contract grant sponsor: Swiss National Science Foundation; Contract grant number: 3100A0-100246 (to M.V.); Contract grant sponsor: DURSI; Contract grant number: SGR2009-68 (to P.G.D.); Contract grant sponsor: Ministerio de Ciencia e Innovacion; Contract grant number: SAF2008-00435.	Acarin L, 1999, NEUROSCIENCE, V92, P827, DOI 10.1016/S0306-4522(99)00022-6; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Asmussen JW, 2009, EUR J CELL BIOL, V88, P433, DOI 10.1016/j.ejcb.2009.04.001; BLAAUWGEERS HGT, 1993, GLIA, V8, P62, DOI 10.1002/glia.440080108; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Capdevila M, 1997, CELL MOL LIFE SCI, V53, P681, DOI 10.1007/s000180050088; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Cols N, 1997, J INORG BIOCHEM, V68, P157, DOI 10.1016/S0162-0134(97)00085-8; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Feng W, 2005, BIOCHEM BIOPH RES CO, V332, P853, DOI 10.1016/j.bbrc.2005.04.170; Giralt M, 2002, NEUROBIOL DIS, V9, P319, DOI 10.1006/nbdi.2002.0480; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; GLANVILLE N, 1981, NATURE, V292, P267, DOI 10.1038/292267a0; Goncalves I, 2008, BIOCHEMISTRY-US, V47, P2244, DOI 10.1021/bi7016377; Hao QA, 2007, J CELL PHYSIOL, V210, P428, DOI 10.1002/jcp.20874; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Holloway AF, 1997, INT J DEV NEUROSCI, V15, P195, DOI 10.1016/S0736-5748(96)00091-3; Kang QH, 2001, PROG BIOCHEM BIOPHYS, V28, P880; Klassen RB, 2004, AM J PHYSIOL-RENAL, V287, pF393, DOI 10.1152/ajprenal.00233.2003; Knipp M, 2005, BIOCHEMISTRY-US, V44, P3159, DOI 10.1021/bi047636d; Lahti DW, 2005, PROTEIN SCI, V14, P1151, DOI 10.1110/ps.041113005; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MASTERS BA, 1994, J NEUROSCI, V14, P5844; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Molinero A, 2003, J NEUROPATH EXP NEUR, V62, P315, DOI 10.1093/jnen/62.3.315; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; NIELSON KB, 1984, J BIOL CHEM, V259, P4941; NIELSON KB, 1983, J BIOL CHEM, V258, P3063; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Ostrakhovitch EA, 2006, FEBS LETT, V580, P1235, DOI 10.1016/j.febslet.2006.01.036; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Penkowa M, 2006, J NEUROSCI RES, V83, P974, DOI 10.1002/jnr.20790; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2000, J CEREBR BLOOD F MET, V20, P1174, DOI 10.1097/00004647-200008000-00003; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; Penkowa M, 2000, GLIA, V32, P247, DOI 10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Pope SN, 2005, J STEROID BIOCHEM, V94, P203, DOI 10.1016/j.jsbmb.2005.01.007; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Romero-Isart N, 2002, J BIOL CHEM, V277, P37023, DOI 10.1074/jbc.M205730200; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SEWELL AK, 1995, BIOCHEMISTRY-US, V34, P4740, DOI 10.1021/bi00014a031; Takahashi Y, 2005, J CELL PHYSIOL, V202, P563, DOI 10.1002/jcp.20158; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Vela JM, 1997, BRAIN RES, V767, P345, DOI 10.1016/S0006-8993(97)00628-8; Wolff NA, 2006, J PHARMACOL EXP THER, V318, P782, DOI 10.1124/jpet.106.102574	66	5	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2010	88	8					1708	1718		10.1002/jnr.22342			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	590RQ	WOS:000277245500009	20127815				2022-02-06	
J	Kutcher, JS				Kutcher, Jeffrey S.			Management of the Complicated Sports Concussion Patient	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; management; return-to-play; complicated	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; EPIDEMIOLOGY; RECOVERY	Context: Whereas the majority of sports concussions are isolated self-limited events, some patients have more complicated presentations and management needs. This review presents a framework for the management of these complicated concussion patients. Evidence Acquisition: A MEDLINE search for the years 1990 to 2009 was performed using the search terms concussion and athletic injuries. Secondary search terms included symptom, incidence, treatment, and risk factor. The Strength of Recommendation Taxonomy grading system was used for all clinical recommendations. Results: Patterns of complicated sports concussion presentations were identified from literature review, anecdote, and personal experience of the author and colleagues. All clinical recommendations carry a grade of C, unless otherwise noted. Conclusion: The sports medicine provider should be aware of certain patterns of complicated sports concussion presentations in order to use a patient-focused approach to management.	[Kutcher, Jeffrey S.] Univ Michigan, 1500 East Med Ctr Dr,1914 TC, Ann Arbor, MI 48109 USA		Kutcher, JS (corresponding author), Univ Michigan, 1500 East Med Ctr Dr,1914 TC, Ann Arbor, MI 48109 USA.	jkutcher@umich.edu					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dimberg EL, 2005, CLIN SPORT MED, V24, P637, DOI 10.1016/j.csm.2005.04.002; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kelly JP, 1997, NEUROLOGY, V48, P581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McHugh T, 2006, BRAIN COGNITION, V60, P209; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	21	5	5	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2010	2	3					197	202		10.1177/1941738109357305			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V14HI	WOS:000214471700004	23015938	Green Published			2022-02-06	
J	Lull, N; Noe, E; Lull, JJ; Garcia-Panach, J; Garcia-Marti, G; Chirivella, J; Ferri, J; Sopena, R; de La Cueva, L; Robles, M				Lull, N.; Noe, E.; Lull, J. J.; Garcia-Panach, J.; Garcia-Marti, G.; Chirivella, J.; Ferri, J.; Sopena, R.; de La Cueva, L.; Robles, M.			Thalamic metabolism and neurological outcome after traumatic brain injury. A voxel-based morphometric FDG-PET study	NEUROLOGIA			Spanish	Article						Voxel-based analysis; Consciousness; PET-FDG; Prognostic; Thalamus; Traumatic brain injury; Positron emission tomography	DIFFUSE AXONAL INJURY; REGIONAL CEREBRAL METABOLISM; VEGETATIVE STATE; GLUCOSE-METABOLISM; RECOVERY; MRI; NEUROPATHOLOGY; CONSCIOUSNESS; CONNECTIVITY; SEVERITY	Objective: To study the relationship between thalamic metabolism and neurological outcome in patients who had sustained a traumatic brain injury (TBI). Methods: Nineteen patients who had sustained a severe TBI and ten control subjects were included in this study. Six of the 19 patients had a low level of consciousness (vegetative state or minimally conscious state), while thirteen showed normal consciousness. All patients underwent a PET with 18F-FDG, 459.4 +/- 470.9 days after the TBI. The FDG-PET images were normalized in intensity, with a metabolic template being created from data derived from all subjects. The thalamic trace was generated automatically with a mask of the region of interest in order to evaluate its metabolism. A comparison between the two groups was carried out by a two sample voxel-based T-test, under the General Linear Model (GLM) framework. Results: Patients with low consciousness had lower thalamic metabolism (MNI-Talairach coordinates: 12, -24, 18; T = 4.1) than patients with adequate awareness (14, -28, 6; T = 5.5). Control subjects showed the greatest thalamic metabolism compared to both patients groups. These differences in metabolism were more pronounced in the internal regions of the thalamus. Conclusions: The applied method may be a useful ancillary tool to assess neurological outcomes after a TBI, since it permits an objective quantitative assessment of metabolic function for groups of subjects. Our results confirm the vulnerability of the thalamus to suffering the effects of the acceleration-deceleration forces generated during a TBI. It is hypothesized that patients with low thalamic metabolism represent a subset of subjects highly vulnerable to neurological and functional disability after TBI. (C) 2009 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L. All rights reserved.	[Noe, E.; Garcia-Panach, J.; Chirivella, J.; Ferri, J.] IVAN, Serv Dano Cerebral Hosp NISA, Valencia, Spain; [Lull, N.; Lull, J. J.; Garcia-Panach, J.; Robles, M.] Univ Politecn Valencia, Inst ITACA, ITACA Grp Informat Biomed, E-46071 Valencia, Spain; [Lull, N.] Univ CEU Cardenal Herrera, Valencia, Spain; [Garcia-Marti, G.] Hosp Quiron, Valencia, Spain; [Sopena, R.] Hosp 9 Octubre, Nucl Med Serv, Valencia, Spain; [de La Cueva, L.] Hosp Miguel Servet, Nucl Med Serv, Zaragoza, Spain		Noe, E (corresponding author), IVAN, Serv Dano Cerebral Hosp NISA, Valencia, Spain.	enoe@comv.es	Marti, Gracian Garcia/I-5299-2013; Lull, Juan Jose/AAB-5154-2019; Robles, Montserrat/A-6722-2016	Lull, Juan Jose/0000-0002-4399-950X; Robles, Montserrat/0000-0002-7705-1389; Garcia Marti, Gracian/0000-0002-9850-2580; de la Cueva Barrao, Maria Leticia/0000-0003-0962-7689; Noe Sebastian, Enrique/0000-0002-2547-8727			Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Burruss JW, 2000, RADIOLOGY, V214, P227, DOI 10.1148/radiology.214.1.r00ja43227; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; de la Cueva-Barrao L, 2009, REV NEUROLOGIA, V49, P58, DOI 10.33588/rn.4902.2008676; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gispert JD, 2003, NEUROIMAGE, V19, P601, DOI 10.1016/S1053-8119(03)00072-7; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hattori N, 2003, J NUCL MED, V44, P1709; ICHISE M, 1994, J NUCL MED, V35, P217; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Marshall S B, 1988, J Neurosci Nurs, V20, P253; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Rudolf J, 1999, J NEUROSURG ANESTH, V11, P17, DOI 10.1097/00008506-199901000-00004; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	45	5	5	0	4	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	APR	2010	25	3					174	180					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737MR	WOS:000288573400006	20492864	Bronze			2022-02-06	
J	Hammond-Tooke, GD; Goei, J; du Plessis, LJ; Franz, EA				Hammond-Tooke, G. D.; Goei, J.; du Plessis, L. J.; Franz, E. A.			Concussion causes transient dysfunction in cortical inhibitory networks but not the corpus callosum	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Bimanual cost; Concussion; Corpus callosum; Reaction times	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; REACTION-TIME; HEAD-INJURY; INFORMATION	The Corpus callosum (CC) is thought to be especially vulnerable in traumatic brain injury. Bimanual cost (a slowing of reaction time with bimanual compared to unimanual responses) is a sensitive indicator of CC function. To determine whether CC dysfunction is a significant feature of mild traumatic brain injury, unimanual and bimanual reaction times were studied in 10 recently concussed patients and 10 healthy participants. Reaction times were studied within 1 week of concussion and again after I month. Concussion symptoms were assessed with the Rivermead Postconcussion Symptoms Questionnaire. The bimanual cost was present at both testing sessions in patients and healthy controls. Although overall reaction times were slower in concussed patients during session 1, these had improved by session 2, as did the symptom scores. These findings suggest that the pathogenesis of mild traumatic brain injury involves intrahemispheric cortical networks rather than impaired interhemispheric communication via the CC. (C) 2009 Elsevier Ltd. All rights reserved.	[Hammond-Tooke, G. D.; du Plessis, L. J.] Univ Otago, Dept Med & Surg Sci, Dunedin 9054, New Zealand; [Goei, J.; Franz, E. A.] Univ Otago, Dept Psychol, Dunedin 9054, New Zealand; [Hammond-Tooke, G. D.; du Plessis, L. J.] Dunedin Publ Hosp, Dept Neurol, Dunedin, New Zealand		Hammond-Tooke, GD (corresponding author), Univ Otago, Dept Med & Surg Sci, POB 913, Dunedin 9054, New Zealand.	graemeH@healthotago.co.nz					Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Franz EA, 2007, PSYCHOL SCI, V18, P1030, DOI 10.1111/j.1467-9280.2007.02020.x; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gennarelli T. A., 1987, HEAD INJURY, P108; Gestaldo E, 2001, ARCH CLIN NEUROPSYCH, V16, P825; Hughes CML, 2007, J MOTOR BEHAV, V39, P3, DOI 10.3200/JMBR.39.1.3-8; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; JALL JI, 2000, NEUROLOGY CLIN PRACT, V2, P1080; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Marzi CA, 1999, EXP BRAIN RES, V126, P451, DOI 10.1007/s002210050752; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkinson D, 1996, SURG NEUROL, V45, P459, DOI 10.1016/0090-3019(95)00210-3; Povlishock JT, 1996, ACT NEUR S, V66, P81; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shen YC, 2005, J MOTOR BEHAV, V37, P3, DOI 10.3200/JMBR.37.1.3-9; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	28	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2010	17	3					315	319		10.1016/j.jocn.2009.06.026			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	559QI	WOS:000274840700010	20089407				2022-02-06	
J	Jeffcote, T; Ho, KM				Jeffcote, T.; Ho, K. M.			Associations between cerebrospinal fluid protein concentrations, serum albumin concentrations and intracranial pressure in neurotrauma and intracranial haemorrhage	ANAESTHESIA AND INTENSIVE CARE			English	Article						blood-brain barrier; head injury; haemodynamic resuscitation; intravenous fluid	BLOOD-BRAIN-BARRIER; SEVERE HEAD-INJURY; COLLOID ONCOTIC THERAPY; SUBARACHNOID HEMORRHAGE; EDEMA; VOLUME; PERMEABILITY; PRINCIPLES; HEALTH; MRI	Recent evidence suggests that using intravenous isotonic albumin solution for haemodynamic resuscitation in neurotrauma is associated with adverse outcomes. This study assessed the correlations between cerebrospinal fluid protein concentrations, serum albumin concentrations and intracranial pressure in a cohort of neurosurgical patients. After obtaining ethics committee approval, correlations between concomitant cerebrospinal fluid protein concentrations, serum albumin concentrations and the mean daily intracranial pressure of 63 consecutive neurosurgical patients, grouped as neurotrauma or intracranial haemorrhage, admitted between 1 January and 37 December 2007, were assessed. The mean daily intracranial pressure was significantly associated with cerebrospinal fluid protein concentrations (Spearman correlation coefficient [SCC] =0.496, P=0.001), white cell counts (SCC=0.359, P=0.001), red cell counts (SCC=0.399, P=0.001) and serum albumin concentrations (SCC=0.431, P=0.001) in patients with neurotrauma (n=23). Cerebrospinal fluid protein concentrations were also significantly associated with concomitant serum albumin concentrations (SCC=0.393, P=0.001) in these patients. hi patients with intracranial haemorrhage (n=40), the mean daily intracranial pressure was only significantly associated with cerebrospinal fluid white cell and red cell counts but not cerebrospinal fluid protein and serum albumin concentrations. In summary, intracranial pressure is correlated with cerebrospinal fluid protein and serum albumin concentrations in patients with severe neurotrauma, and these suggest that blood-brain barrier may not be completely intact after severe neurotrauma.	[Ho, K. M.] Royal Perth Hosp, Intens Care Unit, Dept Intens Care, Perth, WA 6000, Australia		Jeffcote, T (corresponding author), Royal Perth Hosp, Intens Care Unit, Dept Intens Care, Perth, WA 6000, Australia.		Jeffcote, Toby/AAP-7945-2021; Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; BECHER H, 1992, STAT MED, V11, P1747, DOI 10.1002/sim.4780111308; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BRACKENRIDGE CJ, 1962, J CLIN PATHOL, V15, P206, DOI 10.1136/jcp.15.3.206; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Busch E, 1998, STROKE, V29, P2155, DOI 10.1161/01.STR.29.10.2155; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; CAO MH, 1984, J NEUROSURG, V61, P707, DOI 10.3171/jns.1984.61.4.0707; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Eker C, 2000, BRAIN INJURY, V14, P605; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Grande PO, 2008, ACTA ANAESTH SCAND, V52, P738, DOI 10.1111/j.1399-6576.2008.01688.x; HAKAMATA Y, 1995, STROKE, V26, P2149, DOI 10.1161/01.STR.26.11.2149; Is M, 2005, NEUROL RES, V27, P67, DOI 10.1179/016164105X18296; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MATSUI T, 1993, NEUROSURGERY, V33, P293, DOI 10.1227/00006123-199308000-00017; Mayer SA, 1998, NEUROSURGERY, V42, P759, DOI 10.1097/00006123-199804000-00048; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Okimura Y, 1996, J NEUROTRAUM, V13, P385, DOI 10.1089/neu.1996.13.385; Orakcioglu B, 2005, EXP NEUROL, V193, P369, DOI 10.1016/j.expneurol.2005.01.017; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; TONE O, 1994, ACTA NEUROCHIR, P568; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583	32	5	6	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	MAR	2010	38	2					274	279		10.1177/0310057X1003800208			6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	575GK	WOS:000276054800008	20369759	Bronze			2022-02-06	
J	Joghataei, MT; Bakhtiari, M; Pourheydar, B; Mehdizadeh, M; Faghihi, A; Mehraein, F; Behnam, B; Pirhajati, V				Joghataei, Mohammad Taghi; Bakhtiari, Mehrdad; Pourheydar, Bagher; Mehdizadeh, Mehdi; Faghihi, Abolfazt; Mehraein, Fereshteh; Behnam, Babak; Pirhajati, Vahid			Co-transplantation of Schwann and Bone Marrow Stromal Cells Promotes Locomotor Recovery in the Rat Contusion Model of Spinal Cord Injury	YAKHTEH			English	Article						Bone Marrow Stromal Cell; Schwann Cell; Transplantation; Spinal Cord Injury; Functional Recovery	OLFACTORY ENSHEATHING GLIA; TRAUMATIC BRAIN INJURY; MESENCHYMAL STEM-CELLS; FUNCTIONAL RECOVERY; PARAPLEGIC RATS; NERVOUS-SYSTEM; ADULT RATS; DIFFERENTIATION; REGENERATION; MIGRATION	Objective: Previous studies have shown that transplantation of bone marrow stromal cells (BMSCs) into the contused spinal cord improves functional recovery and that administration of Schwann cells (SCs) after spinal cord injury (SCI) facilitates axonal regeneration. Although the efficacy of these treatments have been proven, when used individually, their resulting number of regenerated axons is small and locomotor recovery is modest; therefore, we decided to research whether co-transplantation of these cells can improve the outcome. Materials and Methods: Adult male Wistar rats (n=56), each weighting 250-300 grams were used. BMSCs and SCs were cultured and prelabeled with BrdU and 1,1' dioctadecyl 3,3,3,3' tetramethylindocarbocyanin perchlorate respectively. Contusion model of SCI was performed at the T8-9 level using NYU device (New York University device). The rats were divided into seven groups, each consisting of 8 animals. These groups included: a control group, three experimental groups and three sham groups. In the control group, only a laminectomy was performed. The three experiment groups were the BMSC, SC and co-transplant groups, and 7 days after injury, they received intraspinal BMSCs, SCs and the combination of BMSCs & SCs respectively. The sham groups received serum in the same manner. Locomotion in the groups was assessed using the basso, beatie and bresnahan (BBB) test at 1, 7, 14, 21, 28, 35, 42, 49 and 56 days after SCI. Results: More significant improvement was observed in the BBB scores of the co-transplant group (p<0.05) in comparison with BMSC and SC groups. Conclusion: This study shows that co-transplantation of BMSCs and SCs may provide a powerful therapy for SCI and become required for the development of combinatory treatment strategies in the future.	[Joghataei, Mohammad Taghi; Bakhtiari, Mehrdad; Pourheydar, Bagher; Mehdizadeh, Mehdi; Faghihi, Abolfazt; Mehraein, Fereshteh; Pirhajati, Vahid] Iran Univ Med Sci, Dept Anat, Cellular & Mol Res Ctr, Fac Med, Tehran, Iran; [Pourheydar, Bagher] Urmieh Univ Med Sci, Dept Anat, Fac Med, Urmieh, Iran; [Behnam, Babak] Iran Univ Med Sci, Dept Genet & Mol Biol, Fac Med, Tehran, Iran		Pourheydar, B (corresponding author), Iran Univ Med Sci, Dept Anat, Cellular & Mol Res Ctr, Fac Med, POB 14155-6183, Tehran, Iran.	bpourheydar@yahoo.com	Pourheydar, Bagher/G-8190-2017; mehraein, fereshteh/AAE-6771-2021; mehdizadeh, mehdi/O-5737-2018	Pourheydar, Bagher/0000-0001-9823-6887; mehdizadeh, mehdi/0000-0002-9268-7318; Behnam, Babak/0000-0002-1266-1602; Joghataei, Mohammad Taghi/0000-0003-0492-8239	Cellular and Molecular Research Center at Iran University of Medical Sciences	This study was financially supported by a grant from the Cellular and Molecular Research Center at Iran University of Medical Sciences. The cryo-sectioning process of this research was performed at the anatomy department of Tarbiat Modarres University. We express our deep appreciation for Dr. Salehnia, Mrs. Ebrahimi and Mr. Pourbeyram-vand's support. There is no conflict of interest in this article.	Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102; ASIM M, 2002, J NEUROTRAUM, V19, P1609; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Ban DX, 2009, BRAIN RES, V1256, P149, DOI 10.1016/j.brainres.2008.11.098; Billon Nathalie, 2006, V330, P15; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; BUNGE PM, 2006, TXB NEURAL REPAIR RE, P513; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Delaviz H, 2008, YAKHTEH, V10, P185; Feng SQ, 2008, BRAIN RES, V1209, P40, DOI 10.1016/j.brainres.2008.02.075; Feng SQ, 2005, NEUROTOX RES, V7, P169, DOI 10.1007/BF03033785; Firouzi M, 2006, NEUROSCI LETT, V402, P66, DOI 10.1016/j.neulet.2006.03.070; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; Keirstead HS, 1999, EXP NEUROL, V159, P225, DOI 10.1006/exnr.1999.7100; Khalatbary AR, 2007, NEUROL RES, V29, P21, DOI 10.1179/016164107X165642; Khalatbary Ali Reza, 2009, Iranian Biomedical Journal, V13, P43; KIM SM, 2006, ORAL MAXILLOFAC SURG, V32, P42; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Lang KJD, 2004, J NEUROSCI RES, V76, P184, DOI 10.1002/jnr.20036; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Li Y, 2001, CELL TRANSPLANT, V10, P31; Lim PAC, 2007, ANN ACAD MED SINGAP, V36, P49; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Oudega M, 2005, BRAZ J MED BIOL RES, V38, P825, DOI 10.1590/S0100-879X2005000600003; Pearse Damien D, 2006, Expert Opin Biol Ther, V6, P639, DOI 10.1517/14712598.6.7.639; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Smith PM, 2002, EXP NEUROL, V176, P402, DOI 10.1006/exnr.2002.7936; Song S, 2004, EXP NEUROL, V185, P191, DOI 10.1016/j.expneurol.2003.09.003; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201; Takami T, 2002, J NEUROSCI, V22, P6670; Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069	47	5	5	1	2	ROYAN INST	TEHRAN	ROYAN INST, PO BOX 19395-4644, TEHRAN, 00000, IRAN	1561-4921			YAKHTEH	Yakhteh	SPR	2010	12	1					7	+					11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	607PR	WOS:000278518800002					2022-02-06	
J	Kim, CT; Moberg-Wolff, E; Trovato, M; Kim, H; Murphy, N				Kim, Chong Tae; Moberg-Wolff, Elizabeth; Trovato, Melissa; Kim, Heakyung; Murphy, Nancy			Pediatric Rehabilitation: 1. Common Medical Conditions in Children With Disabilities	PM&R			English	Article								Objective: This self-directed learning module focuses on the physiatric management of the common morbidities associated with pediatric traumatic brain injury and cerebral palsy. It is part of the study guide on pediatric rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation and pediatric medicine. The goal of this article is to enhance the learner's knowledge regarding current physiatric management of complications related with pediatric traumatic brain injury and cerebral palsy. PM R 2010;2:S3-S11	[Kim, Chong Tae] Univ Penn, Sch Med, Dept PM&R, Philadelphia, PA 19096 USA; [Kim, Chong Tae] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Moberg-Wolff, Elizabeth] Med Coll Wisconsin, Dept PM&R, Milwaukee, WI 53226 USA; [Trovato, Melissa] Johns Hopkins Univ, Sch Med, Dept PM&R, Baltimore, MD USA; [Kim, Heakyung] Univ Penn, Sch Med, Dept PM&R & Pediat, Philadelphia, PA 19096 USA; [Murphy, Nancy] Univ Utah, Div Gen Pediat, Salt Lake City, UT USA		Kim, CT (corresponding author), Univ Penn, Sch Med, Dept PM&R, 3405 Civ Ctr Blvd, Philadelphia, PA 19096 USA.	kim@email.chop.edu					Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Akbunar AT, 2003, ANN NUCL MED, V17, P415, DOI 10.1007/BF03006612; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Andersson T, 1997, EPILEPSIA, V38, P225, DOI 10.1111/j.1528-1157.1997.tb01101.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Apkon Susan D, 2002, Phys Med Rehabil Clin N Am, V13, P839, DOI 10.1016/S1047-9651(02)00026-8; Apkon SD, 2008, J PEDIATR REHAB MED, V1, P115; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Aschwanden M, 2001, THROMB HAEMOSTASIS, V85, P42, DOI 10.1055/s-0037-1612901; Azu MC, 2005, J TRAUMA, V59, P1345, DOI 10.1097/01.ta.0000196008.48461.47; Bachrach SJ, 1998, CLIN PEDIATR, V37, P485, DOI 10.1177/000992289803700805; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; BERG AT, 1994, NEUROLOGY, V44, P601, DOI 10.1212/WNL.44.4.601; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; BLASCO PA, 1992, DEV MED CHILD NEUROL, V34, P849; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Caulton JM, 2004, ARCH DIS CHILD, V89, P131, DOI 10.1136/adc.2002.009316; Chad KE, 1999, J PEDIATR-US, V135, P115, DOI 10.1016/S0022-3476(99)70340-9; CHADWICK D, 1991, LANCET, V337, P1175; Chadwick D, 1996, EPILEPSIA, V37, P1043, DOI 10.1111/j.1528-1157.1996.tb01023.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; Cockrell J, 1996, MED REHABILITATION T, P181; Collier BD, 1997, AM J MED, V103, p135S, DOI 10.1016/S0002-9343(97)00339-2; Cook SP, 1997, INT J PEDIATR OTORHI, V41, P353, DOI 10.1016/S0165-5876(97)00102-X; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Costa J, 2008, J NEUROL, V255, P545, DOI 10.1007/s00415-008-0738-5; CRAMER K, 2004, ORTHOPEDIC SURG ESSE, P44; CRYSDALE W S, 1989, Ear Nose and Throat Journal, V68, P825; Crysdale WS, 2006, INT J PEDIATR OTORHI, V70, P519, DOI 10.1016/j.ijporl.2005.07.021; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Cyr C, 2006, ACTA HAEMATOL-BASEL, V115, P198, DOI 10.1159/000090935; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; DELGADOESCUETA AV, 1984, NEUROLOGY, V34, P285, DOI 10.1212/WNL.34.3.285; Dorman J., 2005, PEDIAT ORTHOPAEDICS; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Gissel T, 2007, EXPERT OPIN DRUG SAF, V6, P267, DOI 10.1517/14740338.6.3.267; Gupta MC, 2007, SPINE, V32, P691, DOI 10.1097/01.brs.0000257524.23074.ed; Harcke HT, 1998, PEDIATR RADIOL, V28, P241, DOI 10.1007/s002470050341; HASELKORN JK, 1991, ARCH PHYS MED REHAB, V72, P227; Hedequist DJ, 2007, ORTHOP CLIN N AM, V38, P497, DOI 10.1016/j.ocl.2007.05.002; Hell AK, 2005, J PEDIATR ORTHOP B, V14, P287, DOI 10.1097/01202412-200507000-00011; HENDERSON RC, 1995, J BONE JOINT SURG AM, V77A, P1671, DOI 10.2106/00004623-199511000-00005; Henderson RC, 1997, J CHILD NEUROL, V12, P443, DOI 10.1177/088307389701200706; Henderson RC, 2004, DEV MED CHILD NEUROL, V46, P416, DOI 10.1017/S0012162204000672; Henderson RC, 2002, J PEDIATR-US, V141, P644, DOI 10.1067/mpd.2002.128207; Henderson RC, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e5; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hillesund E, 2007, ACTA PAEDIATR, V96, P1195, DOI 10.1111/j.1651-2227.2007.00354.x; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; Inga CT, 2001, AM ACAD PEDIAT DENT, V23, P241; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Jongerius PH, 2005, J PEDIATR GASTR NUTR, V41, P351, DOI 10.1097/01.mpg.0000175565.61072.1a; Jongerius PH, 2004, NEUROLOGY, V63, P1371; Jongerius PH, 2004, LARYNGOSCOPE, V114, P1801, DOI 10.1097/00005537-200410000-00023; Junger M, 2006, CURR MED RES OPIN, V22, P593, DOI 10.1185/030079906X89838; Kim H, 2006, ARCH PHYS MED REHAB, V87, P141, DOI 10.1016/j.apmr.2005.08.112; King W, 2003, DEV MED CHILD NEUROL, V45, P12, DOI 10.1017/S0012162203000033; Kuclsk KA, 2001, SURGERY, p[1, 8, 12]; Larsson ELC, 2005, SPINE, V30, P2145, DOI 10.1097/01.brs.0000180403.11757.6a; Leet AI, 2006, J PEDIATR ORTHOPED, V26, P624, DOI 10.1097/01.bpo.0000235228.45539.c7; Leopando MT, 1999, PEDIATR PULM, V28, P53, DOI 10.1002/(SICI)1099-0496(199907)28:1<53::AID-PPUL9>3.0.CO;2-2; LETTS M, 1992, J PEDIATR ORTHOPED, V12, P470, DOI 10.1097/01241398-199207000-00010; Lindenmayer JP, 2000, J CLIN PSYCHIAT, V61, P5; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Matthews DJ, 1999, PEDIAT REHABILITATIO, V3rd, P193; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; Michaud L, 2004, J PEDIATR GASTR NUTR, V38, P426, DOI 10.1097/00005176-200404000-00011; Mirrett Penny L., 1994, Dysphagia, V9, P174, DOI 10.1007/BF00341262; Murphy N, 2006, J PED ORTHOP, V23, P211; MYERS MA, 1996, MED REHABILITATION T, P515; NASH CL, 1969, J BONE JOINT SURG AM, VA 51, P223, DOI 10.2106/00004623-196951020-00002; Olafsson Y, 1999, J PEDIATR ORTHOPED, V19, P376, DOI 10.1097/00004694-199905000-00017; Ondo WG, 2004, NEUROLOGY, V62, P37, DOI 10.1212/01.WNL.0000101713.81253.4C; PEDOTO MJ, 1995, ARCH PHYS MED REHAB, V76, P871, DOI 10.1016/S0003-9993(95)80555-9; Pena AH, 2009, J VASC INTERV RADIOL, V20, P368, DOI 10.1016/j.jvir.2008.11.011; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Peters ACB, 1998, NEUROLOGY, V50, P724, DOI 10.1212/WNL.50.3.724; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Presedo A, 2007, J PEDIATR ORTHOPED, V27, P147, DOI 10.1097/BPO.0b013e3180317403; RADECKI RT, 1994, ARCH PHYS MED REHAB, V75, P248, DOI 10.1016/0003-9993(94)90023-X; RAGONE DJ, 1986, ARCH PHYS MED REHAB, V67, P339; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Raval TH, 2008, ANN OTO RHINOL LARYN, V117, P118, DOI 10.1177/000348940811700209; Rivkees SA, 2008, CURR OPIN PEDIATR, V20, P448, DOI 10.1097/MOP.0b013e328305e403; Sachdev P, 1996, AUST NZ J PSYCHIAT, V30, P38, DOI 10.3109/00048679609076071; Sandoval JA, 2008, J VASC SURG, V47, P837, DOI 10.1016/j.jvs.2007.11.054; Savarese R, 2004, AM J PHYS MED REHAB, V83, P304, DOI 10.1097/01.PHM.0000104680.28335.B9; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; SHINNAR S, 1985, NEW ENGL J MED, V313, P976, DOI 10.1056/NEJM198510173131603; Simosa HF, 2007, AM SURGEON, V73, P461; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Smith JT, 2007, ORTHOP CLIN N AM, V38, P547, DOI 10.1016/j.ocl.2007.03.009; SOBUS KM, 1993, ARCH PHYS MED REHAB, V74, P547, DOI 10.1016/0003-9993(93)90123-R; Staheli L. T., 2006, PRACTICE PEDIAT ORTH; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc6802; Stevenson Richard D, 2006, Pediatr Rehabil, V9, P396, DOI 10.1080/13638490600668061; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Suskind DL, 2002, LARYNGOSCOPE, V112, P73, DOI 10.1097/00005537-200201000-00014; Tahmassebi JF, 2003, DEV MED CHILD NEUROL, V45, P613, DOI 10.1017/S0012162203001117; Tan EK, 2006, EUR J NEUROL, V13, P60, DOI 10.1111/j.1468-1331.2006.01447.x; Tejas H, 2008, ANN OTO RHINOL LARYN, V117, P118; Teymoortash A, 2007, BRIT J PHARMACOL, V152, P161, DOI 10.1038/sj.bjp.0707375; Torre-Healy A, 2007, NEUROSURG CLIN N AM, V18, P697, DOI 10.1016/j.nec.2007.07.002; Truitt AK, 2005, J PEDIATR SURG, V40, P124, DOI 10.1016/j.jpedsurg.2004.09.017; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	120	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	MAR	2010	2	3					S3	S11		10.1016/j.pmrj.2009.12.004			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V23RZ	WOS:000208361200014	20359677				2022-02-06	
J	Krakau, K; Hansson, A; Olin, AO; Karlsson, T; de Boussard, CN; Borg, J				Krakau, Karolina; Hansson, Annette; Olin, Ann Odlund; Karlsson, Torbjorn; de Boussard, Catharina Nygren; Borg, Jorgen			Resources and routines for nutritional assessment of patients with severe traumatic brain injury	SCANDINAVIAN JOURNAL OF CARING SCIENCES			English	Article						nutrition; head injury; nutritional assessment; critical care; questionnaires; quantitative approaches	SEVERE HEAD-INJURY; ENERGY-EXPENDITURE; CONTROLLED POPULATION; HOSPITAL ADMISSION; NURSING STAFF; NITROGEN-EXCRETION; METABOLIC CHANGES; DANISH HOSPITALS; BODY-COMPOSITION; MALNUTRITION	Objective: To describe the resources and routines for nutritional management until 6 months after severe traumatic brain injury. Methods: Data collection was performed by use of questionnaires to staff professionals at three regional neurosurgical intensive and 75 other care units and a retrospective survey of medical and nursing records from 64 patients treated at these units. Results: Resources in terms of qualified staff members were reportedly good, while nutritional guidelines were adopted in less than half of the units. Screening for malnutrition at admission was rarely performed and the nutritional data in medical and nursing records were incomplete, i.e. there was a lack of body weight measurements in more than one-third of the care unit episodes and of body height data in more than half of the patients and a declining surveillance of energy intake when patients changed from parenteral or enteral nutrition to oral intake. Assessment of energy requirements relied on calculations and the assignment of who was to estimate it varied depending on which nutritional route was used and also between unit specialities. Finally, information on energy requirement, weight development and body mass index was present in only 16%, 7% and in 2% of the transferrals. Conclusions: Despite good resources of qualified staff, the nutritional assessment routines were deficient, resulting in incomplete nutritional data and lost nutritional information.	[Krakau, Karolina; de Boussard, Catharina Nygren] Danderyd Hosp, Dept Rehabil Med Stockholm, SE-18288 Stockholm, Sweden; [Krakau, Karolina; Borg, Jorgen] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden; [Hansson, Annette] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Anesthesia & Intens Care, Stockholm, Sweden; [Olin, Ann Odlund] Karolinska Univ Hosp, Dept Qual & Patient Safety, Stockholm, Sweden; [Olin, Ann Odlund] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Karlsson, Torbjorn] Univ Uppsala Hosp, Dept Surg Sci Anesthesiol & Intens Care, Uppsala, Sweden		Krakau, K (corresponding author), Danderyd Hosp, Dept Rehabil Med Stockholm, SE-18288 Stockholm, Sweden.	karolina.krakau@ds.se		Borg, Jorgen/0000-0002-2372-7478			AKNER G, 2000, NARINGSPROBLEM VARD, P9; Annette Hansson, 2005, Nurs Health Sci, V7, P266, DOI 10.1111/j.1442-2018.2005.00246.x; Bachrach-Lindstrom M, 2007, J CLIN NURS, V16, P2007, DOI 10.1111/j.1365-2702.2006.01868.x; Bavelaar JW, 2008, CLIN NUTR, V27, P431, DOI 10.1016/j.clnu.2008.01.016; Beck AM, 2001, CLIN NUTR, V20, P455, DOI 10.1054/clnu.2001.0494; *BRAIN TRAUM FDN, 2000, NUTR J NEUROTRAUMA, V7, P539; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; BRUDER N, 1991, CRIT CARE MED, V19, P43, DOI 10.1097/00003246-199101000-00013; Bruun LI, 1999, CLIN NUTR, V18, P141, DOI 10.1016/S0261-5614(99)80003-X; Carlsson E, 2006, STUD HEALTH TECHNOL, V122, P909; CHARLIN V, 1993, REV MED CHILE, V121, P626; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DICKERSON RN, 1990, J AM COLL NUTR, V9, P86; Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; FELL D, 1984, CRIT CARE MED, V12, P649, DOI 10.1097/00003246-198408000-00009; FUGAZZA G, 1998, EUROPA MEDICOPHYSICA, V34, P125; Green M, 2003, DIS RELATED MALNUTRI; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Harris J.A., 1919, BIOMETRIC STUDY BASA; JOHANSSON U, 2006, LAKARTIDNINGEN, V22, P1718; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kyle UG, 2003, CLIN NUTR, V22, P473, DOI 10.1016/S0261-5614(03)00049-9; Kyle UG, 2002, NUTRITION, V18, P463, DOI 10.1016/S0899-9007(01)00804-8; Kyle UG, 2002, J AM DIET ASSOC, V102, P944, DOI 10.1016/S0002-8223(02)90216-6; LARSSON J, 2006, NUTRITIONSBEHANDLING; Lelovics Z, 2008, ACTA PHYSIOL HUNG, V95, P107, DOI 10.1556/APhysiol.95.2008.1.8; LONG CL, 1979, JPEN-PARENTER ENTER, V3, P69, DOI 10.1177/014860717900300269; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Meijers JM, 2008, BR J NUTR, P1; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; MOSSBERG T, 2001, KLIN NUTR VATSKEBEHA; Mowe M, 2008, CLIN NUTR, V27, P196, DOI 10.1016/j.clnu.2007.10.014; Mowe M, 2006, CLIN NUTR, V25, P524, DOI 10.1016/j.clnu.2005.11.011; OLIN AO, 2005, REGIONALT VARDPROGRA; Pawellek I, 2008, CLIN NUTR, V27, P72, DOI 10.1016/j.clnu.2007.11.001; Peake H, 2001, J HUM NUTR DIET, V14, P225, DOI 10.1046/j.1365-277X.2001.00287.x; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Planas M, 2004, CLIN NUTR, V23, P1016, DOI 10.1016/j.clnu.2004.01.003; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Rasmussen HH, 1999, CLIN NUTR, V18, P153, DOI 10.1016/S0261-5614(99)80005-3; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Stratton RJ, 2006, BRIT J NUTR, V96, P870, DOI 10.1017/BJN20061852; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	56	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0283-9318	1471-6712		SCAND J CARING SCI	Scand. J. Caring Sci.	MAR	2010	24	1					3	13		10.1111/j.1471-6712.2008.00677.x			11	Nursing	Social Science Citation Index (SSCI)	Nursing	553TO	WOS:000274389900002	19497027				2022-02-06	
J	Piskunov, AK				Piskunov, A. K.			Neuroinflammation biomarkers	NEUROCHEMICAL JOURNAL			English	Article						neuroinflammation; biomarker; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MINOR HEAD-INJURY; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; INFLAMMATORY CYTOKINES; BREAKDOWN PRODUCTS; CNS REMYELINATION; PROTEIN S100B; NITRIC-OXIDE	Neuroinflammation is an adaptive response of brain tissue to mechanical damage, hypoxia, and metabolic stress. Inflammatory processes have been implicated in most acute, neurodegenerative, and some psychiatric disorders. The function of neuroinflammation consists in adaptation to damage or to homeostatic disturbances as well as in initiating reparation. However, if unregulated, this protective reaction may cause brain damage by itself. Cytotoxic mechanisms of neuroinflammation have been studied by numerous researchers. A number of potentially neuroprotective strategies are based on inhibition of inflammatoty mediators. Nevertheless, this approach seems to be inapplicable under clinical conditions because intensity and exact pathogenic effect of the process inhibited is unknown. Studies of neuroinflammation regulatory mechanisms and its neuroprotective properties in greater detail are evidently necessary for safer and more efficient therapy of brain disorders. Under clinical conditions, neuroinflammatory biomarkers are expected to give data on neurochemical mechanisms of brain inflammation.	[Piskunov, A. K.] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Lab Funct Biochem Nervous Syst, Moscow 117901, Russia		Piskunov, AK (corresponding author), Ul Butlerova 5A, Moscow, Russia.	1830255@gmail.com		Alexey, Piskunov/0000-0001-6439-7121			Adams JM, 2009, ACTA PHYSIOL HUNG, V96, P19, DOI 10.1556/APhysiol.96.2009.1.2; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; [Anonymous], 1999, Neurology, V53, P457; Asea Alexzander, 2008, V183, P111; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; BALABAN PM, 2006, ROS FIZIOL ZH IM SEC, V92, P151; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bartosik-Psujek H, 2001, Ann Univ Mariae Curie Sklodowska Med, V56, P389; Bate C, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-5; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Boelen A, 1996, ENDOCRINOLOGY, V137, P5250, DOI 10.1210/en.137.12.5250; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; BRYLEV LV, 2009, NEJROKHIMIYA, V29; Castellanos M, 2002, STROKE, V33, P982, DOI 10.1161/hs0402.105339; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castellanos M, 2007, STROKE, V38, P1855, DOI 10.1161/STROKEAHA.106.481556; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chida D, 2005, ENDOCRINOLOGY, V146, P5496, DOI 10.1210/en.2005-0409; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Craft JM, 2005, GLIA, V51, P209, DOI 10.1002/glia.20194; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Czeisler Barry M, 2006, Recent Pat CNS Drug Discov, V1, P157, DOI 10.2174/157488906777452712; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; de Araujo EG, 2009, ANN NY ACAD SCI, V1153, P57, DOI 10.1111/j.1749-6632.2008.03974.x; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; DYER CA, 1994, J NEUROSCI RES, V39, P97, DOI 10.1002/jnr.490390112; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Ganea E, 2007, BIOCHEM SOC T, V35, P689, DOI 10.1042/BST0350689; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gorlach Bonello, 2008, BIOCHEM J, V412, P17; GREEN PG, 1992, NEUROSCIENCE, V50, P745, DOI 10.1016/0306-4522(92)90461-A; Guan Wei, 2003, Chin J Traumatol, V6, P218; Hans VHJ, 1999, NEUROREPORT, V10, P409; HANSSON E, 1984, BRAIN RES, V300, P9, DOI 10.1016/0006-8993(84)91335-0; HARA H, 1993, NEUROSURGERY, V32, P822, DOI 10.1227/00006123-199305000-00016; Hardison JL, 2006, EXP NEUROL, V197, P420, DOI 10.1016/j.expneurol.2005.10.016; Harry GJ, 2008, EXPERT OPIN DRUG MET, V4, P1265, DOI [10.1517/17425255.4.10.1265, 10.1517/17425255.4.10.1265 ]; Hatton J, 2006, J NEUROSURG, V105, P843, DOI 10.3171/jns.2006.105.6.843; HEDEGAARD C, 2008, IMMUNOLOGY, V18; Hoyte L, 2004, CURR MOL MED, V4, P131, DOI 10.2174/1566524043479248; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ichiyama T, 2001, BRAIN RES, V911, P56, DOI 10.1016/S0006-8993(01)02672-5; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; IWANAGA T, 1989, ARCH HISTOL CYTOL, V52, P13, DOI 10.1679/aohc.52.Suppl_13; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Knuepfer H, 2008, IMMUNOL CELL BIOL, V86, P87, DOI 10.1038/sj.icb.7100113; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; LIU J, 2008, SCI SIGNAL, V8, P14; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Mengozzi M, 2008, MOL MED, V14, P682, DOI 10.2119/2008-00086.Mengozzi; Molnar I, 2002, IMMUNOL LETT, V80, P3, DOI 10.1016/S0165-2478(01)00301-7; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Morrow JD, 1997, PROG LIPID RES, V36, P1, DOI 10.1016/S0163-7827(97)00001-5; Mowery NT, 2009, J TRAUMA, V66, P145, DOI 10.1097/TA.0b013e3181938c5e; Mullington JM, 2001, ANN NY ACAD SCI, V933, P201; Muroi C, 2008, J NEUROSURG ANESTH, V20, P193, DOI 10.1097/ANA.0b013e31817996bf; Murphy S, 2007, BIOCHEM SOC T, V35, P1133, DOI 10.1042/BST0351133; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pineau I, 2009, GLIA, V57, P351, DOI 10.1002/glia.20763; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; PISKUNOV AK, 2008, RUSSIAN FORUM NANOTE; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; Posmantur RM, 1998, NEUROCHEM RES, V23, P1265, DOI 10.1023/A:1020792132629; POTAPOV AA, 2006, VOPROSY NEIROKHIRURG; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Smirnov A.N, 2008, ELEMENTY ENDOKRINNOI; Sorokina E G, 2009, Neurosci Behav Physiol, V39, P329, DOI 10.1007/s11055-009-9147-1; Sotgiu S, 2006, EUR J NEUROL, V13, P505, DOI 10.1111/j.1468-1331.2006.01280.x; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; THOMAS D, 1978, LANCET, V8056, P113; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Tsagarakis S, 2005, Pituitary, V8, P251, DOI 10.1007/s11102-006-6049-x; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Vandromme M, 2008, CRIT CARE, V12, DOI 10.1186/cc6899; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Yilmaz G, 2008, NEUROL RES, V30, P783, DOI 10.1179/174313208X341085; Yong VW, 2007, NEUROTHERAPEUTICS, V4, P580, DOI 10.1016/j.nurt.2007.07.005; Yu JC, 2000, J BIOL CHEM, V275, P38296, DOI 10.1074/jbc.M004866200	125	5	5	8	16	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1819-7124	1819-7132		NEUROCHEM J+	Neurochem. J.	MAR	2010	4	1					55	63		10.1134/S1819712410010101			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	574LG	WOS:000275990100010					2022-02-06	
J	Rodriguez-Martin, J; Pretell-Mazzini, J; Cecilia-Lopez, D; Resines-Erasun, C				Rodriguez-Martin, Juan; Pretell-Mazzini, Juan; Cecilia-Lopez, David; Resines-Erasun, Carlos			Medial Complex Elbow Dislocation: An Unusual Pattern of Injury	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						dislocation; elbow; fracture; instability	CORONOID PROCESS; FRACTURES; STABILITY; HEAD; ULNA	A 47-year-old man sustained a medial complex dislocation of the right elbow. After initial evaluation, closed reduction was performed. On examination under general anesthesia, the elbow was unstable under varus and valgus stress. Computed tomography scan showed a medial epicondyle and a coronoid fracture. Both medial and lateral approaches were used to fix the epicondylar fragment, the coronoid fragment, and the complex damage to the soft tissues. Immobilization in a cast for 1 week followed by early motion in a dynamic orthosis resulted in a good outcome. Follow up at 2 years showed a range of motion of 110 degrees of flexion-extension and 170 degrees of pronation-supination. Radiographs showed no significant arthritis or heterotopic ossifications.	[Rodriguez-Martin, Juan; Pretell-Mazzini, Juan; Cecilia-Lopez, David; Resines-Erasun, Carlos] Hosp 12 Octubre, E-28041 Madrid, Spain		Rodriguez-Martin, J (corresponding author), Calle Adelfas 20 4 E, Madrid 28007, Spain.	juanrodmar@yahoo.es		Cecilia, David/0000-0002-3455-9561			BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; Doornberg JN, 2006, J HAND SURG-AM, V31A, P794, DOI 10.1016/j.jhsa.2006.01.004; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; HASTINGS H, 1994, HAND CLIN, V10, P417; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JOSEFSSON PO, 1986, ACTA ORTHOP SCAND, V57, P537, DOI 10.3109/17453678609014788; Khan S A, 2002, Acta Orthop Belg, V68, P83; Kim Sung-Jae, 2007, J Shoulder Elbow Surg, V16, pe1, DOI 10.1016/j.jse.2006.09.013; Morrey BF, 2005, J SHOULDER ELB SURG, V14, p174S, DOI 10.1016/j.jse.2004.09.031; MORREY BF, 1983, AM J SPORT MED, V11, P315, DOI 10.1177/036354658301100506; MORREY BF, 2000, FUNCTIONAL EVALUATIO; NEVIASER JS, 1977, SOUTHERN MED J, V70, P172, DOI 10.1097/00007611-197702000-00013; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Paksima Nader, 2004, Bull Hosp Jt Dis, V62, P33; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Ring D, 2006, J HAND SURG-AM, V31A, P1679, DOI 10.1016/j.jhsa.2006.08.020; ROYLE SG, 1991, CLIN ORTHOP RELAT R, P201; Sotereanos Dean G, 2007, Instr Course Lect, V56, P369; Stein Drew A, 2003, Bull Hosp Jt Dis, V61, P151	20	5	6	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2010	24	3					E21	E24		10.1097/BOT.0b013e3181ad629d			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	564DK	WOS:000275193300012	20182246				2022-02-06	
J	Sudhakar, P; Bapuraj, JR				Sudhakar, Padmaja; Bapuraj, J. Rajiv			CT Demonstration of Dorsal Midbrain Hemorrhage in Traumatic Fourth Cranial Nerve Palsy	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article								A 21-year-old man who suffered a traumatic brain injury from a motor vehicle accident recovered brain function except for an isolated left fourth cranial nerve palsy. Brain CT showed a focal hemorrhage in the right dorsal midbrain, directly in the brainstem path of what would become the left fourth cranial nerve. Although there has been previous imaging documentation of midbrain and cisternal hemorrhage in patients with isolated post-traumatic fourth cranial nerve palsy, this is the first report to show a large midbrain hemorrhage on CT. The mechanism is likely to be concussive impact of the dorsal midbrain on the tentorium cerebelli.	[Sudhakar, Padmaja] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Bapuraj, J. Rajiv] Univ Michigan, Dept Radiol Neuroradiol, Ann Arbor, MI 48105 USA		Sudhakar, P (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	padmajas@med.umich.edu	Bapuraj, Jayapalli Rajiv/P-2279-2017	Bapuraj, Jayapalli Rajiv/0000-0003-3933-203X			ABARBANEL JM, 1986, DEV MED CHILD NEUROL, V28, P509; BURGERMAN RS, 1989, NEUROSURGERY, V25, P978, DOI 10.1227/00006123-198912000-00023; Hara N, 2001, AM J OPHTHALMOL, V132, P443, DOI 10.1016/S0002-9394(01)00932-1; Hoya K, 2000, NEUROL MED-CHIR, V40, P358, DOI 10.2176/nmc.40.358; Ishizaki Eri, 2003, Rinsho Shinkeigaku, V43, P571; KEANE JR, 1986, J CLIN NEURO-OPHTHAL, V6, P242; LAVIN PJM, 1984, ARCH NEUROL-CHICAGO, V41, P679, DOI 10.1001/archneur.1984.04210080091022; Lindenberg R, 1964, Clin Neurosurg, V12, P129; Prosst Ruediger L, 2007, J Trauma, V62, pE1, DOI 10.1097/01.ta.0000232057.36209.03; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154	10	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022			J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	MAR	2010	30	1					59	63		10.1097/WNO.0b013e3181ce1b1d			5	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	562OJ	WOS:000275061500015	20182210				2022-02-06	
J	Wu, TC; Allen, MD; Goodrich-Hunsaker, NJ; Hopkins, RO; Bigler, ED				Wu, Trevor ChuangKuo; Allen, Mark D.; Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.; Bigler, Erin D.			Functional Neuroimaging of Symptom Validity Testing in Traumatic Brain Injury	PSYCHOLOGICAL INJURY & LAW			English	Article						Functional magnetic resonance imaging (fMRI); Traumatic brain injury (TBI); Word memory test (WMT); Symptom validity test (SVT)		The Word Memory Test (WMT) is a commonly used symptom validity test (SVT) that assesses recognition verbal memory. The task has been adapted for use within a functional magnetic resonance imaging (fMRI) paradigm so the neural correlates of WMT activation patterns can be studied. In the current investigation, performance on the delayed recognition subtest of the WMT was examined in two patients who sustained severe TBI and compared to ten healthy controls. The patients underwent comprehensive neuropsychological evaluations and structural MRI. All participants completed two versions of the WMT: full-effort and simulated poor effort conditions. Despite extensive structural brain damage, the fMRI activation patterns during full-effort WMT performance were somewhat similar in the two TBI patients and likewise, somewhat similar to controls. The fMRI activation pattern in both patients demonstrated intact activation of the basic neural structures necessary to perform the WMT. Dissimilar patterns of activation were obtained during the simulated poor effort condition of WMT performance suggesting that fMRI techniques may be sensitive in demonstrating non-credible cognitive performance. The results of our study represent the first fMRI investigation of normal and simulated poor effort SVT performance in individuals with documented brain damage. The implications of fMRI techniques in SVT research and their clinical application are discussed.	[Wu, Trevor ChuangKuo; Allen, Mark D.; Hopkins, Ramona O.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Allen, Mark D.; Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.; Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Goodrich-Hunsaker, Naomi J.] Univ Calif Davis, Davis Med Ctr, Dept Psychiat, NeuroTherapeut Res Inst, Sacramento, CA 95817 USA; [Hopkins, Ramona O.] Intermountain Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, UT USA; [Hopkins, Ramona O.; Bigler, Erin D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA		Allen, MD (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.	m_allen@byu.edu					Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Allen MD, 2008, BEHAV NEUROL, V20, P141, DOI [10.1155/2008/931938, 10.3233/BEN-2008-0224]; Allen MD, 2008, BEHAV NEUROL, V20, P127, DOI [10.3233/BEN-2008-0223, 10.1155/2008/713412]; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Boone K. B., 2008, CLIN NEUROPSYCHOL, P1; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Dodrill CB, 2008, EPILEPSIA, V49, P691, DOI 10.1111/j.1528-1167.2007.01457.x; Ensalada LH, 2000, OCCUP MED-STATE ART, V15, P739; Esposito F., 2009, NEUROIMAGE; Esposito F, 2009, NEUROIMAGE, V47, P112, DOI 10.1016/j.neuroimage.2009.03.074; Frazier TW, 2007, ARCH CLIN NEUROPSYCH, V22, P197, DOI 10.1016/j.acn.2006.12.007; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P., 2003, MANUAL WORD MEMORY T; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; McCarney R. W., 2009, COCHRANE LIB, P1; Morgan J.E., 2008, NEUROPSYCHOLOGY MALI; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Sarter M, 2004, NEUROSCI BIOBEHAV R, V28, P645, DOI 10.1016/j.neubiorev.2004.09.005; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Seghier ML, 2008, HUM BRAIN MAPP, V29, P461, DOI 10.1002/hbm.20410; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Bernd W, 2007, EPILEPSY BEHAV, V10, P442, DOI 10.1016/j.yebeh.2007.01.013	32	5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2010	3	1			SI		50	62		10.1007/s12207-010-9067-y			13	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3XZ	WOS:000415448300005					2022-02-06	
J	Boender, ZJ; Ultee, J; Hovius, SER				Boender, Z. J.; Ultee, J.; Hovius, S. E. R.			Cognitive capacity: No association with recovery of sensibility by Semmes Weinstein test score after peripheral nerve injury of the forearm	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Cognition; Sensibility; Somatosensory cortex; Nerve injury; Semmese-Weinstein monofilaments	SECONDARY MICROSURGICAL REPAIR; FUNCTIONAL SENSIBILITY; CONDUCTION VELOCITY; MEDIAN NERVES; HAND; REORGANIZATION; MONKEYS; ULNAR; REEDUCATION; ADULT	In the recovery process of sensibility after repair of a peripheral nerve injury of the forearm, not only age but also surgical repair techniques are of importance. If regenerating axons are misdirected, reorganisation or other adaptic processes are needed at the level of the somatosensory brain cortex. These processes are thought to be dependent on the patient's cognitive capacity. We conducted a prospective multicentre study to assess the association between cognitive capacity and recovery of sensibility after peripheral nerve damage of the forearm. Patients with a traumatic peripheral nerve lesion of the forearm and consecutive surgical repair were included. After 12 months, the patients were assessed with respect to recovery of sensibility (Semmes-Weinstein monofilaments) and cognitive capacity, with four tests assessing different aspects of cognitive functioning. Twenty-eight patients (25 male, three female; median age: 28.5 years; range: 15-79 years) with median and/or ulnar nerve injury of the forearm were included in the study. Younger age showed a positive association with sensory recovery (beta = -0.845, 95% CI: -1.456 to -0.233; p = 0.01). No association was found between the cognitive-capacity tests used and sensory recovery. The present prospective study did not reveal any association between recovery of sensibility measured by Semmes-Weinstein test score and cognitive capacity. Further studies should be performed to confirm these results. (C) 2008 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Boender, Z. J.; Ultee, J.; Hovius, S. E. R.] Erasmus MC, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands		Boender, ZJ (corresponding author), Acad Med Ctr, Room H1-115,POB 22700, NL-1100 DE Amsterdam, Netherlands.	z.j.boender@amc.uva.nl					ALMQUIST E, 1970, J BONE JOINT SURG AM, VA 52, P791, DOI 10.2106/00004623-197052040-00009; ALMQUIST EE, 1983, J HAND SURG-AM, V8, P406, DOI 10.1016/S0363-5023(83)80199-3; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Bell-Krotoski J, 1993, J Hand Ther, V6, P114; BELLKROTOSKI J, 1987, J HAND SURG-AM, V12A, P155, DOI 10.1016/S0363-5023(87)80189-2; Botman Y A, 2001, Ned Tijdschr Geneeskd, V145, P1316; Bruyns CNP, 2003, J HAND SURG-AM, V28A, P28, DOI 10.1053/jhsu.2003.50026; DELLON AL, 1974, PLAST RECONSTR SURG, V53, P297, DOI 10.1097/00006534-197403000-00008; DELLON AL, 2000, SOMATOSENSORY TESTIN, P213; Florence SL, 1996, NATURE, V381, P69, DOI 10.1038/381069a0; FLORENCE SL, 1994, CEREB CORTEX, V4, P391, DOI 10.1093/cercor/4.4.391; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; HAMMES JGW, 1987, STROOP COLOUR WORD T; IMAI H, 1991, J HAND SURG-AM, V16A, P60, DOI 10.1016/S0363-5023(10)80014-0; Jain N, 1998, NEWS PHYSIOL SCI, V13, P143; Jaquet JB, 2001, J TRAUMA, V51, P687, DOI 10.1097/00005373-200110000-00011; KALLIO PK, 1993, J HAND SURG-BRIT EUR, V18B, P320, DOI 10.1016/0266-7681(93)90052-H; KALLIO PK, 1993, J HAND SURG-BRIT EUR, V18B, P97, DOI 10.1016/0266-7681(93)90205-T; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Lundborg G, 2000, J HAND SURG-BRIT EUR, V25B, P242, DOI 10.1054/jhsb.1999.0339; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; MULDER JL, 1996, DUTCH VERSION CALIFO; Oud T, 2007, CLIN REHABIL, V21, P483, DOI 10.1177/0269215507074395; Parry C B, 1976, Hand, V8, P250; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosen B, 2001, J HAND SURG-BRIT EUR, V26, P196, DOI 10.1054/jhsb.2001.0567; ROSEN B, 1994, J HAND SURG-BRIT EUR, V19B, P452, DOI 10.1016/0266-7681(94)90209-7; Rosen B, 2000, J HAND SURG-AM, V25A, P535, DOI 10.1053/jhsu.2000.6458; Schmand B, 1992, DUTCH ADULT READING; TAJIMA T, 1989, MICROSURG, V10, P145, DOI 10.1002/micr.1920100217; THURSTONE LL, 1996, NEUROPSYCHOLOGICAL D; VASTAMAKI M, 1993, J HAND SURG-BRIT EUR, V18B, P323, DOI 10.1016/0266-7681(93)90053-I; WALL JT, 1986, J NEUROSCI, V6, P218; Wiech K, 2000, J NEUROSURG, V93, P876, DOI 10.3171/jns.2000.93.5.0876; [No title captured]	37	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	FEB	2010	63	2					354	359		10.1016/j.bjps.2008.10.010			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	551IS	WOS:000274201900028	19054722				2022-02-06	
J	Aleksijevic, D; Zapletalova, J; Smolka, V; Klaskova, E; Wiedernnann, J; Krahulik, D; Vaverka, J; Frysak, Z				Aleksijevic, D.; Zapletalova, J.; Smolka, V.; Klaskova, E.; Wiedernnann, J.; Krahulik, D.; Vaverka, J.; Frysak, Z.			Neuro-endocrine Dysfunction in Children and Adolescents after Brain Injury	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						traumatic brain injury; children; post-traumatic hormonal disorder; growth hormone deficiency; precocious puberty; risk factors	PITUITARY-FUNCTION; PUBERTAL CHANGES; HEAD TRAUMA; HYPOPITUITARISM; PATTERN	Background: Neuro-endocrine dysfunction after traumatic brain injury is found in 23-60% of adult patients. Objectives: To evaluate growth, pubertal development and endocrine function in children and adolescents after traumatic brain injury. Patients and methods: We evaluated growth, pubertal development and bone age in 30 patients (18 boys) after traumatic brain injury. They underwent standard endocrine tests - thyreotropin, free thyroxin, insulin-like growth factor, prolactin, morning cortisol, gonadotropins, testosterone (in boys) and oestradiol (in girls). Dynamics tests were performed in patients with abnormalities revealed by clinical examination and/or laboratory results. Median patient age at the time of brain trauma was 9.7 (0.4-14.8) years; 75% of patients were prepubertal. Their range of Glasgow Coma Scale (GCS) was 3-12 (11 of these <8). Results: Diabetes insipidus was observed in three patients and syndrome of inappropriate adiuretine hormone secretion in a further three. The period since trauma ranged from 26 to 36 months (median 29 months). We found growth hormone deficiency in two boys (in one of them combined with thyreotropin deficiency and diabetes insipidus; precocious puberty in one girl (8.3 years) and one boy (7 years); and hypogonadotrophic hypogonadism in one adolescent girl masked by taking contraceptives pills. Conclusion: We found neuroendocrine dysfunction in 16.7% of patients. Brain-imaging techniques revealed abnormalities in most of them. We have started a prospective study in a large cohort of patients after traumatic brain injury, evaluating the frequency of hormonal disorder and its relations to the type of head trauma and the course of acute post-traumatic phase, with a view to identifying risk factors that predispose to hormonal disorder.	[Aleksijevic, D.; Zapletalova, J.; Smolka, V.; Klaskova, E.; Wiedernnann, J.] LF UP FN Olomouc, Detska Klin, Olomouc 77520, Czech Republic; [Krahulik, D.; Vaverka, J.] LF UP FN Olomouc, Neurochirurg Klin, Olomouc 77520, Czech Republic; [Frysak, Z.] LF UP FN Olomouc, Interni Klin 3, Olomouc 77520, Czech Republic		Aleksijevic, D (corresponding author), LF UP FN Olomouc, Detska Klin, IP Pavlova 6, Olomouc 77520, Czech Republic.	darina.aleksijevic@seznam.cz		Klaskova, Eva/0000-0002-6338-9055			Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Escamilla R F, 1938, Cal West Med, V48, P343; Goldman M, 1997, PEDIATR NEUROL, V17, P339, DOI 10.1016/S0887-8994(97)00168-9; Greuliche WW, 1959, RADIOGRAPHIC ATLAS S; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; KRAHULIK D, 2009, DYSFUNCTION IN PRESS; Krejovsky, 2003, CESK SLOV PEDIAT, V58, P766; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Ranke MB, 2003, DIAGNOSTICS ENDOCRIN; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	21	5	5	0	4	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859			CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2010	73	4					409	414					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	648IK	WOS:000281685800008					2022-02-06	
J	Bartle-Meyer, CJ; Murdoch, BE				Bartle-Meyer, Carly J.; Murdoch, Bruce E.			A kinematic investigation of anticipatory lingual movement in acquired apraxia of speech	APHASIOLOGY			English	Article						Apraxia of speech; Articulation; Electromagnetic articulography; Electropalatology; Coarticulation	TRAUMATIC BRAIN-INJURY; PERCEPTUAL CHARACTERISTICS; COARTICULATION; SPEAKERS; APHASIA; ACCURACY; SENTENCE; WORD	Background: Apraxia of speech (AOS) is considered a disorder of speech planning or programming. Evidence for this stems from perceptual, acoustic, and electropalatographic investigations of articulation in AOS that revealed a delayed onset of anticipatory vowel gestures. Articulatory prolongation and syllable segregation have been attributed to a disturbance in anticipatory coarticulation. Aims: The aim of the current study was to investigate anticipatory lingual movement for consonantal gestures in AOS, and its impact on absolute and relative speech timing. Methods Procedures: Tongue-tip movement and tongue-to-palate contact patterns were recorded for three speakers with AOS and a concomitant aphasia (age range = 35-63 years; M = 50.67 years; SD = 14.29) and five healthy talkers (age range = 29-65 years; M = 52.6 years; SD = 14.5) during the phrases oa scarleto and oa sergeanto, using electromagnetic articulography (EMA) (AG-200 system) and electropalatography (EPG) (Reading Electropalatograph system). Anticipatory lingual movement and speech timing were analysed during the final C1VC/C2 syllable in each of these phrases, where C represented an alveolar or postalveolar consonant. Specifically, tongue-tip displacement was calculated from the onset of release to the end of release of C1 to provide an indication of anticipatory lingual movement. With respect to speech timing, absolute (i.e., duration from time of maximum contact for C1 to time of maximum contact for C2) and relative (i.e., absolute duration expressed as a function of total syllable duration) durational measures were recorded, as was the stability of each. The results recorded for each of the participants with AOS were individually compared to those obtained by the control group. Outcomes Results: The EMA results indicated that two participants with AOS exhibited reduced anticipatory lingual movement (i.e., greater tongue-tip displacement) during repetitions of osergeanto; however, all speakers produced a comparable tongue-tip displacement to that produced by the control group during the release of /l/ in oscarleto. The EPG results indicated that absolute duration was significantly prolonged during the final syllables of both stimuli for each of the apraxic speakers. Equivocal results were reported for relative timing and temporal stability. Conclusions: The results provide some preliminary evidence of reduced anticipatory lingual movement in AOS, and have demonstrated that this can have a significant impact on absolute speech timing. However, measures of relative timing were suggestive of either unimpaired or more extensive coarticulation. Additional research is required to resolve this issue.	[Bartle-Meyer, Carly J.; Murdoch, Bruce E.] Univ Queensland, Brisbane, Qld, Australia		Bartle-Meyer, CJ (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	carly.meyer@uq.edu.au	Meyer, Carly/L-7240-2019; Murdoch, Bruce E/C-1397-2012; Meyer, Carly/E-4519-2010	Meyer, Carly/0000-0002-2268-3055; Meyer, Carly/0000-0002-2268-3055			Bartle-Meyer CJ, 2009, CLIN LINGUIST PHONET, V23, P93, DOI 10.1080/02699200802564284; BARTLEMEYER CJ, 2008, 5 INT EPG S ED SEP; Brown J.R., 1975, MOTOR SPEECH DISORDE; Clark HM, 1998, APHASIOLOGY, V12, P699, DOI 10.1080/02687039808249567; Dabul B. L., 2000, APRAXIA BATTERY ADUL; Dogil G., 1998, PHONOLOGY, V15, P143, DOI DOI 10.1017/S095267579800356X; Duffy, 2005, MOTOR SPEECH DISORDE; DUNLOP JM, 1977, CORTEX, V13, P17, DOI 10.1016/S0010-9452(77)80050-6; Enderby P, 1983, FRENCHAY DYSARTHRIA; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; KUHNERT B, 1999, COARTICULATION THEOR, P7; LAPOINTE LL, 1975, J COMMUN DISORD, V8, P259, DOI 10.1016/0021-9924(75)90018-0; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P19, DOI 10.1080/0269-9200400001069; McNeil M., 1997, CLIN MANAGEMENT SENS, P311; MCNEIL MR, 1994, CLIN APHASIOL, V22, P203; MCNEIL MR, 1990, BRAIN LANG, V38, P135, DOI 10.1016/0093-934X(90)90106-Q; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; ODELL K, 1991, J SPEECH HEAR RES, V34, P67, DOI 10.1044/jshr.3401.67; ODELL K, 1990, J SPEECH HEAR DISORD, V55, P345, DOI 10.1044/jshd.5502.345; ROSENBEK JC, 1973, J SPEECH HEAR RES, V16, P22, DOI 10.1044/jshr.1601.22; Scott D, 2002, EPGLAB MANUAL UNPUB; Southwood MH, 1997, CLIN LINGUIST PHONET, V11, P179, DOI 10.3109/02699209708985190; Terband H, 2004, SPEECH MOTOR CONTROL, P389; TROST JE, 1974, BRAIN LANG, V1, P63, DOI 10.1016/0093-934X(74)90026-1; van der Merwe A, 1997, COMSIG '97 - PROCEEDINGS OF THE 1997 SOUTH AFRICAN SYMPOSIUM ON COMMUNICATIONS AND SIGNAL PROCESSING, P1, DOI 10.1109/COMSIG.1997.629970; WEISMER G, 1985, J ACOUST SOC AM, V78, P49, DOI 10.1121/1.392453; Wertz RT, 1991, APRAXIA SPEECH ADULT; ZIEGLER W, 1985, BRAIN LANG, V26, P117, DOI 10.1016/0093-934X(85)90032-X; ZIEGLER W, 1986, BRAIN LANG, V29, P34, DOI 10.1016/0093-934X(86)90032-5; ZIEGLER W, 1986, EUR ARCH PSY CLIN N, V236, P44, DOI 10.1007/BF00641058	35	5	5	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology		2010	24	5					623	642	PII 922545218	10.1080/02687030902869281			20	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	602FI	WOS:000278123500004					2022-02-06	
J	Bianchi-Demicheli, F; Rollini, C; Lovblad, K; Ortigue, S				Bianchi-Demicheli, Francesco; Rollini, Christian; Lovblad, Karl; Ortigue, Stephanie			"Sleeping Beauty paraphilia": Deviant desire in the context of bodily self-image disturbance in a patient with a fronto-parietal traumatic brain injury	MEDICAL SCIENCE MONITOR			English	Article						paraphilia; body image disturbance; sex offenders; sexual deviant behaviour; self representation; desire; intention	MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGY; HYPERSEXUALITY	Background: Several case series and reports describe paraphilia as occurring after brain damage, mostly in the frontal lobes and diencephalic structures. Hypersexuality and paraphilic behaviors are also documented in a variety of other neurologic disorders, (e. g., Kluver Bucy syndrome, and more rarely in multiple sclerosis). In multiple sclerosis, hypersexual behavior and paraphilias have been associated with various focal brain lesions in the frontal and temporal lesions when inflammatory demyelination involves the hypothalamus and septal regions. Case Report: A case of a patient who developed a particular and progressive sexual deviant behaviour after a head trauma. This men felt sexually aroused from seeing sleeping women as well as from taking care of their hands and nails while they were asleep. The patient was diagnosed with a moderate dysexecutive syndrome characteristic of a frontal disorder and a very specific parietal-related bodily self image disorder characterized by an incomplete mental image of his hands. The clinical hypothesis was that the paraphilia might be related to his post-traumatic disturbed bodily self image and more specifically to its related impulsive needs to complete his hands representation. Conclusions: This case report highlights the potential link between paraphilia, deviant and aggressive sexual behaviour, neurological disturbance and self-representation. The treatment of paraphilias remains very complex, and requires taking into account not only the social and psychological aspects of the disease, but also its organic dimensions.	[Bianchi-Demicheli, Francesco; Rollini, Christian] Univ Geneva, Psychosomat Gynaecol & Sexol Unit, Emergency & Liaison Serv, Ctr Psychiat, CH-1205 Geneva, Switzerland; [Lovblad, Karl] Univ Hosp Geneva, Div Neuroradiol, Dept Radiol, Geneva, Switzerland; [Ortigue, Stephanie] Syracuse Univ, Dept Psychol, Syracuse, NY USA		Bianchi-Demicheli, F (corresponding author), Univ Geneva, Psychosomat Gynaecol & Sexol Unit, Emergency & Liaison Serv, Ctr Psychiat, 15 Rue Pitons, CH-1205 Geneva, Switzerland.	francesco.bianchi-demicheli@hcuge.ch	Lovblad, Karl/AAF-7678-2020	lovblad, karl-olof/0000-0003-2768-9779			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bianchi-Demicheli F, 2007, NEUROPSYCHOLOGIA, V45, P2645, DOI 10.1016/j.neuropsychologia.2007.04.016; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Briken P, 2005, J FORENSIC SCI, V50, P1204; Frohman EM, 2002, ARCH NEUROL-CHICAGO, V59, P1006, DOI 10.1001/archneur.59.6.1006; GAUTIERSMITH PC, 1980, REV NEUROL, V136, P311; HUWS R, 1991, BRIT J PSYCHIAT, V158, P280, DOI 10.1192/bjp.158.2.280; Joyal CC, 2007, SEX ABUSE-J RES TR, V19, P155, DOI 10.1177/107906320701900206; Langevin R, 2006, BRAIN COGNITION, V60, P206; LEHNE GK, 2005, BEHAV SCI, P145; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Ortigue S, 2006, NEUROLOGY, V66, P1414, DOI 10.1212/01.wnl.0000210440.49932.e7; Ortigue S, 2008, NEUROIMAGE, V43, P337, DOI 10.1016/j.neuroimage.2008.07.059; Ortigue S, 2008, MED HYPOTHESES, V71, P941, DOI 10.1016/j.mehy.2008.07.016; Walter M, 2007, BIOL PSYCHIAT, V62, P698, DOI 10.1016/j.biopsych.2006.10.018	15	5	5	0	9	INT SCIENTIFIC LITERATURE, INC	ALBERTSON	1125 WILLIS AVE, ALBERTSON, NY 11507 USA	1234-1010			MED SCI MONITOR	Med. Sci. Monitor		2010	16	2					CS15	CS17					3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	555MJ	WOS:000274514600013	20110923				2022-02-06	
J	de Guise, E; Leblanc, J; Gosselin, N; Marcoux, J; Champoux, MC; Couturier, C; Lamoureux, J; Dagher, JH; Maleki, M; Feyz, M				de Guise, Elaine; Leblanc, Joanne; Gosselin, Nadia; Marcoux, Judith; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Dagher, Jehane H.; Maleki, Mohammed; Feyz, Mitra			Neuroanatomical correlates of the clock drawing test in patients with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; clock drawing; neuroanatomical correlates; acute care setting; imaging	ALZHEIMERS-DISEASE; PERFORMANCE; DEMENTIA	Objective: The clock drawing test (CDT) is a quick and easy to administer test that has traditionally shown parietal lobe dysfunction. The aim of this study was to correlate performance on the CDT with the presence of acute traumatic cerebral injuries sustained after traumatic brain injury (TBI). Methods: A retrospective study was conducted on 170 patients with TBI of all severity admitted to an acute care setting. These patients sustained different types of injuries (epidural haematoma, subdural haematoma, subarachnoid haemorrhage, intraparenchymal haematoma and brain oedema) in different sites (frontal, temporal, parietal, occipital lobes, bilateral and right or left hemisphere). Results: The CDT total score was significantly lower for subjects presenting subarachnoid haemorrhage (4.80 +/- 3.34 vs 7.04 +/- 3.14, t(168df) 4.477, p < 0.001) and for those presenting brain oedema (4.50 +/- 3.06 vs 6.69 +/- 3.38, t(168df) = 4.214, p < 0.001), parietal injury (5.15 +/- 3.17 vs 6.42 +/- 3.52, t(168df) = 2.416, p = 0.017) or bilateral injuries (5.28 +/- 3.31 vs 6.62 +/- 3.44, t(168df) = 2.569, p = 0.011) compared to those who did not. Conclusion: This study provides empirical evidence of the relationship between TBIs and results on the CDT, supporting previous studies done with other populations.	[de Guise, Elaine; Leblanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Gosselin, Nadia] McGill Univ, Ctr Hlth, Montreal Neurol Inst, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Dagher, Jehane H.] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Rehabil Med, Montreal, PQ H3G 1A4, Canada		de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Montreal Neurol Inst, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.	elaine.deguise@muhc.mcgill.ca		Lamoureux, Julie/0000-0002-4986-2504			Blair M, 2006, J INT NEUROPSYCH SOC, V12, P159, DOI 10.1017/S1355617706060255; Cahn-Weiner Deborah A, 2003, Cogn Behav Neurol, V16, P85, DOI 10.1097/00146965-200306000-00001; DUCKWORTH JL, 2010, CURRENT OPINION CRIT, V10, P1097; Esteban-Santillan C, 1998, J AM GERIATR SOC, V46, P1266, DOI 10.1111/j.1532-5415.1998.tb04543.x; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Hanlon RE, 2005, BRAIN INJURY, V19, P257, DOI 10.1080/02699050400004955; Ino T, 2003, NEUROSCI RES, V45, P71, DOI 10.1016/S0168-0102(02)00194-3; ISHIAI S, 1993, NEUROLOGY, V43, P106, DOI 10.1212/WNL.43.1_Part_1.106; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KOROZA E, 1994, ASSESSMENT, V1, P179; LIBON DJ, 1993, ARCH CLIN NEUROPSYCH, V8, P405, DOI 10.1016/0887-6177(93)90004-K; Loring DW., 2004, NEUROPSYCHOLOGICAL A, P531; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Peters R, 2008, DEMENT GERIATR COGN, V26, P351, DOI 10.1159/000162261; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Suhr JA, 1999, ARCH PHYS MED REHAB, V80, P773, DOI 10.1016/S0003-9993(99)90226-5; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; Takahashi M, 2008, PSYCHIAT CLIN NEUROS, V62, P167, DOI 10.1111/j.1440-1819.2008.01750.x; TONG KA, 2007, AM J NEURORADIOL, V29, P9; Tranel D, 2008, NEUROPSYCHOLOGY, V22, P553, DOI 10.1037/0894-4105.22.5.553; von Gunten A, 2008, EUR NEUROL, V60, P73, DOI 10.1159/000131895; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730	23	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	13-14					1568	1574		10.3109/02699052.2010.523052			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800006	20973630				2022-02-06	
J	Fager, S; Spellman, C				Fager, Susan; Spellman, Colleen			Augmentative and alternative communication intervention in children with traumatic brain injury and spinal cord injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Children; AAC; communication; assistive technology; TBI; SCI		Children and youth who sustain a traumatic brain injury (TBI) and/or spinal cord injury (SCI) may have temporary or permanent disabilities that affect their speech, language and communication abilities. Having a way to communicate can help reduce children's confusion and anxiety, as well as enable them to participate more actively in the rehabilitation process and thus, recover from their injuries. In addition, effective communication with family, care staff, peers, teachers and friends is essential to long-term recovery and positive outcomes for children with TBI and SCI as they are integrated back into their communities. This article describes how rehabilitation teams can use augmentative and alternative communication (AAC) and assistive technologies (AT) to support the communication of children recovering from TBI and SCI over time.	[Fager, Susan; Spellman, Colleen] Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, 5401 South St, Lincoln, NE 68506 USA		Fager, S (corresponding author), Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, 5401 South St, Lincoln, NE 68506 USA.	sfager@madonna.org		Fager, Susan/0000-0001-8125-5977; Spellman, Colleen/0000-0002-3350-1990	Rehabilitation Engineering Research Center on Communication Enhancement (AAC-RERC) from the National Institute on Disability and Rehabilitation Research (NIDRR) in the U.S. Department of Education's Office of Special Education and Rehabilitative Services ( [H133E080011]; Madonna Rehabilitation Hospital	The preparation of this manuscript was supported in part by the Rehabilitation Engineering Research Center on Communication Enhancement (AAC-RERC) funded under grant #H133E080011 from the National Institute on Disability and Rehabilitation Research (NIDRR) in the U.S. Department of Education's Office of Special Education and Rehabilitative Services (OSERS) and Madonna Rehabilitation Hospital. The authors would like to thank the patients, families, members of the spinal cord injury team, and members of the traumatic brain injury team at Madonna Rehabilitation Hospital.	American Spinal Injury Association & International Medical Society of Paraplegia, 2000, INT STAND NEUR FUNCT; Beukelman D. R., 2005, AUGMENTATIVE ALTERNA, P219; Blackstone SW, 2007, AUGMENT ALTERN COMM, V23, P191, DOI 10.1080/07434610701553684; Britton D., 2007, AUGMENTATIVE COMMUNI, P91; Capoor Jaishree, 2005, Phys Med Rehabil Clin N Am, V16, P129, DOI 10.1016/j.pmr.2004.06.016; DERUYTER F, 1989, AUGMENTATIVE ALTERNA, V5, P49, DOI DOI 10.1080/07434618912331274966; Dongilli P, 1992, J HEAD TRAUMA REHAB, V7, P91; DUDGEON BJ, 1996, AM J OCCUPATIONAL TH, V51, P553; Fager S., 2005, AUGMENTATIVE ALTERNA, P517; Fager S., 2010, ASSISTING SURVIVORS; Fager S., 2003, AM SPEECH LANG HEAR; Fager S. K., 2007, AUGMENTATIVE COMMUNI, P131; Hagan C., 1982, COGNITIVE REHABILITA, P131; Horn E., 1996, AUGMENT ALTERN COMM, V12, P23, DOI [DOI 10.1080/07434619612331277448, 10.1080/07434619612331277448]; JORDAN FM, 1994, BRAIN INJURY, V8, P277, DOI 10.3109/02699059409150979; Ladtkow M. C., 1992, AUGMENTATIVE COMMUNI, P59; Light J., 1988, AUGMENTATIVE ALTERNA, V4, P2, DOI DOI 10.1080/07434618812331274557; Light J, 2007, AUGMENT ALTERN COMM, V23, P204, DOI 10.1080/07434610701553635; McCarthy J, 2006, AUGMENT ALTERN COMM, V22, P269, DOI 10.1080/00498250600718621; McKinley W, 2004, NEUROREHABILITATION, V19, P141; Padman R, 2003, NEUROREHAB NEURAL RE, V17, P32, DOI 10.1177/0888439003251751; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Peterson K., 2000, AUGMENTATIVE ALTERNA, V16, P28; Sandford PR, 1999, ARCH PHYS MED REHAB, V80, P885, DOI 10.1016/S0003-9993(99)90078-3; Smith MM, 2005, AUGMENT ALTERN COMM, V21, P67, DOI 10.1080/10428190400006625; Staff from Denver Child's Hospital, 1989, NOT PED REH TRAUM BR; Vogel Lawrence C, 2004, Orthop Nurs, V23, P300, DOI 10.1097/00006416-200409000-00004; Wagner BT, 2006, J SPEECH LANG HEAR R, V49, P113, DOI 10.1044/1092-4388(2006/009); WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657; Ylvisaker M., 1998, COLLABORATIVE BRAIN, P131	30	5	5	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2010	3	4					269	277		10.3233/PRM-2010-0142			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7JX	WOS:000448273200005	21791861				2022-02-06	
J	Faure, C; Pemberton, CLA				Faure, Caroline; Pemberton, Cynthia Lee A.			Concussion and the Young Athlete Critical Management Strategies	JOURNAL OF PHYSICAL EDUCATION RECREATION AND DANCE			English	Article									[Faure, Caroline] Idaho State Univ, Dept Sport Sci & Phys Educ, Pocatello, ID 83209 USA; [Pemberton, Cynthia Lee A.] Idaho State Univ, Grad Sch, Pocatello, ID 83209 USA; [Pemberton, Cynthia Lee A.] Idaho State Univ, Educ Leadership, Pocatello, ID 83209 USA		Faure, C (corresponding author), Idaho State Univ, Dept Sport Sci & Phys Educ, Pocatello, ID 83209 USA.	faurcaro@isu.edu; pembcynt@isu.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BREWER BW, 1995, CLIN J SPORT MED, V5, P241, DOI 10.1097/00042752-199510000-00006; Burgeson CR, 2001, J SCHOOL HEALTH, V71, P279, DOI 10.1111/j.1746-1561.2001.tb03505.x; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Community Newspaper Holdings, 2007, PLAY HURT SURV SHOWS; Cotten D., 2003, LAW RECREATION SPORT; Faure C. E., 2006, THESIS; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hambidge SJ, 2002, PEDIATRICS, V109, P559, DOI 10.1542/peds.109.4.559; Kelly J. P., 1991, JAMA-J AM MED ASSOC, V282, P989; KIMIECIK JC, 1988, PHYSICIAN SPORTSMED, V16, P124, DOI 10.1080/00913847.1988.11709651; King N. S., 2004, BRIT J PSYCHIAT, V184, P86; Koester MC, 2000, J ATHL TRAINING, V35, P466; Kozlowski J. C., 1992, PARKS RECREATION EL; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; National Association for Sport and Physical Education, 1995, NAT STAND ATH COACH; National Association of State Boards of Education, 2003, NASBE POL UPD, V11; National Athletic Trainers' Association, 2007, GUID PREP MAN SUDD C; National Athletic Trainers' Association, 2008, ATH TRAIN TECHN; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ransone J, 1999, J ATHL TRAINING, V34, P267; Schwarz Alan, 2007, NY TIMES; Silver J, 2004, TXB TRAUMATIC BRAIN; Theye Fred, 2004, Clin Med Res, V2, P165; Van Kampen D. A., 2006, AM J SPORTS MED, V10; Wong G. M., 2002, ESSENTIALS SPORTS LA	37	5	5	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0730-3084	2168-3816		J PHYS EDUC RECREAT	J. Phys. Educ. Recreat. Dance		2010	81	1					19	26		10.1080/07303084.2010.10598410			8	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V23AQ	WOS:000215062700006					2022-02-06	
S	Friedman, D; Hirsch, LJ		Varelas, P		Friedman, Daniel; Hirsch, Lawrence J.			Diagnosing and Monitoring Seizures in the ICU: The Role of Continuous EEG for Detection and Management of Seizures in Critically III Patients	SEIZURES IN CRITICAL CARE: A GUIDE TO DIAGNOSIS AND THERAPEUTICS, SECOND EDITION	Current Clinical Neurology		English	Article; Book Chapter						Continuous EEG monitoring; Intensive care unit; Neurotelemetry; Nonconvulsive seizures; Critical care; Status epilepticus	NONCONVULSIVE STATUS EPILEPTICUS; INTENSIVE-CARE-UNIT; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; GRADE SUBARACHNOID HEMORRHAGE; CORTICAL SPREADING DEPRESSION; REFRACTORY STATUS EPILEPTICUS; LONG-TERM; CAROTID-ENDARTERECTOMY	Recent advances in computer technology have made it possible to perform prolonged digital continuous video EEG monitoring of many critically ill patients simultaneously. Recent studies using continuous EEG monitoring (cEEG) have found that these patients, especially those with coma, acute brain injury, or prior clinical seizures, often have nonconvulsive seizures (NCSz), and that these may contribute to secondary brain injury. The majority of seizures in the critically ill are nonconvulsive and can only be identified with EEG recording. Rapidly improving quantitative EEG (qEEG) software speeds data review to allow screening of multiple prolonged recordings to detect NCSz and has the potential to provide continuous information about changes in brain function in real time at the bedside. Optimal sensitivity and specificity of qEEG tools are obtained with full electrode montages and careful maintenance of scalp electrodes. New electrode technologies, such as MRI-compatible electrodes, help reduce the burden on EEG technologists while limiting interruptions in recordings. In addition to detecting NCSz, cEEG can also be used for dynamic. detection of other changes in brain function such as ischemia, and can be coupled with other modalities of monitoring brain physiology such as microdialysis, tissue oximetry, and intracranial electrophysiology. Together, these tools can allow early detection of brain at risk for injury and alert the physician to intervene before the damage becomes irreversible.	[Friedman, Daniel; Hirsch, Lawrence J.] Columbia Univ, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10027 USA		Friedman, D (corresponding author), Columbia Univ, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10027 USA.						Abou Khaled KJ, 2006, CRIT CARE CLIN, V22, P637, DOI 10.1016/j.ccc.2006.06.004; ADAMS DC, 1995, ANESTH ANALG, V81, P80, DOI 10.1097/00000539-199507000-00016; Agarwal R, 1998, ELECTROEN CLIN NEURO, V107, P44, DOI 10.1016/S0013-4694(98)00009-1; Aminoff MJ, 1998, ARCH NEUROL-CHICAGO, V55, P119, DOI 10.1001/archneur.55.1.119; Arnold M, 1997, STROKE, V28, P1345, DOI 10.1161/01.STR.28.7.1345; Assal F, 2001, SEIZURE-EUR J EPILEP, V10, P260, DOI 10.1053/seiz.2000.0506; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bauerle K, 2004, BRIT J ANAESTH, V92, P841, DOI 10.1093/bja/aeh142; Bottaro FJ, 2007, EPILEPSIA, V48, P966, DOI 10.1111/j.1528-1167.2007.01033.x; Bozkurt MF, 2002, CLIN ELECTROENCEPHAL, V33, P171, DOI 10.1177/155005940203300407; Brenner RP, 2002, EPILEPSIA, V43, P103, DOI 10.1046/j.1528-1157.43.s.3.9.x; CAVAZOS JE, 1994, J NEUROSCI, V14, P3106; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x; DEGIORGIO CM, 1992, EPILEPSIA, V33, P23, DOI 10.1111/j.1528-1157.1992.tb02278.x; DeGiorgio CM, 1996, EPILEPSIA, V37, P606, DOI 10.1111/j.1528-1157.1996.tb00623.x; DeGiorgio CM, 1999, NEUROLOGY, V52, P746, DOI 10.1212/WNL.52.4.746; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Drislane FW, 2008, J CLIN NEUROPHYSIOL, V25, P181, DOI 10.1097/WNP.0b013e31817be70e; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.3.CO;2-N; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006; Friedman DE, 2008, EPILEPSIA, V49, P281, DOI 10.1111/j.1528-1167.2007.01327.x; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; GABOR AJ, 1984, ELECTROEN CLIN NEURO, V57, P497, DOI 10.1016/0013-4694(84)90085-3; Gotman J, 1999, J CLIN NEUROPHYSIOL, V16, P130, DOI 10.1097/00004691-199903000-00005; HANDFORTH A, 1994, EPILEPSIA, V35, P876, DOI 10.1111/j.1528-1157.1994.tb02526.x; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hirsch LJ, 2008, EPILEPSIA, V49, P968, DOI 10.1111/j.1528-1167.2007.01481.x; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; Husain AM, 1999, J CLIN NEUROPHYSIOL, V16, P51, DOI 10.1097/00004691-199901000-00005; Jaitly R, 1997, J CLIN NEUROPHYSIOL, V14, P326, DOI 10.1097/00004691-199707000-00005; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JOHNSON DW, 1993, AM J NEURORADIOL, V14, P245; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P332, DOI 10.1097/00004691-199907000-00005; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; Kaplan PW, 2002, EPILEPSY BEHAV, V3, P122, DOI 10.1006/ebeh.2002.0336; Kolls BJ, 2007, EPILEPSIA, V48, P959, DOI 10.1111/j.1528-1167.2007.01078.x; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Krsek P, 2004, EPILEPSY BEHAV, V5, P180, DOI 10.1016/j.yebeh.2003.11.032; Kull LL, 2005, J CLIN NEUROPHYSIOL, V22, P107, DOI 10.1097/01.WNP.0000158361.24544.2D; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; LOTHMAN EW, 1989, EPILEPSY RES, V3, P107, DOI 10.1016/0920-1211(89)90038-7; LOWENSTEIN DH, 1992, NEUROLOGY, V42, P100, DOI 10.1212/WNL.42.1.100; Marienne J P, 1979, Acta Neurochir Suppl (Wien), V28, P89; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V29, P82, DOI 10.1001/archneur.1973.00490260026003; Mirsattari SM, 2004, CLIN NEUROPHYSIOL, V115, P2175, DOI 10.1016/j.clinph.2004.04.011; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Palmio J, 2008, EPILEPSY RES, V81, P155, DOI 10.1016/j.eplepsyres.2008.05.006; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; PohlmannEden B, 1996, J CLIN NEUROPHYSIOL, V13, P519, DOI 10.1097/00004691-199611000-00007; Prichep LS, 2004, BRIT J ANAESTH, V92, P393, DOI 10.1093/bja/aeh082; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Rabinowicz AL, 1996, EPILEPSIA, V37, P122, DOI 10.1111/j.1528-1157.1996.tb00002.x; REIHER J, 1991, ELECTROEN CLIN NEURO, V78, P12, DOI 10.1016/0013-4694(91)90013-T; ROUSTAN JP, 2005, IARS, P1141; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Shah AK, 2006, NEUROCRIT CARE, V5, P124, DOI 10.1385/NCC:5:2:124; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Shellhaas RA, 2007, PEDIATRICS, V120, P770, DOI 10.1542/peds.2007-0514; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Simmons LE, 1999, CRIT CARE MED, V27, P1499, DOI 10.1097/00003246-199908000-00016; SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; SUNDT TM, 1974, J NEUROSURG, V41, P310, DOI 10.3171/jns.1974.41.3.0310; TERZANO MG, 1986, EPILEPSIA, V27, P446, DOI 10.1111/j.1528-1157.1986.tb03566.x; Toet MC, 2002, PEDIATRICS, V109, P772, DOI 10.1542/peds.109.5.772; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; VESPA PM, 2007, CRITICAL CARE MED; Walker M, 2005, EPILEPTIC DISORD, V7, P253; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Waziri A, 2007, EPILEPSIA, V48, P138; WESTMORELAND BF, 1986, ARCH NEUROL-CHICAGO, V43, P494, DOI 10.1001/archneur.1986.00520050066024; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117; Young GB, 1996, NEUROLOGY, V47, P83; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Young GB, 1999, J CLIN NEUROPHYSIOL, V16, P40, DOI 10.1097/00004691-199901000-00003; ZAMPELLA E, 1991, NEUROSURGERY, V29, P727, DOI 10.1227/00006123-199111000-00014; Zhou JL, 2007, EUR J NEUROSCI, V25, P3667, DOI 10.1111/j.1460-9568.2007.05598.x	106	5	5	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1559-0585		978-1-60327-531-6	CURR CLIN NEUROL	Cur. Clin. Neurol.		2010							21	47		10.1007/978-1-60327-532-3_2	10.1007/978-1-60327-532-3		27	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BNK18	WOS:000274785400002					2022-02-06	
J	Iznak, EV; Iznak, AF; Pankratova, EA; Zavadenko, NN; Guzilova, LS; Guzilova, YI				Iznak, E. V.; Iznak, A. F.; Pankratova, E. A.; Zavadenko, N. N.; Guzilova, L. S.; Guzilova, Yu. I.			Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						traumatic brain injury; adolescents; nootropic therapy; EEG; cognitive evoked potentials		To assess objectively a dynamics of brain functional state, EEG spectral power and peak latency of the P300 component of cognitive auditory evoked potentials have been analyzed in adolescents during the course of nootropic therapy of residual asthenic consequences of traumatic brain injury (ICD-10 F07.2). The study included 76 adolescents, aged 12-18 years, who have undergone severe closed head trauma with brain commotion 1/2-5 years ago. Patients have been divided into 3 groups treated during one month with cerebrolysin, piracetam or magne-B-6, respectively. After the end of the nootropic therapy, 77% of patients treated with cerebrolysin as well as 50% of patients treated with piracetam and magne-B-6, have demonstrated the positive dynamics of their brain functional state that manifested itself in the appearance of occipital EEG alpha rhythm or in the increase of its spectral power; in the normalization of alpha rhythm frequency; in the decrease in the spectral power of slow wave (theta and delta) EEG activity, in the amount (up to the disappearance) of paroxysmal EEG activity, in the EEG response to hyperventilation and in the shortening of the P300 peak latency. Such positive changes of neurophysiological parameters have been associated with the improvement of clinical conditions of patients and correlated significantly with the dynamics of psychometric scores of attention and memory.	[Iznak, E. V.] Russian Acad Sci, Mental Hlth Res Ctr, Moscow, Russia; Russian State Med Univ, Moscow 117437, Russia		Iznak, EV (corresponding author), Russian Acad Sci, Mental Hlth Res Ctr, Moscow, Russia.	iznak@inbox.ru	Zavadenko, Nikolay/AAI-1014-2019; Iznak, Andrey/C-1016-2016; Iznak, EV/C-1107-2016	Zavadenko, Nikolay/0000-0003-0103-7422; Iznak, Andrey/0000-0003-3687-4319; Iznak, EV/0000-0003-1445-863X			ACHENBACH TM, 1991, MANUAL CHILD BEHAV C, P62; *AM EEG SOC, 1993, J CLIN NEUROPHYSIO S, V1; BLAGOSKLONOVA NL, 1994, DETSKAYA KLIN ELEKTR, P205; CHRISTENSEN JR, 1996, DEV DISABILITY INFAN, P245; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; EYDEMILLER EG, 2005, DETSKAYA PSIKHIATRIY, P1120; FARBER DA, 1988, STRUKTURNO FUNKTSION, P284; GNEZDITSKY VV, 1997, VYZVANNYE POTENTSIAL, P252; Gusev EI, 2004, ZH NEVROPATOL PSIKH, V104, P73; ISTRATOVA ON, 2005, PSIKHODIAGN KOLLEKTS, P91; Iznak A F, 2001, Vestn Ross Akad Med Nauk, P48; IZNAK AF, 2005, PSIKHIATR PSIKHOFARM, V7, P24; MIKADZE YUV, 1994, NEYROPSIKHOLOG DIAGN, P64; PETRUKHIN AS, 2004, NEVROLOGIYA DETSKOGO, P783; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; [Заваденко Н.Н. Zavadenko N.N.], 2006, [Вопросы современной педиатрии, Current pediatrics, Voprosy sovremennoi pediatrii], V5, P14; ZAVADENKO NN, 2005, GIPERAKTIVN DIFITSIT, P236; ZHIRMUNSKAYA YEA, 1991, KLIN ELEKTROENTSEFAL, P77	18	5	11	0	1	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2010	110	5					27	32					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	627OO	WOS:000280049500005	21322822				2022-02-06	
J	Lamontagne, ME; Swaine, BR; Lavoie, A; Champagne, F; Marcotte, AC				Lamontagne, Marie-Eve; Swaine, Bonnie R.; Lavoie, Andre; Champagne, Francois; Marcotte, Anne-Claire			Perceptions of traumatic brain injury network participants about network performance	BRAIN INJURY			English	Article						Brain injury; integrated healthcare delivery; network; evaluation; performance	HOSPITAL PERFORMANCE; CARE PERFORMANCE; HEALTH-CARE; MODEL	Background: Networks have been implemented within trauma systems to overcome problems of fragmentation and lack of coordination. Such networks regroup many types of organizations that could have different perceptions of network performance. No study has explored the perceptions of traumatic brain injury (TBI) network participants regarding network performance. Objective: To document the perceptions of TBI network participants concerning the importance of different dimensions of performance and to explore whether these perceptions vary according to organization types. Methodology: Participants of network organizations were surveyed using a questionnaire based on a conceptual framework of performance (the EGIPSS framework). Results: Network organizations reported dimensions related to goal attainment to be more important than dimensions related to process. Differences existed between the perceptions of various types of network organizations for some but not all domains and dimensions of performance. Conclusion: Network performance appears different from the performance of an individual organization and the consideration of the various organizations' perceptions in clarifying this concept should improve its comprehensiveness and its acceptability by all stakeholders.	[Lamontagne, Marie-Eve; Lavoie, Andre] Univ Quebec, CHA, Ctr Rech FRSQ, Unite Traumatol Urgence Soins Intensifs, Quebec City, PQ, Canada; [Lamontagne, Marie-Eve; Swaine, Bonnie R.; Champagne, Francois] Univ Montreal, Montreal, PQ, Canada; [Lamontagne, Marie-Eve; Swaine, Bonnie R.] Ctr Interdisciplinaire Rech Readaptat Montreal Me, Montreal, PQ, Canada; [Lamontagne, Marie-Eve; Champagne, Francois] Programme Anal & Evaluat Intervent Sante AnEIS, Montreal, PQ, Canada; [Marcotte, Anne-Claire] AETMIS, Montreal, PQ, Canada		Lamontagne, ME (corresponding author), Hop Enfants Jesus, CHA, Ctr Rech, Unite Rech Traumatol Urgence Soins Intensifs, Local H-041,1401,18E Rue, Quebec City, PQ G1J 1Z4, Canada.	eve.lamontagne@umontreal.ca		Lamontagne, Marie-Eve/0000-0002-3301-7429	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); ANEIS program; Programme de recherche en readaptation et en Integration sociale (PRISST)	Preparation of this article was supported by scholarships awarded to the first author by the Canadian Institutes for Health Research, the ANEIS program, and the Programme de recherche en readaptation et en Integration sociale (PRISST).	Adair Carol E, 2006, Healthc Policy, V2, P56; Adair Carol E, 2006, Healthc Policy, V1, P85; Borgatti SP, 2003, J MANAGE, V29, P991, DOI 10.1016/S0149-2063(03)00087-4; Brass DJ, 2004, ACAD MANAGE J, V47, P795, DOI 10.2307/20159624; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Connolly T., 1980, ACAD MANAGE REV, V5, P211, DOI DOI 10.5465/AMR.1980.4288727; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; COPE DN, 2005, TXB TRAUMATIC BRAIN, P559; Finucane PM, 2002, MED EDUC, V36, P959, DOI 10.1046/j.1365-2923.2002.01314.x; Fleury M. J., 2005, INT J INTEGR CARE, V5, P7; Fleury MJ, 2006, HEALTH SERV MANAG RE, V19, P153, DOI 10.1258/095148406777888080; Fleury MJ, 2002, ADM POLICY MENT HLTH, V30, P55, DOI 10.1023/A:1021227600823; Gagliardi A, 2008, INT J HEALTH CARE Q, V21, P175, DOI 10.1108/09526860810859030; Gibberd RW, 2005, INT J QUAL HEALTH C, V17, P185, DOI 10.1093/intqhc/mzi045; Goddard M, 2002, J ROY SOC MED, V95, P549, DOI 10.1258/jrsm.95.11.549; Goddard M, 2002, J ROY SOC MED, V95, P508, DOI 10.1258/jrsm.95.10.508; Guisset AL, 2002, SCI SOC SANTE, V20, P65, DOI 10.3406/sosan.2002.1553; Hebert R, 2003, CAN FAM PHYSICIAN, V49, P992; Hoyt DB, 2007, SURG CLIN N AM, V87, P21, DOI 10.1016/j.suc.2006.09.012; Huberman AM., 1994, HDB QUALITATIVE RES, P428; Kenis P, 2009, PUBLIC ADMIN, V87, P440, DOI 10.1111/j.1467-9299.2009.01775.x; KLASSEN A, 2009, INT J QUAL HEALTH C, V69, P22; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; LEGGAT S, 1997, HEALTHCARE MANAGEMEN, V10, P19; LEMIEUXCHARLES L, 2002, NETWORK EVOLUTION EF; Leutz WN, 1999, MILBANK Q, V77, P77, DOI 10.1111/1468-0009.00125; Mandell Myrna, 2007, PUBLIC PERFORM MANAG, V30, P574, DOI DOI 10.2753/PMR1530-9576300406; Mannion R, 2002, J EVAL CLIN PRACT, V8, P215, DOI 10.1046/j.1365-2753.2002.00331.x; Minvielle E, 2008, HEALTH POLICY, V87, P8, DOI 10.1016/j.healthpol.2007.09.017; Pett MA, 1997, NONPARAMETRIC STAT H; Sicotte C, 1998, Health Serv Manage Res, V11, P24; Smits PA, 2008, INT J QUAL HEALTH C, V20, P47, DOI 10.1093/intqhc/mzm056; Tregunno D, 2004, HEALTH SERV RES, V39, P771, DOI 10.1111/j.1475-6773.2004.00257.x; Vander Laan R, 2001, NEUROREHABILITATION, V16, P17	35	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	6					812	822		10.3109/02699051003789252			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700003	20433284				2022-02-06	
J	McPherson, KM; Taylor, WJ; Leplege, A				McPherson, Kathryn M.; Taylor, William J.; Leplege, Alain			Rehabilitation outcomes: values, methodologies and applications	DISABILITY AND REHABILITATION			English	Article						Methods; values; ethics; measurement; concepts	TRAUMATIC BRAIN; INJURY; HEALTH	Background. Just what defines a 'good' outcome in rehabilitation has been a much-debated issue. Indeed, this question remains a major focus in research, clinical practice and policy (with funding in many countries now being linked to outcomes achieved rather than outputs or services provided). Despite this rather constant attention, complexity, contention and confusion remain. Purpose. This special issue presents 10 papers that take a fresh look at some of the long-standing problems concerning rehabilitation outcomes and, proposes novel ways to reconsider things and move forward. Results. In this article, we provide a brief commentary on key issues raised by authors all of which focus on one or more of the following three key themes: the place of values in selecting and targeting outcomes; novel methodologies that may usefully inform measurement of outcome and finally; application of the thinking about outcomes in specific examples. Conclusion. The papers in this special issue address a number of key issues concerning the evaluation of outcomes in rehabilitation. In so doing, some of the prevalent assumptions underpinning common approaches are questioned and novel ways forward are proposed.	[McPherson, Kathryn M.] AUT Univ, Hlth & Rehabil Res Inst, Auckland 1142, New Zealand; [Taylor, William J.] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Leplege, Alain] Univ Paris Diderot, Dept Hist & Philosophy Sci, Paris, France		McPherson, KM (corresponding author), AUT Univ, Hlth & Rehabil Inst, Private Bag 92006, Auckland 1142, New Zealand.	kathryn.mcpherson@aut.ac.nz	Atkin, Helen/D-3550-2012	McPherson, Kath/0000-0003-0487-8497; McPherson, Kathryn/0000-0003-1240-8882	Accident Compensation Corporation (ACC), Wellington, New Zealand	This Special Issue was part-funded and supported by the Accident Compensation Corporation (ACC), Wellington, New Zealand. Views and/or conclusions in this article are those of the authors and may not reflect the position of ACC. We are grateful to all the participants who worked with us on the 2-day workshop that informed this work: Ian Cameron, Jackie Fawcett, Valery Feigin, Sara Georgeson, Gill Hall, Matire Harwood, Paula Kersten, William Levack, Nicola Kayes, Harry McNaughton, Philip Patson, Richard Siegert, Gerold Stucki, Julian Verkaaik and Gale Whiteneck. We also thank Professor Dave Muller and the team at Disability and Rehabilitation.	Bond TG, 2008, EUR J PHYS REHAB MED, V44, P359; Cameron ID, 2010, DISABIL REHABIL, V32, P1051, DOI 10.3109/09638281003672377; Dobkin BH, 2009, CURR OPIN NEUROL, V22, P563, DOI 10.1097/WCO.0b013e3283314b11; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Hale ED, 2007, RHEUMATOLOGY, V46, P904, DOI 10.1093/rheumatology/kem060; Harwood M, 2010, DISABIL REHABIL, V32, P972, DOI 10.3109/09638281003775378; Kayes NM, 2010, DISABIL REHABIL, V32, P1011, DOI 10.3109/09638281003775501; Kersten P, 2010, DISABIL REHABIL, V32, P1028, DOI 10.3109/09638281003775568; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Mcpherson KM, 2007, DISABIL REHABIL, V29, P1551, DOI 10.1080/09638280701618752; Metasynthesis Downe S., 2008, EVID BASED MIDWIFERY, V6, P4, DOI DOI 10.1111/J.1365-2648.2005.03380.X.RETRIEVED; Pachoud B, 2010, DISABIL REHABIL, V32, P1043, DOI 10.3109/09638281003775618; Reinhardt JD, 2010, DISABIL REHABIL, V32, P1000, DOI 10.3109/09638281003775410; Siegert RJ, 2010, DISABIL REHABIL, V32, P965, DOI 10.3109/09638281003775360; Taylor WJ, 2010, DISABIL REHABIL, V32, P1020, DOI 10.3109/09638281003775535; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Verkaaik J, 2010, DISABIL REHABIL, V32, P978, DOI 10.3109/09638281003775386; Wade D, 2009, CLIN REHABIL, V23, P867, DOI 10.1177/0269215509343849; Whiteneck G, 2010, DISABIL REHABIL, V32, P1035, DOI 10.3109/09638281003775584; World Health Organization, 2007, INT CLASS FUNCT DIS	21	5	5	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2010	32	12					961	964		10.3109/09638281003672393			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	608OC	WOS:000278592600001	20222829				2022-02-06	
S	Raghavan, R		Jain, KK		Raghavan, Raghu			Intraparenchymal Delivery and Its Discontents	DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM	Neuromethods		English	Article; Book Chapter						Intracerebral drug delivery; convection-enhanced delivery; infusion; brain; intraparenchymal catheters; catheters	BLOOD-BRAIN-BARRIER; CONVECTION-ENHANCED DELIVERY; DRUG-DELIVERY; CEREBROSPINAL-FLUID; FOCUSED ULTRASOUND; CONSOLIDATION THEORY; THERAPEUTIC AGENTS; INCREASED EFFICACY; AGAROSE GELS; FLOW	In the treatment of central nervous system diseases, therapeutic particles need to breach the blood-brain barrier (BBB) to reach their intended target, and it has long been known that this is a difficult barrier to breach. The barrier is both passive with tight junctions hindering passage of even rather small molecules, as well as active with transporters that can pump select molecules back into the bloodstream. The diseases include both those where this barrier has been compromised such as brain tumors, hemorrhagic stroke, and neurotrauma; as well as neurodegenerative disorders where the compromise is substantially less and often unnoticeable. In addition to the pharmaceutical solution which involves design of small molecules that may be administered orally or at least systemically, there is also a compelling need at present to design devices for direct delivery of therapeutics into the central nervous system. Such delivery methods arc unpopular because of their intrusiveness; however, the lack of success of the systemic route ill the treatment of many of the most severe brain diseases has established a need for such devices, and the Success and popularity of deep brain stimulation (DBS) has lowered the psychological barrier to these. Many clinical trials are under way which demand direct delivery of therapeutics to the brain. Such therapeutics range from small Molecules, large proteins, nanoparticles, and viral carriers for gene therapies, to cells. This chapter is a review of intraparenchymal delivery of such therapies fir brain diseases and Of the devices used for such purposes.	Therataxis LLC, Baltimore, MD USA		Raghavan, R (corresponding author), Therataxis LLC, Baltimore, MD USA.						Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; ASIRVATHAM SJ, 2005, Patent No. 60738718; ATTWOOD TK, 1988, BIOPOLYMERS, V27, P201, DOI 10.1002/bip.360270204; Bear J., 1988, DYNAMICS FLUIDS PORO; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bruch L. W., 1997, PHYS ADSORPTION FORC; Burns J, 2004, CAN J NEUROL SCI, V31, P520, DOI 10.1017/S0317167100003759; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; CHUI MM, 1995, J COLLOID INTERF SCI, V174, P336, DOI 10.1006/jcis.1995.1399; Coussy O, 2004, MECH POROUS CONTINUA; Coussy O, 2004, POROMECHANICS; Craciun G, 2005, J THEOR BIOL, V237, P316, DOI 10.1016/j.jtbi.2005.04.018; Croteau D, 2005, J NEUROSURG, V102, P90, DOI 10.3171/jns.2005.102.1.0090; DAVSON H, 1996, PHYSL CEREBROSPINAL; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dempsey JF, 1998, INT J RADIAT ONCOL, V42, P421, DOI 10.1016/S0360-3016(98)00215-6; Dermietzel R., 2006, BLOOD BRAIN BARRIERS; Fan XJ, 2003, PHYS FLUIDS, V15, P11, DOI 10.1063/1.1522750; Freud S., 1989, CIVILIZATION ITS DIS; Friedman A, 2005, J MATH BIOL, V51, P217, DOI 10.1007/s00285-004-0285-3; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; HEART G, 2004, Patent No. 20040267234; Hornung U., 1997, HOMOGENIZATION POROU, V6th; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; JAIN RK, 1990, CANCER METAST REV, V9, P253, DOI 10.1007/BF00046364; JAIN RK, 1986, CRC CR REV ONCOL-HEM, V5, P115, DOI 10.1016/S1040-8428(86)80023-3; JAIN RK, 1988, CANCER RES, V48, P7022; Johanson CE, 2005, PHARM RES-DORDR, V22, P1011, DOI 10.1007/s11095-005-6039-0; JOHNSON DL, 1987, J FLUID MECH, V176, P379, DOI 10.1017/S0022112087000727; JOHNSON DL, 1982, J CHEM PHYS, V77, P1531, DOI 10.1063/1.443934; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KRAUZE MT, 2007, J NEUROSURG, V103, P923; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; LEWIS G, 2007, BMES ANN C; LIGHTHILL J, 1978, J SOUND VIB, V61, P391; Liu XR, 2008, J PHARMACOL EXP THER, V325, P349, DOI 10.1124/jpet.107.130294; LIU Y, 2009, ULTRASOUNDASSISTED D; Lonser RR, 1998, J NEUROSURG, V89, P610, DOI 10.3171/jns.1998.89.4.0610; Lonser RR, 1998, J NEUROSURG, V89, P616, DOI 10.3171/jns.1998.89.4.0616; Lonser RR, 2002, J NEUROSURG, V97, P905, DOI 10.3171/jns.2002.97.4.0905; Mardor Y, 2005, CANCER RES, V65, P6858, DOI 10.1158/0008-5472.CAN-05-0161; Morrison PF, 1999, AM J PHYSIOL-REG I, V277, pR1218, DOI 10.1152/ajpregu.1999.277.4.R1218; MORRISON PF, 1994, AM J PHYSIOL, V266, pR292, DOI 10.1152/ajpregu.1994.266.1.R292; Nisslert R, 2007, J MICROSC-OXFORD, V225, P10, DOI 10.1111/j.1365-2818.2007.01711.x; Olson JJ, 2008, J NEURO-ONCOL, V89, P159, DOI 10.1007/s11060-008-9612-7; PARDRIDGE W, THIS IS ADJECTIVE US; Pardridge William M, 2005, NeuroRx, V2, P3; Perlstein B, 2008, NEURO-ONCOLOGY, V10, P153, DOI 10.1215/15228517-2008-002; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Poesio P, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016309; Powathil G, 2007, PHYS MED BIOL, V52, P3291, DOI 10.1088/0031-9155/52/11/023; RAGHAVAN R, 2009, Patent No. 12319311; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rohlf K, 2001, J BIOMECH, V34, P141, DOI 10.1016/S0021-9290(00)00103-2; ROSE K, 2003, MDL INFORM SYSTEMS W; Rosso L, 2009, CANCER RES, V69, P120, DOI 10.1158/0008-5472.CAN-08-2356; Sampson JH, 2007, NEUROSURGERY, V60, P89, DOI 10.1227/01.NEU.0000249256.09289.5F; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sivaloganathan S, 2005, INT J NONLIN MECH, V40, P1149, DOI 10.1016/j.ijnonlinmec.2005.04.004; Sivaloganathan S, 2005, APPL MATH COMPUT, V165, P687, DOI 10.1016/j.amc.2004.04.086; Sivaloganathan S, 2005, APPL MATH COMPUT, V163, P1097, DOI 10.1016/j.amc.2004.06.037; Sivaloganathan S, 1998, APPL MATH COMPUT, V94, P243, DOI 10.1016/S0096-3003(97)10093-5; SMITH JH, 2006, J MICROVASCULAR RES, V2, P871; SOLAR M, 2008, Patent No. 12152280; Stastna M, 1999, DYN CONTIN DISCRET I, V5, P415; Stylianopoulos T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3021477; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tenti G, 2002, PEDIATR NEUROSURG, V37, P221, DOI 10.1159/000065400; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; WANG H, 2000, LINEAR THEORY POROEL; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001; Zhang XY, 2000, AM J PHYSIOL-HEART C, V279, pH2726, DOI 10.1152/ajpheart.2000.279.6.H2726	78	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-60761-528-6	NEUROMETHODS	Neuromethods		2010	45						85	135		10.1007/978-1-60761-529-3_5	10.1007/978-1-60761-529-3		51	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BND56	WOS:000274229700005					2022-02-06	
J	Reinhard, MJ; Wolf, G; Cozolino, L				Reinhard, Matthew J.; Wolf, Gregory; Cozolino, Louis			Using the MMPI to Assess Reported Cognitive Disturbances and Somatization as a Core Feature of Complex PTSD	JOURNAL OF TRAUMA & DISSOCIATION			English	Article						complex PTSD; somatization; MMPI; childhood sexual abuse; neuropsychiatric; somatic complaints	POSTTRAUMATIC-STRESS-DISORDER; PUNITIVE CHILDHOOD EXPERIENCES; SEXUAL-ABUSE; YOUNG-ADULTS; PROCESSING THERAPY; PROLONGED EXPOSURE; RISK-FACTORS; SELF-REPORT; WOMEN; ADAPTATION	Minnesota Multiphasic Personality Inventory (MMPI) clinical scales as well as 4 sets of MMPI items known to be sensitive to neurological dysfunction (closed head injury, cerebrovascular disorder) were administered to survivors of childhood physical and/or sexual abuse and to non-abused adults. As predicted, relative to the comparison group of psychiatric patients, the abused participants scored significantly higher on Scale 8 (Schizophrenia) and on all 4 sets of items associated with neurological dysfunction. The results suggest that early abuse/trauma is associated with cognitive disturbances and somatization. Findings appear to support the conceptualization of these psychophysical experiences as a central part of what is often called "complex posttraumatic stress disorder." Limitations and suggestions for further study are discussed.	[Reinhard, Matthew J.] Vet Affairs Med Ctr, WRIISC, Washington, DC 20422 USA; [Reinhard, Matthew J.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Wolf, Gregory] James A Haley Vet Adm Med Ctr, Tampa Bay, FL USA; [Cozolino, Louis] Pepperdine Univ, Grad Sch Educ & Psychol, Dept Psychol, Los Angeles, CA USA		Reinhard, MJ (corresponding author), Vet Affairs Med Ctr, WRIISC, 50 Irving St NW MS 127, Washington, DC 20422 USA.	matthew.reinhard@va.gov					ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Ben-Porath Y. S., 1989, PSYCHOL ASSESSMENT J, V1, P345; BENPORATH YS, 1989, J PERS ASSESS, V53, P645, DOI 10.1207/s15327752jpa5304_1; BERGER AM, 1988, CHILD ABUSE NEGLECT, V12, P251, DOI 10.1016/0145-2134(88)90033-6; BERGER AM, 1984, ASSESSING ENV, V3; BRESLAU N, 1992, AM J PSYCHIAT, V149, P671; Escalona R, 2004, PSYCHOSOMATICS, V45, P291, DOI 10.1176/appi.psy.45.4.291; FINKEL K, 1984, HIST PHOTOGR, V8, P22, DOI 10.1080/03087298.1984.10442039; FINKELHOR D, 1990, CHILD ABUSE NEGLECT, V14, P19, DOI 10.1016/0145-2134(90)90077-7; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; GASS CS, 1992, ARCH CLIN NEUROPSYCH, V7, P17, DOI 10.1016/0887-6177(92)90015-F; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; GRAHAM JR, 2000, MMPI ASSESSING PERSO; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; KISER LJ, 1991, J AM ACAD CHILD PSY, V30, P776, DOI 10.1016/S0890-8567(10)80015-2; KNUTSON JF, 1994, CHILD ABUSE NEGLECT, V18, P155, DOI 10.1016/0145-2134(94)90117-1; Korbanka JE, 1997, PSYCHOL REP, V81, P979, DOI 10.2466/pr0.1997.81.3.979; LeDoux J.E., 1992, HDB EMOTION MEMORY R, P269; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; McEwen BS, 1997, ANN NY ACAD SCI, V821, P271, DOI 10.1111/j.1749-6632.1997.tb48286.x; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Perry BD, 1998, CHILD ADOL PSYCH CL, V7, P33, DOI 10.1016/S1056-4993(18)30258-X; Putnam FW, 1997, ANN NY ACAD SCI, V821, P150, DOI 10.1111/j.1749-6632.1997.tb48276.x; RAUSCH K, 1991, CHILD ABUSE NEGLECT, V15, P29, DOI 10.1016/0145-2134(91)90087-T; Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rodriguez N, 1997, J CONSULT CLIN PSYCH, V65, P53, DOI 10.1037/0022-006X.65.1.53; ROLAND BC, 1988, PSYCHOL REP, V63, P447, DOI 10.2466/pr0.1988.63.2.447; ROWAN AB, 1994, CHILD ABUSE NEGLECT, V18, P51, DOI 10.1016/0145-2134(94)90095-7; SCHNEIDERMAN AI, 2008, AM J EPIDEMIOL, DOI DOI 10.1093/AJE/KWN/068; Schnurr PP, 2008, J REHABIL RES DEV, V45, P383, DOI 10.1682/JRRD.2007.06.0099; Schnurr PP, 2004, J TRAUMA STRESS, V17, P85, DOI 10.1023/B:JOTS.0000022614.21794.f4; Schore A.N., 1994, AFFECT REGULATION OR; Siegel DJ, 1996, CHILD ADOL PSYCH CL, V5, P509, DOI 10.1016/S1056-4993(18)30378-X; Spitzer R. L., 1990, STRUCTURED CLIN INTE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teicher MH, 2002, SCI AM, V286, P68, DOI 10.1038/scientificamerican0302-68; Van der Kolk BA, 2006, ANN NY ACAD SCI, V1071, P277, DOI 10.1196/annals.1364.022; Van Der Kolk Bessel A., 1996, P214; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Yehuda R, 2001, REV PSYCHIAT SER, V20, P117; ZAIDI LY, 1989, AGGRESSIVE BEHAV, V15, P137, DOI 10.1002/1098-2337(1989)15:2<137::AID-AB2480150202>3.0.CO;2-O	48	5	5	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1529-9732	1529-9740		J TRAUMA DISSOCIATIO	J. Trauma Dissociation		2010	11	1					57	72		10.1080/15299730903318475			16	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	542MX	WOS:000273499100006	20063248				2022-02-06	
B	Stoica, BA; Faden, AI		Fujikawa, DG		Stoica, Bogdan A.; Faden, Alan I.			Programmed Neuronal Cell Death Mechanisms in CNS Injury	ACUTE NEURONAL INJURY: THE ROLE OF EXCITOTOXIC PROGRAMMED CELL DEATH MECHANISMS			English	Article; Book Chapter							APOPTOSIS-INDUCING FACTOR; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; CYTOCHROME-C RELEASE; HEAT-SHOCK PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; CYCLIN-DEPENDENT KINASES; DEVELOPING RAT-BRAIN; INTERNUCLEOSOMAL DNA CLEAVAGE; POLY(ADP-RIBOSE) PAR POLYMER		[Stoica, Bogdan A.; Faden, Alan I.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA		Faden, AI (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW,Room EP 12, Washington, DC 20057 USA.	fadena@georgetown.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434			Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Arnheim G, 1890, VIRCHOWS ARCH PATHOL, V120, P367; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bitko V, 2001, J CELL BIOCHEM, V80, P441, DOI 10.1002/1097-4644(20010301)80:3<441::AID-JCB170>3.0.CO;2-C; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Boonstra J, 2003, J CELL BIOCHEM, V90, P244, DOI 10.1002/jcb.10617; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cao GD, 2003, J CEREBR BLOOD F MET, V23, P1137, DOI 10.1097/01.WCB.0000087090.01171.E7; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colgan J, 2000, GENOMICS, V68, P167, DOI 10.1006/geno.2000.6295; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dikranian K, 2001, NEUROBIOL DIS, V8, P359, DOI 10.1006/nbdi.2001.0411; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Eguchi Y, 1997, CANCER RES, V57, P1835; Eguchi Y, 1999, CANCER RES, V59, P2174; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FARBER E, 1994, MODERN PATHOL, V7, P605; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Ferrer I, 2003, NEUROPATH APPL NEURO, V29, P472, DOI 10.1046/j.1365-2990.2003.00485.x; Fischer Peter M, 2003, Prog Cell Cycle Res, V5, P235; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Flemming W., 1885, Archiv fuer Anatomie und Physiologie (Anat), P221; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Fujikawa DG, 2007, BRAIN RES, V1135, P206, DOI 10.1016/j.brainres.2006.12.029; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; Fujikawa DG, 2000, TRENDS NEUROSCI, V23, P410, DOI 10.1016/S0166-2236(00)01601-5; Fujikawa DG, 2002, J NEUROCHEM, V83, P229, DOI 10.1046/j.1471-4159.2002.01152.x; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; Graeber MB, 2002, BRAIN PATHOL, V12, P385; Graper L., 1914, ARCH ZELLFORSCH, V12, P373; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; HELEKAR SA, 1994, NEURON, V12, P179, DOI 10.1016/0896-6273(94)90162-7; Hengartner MO, 1999, RECENT PROG HORM RES, V54, P213; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Honig LS, 2000, AM J MED, V108, P317, DOI 10.1016/S0002-9343(00)00291-6; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Ino H, 2001, J NEUROSCI, V21, P6086, DOI 10.1523/JNEUROSCI.21-16-06086.2001; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; KERR JFR, 1971, J PATHOL, V105, P13, DOI 10.1002/path.1711050103; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr JFR, 2002, TOXICOLOGY, V181, P471, DOI 10.1016/S0300-483X(02)00457-2; Kim H, 2005, CLIN IMMUNOL, V116, P217, DOI 10.1016/j.clim.2005.05.004; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Klebs E, 1889, ALLGEMEINE PATHOLOGI; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lee BI, 2005, NEUROSCI LETT, V386, P23, DOI 10.1016/j.neulet.2005.05.058; Lee JP, 1999, P NATL ACAD SCI USA, V96, P3251, DOI 10.1073/pnas.96.6.3251; Lee SH, 2004, STROKE, V35, P2195, DOI 10.1161/01.STR.0000136150.73891.14; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Levin S, 1998, TOXICOL SCI, V41, P155; Levin S, 1999, TOXICOL PATHOL, V27, P484, DOI 10.1177/019262339902700419; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Li F, 2002, AM J PHYSIOL-CELL PH, V283, pC917, DOI 10.1152/ajpcell.00517.2001; LI LJ, 1993, P NATL ACAD SCI USA, V90, P3554, DOI 10.1073/pnas.90.8.3554; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li X, 2007, NEUROSCIENCE, V144, P56, DOI 10.1016/j.neuroscience.2006.08.065; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; LOCKSHIN RA, 1964, J INSECT PHYSIOL, V10, P643, DOI 10.1016/0022-1910(64)90034-4; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Love S, 2003, NEUROSCI LETT, V353, P29, DOI 10.1016/j.neulet.2003.09.004; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MAJNO G, 1995, AM J PATHOL, V146, P3; Majno G, 1999, TOXICOL PATHOL, V27, P494, DOI 10.1177/019262339902700422; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McPherson CA, 2003, NEUROTOX RES, V5, P339, DOI 10.1007/BF03033154; Mikuriya T, 2005, BRAIN RES, V1065, P107, DOI 10.1016/j.brainres.2005.10.045; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Nagai Y, 2005, NEUROSCI LETT, V374, P183, DOI 10.1016/j.neulet.2004.10.070; Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Narkilahti S, 2007, NEUROMOL MED, V9, P129, DOI 10.1007/BF02685887; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nishioka N, 2004, AM J GERIAT PSYCHIAT, V12, P167, DOI 10.1176/appi.ajgp.12.2.167; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nissen F, 1886, ARCH MIKROSK ANAT, V26, P337; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Otsuka Y, 2004, NEUROSCI LETT, V365, P180, DOI 10.1016/j.neulet.2004.04.083; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Panter S. S., 1992, PRINCIPLES PRACTICE, P32; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Rich T, 1999, NAT CELL BIOL, V1, pE69, DOI 10.1038/11038; RIEDEL G, 1995, NEUROPHARMACOLOGY, V34, P559, DOI 10.1016/0028-3908(95)00045-8; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Robertson JD, 2004, EMBO REP, V5, P643, DOI 10.1038/sj.embor.7400153; ROKITANSKY C, 1846, HDB ALLGEMEINEN PATH; Roy M, 1999, TRENDS NEUROSCI, V22, P419, DOI 10.1016/S0166-2236(99)01435-6; Ruchalski K, 2006, J BIOL CHEM, V281, P7873, DOI 10.1074/jbc.M513728200; Saito A, 2004, MOL BRAIN RES, V127, P89, DOI 10.1016/j.molbrainres.2004.05.012; Saito A, 2004, STROKE, V35, P1443, DOI 10.1161/01.STR.0000128416.28778.7a; Saito A, 2003, J CEREBR BLOOD F MET, V23, P1010, DOI 10.1097/01.WCB.0000080702.47016.FF; Sakurai M, 2000, STROKE, V31, P200, DOI 10.1161/01.STR.31.1.200; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; SCHMAUS H, 1894, VIRCHOWS ARCH PATHOL, P138; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Seidberg NA, 2003, J NEUROCHEM, V84, P514, DOI 10.1046/j.1471-4159.2003.01547.x; Semba S, 2006, MOL CANCER RES, V4, P529, DOI 10.1158/1541-7786.MCR-06-0060; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Siegelin M, 2005, NEUROBIOL DIS, V20, P509, DOI 10.1016/j.nbd.2005.04.006; Siegelin MD, 2005, NEUROCHEM INT, V46, P41, DOI 10.1016/j.neuint.2004.07.009; Sloviter RS, 2002, TRENDS PHARMACOL SCI, V23, P19, DOI 10.1016/S0165-6147(00)01867-8; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Snider BJ, 1999, ANN NY ACAD SCI, V893, P243, DOI 10.1111/j.1749-6632.1999.tb07829.x; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Strazza M, 2004, NEUROCHEM RES, V29, P923, DOI 10.1023/B:NERE.0000021236.32785.37; Strobe H, 1892, BEITR PATHOL, V11, P1; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki S, 2001, INT IMMUNOPHARMACOL, V1, P1733, DOI 10.1016/S1567-5769(01)00083-2; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Takahashi K, 1997, J CEREBR BLOOD F MET, V17, P1137, DOI 10.1097/00004647-199711000-00001; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; TRUMP BF, 1974, INFLAMMATORY PROCESS, P115; Tsuchiya D, 2003, NEUROSURGERY, V53, P1179, DOI 10.1227/01.NEU.0000090341.38659.CF; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Verdaguer E, 2003, ANN NY ACAD SCI, V1010, P671, DOI 10.1196/annals.1299.122; Verdaguer E, 2002, NEUROREPORT, V13, P413, DOI 10.1097/00001756-200203250-00010; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VIRCHOW R, 1859, CELLULAR PATHOLOGY B; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Volbracht C, 2001, MOL MED, V7, P36, DOI 10.1007/BF03401837; Von Recklinghausen F., 1910, UNTERSUCHUNGEN RACHI; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; WEIGERT C, 1878, VIRCHOWS ARCH PATHOL, V72, P461; WEISSMANN A, 1889, ESSAYS HEREDITARY KI; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Wen Y, 2004, J BIOL CHEM, V279, P22684, DOI 10.1074/jbc.M311768200; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu YF, 2004, NEUROSCI LETT, V364, P203, DOI 10.1016/j.neulet.2004.04.093; Wyllie A H, 1974, J Clin Pathol Suppl (R Coll Pathol), V7, P35; WYLLIE AH, 1981, CELL DEATH NEW CLASS; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yasuda H, 2005, BRAIN RES, V1032, P176, DOI 10.1016/j.brainres.2004.11.009; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhan RZ, 2001, J CEREBR BLOOD F MET, V21, P529, DOI 10.1097/00004647-200105000-00007; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhang YH, 2005, J CEREBR BLOOD F MET, V25, P868, DOI 10.1038/sj.jcbfm.9600081; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129; Zhu C, 2007, CELL DEATH DIFFER, V14, P775, DOI 10.1038/sj.cdd.4402053; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x; Zychlinsky A, 1997, TRENDS MICROBIOL, V5, P201, DOI 10.1016/S0966-842X(97)01044-5	251	5	5	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-73225-1				2010							169	200		10.1007/978-0-387-73226-8_12	10.1007/978-0-387-73226-8		32	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BMT69	WOS:000273556000012					2022-02-06	
J	Ylioja, S; Hanks, R; Baird, A; Millis, S				Ylioja, Shelley; Hanks, Robin; Baird, Anne; Millis, Scott			Are Cognitive Outcome and Recovery Different in Civilian Penetrating Versus Non-Penetrating Brain Injuries?	CLINICAL NEUROPSYCHOLOGIST			English	Article						Penetrating traumatic brain injury; Non-penetrating traumatic brain injury; Cognition	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; ADULT CIVILIANS; MISSILE WOUNDS; SPEED; REHABILITATION; ATTENTION; SEQUELAE; DEFICITS; BATTERY	The present study sought to determine whether cognitive outcome and course of recovery in civilian penetrating brain injury due to gunshot can be distinguished from that of non-penetrating brain injury due to motor vehicle accident. Matched survivors of penetrating and non-penetrating brain injury were assessed with a brief neuropsychological test battery at inpatient rehabilitation, 1 year post-injury, and 2 years post-injury. The traumatic brain injury groups were found to have patterns of performance marked by reliably distinct differences in isolated areas, with different cognitive predictors of brain injury type present in early versus later recovery. The degree of recovery over the first 2 years appeared to be quite similar for penetrating and non-penetrating injuries.	[Ylioja, Shelley; Hanks, Robin; Baird, Anne; Millis, Scott] Univ Windsor, Windsor, ON N9A 5L1, Canada		Ylioja, S (corresponding author), Univ Windsor, Windsor, ON N9A 5L1, Canada.	ylioja@uwindsor.ca			NIDRR [H133A080044-09]	This project was partially supported by NIDRR grant #H133A080044-09, which funds the SEMTBIS project through the TBI Model System multicenter study.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; [Anonymous], 2001, J TRAUMA, V51, pS1; Berry DA, 2006, AM STAT, V60, P27, DOI 10.1198/000313006X90684; BLACK FM, 1973, CLIN PSYCHOL, V29, P141; BLACK FW, 1974, PERCEPT MOTOR SKILL, V38, P387, DOI 10.2466/pms.1974.38.2.387; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; CORKIN S, 1979, NEUROPSYCHOLOGIA, V17, P585, DOI 10.1016/0028-3932(79)90034-4; Delis D.C., 2000, CALIFORNIA VERBAL LE; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Hamsher K., 1989, MULTILINGUAL APHASIA; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heaton R. K., 2004, REVISED COMPREHENSIV; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; KAUFMAN HH, 1985, NEUROSURGERY, V16, P754, DOI 10.1227/00006123-198506000-00002; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Matthews CG., 1964, INSTRUCTION MANUAL A; McCaffrey R J, 1988, Arch Clin Neuropsychol, V3, P181, DOI 10.1016/0887-6177(88)90062-5; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MILLIS SR, 1995, BRAIN INJURY, V9, P509, DOI 10.3109/02699059509008210; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Oehmichen M, 2001, FORENSIC SCI INT, V115, P189, DOI 10.1016/S0379-0738(00)00335-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Reitan R, 1985, HALSTEAD REITAN NEUR; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sapsford W, 2003, J R Army Med Corps, V149, P5; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schmidt M., 1996, REY AUDITORY VERBAL; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tsuei Yuang-Seng, 2005, J Chin Med Assoc, V68, P126, DOI 10.1016/S1726-4901(09)70233-3; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	51	5	5	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	7					1097	1112	PII 927409910	10.1080/13854046.2010.516021			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	659UM	WOS:000282592400001	20924980				2022-02-06	
J	Kamath, AF; Pandya, NK; Namdari, S; Hosalkar, HS; Keenan, MA				Kamath, Atul F.; Pandya, Nirav K.; Namdari, Surena; Hosalkar, Harish S.; Keenan, Mary Ann			Surgical Technique for the Correction of Adult Spastic Equinovarus	TECHNIQUES IN FOOT AND ANKLE SURGERY			English	Article						spastic equinovarus foot; multiple tendon transfer; split anterior tibialis tendon transfer; traumatic brain injury; stroke		Foot and ankle deformities are common in patients with stroke-related or traumatic brain injury-related spasticity, and represent a significant cause of morbidity. The correction of spastic equinovarus foot requires careful preoperative planning and deformity/gait analysis. This technique paper presents the evaluation, treatment, and complications associated with combined multi-tendon transfers for correction of spastic equinovarus. Equinovarus is the result of abnormal activity in multiple muscles. To address spastic equinovarus deformity, a constellation of procedures are employed, including the split anterior tibial tendon transfer, Achilles lengthening, flexor digitorum longus transfer to the calcaneus, and/or extensor hallucis longus transfer to the middle cuneiform. The goal of these procedures is to establish a more functional, plantigrade foot. The choice of tendon transfers must be tailored to the individual patient, depending on the nature, severity, and suppleness of deformity, as well as functional status and patient expectations. Results after this procedure show reliable establishment of a plantigrade foot, deformity correction, functional improvements in ambulation and progression with ambulatory aids, and improvements in general quality of life. We endorse this multitendon procedure as an effective method of addressing spastic equinovarus foot deformity.	[Kamath, Atul F.; Pandya, Nirav K.; Namdari, Surena; Hosalkar, Harish S.; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA		Keenan, MA (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				BANKS HH, 1977, CLIN ORTHOP RELAT R, P70; BARNES MJ, 1991, J BONE JOINT SURG AM, V73A, P734, DOI 10.2106/00004623-199173050-00012; DiGiovanni CW, 2002, J BONE JOINT SURG AM, V84A, P962, DOI 10.2106/00004623-200206000-00010; Dunkerley D R, 1985, Int Rehabil Med, V7, P39; EDWARDS P, 1993, FOOT ANKLE, V14, P335, DOI 10.1177/107110079301400605; Fuller DA, 2004, ORTHOPEDICS, V27, P372; GARCEAU GJ, 1967, J BONE JOINT SURG AM, VA 49, P207, DOI 10.2106/00004623-196749020-00001; Garceau GJ, 1940, J BONE JOINT SURG, V22, P932; GARCEAU GJ, 1972, CLIN ORTHOP RELAT R, P61, DOI 10.1097/00003086-197205000-00012; HOFFER MM, 1974, ORTHOP CLIN N AM, V5, P31; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Hosalkar H, 2008, CLIN ORTHOP RELAT R, V466, P2500, DOI 10.1007/s11999-008-0395-0; JORDAN C, 1988, CLIN ORTHOP RELAT R, P102; Keenan M A, 1988, Orthop Rev, V17, P1185; KEENAN MA, 1984, CLIN ORTHOP RELAT R, P165; Keenan MA, 1999, NEUROREHABILITATION, V12, P119; KEENAN MA, 1984, FOOT ANKLE, V5, P35, DOI 10.1177/107110078400500105; KEENAN MAE, 1987, FOOT ANKLE, V7, P333, DOI 10.1177/107110078700700604; Keenan MAE, 1999, J HEAD TRAUMA REHAB, V14, P163, DOI 10.1097/00001199-199904000-00006; KEENAN MAE, 2001, CHAPMANS OPERATIVE O, P3201; LAAVEG SJ, 1980, J BONE JOINT SURG AM, V62, P23, DOI 10.2106/00004623-198062010-00004; LAWRENCE SJ, 1994, FOOT ANKLE INT, V15, P340, DOI 10.1177/107110079401500610; LEMPERG R, 1969, ACTA ORTHOP SCAND, V40, P507, DOI 10.3109/17453676909046536; Namdari S, 2009, AM AC ORTH SURG ANN; ONO K, 1980, INT ORTHOP, V4, P225, DOI 10.1007/BF00268160; Paley D, 2002, PRINCIPLES DEFORMITY, P761; PERRY J, 1987, CLIN ORTHOP RELAT R, P8; Perry J, 1978, CLIN ORTHOP RELAT R, V131, P4753; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; Reddy S, 2008, CLIN ORTHOP RELAT R, V466, P1683, DOI 10.1007/s11999-008-0250-3; RICCIARDIPOLLINI PT, 1984, FOOT ANKLE, V5, P107, DOI 10.1177/107110078400500303; ROPER BA, 1978, J BONE JOINT SURG BR, V60, P533, DOI 10.1302/0301-620X.60B4.711804; Silfverskiold N, 1924, ACTA CHIR SCAND, V56, P315; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; WATERS RL, 1982, J BONE JOINT SURG AM, V64, P284, DOI 10.2106/00004623-198264020-00022	35	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0644	1538-1943		TECH FOOT ANKLE SURG	Tech. Foot Ankle Surg.	DEC	2009	8	4					160	167		10.1097/BTF.0b013e3181c24be9			8	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V3E1P	WOS:000218173600003					2022-02-06	
J	Levin, SW; Baker, EH; Gropman, A; Quezado, Z; Miao, N; Zhang, ZJ; Jollands, A; Di Capua, M; Caruso, R; Mukherjee, AB				Levin, Sondra W.; Baker, Eva H.; Gropman, Andrea; Quezado, Zenaide; Miao, Ning; Zhang, Zhongjian; Jollands, Alice; Di Capua, Matteo; Caruso, Rafael; Mukherjee, Anil B.			Subdural Fluid Collections in Patients With Infantile Neuronal Ceroid Lipofuscinosis	ARCHIVES OF NEUROLOGY			English	Article							PALMITOYL-PROTEIN THIOESTERASE; TRAUMATIC BRAIN-INJURY; NEURODEGENERATIVE DISEASE; YOUNG-CHILDREN; MRI EVALUATION; HEMATOMAS; CHILDHOOD; DRUGS	Objective: To describe subdural fluid collections on magnetic resonance imaging as part of the natural history of infantile neuronal ceroid lipofuscinosis. Design: Case series. Setting: Program on Developmental Endocrinology and Genetics, The Clinical Center, National Institutes of Health, Bethesda, Maryland. Patients: Patients with infantile neuronal ceroid lipofuscinosis with subdural fluid collections. Main Outcome Measure: Neurodegeneration on magnetic resonance imaging. Results: During an ongoing bench-to-bedside clinical investigation, magnetic resonance imaging examinations led to the incidental discovery of subdural fluid collections in 4 of 9 patients with infantile neuronal ceroid lipofuscinosis. No particular event (such as trauma) or change in symptoms was linked to this finding, which was already in the chronic phase when discovered. Of the 4 patients, I was followed up for 7 years, 2 for 4 years, and 1 for 2.5 years. Over time, these collections remained stable or decreased in size. Conclusion: Recognition that subdural fluid collections are part of the infantile neuronal ceroid lipofuscinosis disease process may obviate the necessity of additional workup as well as therapeutic interventions in these chronically sick children.	[Levin, Sondra W.] Walter Reed Army Med Ctr, Dept Pediat, Washington, DC 20307 USA; [Baker, Eva H.; Mukherjee, Anil B.] NIH, Mark O Hatfield Clin Res Ctr, Dept Radiol, Bethesda, MD 20892 USA; [Quezado, Zenaide; Miao, Ning] NIH, Dept Anesthesia & Surg Serv, Mark O Hatfield Clin Res Ctr, Bethesda, MD 20892 USA; [Gropman, Andrea] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Jollands, Alice] Ninewells Hosp, Dept Pediat Neurol, Dundee DD1 9SY, Scotland; [Di Capua, Matteo] Bambino Gesu Pediat Hosp, Div Child Neurol, Rome, Italy; [Caruso, Rafael] NEI, Bethesda, MD 20892 USA		Mukherjee, AB (corresponding author), NIH, Mark O Hatfield Clin Res Ctr, Dept Radiol, Bldg 10,Room 9D42,10 Ctr Dr, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov	Quezado, Zenaide/O-4860-2016	Quezado, Zenaide/0000-0001-9793-4368	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD000910] Funding Source: NIH RePORTER	This research was supported in full by the intramural program of the National Institute of Child Health and Human Development, National Institutes of Health.	Besouw M, 2007, MOL GENET METAB, V91, P228, DOI 10.1016/j.ymgme.2007.04.002; Bishop FS, 2007, J NEUROSURG, V106, P222, DOI 10.3171/ped.2007.106.3.222; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; JOHNSEN DE, 1991, NEURORADIOLOGY, V33, P181, DOI 10.1007/BF00588265; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Menkes J H, 2001, Eur J Paediatr Neurol, V5, P175, DOI 10.1053/ejpn.2001.0500; Mitchison HM, 2001, CURR OPIN NEUROL, V14, P795, DOI 10.1097/00019052-200112000-00019; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Nassogne MC, 2002, CHILD NERV SYST, V18, P729, DOI 10.1007/s00381-002-0630-z; Phadke S, 2007, J CLIN ULTRASOUND, V35, P347, DOI 10.1002/jcu.20264; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; Russell-Eggitt IM, 2000, J ROY SOC MED, V93, P591, DOI 10.1177/014107680009301110; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; VANHANEN SL, 1995, J CHILD NEUROL, V10, P444, DOI 10.1177/088307389501000604; VANHANEN SL, 1995, J CHILD NEUROL, V10, P438, DOI 10.1177/088307389501000603; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wisniewski KE, 2001, NEUROLOGY, V57, P576, DOI 10.1212/WNL.57.4.576; Worgall S, 2007, NEUROLOGY, V69, P521, DOI 10.1212/01.wnl.0000267885.47092.40; Zhang ZJ, 2001, NAT MED, V7, P478, DOI 10.1038/86554	22	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0003-9942	1538-3687		ARCH NEUROL-CHICAGO	Arch. Neurol.	DEC	2009	66	12					1567	1571					5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529YB	WOS:000272554200021	20008666	Green Accepted, Bronze			2022-02-06	
J	Podberesky, DJ; Unsell, BJ; Anton, CG				Podberesky, Daniel J.; Unsell, Bryan J.; Anton, Christopher G.			Imaging of American football injuries in children	PEDIATRIC RADIOLOGY			English	Article						Football; Sports injuries; Pediatric	HIGH-SCHOOL SPORTS; RADIOGRAPHIC ABNORMALITIES; SPINE INJURIES; EPIDEMIOLOGY; CONCUSSION; RISK	It is estimated that 3.2 million children ages 6 to 14 years participated in organized youth football in the United States in 2007. Approximately 240,000 children play football in the nation's largest youth football organization, with tackle divisions starting at age 5 years. The number of children playing unsupervised football is much higher, and the overall number of children participating in American football is increasing. Sports are the leading cause of injury-related emergency room visits for teenagers, and football is a leading precipitating athletic activity for these visits. Football is also the most hazardous organized sports in the United States. Though most pediatric football-related injuries are minor, such as abrasions, sprains, and strains of the extremities, football accounts for more major and catastrophic injuries than any other sport. Given football's popularity with children in the United States, combined with the high rate of injury associated with participation in this activity, radiologists should be familiar with the imaging features and injury patterns seen in this patient population.	[Podberesky, Daniel J.; Anton, Christopher G.] Cincinnati Childrens Hosp, Dept Radiol, Med Ctr, Cincinnati, OH 45229 USA; [Unsell, Bryan J.] Wilford Hall USAF Med Ctr, Dept Radiol, San Antonio, TX 78236 USA		Podberesky, DJ (corresponding author), Cincinnati Childrens Hosp, Dept Radiol, Med Ctr, 3333 Burnet Ave,MLC 5031, Cincinnati, OH 45229 USA.	daniel.podberesky@cchmc.org	Podberesky, Daniel/AAS-6572-2020				Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Burroughs KE, 2000, ARCH FAM MED, V9, P1122, DOI 10.1001/archfami.9.10.1122; Caine D, 2006, BRIT J SPORT MED, V40, P749, DOI 10.1136/bjsm.2005.017822; Cantu RC, 1997, CLIN J SPORT MED, V7, P83, DOI 10.1097/00042752-199704000-00001; Chambers R B, 1979, Am J Sports Med, V7, P195, DOI 10.1177/036354657900700312; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Escobedo EM, 2007, AM J ROENTGENOL, V188, P193, DOI 10.2214/AJR.05.0277; Frelinger D P, 1978, J Am Coll Health Assoc, V26, P217; Garry JP, 1998, J FAM PRACTICE, V47, P145; Gill SS, 2008, SPORTS MED ARTHROSC, V16, P2, DOI 10.1097/JSA.0b013e31816293e9; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Goldhaber Gerald M., 1993, Journal of Athletic Training, V28, P306; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Herman Martin J, 2006, Instr Course Lect, V55, P641; HUTCHINSON MR, 2000, COMMON SPORTS INJURI; Iwamoto J, 2004, AM J SPORT MED, V32, P781, DOI 10.1177/0363546503261721; KRAUS JF, 1984, ANNU REV PUBL HEALTH, V5, P163; Laor T, 2006, AM J ROENTGENOL, V186, P1260, DOI 10.2214/AJR.04.1606; Lawrence D W, 1997, J La State Med Soc, V149, P27; MAKI DG, 1982, AM J SPORT MED, V10, P162, DOI 10.1177/036354658201000308; Marker LB, 1996, BRIT J SPORT MED, V30, P71, DOI 10.1136/bjsm.30.1.71; Metzl JD, 1999, PEDIATR EMERG CARE, V15, P363, DOI 10.1097/00006565-199910000-00018; Molsa JJ, 1999, INT J SPORTS MED, V20, P64, DOI 10.1055/s-2007-971095; MUELLER FO, 1986, PHYSICIAN SPORTSMED, V14, P139, DOI 10.1080/00913847.1986.11709202; MUELLER FO, 2006, 24 U N CAR INJ PREV; *NAT FED STAT HIGH, 2006 2007 HIGH SCH A; *NAT RECR PARKS AS, 2008, YOUTH FOOTB IN; *P WARN LITTL SCH, 2009, FOOTB OV; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; PORUBSKY GL, 1986, AM J SPORT MED, V14, P170, DOI 10.1177/036354658601400215; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; Rome E S, 1995, Pediatr Rev, V16, P184, DOI 10.1542/pir.16-5-184; ROSENBERG HK, 1991, AM J ROENTGENOL, V157, P119, DOI 10.2214/ajr.157.1.2048509; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; Stuart Michael J, 2005, Med Sport Sci, V49, P62, DOI 10.1159/000085392; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; Wan J, 2003, J UROLOGY, V170, P1528, DOI 10.1097/01.ju.0000083999.16060.ff; Wasudev NP, 2005, SEMIN MUSCULOSKEL R, V9, P302, DOI 10.1055/s-2005-923376; Yu JS, 2002, SKELETAL RADIOL, V31, P396, DOI 10.1007/s00256-002-0513-0; ZOCH TW, 1996, WIS MED J, V8, P570; 2009, NIGHTLY NEWS    0414	44	5	5	2	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	DEC	2009	39	12					1264	1274		10.1007/s00247-009-1359-6			11	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	519AA	WOS:000271736200002	19774374				2022-02-06	
J	Veevers, AE; Lawler, W; Rutty, GN				Veevers, Abigail E.; Lawler, William; Rutty, Guy N.			Walk and Die: An Unusual Presentation of Head Injury	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; head injury; walk and die; talk and deteriorate; second impact syndrome; posttraumatic apnea; postexercise peril	2ND IMPACT SYNDROME; CONCUSSION; STRESS; TRAUMA; DEATH; TALK	We report three deaths in young adult males following closed blunt trauma to the head and face where the affected individuals were able to walk away from the incident, before subsequently collapsing and dying a short distance from the site of the assault. In each case, due to the rapidity of the posttrauma collapse, the pathologist was faced with a diagnostic difficulty at autopsy; the external examination revealed multiple injuries to the head and face, but internal examinations showed limited findings with no structural explanation for the death. We discuss possible mechanisms that could account for this scenario, the implications of alcohol consumption with a concussive head injury, and parallels that can be drawn with the so-called "talk and die,'' "talk and deteriorate,'' and "second impact syndrome.'' Finally, the possible role of so-called "postexercise peril'' is discussed in relation to these deaths.	[Rutty, Guy N.] Univ Leicester, Leicester Royal Infirm, E Midlands Forens Pathol Unit, Leicester LE2 7LX, Leics, England; [Veevers, Abigail E.] St Lukes Hosp, Bradford BD5 0NA, W Yorkshire, England; [Lawler, William] Dyke Farm, Penrith CA10 3TA, Cumbria, England		Rutty, GN (corresponding author), Univ Leicester, Leicester Royal Infirm, E Midlands Forens Pathol Unit, Robert Kilpatrick Bldg, Leicester LE2 7LX, Leics, England.	gnr3@le.ac.uk					BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CEBELIN MS, 1980, HUM PATHOL, V11, P123, DOI 10.1016/S0046-8177(80)80129-8; DIMSDALE JE, 1984, JAMA-J AM MED ASSOC, V251, P630, DOI 10.1001/jama.251.5.630; ENGEL GL, 1971, ANN INTERN MED, V74, P771, DOI 10.7326/0003-4819-74-5-771; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; ISAYAMA K, 1989, Neurosurgical Review, V12, P446, DOI 10.1007/BF01790689; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kolar A J O, 2008, J Forensic Leg Med, V15, P185, DOI 10.1016/j.jflm.2007.09.002; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Milovanovic AV, 1999, AM J FOREN MED PATH, V20, P6, DOI 10.1097/00000433-199903000-00002; RAMSAY DA, 1995, AM J FOREN MED PATH, V16, P107, DOI 10.1097/00000433-199506000-00004; Ratanalert S, 2002, J CLIN NEUROSCI, V9, P640, DOI 10.1054/jocn.2002.1085; REILLY PL, 1975, LANCET, V2, P375; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	17	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	NOV	2009	54	6					1466	1469		10.1111/j.1556-4029.2009.01201.x			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	509ZS	WOS:000271058400043	19840206				2022-02-06	
J	Astarci, P; Lacroix, V; Glineur, D; Poncelet, A; Rubay, J; El Khoury, G; Noirhomme, P; Verhels, R				Astarci, P.; Lacroix, V.; Glineur, D.; Poncelet, A.; Rubay, J.; El Khoury, G.; Noirhomme, P.; Verhels, R.			Endovascular Treatment of Acute Aortic Isthmic Rupture: Concerning Midterm Results	ANNALS OF VASCULAR SURGERY			English	Article							THORACIC AORTA; REPAIR; INJURY	Background: We evaluated midterm results of endovascular management of traumatic aortic isthmic ruptures. Methods: Between 2001 and 2008, 10 patients (sevenmales, mean age 38 years) underwent endovascular treatment of an acute aortic rupture. Eight procedures were emergent, with four cases of hemodynamic instability with Glasgow scores of 3, 5, and 7. Associated traumas were severe brain, liver, and pelvic bone injuries. All procedures were performed with transoesophageal echocardiography monitoring. We used two AneuRx and nine Medtronic Talent or Valiant stent grafts. Results: All patients survived their traumatic isthmic rupture. In nine patients, stent-graft deployment was successful. One patient experienced a distal migration needing a laparotomy and deployment of an additional new thoracic stent graft. The mean intensive care unit stay was 48 hr (range 24-168). The mean hospital stay was 11 days (range 8-43). All patients were controlled clinically and by contrast computed tomography (CT) according to the EUROSTAR protocol. There were no endoleaks, stent graft-related complications, or late deaths during a mean follow-up of 49 months. The control CT showed a lack of apposition of the proximal part of the stent graft at the inner curve of the aortic arch in three patients. Conclusion: The midterm results of endovascular treatment of acute traumatic aortic isthmic rupture are encouraging and compare favorably to the surgical approach. Late follow-up is required to exclude possible stent-graft complications, especially in young patients with angulated aortic arches.	[Astarci, P.; Lacroix, V.; Glineur, D.; Poncelet, A.; Rubay, J.; El Khoury, G.; Noirhomme, P.; Verhels, R.] St Luc Univ Hosp, Dept Cardiovasc Surg, B-1200 Brussels, Belgium		Astarci, P (corresponding author), St Luc Univ Hosp, Dept Cardiovasc Surg, Ave Hippocrate 10-6107, B-1200 Brussels, Belgium.	parla.astarci@chir.ucl.ac.be					BART EM, 2007, J VASC SURG, V45, P655; Canaud L, 2008, J VASC SURG, V47, P733, DOI 10.1016/j.jvs.2007.12.008; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Ferring M, 1999, INTENS CARE MED, V25, P1006, DOI 10.1007/s001340050997; Hoornweg LL, 2006, J VASC SURG, V43, P1096, DOI 10.1016/j.jvs.2006.01.034; Neschis DG, 2007, J VASC SURG, V45, P487, DOI 10.1016/j.jvs.2006.11.038; Orend KH, 2003, J VASC SURG, V37, P91, DOI 10.1067/mva.2003.69; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Reed AB, 2006, J VASC SURG, V43, P684, DOI 10.1016/j.jvs.2005.12.006; Rousseau H, 2000, CIRCULATION, V101, pE96; Volodos N L, 1991, Vasa Suppl, V33, P93; VONOPPELL UO, 1994, ANN THORAC SURG, V58, P585, DOI 10.1016/0003-4975(94)92270-5	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096			ANN VASC SURG	Ann. Vasc. Surg.	SEP-OCT	2009	23	5					634	638		10.1016/j.avsg.2009.03.001			5	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	492OV	WOS:000269669100013	19467828				2022-02-06	
J	Berg, B; Walker, RA; Murray, WB; Boedeker, BH				Berg, Benjamin; Walker, Richard A.; Murray, W. Bosseau; Boedeker, Ben H.			Airway Intubation in a Helicopter Cabin: Video vs. Direct Laryngoscopy in Manikins	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article						resuscitation; simulation; aviation; evacuation; technology; critical care; laryngoscope; pre-hospital; video laryngoscope; intubation; aeromedical	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; TRACHEAL INTUBATION	BERG B, WALKER RA, MURRAY WB, BOEDEKER BH. Airway intubation in a helicopter cabin: video vs. direct laryngoscopy in manikins. Aviat Space Environ Med 2009; 80:820-3. Introduction: Airway management may be required during medical evacuation in a helicopter when patients deteriorate en route. Laryngoscopist positioning at the head of the patient may not be possible, making it difficult to perform direct laryngoscopy (DIR). An alternative method is video laryngoscopy (VID) that displays magnified images of the glottic opening on a video monitor and allows intubation despite nonstandard positioning. Methods: There were 21 experienced aeromedical emergency medical personnel who intubated a recumbent manikin with the operator seated at the head of a secured helicopter stretcher in a power-off helicopter. Each subject performed intubations using DIR and VID in standard- and difficult-airway manikins (STD and DIF, respectively). Data were collected for subjective glottic visualization grades, intubation times, and intubation success rates. Results: Visualization grades were 2.43 +/- 0.81 for STD-DIR and 1.10 +/- 0.30 for STD-VID, compared to 1.76 +/- 0.54 for DIF-DIR and 3.72 +/- 0.57 for DIF-VID. Success rates were 95% for both STD-DIR and STD-VID, 5%, for DIF-DIR and 95%, DIF-VID. Mean intubation time for DIF-VID was 0.90 min +/- 0.80 min, not different from STD-DIR. Discussion: The success rate for difficult airway intubation by aeromedical personnel in a power-off evacuation helicopter was significantly improved by enhancing glottic visualization using VID vs. DIR in a manikin.	[Berg, Benjamin] Univ Hawaii, Telehlth Res Inst, John A Burns Sch Med, Honolulu, HI 96813 USA; [Walker, Richard A.] Univ Nebraska Med Ctr, Dept Emergency Med, Omaha, NE USA; [Boedeker, Ben H.] Univ Nebraska Med Ctr, Ctr Adv Technol & Telemed, Omaha, NE USA; [Murray, W. Bosseau] Penn State Univ, Simulat Dev & Cognit Sci Lab, Coll Med, Hershey, PA USA		Berg, B (corresponding author), Univ Hawaii, Telehlth Res Inst, John A Burns Sch Med, 651 Ilalo St, Honolulu, HI 96813 USA.	bwberg@hawaii.edu	Berg, Benjamin/AAL-3277-2021		U.S. Army Telemedicine and Advanced Technology Research Center Award, Ft. Detrick, MD [W81XWH-06-1-0019]	This research was supported by the U.S. Army Telemedicine and Advanced Technology Research Center Award # W81XWH-06-1-0019, Ft. Detrick, MD.	Boedeker B, 2007, STUD HEALTH TECHNOL, V125, P49; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Deakin CD, 2000, BRIT MED J, V320, P1006; Frakes Michael A, 2004, Air Med J, V23, P37, DOI 10.1016/j.amj.2004.02.016; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Kaplan MB, 2002, J CLIN ANESTH, V14, P620, DOI 10.1016/S0952-8180(02)00457-9; Low D, 2008, ANAESTHESIA, V63, P195, DOI 10.1111/j.1365-2044.2007.05323.x; Maharaj CH, 2006, ANAESTHESIA, V61, P671, DOI 10.1111/j.1365-2044.2006.04653.x; Marrel J, 2007, EUR J ANAESTH, V24, P1045, DOI 10.1017/S0265021507000889; Robinson Kenneth, 2004, Air Med J, V23, P40, DOI 10.1016/j.amj.2003.10.007; Slagt C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.06.004; Stone C K, 1994, Air Med J, V13, P319, DOI 10.1016/S1067-991X(05)80337-2; Thomas S H, 1996, Air Med J, V15, P65, DOI 10.1016/S1067-991X(96)90003-6; Thomas S H, 1999, Prehosp Emerg Care, V3, P310, DOI 10.1080/10903129908958960; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Woollard M, 2008, ANAESTHESIA, V63, P26, DOI 10.1111/j.1365-2044.2007.05263.x	20	5	5	0	1	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562			AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	SEP	2009	80	9					820	823		10.3357/ASEM.2492.2009			4	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	488FD	WOS:000269333700009	19750881				2022-02-06	
J	Loro, WA; Owens, B				Loro, William A.; Owens, Brett			Unilateral Hypoglossal Nerve Injury in a Collegiate Wrestler: A Case Report	JOURNAL OF ATHLETIC TRAINING			English	Article						twelfth cranial nerve; tongue paralysis; dysarthria; dysphagia	OF-THE-LITERATURE; OCCIPITAL CONDYLE; PALSY; SYRINGOMYELIA; FRACTURE; TONGUE	Objective: To introduce the case of a collegiate wrestler who suffered a traumatic unilateral hypoglossal nerve injury. This case presents the opportunity to discuss the diagnosis and treatment of a 20-year-old man with an injury to his right hypoglossal nerve. Background: Injuries to the hypoglossal nerve (cranial nerve XII) are rare. Most reported cases are the result of malignancy, with traumatic causes less common. In this case, a collegiate wrestler struck his head on the wrestling mat during practice. No loss of consciousness occurred. The wrestler initially demonstrated signs and symptoms of a mild concussion, with dizziness and a headache. These concussion symptoms cleared quickly, but the athlete complained of difficulty swallowing (dysphagia) and demonstrated slurred speech (dysarthria). Also, his tongue deviated toward the right. No other neurologic deficits were observed. Differential Diagnosis: Occipital-cervical junction fracture, syringomyelia, malignancy, iatrogenic causes, cranial nerve injury. Treatment: After initial injury recognition, the athletic trainer placed the patient in a cervical collar and transported him to the emergency department. The patient received prednisone, and the emergency medicine physician ordered cervical spine plain radiographs, brain computed tomography, and brain and internal auditory canal magnetic resonance imaging. The physician consulted a neurologist, who managed the patient conservatively, with rest and no contact activity. The neurologist allowed the patient to participate in wrestling 7 months after injury. Uniqueness: To our knowledge, no other reports of unilateral hypoglossal nerve injury from relatively low-energy trauma (including athletics) exist. Conclusions: Hypoglossal nerve injury should be considered in individuals with head injury who experience dysphagia and dysarthria. Athletes with head injuries require cranial nerve assessments.	[Loro, William A.] US Army, Med Dept Ctr & Sch, Ft Sam Houston, TX 78234 USA; [Owens, Brett] William Beaumont Army Med Ctr, El Paso, TX 79920 USA		Loro, WA (corresponding author), US Army, Med Dept Ctr & Sch, 3151 Scott Rd,Suite 1303, Ft Sam Houston, TX 78234 USA.	william.loro@us.army.mil					Aulino JM, 2005, EMERG RADIOL, V11, P342, DOI 10.1007/s10140-005-0425-0; Brodbelt AR, 2003, ACTA NEUROCHIR, V145, P707, DOI 10.1007/s00701-003-0071-9; CASTLING B, 1995, BRIT J ORAL MAX SURG, V33, P171, DOI 10.1016/0266-4356(95)90292-9; Chugh S, 2006, CAN J NEUROL SCI, V33, P322, DOI 10.1017/S0317167100005229; Cirak B, 2000, NEUROSURG REV, V23, P161, DOI 10.1007/PL00011949; Delamont R S, 1989, Clin Exp Neurol, V26, P239; Demisch S, 1998, CLIN NEUROL NEUROSUR, V100, P44, DOI 10.1016/S0303-8467(97)00111-X; Hong JT, 2006, J NEUROSURG-SPINE, V5, P83, DOI 10.3171/spi.2006.5.1.83; Hudson BR, 2008, J MAN MANIP THER, V16, P82, DOI 10.1179/106698108790818512; KACKER A, 1995, J LARYNGOL OTOL, V109, P770, DOI 10.1017/S0022215100131275; Keane JR, 1996, ARCH NEUROL-CHICAGO, V53, P561, DOI 10.1001/archneur.1996.00550060105023; KENRICK MM, 1977, ARCH PHYS MED REHAB, V58, P578; Klekamp J, 2002, ACTA NEUROCHIR, V144, P649, DOI 10.1007/s00701-002-0944-3; Kuitwaard K, 2005, SURG NEUROL, V64, P525, DOI 10.1016/j.surneu.2005.04.032; Oliaro S, 2001, J ATHL TRAINING, V36, P257; PALEY MD, 1995, BRIT J ORAL MAX SURG, V33, P239, DOI 10.1016/0266-4356(95)90008-X; Schurch B, 1996, J NEUROL NEUROSUR PS, V60, P61, DOI 10.1136/jnnp.60.1.61	17	5	5	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2009	44	5					534	537		10.4085/1062-6050-44.5.534			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	499SP	WOS:000270246100014	19771294	Bronze, Green Published			2022-02-06	
J	McClure, J; Abbott, J				McClure, John; Abbott, Joanne			How Normative Information Shapes Attributions for the Actions of Persons With Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; attributions; misattributions; normative information; premorbid behaviour; rehabilitation	MISCONCEPTIONS; BEHAVIOR	Many citizens misunderstand the actions of persons with brain injury, and these misunderstandings hamper rehabilitation. A specific misunderstanding is where people misattribute behaviours resulting from brain injury to the injured person's personality or life stage (e.g., adolescence). The present study examined if this pattern is explained by the Abnormal Conditions Focus model of attribution, which claims that attributions for behaviours reflect whether the behaviours are normal for the person (Consistency) and the culture (Consensus). Scenarios described an adolescent with brain injury performing four undesirable behaviours and then indicated whether the behaviour was normal or not normal for the person prior to injury and normal or not normal for that person's culture. For each of the four behaviours, students (n = 136) rated three attributions: brain injury, personality and adolescent norms. Participants attributed the behaviours more to brain injury and less to personality when the behaviours were not normal for that person than when they were normal for the person. They attributed the behaviours more to adolescence when the behaviours were normal for the person's culture than when they were not normal for the culture. Rehabilitation implications include assessing individuals' premorbid behaviour to enable citizens and less experienced professionals to make more accurate attributions for behaviours and target treatment more effectively.	[McClure, John] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand		McClure, J (corresponding author), Victoria Univ Wellington, Sch Psychol, POB 600, Wellington, New Zealand.	john.mcclure@vuw.ac.nz	McClure, John/O-9060-2015	McClure, John/0000-0002-9261-4995			Gouvier W. D., 1988, ARCH CLIN NEUROPSYCH, V3, P331; GRIFFITHS K, 1997, GUIDE UNDERSTANDING; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hastings RP, 1995, J INTELL DISABIL RES, V39, P474, DOI 10.1111/j.1365-2788.1995.tb00567.x; HILTON DJ, 1986, PSYCHOL REV, V93, P75, DOI 10.1037/0033-295X.93.1.75; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; LEVY B, 2000, J MENTAL HLTH AGING, V6, P213; MANCHESTER D, 2005, 6 WORLD C BRAIN INJ; Matthews C., 2000, HDB COMMUNICATION PE; McClure J, 1998, J PERS SOC PSYCHOL, V74, P7, DOI 10.1037/0022-3514.74.1.7; MCCLURE J, 2008, SOCIAL PSYCHOL UNPUB; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; MILLER NB, 1999, PEOPLE NONVISIBLE DI; OSBORN CL, 1998, OVER MY HEAD DOCTORS; Redpath SJ, 2004, BRAIN INJURY, V18, P861, DOI 10.1080/02699050410001671838; Stanley B, 2000, BRIT J CLIN PSYCHOL, V39, P157, DOI 10.1348/014466500163185; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; [No title captured]	22	5	5	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2009	10	2					180	187		10.1375/brim.10.2.180			8	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	488UR	WOS:000269376200004					2022-02-06	
J	Foy, K; Murphy, KC				Foy, Kevin; Murphy, Kieran C.			Post-concussion syndrome	BRITISH JOURNAL OF HOSPITAL MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD TRAUMA; POSTCONCUSSION SYNDROME; SYMPTOMS; QUESTIONNAIRE; TOMOGRAPHY	Post-concussion syndrome is common after head injury. it consists of a triad of physical, cognitive and psychological symptoms that occur after a head trauma and cause significant social and occupational disability. This article examines the clinical features, epidemiology, aetiology and treatment of the condition.	[Murphy, Kieran C.] Beaumont Hosp, Dept Psychiat, Dublin 9, Ireland				Murphy, Kieran C/D-3577-2012	Murphy, Kieran/0000-0003-2930-4465			Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Gaetz M, 2000, BRAIN INJURY, V14, P815; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lishman W., 1997, ORGANIC PSYCHIAT PSY; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; [No title captured]	30	5	6	0	7	MA HEALTHCARE LTD	LONDON	ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND	1750-8460	1759-7390		BRIT J HOSP MED	Br. J. Hosp. Med.	AUG	2009	70	8					440	443		10.12968/hmed.2009.70.8.43536			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	495PY	WOS:000269907400013	19684532				2022-02-06	
J	Ashioti, M; Beech, JS; Lowe, AS; Bernanos, M; McCreary, A; Modo, MM; Williams, SCR				Ashioti, Maria; Beech, John S.; Lowe, Andrew S.; Bernanos, Michel; McCreary, Andrew; Modo, Michel M.; Williams, Steve C. R.			Neither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT(1A) agonist in rat models of ischaemic stroke	BMC NEUROSCIENCE			English	Article							5-HT1A RECEPTOR AGONIST; BAY X 3702; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; INFARCT VOLUME; RODENT MODELS; REPINOTAN HCL; MK-801; DAMAGE	Background: 5HT(1A) agonists have previously been shown to promote recovery in animal models of stroke using ex vivo outcome measures which have raised the hopes for a potential clinical implementation. The purpose of this study was to evaluate the potential neuroprotective properties of a novel 5HT(1A) agonist DU123015 in 2 different models of transient focal ischaemic stroke of varying severities using both in vivo neuroimaging and behavioural techniques as primary outcome measures. For these studies, the NMDA receptor antagonist MK-801 was also utilized as a positive control to further assess the effectiveness of the stroke models and techniques used. Results: In contrast to MK-801, no significant therapeutic effect of DU123015 on lesion volume in either the distal MCAo or intraluminal thread model of stroke was found. MK-801 significantly reduced lesion volume in both models; the mild distal MCAo condition (60 min ischaemia) and the intraluminal thread model, although it had no significant impact upon the lesion size in the severe distal MCAo condition (120 min ischaemia). These therapeutic effects on lesion size were mirrored on a behavioural test for sensory neglect and neurological deficit score in the intraluminal thread model. Conclusion: This study highlights the need for a thorough experimental design to test novel neuroprotective compounds in experimental stroke investigations incorporating: a positive reference compound, different models of focal ischaemia, varying the duration of ischaemia, and objective in vivo assessments within a single study. This procedure will help us to minimise the translation of less efficacious compounds.	[Ashioti, Maria; Lowe, Andrew S.; Bernanos, Michel; Modo, Michel M.; Williams, Steve C. R.] Kings Coll London, Inst Psychiat, Neuroimaging Res Grp, London SE5 8AF, England; [Beech, John S.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [McCreary, Andrew] Solvay Pharmaceut, NL-1381 CP Weesp, Netherlands		Ashioti, M (corresponding author), Kings Coll London, Inst Psychiat, Neuroimaging Res Grp, Clin Neurosci PO42,Crespigny Pk,Denmark Hill, London SE5 8AF, England.	m.ashioti@iop.kcl.ac.uk; jsb36@cam.ac.uk; andrew.lowe@kcl.ac.uk; michel.bernanos@kcl.ac.uk; Andrew.Mccreary@solvay.com; mike.modo@kcl.ac.uk; steven.williams@kcl.ac.uk	Lowe, Andrew S/J-4801-2013; Williams, Steve C/D-6979-2011	Lowe, Andrew S/0000-0001-6650-7486; Williams, Steve C/0000-0003-4299-1941; Mesquita, Michel/0000-0002-5594-5605; Modo, Michel/0000-0003-4436-735X; opoku, anita/0000-0001-7243-8157	Solvay PharmaceuticalsSolvay SA	This work was supported by Solvay Pharmaceuticals. The MR imaging spectrometer was provided by the University of London Intercollegiate Research Service scheme and was located at Queen Mary College London managed by Dr Alasdair Preston. We would also like to thank Dr Diana Cash for her assistance with surgery and operator blinding.	Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; Ashioti M, 2007, BRAIN RES, V1145, P177, DOI 10.1016/j.brainres.2007.01.111; BUCHAN AM, 1992, BRAIN RES, V574, P171, DOI 10.1016/0006-8993(92)90814-P; CHALMERS DT, 1991, BRAIN RES, V561, P51, DOI 10.1016/0006-8993(91)90748-K; DEVRY J, 1995, PSYCHOPHARMACOLOGY, V121, P1; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Farr TD, 2006, NEUROBIOL DIS, V23, P552, DOI 10.1016/j.nbd.2006.04.009; Feuerstein GZ, 2008, J CEREBR BLOOD F MET, V28, P217, DOI 10.1038/sj.jcbfm.9600516; Gerriets T, 2003, STROKE, V34, P2234, DOI 10.1161/01.STR.0000087171.34637.A9; Gorgulu A, 2000, ACTA NEUROCHIR, V142, P1287, DOI 10.1007/s007010070027; Harkany T, 2001, NEUROSCIENCE, V108, P629, DOI 10.1016/S0306-4522(01)00444-4; Herz RCG, 1998, EUR J PHARMACOL, V346, P159, DOI 10.1016/S0014-2999(98)00051-X; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Koizumi J, 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kukley M, 2001, NEUROSCIENCE, V107, P405, DOI 10.1016/S0306-4522(01)00369-4; Mauler F, 2001, BRAIN RES, V888, P150, DOI 10.1016/S0006-8993(00)03074-2; Mauler F, 2005, J CEREBR BLOOD F MET, V25, P451, DOI 10.1038/sj.jcbfm.9600038; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Moyanova SG, 2007, BRAIN RES, V1153, P58, DOI 10.1016/j.brainres.2007.03.070; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; PREHN JHM, 1991, EUR J PHARMACOL, V203, P213, DOI 10.1016/0014-2999(91)90717-5; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schaper C, 2000, BRAIN RES, V883, P41, DOI 10.1016/S0006-8993(00)02876-6; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Smart SC, 1996, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1996, P667; Suchanek B, 1998, EUR J PHARMACOL, V355, P95, DOI 10.1016/S0014-2999(98)00469-5; Teal P, 2005, CAN J NEUROL SCI, V32, P61, DOI 10.1017/S0317167100016899; Torup L, 2000, EUR J PHARMACOL, V395, P137, DOI 10.1016/S0014-2999(00)00175-8	33	5	5	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	JUL 16	2009	10								82	10.1186/1471-2202-10-82			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	480BA	WOS:000268705400001	19607699	Green Published, gold			2022-02-06	
J	Keskin, M; Beydes, T; Tosun, Z; Savaci, N				Keskin, Mustafa; Beydes, Tolga; Tosun, Zekeriya; Savaci, Nedim			Close Range Gun Shot Injuries of the Hand With the "Mole Gun"	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Gun shot; Hand; Mole; Posterior interosseous artery flap	POSTERIOR INTEROSSEOUS FLAP; GUNSHOT WOUNDS; RECONSTRUCTION	Introduction: A mole gun is a handmade weapon used as a trap to kill moles by farmers. Their action is based on a simple hammer mechanism: when the moles put their head through the metal ring to get hold of the food, they trigger the mechanism. The hammer strikes the primer, which ignites the gunpowder, propelling the pellets from the barrel. The purpose of this study was to report our experiences in a group of patients who accidentally suffered injuries by mole guns to the hand. Method: Since 2000, 20 patients had attended the clinic with mole gun shot injuries to the hand. Results: The mean age of patients was 38 years. Thirteen cases involved skin defects over the dorsum of the hand associated with extensor tendon and bone injuries. The skin defect was covered with posterior interosseous artery (PIA) flap in 12 cases. In one case, the PIA pedicle was found to be injured so radial forearm flap was used. The main intervention time for these cases was 6.2 days. All flaps except two PIA flap survived uneventfully. One flap was completely lost while other survived with distal necrosis. In remaining seven cases the thumb was the main injured part; it had complete disruption of its arterial supply and was managed with amputation with or without matarcarpal removal. These cases were managed immediately. Conclusion: The risk of injury to the PIA by pellets is low in such close range shots to the hand and PIA flap could be used to cover the defects. In such cases, initial debridement should be minimal and the soft tissue, tendon, and bone injury can be managed in the same stage during the first week of injury.	[Keskin, Mustafa; Beydes, Tolga; Tosun, Zekeriya; Savaci, Nedim] Selcuk Univ, Meram Med Sch, Dept Plast Surg, TR-42080 Konya, Turkey		Keskin, M (corresponding author), Selcuk Univ, Meram Tip Fak, Plast & Rekonstruktif Cerrahi AD, S Blok 211, TR-42080 Konya, Turkey.	drmkeskin@hotmail.com	Keskin, Mustafa/W-5938-2019	Keskin, Mustafa/0000-0003-2066-7454			Agir H, 2007, ANN PLAS SURG, V59, P291, DOI 10.1097/SAP.0b013e31802f8408; Al-Qattan MM, 2006, J HAND SURG-BRIT EUR, V31B, P178, DOI 10.1016/j.jhsb.2005.09.008; Bartlett CS, 2003, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000053164.71678.14; Brunelli F, 2001, ANN PLAS SURG, V47, P25, DOI 10.1097/00000637-200107000-00005; Costa H, 2001, BRIT J PLAST SURG, V54, P28, DOI 10.1054/bjps.2000.3472; Demirci S, 2008, INT J LEGAL MED, V122, P323, DOI 10.1007/s00414-007-0213-3; Ege A, 2003, ARCH ORTHOP TRAUM SU, V123, P323, DOI 10.1007/s00402-003-0540-X; FACKLER ML, 1992, J HAND SURG-AM, V17A, P971, DOI 10.1016/0363-5023(92)90481-4; Kiehn MW, 2005, PLAST RECONSTR SURG, V115, P478, DOI 10.1097/01.PRS.0000149537.88804.17; Komurcu M, 2008, INT ORTHOP, V32, P257, DOI 10.1007/s00264-006-0312-7; Kostakoglu N, 1997, ANN PLAS SURG, V39, P381, DOI 10.1097/00000637-199710000-00009; Rodrigues RL, 2006, ANN PLAS SURG, V56, P122, DOI 10.1097/01.sap.0000196414.70178.ff; Uner HB, 2001, FORENSIC SCI INT, V118, P83, DOI 10.1016/S0379-0738(00)00308-X; Wilson RH, 2003, CLIN ORTHOP RELAT R, P133, DOI 10.1097/01.blo.0000052642.74302.bd; Yilmaz R, 2007, J FORENSIC SCI, V52, P114, DOI 10.1111/j.1556-4029.2006.00326.x; ZANCOLLI EA, 1988, J HAND SURG-BRIT EUR, V13B, P130, DOI 10.1016/0266-7681(88)90121-0	16	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2009	67	1					139	142		10.1097/TA.0b013e318187acd8			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	470CZ	WOS:000267953100024	19590323				2022-02-06	
J	Mittal, R; Vermani, E; Tweedie, I; Nee, PA				Mittal, R.; Vermani, E.; Tweedie, I.; Nee, P. A.			Critical care in the emergency department: traumatic brain injury	EMERGENCY MEDICINE JOURNAL			English	Article							HEAD-INJURY	Head injury outcome is influenced by the initial insult and the various pathophysiological changes that take place in the posttraumatic phase, some of which may be amenable to intervention. Appropriate measures taken during initial emergency department management and subsequently in the intensive therapy unit can significantly improve outcome. The primary goal is to limit secondary brain injury. Early imaging, rather than admission and observation for neurological deterioration, reduces the time to the detection of life-threatening complications. This paper discusses the current management of severe head injury, some prognostic indicators and methods used to rule out an associated spinal injury.	[Nee, P. A.] Whiston Hosp, Dept Crit Care Med, Prescot L35 5DR, Merseyside, England; [Mittal, R.] Royal Liverpool Univ Hosp, Dept Emergency Med, Liverpool, Merseyside, England; [Vermani, E.] Univ Hosp, Dept Anaesthesiol, Liverpool, Merseyside, England; [Tweedie, I.] Walton Ctr Neurol & Neurosurg, Dept Crit Care Med, Liverpool, Merseyside, England		Nee, PA (corresponding author), Whiston Hosp, Dept Crit Care Med, Prescot L35 5DR, Merseyside, England.	patrick.nee@sthk.nhs.uk					Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Banerjee S, 2005, ANAEST INTENS CARE M, V6, P167, DOI 10.1383/anes.6.5.167.65036; *BRAIN TRAUM FDN, BRAIN TRAUM FDN GUID, V1103; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Edwards P, 2005, LANCET, V365, P1957; Girling K., 2004, CONTINUING ED ANAEST, V4, P52; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kirby D, 2005, ANAEST INTENS CARE M, V6, P162, DOI 10.1383/anes.6.5.162.65037; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MORRIS C, EVALUATION SPINAL IN; *NAT I HLTH CLIN E, GUID HEAD INJ TRIAG; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Oncel D, 2007, J TRAUMA, V63, P1010, DOI 10.1097/TA.0b013e318156ee64; WHITELEY SM, 2005, BRAIN INJURY NEUROLO, P223; Wyatt JP, 2006, OXFORD HDB EMERGENCY	17	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2009	26	7					513	517		10.1136/emj.2009.072041			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	461PJ	WOS:000267280000011	19546274				2022-02-06	
J	Durakbasa, O; Guneri, B				Durakbasa, Oguz; Guneri, Bulent			The volar surgical approach in complex dorsal metacarpophalangeal dislocations	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Dorsal metacarpophalangeal dislocation; Volar approach; Functional splint	JOINT; FINGER; CHILDREN; THUMB	Objective: To describe the surgical treatment of complex dorsal metacarpophalangeal dislocations, emphasising the volar approach. Methods: Seven cases of isolated, closed, complex dorsal metacarpophalangeal dislocation, treated surgically using the volar approach, were retrospectively evaluated. The median follow-up period was 91 months. Results: Five of the injuries involved children. The thumb was involved in four cases and the index finger in three. The volar plate was found to impede reduction in all cases. The operated joint was immobilised in a functional brace for a median of 3 weeks. At final follow-up (median 91 months), the metacarpophalangeal range of motion, grip power, stability and sensation were normal. Conclusions: Using the volar surgical approach, the strangulated metacarpal head can be directly visualised and the volar plate, which is longitudinally split for reduction, can be repaired. Reduction should be performed within the first day from injury. and the joint should be immobilised in a functional position no more than 3 weeks. (C) 2008 Elsevier Ltd. All rights reserved.	[Durakbasa, Oguz; Guneri, Bulent] Haydarpasa Numune Educ & Res Hosp, Orthopaed & Traumatol Dept, Istanbul, Turkey		Durakbasa, O (corresponding author), SOYAK Gokyuzu Konutlari, C Blok,D 45,Barbaros Mah,Karayollari Site Sok 5, TR-34662 Istanbul, Turkey.	odurakbasa@yahoo.com	Guneri, Bulent/C-3160-2019	Guneri, Bulent/0000-0002-1302-7531			ALQATTAN MM, 1994, J HAND SURG-BRIT EUR, V19B, P171, DOI 10.1016/0266-7681(94)90158-9; ANDERSEN JA, 1987, J HAND SURG-BRIT EUR, V12B, P264, DOI 10.1016/0266-7681(87)90029-5; BARRY K, 1998, J HAND SURG, V13, P466; BOHART PG, 1982, CLIN ORTHOP RELAT R, P208; DUTTON RO, 1982, CLIN ORTHOP RELAT R, P160; LIGHT TR, 1988, J PEDIATR ORTHOPED, V8, P300, DOI 10.1097/01241398-198805000-00009; Maheshwari R, 2007, J BONE JOINT SURG BR, V89B, P227, DOI 10.1302/0301-620X.89B2.18560; MAY JW, 1988, PLAST RECONSTR SURG, V82, P690, DOI 10.1097/00006534-198810000-00024; Mudgal Chaitanya S, 2006, Tech Hand Up Extrem Surg, V10, P31, DOI 10.1097/00130911-200603000-00006; Stiles Brendon M., 1997, Journal of Emergency Medicine, V15, P669, DOI 10.1016/S0736-4679(97)00146-7; Stowell JF, 2002, J EMERG MED, V23, P355, DOI 10.1016/S0736-4679(02)00567-X; VIEGAS SF, 1989, J TRAUMA, V29, P521, DOI 10.1097/00005373-198904000-00020	12	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JUN	2009	40	6					657	659		10.1016/j.injury.2008.10.027			3	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	456FA	WOS:000266825800016	19232591				2022-02-06	
J	Hillary, FG; Biswal, BB				Hillary, F. G.; Biswal, B. B.			Automated Detection and Quantification of Brain Lesions in Acute Traumatic Brain Injury Using MRI	BRAIN IMAGING AND BEHAVIOR			English	Article						TBI; Brain lesions; Automated; Quantification; Detection; Neurotrauma	MULTIPLE-SCLEROSIS; TISSUE CHARACTERIZATION; SEGMENTATION; MODEL; VALIDATION; STROKE; TRIALS; LOAD	The purpose of this study is to develop a reproducible method for quantifying brain lesions in traumatic brain injury (TBI). Quantifying the effects of neuropathology is an important goal in the study of brain injury and disease, yet examiners have encountered significant difficulty quantifying brain lesions in neurotrauma where there may exist multiple, overlapping forms of injury including large focal lesions and more subtle, diffuse hemorrhage and/or shear injury. In the current study, we used conventional MRI to quantify brain lesion volume at separate time points in individuals with severe TBI. We present an automated method (ISODATA) for quantifying brain lesions that is compared against a standard semi-automated volumetric approach. The ISODATA method makes no assumptions about the location or extent of brain lesions, instead identifying areas of neuropathology via voxelwise comparisons of MRI signal intensity. The data reveal that ISODATA overlaps significantly with a semi-automated approach, is reliable across multiple observations, and is sensitive to change in lesion size during recovery from TBI. This study validates a reproducible, automated lesion quantification method used here to determine the location and extent of brain pathology following TBI. This approach may be used in conjunction with advanced imaging techniques to characterize the relationship between brain lesions and neurometabolism and function.	[Biswal, B. B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA; [Hillary, F. G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Biswal, BB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, 185 S Orange Ave, Newark, NJ 07103 USA.	bbiswal@gmail.com	Hillary, Frank/AAN-8622-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD07522]; NIDRR [H133P970011]; Henry H. Kessler Foundation; Hyde & Watson Foundation, West Orange, Jersey	This research was supported in part by NIH grant HD07522, NIDRR grant H133P970011, and a grant from the Henry H. Kessler Foundation and the Hyde & Watson Foundation, West Orange, Jersey.	Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hasselblatt M, 2003, NEURORADIOLOGY, V45, P164, DOI 10.1007/s00234-002-0924-6; HILLARY FG, 2007, CLIN NEUROPSYCHOLOGI, V4; Itti L, 2001, J NEUROIMAGING, V11, P412, DOI 10.1111/j.1552-6569.2001.tb00071.x; Jacobs MA, 2001, STROKE, V32, P950, DOI 10.1161/01.STR.32.4.950; Jacobs MA, 2001, STROKE, V32, P943, DOI 10.1161/01.STR.32.4.943; Krings T, 2001, J NEUROL NEUROSUR PS, V70, P749, DOI 10.1136/jnnp.70.6.749; Mitsias PD, 2002, STROKE, V33, P2839, DOI 10.1161/01.STR.0000043072.76353.7C; Molyneux PD, 2000, MULT SCLER, V6, P237, DOI 10.1191/135245800678827798; Raff U, 2000, ACAD RADIOL, V7, P237, DOI 10.1016/S1076-6332(00)80473-0; Rovaris M, 1999, MAGN RESON IMAGING, V17, P1105, DOI 10.1016/S0730-725X(99)00068-5; Srivastava S, 2005, NEUROIMAGE, V27, P253, DOI 10.1016/j.neuroimage.2005.03.045; TEASDALE G, 1974, LANCET, V2, P81; Van Leemput K, 2001, IEEE T MED IMAGING, V20, P677, DOI 10.1109/42.938237; WHYTE J, 1998, REHABILITATION MED P, P1191; Xie K, 2005, EUR J RADIOL, V56, P12, DOI 10.1016/j.ejrad.2005.03.028; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	20	5	5	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2009	3	2					111	122		10.1007/s11682-008-9053-0			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	510LS	WOS:000271090600001					2022-02-06	
J	Karwat, ID; Krupa, S; Gorczyca, R				Karwat, Irena Dorota; Krupa, Szczepan; Gorczyca, Rafal			CAUSES AND CONSEQUENCES OF HEAD INJURIES AMONG RURAL INHABITANTS HOSPITALISED IN A MULTI-ORGAN INJURY WARD. II. CIRCUMSTANCES, TYPES AND CONSEQUENCES OF HEAD INJURIES	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						head injuries; rural inhabitants; circumstances; types; consequences		The scope of problems concerning head injuries was investigated among rural patients, compared to urban population, From the aspect of their incidence ill both populations, as well as,in attempt to perform a multi-variable analysis of socio-demographic and geographical risk factors for each of the analysed traits concerning the injury. The, study group were patients treated in the Multi-Organ Injury Ward, at Cardinal Stefan Wyszyfiski Regional Hospital in Lublin during the period 1999-2002. The study covered 265 patients. The group of rural inhabitants covered 34% of the total population in the Study. The Most frequent circumstances of the injury sustained, both among rural and urban patients, was a road accident with the patient either as a passenger or a pedestrian, observed in 30.6% of the total number of people ill the Study. Female gender was an injury risk factor. The second position among circumstances of injuries was occupied in both sub-populations by road accident with the patient as the driver - this concerned 23% of the total number of patients in the Study and the risk factors were: male gender, place of residence in rural area and better educational Status. The majority of patients Sustained an injury ill file Street, with similar frequency among rural and urban inhabitants. Rural patients, significantly more Often than urban inhabitants, sustained injuries at home and ill file Courtyard. The most frequent type of all injury sustained was cerebral concussion, which was noted twice as frequently among urban (59.9%) than rural inhabitants (31.1%). The risk factors of cerebral concussion were: urban place of residence, female gender, and younger age of a patient. Injuries of mesencephalon were placed in the second position with respect to the Frequency of occurrence, and more often concerned rural (46.7%) than urban (24.6%) patients. The risk factors for this injury were: living ill a rural area, and older age in males. Concomitant injuries were observed in 50% of rural patients and in 57.1% Of urban inhabitants. The consequences of injuries ill Various forms were observed in 87.8% of rural inhabitants, and in a similar percentage of urban patients. Age turned out to be the risk factor for the appearance of the negative consequences of the injury. This was also the risk factor of death during treatment, and in balance disorders.	[Karwat, Irena Dorota] Med Univ, Chair & Dept Epidemiol, Lublin, Poland; [Krupa, Szczepan] Cardinal Stefan Wyszynski Reg Specialist Hosp, Multiorgan Injury Ward, Lublin, Poland; [Gorczyca, Rafal] Inst Agr Med, Lublin, Poland		Karwat, ID (corresponding author), Chodzki 1, PL-20293 Lublin, Poland.	epidemiologia@umlub.pl					HALCZUK I, 2002, NOWA KLIN, V9, P765; KARWAT ID, 2000, NIEPELNOSPRAWNOSC PO; Karwat Irena Dorota, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P224; Kiwerski J., 2005, REHABILITACJA MEDYCZ; KOZIERKIEWICZ A, 2001, ZDROWIE WSZYSTKICH 2; KRUPA S, 2002, PROBLEMY REHABILITAC, V2, P127; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Watala C., 2002, BIOSTATYSTYKA WYKORZ; Wojtyniak B., 2003, SYTUACJA ZDROWOTNA L, P9; Zuckerman GB, 1997, PEDIATR ANN, V26, P621, DOI 10.3928/0090-4481-19971001-09; [No title captured]	11	5	5	0	5	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.	JUN	2009	16	1					23	29					7	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	470AK	WOS:000267943700004	19572474				2022-02-06	
J	Reddy, RP; Jamuna, N; Devi, BI; Thennarasu, K				Reddy, Rajakumari P.; Jamuna, N.; Devi, B. Indira; Thennarasu, K.			Neurofeedback training to enhance learning and memory in patient with traumatic brain injury: A single case study	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						head injury; neurofeedback; traumatic brain injury		Road traffic injuries are the leading cause (60%) of brain injury. It is estimated that India would occupy third position for Traumatic brain injury (TBI) by 2020. The most vulnerable group of population is the young adults for TBI. The purpose of the present study was to examine neurofeedback training (NFT) to enhance verbal and visual learning and memory in patients with traumatic brain injury (TBI). Single case pre-and post-intervention study was adopted. The neuropsychological profile of the patient was compared pre and post NFT. Patient with mild head-injury was given 20 sessions of NFT, 45 min / day, 5 days a week. The training incorporated video feedback to increase the frequency of alpha waves (8-12 Hz): and to decrease theta waves (4-7 Hz). The pre assessment showed impairment in verbal learning and memory. Results indicated improvement in both verbal and visual learning memory in patient post NFT. The present study puts forward that NFT should be taken into account to plan for rehabilitation of patients with TBI for enhancement of learning and memory.	[Reddy, Rajakumari P.; Jamuna, N.; Devi, B. Indira; Thennarasu, K.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 29, Karnataka, India; [Reddy, Rajakumari P.; Jamuna, N.; Devi, B. Indira; Thennarasu, K.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropsychol, Bangalore 29, Karnataka, India; [Reddy, Rajakumari P.; Jamuna, N.; Devi, B. Indira; Thennarasu, K.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biostat, Bangalore 29, Karnataka, India		Jamuna, N (corresponding author), NIMHANS, Dept Mental Hlth & Social Psychol, Bangalore 560029, Karnataka, India.	jamunarajan@nimhnas.kar.nic.in					Burgess A P, SHORT DURATION SYNCH; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hardt J. V., 1975, P BIOF RES SOC MONT, V6; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hoffman D. A., 1995, J NEUROTHERAPY, V1, P14, DOI [10.1300/ J184v01n01_03, DOI 10.1300/J184V01N01_03]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Kumar K., 1999, THESIS; MENKES JH, 1990, TXB CHILD NEUROLOGY; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Serino A, 2005, BRAIN INJURY, V22, P132; Thornton K, 2000, J HEAD TRAUMA REHAB, V15, P1285, DOI 10.1097/00001199-200012000-00008; Tunks E, 1991, BEHAV MED CONCEPTS P	16	5	5	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2009	6	1					87	90		10.1016/S0973-0508(09)80037-3			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0Y	WOS:000218379900019					2022-02-06	
J	Cobo, EP; Garcia-Alsina, J; Almazan, CG; Fandino, JO; Mesquida, MEP; Cano, LG; Pastor, BS; Pont, CP; Serra, EC; Matarrubias, C; Reveron, G				Pleguezuelos Cobo, Eulogio; Garcia-Alsina, Joan; Garcia Almazan, Concepcion; Ortiz Fandino, Javier; Perez Mesquida, M. Engracia; Guirao Cano, Lluis; Samitier Pastor, Beatriz; Perucho Pont, Cristina; Coll Serra, Estel; Matarrubias, Carlos; Reveron, Genoveva			Postural control disorders in initial phases of whiplash	MEDICINA CLINICA			Spanish	Article						Posturography; Whiplash; Dizziness; Rehabilitation; Romberg	NECK PAIN QUESTIONNAIRE; PERSISTENT WHIPLASH; SENSORY CONDITIONS; STANDING BALANCE; INJURY; STABILITY; DIZZINESS; HEAD	Background and objective: Dizziness of variable intensity is a frequent complaint in patients who suffered whiplash and largely documented balance disturbances. The objective of the study was to identify balance disorders in early stage of whiplash after road traffic accidents. Patients and method: Ninety nine women were included in the study. Fifty four women had suffered whiplash within two weeks and 45 were included in a healthy control group. Static posturography on a force platform was carried out in all study participants, by means of the Romberg test in four sequential phases, using the Postural sway area (SA) as a dependent variable. Visual Analogic Scale (VAS) and Northwick Park Neck Pain Questionnaire (NPH) were used to evaluate pain and function. Results: Postural sway area increased significantly in each of the consecutive phases in both groups. The differences of the means of the postural sway area were statistically significant in all Romberg phases (p = .009 to P = .000). No correlation was found between SA and VAS or NPH scores. There was a positive correlation between the postural sway area standing on a thick foam cushion placed over the plate with closed eyes and the number of days of transitory incapacity (r = 0.414; P = .009). Conclusions: Patients with recent whiplash show a postural control disturbance revealed trough a sequential static posturography analysis. This suggests that the balance disorder is not only a consequence of late whiplash syndrome evolution. Therefore, we should promote early instauration of a specific therapeutic approach if and when the patient refers dizziness and related symptoms. (C) 2008 Elsevier Espana, S.L. All rights reserved.	[Pleguezuelos Cobo, Eulogio; Garcia-Alsina, Joan; Garcia Almazan, Concepcion; Ortiz Fandino, Javier] INVALCOR, Lab Biomecan, Barcelona, Spain; [Pleguezuelos Cobo, Eulogio; Perez Mesquida, M. Engracia; Guirao Cano, Lluis; Samitier Pastor, Beatriz; Perucho Pont, Cristina; Coll Serra, Estel; Matarrubias, Carlos; Reveron, Genoveva] Hosp Mataro, Serv Med Fis & Rehabil, Barcelona, Spain; [Pleguezuelos Cobo, Eulogio] Univ Pompeu Fabra, Barcelona, Spain		Cobo, EP (corresponding author), INVALCOR, Lab Biomecan, Barcelona, Spain.	34260epc@comb.es	Pleguezuelos, Eulogio/D-9793-2015	Pleguezuelos, Eulogio/0000-0002-0982-2655			Baydal-Bertomeu J M, 2004, Acta Otorrinolaringol Esp, V55, P260; CARETTE S, 1994, NEW ENGL J MED, V330, P1083, DOI 10.1056/NEJM199404143301512; CHESTER JB, 1991, SPINE, V16, P716, DOI 10.1097/00007632-199107000-00004; Dehner C, 2008, GAIT POSTURE, V28, P113, DOI 10.1016/j.gaitpost.2007.10.007; Dickstein Ruth, 1993, Physiotherapy Canada, V45, P102; El-Kahky AM, 2000, ACTA OTO-LARYNGOL, V120, P508, DOI 10.1080/000164800750046018; Gimse R, 1997, J CLIN EXP NEUROPSYC, V19, P838, DOI 10.1080/01688639708403764; Goebel JA, 1997, OTOLARYNG HEAD NECK, V117, P293, DOI 10.1016/S0194-5998(97)70116-5; Gonzalez T, 2001, CLIN EXP RHEUMATOL, V19, P41; Gruber HE, 2007, SPINE, V32, P2529, DOI 10.1097/BRS.0b013e318158cd69; Huskisson E C, 1976, Rheumatol Rehabil, V15, P185; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Karlberg M, 1996, J VESTIBUL RES-EQUIL, V6, P37; Madeleine P, 2004, ARCH PHYS MED REHAB, V85, P432, DOI 10.1016/j.apmr.2003.03.003; Mallinson AI, 1998, AM J OTOL, V19, P814; Nashner L., 1993, HDB BALANCE FUNCTION, P308; OLLE C, ACTUALIZACION SINDRO, P121; Pleguezuelos E, 2008, MED CLIN-BARCELONA, V131, P211, DOI 10.1157/13124610; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; RUBIN AM, 1995, AM J OTOL, V16, P216; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; SCOTT PJ, 1977, RHEUMATOL REHABIL, V16, P257; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; SPITZER WO, 1995, SPINE, V20, pS1; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2005, GAIT POSTURE, V21, P395, DOI 10.1016/j.gaitpost.2004.04.008; VERNON H, 1994, BRIT J RHEUMATOL, V33, P1203	27	5	5	0	6	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0025-7753	1578-8989		MED CLIN-BARCELONA	Med. Clin.	MAY 2	2009	132	16					616	620		10.1016/j.medcli.2008.11.039			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445KY	WOS:000266050900002	19386326				2022-02-06	
J	Carver, MD				Carver, Mandi Doolin			Adaptive Equipment to Assist With One-Handed Intermittent Self-Catheterization: A Case Study of a Patient With Multiple Brain Injuries	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; self care; self-help devices; urinary catheterization	URINARY-INCONTINENCE; OLDER-ADULTS; DEVICES; REHABILITATION	Intermittent self-catheterization is common for patients who have neurogenic bladder associated with traumatic brain injury (TBI). Intermittent self-catheterization is considered the gold standard for bladder drainage because of the significantly decreased incidence of urinary tract infection in comparison with other catheterization methods. Occupational therapists educate patients in how to complete intermittent self-catheterization and assist them with adaptive equipment so that they may catheterize themselves independently, This case study describes adaptive equipment fabricated to allow a male patient with TBI who was independent with intermittent self-catheterization to continue independent intermittent self-catheterization after a second injury resulting in hemiplegia. Without the use of his left hand, the patient could not complete self-catheterization; therefore, a trough-shaped prop was fabricated to maintain the penis in an upright, lengthened position.	Rocky Mt Univ Hlth Profess, Mem Med Ctr, Springfield, IL 62781 USA		Carver, MD (corresponding author), Rocky Mt Univ Hlth Profess, Mem Med Ctr, 701 N 1st St, Springfield, IL 62781 USA.	carver.amanda@mhsil.com					Biering-Sorensen Fin, 2002, Curr Opin Urol, V12, P45; Birch C, 2005, BEST PRACT RES CL OB, V19, P979, DOI 10.1016/j.bpobgyn.2005.08.013; Chang JK, 2001, J BURN CARE REHABIL, V22, P90, DOI 10.1097/00004630-200101000-00021; Chiu CWY, 2004, OTJR-OCCUP PART HEAL, V24, P113, DOI 10.1177/153944920402400305; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Hadfield-Law L, 2001, Accid Emerg Nurs, V9, P257, DOI 10.1054/aaen.2001.0290; Hamid R, 2003, SPINAL CORD, V41, P286, DOI 10.1038/sj.sc.3101455; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Klinger L, 2001, TOP GERIATR REHABIL, V16, P34; Lewis JM, 2007, THESCIENTIFICWORLDJO, V7, P1230, DOI 10.1100/tsw.2007.178; Moiyadi AV, 2007, NEUROREHABILITATION, V22, P93; MOORE JL, 2006, J NEUROLOGIC PHYS TH, V30, P216; NETTINA S, 2005, LIPPINCOTT MANUAL NU; Newman DK, 2004, NURS RES, V53, pS42, DOI 10.1097/00006199-200411006-00007; PHAM HN, 1988, ANN PLAS SURG, V21, P180, DOI 10.1097/00000637-198808000-00017; PROMFRET I, 2007, BRIT J COMMUNITY NUR, V12, P348	16	5	5	0	2	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2009	63	3					333	336		10.5014/ajot.63.3.333			4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	445LM	WOS:000266052300013	19522142				2022-02-06	
J	Papadimas, GK; Rentzos, M; Zouvelou, V; Kilidireas, K; Konstantinopoulou, A; Kokotis, P; Evdokimidis, I				Papadimas, G. K.; Rentzos, M.; Zouvelou, V.; Kilidireas, K.; Konstantinopoulou, A.; Kokotis, P.; Evdokimidis, I.			Superficial Siderosis of Central Nervous System Mimicking Multiple Sclerosis	NEUROLOGIST			English	Article						multiple sclerosis; oligoclonal hands; superficial siderosis		Introduction: Superficial siderosis of the central nervous system is a neurologic disorder mainly characterized by cerebellar involvement, myelopathy, neurosensory hearing loss, and possibly progressive cognitive impairment. Root avulsion due to traumatic plexus injury has been recognized as an extremely rare cause of hemosiderin deposition oil leptomeninges and subpial layers of brain and spinal cord parenchyma. Case Report: A 49-year-old mail presented with progressively evolving ataxia and spastic paraparesis. CSF oligoclonal bands were indicative of an underlying inflammatory process and raised the possibility of a demyelinating disorder. However, spinal cord and brain MRI revealed hemosiderin deposition along the entire neuraxis. A rigorous electrophysiologic study confirmed a functional impairment in many different levels of the nervous system. Conclusion: The demonstration of CSF oligoclonal bands in the reported patient implies that inflammation might be involved in the pathogenesis of superficial siderosis. The diagnosis of this newly recognizable entity needs a high clinical suspicion, but further research is needed to fully elucidate the involved mechanisms.	[Papadimas, G. K.; Rentzos, M.; Zouvelou, V.; Kilidireas, K.; Konstantinopoulou, A.; Kokotis, P.; Evdokimidis, I.] Natl Tech Univ Athens, Sch Med, Dept Neurol, Aeginit Hosp, Athens, Greece		Papadimas, GK (corresponding author), Aeginit Hosp, Athens Med Sch, Dept Neurol, 72-74 Vas Sophias Av, Athens 11528, Greece.	gkpapad@yahoo.gr					Angstwurm K, 2002, J NEUROL, V249, P1223, DOI 10.1007/s00415-002-0815-0; Cohen-Gadol Aaron A, 2004, Neurosurg Focus, V16, pE10; DANIELE D, 1992, EUR NEUROL, V32, P270, DOI 10.1159/000116840; FEARNLEY JM, 1995, BRAIN, V118, P1051, DOI 10.1093/brain/118.4.1051; FISHMAN RA, 1993, ANN NEUROL, V34, P635, DOI 10.1002/ana.410340502; Kale SU, 2003, OTOL NEUROTOL, V24, P90, DOI 10.1097/00129492-200301000-00019; KOEPPEN AH, 1993, ANN NEUROL, V34, P646, DOI 10.1002/ana.410340505; Kumar N, 2006, NEUROLOGY, V66, P1144, DOI 10.1212/01.wnl.0000208510.76323.5b; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Shimo Y, 1998, No To Shinkei, V50, P361; Spengos K, 2007, CLIN NEUROL NEUROSUR, V109, P705, DOI 10.1016/j.clineuro.2007.04.015; van Harskamp NJ, 2005, BRAIN, V128, P1082, DOI 10.1093/brain/awh487	14	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	MAY	2009	15	3					153	155		10.1097/NRL.0b013e31818a5d3a			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	445DJ	WOS:000266029600008	19430272				2022-02-06	
J	Belanger, D				Belanger, D.			Traumatic brain injury and sexual rehabilitation	SEXOLOGIES			English	Article						Sexuality; Therapy; Traumatic brain injury; Rehabilitation; Disability		Objective. - This article describes the various consequences of a traumatic brain injury (TBI) on sexuality. The physical, cognitive, emotional, relational and social consequences of TBI, to which are added "secondary" conditions such as depression, anxiety and fatigue can all influence sexual function and behavior. Method. - A review of the clinical scientific literature along with our experience in a rehabilitation center served this analysis. Results. - The sequellae of a TBI, including the physical, cognitive and social consequences are described as the secondary conditions which can all contribute to the emergence and maintenance of sexual difficulties. Sexual dysfunctions affecting desire, arousal or orgasm can all appear. Disinhibition and hypersexuality are also reported and can become a social handicap for the patients and their surrounding. For those in couple, marital adjustment may become difficult. To overcome these difficulties, different therapeutic strategies can be offered and adapted according to the patient's capacity for introspection, planning and reflection. Our clinical experience leads us to favor the cognitive behavioral approach. The use of a logbook is encouraged to overcome concentration difficulties or memory problems, and the use of modeling, role playing, training with social and sexual habilities, basic sexual education and education on the specific impact of TBI on sexual function may be useful. Extinction of sexually inappropriate behaviors and reinforcement of appropriate behaviors are considered to overcome hypersexuality. Clinicians must be creative and patient. They must repeatedly verify the therapeutic gains and must repeat therapeutic advices. Discussion. - Sex therapy can offer a variety of therapeutic strategies to overcome sexual difficulties arising from TBI. Cognitive behavioral approaches prove useful as they are more directives and can help patients overcoming their sexual difficulties in addition to preventing these difficulties during early interventions. (C) 2009 Elsevier Masson SAS. All rights reserved.	[Belanger, D.] Inst Readaptat Deficience Phys Quebec, 525,Blvd Wilfrid Hamel, Montreal, PQ G1M 2S8, Canada		Belanger, D (corresponding author), Inst Readaptat Deficience Phys Quebec, 525,Blvd Wilfrid Hamel, Montreal, PQ G1M 2S8, Canada.	dany.belanger@irdpq.qc.ca					ABRAHAMSON P, 1997, BRAIN INJURY FAMILY; Anderson-Parente J, 1990, COGN REHABIL, P722; Barry Ruth K, 2000, COUNSELORS PERCEPTIO; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Britton KR, 1998, BRAIN INJURY, V12, P703, DOI 10.1080/026990598122269; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; EMORY LE, 1995, J HEAD TRAUMA REHAB, V10, P47; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Gosling J, 1999, BRAIN INJURY, V13, P785; Griffith ER, 1990, REHABILITATION ADULT, P206; Griffith ER, 1993, SEXUALITY PERSON TRA; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Johnson C, 2006, BRAIN INJURY, V20, P687, DOI 10.1080/02699050600744137; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Lehne GK, 1984, SEX DISABIL, V7, P145; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Limbert J., 1992, CAN J HUM SEX, V1, P187; Mazaux JM, 2002, ACT NEUR S, V79, P49; McLaughlin A. M., 1985, COGNITIVE REHABILITA, V3, P14; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Peters CL, 1990, BRAIN INJURY, V4, P39; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Prigatano GP, AWARENESS DEFICIT BR; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Webster G, 1999, BRAIN INJURY, V13, P593; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Zasler ND, 1991, SEX DISABIL, V9, P11; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163	41	5	5	0	0	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	1158-1360	1878-1829		SEXOLOGIES	Sexologies	APR-JUN	2009	18	2			SI		83	85		10.1016/j.sexol.2009.01.008			3	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	VD6DK	WOS:000437256900003					2022-02-06	
J	Raum, MR; Waydhas, C				Raum, M. R.; Waydhas, C.			Prehospital fluid resuscitation in trauma	NOTFALL & RETTUNGSMEDIZIN			German	Article						Fluid replacement therapy; Multiple trauma; Blood loss; Shock; Permissive hypotension	INFUSION SOLUTIONS; HEMORRHAGE; IMMEDIATE	The indications for and type and amount of fluid resuscitation for trauma patients in the field remains highly controversial. There is unanimity, however, that trauma victims may suffer from acute blood loss. In addition to stopping the bleeding fluid resuscitation is the second mainstay in shock therapy. The insertion of 1 or 2 large-bore i.v. lines is indicated for manifest or threatening shock. Patients without signs of bleeding or hemorrhagic shock do not require fluid replacement therapy. Blood losses from bleeding that has ceased or has been stopped by compression or self-tamponade should be substituted. In uncontrolled bleeding from intraabdominal, pelvic or other internal sources immediate transport to a trauma center is required. In such situations many experts favour a goal-oriented approach of permissive hypotension aiming at a systolic blood pressure of 70-90 mmHg. In patients with severe traumatic brain injury a goal-oriented fluid resuscitation (mean arterial blood pressure of 90 mmHg) is presently recommended. Additional doses of catecholamines may be needed. Crystalloids are the recommended choice of fluid. In the presence of a suspected blood loss of more than 2 L the additional administration of colloids is suggested. However, the impact of colloids and of hyperosmolar colloid solutions with regard to survival of traumatized patients has not yet been determined.	[Raum, M. R.] Univ Groningen, Univ Med Ctr Groningen, Klin Traumatol, NL-30001 Groningen, Netherlands; [Waydhas, C.] Univ Klinikum Essen, Essen, Germany		Raum, MR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Klin Traumatol, Hanzepl 1, NL-30001 Groningen, Netherlands.	m.r.raum@chir.umcg.nl					BANERJEE A, 1994, LANCET, V344, P1450, DOI 10.1016/S0140-6736(94)90283-6; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BUNN F., 2004, COCHRANE DATABASE SY; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; *COMM TRAUM, 2004, ADV TRAUM LIF SUPP A; Conte M A, 1997, CRNA, V8, P31; Druml W, 2005, WIEN KLIN WOCHENSCHR, V117, P67, DOI 10.1007/s00508-005-0319-x; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Healey MA, 1998, J TRAUMA, V45, P894, DOI 10.1097/00005373-199811000-00010; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Kreimeier U, 2002, ANAESTHESIST, V51, P787, DOI 10.1007/s00101-002-0398-2; Kwan I, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002245; Langeron O, 2001, ANESTH ANALG, V92, P855, DOI 10.1097/00000539-200104000-00011; Raum M, 2002, ANASTH INTENSIV NOTF, V37, P356, DOI 10.1055/s-2002-32241; RAUM MR, 2006, NOTFALL RETTUNGSMED, V5, P485; Roberts I, 2004, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858.CD000567.PUB2; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; Turner J, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4310	18	5	5	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	APR	2009	12	3					188	192		10.1007/s10049-009-1168-3			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	441MM	WOS:000265773300006					2022-02-06	
J	Reddy, P; Yeh, YC				Reddy, Prabashni; Yeh, Yu-Chen			Use of Injectable Nicardipine for Neurovascular Indications	PHARMACOTHERAPY			English	Article; Proceedings Paper	13th Annual International Meeting of the International-Society-of-Pharmacoeconomics-and-Outcomes-Research	MAY 03-07, 2008	Toronto, CANADA	Int Soc Pharmacoecon & Outcomes Res		nicardipine; stroke; neurovascular conditions; hypertension	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ASSOCIATION STROKE COUNCIL; CEREBRAL BLOOD-FLOW; QUALITY-OF-CARE; INTRAARTERIAL NICARDIPINE; INTRAVENOUS NICARDIPINE; VASOSPASM; GUIDELINES; EXPERIENCE; MANAGEMENT	Injectable nicardipine is increasingly being used to manage neurovascular conditions. To better understand its place in therapy, we conducted an evidenced-based literature review. Two-hundred twenty-three article abstracts were identified; after independent review by two individuals and a supplemental manual search, 29 were deemed relevant and were included in this review. Nicardipine has been studied or recommended for management of hypertension in many neurovascular settings (ischemic stroke, intracerebral hemorrhage, craniotomy, and spinal surgery), for vasospasm in aneurysmal subarachnoid hemorrhage, and in acute traumatic brain injury In the management of hypertension in acute stroke, nicardipine is one of several recommended options available; expert opinion forms the basis of these recommendations in clinical guidelines, with limited randomized controlled trial evidence to support its use. Among the various antihypertensive agents, nicardipine has the highest drug acquisition cost. In two meta-analyses, intravenous nicardipine had no impact on patient outcomes (death, disability) in patients with acute traumatic brain injury (relative risk [RR] 0.25, 95% confidence interval [CI] 0.05-1.27) or in patients with aneursymal subarachnoid hemorrhage (RR 0.97, 95% CI 0.78-1.20). Intraarterial nicardipine reduced angiographic diameter (p value not reported) and peak systolic velocities on transcranial Doppler images (p<0.001) in published case series. Given nicardipine's high cost relative to that of other agents and the limited evidence to support its use in patients with neurovascular conditions, this drug should be considered only in patients who have failed or have contraindications to alternative agents in the management of hypertension. Although intraarterial nicardipine appears to be promising in aneurysmal subarachnoid hemorrhage, well-designed studies are needed in this setting before its use can be routinely recommended.	[Reddy, Prabashni; Yeh, Yu-Chen] Partners Ctr Drug Policy, Needham, MA 02494 USA		Reddy, P (corresponding author), Partners Ctr Drug Policy, 115 4th Ave, Needham, MA 02494 USA.						ABE K, 1994, J CLIN ANESTH, V6, P99, DOI 10.1016/0952-8180(94)90004-3; Adams, 2007, STROKE, V38, pE38, DOI 10.1161/STROKEAHA.106.110011; Adams, 2007, STROKE, V38, pE96; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; *AM SOC HLTH SYST, HYDR SYST; Avitsian R, 2007, J NEUROSURG ANESTH, V19, P125, DOI 10.1097/ANA.0b013e31802e6438; Badjatia N, 2004, AM J NEURORADIOL, V25, P819; Barth M, 2007, STROKE, V38, P330, DOI 10.1161/01.STR.0000254601.74596.0f; *BAXT HEALTHC CORP, 2005, BREV ESM PRESCR INF; BERNARD JM, 1992, ANESTH ANALG, V75, P179; Brisman JL, 2006, NEUROL RES, V28, P769, DOI 10.1179/016164106X152043; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; ELLIOTT HL, 1984, BRIT J CLIN PHARMACO, V17, P573, DOI 10.1111/j.1365-2125.1984.tb02392.x; FLAMM ES, 1988, J NEUROSURG, V68, P393, DOI 10.3171/jns.1988.68.3.0393; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; HALEY EC, 1993, J NEUROSURG, V78, P548, DOI 10.3171/jns.1993.78.4.0548; Kross RA, 2000, ANESTH ANALG, V91, P904, DOI 10.1097/00000539-200010000-00024; Langham J., 2003, COCHRANE DATABASE SY; Marik PE, 2007, CHEST, V131, P1949, DOI 10.1378/chest.06-2490; MEES SMD, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; *MERCK CO INC, 2000, VAS, V4; PARKEDAVIS, 1999, NITROSTAT NITROGLYCE; *PDL BIOPHARMA INC, 2006, CARD, V4; *PDR STAFF, 2007, RED BOOK PHARM FUND; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; ROCHE US, 1990, NIPRIDE NITROPRUSSID; SHIBUYA M, 1994, ACTA NEUROCHIR, V131, P19, DOI 10.1007/BF01401450; Suzuki M, 2001, NEUROSURG REV, V24, P180, DOI 10.1007/s101430100152; Tejada JG, 2007, AM J NEURORADIOL, V28, P844	30	5	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	APR	2009	29	4					398	409		10.1592/phco.29.4.398			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pharmacology & Pharmacy	427ZL	WOS:000264817500005	19323619				2022-02-06	
J	Nayeb-Hashemi, N; Rosenberg, M; Rosenberg, L; Sharp, S; Thomas, C; Holzer, C; McCauley, R; Herndon, D; Meyer, W				Nayeb-Hashemi, Neema; Rosenberg, Marta; Rosenberg, Laura; Sharp, Sherri; Thomas, Christopher; Holzer, Charles, III; McCauley, Robert; Herndon, David; Meyer, Walter, III			Skull burns resulting in calvarial defects: Cognitive and affective outcomes	BURNS			English	Article						Calvaria; Skull; Neurological; Burns; Electrical; Flame; Neuropsychology; Affective; Cognitive; Psychosocial; Outcomes; Children; Adolescents	TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL-ASPECTS; ELECTRICAL INJURY; CHILDREN; SCALP; ADOLESCENTS; IMPACT; ADAPTATION; 80-PERCENT; MANAGEMENT	Objective: To determine the extent of cognitive and affective difficulties experienced in children with full thickness burns of the calvaria caused by flame and electrical sources. Methods: Medical records were examined retrospectively to identify patients with full thickness burns of the calvaria. Data were reviewed from the acute period and long term for these patients and their matched controls. Results: Fourteen children were identified who sustained full thickness burns. The average age of injury was 7.1 +/- 7.3 years and average percent TBSA was 39.7 +/- 26.3. Of these 14 patients, 8 were under the age of 4 years at the time of injury and suffered flame injuries. Six children were over 11 years old at injury and suffered electrical burns. imaging was performed on 10 patients acutely and revealed 5 with major brain injury. The youngest patients suffering flame injuries experienced significant difficulty with developmental functioning acutely and a trend towards long-term cognitive difficulty. Older children did not differ from their matched controls at any time. Conclusions: Children with burns to the calvarium can be at risk for affective and cognitive sequalae. Therefore, we recommend comprehensive neuropsychological evaluations at multiple time points to adequately assess functioning across time. (C) 2008 Elsevier Ltd and ISBI. All rights reserved.	[Nayeb-Hashemi, Neema] Univ Texas Galveston, Med Branch, Sch Med, Galveston, TX 77550 USA; [Rosenberg, Marta; Rosenberg, Laura; Sharp, Sherri; Thomas, Christopher; McCauley, Robert; Herndon, David; Meyer, Walter, III] Shriners Hosp Children, Shriners Burns Hosp, Galveston, TX 77550 USA; [Rosenberg, Marta; Rosenberg, Laura; Sharp, Sherri; Thomas, Christopher; Holzer, Charles, III; Meyer, Walter, III] Univ Texas Galveston, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77550 USA; [McCauley, Robert; Herndon, David] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77550 USA		Rosenberg, M (corresponding author), Shriners Hosp Children, Dept Psychiat & Psychol, 815 Market St, Galveston, TX 77550 USA.	marosenb@utmb.edu	Herndon, David/AAC-3354-2020				*AM PSYCH ASS INC, 2000, DSM 4 TR DIAGN STAT; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Baker R. A. U., 1996, Journal of Burn Care and Rehabilitation, V17, P327, DOI 10.1097/00004630-199607000-00008; BIZHKO IP, 1992, BURNS, V18, P220, DOI 10.1016/0305-4179(92)90073-4; Blakeney P., 1993, Journal of Burn Care and Rehabilitation, V14, P684, DOI 10.1097/00004630-199311000-00015; Blakeney P, 1988, J Burn Care Rehabil, V9, P661, DOI 10.1097/00004630-198811000-00022; Blakeney P, 1998, J TRAUMA, V44, P625, DOI 10.1097/00005373-199804000-00011; Byrne C, 1986, J Burn Care Rehabil, V7, P247, DOI 10.1097/00004630-198605000-00011; Caffo E, 2003, CHILD ADOL PSYCH CL, V12, P493, DOI 10.1016/S1056-4993(03)00004-X; Deveci M, 2002, BURNS, V28, P591, DOI 10.1016/S0305-4179(02)00070-0; Duff K, 2001, NEUROPSYCHOL REV, V11, P101, DOI 10.1023/A:1016623318049; HUNT J, 1983, ARCH SURG-CHICAGO, V118, P621; Huttenlocher PR, 2003, NAT NEUROSCI, V6, P541, DOI 10.1038/nn0603-541; Ioannides C, 1999, J CRANIO MAXILL SURG, V27, P145, DOI 10.1016/S1010-5182(99)80042-0; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Janus Todd J., 1996, Journal of Burn Care and Rehabilitation, V17, P409, DOI 10.1097/00004630-199609000-00007; Landolt M, 1996, PRAX KINDERPSYCHOL K, V45, P47; Latenser BA, 2007, J BURN CARE RES, V28, P635, DOI 10.1097/BCR.0B013E31814B25B1; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; MALT U, 1980, BURNS, V6, P190, DOI 10.1016/0305-4179(80)90064-9; Matsumura H, 1996, BURNS, V22, P560, DOI 10.1016/0305-4179(96)00016-2; Max JE, 1998, J AM ACAD PSYCHIATRY, V26, P247; Meyer WJ, 2004, J BURN CARE REHABIL, V25, P98, DOI 10.1097/01.BCR.0000107203.48726.67; Meyers-Paal R, 2000, J BURN CARE REHABIL, V21, P43, DOI 10.1097/00004630-200021010-00009; Pliskin NH, 2006, J INT NEUROPSYCH SOC, V12, P17, DOI 10.1017/S1355617706060061; Rosenberg M, 2005, BURNS, V31, P883, DOI 10.1016/j.burns.2005.05.004; Scholz T, 2006, J BURN CARE RES, V27, P917, DOI 10.1097/01.BCR.0000245646.80680.26; Spies M, 2003, J TRAUMA, V54, P765, DOI 10.1097/01.TA.0000046381.36870.A8; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; TARNOWSKI KJ, 1989, J PEDIATR PSYCHOL, V14, P607, DOI 10.1093/jpepsy/14.4.607; TUCKER P, 1986, AUST NZ J PSYCHIAT, V20, P413, DOI 10.3109/00048678609158894; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yu BH, 1999, J BURN CARE REHABIL, V20, P426, DOI 10.1097/00004630-199909000-00017; Zeitlin REK, 1997, BURNS, V23, P467, DOI 10.1016/S0305-4179(97)00045-4	37	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	MAR	2009	35	2					237	246		10.1016/j.burns.2008.07.001			10	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Dermatology; Surgery	412DM	WOS:000263703700009	18950950				2022-02-06	
J	Miracle, A; Denslow, ND; Kroll, KJ; Liu, MC; Wang, KKW				Miracle, Ann; Denslow, Nancy D.; Kroll, Kevin J.; Liu, Ming Cheng; Wang, Kevin K. W.			Spillway-Induced Salmon Head Injury Triggers the Generation of Brain alpha II-Spectrin Breakdown Product Biomarkers Similar to Mammalian Traumatic Brain Injury	PLOS ONE			English	Article								Recent advances in biomedical research have resulted in the development of specific biomarkers for diagnostic testing of disease condition or physiological risk. Of specific interest are alpha II-spectrin breakdown products (SBDPs), which are produced by proteolytic events in traumatic brain injury and have been used as biomarkers to predict the severity of injury in humans and other mammalian brain injury models. This study describes and demonstrates the successful use of antibody-based mammalian SBDP biomarkers to detect head injury in migrating juvenile Chinook salmon (Oncorhynchus tshawytscha) that have been injured during passage through high-energy hydraulic environments present in spillways under different operational configurations. Mortality and injury assessment techniques currently measure only near-term direct mortality and easily observable acute injury. Injury-based biomarkers may serve as a quantitative indicator of subacute physical injury and recovery, and aid hydropower operators in evaluation of safest passage configuration and operation actions for migrating juvenile salmonids. We describe a novel application of SBDP biomarkers for head injury for migrating salmon. To our knowledge, this is the first documented cross-over use of a human molecular biomarker in a wildlife and operational risk management scenario.	Pacific NW Natl Lab, Environm Sustainabil Div, Richland, WA 99352 USA; [Denslow, Nancy D.; Kroll, Kevin J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA; [Denslow, Nancy D.; Kroll, Kevin J.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA; [Liu, Ming Cheng; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovative Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Ctr Neuroproteom & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA		Miracle, A (corresponding author), Pacific NW Natl Lab, Environm Sustainabil Div, Richland, WA 99352 USA.	ann.miracle@pnl.gov		kroll, kevin j/0000-0002-5374-6733; Wang, Kevin/0000-0002-9343-6473	Pacific Northwest National LaboratoryUnited States Department of Energy (DOE)	This work was supported by directed funds from Pacific Northwest National Laboratory to ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Bergman PJ, 2003, CLIN TECH SMALL AN P, V18, P88, DOI 10.1053/svms.2003.36621; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Burger J, 2007, ENVIRON RES, V104, P135, DOI 10.1016/j.envres.2006.08.002; Cianci CD, 1999, BIOCHEMISTRY-US, V38, P15721, DOI 10.1021/bi991458k; de Boer JG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-422; Eason C, 2002, TOXICOLOGY, V181, P517, DOI 10.1016/S0300-483X(02)00472-9; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Gastaldi L, 2007, COMP BIOCHEM PHYS C, V146, P398, DOI 10.1016/j.cbpc.2007.04.014; Johnson GE, 2003, N AM J FISH MANAGE, V23, P441, DOI 10.1577/1548-8675(2003)023<0441:EOJEAH>2.0.CO;2; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; LIVINGSTONE DR, 1993, J CHEM TECHNOL BIOT, V57, P195; Miracle AL, 2005, REPROD TOXICOL, V19, P321, DOI 10.1016/j.reprotox.2004.06.007; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Neitzel DA, 2004, T AM FISH SOC, V133, P447, DOI 10.1577/02-021; *NOAA, 2008, ISS SUMM FED COL RIV; PERKINS EJ, 2008, TOXICOGENOMICS REGUL, P87; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Plummer PJ, 2007, VET CLIN N AM-FOOD A, V23, P481, DOI 10.1016/j.cvfa.2007.07.005; Robbens J, 2007, TRENDS BIOTECHNOL, V25, P460, DOI 10.1016/j.tibtech.2007.08.005; SKALSKI JR, 2003, SURVIVAL CONDITION C; Soutschek J, 1996, DEV BRAIN RES, V97, P279, DOI 10.1016/S0165-3806(96)00145-9; Soutschek J, 1995, NEUROSCI LETT, V202, P133, DOI 10.1016/0304-3940(95)12231-1; Stark KDC, 2006, BMC HEALTH SERV RES, V6, P1, DOI 10.1186/1472-6963-6-20; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Zupanc GKH, 1999, J EXP BIOL, V202, P1435	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4491	10.1371/journal.pone.0004491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	WOS:000265484300016	19214235	Green Submitted, gold, Green Published			2022-02-06	
J	Dinn, WM; Gansler, DA; Moczynski, N; Fulwiler, C				Dinn, Wayne M.; Gansler, David A.; Moczynski, Nancy; Fulwiler, Carl			BRAIN DYSFUNCTION AND COMMUNITY VIOLENCE IN PATIENTS WITH MAJOR MENTAL ILLNESS	CRIMINAL JUSTICE AND BEHAVIOR			English	Article; Proceedings Paper	Annual Meeting of the British-Neuropsychiatric-Association	JUL, 1997	CAMBRIDGE, ENGLAND	British Neuropsychiat Assoc		violence; major mental illness; neuropsychological testing; traumatic head injury; substance abuse	POSITRON-EMISSION-TOMOGRAPHY; VENTROMEDIAL PREFRONTAL CORTEX; MINOR PHYSICAL ANOMALIES; BLUNT HEAD-INJURY; SUBSTANCE-ABUSE; CRIMINAL BEHAVIOR; NEUROPSYCHOLOGICAL DEFICITS; PSYCHIATRIC-INPATIENTS; ORBITOFRONTAL CORTEX; BIRTH COHORT	The objective of this study is to determine whether violence in psychiatric patients is associated with brain dysfunction independent of substance abuse. Psychiatric inpatients with a history of violent behavior in the community were compared to nonviolent inpatients on several variables related to brain dysfunction. The two groups were similar in terms of demographics and psychiatric diagnosis. No significant differences were found in neuropsychological function, but violent patients were significantly more likely to have co-occurring substance abuse and nearly 4 times more likely to have a history of closed-head injury. Logistic regression revealed that the association between violence and head injury can be explained by comorbid substance abuse.	[Dinn, Wayne M.; Gansler, David A.; Moczynski, Nancy; Fulwiler, Carl] Lemuel Shattuck Hosp, Boston, MA USA; [Gansler, David A.] Suffolk Univ, Boston, MA 02114 USA; [Gansler, David A.; Moczynski, Nancy] Tufts Univ, Sch Med, Medford, MA 02155 USA; [Fulwiler, Carl] Univ Massachusetts, Sch Med, Amherst, MA 01003 USA		Dinn, WM (corresponding author), 42 Washington Terrace, Whitman, MA 02382 USA.	dinn@bu.edu					ADAMS JJ, 1990, J NERV MENT DIS, V178, P253, DOI 10.1097/00005053-199004000-00006; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arseneault L, 2000, AM J PSYCHIAT, V157, P917, DOI 10.1176/appi.ajp.157.6.917; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; Barkataki I, 2005, SCHIZOPHR RES, V74, P1, DOI 10.1016/j.schres.2004.08.001; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Best M, 2002, P NATL ACAD SCI USA, V99, P8448, DOI 10.1073/pnas.112604099; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; BRYANT ET, 1984, J CONSULT CLIN PSYCH, V52, P323, DOI 10.1037/0022-006X.52.2.323; CONVIT A, 1991, BIOL PSYCHIAT, V30, P363, DOI 10.1016/0006-3223(91)90292-T; CONVIT A, 1996, AGGRESSION VIOLENCE; Denno D. W., 1990, BIOL VIOLENCE BIRTH; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; Dunn LM, 1965, EXPANDED MANUAL PEAB; ELLIOTT FA, 1992, ARCH NEUROL-CHICAGO, V49, P595, DOI 10.1001/archneur.1992.00530300027006; ELLIOTT FA, 1982, J NERV MENT DIS, V170, P680, DOI 10.1097/00005053-198211000-00007; ELLIOTT FA, 1990, SEMIN NEUROL, V10, P303, DOI 10.1055/s-2008-1041282; Erkiran M, 2006, ADDICT BEHAV, V31, P1797, DOI 10.1016/j.addbeh.2005.12.024; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fulwiler C, 2005, J CLIN PHARMACOL, V45, P94, DOI 10.1177/0091270004270457; Fulwiler C, 1999, COMPR PSYCHIAT, V40, P96, DOI 10.1016/S0010-440X(99)90112-8; Fulwiler C, 1997, PSYCHIAT SERV, V48, P1181; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; HALPERIN JM, 1991, DEV NEUROPSYCHOL, V7, P207, DOI 10.1080/87565649109540488; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harmon-Jones E, 1997, PERS INDIV DIFFER, V22, P439, DOI 10.1016/S0191-8869(96)00235-8; HEATON RK, 1981, WISCONISN CARD SORTI; HEINRICHS RW, 1989, BIOL PSYCHIAT, V25, P174, DOI 10.1016/0006-3223(89)90161-3; Hien D, 1997, PSYCHIATR SERV, V48, P1058; Hodgins S, 2002, ACTA PSYCHIAT SCAND, V105, P179, DOI 10.1034/j.1600-0447.2002.1o109.x; HODGINS S, 1992, ARCH GEN PSYCHIAT, V49, P476, DOI 10.1001/archpsyc.1992.01820060056009; KANDEL E, 1989, ACTA PSYCHIAT SCAND, V79, P103, DOI 10.1111/j.1600-0447.1989.tb09241.x; Krakowski M, 1997, J NEUROPSYCH CLIN N, V9, P549; KRAKOWSKI MI, 1989, AM J PSYCHIAT, V146, P849; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Lafayette JM, 2003, PSYCHIAT SERV, V54, P1635, DOI 10.1176/appi.ps.54.12.1635; LAPIERRE D, 1995, SCHIZOPHRENIA BULL, V21, P253, DOI 10.1093/schbul/21.2.253; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEWIS DO, 1985, AM J PSYCHIAT, V142, P1161; LINDQVIST P, 1989, ACTA PSYCHIAT SCAND, V82, P191; LINK BG, 1992, AM SOCIOL REV, V57, P275, DOI 10.2307/2096235; Lipsey M W, 1997, Recent Dev Alcohol, V13, P245; MANNUZZA S, 1989, ARCH GEN PSYCHIAT, V46, P1073; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miczek Klaus A., 1994, UNDERSTANDING PREVEN, V3, P377; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; Modestin J, 1996, SCHIZOPHRENIA BULL, V22, P69, DOI 10.1093/schbul/22.1.69; Moffitt TE, 1991, NEUROPSYCHOLOGY AGGR, P67; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; MUNGAS D, 1983, J NERV MENT DIS, V171, P354, DOI 10.1097/00005053-198306000-00005; MUNGAS D, 1988, BRIT J PSYCHIAT, V152, P180, DOI 10.1192/bjp.152.2.180; Naudts K, 2006, SCHIZOPHRENIA BULL, V32, P562, DOI 10.1093/schbul/sbj036; New AS, 2004, PSYCHOPHARMACOLOGY, V176, P451, DOI 10.1007/s00213-004-1913-8; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Northoff G, 2000, CEREB CORTEX, V10, P93, DOI 10.1093/cercor/10.1.93; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Quanbeck C, 2006, PSYCHIAT CLIN N AM, V29, P743, DOI 10.1016/j.psc.2006.04.011; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Raine A, 1997, AM J PSYCHIAT, V154, P1265; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; RAINE A, 1996, AGGRESSION VIOLENCE, P169; Rasanen P, 1998, SCHIZOPHRENIA BULL, V24, P437, DOI 10.1093/oxfordjournals.schbul.a033338; Raven J. C., 1960, GUIDE STANDARD PROGR; REGIER D A, 1990, Journal of the American Medical Association, V264, P2511, DOI 10.1001/jama.264.19.2511; Reitan R, 1985, HALSTEAD REITAN NEUR; ROLLS ET, 1995, COGNITIVE NEUROSCIEN, P325; ROLLS ET, 1998, PREFRONTAL CORTEX EX, P67; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Seidenwurm D, 1997, AM J NEURORADIOL, V18, P625; SHANER A, 1993, AM J PSYCHIAT, V150, P758; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Soderstrom H, 2000, PSYCHIAT RES-NEUROIM, V98, P29, DOI 10.1016/S0925-4927(99)00049-9; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Swanson JW., 1994, VIOLENCE MENTAL DISO, P101, DOI DOI 10.1371/JOURNAL.PMED.1000120; Swartz MS, 1998, AM J PSYCHIAT, V155, P226; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tonkonogy J M, 1991, J Neuropsychiatry Clin Neurosci, V3, P189; Volavka J., 1987, CAUSES CRIME NEW BIO, P137; VOLKOW ND, 1987, BRIT J PSYCHIAT, V151, P668, DOI 10.1192/bjp.151.5.668; Volkow ND, 1995, PSYCHIAT RES-NEUROIM, V61, P243, DOI 10.1016/0925-4927(95)02671-J; Wechsler, 1997, WECHSLER ADULT INTEL; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wilkinson, 1984, WIDE RANGE ACHIEVEME; WONG MTH, 1994, ACTA PSYCHIAT SCAND, V90, P97, DOI 10.1111/j.1600-0447.1994.tb01562.x; YEUDALL LT, 1979, HEMISPHERE ASYMMETRI, P341; [No title captured], DOI DOI 10.1177/088626087002002003	100	5	5	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0093-8548	1552-3594		CRIM JUSTICE BEHAV	Crim. Justice Behav.	FEB	2009	36	2					117	136		10.1177/0093854808327507			20	Psychology, Clinical; Criminology & Penology	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Criminology & Penology	396SR	WOS:000262611900001					2022-02-06	
J	Park, JE; Kim, SH; Yoon, SH; Cho, KG; Kim, SH				Park, Jung-Eon; Kim, Sang-Hyun; Yoon, Soo-Han; Cho, Kyung Gi; Kim, Se-Hyuk			Risk Factors Predicting Unfavorable Neurological Outcome during the Early Period after Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Unfavorable neurological outcome; Risk factors	HEAD-INJURY; MANAGEMENT; CELLS; TRANSPLANTATION; PROLIFERATION; NIMODIPINE; VARIABLES; RECOVERY; TREE	Objective : We aimed to identify clinico-radiological risk factors that may predict unfavorable neurological outcomes in traumatic brain injury (TBI), and to establish a guideline for patient selection in clinical trials that would improve neurological outcome during the early post TBI period. Methods : Initial clinico-radiological data of 115 TBI patients were collected prospectively. Regular neurological assessment after standard treatment divided the above patients into 2 groups after 6 months : the Favorable neurological outcome group (GOS : good & moderate disability, DRS : 0-6, LCFS : 8-10) and the Unfavorable group (GOS : severe disability-death, DRS : 7-29 and death, LCFS : 1-7 and death). Results : There was a higher incidence of age >= 35 years, low initial GCS score, at least unilateral pupil dilatation, and neurological deficit in the Unfavorable group. The presence of bilateral parenchymal lesions or lesions involving the midline structures in the initial brain CT was observed to be a radiological risk factor for unfavorable outcome. Multivariate analysis demonstrated that age and initial GCS score were independent risk factors. The majority of the Favorable group patients with at least one or more risk factors showed improvement of GCS scores within 2 months after TBI. Conclusion : Patients with the above mentioned clinico-radiological risk factors who received standard treatment, but did not demonstrate neurological improvement within 2 months after TBI were deemed at risk for unfavorable outcome. These patients may be eligible candidates for clinical trials that would improve functional outcome after TBI.	[Park, Jung-Eon; Kim, Sang-Hyun; Yoon, Soo-Han; Cho, Kyung Gi; Kim, Se-Hyuk] Ajou Univ, Sch Med, Dept Neurosurg, San 5 Woncheon Dong, Suwon 443721, South Korea		Kim, SH (corresponding author), Ajou Univ, Sch Med, Dept Neurosurg, San 5 Woncheon Dong, Suwon 443721, South Korea.	nsksh@ajou.ac.kr			Korea Health 21 RAMP;D Project, Ministry of Health and Welfare, Republic of Korea [0412-DB00-010-0007]	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. 0412-DB00-010-0007).	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	21	5	6	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	FEB	2009	45	2					90	95		10.3340/jkns.2009.45.2.90			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	411NW	WOS:000263657300005	19274118	gold, Green Published, Green Submitted			2022-02-06	
J	Deshmukh, L; Wu, LP; Guttmann, RP; Vinogradova, O				Deshmukh, Lalit; Wu, Liping; Guttmann, Rodney P.; Vinogradova, Olga			NMR structural characterization of the penta-peptide calpain inhibitor	FEBS LETTERS			English	Article						Calpain inhibitor; Calmodulin-like domain (CaMLD); Calpastatin; NMR; Modeling; Cyclo-peptide	NUCLEAR-MAGNETIC-RESONANCE; DISTANCE GEOMETRY; CALPASTATIN; PROTEINS; CALCIUM; DOMAIN	Calpains are ubiquitous intracellular calcium- and thiol-dependent proteases. Their over activation, resulting in the degradation of various substrates, has been implicated in a number of cardiovascular and neurological disorders. Here, we present the first structural characterization of LSEAL pentapeptide, a potent calpain inhibitor, bound to the calmodulin-like domain of calpain. Our in vitro binding data supports the idea that domains other than calpain's active site may be suitable targets for future development of therapeutic agents to be used to treat heart attack, traumatic brain injuries or a variety of neurodegenerative conditions, such as ischemic stroke. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.	[Guttmann, Rodney P.] Univ Kentucky, Sanders Brown Ctr Aging Gerontol Physiol, Lexington, KY 40536 USA; [Deshmukh, Lalit; Wu, Liping; Vinogradova, Olga] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA		Guttmann, RP (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging Gerontol Physiol, Lexington, KY 40536 USA.	rodneyg@email.uky.edu; olga.vinogradova@uconn.edu	Deshmukh, Lalit/C-5073-2015; guttmann, rodney/AAN-8880-2021; Vinogradova, Olga/ABE-8367-2020	guttmann, rodney/0000-0001-5553-3099; Vinogradova, Olga/0000-0001-5101-7361	University of Connecticut Research Foundation; American Heart AssociationAmerican Heart Association [0335233N]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS047635]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS047635] Funding Source: NIH RePORTER	The work was supported in parts by grants from the University of Connecticut Research Foundation to O.V. and American Heart Association (0335233N) and NIH (NS047635) to R. P. G. We thank Frank Delaglio and Dan Garrett for NMR and Alexandre Bovin for modeling software.	BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Bates PA, 2001, PROTEINS, P39; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELANO WL, 2008, DELANO SCI LLC; Dutt P, 1998, FEBS LETT, V436, P367, DOI 10.1016/S0014-5793(98)01167-3; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guttmann RP, 1997, J BIOL CHEM, V272, P2005, DOI 10.1074/jbc.272.3.2005; Guttmann RP, 2005, BIOCHEM BIOPH RES CO, V333, P1087, DOI 10.1016/j.bbrc.2005.06.036; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Koradi R., 1996, J MOL GRAPHICS, V14, P29; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; McCollum AT, 2006, EXP NEUROL, V202, P506, DOI 10.1016/j.expneurol.2006.07.016; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; TORDA AE, 1990, J MOL BIOL, V214, P223, DOI 10.1016/0022-2836(90)90157-H; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Wang KKW, 2000, TRENDS NEUROSCI, V23, P59, DOI 10.1016/S0166-2236(99)01536-2; WILLIAMSON MP, 1985, J MOL BIOL, V182, P295, DOI 10.1016/0022-2836(85)90347-X; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YANG HQ, 1994, J BIOL CHEM, V269, P18977	25	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	JAN 5	2009	583	1					135	140		10.1016/j.febslet.2008.11.037			6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	387JT	WOS:000261949200024	19059407				2022-02-06	
J	Allen, DN; Goldstein, G; Caponigro, JM; Donohue, B				Allen, Daniel N.; Goldstein, Gerald; Caponigro, Janelle M.; Donohue, Bradley			The Effects of Alcoholism Comorbidity on Neurocognitive Function Following Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						alcoholism; Halstead-Reitan Neuropsychological Battery; traumatic brain injury	YOUNG-ADULTS; ABUSE; SCHIZOPHRENIA; INTOXICATION; CONSUMPTION; DYSFUNCTION; LEVEL	Alcoholism and traumatic brain injury (TBI) often produce neuropsychological deficits. However, the extent and manner by which these factors interact is unclear. In this study, it was hypothesized that alcoholism would have compounding cognitive effects in individuals with TBI and alcoholism. Participants were divided into three groups, including a patient comparison (PC) group and groups with TBI with or without alcoholism histories. Participants were administered the Wechsler Adult Intelligence Scale-Revised and major components of the Halstead-Reitan Neuropsychological Test Battery. Comparing the groups on test performance, the TBI groups performed significantly worse than the PC group but did not significantly differ from each other. Thus, the effects of TBI on cognitive function overshadow preexisting deficits from the alcoholism.	[Allen, Daniel N.; Donohue, Bradley] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA; [Goldstein, Gerald; Caponigro, Janelle M.] VA Pittsburgh Healthcare Syst, Mental Illness Res Educ & Clin Ctr, Pittsburgh, PA USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 1999, NEUROPSYCHOLOGY, V13, P62, DOI 10.1037/0894-4105.13.1.62; Allen DN, 2000, NEUROPSY NEUROPSY BE, V13, P184; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 1952, DIAGN STAT MAN MENT; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Beatty WW, 2000, ALCOHOL CLIN EXP RES, V24, P149, DOI 10.1111/j.1530-0277.2000.tb04584.x; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; Goldstein G, 2002, J CLIN EXP NEUROPSYC, V24, P1010, DOI 10.1076/jcen.24.8.1010.8378; GOLDSTEIN G, 1976, EMPIRICAL STUDIES AL, P115; Gordon AJ, 2003, SUBST USE MISUSE, V38, P1017, DOI 10.1081/JA-120017649; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; LANGE RT, ARCH CLIN N IN PRESS; O'Shanick G J, 1984, Psychiatr Med, V2, P131; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Reitan R.M., 1993, HALSTEADREITAN NEURO; REITAN RM, 2000, MILD HEAD INJURY INT; RIMEL RW, 1983, REHABILITATION HEAD, P9; RIVARA FP, 1992, J ADOLESCENT HEALTH, V13, P663, DOI 10.1016/1054-139X(92)90060-O; Snowden CB, 2007, J STUD ALCOHOL DRUGS, V68, P634, DOI 10.15288/jsad.2007.68.634; Tate PS, 1999, BRAIN INJURY, V13, P767; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Wechsler, 1997, WECHSLER ADULT INTEL; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604	30	5	5	0	4	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2009	16	3					186	192		10.1080/09084280903098687			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	500LD	WOS:000270301000007	20183171				2022-02-06	
J	Barca, L; Cappelli, FR; Amicuzi, I; Apicella, MG; Castelli, E; Stortini, M				Barca, Laura; Cappelli, Francesca R.; Amicuzi, Ileana; Apicella, Maria Grazia; Castelli, Enrico; Stortini, Massimo			Modality-specific naming impairment after traumatic brain injury (TBI)	BRAIN INJURY			English	Article						Optic aphasia; alexia; traumatic brain injury; rehabilitation programme	OPTIC APHASIA; PURE ALEXIA; RECOGNITION; DISORDERS; CHILDREN; APRAXIA; CORTEX; FORM	Objective: To investigate neurocognitive and language functions in a single case presenting with modality-specific naming difficulties secondary to traumatic brain injury (TBI). Design: A comprehensive neuropsychological testing and specific assessment of naming and recognition functions were administered. Follow-up testing was administered 2 years post-injury to evaluate syndrome evolution. Rehabilitative intervention is described. Results: Ability to name visually presented objects was greatly impaired. The patient can describe or demonstrate the use of objects she cannot name and to sort them into their appropriate categories, indicating adequate non-verbal recognition. The impairment is specific to visual naming, as recognition through modalities different from vision is adequate (e.g. by touching the object, hearing its sound or being provided with verbal definition of it). This study and follow-up testing illustrated the evolution of the deficit, from a visual agnosic impairment to the co-occurrence of partial deficit of visual naming of objects and letters (optic aphasia and alexia). Conclusion: The patient presents with mild pre-semantic deficit (in mapping visual information with semantics) as well as post-semantic impairments (in the association between semantics and lexical label). Such performance can be accommodated within Farah's formulation which implies superadditive mild damage at several stages of object recognition naming model.	[Barca, Laura] Childrens Hosp Bambino Gesu, Dept Paediat Rehabil, IRCCS, I-00050 Rome, Italy		Barca, L (corresponding author), Childrens Hosp Bambino Gesu, Dept Paediat Rehabil, IRCCS, Via Torre Palidoro, I-00050 Rome, Italy.	laura.barca@istc.cnr.it	Castelli, Enrico/J-1887-2012; Barca, Laura/J-8274-2018; Stortini, Massimo/AAA-6200-2020	Barca, Laura/0000-0002-8553-7717; 	European's Community Seventh Framework Programme [PERG02-GA-2007-224919]	The research leading to these results has received funding from the European's Community Seventh Framework Programme under the grant agreement n degrees PERG02-GA-2007-224919 to Laura Barca. We thank MD and her family for their collaboration.	Ablinger I, 2009, NEUROPSYCHOL REHABIL, V19, P340, DOI 10.1080/09602010802204000; Anderson SW, 2003, NEUROL CLIN, V21, P729, DOI 10.1016/S0733-8619(02)00105-6; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; ASSAL G, 1980, REV NEUROL-FRANCE, V136, P365; Banich M.T., 2004, COGNITIVE NEUROSCIEN; BASSO A, 1995, CONOSCERE RIEDUCARE; BENTON AL, 2000, CONTRIBUTIPER ASSESS; Campbell R, 1996, BRAIN LANG, V53, P183, DOI 10.1006/brln.1996.0044; Chanoine V, 1998, CORTEX, V34, P437, DOI 10.1016/S0010-9452(08)70766-4; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Court, 1986, COLOURED PROGR MATRI; DERENZI E, 1987, BRAIN, V110, P1099, DOI 10.1093/brain/110.5.1099; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; ELLIS A, PHILOS T B IN PRESS; Ellis A., 1988, HUMAN COGNITIVE NEUR; Farah M. J., 1990, VISUAL AGNOSIA DISOR; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; GHENT L, 1956, AM J PSYCHOL, V69, P575, DOI 10.2307/1419081; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HYVARINEN L, 1992, LH TEST SYSTEM; Kerkhoff G, 1992, NEUROPSYCHOL REHABIL, V2, P21, DOI DOI 10.1080/09602019208401393; Leff AP, 2006, J NEUROL NEUROSUR PS, V77, P1004, DOI 10.1136/jnnp.2005.086983; Leff AP, 2000, ANN NEUROL, V47, P171, DOI 10.1002/1531-8249(200002)47:2<171::AID-ANA6>3.0.CO;2-P; Marsh EB, 2005, NEUROCASE, V11, P325, DOI 10.1080/13554790591006320; Miceli G., 1994, BATTERIA ANALISI DEF; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; PENACASANOVA J, 1985, BRAIN LANG, V26, P63, DOI 10.1016/0093-934X(85)90028-8; POECK K, 1983, BRAIN LANG, V20, P79, DOI 10.1016/0093-934X(83)90034-2; Poggi G, 2000, BRAIN INJURY, V14, P833, DOI 10.1080/026990500421930; Roid G. H., 1997, LEITER INT PERFORMAN; SCHINDER A, 1994, CORTEX, V30, P445; Sitton M, 2000, PSYCHOL REV, V107, P709, DOI 10.1037//0033-295X.107.4.709; WARRINGTON E K, 1973, Cortex, V9, P152; WARRINGTON EK, 1978, PERCEPTION, V7, P695, DOI 10.1068/p070695; Wartofsky MW, 1969, BOSTON STUDIES PHILO, V4, P137, DOI DOI 10.1007/978-94-010-3378-7_4; Wechsler D., 1974, WECHSLER INTELLIGENC; [No title captured]	38	5	5	2	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	11					920	929	PII 915243145	10.1080/02699050903283205			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	498JY	WOS:000270137300009	20100129				2022-02-06	
S	Buki, A; Kovesdi, E; Pal, J; Czeiter, E		Ottens, AK; Wang, KKW		Bueki, Andras; Koevesdi, Erzsebet; Pal, Jozsef; Czeiter, Endre			Clinical and Model Research of Neurotrauma	NEUROPROTEOMICS: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Fluid percussion; Impact acceleration; Traumatic brain injury; Biomarkers; Secondary injury; Diffuse axonal injury; Focal injury; Intracranial pressure	TRAUMATIC BRAIN-INJURY; SPECTRIN BREAKDOWN PRODUCTS; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; RAT; PATHOPHYSIOLOGY	Modeling traumatic brain injury represents a major challenge for neuroscientists - to represent extremely complex pathobiological processes kept under close surveillance in the most complex organ of a laboratory animal. To ensure that such models also reflect those alterations evoked by and/or associated with traumatic brain injury (TBI) in man, well-defined, graded, simple injury paradigms should be used with clear endpoints that also enable us to assess the relevance of our findings to human observations. It is of particular importance that our endpoints should harbor clinical significance, and to this end, biological markers ultimately associated with the pathological processes operant in TBI are considered the best candidate. This chapter provides protocols for relevant experimental models of TBI and clinical materials for neuroproteomic analysis.	[Bueki, Andras; Koevesdi, Erzsebet; Pal, Jozsef; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary		Buki, A (corresponding author), Univ Pecs, Dept Neurosurg, Pecs, Hungary.						BIROS MH, 1991, RESUSCITATION, V22, P283, DOI 10.1016/0300-9572(91)90036-X; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Kazanis I, 2005, BRAIN RES REV, V50, P377, DOI 10.1016/j.brainresrev.2005.09.003; Koizumi J, 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Mendelow AD, 2005, HEAD INJURY PATHOPHY, P73; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rensema J. W, 1991, MANUAL MICROSURGERY; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603	29	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-934115-84-8	METHODS MOL BIOL	Methods Mol. Biol.		2009	566						41	55		10.1007/978-1-59745-562-6_3	10.1007/978-1-59745-562-6		15	Biochemical Research Methods; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BLU16	WOS:000271018600003					2022-02-06	
J	Bussone, WR; Moore, TLA; Richards, D; Bove, RT; Scher, I; Prange, MT				Bussone, William R.; Moore, Tara L. A.; Richards, Darrin; Bove, Robert T., Jr.; Scher, Irving; Prange, Michael T.			Measurements of Non-Injurious Head Accelerations of a Pediatric Population	SAE INTERNATIONAL JOURNAL OF PASSENGER CARS-MECHANICAL SYSTEMS			English	Article							TRAUMATIC AXONAL INJURY; SHAKEN BABY SYNDROME; PROFESSIONAL FOOTBALL; CONCUSSION; IMPACTS; PERTURBATIONS; ATTENUATION; SHOCK	While adult head injuries have been studied over the past six decades, few studies have investigated pediatric head injury mechanics. This paper presents noninjurious head accelerations during various activities in a pediatric population. Six males and six females aged 811 years old were equipped with a validated head sensor package and head kinematics were measured while performing a series of playground-type activities. Maximum resultant values across all participants and activities were 25.7 g (range 3.0 g to 25.7 g), 16.0 rad/s (range 10.4 rad/s to 16.0 rad/s), and 1705 rad/s(2) (range 520 rad/s(2) to 1705 rad/s2) for linear acceleration, angular velocity, and angular acceleration, respectively. Mean maximum resultant values across all participants and activities were 9.7 g (range 2.1 g to 9.7 g) and 734 rad/s(2) (range 188 rad/s(2) to 734 rad/s(2)) for linear and angular acceleration, respectively. The peak accelerations measured in this study are approximately twice that of previous everyday acceleration studies undertaken with adult subjects. The present study increases the upper limit of known non-injurious activities and closes the gap between the lower limit of injurious loading and the upper limit of non-injurious loading.	[Bussone, William R.; Moore, Tara L. A.; Richards, Darrin; Bove, Robert T., Jr.; Scher, Irving; Prange, Michael T.] Exponent Inc, Menlo Pk, CA 94025 USA		Bussone, WR (corresponding author), Exponent Inc, Menlo Pk, CA 94025 USA.	wbussone@exponent.com					ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Arndt SR, 2004, P HUMAN FACTOR ERGON, V48, P1973; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; BURDI AR, 1969, J BIOMECH, V2, P267, DOI 10.1016/0021-9290(69)90083-9; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eppinger R., 1984, 840885 SAE; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk J. R., 2007, IRCOBI C MAASTR NETH; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Hilker Christopher E, 2002, Stapp Car Crash J, V46, P417; Irwin A., 1997, 973317 SAE; James HE, 1999, ACT NEUR S, V73, P85; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; Kallieris D, 1976, 760815 SAE; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Mahar AT, 1997, MED SCI SPORT EXER, V29, P1069, DOI 10.1097/00005768-199708000-00013; Melvin J. W., 1995, 950872 SAE; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Mercer JA, 2003, J SPORT SCI, V21, P911, DOI 10.1080/0264041031000140383; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mkandawire C., 2006, FISITA 2006 WORLD AU; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Nuckley DJ, 2005, J BIOMECH, V38, P2266, DOI 10.1016/j.jbiomech.2004.09.021; Ommaya A. K., 1967, 670906 SAE; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pincemaille Y., 1989, 892435 SAE; Pintar F A, 2000, Stapp Car Crash J, V44, P77; POZZO T, 1989, PROG BRAIN RES, V80, P377; Pozzo T., 1989, PROG BRAIN RES, V80, P373; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prasad P., 1984, 841656 SAE; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Scher I., 2005, 2005 SUMM BIOENG C V; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Seluyanov V., 1985, BIOMECHANICS B, VIX-B, P233; Smith DH, 2002, J NEUROTRAUM, V19, P1117, DOI 10.1089/08977150260337921; Snyder R. G., 1977, ANTHROPOMETERY INFAN; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Vijayakumar V, 2006, 2006010247 SAE; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216; WINTER DA, 2004, BIOMECHANICS MOTOR C; Woodman P. D., 1996, P INT 96	53	5	5	0	0	SAE INT	WARRENDALE	400 COMMONWEALTH DR, WARRENDALE, PA 15096 USA	1946-3995	1946-4002		SAE INT J PASSEN CAR	SAE Int. J. Passeng. Cars-Mech. Syst.		2009	2	1					565	586		10.4271/2009-01-0383			22	Transportation Science & Technology	Emerging Sources Citation Index (ESCI)	Transportation	V8A8H	WOS:000421467000041					2022-02-06	
B	Fleming, J		Soderback, I		Fleming, Jennifer			Metacognitive Occupation-Based Training in Traumatic Brain Injury	INTERNATIONAL HANDBOOK OF OCCUPATIONAL THERAPY INTERVENTIONS			English	Article; Book Chapter						Brain injuries; Closed head injuries; Cognition; Human activities; Meta-cognitive strategies; Self-awareness	INTELLECTUAL FUNCTIONS; AWARENESS; THERAPY; REHABILITATION; INTERVENTION; DAMAGE	Clients with impaired self-awareness following brain injury may benefit from an occupation-based approach to metacognitive training that uses real-life meaningful occupations in a supported therapy context. Metacognitive training aims to improve clients' intellectual awareness by demonstrating the impact of impairments on activities and participation, and thereby facilitate realistic collaborative goal setting and strategy use. Occupational performance takes place in real-life contexts to provide familiar structured experiences that allow for error recognition and error correction. Training strategies include the use of self-prediction before occupational performance; self-monitoring and self-checking during performance; and self-evaluation, verbal or video feedback, and education following performance. The occupational therapist plays a supportive role and monitors the client's emotional responses. A small but growing body of research evidence supports the use of occupation-based metacognitive training.	Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.						ABREU BC, 1987, AM J OCCUP THER, V41, P439, DOI 10.5014/ajot.41.7.439; Barco PP, 1991, COGNITIVE REHABILITA, P129; BERQUIST TF, 1993, BRAIN INJURY, V7, P275; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Katz N., 1998, COGNITION OCCUPATION; Katz N., 2005, COGNITION OCCUPATION; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; Landa-Gonzalez BELKIS, 2001, Occup Ther Int, V8, P49, DOI 10.1002/oti.131; Law M., 1994, CANADIAN OCCUPATIONA, V2; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; SODERBACK I, 1988, SCAND J REHABIL MED, V20, P47; SODERBACK I, 1988, SCAND J REHABIL MED, V20, P57; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; UNSWORTH C, 1999, COGNITIVE PERCEPTUAL	20	5	5	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-6739-8				2009							225	231		10.1007/978-0-387-75424-6_20			7	Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Rehabilitation	BPL81	WOS:000279171400020					2022-02-06	
J	Johnson, EG				Johnson, Eric G.			Clinical Management of a Patient with Chronic Recurrent Vertigo Following a Mild Traumatic Brain Injury	CASE REPORTS IN MEDICINE			English	Article							PAROXYSMAL POSITIONAL VERTIGO	Vertigo, was provoked and right torsional up-beat nystagmus was observed in a 47-year-old patient when she was placed into the right Hallpike-Dix test position using infrared goggle technology. The clinical diagnosis was benign paroxysmal positional vertigo (BPPV), specifically right posterior canalithiasis, resulting from a mild traumatic brain injury (TBI) suffered approximately six-months earlier. Previous medical consultations did not include vestibular system examination, and Meclizine was prescribed to suppress her chief complaint of vertigo. Ultimately, the patient was successfully managed by performing two canalith repositioning maneuvers during a single clinical session. The patient reported 100% resolution of symptoms upon reexamination the following day, and the Hallpike-Dix test was negative. Continued symptom resolution was subjectively reported 10 days postintervention via telephone consultation. This case report supports previous publications concerning the presence of BPPV following TBI and the need for inclusion of vestibular system examination during medical consultation. (C) 2009 Eric G. Johnson.	[Johnson, Eric G.] Loma Linda Univ, Dept Phys Therapy, Loma Linda, CA 92350 USA		Johnson, EG (corresponding author), Loma Linda Univ, Dept Phys Therapy, Loma Linda, CA 92350 USA.	ejohnson@llu.edu					Bertholon P, 2005, ANN OTO RHINOL LARYN, V114, P105, DOI 10.1177/000348940511400204; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Furman JM., 1996, BALANCE DISORDERS CA; Gordon Carlos R, 2002, Harefuah, V141, P944; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Herdman S., 2007, VESTIBULAR REHABILIT, P233; Johnson E. G., 2009, DIZZINESS VERTIGO DI; Johnson EG, 2007, J MAN MANIP THER, V15, P225, DOI 10.1179/106698107790819378; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Shepard N. T., 2007, BRAIN INJURY MED, P494; Shumway-Cook A, 2007, VESTIBULAR REHABILIT, P444	11	5	5	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-9627	1687-9635		CASE REP MED	Case Rep. Med.		2009	2009								910596	10.1155/2009/910596			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V24ZV	WOS:000215195800143	19826635	Green Published, gold, Green Submitted			2022-02-06	
J	Lamontagne, ME; Ouellet, MC; Simard, JF				Lamontagne, Marie-Eve; Ouellet, Marie-Christine; Simard, Jean-Francois			A descriptive portrait of human assistance required by individuals with brain injury	BRAIN INJURY			English	Article						Brain injuries; activities of daily living; caregivers; housing; social support	CARERS; PEOPLE; NEEDS; PERSPECTIVES; EFFICACY; ADULTS; IMPACT	Background: Human assistance is a counterweight to disabilities for people living with a traumatic brain injury (TBI). However, there is no clear description of the human assistance used by this population in relation with specific life habits (LH). Objectives: (1) to describe the proportion of LH performed with human assistance; (2) to explore the characteristics of TBI persons with greater needs for human assistance; (3) to clarify the categories of LH for which persons with TBI need human assistance; and (4) to determine the relationship between the human helper and the person with TBI across different residential settings. Method: One hundred and thirty-six individuals with moderate or severe TBI were interviewed using the LIFE-H. Results: Human assistance is used to perform one out of three LH. A greater need for human assistance was associated with the number of impairments, motor limitation to the upper limbs, hemiplegia and receiving public insurance. Human assistance was used more often to perform LH pertaining to social roles than those pertaining to daily living. Close relatives were the most frequent providers of human assistance regardless of the residential setting. Conclusion: Given the importance of human assistance in TBI, it is essential to support human helpers during and after rehabilitation.	[Lamontagne, Marie-Eve; Ouellet, Marie-Christine; Simard, Jean-Francois] Ctr Hosp Affilie Univ Site Enfant Jesus, Ctr Rech, Quebec City, PQ, Canada; [Lamontagne, Marie-Eve] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Ouellet, Marie-Christine] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada		Lamontagne, ME (corresponding author), Hop Enfants Jesus CHA, Ctr Rech CHAUQ, Pavillon Notre Dame,Local H-041,1401 18E Rue, Quebec City, PQ GIJ 1Z4, Canada.	marie-eve.lamontagne@umontreal.ca		Lamontagne, Marie-Eve/0000-0002-3301-7429; Ouellet, Marie-Christine/0000-0003-3477-1893	Regroupement des associations de personnes traumatisees cranio-cerebrales du Quebec (RAPTCCQ); Canadian Institutes for Health Research.Canadian Institutes of Health Research (CIHR)	Preparation of this article was supported by the Regroupement des associations de personnes traumatisees cranio-cerebrales du Quebec (RAPTCCQ) and by scholarships awarded to the first and second authors by the Canadian Institutes for Health Research.	Agree EM, 1999, SOC SCI MED, V48, P427, DOI 10.1016/S0277-9536(98)00369-4; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Desrosiers J, 2004, J REHABIL MED, V36, P177, DOI 10.1080/16501970410027485; Fougeyrollas P, 1998, CLASSIFICATION QUEBE; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; LABBE A, 1999, PROPRIETES PSYCHOMET; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Noreau L, 2004, DISABIL REHABIL, V26, P346, DOI 10.1080/09638280410001658649; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Smith MJ, 2006, J HEAD TRAUMA REHAB, V21, P76, DOI 10.1097/00001199-200601000-00008; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Verbrugge LM, 2002, J GERONTOL B-PSYCHOL, V57, pS366, DOI 10.1093/geronb/57.6.S366; Verbrugge LM, 1997, AM J PUBLIC HEALTH, V87, P384, DOI 10.2105/AJPH.87.3.384; Vincent C., 2002, TECHNOLOGY DISABILIT, V14, P113, DOI DOI 10.3233/TAD-2002-14306; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]	29	5	5	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	7-8					693	701	PII 912686080	10.1080/02699050902970760			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	462QL	WOS:000267370600014	19557573				2022-02-06	
J	Liu, JT; Lee, JK; Tyan, YS; Liu, CY; Chen, YH; Lin, TB				Liu, Jung-Tung; Lee, Jong-Kong; Tyan, Yeu-Sheng; Liu, Che-Yu; Chen, Yung-Hsiang; Lin, Tzer-Bin			Neuromodulation on cervical spinal cord combined with hyperbaric oxygen in comatose patients-a preliminary report	SURGICAL NEUROLOGY			English	Article						Brain injury; Cerebral blood perfusion; Hyperbaric oxygen therapy; Long-term coma; Spinal cord stimulation	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; DBS THERAPY; STIMULATION; MANAGEMENT; PERFUSION	Background: Because both SCS and HBO therapy have shown some promise in treating patients with states of reduced consciousness, we evaluated the combination of therapies in a prospective trial in comatose patients. Methods: Twelve patients who had received median nerve stimulation for 3 months without improvement in consciousness received cSCS for 1 year combined with simultaneous HBO therapy for the first 3 months. Another group enrolled 12 patients who received median nerve stimulation only were served as control. Results: Six patients emerged from coma at 1 year (after conclusion of treatment). Glasgow Coma Scale score, SPECT imaging, and PVS scores (state and reaction subscores) of the 12 patients were all significantly increased at 1 year compared with enrollment (P < .05). Neither respirator nor tracheosiomy was needed to assist respiration in any patient. Only 1 of 12 patients still needed nasogastric tube feeding at 1 year. By contrast, control patients (without cSCS and HBO therapy) showed no apparent improvement. Conclusion: Increase of GCS score, cerebral blood perfusion, and PVS scores were observed in comatose patients treated with combined cSCS and HBO therapy. (C) 2009 Published by Elsevier Inc.	[Liu, Che-Yu; Lin, Tzer-Bin] Chung Shan Med Univ, Dept Physiol, Coll Med, Taichung 40201, Taiwan; [Liu, Jung-Tung] Chung Shan Med Univ, Dept Neurosurg, Taichung 40201, Taiwan; [Lee, Jong-Kong] Chung Shan Med Univ, Dept Nucl Med, Taichung 40201, Taiwan; [Tyan, Yeu-Sheng] Chung Shan Med Univ, Dept Radiol, Taichung 40201, Taiwan; [Liu, Jung-Tung] Chung Shan Med Univ, Inst Med, Coll Med, Taichung 40201, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung 40402, Taiwan		Lin, TB (corresponding author), Chung Shan Med Univ, Dept Physiol, Coll Med, Taichung 40201, Taiwan.	tblin@csmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113	Chung-Shan Medical University Hospital [CSH-2009-C-007]	This study was supported by the grant from Chung-Shan Medical University Hospital (CSH-2009-C-007). The authors thank Miss Yi-Chun Chang, BS, for technical assistance in manuscript preparation.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bleck TP, 2003, TXB CLIN NEUROLOGY, P1; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Falowski S, 2008, NEUROTHERAPEUTICS, V5, P86, DOI 10.1016/j.nurt.2007.10.066; Giszter SF, 2008, NEUROTHERAPEUTICS, V5, P147, DOI 10.1016/j.nurt.2007.10.062; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; Inoue M, 2000, NEUROL RES, V22, P386, DOI 10.1080/01616412.2000.11740688; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 2002, MED FACTS ETHICAL LE; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Liu JT, 2008, ACTA NEUROCHIR SUPPL, V101, P65; Liu JT, 2008, ACT NEUR S, V101, P71; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; MCDONAGH M, 2003, AHRQ PUBLICATION, P13; McDonagh MS, 2007, DEV MED CHILD NEUROL, V49, P942, DOI 10.1111/j.1469-8749.2007.00942.x; Momose T, 1989, Radiat Med, V7, P243; Noda R, 2003, ACTA NEUROCHIR SUPPL, V87, P23; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; Patel S, 2004, NEUROSURGERY, V55, P201, DOI 10.1227/01.NEU.0000126949.28912.71; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Sagher O, 2000, J NEUROSURG, V93, P71, DOI 10.3171/spi.2000.93.1.0071; Shi Xiao-yan, 2003, Chin J Traumatol, V6, P346; Tinianow CL, 2000, BIOMED SCI INSTRUM, V395, P275; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Xie K, 2003, ACT NEUR S, V87, P19; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15	34	5	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2009	72			2			28	35		10.1016/j.surneu.2009.05.029			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	616UA	WOS:000279234100004	19665182				2022-02-06	
J	Morris, S; Dodd, KJ; Morris, M; Matyas, T				Morris, Susan; Dodd, Karen J.; Morris, Meg; Matyas, Thomas			Community-based progressive resistance strength training in traumatic brain injury: A multiple, single-system, trial	EUROPEAN JOURNAL OF PHYSIOTHERAPY			English	Article						Case study; training strength; traumatic brain injury	MOTOR-ASSESSMENT SCALE; STROKE; OUTCOMES; REHABILITATION; PERFORMANCE; DISABILITY; CHILDREN; EXERCISE; PROGRAM; GAIT	The aim of the study was to investigate if progressive resistance strength training (PRST) can have a beneficial effect on muscle weakness, activity limitations and participation restrictions in adults with traumatic brain injury (TBI). Seven people, six men and one woman, participated in this AB single-system trial. The mean age was 35.6 years (range 21.0-63.0, SD = 14.0), the mean time after head injury was 14.5 years (range 4.5-26.0, SD = 8.7) and the mean for length of coma was 11.3 weeks (range 0.3 to 16.0, SD = 6.1). After an 8-week baseline phase, community-based PRST was conducted twice a week for 8 weeks. Changes in maximal isotonic strength (1RM for arm and leg press), activity limitation (maximal gait speed and three items on the Motor Assessment Scale, MAS) and participation restriction (BICRO-39 Scale) were evaluated across the baseline and intervention phases. Leg press strength significantly increased in four participants and arm press strength significantly increased in two participants. Two improved on the sit-to-stand item (MAS). Maximal gait speed and the BICRO-39 Scale scores did not change. Following a TBI, some adults increased their muscle strength and improved their ability to stand up following a community-based PRST programme.	[Morris, Susan; Dodd, Karen J.] La Trobe Univ, Sch Physiotherapy, Bundoora, Vic 3086, Australia; [Morris, Meg] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic 3010, Australia; [Matyas, Thomas] La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia		Morris, S (corresponding author), POB 308, Warrandyte North, Vic 3113, Australia.	sjaj@people.net.au		Morris, Meg/0000-0002-0114-4175			Allen T.J., 2004, PHYSIOTHER CAN, V56, P67, DOI [DOI 10.2310/6640.2004.00004, 10.2310/6640.2004.00004]; Bloom M, 1982, EVALUATING CLIN PRAC; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Choy NL, 2002, AUST J PHYSIOTHER, V48, P35, DOI 10.1016/S0004-9514(14)60280-4; DAMIANO DL, 1995, DEV MED CHILD NEUROL, V37, P731, DOI 10.1111/j.1469-8749.1995.tb15019.x; DAMIANO DL, 1995, PHYS THER, V75, P658, DOI 10.1093/ptj/75.8.658; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Eriksrud O, 2003, PHYS THER, V83, P544, DOI 10.1093/ptj/83.6.544; Gorman BS, 1997, DESIGNS ANAL SINGLE; HACKER B, 1980, AM J OCCUP THER, V34, P103, DOI 10.5014/ajot.34.2.103; Hillier SL, 1997, BRAIN INJURY, V11, P661; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinugasa T, 2004, SPORTS MED, V34, P1035, DOI 10.2165/00007256-200434150-00003; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Lockett K, 1994, CONDITIONING PHYS DI; Moreland JD, 2003, ARCH PHYS MED REHAB, V84, P1433, DOI 10.1016/S0003-9993(03)00360-5; Morely S, BR J CLIN PSYCHOL, V30, P97; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; Morris Susan, 2006, THESIS; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; OLNEY SJ, 1991, ARCH PHYS MED REHAB, V72, P309; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Ploutz-Snyder LL, 2001, J STRENGTH COND RES, V15, P519; POOLE JL, 1988, ARCH PHYS MED REHAB, V69, P195; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Taylor NF, 2006, DISABIL REHABIL, V28, P1119, DOI 10.1080/09638280500531834; Taylor NF, 2004, DISABIL REHABIL, V26, P1128, DOI 10.1080/09638280410001712387; Watson MJ, 2004, PHYSIOTHERAPY, V90, P103; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	33	5	5	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2167-9169	2167-9177		EUR J PHYSIOTHER	Eur. J. Physiother.		2009	11	4					218	226		10.3109/14038190902856778			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V1Z2P	WOS:000217370200007					2022-02-06	
J	Patrick, PD; Wamstad, JB; Mabry, JL; Smith-Janik, S; Gurka, MJ; Buck, ML; Blackman, JA				Patrick, Peter D.; Wamstad, Julia Buch; Mabry, Jennifer L.; Smith-Janik, Shannan; Gurka, Matthew J.; Buck, Marcia L.; Blackman, James A.			Assessing the relationship between the WNSSP and therapeutic participation in adolescents in low response states following severe traumatic brain injury	BRAIN INJURY			English	Article						WNSSP; therapeutic participation; rehabilitation readiness; TBI; low response	REHABILITATION; COMA; CHILDREN; SCALES	Primary objective: This study examines the relationship between scores on the Western Neuro Sensory Stimulation Profile (WNSSP) and therapeutic participation as it relates to rehabilitation readiness (RR) in adolescents with low response following severe traumatic brain injury (TBI). Research design: This is a serial observational design using multiple measures of clinical status and participation. Methods and procedures: Ten children, mean age 16.7 years, who remained in a low response state (30 days or more) were assessed with the WNSSP and videotaped during physical and occupational therapy sessions. Associations were evaluated between WNSSP scores and participation scores related to arousal, awareness and communication. Main outcomes and results: The WNSSP was only associated with the communication score (p 0.0001). The arousal and awareness scores had no significant impact on the WNSSP score. Conclusions: These results suggest that scores on the WNSSP may be related to the return of communication skills in adolescents in low response states as one part of assessing their therapeutic participation and ultimate rehabilitation readiness. This ability may assist in making decisions regarding care planning.	[Patrick, Peter D.; Wamstad, Julia Buch; Gurka, Matthew J.; Buck, Marcia L.; Blackman, James A.] Univ Virginia, Charlottesville, VA 22901 USA; [Mabry, Jennifer L.] Radford Univ, Radford, VA 24142 USA; [Smith-Janik, Shannan] Penn State Univ, University Pk, PA 16802 USA		Patrick, PD (corresponding author), Univ Virginia, 2270 Ivy Rd, Charlottesville, VA 22901 USA.	pdp2n@virginia.edu					ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Ansell BJ, 1989, W NEUROSENSORY STIMU; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Bedell Gary M, 2002, Pediatr Rehabil, V5, P107, DOI 10.1080/1363849021000013540; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; SAS Institute,, 2003, SAS STAT US GUID VER; Wiedl KH, 1999, PSYCHIAT SERV, V50, P1411, DOI 10.1176/ps.50.11.1411; [No title captured]	14	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	6					528	534	PII 911809600	10.1080/02699050902926325			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	451SF	WOS:000266489800006	19484626				2022-02-06	
J	Tonks, J; Yates, P; Slater, A; Williams, WH; Frampton, I				Tonks, James; Yates, Phil; Slater, Alan; Williams, W. Huw; Frampton, Ian			Visual-spatial functioning as an early indicator of socioemotional difficulties	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Paediatrics; Brain injury; Executive function; Visual-Spatial performance; Behaviour; Socioemotional difficulties	TRAUMATIC BRAIN-INJURY; VISUOSPATIAL WORKING-MEMORY; TURNER-SYNDROME; EXECUTIVE FUNCTIONS; COGNITIVE DEFICITS; UNITED-STATES; QUESTIONNAIRE; STRENGTHS; MRI	Primary objective: As children with acquired brain injuries (ABI) mature to become adolescents they develop a range of previously undetected social and emotional difficulties, which are commonly associated with executive dysfunctions. The authors wanted to determine whether visual-spatial performance is subject to age-related improvement, whether such skills can differentiate between children with ABI and healthy children and whether visual-spatial performance is a correlate of socioemotional functioning. Research design: The 'Cube analysis' and 'Dot discrimination' tests from the ` Visual Object Space Perception (VOSP)' battery and the Strengths and Difficulties Questionnaire (SDQ) were administered for 18 children, 9-15 years, with ABI and compared against 67 'healthy' children. Results: Cube analysis scores improved significantly at similar to 10 years old in the control group. The ABI group performed the task significantly poorer than controls. Analysis indicated that visual discrimination skill did not account for performance difficulties. Visual-spatial performance was correlated with greater impact of reported difficulties on the SDQ. Conclusions: Visual-spatial tests are sensitive in differentiating between healthy children and children with ABI. Impairment of visuo-spatial skills may provide an index of psychosocial risk during later teenage years and adulthood.	[Tonks, James] Univ Exeter, Sch Psychol, Washington Singer Labs, Exeter EX4 4QG, Devon, England; [Yates, Phil] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Frampton, Ian] Cornwall Partnership NHS Trust, St Austell, England		Tonks, J (corresponding author), Univ Exeter, Sch Psychol, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	j.tonks@exeter.ac.uk		Tonks, James/0000-0003-3930-9294; FRAMPTON, Ian/0000-0003-0018-472X; williams, huw/0000-0003-0670-2620			Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson VA, 2003, STUD NEUROPSYCHOL DE, P217; BAENNINGER M, 1989, SEX ROLES, V20, P327, DOI 10.1007/BF00287729; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benson D.F., 1986, FRONTAL LOBES; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Cannon R, 2009, INT J NEUROSCI, V119, P404, DOI 10.1080/00207450802480325; CORNOLDI C, 2003, VISIOSPATIAL WORKING; DOWNEY J, 1989, J NERV MENT DIS, V177, P191, DOI 10.1097/00005053-198904000-00002; Elderkin-Thompson V, 2008, NEUROPSYCHOLOGY, V22, P626, DOI 10.1037/0894-4105.22.5.626; Emslie H., 2003, BEHAV ASSESSMENT DYS; Engel-Yeger B., 2009, NEUROPSYCHOL REHABIL, V21, P1; Evans JJ, 2003, STUD NEUROPSYCHOL DE, P53; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1111/1469-7610.00494; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Haberecht MF, 2001, HUM BRAIN MAPP, V14, P96, DOI 10.1002/hbm.1044; Hart SJ, 2006, BRAIN, V129, P1125, DOI 10.1093/brain/awl046; KOLB B, 2003, FUNDAMENTALS HUMAN N; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; MCCAULEY E, 1987, CHILD DEV, V58, P464, DOI 10.1111/j.1467-8624.1987.tb01394.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; PERNA RB, 2002, BRAIN INJURY SOURCE, V6, P32; Powell T. J., 2004, HEAD INJURY PRACTICA; Romans SM, 1998, AM J MED GENET, V79, P140, DOI 10.1002/(SICI)1096-8628(19980901)79:2<140::AID-AJMG10>3.3.CO;2-J; ROURKE BP, 1995, ORTON DYSLEXIA SOC, V21, P10; Rourke BP., 1989, NONVERBAL LEARNING D; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Warrington E. K., 1991, VISUAL OBJECT SPACE; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; YATES PJ, 2006, J NEUROL NEUROSUR PS, V19, P85	35	5	5	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2009	12	5					313	319		10.3109/17518420903087913			7	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	V15FS	WOS:000207788500006	20477560				2022-02-06	
J	Tulner, DM; Smith, ORF; de Jonge, P; van Melle, JP; Slomp, J; Storm, H; Quere, M; den Boer, JA; Honig, A; Korf, J				Tulner, Dorien M.; Smith, Otto R. F.; de Jonge, Peter; van Melle, Joost P.; Slomp, Jennichjen; Storm, Huib; Quere, Michel; den Boer, Johan A.; Honig, Adriaan; Korf, Jakob			Circulating Cerebral S100B Protein Is Associated with Depressive Symptoms following Myocardial Infarction	NEUROPSYCHOBIOLOGY			English	Article						S100B protein; Depressive symptoms; Myocardial infarction	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; NECROSIS-FACTOR-ALPHA; WHITE-MATTER LESIONS; MINOR HEAD-INJURY; CARDIAC-SURGERY; MAJOR DEPRESSION; HIPPOCAMPAL NEUROGENESIS; CARDIOVASCULAR EVENTS; SERUM S100B	Background: Prevalence of depressive symptoms in the post-myocardial infarction (MI) period varies from 8 to 30%. Cerebral damage after MI, caused by transient ischemia, an inflammatory response or both, may contribute to development of post-MI depression. S100B is an established protein marker of cerebral damage. In a pilot study, the authors assessed whether S100B serum levels are: (1) increased during the week after MI, and (2) related to depressive symptoms during index hospital admission and the year following MI. Methods: This pilot study is a substudy of the Myocardial Infarction and Depression Intervention Trial (MIND-IT). In 48 patients, serum levels of S100B were available at 1, 2, 3, 4 and 8 days following MI. Subsequently, in 27 patients, depressive symptoms were measured at 0, 3, 6, 9 and 12 months following MI with the Beck Depression Inventory (BDI). In 21 of the initial 48 patients, BDI data were lacking due to refusals to fill out BDI forms or missing data. Results: Significant and transient increases in serum S100B were observed in 81.3% of the 48 patients: 37.5% reached S100B serum levels comparable to serum levels found in acute brain injury (>0.20 mu g/l) and 43.8% reached mildly elevated S100B serum levels comparable to serum levels found in depressive disorder (0.10-0.20 mu g/l). In 18.7%, no S100B was detected in serum. Using non-parametric Spearman rank correlation tests, a trend towards an association was found between serum S100B and depressive symptoms during the post-MI year (rho values between 0.16 and 0.53) in 27 patients who completed both the S100B serum study and the BDI study. Conclusion: Transiently elevated levels of S100B are suggestive of minor acute cerebral damage in the first days following MI and associated with depressive symptoms in the year following MI. Cerebral damage could be an important mechanism in the pathogenesis in a subtype of post-MI depression. Copyright (C) 2009 S. Karger AG, Basel	[Tulner, Dorien M.] Med Ctr Leeuwarden, Dept Hosp Pyschiat, NL-8934 AD Leeuwarden, Netherlands; [Storm, Huib] Med Ctr, Dept Clin Chem, Leeuwarden, Netherlands; [Quere, Michel] Med Ctr, Dept Cardiol, Leeuwarden, Netherlands; [de Jonge, Peter] Tilburg Univ, Ctr Res Psychol Somat Dis, Tilburg, Netherlands; [de Jonge, Peter] Univ Med Ctr, Dept Internal Med & Psychiat, Groningen, Netherlands; [van Melle, Joost P.] Univ Med Ctr, Ctr Thorax, Groningen, Netherlands; [den Boer, Johan A.; Korf, Jakob] Univ Med Ctr, Univ Ctr Psychiat, Groningen, Netherlands; [Slomp, Jennichjen] Lab Clin Chem & Haematol, Twente, Netherlands; [Honig, Adriaan] St Lucas Andreas Hosp, Dept Psychiat, Amsterdam, Netherlands; [Smith, Otto R. F.] Univ Bergen, Fac Psychol, Res Ctr Hlth Promot, Bergen, Norway		Tulner, DM (corresponding author), Med Ctr Leeuwarden, Dept Hosp Pyschiat, Henri Dunantweg 2, NL-8934 AD Leeuwarden, Netherlands.	dmtulner@home.nl	de Jonge, peter/L-6395-2013	de Jonge, peter/0000-0002-0866-6929	The Netherlands Heart FoundationNetherlands Heart Foundation [97.016]; Organon (Oss, The Netherlands)Netherlands Government; Lundbeck (Amsterdam, The Netherlands)Lundbeck CorporationNetherlands Government	The MIND-IT study was funded by The Netherlands Heart Foundation (No. 97.016; principal investigator: Dr. J. Ormel). The MIND-IT received educational grants from Organon (Oss, The Netherlands) and Lundbeck (Amsterdam, The Netherlands). The sub-study reported in this paper received additional support from The Netherlands Heart Foundation (No. 2002. B207; principal investigator: Dr. A. Honig).	Anderson RE, 2000, ANN THORAC SURG, V69, P847, DOI 10.1016/S0003-4975(99)01526-X; Arolt V, 2003, EUR NEUROPSYCHOPHARM, V13, P235, DOI 10.1016/S0924-977X(03)00016-6; Bergh CD, 2007, SCAND CARDIOVASC J, V41, P109, DOI 10.1080/14017430601024269; Bernaards CA, 2000, MULTIVAR BEHAV RES, V35, P321, DOI 10.1207/S15327906MBR3503_03; BOTS ML, 1993, LANCET, V341, P1232, DOI 10.1016/0140-6736(93)91144-B; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; de Jonge P, 2007, AM J PSYCHIAT, V164, P1371, DOI 10.1176/appi.ajp.2007.06091492; de Jonge P, 2006, J AM COLL CARDIOL, V48, P2204, DOI 10.1016/j.jacc.2006.06.077; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dissmann R, 1998, AM HEART J, V135, P1, DOI 10.1016/S0002-8703(98)70335-7; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Eriksen JL, 2002, DEV BRAIN RES, V139, P97, DOI 10.1016/S0165-3806(02)00510-2; Frasure-Smith N, 2003, ARCH GEN PSYCHIAT, V60, P627, DOI 10.1001/archpsyc.60.6.627; Hetzel G, 2005, PSYCHOPHARMACOLOGY, V178, P161, DOI 10.1007/s00213-004-1999-z; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Johnsson P, 2003, ANN THORAC SURG, V75, P162, DOI 10.1016/S0003-4975(02)04318-7; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Jonsson H, 2003, RESTOR NEUROL NEUROS, V21, P151; Jonsson H, 1998, ANN THORAC SURG, V65, P1639, DOI 10.1016/S0003-4975(98)00229-X; Jonsson H, 2001, ANN THORAC SURG, V71, P1433, DOI 10.1016/S0003-4975(00)02612-6; Kilminster S, 1999, STROKE, V30, P1869, DOI 10.1161/01.STR.30.9.1869; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Mazzini GS, 2005, LIFE SCI, V77, P882, DOI 10.1016/j.lfs.2004.12.035; Missler U, 2000, CLIN CHEM, V46, P993; Missler U, 2002, CLIN CHIM ACTA, V321, P29, DOI 10.1016/S0009-8981(02)00061-X; Mocellin S, 2008, INT J CANCER, V123, P2370, DOI 10.1002/ijc.23794; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Patel SC, 1999, PROG CARDIOVASC DIS, V42, P217, DOI 10.1016/S0033-0620(99)70004-6; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Rothermundt M, 2001, J AFFECT DISORDERS, V66, P89, DOI 10.1016/S0165-0327(00)00321-9; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021; Snyder-Ramos SA, 2004, ANAESTHESIA, V59, P344, DOI 10.1111/j.1365-2044.2004.03663.x; Strik JJMH, 2001, PSYCHOSOMATICS, V42, P423, DOI 10.1176/appi.psy.42.5.423; Ter Horst GJ, 1998, AM J PHYSIOL-HEART C, V275, pH1910, DOI 10.1152/ajpheart.1998.275.5.H1910; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; van den Brink RHS, 2002, AM HEART J, V144, P219, DOI 10.1067/mhj.2002.123580; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c	49	5	7	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0302-282X			NEUROPSYCHOBIOLOGY	Neuropsychobiology		2009	59	2					87	95		10.1159/000209860			9	Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	436MK	WOS:000265418000046	19325251	Green Published			2022-02-06	
J	Bianco, M; Ferri, M; Fabiano, C; Scardigno, A; Tavella, S; Caccia, A; Manili, U; Faina, M; Casasco, M; Zeppilli, P				Bianco, Massimiliano; Ferri, Matteo; Fabiano, Carmela; Scardigno, Anna; Tavella, Sofia; Caccia, Anna; Manili, Umberto; Faina, Marcello; Casasco, Maurizo; Zeppilli, Paolo			Comparison of Baseline Neuropsychological Testing in Amateur Versus Professional Boxers	PHYSICIAN AND SPORTSMEDICINE			English	Article						boxing; CogSport; reaction time; neuropsychological test	TRAUMATIC BRAIN-INJURY; SPORTS CONCUSSION; FOOTBALL PLAYERS; MEDICAL ASPECTS; RECOVERY; DAMAGE; TIME	The aim of the study is to investigate cognitive functions in boxers. The study population was composed of 2 groups of male boxers with no history of head concussions (except during boxing): a) 33 amateurs at their first examination; b) 27 professionals. Subjects were requested to: a) fulfill a questionnaire collecting demographic data, level of education, occupational status, boxing record (for professionals), and number of head concussions during boxing; b) undergo a computerized neuropsychological (NP) test (CogSport) measuring simple and complex reaction time (RT). Professionals were significantly (P < 0.0001) older (29.4 +/- 4.19 years) and started boxing at a younger age (14.5 +/- 3.94 vs 20.3 +/- 4.77 years, P < 0.0001) than debutants (24.1 +/- 5.13 years). Debutants showed significantly shorter simple RTs than professionals, both at the beginning (0.244 +/- 0.007 vs 0.249 +/- 0.007 s, P = 0.005) and the end (0.247 +/- 0.007 vs 0.251 +/- 0.008 s, P = 0.028) of NP test. Complex RTs did not differ between groups. Professionals showed a positive significant correlation between simple RT at the beginning of NP test and the total number of disputed (P = 0.043) and won (P = 0.035) bouts. In conclusion, professionals show a longer simple RT compared with debutants, with no difference regarding more complex cognitive tasks. A possible explanation may be found in an adaptation of skilled boxers to better (and longer) evaluate external stimuli before giving a motor response.	[Bianco, Massimiliano] Catholic Univ, Sports Med Dept, Internal Med & Geriatr Inst, I-00168 Rome, Italy; [Bianco, Massimiliano; Faina, Marcello] Italian Boxing Federat, Med Commiss, Rome, Italy; [Tavella, Sofia; Caccia, Anna; Manili, Umberto; Faina, Marcello] Natl Italian Olymp Comm, Sports Med & Sci Inst, Rome, Italy		Bianco, M (corresponding author), Catholic Univ, Sports Med Dept, Internal Med & Geriatr Inst, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	massimiliano.bianco@fastwebnet.it	Tavella, Sofia/AAO-9903-2020; Zeppilli, Paolo/AAA-8877-2019; Abrams, William R/A-5782-2008; Bianco, Massimiliano/M-9907-2019	Tavella, Sofia/0000-0002-2310-9944; Bianco, Massimiliano/0000-0002-0587-5899; Zeppilli, Paolo/0000-0002-5228-3634			BETTI O O, 1969, Acta Neurologica Latinoamericana, V15, P47; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brown CN, 2003, J ATHL TRAINING, V38, pS24; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; STEWART WF, 1995, BOXING MED, P33; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; 1982, OFFICIAL GOVT J ITAL, P62; 1995, OFFICIAL GOVT J ITAL, P98	27	5	5	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	DEC	2008	36	1					95	102		10.3810/psm.2008.12.17			8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	V17IK	WOS:000207930700018	20048477				2022-02-06	
J	Slovis, N				Slovis, Nathan			Review of Equine Hyperbaric Medicine	JOURNAL OF EQUINE VETERINARY SCIENCE			English	Article						Hyperbaric oxygen; Oxygen therapy; Hyperbaric chamber; Boyle's law; Equine	OXYGEN THERAPY; PSEUDOMONAS-AERUGINOSA; NITRIC-OXIDE; INJURIES; EDEMA	Hyperbaric oxygen therapy appears to be a promising adjunctive treatment for a variety of equine disorders, including laminitis and other ischemic injuries. Hyperbaric oxygen (HBO) is a high-dose oxygen inhalation therapy that is achieved by having the patient breathe 100% oxygen inside a pressurized hyperbaric chamber. The delivery of oxygen to the tissues is through respiration because there is insufficient absorption of oxygen through the skin. The benefits of HBO are derived from both the physiologic and pharmacologic effects of high dose oxygen. HBO is based on two physical factors related to the hyperbaric environment mechanical effects of pressure and increased oxygenation of tissues. The use of HBO by veterinary medical hospitals is in its infancy. Our clinic has currently treated more than 250 patients in our HBO chamber. Patients included pregnant animals as well as neonatal foals, with no adverse effects noted. Patients have been pressurized from 1.5 to 3 ATA (ATM absolute) ranging from 60 to 90 minutes at treatment pressure (depth): Hagyard Equine Medical Institute has used HBO as adjunctive therapy for fungal disease (fungal pneumonia); thermal burns, carbon monoxide, smoke inhalation; closed head injuries; ileus; central nervous system edema/perinatal asphyxia; peripheral neuropathies; sports injuries (exertional rhabdomyolysis); cellulitis; compartment syndrome; and ischemic injuries (laminitis). In carefully selected patients, the addition of HBO therapy to standard measures may improve clinical outcomes. Further research is needed in the field of equine HBO medicine.	McGee Med Ctr, Hagyard Equine Med Inst, Lexington, KY 40511 USA		Slovis, N (corresponding author), McGee Med Ctr, Hagyard Equine Med Inst, 4250 Iron Works Pike, Lexington, KY 40511 USA.						BAILINA ML, 1987, AKUSH GINEKOL, V1, P32; Boerema I, 1960, J CARDIOVASC SURG, V1, P133; Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023; CROSS FS, 1952, SURG FORUM, V3, P111; CROSS FS, 1954, SURGERY, V36, P1001; Elayan IM, 2000, J NEUROPHYSIOL, V83, P2022, DOI 10.1152/jn.2000.83.4.2022; Feldmeier JJ, 2003, HYPERBARIC OXYGEN TH; GIMBEL M, 2002, HYPERBARIC MED PRACT, P169; Hammarlund C., 2002, HYPERBARIC MED PRACT, P37; Hsu RWW, 2004, J TRAUMA, V57, P1060, DOI 10.1097/01.TA.0000149247.63934.12; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; HUNT TK, 1977, HYPERBARIC OXYGEN TH, P111; KINDWALL E, 2002, HYPERBARIC MED PRACT, P1; Monstrey SJ, 1997, ANN PLAS SURG, V38, P163, DOI 10.1097/00000637-199702000-00011; NIINIKOS.J, 1969, ACTA PHYSIOL SCAND, P1; NYLANDER G, 1985, PLAST RECONSTR SURG, V76, P596, DOI 10.1097/00006534-198510000-00021; NYLANDER G, 1984, BURNS, V10, P193, DOI 10.1016/0305-4179(84)90026-3; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; PAKMAN LM, 1971, INFECT IMMUN, V4, P479, DOI 10.1128/IAI.4.4.479-487.1971; PARK MK, 1991, ANTIMICROB AGENTS CH, V35, P691, DOI 10.1128/AAC.35.4.691; PARK MK, 2002, HYPERBARIC MED PRACT, P205; PROSHINA IV, 1985, ANESTEZIOL REANIMAT, V4, P34; ROCKSWOLD GL, 2004, J NEUROSURG, V101, P435; SANCHEZ EC, 2008, HYPERBARIC OXYGENATI, P427; SANCHEZ EC, 2005, J UNDERSEA HYPERBAR, V32, P277; SHEFFIELD JC, 2002, P 14 INT C HYP MED; Sheffield P., 1988, PROBLEM WOUNDS ROLE, P17; Sheffield P.J., 2002, HYPERBARIC SURG PERI, P63; SHEFFIELD PJ, 1985, HYPERBARIC OXYGEN RE, V6, P18; SUKHOTNIK I, 2005, J UNDERSEA HYPERBAR, V32, P271; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; THOM SR, 1997, AM J PHYSIOL, V26, P82; WANG X, 1995, GROWTH FACTORS, V12, P29; Zamboni WA, 1996, ARCH SURG-CHICAGO, V131, P756; ZHAO LL, 1998, INT J RADIAT ONCOL, V40, P189	35	5	5	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0737-0806	1542-7412		J EQUINE VET SCI	J. Equine Vet. Sci.	DEC	2008	28	12					760	767		10.1016/j.jevs.2008.10.017			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	387QJ	WOS:000261966400013					2022-02-06	
J	Suh, M; Kolster, RA; Niogi, S; Mccandliss, BD; Ivry, RB; Voss, HU; Sarkar, R; Ghajar, J				Suh, Minah; Kolster, Rachel A.; Niogi, Sumit; Mccandliss, Bruce D.; Ivry, Richard B.; Voss, Henning U.; Sarkar, Ranjeeta; Ghajar, Jamshid		Cognitive and Neurobiological Con	Degree of Brain Connectivity Predicts Eye-Tracking Variability	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Mild head injury; Oculomotor; DAI; Attention; Delayed working memory	DUAL-TASK DEMANDS; SMOOTH-PURSUIT; TARGET BLANKING; ATTENTION; DEFICITS; INJURY	Mild traumatic brain injury (mTBI) is commonly associated with diffuse axonal injury (DAI), as well as performance variability and attention and working memory deficits. A visual tracking task with concurrent working memory loading may induce differential effects on performance variability among mTBI patients with varying degrees of DAI and therefore different degrees of brain connectivity. Using a multi-linear regression technique, we examined correlations between white matter integrity its detected by magnetic resonance diffusion tensor imaging and eye tracking variability under a working memory load in mTBI patients. The impact of increased working memory load on tracking variability was correlated with the degree of white matter integrity. Our results suggest that eye tracking variability under working memory loading may be used to assess the degree of DAI in mTBI patients.	[Suh, Minah; Ghajar, Jamshid] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [Kolster, Rachel A.; Niogi, Sumit; Mccandliss, Bruce D.] Cornell Univ, Weill Med Coll, Sackler Inst, Dept Psychiat, New York, NY 10021 USA; [Kolster, Rachel A.; Sarkar, Ranjeeta; Ghajar, Jamshid; Cognitive and Neurobiological Con] Brain Trauma Fdn, New York, NY USA; [Ivry, Richard B.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Voss, Henning U.] Cornell Univ, Weill Med Coll, Citigrp Biomed Imaging Ctr, New York, NY 10021 USA		Suh, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA.	minahsuh@skku.edu	Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074	McDonnell Foundation	Supported by a collaborative grant from the McDonnell Foundation to the Brain Trauma Foundation, with lead investigators from Weill Cornell Medical College, UC San Francisco and UC Berkeley. We thank Drs. Robert Zimmerman and Carl Johnson for certifying the MRI scans, as well as Drs. Jun Maruta, Pratik Mukherjee and Jonathan Victor and his group for helpful discussions regarding this manuscript.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; Kalashnikova L A, 2005, Neurosci Behav Physiol, V35, P773, DOI 10.1007/s11055-005-0123-0; Kathmann N, 1999, PSYCHOPHYSIOLOGY, V36, P158, DOI 10.1017/S0048577299981167; Lim YJ, 2006, J KOREAN PHYS SOC, V48, pS163; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MORI S, 2004, MRI ATLAS HUMAN WHIT, P7; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; VANGELDER P, 1995, VISION RES, V35, P667, DOI 10.1016/0042-6989(94)00161-E; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Yoo CS, 2006, J KOREAN PHYS SOC, V48, P670	24	5	5	0	8	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	DEC	2008	53	6					3468	3473		10.3938/jkps.53.3468			6	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	384FY	WOS:000261731900063					2022-02-06	
J	Ozier, Y				Ozier, Y.			Blood transfusion and adjunctive therapy in the bleeding trauma patient	TRANSFUSION CLINIQUE ET BIOLOGIQUE			French	Article						Hemorrhage; Trauma patient; Adjunctive therapy	FRESH-FROZEN PLASMA; DILUTIONAL COAGULOPATHY; HYDROXYETHYL STARCH; MASSIVE TRANSFUSION; CLOT FORMATION; MAJOR TRAUMA; FACTOR-VIIA; IN-VITRO; FIBRINOGEN; RESUSCITATION	Uncontrolled hemorrhage is the most common cause of potentially preventable death in massive trauma. In addition to the early identification of potential bleeding sources and angiographic embolisation or surgical bleeding control, in-hospital management will aim at maintain tissue oxygenation with volume replacement using crystalloids, colloids and RBC. In general, RBC transfusion is recommended to maintain hemoglobin between 7-10 g/dL. The complex combination of clotting factors and platelets consumption, loss and dilution, shock, hypothermia, acidosis and colloid-induced hemostatic alterations leads to coagulopathic bleeding. Most guidelines recommend the use of FFP in significant bleeding complicated by coagulopathy (PT, aPTT > 1.5 times control). Platelets should be administered to maintain a platelet count above 50 x 109[L (100 x 10(9)/L in patients with traumatic brain injury). However, standard laboratory tests have poor correlation with in vivo coagulopathy and the test results are not rapidly available. Empiric guidelines derived from mathematical hemodilution models developed in elective surgery settings may not be appropriate for trauma settings where significant bleeding may have already occurred. Moreover, coagulopathy is frequently present on admission in severely injured patients. Recent litterature suggests that FFP and platelets should be given early and more often to injured patients requiring massive transfusion. The place of adjunctive hemostatic therapy is discussed. (C) 2008 Elsevier Masson SAS. Tons droits reserves.	Univ Paris 05, Hop Cochin, AP HP, Serv Anesthesie Reanimat Chirurg, F-75014 Paris, France		Ozier, Y (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Serv Anesthesie Reanimat Chirurg, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	yves.ozier@cch.aphp.fr					*AFSS, 2002, REC PRAT CLIN TRANSF; Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Chowdhury P, 2004, BRIT J HAEMATOL, V125, P69, DOI 10.1111/j.1365-2141.2004.04868.x; COLLINS JA, 1974, SURGERY, V75, P274; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; De Lorenzo C, 2006, ANESTH ANALG, V102, P1194, DOI 10.1213/01.ane.0000200297.98089.ce; Egli GA, 1997, BRIT J ANAESTH, V78, P684, DOI 10.1093/bja/78.6.684; Fenger-Eriksen C, 2005, BRIT J ANAESTH, V94, P324, DOI 10.1093/bja/aei052; Fries D, 2006, ANESTH ANALG, V102, P347, DOI 10.1213/01.ane.0000194359.06286.d4; Fries D, 2005, BRIT J ANAESTH, V95, P172, DOI 10.1093/bja/aei160; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Hardy JF, 2006, CAN J ANAESTH, V53, pS40, DOI 10.1007/BF03022251; Hess JR, 2008, TRANSFUSION, V48, P1763, DOI 10.1111/j.1537-2995.2008.01743.x; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Hirshberg A, 2003, J TRAUMA, V54, P454, DOI 10.1097/01.TA.0000053245.08642.1F; Ho AMH, 2005, CAN J SURG, V48, P470; Innerhofer P, 2002, ANESTH ANALG, V95, P858, DOI 10.1097/00000539-200210000-00012; Ketchum L, 2006, J TRAUMA, V60, pS51, DOI 10.1097/01.ta.0000199432.88847.0c; Kozek-Langenecker SA, 2005, ANESTHESIOLOGY, V103, P654, DOI 10.1097/00000542-200509000-00031; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Mardel SN, 1998, BRIT J ANAESTH, V80, P204, DOI 10.1093/bja/80.2.204; McLoughlin TM, 1996, ANESTH ANALG, V83, P459, DOI 10.1097/00000539-199609000-00003; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc5026; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC	32	5	5	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1246-7820			TRANSFUS CLIN BIOL	Transfu. Clin. Biol.	NOV	2008	15	5					240	245		10.1016/j.tracli.2008.09.010			6	Hematology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Immunology	373BG	WOS:000260945400011	18930423				2022-02-06	
J	Jeng, TC; Haspani, MSM; Adnan, JS; Naing, NN				Jeng, Toh Charng; Haspani, Mohd Saffari Mohd; Adnan, Johari Siregar; Naing, Nyi Nyi			DELAYED TRAUMATIC INTRACRANIAL HAEMORRHAGE AND PROGRESSIVE TRAUMATIC BRAIN INJURY IN A MAJOR REFERRAL CENTRE BASED IN A DEVELOPING COUNTRY	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						delayed; intracranial; haemorrhage; progressive brain injury; computer tomographic scan		A repeat Computer Tomographic (CT) brain after 24-48 hours from the 1st scanning is usually practiced in most hospitals in South East Asia where intracranial pressure monitoring (ICP) is routinely not done. This interval for repeat CT would be shortened if there was a deterioration in Glasgow Coma Scale (GCS). Most of the time the prognosis of any intervention may be too late especially in hospitals with high patient-to-doctor ratio causing high mortality and morbidity. The purpose of this study was to determine the important predictors for early detection of Delayed Traumatic Intracranial Haemorrhage (DTICH) and Progressive Traumatic Brain Injury (PTBI) before deterioration of GCS occurred, as well as the most ideal timing of repeated CT brain for patients admitted in Malaysian hospitals. A total of 81 patients were included in this study over a period of six months. The CT scan brain was studied by comparing the first and second CT brain to diagnose the presence of DTICH/PTBI. The predictors tested were categorised into patient factors, CT brain findings and laboratory investigations. The mean age was 33.1 +/- 15.7 years with a male preponderance of 6.36:1. Among them, 81.5% were patients from road traffic accidents with Glasgow Coma Scale ranging from 4 - 15 (median of 12) upon admission. The mean time interval delay between trauma and first CT brain was 179.8 +/- 121.3 minutes for the PTBI group. The DTICH group, 9.9% of the patients were found to have new intracranial clots. Significant predictors detected were different referral hospitals (p=0.02), total GCS status (p=0.026), motor component of GCS (p=0.043), haemoglobin level (p<0.001), platelet count (p=0.011) and time interval between trauma and first CT brain (p=0.022). In the PTBI group, 42.0% of the patients were found to have new changes ( new clot occurrence, old clot expansion and oedema) in the repeat CT brain. Univariate statistical analysis revealed that age (p=0.03), race (p=0.035), types of admission (p=0.024), GCS status (p=0.02), pupillary changes (p=0.014), number of intracranial lesion (p=0.004), haemoglobin level (p=0.038), prothrombin time (p=0.016) as the best predictors of early detection of changes. Multiple logistics regression analysis indicated that age, severity, GCS status (motor component) and GCS during admission were significantly associated with second CT scan with changes. This study showed that 9.9% of the total patients seen in the period of study had DTICH and 42% had PTBI. In the early period after traumatic head injury, the initial CT brain did not reveal the full extent of haemorrhagic injury and associated cerebral oedema. Different referral hospitals of different trauma level, GCS status, motor component of the GCS, haemoglobin level, platelet count and time interval between trauma and the first CT brain were the significant predictors for DTICH. Whereas the key determinants of PTBI were age, race, types of admission, GCS status, pupillary changes, number of intracranial bleed, haemoglobin level, prothrombin time and of course time interval between trauma and first CT brain. Any patients who had traumatic head injury in hospitals with no protocol of repeat CT scan or intracranial pressure monitoring especially in developing countries are advised to have to repeat CT brain at the appropriate quickest time.	[Jeng, Toh Charng] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; [Jeng, Toh Charng] Hosp Univ Kebangsaan Malaysia, Dept Surg, Unit Neurosurg, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia; [Haspani, Mohd Saffari Mohd] Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kubang Kerian 16150, Kelantan, Malaysia; [Naing, Nyi Nyi] Univ Sains Malaysia, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian 16150, Kelantan, Malaysia; [Haspani, Mohd Saffari Mohd] Hosp Kuala Lumpur, Dept Neurosurg, Kuala Lumpur, Malaysia; [Adnan, Johari Siregar] Hosp Sultanah Aminah, Dept Neurosurg, Johor Baharu, Johor, Malaysia		Jeng, TC (corresponding author), Hosp Univ Kebangsaan Malaysia, Dept Surg, Unit Neurosurg, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.	cjtoh72@yahoo.com	Naing, Nyi Nyi/AAB-3851-2021; Naing, Nyi Nyi/M-3455-2015	Naing, Nyi Nyi/0000-0001-8308-5625			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arboix A, 2000, CEREBROVASC DIS, V10, P229, DOI 10.1159/000016061; BARATHAM G, 1972, J NEUROL NEUROSUR PS, V35, P698, DOI 10.1136/jnnp.35.5.698; BRODERICK JP, 1990, J NEUROSURG, V72, P195, DOI 10.3171/jns.1990.72.2.0195; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Miller J, 1982, NEUROLOGICAL SURG, P1896; ROBERSON FC, 1979, SURG NEUROL, V12, P161; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2002, ACT NEUR S, V81, P81; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sethi D, 2002, J TRAUMA, V53, P508, DOI 10.1097/00005373-200209000-00019; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; TEASDALE G, 1974, LANCET, V2, P81; Tseng Sheng-Hong, 1992, Journal of the Formosan Medical Association, V91, P585; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	23	5	5	0	2	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	OCT	2008	15	4					56	67					12	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V6L7W	WOS:000420399900013	22589639				2022-02-06	
J	Koob, AO; Harris, BT; Duhaime, AC				Koob, Andrew O.; Harris, Brent T.; Duhaime, Ann-Christine			Cellular genesis in the postnatal piglet	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						neurogenesis; stereology; piglet; 5-bromodeoxyuridine; doublecortin; subventricular zone	TRAUMATIC BRAIN-INJURY; CENTRAL NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; MINIATURE SWINE; HEAD-INJURY; NEUROGENESIS; MIGRATION; NEURONS; PRIMATES; TRIALS	Because of the anatomical and developmental similarity of the piglet brain to the human brain we were interested in characterizing the areas of cellular genesis which occur postnatally to validate the model for subsequent neurobiological research. In this study, four piglets were injected with 5-bromodeoxyuridine (BrdU) at 6, 7 and 8 days of age. The animals were sacrificed at 13 days of age and the brains were analyzed to characterize areas of cellular genesis. BrdU was seen throughout the brain and found to be most abundant in the subventricular zone (SVZ); doublecortin (DCX) expressing cells were found throughout the white matter-with an extensive DCX network in the SVZ. Here we describe for the first time the use of immunohistochemistry for BrdU and DCX to study cellular genesis in the piglet brain. (C) 2008 ISDN. Published by Elsevier Ltd. All rights reserved.	[Koob, Andrew O.; Duhaime, Ann-Christine] Dartmouth Hitchcock Med Ctr, Dept Pediat Neurosurg, Lebanon, NH 03756 USA; [Harris, Brent T.] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03756 USA		Koob, AO (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MTF 313, La Jolla, CA 92093 USA.	koob@ucsd.edu		Koob, Andrew/0000-0003-3381-6770			ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; Choi SC, 2001, NEUROL RES, V23, P190, DOI 10.1179/016164101101198325; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Duhaime AC, 2006, J NEUROSURG, V104, P259, DOI 10.3171/ped.2006.104.4.259; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Koob AO, 2006, J NEUROSCI RES, V83, P1558, DOI 10.1002/jnr.20837; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Rakic P, 2002, CLIN NEUROSCI RES, V2, P29, DOI 10.1016/S1566-2772(02)00005-1; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rankin SL, 2004, BRAIN RES PROTOC, V13, P69, DOI 10.1016/j.brainresprot.2004.01.002; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; THOMAS JM, 1971, GROWTH, V35, P259	27	5	5	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	OCT	2008	26	6					641	646		10.1016/j.ijdevneu.2008.04.001			6	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	338BU	WOS:000258480700014	18508228				2022-02-06	
J	Sheeehan, W; Thurber, S				Sheeehan, William; Thurber, Steven			Review of two years of experiences with SPECT among psychiatric patients in a rural hospital setting	JOURNAL OF PSYCHIATRIC PRACTICE			English	Article						tomography; single proton emission computed tomography (SPECT); psychiatric diagnosis; traumatic brain injury; mood disorders	TRAUMATIC BRAIN-INJURY; DISORDER; PERFUSION	We summarize single proton emission computed tomography (SPECT) findings from 63 psychiatric patients in a small rural hospital in western Minnesota. SPECT scans were ordered only for patients in whom documentation of hypoperfusion and functional deficits might be helpful in clarifying diagnoses and treatment planning. The patients referred for SPECT scans had histories of traumatic brain injuries, atypical psychiatric symptom presentations, or conditions that were refractory to standard treatments. In the context of strict referral guidelines and close psychiatrist-radiologist collaboration, a much higher yield of significant findings was obtained compared with those noted in other reports in the literature.	[Thurber, Steven] Woodland Ctr, Dept Psychol, Willmar, MN USA; [Sheeehan, William] Willmar Reg Treatment Ctr, Willmar, MN USA; [Sheeehan, William] Geneva Med Imaging Inc, Geneva, WI USA		Thurber, S (corresponding author), Woodland Ctr, Dept Psychol, 1125 SE 6th St, Willmar, MN USA.	steven_thurber@yahoo.com					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; *AM COLL RAD, 2002, ACR PRACTICE GUIDANC, V19, P487; Baulieu F, 2001, J NEUROIMAGING, V11, P112, DOI 10.1111/j.1552-6569.2001.tb00020.x; *EUR ASS NUCL MED, 2002, EUR J NUCL MED, V10, P36; FANN JR, 1995, AM J PSYCHIAT, V152, P1492; FEDEROFF JP, 1992, AM J PSYCHIAT, V149, P918; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; HENNIGAN DB, 1983, CLIN NUCL MED, V9, P121; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MALASPINA D, 2000, FUNCTIONAL CEREBRAL, P255; Mueller C, 2006, ACTA PSYCHIAT SCAND, V114, P91, DOI 10.1111/j.1600-0447.2006.00848.x; ORSUCH E, 2006, ACTA PSYCHIAT SCAND, V114, P73; ORSUCH E, 2006, ACTA PSYCHIAT SCAND, V114, P143; Rakauskas M.E., 2007, RURAL URBAN SAFETY C; SAXE GN, 1992, J NERV MENT DIS, V180, P662, DOI 10.1097/00005053-199210000-00009; Sheehan W, 2006, ACTA PSYCHIAT SCAND, V114, P140, DOI 10.1111/j.1600-0447.2006.00869.x; Sheehan W, 2006, AUST NZ J PSYCHIAT, V40, P374, DOI 10.1111/j.1440-1614.2006.01806.x; Sheehan W, 2006, AUST NZ J PSYCHIAT, V40, P277; Takanashi J, 2003, AM J NEURORADIOL, V24, P1184	22	5	5	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1527-4160			J PSYCHIATR PRACT	J. Psychiatr. Pract.	SEP	2008	14	5					318	323		10.1097/01.pra.0000336760.88178.e5			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	356CV	WOS:000259757200009	18832964				2022-02-06	
J	Sousa, OA; Xavier, EP; Vieira, LJED				Sousa Filho, Osvaldo Albuquerque; Xavier, Erika Porto; Eyre de Souza Vieira, Luiza Jane			Hospitalization from the traffic victims' and their family caregivers' points of view	REVISTA DA ESCOLA DE ENFERMAGEM DA USP			English	Article						Accidents, traffic; Family; Hospitalization	TRAUMATIC BRAIN-INJURY	This study describes the context of hospitalization experienced by traffic accident victims and their family caregivers. Using a qualitative approach and orientated by the convergent analysis, the investigation took place at an emergency hospital, in Fortaleza, Ceara, in 2004, with 14 people seven patients with skeletal muscle trauma and seven relatives accompanying them. In the participants' standpoint, the hospitalization moment is permeated by depression, anxiety, sadness, fear, concern, unawareness, affront from the health team to the patient and family, being exacerbated by the physical traumas, economical difficulties, social and legal implications. According to the integral principle, care to traffic victims should be extended to their relatives, because the latter also suffer injuries when they come across sudden death, serious traumas and sequels in significant persons.	[Sousa Filho, Osvaldo Albuquerque] Inst Dr Jose Frota, Traumatol Unit, Fortaleza, Ceara, Brazil; [Eyre de Souza Vieira, Luiza Jane] Univ Fortaleza UNIFOR, Grad Nursing Course, Fortaleza, Ceara, Brazil; [Xavier, Erika Porto] FIC, Fortaleza, CE, Brazil; [Eyre de Souza Vieira, Luiza Jane] Univ Fortaleza UNIFOR, Masters Degree Publ Hlth Program, Fortaleza, Ceara, Brazil		Vieira, LJED (corresponding author), Rua Ceres,1157 Edson Queiroz, BR-60384180 Fortaleza, CE, Brazil.	osvaldoasf2005@oi.com.br; erikaporto@ibest.com.br; janeeyre@unifor.br			National Council of Scientific and Technological DevelopmentConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [50.4458/2004-3]	This paper was financially supported by the National Council of Scientific and Technological Development ( no. 50.4458/2004-3)	Barros Aluísio J. D., 2003, Cad. Saúde Pública, V19, P979, DOI 10.1590/S0102-311X2003000400021; Barroso MGT, 2003, EDUCACAO SAUDE CONTE; BOSCOLO L, 1993, TERAPIA FAMILIAR SIS; Boyle GJ, 2002, PSYCHOL REP, V90, P415, DOI 10.2466/PR0.90.2.415-425; *BRAS MIN SAUD, 2002, REV SAUDE PUBL, V36, P114; *BRAS MIN SAUD, 2005, INF SAUD EST VIT; CAMARGO KR, 2003, CONSTRUCAO INTEGRALI, P35; Conselho Nacional de Saude, 1996, BIOETICA S, V4, P15; Azevedo Gisele Regina de, 2006, Rev. Latino-Am. Enfermagem, V14, P770; FARIA AB, 2003, THESIS U SAO PAULO S; Feuerwerker L., 2002, ALEM DISCURSO MUDANC; Gawryszewski Vilma Pinheiro, 2004, Cad. Saúde Pública, V20, P995, DOI 10.1590/S0102-311X2004000400014; Hoga Luiza Akiko Komura, 2004, Rev. esc. enferm. USP, V38, P13; Hora Edilene Curvelo, 2005, Rev. esc. enferm. USP, V39, P343, DOI 10.1590/S0080-62342005000300013; Hora Edilene Curvelo, 2005, Rev. Latino-Am. Enfermagem, V13, P93; Marín-León Leticia, 2003, Cad. Saúde Pública, V19, P515, DOI 10.1590/S0102-311X2003000200018; Martins Josiane de Jesus, 2007, Texto contexto - enferm., V16, P254; Melione Luís Paulo Rodrigues, 2004, Rev. bras. epidemiol., V7, P461; Peden M., 2004, WORLD REPORT ROAD TR; ROTHSCHIL AJ, 1994, MANUAL EMERGENCIAS P, P55; Sarti Cynthia Andersen, 2005, Physis, V15, P107, DOI 10.1590/S0103-73312005000100007; Sauer Maria Teresa Nardin, 2003, Cad. Saúde Pública, V19, P1519, DOI 10.1590/S0102-311X2003000500030; Serna Edilene Curvelo Hora, 2005, Acta paul. enferm., V18, P131, DOI 10.1590/S0103-21002005000200003; Soubhi H., 2000, SETTINGS HLTH PROMOT, P44; SOUZA ER, 2005, IMPACTO VIOLENCIA SA, P279; TESAR GE, 1994, MANUAL EMERGENCIAS P, P193; Trentini M, 1999, PESQUISA ENFERMAGEM; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110	28	5	5	0	1	UNIV SAO PAOLO	CERQUERA CESAR	AV  DR ENEAS DE CARVALHO AGUIAR, 419, CERQUERA CESAR, SP 05403-000, BRAZIL	0080-6234	1980-220X		REV ESC ENFERM USP	Rev. Esc. Enferm. USP	SEP	2008	42	3					531	538					8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	380LH	WOS:000261466700018					2022-02-06	
J	Gill, HS; van As, AB				Gill, Hardeep Singh; van As, Arjan Bastiaan			Tension pneumocranium in childhood trauma	WORLD JOURNAL OF PEDIATRICS			English	Article						head injuries; peri-ocular trauma; pneumocranium; trauma	PNEUMOCEPHALUS; SURGERY; COMPLICATION; FRACTURE; SIGN	Background. To report a case of fatal tension pneumocephalus in a 9-year-old boy following a severe motor vehicle accident. Methods: A young boy with a serious closed head injury was resuscitated in the emergency room and underwent CT scan of the head and orbits. Results: The CT-scan revealed a fracture of the orbital roof with extensive bilateral pneumocephalus. Conclusions: A high index of suspicion for tension pneumocephalus is required in patients with severe head injuries presenting with periorbital swelling and perioccular trauma. A prompt CT scan and neurosurgical intervention are indicated.	[Gill, Hardeep Singh; van As, Arjan Bastiaan] Univ Cape Town, Red Cross War Mem Childrens Hosp, Trauma Unit, Dept Pediat Surg, ZA-7701 Cape Town, South Africa		van As, AB (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Trauma Unit, Dept Pediat Surg, 6th Floor,ICH Bldg, ZA-7701 Cape Town, South Africa.	Sebastian.vanas@uct.ac.za					Avellanal M, 1996, ANESTHESIOLOGY, V85, P423, DOI 10.1097/00000542-199608000-00026; Campanelli J, 1997, OTOLARYNG HEAD NECK, V116, P247, DOI 10.1016/S0194-5998(97)70335-8; ISHIWATA Y, 1988, J NEUROSURG, V68, P58, DOI 10.3171/jns.1988.68.1.0058; Kuncz Adam, 2004, Ideggyogy Sz, V57, P313; Markham J W, 1967, Acta Neurochir (Wien), V16, P1; McIntosh BC, 2005, J CRANIOFAC SURG, V16, P461, DOI 10.1097/01.SCS.0000157249.31826.B7; Michel SJ, 2004, RADIOLOGY, V232, P449, DOI 10.1148/radiol.2322021556; RAM Z, 1992, CHILD NERV SYST, V8, P351, DOI 10.1007/BF00296568; Sawka AM, 1999, J CLIN ENDOCR METAB, V84, P4731, DOI 10.1210/jc.84.12.4731; Tobey JD, 1996, AM J ROENTGENOL, V166, P711, DOI 10.2214/ajr.166.3.8623656; WARING GO, 1975, ARCH OPHTHALMOL-CHIC, V93, P847, DOI 10.1001/archopht.1975.01010020727012; Webber-Jones Joan E, 2005, J Neurosci Nurs, V37, P272	12	5	5	0	0	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	CHILDRENS HOSPITAL, 57 ZHUGAN XIANG, HANGZHOU, 310003, PEOPLES R CHINA	1708-8569	1867-0687		WORLD J PEDIATR	World Journal of Pediatrics	AUG	2008	4	3					231	233		10.1007/s12519-008-0043-5			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	338AN	WOS:000258477300012	18822935				2022-02-06	
J	Agrawal, A; Pratap, A; Rauniar, RK; Kumar, A; Nepal, U				Agrawal, A.; Pratap, A.; Rauniar, R. K.; Kumar, A.; Nepal, U.			Intracranial Ricocheting of Bullet from Anterior Clinoid Process	JOURNAL OF NEPAL MEDICAL ASSOCIATION			English	Article						bullet; gunshot wounds; firearm	SPONTANEOUS MOVEMENT; BRAIN	Gunshot wounds to the head are usually mortal injuries. We present a unique case of intracranial ricocheting of bullet without neurologic deficits. Patient was treated conservatively with antibiotics for one week and prophylactic anticonvulsants for six weeks. Patient is doing well at six months follow up. Repeat X-ray skull showed that bullet was lying in the occipital region. It is recommended that deep seat bullets should be left behind as any attempt to remove that bullet may increase the morbidity and mortality. However close follow up of these patients is very important as these patients may come back with brain abscess.	[Agrawal, A.; Pratap, A.; Kumar, A.; Nepal, U.] BPKIHS, Dept Surg, Dharan, Nepal; [Rauniar, R. K.] BPKIHS, Dept Radiol, Dharan, Nepal		Agrawal, A (corresponding author), BPKIHS, Dept Surg, Dharan, Nepal.	dramitagrawal@gmail.com	Agrawal, Amit/C-1511-2011	Agrawal, Amit/0000-0002-3287-5448			Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Karabagli H, 2005, PEDIATR NEUROSURG, V41, P148, DOI 10.1159/000085873; LIEBESKIND AL, 1973, NEURORADIOLOGY, V5, P129, DOI 10.1007/BF00341526; MILHORAT TH, 1993, NEUROSURGERY, V32, P140; Ozkan U, 2006, CLIN NEUROL NEUROSUR, V108, P573, DOI 10.1016/j.clineuro.2005.03.002	5	5	5	0	1	NEPAL MEDICAL ASSOC	KATHMANDU	NMA BUILDING, SIDDIHI SADAN, PO BOX 189, EXHIBITION RD, KATHMANDU, 00000, NEPAL	0028-2715			J NEPAL MED ASSOC	J. Nepal Med. Assoc.	JUL-SEP	2008	47	3					145	146					2	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	423MF	WOS:000264499700014	19079382				2022-02-06	
J	Nayak, C; Nayak, D; Raja, A; Rao, A				Nayak, Chandrika; Nayak, Dinesh; Raja, Annaswamy; Rao, Anjali			Relationship between markers of lipid peroxidation, thiol oxidation and Glasgow coma scale scores of moderate head injury patients in the 7 day post-traumatic period	NEUROLOGICAL RESEARCH			English	Article						erythrocytes; lipid peroxidation; moderate head injury; thiol oxidation	TRAUMATIC BRAIN-INJURY; TIME-LEVEL RELATIONSHIP; ENERGY-METABOLISM; ERYTHROCYTE-MEMBRANE; STRESS; RATS; DYSFUNCTION; SUPEROXIDE; BIOMARKERS; RESPONSES	Objective: Epidemiologic works reveal that moderate head injury ( MHI) is more frequent and a substantial number of these patients develop complications resulting in neurological disabilities. Reactive oxygen species (ROS) play a major role in post-traumatic neuronal damage following traumatic head injury. Thus, the current study analysed the post-traumatic changes in the erythrocyte markers of oxidative damage and the relationship between these parameters and Glasgow coma scale (GCS) scores of MHI patients during the 7 day study period. Methods: Peripheral venous blood samples were taken at the time of hospital admission (d1 of injury) and on d7 from 25 MHI patients (admission GCS score. 8). These were compared with samples from 25 healthy individuals (normal controls, NC). GCS scores were recorded at the same time points of the study period. Erythrocyte lipid peroxidation (LP) and thiol oxidation levels were estimated and compared with that of NC. The relationship between GCS scores and erythrocyte markers were also studied. Results: Erythrocyte thiobarbituric acid reactive substance (TBARS) levels reflecting lipid peroxidative damage remained significantly elevated at both time points of the study period in MHI patients as compared to NC (p < 0.001). There was a significant decrease in the level of nonprotein thiols in MHI patients as compared to NC (p < 0.01) at the same time points of the study. However, on d7 there were no further significant changes in the markers of oxidative damage in MHI patients as compared to on d1. Conclusion: These findings suggest that a condition of oxidative stress occurs during the entire post-traumatic period in MHI patients and the utility of markers of oxidative damage in the prognosis of head injury needs to be addressed in further works.	[Nayak, Chandrika] Melaka Manipal Med Coll, Dept Biochem, Int Ctr Hlth Sci, Manipal 576104, Karnataka, India; [Nayak, Dinesh] Kasturba Med Coll & Hosp, Dept Pediat, Manipal 576104, Karnataka, India; [Raja, Annaswamy] Kasturba Med Coll & Hosp, Dept Neurosurg, Manipal 576104, Karnataka, India; [Rao, Anjali] Kasturba Med Coll & Hosp, Dept Biochem, Manipal 576104, Karnataka, India		Nayak, C (corresponding author), Melaka Manipal Med Coll, Dept Biochem, Int Ctr Hlth Sci, Manipal Campus, Manipal 576104, Karnataka, India.	chandrikadinesh@yahoo.com		Nayak, Dinesh M/0000-0001-7384-8916; Rao, Anjali/0000-0002-2676-2762; Nayak, Chandrika D/0000-0002-4674-7359			Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Cernak I, 1999, BRAIN INJURY, V13, P1005; Christman JW, 2000, BRAIN PATHOL, V10, P153; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Giustarini D, 2003, CLIN CHEM, V49, P327, DOI 10.1373/49.2.327; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; HORNETS VI, 1998, PATOL FIZIOL EKSP TE, V3, P22; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B., 2005, NEPAL J NEUROSCI, V2, P24; Juurlink BHJ, 1999, NEUROTOX RES, V1, P119, DOI 10.1007/BF03033276; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LYNCH RE, 1978, J BIOL CHEM, V253, P1838; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Nayak C, 2006, CLIN CHEM LAB MED, V44, P460, DOI 10.1515/CCLM.2006.068; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Polidori MC, 2001, STROKE, V32, P898, DOI 10.1161/01.STR.32.4.898; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Siems WG, 2000, CLIN NEPHROL, V53, pS9; SUTKOVOI DA, 1999, LIK SPRAVA, V2, P57; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tentori L, 1981, Methods Enzymol, V76, P707, DOI 10.1016/0076-6879(81)76152-4; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004	33	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2008	30	5					461	464		10.1179/016164107X251790			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	333EZ	WOS:000258137100006	18953735				2022-02-06	
J	O'Brien, L; Bailey, M				O'Brien, Lisa; Bailey, Michael			Determinants of compliance with hand splinting in an acute brain injured population	BRAIN INJURY			English	Article						traumatic brain injury; therapy; compliance; acute care; agitation; post traumatic amnesia; Westmead PTA scale	HEAD-INJURY; AGITATION; SCALE; PREDICTION; FRACTURES; RECOVERY	Purpose: Poor compliance with hand splinting treatment in the acute injury stage increases the risk of ongoing disability by affecting recovery and functioning. The aims of this study were to identify key predictors of splinting non-compliance in acute traumatic brain injury (TBI) patients and to determine the suitability of the Westmead PTA scale for predicting splinting compliance in TBI. Method: Retrospective medical record review of all patients who were (1) admitted to a major adult trauma hospital in 2005-2006 and (2) flagged as having concurrent brain and upper limb injuries. Data extracted included demographic information, co-morbidity, injury mechanism, TBI severity, incidence and duration of agitation. Compliance data included loss, removal or agitation with the splint or brace. Results: Of the 71 subjects, 39.5% (n=28) were non-compliant with their splint or brace; 60.5% (n=43) were compliant. The presence and duration of agitation were the strongest predictors of non-compliance with splinting (p=0.001 and p=0.003, respectively). Conclusion: PTA status at splint application does not accurately predict compliance with splinting. This highlights a specific clinical gap in the management of hand injuries against a background of agitation and cognitive impairment.	[O'Brien, Lisa] Alfred Hosp, Dept Occupat Therapy, Melbourne, Vic, Australia; [O'Brien, Lisa] Monash Univ, Sch Occupat Therapy, Clayton, Vic 3168, Australia; [Bailey, Michael] Monash Univ, Alfred Hosp, Fac Med Nursing & Hlth Sci, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia		O'Brien, L (corresponding author), Monash Univ, Dept Occupat Therapy, POB 527, Frankston, Vic 3199, Australia.	lisa.obrien@med.monash.edu.au	Bailey, Michael J/A-4499-2012	Bailey, Michael J/0000-0002-5551-1401; O'Brien, Lisa/0000-0002-4149-6669			Australian Bureau of Statistics, 2005, 12210 ANZSCO; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Charalambous CP, 2003, ALCOHOL ALCOHOLISM, V38, P357, DOI 10.1093/alcalc/agg085; Cooper C, 1993, J Hand Ther, V6, P205; CORRIGAN J, 1992, BRAIN INJURY, V62, P155; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Feehan Lynne M, 2004, J Hand Ther, V17, P300, DOI 10.1197/j.jht.2004.02.014; Feehan Lynne M, 2003, J Hand Ther, V16, P161; FEINBERG J, 1988, PATIENT EDUC COUNS, V11, P171, DOI 10.1016/0738-3991(88)90018-3; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fleminger S, 2003, BMJ-BRIT MED J, V327, P4, DOI 10.1136/bmj.327.7405.4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Groth G N, 1995, J Hand Ther, V8, P18; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Kim E, 2002, NEUROREHABILITATION, V17, P297; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kirwan Theresa, 2002, J Hand Ther, V15, P31, DOI 10.1053/hanthe.2002.v15.01531; LARRAT E P, 1990, American Pharmacy, V30, P18; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lyngcoln Anthony, 2005, J Hand Ther, V18, P2, DOI 10.1197/j.jht.2004.10.008; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Meichenbaum D., 1987, FACILITATING TREATME; Muller MGS, 2003, ARCH ORTHOP TRAUM SU, V123, P534, DOI 10.1007/s00402-003-0580-2; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; STEFANICH RJ, 1992, J HAND SURG-AM, V17A, P284, DOI 10.1016/0363-5023(92)90407-G; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412	34	5	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2008	22	5					411	418		10.1080/02699050802008067			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	302RH	WOS:000255986500006	18415721				2022-02-06	
J	Bilgen, M; Rumboldt, Z				Bilgen, Mehmet; Rumboldt, Zoran			Neuronal and vascular biomarkers in syringomyelia: investigations using longitudinal MR1	BIOMARKERS IN MEDICINE			English	Article						magnetic resonance imaging; neurotrauma; post-traumatic syringomyelia; spinal cord; spinal cord injury; syringomyelia	SPINAL-CORD-INJURY; POSTTRAUMATIC SYRINGOMYELIA; NONCOMMUNICATING SYRINGOMYELIA; WALLERIAN DEGENERATION; EXPERIMENTAL-MODEL; ENHANCED MRI; RF COIL; 9.4 T; RATS; CAVITATION	Aims: Syringomyelia is a formation of fluid-filled cavities in the spinal cord, caused by a number of situations including trauma. To understand the origin and progression of syringomyelia, animal models were developed to mimick the condition and computer models were implemented for performing numerical analysis. This article characterizes the neuropathological stages of a contused spinal cord before and after the syringomyelia formation using longitudinal in vivo MRI. Materials & methods: Rat was subject to a contusion-type spinal cord injury (SCI) at the T12 level. MRI data were gathered on post-injury days 3, 14, 28, 72, 94 and 404 using a 9.4 T scanner. In addition, neurobehavioral tests were performed prior to the scans on these days. Results: Pathological consequences of SO included significant edema and, to a lesser degree, hemorrhage in the acute phase, followed by neuronal loss, tissue alterations and vascular changes in the late stages. The images from the post-injury day 14 indicated shrinkage of the injured tissue and occlusion of the central canal. Subsequently, syringomyelia was initiated cranial to the occlusion and the fluid-filled cavities enlarged with time. The neurologic deficits of the injured rat also worsened overtime. Conclusion: The inflammatory, but not the hemostatic, component seems to be a prerequisite for syringomyelia proceeding contusive SO and abnormal flow of the cerebrospinal fluid (CSF) is likely the main factor. Bioimaging markers from high-resolution MRI sensitized to inflammation and CSF flow may be used for early detection of syringomyelia and assessing its prognosis.	[Bilgen, Mehmet; Rumboldt, Zoran] Med Univ S Carolina, Charleston, SC 29425 USA		Bilgen, M (corresponding author), Med Univ S Carolina, 169 Ashley Ave, Charleston, SC 29425 USA.	bilgen@musc.edu; rumbolz@musc.edu	Rumboldt, Zoran/AAA-9893-2019	Rumboldt, Zoran/0000-0001-6833-9762			BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BECERRA JL, 1995, AM J NEURORADIOL, V16, P125; Berens SA, 2005, AM J NEURORADIOL, V26, P1612; Bilgen M, 2004, MAGN RESON MED, V52, P937, DOI 10.1002/mrm.20228; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bilgen M, 2005, MAGNET RESON MED, V53, P1459, DOI 10.1002/mrm.20471; Bilgen M, 2002, MAGN RESON IMAGING, V20, P337, DOI 10.1016/S0730-725X(02)00504-0; Bilgen M, 2001, MAGNET RESON MED, V45, P614, DOI 10.1002/mrm.1083; Bilgen M, 2000, MAGN RESON MED, V43, P594; Bilgen M., 2006, NEUROANATOMY, V5, P12; Bilgen Mehmet, 2006, BMC Med Imaging, V6, P15, DOI 10.1186/1471-2342-6-15; Bilgen M, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-3; Bilgen M, 2007, J NEUROSCI METH, V159, P93, DOI 10.1016/j.jneumeth.2006.06.024; Bilgen M, 2006, J NEUROSCI METH, V156, P17, DOI 10.1016/j.jneumeth.2006.02.001; BIYANI A, 1994, PARAPLEGIA, V32, P723, DOI 10.1038/sc.1994.117; Brodbelt AR, 2003, J NEUROTRAUM, V20, P883, DOI 10.1089/089771503322385818; Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0; CHO KH, 1994, J NEUROSURG, V80, P133, DOI 10.3171/jns.1994.80.1.0133; ElMasry WS, 1996, J NEUROL NEUROSUR PS, V60, P141, DOI 10.1136/jnnp.60.2.141; Green BA, 1997, TOP SPINAL CORD INJ, V2, P36; Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5; GUIZARSAHAGUN G, 1994, SURG NEUROL, V41, P241, DOI 10.1016/0090-3019(94)90131-7; Jinkins JR, 1998, AM J NEURORADIOL, V19, P177; Josephson A, 2001, NEUROSURGERY, V48, P636, DOI 10.1097/00006123-200103000-00039; KUHN MJ, 1989, RADIOLOGY, V172, P179, DOI 10.1148/radiology.172.1.2740501; MILHORAT TH, 1993, J NEUROSURG, V78, P274, DOI 10.3171/jns.1993.78.2.0274; MILHORAT TH, 1995, J NEUROSURG, V82, P802, DOI 10.3171/jns.1995.82.5.0802; MILHORAT TH, 1995, NEUROSURGERY, V37, P206, DOI 10.1227/00006123-199508000-00003; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Perrouin-Verbe B, 1998, SPINAL CORD, V36, P137, DOI 10.1038/sj.sc.3100625; Schwartz ED, 1999, AM J ROENTGENOL, V173, P487, DOI 10.2214/ajr.173.2.10430159; Schwartz ED, 1999, AM J NEURORADIOL, V20, P1422; Sgouros S, 1996, J NEUROSURG, V85, P197, DOI 10.3171/jns.1996.85.2.0197; Stoodley MA, 1999, NEUROSURGERY, V44, P1065, DOI 10.1097/00006123-199905000-00068; Stoodley MA, 1999, NEUROSURGERY, V44, P1075; Vroemen M, 2006, AM J NEURORADIOL, V27, P598; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445	37	5	5	0	3	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1752-0363	1752-0371		BIOMARK MED	Biomark. Med.	APR	2008	2	2					113	124		10.2217/17520363.2.2.113			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	344IY	WOS:000258921300008	20477433				2022-02-06	
J	Kaliyaperumal, K; Sathappan, SS; Peng, LY				Kaliyaperumal, Kannan; Sathappan, Sathappan S.; Peng, Low Yin			Total hip arthroplasty for ankylosed hip secondary to heterotopic ossification	JOURNAL OF ARTHROPLASTY			English	Article						neurogenic heterotopic ossification; traumatic brain injury; total hip arthroplasty	TRAUMATIC BRAIN-INJURY; SPINAL-CORD INJURY; BONE-FORMATION; JOINT REPLACEMENT; HEAD-INJURY; FOLLOW-UP; PREVENTION; CONVERSION; ANTIGENS; INDOMETHACIN	Heterotopic ossification (HO) secondary to traumatic brain injury occurs at various sites and most commonly at the elbow, shoulder, and hip. There are few published reports on the assessment and surgical resection techniques of HO. A complete preoperative physical examination and radiologic assessment with a computed tomographic scan are important for the thorough evaluation of a patient. We describe a patient with neurogenic HO of the hip secondary to traumatic brain injury who underwent a total hip arthroplasty (THA). In selected patients with hip HO, THA supplemented with postoperative radiotherapy and indomethacin prophylaxis can facilitate progressive functional movements of the hip. To our knowledge, there is no report in the English literature of a THA being preformed for HO.	[Kaliyaperumal, Kannan; Sathappan, Sathappan S.; Peng, Low Yin] Tan Tock Seng Hosp, Dept Orthopaed Surg, Singapore 308433, Singapore		Sathappan, SS (corresponding author), Tan Tock Seng Hosp, Dept Orthopaed Surg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.						AMSTUTZ HC, 1975, J BONE JOINT SURG AM, V57, P619, DOI 10.2106/00004623-197557050-00006; AYERS DC, 1991, CLIN ORTHOP RELAT R, P87; BAUMANN F, 1969, ARCH ORTHOPAD UNFALL, V66, P1, DOI 10.1007/BF00419113; BOLGER JT, 1975, ARCH PHYS MED REHAB, V56, P36; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; BREWSTER RC, 1975, J BONE JOINT SURG AM, VA 57, P27, DOI 10.2106/00004623-197557010-00005; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; CHANTRAINE A, 1981, SCAND J REHABIL MED, V13, P31; CLARK JM, 1987, J BONE JOINT SURG AM, V69A, P1021, DOI 10.2106/00004623-198769070-00010; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V3, P337, DOI 10.1016/0221-8747(81)90050-3; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Hamadouche M, 2001, J BONE JOINT SURG AM, V83A, P992, DOI 10.2106/00004623-200107000-00003; HARDINGE K, 1977, J BONE JOINT SURG BR, V59, P385, DOI 10.1302/0301-620X.59B4.925046; HUNTER T, 1980, RHEUMATOL REHABIL, V19, P97, DOI 10.1093/rheumatology/19.2.97; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; JOHNSON JTH, 1957, J BONE JOINT SURG AM, V39, P189, DOI 10.2106/00004623-195739010-00016; KILGUS DJ, 1990, J BONE JOINT SURG AM, V72A, P45, DOI 10.2106/00004623-199072010-00008; KJAERSGAARDANDERSEN P, 1993, ACTA ORTHOP SCAND, V64, P639, DOI 10.3109/17453679308994587; LIMBERS PA, 1970, MED J AUSTRALIA, V2, P540, DOI 10.5694/j.1326-5377.1970.tb50167.x; LUBAHN JD, 1980, CLIN ORTHOP RELAT R, V153, P146; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; MUHEIM G, 1973, AM J ROENTGENOL, V54, P354; PAKOS EE, 2006, INT ORTHOP; REIKERAS O, 1995, J ARTHROPLASTY, V10, P529, DOI 10.1016/S0883-5403(05)80156-1; RITTER MA, 1985, CLIN ORTHOP RELAT R, P217; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; STRATHY GM, 1988, J BONE JOINT SURG AM, V70A, P963, DOI 10.2106/00004623-198870070-00002; WENNER SM, 1986, CLIN ORTHOP RELAT R, P231	35	5	5	0	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	APR	2008	23	3					470	475		10.1016/j.arth.2007.03.041			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	287AF	WOS:000254887900025	18358392				2022-02-06	
J	Rathore, MFA; Gill, ZA; Malik, AA; Farooq, F				Rathore, M. F. A.; Gill, Z. A.; Malik, A. A.; Farooq, F.			Acute flaccid paraplegia: a rare complication of meningococcal meningitis	SPINAL CORD			English	Article						meningococcal meningitis; non-traumatic spinal cord injury; paraplegia; thoracic myelopathy	SPINAL-CORD DYSFUNCTION; BACTERIAL-MENINGITIS; MRI FINDINGS	Study design: A case report of spinal cord dysfunction following meningococcal meningitis. Objectives: To describe a rare complication of meningococcal meningitis. Setting: Spinal Unit, Armed Forces Institute of Rehabilitation Medicine, Rawalpindi, Pakistan. Methods: A young healthy male developed meningococcal meningitis followed by acute onset low thoracic flaccid paraplegia with complete motor and sensory loss and sphincter disturbance. He responded well to antibiotics but was not investigated for causes of paraplegia. While at home in a rural area, he developed pressure ulcers, anemia and depression. Magnetic resonance imaging of the whole spine and computed tomography scan of the brain performed after 4 and 10 weeks were normal. Results: The patient had a comprehensive rehabilitation at our institute. Recovery was complicated by ossification in the right thigh, which responded well to radiotherapy. At 1-year follow-up, the motor deficit and neurogenic bladder and bowel persisted and the patient remained wheelchair dependent for mobility. Conclusion: Several mechanisms have been proposed to explain spinal cord damage after meningitis. These include spinal cord infarction; autoimmune-mediated inflammatory myelopathy and direct infection of the cord. Most probable cause of spinal cord dysfunction in this case was thoracic myelopathy.	[Rathore, M. F. A.; Gill, Z. A.; Malik, A. A.] Armed Forces Inst Rehabil Med, Spinal Rehabil Unit, Rawalpindi 46000, Pakistan; [Farooq, F.] Army Med Coll, Dept Biochem & Mol Biol, Rawalpindi, Pakistan		Rathore, MFA (corresponding author), Armed Forces Inst Rehabil Med, Spinal Rehabil Unit, Abid Majeed Rd, Rawalpindi 46000, Pakistan.	farooqrathore@gmail.com	Rathore, Farooq Azam/B-8232-2008	Rathore, Farooq Azam/0000-0002-4759-0453			Bhojo AK, 2002, AM J MED SCI, V323, P263, DOI 10.1097/00000441-200205000-00006; Choudhary N, 2007, CENT EUR J MED, V2, P122, DOI 10.2478/s11536-007-0002-x; Duke T, 2003, EXPERT OPIN PHARMACO, V4, P1227, DOI 10.1517/14656566.4.8.1227; Kastenbauer S, 2001, ARCH NEUROL-CHICAGO, V58, P806, DOI 10.1001/archneur.58.5.806; KHAN J, 1990, POSTGRAD MED J, V66, P302, DOI 10.1136/pgmj.66.774.302; Tunkel AR, 1995, LANCET, V346, P1675, DOI 10.1016/S0140-6736(95)92844-8	6	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	APR	2008	46	4					314	316		10.1038/sj.sc.3102120			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	283FF	WOS:000254621400011	17846638	Bronze			2022-02-06	
J	Sullivan, SJ; Schneiders, AG; McCrory, P; Gray, A				Sullivan, S. J.; Schneiders, A. G.; McCrory, P.; Gray, A.			Physiotherapists' use of information in identifying a concussion: an extended Delphi approach	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORTS-MEDICINE; GUIDELINES; STATEMENT	Objective: To determine the relative importance of signs and symptoms that a selected cohort of sports physiotherapists use to identify a sports concussion. Methods: A two-round Delphi methodology was used to achieve consensus in a cohort of 21 sports physiotherapists. A subsequent round involving an educational intervention provided the participants with an opportunity to modify their knowledge base through the provision of a relevant resource article. Results: Participants provided 123 responses, which were grouped into eight descriptive categories with consensus (>80%) being reached for the importance of: cognition/orientation, memory, motor dysfunction and state of consciousness. The category "state of consciousness'' remained the most important information source at the completion of the study. Conclusion: Participants placed considerable importance on the player's level of consciousness in their decision making. This would appear to be in conflict with recent trends to place greater importance on the role of symptoms in identifying a concussion.	[Sullivan, S. J.; Schneiders, A. G.] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [McCrory, P.] Univ Melbourne, Ctr Hlth Exercise Sports Med, Melbourne, Vic, Australia; [Gray, A.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand		Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	McCrory, Paul/Q-8688-2019; Gray, Andrew Robert/L-9161-2015; Schneiders, Anthony/F-4212-2015	Gray, Andrew Robert/0000-0003-4299-2194; Schneiders, Anthony/0000-0002-1583-3879			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Cantu R, 2004, LANCET NEUROL, V3, P437; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cook C, 2006, MANUAL THER, V11, P11, DOI 10.1016/j.math.2005.01.002; Fallon KE, 2006, BRIT J SPORT MED, V40, P139, DOI 10.1136/bjsm.2005.020602; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2005, BRIT J SPORT MED, V39, P1; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; Quinn B, 2000, BRAIN INJURY, V14, P1063; Stewart J, 1999, BMJ-BRIT MED J, V319, P224, DOI 10.1136/bmj.319.7204.224; Thompson B, 2004, BRIT J SPORT MED, V38, P214, DOI 10.1136/bjsm.2003.004689	15	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2008	42	3					175	177		10.1136/bjsm.2007.039297			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	272RT	WOS:000253878100008	18048431				2022-02-06	
J	Belanger, HG; King-Kallimanis, B; Nelson, AL; Schonfeld, L; Scott, SG; Vanderploeg, RD				Belanger, Heather G.; King-Kallimanis, Bellinda; Nelson, Audrey L.; Schonfeld, Lawrence; Scott, Steven G.; Vanderploeg, Rodney D.			Characterizing wandering behaviors in persons with traumatic brain injury residing in Veterans Health Administration nursing homes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; nursing homes; rehabilitation	RESIDENTS; DEMENTIA; RISK; SCALE	Objective: To examine the prevalence and correlates of wandering in persons with traumatic brain injury (TBI) in nursing homes (NHs). Design: Using a cross-sectional design. logistic regression modeling was used to analyze a national database. Setting: One hundred thirty-four NH facilities operated by the Veterans Health Administration. Participants: NH residents (N=625) with TBI as well as a sample (n = 164) drawn from a larger dataset of NH residents without TBI using 1:K matching on age. Interventions: Not applicable. Main Outcome Measure: Wandering. Results: Wanderers with and without TBI did not differ significantly overall. The prevalence of wandering among patients with TBI was 14%, compared with 6.5% of the general nursing home population. The results of the multivariate logistic regression suggested that wandering was associated with poor memory, poor decision making. behavior problems, independence in locomotion and ambulation, and dependence in activities of daily living related to basic hygiene. Conclusions: Wandering is relatively common in NH residents with TBI. As expected. it is associated with cognitive, social, and physical impairments. Further research with a larger sample should examine those with comorbid dementia and/or psychiatric diagnoses.	[Belanger, Heather G.; Vanderploeg, Rodney D.] James A Haley Vet Adm Med Ctr, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Scott, Steven G.] James A Haley Vet Adm Med Ctr, Dept Phys Med & Rehabil, Tampa, FL 33612 USA; [Belanger, Heather G.; Scott, Steven G.; Vanderploeg, Rodney D.] Def & Vet Brain Inury Ctr, Washington, DC USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [King-Kallimanis, Bellinda; Schonfeld, Lawrence] Univ S Florida, Louis Parte Florida Mental Hlth Inst, Tampa, FL USA; [Nelson, Audrey L.] Univ S Florida, Coll Nursing, James A Haley Vet Hosp, Patient Safety Ctr Injury, Tampa, FL USA		Belanger, HG (corresponding author), PM&R-117,13000 Bruce B Downs, Tampa, FL 33612 USA.	Heather.Belanger@va.gov					Algase DL, 2003, ANN LONG TERM CARE, V11, P33; ALGASE DL, 1992, THOROFARE SLACK, P651; Buchanan RJ, 2003, BRAIN INJURY, V17, P507, DOI 10.1080/0269905031000070215; CANCRO R, 1968, B MENNINGER CLIN, V32, P228; Centers for Medicare and Medicaid Services, 2011, MIN DAT SETS 2 0 OV; Cohen-Mansfield J, 1998, J GERONTOL A-BIOL, V53, pM65, DOI 10.1093/gerona/53A.1.M65; Edgerly ES, 1998, AM J ALZHEIMERS DIS, V13, P317; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOMPALOY J, 1998, J PSYCHOSOC NURS MEN, V26, P8; GIFFORD DR, 2000, ANN LONG TERM CARE, V8, P53; Gottlieb S, 2000, BRIT MED J, V321, P1100; Gruber-Baldini AL, 2000, J AM GERIATR SOC, V48, P1601, DOI 10.1111/j.1532-5415.2000.tb03870.x; HARTMAIER SL, 1994, J AM GERIATR SOC, V42, P1173, DOI 10.1111/j.1532-5415.1994.tb06984.x; Hope T, 2001, INT PSYCHOGERIATR, V13, P137, DOI 10.1017/S1041610201007542; HOPE T, 1994, INT J GERIATR PSYCH, V9, P149, DOI 10.1002/gps.930090209; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kiely DK, 2000, INT J GERIATR PSYCH, V15, P1013, DOI 10.1002/1099-1166(200011)15:11<1013::AID-GPS226>3.0.CO;2-X; Kiely DK, 1998, J AM GERIATR SOC, V46, P551, DOI 10.1111/j.1532-5415.1998.tb01069.x; Kopetz S, 2000, INT J GERIATR PSYCH, V15, P586, DOI 10.1002/1099-1166(200007)15:7<586::AID-GPS148>3.3.CO;2-4; LANGLOIS JA, 2006, J HEAT TRAUMA RAHABI, V21, P33; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mor V, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-20; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; *OFF ASS DEP SECR, 2006, VET AFF SIT TRACK SY; RHEAUME Y, 1987, J NUTR ELDER, V7, P3; Schonfeld L, 2007, J AM GERIATR SOC, V55, P692, DOI 10.1111/j.1532-5415.2007.01135.x; SNYDER LH, 1978, GERONTOLOGIST, V18, P272, DOI 10.1093/geront/18.3.272; SOVERINI S, 1968, GIORN GERONTOL, V16, P846; STOKES G, 1986, COMMON PROBLEMS ELDE; Vaughan N, 1997, BRAIN INJURY, V11, P815, DOI 10.1080/026990597123025; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004	33	5	5	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2008	89	2					244	250		10.1016/j.apmr.2007.08.145			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	260OD	WOS:000253018700007	18226647				2022-02-06	
J	Grossi, PM; Ellis, MJ; Cummings, TJ; Gray, LL; Fukushima, T; Sampson, JH				Grossi, Peter M.; Ellis, Michael J.; Cummings, Thomas J.; Gray, Linda L.; Fukushima, Takanori; Sampson, John H.			Cholesterol granuloma of the lateral ventricle	JOURNAL OF NEUROSURGERY			English	Article						brain neoplasm; cerebral ventricle neoplasm; cholesterol granuloma; lateral ventricle	CHOROID-PLEXUS; CEREBELLOPONTINE ANGLE; XANTHOGRANULOMA; MANAGEMENT; XANTHOMA	Cholesterol granulomas (CGs) are benign lesions resulting from an inflammatory reaction to cholesterol and hemosiderin. These masses most often arise within the temporal bone or nasal sinuses; intracerebral CGs are extremely rare. In this report the authors present an unusual case of a CG arising within the lateral ventricle. The patient presented with transient hemiparesis and numbness. Computed tomography and magnetic resonance imaging demonstrated a cystic partially enhancing midline mass within the right lateral ventricle, expanding the ventricle and displacing the septum pellucidum. The patient underwent an interhemispheric, transcallosal resection of the lesion. Microscopic examination revealed a granulomatous inflammatory lesion containing cholesterol clefts, macrophages, and hemosiderin. Embedded within the granulomatous response were foci of tiny cystlike structures lined by nonciliated flattened cuboidal epithelium, consistent with the diagnosis of CG. To the authors' knowledge this is the first reported case of CG presenting as an intraventricular mass. The origin of this lesion is unclear, but it may relate to prior traumatic brain injury. The authors describe the presentation, imaging findings, histopathological characteristics, and surgical treatment of this rare lesion and related pathological entities.	[Grossi, Peter M.; Ellis, Michael J.; Fukushima, Takanori; Sampson, John H.] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Cummings, Thomas J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gray, Linda L.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA		Sampson, JH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Box 3050,220 Sands Bldg,Res Dr, Durham, NC 27710 USA.	john.sampson@duke.edu		Sampson, John/0000-0002-0104-7658			AYRES WW, 1960, J NEUROPATH EXP NEUR, V19, P280, DOI 10.1097/00005072-196004000-00008; Brodkey JA, 1996, J NEUROSURG, V85, P625, DOI 10.3171/jns.1996.85.4.0625; HICKS MJ, 1993, CLIN NEUROPATHOL, V12, P92; HOUSE JL, 1982, ARCH OTOLARYNGOL, V108, P504; LUNARDI P, 1992, CLIN NEUROL NEUROSUR, V94, P265, DOI 10.1016/0303-8467(92)90102-9; Muenchau A, 1997, CLIN NEUROPATHOL, V16, P72; SABIN HI, 1987, NEUROSURGERY, V21, P798, DOI 10.1227/00006123-198712000-00004	7	5	5	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	2008	108	2					357	360		10.3171/JNS/2008/108/2/0357			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	259JB	WOS:000252934500023	18240934				2022-02-06	
J	Apuzzo, MLJ				Apuzzo, Michael L. J.			The National Football League: Cerebral concussion, peer-review, and the oath of hippocrates: Keynote address - NFL concussion summit, Chicago 2007	NEUROSURGERY			English	Article						concussion; mild traumatic brain injury; National Football League; sports	METABOLIC BRAIN VULNERABILITY; PROFESSIONAL FOOTBALL; TEMPORAL WINDOW; GAME IMPACTS; INJURIES; BIOMECHANICS; PERFORMANCE; PLAYER	THE FOLLOWING COMMENTS convey the assembled keynote points made at a summit called by Commissioner Roger Goodell involving all leading medical personnel in the National Football League, outside experts and players union representatives.	[Apuzzo, Michael L. J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90089 USA		Apuzzo, MLJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90089 USA.						Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	17	5	5	1	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2008	62	1					202	+		10.1227/01.NEU.0000311078.58272.3E			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	259YZ	WOS:000252978100041	18300908				2022-02-06	
J	Burke, R; Wassink, K; Martin, T; Seikel, AJ				Burke, Rebecca; Wassink, Kimberlee; Martin, Tracy; Seikel, Anthony J.			Message retrieval for survivors of traumatic brain injury	AUGMENTATIVE AND ALTERNATIVE COMMUNICATION			English	Article						head injury; augmentative and alternative communication; message organization; word retrieval		Survivors of traumatic brain injury often lose their ability to use natural speech to communicate and then rely on augmentative and alternative communication (AAC) devices. Survivors may also have concomitant cognitive communication disorders that negatively impact memory and organization skills. AAC devices need to incorporate a word retrieval organization strategy that is fast and effective. The current study compared the conditions of topic, place, and alphabet for message recognition. The participants were asked a delayed recall question to elicit a communicative response. Results showed that alphabet is significantly more accurate than place and significantly faster than place and topic. However, participants chose to retrieve words using all three strategies.	[Burke, Rebecca; Wassink, Kimberlee; Seikel, Anthony J.] Idaho State Univ, Dept Commun Sci & Disorders, Pocatello, ID 83209 USA; [Burke, Rebecca; Wassink, Kimberlee; Seikel, Anthony J.] Idaho State Univ, Dept Educ Deaf, Pocatello, ID 83209 USA; [Martin, Tracy] Life Inc, Pocatello, ID 83201 USA		Burke, R (corresponding author), Fort Vancouver Convalescent Ctr, 8507 NE 8th Way, Vancouver, WA 98664 USA.	rebeccadailburke@yahoo.com					Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Beukelman D. R., 1991, AUGMENT ALTERN COMM, V7, P171, DOI [10.1080/07434619112331275883, DOI 10.1080/07434619112331275883]; Beukelman D. R., 2005, AUGMENTATIVE ALTERNA; Burke R, 2004, BRAIN INJURY, V18, P497, DOI 10.1080/02699050310001645784; BURKE R, 2000, UNPUB OLDER ADULTS A; CAMPBELL L, 2002, ADV SPEECH LANGUAGE, V24, P89, DOI DOI 10.1080/14417040210001669311; CHERNEY LR, 1991, CLIN MANAGEMENT COMM, P9; DeRuyter F, 1991, COMMUNICATION DISORD, P317; DIETZ AR, 2005, AM SPEECH LANG HEAR; Dongilli P, 1992, J HEAD TRAUMA REHAB, V7, P91; FISHMAN I, 1987, ELECT COMMUNICATION; Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; Fuller D., 1991, AUGMENTATIVE ALTERNA, V7, P215, DOI DOI 10.1080/07434619112331275913; Hux K, 2003, ASSISTING SURVIVORS OF TRAUMATIC BRAIN INJURY, P93; Hux K, 2001, J MED SPEECH-LANG PA, V9, P71; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kertesz A., 1982, W APHASIA BATTERY; Ladtkow Margaret, 1993, Seminars in Speech and Language, V14, P61, DOI 10.1055/s-2008-1064159; LIGHT J, 1990, AAC (Augmentative and Alternative Communication), V6, P184, DOI 10.1080/07434619012331275454; Light J., 1988, AUGMENTATIVE ALTERNA, V4, P2, DOI DOI 10.1080/07434618812331274557; Olsson E, 2006, NEUROPSYCHOL REHABIL, V16, P257, DOI 10.1080/09602010500176328; Pickett J. M., 1980, SOUNDS SPEECH COMMUN; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Wilkinson K.M., 2004, AUGMENT ALTERN COMM, V20, P123, DOI 10.1080/07434610410001699717; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; [No title captured]	26	5	5	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0743-4618	1477-3848		AUGMENT ALTERN COMM	Augment. Altern. Commun.		2008	24	1					56	63		10.1080/07434610701421015			8	Audiology & Speech-Language Pathology; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Rehabilitation	259IM	WOS:000252933000006	18938757				2022-02-06	
J	Casson, IR; Viano, DC; Pellman, EJ				Casson, Ira R.; Viano, David C.; Pellman, Elliot J.			Synopsis of the National Football League player health and safety meeting: Chicago, Illinois, June 19, 2007	NEUROSURGERY			English	Article						concussion; mild traumatic brain injury; National Football League; sports	CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL; CONCUSSION; INJURIES; GAME; BIOMECHANICS; IMPACTS		[Viano, David C.] ProBiomech LLC, Bloomfield Hills, MI 48304 USA; [Casson, Ira R.; Viano, David C.; Pellman, Elliot J.] Natl Football League, Mild Traumat Brain Injury Comm, New York, NY USA; [Casson, Ira R.] Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY 11042 USA; [Casson, Ira R.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Pellman, Elliot J.] ProHlth Care Assoc, LLP, Lake Success, NY USA; [Pellman, Elliot J.] Mt Sinai Sch Med, Dept Med & Orthoped, New York, NY USA		Viano, DC (corresponding author), ProBiomech LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net					Casson Ira R, 2006, Neurosurgery, V59, pE1152; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	20	5	6	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2008	62	1					204	209		10.1227/01.NEU.0000311079.65895.3E			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	259YZ	WOS:000252978100042	18300909				2022-02-06	
J	Chaudhuri, S				Chaudhuri, Sibaji			Closed reduction, internal fixation with quadratus femoris muscle pedicle bone grafting in displaced femoral neck fracture	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Avascular necrosis of femoral head; closed reduction internal fixation; femoral neck fracture; muscle pedicle bone graft; quadratus femoris muscle pedicle bone grafting	AVASCULAR NECROSIS; YOUNG-ADULTS; HEAD; HEMIARTHROPLASTY; FEMUR; END; HIP	Background: Management of femoral neck fracture is still considered as an unsolved problem. It is more evident in displaced fractures where this fracture is considered as some sort of vascular insult to the head of the femur. We have used closed reduction, internal fixation and quadratus femoris muscle pedicle bone grafting in fresh displaced femoral neck fractures. Materials and Methods: From April 1996 to December 2004 we operated 73 consecutive patients of displaced femoral neck fracture in the age group of 24 to 81 years, mean age being 54.6 years. The patients were operated within one week of injury, the mean delay being 3.6 days. Closed reduction internal fixation along with quadratus femoris muscle pedicle bone grafting was done in all cases. They were followed up for an average period of 5.6 years (range 2-11 years). Results: Results were assessed according to modified Harris Hip Scoring system and found to be excellent in 53, good in 12, fair in six and poor in two patients. Bony union occurred in 68 cases, no patient developed avascular necrosis (AVN) till date. Conclusion: For fresh displaced femoral neck fracture in physiologically active patients closed reduction, internal fixation and quadratus femoris muscle pedicle bone grafting is a suitable option to secure union and prevent development of AVN.	[Chaudhuri, Sibaji] Bardhaman Med Coll, Kolkata 700004, India; [Chaudhuri, Sibaji] RG Kar Med Coll, Kolkata 700004, India		Chaudhuri, S (corresponding author), 247 Lake Gardens, Kolkata 700045, W Bengal, India.	sibajichaudhuri@yahoo.com					Abbas D, 2005, J BONE JOINT SURG BR, V87B, P1701, DOI 10.1302/0301-620X.87B12.16970; AGUR AM, 1999, BLOOD SUPPLY HEAD FE, V5, P339; ALOK S, 2000, INDIAN J ORTHOP, V34, P151; Andersson G, 1972, J Bone Joint Surg Br, V54, P621; Asif N, 1999, INDIAN J ORTHOP, V33, P23; ASKIN SR, 1976, CLIN ORTHOP RELAT R, P259; BAKSI DP, 1986, J BONE JOINT SURG BR, V68, P239, DOI 10.1302/0301-620X.68B2.3958010; Bartonicek J, 2004, CLIN ORTHOP RELAT R, P306, DOI 10.1097/01.blo.0000116316.28472.d8; CAMPBELL S, 1992, FRACTURES HIP PELVIS, P931; Catto M, 1965, J Bone Joint Surg Br, V47, P749; Cho MR, 2007, J ORTHOP TRAUMA, V21, P158, DOI 10.1097/BOT.0b013e31803773ae; Chua D, 1997, CAN J SURG, V40, P271; DAY B, 1984, CLIN ORTHOP RELAT R, P262; DEYERLE W M, 1965, Clin Orthop Relat Res, V39, P135; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Hirata T, 2001, CLIN ORTHOP RELAT R, P294; JUDET R, 1962, Acta Orthop Scand, V32, P421, DOI 10.3109/17453676208989601; KUMAR S, 2000, INDIAN J ORTHOP, V34, P148; Maurer Stephen G, 2003, Am J Orthop (Belle Mead NJ), V32, P438; MEYERS MH, 1973, J BONE JOINT SURG AM, VA 55, P257, DOI 10.2106/00004623-197355020-00002; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Partanen J, 2004, INT ORTHOP, V28, P28, DOI 10.1007/s00264-003-0517-y; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; SINGH M, 1970, J BONE JOINT SURG AM, VA 52, P457, DOI 10.2106/00004623-197052030-00005; Sugano N, 1996, J BONE JOINT SURG BR, V78B, P253, DOI 10.1302/0301-620X.78B2.0780253; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; TOOKE SMT, 1985, J BONE JOINT SURG AM, V67A, P1255, DOI 10.2106/00004623-198567080-00018	28	5	9	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	JAN-MAR	2008	42	1					33	38		10.4103/0019-5413.38578			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	505VU	WOS:000270728100006	19823652	Green Published			2022-02-06	
J	Coates, RC				Coates, Richard C.			Use of the emotional Stroop to assess psychological trauma following traumatic brain injury	BRAIN INJURY			English	Article						brain injury; emotional stroop; implicit memory; road traffic accident	POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; AMNESIA; EVENT; CONSEQUENCES; INFORMATION; ACCIDENTS; SYMPTOMS; THREAT; MEMORY	Primary objective: A modified Stroop task was used to investigate the hypothesis that implicit memory may be a possible mechanism for the development of acute stress disorder (ASD) in patients who have suffered a closed head injury. Research design: Three groups of hospital patients were compared within 1 month post-trauma: road traffic accident (RTA) patients with a brain injury (n = 15), RTA patients without a brain injury (n = 13) and a control group of orthopaedic and plastics patients (n = 15). Methods and procedures: Participants named colours of five types of words: RTA-related words, words related to hospitalization, obsessive-compulsive disorder (OCD) words, positive words and neutral words. Participants were also administered the Acute Stress Disorder Interview and the State-Trait Anxiety Inventory. Main outcomes and results: Both RTA patients with and without a brain injury demonstrated significant interference on words related to an RTA. Significant interference was unexpectedly observed for OCD words in RTA patients. Control patients did not display significant interference effects. Conclusions: Findings suggested that patients, both with and without explicit recall for an RTA, responded similarly on a task involving implicit memory for trauma. Possible implications for ASD and Post-traumatic Stress Disorder are discussed.	Royal Hosp Neuro Disabil, Dept Clin Psychol, London, England		Coates, RC (corresponding author), Royal Hosp Neuro Disabil, Dept Clin Psychol, London, England.	rcoates@rhn.org.uk					BRYANT RA, 1995, J ABNORM PSYCHOL, V104, P537, DOI 10.1037/0021-843X.104.3.537; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; CASSIDAY KL, 1992, COGNITIVE THER RES, V16, P283, DOI 10.1007/BF01183282; CONNOR A, 1988, INT J CLIN NEUROPSYC, V10, P1; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Harvey AG, 1996, COGNITIVE THER RES, V20, P613, DOI 10.1007/BF02227964; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.psych.46.1.209; Leech Geoffrey., 2001, WORD FREQUENCIES WRI; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; MCNALLY RJ, 1990, J ABNORM PSYCHOL, V99, P398, DOI 10.1037/0021-843X.99.4.398; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; MEGA MS, 2001, FRONTAL LOBES NEUROP, P15; RATTOCK J, 1993, J CLIN EXPT NEUROPSY, V6, P243; Salkovskis PM, 2000, BEHAV RES THER, V38, P347, DOI 10.1016/S0005-7967(99)00071-6; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SPIELBERGER CD, 1983, MANUAL STAT TRAIT AN; THRASHER SM, 1994, BEHAV RES THER, V32, P247, DOI 10.1016/0005-7967(94)90119-8; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	34	5	6	1	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	4					353	360		10.1080/02699050801992824			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	279HS	WOS:000254346900008	18365849				2022-02-06	
J	Eghwrudjakpor, PO; Essien, AA				Eghwrudjakpor, P. O.; Essien, A. A.			Hypersexual Behavior Following Craniocerebral Trauma An Experience with Five Cases	LIBYAN JOURNAL OF MEDICINE			English	Article						Brain injury; Disinhibition; Hypersexuality		Hypersexual behaviour is a recognized complication of head injuries which can be a source of great distress to patients and persons with whom these patients share significant relationships. In this article, we describe 5 patients who exhibited aberrant sexual behaviours following traumatic brain injury and discuss the relevant literature.	[Eghwrudjakpor, P. O.] Univ Port Harcourt, Teaching Hosp, Neurosurg Unit, Dept Surg, Port Harcourt, Nigeria; [Essien, A. A.] Univ Port Harcourt, Teaching Hosp, Dept Neuropsychiat, Port Harcourt, Nigeria		Eghwrudjakpor, PO (corresponding author), Univ Port Harcourt, Teaching Hosp, Neurosurg Unit, Dept Surg, Port Harcourt, Nigeria.						BLACKERBY W, DISRUPTION SEXUALITY; CATALAN J, 1995, J FORENSIC PSYCHIATR, V6, P255, DOI 10.1080/09585189508409891; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; GORMAN DG, 1992, ARCH NEUROL-CHICAGO, V49, P308, DOI 10.1001/archneur.1992.00530270128029; Goscinski I, 1997, J Neurosurg Sci, V41, P269; JENSEN B, TREATMENT HYPERSEXUA; KLEIN MJ, SEXUALITY DISABILITY; Levitsky AM, 1999, J AM GERIATR SOC, V47, P231, DOI 10.1111/j.1532-5415.1999.tb04583.x; LIMBERT J, HEAD INJURY SEXUALIT; LISK RD, 1966, J EXP ZOOL, V161, P129, DOI 10.1002/jez.1401610112; Malladi SS, 2005, INT J NEUROPSYCHOPH, V8, P635, DOI 10.1017/S1461145705005493; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Mutarelli EG, 2006, ARQ NEURO-PSIQUIAT, V64, P146, DOI 10.1590/S0004-282X2006000100032; Nagaratnam N, 2002, ARCH GERONTOL GERIAT, V35, P195, DOI 10.1016/S0167-4943(02)00026-2; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SCHAERF FW, USE MEDROXYPROGESTER; Sebit M. B., 1996, Central African Journal of Medicine, V42, P51; SIMKINS CN, SEXUAL DYSFUNCTION I; Spinella M, 2004, INT J NEUROSCI, V114, P1581, DOI 10.1080/00207450490509339; WALKER EA, 1975, CEREBRAL LOCALIZATIO; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163	22	5	5	0	5	UNIV ALFATEH, FAC MED	TRIPOLI	PO BOX 13040, TRIPOLI, 00000, LIBYA	1993-2820			LIBYAN J MED	Libyan J. Med.		2008	3	4					192	194					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V10HY	WOS:000207456300009	21503151	Green Published, gold, Green Submitted			2022-02-06	
J	Feist, F; Gugler, J; Giorda, A; Avalle, M; Puppini, R				Feist, F.; Gugler, J.; Giorda, A.; Avalle, M.; Puppini, R.			Improvements to the protection of vulnerable road users: Retrofittable, energy-absorbing front end for heavy goods vehicles	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Vulnerable road users; pedestrian; bicyclist; heavy goods vehicles; protection device; bull bar		Reducing road fatalities by 50% - as postulated in the European Union (EU) White Paper - requires research on road user groups and accident configurations that have not been addressed adequately so far: The Workpackage 2.1 of the EU-funded project APROSYS initiated the research on accidents involving heavy goods vehicles (HGVs) and vulnerable road users (VRUs). The project provides tools for evaluating the aggressiveness of HGV in relation to VRU and outlines the add-on solutions and improved designs for an enhanced protection of VRU. Priorities for enhanced VRU protection include the avoidance of run over at closing velocities below 20 km/h by improving the sight to the front and the side of the vehicle and the mitigation of primary and secondary impacts of VRUs at closing velocities between 15 and 40 km/h by increasing the energy absorption and changing the shape of the front end. The Graz University of Technology, the Politecnico di Torino and the Centro Ricerche FIAT studied the different approaches for an energy-absorbing front end that is lightweight, cost-efficient, retrofittable and compact - and that does not limit either the cooling or the lighting of the HGV. The study highlights the injury risk reduction by means of numerical simulations and experimental testing - including a full-scale test with a pedestrian dummy. It is shown that the risk for injuries to head and lower extremities may be reduced by up to 90% at impact velocities of up to 40 km/h. The study also shows that the concept of an energy-absorbing front end for HGVs might contribute to the aims defined in the EU White Paper at low costs.	[Feist, F.; Gugler, J.] Graz Univ Technol, Vehicle Safety Inst, A-8010 Graz, Austria; [Giorda, A.; Avalle, M.] Politecn Torino, Inst Mech, I-10129 Turin, Italy; [Puppini, R.] Ctr Ric FIAT, Orbassano, Italy		Feist, F (corresponding author), Graz Univ Technol, Vehicle Safety Inst, A-8010 Graz, Austria.	florian.feist@tugraz.at	Avalle, Massimiliano/S-5506-2017	Avalle, Massimiliano/0000-0002-1599-8219; Feist, Florian/0000-0003-4384-226X			*ALT ENG INC, 2004, RAD START MAN VERS 4; Avalle M, 2007, INT J IMPACT ENG, V34, P3, DOI 10.1016/j.ijimpeng.2006.06.012; Ballesteros MF, 2004, ACCIDENT ANAL PREV, V36, P73, DOI 10.1016/S0001-4575(02)00129-X; BELINGARDI G, 2005, P 9 FLOR ATA C FLOR; BELINGARDI G, 2002, P 2002 IBEC C PAR FR; BOVENKERK J, 2006, D212ABAPSP210062 APR; BOWERMAN N, 2008, PEDESTRIAN PROTECTIO; BURG H, 2007, HDB UNFALLREKONSTRUK; CHAWLA A, 1998, IRCOBI C GOT; *CONC MOULD LTD, 2008, FRONT PROT SYST ADV; DELANGE R, 2006, 2 INT C EXP S ACC RE; *EEVC WORK GROUP, 2002, 17 EEVC WORK GROUP; EGGERT E, 1998, EXPT UNTERSUCHUNGSME; ENOMOTO H, 2005, P 19 ESV C WASH DC U; ENOMOTO H, 2005, 19 TECHN C ENH SAF V; *ESI GROUP, 2005, PAMCRASH PAMSAFE 200; European New Car Assessment Program (EuroNCAP), 2004, PED TEST PROT VERS 4; FASSBENDER S, 2007, D213APSP210077 APROS; FEIST F, 2008, ICRASH C ATH; FEIST F, 2006, P ICRASH 2006 C ATH; FEIST F, 2007, D211BAPSP210069 APRO; FEIST F, 2008, WORKSH VULN ROAD US; FILDES B, 2004, IRCOBI C GRAZ; HUGEMANN W, 2007, UNFALLREKONSTRUKTION, V1; JANSSEN EG, 1996, P 15 ESV C; KAJZER J, 1992, IRCOBI C VER; LEE KB, 2007, P 20 ESV C LYON FRAN; LEFLER DE, 2001, P 17 ESV C; LONGHITANO D, 2005, SAE WORLD C DETR; NAGATOMI K, 2005, P 19 ESV C; NEILSON ID, 2001, 17 INT TECHN C ENH V; PIPKORN B, 2007, P 20 ESV C; SMITH T, 2008, D214APSP210086 APROS; SMITH T, 2005, APSP210038 APROSYS T; SMITH T, 2007, P 20 ESV C; STURTZ G, 1984, GLOBAL UND KOMPONENT; *TNO MADYMO BV, 2004, MADYMO MAN VERS 6 2	37	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1358-8265			INT J CRASHWORTHINES	Int. J. Crashworthiness		2008	13	6					609	627	PII 906411132	10.1080/13588260802412943			19	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	379RW	WOS:000261414900004					2022-02-06	
J	Ham, OK				Ham, Ok Kyung			Psychosocial factors associated with lifetime experience of serious unintentional injury in south Korea	PUBLIC HEALTH NURSING			English	Article						health-related quality of life; prevalence; risk-taking behavior; unintentional injury	QUALITY-OF-LIFE; TRAUMATIC BRAIN INJURY; RISK-FACTORS; PREVENTION; POPULATION; VIOLENCE; SUICIDE; ADULTS	Purpose: The purpose of this study was to determine the prevalence of lifetime unintentional-injury experience and evaluate the quality of life of unintentional-injury victims, to provide useful data for the development of interventions aimed at decreasing the incidence of unintentional injuries. Design, sample, and methods: This study utilized data obtained from cross-sectional surveys of 24,327 Korean individuals aged 19-65 years, performed using face-to-face interviews. Demographic characteristics, unintentional-injury experience, attributes of health behavior, and health-related quality of life (HRQoL) questions were included in the study instruments. Results: About 11.8% of the subjects had experienced an unintentional injury that required hospitalization at least once in their lifetime. Being older, being male, having less education and lower income, working in a blue-collar job, and being enrolled in medical aid progams were associated with increased likelihood of having an unintentional injury. Among the HRQoL and risk-taking behavior variables, limitations in daily activities, suicide ideation, and binge drinking were significantly associated with injury experience. Conclusion: Public health efforts to prevent unintentional injuries should target high-risk populations such as males, those with low incomes and education levels, and binge drinkers. Efforts should also be made to enhance the HRQoL of injury victims.	[Ham, Ok Kyung] Inha Univ, Dept Nursing, Inchon, South Korea		Ham, OK (corresponding author), 253 Yonghyun Dong, Inchon 402751, South Korea.	okkyung@inba.ac.kr					Aitken LM, 2007, INJURY, V38, P19, DOI 10.1016/j.injury.2006.05.020; CHIPMAN ML, 1995, ACCIDENT ANAL PREV, V27, P699, DOI 10.1016/0001-4575(95)00013-P; Easton A., 2004, Central European Journal of Public Health, V12, P94; Gielen AC, 2002, PATIENT EDUC COUNS, V46, P163; Girasek DC, 2003, HEALTH EDUC BEHAV, V30, P287, DOI 10.1177/1090198103030003005; GROSSMAN DC, 1993, EPIDEMIOLOGY, V4, P115, DOI 10.1097/00001648-199303000-00006; Hang HM, 2003, SCAND J PUBLIC HEALT, V31, P38, DOI 10.1080/14034950310015095; KANG KM, 1998, GOSPEL CHURCH, V10, P163; KIM SI, 2001, J KOREAN NEUROPSYCHI, V40, P416; *KOR MIN GOV LEG, 2004, LOC HLTH LAW; *KOR MIN GOV LEG, 2006, SPEC LAW HLTH CAR FI; *KOR MIN HLTH WEL, 2003, DIS CAUS DEATH; *KOR NURS ASS, 2004, MED PAR PERS HLTH CT; Korea National Statistical Office, 2005, CAUS DEATH STAT; Korean Ministry of Health and Welfare, 2005, HLTH PLAN 2010; Lam CLK., 2003, ASIA PACIFIC FAM MED, V2, P98, DOI [10.1046/j.1444-1683.2003.00064.x, DOI 10.1046/J.1444-1683.2003.00064.X]; LEE JS, 2004, THESIS ULSAN U ULSAN; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; PLASENCIA A, 1995, ACCIDENT ANAL PREV, V27, P591, DOI 10.1016/0001-4575(95)00007-M; Prause W, 2005, HUM PSYCHOPHARM CLIN, V20, P359, DOI 10.1002/hup.699; Ramstad SM, 2004, J TRAUMA STRESS, V17, P529, DOI 10.1007/s10960-004-5802-z; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Stea JB, 2002, MIL MED, V167, P944, DOI 10.1093/milmed/167.11.944; *US CDCP, 2003, INJ CTR; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Vollrath M, 2005, J PEDIATR PSYCHOL, V30, P481, DOI 10.1093/jpepsy/jsi073; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Watson Wendy L, 2005, Int J Inj Contr Saf Promot, V12, P227, DOI 10.1080/17457300500172875; *WHO DEP MENT HLTH, 2004, GLOB STAT REP ALC 20; *WHO REG OFF W PAC, 2004, INJ VIOL PREV; *WHO STAT INF SYST, 2004, CAUS DEATH STAT EST; Wilson ALG, 2003, PREV MED, V36, P124, DOI 10.1006/pmed.2002.1054; Zambon F, 2006, ACCIDENT ANAL PREV, V38, P1183, DOI 10.1016/j.aap.2006.05.005; Zhu XL, 2001, BRIT J NEUROSURG, V15, P464, DOI 10.1080/02688690120097688; [No title captured]	35	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0737-1209	1525-1446		PUBLIC HEALTH NURS	Public Health Nurs.	JAN-FEB	2008	25	1					37	45		10.1111/j.1525-1446.2008.00678.x			9	Public, Environmental & Occupational Health; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nursing	262QT	WOS:000253163800006	18173584				2022-02-06	
J	Jovicic, ME; Popovic, M; Nesica, KJ; Popovic, N; Pavlovic, SJ; Rakic, L				Jovicic, Milena Eric; Popovic, Miroljub; Nesica, Katica Jovanova; Popovic, Natalija; Pavlovic, Svetlana Jovicic; Rakic, Ljubisav			Aging, aluminium and basal forebrain lesions modify substrate kinetics of erythrocyte membrane Na, K-ATPase in the rat	JOURNAL OF ALZHEIMERS DISEASE			English	Article						aging; aluminium; Alzheimer's disease; K-ATPase; Na; nucleus basalis magnocellularis; rats	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NUCLEUS BASALIS; OXIDATIVE STRESS; NA+/K+-ATPASE; SODIUM-PUMP; HUNTINGTONS-DISEASE; MEMORY IMPAIRMENTS; LIPID-PEROXIDATION; TRANSGENIC MICE	Several studies suggested that the activity of erythrocyte Na, K-ATPase declines with aging. Here, it is postulated that alterations in the substrate kinetics of the erythrocyte membrane Na, K-ATPase could be more aggravated in conditions of brain cholinergic dysfunction seen in Alzheimer's disease than in normal aging. To test this hypothesis, we compared the Na, K-ATPase activity (Vmax/Km parameters) in aged rats with those in young rats with brain cholinergic dysfunction induced by electrolytic-, kainic acid-lesioned nucleus basalis magnocellularis (NBM) or by intracerebroventricular AlCl3 administration. In the above mentioned groups, Vmax values were significantly lower in comparison to the control animals. Furthermore, Km values were significantly higher in animals with electrolytic-induced NBM lesions, AlCl3 treated rats and aged animals. However, Km was significantly lower in kainic acid-induced NBM lesions compared to the control group. The Na, K-ATPase catalytic efficiency, estimated by the ratio Vm/Km, decreased as followed: young animals > aged animals > kainic acid lesion > electrolityc lesion > AlCl3. Our data suggest that neurodegenerative processes similar to those seen in Alzheimer's disease affect the sodium/potassium pump functionality which might be detected in peripheral blood erythrocyte membranes.	[Jovicic, Milena Eric; Nesica, Katica Jovanova] Inst Virol Vaccines & Sera Torlak, Belgrade 11221, Serbia; [Popovic, Miroljub] Univ Murcia, Fac Med, Dept Anat Human & Psicobiol, Murcia 30100, Spain; [Popovic, Natalija] Univ Murcia, Fac Biol, Dept Fisiol Anim, Murcia 30100, Spain; [Popovic, Natalija] Fac Med, Ctr Clin, Inst Nephrol, Belgrade 11000, Serbia; [Rakic, Ljubisav] Serbian Acad Sci & Art, Belgrade 11001, Serbia		Jovicic, ME (corresponding author), Inst Virol Vaccines & Sera Torlak, Vojvode Stepe 458, Belgrade 11221, Serbia.	ericjovicic@sbb.co.yu	Popovic, Miroljub/L-5320-2014; Popovic, Natalija/L-5377-2014; Pavlovic, Svetlana Jovicic/AAQ-6436-2020	Popovic, Miroljub/0000-0002-1326-3876; 			Aggarwal Sarita, 2006, J Cancer Res Ther, V2, P24; AMANO M, 1989, TOHOKU J EXP MED, V159, P131, DOI 10.1620/tjem.159.131; ANDERSON WR, 1994, EPILEPSY RES, V17, P221, DOI 10.1016/0920-1211(94)90052-3; ARENDASH GW, 1987, SCIENCE, V238, P952, DOI 10.1126/science.2890210; Arianna V, 2007, NEUROBIOL AGING, V28, P987, DOI 10.1016/j.neurobiolaging.2006.05.010; Bala K, 2006, BIOGERONTOLOGY, V7, P81, DOI 10.1007/s10522-006-6495-x; BENINGER RJ, 1986, PHARMACOL BIOCHEM BE, V24, P1353, DOI 10.1016/0091-3057(86)90195-4; BERNSTEIN HG, 1994, PHARMACOL BIOCHEM BE, V47, P587, DOI 10.1016/0091-3057(94)90163-5; Bores GM, 1998, BRAIN RES BULL, V46, P423, DOI 10.1016/S0361-9230(97)00382-1; BOZZO C, 1990, METABOLISM, V39, P808, DOI 10.1016/0026-0495(90)90123-T; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; BUTTERFIELD DA, 1978, ANN NEUROL, V4, P60, DOI 10.1002/ana.410040111; CASPERS ML, 1993, MOL CHEM NEUROPATHOL, V19, P65, DOI 10.1007/BF03160169; CONDELLI WS, 1993, AM J DRUG ALCOHOL AB, V19, P65, DOI 10.3109/00952999309002666; Dickey CA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-7; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Dosunmu Remi, 2007, Expert Rev Neurother, V7, P887, DOI 10.1586/14737175.7.7.887; DRAGO F, 1992, PHARMACOL BIOCHEM BE, V41, P445, DOI 10.1016/0091-3057(92)90124-X; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; ELDEFRAWY SR, 1985, NEUROBIOL AGING, V6, P325, DOI 10.1016/0197-4580(85)90011-9; GAMBERT SR, 1983, J GERONTOL, V38, P23, DOI 10.1093/geronj/38.1.23; Gibson GE, 2002, FRONT BIOSCI, V7, pD1007, DOI 10.2741/gibson; Gorini A, 2002, PROG NEURO-PSYCHOPH, V26, P81, DOI 10.1016/S0278-5846(01)00233-0; Hattori N, 1998, NEUROSCI LETT, V254, P141, DOI 10.1016/S0304-3940(98)00654-5; HEGNER D, 1979, MECH AGEING DEV, V10, P117, DOI 10.1016/0047-6374(79)90075-7; HEPLER DJ, 1985, BRAIN RES, V346, P8, DOI 10.1016/0006-8993(85)91088-1; HOKINNEAVERSON M, 1977, CLIN CHIM ACTA, V76, P399, DOI 10.1016/0009-8981(77)90167-X; Jayakumar R, 2003, BBA-GEN SUBJECTS, V1622, P20, DOI 10.1016/S0304-4165(03)00101-6; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jovanova-Nesic K, 2006, INT J NEUROSCI, V116, P681, DOI 10.1080/00207450600674830; Kairane C, 2002, FEBS LETT, V531, P241, DOI 10.1016/S0014-5793(02)03510-X; Karageuzyan Konstantin G., 2005, Current Drug Targets - Inflammation and Allergy, V4, P85, DOI 10.2174/1568010053622939; Kaur J, 1998, INDIAN J BIOCHEM BIO, V35, P364; Kawamoto EM, 2005, NEUROBIOL AGING, V26, P857, DOI 10.1016/j.neurobiolaging.2004.08.011; Kumar S, 1999, MED HYPOTHESES, V52, P557, DOI 10.1054/mehy.1997.0693; Laura N, 2005, EXP GERONTOL, V40, P519, DOI 10.1016/j.exger.2005.03.009; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Li L, 1998, CHINESE MED J-PEKING, V111, P638; LIGURI G, 1990, NEUROSCI LETT, V112, P338, DOI 10.1016/0304-3940(90)90227-Z; Looney S W, 1997, Depress Anxiety, V5, P53, DOI 10.1002/(SICI)1520-6394(1997)5:2<53::AID-DA1>3.0.CO;2-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luth HJ, 2001, BRAIN RES, V913, P57, DOI 10.1016/S0006-8993(01)02758-5; Mazzanti L, 1997, METABOLISM, V46, P59, DOI 10.1016/S0026-0495(97)90168-2; MAZZANTI L, 1992, CLIN BIOCHEM, V25, P41, DOI 10.1016/0009-9120(92)80044-H; MIYAMOTO M, 1985, BRAIN RES, V328, P97, DOI 10.1016/0006-8993(85)91327-7; MRSULJA BB, 1993, IUGOSL PHYSL PHARM A, V29, P115; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; NAYLOR GJ, 1977, GERONTOLOGY, V23, P256, DOI 10.1159/000212195; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Petronijevic ND, 2003, PROG NEURO-PSYCHOPH, V27, P431, DOI 10.1016/S0278-5846(03)00030-7; Platt B, 2001, BRAIN RES BULL, V55, P257, DOI 10.1016/S0361-9230(01)00511-1; Popovic M, 2006, EXP BRAIN RES, V170, P368, DOI 10.1007/s00221-005-0219-3; Popovic M, 1996, INT J NEUROSCI, V86, P281, DOI 10.3109/00207459608986719; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; Repetto MG, 1999, EUR J CLIN INVEST, V29, P643; Rodrigo R, 2007, MOL CELL BIOCHEM, V303, P73, DOI 10.1007/s11010-007-9457-y; SCHMALZING G, 1981, LIFE SCI, V29, P371, DOI 10.1016/0024-3205(81)90330-1; Silva VS, 2007, TOXICOLOGY, V236, P158, DOI 10.1016/j.tox.2007.04.017; SIMAT BM, 1984, AM J CLIN NUTR, V40, P339, DOI 10.1093/ajcn/40.2.339; Skoumalova A, 2003, EXP GERONTOL, V38, P711, DOI 10.1016/S0531-5565(03)00071-8; Stoehr JD, 1997, NEUROBIOL LEARN MEM, V67, P214, DOI 10.1006/nlme.1997.3768; STOJANOVIC T, 1988, METAB BRAIN DIS, V3, P265, DOI 10.1007/BF00999536; SUN AY, 1992, MOL CHEM NEUROPATHOL, V17, P51, DOI 10.1007/BF03159981; SZTRIHA L, 1987, J NEUROCHEM, V49, P83, DOI 10.1111/j.1471-4159.1987.tb03397.x; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Toledano A., 2004, Current Alzheimer Research, V1, P189, DOI 10.2174/1567205043332117; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Walton JR, 2007, J INORG BIOCHEM, V101, P1275, DOI 10.1016/j.jinorgbio.2007.06.001; Yokel RA, 2000, NEUROTOXICOLOGY, V21, P813; ZANELLA A, 1980, J NEUROL SCI, V47, P93, DOI 10.1016/0022-510X(80)90028-3	70	5	5	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2008	14	1					85	93					9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	311TW	WOS:000256624300008	18525130				2022-02-06	
J	Liesiene, R; Kevalas, R; Uloziene, I; Gradauskiene, E				Liesiene, Rueta; Kevalas, Rimantas; Uloziene, Ingrida; Gradauskiene, Egle			Search for clinical and neurophysiological prognostic patterns of brain coma outcomes in children	MEDICINA-LITHUANIA			English	Article						severe brain trauma; early prognosis of brain coma outcome; electroencephalography; brainstem auditory evoked-potentials	INTENSIVE-CARE-UNIT; ELECTROENCEPHALOGRAM; ENCEPHALOPATHY; TOMOGRAPHY; PREDICTION; INJURY	Objective. The aim of the study was to evaluate the possible predictive values of clinical examinations combined with the recordings of electroencephalography and brainstem auditory-evoked potentials in traumatic coma of pediatric patients. Material and methods. A total of 43 children in coma with severe acute head trauma were included in the study. They were investigated and treated in pediatric intensive care unit using standard evaluation and treatment protocol. Evaluation of coma was performed using Glasgow Coma Scale. Electroencephalography for 35 patients and brainstem auditory-evoked potentials for 24 patients were recorded. Results. Glasgow coma scale statistic pool median was equal to 4 points as measured in presence of brain edema, meanwhile it was 6 as measured in absence of edema. In case of supratentorial damage, median duration of consciousness recovery was 10 days. In absence of above-mentioned supratentorial damage, recovery of the consciousness was earlier - median was 5 days. Determined duration of artificial lung ventilation was statistically significantly shorter for those who had edema (P=0.048). In 20 patients (57% of all cases), constant or alternating slow wave activity was observed during the first electroencephalographic recording. In other cases, "alpha coma" or low amplitude of arrhythmic activity and local slowing activity corresponding to brain damage seen on computerized tomography were recorded. For 24 patients, brainstem auditory-evoked potentials were recorded. In 9 cases, they were abnormal; in these cases, the consciousness of the patients recovered after 44 days or did not recover. Conclusions. Glasgow coma scale results alone may have limited prognostic value in absence of other objective neurophysiologic investigation data concerning the coma outcome in children. Prognosis may be worse if pathological brainstem auditory-evoked potentials correlate with pathological dynamic changes in electroencephalography and brain lesions, diagnosed during computerized tomography scan.	[Liesiene, Rueta; Kevalas, Rimantas] Kaunas Univ Med, Dept Children Dis, LT-50009 Kaunas, Lithuania; [Uloziene, Ingrida] Kaunas Univ Med, Biomed Res Inst, Neurosci Lab, LT-50009 Kaunas, Lithuania; [Gradauskiene, Egle] Kaunas Univ Med, Dept Otorhinolaryngol, LT-50009 Kaunas, Lithuania		Liesiene, R (corresponding author), Kaunas Univ Med, Dept Children Dis, Eiveniu 2, LT-50009 Kaunas, Lithuania.	ruta_liesiene@yahoo.com		Uloziene, Ingrida/0000-0003-2868-4574			Biagioni E, 2001, PEDIATRICS, V107, P461, DOI 10.1542/peds.107.3.461; Gire C, 2000, NEUROPHYSIOL CLIN, V30, P97, DOI 10.1016/S0987-7053(00)00061-7; Grinkeviciute Dovile, 2006, Medicina (Kaunas), V42, P278; Guerit JM, 2005, PROG BRAIN RES, V150, P415, DOI 10.1016/S0079-6123(05)50029-3; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Liesiene Ruta, 2006, Medicina (Kaunas), V42, P355; LIESIENE V, 1998, NEUROLOGINES DIAGNOS, V2, P62; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; SANCHEZCHAVEZ JJ, 1988, REV NEUROL, V27, P213; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Shalak LF, 2003, PEDIATRICS, V111, P351, DOI 10.1542/peds.111.2.351; *STAT DEP LIET RES, 2007, LIET VAIK; Toet MC, 2002, PEDIATRICS, V109, P772, DOI 10.1542/peds.109.5.772; ULOZIENE I, 1998, NEUROLOGINES DIAGNOS, V2, P80; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; van Putten MJAM, 2003, J CLIN NEUROPHYSIOL, V20, P320, DOI 10.1097/00004691-200309000-00004; YAMAKAMI I, 1991, JAP SHINKEI GEKA, V19, P939; 2007, DECISION IMPLEMENTAT	19	5	10	0	1	KAUNAS UNIV MEDICINE & VILNIUS UNIV	KAUNAS	KAUNAS UNIV MEDICINE, A MICKEVICIAUS 9, KAUNAS, LT-44307, LITHUANIA	1010-660X			MED LITH	Med. Lith.		2008	44	4					273	279		10.3390/medicina44040035			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302VV	WOS:000255998900003	18469503	hybrid, Green Submitted			2022-02-06	
J	Michiue, T; Ishikawa, T; Quan, L; Zhu, BL; Maeda, H				Michiue, Tomomi; Ishikawa, Takaki; Quan, Li; Zhu, Bao-Li; Maeda, Hitoshi			Forensic pathological evaluation of injury severity and fatal outcome in traffic accidents: five illustrative autopsy cases of clinically unexpected death	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article						Traumatology; Injury severity; Preventable trauma death; Traffic accident	HANDLEBAR INJURIES; TRAUMA SCORE; CHILDREN; FRACTURE; CARE	In forensic casework, investigation of injury severity in traffic accidents is important for evaluating the mortality, occasionally in terms of the adequacy of clinical management. The present study evaluated 5 cases of clinically unexpected delayed collapse followed by death using the abbreviated injury scale (AIS), injury severity score (ISS), and a clinical trauma care method (trauma and injury severity score, TRISS). In these cases, major injury (AIS = 3-5) was found in the head, chest and/or abdomen at autopsy, and ISS was estimated to be 11-45 (serious to critical but not incompatible with life). By the TRISS method, the probability of survival (P(s)) was estimated to be >0.5 for all cases (0.60-0.99), suggesting that these were preventable deaths. However, the present cases showed several common features: (a) fatality due to closed injury/-ies to the thoracic and/or abdominal viscera, (b) alert and poor symptoms/clinical signs, and (c) poor positive findings in diagnostic imaging at early times after injury, and (d) complications of other evident injuries, suggesting difficulties in the clinical diagnosis of potentially fatal injuries, but (c) possibly predictable fatal injury when typical patterns of traffic accident injury were considered.	[Michiue, Tomomi; Ishikawa, Takaki; Quan, Li; Zhu, Bao-Li; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Osaka 5458585, Japan; [Zhu, Bao-Li] China Med Univ, Sch Forens Med, Dept Forens Pathol, Shenyang 110001, Liaoning Prov, Peoples R China		Michiue, T (corresponding author), Osaka City Univ, Sch Med, Dept Legal Med, Abeno Ku, Asahi Machi 1-4-3, Osaka 5458585, Japan.	michi.leg@med.osaka-cu.ac.jp	Ishikawa, Takaki/AAP-7005-2020				Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL AIS 20; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Canty TG, 1999, J TRAUMA, V46, P234, DOI 10.1097/00005373-199902000-00005; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Clarnette TD, 1997, AUST NZ J SURG, V67, P338, DOI 10.1111/j.1445-2197.1997.tb01986.x; Crestanello JA, 1999, J TRAUMA, V47, P161, DOI 10.1097/00005373-199907000-00034; Friedman Z, 1996, AM J FOREN MED PATH, V17, P233, DOI 10.1097/00000433-199609000-00011; Gamblin TC, 2005, J TRAUMA, V59, P1231, DOI 10.1097/01.ta.0000197270.25280.7c; HILL JR, 1994, ACCIDENT ANAL PREV, V26, P11, DOI 10.1016/0001-4575(94)90065-5; Lam JPH, 2001, BRIT MED J, V322, P1288, DOI 10.1136/bmj.322.7297.1288; OTREMSKI I, 1990, INJURY, V21, P81, DOI 10.1016/0020-1383(90)90059-4; Saukko P, 2004, KNIGHTS FORENSIC PAT; WILLIAMS JS, 1971, J TRAUM, V11, P207, DOI 10.1097/00005373-197103000-00002; Wyatt JP, 1998, FORENSIC SCI INT, V95, P57, DOI 10.1016/S0379-0738(98)00085-1; Yasuhara H, 2000, EUR J VASC ENDOVASC, V20, P517, DOI 10.1053/ejvs.2000.1235; [No title captured]	19	5	8	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X			FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.		2008	4	3					153	158		10.1007/s12024-007-9025-5			6	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	484GQ	WOS:000269032400003	19291453				2022-02-06	
J	Swihart, AA; Harris, KM; Hatcher, LL				Swihart, Andrew A.; Harris, Kristen M.; Hatcher, Larry L.			Inability of the Rarely Missed Index to identify simulated malingering under more realistic assessment conditions	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	111th Annual Convention of the American-Psychological-Association	AUG 07-10, 2003	Toronto, CANADA	Amer Psychol Assoc			ITEM RESPONSE BIASES; WMS-III; VALIDITY	The Wechsler Memory Scale-III (WMS-III) Rarely Missed Index (RMI) was developed by Killgore and DellaPietra (1999b, 2000b, 2001) to detect malingering. Its development was based on item-response biases in the Logical Memory Delayed Recognition (LMDR) items of the WMS-III (Killgore DellaPietra, 1999a, 2000a). We completed replication studies using undergraduates, analog malingerers, and patients. In Experiment 1, 100 undergraduates nave to the WMS-III Logical Memory stories were administered the LMDR, and item-response biases were explored. In Experiment 2, 49 undergraduates feigned brain injury on cognitive and symptom validity tests. Data were also extracted from 83 traumatic brain injury (TBI), dementia, psychiatric/pain, stroke, and other patient files. Neither the previously reported item-response biases nor the diagnostic utility of the RMI in identifying simulated malingerers were replicated.	[Swihart, Andrew A.; Harris, Kristen M.; Hatcher, Larry L.] Saginaw Valley State Univ, Dept Psychol, University Ctr, MI 48710 USA		Swihart, AA (corresponding author), Saginaw Valley State Univ, Dept Psychol, 7400 Bay Rd, University Ctr, MI 48710 USA.	aswihart@svsu.edu					BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Killgore WDS, 2000, PSYCHOL REP, V86, P851, DOI 10.2466/PR0.86.3.851-857; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; KILLGORE WDS, 2001, J INT NEUROPSYCH SOC, V7, P144; KILLGORE WDS, 1999, 27 ANN M INT NEUR SO; Killigore WDS, 1999, ARCH CLIN NEUROPSYCH, V14, P92; Lange R, 2003, ARCH CLIN NEUROPSYCH, V18, P786; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P412, DOI 10.1080/13803390490520319; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Meyers JE., 1995, REY COMPLEX FIGURE T; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Slick D., 1997, VSVT VICTORIA SYMPTO; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; [No title captured]	21	5	5	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	1					120	126		10.1080/13803390701249044			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	251AP	WOS:000252343000012	17852585				2022-02-06	
J	Tamplin, J; Grocke, D				Tamplin, Jeanette; Grocke, Denise			A Music Therapy Treatment Protocol for Acquired Dysarthria Rehabilitation	MUSIC THERAPY PERSPECTIVES			Spanish	Article								Dysarthria is a common form of speech impairment, affecting 20-50% of stroke patients and 10-60% of traumatic brain injury patients (Sellars, Hughes, & Langhorne, 2002). Very little research has been conducted on the effect of treatments for clysarthria and even less has been reported on rehabilitative music therapy interventions. In the current climate of evidence-based practice (Edwards, 2002) the music therapy profession needs to develop and rigorously test interventions designed to address specific disorders such as dysarthria. This paper discusses theoretical foundations for the use of singing interventions to treat dysarthria and presents a music therapy dysarthria treatment protocol incorporating vocal and respiratory exercises and therapeutic singing.	[Tamplin, Jeanette] Austin Hlth, Royal Talbot Rehabil Ctr, Melbourne, Vic, Australia; [Grocke, Denise] Univ Melbourne, Melbourne, Vic, Australia; [Grocke, Denise] Univ Melbourne, Mus Therapy, Melbourne, Vic, Australia		Tamplin, J (corresponding author), Austin Hlth, Royal Talbot Rehabil Ctr, Melbourne, Vic, Australia.		Tamplin, Jeanette/AAR-2855-2021	Tamplin, Jeanette/0000-0002-3623-033X			Abbs J. H., 1989, DISORDERS COMMUNICAT, P206; Adamek M. S., 2000, EFFECTIVENESS MUSIC; Baker F., 2004, MUSIC THERAPY PERSPE, V22, P4; Baker F., 2004, THESIS; Baker F., 2004, NORD J MUSIC THER, V13, P20, DOI DOI 10.1080/08098130409478095; Baker F.A., 2000, MUSIC THER PERSPECT, V18, P110, DOI [10.1093/mtp/18.2.110, DOI 10.1093/MTP/18.2.110]; Brookshire R. H., 2003, INTRO NEUROGENIC COM; Brown J.R., 1975, MOTOR SPEECH DISORDE; Claeys M. S., 1989, MUSIC THERAPY PERSPE, V6, P71; Cohen N., 1995, MUSIC THERAPY PERSPE, V13, P69; COHEN NS, 1988, J MUSIC THER, V25, P85, DOI 10.1093/jmt/25.2.85; COHEN NS, 1992, J MUSIC THER, V29, P87, DOI 10.1093/jmt/29.2.102; COHEN NS, 1993, J MUSIC THER, V30, P81, DOI 10.1093/jmt/30.2.81; Cohen NS., 1994, MUSIC THER PERSPECT, V12, P8; Darrow A. A., 1991, CASE STUDIES MUSIC T, P193; DARROW AA, 1986, J MUSIC THER, V23, P194, DOI 10.1093/jmt/23.4.194; Edwards, 2002, BRIT J MUSIC THERAPY, V16, P29; Fletcher S. G., 1992, ARTICULATION PHYSIOL; Gilbertson S. K., 2004, THESIS; Hamilton L., 2001, AUSTR J MUSIC THERAP, V12, P13; HAMMEN VL, 1994, J SPEECH HEAR RES, V37, P244, DOI 10.1044/jshr.3702.244; Haneishi E, 2001, J MUSIC THER, V38, P273, DOI 10.1093/jmt/38.4.273; KENNEDY G, 1993, EUR J DISORDER COMM, V28, P213; Kent R. D., 1994, MOTOR SPEECH DISORDE, P3; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; KOTBY MN, 1995, ACCENT METHOD VOICE; Livingston F., 1996, AUSTR J NEUROSCI, V9, P12; Mateer CA, 2000, BRAIN COGNITION, V42, P106, DOI 10.1006/brcg.1999.1175; Mclntosh G. C., 1995, J NEUROLOGICAL REHAB, V9, P131; Nudo R. J., 2000, CEREBRAL REORGANIZAT, P168; Pilon MA, 1998, BRAIN INJURY, V12, P793, DOI 10.1080/026990598122188; PRIOR M, 1990, J CLIN EXP NEUROPSYC, V12, P301, DOI 10.1080/01688639008400976; Rosenbek J.C., 1985, CLIN MANAGEMENT NEUR, V2nd ed., P97; Sacks O, 1998, CLIN APPL MUSIC NEUR, P1; SAMSON S, 1992, NEUROPSYCHOLOGIA, V30, P815, DOI 10.1016/0028-3932(92)90085-Z; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Sellars C, 2002, CLIN REHABIL, V16, P61, DOI 10.1191/0269215502cr468oa; Tamplin J, 2008, NEUROREHABILITALION, V23, P1; Tamplin J., 2005, THESIS; Taylor D., 1997, BIOMEDICAL FDN MUSIC; Thaut M. H., 2005, MED CODING RECORDS M; Thaut M. H., 2000, SCI MODEL MUSIC THER; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH., 2005, RHYTHM MUSIC BRAIN S; Thaut MH, 1993, J NEUROL REHABIL, V7, P9, DOI DOI 10.1177/136140969300700103; van der Merwe A, 1997, COMSIG '97 - PROCEEDINGS OF THE 1997 SOUTH AFRICAN SYMPOSIUM ON COMMUNICATIONS AND SIGNAL PROCESSING, P1, DOI 10.1109/COMSIG.1997.629970; Yiu EM-L, 2002, ASIA PAC J SPEECH LA, V7, P123; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; YORKSTON KM, 1990, J SPEECH HEAR DISORD, V55, P550, DOI 10.1044/jshd.5503.550; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; [No title captured]	51	5	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0734-6875	2053-7387		MUSIC THER PERSPECT	Music Ther. Perspect.		2008	26	1					23	29		10.1093/mtp/26.1.23			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VG1IX	WOS:000445362600003					2022-02-06	
J	Uomoto, JM				Uomoto, Jay M.			Older adults and neuropsychological rehabilitation following acquired brain injury	NEUROREHABILITATION			English	Article						Geriatric; brain injury; excess disability; rehabilitation	INDUCED MOVEMENT THERAPY; DEPRESSION; STROKE; OUTCOMES; PAIN; IMPACT; MILD; INTERVENTION; EPIDEMIOLOGY; IMPAIRMENT	The literature related to neurorehabilitation methods specific to older adults is now emerging, the timing of which is important given the epidemiology of acquired brain injury in this population. Examined are epidemiological characteristics of acquired brain injury, with a focus on traumatic brain injury and stroke. Principles of geriatric neurorehabilitation are proposed by using a Neo-Lurian framework, and employing the PASS model of brain-behavior relationship forwarded by J. P. Das. Discussed are specific issues and strategies of geriatric neurorehabilitation by removing excess disability that complicates acquired brain injury. These include addressing depression, sleep disturbance, chronic pain, and social support. Restorative interventions may now also appear as a part of geriatric neurorehabilitation practices. A focus on team functioning as a critical contributor to functional outcomes in those older adults with acquired brain injury is presented along with future directions that capitalize upon the ideals of primary, secondary, and tertiary prevention.	VA Puget Sound Hlth Care Syst, Rehabil Care Serv, Ctr Polytrauma Care, Seattle, WA 98108 USA		Uomoto, JM (corresponding author), VA Puget Sound Hlth Care Syst, Rehabil Care Serv, Ctr Polytrauma Care, S-117-RCS,1660 S Columbian Way, Seattle, WA 98108 USA.	jay.uomoto@va.gov	Uomoto, Jay/AAF-4809-2019				Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P469; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Barker-Collo S, 2006, NEUROPSYCHOL REV, V16, P53, DOI 10.1007/s11065-006-9007-5; Barnes C, 2004, ARCH PHYS MED REHAB, V85, P1602, DOI 10.1016/j.apmr.2004.02.025; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Butefisch CM, 2006, NEUROL SCI, V27, pS18, DOI 10.1007/s10072-006-0540-z; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; *CDCP, 2006, MMWR WEEKLY, V56, P201; Christensen AL, 1999, NEUROPSYCHOL REV, V9, P71, DOI 10.1023/A:1025655707095; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Das JP, 1999, NEUROPSYCHOL REV, V9, P107, DOI 10.1023/A:1025611924842; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Espiritu DAV, 2001, INT J GERIATR PSYCH, V16, P1098, DOI 10.1002/gps.476; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FENN H, 1993, INT J GERIATR PSYCH, V8, P67, DOI 10.1002/gps.930080111; Flanagan SR, 2008, ARCH PHYS MED REHAB, V89, pS9, DOI 10.1016/j.apmr.2007.12.010; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Glozman JM, 1999, NEUROPSYCHOL REV, V9, P33, DOI 10.1023/A:1025690920712; Goldstein F. C., 2005, REHABILITATION TRAUM, P235; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Goldstein FC, 1997, J AM GERIATR SOC, V45, P35, DOI 10.1111/j.1532-5415.1997.tb00975.x; Gooneratne NS, 2003, J AM GERIATR SOC, V51, P642, DOI 10.1034/j.1600-0579.2003.00208.x; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Jobe JB, 2001, CONTROL CLIN TRIALS, V22, P453, DOI 10.1016/S0197-2456(01)00139-8; Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45; Keiski MA, 2007, CLIN NEUROPSYCHOL, V21, P744, DOI 10.1080/13854040600775346; Kothari S., 2007, BRAIN INJURY MED PRI, P169; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Luria A.R., 1973, WORKING BRAIN INTRO; Luria AR, 1963, RESTORATION FUNCTION; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Napolitano E, 2007, BRAIN INJURY MED PRI, P57; Ng YS, 2005, ARCH PHYS MED REHAB, V86, P2138, DOI 10.1016/j.apmr.2005.07.289; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Phelan EA, 2002, J AM GERIATR SOC, V50, P1306, DOI 10.1046/j.1532-5415.2002.t01-1-50324.x; Pomeroy VM, 2007, NEUROREHAB NEURAL RE, V21, P509, DOI 10.1177/1545968307300418; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Strasser D C, 1997, Top Stroke Rehabil, V4, P15, DOI 10.1310/KL5R-U470-VF9M-3HLN; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P10, DOI 10.1016/j.apmr.2007.08.127; Strasser DC, 2005, ARCH PHYS MED REHAB, V86, P403, DOI 10.1016/j.apmr.2004.04.046; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tupper DE, 1999, NEUROPSYCHOL REV, V9, P1, DOI 10.1023/A:1025634702965; Tupper DE, 1999, NEUROPSYCHOL REV, V9, P57, DOI 10.1023/A:1025693006186; US Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; VOCATE DR, 1987, THEORY AR LURIA FUNC; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162	60	5	5	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2008	23	5					415	424					10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	372PW	WOS:000260914500005	18957728				2022-02-06	
J	Zang, H; Davis, SR				Zang, Hong; Davis, Susan R.			Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism	DRUGS			English	Article							SEXUAL DESIRE DISORDER; SURGICALLY MENOPAUSAL WOMEN; BONE-MINERAL DENSITY; ESTROGEN-REPLACEMENT; TESTOSTERONE THERAPY; DEHYDROEPIANDROSTERONE REPLACEMENT; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; ADRENAL INSUFFICIENCY; PLASMA TESTOSTERONE	Hypopituitarism is a rare disorder, but its prevalence has increased as a result of an increase in secondary causes of hypopituitarism such as traumatic brain injury and cranial irradiation. Estrogen with or without progestogen (progestin) treatment is conventional therapy in women with hypopituitarism. Recent data demonstrate that women with hypopituitarism may experience marked androgen deficiency as a consequence of secondary loss of function of the adrenal cortex and/or ovaries. This deficiency is not always considered and therefore androgen therapy is not routinely prescribed. Recent clinical trials indicate that testosterone supplementation in physiological doses for androgen-deficient women with hypopituitarism may improve psychological well-being and sexual function, and increase bone mineral density and lean body mass. Dehydroepiandrosterone (DHEA; prasterone) supplementation may be an option for women with hypopituitarism who have secondary adrenal insufficiency and low levels of DHEA and DHEA sulfate. While short-term treatment with testosterone or DHEA appears to be safe, long-term safety data are lacking. Androgenic adverse effects limit the acceptability of treatment for some women. Further studies to establish the efficacy and safety of androgen treatment for long-term intervention in a larger group of hypopituitary androgen-deficient women are needed.	[Zang, Hong] Dalian Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Dalian 116011, Liaoning, Peoples R China; [Davis, Susan R.] Monash Univ, Dept Med, Womens Hlth Program, Prahran, Vic, Australia		Zang, H (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 222 Zhongshan Rd, Dalian 116011, Liaoning, Peoples R China.	hzang@hotmail.com	Davis, Susan R/A-3111-2009	Davis, Susan R/0000-0002-2955-0415			Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Aimaretti G, 2000, J ENDOCRINOL INVEST, V23, P5, DOI 10.1007/BF03343668; Arlt W, 1998, J CLIN ENDOCR METAB, V83, P1928, DOI 10.1210/jc.83.6.1928; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Basson R, 2007, LANCET, V370, P737, DOI 10.1016/S0140-6736(07)61368-3; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Braunstein GD, 2007, J SEX MED, V4, P859, DOI 10.1111/j.1743-6109.2007.00516.x; Brooke AM, 2006, J CLIN ENDOCR METAB, V91, P3773, DOI 10.1210/jc.2006-0316; BURGER H, 1987, BRIT MED J, V294, P936, DOI 10.1136/bmj.294.6577.936; Christiansen JJ, 2007, CLIN ENDOCRINOL, V66, P426, DOI 10.1111/j.1365-2265.2007.02750.x; COERT A, 1975, ACTA ENDOCRINOL-COP, V79, P789, DOI 10.1530/acta.0.0790789; CRILLY RG, 1981, CLIN ENDOCRINOL META, V10, P115, DOI 10.1016/S0300-595X(81)80041-2; DAVIS SR, 1995, MATURITAS, V21, P227, DOI 10.1016/0378-5122(94)00898-H; Davis SR, 2000, MENOPAUSE, V7, P395, DOI 10.1097/00042192-200011000-00005; Davis SR, 2006, MENOPAUSE, V13, P37, DOI 10.1097/01.gme.0000168061.32917.83; Davis S, 2008, ANN INTERN MED, V148, P569, DOI 10.7326/0003-4819-148-8-200804150-00001; Davis SR, 2006, MENOPAUSE, V13, P387, DOI 10.1097/01.gme.0000179049.08371.c7; Davison SL, 2006, SEMIN REPROD MED, V24, P71, DOI 10.1055/s-2006-939565; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Dhatariya K, 2005, DIABETES, V54, P765, DOI 10.2337/diabetes.54.3.765; Diamond MP, 1998, J CLIN ENDOCR METAB, V83, P4420, DOI 10.1210/jc.83.12.4420; Dimitrakakis C, 2003, MENOPAUSE, V10, P292, DOI 10.1097/01.GME.0000055522.67459.89; Dobs AS, 2002, J CLIN ENDOCR METAB, V87, P1509, DOI 10.1210/jc.87.4.1509; Floter A, 2002, CLIMACTERIC, V5, P357, DOI 10.1080/713605315; Goldstat R, 2003, MENOPAUSE, V10, P390, DOI 10.1097/01.GME.0000060256.03945.20; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Gurnell EM, 2008, J CLIN ENDOCR METAB, V93, P400, DOI 10.1210/jc.2007-1134; Ho KKY, 2006, FRONT HORM RES, V35, P115, DOI 10.1159/000094314; Hofling M, 2007, MENOPAUSE, V14, P183, DOI 10.1097/01.gme.0000232033.92411.51; Houwing NS, 2003, PHARMACOTHERAPY, V23, P1257, DOI 10.1592/phco.23.12.1257.32707; HUGHES CL, 1991, GYNECOL ONCOL, V40, P42, DOI 10.1016/0090-8258(91)90083-H; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P2046, DOI 10.1210/jc.87.5.2046; KASPERK CH, 1989, ENDOCRINOLOGY, V124, P1576, DOI 10.1210/endo-124-3-1576; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Lovas K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769; Mah PM, 2005, J CLIN ENDOCR METAB, V90, P5964, DOI 10.1210/jc.2005-1207; Mazer NA, 2000, MENOPAUSE, V7, P350, DOI 10.1097/00042192-200007050-00009; Miller KK, 2007, J CLIN ENDOCR METAB, V92, P2474, DOI 10.1210/jc.2007-0195; Miller KK, 2006, J CLIN ENDOCR METAB, V91, P1683, DOI 10.1210/jc.2005-2596; Miller KK, 2001, J CLIN ENDOCR METAB, V86, P561, DOI 10.1210/jc.86.2.561; Moore K, 2003, CLIN MED, V3, P28, DOI 10.7861/clinmedicine.3-1-28; *N AM MEN SOC, 2005, MENOPAUSE, V12, P649; *N AM MEN SOC, 2005, MENOPAUSE, V12, P496; NATHORSTBOOS J, 1993, J PSYCHOSOM OBST GYN, V14, P283; Panjari M, 2007, HUM REPROD UPDATE, V13, P239, DOI 10.1093/humupd/dml055; RAYMOND JP, 1979, J CLIN ENDOCR METAB, V48, P1033, DOI 10.1210/jcem-48-6-1033; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Segraves R, 2006, J SEX MED, V3, P408, DOI 10.1111/j.1743-6109.2006.00246.x; SHERWIN BB, 1987, PSYCHOSOM MED, V49, P397, DOI 10.1097/00006842-198707000-00009; SHERWIN BB, 1988, J AFFECT DISORDERS, V14, P177, DOI 10.1016/0165-0327(88)90061-4; Shifren JL, 2007, MENOPAUSE, V14, P985, DOI 10.1097/gme.0b013e31803867a; Shifren JL, 2006, MENOPAUSE, V13, P770, DOI 10.1097/01.gme.0000227400.60816.52; Shifren JL, 2000, NEW ENGL J MED, V343, P682, DOI 10.1056/NEJM200009073431002; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Somboonporn W, 2004, ENDOCR REV, V25, P374, DOI 10.1210/er.2003-0016; Somboonporn W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004509.pub2; Somboonporn W, 2006, SEMIN REPROD MED, V24, P115, DOI 10.1055/s-2006-939570; Steckelbroeck S, 1999, J NEUROENDOCRINOL, V11, P457; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Tuiten A, 2000, ARCH GEN PSYCHIAT, V57, P149, DOI 10.1001/archpsyc.57.2.149; van Thiel SW, 2005, J CLIN ENDOCR METAB, V90, P3295, DOI 10.1210/jc.2004-1802; Vermeulen A, 1998, J REPROD MED, V43, P725; Warren MP, 2006, GROWTH HORM IGF RES, V16, pS98, DOI 10.1016/j.ghir.2006.04.003; Warren MP, 2005, CONTRACEPTION, V72, P206, DOI 10.1016/j.contraception.2005.03.007; WATTS NB, 1995, OBSTET GYNECOL, V85, P529, DOI 10.1016/0029-7844(94)00448-M; Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121; Young J, 1997, J CLIN ENDOCR METAB, V82, P2578, DOI 10.1210/jc.82.8.2578; Zang H, 2007, J CLIN ENDOCR METAB, V92, P2169, DOI 10.1210/jc.2006-2171; Zang H, 2006, FERTIL STERIL, V86, P136, DOI 10.1016/j.fertnstert.2005.12.039; ZUMOFF B, 1995, J CLIN ENDOCR METAB, V80, P1429, DOI 10.1210/jc.80.4.1429	75	5	7	1	3	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0012-6667	1179-1950		DRUGS	Drugs		2008	68	15					2085	2093		10.2165/00003495-200868150-00001			9	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	373IK	WOS:000260965100001	18840000				2022-02-06	
J	Kafadar, AM; Sanus, GZ; Is, M; Coskun, A; Tanriverdi, T; Hanimoglu, H; Uzan, M				Kafadar, Ali Metin; Sanus, Galip Zihni; Is, Merih; Coskun, Abdurrahman; Tanriverdi, Taner; Hanimoglu, Hakan; Uzan, Mustafa			Prolonged elevation of magnesium in the cerebrospinal fluid of patients with severe head injury	NEUROLOGICAL RESEARCH			English	Article						calcium; cerebrospinal fluid; head injury; magnesium	TRAUMATIC BRAIN-INJURY; SERUM IONIZED MAGNESIUM; SUBARACHNOID HEMORRHAGE; CHILDREN; PATHOPHYSIOLOGY; HYPOMAGNESEMIA; CALCIUM; SULFATE; HUMANS; RATS	Objectives: Several works have investigated the role of serum magnesium (Mg) concentrations in traumatic brain injury. However, there is restricted information about cerebrospinal fluid (CSF) levels of Mg in patients with severe head injury (SHI). We assessed the changes of Mg concentrations in CSF and serum in patients with SHI during the first 10 days after the trauma. Methods: Eleven patients with SHI were studied prospectively on days 1-3, 5 and 10 with analysis of CSF and serum levels of Mg and Ca. The control group consisted of nine patients with hydrocephalus. Results: CSF levels of Mg were significantly higher in patients than controls in the corresponding time points except on days 5 and 10 of trauma. The CSF Mg levels tended to decrease and the highest level was found on day 1 after trauma (2.81 +/- 0.65 mg/dl). In the control group, the CSF level of Mg was 1.95 +/- 0.66 mg/dl. No significant difference can be detected between controls and patients regarding serum Mg and Ca levels. In addition, significantly higher values of Ca in the CSF were observed in all time points after trauma in patients with SHI than in the controls. There was no correlation between the CSF and serum levels of Mg and Ca levels. Discussion: Our study demonstrates that in patients with SHI, CSF levels of Mg and Ca are elevated during the whole observation period. Further works should be designed in order to show the role and importance of CSF levels of ionized Mg in outcome of patients with SHI.	[Kafadar, Ali Metin; Sanus, Galip Zihni; Hanimoglu, Hakan] Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, TR-34301 Istanbul, Turkey; [Is, Merih] Abant Izzet Baysal Univ, Duzce Med Fac, Dept Neurosurg, Duzce, Turkey; [Coskun, Abdurrahman] Abant Izzet Baysal Univ, Duzce Med Fac, Dept Clin Biochem, Duzce, Turkey		Kafadar, AM (corresponding author), Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, POB 5, TR-34301 Istanbul, Turkey.	kafadar@istanbul.edu.tr	Sanus, Galip Zihni/D-6715-2019; Coskun, Abdurrahman/C-3906-2015; Kafadar, Ali/AAH-9387-2019; Uzan, Mustafa/D-6571-2019; Tanriverdi, Taner/C-9003-2019	Coskun, Abdurrahman/0000-0002-1273-0604; Kafadar, Ali/0000-0002-3312-3192; Uzan, Mustafa/0000-0001-7214-380X; Sanus, Galip Zihni/0000-0001-6539-7254			BAKAY RAE, 1986, NEUROSURGERY, V18, P234, DOI 10.1227/00006123-198602000-00023; CERDA M, 1985, CHILD NERV SYST, V1, P306, DOI 10.1007/BF00270813; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hristova EN, 1997, CLIN CHEM, V43, P394; HRISTOVA EN, 1995, CLIN CHEM, V41, P1649; Kahraman S, 2003, CLIN CHIM ACTA, V334, P211, DOI 10.1016/S0009-8981(03)00235-3; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; Levine J, 1999, NEUROPSYCHOBIOLOGY, V39, P63, DOI 10.1159/000026562; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Mendez DR, 2005, PEDIATR RES, V57, P347, DOI 10.1203/01.PDR.0000150803.36315.FF; MIURA K, 1988, Neurological Surgery, V16, P1251; Miyamoto Y, 2004, PEDIATR INT, V46, P394, DOI 10.1111/j.1442-200x.2004.01922.x; Morris M E, 1992, Magnes Res, V5, P303; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Sakamoto T, 2005, J TRAUMA, V58, P1103, DOI 10.1097/01.TA.0000169950.51735.C4; Sato N, 1999, NUCL INSTRUM METH B, V150, P214, DOI 10.1016/S0168-583X(98)01002-7; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; van den Bergh WM, 2004, MAGNESIUM RES, V17, P301; van den Bergh WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E; von Holst H, 1990, Br J Neurosurg, V4, P123	26	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2007	29	8					824	829		10.1179/016164107X181879			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	246QN	WOS:000252022100010	17553217				2022-02-06	
J	Du, W; Finch, CF; Hayen, A; Hatfield, J				Du, Wei; Finch, Caroline F.; Hayen, Andrew; Hatfield, Julie			Trends in hospitalisation rates for road traffic injuries in child motor vehicle passengers in New South Wales, July 1998 June 2005	MEDICAL JOURNAL OF AUSTRALIA			English	Article								Objective: To analyse changes in the incidence of injuries requiring hospitalisation for child passengers in motor vehicle crashes. Design, setting and participants: Population-based study of children (aged 0-15 years) residing in New South Wales and admitted to hospital for injuries resulting from a traffic crash in the period 1 July 1998 - 30 June 2005, identified from the NSW Inpatient Statistics Collection. Main outcome measures: Age-standardised rates of hospitalisation for injuries, and trends by inpatient demographics, severity of injuries, and injury sites and types. Results: 2297 children were hospitalised for injuries sustained in a motor vehicle crash over the study period. The overall hospitalisation rate for injuries was relatively constant, with a non-significant decline of -0.4% (95% Cl, -3.1% to 2.3%). The rate of hospitalisation for serious injuries also declined non-significantly (-5.5% [95% Cl, -11.8% to 1.1%]). Only hospitalisation rates for traumatic brain injuries declined significantly (-11.1% [95% Cl, -19.0% to -2.8%]) over the study period. Conclusion: The rate of hospitalisation for injuries to NSW-resident child motor vehicle passengers due to traffic crashes has not significantly decreased. High hospitalisation rates and the subsequent burden to the community and public health system make further injury prevention efforts for child motor vehicle passengers a priority.	[Du, Wei; Hayen, Andrew; Hatfield, Julie] Univ New S Wales, NSW Injury Risk Management Res Ctr, Sydney, NSW, Australia; [Finch, Caroline F.] Univ Ballarat, Sch Human Movement & Sport Sci, Ballarat, Vic, Australia		Du, W (corresponding author), Univ New S Wales, NSW Injury Risk Management Res Ctr, Sydney, NSW, Australia.	w.du@unsw.edu.au	Du, Wei/H-5376-2012	Du, Wei/0000-0003-3622-2265; Hayen, Andrew/0000-0003-4046-8030; Hatfield, Julie/0000-0002-1814-0357			*AUSTR TRANSP SAF, 2005, ROAD DEATHS AUSTR 20; *AUSTR TRANSP SAF, 2004, ROAD SAF STAT REP; Australian Transport Council, 2000, NAT ROAD SAF STRAT 2; CRYER C, 2006, 6 INT C MEAS BURD IN; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; *EP SURV BRANC, HLTH OUTC INF STAT T; Fay MP, 2006, BIOMETRICS, V62, P847, DOI 10.1111/j.1541-0420.2006.00528.x; Finch CF, 2006, INJURY PREV, V12, P2, DOI 10.1136/ip.2005.010587; *INJ SURV WORKGR, 2003, STAT TERR INJ PREV D; Javouhey E, 2006, ARCH DIS CHILD, V91, P304, DOI 10.1136/adc.2005.084756; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; National Centre for Classification in Health, 2000, INT STAT CLASS DIS R; *NSW CHILD DEATH R, 2005, ANN REP 2004; Stephenson S, 2005, ACCIDENT ANAL PREV, V37, P825, DOI 10.1016/j.aap.2005.03.024; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561	15	5	5	0	3	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	0025-729X	1326-5377		MED J AUSTRALIA	Med. J. Aust.	NOV 5	2007	187	9					515	518		10.5694/j.1326-5377.2007.tb01393.x			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240IQ	WOS:000251581700012	17979617	Green Submitted			2022-02-06	
J	Rios-Romenets, S; Castano-Monsalve, B; Bernabeu-Guitart, M				Rios-Romenets, S.; Castano-Monsalve, B.; Bernabeu-Guitart, M.			pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury	REVISTA DE NEUROLOGIA			French	Article						cholinesterase inhibitors; cognitive disorders; dopaminergic agents; neurotransinitters; psychostimulants; traumatic; brain injury; treatment	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; CEREBROSPINAL-FLUID; NEUROPSYCHIATRIC SEQUELAE; METHYLPHENIDATE TREATMENT; ATTENTION DEFICITS; CONTROLLED-TRIAL; GLUTAMATE; MEMORY; AMANTADINE	Aim. To review and correlate the most common cognitive disorders secondary to traumatic brain injuries (TBI), the neurobiology of these deficits and their possible modulation by neuropharmacological means. Development. As of a complex cascade of injuries to the brain, patients with TBI may experience alterations that affect the cognitive domain on different levels and to varying degrees, the most common being alteration of the level of alertness; slowing of the speed at which information is processed; attention, memory and learning deficits; language and communication disorders; and impaired executive functions. Brain damage may be caused by a range of pathological mechanisms, such as focal bruising, diffuse axonal damage, cytotoxic damage and neurotransmitter excitotoxicity Certain pharmacological agents have an effect on the cognitive functions. Pharmacological agents that improve cognitive performance include dopaminergic agents, psychostimulants, some antidepressants and cholinesterase inhibitors. Conclusions. Studies into the pharmacological neuromodulation of the cognitive disorders secondary, to TBI are currently in the early stages. The information we have available on the neurochemical bases of cognition and cognitive disorders due to TBI suggest that the most important goals of pharmacological intervention in this group of patients are the stimulation of the catecholaminic and cholinergic functions.	Inst Neurorrehabil Guttamnn, Unidad Dano Cerebral Adquirido, E-08916 Barcelona, Spain		Rios-Romenets, S (corresponding author), Inst Neurorrehabil Guttamnn, Unidad Dano Cerebral Adquirido, Cami Can Ruti S-N, E-08916 Barcelona, Spain.	silvia.riosrom@hotmail.com					Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; [Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; BERNABEU TR, 1999, REHABILITACION TRAUM; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P49; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; EGHWRUDJAKPOR PO, 1991, SURG NEUROL, V35, P273, DOI 10.1016/0090-3019(91)90004-S; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Faraone SV, 2005, J CHILD ADOL PSYCHOP, V15, P664, DOI 10.1089/cap.2005.15.664; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Foster DJ, 2006, ARCH PHYS MED REHAB, V87, P216, DOI 10.1016/j.apmr.2005.08.131; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Gopinath SP, 2000, ACT NEUR S, V76, P437; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Page G, 2000, EUR J PHARMACOL, V403, P75, DOI 10.1016/S0014-2999(00)00573-2; Papakostas GI, 2006, J PSYCHIAT RES, V40, P370, DOI 10.1016/j.jpsychires.2005.04.013; Parton A, 2005, CURR OPIN NEUROL, V18, P675, DOI 10.1097/01.wco.0000189872.54245.13; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Peeters M, 2004, EUR J NEUROSCI, V19, P2212, DOI 10.1111/j.0953-816X.2004.03297.x; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; POWELL, 1994, HEAD INJURY PRACTICA; Quack G, 1995, J NEURAL TRANSM-SUPP, P97; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rao VLR, 2001, BRAIN RES, V911, P96; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Rothman K J, 1990, Epidemiology, V1, P232, DOI 10.1097/00001648-199005000-00009; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Taylor FB, 2000, J CHILD ADOL PSYCHOP, V10, P311, DOI 10.1089/cap.2000.10.311; Teitelman E, 2001, AM J PSYCHIAT, V158, P1341, DOI 10.1176/ajp.158.8.1341; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Tzavara ET, 2006, MOL PSYCHIATR, V11, P187, DOI 10.1038/sj.mp.4001763; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Worzniak M, 1997, J FAM PRACTICE, V44, P495; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; Yamaki T, 1998, BRAIN RES PROTOC, V3, P100, DOI 10.1016/S1385-299X(98)00030-0; Yamamoto T, 1999, ACT NEUR S, V75, P17; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	89	5	9	0	7	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	NOV 1	2007	45	9					563	570		10.33588/rn.4509.2007279			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	232BI	WOS:000250992700009	17979087				2022-02-06	
J	Gupta, S; Kumar, A				Gupta, Shalu; Kumar, Ashok			Child abuse: Inflicted traumatic brain injury	INDIAN PEDIATRICS			English	Article						child abuse; Inflicted brain injury	YOUNG-CHILDREN; HEAD TRAUMA	We report a one year old boy with clinical and neuroimaging findings of inflicted traumatic brain injury. The clinicians often overlook this form of physical abuse. The family structure also plays an important role in neglecting this form of problem.	Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi 221005, Uttar Pradesh, India		Gupta, S (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi 221005, Uttar Pradesh, India.	drshalugupla@yahoo.co.in	Kumar, Ashok/AAX-3875-2020				Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355	9	5	5	0	1	INDIAN ACAD PEDIATRICS	NEW DELHI	MAULANA AZAD MEDICAL COLLEGE, DEPT PEDIATRICS, NEW DELHI, 110 002, INDIA	0019-6061			INDIAN PEDIATR	Indian Pediatrics	OCT	2007	44	10					783	784					2	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	224LZ	WOS:000250449800010	17998581				2022-02-06	
J	Ryder, S; Gorczyca, JT				Ryder, Steven; Gorczyca, John T.			Routine removal of external fixators without anesthesis	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						external fixator; removal; fractures	FRACTURES	Objective: To examine the degree of discomfort experienced by patients with routine removal of all external fixators without anesthesia. Design: Retrospective review. Setting: Outpatient clinic and hospital. Patients: A total of 106 consecutive patients for whom removal of external fixators was indicated. Intervention: External fixators were removed without anesthesia. Main Outcome Measurements: Visual Analog Pain Scale (VAS) following external fixator removal and patients' reported willingness to repeat the procedure without anesthesia. Results: Patients with pin site inflammation had a significantly higher VAS (4.82 vs. 2.92, P < 0.0001). The chi(2) test revealed that pin site inflammation was less common with wrist spanning fixators than with lower extremity and pelvic fixators. No correlation existed between age, site of fixator, closed head injury, use of olive wires, or the duration of fixation and VAS. In all, 95 of 106 patients (89.6%) responded yes when asked if they would undergo removal of their fixator again without anesthesia. Despite the association between inflamed pin sites and a higher VAS, in 84% (37/44) of the cases with inflamed pin sites, the patient would choose to undergo fixator removal without anesthesia again. Conclusions: Removal of external fixators without anesthesia is well tolerated by the great majority of patients. Inflammation at pin sites is associated with a higher degree of discomfort during external fixator removal. Despite the higher pain score, most patients with pin-site inflammation report that they would repeat the procedure without anesthesia.	Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Kaiser Med Ctr, Roseville, CA USA		Ryder, S (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA.	john_gorczyca@urmc.rochester.edu					Anderson R, 1934, SURG GYNECOL OBSTET, V58, P639; DiCicco JD, 1998, J ORTHOP TRAUMA, V12, P569, DOI 10.1097/00005131-199811000-00007; HOFFMANN R, 1942, ACTA CHIR SCAND, V86, P235; INFANTE AF, 2003, ORTH TRAUM ASS ANN M; LAMBRET O, 1910, B MEM SCO CHIR PARIS, V36, P871; MALGAIGNE JF, 1853, J CONNAISSANCES MED, V16, P9; MEARS DC, 1983, EXTERNAL SKELETAL FI; NEPOLA JV, 1996, FRACTURES ADULTS; OHNHAUS EE, 1975, PAIN, V1, P379, DOI 10.1016/0304-3959(75)90075-5; PARKHILL C, 1897, T AM SURG ASS, V15, P251; Pommer A, 2002, J BONE JOINT SURG AM, V84A, P1162, DOI 10.2106/00004623-200207000-00011; SELIGSON D, 1982, CONCEPTS EXTERNAL FI; VIDAL J, 1983, CLIN ORTHOP RELAT R, P83	13	5	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	SEP	2007	21	8					571	573		10.1097/BOT.0b013e31814b81bc			3	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	211US	WOS:000249549400008	17805024				2022-02-06	
J	Shibuya, TY; Karam, AM; Doerr, T; Stachler, RJ; Zormeier, M; Mathog, RH; McLaren, CL; Li, KT				Shibuya, Terry Y.; Karam, Amir M.; Doerr, Timothy; Stachler, Robert J.; Zormeier, Michele; Mathog, Robert H.; McLaren, Christine L.; Li, Kuo-Tung			Facial fracture repair in the traumatic brain injury patient	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							CLOSED-HEAD INJURIES; CRANIOFACIAL TRAUMA; FEMUR FRACTURES; FIXATION; MANAGEMENT; VICTIMS; IMPACT; SCALE	Purpose: To review the surgical complications of patients who had facial fractures repairs in the setting of a traumatic brain injury (TBI). Patients and Methods: A review of all individuals admitted with the diagnosis of TBI based on an evaluation by the neurotrauma service who also underwent facial fracture repair was performed. More than 600 charts were reviewed and 99 patients met study criteria. Univariate and mulitvariate logistic regression model analysis were performed comparing the complication rate in the immediate postoperative period to the patients' age, gender, mechanism of injury, zone of facial injury, preoperative Glasgow Coma score, presence of multisystem injury, mechanism of TBI and treatment, length of time from injury to surgical repair and length of surgical procedure. Results: Of the 99 individuals studied, there was an 11% complication rate (8 minor, 3 major) in the immediate postoperative period. After univariate analysis, the length of time from injury to surgical repair, zone I facial injury and low Glasgow Coma score were all factors associated with increased complications. Multivariate logistic regression model analysis revealed that the odds of a patient sustaining a postoperative complication was 1.298 as the hour of procedure increased by 1 hour (95% CI, 1.065-1.582) and was 1.152 as the days of repair increased by 1 day (95% CI, 1.030-1.288). Conclusions: The overall complication rate of facial fracture repair in the TBI patient was 11%. A prolonged surgical procedure and delay in surgical repair were associated with higher complication rates as identified by multivariate logistical regression analysis. (C) 2007 American Association of Oral and Maxillofacial Surgeons.	So Calif Permanente Med Grp, Dept Head & Neck Surg, Orange, CA USA; Univ Calif Irvine, Coll Med, Dept Otolaryngol Head & Neck Surg, Orange, CA 92668 USA; Univ Rochester, Sch Med, Dept Otolaryngol Head & Neck Surg, Rochester, NY USA; Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA; Univ Calif Irvine, Coll Med, Div Epidemiol, Dept Med, Orange, CA 92668 USA; Univ Calif Irvine, Coll Med, Chao Family Comperhens Canc Ctr, Orange, CA 92668 USA		Shibuya, TY (corresponding author), Dept Head & Neck Surg, 411 Lakeview Ave, Anaheim, CA 92807 USA.	terryshibuya@yahoo.com					BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BENZIL DL, 1992, NEUROSURGERY, V30, P166, DOI 10.1227/00006123-199202000-00003; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BRANDT KE, 1991, J TRAUMA, V31, P15, DOI 10.1097/00005373-199101000-00003; CHARASH WE, 1994, J TRAUMA, V37, P667, DOI 10.1097/00005373-199410000-00023; CONFORTI PJ, 1993, J ORAL MAXIL SURG, V51, P298, DOI 10.1016/S0278-2391(10)80179-X; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; DERDYN C, 1990, PLAST RECONSTR SURG, V86, P238, DOI 10.1097/00006534-199008000-00005; ELDEGWI A, 1993, OTOLARYNG HEAD NECK, V108, P213, DOI 10.1177/019459989310800302; GRUSS JS, 1986, PLAST RECONSTR SURG, V78, P9; HARSH GR, 1965, NEUROLOGICAL SURGERY, P135; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; JANE JA, 1982, CLIN NEUR, V29, P346; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KAUFMAN MS, 1984, J ORAL MAXIL SURG, V42, P250, DOI 10.1016/0278-2391(84)90457-9; KOTWICA Z, 1990, ACTA NEUROCHIR, V102, P19, DOI 10.1007/BF01402180; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; MANSON PN, 1985, PLAST RECONSTR SURG, V76, P1; MERIOWSKY AM, 1965, NEUROLOGICAL SURG TR, P103; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; PRESS BHJ, 1983, ANN PLAS SURG, V11, P121, DOI 10.1097/00000637-198308000-00005; ROWE SN, 1945, J NEUROSURG, V2, P391, DOI 10.3171/jns.1945.2.5.0391; Theogaraj SD, 1989, HEAD INJURY, P348; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6	26	5	5	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391			J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2007	65	9					1693	1699		10.1016/j.joms.2006.06.309			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	206HJ	WOS:000249174200005	17719385				2022-02-06	
J	Sihlbom, C; Wilheimsson, U; Li, LZ; Nilsson, CL; Pekny, M				Sihlbom, Carina; Wilheimsson, Ulrika; Li, Lizhen; Nilsson, Carol L.; Pekny, Milos			14-3-3 expression in denervated hippocampus after entorhinal cortex lesion assessed by culture-derived isotope tags in quantitative proteomics	JOURNAL OF PROTEOME RESEARCH			English	Article						quantitative proteomics; neuroregeneration; neurodegeneration; hippocampus; astrocytes; brain injury; 14-3-3 protein; isoform; FTICR mass spectrometry	FIBRILLARY ACIDIC PROTEIN; GLYCOGEN-SYNTHASE KINASE-3-BETA; CREUTZFELDT-JAKOB-DISEASE; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; MICE DEFICIENT; MEDIATES PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; INTERMEDIATE-FILAMENTS; GEL-ELECTROPHORESIS	Activation of astrocytes accompanies many brain pathologies. Reactive astrocytes have a beneficial role in acute neurotrauma but later on might inhibit regeneration. 2D-gel electrophoresis and mass spectrometry were applied to study the proteome difference in denervated hippocampus in wildtype mice and mice lacking intermediate filament proteins glial fibrillary acidic protein (GFAP) and vimentin (GFAP(-/-)Vim(-/-)) that show attenuated reactive gliosis and enhanced posttraumatic regeneration. Proteomic data and immunohistochemical analyses showed upregulation of the adapter protein 14-3-3 four days postlesion and suggested that 14-3-3 upregulation after injury is triggered by reactive gliosis. Culture-derived isotope tags (CDIT) and mass spectrometry demonstrated that 14-3-3 epsilon was the major isoform upregulated in denervated hippocampus and that its upregulation was attenuated in GFAP(-/-)Vim(-/-) mice and thus most likely connected to reactive gliosis.	Univ Gothenburg, Inst Biomed, Dept Clin Neurosci & Rehabilil, Dept Med Chem & Cell Biol, S-40530 Gothenburg, Sweden; Florida State Univ, Natl Hig Magnet Field Lab, Tallahassee, FL 32306 USA		Pekny, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabilitat, Box 440, S-40530 Gothenburg, Sweden.	milos.peknv@medkem.gu.se		Wilhelmsson, Ulrika/0000-0003-3227-2687			Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; ANGRAND PO, 2006, IN PRESS MOL CELL PR; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Bradshaw JM, 2003, ADV PROTEIN CHEM, V61, P161; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Castagna A, 2002, ELECTROPHORESIS, V23, P339, DOI 10.1002/1522-2683(200202)23:2<339::AID-ELPS339>3.0.CO;2-Y; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chun J, 2004, MOL CELLS, V18, P360; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Green AJE, 2002, BIOCHEM SOC T, V30, P382, DOI 10.1042/bst0300382; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Ishihama Y, 2005, NAT BIOTECHNOL, V23, P617, DOI 10.1038/nbt1086; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; Kawamoto Y, 2006, STROKE, V37, P830, DOI 10.1161/01.STR.0000202587.63936.37; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P302, DOI 10.1007/s00401-004-0892-5; Kawamoto Y, 2004, ACTA NEUROPATHOL, V107, P137, DOI 10.1007/s00401-003-0785-z; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Krasnianski Anna, 2004, Folia Neuropathol, V42 Suppl B, P24; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Mingorance A, 2005, MOL CELL NEUROSCI, V29, P471, DOI 10.1016/j.mcn.2005.03.016; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 1998, EXP CELL RES, V239, P332, DOI 10.1006/excr.1997.3922; Pekny Milos, 2006, P10; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rabilloud T, 2000, ANAL CHEM, V72, p48A, DOI 10.1021/ac002709u; Romijn EP, 2005, MOL CELL PROTEOMICS, V4, P1297, DOI 10.1074/mcp.M500123-MCP200; ROSE G, 1976, BRAIN RES BULL, V1, P87, DOI 10.1016/0361-9230(76)90052-6; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Satoh J, 2004, AM J PATHOL, V165, P577, DOI 10.1016/S0002-9440(10)63322-6; Shevchenko A, 1997, J PROTEIN CHEM, V16, P481, DOI 10.1023/A:1026361427575; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEWARD O, 1990, J NEUROSCI, V10, P2373; Stone DJ, 1998, J NEUROSCI, V18, P3180; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Ubl A, 2002, MOL BRAIN RES, V108, P33, DOI 10.1016/S0169-328X(02)00510-7; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Van Everbroeck BRJ, 2005, J NEUROL NEUROSUR PS, V76, P100, DOI 10.1136/jnnp.2003.032037; WIDESTRAND A, 2007, IN PRESS STEM CELLS; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yang JW, 2004, ELECTROPHORESIS, V25, P1169, DOI 10.1002/elps.200305809; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zhou Y, 2005, MOL CELL PROTEOMICS, V4, P1471, DOI 10.1074/mcp.M500114-MCP200	62	5	5	0	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	SEP	2007	6	9					3491	3500		10.1021/pr070108e			10	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	209EE	WOS:000249371000016	17663576				2022-02-06	
J	Bener, A; Justham, D; Azhar, A; Rysavy, M; Al-Mulla, FH				Bener, Abdulbari; Justham, David; Azhar, Abdulaziz; Rysavy, Martin; Al-Mulla, Fatima Hamad			Femoral fractures in children related to motor vehicle injuries	INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING			English	Article						Epidemiology; Children; Femur fractures; Motor vehicle injuries; Trauma; Qatar		The aim of this study is to determine the incidence of injuries in children aged from 1 to 16 years old who sustain a femoral fracture associated with a motor vehicle accident in the State of Qatar. It is a retrospective descriptive case series study conducted in the Accident Emergency Department at the Hamad General Hospital, State of Qatar, from January 1992 to December 2004. A total of 256 subjects aged 1-16 years with femoral fractures, secondary to a motor vehicle accidents were studied. All of them were seen at the Accident Emergency Department (AED), Critical Care, and Physiotherapy Departments of the Hospital. The socio-demographic information and the details of the injury of the studied subjects were collected. Of the 256 children, 82% of them were boys and 18% were girls with a male to female ratio of 4.6: 1. Most femoral fractures were secondary to automobile-pedestrian accidents (43.4%), followed by motor vehicle crashes (30.1%). Of the 256 fractured femurs, 38 were open (15%) and 218 were closed (85%). Two hundred and ninety-eight associated injuries occurred in 240 patients (93.8%). Nonfemoral fractures were common (46.6%), followed by soft-tissue injuries (21.5%) and head injuries (14.4%). The lower limbs were most commonly involved with associated fractures (38.1%), followed by upper limbs (27.4%) and soft-tissue injuries (21.4%). The incidence of intra-abdominal injury was 5.4%. Ninety children (35.2%) developed 1 or more complications. Furthermore, there was a statistically significant correlation between the duration of hospital stay and the fracture site (r = 0.820, p = 0.01), and between age (r = 0.295, p = 0.01) and type of injury (r = 0.241, p = 0.01). The study revealed that the fracture of the femur secondary to motor vehicle accidents is a common injury among children in Qatar. There was an increased incidence of lower and upper limb injuries associated with femoral fracture in children involved in motor vehicle injuries. One third of the children developed one or more complications. Complications of injuries influenced the length of stay in hospital. (C) 2007 Elsevier Ltd. All rights reserved.	[Bener, Abdulbari] Hamad Gen Hosp, Weill Cornell Med Coll Qatar, Hamad Med Corp, Dept Med Stat & Epidemiol, Doha, Qatar; [Justham, David] Univ Manchester, Sch Epidemiol & Hlth Sci, Dept Evidence Populat Hlth Unit, Manchester, Lancs, England; [Azhar, Abdulaziz] Univ Nottingham, Sch Nursing, Nottingham, England; [Al-Mulla, Fatima Hamad] Hamad Gen Hosp, Dept Orthopaed, Doha, Qatar		Bener, A (corresponding author), Hamad Gen Hosp, Weill Cornell Med Coll Qatar, Hamad Med Corp, Dept Med Stat & Epidemiol, Doha, Qatar.	abener@hmc.org.qa	BENER, ABDULBARI/AAC-4436-2020				Beaty, 1995, J Am Acad Orthop Surg, V3, P207; Bener A, 1998, EUR J EPIDEMIOL, V14, P175, DOI 10.1023/A:1007444109260; Bener A, 1997, Inj Prev, V3, P224, DOI 10.1136/ip.3.3.224; Bener Abdulbari, 2005, Int J Inj Contr Saf Promot, V12, P45, DOI 10.1080/1745730051233142225; BUCKLEY SL, 1994, J PEDIATR ORTHOPED, V14, P449, DOI 10.1097/01241398-199407000-00005; HEDLUND R, 1986, J PEDIATR ORTHOPED, V6, P47, DOI 10.1097/01241398-198601000-00010; Hinton RY, 1999, J BONE JOINT SURG AM, V81A, P500, DOI 10.2106/00004623-199904000-00007; Huurman W W, 1997, Pediatr Rev, V18, P429; Jawadi Ayman H, 2003, Am J Orthop (Belle Mead NJ), V32, P459; MacKenzie W. G., 1994, MANAGEMENT PEDIAT FR, P539; Mohan D., 1991, ACCIDENTS CHILDHOOD, P31; NAFEI A, 1992, J PEDIATR ORTHOPED, V12, P499, DOI 10.1097/01241398-199207000-00016; NEWTON PO, 1994, J PEDIATR ORTHOPED, V14, P508, DOI 10.1097/01241398-199407000-00017; TAYLOR MT, 1994, INJURY, V25, P641, DOI 10.1016/0020-1383(94)90003-5; TAYLOR MT, 1994, INJURY, V25, P185, DOI 10.1016/0020-1383(94)90160-0	15	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1878-1241	1878-1292		INT J ORTHOP TRAUMA	Int. J. Orthop. Trauma Nurs.	AUG-NOV	2007	11	3-4					146	150		10.1016/j.joon.2007.02.014			5	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V03LF	WOS:000213738200005					2022-02-06	
J	Bouras, T; Stranjalis, G; Sakas, DE				Bouras, Triantafyllos; Stranjalis, George; Sakas, Damianos E.			Traumatic midbrain hematoma in a patient presenting with an isolated palsy of voluntary facial movements	JOURNAL OF NEUROSURGERY			English	Article						facial palsy; head trauma; neuroanatomy; thalamus-midbrain hematoma; traumatic brain injury	BRAIN-STEM LESIONS; PONTINE ISCHEMIA; HEAD-INJURY; HEMORRHAGE; PARESIS	The authors report on the case of a young man with a mild head injury and an isolated palsy of voluntary facial movements, attributed to a midbrain traumatic hematoma. This exception to the generally accepted conjunction between brainstem contusion and poor prognosis pertains to a special entity of midbrain laceration due to hyperextension of the head, with minimal influence on the level of consciousness. The clinical presentation of this lesion with facial palsy sparing emotion-related movement has rarely been described and offers a clue for exploring the neuroanatomy of facial movement.	Univ Athens, Dept Neurosurg, Evangelismos Hosp, GR-10679 Athens, Greece		Stranjalis, G (corresponding author), 32 Skoufa Str, Athens 10673, Greece.	stranjal@otenet.gr					BRODAL A, 1981, NEUROLOGICAL ANATOMY, P495; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; GOSCINSKI I, 1995, ACTA NEUROCHIR, V134, P16, DOI 10.1007/BF01428496; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; HERSHKOWITZ N, 1989, NEUROLOGY, V39, P452, DOI 10.1212/WNL.39.3.452; HOPF HC, 1992, NEUROLOGY, V42, P1918, DOI 10.1212/WNL.42.10.1918; HOPF HC, 1990, STROKE, V21, P1754, DOI 10.1161/01.STR.21.12.1754; Jox R, 2004, NEUROLOGY, V63, P756, DOI 10.1212/01.WNL.0000135023.68233.56; MELO TP, 1992, NEUROLOGY, V42, P789, DOI 10.1212/WNL.42.4.789; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; ROPPER AH, 1985, ANN NEUROL, V18, P80, DOI 10.1002/ana.410180114; Ross RT, 1998, NEW ENGL J MED, V338, P1515, DOI 10.1056/NEJM199805213382105; Sganzerla E P, 1992, Acta Neurochir Suppl (Wien), V55, P29; TOPPER R, 1995, J NEUROL NEUROSUR PS, V58, P732, DOI 10.1136/jnnp.58.6.732; Trepel M, 1996, J NEUROL NEUROSUR PS, V61, P531, DOI 10.1136/jnnp.61.5.531; Urban PP, 1998, NEUROLOGY, V50, P1859, DOI 10.1212/WNL.50.6.1859; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842	17	5	5	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUL	2007	107	1					158	160		10.3171/JNS-07/07/0158			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	186TA	WOS:000247799900022	17639886				2022-02-06	
J	Lescot, T; Abdennour, L; Degos, V; Boch, AL; Puybasset, L				Lescot, Thomas; Abdennour, Lamine; Degos, Vincent; Boch, Anne-Laure; Puybasset, Louis			Management of severe traumatic brain injury	PRESSE MEDICALE			French	Article							SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; MODERATE HYPOTHERMIA; PROPOFOL INFUSION; HEMATOMAS; PRESSURE; COMPLEX; TISSUE; DAMAGE	Severe brain injuries, most often occurring in young subjects, ore a major source of lost work years. These injuries ore medical and surgical emergencies. Prehospital management of severe brain injuries requires intubation and mechanical ventilation aimed at normal arterial carbon dioxide pressure. Signs of transtentorial herniation: Uni- or bilateral mydriasis requires immediate perfusion of 20% mannitol or hypertonic sodium chloride. Neurological disorders after head injury justify emergency cerebral computed tomography. The presence of a mass syndrome or signs of transtentorial herniation are in principle indications for surgery. Specialized hospital management is essential. In the case of refractory intracranial hypertension, the cerebral perfusion pressure and osmotherapy should be adopted to the volume of the cerebral contusion. The use of deep hypothermia and barbiturates should be minimized as much as possible. Magnetic resonance imaging makes it possible to identify the cerebral lesions.	Univ Paris 06, Dept Anesthesie Reanimat, Unite Neuro Anestheise Reanimat, Hop La Pitie Salpetriere,AP HP, F-75013 Paris, France		Puybasset, L (corresponding author), Univ Paris 06, Dept Anesthesie Reanimat, Unite Neuro Anestheise Reanimat, Hop La Pitie Salpetriere,AP HP, 47-83 Blvd Hop, F-75013 Paris, France.	louis.puybasset@psl.ap-hop-paris.fr					BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CAO MH, 1984, J NEUROSURG, V61, P707, DOI 10.3171/jns.1984.61.4.0707; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Cruz J, 2001, NEUROSURGERY, V49, P864; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; Muller M, 2003, ACTA NEUROCHIR, V145, P643, DOI 10.1007/s00701-003-0060-z; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2003, CRIT CARE MED, V31, P584, DOI 10.1097/01.CCM.0000050287.68977.84; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; *SFAR, 1998, PRIS CHARG TRAUM CRA; SIMPSON DA, 1991, SURG NEUROL, V35, P159, DOI 10.1016/0090-3019(91)90270-J; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; TEASDALE E, 1997, IMAGING INJURY HEAD, P168; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; Van den Berghe G, 2001, J CLIN ENDOCR METAB, V86, P3217, DOI 10.1210/jc.86.7.3217; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; 2000, J RADIOL, V81, P643; 1996, J NEUROTRAUMA, V13, P731	37	5	7	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0755-4982	2213-0276		PRESSE MED	Presse Med.	JUL-AUG	2007	36	7-8					1117	1126		10.1016/j.lpm.2007.01.017			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192EM	WOS:000248183600011	17317088				2022-02-06	
J	Lux, WE				Lux, Warren E.			The neurocognitive basis of compromised autonomy after traumatic brain injury: Clinical and ethical considerations	NEUROTHERAPEUTICS			English	Article; Proceedings Paper	Symposium on the Neuroethics of Brain Damage	DEC, 2002	Washington Univ, St Louis, MO		Washington Univ	autonomy; axonal strain injury; executive function; self-assessment; self-awareness; traumatic brain injury	OBSESSIVE-COMPULSIVE DISORDER; CLOSED-HEAD-INJURY; HOMOVANILLIC-ACID; 5-HYDROXYINDOLE-ACETIC ACID; CEREBROSPINAL-FLUID; CONSCIOUSNESS; UNCONSCIOUSNESS; LESIONS; CSF	It is widely accepted, based on the principle of respect for autonomy, that there are ethical constraints on the range of tactics that persons may use to influence the decisions and behaviors of others. However, accurate ascriptions of autonomy to either persons or acts may vary considerably, depending on properties of the person, the situation, or both. Traumatic brain injury affects cognitive domains that are critical for the effective exercise of autonomy, and so offers a context for further examination of this variability. Analysis of the neuropathology of traumatic brain injury and its neurocognitive consequences provides a foundation for understanding cases in which autonomy is compromised even though legal competency may be preserved. Respecting autonomy in these cases is not always straightforward; it may entail both special ethical obligations and consideration of tactics that would not be morally permissible under other circumstances.	US EPA, Off Sci Advisor, Progam Human Res Eth, Washington, DC 20460 USA; Georgetown Univ, Ctr Clin Bioeth, Washington, DC 20057 USA		Lux, WE (corresponding author), US EPA, 1200 Penn Ave,NW,Mail Code 8105R, Washington, DC 20460 USA.	lux.warren@epa.gov					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson J, 2004, PHILOS PSYCHIAT PSYC, V11, P279, DOI DOI 10.1353/PPP; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; Beauchamp TL, 2001, PRINCIPLES BIOMEDICA, P57; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; BERTHIER ML, 1996, NEUROLOGY, V48, P855; DEVETTERE RJ, 2000, PRACTICAL DECISION M, P132; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Frankfurt Harry G., 1999, NECESSITY VOLITION L, P129, DOI DOI 10.1017/CBO9780511624643; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Hollander E, 1996, NEUROPSY NEUROPSY BE, V9, P230; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANWOERKOM TCAM, 1977, LANCET, V1, P812; VECHT CJ, 1975, LIFE SCI, V16, P1179, DOI 10.1016/0024-3205(75)90201-5; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	24	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-7213			NEUROTHERAPEUTICS	Neurotherapeutics	JUL	2007	4	3					525	530		10.1016/j.nurt.2007.04.002			6	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	214UD	WOS:000249762800020	17599717	Bronze, Green Published			2022-02-06	
J	Rimal, D; Thapa, SR; Munasinghe, N; Errington, M				Rimal, Debesh; Thapa, Sonu R.; Munasinghe, Namal; Errington, Mark			An unusual presentation of a minor head injury sustained during a game of rugby	EMERGENCY MEDICINE JOURNAL			English	Article							BRAIN-ABSCESS; CONCUSSION; HEMATOMA; SINUS	In the UK, about 2% of the population attend the accident and emergency (A&E) department every year after a head injury. A majority of the patients have minor head injury and are discharged. Studies reveal that patients who reattend the A&E after a minor head injury represent a high-risk group. Concussion injuries are common and not all require treatment at the time of presentation. However, some may worsen after initial presentation and develop signs of serious head injury. A case of minor head injury as a result of head butt during a game of rugby, not associated with alteration in conscious state or focal neurological signs, and subsequent development of frontal lobe abscess a month later is reported. It is important that patients fit to be discharged at the time of consultation are discharged in the care of a responsible adult with clear head injury instruction sheets and are advised to return should their symptoms change. A high index of suspicion should be maintained and an early imaging technique, such as CT scan should be considered in patients reattending the A&E with persistent symptoms even after minor head injury.	James Paget Univ Hosp, NHS Fdn Trust, Great Yarmouth NR31 6LA, Norfolk, England		Rimal, D (corresponding author), James Paget Univ Hosp, NHS Fdn Trust, Great Yarmouth NR31 6LA, Norfolk, England.	kathmanducity@aol.com					Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; BERT F, 1995, EUR J CLIN MICROBIOL, V14, P366, DOI 10.1007/BF02116536; El Khatib K, 2004, J CRANIO MAXILL SURG, V32, P314, DOI 10.1016/j.jcms.2004.04.007; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Keller TM, 1998, BRIT J SPORT MED, V32, P338, DOI 10.1136/bjsm.32.4.338; KIRKPATRICK PJ, 2002, J NEUROL NEUROSUR PS, V73, P3; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MANIGLIA AJ, 1989, ARCH OTOLARYNGOL, V115, P1424; Marquardt G, 2000, BRIT J NEUROSURG, V14, P246; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; McCrory PR, 2002, PHYSICIAN SPORTSMED, V30, P43, DOI 10.3810/psm.2002.08.403; Stan AC, 1996, FORENSIC SCI INT, V77, P37, DOI 10.1016/0379-0738(95)01842-5; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; WALL BM, 1998, FACIAL PLAST SURG, V14, P59; Wallis W E, 1983, Acta Neurochir Suppl (Wien), V32, P125	16	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL 1	2007	24	7					485	486		10.1136/emj.2006.042895			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	181KF	WOS:000247434900011	17582040	Green Published			2022-02-06	
J	Sawauchi, S; Murakami, S; Ogawa, T; Abe, T				Sawauchi, Satoshi; Murakami, Shigeyuki; Ogawa, Takeki; Abe, Toshiaki			Mechanism of injury in acute subdural hematoma and diffuse brain injury: Analysis of 587 cases in the Japan neurotrauma data bank	NEUROLOGICAL SURGERY			English	Article						Japan Neurotrauma Data Bank; acute subdural hematoma; diffuse brain injury; traumatic brain injury; mechanism of injury	HEAD-INJURY; AXONAL INJURY; ALCOHOL	Objective The aim of this study was to analyze and compare the epidemiology of injury mechanisms in acute subdural hematoma (ASDH) with those of diffuse brain injury (DBI) in the Japan Neurotrauma Data Bank. Methods Data in the Japan Neurotrauma Data Bank were reviewed for 1,002 patients with; severe head injury treated at hospitals between 1998 and 2001 (ASDH, n=246; DBI, n=341). Clinical variables including mechanisms of injury were evaluated. Results Patients with DBI were significantly younger, with higher incidence of skull fracture, lower Glasgow coma scale score and higher injury severity score than patients with ASDH. Different mechanisms of injury were involved, with ASDH occurring much more commonly in non-vehicular injuries, particularly falls (47.2%), while DBI resulted almost exclusively from i vehicular injuries (79.7%). Impact sites on the head with ASDH were more commonly occipital or temporal, while those for DBI were frontal, temporal or facial. Alcohol use was involved in 13.8% of drivers with ASDH and 33.6% of drivers with DBI. Conclusion The principal mechanical damage in DBI was to the brain itself, while primary damage in ASDH occurred to surface blood vessels. ASDH and DBI remain the two worst and most-important types of traumatic brain injury, although the pathogenesis differs with age and mechanism injury.	Jikei Univ, Sch Med, Kashiwa Hosp, Dept Neurosurg, Kashiwa, Chiba 2778567, Japan; Jikei Univ, Sch Med, Dept Emergency Med, Kashiwa, Chiba, Japan		Sawauchi, S (corresponding author), Jikei Univ, Sch Med, Kashiwa Hosp, Dept Neurosurg, 163-1 Kashiwashita, Kashiwa, Chiba 2778567, Japan.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461	12	5	6	0	3	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	JUL	2007	35	7					665	671					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	200EL	WOS:000248746600003	17633509				2022-02-06	
J	Silva, SCFE; de Sousa, RMC				Silva, Silvia Cristina Fuerbringer e; de Sousa, Regina Marcia Cardoso			Galveston orientation and amnesia test: Applicability and relation with the Glasgow Coma Scale	REVISTA LATINO-AMERICANA DE ENFERMAGEM			English	Article						amnesia; craniocerebral trauma; Glasgow Coma Scale	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; RECOVERY	Restrictions in the application of the Galveston Orientation and Amnesia Test and questionings about the relationship between conscience and post-traumatic amnesia motivated this study, which aims to identify, through the Glasgow Coma Scale scores, when to initiate the application of this amnesia test, as well to verify the relationship between the results of these two indicators. The longitudinal prospective study was carried at a referral center for trauma care in Sao Paulo - Brazil. The sample consisted of 73 victims of blunt traumatic brain injury admitted at this institution between January 03(rd) and May 03(rd) 2001. Regarding the applicability, the test could be applied in patients with a Glasgow Coma Scale score > 12; however, the end of post traumatic amnesia was verified in patients who scored > 14 on the scale. A significant relationship (r(s) = 0.65) was verified between these measures, although different kinds of relationship between the end of the amnesia and changes in consciousness were observed.	[de Sousa, Regina Marcia Cardoso] Univ Sao Paulo, Sch Nursing, BR-05508 Sao Paulo, Brazil			vian@usp.br	Sousa, Regina M/H-1108-2012	Sousa, Regina M/0000-0002-2575-7937			Alves D, 2000, Rev Lat Am Enfermagem, V8, P91; ALVES D, 1999, ACTA PAUL ENFERM, V12, P92; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; De Guise E, 2005, BRAIN INJURY, V19, P263, DOI 10.1080/02699050400004971; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; JENNETT B, 1976, LANCET, V1, P1031; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Ladera-Fernandez V, 2001, REV NEUROLOGIA, V32, P467, DOI 10.33588/rn.3205.2000170; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Orient-Lopez F, 2004, REV NEUROLOGIA, V39, P901, DOI 10.33588/rn.3910.2004302; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Wilson J. T., 1993, J NEUROL NEUROSUR PS, V56, P198, DOI 10.1136/jnnp.57.2.198	18	5	5	0	2	UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO	RIBEIRAO PRETO	AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL	1518-8345			REV LAT-AM ENFERM	Rev. Latino-Am. Enfermagem	JUL-AUG	2007	15	4					651	657		10.1590/S0104-11692007000400020			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	272GI	WOS:000253847500020	17923984	gold			2022-02-06	
J	Gjertsen, O; Nakstad, PHJ; Pedersen, HKR; Josefsen, R				Gjertsen, O.; Nakstad, P. H. J.; Pedersen, H. K. R.; Josefsen, R.			Traumatic aneurysm of the superior cerebellar artery	INTERVENTIONAL NEURORADIOLOGY			English	Article						trauma; aneurysm; endovascular treatment; posterior circulation; superior cerebellar artery	CLOSED HEAD TRAUMA; PERICALLOSAL ARTERY; CEREBRAL-ARTERIES; BASILAR ARTERY; DIAGNOSIS; INJURY	Following a head trauma in a 40-year-old male, massive subarachnoid hemorrhage and fractures of the skull base/clivus was found at CT. CT angiography demonstrated an aneurysm on the proximal part of the right superior cerebellar artery. The aneurysm was successfully coiled without any complication and the patient improved clinically during the following three months. The decline in use of angiography in head trauma patients during the last two decades may lead to a lower detection of traumatic aneurysm than in previous times. The value of angiographic procedures in patients suffering head traumas with SAH and skull base fractures is therefore emphasized.	Univ Oslo, N-407 Oslo, Norway; Ullevaal Univ Hosp, Dept Neuroradiol, Oslo, Norway; Ullevaal Univ Hosp, Dept Neurosurg, Oslo, Norway		Nakstad, PHJ (corresponding author), Univ Oslo, Ulleval Univ Hosp, Kirkeveien 166, N-407 Oslo, Norway.	pena@uus.no					ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; Chambers N, 2002, PAEDIATR ANAESTH, V12, P356, DOI 10.1046/j.1460-9592.2002.00831.x; CROCKHILL HH, 1977, J NEUROSURG, V46, P377; FREYTAG E, 1966, ARCH PATHOL, V81, P416; GIANNOTTA SL, 1982, CLIN NEUR, V29, P288; HARDY DG, 1980, NEUROSURGERY, V6, P10, DOI 10.1227/00006123-198001000-00002; Mendez JC, 2005, CARDIOVASC INTER RAD, V28, P107, DOI 10.1007/s00270-004-4068-4; Moron F, 2005, AM J NEURORADIOL, V26, P58; NAKSTAD P, 1987, NEURORADIOLOGY, V29, P312, DOI 10.1007/BF00451778; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NAKSTAD PH, 1992, ACTA RADIOL, V33, P145; NOV AA, 1984, J NEURORADIOLOGY, V11, P3; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; Redekop G, 2001, J NEUROSURG, V95, P412, DOI 10.3171/jns.2001.95.3.0412; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; TOUNAGA K, 2001, AM J NEURORADIOL, V22, P35	22	5	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	JUN	2007	13	2					167	171		10.1177/159101990701300207			5	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	215HT	WOS:000249799700011	20566145	Green Published			2022-02-06	
J	Kreipke, CW; Morgan, R; Kallakuri, S; Rafols, JA				Kreipke, Christian W.; Morgan, Randy; Kallakuri, Srinivas; Rafols, Jose A.			Behavioral pre-conditioning enhances angiogenesis and cognitive outcome after brain trauma	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; VEGFR2; capillary density; angiogenesis	CEREBRAL-ISCHEMIA; INJURY TBI; RATS; EXPRESSION; EXERCISE; NEUROPROTECTION; MODEL; VEGF; OVEREXPRESSION; ENDOTHELIN-1	Objectives: In this study, we used Marmarou's model of traumatic brain injury (TBI) and sought to determine: (1) the effect of TBI on cognitive outcome measured on a radial arm maze; (2) the effect of behavioral conditioning before TBI, i. e. pre-conditioning, on cognitive outcome; (3) the effect of pre- conditioning on angiogenesis. Methods: Cognitive outcome was measured by performance on an eight-arm radial maze. Behavioral conditioning consisted of daily exposure of animals to the radial arm maze. Latency and number of errors were recorded as an index of overall performance and acquisition of the test. Extent of angiogenesis was measured by vascular endothelial growth factor receptor 2 (VEGFR2) immunofluorescence and by determining capillary density. Results: Our results indicated that trauma alone causes significant cognitive impairments. Preconditioning caused a marked improvement in radial arm maze performance following injury. These results coincide with both a significant increase in VEGFR2 expression and increased capillary density within the cortex and hippocampus. Discussion: TBI causes significant impairments in cognition. These deficits can be ameliorated using a pre- conditioning paradigm. While the precise mechanism has yet to be elucidated, our results indicate that angiogenesis may underlie the cognitive sparing seen in pre- conditioned animals.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Scott Hall,Room 9312,540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Briones TL, 2005, BRAIN RES, V1033, P51, DOI 10.1016/j.brainres.2004.11.017; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ding YH, 2006, CURR NEUROVASC RES, V3, P15, DOI 10.2174/156720206775541787; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Frydelund-Larsen L, 2007, EXP PHYSIOL, V92, P233, DOI 10.1113/expphysiol.2006.034769; Grondard C, 2005, J NEUROSCI, V25, P7615, DOI 10.1523/JNEUROSCI.1245-05.2005; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hong Jun, 2002, Chin J Traumatol, V5, P36; *I LAB AN RES COMM, 1996, NIH PUBL; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Kallakuri S, 2007, NEUROL RES, V29, P362, DOI 10.1179/016164107X204675; Kreipke CW, 2007, NEUROL RES, V29, P369, DOI 10.1179/016164107X204684; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Li J, 2004, NEUROL RES, V26, P404, DOI 10.1179/016164104225016038; Mabandla M, 2004, METAB BRAIN DIS, V19, P43, DOI 10.1023/B:MEBR.0000027416.13070.c3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	33	5	5	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2007	29	4					388	394		10.1179/016164107X204710			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	192PM	WOS:000248214200009	17626735				2022-02-06	
J	Reeves, D; Elsmore, T; Wiederhold, MD; Wood, D; Murphy, J; Center, C; Spira, J; Wiederhold, BK				Reeves, Dennis; Elsmore, Timothy; Wiederhold, Mark D.; Wood, Dennis; Murphy, Jennifer; Center, Christy; Spira, James; Wiederhold, Brenda K.			Handheld Computerized Neuropsychological Assessment in a Virtual Reality Treatment Protocol for Combat PTSD	ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE			English	Article						Neuropsychological assessment; Palm OS; ANAM; ARES; PTSD; Virtual Reality; Concussion; Combat; Stress		In this paper we introduce a new handheld computerized neuropsychological assessment system, i.e., BrainCheckers. This test system includes the Mental Efficiency and Workload Test (MEWT) designed for Primary Care and Pharmaceutical research, a Concussion Toolbox, and our Combat Stress Assessment (CSA). Focus will be on the CSA. It has been designed for assessment of injuries such as concussion due to blast exposure and/or Post Traumatic Stress Disorder (PTSD). It is presently being implemented as a key assessment instrument by the Virtual Reality Medical Center, San Diego, CA in a Virtual Reality (VR) treatment program for veterans from Iraq who have been diagnosed with PTSD. BrainCheckers runs on handheld Palm (R) personal digital assistants (PDA). It includes a library of 20 tests that have been modeled after the Automated Neuropsychological Assessment Metrics (ANAM). Tests assess attention and concentration, working memory, mental flexibility, spatial processing, cognitive processing efficiency, memory recall, mood, and fatigue. It includes norms, and new tests such as an Emotional Stoop (E-Stroop). Our E-Stroop has been designed specifically for repeated assessment of PTSD treatment outcomes for veterans who have experienced psychological combat trauma in Iraq. This system is presently being used in a variety of medical settings including military and Veterans Administration medical hospitals where efficient, cost-effective, and repeated assessments are essential.	[Reeves, Dennis; Elsmore, Timothy] Behav Neurosci Syst LLC, Springfield, MO 65807 USA; [Wiederhold, Mark D.; Wood, Dennis; Murphy, Jennifer; Wiederhold, Brenda K.] Virtual Real Med Ctr, San Diego, CA USA		Reeves, D (corresponding author), Behav Neurosci Syst LLC, Springfield, MO 65807 USA.		Wiederhold, Brenda K/Z-1993-2019	Wiederhold, Brenda K/0000-0002-3320-0303			Beck JG, 2001, J ABNORM PSYCHOL, V110, P536, DOI 10.1037//0021-843X.110.4.536; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Constans JI, 2004, J ABNORM PSYCHOL, V113, P315, DOI 10.1037/0021-843X.113.2.315; Elsmore T, 2004, ANAM READINESS EVALU; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Farmer K, 2000, HEADACHE, V40, P657, DOI 10.1046/j.1526-4610.2000.040008657.x; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; Farmer K., 2003, REDUCING BURDEN HEAD, P46; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Proctor S. P., 2003, 6 ANN FORC HLTH PROT; Proctor S. P., 2002, INT APPL MIL WORKSH; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; THORNE DR, 1985, NEUROBEH TOXICOL TER, V7, P415; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD	14	5	5	0	1	INTERACTIVE MEDIA INST	SAN DIEGO	9565 WAPLES ST, STE 200, SAN DIEGO, CA 92121 USA	1554-8716	2352-927X		ANN REV CYBERTHERAPY	Ann. Rev. CyberTherapy Telemed.	SUM	2007	5						173	184					12	Computer Science, Cybernetics	Emerging Sources Citation Index (ESCI)	Computer Science	V1H4D	WOS:000216906200019					2022-02-06	
J	Annaswamy, T; Mallempati, S; Allison, SC; Abraham, LD				Annaswamy, Thiru; Mallempati, Srinivas; Allison, Stephen C.; Abraham, Lawrence D.			Measurement of plantarflexor spasticity in traumatic brain injury - Correlational study of resistance torque compared with the modified Ashworth Scale	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injury; spasticity; reflex; stretch; biomechanics; measurement	SPINAL-CORD INJURY; CEREBRAL-PALSY; MUSCLE SPASTICITY; STRETCH REFLEXES; RELIABILITY; HYPERTONIA; CHILDREN; MANAGEMENT; MECHANISMS; MOVEMENT	Objectives: To-examine the usefulness of a biomechanical measure, resistance torque (RT), in quantifying spasticity by comparing its use with a clinical scale, the modified Ashworth scale (MAS), and quantitative electrophysiological measures. Design: This is a correlational study of spasticity measurements in 34 adults with traumatic brain injury and plantarflexor spasticity. Plantarflexor spasticity was measured in the seated position before and after cryotherapy using the MAS and also by strapping each subject's foot and ankle to an apparatus that provided a ramp and hold stretch. The quantitative measures were (1) reflex threshold angle (RTA) calculated through electromyographic signals and joint angle traces, (2) H-dorsiflexion (Hdf)/H-control (Hctrl) amplitude ratio obtained through reciprocal inhibition of the soleus H-reflex, (3) H-vibration (Hvib)/Hctrl ratio obtained through vibratory inhibition of the soleus H-reflex, and (4) RT calculated as the time integral of the torque graph between the starting and ending pulses of the stretch. Results: Correlation coefficients between RT and MAS scores in both pre-ice (0.41) and post-ice trials (0.42) were fair (P = 0.001). The correlation coefficients between RT scores and RTA scores in both the pre-ice (0.66) and post-ice trials (0.75) were moderate (P < 0.001). Conclusion: RT is a measure of the cumulative torque during an imposed stretch. The MAS is a subjective measure of the cumulative resistance perceived by the clinician during an imposed stretch. RT seems to be a fair quantitative correlate of the MAS in assessing spasticity.	Dallas Va Med Ctr, Spine Sect, PM&R Serv 117, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dept PM&R, Dallas, TX 75216 USA; Rocky Mt Univ Hlth Prof, Provo, UT USA; Univ Texas, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA		Annaswamy, T (corresponding author), Dallas Va Med Ctr, Spine Sect, PM&R Serv 117, Dallas, TX 75216 USA.		Annaswamy, Thiru/AAE-1965-2019	Annaswamy, Thiru/0000-0002-3969-9221			Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; ALLISON SC, 1995, J NEUROL, V242, P699, DOI 10.1007/BF00866923; Allison SC, 2001, INT J REHABIL RES, V24, P15, DOI 10.1097/00004356-200103000-00003; Blackburn M, 2002, PHYS THER, V82, P25, DOI 10.1093/ptj/82.1.25; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; CORCOS DM, 1986, BRAIN, V109, P1043, DOI 10.1093/brain/109.5.1043; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Engsberg JR, 2000, DEV MED CHILD NEUROL, V42, P42, DOI 10.1017/S0012162200000086; FIROOZBAKHSH KK, 1993, AM J PHYS MED REHAB, V72, P379; Haas BM, 1996, SPINAL CORD, V34, P560, DOI 10.1038/sc.1996.100; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; LEHMANN JF, 1989, ARCH PHYS MED REHAB, V70, P6; LEONARD CT, 1990, DEV MED CHILD NEUROL, V32, P974; LEVIN MF, 1993, J NEUROL, V240, P63, DOI 10.1007/BF00858718; MILANOV IG, 1992, ACTA NEUROL SCAND, V85, P305; NANCE PW, 1989, PARAPLEGIA, V27, P296, DOI 10.1038/sc.1989.44; PEIRROTDESEILLI.E, 1990, NEW TRENDS ADV TEC S, V41, P264; Platz T, 2005, DISABIL REHABIL, V27, P7, DOI 10.1080/09638280400014634; PRICE R, 1991, DEV MED CHILD NEUROL, V33, P585; Priebe MM, 1996, ARCH PHYS MED REHAB, V77, P713, DOI 10.1016/S0003-9993(96)90014-3; Rymer WZ., 1994, PHYS MED REHABIL STA, V8, P441; Sehgal N, 1998, Phys Med Rehabil Clin N Am, V9, P949; Wolf SL, 1996, PHYS THER, V76, P586, DOI 10.1093/ptj/76.6.586; Yablon SA, 2004, AM J PHYS MED REHAB, V83, pS10, DOI 10.1097/01.PHM.0000141126.11008.7D	26	5	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2007	86	5					404	411		10.1097/PHM.0b013e31804a7d85			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	160AI	WOS:000245908800010	17449985				2022-02-06	
J	Hiraishi, T; Tomikawa, M; Kobayashi, T; Kawaguchi, T				Hiraishi, Tetsuya; Tomikawa, Masaru; Kobayashi, Tsutomu; Kawaguchi, Tadashi			Delayed brain abscess after penetrating transorbital injury	NEUROLOGICAL SURGERY			Japanese	Article						brain abscess; penetrating injury; chop stick	FOREIGN-BODY; TRAUMA	We report a case of brain abscess caused by a penetrating head injury that occurred 9 years earlier. A 14-year-old girl presenting with fever, headache, and stiff neck was admitted to our hospital. She was diagnosed with aseptic meningitis and treated conservatively. Seven days after admission she became stuporous and showed left hemiparesis. Computed tomography (CT) revealed two ring-enhancing masses with perifocal edema in the right frontal lobe. We diagnosed brain abscess and performed right Pronto-temporal decompressive craniectomy and stereotactic aspiration, followed by systemic antibiotic therapy. Post-surgery bone window CT revealed a well-defined, low-density foreign body passing from the left orbita to the right frontal lobe through the ethmoid sinus. We learned that the patient had been struck with a plastic chopstick in the left medial eyelid at the age of 5 years. No particular symptoms developed during the following 9 years. After the cerebral edema had diminished over the next 10 days, a second surgery was performed to remove the residual chopstick, repair the fistula at the base of the skull, and perform cranioplasty. The patient was discharged with only slight hyposmia after a 4-week course of antibiotics. This case showed that it is necessary to remove a residual foreign body and to close the dural fistula if there is a possibility of recurrent central nervous system infection. When a child presents with brain abscess, previous penetrating head injury should be considered.	Nagaoka Red Cross Hosp, Dept Neurosurg, Nagaoka, Niigata 9402085, Japan		Kawaguchi, T (corresponding author), Nagaoka Red Cross Hosp, Dept Neurosurg, 2-297-1 Sensyu, Nagaoka, Niigata 9402085, Japan.						BEHRMAN RE, 2000, NELSON TXB PEDIAT, P1857; DUJOVNY M, 1974, OPHTHALMOLOGICA, V168, P261, DOI 10.1159/000307048; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GUTHKELCH AN, 1960, BRIT MED J, V2, P842, DOI 10.1136/bmj.2.5202.842; Kawamura Shingo, 1997, Neurologia Medico-Chirurgica, V37, P332, DOI 10.2176/nmc.37.332; Maruya J, 2002, NEUROL MED-CHIR, V42, P143, DOI 10.2176/nmc.42.143; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; MILLER CF, 1977, SURG NEUROL, V7, P95; Nishio Y, 2004, ACTA NEUROCHIR, V146, P847, DOI 10.1007/s00701-004-0283-7; RUSSELL T, 1984, NEUROSURGERY, V15, P705, DOI 10.1227/00006123-198411000-00013; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010	12	5	7	0	3	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	MAY	2007	35	5					481	486					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	174AA	WOS:000246912400006	17491344				2022-02-06	
J	Zarza-Lucianez, A; Arce-Arce, S; Bhathal, H; Sanjuan-Martin, F				Zarza-Lucianez, A.; Arce-Arce, S.; Bhathal, H.; Sanjuan-Martin, F.			Mismatch negativity and conscience level in severe traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						coma; endogenous potentials; minimally conscious state; mismatch negativity; MMN; traumatic brain injury.; vegetative stage	PERSISTENT VEGETATIVE STATE; EVENT-RELATED POTENTIALS; SEVERE HEAD-INJURY; COMATOSE PATIENTS; MEDICAL ASPECTS; MEMORY; PITCH	Introduction. The mismatch negativity (MMN) is a component of the long-latency auditory evoked potentials, that are used to check the functionality of automatic attentional processes of attentive information processing. Vegetative state diagnosis is frequent following severe traumatic brain injury (TBI). Eventually, some patients improve their condition to another one called minimal conscientious state. Aim. To evaluate the diagnostic usefulness of MMN in severe TBI patients during the subacute phase after leaving the neurological intensive care unit. Patients and methods. We gathered MMN results from 19 patients (12 males and 7 females; 8 vegetative state and 11 minimal conscientious state) with ages between 17 and 59 years (mean: 27.3 years). The delay between TBI onset and MMN recordings were greater than 2 months (mean: 181 days). During the recording session, patients were evaluated by means of the Multisociety Task Force on Persistent Vegetative State scale. Results. All the minimal conscientious state patients (100%) showed MMN potential. In seven of the vegetative state patients (87.5%) the MMN was not found. The remaining MMN potential positive vegetative state patient improved to MCS 16 days after testing. Conclusions. MMN is a valid tool for differentiating vegetative state from MCS during the subacute phase of severe TBI. Hence it is a useful aid to the clinical evaluation. This would diminish the impact of a possible diagnostic error and its prognosis on therapeutical management, family and health costs. It can also be used for evaluating other brain disorders with altered consciousness.	Ctr ECOPLAR, Unidad Asistencial San Vicente Neurol Neurofisiol, Serv Neurofisiol Clin, E-28035 Madrid, Spain; Ctr ECOPLAR, Unidad Asistencial San Vicente Neurol Neurofisiol, Serv Psiquiatria, E-28035 Madrid, Spain; Ctr ECOPLAR, Unidad Asistencial San Vicente Neurol Neurofisiol, Serv Neurol, E-28035 Madrid, Spain; Ctr ECOPLAR, Unidad Asistencial San Vicente Neurol Neurofisiol, Serv Neurocirugia, E-28035 Madrid, Spain		Zarza-Lucianez, A (corresponding author), Ctr ECOPLAR, Unidad Asistencial San Vicente Neurol Neurofisiol, Serv Neurofisiol Clin, Avda Ventisquero Condesa 46, E-28035 Madrid, Spain.	dzarza@hotmail.com					Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BONTKE CF, 1996, NEUROTRAUMA, P841; CHIAPPA KH, 1989, EVOKEDP POTENTIALS C; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Escera C, 2002, REV PSIQUIATRIA FACU, V29, P362; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grossman P, 1996, DISABIL REHABIL, V18, P1; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JENNETT B, 1972, LANCET, V1, P734; Kane NM, 2000, AUDIOL NEURO-OTOL, V5, P186, DOI 10.1159/000013879; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; LANKEN PN, 1991, AM REV RESPIR DIS, V144, P726, DOI 10.1164/ajrccm/144.3_Pt_1.726; Lehmann U, 1997, UNFALLCHIRURG, V100, P552, DOI 10.1007/s001130050157; Lehmann U, 1999, EUR J SURG, V165, P1116, DOI 10.1080/110241599750007603; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; NAATANEN R, 1989, NEUROSCI LETT, V107, P347, DOI 10.1016/0304-3940(89)90844-6; Naccache L, 2005, CLIN NEUROPHYSIOL, V116, P988, DOI 10.1016/j.clinph.2004.10.009; Plum F., 1987, HDB PHYSL 1 NERVOUS, V5, P519	26	5	8	0	7	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	APR 16	2007	44	8					465	468		10.33588/rn.4408.2006306			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	164ZJ	WOS:000246273200004	17455159				2022-02-06	
J	Duda, JE				Duda, John E.			History and prevalence of involuntary emotional expression disorder	CNS SPECTRUMS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; PSEUDOBULBAR AFFECT; PATHOLOGICAL LAUGHTER; MULTIPLE-SCLEROSIS; STROKE; INCONTINENCE; DISEASE; DIAGNOSIS; LABILITY	The syndrome now known as involuntary emotional expression disorder (IEED) is a condition characterized by uncontrollable episodes of laughing and/or crying. It has been known for more than a century, but confusing and conflicting terminology may have hampered the progress of physicians in recognizing this condition. IEED is associated with various neurological disorders and neurodegenerative diseases, including amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease and other dementias, and neurological injuries such as stroke and traumatic brain injury. It is hoped that better defined terminology for IEED may help in the future diagnosis of this debilitating condition, the establishment of accurate prevalence rates for IEED in the varying underlying conditions, and also in removing blame and stigma from sufferers by providing reassurance about the nature of their condition.	Philadelphia VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA		Duda, JE (corresponding author), Philadelphia VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA 19104 USA.	john.duda@med.va.gov					Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; Brissaud E., 1895, LECONS MALADIES NERV; Brooks BR, 2004, NEUROLOGY, V63, P1364; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Damasio A., 1994, DESCARTES ERROR EMOT; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Darwin C., 1965, EXPRESS EMOT MAN; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; Fere C, 1903, REV NEUROL-FRANCE, V11, P353; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; GIANNULI A, 1905, ANN I PSICH U ROMA, V4, P213; GREEN RL, 1999, MOVEMENT DISORDERS N; GUBBAY SS, 1985, J NEUROL, V232, P295, DOI 10.1007/BF00313868; HIPOCRATES, SACRED DIS; HOBI V, 1976, INT J CLIN PHARM BI, V13, P36; Houeto JL, 2002, J NEUROL NEUROSUR PS, V72, P701, DOI 10.1136/jnnp.72.6.701; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Kaschka WP, 2001, PHARMACOPSYCHIATRY, V34, P254, DOI 10.1055/s-2001-18031; Keller R, 1999, ITAL J NEUROL SCI, V20, P49, DOI 10.1007/s100720050010; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; KOUFEN H, 1977, MED KLIN, V72, P739; LADER M, 1987, TXB MED TREATMENT, P285; LEVINSON B, 1985, S AFR MED J, V68, P302; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; MAGNUS A, 1837, MULLERS ARCH ANAT PH, P258; MINDEN SL, 1990, ARCH NEUROL-CHICAGO, V47, P98, DOI 10.1001/archneur.1990.00530010124031; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Okuda DT, 2005, MOVEMENT DISORD, V20, P1389, DOI 10.1002/mds.20607; Okun MS, 2001, ARCH NEUROL-CHICAGO, V58, P1682, DOI 10.1001/archneur.58.10.1682; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; POECK K, 1969, DISORDERS EMOTION, P343; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; SANDYK R, 1985, J AM GERIATR SOC, V33, P375, DOI 10.1111/j.1532-5415.1985.tb07141.x; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; SCHIFFER RB, 1983, PSYCHOSOMATICS, V24, P1094, DOI 10.1016/S0033-3182(83)73113-0; SELIGER G M, 1992, Brain Injury, V6, P267, DOI 10.3109/02699059209029668; SHAIBANI AT, 1994, NEUROPSY NEUROPSY BE, V7, P243; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; SOUEIF MI, 1975, DRUG ALCOHOL DEPEN, V1, P125, DOI 10.1016/0376-8716(75)90014-9; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Tang WK, 2004, J NEUROL, V251, P865, DOI 10.1007/s00415-004-0450-z; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Weiss TG., 2005, UN VOICES STRUGGLE D, P1; Wild B, 2006, NEUROLOGY, V66, P887, DOI 10.1212/01.wnl.0000203123.68747.02; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; WOLF JK, 1979, NEUROLOGY, V29, P1435, DOI 10.1212/WNL.29.10.1435-b; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160	49	5	7	1	7	M B L COMMUNICATIONS, INC	NEW YORK	333 HUDSON ST, 7TH FLOOR, NEW YORK, NY 10013 USA	1092-8529			CNS SPECTRUMS	CNS Spectr.	APR	2007	12	4		5			6	10		10.1017/S1092852900025955			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	170WT	WOS:000246697600002	17426669				2022-02-06	
J	Frenette, AJ; Perreault, MM; Lam, S; Williamson, DR				Frenette, Anne Julie; Perreault, Marc M.; Lam, Stefanie; Williamson, David R.			Thiopental-induced neutropenia in two patients with severe head trauma	PHARMACOTHERAPY			English	Article						thiopental; barbiturates; neutropenia; nuclear factor-kappa B; calcineurin	NF-KAPPA-B; VANCOMYCIN-INDUCED NEUTROPENIA; DRUG-INDUCED AGRANULOCYTOSIS; NUCLEAR-FACTOR; GRANULOCYTE APOPTOSIS; BARBITURATE COMA; INHIBITION; ACTIVATION; SUPPRESSION; RESPONSES	Thiopental has been used for decades in the treatment of refractory intracranial hypertension in patients with traumatic and nontraumatic head injuries. Commonly reported adverse effects include hypotension, hypokalemia, respiratory complications, and hepatic dysfunction. Neutropenia has rarely been reported as an adverse effect of thiopental. We witnessed probable thiopental-induced neutropenia in two patients with traumatic brain injuries who developed increased intracranial hypertension that was refractory to standard therapy. Based on a MEDLINE search of published case reports and literature, we propose two mechanisms by which thiopental-related neutropenia might be explained. The first is inhibition of inflammatory mediator nuclear factor-kappa B (NF-kappa B), leading to granulocyte apoptosis. The second mechanism involves inhibition of calcineurin. Although the precise link between these two mechanisms has not been elucidated, calcineurin is known to regulate NF-kappa B activity. Development of neutropenia does not appear to be correlated with time but may correlate with plasma concentrations of thiopental. The optimum management of drug-induced neutropenia is unclear. The decision to discontinue thiopental in patients who develop neutropenia should be made by weighing the risks versus benefits. Broad-spectrum antibiotics may be required in the presence of fever. The role of hematopoietic growth factors such as granulocyte colony-stimulating factor is not yet defined. Given the adverse infectious consequences of neutropenia, it is essential to closely monitor neutrophil counts in patients receiving thiopental.	Hop Sacre Coeur, Dept Pharm Serv, Montreal, PQ H4J 1C5, Canada; Montreal Gen Hosp, Dept Pharm Serv, Montreal, PQ H3G 1A4, Canada; Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; Univ British Columbia, Fac Pharm, Vancouver, BC V5Z 1M9, Canada		Frenette, AJ (corresponding author), Hop Sacre Coeur, Dept Pharm Serv, 5400 Gouin W, Montreal, PQ H4J 1C5, Canada.	anjue@yahoo.com					Andres E, 2006, REV MED INTERNE, V27, P209, DOI 10.1016/j.revmed.2005.06.008; Andres E, 2001, QJM-MON J ASSOC PHYS, V94, P423, DOI 10.1093/qjmed/94.8.423; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beauchesne MF, 1999, PHARMACOTHERAPY, V19, P299, DOI 10.1592/phco.19.4.299.30941; Blackburn SCF, 1998, PHARMACOTHERAPY, V18, P1277; DONEGAN JH, 1985, AM J PHYSIOL, V249, pH421, DOI 10.1152/ajpheart.1985.249.2.H421; EBERHARDT KEW, 1992, INFECTION, V20, P12, DOI 10.1007/BF01704886; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Finfer SR, 1999, INTENS CARE MED, V25, P406, DOI 10.1007/s001340050866; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Kane-Gill SL, 2005, ANN PHARMACOTHER, V39, P1823, DOI 10.1345/aph.1G177; Kumar Ashish, 2003, BMC Clin Pharmacol, V3, P2, DOI 10.1186/1472-6904-3-2; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; Loop T, 2002, ANESTHESIOLOGY, V96, P1202, DOI 10.1097/00000542-200205000-00025; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MORRIS A, 1991, J INFECTION, V22, P217, DOI 10.1016/S0163-4453(05)80002-7; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; PATTON WN, 1994, DRUG SAFETY, V11, P445, DOI 10.2165/00002018-199411060-00006; Peralta FG, 2003, CLIN INFECT DIS, V37, P1568, DOI 10.1086/379519; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schwartz MD, 2002, PHARMACOTHERAPY, V22, P783, DOI 10.1592/phco.22.9.783.34059; Segarra-Newnham M, 2004, ANN PHARMACOTHER, V38, P1855, DOI 10.1345/aph.1E187; SHINOHARA YT, 1994, ANN PHARMACOTHER, V28, P723, DOI 10.1177/106002809402800607; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P537; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Ward C, 2004, BIOCHEM SOC T, V32, P465, DOI 10.1042/BST0320465; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801	34	5	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	MAR	2007	27	3					464	471		10.1592/phco.27.3.464			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	141YY	WOS:000244616400015	17316158				2022-02-06	
J	Kaptigau, WM; Ke, L; Rosenfeld, JV				Kaptigau, W. Matui; Ke, Liu; Rosenfeld, J. V.			Trends in traumatic brain injury outcomes in Port Moresby General Hospital from January 2003 to December 2004	PAPUA NEW GUINEA MEDICAL JOURNAL			English	Article								Background: Traumatic brain injury (TBI) has been responsible for 25-30% of surgical deaths in Port Moresby General Hospital (PMGH) over the last 30 years despite being responsible for only 5% of the admissions. Aim: To document the epidemiology of TBI over a period of two years from 2003 to 2004 and compare this to the previous two decades in PMGH and elsewhere. The treatment and outcome of TBI cases are analyzed. Methods: All TBI cases were included from January 2003 to December 2004. The Glasgow Coma Score (GCS) and Glasgow Outcome Scale (GOS) were documented at admission and discharge. These cases were followed up in the outpatient department for at least 6 months. Results: There were 262 cases of TBI admitted between January 2003 and December 2004. There were 31 deaths during this period. 28 deaths were in the severe TBI category (GCS 3-8) and 3 in the moderate category (GCS 9-12). Conclusion: The case fatality rate of severe TBI has been reduced from 60% to just below 30% over the period of 2 years. The formation of a single unit managing TBI over two years may be one factor contributing to this improvement. Interpersonal violence has replaced motor vehicle accidents as the leading cause of death from TBI.			Kaptigau, WM (corresponding author), Port Moresby Gen Hosp, Dept Surg, Free Mail Bag,NCD 111, Boroko, Papua N Guinea.		Rosenfeld, Jeffrey V/B-7249-2011				*AM COLL SURG, 2004, NAT TRAUM DAT BANK R; American College of Surgeons, 1997, ADV TRAUM LIF SUPP D, V6th ed; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; *EM DEP, 2004, DEAD ARR REG PORT MO; Faillace WJ, 2002, SURG CLIN N AM, V82, P349, DOI 10.1016/S0039-6109(02)00010-5; KAMINIEL P, 2001, THESIS U PAPUA NEW G; Kaptigau WM, 2007, PAPUA NEW GUINEA MED, V50, P77; KAPTIGAU WM, 2004, ANN REPORT NEUROSURG; KAPTIGAU WM, 2005, ANN REPORT NEUROSURG; KAPTIGAU WM, 2003, INTERIM REPORT NEURO; KELSON D, 2007, INFORM PAPER PAPUA N; Liko O., 1996, Papua New Guinea Medical Journal, V39, P100; *PATH DEP, 2004, POST MORT REG PORT M; PYAKU T, 2003, THESIS U PAPUA NEW G; SINHA SN, 1983, PNG MED J, V24, P222; Watters D A, 1988, J R Coll Surg Edinb, V33, P35	16	5	5	0	0	MEDICAL SOC PAPUA NEW GUINEA	GOTOKA EHP	PO BOX 60, GOTOKA EHP, PAPUA N GUINEA	0031-1480			PAPUA NEW GUINEA MED	Papua N. Guinea Med. J.	MAR-JUN	2007	50	1-2					50	57					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V90KQ	WOS:000206111600009	19354012				2022-02-06	
J	McCrea, SM				McCrea, Simon M.			Measurement of recovery after traumatic brain injury: A cognitive-neuropsychological comparison of the WAIS-R with the Cognitive Assessment System (CAS) in a single case of atypical language lateralization	APPLIED NEUROPSYCHOLOGY			English	Article						Cognitive Assessment System; language lateralization; TBI; WAIS-R	PERFORMANCE; INDEX	A 20-year-old preferentially left-handed male suffered an extensive right, focal, medial, prefrontal hematoma and contusion with associated swelling, and an initially undetected progressive loss of consciousness following trauma to the forehead. Performance on the Cognitive Assessment System (CAS) at 1 and 6 months after traumatic brain injury was compared with performance on the WAIS-R at 6 months post-injury. The patient demonstrated significant residualized impairment on selected subtests of the CAS at 6 months post-injury (all ps < 0.05). The patient was also significantly impaired on the Information, Vocabulary, Arithmetic and Comprehension verbal subtests of the WAIS-R. The magnitude of these WAIS-R subtest discrepancies occurred with a low base rate (< 1%) in the WAIS-R standardization sample. In addition there was a significant VIQ versus PIQ discrepancy favouring PIQ of a magnitude occurring in less than 5% of the WAIS-R standardization sample. These findings could not be explained on the basis of any prior learning disability, poor educational opportunities, medication use, response bias, confabulation, or low level of general ability. The low scores on the verbal subtests of the WAIS-R in conjunction with the impairment on the CAS subtests are highly suggestive of lasting frontal-executive dysfunction in this patient. Incidental findings of persisting anomia, impaired processing of proverbs, acalculia, and fluctuating verbal attention, as well as impaired retrieval of verbal information in the context of intact PIQ and superior constructional praxis suggest some degree of bilateral representation of linguistic Junctions. The differential assessment of cognitive domains by these two instruments as well as theoretical concordance in the pattern of results is also addressed.	[McCrea, Simon M.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada		McCrea, SM (corresponding author), Univ British Columbia, Dept Neuropathol, 2550 Willow St, Vancouver, BC V5Z 3N9, Canada.	smccrea@interchange.ubc.ca					BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Basso A, 2000, CORTEX, V36, P265, DOI 10.1016/S0010-9452(08)70528-8; Basso A., 1999, HDB CLIN EXPT NEUROP, P181; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BLACK FW, 1978, CORTEX, V14, P12, DOI 10.1016/S0010-9452(78)80003-3; Cappa S.F., 1999, HDB CLIN EXPT NEUROP, P155; Chee MWL, 2002, NEUROLOGY, V59, P1928, DOI 10.1212/01.WNL.0000036910.41133.F3; D'Esposito M, 1996, J Int Neuropsychol Soc, V2, P565; DELOCHE G, 1982, BRAIN, V105, P719, DOI 10.1093/brain/105.4.719; DODRILL CB, 1991, EPILEPSY LIFE PERFOR; GROSSMAN FM, 1983, J CONSULT CLIN PSYCH, V51, P641, DOI 10.1037/0022-006X.51.4.641; Gutentag SS, 1998, ASSESSMENT, V5, P263, DOI 10.1177/107319119800500306; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Heilman KM, 2003, CLIN NEUROPSYCHOLOGY; HIRSCHENFANG S, 1960, J CLIN PSYCHOL, V16, P351, DOI 10.1002/1097-4679(196007)16:3<351::AID-JCLP2270160339>3.0.CO;2-X; Kaplan E., 1991, WAISR NEUROPSYCHOLOG; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Llabre M. M., 1984, TEST CRITIQUES, V1, P595; McCrea SM, 2006, ARCH CLIN NEUROPSYCH, V21, P321, DOI 10.1016/j.acn.2006.04.003; McCrea SM, 2002, BRAIN COGNITION, V49, P207, DOI 10.1006/brcg.2001.1467; NAGLERI JA, 1997, COGNITIVE ASSESSMENT; Naglieri JA, 2005, APPL NEUROPSYCHOL, V12, P208, DOI 10.1207/s15324826an1204_4; OLEARY UM, 1991, J CLIN PSYCHOL, V47, P277, DOI 10.1002/1097-4679(199103)47:2<277::AID-JCLP2270470215>3.0.CO;2-I; RZECHORZEK A, 1979, BRAIN IMPAIRMENT; SCHNIDER A, 1999, SCI PRACT NEUROPSYCH, P487; SERON X, 1983, BRAIN, V106, P735, DOI 10.1093/brain/106.3.735; SILVERSTEIN AB, 1984, J CONSULT CLIN PSYCH, V52, P936, DOI 10.1037/0022-006X.52.6.936; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stein RA, 1998, ARCH CLIN NEUROPSYCH, V13, P259, DOI 10.1016/S0887-6177(97)00027-9; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D., 1988, WECHSLER ADULT INTEL; Yin R. K., 1994, CASE STUDY RES DESIG, V2nd	34	5	5	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2007	14	4					296	304		10.1080/09084280701719419			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	250OY	WOS:000252311100009	18067427				2022-02-06	
J	Nestvold, K; Stavem, K				Nestvold, Knut; Stavem, Knut			Headache 22 years after hospitalization for head injury compared with matched community controls	NEUROEPIDEMIOLOGY			English	Article						head injury; epidemiology; long-term headache; matched cohort study; post-traumatic headache	NORWAY; CONCUSSION; SYMPTOMS; ADULTS	Objectives: Little information is available on long- term headache following head injury. We compared the prevalence of headache in a cohort with previous hospitalization for head injury and matched controls. Materials and Methods: A questionnaire about headache was sent to 361 patients who were hospitalized for head injury in 1974 - 1975 and 722 matched community controls. Results: In multivariate conditional regression analysis among 192 responding case/ control pairs, there was no evidence of higher odds of headache 6 1 day per month (odds ratio, OR 1.04, 95% CI 0.56 - 1.92, p = 0.90) compared with controls. However, there was a tendency to higher odds of headache >= 1 day per month among female cases than among controls (OR 2.03, 95% CI 0.94 - 4.39, p = 0.07). Conclusions: The study could not show increased odds of headache in a cohort 22 years following hospitalization for head injury, but it is possible that females are more likely to report long-term headache following head injury than matched controls. Copyright (c) 2007 S. Karger AG, Basel.	Akershus Univ Hosp, Dept Neurol, NO-1478 Lorenskog, Norway; Norwegian Hlth Serv Res Ctr, Oslo, Norway; Akershus Univ Hosp, Dept Med, Lorenskog, Norway; Akershus Univ Hosp, Helse Ost Hlth Serv Res Ctr, Lorenskog, Norway		Nestvold, K (corresponding author), Akershus Univ Hosp, Dept Neurol, NO-1478 Lorenskog, Norway.	knut.nestvold@ahus.no					Cartlidge NEF, 1981, HEAD INJURY, P95; Edna T H, 1987, J Oslo City Hosp, V37, P41; Hagen K, 2002, CEPHALALGIA, V22, P672, DOI 10.1046/j.1468-2982.2002.00413.x; Hagen K, 2000, CEPHALALGIA, V20, P244, DOI 10.1046/j.1468-2982.2000.00049.x; Hagen K, 2002, EUR J NEUROL, V9, P527, DOI 10.1046/j.1468-1331.2002.00451.x; *HEAD CLASS SUBC I, 2004, CEPHALALGIA S1, V24; Huberman M, 1999, AM J EPIDEMIOL, V150, P1340; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Puca F, 1999, CEPHALALGIA, V19, P159, DOI 10.1046/j.1468-2982.1999.1903159.x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, V2, P100; RUSSO D, 1996, CURR OPIN ENDOCRINOL, V3, P428; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Solomon S, 2001, MED CLIN N AM, V85, P987, DOI 10.1016/S0025-7125(05)70355-2; SYMONDS CP, 1945, BRIT MED BULL, V3, P14, DOI 10.1093/oxfordjournals.bmb.a071858; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	22	5	5	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350			NEUROEPIDEMIOLOGY	Neuroepidemiology		2007	29	1-2					113	120		10.1159/000109825			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	230SJ	WOS:000250895900017	17940343				2022-02-06	
J	Stegmaier, J; Kirchhoff, C; Kanz, KG; Mayer, V; Landes, J; Euler, E; Mutschler, W; Biberthaler, P				Stegmaier, Julia; Kirchhoff, Chlodwig; Kanz, Karl-Georg; Mayer, Verena; Landes, Juergen; Euler, Ekkehard; Mutschler, Wolf; Biberthaler, Peter			Analysis of NF-kappa B nuclear translocation in PMN-neutrophils of major trauma patients in the early post-traumatic period: A pilot study	WORLD JOURNAL OF SURGERY			English	Article							MULTIPLE ORGAN FAILURE; INJURY SEVERITY SCORE; TUMOR-NECROSIS-FACTOR; INFLAMMATORY RESPONSE; TNF-ALPHA; MONONUCLEAR-CELLS; BRAIN-INJURY; EXPRESSION; INHIBITION; SUPPRESSION	Background: Post-traumatic inflammation is connected to polymorphonuclear neutrophil (PMN)-dysfunction characterized by reduced nuclear translocation of NF-kappa B during the post-traumatic period. However, the dynamic of NF-kappa B translocation in PMN of major trauma patients remains unclear. Hence, the aim of this pilot study was to analyze NF-kappa B in PMN from multiply injured patients immediately after trauma. Patients and Methods: Blood samples of major trauma patients (ISS > 16) were drawn on admission within 90 minutes after trauma and at 6, 12, 24, 48, and 72 hours after trauma. Neutrophilic NF-kappa B-translocation was analyzed by EMSA and quantified by densitometry as (arbitrary units). In addition, PMN of healthy volunteers were analyzed either in their native state (-control) or after LPS stimulation (+control). Results: Twelve patients (NISS: 34 +/- 10 [mean +/- SEM]) were enrolled. NF-kappa B translocation was significantly increased in trauma patients on admission and after 6 hours. Interestingly, a second activity peak was present after 24 hours. In patients who later died, NF-kappa B activity was significantly elevated initially, to be rapidly diminished after 6 hours, while it increased in the survivors group. After 24 hours NF-kappa B activity increased significantly in the survivors group, to become reduced in both groups at a later time. Conclusions: Within this pilot study, the dynamic of NF-kappa B translocation in PMN of multiply injured patients immmediately after trauma was analyzed for the first time. Enabled by closely matched sequential blood sampling strictly standardized to the traumatic event, an essential biphasic increase of neutrophilic signal transduction could be investigated in the very early post-traumatic period, which preceded the downregulation of the innate immune system.	Univ Munich, Dept Traumatol & Orthoped Surg, D-80336 Munich, Germany		Stegmaier, J (corresponding author), Univ Munich, Dept Traumatol & Orthoped Surg, Nussbaumstr 20, D-80336 Munich, Germany.	julia.stegmaier@med.uni-muenchen.de					Adib-Conquy M, 2003, AM J RESP CRIT CARE, V168, P158, DOI 10.1164/rccm.200209-1077OC; Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30; Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Aslar AK, 2004, INJURY, V35, P746, DOI 10.1016/j.injury.2003.09.030; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Baue AE, 2000, LANGENBECK ARCH SURG, V385, P441, DOI 10.1007/s004230000162; Biberthaler P, 2004, SHOCK, V22, P527, DOI 10.1097/01.shk.0000142819.68823.14; BOTHA AJ, 1995, J TRAUMA, V39, P411; CIOFFI WG, 1993, ARCH SURG-CHICAGO, V128, P1260; CIOFFI WG, 1992, SURGERY, V112, P860; Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1; Cryer HG, 1999, J TRAUMA, V46, P597, DOI 10.1097/00005373-199904000-00007; Dunican AL, 2000, SHOCK, V14, P284, DOI 10.1097/00024382-200014030-00007; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; FAIST E, 1994, IMMUN INFEKT, V22, P203; Goris RJA, 2000, EUR J SURG, V166, P100, DOI 10.1080/110241500750009438; GREEN DR, 1988, IMMUNOL TODAY, V9, P253, DOI 10.1016/0167-5699(88)91300-X; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Kamolz LP, 2005, BURNS, V31, P986, DOI 10.1016/j.burns.2005.06.019; Lakics V, 2000, J IMMUNOL, V165, P2729, DOI 10.4049/jimmunol.165.5.2729; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Lefering R, 2002, LANGENBECK ARCH SURG, V387, P14, DOI 10.1007/s00423-001-0269-3; LEHMANN U, 1995, UNFALLCHIRURG, V98, P442; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Muller JM, 1997, METHODS, V11, P301, DOI 10.1006/meth.1996.0424; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; Nolan B, 2000, J TRAUMA, V48, P599, DOI 10.1097/00005373-200004000-00004; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Partrick D A, 1996, New Horiz, V4, P194; Pepperl S, 2001, AM J PHYSIOL-LUNG C, V280, pL905, DOI 10.1152/ajplung.2001.280.5.L905; Schinkel C, 2001, J TRAUMA, V50, P321, DOI 10.1097/00005373-200102000-00020; Schulman AM, 2004, J TRAUMA, V57, P795, DOI 10.1097/01.TA.0000140835.65944.54; Tinnell SB, 1998, INT IMMUNOL, V10, P1529, DOI 10.1093/intimm/10.10.1529; van den Berg R, 2001, BRIT J NUTR, V86, pS121, DOI 10.1079/BJN2001340; Volk HD, 2000, CHEM IMMUNOL, V74, P162; Waydhas C, 1996, J TRAUMA, V40, P624, DOI 10.1097/00005373-199604000-00018; Zahler S, 1997, J IMMUNOL METHODS, V200, P173, DOI 10.1016/S0022-1759(96)00206-2; Zhou ZX, 2004, AM J PATHOL, V164, P1547, DOI 10.1016/S0002-9440(10)63713-3	46	5	6	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2006	30	12					2142	2151		10.1007/s00268-006-0200-8			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	111HE	WOS:000242441200010	17102914				2022-02-06	
J	McGhee, H; Cornwell, P; Addis, P; Jarman, C				McGhee, Hannah; Cornwell, Petrea; Addis, Paula; Jarman, Carly			Treating dysarthria following traumatic brain injury: Investigating the benefits of commencing treatment during post-traumatic amnesia in two participants	BRAIN INJURY			English	Article						traumatic brain injury; dysarthria; post-traumatic amnesia; rehabilitation	CLOSED-HEAD-INJURY; SPEECH; RELIABILITY; RATINGS; LONG	Primary objective: The aims of this preliminary study were to explore the suitability for and benefits of commencing dysarthria treatment for people with traumatic brain injury (TBI) while in post-traumatic amnesia ( PTA). It was hypothesized that behaviours in PTA don't preclude participation and dysarthria characteristics would improve post-treatment. Research design: A series of comprehensive case analyses. Methods and procedures: Two participants with severe TBI received dysarthria treatment focused on motor speech deficits until emergence from PTA. A checklist of neurobehavioural sequelae of TBI was rated during therapy and perceptual and motor speech assessments were administered before and after therapy. Main outcomes and results: Results revealed that certain behaviours affected the quality of therapy but didn't preclude the provision of therapy. Treatment resulted in physiological improvements in some speech sub-systems for both participants, with varying functional speech outcomes. Conclusions: These findings suggest that dysarthria treatment can begin and provide short-term benefits to speech production during the late stages of PTA post-TBI.	Univ Queensland, Sch Hlth & Rehabil Sci, Div Speech Pathol, St Lucia, Qld 4072, Australia; Princess Alexandra Hosp, Speech Pathol Dept, Brisbane, Qld 4102, Australia		Cornwell, P (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Speech Pathol, St Lucia, Qld 4072, Australia.	petrea.cornwell@uq.edu.au	Cornwell, Petrea/AAE-5547-2019				Ahmed S, 2000, BRAIN INJURY, V14, P765; Chapey R., 1994, LANGUAGE INTERVENTIO; COGSTAD AC, 1976, SOC SCI MED, V10, P283; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; Duffy JR., 2020, MOTOR SPEECH DISORDE; ENDERBY P, 1990, BRIT J DISORD COMMUN, V25, P341; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fukusako Y., 1989, ANN B RILP, V23, P119; HARRIS B, 1984, ARCH PHYS MED REHAB, V65, P408; KEARNS KP, 1988, J SPEECH HEAR RES, V31, P131, DOI 10.1044/jshr.3101.131; KEATLEY A, 1994, EUR J DISORDER COMM, V29, P183; Knock TR, 2000, APHASIOLOGY, V14, P653, DOI 10.1080/026870300401379; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; LANDIS JR, 1977, BIOMETRICS, V33, P174; MARRIOTTLLOYD N, 1997, COGNITIVE ISSUES PRO; McDonald S., 1999, BRAIN DAM B; MCHENRY MA, 1994, J MED SPEECH-LANG PA, V2, P59; McNeil M., 1997, CLIN MANAGEMENT SENS, P311; MCREYNOLDS LV, 1986, J SPEECH HEAR DISORD, V51, P194, DOI 10.1044/jshd.5103.194; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; MURDOCH BE, 1999, BRAIN DAM B, P211; Murdoch BE, 1998, DYSARTHRIA PHYSL APP; RAMIG LO, 1995, J SPEECH HEAR RES, V38, P1232, DOI 10.1044/jshr.3806.1232; ROSENBEK JC, 1978, CLIN MANAGEMENT NEUR, P97; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; SCHULMAN R, 1989, J ACOUST SOC AM, V85, P295, DOI 10.1121/1.397737; SHEARD C, 1991, J SPEECH HEAR RES, V34, P285, DOI 10.1044/jshr.3402.285; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snow P, 1995, TRAUMATIC BRAIN INJU, P33; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, P27; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Theodoros DG, 2001, TRAUMATIC BRAIN INJU, P155; UZZELL BP, 1986, RECOVERY TRAUMATIC B; Ward EC, 2000, J MED SPEECH-LANG PA, V8, P331; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; WIER N, IN PRESS BRAIN INJUR; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; [No title captured]	43	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2006	20	12					1307	1319		10.1080/02699050601081851			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	110DF	WOS:000242357800009	17132553				2022-02-06	
J	Tombaugh, TN; Stormer, P; Rees, L; Irving, S; Francis, M				Tombaugh, Tom N.; Stormer, Peter; Rees, Laura; Irving, Susan; Francis, Margaret			The effects of mild and severe traumatic brain injury on the auditory and visual versions of the Adjusting-Paced Serial Addition Test (Adjusting-PSAT)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						adjusting-PSAT; PASAT; TBI	MULTIPLE-SCLEROSIS; MODALITY; SPEED; TASK	Auditory and visual versions of the Adjusting-PSAT [Tombaugh, T. N. (1999). Administrative manual for the adjusting-paced serial addition test (Adjusting-PSAT). Ottawa, Ontario: Carleton University] were used to examine the effects of mild and severe traumatic brain injury (TBI) on information processing. The Adjusting-PSAT, a computerized modification of the original PASAT [Gronwall, D., & Sampson, H. (1974). The psychological effects of concussion. Auckland, New Zealand: Auckland University Press], systematically varied the inter-stimulus interval (ISI) by making the duration of the ISI contingent on the correctness of the response. This procedure permitted calculation of a temporal threshold measure that represented the fastest speed of digit presentation at which a person was able to process the information and provide the correct answer. Threshold values progressively declined as a function of the severity of TBI with visual thresholds significantly lower than auditory thresholds. The major importance of the current study is that the threshold measure offers a potentially more precise way of evaluating how TBI affects cognitive functioning than is achieved using the traditional PASAT and the number of correct responses. The Adjusting-PSAT offers the additional clinical advantages of eliminating the need to make a priori decisions about what ISI should be used in different clinical applications, and avoiding spuriously high levels of performance that occur when an "alternate answer" or chunking strategy is used. Unfortunately, the Adjusting-PSAT did not reduce the high level of frustration previously associated with the traditional PASAT. (c) 2006 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Carleton Univ, Dept Psychol, Ottawa, ON, Canada; Hawkes Bay Dist Hlth Board, Rehabil Unit, Hastings, New Zealand; Rehabil Ctr, Ottawa, ON, Canada; St Marys Lake Hosp, Dept Psychol, Kingston, ON, Canada; Univ Auckland, Auckland 1, New Zealand		Tombaugh, TN (corresponding author), Carleton Univ, Dept Psychol, 1125 Colonel Dr, Ottawa, ON, Canada.	ttombaug@ccs.carleton.ca					Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hiscock M, 1998, J CLIN EXP NEUROPSYC, V20, P463, DOI 10.1076/jcen.20.4.463.1466; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; Lengenfelder J, 2006, ARCH CLIN NEUROPSYCH, V21, P229, DOI 10.1016/j.acn.2005.12.001; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; SAMPSON H, 1960, AUST J PSYCHOL, V12, P70, DOI 10.1080/00049536008255188; SAMPSON H, 1958, CAN J PSYCHOL, V112, P197; SNYDER PJ, 1993, J CLIN EXP NEUROPSYC, V15, P18; SPREEN L, 1998, COMPENDIUM NEUROPSYC; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 2004, J CLIN EXP NEUROPSYC, V26, P257, DOI 10.1076/jcen.26.2.257.28080; TOMBAUGH TN, 2006, ARCH CLIN NEUROPSYCH; Tombaugh TN, 1999, ADM MANUAL ADJUSTING; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY	20	5	5	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2006	21	7					753	761		10.1016/j.acn.2006.08.009			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	112JR	WOS:000242522400017	17071365	Bronze			2022-02-06	
J	de Boussard, CN; Bellocco, R; Geijerstam, JLA; Borg, J; Adami, J				de Boussard, Catharina Nygren; Bellocco, Rino; Geijerstam, Jean-Luc af; Borg, Jogen; Adami, Johanna			Delayed intracranial complications after concussion	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						brain concussion; mild traumatic brain injury; computerized tomography; late complications; nested case-control study	MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; BRAIN INJURY; RISK; TRAUMA; POPULATION; MANAGEMENT; SWEDEN; DETERIORATION; IMPAIRMENT	Background and Methods: The incidence of readmissions because of delayed intracranial complications within 3 weeks after observation for the sole diagnosis of concussion was examined in a national cohort. A nested case-control design was used to analyze the association between clinical factors as well as early computed tomography (CT) scan examination and these complications. Results: Out of 100,784 patients hospitalized because of concussion during ten years, 127 (0.13%) patients were readmitted because of a delayed intracranial complication. High clinical severity grade (odds ratio [OR] 2.0, confidence interval [CI] 1.2-3.6), minor CT scan abnormalities (OR 1.7, CI 0.8-3.4) and male gender (OR 2.2, CI 1.4-3.5) were associated with an increased risk of delayed, intracranial complications. Conclusion: The incidence of delayed intracranial complications after primarily uncomplicated concussion was low. High clinical severity grade and male gender were risk factors. We failed to demonstrate an additional value of the acute CT scan examination to predict these complications.	Karolinska Inst, Dept Rehabil Med, Stockholm, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, Clin Med Unit, Stockholm, Sweden; Karolinska Inst, Dept Med, Stockholm, Sweden; Uppsala Univ, Dept Neurosci Rehabil Med, Uppsala, Sweden		de Boussard, CN (corresponding author), Danderyd Hosp, Dept Rehabil Med, Karolinska Inst, SE-18288 Stockholm, Sweden.	catharina.deboussard@ds.se	Bellocco, Rino/E-7674-2018; Adami, Johanna/AAA-3312-2021	Borg, Jorgen/0000-0002-2372-7478			af Geijerstam JL, 2000, EUR J SURG, V166, P526; Agresti A., 1990, CATEGORICAL DATA ANA; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAVIS RL, 1994, ANN EMERG MED, P24640; Dunham CM, 1996, J TRAUMA, V41, P679, DOI 10.1097/00005373-199610000-00014; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Holmes JF, 1997, ACAD EMERG MED, V4, P788, DOI 10.1111/j.1553-2712.1997.tb03786.x; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Hung CC, 1996, J FORMOS MED ASSOC, V95, P294; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; MILLER JD, 1990, BRIT J SURG, V77, P241, DOI 10.1002/bjs.1800770302; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Nilsson AC., 1994, LAKARTIDNINGEN, V91, P603; NYREN O, 1995, J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395	35	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2006	61	3					577	581		10.1097/01.ta.0000224901.67930.ce			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	084YL	WOS:000240570200015	16966990				2022-02-06	
J	Mukherjee, KK; Mohindra, S; Gupta, SK; Gupta, R; Khosla, VK				Mukherjee, Kanchan Kumar; Mohindra, Sandeep; Gupta, Sunil Kumar; Gupta, Rahul; Khosla, Virender Kumar			True hemicranial decompression for severe pediatric cranial trauma: a short series of 4 cases and literature review	SURGICAL NEUROLOGY			English	Article						acute SDH; pediatric head injury; decompressive surgery; traumatic infarct	CEREBRAL INFARCTION; BRAIN INJURY; HEAD-INJURY; CRANIECTOMY; CHILDREN; CRANIOTOMY; ARTERY	Background: Traumatic acute SDH in pediatric patients is a life-threatening situation. There is a severe increase in ICP caused by acute SDH or diffuse brain swelling or secondary to ischemic brain damage. In certain situations, conventional measures may fail to control such a rapid increase in ICP. \ Case Description: The cases of 4 pediatric patients with cranial trauma with raised ICP, in whom hemicranial decompression was performed, are described. All patients had acute SDH with diffuse brain injury; in addition, 2 of them had associated massive infarcts. Three of them survived and had a favorable outcome. Conclusions: In certain situations, pediatric patients with cranial trauma may be offered hemicranial decompression as a surgical option. These children may have a better long-term outcome despite massive infarcts. (c) 2006 Elsevier Inc. All rights reserved.	Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India		Mohindra, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India.	satya_sandee@yahoo.com					Abe M, 2003, SURG NEUROL, V59, P464, DOI 10.1016/S0090-3019(03)00078-8; Bauchet L, 2003, REV NEUROL-FRANCE, V159, P1049; Cagavi F, 2005, ANGIOLOGY, V56, P107, DOI 10.1177/000331970505600116; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; El-Watidy S, 2005, PEDIATR NEUROSURG, V41, P151, DOI 10.1159/000085874; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Goel A, 1995, SURG NEUROL, V44, P181, DOI 10.1016/0090-3019(95)00161-1; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Martinez-Lage J, 2006, CHILD NERV SYST, V22, P139, DOI 10.1007/s00381-005-1232-3; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Mori K, 2001, ACTA NEUROCHIR, V143, P483, DOI 10.1007/s007010170078; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Robertson SC, 2004, NEUROSURGERY, V55, P55, DOI 10.1227/01.NEU.0000126875.02630.36; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Server A, 2001, ACTA RADIOL, V42, P254; SHIGEMORI M, 1980, ACTA NEUROCHIR, V54, P61, DOI 10.1007/BF01401944; Spagnuolo E, 2004, NEUROCIRUGIA, V15, P36; Subramaniam S, 2005, NEUROLOGIST, V11, P150, DOI 10.1097/01.nrl.0000159987.70461.d7; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Tazbir Janice, 2005, J Neurosci Nurs, V37, P194	24	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	2006	66	3					305	310		10.1016/j.surneu.2005.12.035			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	085OQ	WOS:000240613800011	16935641				2022-02-06	
J	van Beilen, M; Withaar, FK; van Zomeren, EH; Van den Bosch, RJ; Bouma, A				van Beilen, Marije; Withaar, Frederiec K.; van Zomeren, Ed H.; van den Bosch, Robert J.; Bouma, Anke			Deviant strategy on the modified six elements test in patients with schizophrenia	CLINICAL NEUROPSYCHOLOGIST			English	Article							DYSEXECUTIVE SYNDROME; NEGATIVE SYMPTOMS; DEFICITS; DYSFUNCTIONS; ATTENTION; MEMORY; SCALE	Impaired executive functioning is found in a considerable proportion of schizophrenia patients. Neuropsychological tests are originally designed to measure the behavior of neurological patients and may therefore miss psychiatry-related cognitive deficits. Qualitative information on tests for executive functioning is important in psychiatric populations. The Modified Six Elements Test (MSET) is a planning test that consists of 6 tasks, for which subjects have limited time and have to obey to switching rules. This study concerns a qualitatively different approach schizophrenia patients use on the MSET, and its relationship with cognitive measures. MSET scores and strategies of schizophrenia patients were compared to those of healthy controls, closed-head-injury patients, and peripheral injury patients. Also, schizophrenia patients and healthy controls were compared on verbal memory and vigilance. Schizophrenia patients finish fewer assignments on the MSET, receive a lower profile score compared to healthy controls, and use a different strategy on the test compared to the other groups. They also perform below healthy controls on the tests for verbal memory and vigilance. Use of the different strategy in schizophrenia patients was related to impaired cognitive functioning. An interesting strategy used by schizophrenia patients on the MSET appears to be indicative of impaired cognitive functioning. This strategy may be a compensatory strategy to spare cognitive resources. It could also be the result of a concrete interpretation of the test instructions.	Univ Groningen, Med Ctr, Dept Neurol, NL-9700 RB Groningen, Netherlands; GGZ Drenthe, Dept Psychot Disorders, Assen, Neth Antilles; Univ Groningen, Med Ctr, Dept Psychol, Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Psychiat, Groningen, Netherlands; Univ Groningen, Sch Behav & Cognit Neurosci, Groningen, Netherlands; GGZ Groningen, Ctr Neuropsychiat, Zuidlaren, Netherlands		van Beilen, M (corresponding author), Univ Groningen, Med Ctr, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m.van.beilen@neuro.umcg.nl	van Beilen, Marije/A-7435-2011				Acker MB, 1990, NEUROPSYCHOLOGY EVER, P19; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chan RCK, 2004, EUR ARCH PSY CLIN N, V254, P256, DOI 10.1007/s00406-00-0492-3; Cripe L., 1996, ECOLOGICAL VALIDITY, P171; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; FRITH CD, 1992, NEUROPSYCHOLOGY SCHI; Glahn DC, 2000, BIOL PSYCHIAT, V47, P34, DOI 10.1016/S0006-3223(99)00187-0; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Holthausen EAE, 2002, PSYCHIAT RES, V112, P1, DOI 10.1016/S0165-1781(02)00184-1; Johnson-Selfridge M, 2001, SCHIZOPHRENIA BULL, V27, P305, DOI 10.1093/oxfordjournals.schbul.a006876; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krabbendam L, 2001, AM J MED GENET, V105, P183, DOI 10.1002/ajmg.1197; Krabbendam L, 1999, CLIN NEUROPSYCHOL, V13, P370, DOI 10.1076/clin.13.3.370.1739; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; PIJNENBORG GHM, 2003, 5 ANN C PSYCH TREATM; Reitan R., 1979, MANUAL ADM NEUROPSYC; SAAN RJ, 1986, 15 WOORDEN TESTS MAN; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; SCHMAN B, 1991, THESIS UTRECHT U; SCHMAND B, 1994, PSYCHOL MED, V24, P869, DOI 10.1017/S0033291700028968; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Beilen M, 2004, SCHIZOPHR RES, V69, P267, DOI 10.1016/j.schres.2003.09.007; van Beilen M, 2002, ACTA NEUROPSYCHIATR, V14, P106, DOI 10.1034/j.1601-5215.2002.140302.x; VANBEILEN M, 2004, THESIS GRONINGEN U M; vandenBosch RJ, 1996, SCHIZOPHRENIA BULL, V22, P643, DOI 10.1093/schbul/22.4.643; WITHAAR FK, 1998, J INT NEUROPSYCH SOC, V4, P224	36	5	5	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					469	479		10.1080/13854040590967126			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000008	16895859				2022-02-06	
J	Barba, C; Formisano, R; Sabatini, U; Cicinelli, P; Hagberg, GE; Marconi, B; Ciurli, P; Bianciardi, M; Matteis, M				Barba, Carmen; Formisano, Rita; Sabatini, Umberto; Cicinelli, Paola; Hagberg, Gisela Elisabeth; Marconi, Barbara; Ciurli, Paola; Bianciardi, Marta; Matteis, Maria			Dysfunction of a structurally normal motor pathway in a brain injury patient as revealed by multimodal integrated techniques	NEUROCASE			English	Article							HEMODYNAMICS; STROKE; MRI	We report on a patient with left hemiparesis and peripersonal neglect after post-traumatic left frontal hemorrhage, who underwent fMRI, TMS and TCD to identify the functional abnormalities that account for his neurological symptoms, in the absence of any detectable lesion affecting right motor areas.	Fdn Santa Lucia, IRCCS, I-00179 Rome, Italy		Barba, C (corresponding author), Fdn Santa Lucia, IRCCS, Via Ardeatina 306, I-00179 Rome, Italy.	carmen.barba@tiscali.it	barba, carmen/K-4942-2016; Barba, Carmen/AAB-7162-2022; Sabatini, Umberto/K-4659-2016; Sabatini, Umberto/A-8484-2010; Hagberg, Gisela E/A-2134-2010	barba, carmen/0000-0001-5445-5842; Sabatini, Umberto/0000-0001-5321-8626; Hagberg, Gisela E/0000-0003-2176-7086			Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; Cipolla MJ, 2002, STROKE, V33, P2094, DOI 10.1161/01.STR.0000020712.84444.8D; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Hagberg GE, 2003, MAGN RESON IMAGING, V21, P1241, DOI 10.1016/j.mri.2003.09.003; Hagberg GE, 2002, MAGNET RESON MED, V48, P877, DOI 10.1002/mrm.10283; Hagen C., 1972, LEVELS COGNITIVE FUN; Krakauer JW, 2004, ANN NEUROL, V56, P796, DOI 10.1002/ana.20286; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; TEASDALE G, 1974, LANCET, V2, P81; Terakawa H, 2000, NEUROLOGY, V54, P1801, DOI 10.1212/WNL.54.9.1801	16	5	6	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1355-4794			NEUROCASE	Neurocase	AUG	2006	12	4					232	235		10.1080/13554790600878879			4	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	087NS	WOS:000240749700006	17000593				2022-02-06	
J	Cantagallo, A; Carli, S; Simone, A; Tesio, L				Cantagallo, Anna; Carli, Silvia; Simone, Anna; Tesio, Luigi			MINDFIM: A measure of disability in high-functioning traumatic brain injury outpatients	BRAIN INJURY			English	Article						traumatic brain injury; disability assessment; outcome; Rasch analysis; MINDFIM	MEDICAL REHABILITATION; PHYSICAL-DISABILITY; RASCH ANALYSIS; IMPAIRMENT; MEMORY; LEVEL; MODEL	Primary objective: The study aimed at developing a new valid measure of disability in TBI outpatients. Research design and methods: The Rasch model (Winsteps 3.45 software, 2005) was adopted to achieve a linear measure, unidimensional and reliable. The predictive capacity with respect to return to school or job was also tested (logistic regression, STATA 8.0 software, 2004). Experimental interventions: Either tests of Attention, Memory and Verbal Fluency or the FIM were administered to 160 TBI ambulatory outpatients (52 women, age 14-72, 2-117 months after trauma, I 11 cases with coma >= I week). Fifty of them (31%) had returned to school or job. Main outcomes and results: A new scale called MINDFIM could be successfully developed. It includes three cognitive and four FIM motor items (Grooming, Upper Body Dressing, Bathing and Tub/Shower Transfer). The scale raises the ceiling affecting existing instruments. The summated scores are predictive of return to community (74% correct classification). Conclusions: MINDFIM is valid and useful measure of disability in TBI outpatients.	IRCCS, Ist Auxol Italiano, Clin & Res Unit Neuromotor Rehabil, I-20122 Milan, Italy; Hosp Ferrara, Dept Rehabil, Ferrara, Italy; Univ Ferrara, Unit Neuropsychol Rehabil, I-44100 Ferrara, Italy		Tesio, L (corresponding author), IRCCS, Ist Auxol Italiano, Clin & Res Unit Neuromotor Rehabil, Via Mercalli 32, I-20122 Milan, Italy.	l.tesio@auxologico.it	TESIO, Luigi/J-6202-2019; Simone, Anna/A-8198-2011; TESIO, Luigi/A-1083-2008	TESIO, Luigi/0000-0003-0980-1587; Simone, Anna/0000-0003-1537-3187; TESIO, Luigi/0000-0003-0980-1587			Andrich D., 1988, 68 SAG U; BACHYRITA P, 1981, SCAND J REHABIL MED, V13, P73; Badia X., 2002, RASCH MEAS T, V16, P889; Bond T, 2001, APPL RASCH MODEL FUN; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CAPITANI E, 1991, ITAL J NEUROL SCI, V12, P461, DOI 10.1007/BF02335507; CAPITANI E, 1988, DEV NEUROPSYCHOL, V4, P325, DOI 10.1080/87565648809540416; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; LINACRE JM, 2003, RASCH MEASUREMENT T, V1, P942; Linacre John M, 2002, J Appl Meas, V3, P85; Linn R T, 1999, J Outcome Meas, V3, P339; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Smith R M, 2000, J Appl Meas, V1, P199; Spinnler H., 1987, ITAL J NEUROL SCI, V8, P111, DOI [10.1007/BF02337583, DOI 10.1007/BF02337583]; Stineman MG, 1997, HEALTH SERV RES, V32, P529; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Tesio L, 2002, AM J PHYS MED REHAB, V81, P168, DOI 10.1097/00002060-200203000-00003; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Tesio L, 1998, J Outcome Meas, V2, P79; Tesio L, 1997, FUNCT NEUROL, V12, P255; Tesio L., 1997, EUROPA MEDICOPHYSICA, V33, P55; Tesio Luigi, 2002, J Appl Meas, V3, P50; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; Wald A, 1943, ANN MATH STAT, V14, P45, DOI 10.1214/aoms/1177731491; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WEHMAN PH, 1991, ARCH PHYS MED REHAB, V72, P101; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; World Health Organization, 2007, INT CLASS FUNCT DIS; Wright B., 2002, RASCH MEAS T, V16, P888; Wright B. D., 1996, RASCH MEASUREMENT T, V9; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; Wright BD., 1982, RATING SCALE ANAL; [No title captured]	36	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2006	20	9					913	925		10.1080/02699050600832742			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	094ZN	WOS:000241278100004	17062423				2022-02-06	
J	Salci, K; Nilsson, P; Goiny, M; Contant, C; Piper, I; Enblad, P				Salci, Konstantin; Nilsson, Pelle; Goiny, Michel; Contant, Charles; Piper, Ian; Enblad, Per			Low intracranial compliance increases the impact of intracranial volume insults to the traumatized brain: A microdialysis study in a traumatic brain injury rodent model	NEUROSURGERY			English	Article						intracranial compliance; microdialysis; rat; traumatic brain injury	HEAD-INJURY; COMPLIANCE MONITOR; REGIONAL CHANGES; AMINO-ACIDS; PRESSURE; DYNAMICS; RATS; APOPTOSIS; GLUTAMATE; DEATH	OBJECTIVE: The vulnerability of the brain is Considered to be increased after trauma. The present study was undertaken to determine whether intracranial volume insults in the posttraumatic period led to increased metabolic disturbances if intracranial compliance was decreased. METHODS: A weight drop technique with a brain compression of 1.5 mm was used for injury. Intracranial compensatory volume was decreased 60 mu l by placing rubber film between the dura mater and the bone. Intracranial volume insults were induced using the Bolus injection technique. Microdialysis was used to measure interstitial lactate, pyruvate, hypoxanthine, and glycerol. Fifty-two-rats Were allocated to trauma and sham groups with 0 to 3 layers of rubber film with and without intracranial volume insults. RESULTS: In the groups with reduced intracranial volume exposed to intracranial volume insults, the time course of metabolic markers showed higher increases and slower recovery rates than for the other groups. Reduced intracranial volume or intracranial volume insults alone did not cause any changes compared with controls. CONCLUSION: These results support the hypothesis that decreased intracranial compliance increases the vulnerability of the brain for secondary volume insults even with intracranial pressure at low levels between the insults. This finding has important clinical implications in that it stresses the need to identify patients with low intracranial compliance so that their treatment can be optimized.	Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland		Enblad, P (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden.	Per.Enblad@neurokir.uu.se					BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Conti AC, 1998, J NEUROSCI, V18, P5663; Elf K, 2003, EUR J TRAUMA, V29, P74; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KINGMAN TA, 1988, J NEUROPATH EXP NEUR, V47, P128, DOI 10.1097/00005072-198803000-00005; KOSTELJANETZ M, 1986, NEUROSURGERY, V18, P17, DOI 10.1227/00006123-198601000-00004; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; MILLER JD, 1975, J NEUROSURG, V42, P274, DOI 10.3171/jns.1975.42.3.0274; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; REILLY PL, 1975, LANCET, V2, P375; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Salci K, 2004, J NEUROTRAUM, V21, P317, DOI 10.1089/089771504322972103; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SPIEGELBERG A, 1996, WORK C INT GROUP INT; SULLIVAN HG, 1978, SURG NEUROL, V9, P47; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810; Yau Y, 2002, ACTA NEUROCHIR SUPPL, V81, P167; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	30	5	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	AUG	2006	59	2					367	373		10.1227/01.NEU.0000222648.61065.38			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	073SV	WOS:000239763800045	16883177				2022-02-06	
J	Sheehan, W; Thurber, S				Sheehan, W.; Thurber, S.			Psychosis or temporal lobotomy: SPECT findings in a paraplegic patient with chronic mental illness	ACTA PSYCHIATRICA SCANDINAVICA			English	Article						neuroimaging; medical error; traumatic brain injury		Objective: To ascertain if single proton emission computerized tomography (SPECT) imaging involving a patient with a history of head trauma, paraplegia, and chronic mental illness, would provide useful information regarding diagnosis and treatment. Method: A case report. Results: SPECT data indicated a convexity of the temporal lobe; it was significantly crumpled inward in the location of the traumatic blow suffered 18 years earlier. The center of hypoperfusion suggested a complete disruption of connections between the temporal lobe and Broca's area, and a practically ablated left temporal area. Conclusion: The patient was reclassified with an organic psychosis and as an individual who might benefit more from medications to treat temporal lobe irritability rather than antipsychotic medications. Despite these findings and recommendations, psychiatric personnel discharged the patient without implementation. He is currently in critical condition following a suicide attempt.	Rice Mem Hosp, Willmar, MN 56201 USA; Woodland Ctr, Willmar, MN USA		Sheehan, W (corresponding author), Rice Mem Hosp, 301 Becker Ave SW, Willmar, MN 56201 USA.	steven_thurber@yahoo.com					Camargo EE, 2001, J NUCL MED, V42, P611; FRAN JR, 1995, AM J PSYCHIAT, V152, P1492; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Kessing LV, 2005, ACTA PSYCHIAT SCAND, V111, P396, DOI 10.1111/j.1600-0447.2004.00453.x; Leyhe T, 2005, ACTA PSYCHIAT SCAND, V111, P392, DOI 10.1111/j.1600-0447.2004.00452.x; RAUCH SL, 1995, HARVARD REV PSYCHIAT, V2, P297, DOI 10.3109/10673229509017151; Reisch T, 2005, ACTA PSYCHIAT SCAND, V112, P159, DOI 10.1111/j.1600-0447.2004.00480.x; Shermer M, 2004, SCI AM, V291, P38	8	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-690X	1600-0447		ACTA PSYCHIAT SCAND	Acta Psychiatr. Scand.	AUG	2006	114	2					140	142		10.1111/j.1600-0447.2006.00869.x			3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	068PW	WOS:000239387900009	16836602				2022-02-06	
J	Woldag, H; Atanasova, R; Renner, C; Hummelsheim, H				Woldag, H.; Atanasova, R.; Renner, C.; Hummelsheim, H.			Functional outcome after decompressive craniectomy: A retrospective and prospective clinical study	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article							CEREBRAL-ARTERY INFARCTION; HEMICRANIECTOMY; STROKE; DISABILITY	Decompressive craniectomy has been revived as a radical surgical treatment in increased ICP. While the life saving effect is undisputable, reports about the functional outcome are controversial. Furthermore, there are no data comparing the outcome of craniectomised patients with different aetiologies. In a retrospective and prospective study we assessed the functional outcome of craniectomised patients (41 stroke and 24 traumatic brain injury (TBI) patients). The majority of patients considerably benefits from the rehabilitation process. Nevertheless, most of them remained dependent upon caregivers. In stroke patients there was a significant negative correlation between age and outcome. Even though TBI were younger than stroke patients there were no outcome differences between these groups. We found no correlation between the side of the hemisphere injured and outcome.	Univ Leipzig, Neurol Rehabil Zentrum Leipzig, D-04828 Leipzig, Germany		Woldag, H (corresponding author), Univ Leipzig, Neurol Rehabil Zentrum Leipzig, Muldentalweg 1, D-04828 Leipzig, Germany.	woldag@sachsenklinik.de					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; GUERRA WK, 1990, J NEUROSURG, V90, P187; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Macciocchi SN, 1998, ARCH PHYS MED REHAB, V79, P1255, DOI 10.1016/S0003-9993(98)90271-4; MAHONEY F I, 1965, Md State Med J, V14, P61; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; Sakai K, 1998, NEUROL MED-CHIR, V38, P131, DOI 10.2176/nmc.38.131; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; VONWILD K, 1990, NEUROLOGISCHE FRUHRE; Walz B, 2002, J NEUROL, V249, P1183, DOI 10.1007/s00415-002-0798-x; [No title captured]	16	5	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299			FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	JUL	2006	74	7					367	370		10.1055/s-2006-932142			4	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	068RC	WOS:000239391100011	16586266				2022-02-06	
J	Chiara, O; Cimbanassi, S; Brioschi, PR; Bucci, L; Terzi, V; Vesconi, S				Chiara, O.; Cimbanassi, S.; Brioschi, P. R.; Bucci, L.; Terzi, V.; Vesconi, S.			Treatment of critical bleeding in trauma patients	MINERVA ANESTESIOLOGICA			English	Article; Proceedings Paper	Symposium on Extension Anesthesia Resuscitation and Intensive Therapy	MAY 10-12, 2006	Milan, ITALY			hemorrhage; trauma; recombinant activated FVII	RECOMBINANT-FACTOR-VIIA; TRANSFUSION	Aim. Massive haemorrhage after trauma is a big challenge for care-givers, being a leading cause of early in-hospital mortality. Surgical bleeding may be easily controlled with several techniques. Otherwise, consumptive coagulopathy is often extremely difficult to stop. An adjunctive strategy to treat traumatic coagulopathic bleeding is recombinant activated factor VII (rFVIIa) (NovoSeven(R), Novo Nordisk A/S, Bagsvaerd, Denmark). Methods. All major trauma victims haemodinamically unstable (systolic blood pressure < 90 mmHg or > 90 mmHg with massive infusions or vasopressors) admitted to the Emergency Department of the Niguarda Ca' Granda Hospital in Milan from October 2002 to September 2005 were reviewed. Mechanical bleeding was controlled with interventional techniques when indicated. Blood derivatives were administrated to maintain haemoglobin > 7g/dL, INR < 1.5, fibrinogen > 1 and platelet count > 50x109. Off-label administration of rFVIIa was performed in the last year in any coagulopathic salvageable patient when all other strategies failed to control bleeding. Results. Major trauma were 942, mean age 32.49 +/- 18.44 years, 94% blunt trauma, 25-13% haemodynamically unstable. Deaths occurred in 17.02% of cases before any procedure. Emergency invasive treatments were performed in 72-34% of cases. infusions restored haemodynamic stability in 10.63% of patients. in average 9.4 +/- 4.1 units of red blood cells were transfused in unstable patients. rFVIIa (dosing 60-100 mg/kg) was administrated in 12 patients. mortality occurred in 33.33% of cases. The principal cause of death was brain injury. A femoral artery thrombosis was observed in a mangled leg. No other adverse effects due to rFVIIa were documented. Conclusion. Off-label administration of rFVIIa was able to reverse life-threatening bleeding not manageable with standard strategies in our series of major trauma patients without systemic adverse effects.	Osped Niguarda Ca Granda, Trauma Team Unit, DEA EAS, I-20162 Milan, Italy; Osped Niguarda Ca Granda, Anesthesiol & Intens Care Unit 1, DEA EAS, I-20162 Milan, Italy		Chiara, O (corresponding author), Osped Niguarda Ca Granda, Trauma Team Unit, DEA EAS, Piazza Benefattori Osped 3, I-20162 Milan, Italy.	ochiara@yahoo.com					Aldouri M, 2002, PATHOPHYSIOL HAEMO T, V32, P41, DOI 10.1159/000057301; Allen GA, 2002, CAN J ANAESTH, V49, pS7; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Grounds M, 2003, BLOOD REV, V17, pS11, DOI 10.1016/S0268-960X(03)90002-6; Hendriks HGD, 2001, TRANSPLANTATION, V71, P402, DOI 10.1097/00007890-200102150-00011; Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2; Holcomb JB, 2004, CRIT CARE, V8, pS57, DOI 10.1186/cc2407; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Lynn M, 2002, INTENS CARE MED, V28, pS241, DOI 10.1007/s00134-002-1471-7; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Martinowitz U, 2001, J TRAUMA, V50, P721, DOI 10.1097/00005373-200104000-00021; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; STAINSBY M, 2000, BRIT J ANAESTH, V85, P467	17	5	6	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUN	2006	72	6					383	387					5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology; General & Internal Medicine	103WT	WOS:000241918600007	16682905				2022-02-06	
J	Buse, GJ; Wood, RM				Buse, George J.; Wood, Robert M.			Safety profile of amateur kickboxing among military and civilian competitors	MILITARY MEDICINE			English	Article; Proceedings Paper	50th Annual Symposium of the Society-of-Air-Force-Clinical-Surgeons	MAR 30-APR 03, 2003	San Antonio, TX	Soc Air Force Clin Surg			BOXING-RELATED INJURIES; UNITED-STATES-ARMY; HEAD-INJURY; CONCUSSION	The purpose of this study was to identify match-ending injuries in amateur kickboxing (KB) among military and civilian competitors. A total of 148 competitors, of whom 5 were on active duty in the U.S. Air Force or Marine Corps, participated in amateur KB matches (N = 74) from 1999 to 2001. Match-ending injuries were observed and managed from ringside by one author (G.J.B.). Of all matches, 23 (31.1%) were stopped because of injury. Of the 23 matches, 15 (65.2%) ended because of traumatic brain injury, 4 (17.4%) because of orthopedic trauma, 3 (13.0%) because of thoracoabdominal trauma, and 1 (4.4%) because of ocular trauma. The incidence of traumatic brain injury was greater than that of all other match-ending injuries combined (p < 0.01). Because of the incidence and potentially serious sequelae of injuries associated with competitive KB, military commanders should exercise operational risk management in an attempt to safeguard personnel from unnecessary hazard.	Cannon USAF Clin, Dept Aerosp Med, Cannon AFB, NM 88103 USA; Keesler USAF Med Ctr, Dept Emergency Med, Keesler AFB, MS 39534 USA		Buse, GJ (corresponding author), Cannon USAF Clin, Dept Aerosp Med, Cannon AFB, NM 88103 USA.						Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BARELA T, 1999, AIRMAN           JUN, P34; BELSON K, 2003, NY TIMES        1225, pD7; Birrer R B, 1983, Br J Sports Med, V17, P131; Birrer RB, 1996, AM J SPORT MED, V24, pS72, DOI 10.1177/036354659602406S21; BOOHER JM, 2000, ATHLETIC INJURY ASSE; Bourliere M, 2000, GASTROENTEROLOGY, V119, P507, DOI 10.1053/gast.2000.9303; de Rougomont R R, 1989, Mil Med, V154, P581; ENZENAUER RW, 1987, MIL MED, V152, P536; ENZENAUER RW, 1989, JAMA-J AM MED ASSOC, V261, P1463, DOI 10.1001/jama.261.10.1463; ENZENAUER RW, 1994, JAMA-J AM MED ASSOC, V272, P1821, DOI 10.1001/jama.1994.03520230031028; ENZENAUER RW, 1989, SOUTH MED J, V82, P547; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; Finch CF, 2002, J SCI MED SPORT, V5, P46, DOI 10.1016/S1440-2440(02)80297-3; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; *INT KICKB FED, 1999, PAST IKF NEWS    APR; JORDAN BD, 1993, MED ASPECTS BOXING, P17; Kelly JP, 1997, NEUROLOGY, V48, P581; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; LUNDBERG GD, 1994, JAMA-J AM MED ASSOC, V271, P1790, DOI 10.1001/jama.271.22.1790; McNally J J, 1989, Mil Med, V154, P102; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; MULERO A, 2002, MARINE CORPS NE 1010; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; PERKINS J, 2003, NAVAL AMPHIBIOUS AUG; POYSER N, 1997, INSCOM J         MAY; PRAYUKVONG K, 2001, MUAY THAI LIVING LEG, P14; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Ross RT, 1999, MIL MED, V164, P68, DOI 10.1093/milmed/164.1.68; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Saengsirisuwan V, 1998, BRIT J SPORT MED, V32, P304, DOI 10.1136/bjsm.32.4.304; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; STEWART L, 2003, LOS ANGELES TIM 1111, pD2; SWARTZBERG D, 1995, JAMA-J AM MED ASSOC, V274, P784, DOI 10.1001/jama.1995.03530100018006; TYRANGIEL J, 2001, TIME            0903, P67; *US AM BOX, 2004, US BOX OFF RUL, P43	39	5	5	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2006	171	5					443	447		10.7205/MILMED.171.5.443			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	041ZR	WOS:000237496800021	16761897	Bronze			2022-02-06	
J	Kobori, N; Moore, AN; Dash, PK				Kobori, Nobuhide; Moore, Anthony N.; Dash, Pramod K.			GDNF abates serum deprivation-induced tyrosine hydroxylase Ser19 phosphorylation and activity	BRAIN RESEARCH			English	Article						catecholamine; tyrosine hydroxylase; GDNF; traumatic brain injury; Parkinson's disease; retinoic acid	ADRENAL CHROMAFFIN CELLS; NEUROTROPHIC FACTOR; PROTEIN-KINASE; DOPAMINERGIC-NEURONS; BRAIN-INJURY; CATECHOLAMINE BIOSYNTHESIS; INTRACELLULAR PH; IN-VITRO; ACTIVATION; ISCHEMIA	High dopamine levels can contribute to neuronal dysfunction, impair plasticity and be toxic to neuronal cells in pathological conditions. The synthesis of dopamine is regulated by phosphorylation of the rate-limiting enzyme tyrosine hydroxylase (TH) under physiological conditions, with the phosphorylation of Ser31 and Ser40 directly increasing TH activity. Although a third phosphorylation site, Ser19, does not appear to directly regulate TH activity in physiological conditions, its role in pathological conditions is poorly understood. In this study, we examined the effects of serum deprivation (to mimic loss of retrogradely/anterogradely transported target-derived neurotrophic factors following axonal injury) and glutamate receptor stimulation (to mimic excitotoxicity) on TH phosphorylation and activity in a cell line and in mesencephalic primary culture cells. In addition, we also tested whether glial cell line-derived neurotrophic factor (GDNF) can alter these changes. We demonstrate that serum-deprivation resulted in a sustained increase in Ser19 phosphorylation beginning at 3 h and lasting up to 10 h without any detectable change in Ser31 or Ser40 phosphorylation within this time frame. This increase in Ser19 phosphorylation was associated with enhanced TH activity and was due, in part, to glutamate-receptor-mediated calcium influx and possibly calcium/calmodulin-dependent protein kinase II (CaMKII) activation. Interestingly in this serum-deprivation model, GDNF blocked the increase in Ser19 phosphorylation and TH activity at the 10-h time point following serum deprivation. Furthermore, GDNF also blocked the glutamate-mediated increase in Ser19 phosphorylation in rat primary mesencephalic neuronal cultures. Taken together, these findings suggest that GDNF may reduce dopamine synthesis in pathological conditions. (c) 2006 Elsevier B.V. All rights reserved.	Univ Texas, Sch Med, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX 77255 USA; Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, Houston, TX 77255 USA		Dash, PK (corresponding author), Univ Texas, Sch Med, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, POB 20708, Houston, TX 77255 USA.	p.dash@uth.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049160, R01NS035457] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35457, NS049160] Funding Source: Medline		Barzilai A, 2001, CELL MOL NEUROBIOL, V21, P215, DOI 10.1023/A:1010991020245; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; Bevilaqua LRM, 2001, J BIOL CHEM, V276, P40411, DOI 10.1074/jbc.M105280200; BUNN SJ, 1995, J NEUROCHEM, V64, P1370; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; Clarkson ED, 1997, CELL TISSUE RES, V289, P207, DOI 10.1007/s004410050867; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FILLOUX F, 1993, EXP NEUROL, V119, P79, DOI 10.1006/exnr.1993.1008; Fornai F, 2003, J NEUROSCI, V23, P8955; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; HAAVIK J, 1990, FEBS LETT, V262, P363, DOI 10.1016/0014-5793(90)80230-G; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; HAYCOCK JW, 1993, NEUROCHEM RES, V18, P15, DOI 10.1007/BF00966919; Haycock JW, 1998, J NEUROCHEM, V71, P1670; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; ISOBE T, 1991, J MOL BIOL, V217, P125, DOI 10.1016/0022-2836(91)90616-E; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Keir SD, 2001, J NEUROVIROL, V7, P437; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; Kobori N, 2004, J BIOL CHEM, V279, P2182, DOI 10.1074/jbc.M310734200; Larsen KE, 2002, J NEUROSCI, V22, P8951; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; LEVINE RA, 1984, ANAL BIOCHEM, V143, P205, DOI 10.1016/0003-2697(84)90577-3; Lew JY, 1999, MOL PHARMACOL, V55, P202, DOI 10.1124/mol.55.2.202; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; MABE H, 1983, J CEREBR BLOOD F MET, V3, P109, DOI 10.1038/jcbfm.1983.13; Mani SK, 2000, SCIENCE, V287, P1053, DOI 10.1126/science.287.5455.1053; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Perrelet D, 2002, NAT CELL BIOL, V4, P175, DOI 10.1038/ncb751; Rabinovic AD, 2000, NEUROSCIENCE, V101, P67, DOI 10.1016/S0306-4522(00)00293-1; ROSS RA, 1981, CELL MOL NEUROBIOL, V1, P301, DOI 10.1007/BF00710685; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Sawada H, 2000, J NEUROCHEM, V74, P1175; SIEMKOWICZ E, 1981, STROKE, V12, P236, DOI 10.1161/01.STR.12.2.236; Siesjo B K, 1982, Ciba Found Symp, V87, P77, DOI 10.1002/9780470720691.ch5; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; Thomas G, 1997, EUR J BIOCHEM, V247, P1180, DOI 10.1111/j.1432-1033.1997.01180.x; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Toska K, 2002, ANN NY ACAD SCI, V971, P66, DOI 10.1111/j.1749-6632.2002.tb04435.x; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; WAYMIRE JC, 1991, J NEUROCHEM, V57, P1313, DOI 10.1111/j.1471-4159.1991.tb08296.x; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; Zigmond MJ, 2002, PARKINSONISM RELAT D, V8, P389, DOI 10.1016/S1353-8020(02)00019-6; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.neuro.12.1.415	59	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 1	2006	1086						142	151		10.1016/j.brainres.2006.02.111			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	049FN	WOS:000238001500017	16626642				2022-02-06	
J	Chachad, S; Khan, A				Chachad, S; Khan, A			Concussion in the athlete: A review	CLINICAL PEDIATRICS			English	Article							CLOSED-HEAD INJURY; CEREBRAL CONCUSSION; MANAGEMENT; SPORTS; MILD		W Virginia Univ Hosp, Dept Pediat, Morgantown, WV 26506 USA		Chachad, S (corresponding author), W Virginia Univ Hosp, Dept Pediat, Morgantown, WV 26506 USA.						Bailes JE, 2001, J ATHL TRAINING, V36, P236; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; *CO MED SOC SPORTS, 1990, COLO MED, P81; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Osborne B, 2001, J ATHL TRAINING, V36, P316; Parkinson D, 1996, SURG NEUROL, V45, P459, DOI 10.1016/0090-3019(95)00210-3; PICKLES W, 1950, NEW ENGL J MED, V241, P607; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Stein SC, 1996, NEUROSURG QUART, V6, P108, DOI 10.1097/00013414-199606000-00004; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008; 1997, MMWR MORB MORTAL WKL, V48, P224	15	5	5	0	2	WESTMINSTER PUBL INC	GLEN HEAD	708 GLEN COVE AVE, GLEN HEAD, NY 11545 USA	0009-9228			CLIN PEDIATR	Clin. Pediatr.	APR	2006	45	3					285	288		10.1177/000992280604500314			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	041GU	WOS:000237443300014	16708145				2022-02-06	
J	Hensold, TC; Guercio, JM; Grubbs, EE; Upton, JC; Faw, G				Hensold, Tom C.; Guercio, John M.; Grubbs, Elizabeth E.; Upton, Johnna C.; Faw, Gerry			A personal intervention substance abuse treatment approach: Substance abuse treatment in a least restrictive residential model	BRAIN INJURY			English	Article						acquired brain injury; treatment options; neurobehavioural treatment; contemporary approaches	TRAUMATIC BRAIN-INJURY; UTILITY	The following paper will detail demographic information about alcohol and substance abuse issues in the acquired brain injury (ABI) population. Included in such a review will be a systematic presentation of the current data on the incidence of such issues as well as a comprehensive treatment model with outcome data provided. Pre- and post-test measures of separate functional outcome areas were employed to assess the effects of the treatment package. The paper will document the core elements of a substance abuse treatment programme that is based upon community inclusion and positive, proactive treatment methods in facilitating decreases in substance abuse behaviour. The programme employed a host of individual and group session protocols specifically targeted at education and self-monitoring of behaviour in order to facilitate more effective self-control of addictive behaviours. The positive outcomes achieved by the participants involved in the study provide clinical justification for a proactive behavioural approach to substance abuse in the ABI population.	Ctr Comprehens Serv, Personal Intervent Neurobehav Program, Mentor ABI Grp, Carbondale, IL 62901 USA		Guercio, JM (corresponding author), Ctr Comprehens Serv, Personal Intervent Neurobehav Program, Mentor ABI Grp, 306 W Mill St, Carbondale, IL 62901 USA.	John.Guercio@TheMentorNetwork.com					Arenth PM, 2001, BRAIN INJURY, V15, P499, DOI 10.1080/02699050010006002; Cherner M, 2001, ARCH PHYS MED REHAB, V82, P780, DOI 10.1053/apmr.2001.23263; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; FULLER MG, 1994, J NEUROPSYCH CLIN N, V6, P143; Guercio John M, 2004, Case Manager, V15, P66, DOI 10.1016/j.casemgr.2004.02.001; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; MCMORROW MJ, 1977, INNOVATIONS HEAD INJ; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; SEATON JD, 1990, J HEAD TRAUMA REHAB, V5, P41; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; STRAUSS D, 2001, BRAIN INJURY SOURCE, V5, P8; STRAUSS D, 2001, BRAIN INJURY SOURCE, V5, P40; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Tucker Jalie A., 1995, Experimental and Clinical Psychopharmacology, V3, P195, DOI 10.1037/1064-1297.3.2.195; Vuchinich RE, 1996, EXP CLIN PSYCHOPHARM, V4, P19	19	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2006	20	4					369	381		10.1080/02699050500487563			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700002	16716983				2022-02-06	
J	Korsic, M; Jugovic, D; Kremzar, B				Korsic, M; Jugovic, D; Kremzar, B			Intracranial pressure and biochemical indicators of brain damage: Follow-up study	CROATIAN MEDICAL JOURNAL			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; OXYGEN; TENSION; PH	Aim To investigate the relation between metabolic parameters of the brain tissue, as direct indicators of real metabolic conditions within the brain, and intracranial pressure, as the consequence of pathophysiological changes. Methods Twelve patients with closed head injuries were followed up for 24 hours after injury. A Codman parenchymal intracranial pressure and a Neurotrend electrode were inserted within 3 hours after injury to monitor parenchymal intracranial pressure, brain tissue partial oxygen pressure (p(br)O(2)), brain tissue partial carbon dioxide pressure (p(br)CO(2)), pH, and brain tissue temperature. Data detected at 8-hourly intervals were compared with repeated measures analysis of variance. Result At the initial observation, the mean value of intracranial pressure was 22.2 +/- 3.2 mm Hg. Although it increased at the second and decreased at the third measurement, the differences between the measurements were not significant (P = 0.320). The value of PbrCO2 Was increased from the beginning (63.3 +/- 6.0 mm Hg), whereas PbrO2 Was within the normal range at the first measurement (38.9 +/- 6.9 mm Hg), but significantly decreased after 8 hours (P = 0.004), remaining low at later time points. Conclusion After brain injury, changes in PbrCO2 are visible earlier than those in PbrO2. Improvement in intracranial pressure values did not necessary mean improvement in the brain tissue oxygenation. In addition to intracranial pressure, PbrO2. PbrCO2 and pH should also be monitored, as they directly reflect the real metabolic conditions within brain tissue and may be used in predictions about the outcome and possible therapeutic approaches.	Univ Ljubljana, Med Ctr, Dept Neurosurg, SI-1525 Ljubljana, Slovenia; Univ Ljubljana, Med Ctr, Dept Anesthesiol & Intens Therapy, Ljubljana, Slovenia		Korsic, M (corresponding author), Univ Ljubljana, Med Ctr, Dept Neurosurg, Zaloska 7, SI-1525 Ljubljana, Slovenia.	marjan.korsic@kcli.si	Jugovic, Domagoj/O-4129-2014				Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Bruzzone P, 1998, ACT NEUR S, V71, P111; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Stocchetti N, 1998, ACT NEUR S, V71, P162; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	16	5	7	0	1	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-9504	1332-8166		CROAT MED J	Croat. Med. J.	APR	2006	47	2					246	252					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039PC	WOS:000237317700006	16625689				2022-02-06	
J	Sherwin, E; Whiteneck, G; Corrigan, J; Bedell, G; Brown, M; Abreu, B; Depompei, R; Gordon, W; Kreutzer, J				Sherwin, E.; Whiteneck, G.; Corrigan, J.; Bedell, G.; Brown, M.; Abreu, B.; Depompei, R.; Gordon, W.; Kreutzer, J.			Domains of a TBI minimal data set: Community reintegration phase	BRAIN INJURY			English	Article						traumatic brain injury; community reintegration; minimal data set	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; REHABILITATION OUTCOMES; MULTICENTER ANALYSIS; DISABILITY RESEARCH; SATISFACTION; INDIVIDUALS; CHILDREN; PARTICIPATION; HEALTH	Efforts to establish a minimal data set for the period of community integration after traumatic brain injury (TBI) have been the focus of a working group of leading researchers, clinicians and advocates attending the Galveston Brain Injury Symposium in 2001 and 2002. The purpose of the data set is to increase the consistency and interpretability of TBI research and programme evaluation by providing a common set of measures to document key aspects of community integration. It is intended to be sensitive to intervention, comprehensive, reflect satisfaction and outcome and promote future treatment/therapy. In deciding on the components of a minimal data set, the tri-partite model of outcomes was adopted (initially employed in psychotherapy, adapted to TBI) which focuses on the needs of the individual, society and the health provider. Scales are recommended for the respective components of the model.	Univ Arkansas, Dept Psychol, Little Rock, AR 72204 USA; Craig Hosp, Englewood, CO USA; Ohio State Univ, Columbus, OH 43210 USA; Tufts Univ, Medford, MA 02155 USA; Mt Sinai Sch Med, New York, NY USA; Univ Texas, Med Branch, Galveston, TX 77555 USA; Univ Akron, Akron, OH 44325 USA; Virginia Commonwealth Univ, Richmond, VA USA		Sherwin, E (corresponding author), Univ Arkansas, Dept Psychol, 2801 S Univ Ave, Little Rock, AR 72204 USA.	ebsherwin@ualr.edu	Corrigan, John D./E-2921-2011	Bedell, Gary/0000-0002-9555-8861			Achenbach TM, 1991, MANUAL CHILD BEHAV C; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Brandt EN, 1997, ENABLING AM ASSESSIN; Brown M, 2004, ARCH PHYS MED REHAB, V85, pS13, DOI 10.1016/j.apmr.2003.08.110; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Brown M, 1999, MT SINAI J MED, V66, P160; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; CARNEY N, 1999, EVIDENCE REPORT REHA; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Craig Hospital Research Department, 2001, CRAIG HOSP INV ENV F; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers M, 1999, AM J PHYS MED REHAB, V78, P286, DOI 10.1097/00002060-199905000-00022; DIJKERS M, 2002, SELF REPORT QUALITY; Dijkers MP, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50241; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; FUHRER MJ, 1997, ASSESSING MED REHABI; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Landgraf JM, 1996, CHILD HLTH QUESTIONN; LANGLOIS JA, 2000, TRAUMATIC INJURY US; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; *NHIS, 1999, CHILD DIS SUPPL; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; SIMEONSSON RJ, 2001, PARTICIPATION ENV IN; STRUPP HH, 1977, AM PSYCHOL, V32, P187, DOI 10.1037/0003-066X.32.3.187; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; *TRAUM BRAIN INJ S, WHO HELPS ADV PEOPL; Tulsky DS, 2002, ARCH PHYS MED REHAB, V83, pS1, DOI 10.1053/apmr.2002.36954; *US DEP HHS, 1979, DHHS PUBL; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WHITENECK G, 2005, GUIDE USE CHART CRAI; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WHO, 2002, INT CLASS FUNCT DIS; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; World Health Organization, 1980, INT CLASS IMP DIS HA; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; 2003, LEGAL FINANCIAL ISSU	54	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2006	20	4					383	389		10.1080/02699050600663097			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700003	16716984				2022-02-06	
J	Arenth, PM; Corrigan, JD; Schmidt, LD				Arenth, PM; Corrigan, JD; Schmidt, LD			Exploring the use of social comparison by individuals recovering from traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; social comparison theory; adjustment to disability issues; rehabilitation	AWARENESS; ADJUSTMENT; CANCER; LIFE	Objective: To explore if and how individuals with traumatic brain injury (TBI) use social comparison during adjustment to disability. It was hypothesized that comparison activity may change with time since injury. Methods: Fifty-eight participants with TBI were surveyed within 1 or 6 months of discharge from inpatient rehabilitation. Group responses to instruments measuring social comparison and other measures of emotional and physical functioning were compared. Results: Both groups expressed a need for social comparison at a rate comparable to non-clinical populations. The group surveyed at 6 months expressed a greater need for social comparison and scored lower on a measure of mental health, as compared to the group surveyed earlier. Conclusions: Individuals with TBI appear to successfully use social comparison, at least early in recovery, with a possible reduction in effectiveness of use with increased time from injury. Possible mediating factors and implications for adjustment and future study are discussed.	Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA		Arenth, PM (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Kaufmann Bldg,Suite 202, Pittsburgh, PA 15213 USA.	arenthpm@upmc.edu	Corrigan, John D./E-2921-2011				AFFLECK B, 1991, SOCIAL COMPARISON CO, P369; Affleck G, 2000, J SOC CLIN PSYCHOL, V19, P499, DOI 10.1521/jscp.2000.19.4.499; Bogart LM, 2000, J APPL SOC PSYCHOL, V30, P547, DOI 10.1111/j.1559-1816.2000.tb02496.x; Bogart LM, 2002, J APPL SOC PSYCHOL, V32, P1551, DOI 10.1111/j.1559-1816.2002.tb02762.x; BUUNK BP, 1990, J PERS SOC PSYCHOL, V59, P1238, DOI 10.1037/0022-3514.59.6.1238; *CDCP, TRAUM BRAIN INJ FACT; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Folkman S., 1984, STRESS; Gibbons FX, 1999, J PERS SOC PSYCHOL, V76, P129, DOI 10.1037/0022-3514.76.1.129; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; HELGESON VS, 1993, J APPL SOC PSYCHOL, V23, P1171, DOI 10.1111/j.1559-1816.1993.tb01027.x; HYMAN H, 1942, PSYCHOL BULL, V39, P473; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schacter S, 1959, PSYCHOL AFFILIATION; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherif Muzafer, 1936, PSYCHOL SOCIAL NORMS; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; TAYLOR SE, 1989, PSYCHOL REV, V96, P569, DOI 10.1037/0033-295X.96.4.569; van der Zee KI, 1996, BASIC APPL SOC PSYCH, V18, P453, DOI 10.1207/s15324834basp1804_6; VanderZee K, 1996, PERS INDIV DIFFER, V20, P551, DOI 10.1016/0191-8869(96)00007-4; Ware JE, 1995, SF12 SCORE SF12 PHYS; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Williams RM, 1949, AM SOLDIER ADJUSTMEN, V1; WOOD JV, 1997, HLTH COPING WELL BEI, P299; WOOD JV, 1985, J PERS SOC PSYCHOL, V9, P1169	31	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2006	20	3					253	262		10.1080/02699050500487662			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400005	16537267	Green Submitted			2022-02-06	
J	Satish, U; Streufert, S; Eslinger, PJ				Satish, U; Streufert, S; Eslinger, PJ			Measuring executive function deficits following head injury: An application of SMS simulation technology	PSYCHOLOGICAL RECORD			English	Article							COMPLEX DECISION; INTEGRATION; PERFORMANCE	Neuropsychological tests have limited sensitivity in identifying subtle residual cognitive impairments in patients with good medical recovery from head injury and post-concussive syndrome. Detecting and characterizing residual 'real life' cognitive difficulties can be problematic for treatment purposes. This study investigated the usefulness of a well-standardized and validated cognitive simulation procedure that is based on complexity theory (The Strategic Management Simulation or SMS) for detecting such impairments. Twenty adults who had suffered moderate closed head injury (CHI) but now generated normal or close to normal neuropsychological test scores, yet continued to experience family, work, or other problems, were compared with matched controls. Comparisons of the patient and control group on simulation scores indicated no significant differences for single, well-structured task components or for information search activity. In contrast, the CHI sample was impaired on numerous tasks that require intermediate or complex cognitive efforts. The CHI sample generated significantly lower performance scores for strategic functioning, activity levels, information utilization, emergency responsiveness, planning, and breadth of decision-making. These findings suggest that SMS may provide a highly sensitive assessment tool for the assessment of subtle cognitive deficits after CHI.	SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; Penn State Univ, Coll Med, University Pk, PA 16802 USA		Satish, U (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, 750 E Adams St, Syracuse, NY 13210 USA.	satishu@upstate.edu					Breuer K., 1985, Computers in Education. Proceedings of the IFIP TC3 4th World Conference on Computers in Education - WCCE 85, P239; BREUER K, 1992, PFA SCHRIFTENREIHE P, V4, P87; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Gleick J., 1987, CHAOS MAKING NEW SCI; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Kauffman S. A., 1992, ORIGINS ORDER SELF O; LEZAL ML, 1995, NEUROPSYCHOLOGICAL A; Satish U, 1999, NEUROCASE, V5, P355, DOI 10.1093/neucas/5.4.355; Satish U, 1997, J APPL SOC PSYCHOL, V27, P2117, DOI 10.1111/j.1559-1816.1997.tb01643.x; SATISH U, 1991, J INT NEUROLOGICAL S, V7, P174; SATISH U, 1997, J APPL SOC PSYCHOL, V27, P2046; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; STREUFERT S, 1993, J APPL SOC PSYCHOL, V23, P847, DOI 10.1111/j.1559-1816.1993.tb01009.x; STREUFERT S, 1970, J EXP SOC PSYCHOL, V6, P494, DOI 10.1016/0022-1031(70)90059-4; STREUFERT S, 1988, PERS PSYCHOL, V41, P537, DOI 10.1111/j.1744-6570.1988.tb00643.x; Streufert S, 1997, J APPL SOC PSYCHOL, V27, P2068, DOI 10.1111/j.1559-1816.1997.tb01641.x; Streufert S, 1978, BEHAV COMPLEX ENV; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Swezey RW, 1986, COMPLEXITY MANAGERS; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Waltz JA, 1999, PSYCHOL SCI, V10, P119, DOI 10.1111/1467-9280.00118; [No title captured]	22	5	5	0	6	PSYCHOLOGICAL RECORD	GAMBIER	KENYON COLLEGE, GAMBIER, OH 43022 USA	0033-2933			PSYCHOL REC	Psychol. Rec.	SPR	2006	56	2					181	190		10.1007/BF03395543			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	043KB	WOS:000237598800002					2022-02-06	
J	Yi, HJ; Kim, KM; Ko, Y; Kim, YS; Oh, SJ; Oh, SH				Yi, HJ; Kim, KM; Ko, Y; Kim, YS; Oh, SJ; Oh, SH			A spontaneous giant pseudoaneurysm presenting with chronic headache in adolescent	CHILDS NERVOUS SYSTEM			English	Article						intracranial aneurysm; pseudoaneurysm; spontaneous; headache; adolescent	TRAUMATIC INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; CHILDHOOD; ARTERY	Background: Intracranial pseudoaneurysms are rare vascular lesions, particularly in children and adolescents, and are characterized by the presence of organizing hematoma and fibrosis outside the true lumen, instead of true vascular elements. Most pseudoaneurysms result from an eminent insult, such as major trauma or grave infectious illness. Development of pseudoaneurysm without antecedent incident is rare. Furthermore, clinical manifestation with only a headache is also unusual in this age group. Case history: We now describe one patient who had a giant pseudoaneurysm arising at the distal middle cerebral artery. A 17-year-old boy complained of headache that had become apparent 3 years ago and intractable to medicine 3 months ago. Brain computed tomographic scan and lumbar cerebrospinal spinal fluid study revealed no trace of recent hemorrhage. However, digital subtraction angiography revealed a huge aneurysmal dilatation along the right M2 segment with the features of delayed filling and emptying of contrast agent. Surgical obliteration of the corresponding aneurysm with tandem clipping and aneurysmectomy rendered him free of headache thereafter. Conclusions: The actual cause and mechanisms of this case are not certain; nonetheless, we suggest that traumatic cause produced such a lesion, and minor repeated bleeding also elicited headache, albeit no evidence of recent major injury.	Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul 133792, South Korea		Yi, HJ (corresponding author), Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul 133792, South Korea.	hjyi8499@hanyang.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020				BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; Chedid MK, 2001, J NEUROSURG, V94, P637, DOI 10.3171/jns.2001.94.4.0637; DOWD GC, 2002, TXB NEUROLOGICAL SUR, V3, P2473; GUTIERREZ FA, 1987, CONCEPTS PEDIATR NEU, V7, P153; HEISKANEN O, 1989, CHILD NERV SYST, V5, P66, DOI 10.1007/BF00571112; HUMPHREYS RP, 1985, CONCEPTS PEDIATR NEU, V6, P213; Lath R, 2002, J CLIN NEUROSCI, V9, P466, DOI 10.1054/jocn.2001.1050; MEYER FB, 1989, J NEUROSURG, V70, P420, DOI 10.3171/jns.1989.70.3.0420; MUSTAFA U, 1998, NEUROSURGERY, V43, P1314; Norris JS, 1998, NEUROSURG CLIN N AM, V9, P557; OSTERGAARD JR, 1991, BRIT J NEUROSURG, V5, P575, DOI 10.3109/02688699109002879; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 2001, J NEUROSURG, V94, P733, DOI 10.3171/jns.2001.94.5.0733; Raju BSV, 2001, NEUROL INDIA, V49, P295; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; Wojtacha M, 2001, CHILD NERV SYST, V17, P37, DOI 10.1007/s003810000378	17	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2006	22	3					295	299		10.1007/s00381-005-1198-1			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	015IV	WOS:000235546000015	16496160				2022-02-06	
J	Gonzalez, AL; Marin, AG; Garijo, JAA; Mengual, MV				Gonzalez, AL; Marin, AG; Garijo, JAA; Mengual, MV			Penetrating head injury in a paediatric patient caused by an electrical plug	CHILDS NERVOUS SYSTEM			English	Article						electrical plug; paediatric head injury; penetrating head injury; perforating head injury; superior sagittal sinus; stab wound	STAB WOUNDS	Introduction: Penetrating head injuries are rare especially in the paediatric age group. Relatively minor falls over common household objects can cause potentially life-threatening brain injuries. Case report: We describe a penetrating head injury caused by a household electrical plug in a 6-month-old child. The two rounded pins of the plug were embedded in the posterior parietal area of her head, very close to the cranial midline. There was no neurological deterioration or bleeding. Radiological investigation showed a depressed skull fracture underneath the two pins. One of them came very close to the superior sagittal sinus but there was no evidence of intracranial bleeding. The electrical plug was extracted under general anaesthesia in the operating theatre. The penetrating fracture segments were removed. The sagittal venous sinus was fortunately undamaged. Conclusions: Household objects like electrical plugs may constitute a risk for children. It may be worthwhile to reconsider the design of electrical plugs.	Hosp Univ Fe, Dept Neurosurg, Valencia 46009, Spain		Gonzalez, AL (corresponding author), Ave Maestro Rodrigo,87 Pta 7, Valencia 46015, Spain.	anlopezgon@telefonica.net	Lopez-Gonzalez, Antonio/H-8431-2015	Lopez-Gonzalez, Antonio/0000-0002-5801-6561			ANDERSON ID, 1989, INJURY, V20, P69, DOI 10.1016/0020-1383(89)90142-3; Bauer M, 2002, FORENSIC SCI INT, V129, P122, DOI 10.1016/S0379-0738(02)00271-2; Bock H, 2002, INT J LEGAL MED, V116, P279, DOI 10.1007/s00414-001-0281-8; Couper GW, 2000, J ACCID EMERG MED, V17, P55; DELRIO JAN, 1998, CIR PED, V11, P151; Dinakaran S, 1998, J ACCID EMERG MED, V15, P274; DUTREVOU M, 1991, INJURY, V22, P237, DOI 10.1016/0020-1383(91)90053-H; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Elorza Arizmendi JF, 1997, AN ESP PEDIATR, V46, P464; Fernandez-Melo R, 2002, NEUROCIRUGIA, V13, P397; Gray J, 2004, EUR J EMERG MED, V11, P117, DOI 10.1097/00063110-200404000-00013; HARLOW HM, 1968, MASS MED SOC UBL, V2, P327; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; Hayashi Y, 2003, J TRAUMA, V55, P1178, DOI 10.1097/01.TA.0000025324.27227.D4; Kawamura Shingo, 1997, Neurologia Medico-Chirurgica, V37, P332, DOI 10.2176/nmc.37.332; KELLY AJ, 1992, SURG NEUROL, V38, P471, DOI 10.1016/0090-3019(92)90118-7; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; O'Loughlin Maryann, 2003, J Emerg Nurs, V29, P189, DOI 10.1067/men.2003.37; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SCHUPPEN A, 1993, ELECTRON LETT, V29, P215, DOI 10.1049/el:19930146; Seex K, 1997, J CRANIO MAXILL SURG, V25, P353, DOI 10.1016/S1010-5182(97)80038-8; Tan MH, 2003, INJURY, V34, P950, DOI 10.1016/S0020-1383(02)00167-5	22	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2006	22	2					197	200		10.1007/s00381-005-1141-5			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	009RR	WOS:000235130600025	15928968				2022-02-06	
J	Lifshitz, J; Janmey, PA; McIntosh, TK				Lifshitz, J; Janmey, PA; McIntosh, TK			Photon correlation spectroscopy of brain mitochondrial populations: Application to traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						head injury; mitochondrial swelling; photon correlation spectroscopy; dynamic light scatter; rat	INDUCED PERMEABILITY TRANSITION; RAT-LIVER MITOCHONDRIA; CA-2&-INDUCED MEMBRANE TRANSITION; CYCLOSPORINE-A; LIGHT-SCATTERING; OXIDATIVE PHOSPHORYLATION; SELECTIVE VULNERABILITY; ADENOSINE DIPHOSPHATE; SHRINKAGE PHENOMENA; STRUCTURAL CHANGES	Mitochondrial dysfunction and pathology that contribute to a host of neurodegenerative diseases are deduced from changes in ultrastructure, routinely examined by a host of optical techniques. We adapted the technique of photon correlation spectroscopy (PCs) to evaluate calcium-induced structural alterations in isolated viable cortical and hippocampal mitochondria. In detecting calcium-induced reductions in light intensity, PCs was more sensitive than absorbance across varying calcium concentrations. Mitochondrial populations encompass a broad distribution of sizes, confirmed by ultrastructural profiles, both which remain unaffected by calcium exposure. Cortical and hippocampal populations show fractional calcium-induced reductions in light scatter compared to subsequent maximal alamethicin-induced reductions. Although reductions in light scatter (refractive index) have been interpreted as mitochondrial swelling, PCs quantification of the mean mitochondrial radius demonstrates that mitochondrial size is unaffected by calcium exposure, but not alamethicin. Likewise, the population distribution histograms remain stable with calcium exposure, but shift to larger radii after alamethicin exposure. Furthermore, hippocampal mitochondrial populations from a neurodegenerative model of traumatic brain injury, lateral fluid percussion, demonstrate greater calcium-induced reductions in scatter intensity, which are associated with an initial population of large mitochondria becoming smaller. The disparate responses to calcium and subsequent alamethicin of mitochondria at 3 and 24 It after injury attest to an acute disruption of membrane permeability in mitochondria, from injured brain. PCS provides quantitative indices of refractive index and size in isolated mitochondrial populations, aiding the evaluation of mitochondria in degenerative diseases. (c) 2005 Elsevier Inc. All rights reserved.	Univ Penn, Dept Neurosurg, Taumat Brain Injury Lab, Philadelphia, PA 19104 USA; Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; VA Med Ctr, Philadelphia, PA 19104 USA		Lifshitz, J (corresponding author), Virginia Commonwealth Univ, Dept Anat, POB 980709, Richmond, VA 23298 USA.	jlifshitz@vcu.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG00255] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803, R01-NS40978] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978, P50NS008803] Funding Source: NIH RePORTER		AZZI A, 1965, BIOCHIM BIOPHYS ACTA, V105, P253, DOI 10.1016/S0926-6593(65)80150-3; AZZI A, 1965, BIOCHIM BIOPHYS ACTA, V105, P265, DOI 10.1016/S0926-6593(65)80151-5; BARTLEY W, 1964, BIOCHEM J, V93, P322, DOI 10.1042/bj0930322; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Berman SB, 2000, EXP NEUROL, V164, P415, DOI 10.1006/exnr.2000.7438; BIER M, 1967, METHOD ENZYMOL, V4, P147; Boustany NN, 2002, BIOPHYS J, V83, P1691, DOI 10.1016/S0006-3495(02)73937-4; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; BRYANT FD, 1969, ARCH BIOCHEM BIOPHYS, V135, P109, DOI 10.1016/0003-9861(69)90521-9; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CHANCE B, 1958, BIOCHEM J, V68, P295, DOI 10.1042/bj0680295; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Claes P. D. M., 1992, LASER LIGHT SCATTERI, P66; CLELAND KW, 1952, NATURE, V170, P497, DOI 10.1038/170497a0; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GLATTER O, 1991, PART PART SYST CHAR, V8, P274, DOI 10.1002/ppsc.19910080150; GOTTERER GS, 1961, J BIOPHYS BIOCHEM CY, V10, P15, DOI 10.1083/jcb.10.1.15; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; Hubner S, 1998, EUR J BIOCHEM, V258, P846, DOI 10.1046/j.1432-1327.1998.2580846.x; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER FE, 1967, METHOD ENZYMOL, V10, P689; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Johnson LJ, 2002, NEUROIMAGE, V17, P1649, DOI 10.1006/nimg.2002.1264; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KNIGHT VA, 1981, BIOCHIM BIOPHYS ACTA, V637, P146, DOI 10.1016/0005-2728(81)90220-6; Ko LW, 2001, J MOL NEUROSCI, V17, P361, DOI 10.1385/JMN:17:3:361; Kristal BS, 2000, DEV NEUROSCI-BASEL, V22, P376, DOI 10.1159/000017463; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; LAI JCK, 1989, CARBOHYDRATES ENERGY, P43; LATIMER P, 1972, BIOPHYS J, V12, P764, DOI 10.1016/S0006-3495(72)86120-4; LEHNINGER AL, 1959, J BIOL CHEM, V234, P2465; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MASSARI S, 1972, J MEMBRANE BIOL, V9, P57, DOI 10.1007/BF01868043; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mattiasson G, 2003, J NEUROCHEM, V87, P532, DOI 10.1046/j.1471-4159.2003.02026.x; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PACKER L, 1963, J CELL BIOL, V18, P495, DOI 10.1083/jcb.18.3.495; PACKER L, 1963, J CELL BIOL, V18, P487, DOI 10.1083/jcb.18.3.487; PACKER L, 1960, J BIOL CHEM, V235, P242; PACKER L, 1967, METHOD ENZYMOL, V10, P685; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; RAAFLAUB J, 1953, HELV PHYSIOL PHARM A, V11, P142; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SCHNABLEGGER H, 1991, APPL OPTICS, V30, P4889, DOI 10.1364/AO.30.004889; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; SZABO I, 1992, J BIOL CHEM, V267, P2940; TAPLEY DF, 1956, J BIOL CHEM, V222, P325; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wagner OI, 2003, J NEUROSCI, V23, P9046; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; [No title captured]	75	5	6	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	FEB	2006	197	2					318	329		10.1016/j.expneurol.2005.10.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	009RV	WOS:000235131000007	16289540				2022-02-06	
J	Weaver, CS; Sloan, BK; Brizendine, EJ; Bock, H				Weaver, CS; Sloan, BK; Brizendine, EJ; Bock, H			An analysis of maximum vehicle G forces and brain injury in motorsports crashes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY 17, 2004	Orlando, FL	Soc Acad Emergency Med		head injury; accelerometer; automotive crashes; racing	HEAD-INJURY; EPIDEMIOLOGY	Purpose: Traumatic brain injury from automobile crashes is a major source of trauma deaths. The investigation of crashes to understand factors of occupant injuries is an established practice. Our objective was to evaluate the association between vehicle G forces (G) sustained on impact and brain injury in motor sports crashes. Methods: We analyzed data regarding Indy Racing League (IRL) car crashes from 1996 to 2003 and compared the likelihood of head injury in those drivers who were in a vehicle that sustained an impact of >= 50 G versus those with a lesser impact. The mean maximal G for those with head injury was compared with those without head injury. Results: We analyzed 374 crashes. A driver in a crash with an impact of >= 50 G developed a head injury 16.0% (30/198) versus 1.6% (3/186) in those of < 50 G (P < 0.001). The mean peak G for those with head injury was 79.6 (SD 28.5) versus 50.6 (SD 28.0) in those with no head injury (P < 0.001). Conclusion: Findings were that IRL car crashes with peak vehicle G 50 were associated with the development of traumatic brain injuries.	Indiana Univ, Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Div Biostat, Indianapolis, IN 46202 USA; Indy Racing League, Indianapolis, IN USA		Weaver, CS (corresponding author), Indiana Univ, Sch Med, Dept Emergency Med, 1050 Wishard Blvd,Rm R2200, Indianapolis, IN 46202 USA.	chsweave@iupui.edu					Adekoya N., 2002, SURVEILLANCE TRAUMAT, P1; AGRESTI A, 1996, INTRO CATEGORICAL DA, P104; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kraus JF, 1993, HEAD INJURY, P1; MELVIN JW, 1996, SAE MOT ENG C EXP DE, P127; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; STATES JD, 1969, 13 STAPP CAR CRASH C, P282; WRIGHT PG, 2000, SAE MOT ENG C EXP DE	11	5	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	FEB	2006	38	2					246	249		10.1249/01.mss.0000184773.07870.5e			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Sport Sciences	016SY	WOS:000235641900008	16531891				2022-02-06	
J	Abo, M; Yamauchi, H; Suzuki, M; Sakuma, M; Urashima, M				Abo, Masahiro; Yamauchi, Hideki; Suzuki, Masahiko; Sakuma, Mio; Urashima, Mitsuyoshi			Facilitated beam-walking recovery during acute phase by kynurenic acid treatment in a rat model of photochemically induced thrombosis causing focal cerebral ischemia	NEUROSIGNALS			English	Article						gene expression profiling; cerebral ischemia; animal model	GENE-EXPRESSION PROFILES; TRAUMATIC BRAIN INJURY; GROWTH-FACTOR-I; NMDA RECEPTORS; SENSORIMOTOR CORTEX; CLINICAL-TRIALS; NEONATAL RATS; ACUTE STROKE; AMINO-ACIDS; ANTAGONIST	We previously demonstrated the presence of activated areas in the non-injured contralateral sensorimotor cortex in addition to the ipsilateral sensorimotor cortex of the area surrounding a brain infarction, using a rat model of focal photochemically induced thrombosis (PIT) and functional magnetic resonance imaging. Using this model, we next applied gene expression profiling to screen key molecules upregulated in the activated area. RNA was extracted from the ipsilateral and contralateral sensorimotor cortex to the focal brain infarction and from the sham controlled cortex, and hybridized to gene-expression profiling arrays containing 1,322 neurology-related genes. Results showed that glycine receptors were upregulated in both the ipsilateral and contralateral cortex to the focal ischemic lesion. To prove the preclinical significance of upregulated glycine receptors, kynurenic acid, an endogenous antagonist to glycine receptors on neuronal cells, was administered intrathecally. As a result, the kynurenic acid significantly improved behavioral recovery within 10 days from paralysis induced by the focal PIT (p < 0.0001), as evaluated with beam walking. These results suggest that intrathecal administration of a glycine receptor antagonist may facilitate behavioral recovery during the acute phase after brain infarction. Copyright (c) 2006 S. Karger AG, Basel.	Jikei Univ, Sch Med, Div Clin Res & Dev, Minato Ku, Tokyo 1058461, Japan; Jikei Univ, Sch Med, Dept Rehabil, Tokyo 1058461, Japan; Jikei Univ, Sch Med, Dept Neurol, Tokyo 1058461, Japan		Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Clin Res & Dev, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	urashima@jikei.ac.jp	SUZUKI, MASAHIKO/AAK-7309-2020	Abo, Masahiro/0000-0001-6701-4974			Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Abo M, 2004, BRAIN INJURY, V18, P1017, DOI 10.1080/02699050410001672305; Abo M, 2003, BRAIN INJURY, V17, P799, DOI 10.1080/0269905031000088658; Abo M, 2001, NEUROREPORT, V12, P1543, DOI 10.1097/00001756-200105250-00048; Albers GV, 2001, JAMA-J AM MED ASSOC, V286, P2673, DOI 10.1001/jama.286.21.2673; Albers GW, 1999, STROKE, V30, P508, DOI 10.1161/01.STR.30.3.508; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Ceresoli-Borroni G, 2001, PEDIATR RES, V50, P231, DOI 10.1203/00006450-200108000-00011; CHEN J, 1993, J PHARMACOL EXP THER, V267, P937; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ishibashi Y, 2003, CANCER RES, V63, P5159; Kim YH, 2003, NEUROREPORT, V14, P1329, DOI 10.1097/01.wnr.0000078702.79393.9b; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Nemeth H, 2005, CURR NEUROVASC RES, V2, P249, DOI 10.2174/1567202054368326; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; OLVERMAN HJ, 1984, NATURE, V307, P460, DOI 10.1038/307460a0; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SUGAHARAKOBAYAS.M, 2004, J NEUROSCI RES, V76, P512; Tang Y, 2003, J CEREBR BLOOD F MET, V23, P310, DOI 10.1097/01.WCB.0000048518.34839.DE; Urashima M, 2005, PEDIATR RES, V57, P563, DOI 10.1203/01.PDR.0000155759.29448.13; Ward NS, 2005, PROG BRAIN RES, V150, P527, DOI 10.1016/S0079-6123(05)50036-0; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Yoneda Y, 2003, STROKE, V34, P718, DOI 10.1161/01.STR.0000056171.55342.FF; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Yuza Y, 2003, J PEDIAT HEMATOL ONC, V25, P715, DOI 10.1097/00043426-200309000-00008	44	5	6	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1424-862X			NEUROSIGNALS	Neurosignals		2006	15	2					102	110		10.1159/000094876			9	Biochemistry & Molecular Biology; Biophysics; Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology; Neurosciences & Neurology	080FG	WOS:000240232700005	16888405	Bronze			2022-02-06	
J	Kaakinen, T; Alaoja, H; Heikkinen, J; Dahlbacka, S; Laurila, P; Kiviluoma, K; Salomaki, T; Tuominen, H; Ohtonen, P; Biancari, F; Juvonen, T				Kaakinen, T; Alaoja, H; Heikkinen, J; Dahlbacka, S; Laurila, P; Kiviluoma, K; Salomaki, T; Tuominen, H; Ohtonen, P; Biancari, F; Juvonen, T			Hypertonic saline dextran improves outcome after hypothermic circulatory arrest: A study in a surviving porcine model	ANNALS OF THORACIC SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; SUBARACHNOID HEMORRHAGE; CARDIOPULMONARY BYPASS; INTRACRANIAL-PRESSURE; RESUSCITATION; 7.5-PERCENT; SURGERY; SHEEP; TRIAL	Background. Hypertonic saline dextran (HSD) has been shown to have neuroprotective properties. In the present study we have assessed its potential neuroprotective efficacy in the setting of hypothermic circulatory arrest in a surviving porcine model. Methods. Twenty-four pigs were randomized to receive two 5-minute intravenous infusions (4 mL/kg) of either HSD (7.5% saline, 6% dextran 70) or normal saline immediately after and 4 hours after a 75-minute period of hypothermic circulatory arrest at a brain temperature of 18 degrees C. Results. The 7-day survival was 75% in the HSD group and 66% in the control group (p > 0.9). Brain total histopathologic score was lower in the HSD group (p = 0.01). Postoperative behavioral scores were higher in the HSD group on the second day after surgery (p = 0.03). Intracranial pressure was lower in the HSD group from 45 minutes to 8 hours after hypothermic circulatory arrest (p = 0.03). Cerebral perfusion pressure was higher in the HSD group from 45 minutes to 3 hours after hypothermic circulatory arrest (p = 0.06). Brain lactate concentration was lower in the HSD group when compared with controls (p = 0.05). Furthermore, brain glucose levels tended to be higher and brain lactate-pyruvate ratio and lactate-glucose ratio were lower in the HSD group. Brain tissue oxygen partial pressures were somewhat higher in the HSD group (p = 0.08). Conclusions. The use of HSD in experimental hypothermic circulatory arrest is associated with significantly better neurologic recovery, better histopathology, lower intracranial pressure, higher cerebral perfusion pressure, and better preservation of brain metabolism.	Univ Oulu, Oulu Univ Hosp, Dept Surg, Div Cardiothorac & Vasc Surg, Oulu 90029 OYS, Finland; Univ Oulu, Oulu Univ Hosp, Dept Anesthesiol, Oulu 90029, Finland; Univ Oulu, Oulu Univ Hosp, Dept Pathol, Oulu 90029, Finland		Juvonen, T (corresponding author), Univ Oulu, Oulu Univ Hosp, Dept Surg, Div Cardiothorac & Vasc Surg, POB 21, Oulu 90029 OYS, Finland.	tatu.juvonen@oulu.fi	Biancari, Fausto/A-1039-2008	Biancari, Fausto/0000-0001-5028-8186; Jensen, Hanna/0000-0001-8487-7982; Kaakinen, Timo/0000-0001-5125-245X; Kiviluoma, Kai/0000-0002-7480-8657			Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bueno R, 2004, ANN THORAC SURG, V77, P604, DOI 10.1016/S0003-4975(03)01486-3; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Corso CO, 1998, J SURG RES, V80, P210, DOI 10.1006/jsre.1998.5426; Dahlbacka S, 2005, ANN THORAC SURG, V79, P1316, DOI 10.1016/j.athoracsur.2004.09.022; DUBICK MA, 1995, SHOCK, V3, P137, DOI 10.1097/00024382-199502000-00009; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Hartl R, 1997, ZBL CHIR, V122, P181; Heimann A, 2003, CRIT CARE MED, V31, P2495, DOI 10.1097/01.CCM.0000084893.44650.CB; Jarvela K, 2001, J CARDIOTHOR VASC AN, V15, P210, DOI 10.1053/jcan.2001.21964; Kaakinen T, 2006, ANN THORAC SURG, V81, P183, DOI 10.1016/j.athoracsur.2005.07.017; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; Kuo JR, 2003, INTENS CARE MED, V29, P1567, DOI 10.1007/s00134-003-1854-4; MAZZONI MC, 1990, CIRC SHOCK, V31, P407; MCDANIEL LB, 1994, ANESTH ANALG, V78, P435; MENGER MD, 1993, CIRC SHOCK, V41, P248; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; Pokela M, 2002, SCAND CARDIOVASC J, V36, P302, DOI 10.1080/140174302320774528; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; Stapley SA, 2002, SHOCK, V17, P146, DOI 10.1097/00024382-200202000-00011; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Thiel M, 2001, J LEUKOCYTE BIOL, V70, P261; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VELASCO IT, 1980, AM J PHYSIOL, V239, P664; Wade CE, 2003, J TRAUMA, V55, P413, DOI 10.1097/01.TA.0000057247.02378.5E; WADE CE, 1997, J TRAUMA, V42, P61; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE	29	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2006	81	1					183	190		10.1016/j.athoracsur.2005.07.017			8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	002BC	WOS:000234585400026	16368360				2022-02-06	
J	Leung, FH; Thompson, K; Weaver, DF				Leung, Fok-Han; Thompson, Kara; Weaver, Donald F.			Evaluating spousal abuse as a potential risk factor for Alzheimer's disease: Rationale, needs and challenges	NEUROEPIDEMIOLOGY			English	Article						Alzheimer's disease, risk factors; dementia; spousal abuse; wife assault	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SOCIOECONOMIC-STATUS; POPULATION; DEMENTIA; VIOLENCE; WOMEN	Background: Repetitive head trauma is an identified risk factor for Alzheimer's disease (AD). The violence in wife assault is repetitive and targets the head. This association provides a rationale for studying the relationship between spousal abuse and AD. Design: To preliminarily evaluate the possibility of an increased susceptibility for AD in women subjected to spousal abuse and to identify challenges associated with such a study, we performed a pilot case-control study involving women with AD and compared the incidence of spousal abuse against two control groups. Forty consecutive women with AD referred to a Memory Disorders Clinic were enrolled. Individuals were evaluated at three visits (0, 3, 9 months) and were followed for an additional 12 months to ensure that no other diagnosis emerged. Two control groups were likewise assessed. Results: 17.5% (7/40) of the women (average age 71 years) with AD reported spousal abuse with head trauma. In control group 1, 5.0% (2/40) and in control group 2, 7.5% (3/40) of the women reported spousal abuse with head trauma. Conclusions:The development of AD may be a potential long-term consequence of wife assault. Our study suggests spousal abuse as a possible risk factor for AD, and supports the need for larger studies. However, there are practical challenges associated with the successful execution of such a study. Copyright (c) 2006 S. Karger AG, Basel	Dalhousie Univ, Dept Med, Halifax, NS B3H 4J3, Canada; Dalhousie Univ, Dept Chem, Halifax, NS B3H 4J3, Canada; Dalhousie Univ, Dept Biomed Engn, Halifax, NS B3H 4J3, Canada; Univ Toronto, Sch Med, Toronto, ON, Canada		Weaver, DF (corresponding author), Dalhousie Univ, Dept Med, Halifax, NS B3H 4J3, Canada.	Donald.Weaver@dal.ca		Weaver, Donald/0000-0003-2042-6220			Baer N, 1997, CAN MED ASSOC J, V157, P1579; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GAYFORD JJ, 1977, PRACTITIONER, V219, P122; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Munoz DG, 2000, ARCH NEUROL-CHICAGO, V57, P85, DOI 10.1001/archneur.57.1.85; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Plichta SB, 2001, WOMEN HEALTH ISS, V11, P244, DOI 10.1016/S1049-3867(01)00085-8; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1988, LANCET, V2, P1456; RODGERS K, 1994, WIFE ASSAULT FINDING; ROUNSAVILLE B, 1978, INT J PSYCHIAT MED, V8, P191, DOI 10.2190/CDHJ-DPLG-183Q-T0B8; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; TJADEN P, 1998, NATL I JUSTICE CTR D, P1; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS4, DOI 10.1093/ije/20.Supplement_2.S4; Wilt S, 1996, J Am Med Womens Assoc (1972), V51, P77	23	5	5	1	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2006	27	1					13	16		10.1159/000093894			4	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	066PX	WOS:000239243700002	16770080				2022-02-06	
J	Sarno, S; Erasmus, LP; Frey, M; Lippert, G; Lipp, B				Sarno, Stefania; Erasmus, Lutz-Peter; Frey, Marcel; Lippert, Gerhard; Lipp, Berthold			Electrophysiological correlates of active and passive attentional states after severe traumatic brain injury	FUNCTIONAL NEUROLOGY			English	Article						attention; auditory oddball; ERP; P300; traumatic brain injury	EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; AUDITORY ODDBALL TASK; POSTTRAUMATIC AMNESIA; LATENCY; P300; DISCRIMINATION; COMPONENT; RECOVERY; SCHIZOPHRENIA	We aimed to investigate attentional resources distribution in traumatic brain injury (TBI) patients. Auditory event-related potentials (ERPs) were recorded from 35 severe TBI patients in post-acute care, and 35 age- and gender-matched controls using an auditory oddball paradigm under passive (ignore stimuli) and active (count deviants) conditions. Six components (P1, N1, P2, N2, P3, N3) in four waveforms were studied, i.e., the waveforms elicited by standard and by deviant tones in the passive and active task, respectively. In addition to alterations of latency and/or amplitude of single components, particularly of the late components N2 and P3, we observed in patients a different response pattern to task condition. We found evidence of deficits in the early stages of information processing and allocation of attentional resources. The analysis of the response to standards was crucial for detecting new aspects of attentional impairments.	Therapiezentrum Burgau, D-89331 Burgau, Germany		Sarno, S (corresponding author), Therapiezentrum Burgau, Dr Friedl Str 1, D-89331 Burgau, Germany.	Lerasmus@aol.com					ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Campbell K., 1986, ELECTROENCEPHALOGR S, V38, P486; CAMPBELL KB, 1990, ELECTROEN CLIN NEURO, P202; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; ERWIN RJ, 1986, ELECTROEN CLIN NEURO, V64, P417, DOI 10.1016/0013-4694(86)90075-1; FITZGERALD PG, 1983, BIOL PSYCHOL, V17, P241, DOI 10.1016/0301-0511(83)90003-0; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199606000-00004; GRONWALL D, 1975, LANCET, V2, P995; ISRAEL JB, 1980, PROGR BRAIN RES, V54, P416; JOHNSON JD, 1985, BRIT J PSYCHIAT, V146, P429, DOI 10.1192/bjp.146.4.429; KEITH RA, 1987, ADV CLIN REHABIL, V5, P501; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; Kramer A., 1991, HDB COGNITIVE PSYCHO, P179; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; LINDHOLM E, 1985, INT J PSYCHOPHYSIOL, V3, P121, DOI 10.1016/0167-8760(85)90032-7; MAROSI M, 1993, LANCET, V341, P1473, DOI 10.1016/0140-6736(93)90914-3; Mazzini L, 2001, ARCH PHYS MED REHAB, V82, P57, DOI 10.1053/apmr.2001.18076; Mazzini Letizia, 2004, Phys Med Rehabil Clin N Am, V15, P163, DOI 10.1016/S1047-9651(03)00101-3; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NAATANEN R, 1986, CEREBRAL PSYCHOPHYSI, P169; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Rappaport M, 1990, J Neuropsychiatry Clin Neurosci, V2, P399; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; RITTER W, 1983, PSYCHOPHYSIOLOGY, V20, P168, DOI 10.1111/j.1469-8986.1983.tb03283.x; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; UNSAL A, 1995, PSYCHOPHYSIOLOGY, V32, P249, DOI 10.1111/j.1469-8986.1995.tb02953.x; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74	40	5	5	0	4	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	JAN-MAR	2006	21	1					21	29					9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	062AG	WOS:000238916000003	16734998				2022-02-06	
S	Vuadens, P; Arnold, P; Bellmann, A	Franchignoni, F; Gobelet, C			Vuadens, P.; Arnold, P.; Bellmann, A.	Franchignoni, F; Gobelet, C		Return to work after a traumatic brain injury: a difficult challenge	VOCATIONAL REHABILITATION	Collection de l Academie Europeenne de Medecine de Readaptation		English	Article; Book Chapter							CLOSED-HEAD-INJURY; COMMUNITY INTEGRATION; FOLLOW-UP; SUPPORTED EMPLOYMENT; VOCATIONAL-REHABILITATION; ACUTE PREDICTORS; YOUNG-ADULTS; OUTCOMES; PROGRAM; PEOPLE		[Vuadens, P.; Arnold, P.; Bellmann, A.] Clin Romande Readaptat SuvaCare, Serv Readaptat Neurol, CH-1951 Sion, Switzerland		Vuadens, P (corresponding author), Clin Romande Readaptat SuvaCare, Serv Readaptat Neurol, Av Grand Champsec 90,Case Postale 352, CH-1951 Sion, Switzerland.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; ADAMS D, 1993, J HEAD TRAUMA REHAB, V8, P59; Annoni J M, 1992, Disabil Rehabil, V14, P23; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Barisa MT, 2001, NEUROREHABILITATION, V16, P289; Bell KR, 1998, ARCH PHYS MED REHAB, V79, pS21, DOI 10.1016/S0003-9993(98)90116-2; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Ben-Yishay Y., 1989, NEUROPSYCHOLOGICAL T, V1, P271; BENISHAY Y, 1985, SEMINARS NEUROLOGY, V5, P252; BENISHAY Y, 1990, REHABILITATION ADULT, P393; BRIEL LW, 1996, J VOCATIONAL REHABIL, V7, P151; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; CHESNUT R, TRAUMATIC BRAIN INJU; CIFU D, 1996, J VOCATIONAL REHABIL, V7, P257; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coetzer B R, 2002, Aust J Rural Health, V10, P229, DOI 10.1046/j.1440-1584.2002.00425.x; COHADON F, 1998, TRAUMATISES CRANIENS; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; EZARACHI O, 1991, J HEAD TRAUMA REHAB, V6, P71; FAWBER H, 1987, J HEAD TRAUMA REHAB, V3, P27; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Fraser R. T., 1991, J HEAD TRAUMA REHAB, V6, P46; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; GROSWASSER Z, 1994, BRAIN INJURY NEUROPS; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; HART T, 1986, CLIN NEUROPSYCHOLOGY; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; HURT GD, 2000, NEUROPSYCHOLOGICAL M, P215; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KREUTZER J, 1999, BRAIN INJURY WORKBOO; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LANGLOIS JA, 1997, RESULTS 14 STATE SUR; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Lehmann U, 1997, UNFALLCHIRURG, V100, P552, DOI 10.1007/s001130050157; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; MANK D, 1986, PATHWAYS EMPLOYMENT, P139; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MOON MS, 1988, VOCATIONAL REHABILIT, P17; NAMEROW NS, 1987, NEUROL CLIN, V5, P569, DOI 10.1016/S0733-8619(18)30902-2; Nybo T, 1999, BRAIN INJURY, V13, P759; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; PARENTE R, 1991, J HEAD TRAUMA REHAB, V6, P35; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Possl O, 2001, BRAIN INJURY, V15, P15; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; ROBERTS R, 1992, VOCATIONAL EVALUATIO; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sohlberg M., 2001, COGNITIVE REHABILITA; SPOONSTER J, DEFINING EC DAMAGES; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STUSS DT, 1994, BRAIN INJURY REHABIL; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *TRAUM BRAIN INJ M, INF SECT DAT; TREXLER LE, 2000, INT HDB NEUROPSYCHOL, P137; TRUELLE JL, 1995, NEUROPSYCHOLOGIE TRA; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; VELOZO CA, 1993, AM J OCCUP THER, V47, P203, DOI 10.5014/ajot.47.3.203; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; VOGENTHALER DR, 1989, BRAIN INJURY, V3, P325; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Wehman P, 1985, J ASSOC PERS SEVERE, V10, P3; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; Wood R, 2000, NEUROBEHAVIOURAL DIS; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; 1998, NIH CONSENSUS STATEM, V16, P1; AWARENESS QUESTIONNA	132	5	5	0	3	SPRINGER VERLAG PARIS	PARIS	1 RUE P CEZANNE, 75008 PARIS, FRANCE	1768-529X		978-2-287-29745-8	COLLECT ACAD EUR MED			2006							143	163		10.1007/2-287-29745-6_10	10.1007/2-287-29745-6		21	Public, Environmental & Occupational Health; Rehabilitation	Book Citation Index – Science (BKCI-S)	Public, Environmental & Occupational Health; Rehabilitation	BNO62	WOS:000275133800011					2022-02-06	
J	Latchford, J; Chirwa, EC; Chen, T; Mao, M				Latchford, J; Chirwa, EC; Chen, T; Mao, M			The relationship of seat backrest angle and neck injury in low-velocity rear impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING			English	Article						backrest angle; head restraint; neck injury criterion; rear impact; neck injury; BioRID II		Car-rear-impact-induced cervical spine injuries present a serious burden on society and, in response, seats offering enhanced protection have been introduced. Seats are evaluated for neck protection performance but only at one specific backrest angle, whereas in the real world this varies greatly owing to the variation in occupant physique. Changing the backrest angle modifies the seat geometry and thereby the nature of its interaction with the occupant. Low-velocity rear-impact tests on a BioRID II anthropomorphic test dummy (ATD) have shown that changes in backrest angle have a significant proportionate effect on dummy kinematics. A close correlation was found between changes in backrest angle and the responses of neck injury predictors such as lower neck loading and lower neck shear but not for the neck injury criterion NICmax. Torso ramping was evident, however, with negligible effect in low-velocity impacts. The backrest angle ranged from 20 degrees to 30 degrees whereas the BioRID II spine was adapted to a range from 20 degrees to 26.5 degrees. Nevertheless, in general, instrumentation outputs correlated well, indicating that this ATD could be used for evaluating seats over a 20-30 degrees range rather than solely at 25 degrees as required by current approval test specifications.	Univ Bolton, Dept Engn & Safety, Bolton Automobile & Aerosp Res Grp, Bolton BL3 5AB, England		Chirwa, EC (corresponding author), Univ Bolton, Dept Engn & Safety, Bolton Automobile & Aerosp Res Grp, Bolton BL3 5AB, England.	c.chirwa@bolton.ac.uk					BOSTROM O, 1998, P 16 ESV C; CAPPON H, 2001, P 45 STAPP CAR CRASH; Chirwa E. C., 1996, INT J CRASHWORTHINES, V1, P21; Chirwa EC, 1997, INT J CRASHWORTHINES, V2, P165; DAVIDSON J, 1999, BIORID 2 FINAL REPOR; DAVIDSON J, 1998, P INT IRCOBI C; HEITPLATZ F, 2003, P 18 ESV C NAG JAP; *INT INS WHIPL PRE, 3 M 30 31 JAN 2002 M; Latchford J, 2000, P I MECH ENG D-J AUT, V214, P229, DOI 10.1243/0954407001527385; LATCHFORD J, 1998, P INT CRASHW C DEARB, P401; Research Council for Automobile Repairs, 2001, PROC EV MOT VEH HEAD; SCHMITT KU, 2001, P 1M ESV C AMST NETH; SEVERY DM, 1976, SAE T, V85, P2251; [No title captured]	14	5	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4070			P I MECH ENG D-J AUT	Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.	NOV	2005	219	D11					1293	1302		10.1243/095440705x34946			10	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transportation	986WA	WOS:000233479200004					2022-02-06	
J	Scharpf, J; Dean, R; Stultz, T; Citardi, MJ				Scharpf, J; Dean, R; Stultz, T; Citardi, MJ			The magnetic resonance imaging profile of occult intracranial violations as a result of sinus sumery	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							COMPLICATIONS; SURGERY	Introduction: Intracranial injury is a well-described complication of sinus surgery. Although such complications are typically associated with catastrophic morbidity, the neurological sequelae may be subtle and even unrecognized during the postoperative period. Magnetic resonance imaging (MRI), which can distinguish intracranial hemorrhage and injury, may provide a means for the accurate assessment of atypical presentations of occult intracranial complications. Objective: To describe the MRI profile of occult intracranial complications that result from unrecognized skull base violation during sinus surgery. Method: Retrospective chart review. Results: Two patients, who had endoscopic sinus surgery performed elsewhere, underwent postoperative MR for further evaluation of headache. The available medical records, as well as the patient's personal reports, suggested that no intraoperative cranial base compromise had occurred. Both MRIs showed abnormal signal intensity in the brain parenchyma adjacent to the floor of the anterior cranial fossa; these findings are consistent with traumatic injury presumably from the surgical procedure. Neither patient developed postoperative cerebrospinal fluid rhinorrhea, and neither patient experienced focal neurological deficits. Conclusion: New-onset and/or atypical headache after sinus surgery may be associated with occult intracranial injury. MRI may serve as the diagnostic means for this occult intracranial violation. Significant incongruity may exist between patient symptoms and the objective MR evidence that can suggest serious intracranial injury. MRI signal patterns can provide both temporal and anatomical cues about the specific injury. (c) 2005 Elsevier Inc. All rights reserved.	Cleveland Clin Fdn, Sect Nasal & Sinus Disorders, Head & Neck Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Diagnost Radiol, Div Sect Neuroradiol, Cleveland, OH 44195 USA; Tucson Ear Nose & Throat, Tucson, AZ USA		Citardi, MJ (corresponding author), Cleveland Clin Fdn, Sect Nasal & Sinus Disorders, Head & Neck Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.						Hayman LA, 1996, SURV OPHTHALMOL, V41, P252, DOI 10.1016/S0039-6257(96)80027-0; KENNEDY DW, 1994, OTOLARYNG HEAD NECK, V111, P589, DOI 10.1016/S0194-5998(94)70526-7; KUMMER RV, 2002, STROKE, V33, P1748; MANIGLIA AJ, 1989, LARYNGOSCOPE, V99, P276; MAY M, 1994, LARYNGOSCOPE, V104, P1080; VLEMING M, 1992, ARCH OTOLARYNGOL, V118, P617	6	5	5	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0196-0709			AM J OTOLARYNG	Am. J. Otolaryngol.	NOV-DEC	2005	26	6					411	414		10.1016/j.amjoto.2005.02.021			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	986TQ	WOS:000233473000012	16275414				2022-02-06	
J	Huang, DB; Spiga, R; Koo, H				Huang, DB; Spiga, R; Koo, H			Use of the Zung depression scale in patients with traumatic brain injury: 1 year post-injury	BRAIN INJURY			English	Article						depression; somatic; affective; traumatic brain injury (TBI); Zung depression scale	RHEUMATOID-ARTHRITIS; HEAD-INJURY; REHABILITATION; DISABILITY; SYMPTOMS; VALIDITY	Objective: The purpose of this study was to examine if the physical disabilities of patients with traumatic brain injury (TBI) would influence the assessment of depression when using the Zung depression scale. Method: Patients with TBI (n = 59) were assessed 1 year after injury for depression by both a psychiatrist and the use of the Zung depression scale. Results: By psychiatric evaluation, seven of 17 (41%) patients with severe TBI and one of 20 (5%) of the patients with moderate TBI were diagnosed with major depressive disorder. With the Zung depression scale, 10 of 17 (59%) patients with severe TBI met the cut-off (scored > 55) for depression, whereas none of the patients with moderate (n = 20) or mild (n = 22) TBI did. The mean (SD) scores of the somatic scale were 2.91 (0.93), 2.49 (0.92) and 1.25 (0.43) for each group. The mean scores of the affective scale were 2.58 (0.90), 1.85 (0.79) and 1.24 (0.46). For patients with moderate (p < 0.05) and severe (p < 0.10) TBI, scores on the somatic items exceeded scores on their affective items. No difference in somatic and affective scale scores was noted for the patients with mild TBI. Conclusion: The increased endorsement of somatic results may be the somatic difficulties associated with traumatic brain injury.	Baylor Univ, Dept Internal Med, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Psychiat & Behav Sci, Houston, TX USA		Huang, DB (corresponding author), Baylor Univ, Dept Internal Med, 1 Baylor Plaza,BCM 286,Room N1319, Houston, TX 77030 USA.	dhuang1@bcm.tmc.edu					BURTON LA, 1994, J NEUROLOGICAL REHAB, V8, P63, DOI DOI 10.1177/136140969400800202; Christensen B, 1994, ADV MED PSYCHOTHERAP, V7, P23; Dickens C, 2003, PSYCHOSOMATICS, V44, P209, DOI 10.1176/appi.psy.44.3.209; Dugan W, 1998, PSYCHO-ONCOLOGY, V7, P483, DOI 10.1002/(SICI)1099-1611(199811/12)7:6<483::AID-PON326>3.3.CO;2-D; FRANK RG, 1992, PSYCHIAT RES, V43, P231, DOI 10.1016/0165-1781(92)90056-9; GABRYS JB, 1985, PSYCHOL REP, V57, P1091, DOI 10.2466/pr0.1985.57.3f.1091; GRIFFIN P, 1988, J CLIN PSYCHOL, V4, P756; Hathaway SR, 1942, J PSYCHOL, V14, P73, DOI 10.1080/00223980.1942.9917111; Kennedy P, 2001, SPINAL CORD, V39, P381, DOI 10.1038/sj.sc.3101172; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lane JE, 2000, PRIMARY CARE PSYCHIA, V6, P73, DOI 10.1185/135525700543262; Leung KK, 1998, FAM PRACT, V15, P67, DOI 10.1093/fampra/15.1.67; Lin EHB, 2001, J GEN INTERN MED, V16, P614, DOI 10.1046/j.1525-1497.2001.016009614.x; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; PINCUS T, 1986, ARTHRITIS RHEUM, V29, P1456, DOI 10.1002/art.1780291206; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RODEVICH MA, 1995, REHABIL PSYCHOL, V40, P181; ROUNE B, 1991, JAMA-J AM MED ASSOC, V265, P993; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sartorius N, 2003, J CLIN PSYCHIAT, V64, P3; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SCHUBERT DSP, 1992, PSYCHOTHER PSYCHOSOM, V57, P61, DOI 10.1159/000288575; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SPITZER RL, 1990, STRUCTURAL CLIN INTE; Starkstein SE, 2002, NEUROREHABILITATION, V17, P105; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	31	5	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2005	19	11					903	908		10.1080/02699050400004773			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	983YY	WOS:000233269500005	16299933				2022-02-06	
J	Hartelius, L; Theodoros, D; Murdoch, B				Hartelius, L; Theodoros, D; Murdoch, B			Use of electropalatography in the treatment of disordered articulation following traumatic brain injury: A case study	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							DYSARTHRIA; EPG; THERAPY; SPEAKERS; SPEECH	Electropalatography (EPG) was used as a biofeedback tool in a case study of a 30-year-old male with disordered articulation following traumatic brain injury (TBI). Based on qualitative measures of the participant's intelligibility, improved articulation of the fricatives /s/ and /integral/ were selected as treatment targets. Therapy was administered three times a week for 5 weeks. Results showed that word and sentence intelligibility increased approximately 10%, and error patterns for lingual articulation indicated that fricative -> stop and other fricative errors decreased considerably. EPG measures for /s/ exhibited a significantly more anterior main focus of articulatory contact post therapy. Consonant durations were significantly longer during weeks 3 and 4, and this finding was associated with the emergence of an articulatory contact pattern with a groove rather than complete closure. This articulatory pattern appeared inconsistently and was found to vary across articulations of /s/ but also within a single consonant production. For /integral/, the amount of contact was significantly reduced post therapy and an increase in duration was noted during week 4, similar to that occurring in the production of /s/. Spatial and timing measures were more variable than in normal speakers of English and indicated a general increase in variability across weeks for both /s/ and /integral/. It was concluded that, although the correct fricative patterns appeared only intermittently during production of the consonants, there seemed to be sufficient information for the listener to be able to classify the sound as a fricative. As a part of an intervention program, visual EPG biofeedback therapy would appear to have a definite role in assisting dysarthric speakers exhibiting difficulties with lingual articulation in understanding their errors, learning how to exploit kinesthetic, and acoustic sources of feedback, and how to make appropriate adjustments in tongue articulation to increase the level of speech intelligibility.	Univ Gothenburg, Sahlgrenska Acad, Dept Logoped & Phoniatr, Halsovetenskapligt Centrum, SE-40530 Gothenburg, Sweden; Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld, Australia		Hartelius, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Logoped & Phoniatr, Halsovetenskapligt Centrum, POB 452, SE-40530 Gothenburg, Sweden.	lena.hartelius@logopedi.gu.se	Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012				BARRY RM, 1989, CLIN LINGUIST PHONET, V3, P81, DOI 10.3109/02699208908985273; BARRY RM, 1995, CASE STUDIES CLIN LI, P181; Dagenais P.A., 1994, AM J SPEECH-LANG PAT, V3, P67, DOI [10.1044/1058-0360.0303.67, DOI 10.1044/1058-0360.0303.67]; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; EDWARDS S, 1989, CLIN LINGUIST PHONET, V3, P111, DOI 10.3109/02699208908985275; FARNETANI E, 1991, QUADERNI CENTRO STUD, V10, P118; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Hardcastle W. J., 1992, INTELLIGIBILITY SPEE, P287; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HARDCASTLE WJ, 1997, INSTRUMENTAL CLIN PH; HOWARD S, 1995, EUR J DISORDER COMM, V30, P246; HOWARD S, 1998, THESIS U SHEFFIELD E, V1; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; McAuliffe M J, 2001, Logoped Phoniatr Vocol, V26, P165, DOI 10.1080/14015430152928357; McAuliffe MJ, 2003, CLIN LINGUIST PHONET, V17, P43, DOI 10.1080/0269920021000066846; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, p[53, 75]; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, P27; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; Weismer G., 1992, INTELLIGIBILITY SPEE, V1, DOI [10.1075/sspcl.1.04wei, DOI 10.1075/SSPCL.1.04WEI]; Wood S., 2000, ACQUIRED NEUROGENIC, P203; WOOD S, 1997, THESIS QUEEN M COLLE; Yorkston K.M., 1981, ASSESSMENT INTELLIGE; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; [No title captured]	33	5	5	0	4	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2005	13	3					189	204					16	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	963GO	WOS:000231792200004					2022-02-06	
J	Kuwahara, S; Fukuoka, M; Koan, Y; Miyake, H; Ono, Y; Moriki, A; Mori, K; Mokudai, T; Uchida, Y; Kumano, O				Kuwahara, S; Fukuoka, M; Koan, Y; Miyake, H; Ono, Y; Moriki, A; Mori, K; Mokudai, T; Uchida, Y; Kumano, O			Diffusion-weighted imaging of traumatic subdural hematoma in the subacute stage - Five case reports	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic subdural hematoma; chronic subdural hematoma; diffusion-weighted magnetic resonance imaging; apparent diffusion coefficient; subacute stage	INTRACRANIAL HEMATOMAS; MR	Five cases of traumatic subdural hematomas in the subacute stage (from 7 to 20 days after head injury) were treated in one male and four females, aged from 63 to 82 years, with evacuation via craniotomy in three and aspiration via burr hole surgery in two. All hematomas were evaluated by T-1-, T-2-, and diffusion-weighted magnetic resonance imaging, and measurement of the apparent diffusion coefficient (ADC). Diffusion-weighted imaging showed the hematoma as a crescent high intensity area with a low intensity rim close to the brain surface (two-layered structure) in four cases and as high intensity with low intensity components in one case. The high intensity areas under the dura mater on diffusion-weighted imaging appeared as homogeneous high intensity on T-1- and T-2-weighted imaging in four cases, and inhomogeneous high intensity on T-1- and isointensity on T-2-weighted imaging in one case. The mean ADC value of the high intensity areas was 0.58 +/- 0.23 (mean standard deviation) x 10(-3) mm(2)/sec. The operative findings revealed the high intensity areas as solid clots. The low intensity areas on diffusion-weighted imaging appeared as homogeneous high intensity in four cases and inhomogeneous isointensity with high intensity components in one case on T-1- and T-2-weighted imaging. The mean ADC value of the low intensity areas was 2.03 +/- 0.27 x 10(-3) mm(2)/sec. The operative findings revealed the low intensity areas as mixtures of resolved clot and cerebrospinal fluid. Diffusion-weighted imaging showed the characteristic two-layered structure in traumatic subdural hematomas in the subacute stage, and analysis of the ADC values was useful for differentiating solid from liquid hematoma and for selection of the surgical procedure.	Mominoki Hosp, Dept Neurosurg, Kochi, Japan; Mominoki Hosp, Kochi Gamma Knife Ctr, Kochi, Japan; Uchida Neurosurg Clin, Kochi, Japan; Kochi Kita Hosp, Dept Orthoped, Kochi, Japan		Kuwahara, S (corresponding author), Kochi Orthopaed & Neurosurg Hosp, Dept Neurosurg, 5-6-41 Kami Machi, Kochi 7800901, Japan.						AOKI N, 1990, ACTA NEUROCHIR, V102, P149, DOI 10.1007/BF01405431; Atlas SW, 2000, AM J NEURORADIOL, V21, P1190; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Kang BK, 2001, KOREAN J RADIOL, V2, P183, DOI 10.3348/kjr.2001.2.4.183; Karasawa H, 1995, NO SHINKEI GEKA J, V4, P121; Kuwahara S, 2005, NEUROL MED-CHIR, V45, P125, DOI 10.2176/nmc.45.125; Kuwahara S, 2004, NEUROL MED-CHIR, V44, P376, DOI 10.2176/nmc.44.376; KUWAHARA S, 2003, NO SHINKEI GEKA SOKU, V13, P979; MAKISSOCK W, 1960, LANCET, V1, P1365; Morinaga K, 1990, No To Shinkei, V42, P131; Morinaga K, 1993, No To Shinkei, V45, P969; Okumura Y, 1998, NEUROL SURG TOKYO, V26, P691; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690	13	5	5	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2005	45	9					464	469		10.2176/nmc.45.464			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	965GU	WOS:000231939400006	16195646	Bronze			2022-02-06	
J	Nash, JK				Nash, JK			Neurotherapy with adults	JOURNAL OF ADULT DEVELOPMENT			English	Article						neurotherapy; QEEG; EEG biofeedback; ADHD; brain injury; cognitive behavior therapy	DEFICIT-HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; EMG	Several possible conceptualizations of neurotherapy are discussed: EEG operant conditioning; EEG homeostatic normalization; and utilization of EEG biofeedback as a means of accessing particular states of consciousness. Attention is given to how neurotherapy is actually done and when it may be a useful adjunct to psychological or medical therapies. Integration of neurotherapy with the larger framework of cognitive behavior therapy and the biopsychosocial model is discussed. Three case studies of adults involving the use of neurotherapy are described.	Behav Med Associates Inc, Edina, MN 55439 USA		Nash, JK (corresponding author), Behav Med Associates Inc, 3300 Edinborough Way,Suite 110, Edina, MN 55439 USA.	bmainc@qeeg.com					Aksionoff E B, 1992, J Am Optom Assoc, V63, P554; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hou CR, 2002, ARCH PHYS MED REHAB, V83, P1406, DOI 10.1053/apmr.2002.34834; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Jung TP, 1997, IEEE T BIO-MED ENG, V44, P60, DOI 10.1109/10.553713; LEHRER PM, 1988, PSYCHOPHYSIOLOGY, V25, P562, DOI 10.1111/j.1469-8986.1988.tb01892.x; MAUPIN EW, 1965, J CONSULT PSYCHOL, V29, P139, DOI 10.1037/h0021754; Monastra VJ, 2001, NEUROPSYCHOLOGY, V15, P136, DOI 10.1037//0894-4105.15.1.136; Nash JK, 2000, CLIN ELECTROENCEPHAL, V31, P30, DOI 10.1177/155005940003100109; PENISTON EG, 1989, ALCOHOL CLIN EXP RES, V13, P271, DOI 10.1111/j.1530-0277.1989.tb00325.x; Peniston EG., 1993, ADV MED PSYCHOTHER, V6, P37; Press Leonard J, 2002, Binocul Vis Strabismus Q, V17, P6; ROSENFELD JP, 1995, BIOFEEDBACK SELF-REG, V20, P241, DOI 10.1007/BF01474516; Sterman MB, 2000, CLIN ELECTROENCEPHAL, V31, P45, DOI 10.1177/155005940003100111; TANSEY MA, 1983, BIOFEEDBACK SELF-REG, V8, P25, DOI 10.1007/BF01000534; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P439, DOI 10.1016/S0887-6177(02)00144-0	20	5	5	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-0667	1573-3440		J ADULT DEV	J. Adult Dev.	AUG	2005	12	2-3					105	112		10.1007/s10804-005-7026-8			8	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	990DO	WOS:000233723600004					2022-02-06	
J	Delaney, JS; Frankovich, R				Delaney, JS; Frankovich, R			Head injuries and concussions in soccer	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article									McGill Univ, Sport Med Clin, Ctr Hlth, Dept Emergency Med, Montreal, PQ H2W 1S4, Canada; Palladium Sport Med & Physiotherapy Ctr, Kanata, ON, Canada		Delaney, JS (corresponding author), McGill Univ, Sport Med Clin, Ctr Hlth, Dept Emergency Med, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	j.delaney@mcgill.ca						0	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2005	15	4					212	213					2	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	952WU	WOS:000231037500003					2022-02-06	
J	Garmoe, W; Newman, AC; O'Connell, M				Garmoe, W; Newman, AC; O'Connell, M			Early self-awareness following traumatic brain injury - Comparison of brain injury and orthopedic inpatients using the Functional Self-Assessment Scale (FSAS)	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Functional Self-Assessment Scale (FSAS); inpatient rehabilitation; sey awareness; traumatic brain injury	MINI-MENTAL STATE; HEAD-INJURY; INTERNAL CONSISTENCY; IMPAIRED AWARENESS; QUESTIONNAIRE; PATIENT	Objective: To examine the Functional Self-Assessment Scale (FSAS) in hospitalized orthopedic patients with no brain dysfunction, and compare results to prior self-awareness data collected with brain injury patients. Design: Comparison of patient and staff ratings on FSAS using paired sample t tests. Participants: Thirty-one adult volunteers hospitalized on National Rehabilitation Hospital (NRH) orthopedic treatment unit. Measures: FSAS was used to compare patient and staff ratings of patient performance on tasks relevant for inpatient rehabilitation. Subjects were screened to rule out brain impairment. Results: Statistically significant but very small differences were found between orthopedic patients and therapist ratings using the FSAS. However, brain injury patients' ratings show a significantly larger discrepancy between self-therapist ratings than do orthopedic patients. Conclusion: Impaired self-awareness is related to brain injury rather than nonspecific factors in rehabilitation inpatients.	Natl Rehabil Hosp, Psychol Serv, Washington, DC 20010 USA		Garmoe, W (corresponding author), Natl Rehabil Hosp, Psychol Serv, 102 Irving St NW, Washington, DC 20010 USA.						BLEECKER ML, 1988, NEUROLOGY, V38, P1565, DOI 10.1212/WNL.38.10.1565; Borgaro SR, 2003, BRAIN INJURY, V17, P545, DOI 10.1080/0269905031000070206; BROOKS DN, 1987, NEUROBEHAVIORAL RECO, P57; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1985, NEUROPSYCHOLOGICAL A; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Newman AC, 2000, BRAIN INJURY, V14, P333; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Stuss D., 1991, AWARENESS DEFICIT BR, P63	23	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					348	358		10.1097/00001199-200507000-00006			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800006	16030441				2022-02-06	
J	Faleiro, RM; Pimenta, NJG; Faleiro, LCM; Cordeiro, AF; Maciel, CJ; Gusmao, SNS				Faleiro, RM; Pimenta, NJG; Faleiro, LCM; Cordeiro, AF; Maciel, CJ; Gusmao, SNS			Decompressive craniotomy for the early treatment of traumatic intracranial hypertension	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						head injury; intracranial hypertension; decompressive craniotomy	ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; BRAIN-INJURY; CEREBRAL EDEMA; CRANIECTOMY; HYPOTHERMIA; MANAGEMENT; REDUCTION	There is no clear role for decompressive craniotomy (DC) for the intracranial hypertension (ICH) treatment in the literature. Actually, there is a lack of class I or II published data for DC, so it is recomended as a second tier option for the refractory ICH. Recent studies has analized the role of early DC for pos traumatic ICH. The present study analizes 21 patients who has received the early DC for the treatment of traumatic ICH. The majority of the patients had Glasgow Coma Scale < 9 and harboring a brain swelling or acute subdural hematoma at cranial computadorized tomography. Hydrocephalus was frequent after DC (28.5%). Good results were obtained in 11 patients (52.5%). We favour the early application of DC for pos traumatic hypertension.	Hosp Felicio Rocho, Belo Horizonte, MG, Brazil; Hosp Pronto Socorro Joao 23, Belo Horizonte, MG, Brazil; FHEMIG, Belo Horizonte, MG, Brazil; Hosp Clin UFMG, Belo Horizonte, MG, Brazil; Hosp Luxemburgo, Belo Horizonte, MG, Brazil		Faleiro, RM (corresponding author), Rua Caraca 518-201, BR-30220260 Belo Horizonte, MG, Brazil.	rfaleiro@brfree.com.br					*AM COLL SURG, 1993, ADV TRAUM LIFE SUPP; Bullock R, 1995, GUIDELINES MANAGEMEN; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; CHANG S, 2003, CRANIECTOMY TRAUMATI, V19, P9; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper P R, 1976, Surg Neurol, V5, P25; Da Silva J A, 1976, Arq Neuropsiquiatr, V34, P232; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Greenberg MD, 1994, HDB NEUROSURGERY; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; MARMAROU A, 1989, INTRACRANIAL PRESSUR, V7, P549; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; PEREIRA WC, 1977, ARQ NEURO-PSIQUIAT, V35, P99, DOI 10.1590/S0004-282X1977000200002; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Stavale MA, 1996, BASES TERAPIA INTENS; WHITFIELD P, 1995, STROKE, V26, P1125	22	5	6	0	0	ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2005	63	2B					508	513		10.1590/S0004-282X2005000300026			6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	942VA	WOS:000230309800026	16059607	Green Submitted, Green Published, gold			2022-02-06	
J	Mackin, RS; Horner, MD; Harvey, RT; Stevens, LA				Mackin, RS; Horner, MD; Harvey, RT; Stevens, LA			The relationship between neuropsychological measures and employment problems in outpatients with substance abuse	REHABILITATION PSYCHOLOGY			English	Article							ADDICTION SEVERITY INDEX; TRAUMATIC BRAIN-INJURY; DEPENDENT PATIENTS; COCAINE ABUSERS; ALCOHOL; TESTS	Objective: To determine the relation between standard clinical neuropsychological tests and employment problems in persons with substance abuse. Participants: Sixty-four patients enrolled in an intensive outpatient substance abuse treatment program. Measures: Employment Problem Severity Score (EPSS) of the Addiction Severity Index and a comprehensive neuropsychological evaluation, including standard measures of attention, executive function, and memory. Results: Multiple regression analyses showed that response latency on the Vigilance trial of the Gordon Diagnostic System and scores on list acquisition and long-delay free recall of the California Verbal Learning Test were significant predictors of EPSS. Performance on measures of executive function did not predict EPSS. Conclusions: Neuropsychological tests may help to identify individuals at risk for employment problems, thereby improving outcomes for patients with substance abuse problems and cognitive deficits.	Ralph H Johnson Dept Vet Affairs Med Ctr, Mental Hlth Serv, Charleston, SC USA; Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA		Mackin, RS (corresponding author), Univ Calif San Francisco, Dept Psychiat, 401 Parnassus Ave,Box OVS-0984, San Francisco, CA 94143 USA.	scottm@lppi.ucsf.edu					Alterman AI, 2000, PSYCHOL ADDICT BEHAV, V14, P287, DOI 10.1037/0893-164X.14.3.287; BAUER LO, 1994, ADDICT BEHAV, V19, P599, DOI 10.1016/0306-4603(94)90015-9; BEATTY WW, 1995, DRUG ALCOHOL DEPEN, V37, P247, DOI 10.1016/0376-8716(94)01072-S; BERRY J, 1993, DRUG ALCOHOL DEPEN, V32, P231, DOI 10.1016/0376-8716(93)90087-7; Delis DC, 1987, CALIFORNIA VERBAL LE; FISHER DG, 1987, INT J ADDICT, V22, P115, DOI 10.3109/10826088709027418; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Golden J. C., 1978, STROOP COLOR WORD TE; GORDON M, 1986, INTERPRETATIVE GUIDE; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; Horner MD, 1997, ARCH CLIN NEUROPSYCH, V12, P667, DOI 10.1016/S0887-6177(97)00028-0; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; MCDERMOTT PA, 1997, ADDICTIVE BEHAV READ, P323; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; MEYERS J, 1995, MEYERS SCORING SYSTE; MITTENBERG W, 1993, ARCH CLIN NEUROPSYCH, V8, P477, DOI 10.1016/0887-6177(93)90048-6; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P625; PLATT JJ, 1995, PSYCHOL BULL, V117, P416, DOI 10.1037/0033-2909.117.3.416; Reitan R, 1985, HALSTEAD REITAN NEUR; ROBERTS LA, 1993, PSYCHIAT RES, V46, P229, DOI 10.1016/0165-1781(93)90091-T; ROSELLI M, 1996, J CLIN EXP NEUROPSYC, V18, P122; RYAN CM, 1987, J CLIN EXP NEUROPSYC, V9, P665, DOI 10.1080/01688638708405209; Shipley W. C., 1946, I LIVING SCALE; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Zachary R., 1991, SHIPLEY I LIVING SCA; [No title captured]	31	5	5	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2005	50	2					158	163		10.1037/0090-5550.50.2.158			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	931ND	WOS:000229491100009					2022-02-06	
J	Marsh, NV; Whitehead, G				Marsh, NV; Whitehead, G			Skull fracture during infancy: A five-year follow-up	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; PRESCHOOL-CHILDREN; ADOLESCENTS; PERFORMANCE; RECOVERY; OUTCOMES; TERM; CHILDHOOD; SEVERITY	A group of 19 children, who had received a skull fracture during infancy, were assessed at least 5 years following injury. The majority of the group (89%) had received a mild traumatic brain injury (TBI), with the remaining two (11%) having a moderate injury. The neuropsychological, academic, and psychosocial functioning of the TBI group was compared to that of 20 orthopedic subjects. The two groups were matched on the variables of gender, age, and socio-economic status. The TBI group was impaired on tests of visual attention and memory for faces. The two groups did not differ significantly on measures of language, sensorimotor functions, or visuospatial functioning. There were no statistically significant differences between the two groups on academic performance, or parent and teacher reports of psychosocial functioning. It is concluded that while there is an absence of deficits in the vast majority of functions, skull fracture in infancy can result in enduring impairment in specific cognitive skills related to the processing of complex nonverbal stimuli.	Univ New England, Sch Psychol, Armidale, NSW 2351, Australia; Univ Waikato, Dept Psychol, Hamilton, New Zealand		Marsh, NV (corresponding author), Univ New England, Sch Psychol, Armidale, NSW 2351, Australia.	nmarsh2@pobox.une.edu.au	Marsh, Nigel/ABA-3609-2021; Marsh, Nigel V./F-5433-2019	Marsh, Nigel/0000-0002-4060-6432; Marsh, Nigel V./0000-0002-4060-6432			Achenbach, 1991, MANUAL TEACHERS REPO; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson VA, 2000, BRAIN INJURY, V14, P679; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Broman S. H., 1995, TRAUMATIC HEAD INJUR; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; CASEY R, 1986, PEDIATRICS, V78, P497; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; Choux M., 1986, HEAD INJURIES NEWBOR, P163; Cohen J., 2013, STAT POWER ANAL BEHA; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Donders J, 1996, J HEAD TRAUMA REHAB, V11, P67, DOI 10.1097/00001199-199606000-00010; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; Frush DP, 1998, J PEDIATR-US, V132, P553, DOI 10.1016/S0022-3476(98)70042-3; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; HORTON AM, 1994, BEHAV INTERVENTIONS; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JOHNSON DA, 1989, CHILDREN HEAD INJURY; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Marsh NV, 2002, CURR OPIN PSYCHIATR, V15, P301, DOI 10.1097/00001504-200205000-00012; MCGUIRE TL, 1987, J LEARN DISABIL, V20, P590, DOI 10.1177/002221948702001004; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Psychological Corporation, 1992, WECHSL IND ACH TEST; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); SPREEN O, 1995, DEV NEUROPSYCHOLOGY; STATISTICS NEW ZEALAND, 1997, NZ SOC IND OCC STAT; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TEUBER H, 1962, Dev Med Child Neurol, V4, P3; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; [No title captured]	71	5	5	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	2005	27	3					352	366		10.1080/13803390490515685			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	913HD	WOS:000228141300006	15969357				2022-02-06	
J	Is, M; Tanriverdi, T; Akyuz, F; Ulu, MO; Ustundag, N; Gezen, F; Yavuz, Z; Uzan, M				Is, M; Tanriverdi, T; Akyuz, F; Ulu, MO; Ustundag, N; Gezen, F; Yavuz, Z; Uzan, M			Yings and Yangs of acute ethanol intoxication in experimental traumatic brain injury	NEUROSURGERY QUARTERLY			English	Article						ethanol; head injury; traumatic brain injury	MODERATE ALCOHOL-CONSUMPTION; HEAD-INJURY; HEMORRHAGIC-SHOCK; ACCUMULATION; MODEL; RATS; EXCITOTOXICITY; ABNORMALITIES; FIBRINOLYSIS; ASSOCIATION	Although the deleterious effects of acute alcohol intoxication on traumatic brain injury (TBI) are well known, neuroprotective features of lower doses of ethanol (EtOH) before head trauma have been reported during recent years. Inhibition of N-methyl-D-aspartate receptor (NMDA)-mediated excitotoxicity by lower doses of EtOH has been believed to be responsible for this protection. The aim of this study was to show the neuroprotective effects of low and moderate doses of EtOH and to compare their efficacy in each group. Acute EtOH intoxication at low and moderate doses was induced 40 minutes before trauma. Severe TBI was administered in Sprague-Dawley rats using an impact acceleration model. At 24 hours after trauma, all the rats were decapitated and hippocampi were evaluated under light microscopy. According to our results, red neuron formation and vacuolar degeneration in the CA1 and CA3 sectors of the hippocampi were less prominent in the lowdose and moderate-dose EtOH plus trauma groups than in the trauma only group. In addition, edema formation was less prominent in the EtOH plus trauma group. When comparing the low-dose EtOH Plus trauma and moderate-dose EtOH Plus trauma groups, an almost normal appearance of the hippocampus was noted in the moderate-dose EtOH plus trauma group. EtOH may have a neuroprotective effect when administered at a lower dose, particularly a moderate dose, and this protection may be a result of the inhibition of NMDA receptor-mediated excitotoxicity.	Abant Izzet Baysal Univ, Duzce Med Fac, Dept Neurosurg, Duzce, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey; Abant Izzet Baysal Univ, Duzce Med Fac, Dept Pathol, Duzce, Turkey; Abant Izzet Baysal Univ, Duzce Med Fac, Dept Biochem, Duzce, Turkey		Tanriverdi, T (corresponding author), PK 5,Cerrahpasa, TR-34301 Istanbul, Turkey.	tanerato2000@yahoo.com	Tanriverdi, Taner/C-9003-2019; Ulu, Mustafa Onur/D-6484-2019; Uzan, Mustafa/D-6571-2019	Ulu, Mustafa Onur/0000-0002-6256-0869; 			ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; DeCrescito V, 1974, Surg Forum, V25, P438; ELMER O, 1984, HAEMOSTASIS, V14, P223; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; HAUT MJ, 1974, AM J MED, V56, P22, DOI 10.1016/0002-9343(74)90747-5; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; LOVINGER DM, 1993, ALCOHOL CLIN EXP RES, V17, P19, DOI 10.1111/j.1530-0277.1993.tb00720.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McQueen J D, 1975, Surg Neurol, V4, P375; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; OKIYAMI K, 1989, J NEUROSURG, V24, P825; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PIKAAR NA, 1987, METABOLISM, V36, P538, DOI 10.1016/0026-0495(87)90163-6; Prasad RM, 1997, J NEUROTRAUM, V14, P919, DOI 10.1089/neu.1997.14.919; RIDKER PM, 1994, JAMA-J AM MED ASSOC, V272, P929, DOI 10.1001/jama.272.12.929; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENGREN LE, 1979, ACTA NEUROL SCAND, V59, P119; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; TAKADERA T, 1990, BRAIN RES, V537, P109, DOI 10.1016/0006-8993(90)90346-D; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Uzan M, 2003, NEUROSURG QUART, V13, P59, DOI 10.1097/00013414-200306000-00001; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Zhang L, 2000, MOL BRAIN RES, V79, P174, DOI 10.1016/S0169-328X(00)00124-8; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983	38	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	MAR	2005	15	1					60	64		10.1097/01.wnq.0000152407.39871.c7			5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	901OI	WOS:000227291400009					2022-02-06	
J	Paucard, A; Besson, VC; Plotkine, M; Margaill, I				Paucard, A; Besson, VC; Plotkine, M; Margaill, I			Time course of oxidative stress, lesion and edema after intrastriatal injection of malonate in rat: effect of alpha-phenyl-N-tert-butylnitrone	FUNDAMENTAL & CLINICAL PHARMACOLOGY			English	Article						alpha-phenyl-N-tert-butylnitrone; edema; glutathione; malonate	TRAUMATIC BRAIN-INJURY; BUTYL-NITRONE PBN; CELLULAR GLUTATHIONE; THERAPEUTIC WINDOW; EXCITOTOXICITY; INHIBITION; NEURONS; VULNERABILITY; METABOLISM; ALZHEIMERS	The aim of this study was to characterize the model of oxidative stress consisting in the infection of malonate (3 mumol), an inhibitor of mitochondrial complex II, in the rat striatum. The striatal concentrations of both the reduced and oxidized forms of glutathione (the major endogenous antioxidant) were determined at various times after malonate injection (1-4 h) in order to evaluate the evolution of oxidative stress. The progression of lesion size and edema was also determined up to 24 h after malonate administration. Finally, the effect of alpha-phenyl-N-tert-butylnitrone (PBN), an antioxidant nitrone, was studied. The levels of reduced glutathione (GSH) progressively decreased after malonate injection up to 40% of those of sham animals at 4 h. An increase in the concentrations of oxidized glutathione (GSSG) was also observed as early as 1 h after malonate administration which was maintained up to 4 h. The size of the lesion was maximal within 2 h of malonate injection, whereas edema continued to increase between 2 and 24 h. Injection of PBN at 100 mg/kg i.p. 30 min before and 2 h after malonate administration abolished the GSSG increase caused by malonate but did not modify the drop in GSH. This moderate antioxidant effect of PBN was associated with a slight decrease of the lesion area at two levels (10.7 and 10.2 mm anterior to the interaural line), but the lesion volume remained unchanged. By contrast, PBN reduced edema by 30%. Taken together, these results show that malonate induced a severe oxidative stress leading to the rapid development of the lesion. PBN demonstrates anti-edematous properties that are not sufficient to reduce the lesion.	Univ Paris 05, Pharmacol Lab, UPRES EA2510, F-75006 Paris, France		Margaill, I (corresponding author), Univ Paris 05, Pharmacol Lab, UPRES EA2510, 4 Ave Observ, F-75006 Paris, France.	isabelle.margaill@univ-paris5.fr	Margaill, Isabelle/ABA-4362-2020; BESSON, VALERIE/AAZ-9989-2020; besson, valerie C/L-7388-2017	Margaill, Isabelle/0000-0002-7941-6644; BESSON, VALERIE/0000-0002-1491-2380; besson, valerie C/0000-0002-1491-2380			Asanuma T, 2002, NEUROSCI LETT, V329, P281, DOI 10.1016/S0304-3940(02)00663-8; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; CHEN GM, 1990, FREE RADICAL RES COM, V9, P317, DOI 10.3109/10715769009145690; CHENG HY, 1993, FREE RADICAL BIO MED, V14, P243, DOI 10.1016/0891-5849(93)90021-L; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Ehrhart J, 2001, J NEUROCHEM, V77, P1496, DOI 10.1046/j.1471-4159.2001.00355.x; Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; GREENE JG, 1995, J NEUROCHEM, V64, P430; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hensley K, 1998, J NEUROCHEM, V71, P2549; Klivenyi P, 2000, J NEUROSCI, V20, P1; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Lancelot E, 1997, FREE RADICAL BIO MED, V23, P1031, DOI 10.1016/S0891-5849(97)00128-7; Lecanu L, 1998, NEUROREPORT, V9, P559, DOI 10.1097/00001756-199802160-00032; Lerouet D, 2002, BRAIN RES, V958, P166, DOI 10.1016/S0006-8993(02)03685-5; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; McLaughlin BA, 1998, J NEUROCHEM, V70, P2406; Mesenge C, 2000, DRUG DISCOV TODAY, V5, P432, DOI 10.1016/S1359-6446(00)01554-3; MURPHY ME, 1992, EUR J BIOCHEM, V210, P139, DOI 10.1111/j.1432-1033.1992.tb17401.x; Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Schulz JB, 1995, J NEUROSCI, V15, P8419; SEN S, 1993, FREE RADICAL RES COM, V19, P255, DOI 10.3109/10715769309056513; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; WEBB JL, 1966, ENZYME METABOLISM IN; Zeevalk GD, 1997, EUR J PHARMACOL, V320, P111, DOI 10.1016/S0014-2999(96)00892-8	36	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0767-3981	1472-8206		FUND CLIN PHARMACOL	Fundam. Clin. Pharmacol.	FEB	2005	19	1					57	64		10.1111/j.1472-8206.2004.00297.x			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	891KW	WOS:000226580900005	15660960				2022-02-06	
J	Stein, DJ; Moeller, FG				Stein, DJ; Moeller, FG			The man who turned bad	CNS SPECTRUMS			English	Article							TRAUMATIC BRAIN-INJURY; REHABILITATION; GAGE,PHINEAS; AGGRESSION; BEHAVIOR		Univ Stellenbosch, Cape Town, South Africa; Univ Florida, Gainesville, FL USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA		Stein, DJ (corresponding author), Univ Stellenbosch, Cape Town, South Africa.		Stein, Dan J/A-1752-2008	Stein, Dan J/0000-0001-7218-7810			Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Damasio A., 1994, DESCARTES ERROR EMOT; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Endicott J, 2002, PSYCHIAT RES, V112, P153, DOI 10.1016/S0165-1781(02)00185-3; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; Gerald MS, 2002, ADDICTION, V97, P415, DOI 10.1046/j.1360-0443.2002.00023.x; Higley JD, 1997, ANN NY ACAD SCI, V836, P39, DOI 10.1111/j.1749-6632.1997.tb52354.x; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P1186, DOI 10.1038/sj.npp.1300153; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Johnson PA, 2003, J NEUROPSYCH CLIN N, V15, P397, DOI 10.1176/appi.neuropsych.15.4.397; Lawrie Barbara, 2004, Rehabil Nurs, V29, P9; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; New AS, 2004, PSYCHOPHARMACOLOGY, V176, P451, DOI 10.1007/s00213-004-1913-8; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ratiu PF, 2004, NEW ENGL J MED, V351, pE21, DOI 10.1056/NEJMicm031024; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Stein DJ, 2000, ETHNIC HEALTH, V5, P303, DOI 10.1080/713667458; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Zanarini Mary C, 2004, Curr Psychiatry Rep, V6, P66, DOI 10.1007/s11920-004-0041-9	25	5	5	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529	2165-6509		CNS SPECTRUMS	CNS Spectr.	FEB	2005	10	2					88	90		10.1017/S1092852900019404			3	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	032DB	WOS:000236753000009	15685117				2022-02-06	
J	Dufrene, BA; Watson, TS; Weaver, A				Dufrene, BA; Watson, TS; Weaver, A			Response blocking with guided compliance and reinforcement for a habilitative replacement behavior: Effects on public masturbation and on-task behavior	CHILD & FAMILY BEHAVIOR THERAPY			English	Article							OVERCORRECTION; ELIMINATION	There is limited empirical research regarding effective treatment for public masturbation. In the current case study, the relative and combined effects of reinforcement of an incompatible habilitative replacement behavior and response blocking with guided compliance on masturbation and on-task behavior were evaluated for a seven year-old African-American female with a traumatic brain injury who masturbated in her regular and special education classrooms. Results indicate that response blocking with guided compliance was successful in reducing masturbation. However, response blocking with guided compliance and reinforcement of an incompatible response was most effective for reducing masturbation and simultaneously increasing on-task behavior.	Univ So Mississippi, Dept Psychol, Hattiesburg, MS 39406 USA; Miami Univ, Dept Educ Psychol, Oxford, OH 45056 USA; Loess Hills Area Educ Agcy 13, Harlan Reg Off, Harlan, IA 51537 USA		Dufrene, BA (corresponding author), Univ So Mississippi, Dept Psychol, 118 Coll Dr,5025, Hattiesburg, MS 39406 USA.	Brad.Dufrene@usm.edu; watsonts@muohio.edu; adw@artandcommercegroup.com		Weaver, Adam/0000-0002-8146-7694			Armstrong KJ, 1998, CHILD FAM BEHAV THER, V20, P55, DOI 10.1300/J019v20n01_04; BAKEMAN R, 1976, OBSERVING INTERACTIO; Cook J. W., 1979, BEHAV RES THER, V16, P131; Doggett RA, 2001, SCHOOL PSYCHOL REV, V30, P313; FERGUSON LN, 1979, J SEX RES, V15, P213, DOI 10.1080/00224497909551042; FOXX RM, 1973, J APPL BEHAV ANAL, V6, P1, DOI 10.1901/jaba.1973.6-1; FRIEDRICH WN, 1991, PEDIATRICS, V88, P456; GAGNON JH, 1985, ARCH SEX BEHAV, V14, P451, DOI 10.1007/BF01542005; GILBERT JA, 1916, AM J UROL, V12, P82; JANZEN WB, 1978, AM J PSYCHOTHER, V32, P300, DOI 10.1176/appi.psychotherapy.1978.32.2.300; LALLI JS, 1993, J APPL BEHAV ANAL, V26, P227, DOI 10.1901/jaba.1993.26-227; LEHNER FJ, 1960, BEHAV THERAPY NEUROS; LUISELLI JK, 1977, J BEHAV THER EXP PSY, V8, P201, DOI 10.1016/0005-7916(77)90048-9; MCGUIRE RJ, 1964, CONDITIONING TECHNIQ; WAGNER MK, 1968, J CHILD PSYCHOL PSYC, V9, P61, DOI 10.1111/j.1469-7610.1968.tb02208.x; Watson T. S., 2003, CONDUCTING SCH BASED; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD	17	5	5	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0731-7107	1545-228X		CHILD FAM BEHAV THER	Child Fam. Behav. Ther.		2005	27	4					73	84		10.1300/J019v27n04_04			12	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	011RF	WOS:000235285100004					2022-02-06	
J	Gilby, KL; Kelly, ME; McIntyre, DC; Robertson, HA				Gilby, KL; Kelly, ME; McIntyre, DC; Robertson, HA			Neuro-overprotection? A functional evaluation of clomethiazole-induced neuroprotection following hypoxic-ischemic injury	NEUROSCIENCE			English	Article						kindling; functional recovery; stroke; excitability; learning	FOCAL CEREBRAL-ISCHEMIA; TRANSIENT FOREBRAIN ISCHEMIA; EPILEPTIC SEIZURES; BRAIN; CHLORMETHIAZOLE; EXPRESSION; RECEPTORS; STROKE; DAMAGE; MODEL	Hypoxic-ischemic (H-I) injury produces extensive damage to the hippocampus of young rats. We have recently shown that administration of 125 mg kg(-1) clomethiazole (CMZ), a GABA(A)-agonist, provides complete histological protection against H-I injury if administered 3 In post-H-I (Brain Res 1035 (2005) 194). However, whether that histological protection translates into lasting functional preservation is unclear. To determine whether hippocampal-based circuits remain functionally intact in CMZ-protected H-I rats, we administered 125 mg kg-1 (high dose [CMZ-HD]) or 65 mg kg(-1) (low dose [CMZ-LD]) CMZ, 3 h post-H-I, and examined numerous kindling parameters in the dorsal hippocampus 60 days following H-I. Kindling parameters included afterdischarge (AD) thresholds (ADTs), AD durations and kindling rates. Additional groups assessed included vehicle-injected H-I (VIH), hypoxic, ligated and naive rats. VIH, CMZ-HD, CMZ-LD and hypoxic rats all exhibited significantly faster kindling rates than naive rats. Thus, a previous traumatic event, even hypoxia alone, facilitated subsequent seizure propagation. Still, a significantly slower kindling rate was evident in CMZ-HD rats than in hypoxic, VIH or CMZ-LD rats. Moreover, while longer pre-kindling AD durations were observed in the damaged hippocampus of VIH compared with naive rats, this was not true for either CMZ-treated groups, hypoxic or ligated rats. Collectively, these findings suggest CMZ can suppress the epileptogenic effects of H-I. Surprisingly, however, both groups of CMZ-treated rats exhibited a four to nine times greater ADT than any other group and this effect was most profound in the CMZ-protected hippocampus. Thus, CMZ administration protected local neurons against terminal insult and left network excitability relatively normal with respect to seizure offset mechanisms but also caused profound elevation of local ADTs, which suggests a local hypoexcitability/ increased inhibition. Finally, this study demonstrates, for the first time, that the kindling model can serve as a sensitive measure of function-related neuroprotective efficacy in animal models of ischemia. (c) 2005 Published by Elsevier Ltd on behalf of IBRO.	Dalhousie Univ, Fac Med, Dept Pharmacol, Mol Neurobiol Lab, Halifax, NS B3H 4H7, Canada; Childrens Hosp Philadelphia, Abramson Res Ctr, Stokes Res Inst, Div Neurol, Philadelphia, PA 19104 USA; Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada		Gilby, KL (corresponding author), Carleton Univ, Dept Psychol Neurosci, Ottawa, ON K1S 5B6, Canada.	gilbykrista@hotmail.com					ARAKI T, 1993, PHARMACOL BIOCHEM BE, V45, P945, DOI 10.1016/0091-3057(93)90145-J; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; BALDWIN HA, 1993, NEURODEGENERATION, V2, P139; BORTOLOTTO ZA, 1991, PHYSIOL BEHAV, V49, P667, DOI 10.1016/0031-9384(91)90299-4; CAIN DP, 1989, TRENDS NEUROSCI, V12, P6, DOI 10.1016/0166-2236(89)90146-X; Chaulk D, 2003, EXP NEUROL, V182, P476, DOI 10.1016/S0014-4886(03)00121-3; COCITO L, 1982, STROKE, V13, P189, DOI 10.1161/01.STR.13.2.189; CROSS AJ, 1991, BRIT J PHARMACOL, V104, P406, DOI 10.1111/j.1476-5381.1991.tb12443.x; ERECINSKA M, 1984, BRAIN RES, V304, P9, DOI 10.1016/0006-8993(84)90857-6; Gilby KL, 1997, MOL BRAIN RES, V48, P87, DOI 10.1016/S0169-328X(97)00085-5; Gilby KL, 2005, BRAIN RES, V1035, P196, DOI 10.1016/j.brainres.2004.12.015; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; HEURTEAUX C, 1994, BRAIN RES, V659, P67, DOI 10.1016/0006-8993(94)90864-8; Kelly ME, 1999, NEUROSCIENCE, V91, P305, DOI 10.1016/S0306-4522(98)00656-3; KILPATRICK CJ, 1990, ARCH NEUROL-CHICAGO, V47, P157, DOI 10.1001/archneur.1990.00530020053014; Lazar RM, 2002, STROKE, V33, P283, DOI 10.1161/hs0102.101222; LI HL, 1993, HIPPOCAMPUS, V3, P527, DOI 10.1002/hipo.450030412; Liang SP, 1997, BRAIN RES, V751, P189, DOI 10.1016/S0006-8993(96)01292-9; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Marshall JWB, 1999, EXP NEUROL, V156, P121, DOI 10.1006/exnr.1998.6994; MCINTYRE DC, 1986, PROG NEUROBIOL, V27, P1, DOI 10.1016/0301-0082(86)90010-9; Meldrum BS, 1997, NEUROPATH APPL NEURO, V23, P185, DOI 10.1111/j.1365-2990.1997.tb01201.x; Mittmann T, 1998, NEUROSCIENCE, V85, P15, DOI 10.1016/S0306-4522(97)00638-6; MOLINO A, 1972, PHYSIOL BEHAV, V9, P273, DOI 10.1016/0031-9384(72)90249-1; MOSHE SL, 1983, DEV BRAIN RES, V7, P81, DOI 10.1016/0165-3806(83)90083-4; Pong K, 2004, EXPERT OPIN THER TAR, V8, P125, DOI 10.1517/eott.8.2.125.30244; Qu M, 1998, NEUROSCIENCE, V85, P29, DOI 10.1016/S0306-4522(97)00656-8; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROMIJN HJ, 1994, BRAIN RES, V657, P245, DOI 10.1016/0006-8993(94)90974-1; SATO K, 1994, BRAIN RES BULL, V35, P167, DOI 10.1016/0361-9230(94)90098-1; SATO M, 1990, ELECTROEN CLIN NEURO, V76, P459, DOI 10.1016/0013-4694(90)90099-6; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; SHUAIB A, 1995, NEUROSCI LETT, V197, P109, DOI 10.1016/0304-3940(95)11934-O; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SYDSERFF SG, 1995, NEURODEGENERATION, V4, P323, DOI 10.1016/1055-8330(95)90022-5; SYDSERFF SG, 1995, BRIT J PHARMACOL, V114, P1631, DOI 10.1111/j.1476-5381.1995.tb14950.x; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Wahlgren NG, 1998, CEREBROVASC DIS, V8, P33, DOI 10.1159/000047516; WESTERBERG E, 1989, J NEUROSCI, V9, P798	39	5	5	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2005	131	4					785	792		10.1016/j.neuroscience.2004.11.053			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	908NB	WOS:000227792600002	15749333				2022-02-06	
J	Is, M; Uzan, M; Unal, F; Kiris, T; Tanriverdi, T; Mengi, M; Kilic, N				Is, M; Uzan, M; Unal, F; Kiris, T; Tanriverdi, T; Mengi, M; Kilic, N			Intraventricular albumin: an optional agent in experimental post-traumatic brain edema	NEUROLOGICAL RESEARCH			English	Article						albumin; brain edema; head trauma	FOCAL CEREBRAL-ISCHEMIA; MARKED NEUROPROTECTIVE EFFICACY; COLLOID ONCOTIC THERAPY; INTRACRANIAL HYPERTENSION; HEAD-INJURY; RATS; BARRIER; HEMODILUTION; DIFFUSION; PROTEIN	Hypothesis: Human albumin may be effective in the treatment of posttraumatic brain edema due to its hyperoncotic features. Therefore, the aim of the experimental stud presented in this paper has two points: the first is to evaluate the efficacy of intraventricular hyperoncotic human albumin on post-traumatic brain edema and the second is to try to show the appropriate posttraumatic time window for albumin administration. Method: Traumatic brain injury and subsequent edema was formed by a model of impact acceleration injury in rats. Human albumin was administered via intraventricular route by using a stereotactic head holder. All animals in each roup were decapitated 24 hours after the procedure and the effect of albumin was evaluate by measurement of tissue specific gravity. Results: Tissue specific gravity decreased in edematous tissue (trauma indicator), increased after albumin administration at the 12th (p<0.001), and both at the 1st and 12th hour of the trauma (edema treatment; p<0.001). On the other hand, albumin administered at the 12th, and at both the 1st and 12th hours in the rats without trauma has caused the formation of the brain edema. Conclusion: We conclude that human albumin is effective in cytotoxic, but not in vasogenic edema and exerts its best anti-edematous effect at the 12th hour of severe head trauma and this study may help future studies that will try to show the effects of albumin with different time modalities after severe head injury.	Duzce Izzet Baysal Univ, Med Fac, Dept Neurosurg, Duzce, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg & Physiol, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Expt Anim Res Lab, Istanbul, Turkey; Istanbul Univ, Istanbul Med Fac, Dept Neurosurg, Istanbul, Turkey		Uzan, M (corresponding author), POB 5, TR-34301 Istanbul, Turkey.	uzan@istanbul.edu.tr	Kiris, Talat/AAP-4665-2020; Uzan, Mustafa/D-6571-2019; MENGI, MURAT/Q-7048-2017; Tanriverdi, Taner/C-9003-2019	Kiris, Talat/0000-0002-2985-3758; MENGI, MURAT/0000-0003-1688-814X; Uzan, Mustafa/0000-0001-7214-380X			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; ALBRIGHT AL, 1984, J NEUROSURG, V60, P481, DOI 10.3171/jns.1984.60.3.0481; Balslev Y, 1997, J NEUROCYTOL, V26, P133, DOI 10.1023/A:1018527928760; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; BELAYEV L, 1997, J NEUROTRAUM, V16, P445; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BOGAERT YE, 1998, FREE RADIC BIOL MED, V16, P811; BULLOCK R, 1990, ACT NEUR S, V51, P286; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; GOSLINGA H, 1992, STROKE, V23, P181, DOI 10.1161/01.STR.23.2.181; GROEGER U, 1989, ACTA NEUROCHIR, V101, P134, DOI 10.1007/BF01410529; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HANSEN TD, 1994, NEUROSURGERY, V34, P505, DOI 10.1227/00006123-199403000-00017; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; Huh PW, 1998, BRAIN RES, V804, P105, DOI 10.1016/S0006-8993(98)00674-X; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KITA H, 1994, ACTA NEUROCHIR, P452; LITTLE JR, 1981, NEUROSURGERY, V9, P552, DOI 10.1227/00006123-198111000-00011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATSUI T, 1993, NEUROSURGERY, V33, P293, DOI 10.1227/00006123-199308000-00017; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOLLGARD K, 1987, J NEUROCYTOL, V16, P433, DOI 10.1007/BF01668498; MORI K, 1995, STROKE, V26, P1620, DOI 10.1161/01.STR.26.9.1620; NAWASHIRO H, 1994, ACTA NEUROCHIR, P440; Onal C, 1997, ACTA NEUROCHIR, V139, P661, DOI 10.1007/BF01412002; PELLEGRINO LJ, 1979, STEREO TACTIC ATLAS; POLLAY M, 1985, NEUROSURGERY, V1, P322; POPP AJ, 1996, NEUROSURGERY, V2, P2623; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P85, DOI 10.1046/j.1440-1681.1999.02987.x; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; TODD NV, 1990, ACT NEUR S, V51, P296; TOMINAGA T, 1995, CENTRAL NERVOUS SYST, P85; TOMITA H, 1994, ACTA NEUROCHIR, P547; TONE O, 1994, ACTA NEUROCHIR, P568	49	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2005	27	1					67	72		10.1179/016164105X18296			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	893EE	WOS:000226701300012	15829162				2022-02-06	
J	Kiymaz, N; Yilmaz, N				Kiymaz, N; Yilmaz, N			Penetrating intracranial stone	PEDIATRIC NEUROSURGERY			English	Article						foreign body; head trauma; intracranial stone	CRANIAL INJURY; BRAIN-ABSCESS	Traumatic intracranial foreign objects may cause cranial hemorrhage and contusion at an early stage and epileptic seizures and infections at a later stage, leading to morbidity and mortality in children. In the present study we report a case of a traumatic intracranial stone, which is a rarely encountered foreign object in intracranial traumatic injuries. Copyright (c) 2005 S. Karger AG, Basel.	Yuzuncu Yil Univ, Dept Neurosurg, TR-65200 Van, Turkey		Kiymaz, N (corresponding author), Yuzuncu Yil Univ, Tip Fak Arastirma Hastanesi, TR-65200 Van, Turkey.	nkiymaz@hotmail.com					Arunkumar MJ, 1999, SURG NEUROL, V51, P617, DOI 10.1016/S0090-3019(99)00029-4; BERT F, 1995, J CLIN MICROBIOL, V33, P1950, DOI 10.1128/JCM.33.7.1950-1953.1995; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; JOOMA R, 1984, SURG NEUROL, V21, P236, DOI 10.1016/0090-3019(84)90193-9; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; Ozkan U, 2002, NEUROSURG REV, V25, P231, DOI 10.1007/s101430100173; PENCEK TL, 1986, J NEUROSURG, V64, P813, DOI 10.3171/jns.1986.64.5.0813; Rahman NU, 1997, INT OPHTHALMOL, V21, P13, DOI 10.1023/A:1005834913614; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801	10	5	5	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2005	41	3					145	147		10.1159/000085872			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	942TR	WOS:000230306300006	15995332				2022-02-06	
J	Weinzierl, M; Mautes, AE; Whetstone, W; Lin, Y; Noble-Haeusslein, LJ				Weinzierl, M; Mautes, AE; Whetstone, W; Lin, Y; Noble-Haeusslein, LJ			Endothelin-mediated induction of heme oxygenase-1 in the spinal cord is attenuated in transgenic mice overexpressing superoxide dismutase	BRAIN RESEARCH			English	Article						astrocyte; blood flow; endothelin; macrophage; microglia; spinal cord	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; BLOOD-FLOW; RAT-BRAIN; EXPRESSION; INJECTION; RESPONSES; NEURONS; BARRIER	Spinal cord blood flow and the induction of heme oxygenase-1 (HO-1), an indicator of oxidative stress. were studied in the spinal cords. of adult wild-type and transgenic mice overexpressing the antioxidant copper. zinc superoxide dismutase (CuZn SOD) after intrathecal administration of the potent vasoactive peptide endothelin-1 (ET-1). Gelfoam. saturated with ET-1 (40: 80, or 400 mumol/L), was positioned in the intrathecal space at the midthoracic level in anesthetized animals. Blood flow was continuously monitored by laser Doppler for 10 min after the intrathecal application of ET-1. There was a significant reduction in spinal cord blood flow to approximately 40% of control values by 10 min after the intrathecal application of the peptide in both wild-type and trarsgenic mice. Moreover. SB209670. a nonselective endothelin receptor antagonist, blocked this reduction in flow. Each animal was euthanized 24 h after the intrathecal administration of ET-1 and the spinal cord was prepared for quantitative immunocytochemistry. HO-1 was primarily induced in astrocytes near the dorsal surface of the spinal cord in wild-type mice. This induction was attenuated in both wild-type, treated with SB209670. and untreated transgenic mice. Together, these findings suggest that ET-1 mediates oxidative stress in the spinal cord through the modulation of spinal cord blood flow. (C) 2004 Published by Elsevier B.V.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Rhein Westfal TH Aachen, Dept Neurol Surg, D-5100 Aachen, Germany; Univ Saarland, Dept Neurol Surg, D-6650 Homburg, Germany; Univ Calif San Francisco, Dept Med, Div Emergency Med, San Francisco, CA 94143 USA		Noble-Haeusslein, LJ (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Room C224,521 Parnassus Ave, San Francisco, CA 94143 USA.	noblelj@itsa.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039278, R01NS039847, K08NS043302] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39278, NS39847, NS43302] Funding Source: Medline		ALAM J, 1992, J BIOL CHEM, V267, P21894; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; ASANO T, 1984, Neurological Research, V6, P49; Bidmon HJ, 2001, EXP NEUROL, V168, P1, DOI 10.1006/exnr.2000.7456; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; Fernandez-Patron Carlos, 2002, Biological Procedures Online, V4, P38, DOI 10.1251/bpo32; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; FREEMAN BA, 1982, LAB INVEST, V47, P412; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Geddes JW, 1996, NEUROSCI LETT, V210, P205, DOI 10.1016/0304-3940(96)12703-8; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; HOKFELT T, 1989, ACTA PHYSIOL SCAND, V137, P555, DOI 10.1111/j.1748-1716.1989.tb08798.x; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; IMAIZUMI S, 1990, ACT NEUR S, V51, P236; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; KOZLOV AV, 1995, NEUROSCI LETT, V196, P140, DOI 10.1016/0304-3940(95)11822-E; KUWAKI T, 1995, NEWS PHYSIOL SCI, V10, P228; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Lu XR, 2001, EXP BRAIN RES, V137, P424, DOI 10.1007/s002210000616; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; Mautes AEM, 1998, BRAIN RES, V795, P17, DOI 10.1016/S0006-8993(98)00230-3; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; MOSQUEDAGARCIA R, 1993, CIRC RES, V72, P20, DOI 10.1161/01.RES.72.1.20; Noble LJ, 2002, J NEUROSCI, V22, P7526; OHLSTEIN EH, 1994, P NATL ACAD SCI USA, V91, P8052, DOI 10.1073/pnas.91.17.8052; Salzman SK, 1996, J NEUROTRAUM, V13, P93, DOI 10.1089/neu.1996.13.93; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; WESTMARK R, 1995, NEUROSCI LETT, V192, P173, DOI 10.1016/0304-3940(95)11638-D; WILLETTE RN, 1990, AM J PHYSIOL, V259, pH1688	34	5	5	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 24	2004	1030	1					125	132		10.1016/j.brainres.2004.09.060			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	880WL	WOS:000225820600013	15567344				2022-02-06	
J	Gauggel, S; Bocker, M; Zimmermann, P; Privou, C; Lutz, D				Gauggel, S; Bocker, M; Zimmermann, P; Privou, C; Lutz, D			Item response theory and its application in neurology. Measurement of activity limitations in neurologic patients	NERVENARZT			German	Article						functional independence measure; rating scale analysis; Rasch Analysis; activity limitations	RASCH ANALYSIS; HEALTH-STATUS; REHABILITATION; STROKE	This article is concerned with the measurement of activity limitations in neurologic patients and with the application of the item response theory (IRT), especially the Rasch analysis, in analyzing activity ratings. Activity limitations of 166 patients with different neurologic disorders (e.g., stroke, traumatic brain injury) were assessed with the Functional Independence Measure (FIM) during their stay in a rehabilitation hospital. Data analysis was performed with the Rasch model, which allows testing the psychometric qualities of the FIM. Results indicate that the AM has good psychometric qualities. However, results also show that the 18 AM items define two statistically and clinically different indicators. Thirteen items define disability in motor functions. Five items define disability in cognitive functions. Separate analyses of the two scales help to improve the psychometric quality of the FIM.	Tech Univ Chemnitz, Inst Psychol, D-09120 Chemnitz, Germany; Reha Zentrum Reichshof, Fachklin Neurol Pneumol & Onkol, Reichshof, Eckenhagen, Germany		Gauggel, S (corresponding author), Tech Univ Chemnitz, Inst Psychol, Wilhelm Raabe Str 43, D-09120 Chemnitz, Germany.	siegfried.gauggel@phil.tu-chemnitz.de		Gauggel, Siegfried/0000-0002-2742-4917			Antonucci G, 2002, ARCH PHYS MED REHAB, V83, P1442, DOI 10.1053/apmr.2002.34618; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bond T, 2001, APPL RASCH MODEL FUN; Dittmar S., 1997, FUNCTIONAL ASSESSMEN; Embretson S.E., 2013, ITEM RESPONSE THEORY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; Grimby G, 1998, STROKE, V29, P1843, DOI 10.1161/01.STR.29.9.1843; Haigh R, 2001, J REHABIL MED, V33, P273; HAMILTON BB, 1987, REHABILITATION OUTCO, P115; Hays RD, 2000, MED CARE, V38, P28; Jenkinson C, 2001, J NEUROL NEUROSUR PS, V71, P220, DOI 10.1136/jnnp.71.2.220; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; LINACRE JM, 1999, WINSTEPS PC COMPATIB; Lindeboom R, 2003, NEUROLOGY, V60, P738, DOI 10.1212/01.WNL.0000044402.16315.FC; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; MASUR H, 2000, SKALEN SCORES NEUROL; McHorney CA, 2000, MED CARE, V38, P43; Mungas D, 2000, STAT MED, V19, P1631, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1631::AID-SIM451>3.0.CO;2-P; Tennant A, 2000, BRIT MED BULL, V56, P287, DOI 10.1258/0007142001903210; TENNANT A, 1996, CLIN REHABIL, V0010, P00301, DOI DOI 10.1177/026921559601000407; Tesio L, 1998, J Outcome Meas, V2, P79; Ware JE, 2003, ARCH PHYS MED REHAB, V84, pS43, DOI 10.1053/apmr.2003.50246; Willmes K., 1997, APPL LATENT TRAIT LA, P127; Wright B, 1979, BEST TEST DESIGN; Wright B, 1994, MEASUREMENT T, V8, P370; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857	27	5	5	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-2804			NERVENARZT	Nervenarzt	DEC	2004	75	12					1179	+		10.1007/s00115-004-1734-3			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	884HM	WOS:000226075500005	15586265				2022-02-06	
J	Rajan, GP; Zellweger, R				Rajan, GP; Zellweger, R			Half pipe snowboarding: an (un)forgettable experience or an increasing risk for head injury?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CHRONIC SUBDURAL-HEMATOMA	The case is presented of a professional half pipe snowboarder with a large post-traumatic subdural haematoma, which allowed close to normal functioning and socialisation. It is an example of a potentially life threatening sports injury in an increasingly commercialised and popular winter sport. It highlights that a knowledge of injury patterns and a high level of suspicion should be maintained in the treatment of snowboarding injuries.	Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa		Rajan, GP (corresponding author), Sir Charles Gairdner Hosp, Verdun St, Nedlands, WA 6009, Australia.	guneshrajan@hotmail.com					ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; BLADIN C, 1995, SPORTS MED, V19, P358, DOI 10.2165/00007256-199519050-00005; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; LAIDLOW DJ, 2000, OPERATIVE NEUROSURGE, V1, P241; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Uzura M, 2003, BRIT J SPORT MED, V37, P82, DOI 10.1136/bjsm.37.1.82	8	5	5	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC 1	2004	38	6							e35	10.1136/bjsm.2004.011882			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	873SH	WOS:000225300700035	15562150	Bronze, Green Published			2022-02-06	
J	Park, CO; Hyun, DK				Park, CO; Hyun, DK			Apoptotic change in response to magnesium therapy after moderate diffuse axonal injury in rats	YONSEI MEDICAL JOURNAL			English	Article						ionized magnesium; ionized calcium; apoptosis; MgSO4	EXPERIMENTAL BRAIN INJURY; CEREBRAL-CORTEX; HIPPOCAMPAL-NEURONS; IONIZED MAGNESIUM; DNA FRAGMENTATION; HEAD-INJURY; METABOLISM; ISCHEMIA; CALCIUM; CA-2+	The biochemical factors related to moderation of secondary or delayed damage to the central nervous system (CNS) remain undefined. We have recently demonstrated that the weight- drop induced moderate diffuse axonal injury (mDAI) in rats causes a rapid decline in serum ionized magnesium (Mg2+) and a significant increase in the amount of serum ionized calcium (Ca2+) relative to Mg2+ (Ca2+/ Mg2+). For three hours, serum Mg2+ levels remained significantly depressed at 76% of preinjury values (p<0.05), but total serum magnesium remained unchanged (tMg, p>0.05). Head trauma resulted in a small decrease of Ca2+ (about 10%), but a significant increase in the amount of Ca2+/Mg2+ (mean value in control group: in injured group for 3 hours after trauma = 4.65 +/- 0.012: 5.69 +/- 0.015, p<0.05) was observed. In order to further investigate the relationship between Mg2+ and brain injury, the effect of Mg2+ treatment on posttraumatic histological changes (apoptotic changes) was examined following the weight-drop induced brain injury. At 30 min postinjury, animals treated with MgSO4 (750,mumol/kg) showed significant improvements of apoptotic changes when compared to the control group (54.8 +/- 1.7, 51.5 +/- 3.2 at 12, 24 h in control group, 24.8 +/- 2.6, 20.5 +/- 1.4 at 12, 24 h in treated group, p<0.05). The early decline in serum Mg2+ and the increase in the amount of Ca2+/Mg2+ immediately following brain trauma uncovered by these findings suggest that they may be a critical factor in the development of irreversible tissue injury. If this proves to be the case, treatment with MgSO4 may be effective in improving histological findings following experimental traumatic brain injury in rats.	Inha Univ, Coll Med, Dept Neurosurg, Inchon 400711, South Korea		Park, CO (corresponding author), Inha Univ, Coll Med, Dept Neurosurg, 7-206,3 Ga,Sinheung Dong, Inchon 400711, South Korea.	nspco@inha.ac.kr					ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Bara M., 1984, MAGNESIUM, V3, P212; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FAGIAN MM, 1996, BIOCHIM BIOPHYS ACTA, V85, P131; GARFINKEL L, 1985, Magnesium, V4, P60; GAWAZ M, 1994, THROMB HAEMOSTASIS, V72, P912; GRUBBS RD, 1987, MAGNESIUM, V6, P113; GUNTHER T, 1994, MAGNESIUM-B, V16, P38; HAYASHI H, 1986, AM J PHYSIOL, V250, pR573, DOI 10.1152/ajpregu.1986.250.4.R573; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; HEALTH DL, 1998, J NEUROTRAUM, V15, P183; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; IKEDA Y, 1990, NEUROSURGERY, V27, P1; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; JENKINS WT, 1991, J CEREB BLOOD FLOW M, V11, P1025; JENNETT B, 1975, LANCET, V1, P480; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KUDO Y, 1986, BRIT J PHARMACOL, V89, P191, DOI 10.1111/j.1476-5381.1986.tb11135.x; LINNIK MD, 1995, MOL BRAIN RES, V32, P116, DOI 10.1016/0169-328X(95)00069-5; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1990, CURR OPIN NEUROL NEU, V3, P4; MAUSKOP A, 1993, HEADACHE, V33, P135, DOI 10.1111/j.1526-4610.1993.hed3303135.x; MCINTOSH TK, 1989, BRAIN RES, V482, P261; MCLAURIN RL, 1976, HDB CLIN NEUROLOGY, V23, P109; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Muir KW, 1998, STROKE, V29, P918, DOI 10.1161/01.STR.29.5.918; OGURA A, 1988, EXP BRAIN RES, V73, P447, DOI 10.1007/BF00406601; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; RUBIN H, 1977, J CELL PHYSIOL, V91, P449, DOI 10.1002/jcp.1040910315; SAKAMOTO N, 1986, BRAIN RES, V364, P372, DOI 10.1016/0006-8993(86)90850-4; SEELIG JM, 1983, AM J PHYSIOL, V245, pH22, DOI 10.1152/ajpheart.1983.245.1.H22; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; TSUDA T, 1989, BRAIN RES, V484, P228, DOI 10.1016/0006-8993(89)90365-X; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; WALLIS RA, 1996, J NEUROTRAUM, V13, P626; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zoppi F, 1996, SCAND J CLIN LAB INV, V56, P259, DOI 10.3109/00365519609088646	47	5	9	0	1	YONSEI UNIV COLL MEDICINE	SEOUL	50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA	0513-5796	1976-2437		YONSEI MED J	Yonsei Med. J.	OCT 31	2004	45	5					908	916		10.3349/ymj.2004.45.5.908			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	868FL	WOS:000224899400019	15515203	gold			2022-02-06	
J	Fernandez-Ortega, JF; Prieto-Palomino, MA; Munoz-Lopez, A; Lebron-Gallardo, M; Arias-Verdu, D; Garcia-Caballero, M; Quesada-Garcia, G				Fernandez-Ortega, JF; Prieto-Palomino, MA; Munoz-Lopez, A; Lebron-Gallardo, M; Arias-Verdu, D; Garcia-Caballero, M; Quesada-Garcia, G			Dysautonomic seizures in patients admitted to an intensive care unit following severe traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						autonomic dysfunction; computed tomography; critical care unit; disautonomy; traumatic brain injury	DIENCEPHALIC SEIZURES; INTRATHECAL BACLOFEN; HEAD-INJURY; BROMOCRIPTINE; DYSFUNCTION	Aim. To describe clinical and radiologic features of dysautonomic crisis after severe traumatic brain injury and its influence in the clinical situation six months later. Patients and methods. Retrospective, observatory study of seven patients after severe head injury, with dysautonomic crisis, admitted in the Critical Care Unit (CCU) during six months. No interventions. Its clinical features, its association with intracranial pressure and the treatment for Dysautonomic crisis they have received were extracted from the computed clinical report. We have evaluated his neurologic prognosis with the Jennet-Bond scale and his radiologic characteristics with the Gennarelly scale. Results. Dysautonomic crisis began in the first week if the patients didn't received neuromuscular blocks drugs and they continued when the patients were discharged from, the CCU in a young population with an initial Glasgow scale coma of 5 points. We didn't wait a special radiologic pattern. After the next six months, crisis were disappeared in 86% of patients and all patients reached a good neurologic level in the Jennet-Bond scale. Conclusions. Dysautonomic crisis appeared early in young men after severe head injury. We didn't find a radiologic pattern that predisposes the dysautonomic crisis. They didn't interfere the recovering six months after head injury.	Hosp Reg Univ Carlos Haya, Unidad Cuidados Intens, Malaga, Spain		Fernandez-Ortega, JF (corresponding author), Mirador Candado,1, E-29018 Malaga, Spain.	patferon@eresmas.com		Fernandez Ortega, Juan F/0000-0003-2130-1331			Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; BHIGJEE AI, 1985, J NEUROL SCI, V71, P79; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Cuny E, 2003, NEUROCHIRURGIE, V49, P289; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; DARNELL RB, 1993, NEUROLOGY, V43, P579, DOI 10.1212/WNL.43.3_Part_1.579; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GOMEZTELLO V, 2000, MED INTENSIVA, V24, P307; JENNETT B, 1975, LANCET, V1, P480; KLUG N, 1984, ACTA NEUROCHIR, V72, P219, DOI 10.1007/BF01406872; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; ROVNE R N, 1962, Trans Am Neurol Assoc, V87, P232; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SALOMON GH, 1973, J PEDIAT CHILD HLTH, V83, P277; SILVER JK, 1994, ARCH PHYS MED REHAB, V75, P885, DOI 10.1016/0003-9993(94)90113-9	17	5	5	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	OCT 16	2004	39	8					715	718		10.33588/rn.3908.2004034			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	869HQ	WOS:000224974400004	15514897				2022-02-06	
J	Boviatsis, EJ; Korfias, S; Kouyialis, AT; Sakas, DE				Boviatsis, EJ; Korfias, S; Kouyialis, AT; Sakas, DE			Epidural haematoma after evacuation of contralateral subdural haematoma	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article								Background Sequentially evolving intracranial bilateral haematomas, where the second haematoma develops after the surgical removal of the first one is rarely reported. Aim To report a patient who developed an epidural haematoma after evacuation of a contralateral subdural haematoma. Methods A 49-year-old male was admitted to our department after head injury. A brain computerized tomography (CT) scan revealed an acute subdural haematoma in the right temporal area which was evacuated. During his stay in the intensive care unit, he was submitted to intracranial pressure monitoring, which soon rose. Results A new CT scan showed an acute epidural haematoma in the contralateral parietal area that was also evacuated. Conclusions While rising intracranial pressure after the evacuation of a traumatic haematoma is usually attributed to brain oedema or recurrent haematoma at the craniotomy site, the development of a contralateral epidural haematoma requiring surgical treatment should not be overlooked.	Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg, Athens, Greece		Boviatsis, EJ (corresponding author), Evangelismos Gen Hosp, Dept Neurosurg, 61 Ipsilantous St, Athens 11521, Greece.	eboviats@med.uoa.gr					BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Duffner F, 1993, Aktuelle Traumatol, V23, P345; MARMAROU A, 1991, J NEUROSURG S, V75, P59; POZZATI E, 1980, J TRAUMA, V20, P795, DOI 10.1097/00005373-198009000-00015; TEASDALE G, 1980, INTRACRANIAL PRESSUR, V4, P36	8	5	6	0	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	OCT-DEC	2004	173	4					217	218		10.1007/BF02914555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RD	WOS:000227298700010	16323618				2022-02-06	
J	Fritz, HG; Bauer, R				Fritz, HG; Bauer, R			Traumatic injury in the developing brain - effects of hypothermia	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	4th International Congress of Pathophysiology	JUN 29-JUL 05, 2002	BUDAPEST, HUNGARY			immature; traumatic brain injury; hypothermia; secondary damage; neuroprotection	FOCAL CEREBRAL-ISCHEMIA; ACUTE SUBDURAL-HEMATOMA; CLOSED-HEAD-INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; FLUID-PERCUSSION; HYPOXIA-ISCHEMIA; POSTTRAUMATIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; THERAPEUTIC HYPOTHERMIA	Little is known about the underlying mechanisms of head trauma in the developing brains, despite considerable social and economic impact following such injuries. Age has been shown to substantially influence morbidity and mortality. Children younger than 4 years of age had worse cognitive, motor, and brain atrophy outcomes than children 6 years of age and older. Younger children tend to more frequently suffer from diffuse cerebral swelling compared to adults. Typical autoptic findings also include axonal injury and ischemic neurodegeneration. These differences impact not only the primary response of the brain to injury but the secondary response as well. The complexity of damaging mechanisms in traumatic brain injury contributes to the problem of determining effective therapy. As an alternative/ adjunct to pharmacological approaches, hypothermia has been shown to be cerebroprotective in traumatized adult brains. Although a tame number of animal studies have shown protective effects of hypothermia in a variety of damaging mechanisms after TBI, little data exist for young, developing brains. The injury mechanisms of TBI in the immature. effects of hypothermia following resuscitation on adult and immature traumatized brains, and some possible mechanisms of action of hypothermia in the immature traumatized brain are discussed in this review. (C) 2004 Elsevier GmbH. All rights reserved.	Univ Jena, Univ Klinikum Jena, Dept Anesthesiol & Intens Care Med, D-07740 Jena, Germany; Univ Jena, Univ Klinikum Jena, Inst Pathophysiol & Pathobiochem, D-07740 Jena, Germany		Fritz, HG (corresponding author), Univ Jena, Univ Klinikum Jena, Dept Anesthesiol & Intens Care Med, D-07740 Jena, Germany.	harald.fritz@med.uni-jena.de					Adelson P D, 2000, Clin Neurosurg, V47, P319; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2003, CRIT CARE MED, V31, pS418, DOI 10.1097/00003246-200306006-00002; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Bauer R, 1997, EXP TOXICOL PATHOL, V49, P469, DOI 10.1016/S0940-2993(97)80139-X; Bauer R, 2000, CRIT CARE MED, V28, P1128, DOI 10.1097/00003246-200004000-00036; Berger R, 1998, DEV BRAIN RES, V105, P67, DOI 10.1016/S0165-3806(97)00165-X; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biagas Katherine V., 1998, Current Opinion in Pediatrics, V10, P271, DOI 10.1097/00008480-199806000-00009; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Blumberg RM, 1997, EXP BRAIN RES, V113, P130, DOI 10.1007/BF02454148; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Brambrink AM, 1999, EXP TOXICOL PATHOL, V51, P151, DOI 10.1016/S0940-2993(99)80089-X; BRAMBRINK AM, 2002, NOTFALL RETTUNGSMED, V5, P332; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHESNUT RM, 1997, YB INTENSIVE CARE EM, P749; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRAKE CG, 1964, J NEUROSURG, V21, P575, DOI 10.3171/jns.1964.21.7.0575; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; FAY T, 1959, J NEUROSURG, V16, P239, DOI 10.3171/jns.1959.16.3.0239; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Felberg RA, 2001, CIRCULATION, V104, P1799, DOI 10.1161/hc4001.097037; Felderhoff-Mueser Ursula, 2000, Current Opinion in Neurology, V13, P141, DOI 10.1097/00019052-200004000-00005; Fritz H, 1999, EXP TOXICOL PATHOL, V51, P163, DOI 10.1016/S0940-2993(99)80090-6; Fritz HG, 1999, ANESTHESIOLOGY, V91, pU242; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Garnier Y, 2001, J SOC GYNECOL INVEST, V8, P198, DOI 10.1016/S1071-5576(01)00119-8; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOPINATH SP, 1994, ANESTHESIA NEUROSURG, P661; Greenwald B M, 1995, Adv Pediatr, V42, P47; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; HAYASHI N, 2000, HATTATSU, V32, P122; HIRAMATSU T, 1995, J THORAC CARDIOV SUR, V109, P948, DOI 10.1016/S0022-5223(95)70321-7; Holzer M, 2002, NEW ENGL J MED, V346, P549; Inamasu J, 2002, CHILD NERV SYST, V18, P175, DOI 10.1007/s003810100506; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Kollmar R, 2002, ANESTHESIOLOGY, V97, P868, DOI 10.1097/00000542-200210000-00018; Kollmar R, 2002, STROKE, V33, P1899, DOI 10.1161/01.STR.0000019603.29818.9C; KOREN G, 1987, EUR J CLIN PHARMACOL, V32, P373, DOI 10.1007/BF00543972; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Kurth CD, 1997, CIRCULATION, V96, P358; Laptook AR, 1999, PEDIATR RES, V46, P383, DOI 10.1203/00006450-199910000-00005; LAPTOOK AR, 1994, PEDIATR RES, V35, P436, DOI 10.1203/00006450-199404000-00010; Laussen PC, 2002, PAEDIATR ANAESTH, V12, P199, DOI 10.1046/j.1460-9592.2002.00779.x; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; Okauchi M, 2002, J NEUROTRAUM, V19, P741, DOI 10.1089/08977150260139110; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Satas S, 1996, ACTA ANAESTH SCAND, V40, P452, DOI 10.1111/j.1399-6576.1996.tb04468.x; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Sirimanne ES, 1996, PEDIATR RES, V39, P591, DOI 10.1203/00006450-199604000-00005; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Statler KD, 2003, CRIT CARE MED, V31, P1134, DOI 10.1097/01.CCM.0000054864.43122.52; Su J, 2003, INT J DEV NEUROSCI, V21, P353, DOI 10.1016/S0736-5748(03)00070-4; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; TOWFIGHI J, 1994, ACTA NEUROPATHOL, V87, P598; Whalen MJ, 1997, ACT NEUR S, V70, P260; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X	118	5	5	0	0	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	OCT	2004	56	1-2					91	102		10.1016/j.etp.2004.04.001			12	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	872QF	WOS:000225221900012	15581280				2022-02-06	
J	Adamsbaum, C; Rolland, Y; Husson, B				Adamsbaum, C; Rolland, Y; Husson, B			Pediatric neuroimaging emergencies	JOURNAL OF NEURORADIOLOGY			French	Article						brain; pediatrics-MRI; pediatrics-emergency; pediatrics	HEAD TRAUMA; INTRACRANIAL INJURY; CHILDREN YOUNGER; PREDICTORS; INFANTS	The notion of emergency with regards to pediatric neuroimaging requires a strong knowledge of clinical indications. In children under 2 years of age, head trauma requires a CT scan in case of repeated or prolonged or rapidly increasing vomiting, focal signs, loss of consciousness, unusual behavior, seizures, clinical signs of skull fracture or polytrauma. The "shaken baby syndrome" is usually suspected in case of loss of consciousness or seizures before 8 months of age. The hematomas that are observed are subdural in location, diffuse and deeply located. Imaging is only mandatory for headache suggesting underlying space occupying lesion: permanent or increasing pain, nocturnal headache, headache during postural changes or efforts, associated to seizures or abnormal neurological examination. No imaging is indicated in case of first epileptic seizure associated to normal neurological examination and without any particular context. The presence of trauma, intracranial hypertension, persisting disturbances of consciousness or associated focal sign necessitates urgent neuroimaging. No imaging is indicated in case of typical febrile seizures, i.e. generalized, brief and occurring between I and 5 years of age. Spinal cord symptoms require immediate MRI evaluation. The most frequent tumor is neuroblastoma. In the absence of spinal tumor, brain abnormalities must be excluded (inflammatory disease). In neonates, CT scan or MRI must be readily performed in case of seizures or loss of consciousness to exclude ischemic, traumatic or infectious lesions.	Hop St Vincent de Paul, Serv Radiol, F-75674 Paris 14, France; Hop Kremlin Bicetre, Serv Radiol, Paris, France		Adamsbaum, C (corresponding author), Hop St Vincent de Paul, Serv Radiol, 82 Ave Denfert Rochereau, F-75674 Paris 14, France.	svp.radio@svp.ap-hop-paris.fr					Adamsbaum C, 1999, J RADIOL, V80, P819; Alehan FK, 2002, J CHILD NEUROL, V17, P807, DOI 10.1177/08830738020170110901; BARKOVICH AJ, 1995, PEDIAT NEUROIMAGING, P167; BARLOW CF, 1984, HEADACHES MIGRAINE C; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Berg AT, 2000, PEDIATRICS, V106, P527, DOI 10.1542/peds.106.3.527; Carty H, 1997, EUR RADIOL, V7, P1365, DOI 10.1007/s003300050303; CHATEIL JF, 1995, ANN PEDIATR-PARIS, V42, P384; Chateil JF, 1999, J RADIOL, V80, P553; Girard N, 2003, J RADIOL, V84, P547; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HARWOODNASH DC, 1992, AM J NEURORADIOL, V13, P569; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Maytal J, 2000, EPILEPSIA, V41, P950, DOI 10.1111/j.1528-1157.2000.tb00277.x; Medina LS, 1997, RADIOLOGY, V202, P819, DOI 10.1148/radiology.202.3.9051039; Medina LS, 2003, NEUROIMAG CLIN N AM, V13, P225, DOI 10.1016/S1052-5149(03)00026-1; MOULIN F, 2002, CHECK LIST IMAGERIE; QUAYLE K, 1997, PEDIATRICS, V99, P1; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983	22	5	6	0	1	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	SEP	2004	31	4					272	280		10.1016/S0150-9861(04)97006-X			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	860KF	WOS:000224341800005	15545939				2022-02-06	
J	Murdoch, BE; Goozee, JV; Veidt, M; Scott, DH; Meyers, IA				Murdoch, BE; Goozee, JV; Veidt, M; Scott, DH; Meyers, IA			Introducing the pressure-sensing palatograph - the next frontier in electropalatography	CLINICAL LINGUISTICS & PHONETICS			English	Article						dynamic lingual pressure; instrumentation; electropalatography	TRAUMATIC BRAIN-INJURY; DYSARTHRIA; SPEAKERS; SPEECH; FORCE	Primary Objective. To extend the capabilities of current electropalatography (EPG) systems by developing a pressure-sensing EPG system. An initial trial of a prototype pressure-sensing palate will be presented. Research Design. The processes involved in designing the pressure sensors are outlined, with Hall effect transistors being selected. These units are compact, offer high sensitivity and are inexpensive. An initial prototype acrylic palate was constructed with five embedded pressure sensors. Syllable repetitions were recorded from one adult female. Main Outcomes, Results and Future Directions. The pressure-sensing palate was capable of recording dynamic tongue-to-palate pressures, with minimal to no interference to speech detected perceptually. With a restricted number of sensors, problems were encountered in optimally positioning the sensors to detect the consonant lingual pressures. Further developments are planned for various aspects of the pressure-sensing system. Conclusions. Although only in the prototype stage, the pressure-sensing palate represents the new generation of EPG. Comprehensive analysis of tongue-to-palate contacts, including pressure measures, is expected to enable more specific and effective therapeutic techniques to be developed for a variety of speech disorders.	Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Engn, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Dent, Brisbane, Qld 4072, Australia		Murdoch, BE (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	b.murdoch@uq.edu.au	Murdoch, Bruce E/C-1397-2012	Veidt, Martin/0000-0002-7302-9838			BARRY RM, 1993, CLIN LINGUIST PHONET, V7, P275, DOI 10.1080/02699209308985567; BROWN WS, 1969, J ACOUST SOC AM, V46, P96, DOI 10.1121/1.1973715; BROWN WS, 1973, J SPEECH HEAR RES, V16, P141, DOI 10.1044/jshr.1601.141; Byrd D, 1996, J PHONETICS, V24, P209, DOI 10.1006/jpho.1996.0012; FLETCHER SG, 1989, J SPEECH HEAR RES, V32, P736, DOI 10.1044/jshr.3204.736; GARDINER F, 2001, INT J NEUROSCI, V108, P248; GILBER J, 2003, LINEAR HALL EFFECT S; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HARTELIUS L, 2001, SPEECH MOTOR CONTROL, P192; LEEPER HA, 1971, J ACOUST SOC AM, V51, P1291; MALECOT A, 1966, PHONETICA, V14, P169, DOI 10.1159/000258526; MCAAULIFFE M, 2003, THESIS U QUEENSLAND; McGlone R E, 1972, Cleft Palate J, V9, P229; MCGLONE RE, 1967, PHONETICA, V17, P178, DOI 10.1159/000258586; MCGLONE RE, 1967, J SPEECH HEAR RES, V10, P606, DOI 10.1044/jshr.1003.606; MCNEIL MR, 1990, J SPEECH HEAR RES, V33, P255, DOI 10.1044/jshr.3302.255; MULLER R, 2002, TELEMETRIC PRESSURE; *NAT I STAND TECHN, 2003, HALL EFF; PROFFIT WR, 1975, PHONETICA, V32, P200, DOI 10.1159/000259699; PROFFIT WR, 1965, FOLIA PHONIATR, V17, P115, DOI 10.1159/000263033; Putley E H, 1960, HALL EFFECT RELATED; RHODE AH, 2002, DESIGN DEV MINIATURE; RHODE AH, 2002, P 9 AUSTR INT C SPEE; SONIES BC, 2001, DYSPH RES SOC ANN M; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; Wakumoto M., 1999, J ACOUST SOC AM, V105, P1355; Yokoyama M., 2001, DYSPH RES SOC ANN M; [No title captured]	31	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9206			CLIN LINGUIST PHONET	Clin. Linguist. Phon.	SEP-DEC	2004	18	6-8					433	445		10.1080/02699200410001703628			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	871BV	WOS:000225105200007	15573482				2022-02-06	
J	Dubois-Dauphin, M; Eder-Colli, L; Vallet, P; Stutz, A; Nef, S; Vassalli, ED				Dubois-Dauphin, M; Eder-Colli, L; Vallet, P; Stutz, A; Nef, S; Vassalli, ED			Induction of enhanced green fluorescent protein expression in response to lesions in the nervous system	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						transgenic mouse; hCMV/beta-actin promoter; stroke; axotomy; motoneurons; neurodegeneration; t-PA; 3 ' UTR	TISSUE-PLASMINOGEN-ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY PROMOTER; LONG-TERM POTENTIATION; TRAUMATIC BRAIN-INJURY; ACTIN MESSENGER-RNA; TRANSGENIC MICE; CELL-DEATH; MEIOTIC MATURATION	We have generated a mouse strain carrying a transgene driven by a strong and ubiquitous promoter (human cytomegalovirus hCMV/beta-actin) and containing an enhanced green fluorescent protein (eGFP) coding sequence upstream of the 3' untranslated region (3'UTR) of tissue-type plasminogen activator (t-PA) mRNA. The 3'UTR of t-PA mRNA is known to be involved in the reversible deadenylation and translational repression of transcripts in mouse oocytes. hCMV/beta-actin-eGFP-3'UTR t-PA transgenic mice express eGFP mRNA in all brain structures analyzed but lack eGFP fluorescence, with the exception of blood vessels, choroid plexus, and Purkinje cells. Taking advantage of these features, we tested whether certain pathological conditions, in particular injuries of the nervous system, might trigger eGFP fluorescence in traumatized cells or neurons. From this perspective, we analyzed eGFP mRNA expression and eGFP fluorescence in experimental models of nervous system lesions, such as motoneuron axotomy and cerebral stroke induced by middle cerebral artery occlusion. We found an increase in eGFP fluorescence in specific brain areas in cells suffering or reacting to these injuries. This increased fluorescence is correlated with an increased transcription of eGFP in lesioned cells, presumably enhanced by a release of the translational silencing mediated by the 3'UTR region of the t-PA mRNA. This transgenic mouse model may prove useful to study the development of neurodegenerative lesions. (C) 2004 Wiley-Liss, Inc.	Univ Hosp Geneva, Lab Biol Aging, Dept Geriatr, CH-1225 Geneva, Switzerland; Univ Geneva, Sch Med, Dept Pharmacol, CH-1211 Geneva, Switzerland; Ghent Univ Hosp, Dept Psychiat, CH-1225 Geneva, Switzerland; Univ Geneva, Sch Med, Dept Morphol, CH-1211 Geneva, Switzerland		Dubois-Dauphin, M (corresponding author), Univ Hosp Geneva, Lab Biol Aging, Dept Geriatr, 2,Chemin Petit Bel Air, CH-1225 Geneva, Switzerland.	michel.dubois-dauphin@medecine.unige.ch	Nef, Serge/AAV-6445-2020	Nef, Serge/0000-0001-5462-0676			Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; ASANUMA M, 1993, BRAIN RES, V600, P243, DOI 10.1016/0006-8993(93)91379-7; ASHWELL KW, 1982, J ANAT, V135, P531; CARROLL PM, 1994, DEVELOPMENT, V120, P3173; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; de Bilbao F, 2000, EUR J NEUROSCI, V12, P921, DOI 10.1046/j.1460-9568.2000.00984.x; DeBilbao F, 1996, NEUROSCIENCE, V71, P1111, DOI 10.1016/0306-4522(95)00505-6; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Fritschy JM, 1996, J NEUROSCI, V16, P2275; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GREFTE A, 1993, J INFECT DIS, V167, P270, DOI 10.1093/infdis/167.2.270; Guarin E, 1999, NEUROSCIENCE, V90, P653, DOI 10.1016/S0306-4522(98)00445-X; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; Hata R, 2000, J CEREBR BLOOD F MET, V20, P937, DOI 10.1097/00004647-200006000-00006; Hermann DM, 2001, NEUROSCIENCE, V104, P947, DOI 10.1016/S0306-4522(01)00125-7; Honkaniemi J, 1997, J CEREBR BLOOD F MET, V17, P636; HUARTE J, 1985, CELL, V43, P551, DOI 10.1016/0092-8674(85)90184-9; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Jin KL, 2001, J MOL NEUROSCI, V16, P49, DOI 10.1385/JMN:16:1:49; KOMIYAMA M, 1984, BRAIN BEHAV EVOLUT, V24, P144, DOI 10.1159/000121312; KONDO Y, 1994, RES COMMUN MOL PATH, V86, P139; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; KUMAR K, 1995, MOL BRAIN RES, V30, P149, DOI 10.1016/0169-328X(94)00286-N; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Madani R, 2003, TRENDS MOL MED, V9, P183, DOI 10.1016/S1471-4914(03)00050-9; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Nef S, 1996, MECH DEVELOP, V55, P65, DOI 10.1016/0925-4773(95)00491-2; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pawlak R, 2002, J CLIN INVEST, V109, P1529, DOI 10.1172/JCI200215961; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pfister Y, 2003, BRAIN RES, V966, P26, DOI 10.1016/S0006-8993(02)04147-1; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; RIDEG K, 1994, DIFFERENTIATION, V56, P119, DOI 10.1007/s002580050028; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Salles FJ, 1999, METH MOL B, V118, P441; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; SAPPINO AP, 1991, J CLIN INVEST, V87, P962, DOI 10.1172/JCI115104; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; SINZGER C, 1995, J GEN VIROL, V76, P741, DOI 10.1099/0022-1317-76-4-741; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Strickland S, 2001, THROMB HAEMOSTASIS, V86, P138; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Tanaka K, 2000, NEUROSCIENCE, V100, P345, DOI 10.1016/S0306-4522(00)00289-X; Tanaka K, 1999, BRAIN RES, V818, P520, DOI 10.1016/S0006-8993(98)01263-3; TETZLAFF W, 1988, J NEUROSCI, V8, P3181; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; Yuguchi T, 1997, NEUROREPORT, V8, P419, DOI 10.1097/00001756-199701200-00008; Zilles Karl, 1995, P649	56	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	JUN 14	2004	474	1					108	122		10.1002/cne.20122			15	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	825HW	WOS:000221748100007	15156581				2022-02-06	
J	Martin, JE; Mehta, R; Aarabi, B; Ecklund, JE; Martin, AH; Ling, GSF				Martin, JE; Mehta, R; Aarabi, B; Ecklund, JE; Martin, AH; Ling, GSF			Intracranial insertion of a nasopharyngeal airway in a patient with craniofacial trauma	MILITARY MEDICINE			English	Article							BASILAR SKULL FRACTURE; NASOGASTRIC TUBE; COMPLICATION	Intracranial insertion of a nasopharyngeal airway is an unusual and catastrophic complication of airway management in the patient with a severe closed head injury. We present an unfortunate 43-year-old patient with intracranial insertion of a nasopharyngeal airway during trauma resuscitation. The nasopharyngeal airway was removed. Attempts to resuscitate the patient were continued, but were eventually unsuccessful. Blind nasopharyngeal airway insertion may result in iatrogenic injury when used in the head-injured patient. Oropharyngeal airways may be used to assist with ventilation. However, it is preferable to definitively secure the airway through inline endotracheal intubation or with surgical techniques in this patient population. Should violation of the skull base occur, removal is accomplished in the controlled environment of the operating room.	Walter Reed Army Med Ctr, Natl Capitol Consortium Neurosurg, Washington, DC 20307 USA; Univ Maryland, Med Syst, Dept Neurol Surg, Baltimore, MD 21201 USA; Malcolm Grow Med Ctr, Dept Radiol, Andrews AFB, MD 20762 USA		Martin, JE (corresponding author), Tripler Army Med Ctr, Honolulu, HI 96859 USA.			Martin, Jonathan/0000-0003-3180-2084			*AM COLL SURG, 1993, ADV TRAUM LIF SUPP P, P69; Baskaya MK, 1999, SURG NEUROL, V52, P426, DOI 10.1016/S0090-3019(99)00077-4; FLETCHER SA, 1987, J TRAUMA, V27, P948, DOI 10.1097/00005373-198708000-00017; FREMSTAD JD, 1978, J TRAUMA, V18, P820, DOI 10.1097/00005373-197812000-00009; HANDE A, 1991, British Journal of Neurosurgery, V5, P205, DOI 10.3109/02688699108998469; HASTINGS D, 2000, BASIC TRAUMA LIFE SU, P284; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MUZZI DA, 1991, ANESTHESIOLOGY, V74, P366, DOI 10.1097/00000542-199102000-00026; Sacks A D, 1993, Ear Nose Throat J, V72, P800; SEEBACHER J, 1975, ANESTHESIOLOGY, V42, P100, DOI 10.1097/00000542-197501000-00016; VANDENANKER JN, 1992, PEDIATR RADIOL, V22, P545, DOI 10.1007/BF02013011	11	5	5	0	0	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JUN	2004	169	6					496	497		10.7205/MILMED.169.6.496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	019IX	WOS:000235829900017	15281683	Bronze			2022-02-06	
J	Murrey, GJ; Starzinski, D				Murrey, GJ; Starzinski, D			An inpatient neurobehavioural rehabilitation programme for persons with traumatic brain injury: overview of and outcome data for the Minnesota Neurorehabilitation Hospital	BRAIN INJURY			English	Article							DISABILITY; WORK	Objectives: To review the specialized neurorehabilitation programme at the Minnesota Neurorehabilitation Hospital and evaluate such a programme on persons with TBI and severe neurobehavioural disorders. Participants: Forty-four persons with TBI 3-years post-discharge from the programme. Outcome measures: Review of post-discharge status in regard to behavioural stabilization (frequency, intensity and severity of individual target behaviours), frequency and length of stay of psychiatric hospital readmission, stability of community placement and vocational status. Results: Ninety-seven per cent of patients target behaviours did not increase at the 3-year post-discharge follow-up; only 11% of patients had multiple post-discharge psychiatric admissions with 69% of those patients returning to initial community placement; 50% were employed at least part time. Conclusions: Persons with TBI and severe neurobehavioural disorders demonstrated significant improvement on the outcome measures especially when considering patients pre-admission histories. Also, the majority of patients maintained these gains at 3-year post-discharge follow-up. Further study is certainly needed and welcomed determining specific, cost-effective treatments and services that can benefit persons with TBI and associated neurobehavioural disorders.	Minnesota Neurorehabil Hosp, Brainerd, MN 56401 USA		Murrey, GJ (corresponding author), Minnesota Neurorehabil Hosp, Brainerd, MN 56401 USA.	gregory.murrey@state.mn.us					Buffington ALH, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199710000-00002; DIGRE PG, 1994, J HEAD TRAUMA REHAB, V9, P12; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Jacobs HE, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199710000-00003; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; *MN DEP HLTH, 2001, MINN INJ PREV RES GU; Murrey G. J., 2001, J THERAPTUTIC HORTIC, V12, P4; Murrey GJ, 1998, J HEAD TRAUMA REHAB, V13, P72, DOI 10.1097/00001199-199812000-00008; MURREY GJ, IN PRESS ART THERAPY; MURREY GJ, IN PRESS RECREATIONA; Papero PH, 1997, J HEAD TRAUMA REHAB, V12, P51, DOI 10.1097/00001199-199706000-00006; Prigatano G., 1999, PRINCIPLES NEUROPSYC, P265; PRIGATANO G, 1999, PRINCIPLES NEUROPSYC, P89; PRIGATANO GP, 1999, PRINCIPLES NEUROPSYC, P117; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	25	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2004	18	6					519	531		10.1080/02699050310001646125			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	811DX	WOS:000220753700001	15204334				2022-02-06	
J	Wolf, S; Krammer, M; Trost, HA; Lumenta, CB				Wolf, S; Krammer, M; Trost, HA; Lumenta, CB			Lipofundin((R))-induced intracranial pressure rise after severe traumatic brain injury - A case report	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						traumatic brain injury; parenteral nutrition; lipid emulsion; multimodal monitoring	SEVERE HEAD-INJURY; NUTRITIONAL SUPPORT	Early nutrition is a recognized component of neurosurgical intensive care treatment. The authors present the case of a patient suffering from severe traumatic brain injury who responded with reproducible intracranial pressure (ICP) crisis to infusion of Lipofundin(R), a fatty soybean oil-based emulsion for parenteral nutrition. During the described ICP rise, the patient remained hemodynamically stable, therefore an anaphylactic reaction seems to be unlikely. An increase of brain tissue oxygenation parallel to the ICP rise in this case is suggestive for increased cerebral blood flow as a cause of ICP elevation after application of Lipofundin(R). Without multimodal monitoring and data storage, the described side effect of Lipofundin(R) in our patient would have been difficult to identify.	Tech Univ Munich, Acad Hosp Munich Bogenhausen, Dept Neurosurg, D-8000 Munich, Germany		Wolf, S (corresponding author), Stadt Krankenhaus Munchen Bogenhausen, Abt Neurochirurg, Englschalkinger Str 82, D-81925 Munich, Germany.	stefanwolf@operamail.com					Andersen H L, 1993, Ugeskr Laeger, V155, P2210; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Marshall LF, 1991, J NEUROSURG S, V75, P14; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; PHILLIPS G, 1998, INTENSIVE CARE MANUA, P724; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Senftleben U, 2000, ANAESTHESIST, V49, P340, DOI 10.1007/s001010050839; Takanashi Y, 2001, No To Shinkei, V53, P61; YANAGAWA T, 2000, NUTR SUPPORT HEAD IN; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	13	5	5	0	0	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.	MAY	2004	65	2					81	83					3	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	816ZU	WOS:000221148600006	15118922				2022-02-06	
J	Anderson, MC; Lais, RL				Anderson, MC; Lais, RL			Excision of heterotopic ossification of the popliteal space following traumatic brain injury	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						heterotopic ossification; knee; popliteal; traumatic brain injury	PERIARTICULAR OSSIFICATION; HEAD TRAUMA; KNEE; RESECTION; ADULTS	The occurrence of heterotopic ossification (HO) in traumatic brain injury (TBI) patients has been well described. A 20-year-old male with a fixed knee flexion contracture of 45degrees underwent side excision of heterotopic bone from the popliteal region 17 weeks following a TBI. This case is presented not only for being unique in the location of HO requiring excision but also to emphasize the importance of the awareness of the potential for HO formation in the TBI patient.	Univ Kansas, Sch Med, Dept Surg, Sect Orthopaed, Wichita, KS 67214 USA		Anderson, MC (corresponding author), Dept Orthopaed, Via Christi Reg Med Ctr,St Francais Campus,929 N, Wichita, KS 67214 USA.						Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Garland DE, 2000, J BONE JOINT SURG AM, V82A, P1206, DOI 10.2106/00004623-200008000-00046; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; Ippolito E, 1999, J BONE JOINT SURG AM, V81A, P783, DOI 10.2106/00004623-199906000-00005; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; Patton WC, 2000, AM J SPORT MED, V28, P398, DOI 10.1177/03635465000280032001	10	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2004	18	3					190	192		10.1097/00005131-200403000-00013			3	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	801LX	WOS:000220098500012	15091277				2022-02-06	
J	Kurosu, A; Fujii, T; Ono, G				Kurosu, A; Fujii, T; Ono, G			Post-traumatic leptomeningeal cyst mimicking a skull tumour in an adult	BRITISH JOURNAL OF NEUROSURGERY			English	Article						adult; head trauma; leptomeningeal cyst; skull tumour	FRACTURE	A 53-year-old female presented with a post-traumatic leptomeningeal cyst manifesting as bulging of the scalp, dizziness and tinnitus. She had known of the bulging of her forehead for about 20 years. She had suffered an injury to the head in childhood. Brain CT revealed a bone cyst associated with a round bone defect in the left frontal bone, bulging of the very thin outer layer and the defective inner layer. She was treated surgically with a diagnosis of skull tumour, but only gray cystic membranous tissue was found. The dural defect was repaired with fascia and the bone defect with bone cement. Bulging of the skull in adults can be caused by a bone cyst originating from a skull fracture.	Urayasu Ichikawa Municipal Hosp, Dept Neurosurg, Chiba, Japan		Kurosu, A (corresponding author), Misato Junshin Gen Hosp, Dept Neurosurg, 745 Kobo, Misato, Saitama 3410026, Japan.	df8a-krs@asahi-net.or.jp					Britz GW, 1998, SURG NEUROL, V50, P465, DOI 10.1016/S0090-3019(97)00233-4; Cohen JE, 1998, J TRAUMA, V44, P928, DOI 10.1097/00005373-199805000-00035; DALMEIDA ACG, 1981, J NEUROSURG, V54, P84, DOI 10.3171/jns.1981.54.1.0084; IPLIKCIOGLU AC, 1990, NEUROSURGERY, V27, P1027; KOCANAOGULLARI O, 1984, CLIN NEUROL NEUROSUR, V86, P299, DOI 10.1016/0303-8467(84)90293-2; KURLAY M, 1998, NEUROSURGERY, V43, P72; Patil AA, 1996, J NEUROSURG, V84, P284, DOI 10.3171/jns.1996.84.2.0284; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; Weinberg JS, 1999, ACTA NEUROCHIR, V141, P545, DOI 10.1007/s007010050340	9	5	6	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2004	18	1					62	64		10.1080/02688690410001660463			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	778TK	WOS:000189256700009	15040717				2022-02-06	
S	McCracken, P; Manduca, A; Felmlee, JP; Ehman, RL		Barillot, C; Haynor, DR; Hellier, P		McCracken, P; Manduca, A; Felmlee, JP; Ehman, RL			Transient MR elastography: Modeling traumatic brain injury	MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION - MICCAI 2004, PT 2, PROCEEDINGS	Lecture Notes in Computer Science		English	Article; Proceedings Paper	7th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI 2004)	SEP 26-29, 2004	St Malo, FRANCE	IRISA, CNRS, Univ Rennes			HEAD	Current theory holds that the mechanisms by which head trauma causes hemorrhage, cerebral contusions and diffuse axonal injury result from angular acceleration and its resulting shear motion. We have developed a method for phase contrast MR imaging of small amplitude transient shear displacements as they traverse through the brain in vivo. This technique was successfully implemented and preliminary results suggest that it has promise as a tool for studying the underlying biomechanics of brain trauma and for detailed analysis of injury mechanism models.	Mayo Clin & Mayo Fdn, MRI Res Lab, Rochester, MN 55905 USA		McCracken, P (corresponding author), Mayo Clin & Mayo Fdn, MRI Res Lab, Rochester, MN 55905 USA.	mccracken.paul@mayo.edu					Holbourn AHS, 1943, LANCET, V2, P438; MCCRACKEN PJ, P ISMRM2002; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Sosin DM, 1996, BRAIN INJURY, V10, P47	5	5	5	0	3	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0302-9743	1611-3349	3-540-22977-9	LECT NOTES COMPUT SC			2004	3217		2				1081	1082					2	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	BAZ67	WOS:000224322400146					2022-02-06	
J	Shah, S; Muncer, SJ				Shah, S; Muncer, SJ			A comparison of rehabilitation outcome measures for traumatic brain injury	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						traumatic brain injury; functional outcome; outcome measures	BARTHEL INDEX; STROKE REHABILITATION; FUNCTIONAL ASSESSMENT; HEAD-INJURY; DISABILITY; SCALE	This study evaluates the appropriateness, responsiveness, and predictive ability of the Modified Barthel Index (MBI), the Disability Rating Scale (DRS), the Barry Rehabilitation In-patient Screening of Cognition (BRISC), and the Glasgow Coma Scale (GCS) for 78 patients with traumatic brain injury referred for in-patient rehabilitation. Appropriateness leas evaluated by examining means, standard deviations, coefficients of variation, and ceiling and floor effects. Responsiveness was determined by examining paired t-test results for admission and discharge scores, and oil the basis of all effect size calculation. Predictive power was evaluated by performing two stepwise regressions with length of rehabilitation and total length of hospital stay. The results suggest that although the DRS and GCS have some advantages, notably in low ceiling and floor effects, overall the MBI is the most effective measure, particularly for prediction, with a moderate coefficient of determination (r(2) = 0.42) and no significant differences between predicted and real length of hospital stay.	Univ Tennessee, Coll Allied Hlth Sci, Memphis, TN 38163 USA; Univ Durham, Stockton On Tees, England		Shah, S (corresponding author), Univ Tennessee, Coll Allied Hlth Sci, Memphis, TN 38163 USA.						BARRY P, 1989, ARCH PHYS MED REHAB, V70, P902; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Colombo M, 2001, ARCH GERONTOL GERIAT, P99; DAWSONSAUNDES B, 1994, BASIC CLIN BIOSTATIS, P42; FISHER AG, 1993, AM J OCCUP THER, V47, P199, DOI 10.5014/ajot.47.3.199; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; HOGAN K, 2000, BRIT J THERAPY REHAB, V7, P163; Holmes WC, 1997, QUAL LIFE RES, V6, P561, DOI 10.1023/A:1018464200708; Kucukdeveci AA, 2000, SCAND J REHABIL MED, V32, P87; Licht MH, 1998, READING UNDERSTANDIN, P19; McNeil JE, 1999, NEUROPSYCHOL REHABIL, V9, P321, DOI 10.1080/096020199389400; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Novak S., 1996, CLIN REHABILITATION, V10, P128; Pentland B, 1999, CLIN REHABIL, V13, P498, DOI 10.1191/026921599676188597; RADOMSKI MV, 2002, OCCUPATIONAL THERAPY, P885; SHAH S, 1990, STROKE, V21, P241, DOI 10.1161/01.STR.21.2.241; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Shah S, 1992, Aust Occup Ther J, V39, P5, DOI 10.1111/j.1440-1630.1992.tb01729.x; SHAH S, 2000, BRIT J OCCUPATIONAL, V63, P469; SHAH S, 2000, CLIN REHABIL, V14, P386; SHAH S, 1998, COMPENDIUM QUALITY 2, P1; Turner-Stokes L, 1999, CLIN REHABIL, V13, P273, DOI 10.1191/026921599670005973; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; WILSON JTL, 1993, J NEUROL NEUROSUR PS, V56, P198; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	31	5	5	0	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	1539-4492			OTJR-OCCUP PARTICI H	OTJR-Occup. Particip. Health	WIN	2003	23	1					2	9		10.1177/153944920302300101			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	636JK	WOS:000180451200001					2022-02-06	
J	Borgaro, SR; Prigatano, GP; Alcott, S; Kwasnica, C; Cutter, N				Borgaro, SR; Prigatano, GP; Alcott, S; Kwasnica, C; Cutter, N			The Patient Distress Scale questionnaire: factor structure and internal consistency	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; CLOSED-HEAD-INJURY; BEHAVIORAL LIMITATIONS; IMPAIRED AWARENESS; DEFICITS; ANOSOGNOSIA; DYSFUNCTION	Primary objective: This study examined the factor structure and internal consistency of the Patient Distress Scale (PDS). The PDS is an 11-item questionnaire that was developed to assess acute neurological patients' awareness of emotional disturbances during early rehabilitation. Research design: A retrospective cohort of patients seen for inpatient rehabilitation following brain injury. Procedures: The PDS was administered to patients and family members upon admission to the neurorehabilitation unit as part of their neuropsychological evaluation. Outcomes and results: Subjects were heterogeneous sample of acute neurological inpatients (n = 84) and their relatives (n = 64). A principle components factor analysis with varimax rotation yielded a three factor solution, which together accounted for 62% of the variance. The factor solution provided partial support for the initial structure of the PDS. Analyses revealed relatively strong reliability coefficients for patients (r = 0.82) and relatives (r = 0.86) on the PDS total score. Acceptable reliability coefficients were also found for patients and relatives on each of the factor scores. Conclusions: Preliminary findings support the utility of the PDS as a measure of awareness in acute neurological patients.	St Josephs Hosp, Sect Neuropsychol, Div Neurol, Barrow Neurol Inst,Dept Clin Neuropsychol, Phoenix, AZ 85013 USA		Borgaro, SR (corresponding author), St Josephs Hosp, Sect Neuropsychol, Div Neurol, Barrow Neurol Inst,Dept Clin Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	sborgar@chw.edu					Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; BAER DM, 1983, NEUROLOGICAL REV, V40, P195; BORGARO SR, 2001, BNI Q, V17, P14; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GAINOTTI G, 1975, PSYCHIAT CLIN, V8, P99, DOI 10.1159/000283622; GANS JS, 1983, ARCH PHYSICAL MED RE, V64, P67; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLEY W, 1981, J NEUROL NEUROSUR PS, V46, P527; Najenson T, 1980, Int Rehabil Med, V2, P17; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Prigatano GP, 1996, NEUROPSYCHOL REHABIL, V6, P305, DOI 10.1080/713755515; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; RUFF RM, 1987, SAN DIEGO NEUROPSYCH; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; STARKSTEIN SE, 1993, NEUROPSY NEUROPSY BE, V6, P43; [No title captured]	34	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2003	17	7					545	551		10.1080/0269905031000070206			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	690HG	WOS:000183541900001	12775267				2022-02-06	
J	Cosnard, G; Duprez, T; Morcos, L; Grandin, C				Cosnard, G; Duprez, T; Morcos, L; Grandin, C			MRI of closed head injury	JOURNAL OF NEURORADIOLOGY			French	Article						head trauma; MR imaging; hematoma; subarachnoid hemorrhage; contusion; axonal injury	TRAUMATIC BRAIN INJURY; CHRONIC SUBDURAL-HEMATOMA; DIFFUSE AXONAL INJURY; IMAGING FINDINGS; SUBARACHNOID HEMORRHAGE; SUBSEQUENT DEVELOPMENT; SPATIAL-DISTRIBUTION; CORPUS-CALLOSUM; STEM LESIONS; PROGNOSIS	The superiority of MR imaging to demonstrate the presence of intra- or extra-axial hemorrhage or edematous lesions, including axonal injuries, following closed head trauma has been proven over the last 15 years. CT remains the initial imaging modality in the evaluation of these patients because it is easier to obtain and allows detection of lesions requiring immediate surgical management. However, MRI should replace CT in patients with moderate to mild trauma in order to better precise the extent and degree of injuries, especially in a context of litigation. MRI could also be used following CT to further assess patients following severe trauma for prognosis purposes and better classification of traumatic injuries as well as therapeutic management.	Clin Univ St Luc Univ Catholic Louvain, Dept Radiol, B-1200 Brussels, Belgium		Cosnard, G (corresponding author), Clin Univ St Luc Univ Catholic Louvain, Dept Radiol, Ave Hippocrate 10, B-1200 Brussels, Belgium.	cosnard@rdgn.ucl.ac.be		Duprez, Thierry/0000-0002-1579-0100			Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Ashikaga Ryuichiro, 1996, Nippon Acta Radiologica, V56, P1045; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GENTRY RL, 1989, AJNR, V9, P1129; Gerring J, 2000, BRAIN INJURY, V14, P205; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hoelper BM, 2000, ACT NEUR S, V76, P265; Kaminogo M, 1999, NEURORADIOLOGY, V41, P109, DOI 10.1007/s002340050714; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Kawamata T, 2002, ACTA NEUROCHIR SUPPL, V81, P281; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KUSHI H, 1994, ACTA NEUROCHIR, P472; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Marmarou A, 2000, ACT NEUR S, V76, P349; Mitchell P, 2001, J NEUROL NEUROSUR PS, V70, P205, DOI 10.1136/jnnp.70.2.205; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; ORRISON WW, 1996, AJNR, V17, P507; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Saeki N, 1998, BRIT J NEUROSURG, V12, P151, DOI 10.1080/02688699845302; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Sripairojkul Boonlert, 1998, Journal of the Medical Association of Thailand, V81, P153; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Tanikawa M, 2001, ACTA NEUROCHIR, V143, P613, DOI 10.1007/s007010170067; Tokutomi T, 1997, ACT NEUR S, V70, P80; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Wakamoto H, 1998, NEUROL SURG TOKYO, V26, P985; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842	39	5	5	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	JUN	2003	30	3					146	157					12	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	698NC	WOS:000184004800002	12843871				2022-02-06	
J	Di, X; Alves, OL; Bullock, R				Di, X; Alves, OL; Bullock, R			Cytotoxic edema is independent of NMDA ion channel activation following middle cerebral artery occlusion (MCAO). An in vivo autoradiographic and MRI study	NEUROLOGICAL RESEARCH			English	Article						stroke; MCA occlusion; NMDA ion channel activation; MK801; cerebral edema; autoradiography	ACUTE SUBDURAL-HEMATOMA; TRAUMATIC BRAIN INJURY; RAT-BRAIN; ISCHEMIC DAMAGE; EXPERIMENTAL STROKE; HYPERGLYCEMIC RATS; SPINAL-CORD; BINDING; ANTAGONIST; NEUROPROTECTION	Massive glutamate release is an important factor leading to ionic imbalance after occlusive stroke, which in turn contributes to cytotoxic edema formation. Currently, measurements of cytotoxic edema using 'diffusion weighted' MRI, is being used in human stroke studies, as a 'surrogate' end point for neuroprotective drug trials, including studies with glutamate antagonists. However, it is not fully understood to what extent glutamate-mediated N-methyl-D-aspartate (NMDA) receptor activation is related to 'cytotoxic' edema formation, and thus, to what degree apparent diffusion coefficient (ADC) changes, assessed by magnetic resonance imaging with 'ACD mapping', represent NMDA receptor activation. To study this relationship, four cats underwent permanent middle cerebral artery occlusion (MCAO). Edema formation was investigated using MRI with 'ACD mapping', while NMDA receptor activation was simultaneously detected in the same animals, using radio labeled (125)lodoMK-801, which binds only in activated and open NMDA channels. At 5 h post-occlusion, a large area of edema could be found with significantly lower ADC values in the core and penumbral area of the ischemic lesion when compared to contralateral values. On corresponding sections of the feline brains, increased I-125-MK-801 binding was found in the infarct penumbra. However, there was no significant topographical correlation between ADC values and measured radioactivity. The results indicate that there is not a significant linkage between NMDA receptor activation and 'cytotoxic' edema following permanent MCAO. The detection of a large area of NMDA channel activation within regions of low ADC does however indicate an area of 'penumbral' ischemia susceptible to treatment with NMDA channel blockers.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Bullock, R (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980631,1200 E Broad St, Richmond, VA 23298 USA.	robulloc@hsc.vcu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		BOWERY NG, 1988, BRIT J PHARMACOL, V93, P944, DOI 10.1111/j.1476-5381.1988.tb11484.x; BULLOCK R, 1990, ACT NEUR S, V51, P286; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BULLOCK R, 1990, STROKE, V21, P32; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; COLLINS RC, 1989, ANN INTERN MED, V110, P992, DOI 10.7326/0003-4819-110-12-992; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; Di X, 1997, STROKE, V28, P2244, DOI 10.1161/01.STR.28.11.2244; Di X, 1996, J NEUROSURG, V85, P655, DOI 10.3171/jns.1996.85.4.0655; Di X, 1996, RESTOR NEUROL NEUROS, V9, P231, DOI 10.3233/RNN-1996-9406; FUJISAWA H, 1994, ACT NEUR S, V60, P193; HELPERN JA, 1995, MAGN RESON IMAGING, V13, P1227, DOI 10.1016/0730-725X(95)02036-S; Huang NC, 1996, EXP BRAIN RES, V109, P33; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kim SG, 1997, MAGNET RESON MED, V37, P425, DOI 10.1002/mrm.1910370321; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; LAZAREWICZ JW, 1992, ADV EXP MED BIOL, V318, P73; MAXWELL WL, 1994, ACTA NEUROCHIR, P465; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NAG S, 1992, ACTA NEUROPATHOL, V84, P471, DOI 10.1007/BF00304465; PARK CK, 1994, ACTA NEUROCHIR, V127, P220, DOI 10.1007/BF01808770; PEREZPINZON MA, 1995, J CEREBR BLOOD F MET, V15, P865, DOI 10.1038/jcbfm.1995.108; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PSCHORN U, 1993, MAGNET RESON MED, V30, P174, DOI 10.1002/mrm.1910300205; QUAST MJ, 1995, BRAIN RES, V677, P204, DOI 10.1016/0006-8993(95)00134-C; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595; VALTYSSON J, 1994, ACTA NEUROCHIR, V129, P58, DOI 10.1007/BF01400874; WALLACE MC, 1992, J NEUROSURG, V76, P127, DOI 10.3171/jns.1992.76.1.0127; Werth JL, 1998, BRAIN RES, V782, P248, DOI 10.1016/S0006-8993(97)01286-9	33	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2003	25	4					329	334		10.1179/016164103101201643			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	703EL	WOS:000184267000003	12870257				2022-02-06	
J	Cuny, E				Cuny, E			Intrathecal baclofen and traumatic brain injury. A review	NEUROCHIRURGIE			French	Article; Proceedings Paper	53rd Annual Congress of the Societe-De-Neurochirurgie-De-Langue-Francaise	MAY 09-12, 2003	TOZEUR, TUNISIA	Soc Neurochirurgie Langue Francaise		intrathecal baclofen; severe head trauma; severe autonomic disorders; independence	ALLEVIATES AUTONOMIC DYSFUNCTION; SUPRASPINAL SPASTICITY; DIENCEPHALIC SEIZURES; CEREBRAL ORIGIN; HEAD-INJURY; INFUSION; DYSAUTONOMIA; HYPERTONIA	Severe head injury can induce hypertonia. There are two kinds of hypertonia related to severe injury. The most common one is a spasticity that occurs a long time after the head injury; the second is hypertonia that occurs during the early stage of the post-trauma recovery. Hypertoni is associated with other symptoms and defines post-trauma dysautonomia. Intrathecal baclofen can alleviate spasticity in severe head injury with improvement of the Ashworth score, spasm score or reflex score. But it also improves the number of paroxymal dysautonomic episodes. Real functional improvement is more difficult to show. To be effective, intrathecal baclofen it therapy in fie brain injured patients needs high doses per day, through a spinal catheter in the mediothoracic region, and delivered at least continuously for a few hours to achieve a functional improvement.	CHU Bordeaux, Hop Pellegrin, Serv Neurochirurg, F-33076 Bordeaux, France		Cuny, E (corresponding author), CHU Bordeaux, Hop Pellegrin, Serv Neurochirurg, Pl Amelie Raba Leon, F-33076 Bordeaux, France.						Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Denys P, 1996, BRAIN INJURY, V10, P149, DOI 10.1080/026990596124656; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KOFLER M, 1994, NEUROLOGY, V44, P25, DOI 10.1212/WNL.44.1.25; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1999, AM J PHYS MED REHAB, V78, P247, DOI 10.1097/00002060-199905000-00012; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; PENN RD, 1995, MOVEMENT DISORD, V10, P675, DOI 10.1002/mds.870100524; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Rifici C, 1994, Funct Neurol, V9, P29; Saltuari L, 1992, Acta Neurol (Napoli), V14, P195; SALTUARI L, 1989, LANCET, V26, P503	22	5	5	0	1	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie	MAY	2003	49	2-3	2				289	292					4	Clinical Neurology; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	679JM	WOS:000182917100018	12746704				2022-02-06	
J	Hayman-Abello, BA; Hayman-Abello, SE; Rourke, BP				Hayman-Abello, BA; Hayman-Abello, SE; Rourke, BP			Human neuropsychology in Canada: The 1990s (A review of research by Canadian neuropsychologists conducted over the past decade)	CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE			English	Article; Proceedings Paper	29th Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 2001	CHICAGO, IL	Int Neuropsychol Soc			TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; EARLY-ONSET HYDROCEPHALUS; CLOSED-HEAD-INJURY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRENATAL TESTOSTERONE LEVELS; ANTERIOR TEMPORAL-LOBE; HALSTEAD CATEGORY TEST; SLEEP-APNEA SYNDROME; ALZHEIMERS-DISEASE	This paper presents an overview of the human neuropsychology research activity conducted in Canada during the 1990s. Brief descriptions of the neuropsychological research conducted by prominent researchers at major centres across the country are included. New research developments, concordance with predicted trends (Rourke 1991), and comparison with the research in two previous decades (Fuerst Rourke, 1995; Rourke, Fisk, Strang, & Gates, 1981) are presented. The reviewed work illustrates the continued extensive commitment to human neuropsychological research by Canadian investigators. It is clear that researchers in Canada continue to play a central role in this important area of scientific endeavour.	Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; Yale Univ, New Haven, CT 06520 USA		Rourke, BP (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada.						Alain C, 1999, PSYCHOPHYSIOLOGY, V36, P737, DOI 10.1017/S0048577299980812; ALAIN C, 1993, PSYCHOPHYSIOLOGY, V30, P572, DOI 10.1111/j.1469-8986.1993.tb02083.x; Alfano D P, 1994, Appl Neuropsychol, V1, P57, DOI 10.1207/s15324826an0101&2_10; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P117; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; ALFANO DP, 1991, NEUROPSYCHOLOGY, V5, P35; Alvarez M, 1996, J PEDIATR ENDOCR MET, V9, P447; ARCHIBALD YM, 1994, J NEUROSURG, V80, P247, DOI 10.3171/jns.1994.80.2.0247; Asbjornsen AE, 1998, NEUROPSYCHOLOGIA, V36, P143, DOI 10.1016/S0028-3932(97)00090-0; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Barnes MA, 1998, BRAIN LANG, V61, P309, DOI 10.1006/brln.1998.1843; BARNES MA, 1992, J PEDIATR PSYCHOL, V17, P445, DOI 10.1093/jpepsy/17.4.445; Barreca SR, 1999, CLIN NEUROPSYCHOL, V13, P171, DOI 10.1076/clin.13.2.171.1969; Barron RW, 1998, BEHAV RES METH INS C, V30, P610, DOI 10.3758/BF03209478; Bawden H, 1996, J CLIN EXP NEUROPSYC, V18, P784, DOI 10.1080/01688639608408302; Bawden HN, 1997, J CHILD NEUROL, V12, P248, DOI 10.1177/088307389701200405; BEDARD MA, 1993, J CLIN EXP NEUROPSYC, V15, P330, DOI 10.1080/01688639308402567; BEDARD MA, 1991, J CLIN EXP NEUROPSYC, V13, P950, DOI 10.1080/01688639108405110; Bedard MA, 1999, BRAIN COGNITION, V40, P289, DOI 10.1006/brcg.1999.1083; Bedard MA, 1998, CLIN NEUROPHARMACOL, V21, P108; Beuter A, 1995, INT J NEUROSCI, V83, P281, DOI 10.3109/00207459508986345; BEUTER A, 1990, PROBLEMS MOVEMENT CO, P67; Boone KB, 1999, J INT NEUROPSYCH SOC, V5, P616, DOI 10.1017/S1355617799577047; Bourassa D C, 1996, Laterality, V1, P5, DOI 10.1080/713754206; Bowler JV, 1997, ARCH NEUROL-CHICAGO, V54, P697, DOI 10.1001/archneur.1997.00550180021007; Bowman M. L., 1997, IMPULSIVITY THEORY A, P116; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; BOYLE EA, 1991, ARCH NEUROL-CHICAGO, V48, P1150, DOI 10.1001/archneur.1991.00530230058022; BRANDYS CF, 1991, NEUROPSYCHOLOGICAL V, P73; BRAUN CMJ, 1994, BRAIN COGNITION, V24, P198, DOI 10.1006/brcg.1994.1011; BRAUN CMJ, 1992, NEUROPSYCHOL REV, V3, P171, DOI 10.1007/BF01108842; Braun CMJ, 1998, AM J PSYCHOL, V111, P241, DOI 10.2307/1423488; BRAUN CMJ, 1990, CAN J AGING, V9, P135, DOI 10.1017/S071498080001312X; Braun CMJ, 1999, NEUROPSY NEUROPSY BE, V12, P35; Braun CMJ, 1996, NEUROPSYCHOLOGY, V10, P565; Braun JB, 1999, NEUROLOGY, V53, P527, DOI 10.1212/WNL.53.3.527; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Bryden M P, 1997, Laterality, V2, P317, DOI 10.1080/135765097397512; Bryden M. P., 1991, NEUROPSYCHOLOGICAL F, P411; BRYDEN MP, 1994, BRAIN COGNITION, V26, P103, DOI 10.1006/brcg.1994.1045; BRYDEN MP, 1991, DEV NEUROPSYCHOL, V7, P477, DOI 10.1080/87565649109540506; BULMANFLEMING MB, 1994, NEUROPSYCHOLOGIA, V32, P787, DOI 10.1016/0028-3932(94)90017-5; BulmanFleming MB, 1996, INT J NEUROSCI, V87, P257, DOI 10.3109/00207459609070844; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; Byrne JM, 1998, CHILD NEUROPSYCHOL, V4, P49, DOI 10.1076/chin.4.1.49.3193; Byrne JM, 1998, J CLIN EXP NEUROPSYC, V20, P613, DOI 10.1076/jcen.20.5.613.1121; CADALBERT A, 1994, J CLIN EXP NEUROPSYC, V16, P664, DOI 10.1080/01688639408402679; CADORET G, 1994, EARLY HUM DEV, V36, P157, DOI 10.1016/0378-3782(94)90002-7; *CAN STUD HLTH AG, 1995, CANADIAN J AGING, V13, P470; CANCELLIERE AEB, 1990, BRAIN COGNITION, V13, P133, DOI 10.1016/0278-2626(90)90046-Q; CARBOTTE RM, 1995, J RHEUMATOL, V22, P863; CARBOTTE RM, 1992, J NEUROL NEUROSUR PS, V55, P1054, DOI 10.1136/jnnp.55.11.1054; Carlson JS, 1997, LEARN DISABILITY Q, V20, P93, DOI 10.2307/1511217; Carswell LM, 1997, J CLIN EXP NEUROPSYC, V19, P914, DOI 10.1080/01688639708403772; Carter SL, 1998, CLIN NEUROPSYCHOL, V12, P531, DOI 10.1076/clin.12.4.531.7239; Casey J. E., 1994, NEUROPSYCHOLOGY MENT, P187; Chiappe P, 1999, J EDUC PSYCHOL, V91, P20, DOI 10.1037/0022-0663.91.1.20; CHICOINE AJ, 1992, DEV NEUROPSYCHOL, V8, P381, DOI 10.1080/87565649209540533; CHOUINARD MJ, 1993, J CLIN EXP NEUROPSYC, V15, P591, DOI 10.1080/01688639308402581; Clark Campbell M., 1994, Human Brain Mapping, V2, P95, DOI 10.1002/hbm.460020109; CLARK CM, 1993, BIOL PSYCHIAT, V33, P86, DOI 10.1016/0006-3223(93)90306-X; Clark CM, 1997, J CLIN EXP NEUROPSYC, V19, P63, DOI 10.1080/01688639708403837; Cohen H, 1996, CAN J BEHAV SCI, V28, P310, DOI 10.1037/0008-400X.28.4.310; COHEN H, 1991, BRAIN LANG, V41, P395, DOI 10.1016/0093-934X(91)90163-U; Cohen H, 1998, BRAIN LANG, V64, P409, DOI 10.1006/brln.1998.1981; COHEN H, 1994, NEUROPSY NEUROPSY BE, V7, P166; COHEN H, 1995, CORTEX, V31, P565, DOI 10.1016/S0010-9452(13)80067-6; COLLINS B, 1994, CAN J AGING, V13, P368, DOI 10.1017/S0714980800006188; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; COOPER PJ, 1993, J SAFETY RES, V24, P9, DOI 10.1016/0022-4375(93)90047-Q; COREN S, 1992, J SPEECH HEAR RES, V35, P921, DOI 10.1044/jshr.3504.921; COREN S, 1995, AM J PSYCHOL, V108, P311, DOI 10.2307/1422892; Coren S, 1998, Laterality, V3, P161, DOI 10.1080/135765098397359; COREN S, 1994, PERCEPT MOTOR SKILL, V79, P1003, DOI 10.2466/pms.1994.79.2.1003; COREN S, 1994, ERGONOMICS, V37, P1269, DOI 10.1080/00140139408964905; COREN S, 1991, PSYCHOL BULL, V109, P90, DOI 10.1037/0033-2909.109.1.90; COREN S, 1990, J EXP PSYCHOL HUMAN, V16, P365, DOI 10.1037/0096-1523.16.2.365; Coren S, 1992, LEFT HANDER SYNDROME; COREN S, 1990, LEFT HANDEDNESS BEHA; COREN SL, 1994, SENSATION PERCEPTION; Corkum V, 1995, CHILD NEUROPSYCHOL, V1, P3, DOI 10.1080/09297049508401338; Correa DD, 1996, AGING NEUROPSYCHOL C, V3, P215, DOI 10.1080/13825589608256625; COWELL PE, 1993, NEUROLOGY, V43, P2353, DOI 10.1212/WNL.43.11.2353; CROCKETT DJ, 1993, J CLIN EXP NEUROPSYC, V15, P903, DOI 10.1080/01688639308402607; Crockett DJ, 1996, ARCH CLIN NEUROPSYCH, V11, P637, DOI 10.1016/S0887-6177(96)80001-1; CROCKETT DJ, 1990, ARCH CLIN NEUROPSYCH, V5, P165; Croisile B, 1996, BRAIN LANG, V53, P1, DOI 10.1006/brln.1996.0033; Crossley M, 1997, J CLIN EXP NEUROPSYC, V19, P52, DOI 10.1080/01688639708403836; CROSSLEY M, 1992, PSYCHOL AGING, V7, P499, DOI 10.1037/0882-7974.7.4.499; Dade LA, 1998, ANN NY ACAD SCI, V855, P572, DOI 10.1111/j.1749-6632.1998.tb10626.x; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DAIGNEAULT S, 1993, J CLIN EXP NEUROPSYC, V15, P881, DOI 10.1080/01688639308402605; Das J. P., 1994, ASSESSMENT COGNITIVE; DAS JP, 1992, J PSYCHOEDUC ASSESS, V10, P37, DOI 10.1177/073428299201000103; DAS JP, 1995, RES DEV DISABIL, V16, P11, DOI 10.1016/0891-4222(94)00032-5; DAS JP, 1999, READING DIFFICULTIES; DAS JP, 1998, PROFESSOR PREP PASS; Das JP, 1997, COGNITIVE ASSESSMENT; DAS JP, 1998, COGNITIVE PLANNING P; DAS JP, 1994, J LEARNING DISABILIT, V27, P66; de Guise E, 1999, BRAIN, V122, P1049, DOI 10.1093/brain/122.6.1049; Denburg S D, 1997, J Int Neuropsychol Soc, V3, P377; Denburg SD, 1997, J RHEUMATOL, V24, P998; DENBURG SD, 1999, SYSTEMIC LUPUS ERYTH, P611; DENBURG SD, 1999, J MUSCULOSKEL MED, V16, P356; Dennis M, 1996, J NEURO-ONCOL, V29, P91, DOI 10.1007/BF00165522; Dennis M, 1998, MED PEDIATR ONCOL, P25; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M., 1995, Journal of Neurotrauma, V12, P404; Dennis M, 1999, J AUTISM DEV DISORD, V29, P5, DOI 10.1023/A:1025962431132; DENNIS M, 1993, J PEDIATR PSYCHOL, V18, P639, DOI 10.1093/jpepsy/18.5.639; DENNIS M, 1992, NEUROPSYCHOLOGIA, V30, P257, DOI 10.1016/0028-3932(92)90004-6; DeWolfe NA, 1999, CLIN NEUROPSYCHOL, V13, P458, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT458; DONDERS J, 1991, J CLIN EXP NEUROPSYC, V13, P607, DOI 10.1080/01688639108401075; DOOL CB, 1993, J CLIN CHILD PSYCHOL, V22, P387, DOI 10.1207/s15374424jccp2203_10; Dumont C, 1998, BRAIN COGNITION, V37, P93; Dupont RM, 1996, PSYCHIAT RES-NEUROIM, V67, P99, DOI 10.1016/0925-4927(96)02769-2; DYWAN CA, 1995, J CLIN EXP NEUROPSYC, V17, P431, DOI 10.1080/01688639508405134; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; DYWAN J, 1992, DEV NEUROPSYCHOL, V8, P473, DOI 10.1080/87565649209540539; Dywan J, 1998, BRAIN COGNITION, V36, P390, DOI 10.1006/brcg.1997.0979; DYWAN J, 1994, PSYCHOL AGING, V9, P568, DOI 10.1037/0882-7974.9.4.568; ERKINJUNTTI T, 1993, ARCH NEUROL-CHICAGO, V50, P305, DOI 10.1001/archneur.1993.00540030069017; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Finegan JAK, 1996, BRIT J OBSTET GYNAEC, V103, P214, DOI 10.1111/j.1471-0528.1996.tb09708.x; FINEGAN JAK, 1994, J AM ACAD CHILD PSY, V33, P1307, DOI 10.1097/00004583-199411000-00013; FINEGAN JAK, 1992, DEV PSYCHOL, V28, P1075, DOI 10.1037/0012-1649.28.6.1075; Finlayson M., 1994, BRAIN INJURY REHABIL; Fisher NJ, 1997, CHILD NEUROPSYCHOL, V3, P61, DOI 10.1080/09297049708401368; Fisher NJ, 1996, J CLIN EXP NEUROPSYC, V18, P349, DOI 10.1080/01688639608408993; Fisher NJ, 1999, J CLIN EXP NEUROPSYC, V21, P488, DOI 10.1076/jcen.21.4.488.887; FLETCHER JM, 1992, J LEARN DISABIL, V25, P555, DOI 10.1177/002221949202500903; FORGET H, 1994, BRAIN COGNITION, V26, P243, DOI 10.1006/brcg.1994.1058; FORSTER DC, 1991, CAN J PSYCHOL, V45, P321, DOI 10.1037/h0084300; FOSTER JK, 1994, COGNITIVE NEUROPSYCH, V11, P133, DOI 10.1080/02643299408251971; Foster JK, 1995, AGING COGNITION, V2, P279, DOI 10.1080/13825589508256604; Fraile V, 1999, BRAIN COGNITION, V40, P118; FREEDMAN M, 1991, ANN INTERN MED, V115, P203, DOI 10.7326/0003-4819-115-3-203; FUERST DR, 1990, J CONSULT CLIN PSYCH, V58, P657, DOI 10.1037/0022-006X.58.5.657; FUERST DR, 1993, J ABNORM CHILD PSYCH, V21, P597, DOI 10.1007/BF00916445; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Geschwind N, 1987, CEREBRAL LATERALIZAT; GOOD K, 1992, J NERV MENT DIS, V180, P730, DOI 10.1097/00005053-199211000-00009; GOTTARDO A, 1997, J RES READING, V0020, P00042, DOI DOI 10.1111/1467-9817.00019; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; GOUMENIOUK AD, 1992, CAN J PSYCHIAT, V37, P17, DOI 10.1177/070674379203700105; Grace GM, 1999, J CLIN EXP NEUROPSYC, V21, P477, DOI 10.1076/jcen.21.4.477.876; GRACE GM, 1994, BALANCE MODEL DYSLEX, P133; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Graves RE, 1999, NEUROPSYCHOLOGY, V13, P575; GRAVES RE, 1990, NEUROPSYCHOLOGIA, V28, P1117, DOI 10.1016/0028-3932(90)90144-D; GRAVES RE, 1992, COGN NEUROPSYCHOL, V9, P487, DOI 10.1080/02643299208252069; Graves RE, 1999, PSYCHOL ASSESSMENT, V11, P29, DOI 10.1037/1040-3590.11.1.29; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; GRIMSHAW GM, 1995, NEUROPSYCHOLOGY, V9, P68, DOI 10.1037/0894-4105.9.1.68; GRIMSHAW GM, 1995, BRAIN COGNITION, V29, P85, DOI 10.1006/brcg.1995.1269; Guerin F, 1999, BRAIN COGNITION, V40, P464, DOI 10.1006/brcg.1999.1079; HALL JAY, 1995, ARCH SEX BEHAV, V24, P395, DOI 10.1007/BF01541855; HALL JAY, 1994, BEHAV NEUROSCI, V108, P1203; HAMILTON JM, 1995, BRAIN INJURY, V9, P479, DOI 10.3109/02699059509008207; Hampson E, 1998, DEV NEUROPSYCHOL, V14, P299, DOI 10.1080/87565649809540713; Harris JA, 1996, AGGRESSIVE BEHAV, V22, P321, DOI 10.1002/(SICI)1098-2337(1996)22:5<321::AID-AB1>3.0.CO;2-M; HEINRICHS RW, 1994, SCHIZOPHR RES, V13, P127, DOI 10.1016/0920-9964(94)90093-0; HEINRICHS RW, 1993, AM PSYCHOL, V48, P221, DOI 10.1037/0003-066X.48.3.221; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; HEINRICHS RW, 1993, SCHIZOPHR RES, V9, P49, DOI 10.1016/0920-9964(93)90009-8; Heinrichs RW, 1997, BRAIN COGNITION, V35, P207, DOI 10.1006/brcg.1997.0938; HEINRICHS RW, 1991, PSYCHOL REP, V69, P223, DOI 10.2466/PR0.69.5.223-226; HEINRICHS RW, 1992, PERCEPT MOTOR SKILL, V75, P1027, DOI 10.2466/PMS.75.8.1027-1032; Hermann BP, 1999, NEUROPSYCHOLOGY, V13, P3, DOI 10.1037/0894-4105.13.1.3; Herrick IA, 1997, ANESTH ANALG, V84, P1285, DOI 10.1097/00000539-199706000-00021; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hetherington R, 1999, DEV NEUROPSYCHOL, V15, P25, DOI 10.1080/87565649909540738; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Hochachka PW, 1996, J APPL PHYSIOL, V81, P1355, DOI 10.1152/jappl.1996.81.3.1355; Ida Y, 1996, CAN J EXP PSYCHOL, V50, P234, DOI 10.1037/1196-1961.50.2.234; Iezzi T, 1999, J BEHAV MED, V22, P205, DOI 10.1023/A:1018791622441; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Iverson GL, 1999, J CLIN PSYCHOL, V55, P519, DOI 10.1002/(SICI)1097-4679(199904)55:4<519::AID-JCLP14>3.0.CO;2-B; Iverson GL, 1998, SCHIZOPHR RES, V30, P165, DOI 10.1016/S0920-9964(97)00134-5; James TW, 1997, EVOL HUM BEHAV, V18, P155, DOI 10.1016/S1090-5138(97)00004-4; Jason GW, 1997, PSYCHO-ONCOLOGY, V6, P151, DOI 10.1002/(SICI)1099-1611(199706)6:2<151::AID-PON244>3.0.CO;2-G; Jason GW, 1997, ARCH NEUROL-CHICAGO, V54, P1081, DOI 10.1001/archneur.1997.00550210019008; JEERAKATHIL TJ, 1994, NEUROLOGY, V44, P703, DOI 10.1212/WNL.44.4.703; JonesGotman M, 1997, NEUROPSYCHOLOGIA, V35, P963, DOI 10.1016/S0028-3932(97)00024-9; JonesGotman M, 1997, REV NEUROPSYCHOL, V7, P171; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; JonesGotman M, 1997, BRAIN, V120, P1845, DOI 10.1093/brain/120.10.1845; JONESGOTMAN M, 1991, SURG EPILEPSY, P469; KARBE H, 1994, NEURORADIOLOGY, V36, P1, DOI 10.1007/BF00599183; Kashmere JL, 1997, NEUROLOGY, V49, P887, DOI 10.1212/WNL.49.3.887; Kegl J, 1999, BRAIN COGNITION, V40, P355, DOI 10.1006/brcg.1998.1086; Kertesz A, 1997, ARCH NEUROL-CHICAGO, V54, P1427, DOI 10.1001/archneur.1997.00550230090024; KERTESZ A, 1990, ARCH NEUROL-CHICAGO, V47, P387, DOI 10.1001/archneur.1990.00530040029015; KERTESZ A, 1993, FOUNDATIONS OF APHASIA REHABILITATION, P365; KERTESZ A, 1991, APHASIOLOGY, V5, P207, DOI 10.1080/02687039108248525; KERTESZ A, 1994, J CLIN NEUROPHYSIOL, V11, P205, DOI 10.1097/00004691-199403000-00005; Kertesz A, 1999, DEMENT GERIATR COGN, V10, P46, DOI 10.1159/000051212; Kertesz A, 1998, PICKS DIS PICK COMPL; KERTESZ A, 1993, HDB LINGUISTIC DISOR, P120; Kertesz A, 1997, BEHAV NEUROLOGY NEUR, P167; KERTESZ A, 1994, LOCALIZATION NEUROIM; KIMURA D, 1995, HORM BEHAV, V29, P312, DOI 10.1006/hbeh.1995.1022; Kimura D., 1999, SEX COGNITION; Kimura D, 1993, NEUROMOTOR MECH HUMA; KIRK A, 1991, ARCH NEUROL-CHICAGO, V48, P73, DOI 10.1001/archneur.1991.00530130083024; KIRK A, 1994, APHASIOLOGY, V8, P65, DOI 10.1080/02687039408248641; KIRK A, 1992, PHYSICAL MED REHABIL, P433; KISH SJ, 1994, NEUROLOGY, V44, P1738, DOI 10.1212/WNL.44.9.1738; Kitterle F.L., 1991, CEREBRAL LATERALITY, P35; KLONOFF H, 1991, J NERV MENT DIS, V179, P127, DOI 10.1097/00005053-199103000-00002; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kohler S, 1997, STUD COGNIT, P305; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P129, DOI 10.1016/S0028-3932(97)00098-5; Kohler S, 1998, CEREB CORTEX, V8, P451, DOI 10.1093/cercor/8.5.451; KUBU CS, 1999, NEUROBEHAVIORAL DYSF; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LAFLECHE GC, 1990, CAN J AGING, V9, P120, DOI 10.1017/S0714980800013118; Lakmache Y, 1998, P NATL ACAD SCI USA, V95, P9042, DOI 10.1073/pnas.95.15.9042; LALANDE S, 1992, BRAIN LANG, V42, P165, DOI 10.1016/0093-934X(92)90123-V; LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B; LASSONDE M, 1995, NEUROPSYCHOLOGIA, V33, P989, DOI 10.1016/0028-3932(95)00034-Z; Lassonde M, 1997, J Neurosurg Sci, V41, P67; LASSONDE M, 1991, NEUROPSYCHOLOGIA, V29, P481, DOI 10.1016/0028-3932(91)90006-T; Lassonde M, 1994, CALLOSAL AGENESIS NA; Le Normand MT, 1999, J NEUROLINGUIST, V12, P235, DOI 10.1016/S0911-6044(99)00016-0; Lee DH, 1998, AM J NEURORADIOL, V19, P19; Lennox C, 1996, J EXP CHILD PSYCHOL, V62, P60, DOI 10.1006/jecp.1996.0022; Lepage M, 1996, BRAIN, V119, P1289, DOI 10.1093/brain/119.4.1289; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Levine B, 1997, NEUROPSYCHOLOGY, V11, P367, DOI 10.1037/0894-4105.11.3.367; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Loring DW, 1999, NEUROLOGY, V53, P260, DOI 10.1212/WNL.53.2.260; Lovett MW, 1996, BRAIN LANG, V54, P447, DOI 10.1006/brln.1996.0085; LOVETT MW, 1994, BRAIN LANG, V47, P117, DOI 10.1006/brln.1994.1045; Lovett MW, 1997, LEARN DISABILITY Q, V20, P189, DOI 10.2307/1511308; LOVETT MW, 1994, DEV PSYCHOL, V30, P805, DOI 10.1037/0012-1649.30.6.805; Lovett MW, 1991, LEARN INDIVID DIFFER, V3, P295; LOVETT MW, 1999, CONVERGING METHODS U, P111; LOVETT MW, 1992, HDB NEUROPSYCHOLOGY, V7, P163; Mackenzie IRA, 1996, NEUROLOGY, V46, P425, DOI 10.1212/WNL.46.2.425; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; Martzke JS, 1997, BIOL PSYCHIAT, V42, P721, DOI 10.1016/S0006-3223(96)00442-8; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; MCGARRYROBERTS PA, 1992, INTELLIGENCE, V16, P289, DOI 10.1016/0160-2896(92)90011-F; McGlone J, 1997, NEUROPSY NEUROPSY BE, V10, P125; McGlone J, 1999, EPILEPSIA, V40, P430, DOI 10.1111/j.1528-1157.1999.tb00737.x; MCGLONE J, 1994, EPILEPSIA, V35, P529, DOI 10.1111/j.1528-1157.1994.tb02473.x; McManus I C, 1999, Laterality, V4, P173, DOI 10.1080/135765099397051; McManus I. C., 1993, P679; MCMANUS IC, 1991, PSYCHOL BULL, V110, P237, DOI 10.1037/0033-2909.110.2.237; Mead LA, 1997, HORM BEHAV, V31, P65, DOI 10.1006/hbeh.1997.1363; MEERES SL, 1990, NEUROPSYCHOLOGIA, V28, P1231, DOI 10.1016/0028-3932(90)90039-Q; Melo B, 1999, COGNITIVE NEUROPSYCH, V16, P343, DOI 10.1080/026432999380825; MENEILLY GS, 1994, NEURODEGENER DIS, P383; MERIAN N, 1996, ARCH NEUROL-CHICAGO, V53, P1043; MILES J, 1994, J CLIN EXP NEUROPSYC, V16, P43, DOI 10.1080/01688639408402616; Moffat SD, 1998, BRAIN, V121, P2369, DOI 10.1093/brain/121.12.2369; Moffat SD, 1997, BRAIN RES, V767, P297, DOI 10.1016/S0006-8993(97)00614-8; Morrison S. R., 1991, NEUROPSYCHOLOGICAL F, P79; MORRISON SR, 1991, SUBTYPES OF LEARNING DISABILITIES, P189; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 1990, MODULAR DEFICITS ALZ, P1; Moscovitch M., 1994, NEUROPSYCHOLOGY, V8, P524; MURKIN JM, 1995, J THORAC CARDIOV SUR, V110, P349, DOI 10.1016/S0022-5223(95)70230-X; MURKIN JM, 1993, CARDIAC ANAESTHESI; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nicholson KG, 1996, PERCEPT MOTOR SKILL, V82, P3, DOI 10.2466/pms.1996.82.1.3; NOLDY NE, 1990, PSYCHOPHYSIOLOGY, V27, P417, DOI 10.1111/j.1469-8986.1990.tb02337.x; Norman KE, 1999, BRAIN COGNITION, V40, P207; Nulman I, 1997, NEW ENGL J MED, V336, P258, DOI 10.1056/NEJM199701233360404; NULMAN I, 1994, JAMA-J AM MED ASSOC, V171, P1591; Nyberg L, 1997, NEUROPSYCHOLOGY, V11, P70, DOI 10.1037/0894-4105.11.1.70; Obrzut JE, 1997, DEV NEUROPSYCHOL, V13, P97, DOI 10.1080/87565649709540670; ORANGE JB, 1998, PHYSICAL MED REHABIL, P501; ORourke N, 1997, ARCH CLIN NEUROPSYCH, V12, P257, DOI 10.1016/S0887-6177(97)80001-7; ORourke N, 1996, PSYCHOL AGING, V11, P377, DOI 10.1037/0882-7974.11.2.377; Ostbye T, 1999, NEUROLOGY, V53, P521, DOI 10.1212/WNL.53.3.521; Ouellet C, 1999, J NEUROLINGUIST, V12, P271, DOI 10.1016/S0911-6044(99)00018-4; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Paniak C, 1997, CLIN NEUROPSYCHOL, V11, P198, DOI 10.1080/13854049708407051; Paniak C, 1998, DEV NEUROPSYCHOL, V14, P555, DOI 10.1080/87565649809540728; Paniak C, 1998, J CLIN EXP NEUROPSYC, V20, P852, DOI 10.1076/jcen.20.6.852.1108; PANIAK C, 1996, CANADIAN J REHABILIT, V9, P233; PANIAK CE, 1992, ARCH CLIN NEUROPSYCH, V7, P529, DOI 10.1016/0887-6177(92)90143-B; Patrick L, 1996, AGING-CLIN EXP RES, V8, P328, DOI 10.1007/BF03339589; Pelletier P M, 1994, Appl Neuropsychol, V1, P38, DOI 10.1207/s15324826an0101&2_8; PHILLIPS NA, 1995, J CLIN EXP NEUROPSYC, V17, P713, DOI 10.1080/01688639508405161; POIRIER P, 1993, BRAIN, V116, P53, DOI 10.1093/brain/116.1.53; POULOS MG, 1991, J SPEECH HEAR RES, V34, P5, DOI 10.1044/jshr.3401.05; Purdon SE, 1999, SCHIZOPHR RES, V35, pS51, DOI 10.1016/S0920-9964(98)00166-2; Purdon SE, 1998, J PSYCHIATR NEUROSCI, V23, P163; PURGHE F, 1992, PERCEPT PSYCHOPHYS, V51, P291, DOI 10.3758/BF03212255; PUTNAM SH, 1994, CLIN NEUROPSYCHOL, V8, P245; RAPIN I, 1992, CHILD NEUROPSYCHOL 1; REED RJ, 1992, ALCOHOL CLIN EXP RES, V16, P677, DOI 10.1111/j.1530-0277.1992.tb00660.x; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; RICCIARDI PW, 1991, DEV NEUROPSYCHOL, V7, P523, DOI 10.1080/87565649109540509; Rich JB, 1999, NEUROPSYCHOLOGY, V13, P525, DOI 10.1037/0894-4105.13.4.525; Richer F, 1996, NEUROPSYCHOLOGIA, V34, P509, DOI 10.1016/0028-3932(95)00132-8; Richer F, 1999, NEUROPSYCHOLOGIA, V37, P1427, DOI 10.1016/S0028-3932(99)00029-9; RICHER F, 1993, BRAIN COGNITION, V21, P203, DOI 10.1006/brcg.1993.1016; RIVEST J, 1994, NEUROPSYCHOLOGIA, V32, P69, DOI 10.1016/0028-3932(94)90069-8; ROCKWOOD K, 1994, CAN J NEUROL SCI, V21, P358, DOI 10.1017/S0317167100040968; Rouleau I, 1996, BRAIN COGNITION, V31, P17, DOI 10.1006/brcg.1996.0022; ROULEAU I, 1992, BRAIN COGNITION, V18, P70, DOI 10.1016/0278-2626(92)90112-Y; Rourke B P, 1991, Arch Clin Neuropsychol, V6, P1, DOI 10.1016/0887-6177(91)90017-4; Rourke B.P., 1994, LEARNING DISABILITIE; Rourke B. P., 1991, LEARNING DISABILITIE; Rourke B.P., 1981, CANADIAN PSYCHOL, V22, P85, DOI [https://doi.org/10.1037/h0081139, DOI 10.1037/H0081139]; ROURKE BP, 1993, J LEARN DISABIL, V26, P214, DOI 10.1177/002221949302600402; Rourke BP, 1997, J LEARN DISABIL, V30, P34, DOI 10.1177/002221949703000103; Rourke BP, 1995, CAN PSYCHOL, V36, P259, DOI 10.1037/0708-5591.36.4.259; Rourke BP, 2000, CAN PSYCHOL, V41, P34, DOI 10.1037/h0086856; Rourke BP, 1995, SYNDROME NONVERBAL L; ROURKE BP, 1991, NEUROPSCYHOLOGICAL V; ROURKE BP, 1992, CLIN SYNDROMES ADULT, P452; Rourke SB, 1999, J INT NEUROPSYCH SOC, V5, P234, DOI 10.1017/S1355617799533067; Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P737, DOI 10.1076/jcen.21.6.737.863; Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P757, DOI 10.1076/jcen.21.6.757.852; ROURKE SB, 1996, NEUROPSYCHOLOGICAL A, P379; ROVET J, 1994, J CLIN EXP NEUROPSYC, V16, P820, DOI 10.1080/01688639408402696; Rovet J, 1996, J LEARN DISABIL-US, V29, P180, DOI 10.1177/002221949602900208; Rovet J, 1995, CHILD NEUROPSYCHOL, V1, P150, DOI 10.1080/09297049508402246; ROVET J, 1994, J PEDIATR PSYCHOL, V19, P779, DOI 10.1093/jpepsy/19.6.779; ROVET J, 1995, AM J MED GENET, V60, P356, DOI 10.1002/ajmg.1320600503; ROVET J, 1995, SYNDROME NONVERBAL L, P351; ROVET J, 1995, SYNDROME NONVERBAL L, P255; ROVET JF, 1993, J LEARN DISABIL, V26, P333, DOI 10.1177/002221949302600506; ROVET JF, 1992, J PEDIATR PSYCHOL, V17, P187, DOI 10.1093/jpepsy/17.2.187; ROVET JF, 1995, J PEDIATR-US, V126, P380, DOI 10.1016/S0022-3476(95)70452-3; Rovet JF, 1999, THYROID, V9, P741, DOI 10.1089/thy.1999.9.741; ROVET JF, 1993, J LEARN DISABIL-US, V26, P7, DOI 10.1177/002221949302600102; ROVET JF, 1990, J PEDIATR PSYCHOL, V15, P775, DOI 10.1093/jpepsy/15.6.775; ROY EA, 1993, INT J NEUROSCI, V73, P183, DOI 10.3109/00207459308986668; RUSSELL DL, 1991, NEUROPSYCHOLOGICAL V, P57; Ryan L, 1996, NEUROPSYCHOLOGY, V10, P176, DOI 10.1037/0894-4105.10.2.176; SAINTCYR JA, 1995, BEHAV NEUROLOGY MOVE, P1; SAINTCYR JA, 1992, NEUROPSYCHOLOGICAL D, P204; Saltzman J, 1998, ARCH CLIN NEUROPSYCH, V13, P611, DOI 10.1016/S0887-6177(97)00077-2; Saucier DM, 1998, DEV NEUROPSYCHOL, V14, P385, DOI 10.1080/87565649809540717; SAUERWEIN HC, 1994, ADV BEHAV BIOL, V42, P221; SAUERWEIN HC, 1994, BEHAV BRAIN RES, V64, P229, DOI 10.1016/0166-4328(94)90135-X; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SCHIAVETTO A, 1993, NEUROPSYCHOLOGIA, V31, P695, DOI 10.1016/0028-3932(93)90141-L; Schmidt James P, 1992, Clin Neuropsychol, V6, P185, DOI 10.1080/13854049208401855; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Segalowitz Sidney J., 1995, P579; SEGALOWITZ SJ, 1992, DEV NEUROPSYCHOL, V8, P279, DOI 10.1080/87565649209540528; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; SEGALOWITZ SJ, 1992, CHILD NEUROPSYCHOL 2; SHAFRIR U, 1994, J LEARN DISABIL-US, V27, P123, DOI 10.1177/002221949402700207; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Sherman EMS, 1995, PSYCHOL ASSESSMENT, V7, P440, DOI 10.1037//1040-3590.7.4.440; SIEGEL LS, 1993, ADV CHILD DEV BEHAV, V24, P63, DOI 10.1016/S0065-2407(08)60300-6; Siegel LS, 1995, INFANT BEHAV DEV, V18, P483, DOI 10.1016/0163-6383(95)90037-3; SIEGEL LS, 1995, PSYCHOL SCI, V6, P250, DOI 10.1111/j.1467-9280.1995.tb00601.x; Siegel LS, 1998, WORD RECOGNITION IN BEGINNING LITERACY, P141; SIEGEL LS, 1994, INT J BEHAV DEV, V17, P109, DOI 10.1177/016502549401700107; SIEGEL LS, 1990, LEARNING DISABILITIES : THEORETICAL AND RESEARCH ISSUES, P111; SINGH M, 1994, INT J NEUROSCI, V74, P33, DOI 10.3109/00207459408987227; Ska B, 1998, BRAIN COGNITION, V37, P136; SKA B, 1990, J CLIN EXP NEUROPSYC, V12, P695, DOI 10.1080/01688639008401012; SKA B, 1993, REV NEUROPSYCHOL, V3, P157; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 1997, J NEUROSCI, V17, P5136; Small JA, 1997, PSYCHOL AGING, V12, P3, DOI 10.1037/0882-7974.12.1.3; Small JA, 1997, AGING NEUROPSYCHOL C, V4, P126, DOI 10.1080/13825589708256641; Small JA, 1997, NEUROPSYCHOLOGIA, V35, P1571, DOI 10.1016/S0028-3932(97)00089-4; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; SPREEN O, 1998, ACQUIRED APHASIA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); SPREEN O, 1995, DEV NEUROPSYCHOLOGY; Spreen O, 1991, COMPENDIUM NEUROPSYC; Sprenger-Charolles L, 1998, J EXP CHILD PSYCHOL, V68, P134, DOI 10.1006/jecp.1997.2422; SPRENGERCHAROLL.L, 1998, SCI STUDIES READING, V0002, P00003, DOI [DOI 10.1207/s1532799xssr0201_1, DOI 10.1207/S1532799XSSR0201_1]; Stanovich KE, 1997, FOUNDATIONS OF READING ACQUISITION AND DYSLEXIA, P115; Steenhuis R E, 1999, Laterality, V4, P3, DOI 10.1080/713754324; STEENHUIS RE, 1995, J CLIN EXP NEUROPSYC, V17, P773, DOI 10.1080/01688639508405166; STEENHUIS RE, 1993, NEUROPSYCHOLOGIA, V31, P1243, DOI 10.1016/0028-3932(93)90071-7; STEENHUIS RE, 1990, J CLIN EXP NEUROPSYC, V12, P921, DOI 10.1080/01688639008401031; STELMACK RM, 1990, J CLIN EXP NEUROPSYC, V12, P887, DOI 10.1080/01688639008401029; Stelmack RM, 1995, DEV NEUROPSYCHOL, V11, P445, DOI 10.1080/87565649509540631; Storrie-Baker H J, 1997, J Int Neuropsychol Soc, V3, P394; Strang J. D., 1994, NEUROPSYCHOLOGY MENT, P171; STRANG JD, 1990, EPILEPSIA, V31, pS54, DOI 10.1111/j.1528-1157.1990.tb05872.x; Strauss E, 1995, J CLIN EXP NEUROPSYC, V17, P909, DOI 10.1080/01688639508402439; STRAUSS E, 1995, NEUROPSYCHOLOGY, V9, P457, DOI 10.1037/0894-4105.9.4.457; Strauss E, 1990, Arch Clin Neuropsychol, V5, P417, DOI 10.1016/0887-6177(90)90020-P; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Strong MJ, 1996, J CLIN EXP NEUROPSYC, V18, P291, DOI 10.1080/01688639608408283; Strong MJ, 1999, NEUROLOGY, V53, P1665, DOI 10.1212/WNL.53.8.1665; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; STUSS DT, 1992, BRAIN COGNITION, V19, P253, DOI 10.1016/0278-2626(92)90047-P; Stuss DT, 1996, BRAIN COGNITION, V31, P99, DOI 10.1006/brcg.1996.0036; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Stuss DT, 1997, J CLIN EXP NEUROPSYC, V19, P515, DOI 10.1080/01688639708403741; STUSS DT, 1990, SUBCORTICAL DEMENTIA, P145; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Sweeney J E, 1999, Appl Neuropsychol, V6, P79, DOI 10.1207/s15324826an0602_3; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Szekely C, 1998, DEV NEUROPSYCHOL, V14, P399, DOI 10.1080/87565649809540718; Taylor A E, 1990, J Neuropsychiatry Clin Neurosci, V2, P92; TELLIER A, 1990, J CONSULT CLIN PSYCH, V58, P531; Tierney M, 1994, PSYCHOL ASSESSMENT, V6, P129, DOI DOI 10.1037/1040-3590.6.2.129; Tierney MC, 1999, AGING MENT HEALTH, V3, P88, DOI 10.1080/13607869956479; Tierney MC, 1996, ARCH NEUROL-CHICAGO, V53, P423, DOI 10.1001/archneur.1996.00550050053023; Tierney MC, 1996, CLIN NEUROPSYCHOL, V10, P96, DOI 10.1080/13854049608406668; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; Tombaugh T. N., 1992, PSYCHOL ASSESSMENT, V4, P193, DOI [DOI 10.1037/1040-3590.4.2.193, 10.1037/1040-3590.4.2.193]; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; Toth C, 1996, CAN J NEUROL SCI, V23, P110, DOI 10.1017/S0317167100038816; TRENERRY MR, 1996, ASSESSMENT, V3, P307; Trepanier LL, 1998, NEUROLOGY, V51, P207, DOI 10.1212/WNL.51.1.207; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1996, J CLIN EXP NEUROPSYC, V18, P211, DOI 10.1080/01688639608408276; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; TROYER AK, 1994, AGING COGNITION, V0001, P00045, DOI DOI 10.1080/09289919408251449; Troyer AK, 1994, NEUROPSYCHOLOGY, V8, P95, DOI 10.1037/0894-4105.8.1.95; Tsatsanis KD, 1997, J LEARN DISABIL, V30, P490, DOI 10.1177/002221949703000505; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 1999, HIPPOCAMPUS, V9, P71, DOI 10.1002/(SICI)1098-1063(1999)9:1<71::AID-HIPO8>3.0.CO;2-F; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Tulving E, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P11; Tulving E, 1998, ADVANCES IN PSYCHOLOGICAL SCIENCE, VOL 2, P441; TUOKKO H, 1992, J AM GERIATR SOC, V40, P579, DOI 10.1111/j.1532-5415.1992.tb02106.x; TUOKKO H, 1990, DEV NEUROPSYCHOL, V6, P291, DOI 10.1080/87565649009540468; Tuokko H, 1999, AGING MENT HEALTH, V3, P21, DOI 10.1080/13607869956406; TUOKKO H, 1995, J GERONTOL B-PSYCHOL, V50, pS173, DOI 10.1093/geronb/50B.3.S173; TUOKKO H, 1995, J CLIN EXP NEUROPSYC, V17, P352, DOI 10.1080/01688639508405129; Tuokko H, 1996, J CLIN EXP NEUROPSYC, V18, P479, DOI 10.1080/01688639608405871; TUOKKO H, 1993, NEUROPSYCHOLOGY ALZH, P565; Tuokko H, 1998, ASSESSMENT GUIDE GER; Tuokko H. A., 1991, NEUROPSYCHOLOGY EVER, P135; UMILTA C, 1994, CONSCIOUS NONCONSCIO; VANASSE M, 1994, ADV BEHAV BIOL, V42, P199; VANDENBOS KP, 1994, CURRENT DIRECTIONS D; VANDERVELDEN MC, 1995, READ RES QUART, V30, P854, DOI 10.2307/748201; Vandervelden MC, 1997, ASSESSMENT AND INTERVENTION ISSUES ACROSS THE LIFE SPAN, P77; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1998, CLIN NEUROPSYCHOL, V12, P107, DOI 10.1076/clin.12.1.107.1729; VARNEY NR, 1993, J ASSIST REPROD GEN, V10, P53, DOI 10.1007/BF01204441; Vasilakos K, 1998, J MOTOR BEHAV, V30, P158, DOI 10.1080/00222899809601333; Voelker S, 1997, MENT RETARD, V35, P10, DOI 10.1352/0047-6765(1997)035<0010:DIPATR>2.0.CO;2; VOELKER SL, 1990, MENT RETARD, V28, P305; WATSON NV, 1991, PERS INDIV DIFFER, V12, P375, DOI 10.1016/0191-8869(91)90053-E; Webster W, 1998, J SPEECH LANGUAGE PA, V22, P220; Webster W. G., 1993, NEUROPSYCHOLOGY STUT, P73; WEBSTER WG, 1991, J SPEECH HEAR RES, V34, P708, DOI 10.1044/jshr.3404.708; Webster WG, 1997, INT CONGR SER, V1146, P119; WEBSTER WG, 1997, FACILITATING FLUENCY; Winocur G, 1996, NEUROPSYCHOLOGY, V10, P57, DOI 10.1037/0894-4105.10.1.57; Winocur G, 1996, BRAIN COGNITION, V30, P44, DOI 10.1006/brcg.1996.0004; Winocur G., 1992, HDB AGING COGNITION, P315; YOUNG B, 1992, CLIN NEUROLOGY, P1; Zakzanis KK, 1999, J INT NEUROPSYCH SOC, V5, P556, DOI 10.1017/S1355617799566101; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	487	5	5	0	3	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0708-5591	1878-7304		CAN PSYCHOL	Can. Psychol.-Psychol. Can.	MAY	2003	44	2					100	138		10.1037/h0086931			39	Psychology, Multidisciplinary	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	671TJ	WOS:000182479900003					2022-02-06	
J	Chirivella, J; Ferri, J; Villodre, R; Noe, E				Chirivella, J; Ferri, J; Villodre, R; Noe, E			Complutense Verbal Learning Test versus Wechsler memory Scale-Revised	NEUROLOGIA			Spanish	Article						Wechsler Memory Scale-Revised; Complutense Verbal Learning Test; acquired brain injury.; neuropsychology; convergent validity	TRAUMATIC BRAIN INJURY; HEAD-INJURY; PRACTICAL SCALE; PERFORMANCE; RECOVERY; MODERATE; PATTERNS	Introduction: We present a comparative study (sensitivity and convergent validity) between a new verbal memory test -Complutense Verbal Learning Test (TAVEC)- and the Wechsler Memory Scale-Revised (WMSr) in a sample of patients with acquired brain injury. Patients and methods: Twenty-eight patients with acquired brain injury were included in this study. Twelve patients were reevaluated six months after their inclusion in a cognitive multidisciplinary rehabilitation program. All patients were assessed with the WMSr (verbal memory, general memory and long-term memory) and the TAVEC (verbal learning, immediate memory and delayed memory). Results obtained with both scales were compared (chi-square) and correlated (Pearson correlation). Results: Globally, learning and memory deficits were detected with both scales. Initially 32.1% of our sample showed general memory deficits, and 44.4% long-term memory deficits when assessed with WMSr. These percentages were significantly lower compared to the 57.1%, 75% and 78.5% of our sample who. showed learning, recent memory and delayed memory difficulties when evaluated with the TAVEC. The results obtained by the 12 patients included in a cognitive rehabilitation program significantly improved. Numerous strong correlations between the TAVEC and the WMSr were found, suggesting a high degree of convergence between the two instruments. Conclusions: The TAVEC is a sensitive measure of learning and memory after acquired brain injury. Due to its sensitivity, ecological value and multifactorial structure we recommend this test for the evaluation of learning and memory of these patients.	Hosp NISA Valencia Mar, Serv Dano Cerebral, Valencia 46011, Spain		Noe, E (corresponding author), Hosp NISA Valencia Mar, Serv Dano Cerebral, Rio Tajo 1, Valencia 46011, Spain.			Noe Sebastian, Enrique/0000-0002-2547-8727			Ardila A., 1994, NEUROPSYCHOLOGICAL E; BENEDET MJ, 1999, TEST APRENDIZAJE VER; Benton A. L., 1955, VISUAL RETENTION TES; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Delis DC, 1988, CLIN NEUROPSYCHOL, V2, P188, DOI DOI 10.1080/13854048808520100; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; GARCIAALBEA J, 1998, TEST BOSTON DIAGNOST; GRANT DA, 1996, TEST CLASIFICACION T; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Novack TA, 2000, BRAIN INJURY, V14, P987; PENACASANOVA J, 1998, PROGRAMA INTEGRADO E; RANDOLPH C, 1994, CLIN NEUROPSYCHOL, V8, P99, DOI 10.1080/13854049408401547; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SCHEAR JM, 1989, CLIN NEUROPSYCHOL, V2, P188; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Stamatakis EA, 2002, J NUCL MED, V43, P476; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1999, WAIS 3 ESCALA INTELI; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILSON B, 1999, TEST CONDUCTUAL MEMO; Woodard JL, 1999, J CLIN EXP NEUROPSYC, V21, P553, DOI 10.1076/jcen.21.4.553.878	29	5	5	0	7	S T M EDITORES, S A	BARCELONA	PASEO DE GRACIA 25, 3, 08007 BARCELONA, SPAIN	0213-4853			NEUROLOGIA	Neurologia	APR	2003	18	3					132	138					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	691LM	WOS:000183607800001	12677478				2022-02-06	
J	Ransom, GH; Mann, FA; Vavilala, MS; Haruff, R; Rivara, FP				Ransom, GH; Mann, FA; Vavilala, MS; Haruff, R; Rivara, FP			Cerebral infarct in head injury: relationship to child abuse	CHILD ABUSE & NEGLECT			English	Article; Proceedings Paper	Joint Meeting of the Pediatric-Academic-Societies/American-Academy-of-Pediatrics	MAY 12-16, 2000	BOSTON, MA	Pediat Acad Soc, Amer Acad Pediat		infarct; unintentional injury; CT scan; child abuse	REVERSAL SIGN; CT; TRAUMA; COMA	Background: To determine whether CT-detected cerebral infarct in young children is associated more often with abuse or unintentional head injury. Methods: Retrospective case-control study of injured children under age 6 who had abnormal initial head CT scans and who were admitted to the only Level I pediatric trauma center in Washington State for closed head injury (CHI) from January 1, 1992 to December 31, 1998. Results: Fifteen children developed cerebral infarct after CHI during the 7 year period. These cases were compared to 53 controls (those who did not develop infarct). After adjusting for the presence of SDH and for severity of injury, patients with infarcts were six times more likely to have been abused than patients without infarcts (OR 6.1; 95% CI, 1.02-36.0). Conclusions: Cerebral infarct after CHI appears to result more frequently from abuse than unintentional injury in young children. (C) 2003 Elsevier Science Ltd. All rights reserved.	Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Epidemiol, Seattle, WA 98104 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Univ Washington, Dept Radiol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, King Cty Med Examiners Off, Seattle, WA 98195 USA		Rivara, FP (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pediat, Box 359960,325 9th Ave, Seattle, WA 98104 USA.						Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; AUER RN, 1994, J NEUROL NEUROSUR PS, V57, P500, DOI 10.1136/jnnp.57.4.500; BIRD CR, 1987, RADIOLOGY, V163, P373, DOI 10.1148/radiology.163.2.3562816; COHEN RA, 1985, AM J NEURORADIOL, V6, P883; Cox L A, 1996, Radiol Technol, V67, P513; DHARKER SR, 1993, NEUROSURGERY, V33, P863; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Duval E L, 1998, Eur J Emerg Med, V5, P259; EWINGSCOBBS L, 1999, PEDIAT NEUROSURGERY, V102, P300; GARG BP, 1995, PEDIATR NEUROL, V13, P46, DOI 10.1016/0887-8994(95)00108-R; Gayle Michael O., 1995, Journal of Emergency Medicine, V13, P233, DOI 10.1016/0736-4679(94)00145-6; Gean AD, 1994, IMAGING HEAD TRAUMA; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GLASIER CM, 1987, CLIN NUCL MED, V12, P897, DOI 10.1097/00003072-198711000-00022; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; HAN BK, 1990, AM J ROENTGENOL, V154, P361, DOI 10.2214/ajr.154.2.2105031; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; MIRVIS SE, 1990, AM J NEURORADIOL, V11, P355; Petitti N, 1998, ACAD RADIOL, V5, P215, DOI 10.1016/S1076-6332(98)80287-0; POWELL FC, 1994, STROKE, V25, P117, DOI 10.1161/01.STR.25.1.117; Rao P, 1999, CLIN RADIOL, V54, P495, DOI 10.1016/S0009-9260(99)90845-0; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; *SPSS INC, 1995, SPSS; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; TEASDALE G, 1974, LANCET, V2, P81; Wardlaw JM, 1998, STROKE, V29, P1315, DOI 10.1161/01.STR.29.7.1315	30	5	5	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	APR	2003	27	4					381	392		10.1016/S0145-2134(03)00025-5			12	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Family Studies; Psychology; Social Work	668TR	WOS:000182309700005	12686323				2022-02-06	
J	Bruder, N				Bruder, N			Anaesthesia for patients with intracranial hypertension due to cerebral oedema	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	24th Neuroanesthesia and Neurointensive Care Meeting	NOV 21-22, 2002	GENEVA, SWITZERLAND			anaesthesia; neurosurgery; head injury; subarachnoid haemorrhage; cerebral perfusion pressure; intracranial pressure; mannitol	ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEUROGENIC PULMONARY-EDEMA; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID PRESSURE; BLOOD-FLOW VELOCITY; CERVICAL-SPINE; NEUROSURGICAL PATIENTS; PERFUSION-PRESSURE; TRANSSPHENOIDAL HYPOPHYSECTOMY; FIBEROPTIC INTUBATION	The main objective for anaesthesia in patients with intracranial hypertension (ICH) is to maintain the cerebral perfusion pressure (CPP). Before the operation, the assessment of the level of intracranial pressure relies on the Glasgow coma score and the signs of ICH on the CT-scan. In the perioperative period, repeated transcranial Doppler examinations may help in determining the adequate CPP. Haemodynamic and respiratory complications are common after subarachnoid haemorrhage or head injury. Careful preoperative screening of the cardiovascular and respiratory system is mandatory before anaesthesia. There is no recommended anaesthetic technique for patients with ICH. Nitrous oxide should be avoided in patients with severe ICH or during emergency surgery. Theoretically, intravenous anaesthesia is a better choice than inhalation anesthesia because of the cerebral vasodilatation induced by inhalation agents. In the most severe cases thiopental is the only anaesthetic agent to consider. Treatment of hypovolaemia with fluid loading and the early use of vasoactive agents can be recommended to maintain CPP. Before intracranial surgery, large doses of mannitol have been demonstrated to improve neurological recovery in brain injured patients. The urinary losses due to the infusion of mannitol should be replaced with isotonic saline. Emergence and extubation are best performed in the intensive care unit under close systemic and cerebral haemodynamic control. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.	CHU Timone, Dept Anesthesie Reanimat, F-13385 Marseille, France		Bruder, N (corresponding author), CHU Timone, Dept Anesthesie Reanimat, F-13385 Marseille, France.	nicolas.bruder@ap-hm.fr					ALBANESE J, 1993, ANESTHESIOLOGY, V79, P493, DOI 10.1097/00000542-199309000-00012; ANDREWS BT, 1987, SURG NEUROL, V28, P419, DOI 10.1016/0090-3019(87)90223-0; Bedford NM, 1999, ANESTH ANALG, V89, P170; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Brown MM, 1996, EUR J ANAESTH, V13, P474, DOI 10.1046/j.1365-2346.1996.00973.x; BRUDER N, 1994, ANN FR ANESTH, V13, P537, DOI 10.1016/S0750-7658(05)80691-4; Bruder N, 2002, ANESTH ANALG, V94, P650, DOI 10.1097/00000539-200203000-00031; Bruder N, 1999, J NEUROSURG ANESTH, V11, P282, DOI 10.1097/00008506-199910000-00009; Cenic A, 2002, ANESTH ANALG, V94, P661, DOI 10.1097/00000539-200203000-00033; CONSTANTINI S, 1988, J NEUROSURG, V69, P540, DOI 10.3171/jns.1988.69.4.0540; Cruz J, 2001, NEUROSURGERY, V49, P864; Duffy CM, 2000, J NEUROSURG ANESTH, V12, P128, DOI 10.1097/00008506-200004000-00012; FORTUNE JB, 1995, J TRAUMA, V39, P463; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Fuchs G, 1999, J NEUROSURG ANESTH, V11, P11, DOI 10.1097/00008506-199901000-00003; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Guy J, 1997, ANESTHESIOLOGY, V86, P514, DOI 10.1097/00000542-199703000-00002; HAMILL JF, 1981, ANESTHESIOLOGY, V55, P578, DOI 10.1097/00000542-198111000-00016; HASTINGS RH, 1993, ANESTHESIOLOGY, V78, P580, DOI 10.1097/00000542-199303000-00022; HASTINGS RH, 1994, ANESTHESIOLOGY, V80, P825, DOI 10.1097/00000542-199404000-00015; HAYASHI M, 1988, STROKE, V19, P314, DOI 10.1161/01.STR.19.3.314; HEATH KJ, 1994, ANAESTHESIA, V49, P843, DOI 10.1111/j.1365-2044.1994.tb04254.x; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Hoffman WE, 1998, ANESTHESIOLOGY, V88, P1188, DOI 10.1097/00000542-199805000-00008; Jansen GFA, 1999, ANESTH ANALG, V89, P358, DOI 10.1097/00000539-199908000-00021; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kerr ME, 1999, CRIT CARE MED, V27, P2776, DOI 10.1097/00003246-199912000-00028; Kuroda Y, 1996, ANESTHESIOLOGY, V84, P555, DOI 10.1097/00000542-199603000-00010; LAM AM, 1992, BRIT J ANAESTH, V68, P424, DOI 10.1093/bja/68.4.424; LAM AM, 1994, ANESTH ANALG, V78, P462; LAM AM, 1993, ANESTHESIOLOGY, V78, P191, DOI 10.1097/00000542-199301000-00026; Levis S, 1998, ACT NEUR S, V71, P174; Marshman LAG, 1997, STROKE, V28, P1445, DOI 10.1161/01.STR.28.7.1445; MATTA BF, 1995, BRIT J ANAESTH, V74, P159, DOI 10.1093/bja/74.2.159; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; MAYER SA, 1994, NEUROLOGY, V44, P815, DOI 10.1212/WNL.44.5.815; MCCLELLAN MD, 1989, J APPL PHYSIOL, V67, P1185, DOI 10.1152/jappl.1989.67.3.1185; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; ORNSTEIN E, 1993, ANESTHESIOLOGY, V79, P498, DOI 10.1097/00000542-199309000-00013; OVASSAPIAN A, 1989, BRIT J ANAESTH, V62, P13, DOI 10.1093/bja/62.1.13; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; RAVUSSIN P, 1988, J NEUROSURG, V69, P869, DOI 10.3171/jns.1988.69.6.0869; RAVUSSIN P, 1993, NEUROSURGERY, V32, P236, DOI 10.1227/00006123-199302000-00013; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; RUSSELL GB, 1995, ANESTH ANALG, V81, P806, DOI 10.1097/00000539-199510000-00025; RUSSELL GB, 1994, J TRAUMA, V36, P317, DOI 10.1097/00005373-199403000-00006; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Storey BC, 1999, J AFR EARTH SCI, V29, P1, DOI 10.1016/S0899-5362(99)00075-5; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Talke P, 1999, ANESTHESIOLOGY, V91, P127, DOI 10.1097/00000542-199907000-00020; Talke P, 1996, ANESTHESIOLOGY, V85, P999, DOI 10.1097/00000542-199611000-00006; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; TOUHO H, 1989, NEUROSURGERY, V25, P762, DOI 10.1227/00006123-198911000-00011; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; VOLDBY B, 1982, J NEUROSURG, V56, P186, DOI 10.3171/jns.1982.56.2.0186; WERNER C, 1995, ANESTHESIOLOGY, V83, P721, DOI 10.1097/00000542-199510000-00011; Wijdicks E F, 1990, Acta Neurochir Suppl (Wien), V47, P111; WIJDICKS EFM, 1991, STROKE, V22, P1519, DOI 10.1161/01.STR.22.12.1519; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	65	5	5	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAR	2003	22	3					226	234		10.1016/S0750-7658(03)00011-X			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	686TF	WOS:000183336500011	12747991				2022-02-06	
J	Miller, MA; Burnett, DM; McElligott, JM				Miller, MA; Burnett, DM; McElligott, JM			Congenital and acquired brain injury. 3. Rehabilitation interventions: Cognitive, behavioral, and community reentry	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						arousal; brain injuries; cognition; depression; family; health services; rehabilitation	METHYLPHENIDATE; SERVICES; INDIVIDUALS; AMANTADINE; AGENTS; STATE; CHILDREN; TRIAL	This self-directed learning module highlights the cognitive and psychosocial adjustment aspects of brain injury. It is part of the chapter on congenital and acquired brain injury in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article focuses specifically on evaluation and treatment of mood and behavioral impairments after brain injury, treatment of cognitive impairments, efficacy of cognitive rehabilitation, psychosocial impact of a traumatic brain injury on families, and resources available for community reintegration. Overall Article Objective: To summarize the psychosocial and cognitive impact of brain injury in children and adults.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; E Carolina Univ, Dept Phys Med & Rehabil, Greenville, NC USA		Miller, MA (corresponding author), Columbus Childrens Hosp, Educ Bldg,Rm 478,700 Childrens Dr, Columbus, OH 43205 USA.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Fava M, 1997, PSYCHIAT CLIN N AM, V20, P427, DOI 10.1016/S0193-953X(05)70321-X; Glenn MB, 1998, J HEAD TRAUMA REHAB, V13, P87, DOI 10.1097/00001199-199810000-00010; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Goodall P, 2001, J HEAD TRAUMA REHAB, V16, P94, DOI 10.1097/00001199-200102000-00010; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Laborde A, 1997, J HEAD TRAUMA REHAB, V12, P90, DOI 10.1097/00001199-199708000-00009; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Murrey GJ, 1998, J HEAD TRAUMA REHAB, V13, P72, DOI 10.1097/00001199-199812000-00008; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Schneider WN, 1999, BRAIN INJURY, V13, P863; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; TAYLOR G, IN PRESS REHABIL PSY; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Vaughn SL, 2001, J HEAD TRAUMA REHAB, V16, P20, DOI 10.1097/00001199-200102000-00005; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	33	5	5	0	8	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2003	84	3		1			S12	S17		10.1053/apmr.2003.50053			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	656DP	WOS:000181593800004	12708553				2022-02-06	
J	Perna, RB; Rouselle, A; Brennan, P				Perna, RB; Rouselle, A; Brennan, P			Traumatic brain injury - Depression, neurogenesis, and medication management	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							MAJOR DEPRESSION; HIPPOCAMPAL ATROPHY; GLUCOCORTICOIDS; STRESS; VOLUME		WestSite Neurorehabil Serv Ctr, Lewiston, ME USA; Spaulding Rehabil Hosp, Boston, MA USA; Harvard Med Sch, Boston, MA USA		Perna, RB (corresponding author), Morrill St, Buckfield, ME 04220 USA.		Perna, Robert/AAQ-7719-2021; Perna, Robert/AAA-3871-2020				Andersen G, 1999, J NEUROTRAUM, V16, P341, DOI 10.1089/neu.1999.16.341; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; DAMUN RS, 2001, NEUROPSYCHOPHARMACOL, V25, P36; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; GREENBERG G, 2001, DISCOVER, V22; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Manji HK, 2000, BIOL PSYCHIAT, V48, P740, DOI 10.1016/S0006-3223(00)00979-3; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Patterson DE, 1997, BRAIN INJURY, V11, P287, DOI 10.1080/026990597123593; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sheline YI, 2000, BIOL PSYCHIAT, V48, P791, DOI 10.1016/S0006-3223(00)00994-X; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Vaidya VA, 2001, BRIT MED BULL, V57, P61, DOI 10.1093/bmb/57.1.61	19	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2003	18	2					201	203					3	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	663DU	WOS:000181991600010	12802228				2022-02-06	
J	Bogousslavsky, J				Bogousslavsky, J			The lost love of Gui and Madeleine. Emotional syndrome and right temporal behavior of Guillaume Apollinaire.	REVUE NEUROLOGIQUE			French	Article							HEAD-INJURY	The nature and the neurological consequences of the shell wound to the head of the famous French poet Guillaume Apollinaire, on March 17, 1916, during World War I, remain unclear. However, his contemporaries and biographers have been unanimous to state that this event was a major shift in his life. His personality and behavior changed dramatically, and his affective relationships were deeply modified, the most significant example being his rapid disinterest for his fiancee Madeleine, to whom he had written passionate letters nearly every day before the trauma. The study of Apollinaire's letters, scarce medical reports, available memories from friends, and Apollinaire's helmet allow to understand better what brain lesion he had and why neurobehavioral dysfunction developed. While an 'intracranial abcess" had been emphasized initially, clinical manifestations, free interval, no infectious problem, and quick resolution of hemiparesis and seizures after a burr hole was performed strongly suggest a chronic subdural hematoma in the right temporal region. Irritability, susceptibility, emotional intolerance, affect flattening, anxiety, and personality change fit perfectly with right temporal lobe dysfunction involving the lateral-basal area. Sparing of mesial-temporal, parietal, and frontal regions explained the absence of significant memory, cognitive, and executive impairment, without disturbed creative skills as a poet and art writer. This cognitive-affective dissociation secondary to isolated right temporal post-traumatic lesion allows to delineate the "deep sorrow" of Apollinaire during the two and a half years before he died from Spanish influenza in 1918.	CHU Vaudois, Serv Neurol, CH-1011 Lausanne, Switzerland		Bogousslavsky, J (corresponding author), CHU Vaudois, Serv Neurol, CH-1011 Lausanne, Switzerland.	julien.bogousslavsky@chuv.hospvd.ch					ADEMA M, 1952, GUILLAUME APOLLINAIR; AJURIAGUERRA J, 1964, CORTEX CEREBRAL; ANNONI JM, 2001, ENCY MEDICOCHIRURGIC, P1; Apollinaire G., 1918, CALLIGRAMMES POEMES; APOLLINAIRE G, 1977, OEUVRES PROSE COMPLE, V1; APOLLINAIRE G, 1969, LETT LOU; APOLLINAIRE G, 1991, OEUVRES PROSE COMPLE, V2; APOLLINAIRE G, 1952, TENDRE COMME SOUVENI; APOLLINAIRE G, 1993, OEUVRES PROSE COMPLE, V3; APOLLINAIRE G, 1917, VITAM IMPENDERE AMOR; APOLLINAIRE G, 1971, ALBUM APOLLINAIRE; Bakchine S, 2000, BEHAVIOR AND MOOD DISORDERS IN FOCAL BRAIN LESIONS, P369; BILLY A, 1923, APOLLINAIRE VIVANT A; BOGOUSSLAVSKY J, 1991, ENCY MEDICOCHIRURGIC, P1; BOGOUSSLAVSKY J, 2001, BEHAV MOOD DISORDERS; BRETON A, 1913, ENTRETIENS 1913 1952; CAILLER P, 1965, GUILLAUME APOLLINAIR; Clarke S, 1997, NEUROPSYCHOLOGIA, V35, P1555, DOI 10.1016/S0028-3932(97)00083-3; COURVILLE CB, 1958, TEMPORAL LOBE EPILEP, P220; DECAUDIN M, 2001, COMMUNICATION; EdwardsLee T, 1997, BRAIN, V120, P1027, DOI 10.1093/brain/120.6.1027; EVANS RW, 1996, NEUROLOLGY TRAUMA; GABORY G, 1988, APOLLINAIRE; GILLET R, 1999, STENDHAL R CHAR CABI, P27; GUERIN J, 1986, TRES BEAUX LIVRES 19, P4; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Mendez MF, 2001, NEUROLOGY, V57, P519, DOI 10.1212/WNL.57.3.519; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; PARINAUD A, 1994, APOLLINAIRE; PIA P, 1966, APOLLINAIRE LUIMEME; PICAASOAPOLINAI, 1992, COMMUNICATION; Pierre Marcel Adema, 1968, GUILLAUME APOLLINAIR; POLIZZOTTI M, 1999, A BRETON; Read Peter, 1995, PICASSO APOLLINAIRE; SCHILLER F, 1947, J NEUROL NEUROSUR PS, V10, P183, DOI 10.1136/jnnp.10.4.183; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Silverstein A, 1999, SEMIN NEUROL, V19, P3; SOLLIER P, 1918, TRAITE NEUROLOGIE GU; THIEBAUT F, 1948, PRESSE MED, V56, P837; TYRRELL PJ, 1990, J NEUROL NEUROSUR PS, V53, P1046, DOI 10.1136/jnnp.53.12.1046; 1991, BIBLIOTHEQUE HIST VI; 1948, B MEMOIRES SOC MED H, V64, P1264	42	5	5	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.	FEB	2003	159	2					171	179					9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	656XA	WOS:000181635300004	12660569				2022-02-06	
J	Pierrot, M; Francois, V; Ter Minassian, A; Clavier, N; Boulard, G; Beydon, L				Pierrot, M; Francois, V; Ter Minassian, A; Clavier, N; Boulard, G; Beydon, L			The impact of a French guideline on the clinical management of severe head injury (SHI) published in 1999	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						head injury; brain; guidelines; recommendation; impact; survey	TRAUMATIC BRAIN INJURY; EPIDEMIOLOGY; FRANCE; CARE	Objective - To evaluate the impact of a French guideline on the clinical management of severe head injury (SHI) published in 1999. Study design - Nationwide survey. Methods - 182 medical centres,answered the inquiry. Results - 111 centres declared to manage such patients suffering from SHI. 68 % of doctors from these clinical departments did report to have read these guidelines. Fifty percent of them found in these guidelines useful data fur their clinical practice. Forty four percent of centres could not monitor ICP lacking neurosurgical facility in their hospital. Conversely, all hospitals with neurosurgery available did monitor ICP. Seventy six percent of centres reported difficulties to find a facility, which would take these patients in charge when discharged from ICU. We analysed the main items included in the guidelines and report their impact. Seventy four percent of responders found that clinical management of SHI patients had improved during the last years. Conclusion - The French guidelines had a significant impact and seem to have provided a useful aid to clinical management of SHI patients. ICP monitoring and the shortage in post-ICU facilities are remaining issues. (C) 2003 Editions scientifiques et medicates Elsevier SAS. All rights reserved.	CHU Angers, Dept Anesthesie, F-49033 Angers, France; CHU Bordeaux, Dept Anesthesie, F-33076 Bordeaux, France; CH Cherbourg, Dept Anesthesie, Cherbourg, France		Beydon, L (corresponding author), CHU Angers, Dept Anesthesie, F-49033 Angers, France.	1Beydon.angers@invivo.edu					*BTF AANS, 1995, GUID MAN SERV HEAD I; ELJAMEL MS, 1992, BRIT J NEUROSURG, V6, P559, DOI 10.3109/02688699209002373; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 1997, AM ASS NEUROLOGI SUM, P2; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Picard P, 1997, ANN FR ANESTH, V16, P420, DOI 10.1016/S0750-7658(97)81474-8; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; SAUNDERS RL, 1978, NEUROSURGERY, V3, P130, DOI 10.1097/00006123-197807000-00021; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; 1999, ANN FR ANESTH REANIM, V18, P1	15	5	6	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	JAN	2003	22	1					12	17	PII S0750-7658(02)00003-5	10.1016/S0750-7658(02)00003-5			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	667DN	WOS:000182215800004	12738014				2022-02-06	
J	Jaskiw, GE; Kenny, JF				Jaskiw, GE; Kenny, JF			Limbic cortical injury sustained during adulthood leads to schizophrenia-like syndrome	SCHIZOPHRENIA RESEARCH			English	Article						schizophrenia; limbic cortical injury; adulthood	TRAUMATIC BRAIN INJURY; PREFRONTAL CORTEX; DOPAMINE; PERFORMANCE; DYSFUNCTION; IDENTIFICATION; CLOZAPINE; PSYCHOSIS; DEFICITS; LESION	Within 1 year of severe trauma to the left anterior temporal lobe and minor injury to the frontal lobes, a 35-year-old individual developed classic positive and negative symptoms of schizophrenia. His antipsychotic drug-induced parkinsonism was greater on the left side, suggesting increased left striatal dopaminergic transmission. The authors propose that even in adulthood, significant and selective disruption of fronto-temporal connectivity is sufficient to produce a phenocopy of schizophrenia. Published by Elsevier Science B.V.	Louis Stokes Cleveland VAMC Gen Mental Hlth Care, Cleveland, OH USA; Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA		Jaskiw, GE (corresponding author), Cleveland VAMC, GMH B, 10000 Brecksville Rd, Brecksville, OH 44141 USA.						ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Arango C, 1999, AM J PSYCHIAT, V156, P1349; Brewer WJ, 1996, BIOL PSYCHIAT, V40, P1021, DOI 10.1016/0006-3223(95)00594-3; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; Burke JG, 1999, J PSYCHIATR NEUROSCI, V24, P456; CALEV A, 1984, PSYCHOL MED, V14, P425, DOI 10.1017/S0033291700003676; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; FLEMING K, 1995, PSYCHIAT RES, V56, P55; Friedman L, 1998, BRAIN LANG, V64, P231, DOI 10.1006/brln.1998.1953; Gourovitch ML, 1996, NEUROPSYCHOLOGY, V10, P573; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; HAGGER C, 1993, BIOL PSYCHIAT, V34, P702, DOI 10.1016/0006-3223(93)90043-D; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Heinz A, 1999, SYNAPSE, V32, P71, DOI 10.1002/(SICI)1098-2396(199905)32:2<71::AID-SYN1>3.0.CO;2-Q; KENNY JT, 1991, J NEUROPSYCH CLIN N, V3, P269; KENNY JT, 1994, UNPUB NORMS CLEVELAN; LEWIS SW, 1989, PSYCHOL MED, V19, P5, DOI 10.1017/S0033291700010977; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LIPSKA BK, 1992, BRAIN RES, V585, P1, DOI 10.1016/0006-8993(92)91184-G; LIPSKA BK, 1994, PHARMACOL BIOCHEM BE, V48, P1053, DOI 10.1016/0091-3057(94)90220-8; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; OCALLAGHAN E, 1988, BRIT J PSYCHIAT, V153, P394, DOI 10.1192/bjp.153.3.394; Pang A, 1996, BRIT J PSYCHIAT, V168, P647, DOI 10.1192/bjp.168.5.647; PANTELIS C, 1995, SCHIZOPHR RES, V17, P35, DOI 10.1016/0920-9964(95)00029-L; Paulsen J S, 1995, J Int Neuropsychol Soc, V1, P88; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; SAINTCYR JA, 1988, BRAIN, V111, P941, DOI 10.1093/brain/111.4.941; SEIDMAN LJ, 1991, SCHIZOPHR RES, V6, P55, DOI 10.1016/0920-9964(91)90021-I; SHIMAMURA AP, 1996, BRAIN ORG MEMORY, P159; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430; VARNEY N, 1988, J CLIN EXP PSYCHOL, V19, P250; VERDOUX H, 1995, SCHIZOPHR RES, V14, P133, DOI 10.1016/0920-9964(94)00018-4; *WAIS 3 WMS 3, 1997, TECHN MAN; WARRINGTON EK, 1997, RECOGNITION MEMORY T; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8	39	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964			SCHIZOPHR RES	Schizophr. Res.	DEC 1	2002	58	2-3					205	212	PII S0920-9964(02)00152-4	10.1016/S0920-9964(02)00152-4			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	614NJ	WOS:000179196000011	12409160				2022-02-06	
J	Armstead, WM				Armstead, WM			Age-dependent NOC/oFQ contribution to impaired hypotensive cerebral hemodynamics after brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral circulation; newborn; opioids	OPIOID RECEPTOR FAMILY; K+ CHANNEL FUNCTION; HEAD-INJURY; NOCICEPTIN/ORPHANIN FQ; CLONING; MEMBER; ATP; CEREBROVASODILATION; LOCALIZATION; ACTIVATION	Previous studies have observed that the newly described opioid, nociceptin/orphanin FQ (NOC/oFQ), contributed to age dependent reductions in cerebral blood flow (CBF) and pial artery diameter after fluid percussion brain injury(FPI). Unrelated studies have noted a similar age dependency in impaired hypotensive cerebral autoregulation after FPI. This study was designed to compare the role of NOC/oFQ in impaired hypotensive cerebral autoregulation after FPI in newborn and juvenile pigs equipped with a closed cranial window. Ten minutes of hemorrhagic hypotension (10-15 mL blood/kg) decreased mean arterial blood pressure uniformly in both groups (approximate to44%). In the newborn, hypotensive pial artery dilation was blunted within I h of FPI but partially protected by pretreatment with the NOC/oFQ antagonist, [F/G] NOC/oFQ (1-13) NH2 (1 Mg/kg, i.v.) (34 +/- 1 vs. 8 +/- 1 vs. 20 +/- 2 % for sham control, FPI, and FPI-[F/G] NOC/oFQ (1-13) NH2, respectively). CBF was reduced during normotension by FPI, further reduced by hypotension, but both were partially protected by this antagonist in the newborn (63 +/- 4, 34 +/- 2, and 20 +/- 2 vs. 65 +/- 4, 47 +/- 2, and 29 +/- 2 mL/min-100 g for normotension, normotension-FPI and hypotension-FPI in the absence and presence of [F/G] NOC/oFQ (1-13) NH2, respectively). In contrast, blunted hypotensive pial artery dilation was protected significantly less by this NOC/oFQ antagonist in the juvenile (32 +/- 2 vs. 7 +/- 2 vs. 13 +/- 2 % for sham control, FPI and FPI-NOC/oFQ antagonist, respectively). Similarly, [F/G] NOC/oFQ (1-13) NH2 had less protective effect on normotensive and hypotensive CBF values post FPI in the juvenile. These data indicate that NOC/oFQ contributes to impaired hypotensive cerebral hemodynamics following brain injury in an age-dependent manner.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.						Armstead WM, 2000, J NEUROTRAUM, V17, P751, DOI 10.1089/neu.2000.17.751; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 1997, BRAIN RES, V768, P177, DOI 10.1016/S0006-8993(97)00641-0; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1999, J NEUROTRAUM, V16, P391, DOI 10.1089/neu.1999.16.391; ARMSTEAD WM, 1999, AM J PHYSIOL, V274, pH1888; ARMSTEAD WM, 1997, P SOC EXP BIOL MED, V21, P210; CHEN Y, 1994, FEBS LETT, V347, P279, DOI 10.1016/0014-5793(94)00560-5; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DeWitt DS, 1996, ANESTHESIOLOGY, V85, pA1189; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; FUKUDA K, 1994, FEBS LETT, V343, P42, DOI 10.1016/0014-5793(94)80603-9; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; JULIUS D, 1995, NATURE, V377, P476, DOI 10.1038/377476a0; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	24	5	5	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2002	19	10					1193	1202		10.1089/08977150260337994			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	605MJ	WOS:000178681400008	12427328				2022-02-06	
J	Hymel, KP				Hymel, KP			Inflicted traumatic brain injury in infants and young children	INFANTS & YOUNG CHILDREN			English	Article						brain injury/etiology; child abuse; children; infant; predictors of outcome	NONACCIDENTAL HEAD-INJURY; SHAKEN BABY SYNDROME; COMA DATA-BANK; MENTAL-RETARDATION; IMPACT SYNDROME; ABUSE SYNDROME; SHAKING; DAMAGE; NEUROPATHOLOGY; MECHANISMS	In recent years, there has been a substantial increase in the number of Published reports in the medical literature that specifically describe Outcomes after inflicted traumatic brain injury (TBI) during the first years of life. Though much more work is needed, these early reports are sobering-inflicted cranial injuries have been linked to devastating morbidity and mortality in infants and young children, in this article, we will analyze this emerging body of literature and discuss the implications of these early studies for early intervention specialists.	Inova Fairfax Hosp Children, Dept Pediat, Falls Church, VA USA; Univ Virginia, Dept Pediat, Charlottesville, VA USA		Hymel, KP (corresponding author), Inova Fairfax Hosp Children, Dept Pediat, Falls Church, VA USA.						ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; ALEXANDER RC, 1986, J PEDIATR-US, V109, P975, DOI 10.1016/S0022-3476(86)80279-7; AOKI N, 1986, NEUROSURGERY, V18, P475, DOI 10.1227/00006123-198604000-00017; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; COHEN RA, 1986, AM J ROENTGENOL, V146, P97, DOI 10.2214/ajr.146.1.97; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DYKES LJ, 1986, CHILD ABUSE NEGLECT, V10, P211, DOI 10.1016/0145-2134(86)90082-7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; HAHN YS, 1983, CHILD BRAIN, V10, P229; HANIGAN WC, 1987, PEDIATRICS, V80, P618; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; HELFER RE, 1977, PEDIATRICS, V60, P533; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LYONS TJ, 1993, PEDIATRICS, V92, P125; MERTEN DF, 1984, PEDIATR RADIOL, V14, P272, DOI 10.1007/BF01601874; MERTEN DF, 1990, PEDIATR CLIN N AM, V37, P815; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STARLING SP, 1995, PEDIATRICS, V95, P259; TSAI FY, 1980, CT-J COMPUT TOMOGR, V4, P277, DOI 10.1016/0149-936X(80)90020-X; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9; Winston, 1998, CHILD MALTREATMENT, V3, P116, DOI [DOI 10.1177/1077559598003002006, 10.1177/1077559598003002006]	44	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0896-3746	1550-5081		INFANT YOUNG CHILD	Infants Young Child.	OCT	2002	15	2					57	65		10.1097/00001163-200210000-00008			9	Education, Special; Psychology, Developmental; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology; Rehabilitation	596QY	WOS:000178177800007					2022-02-06	
J	Mursch, K; Muller, CA; Buhre, W; Lang, JK; Vatter, H; Behnke-Mursch, J				Mursch, K; Muller, CA; Buhre, W; Lang, JK; Vatter, H; Behnke-Mursch, J			Blood flow velocities in the basal cerebral vein after head trauma: A prospective study in 82 patients	JOURNAL OF NEUROIMAGING			English	Article						cerebral veins; head injury; hemodynamics; transcranial duplex sonography	TRANSCRANIAL DOPPLER ULTRASOUND; CODED DUPLEX SONOGRAPHY; GLASGOW OUTCOME SCALE; REAL-TIME SONOGRAPHY; INTRACRANIAL-PRESSURE; SINUS THROMBOSIS; BRAIN INJURY; HEMODYNAMICS; ARTERIAL; ADULTS	Background and Purpose. The authors' aim was to evaluate the time course of the basal vein's (BVR) mean flow velocity (V-BVR) in patients after traumatic brain injury and its relation to intracranial pressure (ICP), cerebral perfusion pressure (CPP), and the clinical outcome. Methods. In 82 head-injured patients (13 women and 69 men, median age = 31 years, Glasgow Coma Score = 15 to 3), daily measurement of the basal cerebral vein's and the middle cerebral artery's (MCA) flow velocities and pulsatilities was performed during each patient's entire stay in the intensive care unit. No angle correction was performed. A computerized sonography system (SD 800, Philips, Irvine, CA) with a 2.0-MHz to 2.5-MHz transducer was used for all measurements. The Glasgow Outcome Score (GOS) was evaluated after 6 months. Results. During the study period, V-BVR values on the side of trauma were higher in the patients with favorable outcomes (GOS = 4 and 5) compared to patients with unfavorable outcomes (GOS = 2 and 3). This was statistically significant on days 4, 6, 7, and 11 and was not observed in the mean flow velocity of the MCA (V-MCA). V-BVR values among the good-outcome group tended to exceed the normal mean flow velocity (9.1 cm/s), whereas the unfavorable-outcome group was below this level. A correlation between venous flow velocity or pulsatility and ICP or CPP was not observed. Conclusions. Repetitive Doppler examination of the basal cerebral veins may add new aspects to the monitoring of head-injured patients.	Zent Klin Bad Berka, Dept Neurosurg, D-99438 Bad Berka, Germany; Univ Gottingen, Dept Neurosurg, D-3400 Gottingen, Germany; Univ Gottingen, Dept Anaesthesiol Intens Care & Emergency Med, D-3400 Gottingen, Germany		Behnke-Mursch, J (corresponding author), Zent Klin Bad Berka, Dept Neurosurg, Robert Koch Allee 9, D-99438 Bad Berka, Germany.	kaymu@yahoo.de	Buhre, Wolfgang/X-9192-2018	Buhre, Wolfgang/0000-0002-8296-9426			AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Becker G, 1995, J Neuroimaging, V5, P87; BOGDAHN U, 1990, STROKE, V21, P1680, DOI 10.1161/01.STR.21.12.1680; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; EDVINSSON L, 1983, J CEREBR BLOOD F MET, V3, P226, DOI 10.1038/jcbfm.1983.30; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P28; Mursch K, 1999, CHILD NERV SYST, V15, P110, DOI 10.1007/s003810050344; Mursch K, 2001, ACTA NEUROCHIR, V143, P793, DOI 10.1007/s007010170033; MURSCH K, 1998, CEREBROVASC DIS, V8, P13; OHSUMI H, 1994, ANESTHESIOLOGY, V81, P325, DOI 10.1097/00000542-199408000-00009; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; QUINN MW, 1992, DEV MED CHILD NEUROL, V34, P863; ROBERTSON C, 1993, ACTA NEUROCHIR, P25; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SCHMIDEK HH, 1985, NEUROSURGERY, V17, P663, DOI 10.1227/00006123-198510000-00024; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; Stolz E, 2002, STROKE, V33, P479, DOI 10.1161/hs0202.102371; Stolz E, 1999, STROKE, V30, P1070, DOI 10.1161/01.STR.30.5.1070; Toung TJK, 2000, J APPL PHYSIOL, V88, P655, DOI 10.1152/jappl.2000.88.2.655; Valdueza JM, 1996, STROKE, V27, P1221, DOI 10.1161/01.STR.27.7.1221; WARDLAW JM, 1994, J NEUROSURG, V80, P332, DOI 10.3171/jns.1994.80.2.0332; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	25	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	OCT	2002	12	4					325	329		10.1111/j.1552-6569.2002.tb00140.x			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	598AE	WOS:000178252300005	12380479				2022-02-06	
J	Earnhardt, JN; Streit, WJ; Anderson, DK; O'Steen, WA; Nick, HS				Earnhardt, JN; Streit, WJ; Anderson, DK; O'Steen, WA; Nick, HS			Induction of manganese superoxide dismutase in acute spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						interleukin-1 beta; MnSOD; motoneuron; spinal cord injury	TUMOR-NECROSIS-FACTOR; EXPERIMENTAL TRAUMATIC INJURY; MITOCHONDRIAL CYTOCHROME-C; CHEMOKINE MESSENGER-RNA; ISCHEMIC BRAIN INJURY; NITRIC-OXIDE; INFLAMMATORY RESPONSE; LIPID-PEROXIDATION; CATALASE MIMETICS; CONTUSION INJURY	Free radical-mediated mechanisms of cellular damage have been implicated in the early stages of spinal cord injury (SCI). Manganese superoxide dismutase (MnSOD) is a potent scavenger of superoxide radicals and likely serves an important cytoprotective role in preventing cellular damage after SCI. We have evaluated the expression of MnSOD to address its role during the early events of SCI using a well-established rat contusion model. Northern analysis showed a rapid induction of MnSOD mRNA between 2 and 6 h post injury. Observed time-dependent increases in MnSOD message was maximal 6 h post injury over that of MnSOD mRNA levels induced by laminectomy alone. Immunoblot and immunohistochemical analysis demonstrated increased expression of MnSOD protein 24 h after SCI with localization primarily within neurons. Interestingly, laminectomy alone also caused an induction of MnSOD gene and protein expression. To evaluate one potential mechanism of MnSOD induction, we microinjected the naive spinal cord with IL-1beta, which caused a similar fold induction of MnSOD mRNA levels by 6 h as observed with SCI, thus implicating it as a potential inducer of MnSOD during SCI. In summary, these results demonstrate that this potent cytoprotective antioxidant enzyme is rapidly and significantly induced as a consequence of SCI.	Univ Florida, Dept Neurosci, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Evelyn F & William L McKnight Brain Inst, Gainesville, FL 32610 USA; Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA		Nick, HS (corresponding author), Univ Florida, Dept Neurosci, Coll Med, POB 100244, Gainesville, FL 32610 USA.						AKASHI M, 1995, J BIOL CHEM, V270, P15864, DOI 10.1074/jbc.270.26.15864; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; ANDERSON D K, 1985, Journal of Free Radicals in Biology and Medicine, V1, P59, DOI 10.1016/0748-5514(85)90030-3; ANDERSON DK, 1994, INT ACAD B, V7, P119; ANDERSON DK, 1980, J NEUROSURG, V52, P387, DOI 10.3171/jns.1980.52.3.0387; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; ANDERSON DK, 1978, J NEUROSURG, V48, P232, DOI 10.3171/jns.1978.48.2.0232; ASAYAMA K, 1985, AM J PHYSIOL, V249, P393; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; BENVENISTE EN, 1992, AM J PHYSIOL, V263, P16; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Boveris A, 1977, Adv Exp Med Biol, V78, P67; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DOUGALL WC, 1991, ENDOCRINOLOGY, V129, P2376, DOI 10.1210/endo-129-5-2376; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; EASTGATE J, 1993, BLOOD, V81, P639; Epperly M, 1998, GENE THER, V5, P196, DOI 10.1038/sj.gt.3300580; FEY GH, 1987, MOL BIOL MED, V4, P323; FRIDOVICH I, 1974, ADV ENZYMOL, V41, P36; Fujimura M, 1999, J NEUROSCI, V19, P3414; Ghirnikar RS, 2000, J NEUROSCI RES, V59, P63, DOI 10.1002/(SICI)1097-4547(20000101)59:1<63::AID-JNR8>3.3.CO;2-N; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; GRUNER JA, 1993, J NEUROTRAUM, V10, P327, DOI 10.1089/neu.1993.10.327; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HARRIS CA, 1991, J IMMUNOL, V147, P149; HENSLEY K, 1998, CONTEMP NEUROSCI, P265; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Hohmeier HE, 1998, J CLIN INVEST, V101, P1811, DOI 10.1172/JCI1489; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; HURT J, 1992, NUCLEIC ACIDS RES, V20, P2985, DOI 10.1093/nar/20.12.2985; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Keller JN, 1998, J NEUROSCI, V18, P687; Kifle Y, 1996, J NEUROCHEM, V66, P2128; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO;2-G; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MORNEO S, 1997, J HISTOCHEM CYTOCHEM, V45, P1611; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ransohoff RR, 1996, CYTOKINES CNS; Sambrook J, 1989, MOL CLONING LAB MANU; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Shaw PJ, 1997, J NEUROL SCI, V147, P115, DOI 10.1016/S0022-510X(96)05316-6; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TANNAHILL CL, 1995, GASTROENTEROLOGY, V109, P800, DOI 10.1016/0016-5085(95)90387-9; Tannahill CL, 1997, AM J PHYSIOL-GASTR L, V272, pG1230, DOI 10.1152/ajpgi.1997.272.5.G1230; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Tonai T, 1999, J NEUROCHEM, V72, P302, DOI 10.1046/j.1471-4159.1999.0720302.x; VISNER GA, 1990, J BIOL CHEM, V265, P2856; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; WATSON BD, 1988, OXYGEN RADICALS TISS, P81; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608; ZHONG W, 1996, ONCOGENE, V14, P481	71	5	7	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2002	19	9					1065	1079		10.1089/089771502760341974			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	598KW	WOS:000178275900007	12482119				2022-02-06	
J	McCrory, P				McCrory, P			Sudden death in sport - Commotio cordis	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CARDIAC CONCUSSION; IMPACT		Univ Melbourne, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia; Univ Melbourne, Inst Brain Res, Melbourne, Vic, Australia		McCrory, P (corresponding author), POB 93, Shoreham, Vic 3916, Australia.	pmccrory@compuserve.com	McCrory, Paul/Q-8688-2019				BERNSTEIN R, 1896, Z KLIN MED, V29, P519; Casper Johann Ludwig, 1857, PRACTISCHES HDB GERI; COOPER GJ, 1982, J TRAUMA, V22, P994, DOI 10.1097/00005373-198212000-00004; Curfman GD, 1998, NEW ENGL J MED, V338, P1841, DOI 10.1056/NEJM199806183382511; DIKMAN G, 1978, PHYSICIAN SPORTSMED, V6, P85; EDLICH R F JR, 1987, Journal of Emergency Medicine, V5, P181, DOI 10.1016/0736-4679(87)90176-4; FRAZER M, 1984, AM J FOREN MED PATH, V5, P249, DOI 10.1097/00000433-198409000-00015; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; LUECKING D, 1998, ST LOUIS POST C 0512, P1; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; McCrory PR, 2000, MED J AUSTRALIA, V172, P217, DOI 10.5694/j.1326-5377.2000.tb123912.x; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; Michalodimitrakis EN, 1997, AM J FOREN MED PATH, V18, P282, DOI 10.1097/00000433-199709000-00010; Nesbitt AD, 2001, LANCET, V357, P1195, DOI 10.1016/S0140-6736(00)04338-5; RIEDINGER F, 1903, HDB PRAKTISCHEN CHIR, P373	20	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2002	36	4					236	237		10.1136/bjsm.36.4.236			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	580RU	WOS:000177249300002	12145110	Bronze, Green Published			2022-02-06	
J	Zou, LL; Yotnda, T; Zhao, TJ; Yuan, XQ; Long, Y; Zhou, HS; Yang, KY				Zou, LL; Yotnda, T; Zhao, TJ; Yuan, XQ; Long, Y; Zhou, HS; Yang, KY			Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						adenovirus; helper-dependent; transgene; immune response; brain; trauma	TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; LECITHINIZED SUPEROXIDE-DISMUTASE; CONTROLLED CORTICAL IMPACT; HUMORAL IMMUNE-RESPONSES; MEDIATED GENE-TRANSFER; LONG-TERM EXPRESSION; IN-VIVO; FACTOR-ALPHA; RECOMBINANT ADENOVIRUS	Traumatic brain injury (TBI) causes delayed neuronal deficits that in principle could be prevented by timely intervention with therapeutic genes. However. appropriate vectors for gene transfer to the brain with TBI remain to be developed. First-generation adenoviruses (fgAd) are usually associated with inflammatory and toxic effects when inoculated into brains, despite their high efficiency of gene transfer to these tissues. In this study the authors attempted to determine whether a less immunogenic gene-transfer protocol can be established in the traumatically injured rat brain using helper-dependent adenoviruses (hdAd), a novel adenoviral construct with full deletion of viral coding sequences. Their results show that transgene expression from intrahippocampally inoculated hdAd is maintained for at least 2 months after TBI, in contrast to the much shorter duration of fgAd-mediated gene expression. There was only minimal secretion of proinflammatory IL-1beta and TNF-alpha after inoculation of hdAd. Furthermore, the hdAd-mediated gene expression was associated with less microglial proliferation. astrocytic activation, and macrophage infiltration than observed in fgAd-inoculated brains. There was no additional tissue loss after hdAd inoculation compared with PBS injection. Although both anti-adenoviral and neutralizing antibodies were found in serum after brain inoculation of hdAd, they did not appear to affect transgene expression. The results suggest that hdAd are less immunogenic vectors than conventional adenoviral vectors. and offer improved vehicles for long-term therapeutic transgene transfer to traumatically injured brains.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Dept Vet Affairs Med Ctr, Neurol Care Line, Houston, TX USA		Yang, KY (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS35502-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035502] Funding Source: NIH RePORTER		Abe K, 1997, BRAIN RES, V763, P191, DOI 10.1016/S0006-8993(97)00389-2; Abe K, 1998, NEUROL RES, V20, P689; ABE K, 1988, J NEUROCHEM, V51, P1470, DOI 10.1111/j.1471-4159.1988.tb01113.x; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Balasingam V, 1996, J NEUROSCI, V16, P2945; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Burcin MM, 1999, P NATL ACAD SCI USA, V96, P355, DOI 10.1073/pnas.96.2.355; Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353; Cregan SP, 2000, GENE THER, V7, P1200, DOI 10.1038/sj.gt.3301208; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fink SL, 2000, BRAIN RES, V859, P21, DOI 10.1016/S0006-8993(99)02401-4; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Hilton G, 1994, J Neurosci Nurs, V26, P251; Hisahara S, 1997, J NEUROCHEM, V69, P10; IGARASHI R, 1994, J PHARMACOL EXP THER, V271, P1672; Iwata A, 2000, J HEART LUNG TRANSPL, V19, P1017, DOI 10.1016/S1053-2498(00)00200-X; KAHN MA, 1995, BRAIN RES, V685, P55, DOI 10.1016/0006-8993(95)00411-I; Kajiwara K, 2000, J NEUROIMMUNOL, V103, P8, DOI 10.1016/S0165-5728(99)00220-9; Kajiwara K, 1997, HUM GENE THER, V8, P253, DOI 10.1089/hum.1997.8.3-253; KAY MA, 1995, NAT GENET, V11, P191, DOI 10.1038/ng1095-191; Kochanek PM, 2001, J NEUROTRAUM, V18, P73, DOI 10.1089/089771501750055785; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Lawrence MS, 1996, J CEREBR BLOOD F MET, V16, P181, DOI 10.1097/00004647-199603000-00001; LE GLS, 1993, SCIENCE, V259, P988; Marquette C, 1996, J NEUROIMMUNOL, V68, P45, DOI 10.1016/0165-5728(96)00056-2; Mastrangeli A, 1996, HUM GENE THER, V7, P79, DOI 10.1089/hum.1996.7.1-79; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MILLIGAN CE, 1991, J COMP NEUROL, V314, P125, DOI 10.1002/cne.903140112; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Morsy MA, 1999, MOL MED TODAY, V5, P18, DOI 10.1016/S1357-4310(98)01376-8; MURPHY GM, 1993, J NEUROSCI RES, V35, P643, DOI 10.1002/jnr.490350607; Navarro V, 1999, GENE THER, V6, P1884, DOI 10.1038/sj.gt.3301008; NORRIS JG, 1994, J IMMUNOL, V152, P841; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Parr MJ, 1998, J NEUROVIROL, V4, P194, DOI 10.3109/13550289809114519; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sapolsky RM, 1999, NEUROLOGY, V53, P1922, DOI 10.1212/WNL.53.9.1922; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sauder C, 1999, J NEUROIMMUNOL, V96, P29, DOI 10.1016/S0165-5728(98)00272-0; Shimazaki K, 2000, GENE THER, V7, P1244, DOI 10.1038/sj.gt.3301211; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Thomas CE, 2001, HUM GENE THER, V12, P839, DOI 10.1089/104303401750148829; Wood MJA, 1996, TRENDS NEUROSCI, V19, P497, DOI 10.1016/S0166-2236(96)10060-6; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; YANG YP, 1995, NAT MED, V1, P890, DOI 10.1038/nm0995-890; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403; Yunoki M, 1997, J NEUROTRAUM, V14, P739, DOI 10.1089/neu.1997.14.739; Zou LL, 2000, MOL THER, V2, P105, DOI 10.1006/mthe.2000.0104; Zou LL, 1999, GENE THER, V6, P994, DOI 10.1038/sj.gt.3300936; Zou LL, 2001, HUM GENE THER, V12, P181, DOI 10.1089/104303401750061249	67	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2002	22	8					959	970		10.1097/00004647-200208000-00007			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	579PL	WOS:000177187000007	12172381	Bronze			2022-02-06	
J	Goozee, JV; Murdoch, BE; Theodoros, DG				Goozee, JV; Murdoch, BE; Theodoros, DG			Interlabial contact pressures exhibited in dysarthria following traumatic brain injury during speech and nonspeech tasks	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						lips; pressure; dysarthria; traumatic brain injury	FORCE CONTROL; SPEAKERS	A miniature pressure transducer was used to assess the interlabial contact pressures produced by a group of 19 adults (mean age 30.6 years) with dysarthria following severe traumatic brain injury (TBI) during a set of speech and nonspeech tasks. Ten parameters relating to lip strength, endurance, rate of movement and lip pressure accuracy and stability were measured from the nonspeech tasks. The results attained by the TBI group were compared against a group of 19 age- and sex-matched control subjects. Significant differences between the groups were found for maximum interlabial contact pressure, maximum rate of repetition of maximum pressure, and lip pressure accuracy at 50 and 10% levels of maximum pressure. In regards to speech, the interlabial contact pressures generated by the TBI group and control group did not differ significantly. When expressed as percentages of maximum pressure, however, the TBI group's interlabial pressures appeared to have been generated with greater physiological effort. Copyright (C) 2002 S. Karger AG, Basel.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld, Australia		Goozee, JV (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, St Lucia, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012; Theodoros, Deborah/F-1362-2010				AMERMAN JD, 1993, J SPEECH HEAR RES, V36, P460, DOI 10.1044/jshr.3603.460; BARLOW SM, 1983, J SPEECH HEAR RES, V26, P283, DOI 10.1044/jshr.2602.283; BARLOW SM, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P53; BARLOW SM, 1990, J SPEECH HEAR RES, V33, P660, DOI 10.1044/jshr.3304.660; BARLOW SM, 1988, ASS RES OT ABSTR, V11, P218; Brown J.R., 1975, MOTOR SPEECH DISORDE; HINTON VA, 1992, J SPEECH HEAR RES, V35, P245, DOI 10.1044/jshr.3502.245; Hinton VA, 1996, J PHONETICS, V24, P337, DOI 10.1006/jpho.1996.0018; Hinton VA, 1997, J SPEECH LANG HEAR R, V40, P400, DOI 10.1044/jslhr.4002.400; HOWELL DC, 1992, STAT METHODS PSYCHOL; LUSCHEI ES, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P3; MCHENRY M, 1994, MOTOR SPEECH DISORDE, P135; MCHENRY MA, 1994, J SPEECH HEAR RES, V37, P1271, DOI 10.1044/jshr.3706.1271; MCNEIL MR, 1990, J SPEECH HEAR RES, V33, P255, DOI 10.1044/jshr.3302.255; Muller E. M., 1985, Mathematics and computers in biomedical applications, P363; *SPSS INC, 1997, SPSS ADV STAT 7 5; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; THOMPSON EC, 1997, J MED SPEECH-LANG PA, V5, P191; THOMPSON EC, 1996, INT PERSPECTIVES TRA, P259; [No title captured]	20	5	6	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.	JUL-AUG	2002	54	4					177	189		10.1159/000063191			13	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	585PU	WOS:000177534400003	12169804				2022-02-06	
J	McCarthy, ML; MacKenzie, EJ; Durbin, DR				McCarthy, ML; MacKenzie, EJ; Durbin, DR			Children's health status instruments: Their potential application in the emergency department	AMBULATORY PEDIATRICS			English	Article; Proceedings Paper	Meeting on Improving Emergency Medical Services for Children Through Outcomes Research: An Interdisciplinary Approach	MAR 30-APR 01, 2001	RESTON, VA			child health status; emergency medicine	QUALITY-OF-LIFE; TRAUMATIC BRAIN INJURY; FUNCTIONAL INDEPENDENCE; UTILITIES INDEX; PARENT REPORT; PROFILE; TRENDS; RELIABILITY; ASTHMA; VALIDATION	Objective.-To provide an overview of child health status instruments and their potential application by emergency medicine researchers. Conclusions.-Numerous instruments have recently been developed to measure children's physical, mental, and social health using sound principles of measurement science. These instruments differ from traditional clinical benchmarks of impairment. Health is conceived to be multidimensional and is measured from the child's and/or parents' perspective. Child health status instruments can be used to broaden the evaluation of emergency care in the following ways: 1) to evaluate emergency department (ED) interventions in terms of improvements in children's everyday activities and wellbeing: 2) to assess the appropriateness of ED disposition and follow-up services: and 3) to detect underlying health and social problems. Using these instruments in the ED will be challenging. Methodologic issues remain regarding the measurement of children's health. The most pressing issues are the absence of a universal definition of children's health, the need to take into account the developmental and social contexts of children, and the difficulties in eliciting information from very young children. In addition, the ED presents its own set of challenges. These include the lack of preinjury/pre-illness measures, the absence of case-mix severity instruments, and the difficulty of isolating the effect of ED treatment on patients' health. Recommendations.-Despite these challenges, it is time to use pediatric health status instruments in emergency medicine. Only with their adoption will instruments improve and advances in methodology occur. As patients, providers, and policy makers increasingly focus their attention on the nonfatal consequences of injury and illness. the broader use of these measures becomes imperative.	Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA; Univ Penn, Sch Med, Childrens Hosp Philadelphia, Ctr Clin Epidemiol & Biostat,Dept Pediat, Philadelphia, PA 19104 USA		McCarthy, ML (corresponding author), Suite 6-102,1830 E Monument St, Baltimore, MD 21205 USA.	mmccarth@jhmi.edu	Durbin, Dennis/AAD-7829-2022		ODCDC CDC HHS [R49/CCR319701-01] Funding Source: Medline		Apajasalo M, 1996, QUAL LIFE RES, V5, P205, DOI 10.1007/BF00434742; Asmussen L, 2000, AM J RESP CRIT CARE, V162, P1215, DOI 10.1164/ajrccm.162.4.2001067; BENNETT KJ, 1996, QUALITY LIFE PHARMAC, P253; BERGES W, 1989, Z GASTROENTEROL, V27, P156; Beveridge R, 1999, ANN EMERG MED, V34, P155, DOI 10.1016/S0196-0644(99)70223-4; Bush JW., 1982, HEALTH PSYCHOL, V1, P61, DOI [10.1037/0278-6133.1.1.61, DOI 10.1037/0278-6133.1.1.61]; Cairns CB, 1998, ANN EMERG MED, V31, P166, DOI 10.1016/S0196-0644(98)70324-5; CAMERON JM, 1990, MED CARE, V28, P146, DOI 10.1097/00005650-199002000-00005; CHALLEN AH, 1988, DIABETIC MED, V5, P739, DOI 10.1111/j.1464-5491.1988.tb01100.x; CREER TL, 1983, J ASTHMA, V20, P97, DOI 10.3109/02770908309077072; Drotar D, 1998, MEASURING HLTH RELAT; Durbin DR, 2000, AM J PUBLIC HEALTH, V90, P1782, DOI 10.2105/AJPH.90.11.1782; EISEN M, 1979, MED CARE, V17, P902, DOI 10.1097/00005650-197909000-00003; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Eiser C, 2000, CHILD CARE HLTH DEV, V26, P445, DOI 10.1046/j.1365-2214.2000.00177.x; Eiser C, 2000, CHILD CARE HLTH DEV, V26, P401, DOI 10.1046/j.1365-2214.2000.00154.x; Eiser C, 1997, ARCH DIS CHILD, V77, P350, DOI 10.1136/adc.77.4.350; Eiser C, 2001, Health Technol Assess, V5, P1; Eiser C, 1999, INT J CANCER, P87; EISER C, 1995, ARCH DIS CHILD, V72, P302, DOI 10.1136/adc.72.4.302; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Glaser AW, 1997, QUAL LIFE RES, V6, P43; Gold M., 1996, COST EFFECTIVENESS H; Goodwin DA, 1994, PSYCHOL ASSESSMENT, V6, P321, DOI DOI 10.1037/1040-3590.6.4.321; Guyatt G. H., 1996, QUALITY LIFE PHARMAC, P41; Guyer B, 2000, PEDIATRICS, V106, P1307, DOI 10.1542/peds.106.6.1307; Haley S, 1992, PEDIAT EVALUATION DI; Halterman JS, 2002, ARCH PEDIAT ADOL MED, V156, P141, DOI 10.1001/archpedi.156.2.141; Ingersoll G M, 1991, Diabetes Educ, V17, P114, DOI 10.1177/014572179101700219; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; LANDGRAF JM, 1996, QUALITY LIFE PHARMAC, P793; le Coq EM, 2000, J CLIN EPIDEMIOL, V53, P139, DOI 10.1016/S0895-4356(99)00158-4; LINDSTROM B, 1993, QUAL LIFE RES, V2, P23, DOI 10.1007/BF00642886; LINDSTROM B, 1991, Pediatrician, V18, P121; MCCAIG L, 2001, NATL HOSP AMBULATORY, P1; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Raphael D, 1996, J ADOLESCENT HEALTH, V19, P366, DOI 10.1016/S1054-139X(96)00080-8; Rebok G, 2001, QUAL LIFE RES, V10, P59, DOI 10.1023/A:1016693417166; RICHARDS JM, 1994, AM J RESP CRIT CARE, V149, pS31, DOI 10.1164/ajrccm/149.2_Pt_2.S31; Riley AW, 1998, MED CARE, V36, P1237, DOI 10.1097/00005650-199808000-00011; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Smith KW, 1999, QUAL LIFE RES, V8, P447, DOI 10.1023/A:1008928518577; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Spencer NJ, 1996, CHILD CARE HLTH DEV, V22, P367, DOI 10.1046/j.1365-2214.1996.811811.x; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; Szilagyi PG, 1998, HEALTH SERV RES, V33, P1001; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TORRANCE GW, 1995, PHARMACOECONOMICS, V7, P503, DOI 10.2165/00019053-199507060-00005; Vance YH, 2001, J CHILD PSYCHOL PSYC, V42, P661, DOI 10.1017/S0021963001007314; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Vogels T, 1998, QUAL LIFE RES, V7, P457, DOI 10.1023/A:1008848218806; WARE JE, 1995, ANNU REV PUBL HEALTH, V16, P327, DOI 10.1146/annurev.pu.16.050195.001551; Ware JE., 1996, CHQ USERS MANUAL; Wasson J H, 1995, Arch Fam Med, V4, P51, DOI 10.1001/archfami.4.1.51; WASSON JH, 1994, J FAM PRACTICE, V38, P489; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization, 2020, CONST	66	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1530-1567			AMBUL PEDIATR	Ambul. Pediatr.	JUL-AUG	2002	2	4		S			337	344		10.1367/1539-4409(2002)002<0337:CHSITP>2.0.CO;2			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics	579BB	WOS:000177154600010	12135409				2022-02-06	
J	Barbour, RL; Gebrewold, A; Altura, BT; Altura, BM				Barbour, RL; Gebrewold, A; Altura, BT; Altura, BM			Optical spectroscopy and prevention of deleterious cerebral vascular effects of ethanol by magnesium ions	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						magnesium; alcohol; cerebral microcirculation; cytochrorne oxidase; hernoglobin; stroke; optical spectroscopy	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; HEMORRHAGIC STROKE; HEAD TRAUMA; ALCOHOL; RAT; MG2+; DAMAGE; P-31-NMR; PROTECTS	Previously, it has been suggested that acute ethanol (alcohol) administration can result in concentration-dependent vasoconstriction and decreased cerebral blood flow. Here, we present in vivo results using rapid (240 nm/min) optical backscatter measurements, with an intact cranial preparation in the rat, indicating that acute infusion of ethanol directly into the rat brain rapidly produces dose-dependent vasoconstriction of the cerebral microcirculation associated with a pronounced reduction in tissue blood content, pronounced rises in deoxyhemoglobin, significantly increased levels of reduced cytochrome oxidase and microvascular damage as the dose increases. Furthermore, we present in vivo experiments demonstrating the capability of magnesium ions (Mg2+) to attenuate and prevent these deleterious responses. Optical backscatter spectra (500-800 nm) were obtained by directing a single sending and receiving fiber to a portion of the left parietal cranium (in anesthetized rats), shaved to a translucent appearance to facilitate optical penetration. In the absence of added Mg2+, infusion of a 10% solution of ethanol at 0.34 ml/min (similar to 26.8 mg/min) produced prompt vasoconstriction as evidenced by a greater than 90% loss of oxyhemoglobin from the field-of-view and increases in levels of reduced cytochrome oxidase to between 50% and >90%. These effects were partially, to nearly completely, attenuated by the addition of MgCl2 to the infusate containing added ethanol. Of special interest was the observation that attenuation of the vasoconstrictive effect of ethanol by Mg2+ persisted despite a subsequent ethanol challenge without added Mg2+. The results obtained demonstrate that, depending on dose, ethanol can produce prompt and severe vasoconstriction of the intact cerebral microcirculation and that infusion of moderate doses of Mg2+ can largely attenuate and prevent this response. We conclude that appreciable, graded changes in cerebral cytochrome oxidase aa(3), blood volume and the state of hemoglobin occur at minimal tissue levels of ethanol which can be modulated by Mg2+. (C) 2002 Elsevier Science B.V. All rights reserved.	SUNY Hlth Sci Ctr, Dept Pathol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Ctr Cardiovasc & Muscle Res, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Med, Brooklyn, NY 11203 USA		Altura, BM (corresponding author), Suny Downstate Med Ctr, Box 31,450 Clarkson Ave, Brooklyn, NY 11203 USA.	baltura@netmail.hscbklyn.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA008674] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA-08674] Funding Source: Medline		Altura B M, 1984, Alcohol, V1, P325, DOI 10.1016/0741-8329(84)90056-9; Altura B M, 1991, Magnes Trace Elem, V10, P122; Altura B T, 1984, Magnesium, V3, P195; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; Altura BM, 1998, ALCOHOL, V15, P181, DOI 10.1016/S0741-8329(97)00107-9; Altura BM, 1997, BBA-MOL CELL RES, V1358, P1, DOI 10.1016/S0167-4889(97)00077-3; ALTURA BM, 1994, ALCOHOL CLIN EXP RES, V18, P1057, DOI 10.1111/j.1530-0277.1994.tb00082.x; Altura BM, 1996, NEUROSCI LETT, V220, P207, DOI 10.1016/S0304-3940(96)13268-7; ALTURA BM, 1995, ALCOHOL, V12, P433, DOI 10.1016/0741-8329(95)00026-N; Altura BM, 1998, ALCOHOL, V16, P25, DOI 10.1016/S0741-8329(97)00166-3; Altura BM, 1998, ALCOHOL, V15, P113, DOI 10.1016/S0741-8329(97)00105-5; ALTURA BM, 1995, ALCOHOL, V12, P131, DOI 10.1016/0741-8329(94)00072-7; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P53, DOI 10.3109/00365519409095211; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BERGLUND M, 1981, ALCOHOL CLIN EXP RES, V5, P295, DOI 10.1111/j.1530-0277.1981.tb04903.x; CAMARGO CA, 1989, STROKE, V20, P1611, DOI 10.1161/01.STR.20.12.1611; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; CLARK GD, 1987, NEUROSCIENCE, V21, P665, DOI 10.1016/0306-4522(87)90027-3; DONAHUE RP, 1986, JAMA-J AM MED ASSOC, V255, P2311, DOI 10.1001/jama.255.17.2311; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FISCHER S, 1993, EUR J PHARMACOL, V232, P121, DOI 10.1016/0014-2999(93)90736-2; FRIEDMAN HS, 1984, J CARDIOVASC PHARM, V6, P344, DOI 10.1097/00005344-198403000-00021; GOLDMAN H, 1973, P SOC EXP BIOL MED, V144, P983; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; HADJIDIMO AA, 1968, Q J STUD ALCOHOL, V29, P828; HAMPSON NB, 1990, J APPL PHYSIOL, V69, P907, DOI 10.1152/jappl.1990.69.3.907; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; HILLBOM M, 1978, LANCET, V2, P1181; Hirth C, 1996, NEUROREPORT, V7, P1977, DOI 10.1097/00001756-199608120-00024; HOSHI Y, 1993, J APPL PHYSIOL, V75, P1842, DOI 10.1152/jappl.1993.75.4.1842; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KASS IS, 1988, ANESTHESIOLOGY, V69, P710, DOI 10.1097/00000542-198811000-00012; KATO T, 1993, J CEREBR BLOOD F MET, V13, P516, DOI 10.1038/jcbfm.1993.66; LASSOFF S, 1982, MICROCIRCULATION, V2, P345; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; PORJESZ B, 1983, PATHOGENESIS ALCOHOL, V7, P415; Regan RF, 1998, J NEUROCHEM, V70, P77; TAMURA M, 1978, ARCH BIOCHEM BIOPHYS, V191, P8, DOI 10.1016/0003-9861(78)90062-0; TSUDA T, 1991, NEUROSCIENCE, V44, P335, DOI 10.1016/0306-4522(91)90058-V; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; WALLGREN H, 1970, INT ENCYCLOPEDIA PHA, V1, P161; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; Yang ZW, 2001, STROKE, V32, P249, DOI 10.1161/01.STR.32.1.249; ZHANG A, 1993, EUR J PHARM-ENVIRON, V248, P229, DOI 10.1016/0926-6917(93)90049-V; Zhang AM, 1996, BRAIN RES, V728, P204, DOI 10.1016/S0006-8993(96)00401-5; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zhou ZX, 2001, AM J PATHOL, V159, P329, DOI 10.1016/S0002-9440(10)61699-9	57	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JUN 28	2002	447	1					79	86	PII S0014-2999(02)01831-9	10.1016/S0014-2999(02)01831-9			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	574XU	WOS:000176916100010	12106806				2022-02-06	
J	Babin, PR; Gross, P				Babin, PR; Gross, P			Traumatic brain injury when symptoms don't add up: Conversion and malingering in the rehabilitation setting	JOURNAL OF REHABILITATION			English	Article							MILD HEAD-INJURY; NEUROPSYCHOLOGICAL TEST-SCORES; RECOGNITION MEMORY TEST; VALIDITY; IMPAIRMENT; TESTS; CONCUSSION; DEFICITS; IMPACT; SCALE	Professionals in settings of brain injury rehabilitation treat patients with some of the highest levels of medical complexity. Sometimes the patient's symptoms fail to fit a consistent pattern across multiple assessments, across providers, or across time. Inconsistencies of this kind can perplex the treatment team and the treating physician leading to further confusion in already complex cases. When symptoms don't add up, the team may suspect the patient of "faking" the deficits or the disorder. Malingering refers to the intentional production of medical symptoms in order to obtain secondary gain, such as for a monetary settlement. Conversion is the unintentional and unconscious production of medical symptoms as the result of,psychological factors, and is a subset of psychological problems known as somatoform disorders. Differentiating conversion and related disorders from malingering can help the treatment team achieve more efficient and cost-effective remediation. Treatment is possible for the patient with conversion disorder and for those with related psychological disorders. On the other hand, the intentionally produced symptoms of the malingering individual are not amenable to treatment. Various psychological tests were developed to distinguish the malingering person from the patient with other psychological disorders. We will briefly review the literature as it pertains to conversion and malingering, discuss the most frequently administered tests used to assess these issues, and provide two abbreviated case studies representative of each disorder. Pertinent treatment issues will be addressed.	Charlotte Inst Rehabil, Charlotte, NC 28203 USA		Babin, PR (corresponding author), Charlotte Inst Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARSKY AJ, 1989, COMPREHENSIVE TXB PS, V6, P1009; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Binder LM, 1992, HDB NEUROPSYCHOLOGIC; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; CARROLL S, 1995, COSTS EXCESS MED CLA; Delis D.C., 2001, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FORD CV, 1985, PSYCHOSOMATICS, V26, P371, DOI 10.1016/S0033-3182(85)72845-9; FOX DD, 1994, ARCH CLIN NEUROPSYCH, V9, P211, DOI 10.1016/0887-6177(94)90026-4; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Frederick R. I., 1997, VALIDITY INDICATOR P; GENTILINI M, 1989, MILD HEAD INJURY, P163; GOULD R, 1986, J NERV MENT DIS, V174, P593, DOI 10.1097/00005053-198610000-00003; GRANT I, 1987, NEUROBEHAVIORAL RECO; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Klonoff PS, 1998, CLIN NEUROPSYCHOL, V12, P31, DOI 10.1076/clin.12.1.31.1732; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEININGER BE, 1992, PHYSICAL MED REHABIL, V6, P169; Levin H.S., 1989, MILD HEAD INJURY; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MILLER JD, 1989, INTRACRANIAL PRESSUR, V7, P5; MILLER L, 1990, COGNITIVE REHABILITA, V8, P406; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; REES LM, 1996, ANN M INT NEUR SOC C; Reitan R M, 1995, Appl Neuropsychol, V2, P67, DOI 10.1207/s15324826an0202_3; Reitan RM, 1996, ARCH CLIN NEUROPSYCH, V11, P573, DOI 10.1016/0887-6177(95)00037-2; REITAN RM, 1992, NEUROANATOMY NEUROPA; Resnick P.J., 1988, CLIN ASSESSMENT MALI; Rey A, 1958, LEXAMEN CLINIQUE PSY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rogers R., 1992, STRUCTURED INTERVIEW; ROSENTHAL M, 1985, REHABILITATION HEAD, P41; RUFF RM, 2000, J HEAD TRAUMA REHAB, V15, P60; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SCHRETLEN DJ, 1988, CLIN PSYCHOL REV, V8, P451, DOI 10.1016/0272-7358(88)90074-8; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1995, VICTORIA SYMPTOM VAL; SLICK DJ, 1992, VICTORIA REVISION HI; Speed J, 1996, ARCH PHYS MED REHAB, V77, P147, DOI 10.1016/S0003-9993(96)90159-8; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; TEASDALE G, 1974, LANCET, V2, P81; TEASELL RW, 1994, AM J PHYS MED REHAB, V73, P44, DOI 10.1097/00002060-199473010-00011; TRIESCHMANN R B, 1970, Archives of Physical Medicine and Rehabilitation, V51, P198; Trueblood W, 1997, ARCH CLIN NEUROPSYCH, V12, P13, DOI 10.1016/S0887-6177(96)00027-3; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; WHITE RF, 1992, J OCCUP ENVIRON MED, V34, P140, DOI 10.1097/00043764-199202000-00013; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; ZEIGLER FJ, 1970, POSTGRAD MED, V47, P174; [No title captured]	67	5	5	0	1	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	2002	68	2					4	13					10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	559AK	WOS:000176001800002					2022-02-06	
J	Pena-Casanova, J; Bertran-Serra, I; Serra, A; Bori, I				Pena-Casanova, J; Bertran-Serra, I; Serra, A; Bori, I			Uncommonly long sequences of speech automatisms in a young woman with traumatic brain injury	JOURNAL OF NEUROLINGUISTICS			English	Article						traumatic brain injury; aphasia; automatic speech; palilalia	BASAL GANGLIA; RECURRING UTTERANCES; LANGUAGE; APHASIA; LOCALIZATION; LESION	A common distinction is made between propositional and automatic speech. In contemporary research speech automatism is the general term used to describe stereotyped and unchanging utterances made up of recognizable words. The objective of this paper is to describe a patient (MSC) who suffered traumatic brain injury (TBI) and whose verbal output during a long period of time (5 years) consisted practically of long sequences of speech automatisms. Following traumatic diffuse brain damage, a 16-year-old bilingual woman showed severe language disturbance, consisting in serial automatic speech with no intentional purpose, full of biographical references. A total of 161 different utterances were recorded. All elements produced were fragments of very personal experiences, singers, songs, celebrities from magazines, movies and TV, and other related areas. Names comprised 55.2% of total production. Syntactically correct sentences made up 38.3%. All these elements were of great emotional and personal significance and formed part of the interests, habits and emotional experiences she had had before the TBI. Palilalia was present in 28% of the total units recorded. The evolution of her speech automatism ranged from a stage in which there was an absence of propositional expressions-except expletives-to the occasional appearance of propositional language and to the development of fully propositional sentences. Interestingly it was a final period of 'aphonic' automatic verbalizations. The case displays a peculiar form of cognitive and language disturbance after TBI. We tentatively postulate that the main pathophysiological feature of this case was a peculiar combination of bilateral anterior and posterior hemispheric lesions leading to the release of the lower structures related to over-learned motivational and emotional material. (C) 2001 Elsevier Science Ltd. All rights reserved.	Hosp del Mar, Inst Municipal Assistencia Sanitaria, Sect Behav Neurol & Neuropsychol, Barcelona, Spain; Hosp Valle De Hebron, Serv Rehabil, Barcelona, Spain		Pena-Casanova, J (corresponding author), Hosp del Mar, Inst Municipal Assistencia Sanitaria, Sect Behav Neurol & Neuropsychol, Barcelona, Spain.	18575@imas.imim.es					Adamovich Brenda L. B., 1997, P226; ALAJOUANINE T, 1956, BRAIN, V79, P1, DOI 10.1093/brain/79.1.1; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ASSAL G, 1983, REV NEUROL, V139, P417; Berthier M. L., 1999, TRANSCORTICAL APHASI; BLANKEN G, 1989, COGNITIVE NEUROPSYCH, V6, P211, DOI 10.1080/02643298908253419; BLANKEN G, 1988, APHASIOLOGY, V2, P545, DOI 10.1080/02687038808248965; BLANKEN G, 1990, CORTEX, V26, P41, DOI 10.1016/S0010-9452(13)80074-3; Bookheimer SY, 2000, NEUROLOGY, V55, P1151, DOI 10.1212/WNL.55.8.1151; BRUNNER RJ, 1982, BRAIN LANG, V16, P281, DOI 10.1016/0093-934X(82)90087-6; Butterworth B, 1995, NEUROCASE, V1, P55, DOI 10.1080/13554799508402346; Code C, 1997, BRAIN LANG, V57, P38, DOI 10.1006/brln.1997.1833; CODE C, 1994, J NEUROLINGUIST, V8, P135, DOI 10.1016/0911-6044(94)90021-3; Code Chris, 1991, CHARACTERISTICS APHA, P155; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; Damasio A., 2000, PRINCIPLES BEHAV COG, P294; DEBLESER R, 1985, CORTEX, V21, P405, DOI 10.1016/S0010-9452(85)80005-8; ELLIS AW, 1989, APHASIOLOGY, V3, P581, DOI 10.1080/02687038908249024; Fuster, 2015, PREFRONTAL CORTEX; HAAS JC, 1988, APHASIOLOGY, V2, P557, DOI 10.1080/02687038808248966; JACKSON JH, 1975, BRAIN, V38, P107; KORNHUBER HH, 1977, LANGUAGE HEMISPHERIC, P28; LAMENDELLA JT, 1977, STUDIES NEUROLINGUIS, V3, P157; LEBRUN Y, 1986, BRIT J DISORD COMMUN, V21, P3; LECOURS AR, 1979, APHASIE; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1998, ACQUIRED APHASIA, P481; Marquardt TP, 1990, TRAUMATIC BRAIN INJU, P181; McDonald S., 1999, BRAIN DAM B; MURDOCH BE, 1999, BRAIN DAM B, P211; NAESER MA, 1978, NEUROLOGY, V28, P545, DOI 10.1212/WNL.28.6.545; Nakagawa Y, 1993, Behav Neurol, V6, P135, DOI 10.3233/BEN-1993-6304; POECK K, 1984, BRAIN, V107, P199, DOI 10.1093/brain/107.1.199; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Sarno JE, 1998, ACQUIRED APHASIA, V569-94; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SPEEDIE LJ, 1993, NEUROLOGY, V43, P1768, DOI 10.1212/WNL.43.9.1768; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THOMSEN IV, 1976, FOLIA PHONIATR, V28, P362, DOI 10.1159/000264060; Van Lancker D, 1999, BRAIN RES REV, V31, P83, DOI 10.1016/S0165-0173(99)00060-0; VANDELLEN JR, 1996, NEUROLOGY CLIN PRACT, V2, P941; WALLESCH CW, 2000, BRAIN LANG, V71, P84; [No title captured]	45	5	5	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	APR	2002	15	2					109	128		10.1016/S0911-6044(01)00004-5			20	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	498CH	WOS:000172491900003					2022-02-06	
J	Stevenson, KL; Adelson, PD				Stevenson, KL; Adelson, PD			Neurointensive care of the nonaccidentally injured child	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; INTRA-CRANICAL PRESSURE; EXCITATORY AMINO-ACIDS; COMA DATA-BANK; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; PROLONGED HYPERVENTILATION; NEUTROPHIL ACCUMULATION	The majority of children who suffer a traumatic brain injury after nonaccidental trauma require immediate and aggressive neurosurgical intensive care, The often violent and diffuse nature of nonaccidental brain injury sets in motion a cascade of physiologic, metabolic, and biochemical events that can lead to more severe brain injury or death in the absence of intervention. This article reviews the initial resuscitation and evaluation of the nonaccidentally injured child, the role of intracranial pressure and cerebral blood flow monitoring, pediatric neurophysiology, and the neurointensive care of the nonaccidentally injured child with a specific focus on the management of elevated intracranial pressure.	Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; Presbyterian Univ Hosp, Dept Neurol Surg, Pittsburgh, PA 15213 USA		Adelson, PD (corresponding author), Childrens Hosp Pittsburgh, Dept Neurosurg, 3705 5th Ave, Pittsburgh, PA 15213 USA.	David.Adelson@chp.edu	Adelson, David/W-2083-2019				Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Adelson PD, 1996, J NEUROSURG, V84, P804; ALBRIGHT AL, 1984, J NEUROSURG, V60, P481, DOI 10.3171/jns.1984.60.3.0481; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BECKER DP, 1983, INTRACRANIAL PRESSUR, P309; BELL M, 1996, J NEUROTRAUM, V13, P596; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1972, EUR NEUROL, V8, P200, DOI 10.1159/000114578; BULLOCK MR, 2000, J NEUROTRAUM, V7, P451; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHRISTOFFEL KK, 1990, AM J DIS CHILD, V144, P697, DOI 10.1001/archpedi.1990.02150300095025; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; DARBY JM, 1988, NEUROSURGERY, V23, P84, DOI 10.1227/00006123-198807000-00014; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Forbes ML, 1999, PRINCIPLES AND PRACTICE OF PEDIATRIC NEUROSURGERY, P861; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; GAMBARDELLA G, 1993, CHILD NERV SYST, V9, P470, DOI 10.1007/BF00393552; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; Georgiadis D, 2000, J THORAC CARDIOV SUR, V119, P138, DOI 10.1016/S0022-5223(00)70229-7; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; GOITEIN KJ, 1983, J PEDIATR-US, V103, P40, DOI 10.1016/S0022-3476(83)80772-0; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; GUR D, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P68; HAUSWALD M, 1991, ANN EMERG MED, V20, P450; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Hieu PD, 1996, CHILD NERV SYST, V12, P270; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KHANNA S, 1998, CRIT CARE MED S, V26, pA85; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MANSFIELD RT, 1995, TXB PEDIAT TRANSPORT, P285; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARION DW, 2001, COMMUNICATION; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; MOLLMAN HD, 1988, J NEUROSURG, V68, P737, DOI 10.3171/jns.1988.68.5.0737; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RAJU TNK, 1982, J PEDIATR-US, V100, P139, DOI 10.1016/S0022-3476(82)80255-2; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHICKNER DJ, 1992, SURG NEUROL, V37, P251, DOI 10.1016/0090-3019(92)90147-F; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEVENSON KL, 2000, CONT NEUROSURGERY, V22, P1; STRINGER A, 1993, AM J NEUROSURG RES, V4, P475; STRINGER WA, 1989, J COMPUT ASSIST TOMO, V13, P386, DOI 10.1097/00004728-198905000-00003; SZYMONOWICZ W, 1990, PEDIATR RES, V28, P361, DOI 10.1203/00006450-199010000-00012; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383	86	5	5	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					213	+	PII S1042-3680(01)00008-0	10.1016/S1042-3680(01)00008-0			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500007	12391705				2022-02-06	
J	da Nobrega, JCM; Campos, CR; Limongi, JCP; Teixeira, MJ; Yeng, LT				da Nobrega, JCM; Campos, CR; Limongi, JCP; Teixeira, MJ; Yeng, LT			Movement disorders induced by peripheral trauma	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						movement disorders; peripheral trauma; chorea	REFLEX SYMPATHETIC DYSTROPHY; UNILATERAL ESSENTIAL TREMOR; DYSTONIA; INJURY	Movement disorders induced by central nervous system trauma are well recognized. However, over the last few years, attention has been drawn to the role of peripherally induced movement disorders. We describe three patients presenting respectively dystonia, tremor and choreoathetosis associated with tremor and dystonia of the body parts previously exposed to traumatic injuries. Pathophysiological mechanisms underlying these phenomena are not entirely known, but functional changes in afferent neuronal input to the spinal cord and secondary affection of higher brain stem and subcortical centers are probably involved.	FMUSP, Hosp Clin, Dept Neurol, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Inst Traumatol & Orthopedy, Dept Phys Med & Rehabil, Sao Paulo, Brazil			limongi@uol.com.br	Teixeira, Manoel J/E-3110-2012				BHATIA KP, 1993, BRAIN, V116, P843, DOI 10.1093/brain/116.4.843; Bogduk N., 1994, CLASSIFICATION CHRON, P40; BRIN MF, 1986, NEUROLOGY, V36, P119; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; COLE JD, 1989, J NEUROL NEUROSUR PS, V52, P286, DOI 10.1136/jnnp.52.2.286-a; Factor SA, 1997, MOVEMENT DISORD, V12, P1052, DOI 10.1002/mds.870120634; Glocker FX, 1996, MOVEMENT DISORD, V11, P571, DOI 10.1002/mds.870110514; GOETZ CG, 1992, NEUROL CLIN, V10, P907, DOI 10.1016/S0733-8619(18)30187-7; GOWERS WR, 1888, MANUAL DIS NERVOUS S, P659; HERBAUT AG, 1989, J NEUROL NEUROSUR PS, V52, P1213, DOI 10.1136/jnnp.52.10.1213-a; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; Jankovic J, 2001, MOVEMENT DISORD, V16, P7, DOI 10.1002/1531-8257(200101)16:1<7::AID-MDS1005>3.0.CO;2-0; MARSDEN CD, 1984, BRIT MED J, V288, P173, DOI 10.1136/bmj.288.6412.173; NASHOLD BS, 1988, APPL NEUROPHYSIOL, V51, P76; Sankhla C, 1998, J NEUROL NEUROSUR PS, V65, P722, DOI 10.1136/jnnp.65.5.722; SCHOTT GD, 1985, J NEUROL NEUROSUR PS, V48, P698, DOI 10.1136/jnnp.48.7.698; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; SCHWARTZMAN RJ, 1993, CURR OPIN NEUROL NEU, V6, P531; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Weiner WJ, 2001, MOVEMENT DISORD, V16, P13, DOI 10.1002/1531-8257(200101)16:1<13::AID-MDS1016>3.0.CO;2-W	21	5	5	0	1	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2002	60	1					17	20		10.1590/S0004-282X2002000100004			4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	535ZZ	WOS:000174677400004	11965403	gold, Green Published, Green Submitted			2022-02-06	
J	Prince, S; Haynes, WO; Haak, NJ				Prince, S; Haynes, WO; Haak, NJ			Occurrence of contingent queries and discourse errors in referential communication and conversational tasks: A study of college students with closed head injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; PRAGMATIC LANGUAGE-SKILLS; NARRATIVE DISCOURSE; CHILDREN; ADULTS; ABILITIES; LISTENER; IMPAIRMENTS	Twenty college students participated in a referential communication task aimed at eliciting contingent queries. Ten of the students had a history of a closed head injury (CHI), and the remaining ten served as matched controls. Subjects were given directions to arrange objects in specific ways. Directions contained ambiguous information that needed to be clarified to complete the task correctly. Additionally, a conversational sample and a task in which subjects gave object arrangement directions to the experimenter were analyzed for discourse errors. Statistical analyses revealed there was no significant difference between students with CHI and non-CHI subjects in production of contingent queries during the referential communication task; however, there was a significant difference in the accuracy of the object arrangements in this task with the CHI subjects making more errors. The group with CHI also produced more discourse errors in conversation and the direction-giving task as compared to subjects without a history of CHI. Specific differences were noted in the occurrence of mazing and the total number of discourse errors. Clinical implications are discussed.	Auburn Univ, Dept Commun Disorders, Haley Ctr 1199, Auburn, AL 36849 USA; Reg Med Ctr, Memphis, TN USA		Haynes, WO (corresponding author), Auburn Univ, Dept Commun Disorders, Haley Ctr 1199, Auburn, AL 36849 USA.	haynewo@auburn.edu					*ASHA, 1998, ASHA, V30; BARTKO JJ, 1976, PSYCHOL BULL, V83, P762, DOI 10.1037/0033-2909.83.5.762; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BRINTON B, 1989, CONVERSATIONAL MANAG; Brookshire R., 1997, INTRO NEUROGENIC COM; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Coelho C. A., 1994, DISCOURSE ANAL APPL, P95; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COSGROVE JM, 1977, DEV PSYCHOL, V13, P557, DOI 10.1037/0012-1649.13.6.557; DAMICO JS, 1985, COMMUNICATION SKILLS; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DOLLAGHAN C, 1986, J SPEECH HEAR DISORD, V51, P264, DOI 10.1044/jshd.5103.264; DOLLAGHAN CA, 1987, TOP LANG DISORD, V7, P45, DOI 10.1097/00011363-198703000-00006; DONAHUE M, 1980, APPL PSYCHOLINGUIST, V1, P387, DOI 10.1017/S0142716400009814; DOUGLAS S, 1985, APHASIOLOGY, V9, P365; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; EZELL HK, 1991, J SPEECH HEAR RES, V34, P141, DOI 10.1044/jshr.3401.141; FLAVELL JH, 1968, DEV ROLE TAKING COMM; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Garvey C., 1979, DEV PRAGMATICS; GLUCKSBERG S, 1966, J EXP CHILD PSYCHOL, V3, P333, DOI 10.1016/0022-0965(66)90077-4; GOUVIER WD, 1992, REHABIL PSYCHOL, V37, P165; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HAYNES W, 1979, LANG SPEECH HEAR SER, V10, P104; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; IRONSMITH M, 1978, CHILD DEV, V49, P348, DOI 10.2307/1128697; Jordan F, 1997, APHASIOLOGY, V11, P877, DOI 10.1080/02687039708250462; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LOVE RJ, 1996, NEUROLOGY SPEECH LAN; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILLER J, 1999, SYSTEMATIC ANAL LANG; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; SKARAKISDOYLE E, 1990, J SPEECH HEAR DISORD, V55, P700, DOI 10.1044/jshd.5504.700; SKARAKISDOYLE E, 1990, J SPEECH HEAR DISORD, V55, P461, DOI 10.1044/jshd.5503.461; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 2000, BRAIN INJURY, V14, P397; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wozniak RJ, 1999, BRAIN INJURY, V13, P191, DOI 10.1080/026990599121700; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005; YLVISAKER M, 1994, LANGUAGE INTERVENTIO	53	5	5	0	3	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2002	10	1					19	39					21	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	659LT	WOS:000181778700004					2022-02-06	
J	Sodl, JF; Kozin, SH; Kaufmann, RA				Sodl, JF; Kozin, SH; Kaufmann, RA			Development and use of a wrist fusion plate for children and adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						arthrodesis; pediatrics; wrist		Arthrodesis is a widely accepted treatment for several destructive disorders of the wrist joint. Previous literature has shown that compression plating is a reliable technique for achieving rigid fixation and fusion in adults. The goal of this study was to apply similar principles of adult wrist fusion to children, using a custom-designed fusion plate sized for children. Five children underwent wrist fusion using rigid fixation and dorsal plate application. Mean age at time of surgery was 16.4 years. The indication for surgery was paralysis (spinal cord injury) in three and spasticity (cerebral palsy and traumatic brain injury) in two. Surgery was performed through a dorsal approach and combined with carpectomy in the two patients with spasticity. Follow-up averaged 2.2 years and radiographs showed solid fusion and proper alignment of plate and screws. Improved stability and limb function were noted by patients and family. There were no instances of hardware failure, and plate removal has not been required.	Temple Univ, Sch Med, Philadelphia, PA 19122 USA		Kozin, SH (corresponding author), Shriners Hosp Children, 3551 N Broad St, Philadelphia, PA 19140 USA.	skozin@shrinenet.org					Abbott LC, 1942, J BONE JOINT SURG, V24, P883; Alexander RD, 2000, J PEDIATR ORTHOPED, V20, P490, DOI 10.1097/00004694-200007000-00013; BENKEDDACHE Y, 1984, J HAND SURG-AM, V9A, P256, DOI 10.1016/S0363-5023(84)80155-0; BUTLER AA, 1949, AM J SURG, V78, P625, DOI 10.1016/0002-9610(49)90299-8; CAMPBELL CJ, 1964, J BONE JOINT SURG AM, V46, P1520, DOI 10.2106/00004623-196446070-00011; Hastings H, 1996, J BONE JOINT SURG AM, V78A, P897, DOI 10.2106/00004623-199606000-00013; HOFFER MM, 1988, J HAND SURG-AM, V13A, P667; LARSSON SE, 1974, CLIN ORTHOP RELAT R, P146, DOI 10.1097/00003086-197403000-00018; Lister G, 1978, J Hand Surg Am, V3, P427; MILLENDER LH, 1973, J BONE JOINT SURG AM, VA 55, P1026, DOI 10.2106/00004623-197355050-00011; Pipkin G, 1968, Clin Orthop Relat Res, V57, P179; Pomerance JF, 1996, J HAND SURG-AM, V21A, P828, DOI 10.1016/S0363-5023(96)80199-7; Rayan GM, 1999, J HAND SURG-AM, V24A, P944; RAYAN GM, 1986, J HAND SURG-AM, V11A, P356, DOI 10.1016/S0363-5023(86)80142-3; Richterman I, 1997, HAND CLIN, V13, P681; WEISS APC, 1995, J HAND SURG-AM, V20A, P813, DOI 10.1016/S0363-5023(05)80437-X; WEISS APC, 1995, J HAND SURG-AM, V20A, P50, DOI 10.1016/S0363-5023(05)80058-9; WRIGHT CS, 1983, J HAND SURG-AM, V8, P932, DOI 10.1016/S0363-5023(83)80099-9	18	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	MAR-APR	2002	22	2					146	149		10.1097/00004694-200203000-00002			4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	524EH	WOS:000173999000002	11856919				2022-02-06	
J	Bader, MK; Palmer, S; Stalcup, C; Shaver, T				Bader, MK; Palmer, S; Stalcup, C; Shaver, T			Using a FOCUS-PDCA quality improvement model for applying the severe traumatic brain injury guidelines to practice: Process and outcomes	ONLINE JOURNAL OF KNOWLEDGE SYNTHESIS FOR NURSING			English	Article							SEVERE HEAD-INJURY; MANAGEMENT		Mission Hosp, Reg Med Ctr, Mission Viejo, CA 92691 USA		Bader, MK (corresponding author), Mission Hosp, Reg Med Ctr, 27700 Med Ctr Rd, Mission Viejo, CA 92691 USA.						Baethmann A, 1998, ACT NEUR S, V71, P107; BULLOCK R, 2000, GUIDELINES MANAGEMEN; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Simons R, 1999, J TRAUMA, V46, P811, DOI 10.1097/00005373-199905000-00008	5	5	5	0	1	SIGMA THETA TAU INT	INDIANAPOLIS	550 W NORTH STREET, INDIANAPOLIS, IN 46202 USA	1072-7639			ONLINE J KNOWL SYN N	Online J. Knowl. Synth. Nurs.	FEB 15	2002	9	4C							4C				4	Nursing	Social Science Citation Index (SSCI)	Nursing	561ER	WOS:000176127700001	12089639				2022-02-06	
J	Maas, AIR				Maas, AIR			Guidelines for head injury: Their use and limitations	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; head injury; guidelines; evidence based medicine	RANDOMIZED CLINICAL-TRIAL; SEVERE BRAIN INJURIES; MANAGEMENT; PHENYTOIN; DEXAMETHASONE; PREVENTION; STEROIDS; EPILEPSY; SEIZURES; ADULTS	Within medicine in general, and particularly in the field of head injury a revolution is currently occurring wherein the traditional expert opinion-based approach to therapy is quickly changing towards a standardized approach, based on scientific analysis of available evidence. The guideline movement may be considered a child of this revolution. Correct understanding, interpretation and application of guidelines requires an understanding of the reasons for formulating the guidelines and of the methodology on which they are based. From this perspective the North American guidelines and the EBIC guidelines, as main international exponents towards guidelines in head injury, are discussed. Specific attention is focussed on the interpretation of the practice recommendations from the North American guidelines at the level of a standard. The evidence underlying these standards is critically discussed and the conclusions put in to further perspective. The EBIC guidelines were formulated from a desire to obtain a 'common core approach' to basic therapy in centers participating in clinical trials. The recommendations are more pragmatic, based on an understanding of the pathophysiology, and address various issues not analyzed in the North American guidelines. The recommendations of both initiatives however are very similar, illustrating the consensus that already exists to general approach of management in head injury. Guidelines should be considered a very important topic in clinical practice, but on the other hand recommendations should not always be accepted uncritically. The lack of evidence underlying many aspects of management in head injury as illustrated by the North American approach, should form an incentive for further scientific studies, especially towards targeted therapy, Clinical experience and an understanding of the pathophysiology are the basic ingredients for developing alternative and more targeted approaches which can then be subjected to scientific analysis, Guidelines should be considered a tool which we need to learn how to use; they form part of a process which, following implementation and dissemination should lead to standardized registration, an important element in facilitating improved quality control and assurance.	Acad Hosp Rotterdam Dijkzigt, Dept Neurosurg, NL-3015 GD Rotterdam, Netherlands		Maas, AIR (corresponding author), Acad Hosp Rotterdam Dijkzigt, Dept Neurosurg, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.		Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BRIGGS M, 1984, BRIT MED J, V288, P983; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Cook D, 1998, NEW HORIZ-SCI PRACT, V6, P20; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; GIANNOTTA SL, 1984, NEUROSURGERY, V15, P497, DOI 10.1227/00006123-198410000-00004; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PECHADRE JC, 1991, PRESSE MED, V20, P841; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; van Alphen H A, 1985, Ned Tijdschr Geneeskd, V129, P645; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; 2000, J NEUROTRAUMA, V17, P451	23	5	6	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	JAN	2002	24	1					19	23		10.1179/016164102101199495			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	519WJ	WOS:000173748200004	11787492				2022-02-06	
J	McAlindon, RJ				McAlindon, RJ			On field evaluation and management of head and neck injured athletes	CLINICS IN SPORTS MEDICINE			English	Article							CERVICAL SPINAL STENOSIS; FOOTBALL PLAYERS; CONTACT-SPORTS; 2ND IMPACT; CONCUSSION; GUIDELINES; TRAUMA	Cervical spine injuries, although relatively uncommon, can be devastating. Proper and prompt management is absolutely essential, even though the complexity of the brain and the lack of objective signs and symptoms make injury assessment difficult. Being prepared for head and neck injury is key to its on-field management. In the event of an injury, the equipment needed to evaluate, and if necessary, to transport the injured athlete must be available. The most important objective of on-field management of head and neck injuries is to prevent further damage and recurrent injury.	Hughston Clin PC, Auburn, AL 36832 USA		McAlindon, RJ (corresponding author), Hughston Clin PC, 161 E Univ Dr, Auburn, AL 36832 USA.	auburn@hughston.com					ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; ALBRIGHT JP, 1976, JAMA-J AM MED ASSOC, V236, P1243, DOI 10.1001/jama.236.11.1243; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bruce D A, 1982, Clin Sports Med, V1, P495; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1990, J SPINAL DISORD, V3, P227; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P172; *COL MED SOC, 1991, REP SPORTS MED COMM; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; JACKO JG, 1995, HUGHSTON SPORTS MED, P112; KELLEY LA, 1995, HUGHSTON CLIN SPORTS, P173; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LaPrade RF, 2000, AM J SPORT MED, V28, P800, DOI 10.1177/03635465000280060601; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Palumbo MA, 1996, AM J SPORT MED, V24, P446, DOI 10.1177/036354659602400407; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; TORG JS, 1991, AM J SPORT MED, V19, P6, DOI 10.1177/036354659101900103; TORG JS, 1987, CLIN SPORT MED, V6, P115; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	29	5	5	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2002	21	1					1	+		10.1016/S0278-5919(03)00053-X			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	539UR	WOS:000174890500002	11877864				2022-02-06	
J	Shigemori, M; Tokutomi, T				Shigemori, M; Tokutomi, T			Result of nationwide survey of the management of severe head injury in Japan	NEUROLOGICAL RESEARCH			English	Article						nationwide survey; severe head injury; management; guideline		A nationwide survey of the management of severe head injury was carried out in 1988 by sending the questionnaires to 7,088 main neurosurgical hospitals in Japan. The items of the survey included annual number of patients with closed severe head injury (GCS score of 8 or less), place of patients' care, type of neuromonitorings, medical and surgical treatments, severity and outcome measures. Out of 1,088 questionnaires, 457 (42% response rate) were collected and analyzed. Characteristic features of the management status were the scarcity of patients annually in each institution, limited use of specific neuromonitorings, and variety of the actual managements. Aggressive managements such as hyperventilation, barbiturate and/or hypothermia have been employed in many hospitals to control high ICP. External and internal decompression are also used widely for intradural hematomas. These results clarified not only present status of Japan but also the problems to be solved in the actual managements.	Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan		Shigemori, M (corresponding author), Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan.						Bullock R, 1995, GUIDELINES MANAGEMEN; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; SHIGEMORI M, 1999, JPN J NEUROSURG, V8, P84; YAMAURA A, 2000, NEUROTRAUMA, V23, P1	4	5	5	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	JAN	2002	24	1					41	44		10.1179/016164102101199521			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	519WJ	WOS:000173748200007	11783752				2022-02-06	
J	Wellwood, J; Alcantara, A; Michael, DB				Wellwood, J; Alcantara, A; Michael, DB			Neurotrauma: The role of CT angiogram	NEUROLOGICAL RESEARCH			English	Article						computerized tomography; neurotrauma; angiography; neurovascular	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; ARTERIAL INJURIES; DIAGNOSIS	Cerebrovascular injuries can occur in blunt or penetrating head and neck trauma. A high index of suspicion based on mechanism of injury and clinical assessment warrants screening for intracranial and extracranial vascular lesions, Conventional angiogram has been and remains the gold standard for diagnosis of these injuries, but computerized tomography angiography offers a fast, noninvasive method of imaging for neurotrauma patients, Advantages and disadvantages of each modality are discussed.	Detroit Med Ctr, Dept Neurol Surg, Detroit, MI USA; Detroit Med Ctr, Dept Radiol, Detroit, MI USA; Wayne State Univ, Detroit, MI USA		Michael, DB (corresponding author), 4201 St Antoine,6E-UHC, Detroit, MI 48201 USA.						Anderson GB, 1997, NEUROSURGERY, V41, P522, DOI 10.1097/00006123-199709000-00003; ARABI B, 2001, J TRAUMA, V51, pS26; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; CUMMING JM, 1999, AM J ROENTGENOL, V163, P517; Dagi T. F., 1997, HIST NEUROSURGERY IT, P289; Guyot LL, 2001, NEUROL RES, V23, P291, DOI 10.1179/016164101101198442; HARBAUGH RE, 1995, NEUROSURGERY, V36, P320, DOI 10.1227/00006123-199502000-00011; Kerwin AJ, 2001, J TRAUMA, V51, P308, DOI 10.1097/00005373-200108000-00013; Korogi Y, 1999, RADIOLOGY, V211, P497, DOI 10.1148/radiology.211.2.r99ma02497; LeBlang SD, 2000, AM J ROENTGENOL, V174, P1269, DOI 10.2214/ajr.174.5.1741269; Leclerc X, 1999, RADIOLOGY, V210, P673, DOI 10.1148/radiology.210.3.r99fe46673; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Munera F, 2000, RADIOLOGY, V216, P356, DOI 10.1148/radiology.216.2.r00jl25356; Pogson, 1997, EMERG RADIOL, V4, P200, DOI DOI 10.1007/BF01508171; QUENCER RM, 1988, AM J ROENTGENOL, V150, P13, DOI 10.2214/ajr.150.1.13; RUBIN GD, 1995, RADIOL CLIN N AM, V33, P51	16	5	5	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.		2002	24			1			S13	S16					4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	562FM	WOS:000176186800003	12074431				2022-02-06	
J	Woertgen, C; Rothoerl, RD; Sauer, K; Brawanski, A				Woertgen, C; Rothoerl, RD; Sauer, K; Brawanski, A			Does bungee jumping release S-100B protein?	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						bungee jumping; head injury; protein S-100B	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-DAMAGE; SERUM LEVELS	The S-100B protein is a recognised indicator of traumatic brain damage, but the impact threshold at which S-100B is released into serum still remains unknown. The aim of the study was to investigate whether moderate shear forces are able to release S-100B into serum in people who did, a bungee jump. Eleven healthy probands jumped from a height of 50 m and were exposed to an acceleration of about 2.8 g. Blood samples were drawn before the jump, immediately after and 71 min (mean) after the jump. The initial serum values of S-100B of all probands were normal (mean 0.22 mug/l). Also the serum values directly after and 71-min (mean) after the jump showed no increase of S-100B (0.22 mug/l and 0.23 mug/l, mean). This finding indicates that a moderate acceleration and deceleration force to the brain does not activate the release of the protein S-100B into the serum. (C) 2002 Harcourt Publishers Ltd.	Univ Regensburg, Dept Neurosurg & Anaesthesiol, D-93042 Regensburg, Germany		Woertgen, C (corresponding author), Univ Regensburg, Dept Neurosurg & Anaesthesiol, Franz Josef Str Allee 11, D-93042 Regensburg, Germany.						HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; McIntosh TK, 1996, LAB INVEST, V74, P315; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026	11	5	8	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2002	9	1					51	52		10.1054/jocn.2001.0904			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	519QG	WOS:000173736500011	11749017				2022-02-06	
J	Hadjianastassiou, VG; Karadaglis, D; Gavalas, M				Hadjianastassiou, VG; Karadaglis, D; Gavalas, M			A comparison between different formats of educational feedback to junior doctors: a prospective pilot intervention study	JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH			English	Article						medical audit; emergency service; education; continuing medical education; practice guidelines	INFORMATION	Objectives: Audit feedback is conventionally given in the format of an average performance of the department relative to established guidelines. The impersonality of this feedback format may compromise audit outcome. The aim of the study was to compare personal, peer-comparison feedback, an effective method of changing physician practice, to the 'conventional' departmental one. Methods: Eleven SHOs working at a central London A&E department were audited in terms of the adequacy of their documentation process. The study comprised patients presenting with closed head injury, acute asthma and chest pain of possible cardiac origin. Personal peer-comparison feedback and average departmental feedback was given for the first two groups, respectively. No feedback was given for the chest pain group, acting as a temporal control. The outcome measure was documentation of the minimum variables, as specified by departmental guidelines. Results: The peer-comparison feedback group showed a significant improvement (p-value <0.0001) in two out of three target variables audited, in contrast to the departmental feedback group and the control group which did not show a significant improvement in any of the variables. Conclusions: Personal, confidential peer-comparison feedback was more effective than departmental feedback, in an audit of process of junior doctors. This pilot study should form the basis of a larger study (more SHOs, wider range of conditions) to establish unequivocally the best format for educational feedback.	UCL Hosp, Accident & Emergency Directorate, London WC1E 6AU, England		Hadjianastassiou, VG (corresponding author), John Radcliffe Hosp, Dept Gen Surg, Headley Way,Headington, Oxford OX3 9DU, England.	vassilis@doctors.org.uk	HADJIANASTASSIOU, VASSILIS/AAI-1062-2019				*AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP S, P181; BERWICK DM, 1986, JAMA-J AM MED ASSOC, V255, P1450, DOI 10.1001/jama.255.11.1450; EISENBERG JM, 1981, JAMA-J AM MED ASSOC, V246, P2195, DOI 10.1001/jama.246.19.2195; FROSTICK SP, 1993, MED AUDIT, P37; GRECO PJ, 1993, NEW ENGL J MED, V329, P1271, DOI 10.1056/NEJM199310213291714; GRIVELL AR, 1981, CLIN CHEM, V27, P1717; HANSON JM, 1994, J ACCID EMERG MED, V11, P45; KLEIN D, 1976, PLANN CHANGE, P117; KOGAN M, 1995, MAKING USE CLIN AUDI, P1; MUGFORD M, 1991, BRIT MED J, V303, P398, DOI 10.1136/bmj.303.6799.398; Neville RG, 1997, THORAX, V52, P153, DOI 10.1136/thx.52.2.153; Parrish J.M., 1986, Hunteria, V1, P1; RESTUCCIA JD, 1982, MED CARE, V20, P46, DOI 10.1097/00005650-198201000-00004; Roethlisberger F.J., 1956, MANAGEMENT WORKER; SCHWINGHAMMER TL, 1985, AM J HOSP PHARM, V42, P1745, DOI 10.1093/ajhp/42.8.1745	15	5	5	0	0	ROYAL COLLEGE SURGEONS EDINBURGH	EDINBURGH	NICOLSON ST, EDINBURGH EH8 9DW, SCOTLAND	0035-8835			J ROY COLL SURG EDIN	J. R. Coll. Surg. Edinb.	DEC	2001	46	6					354	357					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	504PK	WOS:000172864900010	11768577				2022-02-06	
J	Rachinsky, M; Pruneau, D; Artru, AA; Kapuler, V; Alonchin, A; Smolanezki, Y; Shapira, Y				Rachinsky, M; Pruneau, D; Artru, AA; Kapuler, V; Alonchin, A; Smolanezki, Y; Shapira, Y			The importance of kinin antagonist treatment timing in closed head trauma	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						bradykinin B2 antagonist; cerebral edema; head injury; neurologic outcome; rat	VASOGENIC BRAIN EDEMA; B-2 RECEPTORS; CLINICAL ROLE; BRADYKININ; RATS; INJURY; HYPERTENSION; PERMEABILITY; CONTUSIONS; MEDIATOR	Background., Giving LF 16-0687 Ms (a bradykinin B2 receptor antagonist) I hour after closed head trauma (CRT) previously was reported to decrease brain edema at 24 hours and improve neurologic severity score (NSS) at 7 days. It is not certain whether a greater benefit could be achieved by treatment sooner after CRT. Methods: To examine the latter possibility we studied a surrogate condition for the earliest possible administration of LF 16-0687 Ms after CRT, e.g., we examined brain edema and NSS when LF 16-0687 Ms was given 15 min before CHT in rats. Results: LF 16-0687 Ms decreased brain water content (80.0 +/- 1.4%, mean +/- SD) at 24 hours and improved NSS (2 +/- 3, median +/- range) at 7 days after CRT in comparison to that with CRT + saline (82.9 +/- 1.3% and 8 +/- 4). Conclusion Similarity of the present results to those previously reported indicates that the benefit of giving LF 16-0687 Ms 1 hour after CRT appears to represent the maximal benefit afforded by this drug.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Div Anesthesiol, Beer Sheva, Israel; Ctr Rech, Labs Fournier, Daix, France		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540,1959 NE Pacific St, Seattle, WA 98195 USA.						Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; DODEY P, 1998, 13 FRENCH JAP S MED; DODEY P, 1998, Patent No. 9824783; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397, DOI 10.1152/ajpheart.1988.255.2.H397; ELLIS EF, 1989, J NEUROSURG, V61, P97; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Gecse A, 1989, Adv Exp Med Biol, V247A, P249; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; KATUSIC ZS, 1993, STROKE, V24, P392, DOI 10.1161/01.STR.24.3.392; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Mayhan WG, 1996, BRAIN RES, V738, P337, DOI 10.1016/S0006-8993(96)01000-1; MENKE JG, 1994, J BIOL CHEM, V269, P21583; NAROTAM PK, 1995, J NEUROSURG, V82, pA350; Narotam PK, 1998, ACTA NEUROCHIR, V140, P793, DOI 10.1007/s007010050181; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; Raidoo DM, 1997, J NEUROIMMUNOL, V77, P39, DOI 10.1016/S0165-5728(97)00048-9; REGOLI D, 1980, PHARMACOL REV, V32, P1; SCHILLING L, 1997, KIDNEY INT S59, V51, pS69; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; XU J, 1991, J NEUROCHEM, V57, P975, DOI 10.1111/j.1471-4159.1991.tb08246.x	30	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2001	51	5					944	948		10.1097/00005373-200111000-00020			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	495QJ	WOS:000172351600026	11706345				2022-02-06	
J	Chan, JW				Chan, JW			Isolated unilateral post-traumatic internuclear ophthalmoplegia	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article						internuclear ophthalmoplegia; head trauma	HEAD-INJURY	A patient developed an isolated unilateral internuclear ophthalmoplegia (INO) after head trauma. An uncommon complication of closed head trauma. INO usually occurs bilaterally and is often associated with other neurologic deficits. The mechanism may be shear injury caused by angular acceleration leading to downward displacement of the posterior brainstem downward, stretching of the nerve fibers of the medial longitudinal fasciculus, or compression and tearing of its arterial supply.	Univ Nevada, Sch Med, Div Neurol, Dept Internal Med, Las Vegas, NV 89154 USA		Chan, JW (corresponding author), Univ Nevada, Sch Med, Div Neurol, Dept Internal Med, 2040 W Charleston Blvd,Suite 200, Las Vegas, NV 89154 USA.						BECK RW, 1981, ANN OPHTHALMOL, V13, P671; CATALANO RA, 1986, AM J OPHTHALMOL, V101, P491, DOI 10.1016/0002-9394(86)90657-4; Constantoyannis C, 1998, BRIT J NEUROSURG, V12, P377, DOI 10.1080/02688699844943; DOSLAK MJ, 1980, INVEST OPHTH VIS SCI, V19, P1506; Hardman J M, 1979, Adv Neurol, V22, P15; JOHNSON RT, 1956, ACTA RADIOL, V46, P250, DOI 10.3109/00016925609170834; KEANE JR, 1987, J CLIN NEURO-OPHTHAL, V7, P165; MUELLER C, 1993, OPHTHALMOLOGY, V35, P158; ROSATI G, 1981, EUR NEUROL, V20, P80, DOI 10.1159/000115211; STRAUSS C, 1995, NEURO-OPHTHALMOLOGY, V15, P15, DOI 10.3109/01658109509044589	10	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022			J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	SEP	2001	21	3					212	213		10.1097/00041327-200109000-00011			2	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	487HJ	WOS:000171867900011	11725189				2022-02-06	
J	Hara, N; Kan, S; Simizu, K				Hara, N; Kan, S; Simizu, K			Localization of post-traumatic trochlear nerve palsy associated with hemorrhage at the subarachnoid space by magnetic resonance imaging	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							DIAGNOSIS; MR	PURPOSE: To report evaluation of traumatic trochlear nerve palsy using head magnetic resonance imaging. DESIGN: Observational case reports. METHODS: We examined two cases involving trochlear nerve palsy after closed head injury. RESULTS: Using a fluid attenuated inversion recovery pulse sequence, MRI showed a high-intensity lesion consistent with subarachnoid hemorrhage at the trochlear nerve area in the ambient cisterns. CONCLUSION: An impact force directed toward the tentorium can be a mechanism of injury in some posttraumatic trochlear nerve palsies. Fluid attenuated inversion recovery pulse sequence is a sensitive method for detection of abnormalities in cases associated with head injury. (Am J Ophthalmol 2001;132:443-445. (C) 2001 by Elsevier Science Inc. All rights reserved.).	Higashiyamato Hosp, Ophthalmol Serv, Tokyo 2070014, Japan; Kitasato Univ, Sch Med, Dept Ophthalmol, Kitasato, Japan; Kitasato Univ, Sch Med, Dept Neuroradiol, Kitasato, Japan		Hara, N (corresponding author), Higashiyamato Hosp, Ophthalmol Serv, 1-13-12 Nangai, Tokyo 2070014, Japan.						BRAZIS PW, 1993, MAYO CLIN PROC, V68, P501, DOI 10.1016/S0025-6196(12)60201-8; DECOENE B, 1992, AM J NEURORADIOL, V13, P1555; LAVIN PJM, 1984, ARCH NEUROL-CHICAGO, V41, P679, DOI 10.1001/archneur.1984.04210080091022; Lindenberg R, 1964, Clin Neurosurg, V12, P129; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404	5	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0002-9394			AM J OPHTHALMOL	Am. J. Ophthalmol.	SEP	2001	132	3					443	445		10.1016/S0002-9394(01)00932-1			3	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	469XM	WOS:000170841400038	11530077				2022-02-06	
J	Bierley, RA; Drake, AI; Ahmed, S; Date, ES; Rosner, M; Warden, D; Salazar, AM				Bierley, RA; Drake, AI; Ahmed, S; Date, ES; Rosner, M; Warden, D; Salazar, AM		Defense Veterans Head Injury Prog	Biased responding: a case series demonstrating a relationship between somatic symptoms and impaired recognition memory performance for traumatic brain injured individuals	BRAIN INJURY			English	Article							BELIEVABLE DEFICITS; VALIDITY; CAPACITY; VALIDATION	Biased responding on the Sternberg Recognition Memory Test was observed in four patients with traumatic brain injury. None of these individuals met the Diagnostic and Statistical Manual's (DSM-IV) criteria for malingering. Individual recognition memory scores were high shortly after injury, declined to chance or below at the 6- and 12-month evaluations, and then showed substantial recovery by the 24-month evaluation. Recall memory performance actually declined slightly across this same 2-year period. Recognition memory scores were related to the extent to which the patients endorsed somatic items on the Hamilton Rating Scale for Depression (HAM-D). Poor performance was associated with high somatic scores. The relationship between memory and somatic scores on the HAM-D in this case series suggests that unconscious processes can influence memory performance and, because of this, that clinicians should not use such performance as a primary indicator of malingering. More importantly, biased responding and actual memory deficits may coexist. This is indicated in the current cases by the failure of recall memory to improve during the 2 years these patients were followed.	Permanente Med Grp Inc, Dept Psychiat, Redwood City, CA 94063 USA; USN, San Diego Med Ctr, San Diego, CA 92152 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Henry M Jackson Fdn, Washington, DC USA		Bierley, RA (corresponding author), Permanente Med Grp Inc, Dept Psychiat, 1150 Vet Blvd, Redwood City, CA 94063 USA.	rex.bierley@kp.org	Litvan, Irene/X-9319-2018	Litvan, Irene/0000-0002-3485-3445; Grafman, Jordan H./0000-0001-8645-4457			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; BRANDT J, 1988, CLIN ASSESSMENT MALI, P65; CARTER AB, 1949, BRIT MED J, V1, P1076, DOI 10.1136/bmj.1.4615.1076; Chouinard M J, 1997, J Int Neuropsychol Soc, V3, P545; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.49.12.997; Connor DJ, 1997, ARCH CLIN NEUROPSYCH, V12, P301; Connor DJ, 1997, NEUROLOGY, V48, P1073; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Delis DC, 1987, CALIFORNIA VERBAL LE; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; DEPAULO BM, 1994, CURR DIR PSYCHOL SCI, V3, P83, DOI 10.1111/1467-8721.ep10770433; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Faust D, 1998, CRIT ISS NE, P1; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FINLAYSON MAJ, 1991, FORENSIC NEUROPSYCHO, P123; FLORHENRY P, 1981, BIOL PSYCHIAT, V16, P601; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; FRIDLUND AJ, 1987, CALIFORNIA VERBAL LE; GORMAN WF, 1982, J FORENSIC SCI, V27, P401; Gouvier WD, 1998, CRIT ISS NE, P55; GREIFFENSTEIN M, 1995, CLIN NEUROPSYCHOL, V9, P74; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LJUNGBERG L, ACTA PSYCHIAT SCANDA, V32, P1957; MCMAHON EA, 1981, HDB CLIN NEUROPSYCHO, P686; MEEHL PE, PSYCHOL B, V52, P194; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Nemeth AJ, 1996, ARCH CLIN NEUROPSYCH, V11, P677, DOI 10.1016/S0887-6177(96)80004-7; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PANKRANTZ L, 1975, J CONSULT CLIN PSYCH, V47, P409; Pankratz L., 1997, CLIN ASSESSMENT MALI, P223; POST F, 1975, PSYCHIATRIC ASPECTS, P99; Reitan RM, 1996, ARCH CLIN NEUROPSYCH, V11, P573, DOI 10.1016/0887-6177(95)00037-2; ROGER R, 1909, CLIN ASSESSMENT MALI, P1; ROGERS R, 1988, CLIN ASSESSMENT MALI, P293; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Travin S, 1984, Psychiatr Q, V56, P189, DOI 10.1007/BF01065010; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; Wechsler D., 1981, WAIS R MANUAL; Williams JM, 1998, CRIT ISS NE, P105	58	5	5	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2001	15	8					697	714		10.1080/02699050010013671			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	462ZJ	WOS:000170452100004	11485610				2022-02-06	
J	Leskovar, A; Turek, J; Borgens, RB				Leskovar, A; Turek, J; Borgens, RB			Giant multinucleated macrophages occur in acute spinal cord injury	CELL AND TISSUE RESEARCH			English	Article						spinal cord injury; macrophage; neurotrauma; inflammation; nerve injury; phagocyte; rat (Sprague Dawley)	STIMULATED HOMOLOGOUS MACROPHAGES; CENTRAL-NERVOUS-SYSTEM; LYMPHOCYTES; EXPRESSION; CELLS	Using a cell-isolation and -culture procedure specific for macrophages, we report the existence of giant (more than 50 mum diameter), multinucleated macrophages within an acute, 5-day-old adult rat spinal cord injury. The size and multinuclearity of these isolated giant cells was confirmed using transmission electron microscopy. Giant macrophages are markers for longterm infection, disease, and chronic injury in other soft tissues and are unexpected in the acute inflammatory stage of central nervous system injury. To our knowledge, this descriptive report is the first confirming the existence of giant macrophages in any injured nervous tissue, with additional data suggesting some of these cells to be multinucleated.	Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; Purdue Univ, Inst Appl Neurol, Ctr Paralysis Res, W Lafayette, IN 47907 USA		Borgens, RB (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.						Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BLIGHT AR, 1993, ADV NEUROL, V59, P91; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Coligan J.E., 1991, CURRENT PROTOCOLS IM; CONTANTINIDES P, 1984, ULTRASTRUCT PATHOL, P361; DUCHEN LW, 1980, BRAIN, V103, P695, DOI 10.1093/brain/103.3.695; EDELSON PJ, 1976, IN VITRO METHODS CEL, P333; EILBOTT DJ, 1989, P NATL ACAD SCI USA, V86, P3337, DOI 10.1073/pnas.86.9.3337; GUILIAN D, 1989, Journal of Neuroscience, V9, P4416; GUILIAN D, 1990, ANN NEUROL, V27, P33; KREIPE H, 1988, AM J PATHOL, V130, P232; KRISHAN A, 1971, J ULTRA MOL STRUCT R, V36, P191, DOI 10.1016/S0022-5320(71)80097-7; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; Leskovar A, 2000, J EXP BIOL, V203, P1783; Moriarty LJ, 1998, J NEUROL SCI, V155, P121, DOI 10.1016/S0022-510X(97)00203-7; OEMICHEN M, 1978, MONONUCLEAR PHAGOCYT; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; PERRY VH, 1991, INT REV CYTOL, V125, P203, DOI 10.1016/S0074-7696(08)61220-6; POSTLETHWAITE AE, 1982, J EXP MED, V155, P168, DOI 10.1084/jem.155.1.168; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Schwartz M, 1999, NEUROSURGERY, V44, P1041, DOI 10.1097/00006123-199905000-00057; SONE S, 1981, AM J PATHOL, V103, P234	25	5	5	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0302-766X			CELL TISSUE RES	Cell Tissue Res.	MAY	2001	304	2					311	315		10.1007/s004410000325			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	438HF	WOS:000169047000014	11396724				2022-02-06	
J	Yoshida, H; Tsutsumi, S				Yoshida, H; Tsutsumi, S			Experimental analysis of a new flexible neck model for low-speed rear-end collisions	ACCIDENT ANALYSIS AND PREVENTION			English	Article						whiplash injury; new flexible neck model; low-speed rear end collision; hybrid III dummy; sled test		Whiplash injuries occur frequently in rear-end automobile accidents even at low-speed. The hybrid III dummy has been used for various tests in order to investigate the mechanism of whiplash injuries. However, since this dummy neck is too rigid for low-speed collisions, we developed a new flexible neck model for low-speed rear-end collisions. Each component of this new flexible neck model is made of polymers with material properties close to those of the human body. Sled tests were conducted to measure the displacements of cervical vertebrae of the new flexible neck model at 11 km/h. The figures of s-shape and shear displacement in the plane of the intervertebral disks were observed, and it was recognized that shear displacement resulted from the inconsistency of motion between the head and neck. The regions of shear displacement agreed well with the statistics of the critical regions where whiplash injuries have frequently occurred. It is assumed that shear displacement is one of the causes of the mechanism of whiplash injuries. (C) 2001 Elsevier Science Ltd. All rights reserved.	Kyoto Univ, Inst Frontier Med Sci, Dept Med Simulat Engn, Sakyo Ku, Kyoto 6068507, Japan		Yoshida, H (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Med Simulat Engn, Sakyo Ku, 53 Kawahara CHo, Kyoto 6068507, Japan.	yoshida@frontier.kyoto-u.ac.jp					AKIASHI F, 1994, J JAP SOC CLIN BIOM, V15, P109; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; *JAP AUT RES I INC, 1997, TRAFF GREEN PAP; KANEOKA K, 1997, INT C NEW FRONT BIOM, P265; Mertz H. J., 1971, 710855 SAE, DOI 10.4271/710855; NOYES FR, 1977, CLIN ORTHOP RELAT R, P210; SEMMANN MR, 1986, STAPP CAR CRASH C; SHIMATOTO N, 1998, 16 ESV C; SUGIMOTO T, 1972, WHIPLASH INJURY; SVENSSON MY, 1992, 1992 INT IRCOBI C BI, P299; SVENSSON MY, 1993130013 SAE, P189; THUNNISSEN JGM, 1996, 15 ESV C; TOTORIBE K, 1994, J JAPANESE SOC CLIN, V15, P99; TSUTSUMI S, 1997, T JAPAN SOC MECH E C, V63, P791; YOSHIDA H, 1997, J JAP SOC CLIN BIOM, V18, P203; YOSHIDA H, 1997, INT C NEW FRONT BIOM, P277	16	5	6	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAY	2001	33	3					305	312		10.1016/S0001-4575(00)00044-0			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	404ZY	WOS:000167133800002	11235792				2022-02-06	
J	Berube, J				Berube, J			The Traumatic Brain Injury Act amendments of 2000	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									Natl Strategies Inc, Washington, DC USA		Berube, J (corresponding author), Natl Strategies Inc, Washington, DC USA.							0	5	5	0	0	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2001	16	2					210	213		10.1097/00001199-200104000-00009			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	422HH	WOS:000168112100008	11275580				2022-02-06	
J	Byard, RW; James, RA				Byard, RW; James, RA			Car window entrapment and accidental childhood asphyxia	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						accidental asphyxia; car window; childhood hanging	DEATH; CHILDREN; INFANTS	A 3-year-old boy was found hanging from a partly opened car window. Attempted resuscitation was unsuccessful. Postmortem reconstruction of events leading up to death indicated that the boy had slipped while standing on his tricycle and entrapped his head as he was attempting either to look into the car, or to climb in through the window. While it is not always possible to completely secure childhood environments, open cars should not be regarded as safe places for young children to play in or around when an adult is not in attendance. To minimize the chance of injury or death to children from parked cars, young children should be removed from vehicles and all windows and doors securely closed and locked, if they are to be left in the vicinity of the car to play unsupervised.	Forens Sci Ctr, Adelaide, SA 5000, Australia		Byard, RW (corresponding author), Forens Sci Ctr, 21 Divett Pl, Adelaide, SA 5000, Australia.			Byard, Roger/0000-0002-0524-5942			Amanuel B, 2000, J PAEDIATR CHILD H, V36, P66, DOI 10.1046/j.1440-1754.2000.00450.x; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; Byard R W, 1996, J Clin Forensic Med, V3, P115, DOI 10.1016/S1353-1131(96)90000-0; Byard RW, 1999, J PAEDIATR CHILD H, V35, P409, DOI 10.1046/j.1440-1754.1999.00379.x; Byard RW, 2000, PEDIATR DEVEL PATHOL, V3, P405, DOI 10.1007/s100240010089; Byard RW, 1996, J FORENSIC SCI, V41, P438; Byard RW, 2000, J PAEDIATR CHILD H, V36, P176, DOI 10.1046/j.1440-1754.2000.00478.x; GILBERTBARNESS E, 1991, AM J FOREN MED PATH, V12, P27, DOI 10.1097/00000433-199103000-00004; KEMP JS, 1991, NEW ENGL J MED, V324, P1858, DOI 10.1056/NEJM199106273242605	9	5	5	0	4	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1034-4810			J PAEDIATR CHILD H	J. Paediatr. Child Health	APR	2001	37	2					201	202		10.1046/j.1440-1754.2001.00586.x			2	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	430PZ	WOS:000168584900022	11328481				2022-02-06	
J	Udstuen, GJ; Claar, JM				Udstuen, GJ; Claar, JM			Imaging of acute head injury in the adult	SEMINARS IN ULTRASOUND CT AND MRI			English	Article							TRAUMATIC BRAIN INJURY; ACUTE SUBDURAL HEMATOMAS; COMPUTED-TOMOGRAPHY; MAXILLOFACIAL TRAUMA; MAGNETIC-RESONANCE; CT FINDINGS; FRACTURES; CLASSIFICATION; MANAGEMENT; MODERATE		Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH 45221 USA		Udstuen, GJ (corresponding author), Univ Hosp, Dept Radiol, 234 Goodman St,POB 670762, Cincinnati, OH 45267 USA.	gudstuen@yahoo.com					Alvi A, 1998, OTOLARYNG HEAD NECK, V119, P609, DOI 10.1016/S0194-5998(98)70020-8; AOKI N, 1990, J NEUROSURG, V73, P201, DOI 10.3171/jns.1990.73.2.0201; ASSAEL LA, 1993, RADIOL CLIN N AM, V31, P209; BALL WS, 1989, RADIOLOGY, V173, P609, DOI 10.1148/radiology.173.3.2813759; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Brocker B, 1991, NEUROIMAG CLIN N AM, V1, P387; CHIRICO PA, 1989, J COMPUT ASSIST TOMO, V13, P1017, DOI 10.1097/00004728-198911000-00014; Cooper P R, 1992, Neurosurg Clin N Am, V3, P659; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; DELBALSO AM, 1991, NEUROIMAG CLIN N AM, V1, P285; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; EVANS GRD, 1995, ANN PLAS SURG, V34, P453, DOI 10.1097/00000637-199505000-00001; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTRY LR, 1983, AM J ROENTGENOL, V140, P523, DOI 10.2214/ajr.140.3.523; GILLESPIE JE, 1987, CLIN RADIOL, V38, P523, DOI 10.1016/S0009-9260(87)80144-7; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; GROSSMAN RI, 1994, NEURORADIOLOGY REQUI, P149; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; Holbourn AHS, 1943, LANCET, V2, P438; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JOHNSON DH, 1984, J COMPUT ASSIST TOMO, V8, P416, DOI 10.1097/00004728-198406000-00010; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Laine F J, 1993, Curr Probl Diagn Radiol, V22, P145; Lawrason JN, 1992, DIAGNOSTIC IMAGING T, P243; Le Fort R, 1901, REV CHIRURG, V23, P208; Lee HK, 1997, INT SOCIOL, V12, P353, DOI 10.1177/026858097012003005; LeFort R, 1901, REV CHIR PARIS, V23, P360; LeFort R, 1901, REV CHIR PARIS, V23, P479; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; MACPHERSON BCM, 1990, CLIN RADIOL, V42, P321, DOI 10.1016/S0009-9260(05)82145-2; MANSON PN, 1980, PLAST RECONSTR SURG, V66, P54, DOI 10.1097/00006534-198007000-00010; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Nasr AM, 1999, OPHTHALMOLOGY, V106, P523, DOI 10.1016/S0161-6420(99)90111-2; NOLASCO FP, 1995, OTOLARYNG HEAD NECK, V112, P549, DOI 10.1177/019459989511200408; Novelline Robert A., 1993, P323; NUMEROW LM, 1994, CAN ASSOC RADIOL J, V45, P23; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; PATHRIA MN, 1989, RADIOL CLIN N AM, V27, P839; POPP JA, 1985, NEUROSURGERY, P1536; REED D, 1986, AM J NEURORADIOL, V7, P417; Remmler D, 2000, ANN PLAS SURG, V44, P553, DOI 10.1097/00000637-200044050-00015; RHEA JT, 2000, EMERGENCY TRAUMA RAD; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rogers LE, 1982, RADIOLOGY SKELETAL T, P229; ROHRICH RJ, 1992, CLIN PLAST SURG, V19, P149; RUSSELL JL, 1990, BRIT J ORAL MAX SURG, V28, P287, DOI 10.1016/0266-4356(90)90098-6; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SEGEV Y, 1995, AM J NEURORADIOL, V16, P1174; Seiff SR, 1996, OPHTHALMOLOGY, V103, P152, DOI 10.1016/S0161-6420(96)30747-1; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SEVEL D, 1983, J COMPUT ASSIST TOMO, V7, P870, DOI 10.1097/00004728-198310000-00022; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; THORNBURY JR, 1984, AM J NEURORADIOL, V5, P459; UNGER JM, 1990, RADIOLOGY, V175, P175, DOI 10.1148/radiology.175.1.2315477; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WEISSMAN JL, 1995, AM J NEURORADIOL, V16, P936; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; ZIMMERMAN RD, 1982, AM J NEURORADIOL, V3, P635; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	72	5	5	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0887-2171	1558-5034		SEMIN ULTRASOUND CT	Semin. Ultrasound CT MRI	APR	2001	22	2					135	147		10.1016/S0887-2171(01)90041-1			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	421VP	WOS:000168084500004	11327528				2022-02-06	
J	Nolin, P; Mathieu, F				Nolin, P; Mathieu, F			The importance to use sensitive neuropsychological tests to detect attention deficits in children with mild traumatic brain injury	REVUE DE NEUROPSYCHOLOGIE			French	Article						mild traumatic brain injury; neuropsychological tests; false negatives; attention deficits	MINOR HEAD-INJURY; COLOR-WORD TEST	The subtle deficits involved in mild traumatic brain injury (MTBI) make it difficult to pose this diagnosis. The purpose of this study is to examine the hypothesis that only sufficiently sensitive neuropsychological tests might be helpful in detecting the attention deficits of children who have sustained a MTBI. As expected, results point to the importance of not limiting diagnosis to the global scores of traditional neuropsychological tests. A more focused analysis of specific components of these tests, concerned with speed of information processing, allows for a more thorough investigation of potential deficits. By not using such an approach we increase the risk of identifying false negatives.	Univ Quebec, Dept Psychol, Grp Rech Dev Enfant & Famille, Trois Rivieres, PQ G9A 5H7, Canada								American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BATCHELOR J, 1995, CLIN NEUROPSYCHOL, V9, P180, DOI 10.1080/13854049508401600; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL D, 1975, LANCET, V2, P995; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; LEININGER BE, 1992, PHYSICAL MED REHABIL, V6, P169; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MELENDEZ F, 1978, CHILDRENS NEUROPSYCH; MIDDLETON J, 1989, J CHILD PSYCHOL PSYC, V30, P663, DOI 10.1111/j.1469-7610.1989.tb00780.x; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; SHALLICE T, 1995, SYMPTOMES MODELES NE; SPREEN O, 1991, COMPENDIUM NEUROPSYC, P3	20	5	5	0	0	ADRSC-ASSOC DIFFUSION RECHERCHES SCIENCES COGNITIVES	MARSEILLE CEDEX 20	C N R S-C R N C, 31, CHEMIN JOSEPH ALGUIER, 13402 MARSEILLE CEDEX 20, FRANCE	1155-4452			REV NEUROPSYCHOL	Rev. Neuropsychol.	MAR	2001	11	1					23	38					16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	425PZ	WOS:000168301500002					2022-02-06	
J	Ardila, A; Rosselli, D				Ardila, A; Rosselli, D		GENECO	Handedness in Colombia: Some associated conditions	LATERALITY			English	Article							HAND PREFERENCE; LANGUAGE DISORDERS; BRAIN-DAMAGE; POPULATION; PATTERNS; JAPANESE; AGE; SINISTRALITY; ILLITERACY; SEX	As part of a national neuroepidemiological study a population-based sample of 6941 subjects, 10 years of age or older, was selected in five different regions in Colombia (South America). Overall, 91.65% of the participants (90.6%) of the males; 92.7% of the females) considered themselves as right-handers. Handedness was significantly correlated with education in men but not in women. Handedness was not associated with age. Prevalence of history of loss of consciousness, tremors, difficulties with speech, and traumatic head injury was observed to be higher in non-handers than in right-handers. This finding was particularly evident in men. Implications of current results are analysed.	Inst Colombiano Neuropsicol, Bogota, Colombia; Univ Javeriana, Clin Epidemiol Unit, Bogota, Colombia		Ardila, A (corresponding author), 12230 NW 8 St, Miami, FL 33182 USA.			Rosselli, Diego/0000-0003-0960-9480; Berrio Parra, Felipe Leopoldo/0000-0001-9297-6016			ANNETT M, 1964, NATURE, V204, P59, DOI 10.1038/204059a0; ANNETT M, 1973, ANN HUM GENET, V37, P93, DOI 10.1111/j.1469-1809.1973.tb01817.x; ANNETT M, 1985, LEFT RIGHT BRAIN RIG; ARDILA A, 1989, NEUROPSYCHOLOGIA, V27, P893, DOI 10.1016/0028-3932(89)90013-4; BETANCUR S, 1987, ZURDOS; BRADSHAWMCANULTY G, 1984, BRAIN COGNITION, V3, P349, DOI 10.1016/0278-2626(84)90027-7; Bryden M., 1982, LATERALITY FUNCTIONA; Bryden M P, 1997, Laterality, V2, P317, DOI 10.1080/135765097397512; BRYDEN MP, 1993, NEUROPSYCHOLOGIA, V31, P301, DOI 10.1016/0028-3932(93)90094-G; COREN S, 1995, CAN J EXP PSYCHOL, V49, P376, DOI 10.1037/1196-1961.49.3.376; COREN S, 1994, INT J NEUROSCI, V76, P231, DOI 10.3109/00207459408986005; COREN S, 1995, BEHAV GENET, V25, P517, DOI 10.1007/BF02327575; DAWSON JLMB, 1977, PSYCHOLOGIA, V20, P121; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GABRIELLI WF, 1980, J ABNORM PSYCHOL, V89, P654, DOI 10.1037/0021-843X.89.5.654; GESCHWIND N, 1982, P NATL ACAD SCI-BIOL, V79, P5097, DOI 10.1073/pnas.79.16.5097; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; GLOSSER G, 1993, J AM GERIATR SOC, V41, P931, DOI 10.1111/j.1532-5415.1993.tb06758.x; HARBURG E, 1978, PERCEPT MOTOR SKILL, V47, P1171, DOI 10.2466/pms.1978.47.3f.1171; HARBURG E, 1981, PERCEPT MOTOR SKILL, V52, P279, DOI 10.2466/pms.1981.52.1.279; HARDYCK C, 1975, HUM BIOL, V47, P369; Harris L. J., 1988, BRAIN LATERALIZATION, P289; Hatta T, 1995, CAN J EXP PSYCHOL, V49, P505, DOI 10.1037/1196-1961.49.4.505; HATTA T, 1994, J GEN PSYCHOL, V121, P377, DOI 10.1080/00221309.1994.9921211; HATTA T, 1976, PERCEPT MOTOR SKILL, V42, P530, DOI 10.2466/pms.1976.42.2.530; HECAEN H, 1964, LEFT HANDEDNESS MANU; IWASAKI S, 1995, PERCEPT MOTOR SKILL, V80, P979, DOI 10.2466/pms.1995.80.3.979; KANG Y, 1993, TENNETT THEOR EXP NE; KAPOOR SK, 1990, NEUROEPIDEMIOLOGY, V9, P287, DOI 10.1159/000110791; LANSKY LM, 1988, NEUROPSYCHOLOGIA, V26, P465, DOI 10.1016/0028-3932(88)90099-1; LECOURS AR, 1988, NEUROPSYCHOLOGIA, V26, P575, DOI 10.1016/0028-3932(88)90114-5; LECOURS AR, 1987, NEUROPSYCHOLOGIA, V25, P231, DOI 10.1016/0028-3932(87)90134-5; LEVY J, 1972, GENETICS, V72, P117; LISHMAN WA, 1976, BRIT J PSYCHIAT, V129, P158, DOI 10.1192/bjp.129.2.158; MARCHANT LF, 1995, ETHOLOGY, V101, P239; MATUTE E, 1988, LENGUAJE ORAL ESCRIT, P310; MCMANUS IC, 1985, PSYCHOL MED S, V8; NEILS JR, 1986, BRAIN LANG, V28, P53, DOI 10.1016/0093-934X(86)90090-8; Penfield W, 1959, SPEECH BRAIN MECH; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; REISS M, 1997, PERCEPT MOTOR SKILL, V85, P269; ROSSELLI D, UNPUB NEUROEPIDEMIOL; ROSSELLI D, 1987, CEPHALALGIA S6, V7, P195; SATZ P, 1973, NEUROPSYCHOLOGIA, V11, P115, DOI 10.1016/0028-3932(73)90071-7; SATZ P, 1988, BRAIN LATERALIZATION, P281; Silva-Rodriguez A, 1996, Gac Med Mex, V132, P29; Stellman SD, 1997, ANN EPIDEMIOL, V7, P167, DOI 10.1016/S1047-2797(96)00158-5; TENG EL, 1976, SCIENCE, V193, P1148, DOI 10.1126/science.986686; Wright P, 1996, PERCEPT MOTOR SKILL, V82, P855, DOI 10.2466/pms.1996.82.3.855; YEO RA, 1993, GENETICA, V89, P281, DOI 10.1007/BF02424521	50	5	5	0	3	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	1357-650X			LATERALITY	Laterality	JAN	2001	6	1					77	87		10.1080/713754398			11	Psychology, Multidisciplinary; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	395NA	WOS:000166585400007	15513161				2022-02-06	
J	Cooper, ER; Ferrara, MS; Mrazik, M; Casto, S				Cooper, ER; Ferrara, MS; Mrazik, M; Casto, S			Definitional problems in mild head injury epidemiology	ATHLETIC THERAPY TODAY			English	Article						concussion; traumatic brain injury	TRAUMATIC BRAIN INJURY; SOCCER PLAYERS; ICE HOCKEY; FOOTBALL PLAYERS; CONCUSSION; SPORTS; GUIDELINES; PREVENTION; DIAGNOSIS; SEVERITY		Georgia Coll & State Univ, Milledgeville, GA 31061 USA; Univ Georgia, Dept Educ Psychol, Athens, GA 30602 USA; Univ Georgia, Sch Exercise Sci, Athens, GA 30602 USA		Cooper, ER (corresponding author), Georgia Coll & State Univ, Milledgeville, GA 31061 USA.			Cooper, Earl/0000-0003-1132-4644			BAILES J, 1998, SPORTS RELATED CONCU; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Cantu, 1991, Adolesc Med, V2, P141; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; *CO MED SOC SPORTS, 1991, GUID MAN CONC SPORTS; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; FRYE RE, 1994, HEAD NECK INJURIES S; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GURDJIAN ES, 1964, CLIN NEUROSURG, V12, P386; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; INGEBRIGTSEN T, 1996, TIKSSKRIFT NORSKE LA, V116, P3597; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus J F, 1970, Med Sci Sports, V2, P162; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; LORENTZON R, 1988, AM J SPORT MED, V16, P389, DOI 10.1177/036354658801600414; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; Maroon J C, 1980, Clin Neurosurg, V27, P414; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; PELLETIER RL, 1993, AM J SPORT MED, V21, P78, DOI 10.1177/036354659302100114; Pforringer W, 1987, J SPORT SCI, V5, P327, DOI 10.1080/02640418708729786; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; RNHEIM DD, 1993, PRINCIPLES ATHLETIC, P680; Roos R, 1996, PHYSICIAN SPORTSMED, V24, P67, DOI 10.3810/psm.1996.10.1327; ROOS R, 1996, PHYSICIAN SPORTSMED, V24, P74; ROOS R, 1996, PHYSICIAN SPORTSMED, V24, P72; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; SHAW DV, 1994, SRA-J SOC RES ADMIN, V26, P5; Sturmi JE, 1998, SPORTS MED, V25, P351, DOI 10.2165/00007256-199825060-00001; Sutherland G W, 1976, Am J Sports Med, V4, P264, DOI 10.1177/036354657600400605; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; VEGSO JJ, 1982, ATHLETIC INJURIES HE, P40; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005	43	5	5	1	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, CHAMPAIGN, IL 61820-2200 USA	1078-7895			ATHLET THER TODAY	Athlet. Ther. Today	JAN	2001	6	1					6	12		10.1123/att.6.1.6			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	482AT	WOS:000171553200003					2022-02-06	
J	Kochanek, PM; Janesko, KL; Jenkins, LW; Yan, HQ; Kibbe, MR; Robichaud, P; Wooditch, AC; Clark, RSB; Dixon, CE; Marion, DW; Billiar, TR				Kochanek, PM; Janesko, KL; Jenkins, LW; Yan, HQ; Kibbe, MR; Robichaud, P; Wooditch, AC; Clark, RSB; Dixon, CE; Marion, DW; Billiar, TR			Adenovirus-mediated transfer and expression of beta-Gal in injured hippocampus after traumatic brain injury in mice	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	29th Annual Meeting of the Society-for-Neuroscience	OCT 23-28, 1999	MIAMI BEACH, FL	Soc Neurosci		controlled cortical impact; gene therapy; head injury; vector	CONTROLLED CORTICAL IMPACT; INTERLEUKIN-1 RECEPTOR ANTAGONIST; PROTEIN-SYNTHESIS; GENE-TRANSFER; CEREBRAL-ISCHEMIA; RECOMBINANT ADENOVIRUS; NERVOUS-SYSTEM; CSF DYNAMICS; RAT-BRAIN; IN-VIVO	In models of focal cerebral ischemia, adenoviral gene transfer is often attenuated or delayed versus naive. After controlled cortical impact (CCI)-induced traumatic brain injury in mice, CA1 and CA3 hippocampus exhibit delayed neuronal death by 3 days, with subsequent near complete loss of hippocampus by 21 days. We hypothesized that adenoviral-mediated expression of the reporter gene beta -Galactosidase (beta -Gal) in hippocampus would be attenuated after CCI in mice. C57BL6 mice (n = 16) were subjected to either CCI to left parietal cortex or sham (burr hole). Adenovirus carrying the beta -Gal gene (AdlacZ; 1 x 10(9) plaque-forming units [pfu]/mL) was then injected into left dorsal hippocampus. At 24 or 72 h, beta -Gal expression was quantified (mU/mg protein). Separate mice (n = 10) were used to study beta -Gal spatial distribution in brain sections. beta -Gal expression in left hippocampus was similar in shams at 24 h (48.4 +/- 4.1) versus 72 h (68.8 +/- 8.8, not significant). CCI did not reduce beta -Gal expression in left hippocampus (68.8 +/- 8.8 versus 88.1 +/- 7.0 at 72 h, sham versus CCI, not significant). In contrast, CCI reduced beta -Gal expression in right (contralateral) hippocampus versus sham (p < 0.05 at both 24 and 72 h). <beta>-Gal was seen in many cell types in ipsilateral hippocampus, including CA3 neurons. Despite eventual loss of ipsilateral hippocampus, adenovirus-mediated gene transfer was surprisingly robust early after CCI providing an opportunity to test novel genes targeting delayed hippocampal neuronal death.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave,Ste 201, Pittsburgh, PA 15260 USA.	kochanekpm@anes.upmc.edu	Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM044100, R37GM044100, R29GM044100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM44100] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline		Abe K, 1997, NEUROSCI LETT, V226, P53, DOI 10.1016/S0304-3940(97)00243-7; Abe K, 1997, BRAIN RES, V763, P191, DOI 10.1016/S0006-8993(97)00389-2; Abe K, 1998, NEUROL RES, V20, P689; ABE K, 1988, J NEUROCHEM, V51, P1470, DOI 10.1111/j.1471-4159.1988.tb01113.x; Antonawich FJ, 1999, EXP NEUROL, V156, P130, DOI 10.1006/exnr.1998.7004; ARAKI T, 1990, ACTA NEUROPATHOL, V79, P501, DOI 10.1007/BF00296109; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; Betz AL, 1998, EXP NEUROL, V150, P136, DOI 10.1006/exnr.1997.6755; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Burda J, 1998, J CEREBR BLOOD F MET, V18, P59, DOI 10.1097/00004647-199801000-00006; Cai RR, 1998, J BIOL CHEM, V273, P11274, DOI 10.1074/jbc.273.18.11274; Cartmell T, 1999, J NEUROSCI, V19, P1517; Christenson SD, 1998, STROKE, V29, P1411, DOI 10.1161/01.STR.29.7.1411; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; DeGracia DJ, 1999, EXP NEUROL, V155, P221, DOI 10.1006/exnr.1998.6986; DeGracia DJ, 1996, J NEUROCHEM, V67, P2005; Freese A, 1997, EPILEPSIA, V38, P759, DOI 10.1111/j.1528-1157.1997.tb01462.x; Geddes BJ, 1996, ENDOCRINOLOGY, V137, P5166, DOI 10.1210/en.137.11.5166; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Kamme F, 1996, ADV NEUROL, V71, P199; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kuo H, 1995, BRAIN RES, V705, P31, DOI 10.1016/0006-8993(95)01065-3; Lawrence MS, 1997, J CEREBR BLOOD F MET, V17, P740; LE GLS, 1993, SCIENCE, V259, P988; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; NEUMAR RW, 1995, J NEUROCHEM, V65, P1391; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schuhmann MU, 1998, ACT NEUR S, V71, P300; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Sullivan JM, 1999, J CEREBR BLOOD F MET, V19, P1010, DOI 10.1097/00004647-199909000-00009; Terashima T, 1997, ANAT EMBRYOL, V196, P363, DOI 10.1007/s004290050105; UNDERWOOD BD, 1999, J NEUROTRAUM, V16, P1002; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; WILLIAMS MA, 1993, CURR OPIN NEUROL, V6, P847, DOI 10.1097/00019052-199312000-00004; Wood MJA, 1996, TRENDS NEUROSCI, V19, P497, DOI 10.1016/S0166-2236(96)10060-6; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yamasaki K, 1998, J CLIN INVEST, V101, P967, DOI 10.1172/JCI2067; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2	49	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2001	18	1					73	82		10.1089/089771501750055785			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	390EU	WOS:000166283400007	11200251				2022-02-06	
J	Magnusson, BM; Koskinen, LOD; Koch, M; Karlsson, K				Magnusson, BM; Koskinen, LOD; Koch, M; Karlsson, K			Biological effects after percutaneous absorption of thyrotropin-releasing hormone and its analogue M-TRH	PEPTIDES			English	Article						transdermal delivery; in vivo; in vitro; peptides; TRH; penetration enhancer	CENTRAL-NERVOUS-SYSTEM; HUMAN EPIDERMIS; TRANSDERMAL PERMEATION; RAT; PHARMACOLOGY; DEGRADATION; ENHANCERS; ETHANOL; DRUGS	Besides its well known endocrinological effects, thyrotropin-releasing hormone (TRH) has potential clinical value in the treatment of neurotrauma and various neurologic and psychiatric disorders. The aim of this study was to assess if transdermal delivery of TRH and its analogue, M-TRH, in the presence of enhancers, is an effective means for administration of the peptides. Using the in vitro diffusion cell method, the effect of ethanol and a terpene on the transdermal penetration of the peptides across full-thickness rat skin were studied. Steady-state permeability values fur TRH and M-TRH were 8.7 +/- 2.2 and 6.7 +/- 1.4 mug/cm(2) h, respectively. The addition of 3% terpene in combination with 47% ethanol increased the penetration of TRH and M-TRH to 16.2 +/- 1.7 and 14.6 +/- 2.1 mug/cm(2) h, respectively. Rats were studied in vivo for release of thyroid-stimulating hormone (TSH) as a biologic effect after transdermally delivered peptide. Topical application of TRH and M-TRH induced an increase in TSH serum concentration from 0.32 +/- 0.09 ng/ml to 32.6 +/- 5.0 and 22.9 +/- 7.6 ng/ml, respectively, after 30 min. The addition of terpene and ethanol in combination with TRH or M-TRH, increased the TSH release to 43.0 +/- 3.8 and 48.4 +/- 4.0 ng/ml, respectively. It is concluded that, in the rat, peptides can be absorbed through the sl;in with retained biologic activity, and in amounts sufficient to elicit a physiological response. (C) 2001 Elsevier Science Inc. All rights reserved.	Def Res Estab, Div NBC Def, Dept Biomed, S-90182 Umea, Sweden; Umea Univ Hosp, Dept Publ Hlth & Clin Med, Sect Dermatol & Venereol, S-90185 Umea, Sweden; Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, Neurosurg Sect, S-90185 Umea, Sweden; Umea Univ Hosp, Dept Med Biosci, Sect Clin Chem, S-90185 Umea, Sweden		Koskinen, LOD (corresponding author), Def Res Estab, Div NBC Def, Dept Biomed, S-90182 Umea, Sweden.	Lars-Owe.Koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502			BARRY BW, 1983, MARCEL DEKKER, P95; BREESE GR, 1975, J PHARMACOL EXP THER, V193, P11; Brooks B. R., 1989, ANN NY ACAD SCI, V553, P431; ELIAS PM, 1981, ARCH DERMATOL RES, V270, P95, DOI 10.1007/BF00417155; EMERSON CH, 1981, ENDOCRINOLOGY, V109, P1375, DOI 10.1210/endo-109-5-1375; ENGEL WK, 1989, ANN NY ACAD SCI, V553, P462; GRIFFITHS EC, 1985, PSYCHONEUROENDOCRINO, V10, P225, DOI 10.1016/0306-4530(85)90001-0; GUILOFF RJ, 1989, ANN NY ACAD SCI, V553, P399; Heuer H, 1998, EUR J NEUROSCI, V10, P1465, DOI 10.1046/j.1460-9568.1998.00158.x; HICHENS M, 1983, DRUG METAB REV, V14, P77, DOI 10.3109/03602538308991382; HOLADAY JW, 1989, ANN NY ACAD SCI, V55, P370; HORITA A, 1986, ANNU REV PHARMACOL, V26, P311; JACKSON IMD, 1979, ENDOCRINOLOGY, V104, P1292, DOI 10.1210/endo-104-5-1292; JACKSON IMD, 1982, NEW ENGL J MED, V306, P145, DOI 10.1056/NEJM198201213060305; KOSKINEN LOD, 1991, PEPTIDES, V12, P1273, DOI 10.1016/0196-9781(91)90206-5; KOSKINEN LOD, 1989, PEPTIDES, V10, P933, DOI 10.1016/0196-9781(89)90171-X; Magnusson BM, 1997, ACTA DERM-VENEREOL, V77, P264; Magnusson BM, 1999, INT J PHARM, V178, P149, DOI 10.1016/S0378-5173(98)00316-0; Magnusson BM, 1997, INT J PHARMACEUT, V157, P113, DOI 10.1016/S0378-5173(97)00235-4; METCALF G, 1982, BRAIN RES REV, V4, P389, DOI 10.1016/0165-0173(82)90012-1; OLEARY R, 1995, J NEUROCHEM, V65, P953; OTURAI PS, 1992, ACTA ENDOCRINOL-COP, V126, P243, DOI 10.1530/acta.0.1260243; SANO K, 1979, ADV NEUROL SCI, V23, P184; SOWERS JR, 1976, J CLIN ENDOCR METAB, V43, P471; WARD DJ, 1987, INT J PEPT PROT RES, V30, P263; WERTZ PW, 1991, PHYSL BIOCH MOL BIOL, P205; WILLIAMS AC, 1992, CRIT REV THER DRUG, V9, P305; WU W, 1992, NEUROSCI LETT, V142, P143, DOI 10.1016/0304-3940(92)90359-F; YARBROUGH GG, 1979, PROG NEUROBIOL, V12, P291, DOI 10.1016/0301-0082(79)90012-1	29	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2001	22	1					73	79		10.1016/S0196-9781(00)00358-2			7	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	404WQ	WOS:000167125400009	11179600				2022-02-06	
J	Marciano, PG; Eberwine, JH; Raghupathi, R; McIntosh, TK				Marciano, PG; Eberwine, JH; Raghupathi, R; McIntosh, TK			The assessment of genomic alterations using DNA arrays following traumatic brain injury: a review	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Brain injury; Differential expression; apoptosis; cell death	GENE-EXPRESSION PATTERNS; CORTICAL IMPACT INJURY; NERVE GROWTH-FACTOR; MESSENGER-RNA; CELL-DEATH; OLIGONUCLEOTIDE ARRAYS; RAT-BRAIN; C-FOS; SACCHAROMYCES-CEREVISIAE; NEURONAL DEATH	Recent advances in DNA microarray technology have enabled the simultaneous evaluation of thousands of genes and the subsequent generation of massive amounts of biological data relevant to injury or diseases of the central nervous system (CNS). This technology has the potential to bridge the gap between molecular and systems neuroscience by efficiently revealing the discrete molecular aspects underlying the perturbations of complex systemic insults such as those resulting from traumatic brain injury (TBI). One of the more intriguing and as of yet not understood aspects of TBI that can be efficiently explored with DNA microarrays, is the sequence of molecular events that results in pronounced cell death in specific areas of the brain. The elucidation of these changes in gene expression underlying the mechanism of cell death following brain injury is of central importance in the design of future therapeutic agents. This review focuses on the technical aspects of microarray manufacture (photolithography, microspotting, and ink jet technology) and their utility in elucidating the molecular sequelae of brain injury.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		Marciano, PG (corresponding author), Univ Penn, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.		Raghupathi, Ramesh/AAX-5538-2021; Eberwine, James/B-2247-2010				ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Blanchard A, 1998, GENET ENG P, V20, P111; BLUMENFELD KS, 1992, J CEREBR BLOOD F MET, V12, P987, DOI 10.1038/jcbfm.1992.136; Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455; Chen ST, 1999, NEUROREPORT, V10, P509, DOI 10.1097/00001756-199902250-00012; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DeRisi J, 1996, NAT GENET, V14, P457; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dichter M., 1995, NEUROSCIENTIST, V1, P200, DOI 10.1177/107385849500100404; Eberwine J, 1996, BIOTECHNIQUES, V20, P584; EBERWINE J, 1992, METHOD ENZYMOL, V216, P80; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Fodor SPA, 1997, SCIENCE, V277, P393, DOI 10.1126/science.277.5324.393; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GILLESPIE D, 1965, J MOL BIOL, V12, P829, DOI 10.1016/S0022-2836(65)80331-X; GRESS TM, 1992, MAMM GENOME, V3, P609, DOI 10.1007/BF00352477; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; HARRISON SMW, 1999, SOC NEUR ABSTR, V29; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; KAFATOS FC, 1979, NUCLEIC ACIDS RES, V7, P1541, DOI 10.1093/nar/7.6.1541; Kaya SS, 1999, J NEUROTRAUM, V16, P1187, DOI 10.1089/neu.1999.16.1187; Kinoshita M, 1997, J CEREBR BLOOD F MET, V17, P507, DOI 10.1097/00004647-199705000-00004; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; Kuang WW, 1998, NUCLEIC ACIDS RES, V26, P1116, DOI 10.1093/nar/26.4.1116; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LENNON GG, 1991, TRENDS GENET, V7, P314, DOI 10.1016/0168-9525(91)90420-U; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; MAGNUSSON K, 1989, NEUROSCI LETT, V96, P264, DOI 10.1016/0304-3940(89)90389-3; Manduchi E, 2000, BIOINFORMATICS, V16, P685, DOI 10.1093/bioinformatics/16.8.685; MARCIANO PG, 2000, SOC NEUR ABSTR, V30; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Morimoto T, 1996, AM J PATHOL, V148, P249; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; O'Dell DM, 1998, BIOTECHNIQUES, V25, P566, DOI 10.2144/98254bm04; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Oh YJ, 1997, MOL BRAIN RES, V51, P133, DOI 10.1016/S0169-328X(97)00229-5; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; PATTERSON SL, 1993, BRAIN RES, V605, P43, DOI 10.1016/0006-8993(93)91354-U; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RINK A, 1995, AM J PATHOL, V147, P1575; SANDBERGNORDQVI.A, 2000, SOC NEUR ABSTR, V30; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.3.CO;2-P; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Walton M, 1999, J NEUROCHEM, V73, P1836; Walton M, 1996, MOL BRAIN RES, V43, P21, DOI 10.1016/S0169-328X(96)00144-1; Watson A, 1998, CURR OPIN BIOTECH, V9, P609, DOI 10.1016/S0958-1669(98)80138-9; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	69	5	5	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2001	18	2-3					105	113					9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	497DY	WOS:000172438500007	11847433				2022-02-06	
J	Dalfen, AK; Feinstein, A				Dalfen, AK; Feinstein, A			Head injury, dissociation and the Ganser syndrome	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; STRESS-DISORDER	Objective: To describe the clinical characteristics and psychiatric correlates of the Ganser syndrome following mild traumatic brain injury (TBI). Method: A retrospective chart review of patients with mild TBI assessed in a tertiary care outpatient clinic. Results: Of 513 patients reviewed in a 1 year period, four subjects with a diagnosis of Ganser syndrome, with the hallmark syndrome of approximate answers ('vorbeigehen') were identified. In three of these patients, symptoms of Acute Stress Disorder (ASD) and/or Post-traumatic Stress Disorder (PTSD) were found. Only one patient was pursuing litigation. Conclusions: While no epidemiologic conclusions can be drawn from the data, clinicians should, nevertheless, be alert to the possibility of patients presenting with Ganser syndrome following TBI. The findings are discussed in the light of data linking the syndrome to dissociative and post-traumatic stress related disorders.	Univ Toronto, Dept Psychiat, Sunnybrook & Womens Coll, Hlth Sci Ctr, N York, ON M4N 3M5, Canada		Dalfen, AK (corresponding author), Univ Toronto, Dept Psychiat, Sunnybrook & Womens Coll, Hlth Sci Ctr, 2075 Bayview Ave, N York, ON M4N 3M5, Canada.		Dalfen, Ariel/N-9092-2016				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; APTER A, 1993, J AM ACAD CHILD PSY, V32, P582, DOI 10.1097/00004583-199305000-00014; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Cantagallo A, 1999, BRAIN INJURY, V13, P219, DOI 10.1080/026990599121593; Ganser SJM, 1965, BRIT J CRIMINOL, V5, P120; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; SANDEL ME, 1990, ARCH PHYS MED REHAB, V71, P523; Ursano RJ, 1999, AM J PSYCHIAT, V156, P1808	9	5	5	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2000	14	12					1101	1105					5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	380YW	WOS:000165736100007	11147582				2022-02-06	
J	Kline, AE; Montanez, S; Bradley, HA; Millar, CJ; Hernandez, TD				Kline, AE; Montanez, S; Bradley, HA; Millar, CJ; Hernandez, TD			Distinctive amygdala kindled seizures differentially affect neurobehavioral recovery and lesion-induced basic fibroblast growth factor (bFGF) expression	BRAIN RESEARCH			English	Article						anteromedial cortex; c-Fos; immunohistochemistry; growth factor; trauma	FACTOR MESSENGER-RNA; CEREBRAL GLUCOSE-UTILIZATION; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; MOTOR CORTEX INJURY; SPINAL-CORD INJURY; C-FOS; FUNCTIONAL RECOVERY; SENSORIMOTOR CORTEX; CORTICAL DAMAGE	The differing effects of partial seizures on neurobehavioral recovery following anteromedial cortex (AMC) injury in rats have previously been reported. Specifically, convulsive Stage 1 seizures evoked ipsilateral to the lesion during the 6-day post-lesion critical period delayed recovery, while non-convulsive Stage 0 seizures were neutral. The present study was designed to elaborate on that research by examining several potential mechanisms for the seizure-associated difference observed in functional outcome. Anesthetized rats sustained unilateral AMC lesions followed by implantation of a stimulating electrode in the amygdala ipsilateral (Expt. 1) or contralateral (Expt. 2) to the lesion. Beginning 48 h after surgery, animals were kindled to evoke Stage 0 or Stage 1 seizure activity during the critical period. Kindling trials and afterdischarge (AD) were controlled to ascertain their role in functional outcome. Recovery from somatosensory deficits was assessed over a two-month period. The results revealed that (i) Stage 0 seizures did not impact recovery regardless of whether initiated ipsilateral or contralateral to the lesion, (ii) Stage 1 seizures prevented recovery only when initiated in the ipsilateral hemisphere during the post-lesion critical period, and (iii) the detrimental effect of Stage 1 seizures appears to be independent of the number of kindling trials provided and cumulative AD. Thus, to determine why Stage 1 seizures evoked in the hemisphere ipsilateral to the lesion impeded recovery, a separate group of animals (Expt. 3) were kindled accordingly and processed for c-Fos and basic fibroblast growth factor (bFGF) immunohistochemistry. It was hypothesized that Stage 1 seizures evoked in the injured hemisphere prevent recovery by blocking lesion-induced bFGF expression in structures shown to he important for recovery after cortex lesions (e.g., striatum). The results confirmed our hypothesis and suggest that thr seizure-associated inhibition of lesion-induced bFGF may alter the growth factor-mediated plasticity necessary for functional recovery. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Colorado, Dept Psychol, Behav Neurosci Program, Boulder, CO 80309 USA		Hernandez, TD (corresponding author), Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	terid@psych.colorado.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS030595] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30595] Funding Source: Medline		ANNETT LE, 1992, BRAIN, V115, P825, DOI 10.1093/brain/115.3.825; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; ARNOLD PS, 1973, EXP NEUROL, V40, P457, DOI 10.1016/0014-4886(73)90087-3; BAFFOUR R, 1995, J NEUROSURG, V83, P105, DOI 10.3171/jns.1995.83.1.0105; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; BARTH TM, 1990, J NEUROSCI, V10, P3449; BARTH TM, 1994, BEHAV NEUROSCI, V108, P818, DOI 10.1037/0735-7044.108.4.818; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; BUGRA K, 1994, EUR J NEUROSCI, V6, P58, DOI 10.1111/j.1460-9568.1994.tb00247.x; BUYTAERT KA, 1998, SOC NEUR ABSTR, V24, P738; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; CLARK M, 1991, MOL BRAIN RES, V11, P55, DOI 10.1016/0169-328X(91)90021-O; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DRAGUNOW M, 1988, EXP NEUROL, V102, P261, DOI 10.1016/0014-4886(88)90103-3; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; ENGEL J, 1978, ANN NEUROL, V3, P538, DOI 10.1002/ana.410030615; Feeney D M, 1987, Brain Inj, V1, P27, DOI 10.3109/02699058709034441; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FOLLESA P, 1994, EXP NEUROL, V127, P37, DOI 10.1006/exnr.1994.1077; FRANK E, 1995, NEUROL RES, V17, P129, DOI 10.1080/01616412.1995.11740300; FREESE A, 1992, BRAIN RES, V575, P351, DOI 10.1016/0006-8993(92)90104-H; GALL CM, 1994, MOL BRAIN RES, V21, P190, DOI 10.1016/0169-328X(94)90250-X; GILMAN S, 1987, ANN NEUROL, V22, P370, DOI 10.1002/ana.410220314; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Goldstein L B, 1990, Restor Neurol Neurosci, V1, P311, DOI 10.3233/RNN-1990-1501; Goldstein LB, 2000, NEUROPHARMACOLOGY, V39, P852, DOI 10.1016/S0028-3908(99)00249-X; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; HAUSER WA, 1984, NEUROLOGY, V34, P746, DOI 10.1212/WNL.34.6.746; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; HERNANDEZ TD, 1995, BRAIN RES, V673, P208, DOI 10.1016/0006-8993(94)01415-E; HERNANDEZ TD, 1989, BRAIN RES, V487, P89, DOI 10.1016/0006-8993(89)90943-8; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hernandez TD, 1998, ADV BEHAV BIOL, V48, P361; Hovda D.A., 1996, NEUROTRAUMA, P1459; IWAMOTO Y, 1994, LIFE SCI, V55, P1651, DOI 10.1016/0024-3205(94)00332-7; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; KOLB B, 1991, BEHAV BRAIN RES, V43, P51, DOI 10.1016/S0166-4328(05)80051-8; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347; Lin DA, 1997, NEUROSCIENTIST, V3, P247, DOI 10.1177/107385849700300412; LIU Z, 1993, BRAIN RES, V626, P335, DOI 10.1016/0006-8993(93)90598-H; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; NAMBA H, 1989, BRAIN RES, V486, P221, DOI 10.1016/0006-8993(89)90508-8; NEARY JT, 1995, BRAIN RES, V675, P27, DOI 10.1016/0006-8993(95)00031-K; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; RIVA MA, 1992, MOL BRAIN RES, V15, P311, DOI 10.1016/0169-328X(92)90123-S; ROSE L, 1994, STROKE, V25, P1973, DOI 10.1161/01.STR.25.10.1973; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Sato K, 1996, EPILEPSIA, V37, P6, DOI 10.1111/j.1528-1157.1996.tb00504.x; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHALLERT T, 1997, BRAIN PLASTICITY ADV, P231; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Teng YD, 1999, J NEUROSCI, V19, P7037, DOI 10.1523/JNEUROSCI.19-16-07037.1999; TESKEY GC, 1991, MOL BRAIN RES, V11, P1; Valouskova V, 1999, NEUROBIOL LEARN MEM, V71, P132, DOI 10.1006/nlme.1998.3877; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; VONMONAKOW C, 1969, MOODS STATES MIND, P27; Wallace AE, 1999, RESTOR NEUROL NEUROS, V14, P35; WATSON CW, 1945, J NEUROPHYSIOL, V8, P221; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	79	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 13	2000	880	1-2					38	50		10.1016/S0006-8993(00)02762-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	365MT	WOS:000089955600005	11032988				2022-02-06	
J	Preston, BL; Warren, RC; Stewart, P				Preston, BL; Warren, RC; Stewart, P			Factors affecting environmental awareness among Head Start families in Mississippi	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article						environmental health; health education; poverty; social justice	EXCESS MORTALITY; CRIMINAL INJUSTICE; MEDICAL-CARE; RISK-FACTORS; PERCEPTIONS; RACE; ATTITUDES; EDUCATION; INJURIES; HARLEM	Conclusions: Socioeconomic and racial/ethnic disparities in health status in the United States may be attributed in part to environmental injustice and differential exposure to environmental hazards among lo cv-income and/or minority populations. However, the environmental justice movement has historically focused on equity in the siting of point-source polluting facilities, giving little attention to environmental hazards and environmental awareness at the level of the individual household. Methods: Heads of 763 low-income households participating in Head Start programs in 20 counties of the Mississippi Delta region were surveyed regarding their education, the physical environment of their home and workplace, sour ces of food and water, awareness of local polluting sites/facilities, knowledge of government agencies, and behaviors that may affect their health or impact their local environment. Survey results were compared to demographic, socioeconomic, and environmental quality indicators. Results: Significant associations existed between both education and race/ethnicity and the responses of survey participants. Being African American was more commonly associated with poor quality-of-life indicators such as renting substandard older homes and living in close proximity to areas of unfavorable watershed quality. Higher education was more commonly and positively associated with indicators of heightened environmental awareness and increased political empowerment. No association was observed between race/ethnicity and the prevalence of polluting facilities. However, a significant association existed between race/ethnicity anti indicators of environmental quality/integrity. Conclusions: Environmental health education interventions that target individual households may be a useful mechanism for increasing the access of low-income communities to government health resources and reducing adverse health effects from the environment. However, racial/ethnic disparities in education and health remain an important consideration.	US Dept HHS, Off Urban Affairs, Agcy Tox Subst & Dis Registry, Atlanta, GA 30333 USA; Univ N Carolina, Carolina Environm Program, Chapel Hill, NC USA; Nat Sci Program, Edwards, MS USA; Environm Educ Program, Edwards, MS USA		Warren, RC (corresponding author), US Dept HHS, Off Urban Affairs, Agcy Tox Subst & Dis Registry, 1600 Clifton Rd NE,Mailstop E-28, Atlanta, GA 30333 USA.		Preston, Benjamin L/B-9001-2012	Preston, Benjamin L/0000-0002-7966-2386			ADAMS JP, 1988, HUM RELAT, V41, P753, DOI 10.1177/001872678804101004; ALLEN D, 1995, W POL SCI ASS ANN M; BAKER DW, 1994, JAMA-J AM MED ASSOC, V271, P1909, DOI 10.1001/jama.271.24.1909; BELVILLE R, 1993, JAMA-J AM MED ASSOC, V269, P2754, DOI 10.1001/jama.269.21.2754; Bullard Robert, 1990, DUMPING DIXIE RACE C; Burger J, 1998, J TOXICOL ENV HEAL A, V53, P255, DOI 10.1080/009841098159268; BURKE L, 1994, GEO INFO SYSTEMS OCT, P44; CURRIE J, 1995, AM ECON REV, V85, P341; CUTTER S, 1994, BUSINESS EC REV, V40, P101; Din-Dzietham R, 1998, AM J PUBLIC HEALTH, V88, P651, DOI 10.2105/AJPH.88.4.651; Ehlers J K, 1993, AAOHN J, V41, P414; ERHARDT CL, 1974, MORTALITY MORBIDITY; Freeman H P, 1993, Ann Epidemiol, V3, P145; Fullilove RE, 1999, AM J PREV MED, V16, P22, DOI 10.1016/S0749-3797(98)00146-9; HALPERN R, 1990, HDB EARLY INTERVENTI; HAMILTON J, 1995, J POLICY ANAL MANAG, V95, P107; HAMILTON JT, 1993, RAND J ECON, V24, P101, DOI 10.2307/2555955; Heiss J, 1996, SOC PROBL, V43, P246, DOI 10.1525/sp.1996.43.3.03x0137g; Henderson ML, 1997, J CRIM JUST, V25, P447, DOI 10.1016/S0047-2352(97)00032-9; KLEINMAN JC, 1981, MED CARE, V19, P1011, DOI 10.1097/00005650-198110000-00004; Leigh JP, 1997, J OCCUP ENVIRON MED, V39, P1170; Mason J O, 1993, Ann Epidemiol, V3, P120; MCCORD C, 1990, NEW ENGL J MED, V322, P173, DOI 10.1056/NEJM199001183220306; Mielke HW, 1999, ENVIRON RES, V81, P117, DOI 10.1006/enrs.1999.3966; MILLER CA, 1981, AM J PUBLIC HEALTH, V71, P15, DOI 10.2105/AJPH.71.1_Suppl.15; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; NATHAN VR, 1995, MISSISSIPPI DELTA PR; NEWACHECK PW, 1983, MED CARE, V21, P981, DOI 10.1097/00005650-198310000-00004; OTTEN MW, 1990, JAMA-J AM MED ASSOC, V263, P845, DOI 10.1001/jama.263.6.845; PIROTH S, 1996, SOCIOL EDUC, V60, P368; POLLOCK PH, 1995, SOC SCI QUART, V76, P294; RIVKIN SG, 1995, J HUM RESOUR, V30, P826, DOI 10.2307/146234; SANDEFUR GD, 1989, SOC SERV REV, V63, P199, DOI 10.1086/603694; SCHNEIDER PA, 1996, UPDATE LAW RELATED E, V20, P21; SELTZER R, 1989, SOCIOL SOC RES, V73, P189; *US DEP HHS, 1985, REP SECR TASK FORC B; Warren R C, 1993, Ann Epidemiol, V3, P127; Wortley S, 1997, LAW SOC REV, V31, P637, DOI 10.2307/3053983	38	5	5	0	14	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0749-3797			AM J PREV MED	Am. J. Prev. Med.	OCT	2000	19	3					174	179		10.1016/S0749-3797(00)00195-1			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	361ME	WOS:000089726200006	11020594				2022-02-06	
J	Stemmer, B; Gahl, B; Lacher, S; Schoenle, PW				Stemmer, B; Gahl, B; Lacher, S; Schoenle, PW			Predicting vocational and independence status from early assessment of motor, cognitive, and social abilities in traumatic brain injury patients	BRAIN AND COGNITION			English	Article								Motor, cognitive, social, demographic, and lesion site data were obtained from traumatic brain injury (TBI) and stroke patients at the time of first admission (between 35 and 43 days post brain damage) to inpatient neurological rehabilitation. The relationship between these data and outcome measures (defined as "basic" independence, "complex" independence, employment status) was investigated. In TBI patients, employment was best predicted by drive, processing speed, and attention, "basic" independence by processing speed and drive, and "complex" independence by drive alone. Brain stem lesions also proved to be strongly related to independence measures and employment status. For stroke patients, no variable predicted employment. Motor function was weakly related to "basic" independence measures, and the ability to establish contact strongly predicted "complex" independence measure. (C) 2000 Academic Press.	Univ Konstanz, Lurija Inst Hlth & Rehabil Sci, Allensbach, Germany; Inst Univ Geriatr Montreal, Ctr Rech, Montreal, PQ, Canada		Stemmer, B (corresponding author), Univ Konstanz, Lurija Inst Hlth & Rehabil Sci, Allensbach, Germany.						Finch M, 1997, BRAIN INJURY, V11, P713, DOI 10.1080/026990597123089; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Macniven E, 1994, BRAIN INJURY REHABIL, P57	3	5	5	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					25	30					6	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300007					2022-02-06	
J	Bridgeford, D; Arciniegas, DB; Batkis, M; Sandberg, E; Beresford, TP				Bridgeford, D; Arciniegas, DB; Batkis, M; Sandberg, E; Beresford, TP			Methylphenidate treatment of neuropsychiatric symptoms of central and extrapontine myelinolysis	JOURNAL OF STUDIES ON ALCOHOL			English	Article							CENTRAL PONTINE MYELINOLYSIS; TRAUMATIC BRAIN INJURY; MANIFESTATIONS	Objective: Previous reports describe the presentation and course of the neurobehavioral manifestations cf central and extrapontine myelinolysis; as of yet, however, there are no specific recommendations far treatment of these problems. We offer the first report of successful treatment. Method: We describe a 55-year-old man with chronic alcoholism who developed central and extrapontine myelinolysis following an episode of heavy drinking and rapid correction of hyponatremia The patient acutely developed motor, cognitive, emotional and behavioral problems best accounted for by central pontine and bilateral striatal myelinolysis. These neuropsychiatric symptoms were treated with methylphenidate over the course of I month in an off-on-off-on fashion. The Neuropsychiatric Inventory and other tests were used to assess treatment response. Results: Marked improvements in the patient's neuropsychiatric status were noted only during treatment with methylphenidate. Conclusions: Methylphenidate effectively reversed the neuropsychiatric symptoms associated with the patient's demyelinating lesions. We discuss possible underlying mechanisms of both symptom formation and treatment effect.	Denver Vet Affairs Med Ctr, Psychiat Serv 116, Denver, CO 80220 USA		Bridgeford, D (corresponding author), Denver Vet Affairs Med Ctr, Mental Hlth Serv, 1055 Clermont St, Denver, CO 80220 USA.		Arciniegas, David/A-3792-2009				ADAMS RD, 1959, ARCH NEURO PSYCHIATR, V81, P154, DOI 10.1001/archneurpsyc.1959.02340140020004; Adams RD, 1997, PRINCIPLES NEUROLOGY, V6th; BAHR M, 1990, J NEUROL, V237, P275, DOI 10.1007/BF00314635; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Fryer JP, 1996, TRANSPLANTATION, V61, P658, DOI 10.1097/00007890-199602270-00026; GOCHT A, 1987, CLIN NEUROPATHOL, V6, P262; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hadfield MG, 1996, CLIN NEUROPATHOL, V15, P96; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; MCCOMB RD, 1989, CLIN NEUROPATHOL, V8, P284; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Menger H, 1999, J NEUROL, V246, P700, DOI 10.1007/s004150050435; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Poeck K., 1969, HDB CLIN NEUROLOGY, P343; PRICE BH, 1987, ARCH NEUROL-CHICAGO, V44, P671, DOI 10.1001/archneur.1987.00520180085025; SLAGER UT, 1986, CLIN NEUROPATHOL, V5, P252; Vermetten E, 1999, GEN HOSP PSYCHIAT, V21, P296, DOI 10.1016/S0163-8343(99)00018-3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002	21	5	6	0	0	ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV	PISCATAWAY	C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA	0096-882X			J STUD ALCOHOL	J. Stud. Alcohol	SEP	2000	61	5					657	660		10.15288/jsa.2000.61.657			4	Substance Abuse; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychology	358KU	WOS:000089557900004	11022803				2022-02-06	
J	Falcao, ALE; Araujo, S; Dragosavac, D; Terzi, RGG; Thiesen, RAS; Cintra, EA; Sardinha, LAC; Neto, AC; Dantas, VP; Quagliato, EMAB				Falcao, ALE; Araujo, S; Dragosavac, D; Terzi, RGG; Thiesen, RAS; Cintra, EA; Sardinha, LAC; Neto, AC; Dantas, VP; Quagliato, EMAB			Cerebral hemometabolism: variability the acute phase of traumatic coma	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						traumatic brain injury; cerebral extraction of oxygen; intracranial pressure; cerebral perfusion pressure; cerebral blood flow	ACUTE BRAIN TRAUMA; SEVERE HEAD-INJURY; BLOOD-FLOW; INTRACRANIAL HYPERTENSION; PERFUSION-PRESSURE; METABOLISM; HYPERVENTILATION; MANAGEMENT; OXYGEN	Objective: to evaluate the interrelationships between cerebral and systemic hemometabolic alterations in patients with severe traumatic brain injury managed according to a standardized therapeutic protocol. Design: prospective, interventional study in patients with traumatic coma. Setting: a general Intensive Care Unit in a teaching hospital. Patients and methods: twenty-seven patients (21M e 6F), aging 14-58 years, with severe acute brain trauma, presenting with three to eight points on the Glasgow Coma Scale, were prospectively evaluated according to a cumulative protocol for the management of acute intracranial hypertension, where intracranial pressure (ICP) and cerebral extraction of oxygen (CEO3) were routinely measured. Hemometabolic interrelationships involving mean arterial pressure (MAP), ICP, arterial carbon dioxide tension (PaCO2), CEO2, cerebral perfusion pressure (CPP) and systemic extraction of oxygen (SEO2) were analyzed. Interventions: routine therapeutic procedures. Results. no correlation was found between CEO2 and CPP (r = -0.07; p = 0.41). There was a significant negative correlation between PaCO2 and CEO2 (r = -0.24; p = 0.005) and a positive correlation between SEO2 and CEO2 (r = 0.24; p = 0 01). The mortality rate in this group of patients was 25.9% (7/27). Conclusion: 1) CPP and CEO2 are unrelated; 2) CEO2 and PaCO2 ore closely related; 3) during optimized hyperventilation, CEO2 and SEO2 are coupled.	Univ Estadual Campinas, Hosp Clin, Unidade Terapia Intens, BR-13081970 Campinas, SP, Brazil; Univ Estadual Campinas, Fac Ciencias Med, Dept Cirurg, BR-13081970 Campinas, SP, Brazil; Univ Sao Paulo, Fac Med, Inst Coracao, BR-05508 Sao Paulo, Brazil; Univ Estadual Campinas, Fac Ciencias Med, Dept Neurol, BR-13081970 Campinas, SP, Brazil								BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; Cruz J, 1997, ARQ NEURO-PSIQUIAT, V55, P24, DOI 10.1590/S0004-282X1997000100005; CRUZ J, 1992, J TRAUMA, V33, P304, DOI 10.1097/00005373-199208000-00022; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; CRUZ J, 1994, J NEUROSURG, V80, P143, DOI 10.3171/jns.1994.80.1.0143; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; CRUZ J, 1993, J NEUROSURG, V78, P552; ENEVOLDSEN EM, 1977, J NEUROSURG, V47, P699, DOI 10.3171/jns.1977.47.5.0699; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FALCAO ALE, 1995, ARQ NEURO-PSIQUIAT, V53, P390, DOI 10.1590/S0004-282X1995000300004; FALCAO ALE, 1997, CRIT CARE MED, V25, P72; KETY SS, 1946, J CLIN INVEST, V25, P107, DOI 10.1172/JCI101680; MCHENRY LC, 1965, ARCH NEUROL-CHICAGO, V12, P270, DOI 10.1001/archneur.1965.00460270046006; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	22	5	6	0	3	ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2000	58	3B					877	882		10.1590/S0004-282X2000000500013			6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	362RD	WOS:000089791300013	11018825	Green Published, gold			2022-02-06	
J	Wrightson, P				Wrightson, P			The development of a concept of mild head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article; Proceedings Paper	Meeting of the Royal-Australasian-College-of-Surgeons	MAY, 1999	AUCKLAND, NEW ZEALAND	Royal Australasian Coll Surgeons		mild head injury; concussion; post concussion syndrome; history	CONCUSSION	Medical and literary sources have described head injury and its effects from early Egyptian times. Though milder injury concussion - must have been familiar, there was little specific written about it until the latter part of the 18th century. Descriptions of persisting symptoms appear in the 19th century, and discussion of their origin and management has continued and intensified since then. There have been several major issues. How does mechanical trauma produce a temporary loss of neurological function and is there some lasting damage? When symptoms persist do they follow a pattern which we recognise as occurring with structural lesions, or are the symptoms a functional reaction to the injury and other life events? Are they both? Over the last 50 years these issues have been debated, often with heat. Whatever the final judgment the present task would seem to be to provide a service to deal with the clinical situation. (C) 2000 Harcourt Publishers Ltd.			Wrightson, P (corresponding author), 18 Crocus Pl, Auckland 1005, New Zealand.						ABERNETHY J, 1830, SURG PHYSL WORKS, V2; COURVILLE CB, 1953, COMMOTIO CEREBRI CER; DACARPI B, 1937, BERENGARIO CARPI SAG; DENCKER SJ, 1958, ACTA PSYCHIAT N S122, V33; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Erichsen J., 1895, SCI ART SURG; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FERRARI A, 1882, SPALLANZANI, V9, P169; FISCHER H, 1871, COMMOTIO CEREBRI; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Hamby WB, 1960, CASE REPORTS AUTOPSY; Hilton J., 1877, REST PAIN; Jacobs A, 1996, J NUCL MED, V37, P1605; KELLY R, 1981, J ROY SOC MED, V74, P242; LIDVAL HF, 1974, ACTA NEUROLOGICA S56, V50; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Nickerson KG, 1997, LANCET, V350, P205, DOI 10.1016/S0140-6736(97)02033-3; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POTT P, 1778, CHIRURG WORKS PERCIV, V1; Romanis W., 1934, SCI PRACTICE SURG, V2; RUESCH J, 1945, AM J PSYCHIAT, V102, P145, DOI 10.1176/ajp.102.2.145; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Sakas DE, 1997, MED HYPOTHESES, V48, P431, DOI 10.1016/S0306-9877(97)90042-6; SYMONDS C, 1962, LANCET, V1, P1; TROTTER W, 1924, LANCET, V1, P933; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; [No title captured]	33	5	5	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2000	7	5					384	388		10.1054/jocn.1999.0678			5	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352YY	WOS:000089248000003	10942657				2022-02-06	
J	Hartnedy, S; Mozzoni, MP				Hartnedy, S; Mozzoni, MP			Managing environmental stimulation during meal time: Eating problems in children with traumatic brain injury	BEHAVIORAL INTERVENTIONS			English	Article								Environmental over-stimulation is common in the first few months following severe brain injury. The reduced ability to attend coupled with increased impulsivity, confusion and disinhibition leaves the person with a brain injury in a bewildering world. By limiting stimulation and reducing the number of stimuli to which the person has to attend can help the person with a brain injury interact more effectively with his/her environment. This study demonstrates the effectiveness of managing environmental stimulation for the confused person resulting in improved nutritional intake. The eating behaviors of two children aged six and 16 were observed in this study to determine the role of distraction as it interfered with their eating behavior. A multiple baseline, reversal design was used to assess the effectiveness of restricting environmental stimulation. Copyright (C) 2000 John Wiley & Sons, Ltd.	Timber Ridge Grp Inc, N Little Rock, AR 72116 USA; Timber Ridge Ranch NeuroRehabil Ctr, Benton, AR USA		Mozzoni, MP (corresponding author), Timber Ridge Grp Inc, 4500 W Commercial Dr, N Little Rock, AR 72116 USA.	mikeaba@ix.netcom.com					COPE N, 1990, REHABILITATION ADULT, P253; KATZ DI, 1997, NEUROLOGIC REHABILIT, P1; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LAMM N, 1988, J APPL BEHAV ANAL, V21, P143, DOI 10.1901/jaba.1988.21-143; Mozzoni MP, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199602000-00003; *NIH, 1999, REP NIH CONS DEV C R; RIORDAN MM, 1984, J APPL BEHAV ANAL, V17, P327, DOI 10.1901/jaba.1984.17-327; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; WILLIAMS GJ, 1990, BRIT J CLIN PSYCHOL, V29, P327, DOI 10.1111/j.2044-8260.1990.tb00889.x	9	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1072-0847	1099-078X		BEHAV INTERVENT	Behav. Intervent.	JUL-SEP	2000	15	3					261	268		10.1002/1099-078X(200007/09)15:3<261::AID-BIN60>3.0.CO;2-N			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	339GT	WOS:000088469800009					2022-02-06	
J	Kubina, RM; Ward, MC; Mozzoni, MP				Kubina, RM; Ward, MC; Mozzoni, MP			Helping one person at a time: Precision teaching and traumatic brain injury rehabilitation	BEHAVIORAL INTERVENTIONS			English	Article							FLUENCY	The managed care movement has had a considerable effect in health care. Professionals and agencies in rehabilitation of traumatic brain injury (TBI) now have increased pressure to produce significant clinical outcomes in an abbreviated time frame. As the interest for effective treatment practices grows, a new resource, precision teaching, offers intriguing possibilities for practitioners and researchers. This article presents a case study illustrating precision teaching with a person with TBI and provides suggestions for incorporating precision teaching into rehabilitative settings. Copyright (C) 2000 John Wiley & Sons, Ltd.	Clarion State Univ, Special Educ & Rehabil Serv, Clarion, PA 16214 USA; Delaware Union Educ Serv Ctr, Delaware, OH USA; Timber Ridge Grp Inc, N Little Rock, AR USA		Kubina, RM (corresponding author), Clarion State Univ, Special Educ & Rehabil Serv, 840 Wood St, Clarion, PA 16214 USA.						BATES S, 1971, TEACHING EXCEPTIONAL, V3, P11; Beck R., 1991, J PRECISION TEACHING, V8, P8; Binder C, 1996, BEHAV ANALYST, V19, P163, DOI 10.1007/BF03393163; BINDER C, 1989, PERFORMANCE INSTRUCT, P17; Binder C., 1990, PERFORMANCE IMPROVEM, V3, P271, DOI DOI 10.1111/J.1937-8327.1990.TB00478.X; COOPER JO, 1998, J PRECISION TEACHING, V15, P56; DESJARDINS EA, 1993, J PRECISION TEACHING, V10, P20; GRAF S, 1989, S GRAFS STANDARD CEL; GRAF SA, 1994, DEV PRODUCE USE SAFM; GRAYSON MA, 1993, HOSPITALS, V5, P6; HAFFEY WJ, 1989, PHYSICAL MED REHABIL; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Haughton, 1980, J PRECISION TEACHING, V1, P3; Haughton E. C, 1972, LETS TRY DOING SOMET, P20; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOHNSON KR, 1992, AM PSYCHOL, V47, P1475, DOI 10.1037/0003-066X.47.11.1475; JOHNSON KR, 1994, BEHAVIOR ANALYSIS IN EDUCATION, P173; Johnston J. M., 1993, STRATEGIES TACTICS B; KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013; KUBINA RM, 1995, ANN M ASS BEH AN WAS; Kubina RM, 1998, J PRECISION TEACHING, V15, P32; KUBINA RM, 1999, THESIS OHIO STATE U; KUBINA RM, 1999, PRECISION TEACHING B; KUBINA RM, 1997, UNPUB PRECISION TEAC; KUBINA RM, 1994, J PRECISION TEACHING, V11, P28; KUBINA RM, 1994, ANN M ASS BEH ASS AT; Lindsley, 1972, HDB STANDARD BEHAV C; Lindsley O. R., 1990, TEACHING EXCEPTIONAL, V22, P10, DOI DOI 10.1177/004005999002200302; Lindsley O. R., 1990, J PRECISION TEACHING, V7, P7; LINDSLEY OR, 1992, J APPL BEHAV ANAL, V25, P51, DOI 10.1901/jaba.1992.25-51; LINDSLEY OR, 1994, J PRECISON TEACHING, V11, P7; Lindsley OR, 1995, J PRECISION TEACHING, V13, P2; Ling JS, 1997, J HEAD TRAUMA REHAB, V12, P51, DOI 10.1097/00001199-199702000-00009; Maloney M, 1990, J PRECISION TEACHING, V7, P36; Maloney M., 1998, TEACH YOUR CHILDREN; MCGREEVY P, 1982, J PRECISION TEACHING, V3, P63; McGreevy P, 1983, TEACHING LEARNING PL; MCGREEVY P, 1984, J PRECISION TEACHING, V5, P28; Merbitz C., 1992, Proceedings of the Johns Hopkins National Search for Computing Applications to Assist Persons with Disabilities (Cat. No.92TH0429-1), P45, DOI 10.1109/CAAPWD.1992.217397; MERBITZ CT, 1992, BEHAV RES METH INSTR, V24, P366, DOI 10.3758/BF03203521; MERBITZ CT, 1985, ARCH PHYS MED REHAB, V66, P433; MILLER T, 1982, J PRECISION TEACHING, V3, P43; MORRELL RF, 1999, ANN M ASS BEH AN CHI; MORRIS SJ, 1995, J MICROSC SOC AM, V1, P47; Nelson RO., 1984, SCI PRACTITIONER RES; POTTS L, 1993, BEHAV ANALYST, V16, P177, DOI 10.1007/BF03392622; Spooner, 1990, TEACHING EXCEPTIONAL, V22, P4, DOI 10.1177/004005999002200301.; Spooner F., 1983, J PRECISION TEACHING, V4, P5; West R.P., 1992, DESIGNS EXCELLENCE B, P113; White O. R., 1980, EXCEPTIONAL TEACHING; WHITE OR, 1986, EXCEPT CHILDREN, V52, P522, DOI 10.1177/001440298605200605	51	5	5	0	5	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	1072-0847			BEHAV INTERVENT	Behav. Intervent.	JUL-SEP	2000	15	3					189	203					15	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	339GT	WOS:000088469800004					2022-02-06	
J	Patrick, PD; Patrick, ST; Poole, JD; Hostler, S				Patrick, PD; Patrick, ST; Poole, JD; Hostler, S			Evaluation and treatment of the vegetative and minimally conscious child: A single subject design	BEHAVIORAL INTERVENTIONS			English	Article							TRAUMATIC BRAIN INJURY; HEAD-INJURY; STATE; AMANTADINE; REHABILITATION; PATIENT; ADULTS; COMA; METHYLPHENIDATE; SYMPTOMS	The impact of modem medical techniques has given rise to an increasing survival of persons with disorders of consciousness including coma, the vegetative state, and the minimally conscious state. The numbers of pediatric and adolescent survivors of brain injury who remain vegetative or minimally conscious are not definitively known, and while these patients have received growing professional consideration, no specific standards of care exist. Pediatric and adolescent treatment recommendations are not differentiated from adult populations although some questions linger regarding the progression and outcome of the disorders in adults as compared to those in children. Kluge Children's Rehabilitation Center has initiated a Low Response and Treatment Protocol for Children Following Acquired Brain Injury to provide structure for diagnostic and therapeutic initiatives. Its single subject design is literature based, empirically driven, and peer recognized. Clinical classifications label a patient's emergence from coma as uncomplicated. complicated by confounding medical conditions, or neuropathic complicated emergence. Patients receiving the neuropathic designation are considered for pharmacological intervention. Beyond optimizing care for the enrolled patient, the protocol is established to provide (Giacino, 1995) an ongoing data store for future group analysis. Case 1 presents the course of treatment and recovery for a 16-year-old male, severely disabled due to an automobile accident. Medical complications are addressed and his failure to progress is deemed complicated neuropathic at 14 weeks postinjury. At 15 weeks post-injury, administration of Amantadine 100 mg bid shows improvements, with almost complete emergence after two weeks at an increased dose of 200 gm bid. Discontinuation at the family's request, approximately a year post-injury, is followed by a measurable loss of functional ability. The patient regained functioning after returning to the Amantadine schedule. Case 2 outlines the course of treatment and recovery for a nine-year-old boy, the victim of a near drowning. Investigation considerations influence the structure of the protocol and analysis of its results. While first a therapeutic tool based on single subject design, the protocol attempts to qualitatively manage various threats to establishing causal relationships between drug interventions and the noted outcomes. Systematic consideration of the single subject design for therapeutic benefit, as well as making a meaningful contribution to the existing evidence base, is suggested until class I evidence is compiled to produce well supported standards of care. Copyright (C) 2000 John Wiley & Sons, Ltd.	Univ Virginia, Childrens Med Ctr, Kluge Childrens Rehabil Hosp, Charlottesville, VA 22901 USA; NeuroPsych Healthcare, Charlottesville, VA USA		Patrick, PD (corresponding author), Univ Virginia, Childrens Med Ctr, Kluge Childrens Rehabil Hosp, 2270 Ivy Rd, Charlottesville, VA 22901 USA.	pdp2n@virginia.edu					ANDREWS K, 1996, INT WORKING PARTY RE; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1992, ANN NEUROL, V32, P570, DOI 10.1002/ana.410320414; *ASP CONS C, 1996, WORKGR VEG MIN CONS; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Childs NL, 1997, J HEAD TRAUMA REHAB, V12, P70, DOI 10.1097/00001199-199708000-00007; Cook TD., 1979, QUASIEXPERIMENTATION; Di Rocco C, 1974, J Neurosurg Sci, V18, P169; EICHELBERGER MR, 1988, J TRAUMA, V28, P430, DOI 10.1097/00005373-198804000-00002; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Goldberg G, 1998, POSTGRAD MED, V104, P91, DOI 10.3810/pgm.1998.08.553; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HANSJOACHIN F, 1999, J TRAUMA, V47, P33; HORIGUCHI J, 1990, CLIN NEUROPHARMACOL, V13, P84, DOI 10.1097/00002826-199002000-00009; HORN LJ, 1996, MED REHABILITATION T; *I MED ETH WORK PA, 1991, LANCET, V331, P96; JENNETT B, 1972, LANCET, V1, P734; KAELIN D, 1996, ARCH PHYSICAL MED RE, V77, P76; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; PATRICK P, 1999, 3 WORLD C INT BRAIN; Phipps E, 1999, AM J PHYS MED REHAB, V78, P77, DOI 10.1097/00002060-199901000-00020; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROSS ED, 1981, NEUROLOGY, V31, P1435, DOI 10.1212/WNL.31.11.1435; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TROCHIM WM, 1999, RES METHODS KNOWLEDB; VANIER M, 1999, 3 WORLD C INT BRAIN; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; WHYTE J, 1999, REHABILITATION ADULT; WILSON BA, 1993, NEUROPSYCHOL REHABIL, V3, P1; WOLF AP, 1995, BRAIN INJURY, V9, P487, DOI 10.3109/02699059509008208; Worzniak M, 1997, J FAM PRACTICE, V44, P495; Zafonte RD, 1998, BRAIN INJURY, V12, P617	45	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1072-0847	1099-078X		BEHAV INTERVENT	Behav. Intervent.	JUL-SEP	2000	15	3					225	242		10.1002/1099-078X(200007/09)15:3<225::AID-BIN58>3.0.CO;2-8			18	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	339GT	WOS:000088469800007					2022-02-06	
J	Schlund, MW; Pace, GM				Schlund, MW; Pace, GM			The experimental analysis of human operant behavior following traumatic brain injury	BEHAVIORAL INTERVENTIONS			English	Article							MOTIVATIONAL DEFICITS; DAMAGE	Traumatic brain injury (TBI) may produce deficits in discriminating and responding appropriately to consequences. Commonly, insensitivity to consequences is attributed to deficits in cognitive processes, particularly executive functioning. The present investigation examined the hypothesis that TBI may reduce control exerted by reinforcers over behavior. Results of basic operant research on reinforcement processes with individuals with TBI may have clinical value for understanding and ultimately remediating deficits associated with TBI. In experiment 1, responding by adults with TBI and non-injured controls was investigated under reinforcement contingencies that differentially reinforced responding and the absence of responding within sessions. Results showed that most TBI subjects obtained lower reinforcement rates than control subjects, especially under contingencies requiring the absence of responding. In experiment 2, results showed that the addition of stimuli correlated with reinforcement improved one subject's performance. These results suggest that TBI may differentially reduce sensitivity to response-reinforcer contingencies and some environmental changes may increase sensitivity. Results also suggest parallels between deficits in executive functioning and deficits in operant behavior. Copyright (C) 2000 John Wiley & Sons, Ltd.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; [Anonymous], 1993, GUIDE UNIFORM DATA S; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MALKMUS D, 1974, RANCHO LOS AMIGOS SC; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NEWLAND MC, 1994, TOXICOL APPL PHARM, V126, P6, DOI 10.1006/taap.1994.1084; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; OSCARBERMAN M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P230; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Wechsler D, 1985, WECHSLER ADULT INTEL	20	5	5	0	5	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	1072-0847			BEHAV INTERVENT	Behav. Intervent.	JUL-SEP	2000	15	3					155	168		10.1002/1099-078X(200007/09)15:3<155::AID-BIN53>3.0.CO;2-F			14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	339GT	WOS:000088469800002					2022-02-06	
J	Wilson, BM; Proctor, A				Wilson, BM; Proctor, A			Oral and written discourse in adolescents with closed head injury	BRAIN AND COGNITION			English	Article; Proceedings Paper	10th Annual Meeting on Tennet - Theoretical and Experimental Neuropsychology	JUN 17-19, 1999	MONTREAL, CANADA	Univ Quebec			CHILDREN; ADULTS	Analysis of oral and written discourse suggested differing cognitive demands for modes of expression. Verbal samples were provided by 8 adolescents with closed head injury (CHI) and 8 controls. A generation task using a picture stimulus was the basis for discourse. Eight measures [productivity, efficiency, semantic ties (lexical, incomplete., elliptical), maze use, coherence (global, local)] were utilized. A covariate model consisting of group membership (CI-II vs control), executive functioning and working memory helps to explain variance in the discourse shills of adolescents with CHI. (C) 2000 Academic Press.	Eastern Illinois Univ, Dept Commun Disorders & Sci, Charleston, IL 61920 USA		Wilson, BM (corresponding author), Eastern Illinois Univ, Dept Commun Disorders & Sci, Charleston, IL 61920 USA.						ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; BRASWELL D, 1992, PROFILE EXECUTIVE CO; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPPELL JE, 1995, IEEE AERO EL SYS MAG, V10, P5; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Glosser G., 1990, BRAIN LANG, V40, P67; GOLDMAN R, 1974, RECOGNITION MEMORY G; GOLDMANRAKIC PS, 1993, MIND BRAIN READINGS, P67; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; SPEAKER R, 1992, READ RES INSTRUCT, V31, P64; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005	12	5	5	0	3	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	JUN-AUG	2000	43	1-3					425	429					5	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	316FU	WOS:000087157600118	10857740				2022-02-06	
J	Bascunana, H; Villarreal, I; Alfonso, S; Bernabeu, M; Terre, R				Bascunana, H; Villarreal, I; Alfonso, S; Bernabeu, M; Terre, R			Agitation in head injury. I. Definition and treatment with anxiolytic neuroleptic and antiepileptic drugs	REVISTA DE NEUROLOGIA			Spanish	Article						agitation; antipsychotic; antiepileptic; anxiolytic; benzodiazepines; head injury; neuroleptic; treatment	TRAUMATIC BRAIN INJURY; DIFFERENTIAL-DIAGNOSIS; MALIGNANT SYNDROME; BUSPIRONE; RISPERIDONE; CARBAMAZEPINE; HALOPERIDOL; RECOVERY; PATIENT; REHABILITATION	Objective. To carry out a bibliographic review of articles indexed in MEDLINE over the past 20 years concerning the pharmacological treatment of agitation in head injury. Development. Head injury may cause different behaviour changes, of which agitation is the most dramatic. The incidence of agitation after severe head injury varies from 11% to 50% depending on the study involved. This incidence is high enough to warrant specific management. Drug treatment has variable results. When there is imminent danger of harm to the patient himself or to others, or when aggressive behaviour makes medical management difficult, the benzodiazepines have been found useful. Antipsychotic drugs are only indicated in head injury when the agitation causes a clinical emergency, and in such a case the more potent drugs such as haloperidol are, best, since they have less sedative effect. They are also effective when the clinical features are similar to those of classical schizophrenia. Antiepileptic drugs have been used successfully for treating agitation-aggressiveness, specially in paroxystic behaviour disorders. We also consider other treatments used for posttraumatic agitation. Conclusion. Thera is no general agreement amongst doctors as to the best treatment for posttraumatic agitation in head injury. However, with regard to certain characteristics of agitation different drugs may be recommended for treatment.	Serv Rehabil Med Fis, E-43202 Tarragona, Spain; Inst Guttmann, Unidad Lesion Cerebral, Barcelona, Spain					Bascunana, Helena/0000-0002-2656-1709			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARBEE JG, 1992, J NEUROPSYCH CLIN N, V4, P308; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Childers MK, 1997, BRAIN INJURY, V11, P537, DOI 10.1080/713802187; CLINTON JE, 1987, ANN EMERG MED, V16, P319, DOI 10.1016/S0196-0644(87)80179-8; Cloyd J C, 1994, Arch Fam Med, V3, P589, DOI 10.1001/archfami.3.7.589; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; CZOBOR P, 1995, J CLIN PSYCHOPHARM, V15, P243, DOI 10.1097/00004714-199508000-00002; Duffy J D, 1994, Ann Clin Psychiatry, V6, P33, DOI 10.3109/10401239409148837; EAMES P, 1985, REHABILITATION SEVER, P130; EDWARDS R, 1991, AUST NZ J PSYCHIAT, V25, P238, DOI 10.3109/00048679109077740; Fava M, 1997, PSYCHIAT CLIN N AM, V20, P427, DOI 10.1016/S0193-953X(05)70321-X; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FISH DN, 1991, CLIN PHARMACY, V10, P456; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; GUALTIERI CT, 1991, J CLIN PSYCHOPHARM, V11, P280, DOI 10.1097/00004714-199108000-00027; Hagen C, 1979, REHABILITATION HEAD; HORN LJ, 1996, MED REHABILITATION T; JOFFE RT, 1993, J CLIN PSYCHIAT, V54, P269; KAPLAN HI, 1993, POCKET HDB PSYCHIAT; KLAWANS H, 1992, TXB CLIN NEUROPHARMA; LAZARUS A, 1992, J NEUROPSYCH CLIN N, V4, P185; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LOTT AD, 1995, J NEUROPSYCH CLIN N, V7, P314; MANDOKI MW, 1995, J CHILD ADOL PSYCHOP, V5, P49, DOI 10.1089/cap.1995.5.49; MATTES JA, 1984, PSYCHOPHARMACOL BULL, V20, P98; MEERT TF, 1989, PSYCHOPHARMACOLOGY, V97, P206, DOI 10.1007/BF00442251; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; NEPPE VM, 1983, J CLIN PSYCHIAT, V44, P326; OWENS DGC, 1994, J CLIN PSYCHIAT, V55, P29; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; POURCHER E, 1994, AM J PSYCHIAT, V151, P150; RAHO N, 1985, ARCH PHYS MED REHAB, V66, P30; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RASKIND M, 1993, PSYCHIAT CLIN N AM, V4, P815; RATEY JJ, 1992, J CLIN PSYCHOPHARM, V12, P362; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; RICKETTS RW, 1994, J AM ACAD CHILD PSY, V33, P270, DOI 10.1097/00004583-199402000-00017; RODGERS RJ, 1985, NEUROSCI BIOBEHAV R, V9, P21, DOI 10.1016/0149-7634(85)90029-6; SAFFERMAN AZ, 1994, J CLIN PSYCHIAT S, V55, pS98; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SANDEL ME, 1993, BRAIN INJURY, V7, P77, DOI 10.3109/02699059309008159; SHALEV A, 1989, J CLIN PSYCHIAT, V50, P18; STANISLAV S, 1994, PSYCHOPHARMACOLOGY, V2, P126; STRAHAN A, 1985, AM J PSYCHIAT, V142, P859; THEODORE WH, 1983, NEUROLOGY, V33, P1115; TRIMBLE MR, 1988, J CLIN PSYCHIAT, V49, P7; VANVALKENBURG C, 1992, DRUGS, V44, P326, DOI 10.2165/00003495-199244030-00003; WIERCISIEWSKI DR, 1997, PHYS MED REHABIL CLI, V8, P763; Wood RLL, 1990, NEUROBEHAVIORAL SEQU; Zimnitzky BM, 1996, J CHILD ADOL PSYCHOP, V6, P75, DOI 10.1089/cap.1996.6.75	55	5	6	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	MAY 1	2000	30	9					850	854		10.33588/rn.3009.99434			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	319JB	WOS:000087336800011	10870200				2022-02-06	
J	Burke, D; Alexander, K; Baxter, M; Baker, F; Connell, K; Diggles, S; Feldman, K; Horny, A; Kokinos, M; Moloney, D; Withers, J				Burke, D; Alexander, K; Baxter, M; Baker, F; Connell, K; Diggles, S; Feldman, K; Horny, A; Kokinos, M; Moloney, D; Withers, J			Rehabilitation of a person with severe traumatic brain injury	BRAIN INJURY			English	Article								A case study report of a long and intensive rehabilitation programme for a young woman after she sustained a severe diffuse axonal injury in a motor vehicle accident is described in detail. The purpose of this paper is to encourage specialist brain injury rehabilitation services to offer extended rehabilitation programmes to patients, even with very severe injuries. Significant functional improvements and enhanced quality of life frequently reward the high cost and hard work involved.	Ivanhoe Manor Provate Rehabil Hosp, Ivanhoe, Vic 3079, Australia		Burke, D (corresponding author), Ivanhoe Manor Provate Rehabil Hosp, 134-144 Ford St, Ivanhoe, Vic 3079, Australia.							0	5	5	0	5	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2000	14	5					463	471					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	316MQ	WOS:000087171500007	10834341				2022-02-06	
J	Petridou, E; Gatsoulis, N; Dessypris, N; Skalkidis, Y; Voros, D; Papadimitriou, Y; Trichopoulos, D				Petridou, E; Gatsoulis, N; Dessypris, N; Skalkidis, Y; Voros, D; Papadimitriou, Y; Trichopoulos, D			Imbalance of demand and supply for regionalized injury services: a case study in Greece	INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE			English	Article						demand; injury; regionalized health services; tourist	EMERGENCY MEDICAL-SERVICES; TRAUMA CENTER; AMERICAN-COLLEGE; CARE; HEALTH; QUALITY; AUDIT; DIAGNOSIS; HOSPITALS	Objective(s). To study regionalized acute injury services on an island with high seasonal fluctuation of the population at risk. Design. An on-going prospective study Setting. The District Hospital in the touristic island of Corfu. Study participants, Of 9432 individuals with traumatic injuries who contacted the hospital during 1996, 1204 were hospitalized. information was recorded on several injury-related clinical and sociodemographic variables. Possible residual disabilities, 6 months after the injury, were also assessed. Main outcome measures. Injury Severity Score (ISS), clinical outcome and duration of hospitalization, odds of transfer to other institutions. Results. Non-residents, whether Greek or foreign nationals are hospitalized for shorter periods. Motor vehicle accident victims are hospitalized on average for 15% longer. Injury victims admitted on a Friday are hospitalized for a longer period. Finally, ISS is a powerful positive predictor of duration of hospitalization. Male injury victims, those injured during late night or early morning and patients injured in July are more likely to be transferred to another institution. Age of the patient and ISS are powerful and independent predictors of an unfavourable outcome. Conclusion. The extra demand created by injured tourists is reflected in the seasonality of admissions for injuries. The district hospital of Kerkyra cannot be considered as deficient in comparison to other district hospitals. Nevertheless, the suboptimal function of the hospital, with respect to injuries, is reflected in the high proportion of injured patients transferred when the injury occurs outside the full working schedule of the hospital. Patients with burns, bone fractures or dislocations and head injuries or concussion are transferred with an overall frequency of about 15% - too high to be compatible with a well functioning secondary care institution.	Univ Athens, Dept Hyg & Epidemiol, Sch Med, Ctr Res & Prevent Injuries, Athens, Greece; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Athens, Sch Med, Dept Surg 2, GR-10679 Athens, Greece		Petridou, E (corresponding author), Univ Athens, Dept Hyg & Epidemiol, Sch Med, Ctr Res & Prevent Injuries, 75 M Asias Str,TK 11527, Athens, Greece.	epetrid@atlas.uoa.gr		PETRIDOU, ELENI/0000-0003-3695-3439			Aaland MO, 1996, SURGERY, V120, P774, DOI 10.1016/S0039-6060(96)80030-4; Ahlamaa-Tuompo J, 1998, Eur J Emerg Med, V5, P429; Alberts K A, 1993, Qual Assur Health Care, V5, P13; BERWICK DM, 1989, MED CARE, V27, P763, DOI 10.1097/00005650-198908000-00001; BICE TW, 1984, INTRO HLTH SERVICES, P375; BOULMONT M, 1994, ACTA CHIR BELG, P240; BROOK RH, 1988, QUALITY CARE TECHNOL, P21; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; Dickinson ET, 1996, ANN EMERG MED, V27, P199, DOI 10.1016/S0196-0644(96)70323-2; Donabedian A, 1980, DEFINITION QUALITY A; FRIEDMAN B, 1995, HEALTH ECON, V4, P301, DOI 10.1002/hec.4730040406; Garrison HG, 1997, ANN EMERG MED, V30, P84, DOI 10.1016/S0196-0644(97)70116-1; Gordon JA, 1998, ANN EMERG MED, V32, P569, DOI 10.1016/S0196-0644(98)70034-4; Halfon N, 1996, PEDIATRICS, V98, P28; Hamilton BH, 1997, HEALTH ECON, V6, P383, DOI 10.1002/(SICI)1099-1050(199707)6:4<383::AID-HEC278>3.0.CO;2-L; HEYES FLP, 1991, INJURY, V22, P369, DOI 10.1016/0020-1383(91)90096-W; *J HOPK U HLTH SER, 1993, INJ SEV SCOR ICDPAM; JANSSON B, 1989, SCAND J SOC MED, V17, P7, DOI 10.1177/140349488901700103; Kazemi AR, 1997, INJURY, V28, P119, DOI 10.1016/S0020-1383(96)00165-9; KIRKUP B, 1990, J PUBLIC HEALTH MED, V12, P45, DOI 10.1093/oxfordjournals.pubmed.a042505; MCDERMOTT FT, 1994, AUST NZ J SURG, V64, P147, DOI 10.1111/j.1445-2197.1994.tb02168.x; MCSWAIN NE, 1990, PROBL GEN SURG, V7, P169; NAYDUCH D, 1994, J TRAUMA, V37, P565, DOI 10.1097/00005373-199410000-00008; NORWOOD S, 1994, ARCH SURG-CHICAGO, V129, P800; Palmer RH, 1998, INT J QUAL HEALTH C, V10, P477; Papadopoulos IN, 1996, J TRAUMA, V41, P864, DOI 10.1097/00005373-199611000-00018; Petridou E, 1999, ACCIDENT ANAL PREV, V31, P611, DOI 10.1016/S0001-4575(99)00017-2; Petridou E, 1997, ACCIDENT ANAL PREV, V29, P687, DOI 10.1016/S0001-4575(97)00038-9; PETRIDOU E, 1986, SOZ PRAVENTIV MED, V31, P308, DOI 10.1007/BF02077506; Petridou E, 1996, COMMUNITY DENT ORAL, V24, P307, DOI 10.1111/j.1600-0528.1996.tb00867.x; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; *ROYAL COLL SURG E, 1988, REP WORK PART MAN PA; Skalkidis Y, 1996, INT J QUAL HEALTH C, V8, P159, DOI 10.1093/intqhc/8.2.159; TRICHOPOULOS D, 1976, HLTH DEV PROGRAM 197, P292; TSIFTSIS D, 1993, ACTA CHIRURG HELLENI, V65, P465; WALDREP DJ, 1994, AM SURGEON, V60, P892; YATES DW, 1992, BRIT MED J, V305, P737, DOI 10.1136/bmj.305.6856.737; YORDY KD, 1988, HEALTH AFFAIR, V7, P5, DOI 10.1377/hlthaff.7.1.5	39	5	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1353-4505	1464-3677		INT J QUAL HEALTH C	Int. J. Qual. Health Care	APR	2000	12	2					105	113		10.1093/intqhc/12.2.105			9	Health Care Sciences & Services; Health Policy & Services	Social Science Citation Index (SSCI)	Health Care Sciences & Services	313HC	WOS:000086993400004	10830667	Bronze			2022-02-06	
J	Vos, PE; Zwienenberg, M; O'Hannian, KL; Muizelaar, JP				Vos, PE; Zwienenberg, M; O'Hannian, KL; Muizelaar, JP			Subarachnoid haemorrhage following rupture of an ophthalmic artery aneurysm presenting as traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						brain injury; subarachnoid haemorrhage; aneurysm; trauma; ophthalmic artery; head injury	HEAD-INJURY; HEMORRHAGE	Head trauma may provoke subarachnoid haemorrhage. The question sometimes arises whether in patients with trauma and subarachnoid haemorrhage the latter is of traumatic or aneurysmal origin. We present a 49-year-old patient who fell from a truck, struck his head and was unconscious immediately. On the brain computed tomography (CT) scan subarachnoid haemorrhage was present, initially diagnosed as of traumatic origin. Four-vessel angiography revealed rupture of a left ophthalmic artery aneurysm. We review the literature and give recommendations for angiography in patients with trauma and subarachnoid haemorrhage. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Nijmegen Hosp, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Radiol, Sacramento, CA 95817 USA		Vos, PE (corresponding author), Univ Nijmegen Hosp, Dept Neurol, Reinier Postlaan 4, NL-6500 HB Nijmegen, Netherlands.		Vos, Pieter/A-6043-2012				DAY AL, 1990, J NEUROSURG, V72, P677, DOI 10.3171/jns.1990.72.5.0677; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ELGINDI S, 1979, ACTA NEUROCHIR, V48, P237, DOI 10.1007/BF02056972; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; INGALL TJ, 1989, STROKE, V20, P718, DOI 10.1161/01.STR.20.6.718; Kakarieka A, 1997, NEUROL RES, V19, P230, DOI 10.1080/01616412.1997.11740804; Kraus JF, 1987, HEAD INJURY, V2, P1; Le Roux PD, 1998, NEUROSURGERY, V42, P1248, DOI 10.1097/00006123-199806000-00026; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Muizelaar JP, 1999, J NEUROSURG, V91, P51, DOI 10.3171/jns.1999.91.1.0051; NUTIK SL, 1988, J NEUROSURG, V69, P340, DOI 10.3171/jns.1988.69.3.0340; OBrien D, 1997, ARCH PHYS MED REHAB, V78, P883, DOI 10.1016/S0003-9993(97)90205-7; PIA HW, 1982, NEUROSURG REV, V5, P77; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; SAKAS DE, 1995, BRIT MED J, V310, P1186, DOI 10.1136/bmj.310.6988.1186; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TAMAKI N, 1991, J NEUROSURG, V74, P567, DOI 10.3171/jns.1991.74.4.0567; VANGIJN J, 1980, CLIN NEUROL NEUROSUR, V82, P11, DOI 10.1016/0303-8467(80)90055-4; Vermeulen M, 1996, J NEUROL, V243, P496, DOI 10.1007/BF00886869; WARLOW CP, 1996, STROKE PRACTICAL GUI, P322	22	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2000	102	1					29	32		10.1016/S0303-8467(99)00073-6			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	299RH	WOS:000086211300008	10717400				2022-02-06	
J	Yanagawa, Y; Sakamoto, T; Saitoh, D; Terai, C; Okada, Y; Nawashiro, H; Shima, K				Yanagawa, Y; Sakamoto, T; Saitoh, D; Terai, C; Okada, Y; Nawashiro, H; Shima, K			Significance of shock in head-injured patients with skull fracture	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						skull base fracture; convexity fracture; shock; head injury	TRAUMA	The clinical differences between patients with skull base and convexity fractures were retrospectively investigated in 324 patients, of whom 110 had suffered head injury resulting in skull fracture. These 110 patients were divided into the skull base and convexity groups. There were no significant differences between the groups with respect to sex, age, Glasgow Coma Scales, injury severity scores, pupil abnormalities, and outcomes. Automobile collisions were the most common causes in the skull base group, and falls in the convexity group. Traumatic Coma Data Bank diffuse 1 type injuries were more frequent in the skull base group and evacuated masses were more frequent in the convexity group. Multiple injuries, shock on admission, lower hemoglobin concentrations, and increased transfusion requirements were evident in the skull base group. Controlling for shock, the outcomes in the skull base group were favorable. Convexity fractures were usually associated with isolated severe head injuries and require brain protection therapy. Skull base fractures were caused by a significant force distributed over a large area of the body with a tendency to induce shock, and require a multidisciplinary approach to treatment.	Natl Def Med Coll, Dept Traumatol & Crit Care Med, Tokorozawa, Saitama 3598513, Japan; Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 359, Japan		Yanagawa, Y (corresponding author), Natl Def Med Coll, Dept Traumatol & Crit Care Med, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.						ASSOCIATION OF THE EUROPEAN SELF MEDICATION INDUSTRY. AESGP, 1990, ABBR INJ SCAL, P1; Baltas I, 1998, J Neurosurg Sci, V42, P85; CHEE CP, 1991, AUST NZ J SURG, V61, P597, DOI 10.1111/j.1445-2197.1991.tb00299.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; DALY MP, 1989, AM FAM PHYSICIAN, V39, P129; FACCO E, 1986, CHILD NERV SYST, V2, P67; ILLINGWORTH G, 1965, LANCET, V11, P511; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kanis JA, 1998, MATURITAS, V30, P229, DOI 10.1016/S0378-5122(98)00090-5; KNOTTENBELT JD, 1991, J TRAUMA, V31, P1396, DOI 10.1097/00005373-199110000-00015; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MURAKAMI WT, 1983, J TRAUMA, V23, P57, DOI 10.1097/00005373-198301000-00012; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; SAKAMOTO T, 1988, J TRAUMA, V28, P840, DOI 10.1097/00005373-198806000-00022; SIMPSON DA, 1989, J TRAUMA, V29, P1519, DOI 10.1097/00005373-198911000-00011; TUNTURI T, 1982, INJURY, V13, P478, DOI 10.1016/0020-1383(82)90162-0; UNGER JM, 1990, RADIOLOGY, V175, P175, DOI 10.1148/radiology.175.1.2315477; WALTER JB, 1974, GEN PATHOLOGY, P421; Yano M, 1988, Neurol Med Chir (Tokyo), V28, P891, DOI 10.2176/nmc.28.891	23	5	5	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	MAR	2000	40	3					133	138		10.2176/nmc.40.133			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	294GK	WOS:000085903300001	10842482	Bronze			2022-02-06	
J	Wyss, R; Bucheli, F; Philipp, W				Wyss, R; Bucheli, F; Philipp, W			Determination of the N-methyl-D-aspartate receptor NR2B subunit blocker Ro 63-1908 in rat, cynomolgus monkey and human plasma by high-performance liquid chromatography with column switching and fluorescence detection	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	23rd International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 99)	MAY 30-JUN 04, 1999	GRANADA, SPAIN			column switching; Ro 63-1908; methyl aspartate receptor blockers		A HPLC method with automated column switching was developed and validated for the determination of Ro 63-1908 in rat and cynomolgus monkey plasma. Human plasma was used for calibration and was also included in the validation process. Ro 63-1908 belongs to a class of neuroprotective N-methyl-o-aspartate (NMDA) receptor blockers which were in development for the treatment of stroke and traumatic brain injury. The method involves deproteinisation of plasma samples with ethanol and direct injection of the supernatant (1.4 ml) into the HPLC column-switching system. To prevent a breakthrough of the analyte and the internal standard on the precolumn (Purospher RP-18, 75 x 4 mm) due to the high ethanol content, the injection solution was diluted, on-line, using an additional pump and a T-piece. 1% ammonium acetate-ethanol (100:2, v/v) was used as mobile phase for injection, as well as for on-line dilution, resulting in pre-concentration of the analyte and the internal standard on the precolumn. As Purospher RP-18 is a non-endcapped stationary phase with a special selectivity for amines, the analyte and the internal standard could then be selectively eluted with 30% acetonitrile (without any buffer in the mobile phase) and transferred to the analytical column [consisting of two coupled columns (125 + 250x4 mm) packed with Superspher 60 RP-select B], where they were separated by gradient elution and detected by fluorescence detection. Compared to the use of a 125 mm long precolumn and dilution of the supernatant with ammonium acetate prior to injection, the 75 mm precolumn and the on-line dilution procedure allowed about one third shorter run times (21 min) and, therefore, a higher sample throughput. The limit of quantification was 1 ng/ml using 0.4 mi plasma. The method was applied to more than 670 plasma samples from pharmacokinetic and toxicokinetic studies and is also suitable for other matrices and NMDA receptor blockers. (C) 2000 Elsevier Science B.V. All rights reserved.	F Hoffmann La Roche & Co Ltd, Div Pharmaceut, PRNS, CH-4070 Basel, Switzerland		Wyss, R (corresponding author), F Hoffmann La Roche & Co Ltd, Div Pharmaceut, PRNS, 68-121A, CH-4070 Basel, Switzerland.	ronald.wyss@roche.com					Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; LUBDA D, COMMUNICATION; McCalley DV, 1997, J CHROMATOGR A, V769, P169, DOI 10.1016/S0021-9673(96)01079-5; SCHMITT M, COMMUNICATION; TIMM U, 1985, J PHARM SCI, V74, P972, DOI 10.1002/jps.2600740913; TIMM U, 1990, DATA HANDL SCI TECHN, V6, P329, DOI 10.1016/S0922-3487(08)70179-5; VIGERCHOUGNET A, COMMUNICATION; Wyss R, 1998, J CHROMATOGR A, V797, P211, DOI 10.1016/S0021-9673(97)01033-9; WYSS R, UNPUB	9	5	5	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673			J CHROMATOGR A	J. Chromatogr. A	FEB 18	2000	870	1-2					189	198		10.1016/S0021-9673(99)01016-X			10	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Chemistry	286QD	WOS:000085455900022	10722076				2022-02-06	
J	Menzel, M; Doppenberg, EMR; Zauner, A; Soukup, J; Henze, D; Clausen, T; Rieger, A; Bullock, R; Radke, J				Menzel, M; Doppenberg, EMR; Zauner, A; Soukup, J; Henze, D; Clausen, T; Rieger, A; Bullock, R; Radke, J			Oxygen reactivity in patients after severe head injury - a prognostic tool?	ZENTRALBLATT FUR NEUROCHIRURGIE			German	Article						brain tissue oximetry; SHI; hyperoxia; outcome	CEREBRAL BLOOD-FLOW; BRAIN INJURY; ACUTE-PHASE; AUTOREGULATION; CIRCULATION; CO2; HYPEROXIA; ISCHEMIA; PRESSURE	Brain tissue oximetry (p(ti)O(2)) using flexible micro-polarographic electrodes is a loco-regional approach to monitor oxygen supply to the injured brain, after neuronal damage. In patients after severe head injury (SHI), disturbances of CBF and CO2 related vasoconstriction have been demonstrated. CO2 reactivity testing may assist to determine outcome in these patients. Not much information is available on the preservation of vasoreactivity to arterial hyperoxia after neuronal damage. Therefore, we studied the response of p(ti)O(2) in 7 piglets and in 14 patients on day one after trauma to 100% FiO(2) ventilation (O-2rea) and analyzed the 3 month outcome using the Glasgow-Outcome-Score (GOS). In the animal study. we placed a Paratrend7 (P7) sensor for p(ti)O(2) measurements in the non injured frontal white matter. The animals were anesthetized and mechanically ventilated. FiO(2) was increased from 30 (+/-5)% to 100% over a period of 5 minutes. In patients, we placed the P7 probe in the frontal lobe. FiO(2) was increased from 35 (+/-5)% to 100% over a period of 6 hours. O-2rea was tested by calculating the percentage change of p(ti)O(2) during 100% FiO(2) ventilation, compared to the baseline value of 35% FiO(2). By analyzing the patient outcome, we were able to define two patient populations according to the GOS at three month (Group I: favorable outcome [GOS 0-2]. Group II: poor outcome [GOS 3-4]). For the non-injured brain tissue in animals we revealed an O-2rea- 0.21 (+/-0.12). Patients: Group I: O-2rea = 0.4 (+/- 0.16); Group II: 0.9 (+/- 0.6). Group I and II were statistical significant different (p < 0.05: unpaired t-test). Oxygen reactivity in severely head patients is a simple test with prognostic value using p(ti)O(2) measurement. These results may be explained by the close relationship of CBF disturbances to oxygen vasoreactivity after traumatic brain injury. The O-2rea in animals without neuronal damage is smaller than in patients after SHI. We speculate. the animal data could be considered as normal value of O-2rea in non injured brain tissue.	Univ Halle Wittenberg, Klin Anasthesiol & Operat Intens Med, D-06097 Halle, Germany; Univ Halle Wittenberg, Klin & Poliklin Neurochirurg, D-06097 Halle, Germany; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA								BERGO GW, 1995, EUR J APPL PHYSIOL O, V71, P475, DOI 10.1007/BF00238548; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; JACKSON WF, 1987, AM J PHYSIOL, V253, pH1120, DOI 10.1152/ajpheart.1987.253.5.H1120; KASSISSIA IG, 1995, CIRC RES, V77, P1201, DOI 10.1161/01.RES.77.6.1201; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; LENIGERFOLLERT E, 1975, PFLUG ARCH EUR J PHY, V359, P81, DOI 10.1007/BF00581279; LODATO RF, 1990, ADV EXP MED BIOL, V277, P807; LopezBarneo J, 1996, TRENDS NEUROSCI, V19, P435; MAHUTTE CK, 1994, INTENS CARE MED, V20, P85, DOI 10.1007/BF01707657; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAULSON OB, 1989, AM J CARDIOL, V63, P26; REINHART K, 1991, CHEST, V99, P690, DOI 10.1378/chest.99.3.690; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1994, INTRACRANIAL PRESSUR, V8, P540; ROSTRUP E, 1995, NMR BIOMED, V8, P41, DOI 10.1002/nbm.1940080109; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; TORBATI D, 1978, AVIAT SPACE ENVIR MD, V49, P963; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; VENKATESH B, 1994, CRIT CARE MED, V22, P588, DOI 10.1097/00003246-199404000-00013; Wahr J A, 1994, J Cardiothorac Vasc Anesth, V8, P342, DOI 10.1016/1053-0770(94)90250-X; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017	29	5	5	0	2	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		2000	61	4					181	187		10.1055/s-2000-15598			7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	431ZP	WOS:000168661900003	11392288				2022-02-06	
J	Schmidt, JG; Schneider, WN				Schmidt, JG; Schneider, WN			Pharmacologic treatment of cognitive deficits and hypersexuality due to "shaken-baby syndrome"	NEUROREHABILITATION AND NEURAL REPAIR			English	Article							CLOSED HEAD-INJURY; BRAIN INJURY; TRAUMA; PROPRANOLOL; INFANTS	Objective : To describe the clinical effects of amantadine and propranolol in an agitated pediatric patient with cognitive deficits, hyperactivity, and hypersexualism secondary to "shaken-baby syndrome." Background: Patients with shaken-baby syndrome can present with cognitive and behavioral impairments. Case: A 9-year-old girl presented with cognitive impairments secondary to shaken-baby syndrome at 3 weeks of age. She was receiving many medications, including dextroamphetamine, methylphenidate, and clonidine, that were not effective in improving her cognitive status or decreasing her hypersexuality. She was weaned from stimulants and clonidine and prescribed amantadine: 100 mg bid with improvement of attention, concentration, and cognition, although hypersexuality remained. Shr was then started on propranolol 10 ms tid. and a gradual increase to 40 mg tid. with amelioration of hypersexuality and hyperactivity and no unwanted effects noted. Self-weaning of propranolol was associated with the return of hypersexuality. The combination of amantadine and propranolol led to improvement of cognition and behavior, especially intellectual functioning and appropriate socialization with peers, respectively. Conclusion: Cognitive deficits and hypersexuality with hyperactive features due to shaken-baby syndrome may respond Co the drug regimen of amantadine and propranolol.	St Marys Hosp, Dept Rehabil & Neurol, Rochester, NY 14611 USA; Univ Rochester, Sch Med & Dent, Dept Phys Med & Rehabil, Rochester, NY USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY USA		Schmidt, JG (corresponding author), St Marys Hosp, Dept Rehabil & Neurol, 89 Genesee St, Rochester, NY 14611 USA.						ATSMON A, 1972, PSYCHOPHARMACOLOGIA, V27, P249, DOI 10.1007/BF00422805; BLUMER D, 1974, PSYCHIAT ASPECTS NEU, P199; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DYKES LJ, 1986, CHILD ABUSE NEGLECT, V10, P211, DOI 10.1016/0145-2134(86)90082-7; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; GARDEN F, 1991, SEX DISABIL, V9, P1; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; Greenspan A I, 1996, Curr Probl Pediatr, V26, P170, DOI 10.1016/S0045-9380(96)80004-1; GUALTIERI C, 1990, NEUROPSYCHIIATRY BEH, P71; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; LILLY R, 1983, NEUROLOGY, V33, P1141, DOI 10.1212/WNL.33.9.1141; Lundberg PO, 1992, ANN REV SEX RES, V3, P121; MERTEN DF, 1983, PEDIATR ANN, V12, P882, DOI 10.3928/0090-4481-19831201-06; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Rutter M, 1970, NEUROPSYCHIATRIC STU; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Schafer Daniel, 1995, TRAUMATIC HEAD INJUR, P55; SCHEIER H, 1979, AM J PSYCHIAT, V136, P840; SCHMIDT JG, 1995, J NEUROL REHABIL, V9, P41; VOLWES GH, 1987, J CLIN PATHOL, V40, P185; ZASLER ND, 1995, SEXUALITY UPDATE, V1, P1; ZASLER ND, 1995, PHYSICAL MED REHABIL, V9, P330	30	5	5	1	2	DEMOS MEDICAL PUBLISHING	NEW YORK	386 PARK AVE SOUTH, STE 201, NEW YORK, NY 10016 USA	0888-4390			NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair		2000	14	2					155	158		10.1177/154596830001400209			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	351ZQ	WOS:000089190400009	15470827				2022-02-06	
J	Wehman, P; Targett, P; Yasuda, S; Brown, T				Wehman, P; Targett, P; Yasuda, S; Brown, T			Return to work for individuals with TBI and a history of substance abuse	NEUROREHABILITATION			English	Article						Traumatic Brain Injury; substance abuse; alcohol abuse; supported employment	TRAUMATIC BRAIN INJURY; SUPPORTED EMPLOYMENT; PROGRAM; ALCOHOL	The highest incidence of TBI is among young adult males who also have the highest incidence of substance abuse [1]. Since these individuals have long life expectancies, it is important that they are productive post injury; however, the employment rate is extremely low. This is understandable, given the fact that a person with either a TBI or substance abuse disorder would have difficulties with work. Naturally, the combination of the two compounds the problem and further complicates matters. This article provides an overview of how a Supported Employment approach can be used to assist persons with a TBI and substance abuse problems with returning to work.	Virginia Commonwealth Univ, Rehabil Res & Training Ctr Workplace Supports, Richmond, VA 23284 USA		Targett, P (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr Workplace Supports, 1314 W Main St,POB 842011, Richmond, VA 23284 USA.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Corrigan J. D., 1999, REHABILITATION ADULT; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; DEPOMPEI R, 1996, CHILDREN ACQUIRED BR, P167; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; GLOW BA, 1989, ALCOHOLISM SUBSTANCE, P65; GORDIS E, 1998, PRINCIPLES ADDICTION; GREER BG, 1986, J REHABIL, V52, P34; KRANZLER HR, 1998, DUAL DIAGNOSIS TREAT; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Krishef C., 1984, ALCOHOL HEALTH RES W, V8, P40; *NIAAA, 1994, ALC HLTH RES WORLD A, V18, P243; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; STORTI SA, 1997, ALCOHOL DISABILITIES; WEHMAN P, 1981, COMPETITIVE EMPLOYME; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; West MD, 1996, J VOCATIONAL REHABIL, V7, P143; 1996, SUBSTANCE ABUSE PREV	24	5	5	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2000	15	1					71	77					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	372MN	WOS:000165237600051	11455083				2022-02-06	
J	Toglia, J; Youngstrom, MJ				Toglia, J; Youngstrom, MJ		Comm Practice	Management of occupational therapy services for persons with cognitive impairments (Statement)	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							TRAUMATIC BRAIN INJURY; ADULTS; REHABILITATION; ATTENTION; WOMAN						Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853			*AM OCC THER ASS, 1998, AM OCC THER ASS POL; American Occupational Therapy Association, 1994, AM J OCCUPATIONAL TH, V48, P1037, DOI 10.5014/ajot.48.11.1037; American Occupational Therapy Association, 1995, COTA INF PACK GUID S; BROWN C, 1993, OCCUP THER J RES, V13, P71, DOI 10.1177/153944929301300201; COOK EA, 1991, AM J OCCUP THER, V45, P652, DOI 10.5014/ajot.45.7.652; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1993, BRAIN INJURY REHABIL; ITZKOVICH M, 1990, LOTCA MANUAL; Katz N, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P323; KATZMANN S, 1994, AM J OCCUP THER, V48, P259, DOI 10.5014/ajot.48.3.259; Nelson DL, 1996, AM J OCCUP THER, V50, P223, DOI 10.5014/ajot.50.3.223; Rustad RA, 1993, COGNITIVE ASSESSMENT; SCHWARTZ SM, 1995, AM J OCCUP THER, V49, P655, DOI 10.5014/ajot.49.7.655; SHIMELMAN A, 1995, AM J OCCUP THER, V49, P973, DOI 10.5014/ajot.49.10.973; Toglia JP, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P5; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113	16	5	6	0	2	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	NOV-DEC	1999	53	6					601	607					7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	255ZX	WOS:000083701000012					2022-02-06	
J	Burke, DT				Burke, DT			Venous thrombosis in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							DEEP-VEIN THROMBOSIS; PROPHYLAXIS; REHABILITATION		Spaulding Rehabil Hosp, Brain Injury Program, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA		Burke, DT (corresponding author), Spaulding Rehabil Hosp, Brain Injury Program, Dept Phys Med & Rehabil, Boston, MA 02114 USA.						Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Bratzler DW, 1998, ARCH INTERN MED, V158, P1909, DOI 10.1001/archinte.158.17.1909; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Clagett GP, 1998, CHEST, V114, p531S, DOI 10.1378/chest.114.5_Supplement.531S; COMEROTA AJ, 1992, AM J SURG, V164, P265, DOI 10.1016/S0002-9610(05)81083-9; Comp PC, 1998, ORTHOPEDICS, V21, P1123; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; KAY R, 1995, NEW ENGL J MED, V333, P1588, DOI 10.1056/NEJM199512143332402; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; SIMONNEAU G, 1993, ARCH INTERN MED, V153, P1541, DOI 10.1001/archinte.153.13.1541	11	5	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1999	14	5					515	519		10.1097/00001199-199910000-00015			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	245MW	WOS:000083113600015					2022-02-06	
J	Jacob, OJ; Rosenfeld, JV; Taylor, RH; Watters, DAK				Jacob, OJ; Rosenfeld, JV; Taylor, RH; Watters, DAK			Late complications of arrow and spear wounds to the head and neck	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							PAPUA-NEW-GUINEA; TRAUMATIC ANEURYSMS; INJURIES; MANAGEMENT; BRAIN; WOOD; WAR; ANGIOGRAPHY; SECONDARY; GUNSHOT		Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia; Port Moresby Gen Hosp, Dept Surg, Port Moresby, Papua N Guinea		Rosenfeld, JV (corresponding author), Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia.		Watters, David Allan/AAI-1022-2020; Rosenfeld, Jeffrey V/B-7249-2011	Watters, David Allan/0000-0002-5742-8417; 			AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; BANK DE, 1993, PEDIATR EMERG CARE, V9, P285; COGBILL TH, 1995, J TRAUMA, V39, P763, DOI 10.1097/00005373-199510000-00030; DANGELICA M, 1995, J TRAUMA, V39, P768, DOI 10.1097/00005373-199510000-00031; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FINGLETON LJ, 1987, BRIT J SURG, V74, P126, DOI 10.1002/bjs.1800740219; GREEN BF, 1990, OPHTHALMOLOGY, V97, P608; HADDAD FS, 1991, NEUROSURGERY, V28, P1; JACOB OJ, 1995, AUST NZ J SURG, V65, P394, DOI 10.1111/j.1445-2197.1995.tb01766.x; Matthew PK, 1996, AUST NZ J SURG, V66, P659, DOI 10.1111/j.1445-2197.1996.tb00712.x; MONO J, 1986, ANN EMERG MED, V15, P589, DOI 10.1016/S0196-0644(86)80998-2; MUTLUKAN E, 1991, BRIT J OPHTHALMOL, V75, P374, DOI 10.1136/bjo.75.6.374; Neal G, 1996, J TRAUMA, V40, P476, DOI 10.1097/00005373-199603000-00030; Nguyen T L, 1994, J Clin Neurosci, V1, P118, DOI 10.1016/0967-5868(94)90086-8; ONEILL OR, 1994, SURG NEUROL, V42, P494, DOI 10.1016/0090-3019(94)90079-5; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; ROY R, 1990, HDB CLIN NEUROLOGY, V57; SPECHT CS, 1992, SURV OPHTHALMOL, V36, P341, DOI 10.1016/0039-6257(92)90110-F; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; Tomaras CR, 1997, NEUROSURGERY, V40, P1291, DOI 10.1097/00006123-199706000-00034; VANGURP G, 1990, J TRAUMA, V30, P183, DOI 10.1097/00005373-199002000-00008; YANG X, 1995, EUR ARCH OTO-RHINO-L, V252, P440	24	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	1999	47	4					768	773		10.1097/00005373-199910000-00026			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	247FE	WOS:000083209800030	10528616				2022-02-06	
J	Jiang, XB; Kuroiwa, T; Ohno, K; Duan, L; Aoyagi, M; Hirakawa, K				Jiang, XB; Kuroiwa, T; Ohno, K; Duan, L; Aoyagi, M; Hirakawa, K			Local mitochondrial function following traumatic brain injury in rats	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						brain injury; mitochondria; succinate dehydrogenase; rat	CEREBRAL GLUCOSE-UTILIZATION; ISCHEMIA; GERBILS; NEURONS	The effect of lateral fluid percussion injury on mitochondrial function in the rat brain was investigated by quantitative imaging of changes in the regional activity of succinate dehydrogenase (SDH), a mitochondrial enzyme of the tricarboxylic acid cycle for adenosine triphosphate production. Regional SDH was measured in the frontal, parietal, temporal, and occipital cortices, CA1 and CA2-3 of the hippocampus, thalamus, corpus callosum, caudate/putamen, and cerebellum 1 hour and 72 hours after low, medium, and high pressure injury. No regional difference between the hemispheres in the activity of SDH was observed in the sham group. The hippocampus showed high SDH activity. The CA2-3 regions showed the highest activity among the regions examined. The corpus callosum, which is white matter, showed the lowest. One hour after low pressure fluid percussion injury, only the frontal lobe showed significantly lower SDH activity than the sham control in the ipsilateral hemisphere, whereas after 72 hours SDH activity was significantly lower in the frontal, parietal, and temporal lobes. SDH activity was significantly lower in the frontal, parietal,;and temporal lobes in the medium and high pressure injury groups than in the sham central 1 hour after injury, and SDH activity in the CA1 and CA2-3 of the hippocampus was significantly decreased 72 hours after injury. No decrease in SDH activity was observed in any region of the contralateral hemisphere either 1 hour or 72 hours after injury. Mitochondrial dysfunction of the ipsilateral cortex and hippocampus following fluid percussion injury is correlated with the severity of injury and advances with time after injury. The results suggest that progression of mitochondrial dysfunction is associated with secondary bioenergetic deterioration.	Tokyo Med & Dent Univ, Dept Neurosurg, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Dept Neuropathol, Tokyo 1138519, Japan		Jiang, XB (corresponding author), Tokyo Med & Dent Univ, Dept Neurosurg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; GUITIERREZDIAZ JA, 1985, SURG NEUROL, V24, P67; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Kuroiwa T, 1996, NEUROSCI LETT, V206, P117, DOI 10.1016/S0304-3940(96)12439-3; OHNO K, 1979, STROKE, V10, P62, DOI 10.1161/01.STR.10.1.62; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Qian Liang, 1996, Bulletin of Tokyo Medical and Dental University, V43, P53; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WREE A, 1988, HISTOCHEMISTRY, V88, P415; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAMAMOTO K, 1986, BRAIN RES, V384, P1, DOI 10.1016/0006-8993(86)91212-6	18	5	5	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	1999	39	9					649	656		10.2176/nmc.39.649			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236DJ	WOS:000082582700001	10563115	Bronze			2022-02-06	
J	Zahn, TP; Mirsky, AF				Zahn, TP; Mirsky, AF			Autonomic activity during task performance in adults with closed head injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						brain injury; autonomic nervous system; skin conductance; heart rate; attention; task demands	TRAUMATIC BRAIN INJURY; DISRUPTIVE BEHAVIOR DISORDERS; REACTION-TIME; SCHIZOPHRENIA; DYSFUNCTION; BOYS	Skin conductance (SC) and heart rate (HR) were recorded in two experiments in persons who had suffered a closed head injury (CHI) at least 2 years previously and in control subjects. Experiment 1 consisted of a rest period, a series of innocuous tones, and a short simple reaction time (RT) task. Experiment 2 consisted of initial and final rest periods and a longer RT task with constant and variable preparatory intervals. The results from both protocols showed no group differences in HR, SC levels, or SC fluctuations during rest periods, but the SC variables increased less to the task instructions in the CHI group. There were no differences in SC response frequency or magnitude to innocuous tones, but the CHI subjects had fewer SC responses to the RT stimuli in both experiments. SC responses to both innocuous tones and RT stimuli had longer latencies in the CHI group. The results show that selective deficits in tonic and phasic autonomic responding to meaningful, significant, or demanding situations and stimuli are long-term sequelae to CHI. These attenuated activation increases may be related to inadequate mobilization of processing resources and to behavioral deficits shown by these patients. Published by Elsevier Science B.V.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA		Zahn, TP (corresponding author), NIMH, Lab Brain & Cognit, Bldg 10,Rm 4C104,MSC 1366, Bethesda, MD 20892 USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ANDREASEN N, 1986, ARCH GEN PSYCHIAT, V43, P136; BUCHSBAUM MS, 1984, ARCH GEN PSYCHIAT, V41, P1159; CULP WC, 1966, PERCEPT MOTOR SKILL, V23, P623, DOI 10.2466/pms.1966.23.2.623; Duncan CC, 1988, ELEMENTS PETIT MAL E, P341; GOLDBERG E, 1986, J CLIN EXP NEUROPSYC, V8, P710, DOI 10.1080/01688638608405191; GOLDBERG E, 1989, CORTEX, V25, P687, DOI 10.1016/S0010-9452(89)80029-2; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; OHMAN A, 1979, ORIENTING REFLEX HUM, P443; RIST F, 1991, HDB SCHIZOPHRENIA, V5, P241; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; VANZOMEREN AH, 1994, CLIN NEUROPSYCHOLOGY, P250; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003; ZAHN TP, 1993, PSYCHOPHYSIOLOGY, V30, P605, DOI 10.1111/j.1469-8986.1993.tb02086.x; ZAHN TP, 1991, J ABNORM CHILD PSYCH, V19, P233, DOI 10.1007/BF00909980; ZAHN TP, 1986, PSYCHOPHYSIOLOGY SYS, P508; ZAHN TP, IN PRESS J CLIN EXP; ZAHN TP, IN PRESS NEUROPSYCHO; ZAHN TP, 1991, HDB SCHIZOPHRENIA, V5, P185; [No title captured]	25	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760			INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	AUG	1999	33	2					113	126		10.1016/S0167-8760(99)00030-6			14	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	232LT	WOS:000082372800002	10489076				2022-02-06	
J	Gorrie, C; Duflou, J; Brown, J; Waite, PME				Gorrie, C; Duflou, J; Brown, J; Waite, PME			Fatal head injury in children: a new approach to scoring axonal and vascular damage	CHILDS NERVOUS SYSTEM			English	Article; Proceedings Paper	XXVI Annual Meeting of the International-Society-for-Pediatric-Neurosurgery	SEP 13-19, 1998	MELBOURNE, AUSTRALIA	Int Soc Pediat Neurosurg		traumatic brain injury; diffuse axonal injury; beta-amyloid precursor protein; tolerance criteria; motor vehicle accidents	AMYLOID PRECURSOR PROTEIN; BRAIN INJURY; TRAUMA	As part of a multidisciplinary study of brain damage in children fatally injured in motor vehicle accidents, a simple method to quantify and visualise the distribution and extent of injury has been developed. Vascular and axonal injury were assessed using coronal brain sections stained for haematoxylin and eosin, or reacted immunohistochemically for P-amyloid precursor protein. Subsequent analysis was carried out using NM Image software, and the resulting information is displayed in schematic diagrams. These summary diagrams simply and clearly show the distribution of injury in both the coronal and horizontal planes. This technique offers an advantage over previous scoring methods in that it provides both a quantitative and a visual summary of the distribution and extent of brain injury. This information can then be used to compare the injury distribution and severity with estimated impact points and acceleration data.	Univ New S Wales, Sch Anat, Neural Injury Res Unit, Sydney, NSW 2050, Australia; Inst Forens Med, Sydney, NSW, Australia		Waite, PME (corresponding author), Univ New S Wales, Sch Anat, Neural Injury Res Unit, Sydney, NSW 2050, Australia.		Duflou, Johan/AAK-2331-2020; Gorrie, Catherine/S-6591-2019	Duflou, Johan/0000-0001-5863-635X; Gorrie, Catherine/0000-0001-5934-2492			AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1989, SCOT MED J, V34, P399, DOI 10.1177/003693308903400106; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; *FORS, 1994, ROAD FAT AUSTR 1993; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; *NIH, 1996, PUBL DOM NIH IM PROG; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RYAN GA, 1994, J TRAUMA, V36, P469; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; SNYDER CL, 1990, J TRAUMA, V30, P1239, DOI 10.1097/00005373-199010000-00008; TARRIERE C, 1995, 1995 INT IRCOBI C BI, P15; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	20	5	5	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUL	1999	15	6-7					322	327		10.1007/s003810050403			6	Clinical Neurology; Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	224GY	WOS:000081890700009	10461781				2022-02-06	
J	Sato, M; Kodama, N; Yamaguchi, K				Sato, M; Kodama, N; Yamaguchi, K			Post-traumatic brain stem distortion: A case report	SURGICAL NEUROLOGY			English	Article						brain stem distortion; trauma; clivus fracture; magnetic resonance imaging	INJURY	BACKGROUND Primary traumatic brain stem injury (BSI) lesions are found most frequently in the dorsal or dorsolateral midbrain, whereas distortion of the brain stem itself is exceedingly rare. CASE REPORT We present a 20-year-old woman with a rare brain stem injury caused by a violent motor vehicle collision. Magnetic resonance imaging at 2 months after injury revealed marked brain stem distortion with loss of the normal shape at the midbrain and pens, which were displaced anteriorly in association with the fracture of the clivus. Moreover, the medulla oblongata showed a loose winding configuration. At discharge about 5 months after injury, the Glasgow Outcome Scale was severe disability. CONCLUSION This BSI was caused by reciprocal actions of fracture of the clivus and the direct effect on the brain stem caused by acceleration or rotational forces. (C) 1999 by Elsevier Science inc.	Fukushima Med Sch, Dept Neurosurg, Fukushima 96012, Japan; Ohta Nishinouchi Hosp, Dept Neurosurg, Koriyama, Fukushima, Japan		Sato, M (corresponding author), Fukushima Med Sch, Dept Neurosurg, 1 Hikarigaoka, Fukushima 96012, Japan.						GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; HASHIMOTO T, 1990, NEUROTRAUMATOLOGY, V13, P93; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; Lindenberg R, 1964, Clin Neurosurg, V12, P129; SANDERS BB, 1973, J NEUROSURG, V39, P610, DOI 10.3171/jns.1973.39.5.0610; WONG CW, 1993, SURG NEUROL, V39, P37, DOI 10.1016/0090-3019(93)90107-C; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	7	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	1999	51	6					613	616		10.1016/S0090-3019(98)00091-3			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	203HK	WOS:000080702300011	10369228				2022-02-06	
J	Mantz, J				Mantz, J			Neuroprotective effects of anaesthetic agents.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						cerebral ischaemia; neuroprotection; anaesthetic agents	TRANSIENT GLOBAL-ISCHEMIA; TEMPORARY FOCAL ISCHEMIA; VOLATILE ANESTHETICS; FOREBRAIN ISCHEMIA; GLUTAMATE RELEASE; CEREBRAL-ISCHEMIA; DOPAMINE RELEASE; MILD HYPOTHERMIA; NEURONAL INJURY; BRAIN INJURY	During cerebral ischaemia, energetic failure of injured cells together with excessive release of glutamate the most common excitatory amino acid in the brain, lead to excitotoxicity and immediate or delayed neuronal death. There is strong experimental evidence to support the neuroprotective role played by anaesthetic agents. Hence, barbiturates, volatile anesthetics or ketamine exhibit significant protective effects against ischaemic injury in numerous experimental models of ischaemia in vitro or in vivo. The neurobiological substrate of this action is probably a reduction of the activity of glutamate receptors (N-methyl-D-aspartate and kainate), and/or downstream biochemical events. Reduction of cerebral metabolism by these agents seems not to be their primary neuroprotective mechanism. However, no data are available at the present time to support any clinical benefit of these actions in neurosurgical patients, head trauma in contrast to mild hypothermia or cerebrovascular disease. Future research should develop models as close as possible to the clinical situation to examine further pathophysiological hypotheses and clinical implications. (C) 1999 Elsevier, Paris.	Hop Bichat, Serv Anesthesie & Reanimat Chirurgicale, F-75018 Paris, France		Mantz, J (corresponding author), Hop Bichat, Serv Anesthesie & Reanimat Chirurgicale, 46 Rue Henri Huchard, F-75018 Paris, France.						ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; AMORIM P, 1995, ANESTHESIOLOGY, V83, P1254, DOI 10.1097/00000542-199512000-00016; Bhardwaj A, 1998, ANESTHESIOLOGY, V89, P289, DOI 10.1097/00000542-199808000-00003; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Charchaflieh J, 1998, ANESTH ANALG, V87, P68, DOI 10.1097/00000539-199807000-00015; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; COTTRELL JE, 1997, CURR OPIN ANAESTH, V10, P67; COTTRELL JE, 1997, ANN REFRESHER COURSE; Himmelseher S, 1996, ANESTH ANALG, V83, P505, DOI 10.1097/00000539-199609000-00011; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Kass IS, 1997, J NEUROSURG ANESTH, V9, P280, DOI 10.1097/00008506-199707000-00015; Keita H, 1997, ANESTHESIOLOGY, V87, P1164, DOI 10.1097/00000542-199711000-00021; Kinoshita M, 1997, J CEREBR BLOOD F MET, V17, P507, DOI 10.1097/00004647-199705000-00004; Kirsch JR, 1996, INT ANESTHESIOL CLIN, V34, P73, DOI 10.1097/00004311-199603440-00007; KOORN R, 1994, ANESTH ANALG, V78, P73; Kuhmonen J, 1997, ANESTHESIOLOGY, V87, P371, DOI 10.1097/00000542-199708000-00025; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MacIver MB, 1996, ANESTHESIOLOGY, V85, P823, DOI 10.1097/00000542-199610000-00018; Mantz J, 1997, DRUGS TODAY, V33, P579, DOI 10.1358/dot.1997.33.8.445510; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V18, P700; Miao N, 1998, ANESTHESIOLOGY, V88, P1643, DOI 10.1097/00000542-199806000-00029; MILLER LP, 1992, J NEUROTRAUM, V9, pS563; Miura Y, 1998, ANESTHESIOLOGY, V89, P391, DOI 10.1097/00000542-199808000-00016; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; Nakashima K, 1996, ANESTHESIOLOGY, V85, P161, DOI 10.1097/00000542-199607000-00022; NEHLS DG, 1987, ANESTHESIOLOGY, V66, P453, DOI 10.1097/00000542-198704000-00002; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; Pittman JE, 1997, ANESTHESIOLOGY, V87, P1139, DOI 10.1097/00000542-199711000-00018; Ratnakumari L, 1998, ANESTHESIOLOGY, V88, P1043, DOI 10.1097/00000542-199804000-00025; SANO T, 1992, ANESTHESIOLOGY, V76, P221, DOI 10.1097/00000542-199202000-00011; Sarraf-Yazdi S, 1998, ANESTH ANALG, V87, P72, DOI 10.1097/00000539-199807000-00016; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Zhu HC, 1997, ANESTHESIOLOGY, V87, P944, DOI 10.1097/00000542-199710000-00030	36	5	5	0	0	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	MAY	1999	18	5					588	592		10.1016/S0750-7658(99)80137-3			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	218ZF	WOS:000081581900017	10427397				2022-02-06	
J	Donders, J				Donders, J			Psychometric intelligence in patients with traumatic brain injury: Utility of a new screening measure	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article								Objective: To evaluate the validity of the General Ability Measure for Adults (GAMA) in a sample of patients with traumatic brain injury (TBI). Design: Comparison with criterion standards of Wechsler Adult Intelligence Scale-Revised (WAIS-R) and measures of injury severity. Setting: Regional rehabilitation center. Participants: One-year prospective series of consecutive rehabilitation referrals, including 42 adult patients with TBI. Main Outcome Measures: GAMA and WAIS-R IQ scores were obtained within 1 year after injury and compared with each other and with measures of injury severity. Results: The GAMA demonstrated statistically significant covariance with the WAIS-R and was able to discriminate severe TBI from mild/moderate TBI. The correlation between the GAMA and length of coma fell just short of statistical significance. Conclusions: The GAMA is sufficiently sensitive to the presence or absence of severe TBI but may not be sufficiently sensitive to the exact degree of injury severity. (C) 1999 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						Cohen J, 1977, STAT POWER ANAL BEHA; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DONDERS J, 1995, ASSESSMENT, V2, P219; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Naglieri J. A., 1997, GEN ABILITY MEASURE; NAUGLE RI, 1993, PSYCHOL ASSESS, V5, DOI DOI 10.1037/1040-3590.5.2.182; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	10	5	5	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1999	80	3					346	347		10.1016/S0003-9993(99)90150-8			2	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	173RX	WOS:000078994500019	10084447				2022-02-06	
J	Ozbudak-Demir, S; Akyuz, M; Guler-Uysal, F; Orkun, S				Ozbudak-Demir, S; Akyuz, M; Guler-Uysal, F; Orkun, S			Postacute predictors of functional and cognitive progress in traumatic brain injury: Somatosensory evoked potentials	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY; PROGNOSTIC IMPLICATIONS; OUTCOME PREDICTION; DISABILITY; DYSFUNCTION; RECOVERY	Objective: To investigate the prognostic value of electrophysiologic studies performed during the postacute phase after traumatic brain injury (TBI). Design: A prospective comparative study in which 26 patients with TBI participated. Patients were grouped according to their admission short-latency somatosensory evoked potential (SEP) results. Nonparametric Kruskal-Wallis and Mann-Whitney U tests were applied to different SEP groups to determine the differences among them in specific functional and cognitive outcome measures. Setting: An inpatient brain injury rehabilitation unit. Participants: Twenty-six patients with TBI who were admitted to the rehabilitation center at the postacute phase for a late inpatient rehabilitation program and 15 age-matched healthy subjects who served as a control group for the electrophysiologic comparison. Main Outcome Measures: Motricity Index, Barthel Index, Disability Rating Scale, Mini-Mental Status Exam, and Rancho Los Amigos Scale. Results: Disability Rating Scale scores at discharge and rate of change of Barthel Index scores differed between median nerve SEP classification groups (p < .05 for both). Disability Rating Scale scores at admission (p < .05) and at discharge (p < .01), Barthel Index scores at discharge (p < .05), and rate of change of Barthel Index scores (p < .05) differed between tibial nerve SEP classification groups. There was a relation between Motricity Index side scores at discharge and the different body side SEP response groups (p < .0001). Cognitive results showed no relation to the SEP groups. Conclusions: Postacute SEP scores after a late admission to a rehabilitation center showed a relation to measures of functional and motor progress. Patients with better SEP responses were more likely to experience greater functional and motor improvement. Cognitive functions were not related to SEP results. (C) 1999 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Ankara Phys Med & Rehabil Ctr, Ankara, Turkey; Cukurova Univ, Sch Med, Dept Phys Med & Rehabil, Adana, Turkey		Ozbudak-Demir, S (corresponding author), Tezel Sok 9-18, TR-06550 Ankara, Turkey.						ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BARELLI A, 1991, CRIT CARE MED, V19, P1374, DOI 10.1097/00003246-199111000-00013; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; BRUCE BG, 1988, REHABILITATION MED, P119; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; COLE JL, 1993, REHABILITATION MED, P308; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; DRAKE ME, 1994, CLIN ELECTROENCEPHAL, V25, P46; EISEN A, 1988, REHABILITATION MED, P26; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman MR, 1995, INT J NEUROSCI, V83, P269, DOI 10.3109/00207459508986343; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1982, ANN NY ACAD SCI, V388, P683, DOI 10.1111/j.1749-6632.1982.tb50835.x; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; JABBARI B, 1987, ELECTROEN CLIN NEURO, V67, P289, DOI 10.1016/0013-4694(87)90115-5; JOHNSTON MV, 1996, MED REHABILITATION T, P197; Kaplan P, 1988, REHABILITATION MED, P119; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; NEWLON PG, 1984, J TRAUMA, V24, P61, DOI 10.1097/00005373-198401000-00010; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RAPPAPORT M, 1990, CLIN ELECTROENCEPHAL, V21, P188, DOI 10.1177/155005949002100406; Rappaport M, 1996, MED REHABILITATION T, P271; RUIJS MBM, 1993, NEUROPEDIATRICS, V24, P307, DOI 10.1055/s-2008-1071562; SHIN DY, 1989, ARCH PHYS MED REHAB, V70, P189; UYSAL FG, 1994, EUR J PHYS MED REHAB, V4, P38	30	5	5	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1999	80	3					252	257		10.1016/S0003-9993(99)90134-X			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	173RX	WOS:000078994500003	10084431				2022-02-06	
J	Kendall, E; Buys, N				Kendall, E; Buys, N			The psychosocial consequences of motor vehicle accidents	JOURNAL OF PERSONAL & INTERPERSONAL LOSS			English	Article							CLOSED-HEAD-INJURY; SPINAL-CORD INJURY; POSTTRAUMATIC-STRESS; TRAFFIC ACCIDENTS; SURVIVORS; ADJUSTMENT; DISORDERS; IDENTITY; ADULTS; TRAUMA	Motor vehicle accidents are extremely common in Australia and generate large social costs, The survivors of these accidents frequently sustain significant permanent disabilities that require ongoing treatment, rehabilitation, and community care. However, the psychosocial consequences of motor vehicle accidents are usually overlooked. For many survivors of motor vehicle accidents, the trauma and psychological or emotional difficulties they experience can be devastating. Socially and vocationally, the losses associated with motor vehicle accidents can be extensive, particularly if a permanent disability has been sustained. Despite the size and potential cost of the problems associated with motor vehicle accidents, this area has been adequately studied as a source of loss and grief. Given that psychosocial Problems can hinder the rehabilitation process, workers must be aware of the adjustment Problems that are likely to arise from this type of loss. Accordingly, the aim of the current article Is to review the available literature concerning the psychosocial consequences of motor vehicle accidents. It is suggested that motor vehicle accidents warrant specific research attention to determine which factors might assist this population to adjust to their losses and to ensure that efficacious and cost-efficient rehabilitation interventions can be developed.	Griffith Univ, Fac Hlth Sci, Ctr Strateg Human Serv, Nathan, Qld 4111, Australia		Kendall, E (corresponding author), Griffith Univ, Fac Hlth Sci, Ctr Strateg Human Serv, Nathan, Qld 4111, Australia.		Buys, Nicholas/AAT-3925-2020; kendall, elizabeth/F-5065-2013	Buys, Nicholas/0000-0002-4780-8088; Kendall, Elizabeth/0000-0003-2399-1460			Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BARNARD D, 1990, PERSPECT BIOL MED, V33, P535; BERLE JO, 1994, GROUP ANAL, V27, P159; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWNE GB, 1990, MED CARE, V28, P43, DOI 10.1097/00005650-199001000-00006; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; BUCKELEW SP, 1990, REHABIL PSYCHOL, V35, P101, DOI 10.1037/h0079053; *BUR TRANSP COMM, 1993, COSTS ROAD CRASH AUS; *BUR TRANSP COMM, 1988, SOC COST ACC AUSTR; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Christoffel KK, 1996, PEDIATRICS, V97, P33; CLARKE JA, 1995, DISABIL REHABIL, V17, P377, DOI 10.3109/09638289509166725; COLLING T, 1992, MATESHIP UNDERSTANIN; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; EVANS RW, 1992, NEUROL CLIN, V10, P975, DOI 10.1016/S0733-8619(18)30191-9; JANOFFBULMAN RJ, 1987, J PERS SOC PSYCHOL, V35, P351; JAWOROWSKI S, 1992, ISRAEL J PSYCHIAT, V29, P174; JOSEPH S, 1993, BRIT J MED PSYCHOL, V66, P185, DOI 10.1111/j.2044-8341.1993.tb01740.x; JOSEPH SA, 1993, J CHILD PSYCHOL PSYC, V34, P247, DOI 10.1111/j.1469-7610.1993.tb00982.x; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KENDALL E, 1991, ACQUIRED BRAIN DAMAG; KIDD PS, 1993, QUALITATIVE HLTH RES, V3, P320; KUCH K, 1994, J ANXIETY DISORD, V8, P181, DOI 10.1016/0887-6185(94)90015-9; LANDOLT AM, 1990, PROGR NEUROLOGICAL S, V13, P1; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MALT UF, 1989, ACTA PSYCHIAT SCAND, V80, P84, DOI 10.1111/j.1600-0447.1989.tb05258.x; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MAYOU R, 1992, International Review of Psychiatry, V4, P45, DOI 10.3109/09540269209066301; MAYOU RA, 1991, INJURY, V22, P356; MENDETSKY HA, 1993, AM J FORENSIC PSYCH, V11, P47; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; OCONNOR P, 1991, ROAD INJURY AUSTR; Ponsford J L, 1990, Brain Inj, V4, P111, DOI 10.3109/02699059009026156; Raphael B., 1994, COPING TRAUMA VICTIM, P1; ROSE V, 1995, P 3 NAT REH C BRISB, P181; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SACHS PR, 1994, AM J FAM THER, V22, P263, DOI 10.1080/01926189408251319; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SCOTT MJ, 1994, BRIT J CLIN PSYCHOL, V33, P71, DOI 10.1111/j.2044-8260.1994.tb01095.x; STALLARD P, 1993, BRIT J PSYCHIAT, V163, P660, DOI 10.1192/bjp.163.5.660; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STURZENEGGER M, 1995, J NEUROL, V242, P443, DOI 10.1007/BF00873547; Taylor S, 1995, CLIN PSYCHOL REV, V15, P721, DOI 10.1016/0272-7358(95)00043-7; TENNEN H, 1990, HDB SOCIAL CLIN PSYC, P624; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P231, DOI 10.1136/jech.46.3.231; WATTS T, 1994, COPING TRAUMA VICTIM, P21; YOSHIDA KK, 1993, SOCIOL HEALTH ILL, V15, P217, DOI 10.1111/1467-9566.ep11346888; YULE W, 1991, BRIT J CLIN PSYCHOL, V30, P131, DOI 10.1111/j.2044-8260.1991.tb00928.x; [No title captured]	51	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1081-1443			J PERS INTERPERS LOS	J. Pers. Interpers. Loss	JAN-MAR	1999	4	1					47	66		10.1080/10811449908409716			20	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	157ML	WOS:000078066200003					2022-02-06	
J	Haber, L; Haber, RN				Haber, L; Haber, RN			Criteria for judging the admissibility of eyewitness testimony of long past events	PSYCHOLOGY PUBLIC POLICY AND LAW			English	Article								Court cases of recovered memories of childhood abuse, in which the victim's testimony may constitute the only evidence available, and a growing body of research demonstrating the inexactitude and suggestibility of autobiographical memory of long past events, are forcing courts and cognitive scientists to seek scientific, principled criteria for admissibility of such testimony. The authors use as examples 2 recent court cases. In the Ist case, a concussion produced total retrograde amnesia for an accident for a period of 3 years, and then, over a few months, the driver claimed his memory returned. In the 2nd, 2 adults reported to the police that they witnessed their sister's murder 35 years earlier, when they were 3 and 5 years old, respectively. The authors provide objective guidelines for courts to determine whether testimony about recovered or very-long-term memory for eyewitnessed events should be admissible. The principles outlined can be expanded easily to include eyewitness testimony in general.	Univ Calif Santa Cruz, Dept Psychol, Santa Cruz, CA 95064 USA; Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA		Haber, L (corresponding author), 730 Rimrock Dr, Swall Meadows, CA 93514 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alpert JL, 1998, PSYCHOL PUBLIC POL L, V4, P941, DOI 10.1037/1076-8971.4.4.941; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARRIGO JM, 1998, CURRENT DIRECTIONS P, V6, P148; Baddeley A. D., 1995, HDB MEMORY DISORDERS; Belli R. F., 1996, REMEMBERING OUR PAST, P157, DOI [DOI 10.1017/CBO9780511527913.006, 10.1017/CBO9780511527913.006]; BREWER WF, 1997, MEMORY EVERYDAY EMOT, P453; Davies G., 1996, PSYCHOL ISSUES EYEWI, P233; ERDEYI MH, 1996, RECOVERY UNCONSCIOUS; FIVUSH R, 1990, KNOWING REMEMBERING, P233; GOODMAN CS, 1993, CHILD VICTIMS CHILD; HABER RN, 1967, J VERB LEARN VERB BE, V6, P618, DOI 10.1016/S0022-5371(67)80026-4; HABER RN, IN PRESS PSYCHOL PUB; Levin H. S., 1992, NEUROPSYCHOLOGY MEMO, P290; Loftus E. F., 1987, EYEWITNESS TESTIMONY; Mandler Jean M, 1984, STORIES SCRIPTS SCEN; Ornstein PA, 1998, PSYCHOL PUBLIC POL L, V4, P1025; Ornstein PA, 1998, PSYCHOL PUBLIC POL L, V4, P1068; PEZDEK K, 1996, RECOVERY MEMORY FALS; PEZDEK K, IN PRESS RES THEORY; Ribot T., 1882, DIS MEMORY ESSAY POS; Ross D.F., 1994, ADULT EYEWITNESS TES, P245; Schank R, 1977, SCRIPTS PLANS GOALS; SQUIRE LR, 1992, NEUROPSYCHOLOGY MEMO; SQUIRE LR, 1996, NEUROPSYCHOLOGICAL A, P232; TERR L, 1988, AM J CHILD ADOLESCEN, V17, P96; Terr L. C., 1989, J TRAUMA STRESS, V2, P3, DOI DOI 10.1007/BF00975763; WAGENAAR WA, 1996, STUDIES AUTOBIOGRAPH, P180; Wagenaar Willem A., 1993, ANCHORED NARRATIVES; WEAVER CA, 1995, ESSAYS HONOR W KINTC; WELLS GL, 1990, PERS SOC PSYCHOL B, V16, P106, DOI 10.1177/0146167290161008; WELLS GL, IN PRESS LAW HUMAN B	32	5	5	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1076-8971	1939-1528		PSYCHOL PUBLIC POL L	Psychol. Public Policy Law	DEC	1998	4	4					1135	1159					25	Health Policy & Services; Law; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Government & Law; Psychology	V2669	WOS:000165539000011					2022-02-06	
J	Kosmorsky, G; Lancione, RR				Kosmorsky, G; Lancione, RR			When fighting makes you see black holes instead of stars	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article						homonymous hemianopia; traumatic brain injury; lateral geniculate body		A young boxer developed a left homonymous hemianopia immediately after a blow to the head. A magnetic resonance image showed a lesion in the right lateral geniculata region that was consistent with a previous cerebral hemorrhage and was likely the cause of the visual field defect.	Cleveland Clin Fdn, Div Ophthalmol, Cleveland, OH 44195 USA		Kosmorsky, G (corresponding author), Cleveland Clin Fdn, Div Ophthalmol, A-31,9500 Euclid Ave, Cleveland, OH 44195 USA.							0	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1070-8022			J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	DEC	1998	18	4					255	257					3	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	306YN	WOS:000086626400006	9858006				2022-02-06	
J	Gedeborg, R; Wiklund, L				Gedeborg, R; Wiklund, L			Experimental model of cardiovascular post-resuscitation syndrome - no effect of platelet activating factor antagonism	RESUSCITATION			English	Article						cardiac arrest; cardiopulmonary resuscitation; open chest cardiac compression; post-resuscitation period; myocardial stunning; platelet activating factor	CARDIAC-ARREST; MYOCARDIAL DYSFUNCTION; RECEPTOR ANTAGONIST; HEMORRHAGIC-SHOCK; TRAUMATIC SHOCK; CO2 REACTIVITY; PIGS; ISCHEMIA; DOGS; AUTOREGULATION	The cardiovascular instability seen in the reperfusion phase after resuscitation from cardiac arrest may contribute to secondary brain injury. The aim of the present study was to characterise post-resuscitation cardiovascular instability in an experimental model of cardiac arrest and to test if cardiovascular stability could be improved by pre-treatment with the platelet activating factor (PAF) antagonist BN52021. Ten anaesthetised pigs received pre-treatment with BN52021 before induction of ventricular fibrillation (arrest/BN52021 group), while ten animals received only the vehicle (arrest/vehicle group). After a non-intervention interval of 9 min, resuscitation was attempted. Resuscitated animals were observed for 5 h and compared to a sham arrear group of seven animals. The haemodynamic situation after resuscitation was characterised by a low cardiac output that was inadequate in relation to the oxygen demand, as reflected by a low mixed venous oxygen saturation. The arterial blood pressure was to some extent reduced and the filling pressures in both the right and left heart were increased, but urinary output was not reduced. The severe haemodynamic compromise was not adequately reflected by standard monitoring variables such as arterial blood pressure and urinary output. Pre-treatment with BN52021 was unable to improve any aspect of short-term survival or haemodynamic stability. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Univ Uppsala Hosp, Dept Surg Sci, Unit Anaesthesiol & Intens Care, S-75185 Uppsala, Sweden		Gedeborg, R (corresponding author), Univ Uppsala Hosp, Dept Surg Sci, Unit Anaesthesiol & Intens Care, S-75185 Uppsala, Sweden.	rolf.gedeborg@anestesi.u.se					AbuZidan FM, 1996, J TRAUMA, V41, P634, DOI 10.1097/00005373-199610000-00007; AbuZidan FM, 1997, EUR SURG RES, V29, P133, DOI 10.1159/000129517; AbuZidan FM, 1996, EUR J SURG, V162, P499; AMES A, 1983, STROKE, V14, P219, DOI 10.1161/01.STR.14.2.219; ARMSTEAD WM, 1988, CIRC RES, V62, P1, DOI 10.1161/01.RES.62.1.1; BITTERMAN H, 1987, METHOD FIND EXP CLIN, V9, P341; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; CERCHIARI EL, 1993, RESUSCITATION, V25, P9, DOI 10.1016/0300-9572(93)90003-9; CHRISTOPHERSON TJ, 1993, J CEREBR BLOOD F MET, V13, P260, DOI 10.1038/jcbfm.1993.32; Cooper S, 1997, RESUSCITATION, V35, P17, DOI 10.1016/S0300-9572(97)00020-8; EZRA D, 1987, PROSTAGLANDINS, V34, P41, DOI 10.1016/0090-6980(87)90261-9; Feuerstein G, 1988, Prog Biochem Pharmacol, V22, P181; FISCHER EG, 1979, STROKE, V10, P423, DOI 10.1161/01.STR.10.4.423; Gazmuri RJ, 1996, CRIT CARE MED, V24, P992, DOI 10.1097/00003246-199606000-00020; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Herbertson MJ, 1997, CRIT CARE MED, V25, P221, DOI 10.1097/00003246-199702000-00004; HOSSMANN KA, 1973, ARCH NEUROL-CHICAGO, V29, P375, DOI 10.1001/archneur.1973.00490300037004; JEHLE D, 1994, AM J EMERG MED, V12, P524, DOI 10.1016/0735-6757(94)90269-0; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; KOCHANEK PM, 1987, LIFE SCI, V41, P2639, DOI 10.1016/0024-3205(87)90278-5; KruseElliott KT, 1996, SHOCK, V5, P265, DOI 10.1097/00024382-199604000-00006; LEFER AM, 1989, CIRC SHOCK, V27, P3; MORRISON PR, 1964, BIOL DATA BOOK, P121; Mozes T, 1992, Mediators Inflamm, V1, P183, DOI 10.1155/S0962935192000280; MOZES T, 1991, J LIPID MEDIATOR, V4, P309; MOZES T, 1989, AM J PHYSIOL, V2, P872; NEMOTO EM, 1975, STROKE, V6, P425, DOI 10.1161/01.STR.6.4.425; ONTELL SJ, 1989, ANN SURG, V209, P200, DOI 10.1097/00000658-198902000-00011; Schurr MJ, 1997, SURGERY, V121, P493, DOI 10.1016/S0039-6060(97)90102-1; STAHL GL, 1989, THROMB RES, V53, P327, DOI 10.1016/0049-3848(89)90107-2; STAHL GL, 1988, EUR J PHARMACOL, V149, P233, DOI 10.1016/0014-2999(88)90653-X; TERASHITA Z, 1988, J CARDIOVASC PHARM, V12, P505, DOI 10.1097/00005344-198811000-00002; WAINWRIGHT CL, 1988, BIOMED BIOCHIM ACTA, V47, pS224; WAINWRIGHT CL, 1989, EUR HEART J, V10, P235, DOI 10.1093/oxfordjournals.eurheartj.a059471	34	5	5	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	OCT-NOV	1998	39	1-2					115	123		10.1016/S0300-9572(98)00127-0			9	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	156FF	WOS:000077990400018	9918458				2022-02-06	
J	Lestage, P; Iris-Hugot, A; Gandon, MH; Lepagnol, J				Lestage, P; Iris-Hugot, A; Gandon, MH; Lepagnol, J			Involvement of nicotinergic mechanisms in thyrotropin-releasing hormone-induced neurologic recovery after concussive head injury in the mouse	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						TRH (thyrotropin-releasing hormone); trauma; nicotine; (mouse)	SPINAL-CORD INJURY; EXPERIMENTAL CEREBRAL CONCUSSION; MUSCARINIC AGONIST; CONTAINING NEURONS; TRH ANALOG; BRAIN; ACETYLCHOLINE; NORADRENALINE; RAT; N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE	A behavioral study was performed in an attempt to understand the neuronal mechanisms involved in the thyrotropin-releasing hormone (TRH)-induced improvement of consciousness after concussive head injury in the mouse. Intravenous administration of TRH dose dependently shortened the duration of unconsciousness after concussion in the mouse (ED50 = 3.2 mg/kg). The improvement of recovery evoked by TRH (3 mg/kg i.v.) after concussion was not affected by i.p. pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine, alpha-methyl-para-tyrosine, p-chlorophenylalanine, scopolamine or methylscopolamine. However, mecamylamine or hexamethonium i.p. pretreatment completely inhibited the TRH-induced improvement of outcome in traumatic brain injury. The results imply that TRH-induced improvement of recovery after concussion is not associated with increased activity of monoaminergic neurons in the brain. These results suggest that the inhibitory effect of TRH upon unconsciousness after concussion in mice is mainly produced by activation of central cholinergic systems via nicotinic receptors whereas muscarinic receptors seem to be not implicated. (C) 1998 Elsevier Science B.V. All rights reserved.	Inst Rech Servier, Div Cerebral Pathol, F-78290 Croissy Sur Seine, France		Lestage, P (corresponding author), Inst Rech Servier, Div Cerebral Pathol, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France.						ABDULLA FA, 1994, BEHAV BRAIN RES, V60, P161, DOI 10.1016/0166-4328(94)90143-0; AII H, 1986, NEUROL MED, V25, P254; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BREESE GR, 1975, J PHARMACOL EXP THER, V193, P11; BURGUS R, 1970, NATURE, V226, P321, DOI 10.1038/226321a0; COTT JM, 1976, J PHARMACOL EXP THER, V196, P594; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; DILSAVER SC, 1991, PROG NEURO-PSYCHOPH, V15, P539, DOI 10.1016/0278-5846(91)90029-Z; DOOLEY DJ, 1983, NEUROSCIENCE, V9, P889, DOI 10.1016/0306-4522(83)90277-4; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; GIOVANNINI MG, 1991, BRIT J PHARMACOL, V102, P363, DOI 10.1111/j.1476-5381.1991.tb12179.x; Goldstein DJ, 1991, J RENAL NUTR, V1, P9; GUIDOTTI A, 1974, NEUROPHARMACOLOGY, V13, P1115, DOI 10.1016/0028-3908(74)90061-6; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HEAL DJ, 1987, NEUROPHARMACOLOGY, V26, P313, DOI 10.1016/0028-3908(87)90183-3; HORITA A, 1986, ANNU REV PHARMACOL, V26, P311; HORITA A, 1976, PSYCHOPHARMACOLOGY, V49, P57; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; INTROINI IB, 1984, PSYCHOPHARMACOLOGY, V82, P107; JAIMETCHEVERRY G, 1980, BRAIN RES, V188, P513, DOI 10.1016/0006-8993(80)90049-9; JEQUIER E, 1967, MOL PHARMACOL, V3, P274; JONES BE, 1973, BRAIN RES, V58, P157, DOI 10.1016/0006-8993(73)90830-5; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; JOUVET M, 1972, ERG PHYSIOL BIOL CH, V64, P166; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; LAMOUR Y, 1985, BRAIN RES, V331, P343, DOI 10.1016/0006-8993(85)91560-4; LEE E T, 1972, Computer Programs in Biomedicine, V2, P315, DOI 10.1016/0010-468X(72)90019-0; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; MANAKA S, 1978, NEUROSCI LETT, V8, P255, DOI 10.1016/0304-3940(78)90131-3; MANAKA S, 1977, BRAIN NERV, V29, P1075; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; MATSUSHITA M, 1993, ARZNEIMITTELFORSCH, V43-2, P813; MAYER GS, 1983, J CHROMATOGR, V255, P533, DOI 10.1016/S0021-9673(01)88308-4; MCDONOUGH JH, 1995, PHARMACOL BIOCHEM BE, V51, P249, DOI 10.1016/0091-3057(94)00372-P; MIYAMOTO M, 1982, PHARMACOL BIOCHEM BE, V17, P797, DOI 10.1016/0091-3057(82)90363-X; Mushiroi Takeshi, 1996, Folia Pharmacologica Japonica, V107, P237, DOI 10.1254/fpj.107.237; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; OSWALD I, 1968, PHARMACOL REV, V20, P273; PRANGE AJ, 1972, LANCET, V2, P999; SANO K, 1979, ADV NEUROL SCI, V23, P184; SANTORI EM, 1981, PSYCHOPHARMACOLOGY, V74, P13, DOI 10.1007/BF00431749; SCHMIDT DE, 1977, COMMUN PSYCHOPHARMAC, V1, P469; SHREWSBURYGEE J, 1988, EXP BRAIN RES, V70, P342; USHIJIMA I, 1984, PSYCHOPHARMACOLOGY, V82, P301, DOI 10.1007/BF00427674; Westfall TC, 1973, FRONTIERS CATECHOLAM, P617, DOI 10.1016/B978-0-08-017922-3.50113-1; WINOKUR A, 1978, BRAIN RES, V150, P205, DOI 10.1016/0006-8993(78)90668-6; YAMAMOTO J, 1988, JPN J PHARMACOL, V47, P123, DOI 10.1254/jjp.47.123; YAMAMOTO M, 1989, NEUROPHARMACOLOGY, V28, P863, DOI 10.1016/0028-3908(89)90179-2; YAMAMOTO M, 1987, N-S ARCH PHARMACOL, V336, P561; YARBROUGH GG, 1979, PROG NEUROBIOL, V12, P291, DOI 10.1016/0301-0082(79)90012-1; YARBROUGH GG, 1976, NATURE, V263, P523, DOI 10.1038/263523a0; YARBROUGH GG, 1983, LIFE SCI, V33, P111, DOI 10.1016/0024-3205(83)90403-4	54	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	SEP 18	1998	357	2-3					163	169		10.1016/S0014-2999(98)00562-7			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	124PP	WOS:000076191100008	9797032				2022-02-06	
J	Ptak, R; Gutbrod, K; Schnider, A				Ptak, R; Gutbrod, K; Schnider, A			Association learning in the acute confusional state	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						confusional state; traumatic brain injury; post-traumatic amnesia	HEAD-INJURY	The usefulness of cognitive rehabilitative treatment in the acute stages after brain injury seems questionable because patients in severe acute confusional state early after coma clinically seem unable to learn and store new information. Therefore, the capability of patients in acute confusional state to learn and retain associative information was assessed. On two occasions pairs of simple nouns were presented to six patients in severe acute confusional state. Stimuli were presented repeatedly either in written form only or with additional pictorial representations. Immediate and 20 minutes delayed recall was measured. Patients in acute confusional state were able to learn progressively more word pairs across several presentations. They retained some information over an interval of 20 minutes. In addition, they learned and remembered pictorially supported associations better than pure verbal associations. Patients in severe acute confusional state may retain some explicit information and may profit from an imagery mnemonic aid. These results were not expected on the basis of clinical findings alone and they have potential implications for the care of patients in acute confusional state.	Univ Hosp Bern, Div Neuropsychol Rehabil, Dept Neurol, CH-3010 Bern, Switzerland		Ptak, R (corresponding author), Univ Hosp Bern, Div Neuropsychol Rehabil, Dept Neurol, CH-3010 Bern, Switzerland.		Ptak, Radek/A-8661-2010	Ptak, Radek/0000-0003-4708-9201; Gutbrod, Klemens/0000-0002-5723-3468			Adams RD, 1989, PRINCIPLES NEUROLOGY; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fuster J.M., 1995, MEMORY CEREBRAL CORT; GESCHWIND N, 1982, PHILOS T ROY SOC B, V298, P173, DOI 10.1098/rstb.1982.0080; KIRSHNER HS, 1986, BEHAV NEUROLOGY PRAC; Levin H. S., 1992, NEUROPSYCHOLOGY MEMO, P290; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; Paivio A., 1991, IMAGES MIND EVOLUTIO; SCHNIDER A, 1998, IN PRESS HUMAN FRONT; STRUB RL, 1988, NEUROBEHAVIORAL DISO; von Cramon D. Y., 1982, HIRNORGANISCHE PSYCH, P42; WILSON BA, 1992, CLIN MANAGEMENT MEMO, P121; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]	14	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	SEP	1998	65	3					390	392		10.1136/jnnp.65.3.390			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	114CX	WOS:000075592500024	9728959	Green Published, Bronze			2022-02-06	
J	Fujii, M; Fujita, K; Hiramatsu, H; Miyamoto, T				Fujii, M; Fujita, K; Hiramatsu, H; Miyamoto, T			Cases of two patients whose food aversions disappeared following severe traumatic brain injury	BRAIN INJURY			English	Article							TASTE	Following traumatic brain injury (TBI) the complete disappearance of food aversions was observed in the cases of two patients. In one of the cases, a young female, this change in her food aversion was manifested several months after the TBI, from the time when she was able to eat normally. The other patient, a young man, exhibited the disappearance of his food aversion immediately after recovery from his unconscious state following TBI. These results indicate that the disappearance of food aversions was a consequence of TBI.	Hamamatsu Univ Sch Med, Div Nursing, Hamamatsu, Shizuoka 43131, Japan; Mikatahara Seirei Hosp, Dept Neurosurg, Hamamatsu, Shizuoka 43131, Japan		Fujii, M (corresponding author), Hamamatsu Univ Sch Med, Div Nursing, 3600 Hnadacho, Hamamatsu, Shizuoka 43131, Japan.						Faber W, 1947, NERVENARZT, V18, P530; GALEF BG, 1990, HDB NEUROBIOLOGY, V10, P329; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; LEVIN J, 1992, BRAIN INJURY, V6, P99; LOGUE AW, 1981, BEHAV RES THER, V19, P319, DOI 10.1016/0005-7967(81)90053-X; Norgren R., 1990, HUMAN NERVOUS SYSTEM, P845; OGAWA H, 1994, NEUROSCI RES, V20, P1, DOI 10.1016/0168-0102(94)90017-5; PONSFORD J, 1995, TRAUMTIC BRAIN INJUR; RODIN PN, 1990, HDB BEHAV NEUROBIOLO, V10, P297; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; WOOD J, 1995, TRAUMATIC BRAIN INJU, P379; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3	13	5	5	1	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1998	12	8					709	713		10.1080/026990598122278			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	108AN	WOS:000075243800008	9724842				2022-02-06	
J	Gasquoine, PG				Gasquoine, PG			Historical perspectives on postconcussion symptoms	CLINICAL NEUROPSYCHOLOGIST			English	Article							MILD HEAD-INJURY	Self-reported symptoms that follow concussion without detectable structural brain injury have historically been described by a variety of syndromes. These syndromes are reviewed beginning with Erichsen's concept of spinal concussion and ending with Gronwall's finding of attentional deficits in the early stages after injury. The period covered is 1866 through 1974 and the syndromes reviewed include: traumatic neurasthenia (railway hysteria), vasomotorischen symptomencomplex, terror neurosis, head-wound syndrome, postcontusional syndrome, postconcussional syndrome, psychoneurosis, accident neurosis, and posttraumatic syndrome. These involved organic (structural brain injury), emotional (anxiety and depression), motivational (malingering),and personality (predisposing) explanations.	S Texas Neuropsychol, Corpus Christi, TX 78411 USA		Gasquoine, PG (corresponding author), S Texas Neuropsychol, 3857 S Staples, Corpus Christi, TX 78411 USA.						ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 1952, DIAGN STAT MAN MENT; [Anonymous], 1942, Proc R Soc Med, V35, P601; BARTELS C, 1996, CLASSIC CASES NEUROP, P53; Benton A. L, 1989, MILD HEAD INJURY, P3; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BOHENEN N, 1992, NEUROSURGERY, V30, P692; BOLTZ OH, 1932, J NERV MENT DIS, V75, P689; Broca, 1861, B SOC ANAT PARIS, V2, P398; CONKEY RC, 1938, ARCH PSYCHOL, V331, P1; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; Dana C. L., 1884, MED REC, V26, P617; Dana CL, 1920, ARCH NEURO PSYCHIATR, V4, P479, DOI 10.1001/archneurpsyc.1920.02180230002001; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; ERICHSEN JE, 1866, CONSCUSSION SPINE NE; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Friedmann M., 1892, ARCH PSYCHIAT, V23, P230; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; GRONWALL D, 1975, LANCET, V2, P995; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GUTTMANN E, 1946, J MENT SCI, V92, P1; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Holbourn AHS, 1943, LANCET, V2, P438; Horn P, 1916, Z GESAMTE NEUROL PSY, V34, P206, DOI 10.1007/BF02897080; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1972, LANCET, V1, P580; OOPPENHEIM H, 1889, TRAUMATISCHEN NEUROS; Page Herbert, 1883, INJURIES SPINE SPINA; PARKER N, 1970, MED J AUSTRALIA, V2, P580; Parkin A. J., 1993, NEUROPSYCHOLOGY AMNE; Rigler Johannes, 1879, FOLGEN VERLETZUNGEN; ROTCH TM, 1880, BOSTON MED SURG J, V102, P132; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; Strauss I, 1934, AM J PSYCHIAT, V91, P189, DOI 10.1176/ajp.91.1.189; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; SYMONDS CP, 1943, LANCET, V2, P7; SYMONDS CP, 1928, BRIT MED J, V1, P829; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON GN, 1965, AM J PSYCHIAT, V121, P1043, DOI 10.1176/ajp.121.11.1043; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; [No title captured]; 1934, J AM MED ASS, V102, P566	57	5	5	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	1998	12	3					315	324		10.1076/clin.12.3.315.1990			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	153UR	WOS:000077851600003					2022-02-06	
J	Gordon, I				Gordon, I			Cerebral imaging in paediatrics	QUARTERLY JOURNAL OF NUCLEAR MEDICINE			English	Article						brain radionuclide imaging; cerebrovascular circulation; child; neurology; psychiatry; neurosurgery	EMISSION COMPUTED-TOMOGRAPHY; TC-99M HMPAO SPECT; BLOOD-FLOW; BRAIN-DEATH; TECHNETIUM-99M-HMPAO; MIGRAINE; CHILDHOOD; CHILDREN; PALSY	Radioisotope brain imaging has focused mainly on regional cerebral blood flow (rCBF). However the use of Ligands which go to specific receptor sites is being introduced in paediatrics, mainly psychiatry. rCBF is potentially available in many institutions, especially with the availability of multi-headed gamma cameras. The use of this technique in paediatrics requires special attention to detail in the manner of data acquisition and handling the child. The interpretation of the rCBF study in a child requires knowledge of normal brain maturation. The major clinical use in paediatrics is epilepsy because of the advances in surgery and the frequency of complex partial seizures. Other indications in paediatric neurology include brain death, acute neurological loss including stroke, language disorders, cerebral palsy, hypertension due to renovascular disease, traumatic brain injury and migraine. There are paediatric psychological conditions in which rCBF has been undertaken, these include anorexia nervosa, autism, Gilles de la Tourette syndrome (GTS) and attention deficit disorder-hyperactivity (ADHD). Research using different ligands to specific receptor sites will also be reviewed in paediatrics.	Great Ormond St Hosp Children, London WC1N 3JH, England		Gordon, I (corresponding author), Great Ormond St Hosp Children, Great Ormond St, London WC1N 3JH, England.						Adelstein W, 1994, J Neurosci Nurs, V26, P118; AHONEN A, 1997, EUR J NUCL MED; BATTISTELLA PA, 1990, HEADACHE, V30, P646, DOI 10.1111/j.1526-4610.1990.hed3010646.x; BAULIEU JL, 1997, EUR J NUCL MED; CROSS JH, 1995, DEV MED CHILD NEUROL, V37, P673; CROSS JH, UNPUB EPILESIA; CROSS JH, 1996, IN PRESS J NEUROL NE; DELARIVA A, 1992, BRIT J RADIOL, V65, P289, DOI 10.1259/0007-1285-65-772-289; DENAYS R, 1989, J NUCL MED, V30, P1825; DENAYS R, 1992, J NUCL MED, V33, P485; DENAYS R, 1990, RADIOLOGY, V175, P111, DOI 10.1148/radiology.175.1.2315468; DENAYS R, 1993, J NUCL MED, V34, P1223; GEORGE MS, 1992, PSYCHIAT RES-NEUROIM, V45, P143, DOI 10.1016/0925-4927(92)90022-V; Gordon I, 1997, INT J EAT DISORDER, V22, P159; GORDON I, 1993, BRIT J RADIOL, V66, P971, DOI 10.1259/0007-1285-66-791-971; GOSHEN E, 1996, IN RPESS NUCL MED CO; KAPUCU LO, 1997, EUR J NUCL MED; MAINI CL, 1990, NUKLEARMED-NUCL MED, V29, P210; MOUNTZ JM, 1995, J NUCL MED, V36, P1156; Muttini P, 1994, J Nucl Biol Med, V38, P14; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; OTUAMA LA, 1993, SEMIN NUCL MED, V23, P255, DOI 10.1016/S0001-2998(05)80106-0; PELLETIER G, 1995, J AM ACAD CHILD PSY, V34, P297, DOI 10.1097/00004583-199503000-00013; PINTON F, 1995, P 2 EUR S PAED NUCL; PORTNOY O, 1997, J NUCL MED, V38, P291; RUBINSTEIN M, 1989, J NUCL MED, V30, P1982; RYU YH, 1997, J NUCL MED, V38, P284; SANPEDRO EC, 1997, J NUCL MED, V38, P13; SPIETH ME, 1994, CLIN NUCL MED, V19, P867, DOI 10.1097/00003072-199410000-00005; Spina A, 1992, Acta Neurol (Napoli), V14, P10; VALENZUELA H, 1995, P 2 EUR S PAED NUCL; VESTERGREN E, P 5 INT RAD DOS	32	5	5	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1125-0135			Q J NUCL MED	Q. J. Nucl. Med.	JUN	1998	42	2					126	132					7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	154NY	WOS:000077896200005	9695665				2022-02-06	
J	Stanislav, SW; Crismon, ML; Childs, NL				Stanislav, SW; Crismon, ML; Childs, NL			Cerebrospinal fluid monoamine metabolites and glucose metabolism in posttraumatic aggression	BIOLOGICAL PSYCHIATRY			English	Article						aggression; brain injury; CSF; monoamine; glucose; head injury	IMPULSIVE FIRE SETTERS; VIOLENT OFFENDERS; BEHAVIOR; SUICIDE	Background: This pilot study was conducted to determine if aggressive, post brain-injured patients have abnormal glucose metabolism or abnormal CSF monoamine metabolite concentrations as compared with non-aggressive, post brain-injured controls. Methods: Subjects with a history of traumatic brain injury underwent a lumbar puncture and glucose tolerance test after a three-week medication wash-out period Monoamine metabolite concentrations and glucose nadirs were compared between aggressive and control subjects. Results: There were no statistical differences between the aggressive (n = 4) and control (n = 6) group with respect To age (28.5 +/- 15.7 versus 28.0 +/- 10.8), weight (72.5 kg +/- 14.1 versus 67.7 kg +/- 10.1) or number of months since brain injury (31.8 +/- 26.1 versus 33.3 +/- 23.3). There were no significant differences between the two groups in glucose nadirs following oral glucose challenge or in levels of CSF monoamine metabolite concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), or 3-methoxy-4-hydroxyphenylglycol (MHPG), although a trend toward significance was noted between the MHPG groups (higher MHPG within aggressive group). Conclusions: The preliminary, data suggest that glucose metabolism and CSF monoamine metabolite concentrations do not differ significantly from aggressive subjects to controls in persons with brain injury. Follow-up prospective studies with larger sample sizes are needed to evaluate these preliminary findings. (C) 1998 Society of Biological Psychiatry.	Univ Texas, Coll Pharm, Austin, TX 78712 USA; Brown Sch Rehabil Ctr, Austin, TX USA		Stanislav, SW (corresponding author), Univ Texas, Coll Pharm, Austin, TX 78712 USA.						ASBERG M, 1986, PSYCHOBIOLOGY SUICID, P243; BALLENGER JC, 1979, ARCH GEN PSYCHIAT, V36, P224; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; LINNOILA M, 1992, J CLIN PSYCHOPHARM, V12, pS19; NINAN PT, 1984, AM J PSYCHIAT, V141, P566; ROY A, 1989, ARCH GEN PSYCHIAT, V46, P609; TRASKMANBENDZ L, 1986, PSYCHOBIOLOGY SUICID, P168; VANPRAAG HM, 1983, LANCET, V2, P977; VIRKKUNEN M, 1987, ARCH GEN PSYCHIAT, V44, P241; VIRKKUNEN M, 1989, ARCH GEN PSYCHIAT, V46, P600; VIRKKUNEN M, 1989, ARCH GEN PSYCHIAT, V46, P604; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	14	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	APR 15	1998	43	8					619	621		10.1016/S0006-3223(97)00405-8			3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	ZG854	WOS:000073046700009	9564449				2022-02-06	
J	Jordan, DL; Sanders, DE; Linscombe, SD; Williams, BJ				Jordan, DL; Sanders, DE; Linscombe, SD; Williams, BJ			Response of four rice (Oryza sativa) cultivars to triclopyr	WEED TECHNOLOGY			English	Article						triclopyr, [(3,5,6-trichloro-2-pyridinyl)oxy]acetic acid; rice, Oryza sativa L. 'Bengal', 'Cypress', 'Kaybonnet'; crop injury; herbicide tolerance		Experiments were conducted from 1994 through 1996 to determine the response of the rice cultivars 'Bengal,' 'Cypress,' 'Jodon,' and 'Kaybonnet' to triclopyr at 0.42 (standard rate) and 0.84 kg ai/ha applied postemergence at the four-leaf and panicle initiation stages of growth, applications at the four-leaf stage were made in close association with fertilization and flood establishment, which often increases the potential for triclopyr to injure rice. Visible injury from triclopyr was slightly higher for the cultivar Jodon than for the cultivars Bengal, Cypress, or Kaybonnet. Injury was 3% or less when triclopyr at 0.42 kg/ha was applied at panicle initiation regardless of the cultivar Triclopyr at 0.42 and 0.84 kg/ha applied at the four-leaf growth stage injured rice 7% and 22%, respectively. Triclopyr at 0.84 kg/ha applied at the four-leaf stage of growth delayed days from seedling emergence to seed head emergence and rice grain yield, irrespective of cultivar.	Louisiana State Univ, Ctr Agr, NE Res Stn, St Joseph, LA 71366 USA		Jordan, DL (corresponding author), N Carolina State Univ, Dept Crop Sci, Box 7620, Raleigh, NC 27695 USA.						BETY JD, 1993, P S WEED SCI SOC, V46, P91; Bollich P. K., 1996, Louisiana Agriculture, V39, P5; GUY CB, 1993, ARKANSAS AGR EX STN, V431, P65; GUY CB, 1994, ARKANSAS AGR EXP STN, V439, P43; GUY CB, 1995, ARKANSAS AGR EXPT ST, V446, P38; HELMS RS, 1994, P S WEED SCI SOC, V47, P214; HILL JE, 1990, PEST MANAGEMENT RICE, P314; 1997, CROP PROTECTION REFE; 1997, LOUISIANA COOPERATIV, V1565	9	5	5	0	0	WEED SCI SOC AMER	LAWRENCE	810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA	0890-037X			WEED TECHNOL	Weed Technol.	APR-JUN	1998	12	2					254	257					4	Agronomy; Plant Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Plant Sciences	104GE	WOS:000075005700009					2022-02-06	
J	Lehner, R; Maassen, MM; Muller, G; Leysieffer, H; Zenner, HP				Lehner, R; Maassen, MM; Muller, G; Leysieffer, H; Zenner, HP			An osseointegrated manipulator device for the positioning and fixation of implantable hearing aid transducers. Part 1: Adaptation to the surgical anatomy of the temporal bone and surgical aspects	HNO			German	Article						implantable hearing aid; ear; Tubingen implant; micromanipulator; temporal bone; intraoperative coupling; ossicular chain; TICA	MIDDLE-EAR; TERM	The first electronic implantable hearing aids for patients with hearing loss are coupled to the ossicular chain or perilymph during implantation and are now available. Our new Tubingen implant designed for sensorineural hearing loss (SNHL) is the combination of an implantable microphone and piezotransducer. To avoid hearing losses during implantation,the Tubingen piezotransducer will be (1) fixed to the mastoid cavity and (2) positioned to one of the ossicular target points. This can be done with a micromanipulator which will be implanted together with transducer and microphone in the mastoid cavity. The manipulator weights 0.7 g. With four degrees of freedom, it allows highly secure and safe positioning of the transducer's probe tip to the ossicular chain under close to stereotactic conditions. The main advantages of the present micromanipulator are (1) easy handling during surgery,(2) the transducer's precise positioning to the ossicular target point with sufficient degrees of freedom,and (3) the transducer's stable fixation in the mastoid cavity in the final position. Following integrated safety as the leading principle, ossicular or inner ear injuries caused, e.g., by the patient's head movement or unintentional manual contact by the surgeon,are minimized. The micromanipulator is, as it were, the surgeon's vibration-free"artificial hand."The manipulator's development and its optimization to the mastoid cavity by test implantation in 50 human temporal bones are shown in detail. While coupling the transducer to the body of the incus, transducer, micro phone, and micromanipulator can be implanted into 76% of all mastoid cavities without protrusion.In the case of transducers coupling to the long process of the incus,the protrusion-free implantation rate of the above-mentioned three implant modules is 78%.	Univ Tubingen, HNO Klin, D-72076 Tubingen, Germany		Lehner, R (corresponding author), Univ Tubingen, HNO Klin, Silcherstr 5, D-72076 Tubingen, Germany.						BALL G, 1995, Patent No. 07283; BALL G, 1995, Patent No. 01710; BALL G, 1996, 2 INT S EL IMPL OT G; DUMON T, 1995, OTOLARYNG CLIN N AM, V28, P173; FREDERICKSON JM, 1995, OTOLARYNG CLIN N AM, V28, P107; Hudde H., 1992, Audiologische Akustik, V31, P144; HUTTENBRINK KB, 1994, HNO, V42, P49; KO WH, 1995, OTOLARYNG CLIN N AM, V28, P29; Lehner R, 1998, HNO, V46, P27, DOI 10.1007/s001060050193; Lehner R, 1997, HNO, V45, P745, DOI 10.1007/s001060050152; LEHNER R, 1998, IN PRESS HNO, V46; Lehner RI, 1997, HNO, V45, P867, DOI 10.1007/s001060050165; Leysieffer H, 1997, HNO, V45, P801, DOI 10.1007/s001060050159; Maassen MM, 1998, HNO, V46, P220, DOI 10.1007/s001060050229; MAASSEN MM, 1997, UNPUB OPERATIONSTECH; MANIGLIA AJ, 1995, OTOLARYNG CLIN N AM, V28, P121; MANIGLIA AJ, 1988, ANN OTOL RHNOL S136, V97, P1; Suzuki J., 1988, ADV AUDIOL, V4, P1; SUZUKI J, 1988, ADV AUDIOL, V4, P160; Suzuki J. I., 1988, ADV AUDIOL, V4, P15; SUZUKI JI, 1995, OTOLARYNG CLIN N AM, V28, P99; YANAGIHARA N, 1995, OTOLARYNG CLIN N AM, V28, P85; Zenner HP, 1997, HNO, V45, P758, DOI 10.1007/s001060050154; Zenner HP, 1997, HNO, V45, P872, DOI 10.1007/s001060050166; Zenner HP, 1997, HNO, V45, P500; Zenner HP, 1997, HNO, V45, P769, DOI 10.1007/s001060050155; Zenner HP, 1997, HNO, V45, P749, DOI 10.1007/s001060050153	27	5	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0017-6192			HNO	HNO	APR	1998	46	4					311	323		10.1007/s001060050246			17	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	ZN527	WOS:000073654800007	9606645				2022-02-06	
J	Kronisch, RL				Kronisch, RL			Mountain biking injuries - Fitting treatment to the causes	PHYSICIAN AND SPORTSMEDICINE			English	Article							BICYCLE SAFETY HELMETS	Mountain bicyclists are subject to various traumatic and overuse injuries, Traumatic injuries range from minor abrasions and contusions to wrist fractures, shoulder injuries, and concussions, Helmet use is important in preventing serious head trauma, Many overuse injuries stem from improper bike fit, anatomic malalignments, and training errors, Treatment includes adjustments to the bike and modification of training habits, Included are tables regarding a variety of malalignments, related overuse injuries, and suggested bicycle adjustments, A companion article (page 71) provides guidance for doctors and patients on proper bike fit.	San Jose State Univ, Student Hlth Ctr, San Jose, CA 95192 USA		Kronisch, RL (corresponding author), San Jose State Univ, Student Hlth Ctr, 1 Washington Sq, San Jose, CA 95192 USA.						BARNETT B, 1993, WESTERN J MED, V159, P708; CHOW TK, 1993, WESTERN J MED, V159, P145; Chow TK, 1995, WILD ENVIRON MED, V6, P385, DOI 10.1580/1080-6032(1995)006[0385:DCBHPA]2.3.CO;2; HOLMES JC, 1995, LOWER EXPTREMITY SPI, P1559; HOLMES JC, 1991, CYCLING SCI, V3, P11; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Kronisch RL, 1996, AM J SPORT MED, V24, P88, DOI 10.1177/036354659602400116; KRONISCH RL, 1994, CLIN J SPORT MED, V4, P240; Le Bescond Y, 1992, Rev Stomatol Chir Maxillofac, V93, P185; LOVELL ME, 1992, INJURY, V23, P499, DOI 10.1016/0020-1383(92)90080-C; MELLION MB, 1994, CLIN SPORT MED, V13, P137; *NAT BIC DEAL ASS, 1997, 1996 97 STATP; *NAT OFF ROAD BIC, 1997, IN PRESS 1997 NORBA; PFEIFFER RP, 1995, SPORTS MED, V19, P311, DOI 10.2165/00007256-199519050-00002; PFEIFFER RP, 1994, CLIN SPORT MED, V13, P207; PFEIFFER RP, 1993, CYCLING SCI, V5, P21; RICHMOND DR, 1994, CLIN SPORT MED, V13, P165; Rivara FP, 1997, J FAM PRACTICE, V44, P481; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; WEISS BD, 1994, CLIN SPORT MED, V13, P175; Wilber RL, 1997, MED SCI SPORT EXER, V29, P1090, DOI 10.1097/00005768-199708000-00015	22	5	6	0	7	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	MAR	1998	26	3					64	70		10.1080/00913847.1998.11440349			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	YZ365	WOS:000072247100018	20086793				2022-02-06	
J	Medlar, T				Medlar, T			The sexuality education program of the Massachusetts Statewide Head Injury Program	SEXUALITY AND DISABILITY			English	Article						sexuality; education; traumatic brain injury		Traumatic brain injury (TBI) can create changes in a person's thinking and emotional self-control that can lead to unwanted and unsuccessful social behaviors. In some instances a person with a severe TBI may lose certain social abilities he or she may have once possessed, and might now show a lack of discretion or empathy or tact in their social behavior. Many individuals who were injured in childhood or adolescence might not have had sufficient opportunity to develop and refine adult socialization skills. These undeveloped, or diminished, social abilities are likely to affect an individual's sense of lovability and capability in terms of social and sexual relationships. Many persons with a TBI report a loss of pre-injury friendships, and increased loneliness and social isolation after an injury. Many individuals also report changes in their sexual drive, or sexual functioning, which additionally affect their ability to pursue intimate relationships, or successfully renegotiate changes in an existing intimate relationship. And yet, a person with a TBI will still experience normal human needs for closeness and affection, as well as normal sexual interests. Therefore, education and skill training and guidance are needed to assist the person with a TBI in making his or her best adjustment to these various changes and challenges. Also, some of the emotional and social challenges faced by the person with a TBI will be exhibited in his or her interactions with clinicians. So education and training is needed for staff as well in order for staff members to understand and respond to these behavioral concerns in an effective and skillful manner To meet these needs, the Massachusetts Statewide Head Injury Program implemented the Sexuality Education Program. This article describes the components of a comprehensive sexuality related staff training and client education program for a statewide network of residential and day treatment programs serving adults with TBI.			Medlar, T (corresponding author), 5 Taylor Way, Middleboro, MA 02346 USA.							0	5	5	0	5	HUMAN SCI PRESS INC	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0146-1044			SEX DISABIL	Sex. Disabil.	SPR	1998	16	1					11	19		10.1023/A:1023067630449			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	ZE153	WOS:000072763400004					2022-02-06	
J	Semlyen, JK; Barnes, MP				Semlyen, JK; Barnes, MP			The further validation and precision of the NIAF-R	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; SICKNESS IMPACT PROFILE; HEAD-INJURY; MEDICAL REHABILITATION; OUTCOMES EVALUATION; TBI REHABILITATION; MEASUREMENT TOOLS; FOLLOW-UP; RECOVERY; SYSTEM	It is essential that any tool which is measuring outcome following head injury is sensitive to change over time. The Newcastle Independence Assessment Form-Research (NIAF-R) has been developed to be appropriate and applicable both in the acute situation and in the long-term. This paper illustrates the NIAF-R's level of sensitivity to change over time from eight weeks through to one year postinjury. There were no ceiling effects demonstrated at follow-up. Such effects can be a problem with other comparable measures. In addition, the results of further concurrent validation with the Barthel index, are reported. The NIAF-R scoring is refined through the development of an Adjusted Severity Indicator for more stringent analysis of level of independence. Scoring can now provide data in 55 individual areas of function for each subject or alternatively give an overall measure of severity of functional independence. Finally, this paper demonstrates the ability of the NIAF-R to predict outcome at follow-up.	Univ Newcastle Upon Tyne, Hunters Moor Reg Rehabil Ctr, Acad Unit Neurol Rehabil, Newcastle Upon Tyne NE2 4NR, Tyne & Wear, England		Barnes, MP (corresponding author), Univ Newcastle Upon Tyne, Hunters Moor Reg Rehabil Ctr, Acad Unit Neurol Rehabil, Newcastle Upon Tyne NE2 4NR, Tyne & Wear, England.			SEMLYEN, JOANNA/0000-0001-5372-1344			BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bowers D., 1989, ARCH PHYS MED REHAB, V70, pA58; BROOKS N, 1984, CLOSED HEAD INJURY P; COLLIN C, 1987, INT J REHABIL RES, V10, P356; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS3; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC2; KEITH RA, 1984, ARCH PHYS MED REHAB, V65, P74; KEITH RA, 1987, ADV CLIN REHABILITAT, V11, P6; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; KNEIPP S, 1991, HEAD INJURY FAMILY M; Kolb B., 1990, FUNDAMENTALS HUMAN N; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MACKENZIE CR, 1986, J CHRON DIS, V39, P429, DOI 10.1016/0021-9681(86)90110-4; MAHONEY F I, 1965, Md State Med J, V14, P61; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Norman, 1995, HLTH MEASUREMENT SCA; NOVAK KT, 1991, J HEAD TRAUMA REHABI, V69, P69; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; POWELL GE, 1994, CLIN REHABIL, V8, P54; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYSICAL MED RE, V63, P18; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; *SANT CLAR VALL ME, FUNCT ASS MEAS; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Semlyen JK, 1996, J NEUROL REHABIL, V10, P251; Wade D T, 1988, Int Disabil Stud, V10, P64; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Willer B., 1993, BRAIN INJURY REHABIL, P355; [No title captured], DOI DOI 10.1177/026921559000400405	41	5	5	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1998	12	2					155	164		10.1080/026990598122782			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YV073	WOS:000071786900006	9492963				2022-02-06	
J	Yoon, KW; Fuse, T; Shah, PT; Nguyen, S; Klein, ML				Yoon, KW; Fuse, T; Shah, PT; Nguyen, S; Klein, ML			Indirect glutamate neurotoxicity	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; excitotoxicity; ischemia; toxin; trauma	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; NEURONAL APOPTOSIS; RAT; ATTENUATION; RECEPTORS; ADENOSINE; HYPOXIA; RELEASE	Indirect glutamate toxicity can be demonstrated by exposing dissociated rat hippocampal cultures to the media of the same culture transiently exposed (1 min) to glutamate (0.5 mM), The toxicity was maximum when the media was collected 5 min after the glutamate exposure. While the primary glutamate toxicity was attenuated by ionotropic glutamate receptor antagonists, the transferred, indirect toxicity was unaffected by the same antagonists. The changes in nuclear morphology indicated chromatin condensation and nuclear fragmentation in both primary and transferred toxicity, The stain for DNA damage by TUNEL method also revealed cells staining positive in both primary and transferred glutamate toxicity, These observations demonstrate that glutamate-induced neurotoxicity can be propagated to the uninjured cells by an unknown toxin released into the extracellular space, This neurotoxin induced both apoptosis and necrosis in cultured rat hippocampal cells.	St Louis Univ, Hlth Sci Ctr, Div Neurosurg, Dept Surg, St Louis, MO 63110 USA		Yoon, KW (corresponding author), St Louis Univ, Hlth Sci Ctr, Div Neurosurg, Dept Surg, 3635 Vista & Grand Blvd, St Louis, MO 63110 USA.						BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chopp M, 1996, STROKE, V27, P363, DOI 10.1161/01.STR.27.3.363; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; MITCHELL HL, 1995, NEUROSURGERY, V36, P1003, DOI 10.1227/00006123-199505000-00017; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; RINK A, 1995, AM J PATHOL, V147, P1575; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; Shah PT, 1997, NEUROSCIENCE, V79, P999, DOI 10.1016/S0306-4522(97)00013-4; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; STURM CD, 1993, J NEUROSURG, V79, P111, DOI 10.3171/jns.1993.79.1.0111; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; VANWINKLE WB, 1976, SCIENCE, V193, P1130, DOI 10.1126/science.959824; Yoon KW, 1996, STROKE, V27, P122, DOI 10.1161/01.STR.27.1.122; ZEEVALK GD, 1990, J PHARMACOL EXP THER, V253, P1285	23	5	8	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1998	15	2					141	147		10.1089/neu.1998.15.141			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YZ744	WOS:000072287300005	9512089				2022-02-06	
J	Stewart, DG; Miller, MA; Cifu, DX				Stewart, DG; Miller, MA; Cifu, DX			The role of subacute rehabilitation services after brain injury	NEUROREHABILITATION			English	Article						subacute rehabilitation; traumatic brain injury	HEAD-INJURY; INPATIENT REHABILITATION; AIRWAY COMPLICATIONS; AGITATION; MANAGEMENT; SPASTICITY; ADMISSION; RECOVERY; PATIENT; STROKE	Subacute rehabilitation is increasingly being used as a treatment option in the continuum of care. What constitutes subacute rehabilitation has not been uniformly defined. Therefore, considerable variability exists in subacute rehabilitation programs. This review outlines assessment and management of early recovery brain-injured individuals and offers a pragmatic schema for levels of care which are best suited to each recovery stage based on the Rancho Los Amigos cognitive scale. (C) 1998 Elsevier Science Ireland Ltd.	HealthSouth Rehabil Hosp Virginia, Richmond, VA 23226 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; HealthSouth Med Ctr, Rehabil Unit, Richmond, VA USA; Stuart Circle Hosp, Special Care Unit, Richmond, VA USA; AI Dupont Inst, Wilmington, DE USA; Virginia Commonwealth Univ, Med Coll Virginia, Rehabil & Res Ctr, Richmond, VA 23298 USA		Stewart, DG (corresponding author), HealthSouth Rehabil Hosp Virginia, 5700 Fitzhugh Ave, Richmond, VA 23226 USA.			Cifu, David/0000-0003-1600-9387			Altmayer T, 1996, ARCH PHYS MED REHAB, V77, P1093, DOI 10.1016/S0003-9993(96)90075-1; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BELL KR, 1995, NEUROREHABILITATION, V5, P233, DOI 10.3233/NRE-1995-5306; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; BOTTE MJ, 1995, ORTHOPEDICS, V18, P151; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Grossman P, 1996, DISABIL REHABIL, V18, P57, DOI 10.3109/09638289609166019; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HILL J, 1994, AM J OCCUP THER, V48, P219, DOI 10.5014/ajot.48.3.219; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KATZ RT, 1992, PHYS MED CLIN N AM, V3, P319; KEITH RA, 1995, ARCH PHYS MED REHAB, V76, P495, DOI 10.1016/S0003-9993(95)80501-X; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; MARKWALDER TM, 1989, J NEUROSURG, V25, P352; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; MILLER DD, 1990, REHABILITATION ADULT, P21; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; NOWAK P, 1987, AM J OTOLARYNG, V8, P91, DOI 10.1016/S0196-0709(87)80030-3; NUGENT JA, 1994, ARCH PHYS MED REHAB, V75, P399, DOI 10.1016/0003-9993(94)90162-7; ORZEL JA, 1985, J NUCL MED, V26, P125; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Pittenger D E, 1991, Orthop Rev, V20, P33; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; ROWLAND T, 1995, NEUROREHABILITATION, V5, P219, DOI 10.3233/NRE-1995-5305; SANDEL ME, 1995, NEUROREHABILITATION, V5, P299, DOI 10.3233/NRE-1995-5404; Sandel ME, 1996, NEUROREHABILITATION, V6, P9, DOI 10.3233/NRE-1996-6103; SINGER BR, 1993, BRIT J HOSP MED, V49, P247; Singer F R, 1995, Adv Endocrinol Metab, V6, P259; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Stern PH, 1971, STROKE, V2, P213, DOI 10.1161/01.STR.2.3.213; VANDONGEN KJ, 1980, NEUROSURGERY, V7, P14, DOI 10.1227/00006123-198007000-00003; Walker WC, 1996, BRAIN INJURY, V10, P65; WOO P, 1989, LARYNGOSCOPE, V99, P725; Wright RE, 1996, ARCH PHYS MED REHAB, V77, P1049, DOI 10.1016/S0003-9993(96)90067-2; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; ZAFONTE RD, 1996, NEUROREHABILITATION, V6, P1932; ZAFONTE RD, SLEEP DISTURBANCE TR	56	5	5	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JAN	1998	10	1					13	23		10.1016/S1053-8135(97)00041-3			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YV946	WOS:000071880300003	24525813				2022-02-06	
J	VanBalen, HGG; VanLimbeek, J; DeMey, HRA				VanBalen, HGG; VanLimbeek, J; DeMey, HRA			The identification of neurologically relevant items in the MMPI-2	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain damage; personality assessment; psychopathology; psychosocial functioning; rehabilitation	BRAIN INJURY	The assessment of personality and (mal) adjustment after brain damage is regarded as an important aspect of rehabilitation. However, the administration of widely used self-report questionnaires, such as the Minnesota Multiphasic Personality Inventory-2 (MMPI-2), is restricted because of the danger of overscoring psychopathology and personality disorders. This is due to the inclusion of items reflecting manifestations of neurological dysfunction. Earlier investigations revealed variable neurologically relevant items (NRIs), within and between discrete cerebral aetiologies for the MMPI as well as the first part of the MMPI-2. In this study, 10 neuropsychologists, 10 neurologists, 10 psychiatrists, and 10 physiatrists identified NRIs in the complete MMPI-2. An item was considered to be an NRI based on professional expertise as well as type of brain damage. Based on a substantial inter-rater agreement index, four sets of clinical relevant NRIs were selected: one for brain damage in general and three partially overlapping sets for stroke, traumatic brain damage, and whiplash. Thus, the findings of this study unveil items which may indicate bona fide symptoms or manifestations related to neurological damage or dysfunction, rather than just reflecting psychopathology or personality disorders. It is advocated to develop an interpretative approach to correct for the impact of these NRIs on MMPI-2 scores.	ST MAARTENSKLIN RES,NIJMEGEN,NETHERLANDS; ST MAARTENS CLIN,DIV REHABIL MED,NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN,DEPT CLIN & PERSONAL PSYCHOL,NIJMEGEN,NETHERLANDS		VanBalen, HGG (corresponding author), ST MAARTENSKLIN NMC,NIJMEGEN CTR MOTOR BEHAV & COGNIT,POB 9011,NL-6500 GM NIJMEGEN,NETHERLANDS.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Beck AT, 1987, BECK DEPRESSION INVE; Chelune G. J, 1986, NEUROPSYCHOLOGY HDB, P489; CLIFFORD DB, 1990, NEUROBIOL DIS, P86; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; DAVIS SW, 1977, ARCH PHYS MED REHAB, V58, P353; DERKSEN JJL, 1995, MMPI 2 HANDLEIDING B; Derogatis LR., 1983, SCL 90 R ADM SCORING; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; GASS CS, 1992, ARCH CLIN NEUROPSYCH, V7, P17, DOI 10.1016/0887-6177(92)90015-F; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P628; GRAHAM JR, 1993, MMPI 2 ASSESSING PER; Greene R. L, 1991, MMPI 2 MMPI INTERPRE; Kaemmer, 1989, MINNESOTA MULTIPHASI; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; Radanov BP, 1996, SPINE, V21, P392, DOI 10.1097/00007632-199602010-00029; SLOORE H, 1993, MMPI 2 VRAGENBOEKJE; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; TAYLOR GP, 1970, J CONSULT CLIN PSYCH, V35, P183, DOI 10.1037/h0030127; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009	26	5	5	0	0	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	1997	20	4					355	370		10.1097/00004356-199712000-00002			16	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	YK718	WOS:A1997YK71800002	9459102				2022-02-06	
J	Christensen, JR				Christensen, JR			Pediatric traumatic brain injury rehabilitation: challenges in care delivery	NEUROREHABILITATION			English	Article						pediatric traumatic brain injury; rehabilitation; transitions; development	MILD HEAD-INJURY; CHILDREN; ADOLESCENTS; SEQUELAE; POPULATION; RECOVERY	The provision of rehabilitation and long-term services to children and adolescents with traumatic brain injury is a challenge, in part related to the issues of growth and development. The needs of and the demands on the child change over time with different stages of development. This can be further complicated by the emergence of new deficits which often become apparent during transitions requiring more independent functioning. Additionally, changing models of care delivery and the need to improve efficiency and effectiveness of services present challenges for the systems providing services to these children and adolescents and their families. Communication and cooperation between and within these systems (medical and educational) must be optimal, to encourage appropriate, effective services and timely transitions. (C) 1997 Elsevier Science Ireland Ltd.			Christensen, JR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,707 N BROADWAY,BALTIMORE,MD 21205, USA.						ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BIJUR PE, 1990, PEDIATRICS, V86, P337; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CARNEY J, 1990, Pediatrician, V17, P222; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Committee on Pediatric Emergency Medicine, 1995, PEDIATRICS, V96, P526; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DISCALA D, 1992, AM J PHYS MED REHABI, V7, P145; DRUBACH DA, 1996, J REHABIL ADM, V20, P37; *EM MED SERV CHILD, 1996, COORD TRANS CARE CHI; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; JENNETT B, 1981, MANAGEMENT HEAD INJU, P89; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; KRAUS JF, 1987, PEDIATRICS, V79, P501; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pace GM, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199602000-00004; Rivara Frederick P., 1986, J HEAD TRAUMA REHAB, V1, P7; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Savage R.C., 1988, COGNIT REHABIL, V6, P10; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; YLVISAKER M, 1989, J HEAD TRAUMA REHAB, V4, P51	32	5	5	0	4	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	SEP	1997	9	2					105	112		10.1016/S1053-8135(97)00020-6			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XQ979	WOS:A1997XQ97900002	24526103				2022-02-06	
J	Tang, YP; Noda, Y; Hasegawa, T; Nabeshima, T				Tang, YP; Noda, Y; Hasegawa, T; Nabeshima, T			Effects of VA-045 on learning and memory deficits in traumatic brain injury (TBI)-induced retrograde and anterograde amnesic mice	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						traumatic brain injury (TBI); learning; retention; anterograde amnesia; retrograde amnesia; VA-045	CEREBRAL BLOOD-FLOW; HEAD-INJURY; LONG-TERM; APOVINCAMINIC ACID; AMINO-ACIDS; RATS; VINPOCETINE; BINDING; RELEASE	1 No specific regimen has been developed to treat post-traumatic amnesia in man. In the present study, we examined the effects of (+)-eburnamenine-14-carboxylic acid (2-nitroxyethyl) ester (VA-045), a novel derivative of apovincaminic acid, on learning and memory deficits associated with a mild traumatic brain injury (TBI) in mice. 2 Two kinds of amnesia, TBI-induced retrograde amnesia (TRA) and anterograde amnesia (TAA), were produced by means of post- and pre-acquisition head injury, respectively, by a simple weight-drop device. A novel procedure of water-finding task was used to assess learning and memory functions. 3 Both TRA and TAA mice were dramatically impaired in the task performance, with prolonged latencies for finding and drinking in either retention test or retest, indicating that retention was impaired in TRA mice while learning and retention were impaired in TAA mice. 4 VA-045 administered 30 min post-trauma in TRA mice dramatically shortened the prolonged latencies for finding and drinking in both retention test and retest, indicating that VA-045 significantly improved the retention deficit observed in TRA mice. 5 VA-045 administered 30 min post-trauma in TAA mice dramatically attenuated the prolonged latencies for finding and drinking in both retention test and retest, indicating that VA-045 significantly improved the learning and retention deficits observed in TAA mice. 6 Administration of VA-045 30 min pre-trauma in normal mice markedly attenuated the delay of latencies for finding and drinking after trauma in both retention test and retest, which shows that VA-045 significantly prevented learning and retention deficits after TBI. 7 Motor activities were not significantly affected by either the TBI or the chemical treatment at the time of task examination in either experimental model. 8 It is concluded that VA-045 may have potential effects on learning and memory deficits observed in either TBI-induced retrograde or anterograde amnesia.	NAGOYA UNIV,SCH MED,DEPT NEUROPSYCHOPHARMACOL & HOSP PHARM,NAGOYA,AICHI 466,JAPAN				Tang, Ya-Ping/A-1035-2011				BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gabri e C., 1985, PROC 5 INT CORAL REE, V1, P1; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAYES RL, 1989, MILD HEAD INJURY, P54; KANEKO S, 1991, EUR J PHARM-MOLEC PH, V207, P119, DOI 10.1016/0922-4106(91)90086-W; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; KISS B, 1991, EUR J PHARMACOL, V209, P109, DOI 10.1016/0014-2999(91)90019-M; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MCLEAN A JR, 1991, Brain Injury, V5, P375, DOI 10.3109/02699059109008110; MISKOLCZI P, 1990, EUR J DRUG METAB PH, V15, P1; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; NABESHIMA T, 1993, METHODS NEUROSCIENCE, V14, P217; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OGAWA S, 1992, CLIN NEUROPHARMAC B, V15, pB563; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OKUYAMA S, 1994, GEN PHARMACOL, V25, P1311; OTOMO E, 1985, CURR THER RES CLIN E, V37, P811; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RISCHKE R, 1991, JPN J PHARMACOL, V56, P349, DOI 10.1254/jjp.56.349; Russell WR, 1935, LANCET, V2, P762; RUTHERFORD WH, 1977, LANCET, V1, P1; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Squire L. R., 1984, NEUROBIOLOGY LEARNIN, P3; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; TANG YP, 1997, IN PRESS J NEUROTRAU; TANG YP, 1997, IN PRESS EUR J NEURO; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	37	5	5	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0007-1188			BRIT J PHARMACOL	Br. J. Pharmacol.	SEP	1997	122	2					257	264		10.1038/sj.bjp.0701385			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XW039	WOS:A1997XW03900010	9313933	Bronze, Green Published			2022-02-06	
J	Persinger, MA				Persinger, MA			Depression following brain trauma is enhanced in patients with mild discrepancies between intelligence and impairment on neuropsychological scores	PERCEPTUAL AND MOTOR SKILLS			English	Article								Analysis of the MMPI (Minnesota Multiphasic Personality Inventory) scores from 135 (20 years to 60 years old) patients who had sustained closed head injuries supported the hypothesis df a nonlinear relationship between the severity of depression and the magnitude of the discrepancy between intelligence and neuropsychological proficiency. Although the MMPI Depression T scores for all groups of patients were elevated (M=78, SD=13), patients with the least and greatest discrepancies between intelligence and neuropsychological proficiency scored lower on Depression than patients with discrepancies within the z-score ranges -2.0 and -1.1. The results of symmetrical covariance for either depression or complex partial epileptic-like experiences before comparisons between groups suggested depression and the epileptic-like experiences share the same source of variance.			Persinger, MA (corresponding author), LAURENTIAN UNIV,CLIN NEUROPSYCHOL LAB,SUDBURY,ON P3E 2C6,CANADA.						BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; PERSINGER MA, 1995, PSYCHOL REP, V77, P7074; PERSINGER MA, UNPUB PERCEPTUAL MOT; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; VINCENT KR, 1984, MMPI 168 CODEBOOK	5	5	5	0	2	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	1997	84	3	2				1284	1286		10.2466/pms.1997.84.3c.1284			3	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	XK332	WOS:A1997XK33200028	9229447				2022-02-06	
J	Pop, E; Soti, F; Biegon, A; Brewster, ME				Pop, E; Soti, F; Biegon, A; Brewster, ME			Allylic and phenolic phosphate esters of dexanabinol	ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL			English	Article							CLOSED-HEAD INJURY; NMDA ANTAGONIST; HU-211; RECEPTOR; RAT		PHARMOS CORP, IL-76326 REHOVOT, ISRAEL		Pop, E (corresponding author), PHARMOS CORP, 2 INNOVAT DR, ALACHUA, FL 32615 USA.						BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; GAJDA T, 1976, SYNTHESIS-STUTTGART, P243; MECHOULAM R, 1990, TETRAHEDRON-ASYMMETR, V1, P315, DOI 10.1016/S0957-4166(00)86322-3; Pop E, 1996, PHARMACEUT RES, V13, P469, DOI 10.1023/A:1016017331353; Pop E, 1996, PHARMACEUT RES, V13, P62, DOI 10.1023/A:1016025216390; POP E, 1995, SYNTHETIC COMMUN, V25, P4099, DOI 10.1080/00397919508011488; POP E, 1995, P 1 WORLD M PHARM BI, P127; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I	13	5	5	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0030-4948	1945-5453		ORG PREP PROCED INT	Org. Prep. Proced. Int.	JUN	1997	29	3					341	347		10.1080/00304949709355209			7	Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Chemistry	WW621	WOS:A1997WW62100013					2022-02-06	
J	Ueda, M; Watanabe, N; Ushikubo, Y; Kasai, K; Tsuzuki, T; Aoki, K; Yamazaki, Y; Samejima, H				Ueda, M; Watanabe, N; Ushikubo, Y; Kasai, K; Tsuzuki, T; Aoki, K; Yamazaki, Y; Samejima, H			The effect of hypothermia on CSD propagation in rats	NEUROLOGICAL SURGERY			Japanese	Article						CSD; rCBF; hypothermia; secondary brain injury; prevention	CORTICAL SPREADING DEPRESSION; MIDDLE CEREBRAL-ARTERY; CONCUSSIVE BRAIN INJURY; AMINO-ACIDS; MILD HYPOTHERMIA; FOCAL ISCHEMIA; BLOOD-FLOW; RELEASE; OCCLUSION; GLUTAMATE	In the cortical zone surrounding an ischemic or traumatic focus, CSD is a transient phenomenon involving interstitial ions, blood flow and metabolism and is believed to be completely reversible. However, it may extend to secondary brain injuries because CSD releases excitatory amino acids into the extracellular space. In order to prevent secondary brain injuries, it may be effective to block repeated CSD. This study was designed to determine whether hypothermia can block CSD propagation and whether this study is a potentially useful means for preventing secondary brain injuries. Male wistar rats weighing 270g on average were used for the experiments. The animals were divided into two groups: hypothermic rats (33.5-34 degrees C, rectal temp.) and normothermic rats (37-37.5 degrees C) The changes in rCBF (regional Cerebral Blood Flow) monitored in order to observe CSD. LDF (Laser Doppler Flowmetry) was used to measure rCBF. The two LDF probes were placed on the parietal cortex (4mm apart). To elicit CSD, a needle stab injury was made on the cortex or a piece of paper soaked with 10% KCl was applied on the cortex. The velocity of CSD propagation was more prolonged in the hypothermic rats than in the normothermic rats (p < 0.01). There were smaller numbers of repeated CSD in the hypothermic rats than in the normothermic rats. Histological examination of the cerebral cortex revealed shrinkage neurons more distinctly in the normothermic rats than in hypothermic rats. From these results, we can speculate that hypothermia may block CSD propagation and that hypothermic therapy has the potential to prevent secondary brain injuries.									BURES J, 1974, INITIATION SPREADING, P26; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; CHEN Q, 1993, J CEREBR BLOOD F MET, V13, P389, DOI 10.1038/jcbfm.1993.52; DIETRICH WD, 1991, ACTA NEUROPATHOL, V81, P615, DOI 10.1007/BF00296371; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; HANSEN AJ, 1984, AN ACAD BRAS CIENC, V56, P457; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HAYASHI N, 1993, ADV NEUROTRAUMA RES, V5, P61; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KARIBE H, 1994, J NEUROSURG, V80, P112, DOI 10.3171/jns.1994.80.1.0112; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; MIES G, 1984, ANN NEUROL, V16, P232, DOI 10.1002/ana.410160212; MIES G, 1994, J CEREBR BLOOD F MET, V14, P802, DOI 10.1038/jcbfm.1994.100; MRAOVITCH S, 1992, CEPHALALGIA, V12, P137, DOI 10.1046/j.1468-2982.1992.1203137.x; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; ROSENTHAL M, 1973, J NEUROPHYSIOL, V36, P739, DOI 10.1152/jn.1973.36.4.739; ROSENTHAL M, 1982, HEAD INJURY BASIC CL, P69; SHIBATA M, 1990, BRAIN RES, V530, P267, DOI 10.1016/0006-8993(90)91294-Q; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SOMJEN GG, 1992, CAN J PHYSIOL PHARM, V70, pS248, DOI 10.1139/y92-268; Strong AJ, 1996, J CEREBR BLOOD F MET, V16, P367, DOI 10.1097/00004647-199605000-00003; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0	30	5	5	0	0	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	JUN	1997	25	6					523	528					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XJ014	WOS:A1997XJ01400005	9181589				2022-02-06	
J	Krauss, JK; Jankovic, J				Krauss, JK; Jankovic, J			Hemidystonia secondary to carotid artery gunshot injury	CHILDS NERVOUS SYSTEM			English	Article						gunshot injury; hemidystonia; posttraumatic movement disorder; stereotactic surgery	HEAD TRAUMA; DYSTONIA	A 9-year-old boy was accidentally shot at close range with a pistol. The bullet entered through the left anterior neck and severed the left common carotid artery. Emergency surgery was performed with an end-to-end anastomosis. He recovered gradually from severe right-sided hemiparesis. CT scans demonstrated left parietal infarction. Within months he developed right hemidystonia, which progressed over the next few years. The movement disorder was refractory to medical therapy. MR scans showed a large demarcated defect in the left parietal lobe extending to the occipital lobe, to the insula and to the posterior ventral putamen. At age 18 the patient underwent a staged left-sided thalamotomy. The hemidystonia improved postoperatively but later partially recurred.	BAYLOR COLL MED,DEPT NEUROSURG,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030								ANDREW J, 1982, J NEUROL NEUROSUR PS, V45, P560, DOI 10.1136/jnnp.45.6.560-a; BOTENELLI MD, 1967, ACTA NEUROL LATINOAM, V13, P249; CARDOSO F, 1995, NEUROSURGERY, V36, P501, DOI 10.1227/00006123-199503000-00009; DSA AAB, 1996, ARTERIAL SURG, P459; FACTOR SA, 1988, MOVEMENT DISORD, V3, P201, DOI 10.1002/mds.870030304; HAWKER K, 1990, MOVEMENT DISORD, V5, P219, DOI 10.1002/mds.870050306; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; Jankovic J, 1993, PARKINSONS DIS MOVEM, P337; Krauss JK, 1996, NEUROLOGY, V47, P1488, DOI 10.1212/WNL.47.6.1488; KRAUSS JK, 1991, NEUROLOGY, V41, P1519, DOI 10.1212/WNL.41.9.1519; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; RICH NM, 1986, EXTRACRANIAL CEREBRO, P319; Scott BL, 1996, NEUROLOGY, V46, P68, DOI 10.1212/WNL.46.1.68; UNGER SE, 1980, SURGERY, V97, P477	18	5	5	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	MAY	1997	13	5					285	288		10.1007/s003810050085			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XK316	WOS:A1997XK31600011	9224919				2022-02-06	
J	Ling, JS; Evans, RW				Ling, JS; Evans, RW			The influence of outcome studies on rehabilitation policy	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						managed care; medical ethics; neurorehabilitation; traumatic brain injury	TRAUMATIC BRAIN INJURY; CARE	A terrific collaborative opportunity exists today for providers and payers of neurorehabilitation services to benefit from one another's initiatives and creativity. That opportunity will be realized when providers and papers candidly address each others' business and clinical missions and also issues of societal and moral obligations (ie, ethical concerns). To date, these discussions have been limited or nonexistent. Substantial existing data document the clinical effectiveness of neurorehabilitation services, which, in an era of managed health care, provide a financial opportunity for the payer community. This article presents a framework by which providers and payers of neurorehabilitation services can initiate discussions and reap mutual benefits.	LEARNING SERV CORP,DURHAM,NC; UNIV N CAROLINA,SCH MED,CHAPEL HILL,NC		Ling, JS (corresponding author), LEARNING SERV CORP MIDWETERN REG,1424 HIGH POINT RD,MIDDLETON,WI 53562, USA.						*AM PSYCH ASS, 1992, ETH PRINC PSYCH; Ashley M. J., 1993, J HEAD TRAUMA REHAB, V8, P30; BANJA J, 1994, ARCH PHYS MED REHAB, V75, P19; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Bush G. W., 1990, J HEAD TRAUMA REHAB, V5, P47; CERVELLI L, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199502000-00010; Cope D., 1993, J HEAD TRAUMA REHAB, V8, P1; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Evans R W, 1991, J Insur Med, V23, P192; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; FORD GT, 1986, J MARKETING, V50, P82, DOI 10.2307/1251587; GARDNER DM, 1975, J MARKETING, V39, P40, DOI 10.2307/1250801; GERVASIO AH, 1996, TRAUM BRAIN INJ MOD; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HALL KM, 1994, ARCH PHYSICAL MED RE, V75, P10; *HEAD INJ FDN, 1992, NAT DIR HEAD INJ REH; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; Jones M L, 1992, J Insur Med, V24, P186; KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; *LEARN SERV, 1989, OUTC VAL SYST; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MELIA RP, 1996, TRAUM BRAIN INJ MOD; *NAT HEAD INJ FDN, 1996, NAT HEAD INJ FDN RES; *NAT HEAD INJ FDN, 1992, ETH MARK SERV DEL PR; NINOMIYA J, 1995, TRAUMATIC BRAIN INJU; PAPASTRAT LA, 1992, J HEAD TRAUMA REHAB, V7, P11; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; REEDER K, 1996, TRAUM BRAIN INJ MOD; ULICNY G, 1994, J HEAD TRAUMA REHAB, V9, P73; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9	32	5	5	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1997	12	1					51	59		10.1097/00001199-199702000-00009			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WG280	WOS:A1997WG28000009					2022-02-06	
J	Marciani, RD; Israel, S				Marciani, RD; Israel, S			Diagnosis of blunt carotid injury in patients with facial trauma	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY			English	Article							ARTERY	Objectives. The purpose of this study was to review the clinical and diagnostic findings associated with blunt carotid artery injury, provide information related to clinical outcome, and report the findings of a retrospective study comparing patients with nonpenetrating and penetrating carotid artery injuries and the attendant facial injuries. Study design. Twenty-one patients admitted to the hospital nonelectively with a subsequent diagnosis of penetrating (11 patients) or nonpenetrating (10 patients) carotid artery injuries were included in the study. Records were analyzed for demographic data, mechanism of injury and time to diagnosis, neurologic status, presence of facial injuries, and outcome. Results. Five patients had facial injuries associated with a blunt carotid artery abnormality; six patients had penetrating carotid wounds. Time from carotid injury by all mechanisms to diagnosis was 20 minutes to 12 hours (mean 4 hours). Seventeen patients survived their injury. Conclusion. Patients with completely asymptomatic head injuries and severe closed-head injuries must be given careful initial evaluation and subsequent secondary evaluation. The relatively high frequency of facial injuries associated with blunt carotid injury should alert the maxillofacial surgeon to consider the diagnosis.			Marciani, RD (corresponding author), UNIV KENTUCKY, COLL DENT, DIV ORAL & MAXILLOFACIAL SURG, 800 ROSE ST, LEXINGTON, KY 40536 USA.						ABAD C, 1993, J CARDIOVASC SURG, V34, P507; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; FAKHRY S M, 1988, Journal of Vascular Surgery, V8, P501, DOI 10.1067/mva.1988.avs0080501; GOODWIN JR, 1994, J TRAUMA, V37, P119, DOI 10.1097/00005373-199407000-00021; HELLNER D, 1993, J CRANIO MAXILL SURG, V21, P234, DOI 10.1016/S1010-5182(05)80039-3; Hickman A M, 1992, J Tenn Med Assoc, V85, P327; KETCHAM AS, 1965, AM J SURG, V110, P649, DOI 10.1016/0002-9610(65)90055-3; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; LI MS, 1994, J TRAUMA, V36, P265, DOI 10.1097/00005373-199402000-00025; LLOYD J, 1971, AM J SURG, V122, P549, DOI 10.1016/0002-9610(71)90486-7; MARTIN RF, 1991, J VASC SURG, V14, P789, DOI 10.1067/mva.1991.32076; PRETRE R, 1994, SURGERY, V115, P375; UNGER SW, 1980, SURGERY, V87, P477	14	5	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1079-2104			ORAL SURG ORAL MED O	Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.	JAN	1997	83	1					5	9		10.1016/S1079-2104(97)90082-2			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	WD102	WOS:A1997WD10200006	9007915				2022-02-06	
J	Picard, P; Waleckx, P; BonnardGougeon, M; Sinardet, D; Lemaire, JJ; Chazal, J				Picard, P; Waleckx, P; BonnardGougeon, M; Sinardet, D; Lemaire, JJ; Chazal, J			Intracranial pressure monitoring in France, Belgium and Switzerland, a retrospective and prospective survey.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	18th French Language Conference on Neuroanesthesia and Reanimation	NOV 21-22, 1996	CLERMONT FERRA, FRANCE			intracranial pressure; monitoring; survey		Objective: To assess the use of ICP monitoring in France and French-speaking Belgium and Switzerland. Participants: Neuro-intensive care unit (ICU) and neuroanaesthesia teams. Methods: Retrospective survey (concerning the year 1995), followed by a prospective one (spread over a period of 4 months in 1996) about policy concerning: frequency, delay, duration, indications, complications and cost of ICP monitoring in their units. Other questions were: type of devices, duration of the device insertion, operators and place of operating. Results: Out of the 77 units which replied, 54 regularly carried out ICP monitoring, corresponding to a total of 2,012 patients in 1995. Only 23 participated in the prospective survey (301 patients). Out of the 54 hospitals, 25 assessed the ICP in more than 50 patients per year. Head trauma was the main indication for ICP monitoring (61%), the second indication was intracranial haemorrhage (23% of patients). The most often monitored patients were young males for head trauma, whereas females were mainly monitored for intracranial haemorrhage. The delay for starting ICP monitoring was 16 hours and was maintained for 7 days in head trauma patients. Intraventricular catheter and fibreoptic devices were chosen in the same proportion, a subdural system was used in 8% of the cases. The devices were inserted by neurosurgeons in 80% of cases, anaesthetists also participated in this operation. Risk of haemorrhage was very low (0.7%), the risk of infection was 4% and always concerned intraventricular catheters. Conclusion: ICP monitoring is widely practised in France and French-speaking Belgium and Switzerland, especially for traumatic brain injury in young males. Anaesthetists mainly took part in the operation, especially for the fibreoptic devices.			Picard, P (corresponding author), HOP FONTMAURE,CHRU,DEPT ANESTHESIE REANIMAT,F-63407 CHAMALIERES,FRANCE.						ALBERTI R, 1993, INTRACRANIAL PRESSUR, V8, P519; AVEZAAT CJJ, 1993, INTRACRANIAL PRESSUR, V8; BOULARD G, 1994, C ACT C NAT AN REAN, P25; LEMAIRE JJ, 1994, COMPUT METH PROG BIO, V42, P1, DOI 10.1016/0169-2607(94)90133-3; Lemaire JJ, 1994, INTRACRANIAL PRESSUR, VIX, P184; LEMAIRE JJ, 1994, INTRACRANIAL PRESSUR, V9, P498; Melon E, 1988, Agressologie, V29, P333; MELON E, 1995, REANIMATION NEUROLOG, P53; MILLER JD, 1989, INTRACRANIAL PRESSUR, V7; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046	10	5	6	0	0	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	141 RUE JAVEL, 75747 PARIS, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1997	16	4					420	428		10.1016/S0750-7658(97)81474-8			9	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	XF746	WOS:A1997XF74600016	9750593				2022-02-06	
J	Rosenberg, NL; Sharp, CW				Rosenberg, NL; Sharp, CW			Solvent toxicity: A neurological focus	SUBSTANCE USE & MISUSE			English	Article						inhalants; toxicity; central nervous system; treatment		Adverse acute and reversible health effects related to inhalant use and, solvent inhalation can occur from effects on heart, lung, kidney, liver, skeletal muscle, and brain. Chronic inhalant use may lead to chronic central nervous system dysfunction. Magnetic resonance imaging (MRI) shows that organic solvents primarily effect the white matter. Despite anatomic brain pathology, significant improvement can occur and aggressive therapeutic intervention similar to that used in traumatic brain injury should be encouraged.			Rosenberg, NL (corresponding author), INT INST INHALANT ABUSE,450 W JEFFERSON AVE,ENGLEWOOD,CO 80110, USA.							0	5	5	0	0	MARCEL DEKKER INC	NEW YORK	270 MADISON AVE, NEW YORK, NY 10016	1082-6084			SUBST USE MISUSE	Subst. Use Misuse		1997	32	12-13					1859	1864		10.3109/10826089709035594			6	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	YF362	WOS:A1997YF36200041					2022-02-06	
J	Sgouros, S; Williams, B				Sgouros, S; Williams, B			A critical appraisal of pediculated omental graft transposition in progressive spinal cord failure	BRITISH JOURNAL OF NEUROSURGERY			English	Article						omental graft transposition; paraplegia; post-traumatic syringomyelia; revascularization; spinal cord injury	CHRONIC TRAUMATIC PARAPLEGIA; MYELO-SYNANGIOSIS; MOYAMOYA DISEASE; INTACT OMENTUM; MANAGEMENT; BRAIN; REVASCULARIZATION; VASCULARIZATION; TRANSPLANTATION	A critical review of patients who had pediculated omental grafting for progressive spinal cord failure was performed in order to assess the impact of this procedure on the natural history of the spinal cord function after spinal cord injury. Ten patients were reviewed; all had complete or partial paraplegia. Mean age at injury was 29.1 years. There was an average interval of 9.7 years between injury and onset of progressive worsening of symptoms, and 5.6 years between onset of such symptoms and diagnosis. Average follow-up was 24.5 months. Five patients underwent omental grafting as primary surgical treatment whereas the other five had earlier procedures. One patient died in the postoperative period. Significant morbidity was also observed. All the surviving patients were asked to score themselves by answering a questionnaire exploring the effect of surgery in limb function and performance on activities of daily living. Only two patients improved following the procedure. Two others remained unchanged, while the remaining six continued to deteriorate. There was no difference in clinical outcome between the primary surgery group and the ones that had had previous procedures. Delayed omental grafting done as tried in this clinic did not seem to improve the prognosis of the injured cord and was associated with significant morbidity.	MIDLAND CTR NEUROSURG & NEUROL,BIRMINGHAM,W MIDLANDS,ENGLAND				Sgouros, Spyridon/AAH-1361-2020	Sgouros, Spyridon/0000-0003-4615-0808			ABRAHAM J, 1987, PARAPLEGIA, V25, P44, DOI 10.1038/sc.1987.12; BURKOV IV, 1993, KHIRURGIIA, V2, P43; DELATORRE JC, 1990, ACTA NEUROCHIR, V102, P152, DOI 10.1007/BF01405432; DELATORRE JC, 1990, OMENTUM RES CLIN APP, P63; Goldsmith H S, 1987, Br J Neurosurg, V1, P359, DOI 10.3109/02688698709023778; Goldsmith H S, 1987, Br J Neurosurg, V1, P463, DOI 10.3109/02688698708999637; GOLDSMITH HS, 1979, STROKE, V10, P471, DOI 10.1161/01.STR.10.4.471; GOLDSMITH HS, 1986, PARAPLEGIA, V24, P173, DOI 10.1038/sc.1986.23; GOLDSMITH HS, 1994, NEUROL RES, V16, P159; GOLDSMITH HS, 1985, PARAPLEGIA, V23, P100, DOI 10.1038/sc.1985.18; GOLDSMITH HS, 1975, AM J SURG, V129, P262, DOI 10.1016/0002-9610(75)90236-6; GOLDSMITH HS, 1973, ARCH SURG-CHICAGO, V106, P695; Goldsmith HS, 1990, OMENTUM RES CLIN APP; Goldsmith HS, 1990, OMENTUM RES CLIN APP, P45; HAVLIK RJ, 1992, SURGERY, V111, P156; *JAP ORTH ASS, 1975, J JPS ORTHOP ASS, V49; KAKOULAS BA, 1984, CNS TRAUMA, V1, P117; KARASAWA J, 1993, J NEUROSURG, V79, P192, DOI 10.3171/jns.1993.79.2.0192; MAFAEL H, 1991, MUNDO MEDICO, V18, P43; MASUMORI Y, 1992, SURG NEUROL, V38, P411, DOI 10.1016/0090-3019(92)90108-Y; MCINTOSH TK, 1990, OMENTUM RES CLIN APP, P75; MOLINA H, 1991, PARAPLEGIA, P33; NAGASHIMA C, 1991, Neurological Surgery, V19, P309; NeilDwyer G, 1996, BRIT J NEUROSURG, V10, P133, DOI 10.1080/02688699650040269; RAFAEL H, 1992, ACTA NEUROCHIR, V114, P145, DOI 10.1007/BF01400604; RAFAEL H, 1991, MUNDO MEDICO, V18, P11; Sgouros S, 1996, J NEUROSURG, V85, P197, DOI 10.3171/jns.1996.85.2.0197; SGOUROS S, 1995, J NEUROSURG, V82, P1, DOI 10.3171/jns.1995.82.1.0001; TIBLIEV GS, 1994, ZH VOPR NEIROKHIR IM, V2, P27; TIGLIEV GS, 1994, ZH VOPR NEIROKHIN IM, V2, P27; Williams B., 1995, OPERATIVE NEUROSURGI, P2119; ZHAN MS, 1990, OMENTUM RES CLIN APP, P173	32	5	5	0	1	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	1996	10	6					547	553		10.1080/02688699646844			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WD428	WOS:A1996WD42800003	9115649				2022-02-06	
J	Tofil, S; Clinchot, DM				Tofil, S; Clinchot, DM			Recovery of automatic and cognitive functions in traumatic brain injury using the functional independence measure	BRAIN INJURY			English	Article							MEDICAL REHABILITATION; PERFORMANCE	Automatic tasks are performed with minima attentional guidance. Neural pathways subserving attention are often impaired in traumatic brain injury (TBI). Therefore, the process of automatization is crucial in skill development, due to the fact that it allows attention to be directed towards the more abstruse components of task [1]. Automatic and cognitive categories were created by aggregating three of the motor items and three of the cognitive items respectively of the Functional Independence Measure (FIM). The averages of these categories were calculated for every evaluation of the FIM, and their relationshp to each other was examined. Over a 9-month period 24 patients were selected from a TBI population with a major component of diffuse axonal injury (DAI). Eight-eight per cent (n = 21) of the patients reached independence for the automatic category, but only 29% (v = 7) reached this level for the cognitive category. When independence was achieved, the average time to do so for the automatic category 6.7 weeks) was not significantly different from the time it took to reach cognitive independence (6.9 weeks). It was found that there were significant statistical differences in the scores between the two categories. Premorbid IQ had no effect on these categories. However, the rate which these two categories increased, from the time of admission to discharge, was not significantly different.	OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210					Clinchot, Daniel/0000-0002-2810-7227			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; DEVORE JL, 1982, PROBABILITY STAT ENG; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P33, DOI 10.1097/00002060-199302000-00008; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HIRSCH RP, 1992, STAT 1 AID INTERPRET; LONG WB, 1994, ARCH PHYSICAL MED RE, V75, P1144; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; PARKER JR, 1990, ANN CLIN LAB SCI, P220; RUSSELL EW, 1979, J CLIN PSYCHOL, V35, P611, DOI 10.1002/1097-4679(197907)35:3<611::AID-JCLP2270350325>3.0.CO;2-V; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; SILVERSTEIN B, 1992, ARCH PHYS MED REHAB, V73, P507; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P940	18	5	5	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1996	10	12					901	910		10.1080/026990596123873			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	VU408	WOS:A1996VU40800004	8939308				2022-02-06	
J	Olsen, CG; Wong, CP; Gordon, RE; Harper, DJ; Whitecar, PS				Olsen, CG; Wong, CP; Gordon, RE; Harper, DJ; Whitecar, PS			The role of the family physician in the day care setting	AMERICAN FAMILY PHYSICIAN			English	Article							CHILD DAY-CARE; INFECTIOUS-DISEASES; PRESCHOOL-CHILDREN; CENTERS; TRANSMISSION; INJURIES; RISK; FACILITIES	Injuries and infectious respiratory, gastrointestinal and dermatologic diseases are common in day care settings. Most day care injuries are contusions, abrasions and cuts involving the head and extremities. Impact-absorbing surfaces under playground equipment, safety-proofing of ail play areas, increased staff supervision, and staff and parental education might reduce injuries by as much as 75 percent. Respiratory illnesses are the most common day care infections. Chemoprophylaxis with rifampin is required for all close contacts of children infected with Haemophilus influenzae type B and Neisseria meningitidis. Diarrheal illness may be caused by viral pathogens, bacterial agents such as Shigella, Campylobacter or Salmonella, or parasitic infections caused by Giardia lamblia and Cryptosporidium. Strict hand-washing procedures, especially before food preparation and after toileting, may reduce diarrheal illness by 50 percent. Head lice (Pediculosis capitis) and scabies are common dermatologic infections spread by direct contact and through clothing, bedding and hair brushes. Screening and treating affected children with permethrin preparations and thoroughly washing bedding and clothing are necessary to stop outbreaks. Use of universal precautions for the handling of stool is essential to prevent the spread of both ordinary diarrheal illnesses and serious infections such as hepatitis A and B, human immunodeficiency virus and cytomegalovirus.			Olsen, CG (corresponding author), WRIGHT STATE UNIV,SCH MED,DEPT FAMILY MED,627 EDWIN C MOSES BLVD,DAYTON,OH 45408, USA.						ADDISS DG, 1994, AM J PUBLIC HEALTH, V84, P1161, DOI 10.2105/AJPH.84.7.1161; *AM AC PED, 1994, 1994 RED BOOK; *AM PUBL HLTH ASS, 1992, CAR OUR CHILDR NAT H; BLACK RE, 1981, AM J EPIDEMIOL, V113, P445, DOI 10.1093/oxfordjournals.aje.a113112; BUTZ AM, 1993, PEDIATRICS, V92, P202; CARSON DS, 1987, DRUG INTEL CLIN PHAR, V21, P694, DOI 10.1177/106002808702100902; CHANG A, 1989, PEDIATRICS, V83, P272; CHERIAN T, 1994, JAMA-J AM MED ASSOC, V271, P695, DOI 10.1001/jama.271.9.695; CRAWFORD FG, 1987, PEDIATR INFECT DIS J, V6, P744, DOI 10.1097/00006454-198708000-00010; DENNY FW, 1986, REV INFECT DIS, V8, P527; ELARDO R, 1987, AM J ORTHOPSYCHIAT, V57, P60, DOI 10.1111/j.1939-0025.1987.tb03509.x; FALCK G, 1992, PEDIATR INFECT DIS J, V11, P914, DOI 10.1097/00006454-199211110-00002; FORDJONES EL, 1987, CAN MED ASSOC J, V137, P105; HALLORAN ME, 1994, AM J EPIDEMIOL, V140, P81, DOI 10.1093/oxfordjournals.aje.a117238; HENDERSON FW, 1986, REV INFECT DIS, V8, P533; HUSE DM, 1994, J PEDIATR-US, V124, P869, DOI 10.1016/S0022-3476(05)83173-7; LABORDE DJ, 1993, AM J EPIDEMIOL, V138, P243, DOI 10.1093/oxfordjournals.aje.a116853; LANDMAN PF, 1987, AM J DIS CHILD, V141, P292, DOI 10.1001/archpedi.1987.04460030070027; LELAND NL, 1993, AM J DIS CHILD, V147, P826, DOI 10.1001/archpedi.1993.02160320028014; NOLAN CM, 1987, PEDIATRICS, V79, P630; OCONNOR MAS, 1992, AM J PREV MED, V8, P14, DOI 10.1016/S0749-3797(18)30857-2; PASS RF, 1986, REV INFECT DIS, V8, P599; Pass RF., 1990, SEMIN PEDIATR INFECT, V1, P245; PICKERING LK, 1987, PEDIATR INFECT DIS J, V6, P614, DOI 10.1097/00006454-198706000-00039; SACKS JJ, 1992, AM J PUBLIC HEALTH, V82, P429, DOI 10.2105/AJPH.82.3.429; SHAPIRO ED, 1987, J PEDIATR-US, V110, P90, DOI 10.1016/S0022-3476(87)80296-2; SHIRLEY LR, 1989, J PEDIATR-US, V114, P425, DOI 10.1016/S0022-3476(89)80563-3; STEKETEE RW, 1989, AM J PUBLIC HEALTH, V79, P485, DOI 10.2105/AJPH.79.4.485; Taras H L, 1993, J Community Health, V18, P261, DOI 10.1007/BF01321787; THACKER SB, 1992, JAMA-J AM MED ASSOC, V268, P1720, DOI 10.1001/jama.268.13.1720; TSOUKAS CM, 1988, J ACQ IMMUN DEF SYND, V1, P505; 1992, MMWR MORB MORTAL WEE, V41, P440	32	5	5	0	6	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	SEP 15	1996	54	4					1257	1265					9	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VJ808	WOS:A1996VJ80800010	8816571				2022-02-06	
J	Johnstone, B				Johnstone, B			Predicting independence from neuropsychological tests following traumatic brain injury - Response	BRAIN INJURY			English	Article							REHABILITATION				Johnstone, B (corresponding author), UNIV MISSOURI,SCH MED,DEPT PHYS MED & REHABIL,RUSK REHABIL CTR 501,1 HOSP DR,COLUMBIA,MO 65212, USA.			Johnstone, Brick/0000-0001-8845-9649			FARMER JE, 1995, NEUROREHABILITATION, V5, P49, DOI 10.3233/NRE-1995-5105; FISHER WP, 1995, NEUROREHABILITATION, V5, P3, DOI 10.3233/NRE-1995-5102; FRASER RT, 1995, NEUROREHABILITATION, V5, P39, DOI 10.3233/NRE-1995-5104; HENRICHS WR, 1990, PROFESSIONAL PSYCHOL, V21, P171; JOHNSTONE B, 1995, NEUROREHABILITATION, V5, P75, DOI 10.3233/NRE-1995-5107; KIRESUK TJ, GOAL ATTAINMENT SCAL; LEZAK M, NEUROPSYCHOLOGICAL A; Lipsitz J. D., 1993, PSYCHOL ASSESSMENT, V5, P430; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241	9	5	5	1	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1996	10	9					627	630		10.1080/026990596124052			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VB635	WOS:A1996VB63500001	8853866				2022-02-06	
J	Parzhuber, A; Ruchholtz, S; Schweiberer, L				Parzhuber, A; Ruchholtz, S; Schweiberer, L			Severe head and brain injury	UNFALLCHIRURG			German	Article						severe head and brain injury	HEMATOMA	In medical services where acute accident patients are encountered, general and traumatic surgeons are faced with the problem of treating severe head and brain injuries. In the Department of Surgery at the University Hospital in Munich, we have been performing neurotraumatological treatment since 1983. We had 162 patients with seven head and brain injuries, 95 intracerebral contusional bleeding, 8 depression fractures, and 3 hygromas. All these patients underwent surgical treatment. Osteoplastic trepanation was performed in 68 patients and osteoclastic trepanation in 65. Further interventions were elevation of the 8 depression fractures and evacuation of the 3 hygromas. Comparison with other investigations in departments of neurosurgical surgery in the United States suggest that our results reflect a similar outcome (according to Jennet and Bond's outcome scale: 1 cured; 2 slightly; 3 severely handicapped; 4 vegetative state; 5 expired). The Traumatic Coma Data Bank (1991) recorded the outcome of severe head and brain injuries as follows: 1, 27%; 2, 16%; 3, 16%; 4, 5%; 5, 36%; and our own results were: 1, 25%; 2, 16%; 3, 15%, 4, 5%; 5, 39%. Organization procedures and treatment strategies are suggested.			Parzhuber, A (corresponding author), UNIV MUNICH,KLINIKUM INNENSTADT,CHIRURG KLIN & POLIKLIN,NUSSBAUMSTR 20,D-80336 MUNICH,GERMANY.						BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BRUCE DH, 1978, CRIT CARE MED, V6, P244; CANTORE GP, 1978, ACTA NEUROCHIR, V41, P349, DOI 10.1007/BF01811347; FROWEIN RA, 1972, AKTUEL TRAUMATOL, V4, P205; Gaab MR., 1980, THESIS JULIUS MAXIMI; GALLAGHE.JP, 1968, J NEUROSURG, V29, P1, DOI 10.3171/jns.1968.29.1.0001; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; HEMMER R, 1965, DEUT MED WOCHENSCHR, V90, P1945, DOI 10.1055/s-0028-1113451; JAMIESON KG, 1972, J NEUROSURG, V31, P137; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; KRETSCHMER H, 1981, Aktuelle Traumatologie, V11, P17; KRETSCHMER H, 1981, Aktuelle Traumatologie, V11, P43; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; MARGUTH E, 1980, LANGENBECKS ARCH CHI, V352, P232; MCKISSOCK W, 1960, LANCET, V1, P167; MILO R, 1987, ACTA NEUROCHIR, V84, P13, DOI 10.1007/BF01456345; MURR R, 1992, CURR OPIN ANAESTH, V5, P285; ROSENORN J, 1978, J NEUROSURG, V48, P345, DOI 10.3171/jns.1978.48.3.0345; SINGBARTL G, 1987, NOTARZT, V3, P112; TODOROW S, 1992, PRAKTISCHE HIRNTRAUM; [No title captured]	22	5	5	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	AUG	1996	99	8					541	547					7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	VE766	WOS:A1996VE76600003	8975374				2022-02-06	
J	Schalow, G; Zach, GA				Schalow, G; Zach, GA			External loops of human premotor spinal oscillators identified by simultaneous measurements of interspike intervals and phase relations	GENERAL PHYSIOLOGY AND BIOPHYSICS			English	Article						human; spinal cord injury; single nerve-fibre action potentials; interspike intervals; phase relations; spinal oscillators; external loop; synchronization	DETRUSOR-SPHINCTERIC DYSSYNERGIA; ANKLE EXTENSOR MUSCLES; GROUP IB AFFERENTS; LOCOMOTOR RHYTHM; GENERATION; LAMPREY; INTERNEURONS; ENTRAINMENT; REFLEX; CATS	Single nerve-fibre action potentials (APs) were recorded extracellularly from alpha and gamma-motoneurons and secondary muscle spindle afferents from a ventral S4 nerve root (some afferents are contained in lower sacral motor roots) in an individual with traumatic spinal cord lesion sub TH1. Simultaneous interspike intervals (IIs) of, and phases between, the APs of 5 nerve fibres were measured, and distributions were constructed. The II distributions were of a broad peak type. Phase distributions showed 1 to 3 peaks interpreted as phase relations between the firings of the nerve fibres. Under certain phase relations, the rhythmic firing of alpha and gamma-motoneurons is further interpreted as an interaction of oscillatory firing neuronal subnetworks driving alpha and gamma-motoneurons. Following repetitive touch and pin-prick stimulation in- and outside the anal reflex area, the II distributions of alpha and gamma-motoneurons and of secondary spindle afferents assimilated partly or fully, while preserving their phase relations. This coordinated firing is interpreted as the oscillatory firing of alpha neuronal networks building up an external loop to the periphery via the gamma-loop. Upon touch, pin-prick, and anal reflex stimulation, and anal and bladder catheter pulling, the values and the number of the phase relations changed. Mostly two phase relations per oscillation cycle were observed. Two phase relations probably represent the physiologic case for the somatic nervous system. Only one phase relation was found when full synchronization of all units occurred. Three phase relations were found when the parasympathetic nervous system division interacted with the somatic one. Based on data obtained from brain-dead individuals it is discussed that the increased synchronization and instability in the number and the values of phase relations suggested pathologic functioning of the caudal functionally disconnected spinal cord in patients with spinal cord lesions: Oscillatory firing neuronal networks, which lost their specific properties, interacted more easily and unspecifically with other oscillatory firing networks. Further, it is discussed that physiologic tremor is caused by chance synchronization of oscillatory firing neuronal networks and therefore originates in the central nervous system (CNS). Since spinal oscillators build up external loops to the periphery, it is suggested that in patients with incomplete spinal cord lesions it should be possible to re-preformate oscillatory firing neuronal networks by a rhythm training, to reduce spasticity and to re-train useful movements, especially locomotion.			Schalow, G (corresponding author), SWISS PARAPLEG CTR NOTTWIL,DEPT CLIN RES,CH-6207 NOTTWIL,SWITZERLAND.						AGARWAL GC, 1977, J PHYSIOL-LONDON, V268, P151, DOI 10.1113/jphysiol.1977.sp011852; BAYEV KV, 1981, NEIROFIZIOLOGIYA, V13, P57; BERKINBLIT MB, 1978, J NEUROPHYSIOL, V41, P1040, DOI 10.1152/jn.1978.41.4.1040; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; Cohen A., 1988, NEURAL CONTROL RHYTH; Cohen A.H., 1988, NEURAL CONTROL RHYTH, P129; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; Creed RS, 1932, REFLEX ACTIVITY SPIN; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; FORSSBERG H, 1977, BRAIN RES, V132, P121, DOI 10.1016/0006-8993(77)90710-7; GOSSARD JP, 1994, EXP BRAIN RES, V98, P213; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; GRILLNER S, 1981, BRAIN RES, V217, P380, DOI 10.1016/0006-8993(81)90015-9; GRILLNER S, 1977, EXP BRAIN RES, V30, P1; GRILLNER S, 1985, J EXP BIOL, V98, P1; HAGBARTH KE, 1979, BRAIN, V102, P509, DOI 10.1093/brain/102.3.509; HESS WR, 1981, BIOL ORDER BRAIN ORG, P3; Jung R, 1941, Z GESAMTE NEUROL PSY, V173, P263, DOI 10.1007/BF02871623; PAVLASEK J, 1994, RETICULAR FORMATION; PAVLIDIS T, 1973, BIOL OSCILLATORS THE; PEARSON KG, 1993, J NEUROPHYSIOL, V70, P1009, DOI 10.1152/jn.1993.70.3.1009; PEARSON KG, 1992, EXP BRAIN RES, V90, P557; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; SCHAFER CBA, 1992, RADIOLOGE, V32, P259; SCHALOW G, 1995, J AUTONOM NERV SYST, V52, P181, DOI 10.1016/0165-1838(94)00155-D; SCHALOW G, 1995, J AUTONOM NERV SYST, V52, P151, DOI 10.1016/0165-1838(94)00154-C; Schalow G, 1996, GEN PHYSIOL BIOPHYS, V15, P57; Schalow G, 1993, Electromyogr Clin Neurophysiol, V33, P465; SCHALOW G, 1991, Electromyography and Clinical Neurophysiology, V31, P323; SCHALOW G, 1991, Electromyography and Clinical Neurophysiology, V31, P265; Schalow G, 1993, Electromyogr Clin Neurophysiol, V33, P401; Schalow G, 1996, GEN PHYSIOL BIOPHYS, V15, P121; Schalow G, 1993, Electromyogr Clin Neurophysiol, V33, P477; Schalow G, 1996, GEN PHYSIOL BIOPHYS, V15, P75; Schalow G, 1996, GEN PHYSIOL BIOPHYS, V15, P5; Schalow G, 1993, Electromyogr Clin Neurophysiol, V33, P409; Schalow G, 1993, Electromyogr Clin Neurophysiol, V33, P451; SCHALOW G, 1994, PHYSIOL RES, V43, P7; SCHALOW G, 1995, J AUTONOM NERV SYST, V52, P125, DOI 10.1016/0165-1838(94)00153-B; VANHOLST E, 1939, ERG PHYSL, V42, P228; WALLEN P, 1984, J EXP BIOL, V113, P493; WALLEN P, 1980, EXP BRAIN RES, V39, P193; WINDHORST U, 1988, BRAIN LIKE IS SPINAL	43	5	5	0	1	GENERAL PHYSIOL AND BIOPHYSICS	BRATISLAVA	INST OF MOLEC PHYSIOL GENETICS SLOVAK ACAD OF SCI VLARSKA 5, 83334 BRATISLAVA, SLOVAKIA	0231-5882			GEN PHYSIOL BIOPHYS	Gen. Physiol. Biophys.	AUG	1996	15			1			95	119					25	Biochemistry & Molecular Biology; Biophysics; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Physiology	VR486	WOS:A1996VR48600005	8934199				2022-02-06	
J	Hammond, FM; Yablon, SA; Bontke, CA				Hammond, FM; Yablon, SA; Bontke, CA			Potential role of serum prolactin measurement in the diagnosis of late posttraumatic seizures - A case report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						prolactin; traumatic brain injury; posttraumatic seizure	ELECTROCONVULSIVE-THERAPY; CARBAMAZEPINE THERAPY; EPILEPTIC PATIENTS; CORTISOL-LEVELS; GROWTH-HORMONE; RESPONSES	Posttraumatic seizures are an important medical complication after traumatic brain injury. However, the diverse clinical presentation of posttraumatic seizures, combined with the cognitive and behavior deficits frequently seen in this patient population, can make the diagnosis of posttraumatic seizures particularly challenging. Electroencephalography and imaging studies are often abnormal and nonspecific. It has been reported that serum prolactin levels frequently rise after epileptic seizures. This case report describes the use of prolactin measurement to confirm two suspected posttraumatic seizure episodes in a 42-yr-old male with severe traumatic brain injury. Each episode lasted less than 1 min and involved conspicuously altered postural tone and respiratory pattern, followed by a change in verbal and motor responsiveness. No rhythmic extremity movements were observed. Diagnostic evaluation included electroencephalography and imaging studies, which demonstrated nonspecific abnormalities. Serum prolactin levels obtained within 20 to 40 min were markedly elevated and two to three times greater than the baseline level. The use of prolactin levels in the diagnosis of posttraumatic seizures is reviewed, accompanied by discussion of pertinent aspects of normal and abnormal states of prolactin secretion and regulation.	BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030; REHABIL HOSP CONNECTICUT,HARTFORD,CT		Hammond, FM (corresponding author), CHARLOTTE INST REHABIL,1100 BLYTHE BLVD,CHARLOTTE,NC 28203, USA.						ABRAHAM RR, 1985, CLIN ENDOCRINOL, V22, P639, DOI 10.1111/j.1365-2265.1985.tb03000.x; ARATO M, 1980, ACTA PSYCHIAT SCAND, V61, P239, DOI 10.1111/j.1600-0447.1980.tb00873.x; COLLINS WCJ, 1983, J NEUROL NEUROSUR PS, V46, P505, DOI 10.1136/jnnp.46.6.505; CORDINGLEY G, 1993, AM J EMERG MED, V11, P251, DOI 10.1016/0735-6757(93)90139-3; DANAHAERI J, 1984, CLIN ENDOCRINOL, V20, P163, DOI 10.1111/j.1365-2265.1984.tb00071.x; DANAHAERI J, 1983, J NEUROL NEUROSUR PS, V46, P331, DOI 10.1136/jnnp.46.4.331; DEMEIRLEIR K, 1986, J CLIN ENDOCR METAB, V60, P1250; ISOJARVI JIT, 1990, EPILEPSIA, V31, P438, DOI 10.1111/j.1528-1157.1990.tb05500.x; ISOJARVI JIT, 1991, EPILEPSY RES, V9, P139, DOI 10.1016/0920-1211(91)90025-B; LAL S, 1981, J NEURAL TRANSM, V50, P39, DOI 10.1007/BF01254912; LAXER KD, 1985, NEUROLOGY, V35, P31, DOI 10.1212/WNL.35.1.31; LEONG DA, 1983, ANNU REV PHYSIOL, V45, P109, DOI 10.1146/annurev.ph.45.030183.000545; LUGER A, 1992, NEUROENDOCRINOLOGY, V56, P112, DOI 10.1159/000126912; MEIERKORD H, 1992, ARCH NEUROL-CHICAGO, V49, P225, DOI 10.1001/archneur.1992.00530270039016; ODEA JPK, 1978, AM J PSYCHIAT, V135, P609; OHMAN R, 1976, LANCET, V1, P936; PRITCHARD PB, 1985, ANN NEUROL, V18, P87, DOI 10.1002/ana.410180115; RONDI E, 1981, NEUROPSYCHOBIOLOGY, V7, P17; TOMSON T, 1989, J NEUROL NEUROSUR PS, V52, P1435, DOI 10.1136/jnnp.52.12.1435; TRIMBLE MR, 1978, BRIT MED J, V2, P1682, DOI 10.1136/bmj.2.6153.1682; WROE SJ, 1989, EPILEPSY RES, V3, P248, DOI 10.1016/0920-1211(89)90031-4; WYLLIE E, 1984, NEUROLOGY, V34, P1601, DOI 10.1212/WNL.34.12.1601; ZELNIK N, 1991, PEDIATRICS, V88, P486	23	5	5	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1996	75	4					304	306		10.1097/00002060-199607000-00012			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	VC325	WOS:A1996VC32500009	8777026				2022-02-06	
J	Donovick, PJ; Burright, RG; Burg, JS; Gronendyke, SJ; Klimczak, N; Matthews, A; Sardo, J				Donovick, PJ; Burright, RG; Burg, JS; Gronendyke, SJ; Klimczak, N; Matthews, A; Sardo, J			The K-BIT: A screen for IQ in six diverse populations	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						Kaufman Brief Intelligence Test; closed head injury; learning disability; neuropsychology; IQ	TRAUMATIC BRAIN INJURY; VALIDITY; CHILDREN	Performance data were collected on the Kaufman Brief Intelligence Test (K-BIT) from a total of 196 individuals from sir diverse populations. College students did best, followed closely by closed head-injured adults and their controls; the order of performance then was learning-disabled children, psychiatric patients, and finally, neurosurgical patients in the acute stages of recovery.	UNITED HLTH SERV HOSP,DEPT NEUROSCI,JOHNSON CITY,NY; UNITED HLTH SERV HOSP,DEPT PSYCHIAT,JOHNSON CITY,NY; SUNY BINGHAMTON,DEPT PSYCHOL,CHILDRENS UNIT LEARNING DISABIL,BINGHAMTON,NY 13902		Donovick, PJ (corresponding author), SUNY BINGHAMTON,DEPT PSYCHOL,ENVIRONM NEUROPSYCHOL LAB,BINGHAMTON,NY 13902, USA.		Matthews, Alicia K/R-4704-2018	Matthews, Alicia K/0000-0002-0074-681X			DONDERS J, 1992, J CLIN PSYCHOL, V48, P364, DOI 10.1002/1097-4679(199205)48:3<364::AID-JCLP2270480315>3.0.CO;2-A; DONDERS J, 1992, J CLIN PSYCHOL, V48, P225, DOI 10.1002/1097-4679(199203)48:2<225::AID-JCLP2270480213>3.0.CO;2-S; Kaufman A. S., 1990, MANUAL KAUFMAN BRIEF; KAUFMAN AS, 1992, J PSYCHOEDUC ASSESS, V10, P219, DOI 10.1177/073428299201000302; NAUGLE RI, 1993, PSYCHOL ASSESS, V5, DOI DOI 10.1037/1040-3590.5.2.182; PANIAK CE, 1992, J CLIN PSYCHOL, V48, P219, DOI 10.1002/1097-4679(199203)48:2<219::AID-JCLP2270480212>3.0.CO;2-K; REYNOLDS CR, 1987, J SCH PSYCHOL, V25, P232	7	5	5	0	2	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	JUN	1996	3	2					131	139		10.1007/BF01996133			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UW929	WOS:A1996UW92900004	24226640				2022-02-06	
J	Heath, DL; Vink, R				Heath, DL; Vink, R			Brain intracellular free magnesium declines after impact-acceleration induced brain injury in rats	NEUROSCIENCE RESEARCH COMMUNICATIONS			English	Article						trauma; bioenergetics; nuclear magnetic resonance; magnesium	METABOLISM	Significant declines in brain intracellular free magnesium concentration (Mgf) have been reported following focal traumatic brain injury but not following diffuse axonal brain injury. Since diffuse axonal brain injury is a common feature of clinical trauma, we have used P-31 magnetic resonance spectroscopy to determine whether Mgf decline is also a feature of a nonfocal traumatic brain injury model that primarily induces widespread axonal injury. Impact acceleration-induced injury resulted in a highly significant decline in Mgf with an associated decline in cytosolic phosphorylation ratio. There were no significant changes in either ATP concentration or brain pH. We propose that decline in brain Mgf may be a common feature of both focal and diffuse forms of traumatic brain injury and therefore a possible target for therapeutic intervention.			Heath, DL (corresponding author), JAMES COOK UNIV N QUEENSLAND, DEPT PHYSIOL & PHARMACOL, TOWNSVILLE, QLD 4811, AUSTRALIA.		Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, J NEUROTRAUMA, V5, P365	15	5	5	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0893-6609			NEUROSCI RES COMMUN	Neurosci. Res. Commun.	MAY-JUN	1996	18	3					163	168					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU677	WOS:A1996UU67700004					2022-02-06	
J	Patel, F				Patel, F			Traumatic baso-brainstem subarachnoid haemorrhage	MEDICINE SCIENCE AND THE LAW			English	Article							HEMORRHAGE	Traumatic basal subarachnoid haemorrhage is an uncommon disorder that is well described in the forensic literature. The aetiology traditionally has been a relatively minor blunt trauma which is sustained typically at the level of the base of head and injures the arterial system to the brain. The site of trauma may be occult and not always demonstrable. In the case discussed, an acute baso-brainstem subarachnoid haemorrhage was caused by a severed extracranial vertebral artery due to a stabwound injury to the upper neck. A gravitational factor and alcohol intoxication, which might contribute to the basal intracranial haematoma, is given a novel thought.			Patel, F (corresponding author), UNIV LONDON,UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,LONDON BRIDGE,LONDON,ENGLAND.						BIOUSSE V, 1995, LANCET, V346, P767, DOI 10.1016/S0140-6736(95)91525-7; BOSTROM K, 1992, FORENSIC SCI INT, V53, P61, DOI 10.1016/0379-0738(92)90133-H; CAMERON JM, 1972, MED SCI LAW, V12, P66, DOI 10.1177/002580247201200108; CONTOSTAVLOS D L, 1971, Journal of Forensic Sciences, V16, P40; DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; FARAG AM, 1988, FORENSIC SCI INT, V38, P275, DOI 10.1016/0379-0738(88)90173-9; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; KAPLAN JA, 1994, J FORENSIC SCI, V39, P552; MANT AK, 1972, J FORENSIC SCI SOC, V12, P567; SIMONSEN J, 1963, J Forensic Sci, V8, P97; SIVALOGANATHAN S, 1990, MED SCI LAW, V30, P138, DOI 10.1177/002580249003000211; VANEZIS P, 1979, FORENSIC SCI INT, V13, P159, DOI 10.1016/0379-0738(79)90280-9	12	5	5	0	0	CHILTERN PUBLISHING	BEACONSFIELD	34 AYLESBURY END, BEACONSFIELD, BUCKS, ENGLAND HP9 1LW	0025-8024			MED SCI LAW	Med. Sci. Law	APR	1996	36	2					178	181		10.1177/002580249603600214			4	Law; Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Government & Law; Legal Medicine; Pathology	UG240	WOS:A1996UG24000014	8999281				2022-02-06	
J	Perugini, S; Bonetti, MG; Ghirlanda, S; Fresina, A; Salvolini, U				Perugini, S; Bonetti, MG; Ghirlanda, S; Fresina, A; Salvolini, U			CT scout views of the cervical spine in severely head-injured patients	SKELETAL RADIOLOGY			English	Article						trauma radiology; head injuries; cervical spine; CT; scout views		The objective of this study was the validation of a CT multiprojection scout view method for the evaluation of cervical spine integrity in severely head-injured patients. Following brain CT, 130 consecutive patients underwent anteroposterior, laterolateral, and 45 degrees right and left oblique scout views of the cervical spine. The method allowed direct and prompt detection of traumatic lesions of the cervical spine in ten cases without moving the patients from the scanner table.	UNIV ANCONA,CATTEDRA NEURORADIOL,I-60100 ANCONA,ITALY; OSPED UMBERTO 1,REPARTO RADIOL & DIAGNOST IMMAGINI,I-60100 ANCONA,ITALY; OSPED SAN SALVATORE,REPARTO RADIOL,I-61100 PESARO,ITALY								BERQUIST TH, 1992, IMAGING ORTHOPEDIC T, P123; BOECHAT MI, 1987, AM J ROENTGENOL, V148, P97, DOI 10.2214/ajr.148.1.97; CACAYORIN ED, 1992, RADIOL CLIN N AM, V20, P185; DAFFNER RH, 1990, SKELETAL RADIOL, V19, P103; Greenspan A, 1992, ORTHOPEDIC RADIOLOGY; MIRVIS SE, 1989, RADIOLOGY, V170, P831, DOI 10.1148/radiology.170.3.2492671; ROGERS WA, 1957, J BONE JOINT SURG AM, V39, P341, DOI 10.2106/00004623-195739020-00011; SENER RN, 1993, NEURORADIOLOGY, V35, P229; TEHRANZADEH J, 1994, SKELETAL RADIOL, V23, P349, DOI 10.1007/BF02416991	9	5	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0364-2348			SKELETAL RADIOL	Skeletal Radiol.	APR	1996	25	3					247	249		10.1007/s002560050073			3	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	UE924	WOS:A1996UE92400009	8741060				2022-02-06	
J	Beni, L; Constantini, S; Matoth, I; Pomeranz, S				Beni, L; Constantini, S; Matoth, I; Pomeranz, S			Subclinical status epilepticus in a child after closed head injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							POST-TRAUMATIC EPILEPSY; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; POSTTRAUMATIC EPILEPSY; PROGNOSTIC FACTORS; SEIZURES; PROPHYLAXIS; FAILURE	A 14-year-old girl with closed head injury and a normal computerized tomographic scan underwent an electroencephalographic tracing that surprisingly revealed typical status epilepticus electrical activity, No episodes of motor clinical convulsion were observed from the moment of trauma throughout the admission period, Treatment with phenytoin caused a dramatic clinical improvement. Repeated electroencephalogram (EEG) 4 days later was within normal limits. Posttraumatic seizures reported after head injury, yet, the issue of ''invisible'' or ''subclinical'' seizures associated with trauma is not discussed, In these cases EEG, (an uncommon examination in the early period after head injury) may be the only tool for proper diagnosis and treatment with anticonvulsants. This case report raises the question of the role of EEG in the unconscious patient who does not present with obvious convulsions, Clinical indications for performing EEG after head trauma without seizures are discussed.	HEBREW UNIV JERUSALEM,HADASSAH HOSP,DEPT PEDIAT NEUROL,IL-91121 JERUSALEM,ISRAEL		Beni, L (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH HOSP,DEPT NEUROSURG,IL-91121 JERUSALEM,ISRAEL.						ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Black P, 1975, CIBA F S, V34, P215; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Elvidge A, 1939, T AM NEUROL ASSOC, V65, P125; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; JENNETT B, 1975, EPILEPSY NONMISSILE; PENRY JK, 1979, NEUROLOGY, V29, P600; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TEMKIN RN, 1991, NEUROSURG CLIN N APR; WALKER AE, 1961, FOLLOW STUDY HEAD WO; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WEISS GH, 1972, J NEUROSURG, V37, P164, DOI 10.3171/jns.1972.37.2.0164; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	17	5	5	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1996	40	3					449	451		10.1097/00005373-199603000-00022			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	UA973	WOS:A1996UA97300023	8601866				2022-02-06	
J	Nelson, DL; Lenhart, DA				Nelson, DL; Lenhart, DA			Resumption of outpatient occupational therapy for a young woman five years after traumatic brain injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						cognition; head injuries; occupations			ST FRANCIS HLTH CARE CTR,OCCUPAT THERAPY DEPT,GREEN SPRINGS,OH; HEARTLAND REHABIL,TOLEDO,OH		Nelson, DL (corresponding author), MED COLL OHIO,SCH ALLIED HLTH,DEPT OCCUPAT THERAPY,TOLEDO,OH 43699, USA.						BOUSKA MJ, 1983, MANUAL APPLICATION M; Colarusso RP, 1972, MOTOR FREE VISUAL PE; GILES GM, 1994, AM J OCCUP THER, V48, P199, DOI 10.5014/ajot.48.3.199; Hooper HE., 1983, HOOPER VISUAL ORG TE; KATZMANN S, 1994, AM J OCCUP THER, V48, P259, DOI 10.5014/ajot.48.3.259; MALKMUS D, 1980, REHABILITATION BRAIN; *NY STAT OPT ASS, NYSOA KINGD TEST; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PULASKI KH, 1994, AM J OCCUP THER, V48, P263, DOI 10.5014/ajot.48.3.263; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SANDLER AB, 1992, AM J OCCUP THER, V46, P163, DOI 10.5014/ajot.46.2.163; SLADYK K, 1992, AM J OCCUP THER, V46, P267, DOI 10.5014/ajot.46.3.267; *STER OPT CO, 1984, OPT 2000 VIS TEST IN; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Visser RSH, 1973, MANUAL COMPLEX FIGUR; Wechsler, 1997, WECHSLER ADULT INTEL; Wilson BA., 1985, RIVERMEAD BEHAVIOURA	17	5	5	0	0	AMER OCCUPATION THERAPY ASSN	ROCKVILLE	1383 PICCARD DRIVE PO BOX ROCKVILLE, MD 20850-4375	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAR	1996	50	3					223	228		10.5014/ajot.50.3.223			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	TU715	WOS:A1996TU71500010	8822246				2022-02-06	
J	Schmoker, JD; Shackford, SR; Zhuang, J				Schmoker, JD; Shackford, SR; Zhuang, J			The effect of lesion volume on cerebral vasomotor tone after focal brain injury and shock	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; lesion size; pial arterioles	SEVERE HEAD-INJURIES; BLOOD-FLOW; OXYGEN DELIVERY; VASCULAR REACTIVITY; CRYOGENIC INJURY; NITRIC-OXIDE; METABOLISM; PRESSURE; CATS; ABNORMALITIES	We have previously shown that the volume of a focal brain injury influences cerebral blood flow, We hypothesized that the cerebral vasomotor tone after traumatic brain injury and shock is related to lesion volume and that the size of the lesion would affect vasomotor reactivity. Swine were randomized to receive either a large or small cryogenic injury followed by shock, and were studied for 5 h postresuscitation, A small brain injury and shock produced a significant and sustained increase in bihemispheric pial arteriolar diameter when compared to the large lesion group and controls, A large brain injury and shock resulted in a significant decrease in the pial arteriolar diameter in the injured hemisphere, We also noted significant differences between and within groups in interhemispheric pial arteriolar diameter and pial arteriolar reactivity to acetylcholine and hypocarbia. These data suggest that the volume of injured tissue influences cerebral blood flow by a vascular mechanism, which may be due in part to an alteration in cerebral endothelial cell function.	UNIV VERMONT, COLL MED, DEPT SURG, BURLINGTON, VT 05405 USA						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028637, P20NS030324] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20 NS30324-03, R01 NS28637-02] Funding Source: Medline		ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; BAEZ S, 1966, J APPL PHYSIOL, V21, P229; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397, DOI 10.1152/ajpheart.1988.255.2.H397; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; FURUSE M, 1977, ACTA NEUROL SCAND, V56, P502; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MADSEN FF, 1990, ACTA NEUROCHIR, V105, P150, DOI 10.1007/BF01670000; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARTINS AN, 1978, STROKE, V9, P509, DOI 10.1161/01.STR.9.5.509; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MONCADA S, 1991, PHARMACOL REV, V43, P109; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MURR R, 1989, PROGR APPL MICR, P61; NAKASHIMA K, 1985, J NEUROL SCI, V70, P117, DOI 10.1016/0022-510X(85)90081-4; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; REILLY PL, 1977, J NEUROL NEUROSUR PS, V40, P1092, DOI 10.1136/jnnp.40.11.1092; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; SCHMOKER JD, 1993, J TRAUMA, V35, P627; SCHMOKER JS, 1993, CRIT CARE MED, V21, pS206; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; VELARDE F, 1992, J NEUROTRAUM, V9, P402; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Ward JD, 1989, INTRACRANIAL PRESSUR, P630; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YAMAMOTO L, 1979, DYNAMICS BRAIN EDEMA, P59; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; ZHUANG J, 1992, TRAUMA, V3, P83; Zimmerman RC, 1987, STROKE MICROCIRCULAT, P303	49	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	1996	13	2					67	78		10.1089/neu.1996.13.67			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UE544	WOS:A1996UE54400003	9094377				2022-02-06	
J	Packard, RC; Ham, LP				Packard, RC; Ham, LP			Evaluation of cognitive evoked potentials in post-traumatic headache cases with cognitive dysfunction	HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH			English	Article						post-traumatic headache; cognitive evoked potentials; mild head injury	POSTTRAUMATIC HEADACHE; INJURY; CONCUSSION; COMPONENTS; SPECT; MRI; CT	Objective: Patients presenting for treatment of post-traumatic headache (PTH) may also have cognitive symptoms that may be subtle and difficult to evaluate. Event-related (cognitive) potentials, such as P300 and N100, have shown some preliminary success in identifying cognitive deficits. The aim of this study was to examine the clinical utility of cognitive-evoked potentials in a group of post-traumatic headache patients with memory and/or concentration difficulties following mild head injury. Patients: Subjects consisted of 50 outpatients presenting to a private headache clinic primarily for evaluation of PTH but also reporting difficulties with memory and/or concentration. Evaluation: Patients were evaluated with topographic EEG brain mapping of cognitive-evoked potentials and were compared to 20 age-matched, neurologically normal subjects without symptoms of cognitive dysfunction. N100 and P300 amplitude, latency, and topography were determined and any relationship with a history of brief loss of consciousness, presence of headache, and/or depression at the time of testing were noted. Results: Values for N100 and P300 amplitude and latency were considered abnormal if greater than two standard deviations from the mean of the control group. According to this criteria, eight patients had abnormal N100 and 27 patients had abnormal P300 latencies or amplitudes. Topography was midline for all controls and off midline for 20 patients. Including topography, 78 percent of patients had abnormal studies. Loss of consciousness or presence of headache and/or depression at the time of testing did not appear related to abnormalities on cognitive-evoked potentials. Medication within 24 hours of the study did not influence results. Conclusion: Our data indicate cognitive-evoked potentials, particularly P300, can be clinically useful in assessing and detecting cognitive dysfunction in patients sustaining mild head injury and reporting difficulties with concentration and/ or memory. Furthermore, cognitive-evoked potentials do not seem affected by other variables such as headache, depression, or medication.	HEADACHE MANAGEMENT & NEUROL, PENSACOLA, FL 32503 USA; UNIV W FLORIDA, PENSACOLA, FL 32514 USA								ALAVI A, 1987, J CEREB BLOOD FLO S1, V7, pS646; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; [Anonymous], 1989, Neurology, V39, P1100; BARNAT MR, 1986, HEADACHE, V26, P271, DOI 10.1111/j.1526-4610.1986.hed2606271.x; Brown W S, 1982, Bull Los Angeles Neurol Soc, V47, P91; DEVOUS MD, 1989, BRAIN IMAGING APPLIC, P147; DIAMOND S, 1987, PSYCHIAT ASPECTS HEA, P259; EPSTEIN CM, 1994, NEUROLOGY, V44, P1566, DOI 10.1212/WNL.44.9.1566; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; GOODIN DS, 1992, AAN BREAKFAST S, V211; GRAY BG, 1992, J NUCL MED, V33, P52; Gronwall D, 1989, MILD HEAD INJURY, P153; GROSS MM, 1965, ELECTROEN CLIN NEURO, V18, P451, DOI 10.1016/0013-4694(65)90125-2; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HOLCOMB HH, 1989, BRAIN IMAGING APPLIC, P235; JOLLES PR, 1989, J NUCL MED, V30, P1589; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; MEADOR KJ, 1992, AAN BREAKFAST S, V211; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; NUWER MR, 1989, ARCH NEUROL-CHICAGO, V46, P1134, DOI 10.1001/archneur.1989.00520460130026; OLBRICH HM, 1986, ACTA NEUROCHIR, V80, P116, DOI 10.1007/BF01812285; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; PACKARD RC, 1994, SEMIN NEUROL, V14, P74, DOI 10.1055/s-2008-1041062; PACKARD RC, 1994, J NEUROPSYCH CLIN N, V6, P229; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; PACKARD RC, 1993, HEADACHE Q-CURR TREA, V4, P42; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PATTERSON JV, 1988, ELECTROEN CLIN NEURO, V71, P450, DOI 10.1016/0168-5597(88)90049-4; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; POLICH J, 1991, American Journal of EEG Technology, V31, P201; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; PRITCHARD WS, 1986, PSYCHOL BULL, V100, P43, DOI 10.1037/0033-2909.100.1.43; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; STOCKARD JJ, 1980, ELECTRODIAGNOSIS CLI, P503; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; WILKINSON RT, 1967, ELECTROEN CLIN NEURO, V23, P50, DOI 10.1016/0013-4694(67)90140-X; WOLDORFF M, 1987, CURRENT TRENDS EVENT, P146	38	5	5	0	4	INT UNIV PRESS INC	MADISON	59 BOSTON POST RD PO BOX 1524, MADISON, CT 06443-1524				HEADACHE Q-CURR TREA	Headache Q.-Curr. Treat. Res.		1996	7	3					218	224					7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VE855	WOS:A1996VE85500005					2022-02-06	
J	Stein, H; Barth, H; Eichmann, T; Mehdorn, HM				Stein, H; Barth, H; Eichmann, T; Mehdorn, HM			Traumatic primary brain stem lesion - Follow up and prognostic factors	ZENTRALBLATT FUR CHIRURGIE			German	Article						head injury; brain stem lesion; primary; prognosis	HEAD-INJURY; DAMAGE	Within 27 months 122 patients with severe head injury were treated at our clinic. Of these patients twelve (9, 8 %) were categorized as having a primary brain stem lesion (9 male and 3 female, mean age 28,3 years (17 to 73 years). Their injuries were caused primarily by traffic accidents. Initial and follow-up CT ruled out mass lesions or other causes for transtentorial herniation, supporting the diagnosis of primary brain stem lesion. Respiratory insufficiency and control of vegetative function demanded artificial ventilation and analgo-sedation for up to 32 days (mean 18 days) on our Intensive Care Unit. In all patients we performed initial and follow-up CT scans, ICP monitoring, evoked potentials (AEP, SSEP) and TCD. MRI was carried out in four patients. One patient died during the acute hospital phase, 7 were transfered in poor and four in good condition. During rehabilitation one patient died, two, one in a vegetative state and one in poor condition were transfered to a caring facility. Eight patients with a good or moderate recovery were dismissed home, subsequently regaining their prior social function. The primary traumatic brain stem lesion presents as a dramatic clinical picture. As shown in our series the prognosis is good independent of the duration of coma. The important prognostic factors were the primary neurological state according to the Gerstenbrand and Luecking classification, the degree of the brain stem lesion in CT scan and MRI, and normal evoked potentials, indicating a favourable outcome.	CHRISTIAN ALBRECHTS UNIV KIEL, NEUROCHIRURG KLIN, D-24106 KIEL, GERMANY				Mehdorn, Maximilian/D-2495-2010				ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; CROMPTON MR, 1971, LANCET, V1, P669; GAAB MR, 1982, TRAUMATISCHE MITTELH, P72; GERSTENBRAND F, 1970, Archiv fuer Psychiatrie und Nervenkrankheiten, V213, P264, DOI 10.1007/BF00342662; GERSTENBRAND F, 1984, INTENSIVBEHANDLUNG, V9, P133; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; JENNETT B, 1975, LANCET, V1, P480; KLINGELE TG, 1980, J NEUROSURG, V53, P249, DOI 10.3171/jns.1980.53.2.0249; LANKSCH W, 1982, TRAUMATISCHE MITTELH, P36; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Mayer E T, 1967, Arch Psychiatr Nervenkr (1970), V210, P238, DOI 10.1007/BF00367551; MITCHELL DE, 1973, LANCET, V2, P215; PILZ P, 1982, J NEUROL NEUROSUR PS, V45, P422, DOI 10.1136/jnnp.45.5.422; ZENTNER J, 1992, NEUROSURGERY, V31, P429, DOI 10.1227/00006123-199209000-00007	15	5	5	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-409X	1438-9592		ZBL CHIR	Zent.bl. Chir.		1996	121	11					985	989					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	VV723	WOS:A1996VV72300009	9027154				2022-02-06	
J	DiPace, E; Guariglia, C; Judica, A; Spinelli, D; Zoccolotti, P				DiPace, E; Guariglia, C; Judica, A; Spinelli, D; Zoccolotti, P			Selective reading slowness in a traumatic patient with impairment in basic visual processes	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							SPATIAL CONTRAST SENSITIVITY; NEGLECT; PERCEPTION; DEFICITS; LESIONS; VISION; ALEXIA	Following a closed-head injury, G.M., a 17-year-old male, showed a reading disturbance in the absence of other cognitive deficits. G.M.'s reading was exceedingly slow, although virtually error free. Analysis of his disorder indicated an inability to read words presented tachistoscopically to the left (spared) visual field. Therefore the reading deficit cannot be interpreted as simply due to the visual field reduction (hemianopic alexia). Reading speed was clearly affected by word length, a finding typical of letter-by-letter reading. Both behavioral and psychophysical testing indicated a selective reduction of visual discrimination and detection (particularly in the range of high spatial frequency information) in portions of the left hemifield which appeared spared upon perimetric examination. Overall, it is suggested that the reading deficit, phenomenologically similar to that of other letter-by-letter readers, can be interpreted as due to a combination of basic visual perturbations: visual field cut with macular splitting and deficit of processing of high spatial frequency information.	UNIV ROMA LA SAPIENZA,DEPT PSYCHOL,ROME,ITALY; IRCCS CLIN S LUCIA,RES CTR,ROME,ITALY				Judica, Anna/I-6585-2013; Zoccolotti, Pierluigi/H-4437-2019	Judica, Anna/0000-0003-0754-9736; Zoccolotti, Pierluigi/0000-0002-6351-2455; guariglia, cecilia/0000-0001-7474-6030; SPINELLI, Donatella/0000-0002-4890-6931			ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; ARRIGONI G, 1964, CORTEX, V1, P170; Benton A. L., 1975, TEST FACIAL RECOGNIT; BODISWOLLNER I, 1976, BRAIN, V99, P695, DOI 10.1093/brain/99.4.695; BORTOLINI U, 1972, LESSICO FREQUENZA LI; BULENS C, 1989, BRAIN, V112, P507, DOI 10.1093/brain/112.2.507; BURR DC, 1987, PERCEPTION, V16, P240; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; CARAMAZZA A, 1990, COGNITIVE NEUROPSYCH, V7, P391, DOI 10.1080/02643299008253450; DERENZI E, 1966, J NERV MENT DIS, V142, P515, DOI 10.1097/00005053-196606000-00002; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Diller L, 1974, REHABILITATION MONOG, V50; DIPACE E, 1989, GIORNALE ITALIANO PS, V16, P158; FARAH MJ, 1991, COGN NEUROPSYCHOL, V8, P313, DOI 10.1080/02643299108253376; Gianutsos R., 1987, NEUROPSYCHOL REHABIL, P202; Gjerris F, 1976, HDB CLIN NEUROLOGY, V24, P27; HESS RF, 1986, OPTIC NEURITIS, P109; ISHIHARA S, 1979, TESTS COLOR BLINDNES; JUOLA JF, 1988, APPL COGNITIVE PSYCH, V2, P87, DOI 10.1002/acp.2350020108; KAY J, 1991, COGNITIVE NEUROPSYCH, V8, P249, DOI 10.1080/02643299108253374; Kerkhoff G, 1992, NEUROPSYCHOL REHABIL, V2, P21, DOI DOI 10.1080/09602019208401393; KINSBOURNE M, 1962, BRAIN, V85, P461, DOI 10.1093/brain/85.3.461; Kolb B, 1980, FUNDAMENTALS HUMAN N; LEGGE GE, 1985, VISION RES, V25, P253, DOI 10.1016/0042-6989(85)90118-X; LONGONI AM, 1984, ASPECTS READING DYSL, P151; Marr D., 1982, VISION; MASSIRONI M, 1988, NEUROPSYCHOLOGIA, V26, P161, DOI 10.1016/0028-3932(88)90039-5; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; PATTERSON K, 1982, Q J EXP PSYCHOL-A, V34, P411, DOI 10.1080/14640748208400852; Pizzamiglio L, 1989, PSYCHOL ASSESSMENT, V5, P199; PLANT GT, 1987, BRAIN, V110, P489, DOI 10.1093/brain/110.2.489; PRICE CJ, 1992, COGNITIVE NEUROPSYCH, V9, P427, DOI 10.1080/02643299208252067; RAPP BC, 1991, COGNITIVE NEUROPSYCH, V8, P275, DOI 10.1080/02643299108253375; Rayner K., 1987, ATTENTION PERFORM, V12, P327; REGAN D, 1984, DIAGNOSIS MULTIPLE S, P64; REUTERLORENZ PA, 1990, COGN NEUROPSYCHOL, V7, P1, DOI 10.1080/02643299008253432; SCALISI TG, 1990, RASSEGNA PSICOLOGIA, V7, P61; SCHNEIDER W, 1988, BEHAV RES METH INSTR, V20, P206, DOI 10.3758/BF03203833; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; SPINELLI D, 1992, NEUROPSYCHOLOGIA, V30, P393, DOI 10.1016/0028-3932(92)90112-Y; STALLER J, 1978, BRAIN LANG, V5, P378, DOI 10.1016/0093-934X(78)90033-0; Vignolo, 1966, CORTEX, V2, P50, DOI [10.1016/S0010-9452(66)80028-X, DOI 10.1016/S0010-9452(66)80028-X]; Warrington E. K., 1991, VISUAL OBJECT SPACE; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; WILBRAND H, 1907, KLIN MONATSBL AUGENH, V45, P1; Wilson BA., 1985, RIVERMEAD BEHAVIOURA; ZIHL J, 1988, KLIN MONATSBL AUGENH, V192, P555, DOI 10.1055/s-2008-1050177; ZIHL J, 1986, ZEREBRALE SEHSTORUNG; ZOCCOLOTTI P, 1992, METODOLOGIE RIABILIT, P159; [No title captured]	52	5	5	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	1995	17	6					878	899					22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TM776	WOS:A1995TM77600008	8847394				2022-02-06	
J	EZZAT, W; ANG, LC; NYSSEN, J				EZZAT, W; ANG, LC; NYSSEN, J			PONTOMEDULLARY RENT - A SPECIFIC TYPE OF PRIMARY BRAIN-STEM TRAUMATIC INJURY	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						BRAIN-STEM LACERATION; DIFFUSE AXONAL INJURY; HYPEREXTENSION INJURY; HEAD TRAUMA		Pontomedullary rent is a primary injury to the brainstem that may occur in high-speed accidents. We present a series of 13 autopsies with complete or partial pontomedullary rent documented over a 12-year period. Of the 13 cases, seven had associated basal skull fractures and three had fractures of the cervical spine. In five patients, the rent was an isolated traumatic lesion of the brain. While pontomedullary rents are mostly caused by traumatic craniocervical hyperextension, some authors feel that these rents could be a form of diffuse axonal injury caused by angular acceleration of the head. In this study, two patients had documented features of diffuse axonal injury. More than one mechanism of injury could therefore be involved. Pontomedullary rents could be underdiagnosed, as partial rent is compatible with survival and, when there are no associated fractures, these tears may be attributed to artifactual damage occurring during removal of the brain at autopsy.	ST PAULS HOSP,DEPT PATHOL,SASKATOON,SK,CANADA									0	5	5	1	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	1995	16	4					336	339		10.1097/00000433-199512000-00008			4	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	TH072	WOS:A1995TH07200008	8599343				2022-02-06	
J	MCINTOSH, TK; SMITH, DH				MCINTOSH, TK; SMITH, DH			THERAPEUTIC STRATEGIES IN CURRENT CLINICAL-TRIALS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						CLINICAL TRIALS; THERAPEUTIC STRATEGIES	TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; AMINO-ACIDS; PHASE-II; PROTECTION; BLOCKER	Through the use of newly developed experimental models of traumatic brain injury (TBI), researchers now recognize that much of the delayed neuronal damage that develops over hours to days following the initial injury may result from pathological alterations in the brain's endogenous neurochemistry. This disregulation of central nervous system (CNS) homeostasis may lead to cell swelling, membrane disruption, cytoskeletal disorganization and proteolysis, alterations in brain metabolism and blood flow, and changes in neurotransmitter receptor physiology. The recent identification of many molecular and cellular responses to brain trauma has assisted in the development of rational targeted neuroprotective therapies. This column summarizes recent experimental advances in the development of therapeutic strategies and will provide an overview of the pharmacological compounds that are now being considered for, or used in, clinical trials for brain trauma.			MCINTOSH, TK (corresponding author), UNIV PENN,DIV NEUROSURG,CTR HEAD INJURY,3320 SMITH WALK,SUITE 105,PHILADELPHIA,PA 19104, USA.		smith, douglas/A-1321-2007				BAILEY I, 1992, Journal of Neurotrauma, V9, pS545; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FADEN AI, 1989, SCIENCE, V244, P789; HALL ED, 1992, J NEUROTRAUM, V9, pS165; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KOSTRON H, 1984, Neurological Research, V6, P29; KOSTRON H, 1985, ACTA NEUROCHIR WEIN, V28, P103; LEVERE TE, 1989, BEHAV NEUROSCI, V103, P561, DOI 10.1037/0735-7044.103.3.561; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P417; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; OKIYAMA K, 1994, NEUROTRAUMA, V11, P83; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; PALMER AM, IN PRESS NEUROREPORT; Povlishock J T, 1992, Hum Cell, V5, P345; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185	35	5	5	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1995	10	6					1	6					6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ661	WOS:A1995TJ66100003					2022-02-06	
J	KEYSER, L; WITOL, AD; KREUTZER, JS; ROSENTHAL, M				KEYSER, L; WITOL, AD; KREUTZER, JS; ROSENTHAL, M			A MULTICENTER INVESTIGATION OF NEUROBEHAVIORAL OUTCOME AFTER TRAUMATIC BRAIN INJURY	NEUROREHABILITATION			English	Article						NEUROBEHAVIORAL; BRAIN INJURY; ASSESSMENT AGITATION	CLOSED HEAD-INJURY; BEHAVIORAL SEQUELAE; RELATIVES VIEW; FOLLOW-UP; SCALE; AGITATION	Outcome of 295 rehabilitation patients with mild, moderate, and severe brain injury was investigated prospectively at five regional medical centers using the Neurobehavioral Rating Scale. Mean factor scale scores were generally low, with the cognition mean highest and the excitement mean lowest. Regardless of scale, the most significant neurobehavioral difficulties were related to memory, insight, attention, alertness, fatigue, and blunted affect. Conversely, problems rated as least severe included hallucinations, guilt, excitement and lability of mood. Approximately 9% of the sample had at least a moderate problem with agitation, an item on the excitement scale. The general pattern of mean factor scale elevations was consistent with other studies. No relationship was found between injury severity and neurobehavioral characteristics. The relatively low incidence of neurobehavioral problems may reflect recovery and effective interdisciplinary management.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROL SURG, RICHMOND, VA 23298 USA; WAYNE STATE UNIV, SCH MED, DETROIT, MI USA		KEYSER, L (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHYS MED & REHABIL, RICHMOND, VA 23298 USA.						BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chiu Wen-Ta, 1993, Journal of the Formosan Medical Association, V92, P255; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; EAMES P, 1988, J HEAD TRAUMA REHAB, V3, P1; GALSKI T, 1994, ARCH PHYS MED REHAB, V75, P380, DOI 10.1016/0003-9993(94)90158-9; GOETHE KE, 1984, PSYCHIAT ANN, V14, P540, DOI 10.3928/0048-5713-19840701-11; Harris R. J., 1975, PRIMER MULTIVARIATE; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JACOBS HE, 1993, BEHAVIOR ANAL GUIDEL; JENNETT B, 1975, LANCET, V1, P480; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1990, COMMUNITY INTEGRATIO, P49; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M, 1994, NEUROPSYCHOLOGICAL A; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Silver J M, 1991, J Neuropsychiatry Clin Neurosci, V3, pS22; Tabachnick B. G., 1989, USING MULTIVARIATE S; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WOOD R, 1988, J HEAD TRAUMA REHAB, V3, P53	32	5	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	JUL	1995	5	3					255	267		10.1016/1053-8135(95)00123-P			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RP776	WOS:A1995RP77600008	24525540				2022-02-06	
J	MCNENY, R; BENJAMIN, J				MCNENY, R; BENJAMIN, J			AGITATION IN THE THERAPY SETTING - MANAGING THE PATIENT WITH BRAIN INJURY	NEUROREHABILITATION			English	Article						THERAPY; AGITATION; BRAIN INJURY	CLOSED HEAD-INJURY; REHABILITATION	Though agitation frequently occurs following brain injury, allied health professionals on brain injury teams may not possess sufficient clinical competency to manage the manifestations of agitation. Traditional therapy approaches are inadequate for patients experiencing agitation. This paper reviews practical strategies the authors have found effective when treating agitated patients.	MED COLL VIRGINIA HOSP,OCCUPAT THERAPY & THERAPEUT RECREAT REHABIL & RES,RICHMOND,VA 23298								BERROL S, 1988, ARCH PHYS MED REHAB, V69, P527; BLACKERBY WF, 1991, NEUROREHABILITATION, V1, P53; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKE MM, 1993, ARCH PHYS MED REHAB, V73, P917; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DUNN ME, 1992, ARCH PHYS MED REHAB, V73, P316, DOI 10.1016/0003-9993(92)90002-E; EAMES P, 1988, J HEAD TRAUMA REHAB, V3, P1; GALSKI T, 1994, ARCH PHYS MED REHAB, V75, P380, DOI 10.1016/0003-9993(94)90158-9; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; Herbel K, 1990, Rehabil Nurs, V15, P66; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; MALKMUS D, 1980, REHABILIATION HEAD I; MCNENY R, 1990, REHABILITATION ADULT; Patterson T S, 1990, Rehabil Nurs, V15, P248; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; *REH RES CTR, 1992, BEH MAN; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20	20	5	5	0	3	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUL	1995	5	3					211	217					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RP776	WOS:A1995RP77600004	24525536				2022-02-06	
J	PARKER, R				PARKER, R			ENHANCING INFORMATION-GATHERING AFTER MILD HEAD-INJURY IN THE ACUTE AND CHRONIC PHASES	JOURNAL OF NEUROLOGICAL AND ORTHOPAEDIC MEDICINE AND SURGERY			English	Article						HEAD INJURY; NEUROPSYCHOLOGY; CONCUSSION; WHIPLASH; PERSONALITY CHANGES	GROWTH-HORMONE DEFICIENCY; TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; WHIPLASH INJURY; COMPENSATION; SYMPTOMS	Imprecise information gathering and reliance upon focal neurological and radiological examinations after minor head injury can lead to incorrect conclusions about lack of brain injury, and mislead the patient and discourage prompt treatment. Information is obtained while the patient is in altered consciousness, or incorrect conclusions are drawn about neurobehavioral impairment prior to the examination. Examples of errors are offered concerning trauma to the head, altered consciousness, and persistent symptoms. Not diagnosing brain injury due to incorrect information and patient avoidance causes misattribution of late arising or persistent symptoms. Poor outcome can result from the interaction of lesions with distracters such as pain and stress symptoms. Lack of awareness of the seriousness of mild head injury (concussion) and whiplash, and assumptions about exaggerations in forensic cases, lead to slow resolution of claims with enhancement of symptoms. An interview protocol is offered for altered consciousness, head injury, and personality changes.	NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016								Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adams RD, 1989, PRINCIPLES NEUROLOGY; ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; ATTIE KM, 1990, J CLIN ENDOCR METAB, V71, P975, DOI 10.1210/jcem-71-4-975; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; COOK JB, 1971, SCANDJ REHABIL MED, V4, P27; DAVIDOFF RA, 1995, MIGRAINE; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; DeLorenzo R. J., 1991, NEUROLOGY CLIN PRACT, P1443; EICHLER I, 1988, J ENDOCRINOL INVEST, V11, P409, DOI 10.1007/BF03349069; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Findling J.W, 1991, BASIC CLIN ENDOCRINO, P79; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; HARTLAGE LC, 1990, NEUROPSYCHOLOGICAL E; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; KARZMARK P, 1994, BRAIN INJURY, V9, P21; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KERR DS, 1991, J NEUROSCI, V11, P1316; Kroening R. J., 1990, NEUROLOGICAL SURG, P3803; Levin H. S., 1992, NEUROPSYCHOLOGY MEMO, P290; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; MANZONI GC, 1983, CEPHALALGIA, V3, P21, DOI 10.1046/j.1468-2982.1983.0301021.x; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; MCEWEN B, 1994, SEMIN NEUROSCI, V6, P195, DOI 10.1006/smns.1994.1025; McEwen B.S, 1994, SEMIN NEUROSCI, V6, P239, DOI 10.1006/smns.1994.1031; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MENDELSON G, 1982, MED J AUSTRALIA, V2, P132, DOI 10.5694/j.1326-5377.1982.tb124267.x; Merskey H., 1993, NEUROLOGICAL REHABIL, P413; MIKAIL SF, 1994, CLIN PSYCHOL REV, V14, P1, DOI 10.1016/0272-7358(94)90045-0; MILLER H, 1961, BRIT MED J, P920; MORDEN RS, 1982, ANN SURG, V196, P18, DOI 10.1097/00000658-198207000-00004; Moss NE., 1994, CLIN REHABIL, V8, P149; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1990, NEUROLOGICAL SURGERY, P1877; PARKER R, 1990, TRAUMATIC BRAIN INJU; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; PARKER RS, 1994, GUIDE ANAL UNDERSTAN, P79; PARKER RS, 1994, GUIDE ANAL UNDERSTAN, P309; PARKER RS, IN PRESS J CLIN PSYC; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; PEARCE JMS, 1992, HEADACHE Q-CURR TREA, V3, P45; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RANDOLPH C, 1988, NEUROPSYCHOBIOLOGY, V20, P43, DOI 10.1159/000118471; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERT GW, 1995, J INT NEUROPSYCHOL S, V1, P184; ROBERTSON E, 1994, CLIN NEUROPSYCHOL, V8, P69; ROSS ED, 1993, NEUROL CLIN, V11, P9, DOI 10.1016/S0733-8619(18)30168-3; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; STERN Y, 1995, J INT NEUROPSYCHOL S, V1, P183; Tupper D, 1986, CHILD NEUROPSYCHOL, V2, P139; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482; 1992, MERCK MANUAL, P762	58	5	5	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0890-6599			J NEUROL ORTH MED S	J. Neurol. Orthop. Med. Surg.	SUM	1995	16	3					118	125					8	Neurosciences; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	TJ076	WOS:A1995TJ07600002					2022-02-06	
J	DAHLGROVE, DL; CHANDE, VT; BARNOSKI, A				DAHLGROVE, DL; CHANDE, VT; BARNOSKI, A			CLOSED-HEAD INJURIES IN CHILDREN - IS HOSPITAL ADMISSION ALWAYS NECESSARY	PEDIATRIC EMERGENCY CARE			English	Article						HEAD INJURY; GLASGOW COMA SCALE; ABBREVIATED INJURY SCORE; COMPUTERIZED TOMOGRAPHY		The objective of this study was to identify a group of patients with mild closed head injury, lack of other significant trauma, and normal head computerized tomograph (CT), who could be safely observed at home by a reliable caretaker. Data were from a retrospective chart review of pediatric emergency department (PED) and hospital course of an urban university children's hospital. The pediatric trauma registry was used to identify patients one to 17 years old seen in the PED with closed-head injury and normal head CT between June 1991 and August 1992. A total of 746 patients with head injury were seen in the PED, and 161 patients with closed-head injury were admitted during the study period. Sixty-two patients (mean age=8.5 +/- 5 years) met inclusion criteria with hospital admission, mild head injury, Glasgow Coma Scale greater than or less than 13, and normal head CT. Of the patients 63% (34) were male and 37% (23) were female, with 74% (46) African-American and 26% (16)Caucasian. The most frequent mechanisms of injury were 27% (17) fall from height (mean height =6.7 +/- 4.6 feet) and 18% (11) passenger in a motor vehicle accident. Patients had a median Glasgow Coma Scale of 15 (mean 14.8) and median abbreviated injury score of 2 (mean =1.8). Thirty-seven percent of patients (23) had a history of loss of consciousness (range one to five minutes) and 6% (4) had generalized tonic-clonic seizure after the injury. Initial neurologic examination in the PED was normal in 79% (49) patients. Head CT scans performed on patients showed no acute signs of injury. All patients had an uncomplicated hospital course with mean duration of stay 1.3 +/- 0.6 days. Discharge neurologic examination was normal for 95% (60) patients; two remaining patients had prior neurologic injury and short-term memory loss, respectively. The negative predictive value of a normal head CT scan in patients with mild closed head injury and normal neurologic examination was 100% (95% confidence interval -94-100%). This retrospective chart review suggests that pediatric patients with mild closed-head injury who have a nonfocal neurologic examination and a normal head CT are unlikely to develop neurologic deficits during their hospital course. These patients may be candidates for observation at home by a reliable caretaker, rather than in the hospital.			DAHLGROVE, DL (corresponding author), CASE WESTERN RESERVE UNIV,RAINBOW BABIES & CHILDRENS HOSP,DEPT PEDIAT,DIV PEDIAT EMERGENCY MED,CLEVELAND,OH 44106, USA.							0	5	5	0	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	APR	1995	11	2					86	88		10.1097/00006565-199504000-00007			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	QV310	WOS:A1995QV31000006	7596884				2022-02-06	
J	MILLER, HB; PANIAK, CE				MILLER, HB; PANIAK, CE			MMPI AND MMPI-2 PROFILE AND CODE TYPE CONGRUENCE IN A BRAIN-INJURED SAMPLE	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article								Examined the comparability of the Minnesota Multiphasic Personality Inventory (MMPI) and Minnesota Multiphasic Personality Inventory-2 (MMPI-2) in a sample of brain-injured patients. There were 53 patients (36 males, 17 females; M age = 27.25, SD = 11.45), the majority of whom had suffered a closed-head injury. The MMPI-2 and MMPI items were administered in the context of an extensive neuropsychological examination. Results revealed a lack of congruence between the MMPI and MMPI-2 when the entire profile was compared using profile analysis. Analyses of code types found congruence to be high for single point elevations but modest for 2-point code types. The degree of congruence appears related to the nature of analysis, and for clinical purposes, code-type interpretation may be most relevant. These results provide some support for the congruence of the MMPI and MMPI-2. for brain-injured patients, but particular caution should be exercised in the interpretation of 2-point code types.			MILLER, HB (corresponding author), GLENROSE REHABIL HOSP,DEPT PSYCHOL,10230-111 AVE,EDMONTON,AB T5G 0B7,CANADA.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Ben-Porath Y. S., 1989, PSYCHOL ASSESSMENT J, V1, P345; BORNSTEIN RA, 1990, NEUROPSY NEUROPSY BE, V3, P200; BUTCHER J, 1989, MINNESOTA MULTIPHASI, V2; BUTCHER JN, 1991, MMPI 2 NEWS PROFILES, V2, P3; BUTCHER JN, 1991, MMPI 2 NEWS PROFILES, V2, P12; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P628; Graham J.R., 1990, MMPI 2 ASSESSING PER; Graham J. R., 1987, MMPI PRACTICAL GUIDE; GRAHAM JR, 1991, J PERS ASSESS, V57, P205, DOI 10.1207/s15327752jpa5702_2; GRAHAM JR, 1988, 96TH S ANN CONV AM P; Greene R. L., 1980, MMPI INTERPRETIVE MA; HATHAWAY SR, 1983, MANUAL ADM SCORING M; MEYERINK LH, 1988, J CLIN PSYCHOL, V44, P764, DOI 10.1002/1097-4679(198809)44:5<764::AID-JCLP2270440517>3.0.CO;2-Y; MUNLEY PH, 1991, J CLIN PSYCHOL, V47, P87, DOI 10.1002/1097-4679(199101)47:1<87::AID-JCLP2270470113>3.0.CO;2-M; WARD LC, 1991, PSYCHOL ASSESSMENT J, V3, P688; Wilkinson, 1984, WIDE RANGE ACHIEVEME; WOODCOCK RW, 1989, WOODCOCKJOHNSON PSYC, P13; [No title captured]	19	5	5	0	0	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	1995	17	1					58	64		10.1080/13803399508406581			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	QJ150	WOS:A1995QJ15000007	7608302				2022-02-06	
J	MILLIS, SR				MILLIS, SR			FACTOR STRUCTURE OF THE CALIFORNIA VERBAL-LEARNING TEST IN MODERATE AND SEVERE CLOSED-HEAD INJURY	PERCEPTUAL AND MOTOR SKILLS			English	Article								A factor analysis with principal components extraction and varimax rotation was performed on 19 California Verbal Learning Test age-uncorrected scores from a sample of 75 moderate and severe dosed-head-injured patients. A 6-factor solution was obtained that accounted for 80%, of the total Variance and was similar to those reported previously. The factors were labeled General Verbal Learning, Response Discrimination, Learning Strategy, Proactive Effect, Self-monitoring, and Serial Position. Factor scores were derived and correlated with other neuropsychological measures. The General Verbal Learning factor scores were significantly correlated with those on measures of memory, complex attention, and strategy induction.			MILLIS, SR (corresponding author), WAYNE STATE UNIV,SCH MED,REHABIL INST MICHIGAN,261 MACK BLVD,DETROIT,MI 48201, USA.				NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HI33A2001693A] Funding Source: Medline		DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Hamster K., 1983, MULTILINGUAL APHASIA; Heaton R.K., 1981, WISCONSIN CARD SORTI; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; VANDERPLOEG RD, 1994, J CLIN EXP NEUROPSYC, V16, P243, DOI 10.1080/01688639408402635; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D, 1987, MEMORY SCALE REVISED; WILDE MC, 1994, ARCH CLIN NEUROPSYCH, V9, P202; Wolfson, 1993, HALSTEAD REITAN NEUR; [No title captured]	11	5	5	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	FEB	1995	80	1					219	224		10.2466/pms.1995.80.1.219			6	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	QW474	WOS:A1995QW47400038	7624196				2022-02-06	
J	Loschmann, PA; Eblen, F; Wullner, U; Klockgether, T				Loschmann, PA; Eblen, F; Wullner, U; Klockgether, T			NMDA-mediated toxicity to striatal neurons is not reversed by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase	JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT			English	Article							GLUTAMATE NEUROTOXICITY; ENDOTHELIAL-CELLS; CEREBRAL-ISCHEMIA; 7-NITRO INDAZOLE; NERVOUS-SYSTEM; L-ARGININE; RECEPTORS; MECHANISM; MICE	L-glutamate itself and compounds activating glutamate receptor subtypes such as N-methyl-D-aspartate (NMDA) can produce excitotoxic lesions similar to neuronal cell damage following ischemia, traumatic brain injury or as seen in human neurodegenerative disorders. Competitive and non-competitive NMDA-receptor antagonists have neuroprotective properties in a number of in-vitro and in-vivo models for these disorders. The discovery of nitric oxide (NO) in the central nervous system (CNS) and the demonstration of the link between glutamate receptor activation and NO formation led to the hypothesis that NMDA toxicity may be mediated by NO because of its ability to promote free radical generation. Three isoforms of nitric oxide synthase (NOS) have been described, one of which is expressed constitutively in neuronal tissues (nNOS) and is perferentially inhibited by 7-nitroindazole (7-NI). One day after intrastriatal injection of NMDA, systemic pretreatment of rats with 7-NI had no effect on lesion volumes. It is concluded that formation of NO subsequent to NMDA receptor stimulation is not critically involved in excitotoxicity seen in this model.	UNIV TUBINGEN,INST PHARMACOL,D-72076 TUBINGEN,GERMANY		Loschmann, PA (corresponding author), UNIV TUBINGEN,DEPT NEUROL,HOPPE SEYLER STR 3,D-72076 TUBINGEN,GERMANY.		Wullner, Ullrich/R-6790-2019				BABBEDGE RC, 1993, BRIT J PHARMACOL, V110, P225, DOI 10.1111/j.1476-5381.1993.tb13796.x; CHAPMAN AG, 1993, EUR J PHARMACOL, V231, P301, DOI 10.1016/0014-2999(93)90465-T; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Connop B. P., 1993, Society for Neuroscience Abstracts, V19, P1345; CONNOP BP, 1994, NEUROPHARMACOLOGY, V33, P1439, DOI 10.1016/0028-3908(94)90047-7; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; FURCHGOTT R F, 1988, P401; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARTHWAITE G, 1994, NEUROPHARMACOLOGY, V33, P1431, DOI 10.1016/0028-3908(94)90046-9; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; HENRY Y, 1993, FASEB J, V7, P1124, DOI 10.1096/fasebj.7.12.8397130; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; KNOWLES RG, 1992, TRENDS BIOCHEM SCI, V17, P399, DOI 10.1016/0968-0004(92)90008-W; Konig J. F. R., 1963, RAT BRAIN STEREOTAXI; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LIPTON SA, 1994, ANN NY ACAD SCI, V738, P382; LOSCHMANN PA, 1994, J NEURAL TRANSM-SUPP, V43, P133; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKENZIE GM, 1994, NEUROREPORT, V5, P1993, DOI 10.1097/00001756-199410000-00039; MONCADA S, 1991, PHARMACOL REV, V43, P109; MOORE PK, 1993, BRIT J PHARMACOL, V110, P219, DOI 10.1111/j.1476-5381.1993.tb13795.x; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; OLNEY JW, 1989, DRUG DEVELOP RES, V17, P299, DOI 10.1002/ddr.430170406; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SCHULZ JB, 1995, J NEUROCHEM, V64, P936, DOI 10.1046/j.1471-4159.1995.64020936.x; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SONSALLA PK, 1992, J NEUROCHEM, V58, P1979, DOI 10.1111/j.1471-4159.1992.tb10081.x; STEINER AL, 1972, J BIOL CHEM, V247, P1114; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; WROBLEWSKI JT, 1991, EXCITATORY AMINO ACI, P103; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123	34	5	6	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0303-6995			J NEURAL TRANSM-SUPP	J. Neural Transm.-Suppl.		1995		46					87	95					9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TQ521	WOS:A1995TQ52100008	8821044				2022-02-06	
J	KONASIEWICZ, SJ; MOULTON, RJ				KONASIEWICZ, SJ; MOULTON, RJ			ELECTROPHYSIOLOGIC ASSESSMENT OF INTRACEREBRAL CONTUSIONS IN CLOSED-HEAD INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							MULTIMODALITY EVOKED-POTENTIALS; HEMATOMAS	To determine whether intracerebral contusions should be evacuated in severe closed head injuries, patients with Glasgow Coma Scale scores less than or equal to 8 and with radiologic evidence of midline shift on computed tomography admitted from 1987 through 1993 to our intensive care unit were monitored with median nerve somatosensory evoked potentials (SSEPs). A total of 44 patients and 84 hemispheres were included in the study. Initial SSEPs, calculated by a quantitative peak-peak amplitude method, were not significantly different between hemispheres that contained localized contusions greater than or equal to 2.5 cm, those that had evidence of diffuse injury or punctate lesions <2.5 cm not considered suitable for surgical evacuation, and those without evidence of parenchymal hemorrhage (mean 14.64 mu V, p = 0.43). The SSEPs deteriorated 41.2% from initial baseline levels in diffusely injured and 22.6% in contused hemispheres, whereas in normal-appearing hemispheres, SSEPs improved 51.1% (p = 0.01). The difference in SSEPs, however, was not significant between the contused and diffusely injured hemispheres. The results suggest that in severe closed head injury, cerebral hemispheres without radiologic evidence of structural damage have a high likelihood of improving after initial impact injury. Furthermore, hemispheres with localized contusions showed no more deterioration than those with more diffuse injury, implying that hemispheric electrical deterioration is not related to size of localized contusions but rather to underlying axonal damage. This indicates that surgical evacuation of localized contusions unless accompanied by mass effect is probably not warranted.	UNIV TORONTO,ST MICHAELS HOSP,DIV NEUROSURG,TORONTO M5B 1A6,ON,CANADA								ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKER DP, 1979, NEURAL TRAUMA, P313; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; JENNETT B, 1975, LANCET, V1, P480; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; Mackey-Hargadine J R, 1985, Cent Nerv Syst Trauma, V2, P187; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; MOULTON RJ, 1994, J NEUROL SCI S1, V21, pS17; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; OKEN BS, 1985, CENTRAL NERVOUS SYST, P177; Rivano C, 1980, J Neurosurg Sci, V24, P77; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; TEASDALE G, 1976, J NEUROL NEUROSUR PS, V39, P918; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P320, DOI 10.1007/BF00395288; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	21	5	5	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1994	37	3					370	374		10.1097/00005373-199409000-00006			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	PG534	WOS:A1994PG53400006	8083895				2022-02-06	
J	SALOKUN, SO				SALOKUN, SO			MINIMIZING INJURY RATES IN SOCCER THROUGH PRESELECTION OF PLAYERS BY SOMATOTYPES	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						SOCCER; SOMATOTYPES; WOUNDS AND INJURIES		Incidence and types of injuries were investigated among 180 Nigerian soccer players selected from 6 clubs by a stratified random technique on the basis of somatotypes. The purpose was to identify physique types that are most prone to common injuries in soccer, in the groups during an 8-week duration of intensive training. A total of 552 injuries: sprains and strains (45%), bruises and cuts (30%), dislocations (15%), fractures (5%) and concussion (5%) were recorded sustained by players who participated in the 8-week period of vigorous daily training. The study found that 45% of the meso-ectomorphs (n = 65) and 44% of the mesomorphs (n = 50) sustained injuries while 85% of the ectomorphs (n = 25) and 50% of the ectomesomorphs (n = 40) were injured. The study concluded that soccer players whose somatotypes range between meso-ectomorphic to the mesomorphic builds are less prone to injuries than their more fragile linear counterparts. It recommended that soccer players should be preselected on the basis of somatotypes and in most cases, mesomorphic and meso-ectomorphic types should be finally considered. It proposed that match referees should endeavour to enforce the soccer rules and escbew prejudice to prevent frustration-aggression reactions which are good causes of injuries to players.			SALOKUN, SO (corresponding author), OBAFEMI AWOLOWO UNIV,INST PHYS EDUC,IFE,NIGERIA.							0	5	6	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707			J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	MAR	1994	34	1					64	69					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NW729	WOS:A1994NW72900008	7934013				2022-02-06	
J	VANDENBRINK, WA; SANTOS, BO; MARMAROU, A; AVEZAAT, CJJ				VANDENBRINK, WA; SANTOS, BO; MARMAROU, A; AVEZAAT, CJJ			QUANTITATIVE-ANALYSIS OF BLOOD-BRAIN-BARRIER DAMAGE IN 2 MODELS OF EXPERIMENTAL HEAD-INJURY IN THE RAT	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; BLOOD BRAIN BARRIER; HYPERTENSION		The integrity of the blood-brain barrier was studied in a new model of closed head injury, and in an established model of fluid percussion injury, in the rat. Brain injury in this new model is induced by impact and acceleration of the protected rat skull. Severe hypertension is not a characteristic of this new model as compared to the tremendous surge following direct dural percussion. This is important because of the well known sensitivity of the cerebral microvasculature for acute hypertension. Using a radioactive tracer technique the dysfunction of the barrier was quantified. It is shown that the BBB is temporarily damaged due to trauma, subsequent arterial pressure surge, as seen in the percussed animals, deteriorates the dysfunction of the barrier even further. This study indicates that vascular damage is a key event following head injury. Yet the concomitant basic pathophysiological sequelae of different models must be considered when studying barrier damage and cerebral edema following brain injury. Time window studies of the barrier indicate that the barrier seals within a few hours following severe concussive head injury, and in the absence of a hypertensive surge.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DIV NEUROSURG, MCV STN, POB 509, RICHMOND, VA 23298 USA; DIJKZIGT ACAD HOSP, ROTTERDAM, NETHERLANDS								DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1988, J NEUROTRAUM, V5, P99; HARDEBO JE, 1981, ACTA PHYSIOL SCAND, V111, P43, DOI 10.1111/j.1748-1716.1981.tb06703.x; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JOHANSSON B, 1974, ACTA NEUROL SCAND, V50, P360; KUROIWA T, 1990, ADV NEUROL, P11; Marmarou A, 1990, Adv Neurol, V52, P233; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261; VANDENBRINK WA, 1991, ICP, V8; ZHANG XM, 1990, AM J PHYSL	11	5	5	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			456	458					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600125					2022-02-06	
J	VANVUGT, AB; OOSTERWIJK, WM; GORIS, RJA				VANVUGT, AB; OOSTERWIJK, WM; GORIS, RJA			PREDICTIVE VALUE OF EARLY SCINTIMETRY IN INTRACAPSULAR HIP-FRACTURES - A PROSPECTIVE-STUDY WITH REGARD TO FEMORAL-HEAD NECROSIS, DELAYED UNION AND NONUNION	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article							INTERNAL-FIXATION; NECK FRACTURES; SUBCAPITAL FRACTURES; FEMUR	In 84 patients with an intracapsular hip fracture, early technetium-99m methylene diphosphonate (Tc-99m-MDP) scintimetry could be carried out preoperatively of in the case of conservative treatments within 72 h after injury. Fifty-four patients were available for a 3-year follow-up. The corrected uptake ratio showed a very high accuracy in predicting secondary dislocation, non-union (NU), delayed union (DU) or femoral head necrosis (FHN) and was far more reliable than the uncorrected uptake ratio. The predictive value of scintimetric follow-up at a 2- or 12-week interval could not reach the same accuracy of early scintimetry in predicting poor outcome. A comparison of follow-up scintimetry after conservative treatment and osteosynthesis showed that the major vascular injury to the femoral head is caused at the moment of the initial trauma and that no additional damage occurs perioperatively with closed reduction and fixation with a Dynamic Hip Screw device. Scintimetry is a useful tool in predicting poor outcome due to FHN and/or NU in the treatment of intracapsular hip fractures.	MUNICIPAL HOSP LEYENBURG,DEPT GEN SURG,THE HAGUE,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT GEN SURG,NIJMEGEN,NETHERLANDS		VANVUGT, AB (corresponding author), ACAD HOSP LEIDEN,DEPT TRAUMATOL,POB 9600,2300 RC LEIDEN,NETHERLANDS.						ALBERTS KA, 1987, ARCH ORTHOP TRAUM SU, V106, P168, DOI 10.1007/BF00452204; ARDEN GP, 1960, J BONE JOINT SURG BR, V42, P21, DOI 10.1302/0301-620X.42B1.21; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; BOHLER J, 1978, UNFALLHEILKUNDE, V81, P155; BOYD HB, 1955, J BONE JOINT SURG AM, V37, P260, DOI 10.2106/00004623-195537020-00004; BROOS PLO, 1987, UNFALLCHIRURG, V90, P347; BRUMMER R, 1983, ACTA ORTHOP SCAND, V54, P865, DOI 10.3109/17453678308992924; BRUNNER S, 1976, ACTA CHIR SCAND, V133, P449; CAI RB, 1983, CHINESE MED J-PEKING, V96, P897; CALLANDRUCCIO RA, 1980, CLIN ORTHOPAEDICS, V152, P49; CHRISTIE J, 1988, J BONE JOINT SURG BR, V70, P199, DOI 10.1302/0301-620X.70B2.3346287; DAMBROSIA RD, 1975, SURG FORUM, P521; DAMBROSIA RD, 1976, CLIN ORTHOP RELAT R, V121, P143; FIELDING WJ, 1974, J BONE JOINT SURG AM, V56, P1464; GARDEN RS, 1977, INJURY, V9, P5, DOI 10.1016/0020-1383(77)90042-0; GREIFF J, 1980, ACTA ORTHOP SCAND, V51, P119, DOI 10.3109/17453678008990776; GRIFFITHS HJ, 1981, JAMA-J AM MED ASSOC, V246, P2615; HOLMBERG S, 1985, J NUCL MED, V26, P353; HOLMBERG S, 1984, ACTA ORTHOP SCAND, V55, P430, DOI 10.3109/17453678408992389; HULTH A, 1958, J BONE JOINT SURG AM, V40, P844, DOI 10.2106/00004623-195840040-00008; HUNTER GA, 1974, BRIT J SURG, V61, P382, DOI 10.1002/bjs.1800610514; HUNTER GA, 1969, BRIT J SURG, V56, P299; KIRGIS A, 1983, UNFALLHEILKUNDE, V86, P477; LEADBETTER GW, 1935, J BONE JOINT SURG, V15, P931; LUCIE RS, 1981, CLIN ORTHOPAEDICS, V161, P207; MASSIE WK, 1973, CLIN ORTHOP RELAT R, V92, P16; MEYERS MH, 1973, J BONE JOINT SURG AM, V55, P157; NICOLL EA, 1986, J BONE JOINT SURG BR, V45, P239; NORDKILD P, 1986, INJURY, V17, P345, DOI 10.1016/0020-1383(86)90160-9; PHILLIPS JE, 1988, INJURY, V19, P93, DOI 10.1016/0020-1383(88)90081-2; PRICE ER, 1962, J BONE JOINT SURG BR, V44, P854; RAAYMAKERS ELF, 1988, THESIS U AMSTERDAM A; RAGNARSSON JI, 1989, ACTA RADIOL, V30, P247; RAINE GET, 1973, INJURY, V5, P25, DOI 10.1016/S0020-1383(73)80005-1; REGAZZONI P, 1984, DYNAMIC HIP SCREW IM; ROOK FW, 1953, AM J SURG, V86, P404, DOI 10.1016/0002-9610(53)90454-1; SCHWARZ N, 1982, UNFALLHEILKUNDE, V85, P457; SIKORSKI JM, 1981, J BONE JOINT SURG BR, V63, P357, DOI 10.1302/0301-620X.63B3.7263746; SOREIDE O, 1979, BRIT J SURG, V66, P56, DOI 10.1002/bjs.1800660118; STEWART HD, 1983, INJURY, V15, P227; STROMQVIST B, 1981, ARCH ORTHOP TRAUM SU, V99, P1, DOI 10.1007/BF00400903; STROMQVIST B, 1984, J BONE JOINT SURG BR, V66, P49, DOI 10.1302/0301-620X.66B1.6229544; STROMQVIST B, 1983, ACTA ORTHOP SCAND S, V54, P200; STROMQVIST B, 1987, CLIN ORTHOPAEDICS, V218, P58; SVENNINGSEN S, 1984, ACTA ORTHOP SCAND, V55, P423, DOI 10.3109/17453678408992388; TUCKER FR, 1950, J BONE JOINT SURG BR, V32, P100, DOI 10.1302/0301-620X.32B1.100; TURNER JH, 1983, J BONE JOINT SURG AM, V65, P786, DOI 10.2106/00004623-198365060-00010; VEGTER J, 1987, J BONE JOINT SURG BR, V69, P530, DOI 10.1302/0301-620X.69B4.3611153; VILLAR RN, 1986, INJURY, V17, P61, DOI 10.1016/0020-1383(86)90024-0; WOODHOUSE CF, 1961, J BONE JOINT SURG AM, V43, P819, DOI 10.2106/00004623-196143060-00003	50	5	5	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	DEC	1993	113	1					33	38		10.1007/BF00440592			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	MM532	WOS:A1993MM53200007	8117508				2022-02-06	
J	VERBRAAK, MJPM; HOOGDUIN, CAL; SCHAAP, C				VERBRAAK, MJPM; HOOGDUIN, CAL; SCHAAP, C			THE HETEROGENEITY OF SCHIZOPHRENIC INFORMATION-PROCESSING AND NEGATIVE VERSUS POSITIVE SYMPTOMS	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							BACKWARD-MASKING; REACTION-TIME; PERFORMANCE; DEFINITION; SPECTRUM; DEFICIT; SPAN	In this study, 20 schizophrenic patients were subdivided into a schizophrenia group with positive symptoms (N = 11) and a schizophrenia group with negative symptoms (N = 9) by Andreasen's rating scales: the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms. These groups were compared with 17 normal controls and 17 subjects with a closed head injury Indices of information processing derived from Coglab, a multiparadigmatic cognitive test battery developed by Spaulding et al., were used for comparison. The ''negative'' schizophrenia subjects were characterized by a more pervasive deficient information-processing capacity than the ''positive'' schizophrenia subjects. The deficits both groups had in common were, however, not of equal severity. The closed head injury group, who served as an indirect control for the presumed generalized deterioration in the negative schizophrenia group, did not compare very well to this latter group. The results are discussed in relation to the question of whether the information-processing deficiencies stem from a single causal process, or whether these deficiencies are independent and associated with many etiological pathways.	CATHOLIC UNIV NIJMEGEN,DEPT CLIN PSYCHOL,PSYCHOL LAB,6500 HE NIJMEGEN,NETHERLANDS		VERBRAAK, MJPM (corresponding author), REINIER DE GRAAF HOSP,DEPT PSYCHIAT,REINIER DE GRAAFWEG 11,2625 AD DELFT,NETHERLANDS.		Verbraak, Marc/E-7779-2012				American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ANDREASEN NC, 1985, SCHIZOPHRENIA BULL, V11, P380, DOI 10.1093/schbul/11.3.380; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; ANDREASEN NC, 1990, ARCH GEN PSYCHIAT, V47, P615; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; Andreasen NC, 1984, SCALE ASSESSMENT NEG; ASARNOW RF, 1983, J NERV MENT DIS, V171, P662, DOI 10.1097/00005053-198311000-00004; ASARNOW RF, 1978, NATURE SCHIZOPHRENIA; BELLISSIMO A, 1972, J ABNORM PSYCHOL, V80, P229; BRAFF DL, 1985, AM J PSYCHIAT, V142, P170; BRODY D, 1980, J ABNORM PSYCHOL, V89, P617, DOI 10.1037/0021-843X.89.5.617; BROUWER WH, 1985, THESIS MEPPEL; CROMWELL RL, 1978, PHENOMENOLOGY TREATM; CROW TJ, 1985, SCHIZOPHRENIA BULL, V11, P471, DOI 10.1093/schbul/11.3.471; CROW TJ, 1982, TRENDS NEUROSCI, V5, P351, DOI 10.1016/0166-2236(82)90202-8; CURRY SH, 1980, PROGR BRAIN RES, V54; GREEN M, 1986, AM J PSYCHIAT, V143, P181; GREEN M, 1984, AM J PSYCHIAT, V141, P1273; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; NEALE JM, 1971, J ABNORM PSYCHOL, V77, P196, DOI 10.1037/h0030751; Neuchterlein KH, 1984, SCHIZOPHREN B, V10, P160; Rodnick EH, 1940, AM J PSYCHIAT, V97, P214, DOI 10.1176/ajp.97.1.214; SACCUZZO DP, 1981, J ABNORM PSYCHOL, V90, P305, DOI 10.1037/0021-843X.90.4.305; SACCUZZO DP, 1984, J CLIN PSYCHOL, V40, P1288, DOI 10.1002/1097-4679(198411)40:6<1288::AID-JCLP2270400602>3.0.CO;2-F; SPAULDING W, 1989, BRIT J PSYCHIAT, V155, P69, DOI 10.1192/S0007125000296025; SPAULDING W, 1989, J NERV MENT DIS, V177, P717, DOI 10.1097/00005053-198912000-00002; STEFFY RA, 1980, J ABNORM PSYCHOL, V89, P419, DOI 10.1037/0021-843X.89.3.419; STEFFY RA, 1974, J ABNORM PSYCHOL, V83, P227, DOI 10.1037/h0036704; VANDENBOSCH RJ, 1982, THESIS; WEINBERGER DR, 1983, SCHIZOPHRENIA BULL, V9, P193, DOI 10.1093/schbul/9.2.193	31	5	6	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	DEC	1993	181	12					738	743		10.1097/00005053-199312000-00005			6	Clinical Neurology; Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	MN129	WOS:A1993MN12900004	8254325				2022-02-06	
J	BOOTZ, F				BOOTZ, F			EMERGENCY MANAGEMENT OF TRAUMA TO THE SOFT-TISSUE OF THE HEAD AND NECK	HNO			German	Article								Most injuries to the head and neck region are accompanied by trauma to the soft tissue. The management of the wound depends on whether it is a superficial or a penetrating trauma. Penetrating traumas may injure bloodvessels, nerve structures and the upper aerodigestive tract. The initial evaluation of a patient with a neck wound should proceed with the basic rules of trauma management (Airway, Bleeding, Circulation). It is suggested, that all wounds deep to the platysma should be explored. Penetrating injuries through the airway should be considered in cases of hoarsness, dyspnea or direct visualization of the airway. In case of dyspnoe the patient should be intubated. In an unstable airway a tracheotomy must be considered. Injuries to the airway demand special care and immediate reconstruction since otherwise it can lead to permanent damage. Hemorrhage and hematoma are the most common symptoms of penetrating neck injuries. Poor initial control of bleeding is the most common cause of death. Uncontrolled clamping of vessels in the neck should be avoided since it can lead to damage of uninvolved structures especially nerves. The neck is divided into 3 zones. Zone I is the area below the sternal notch, Zone II lies between the sternal notch and the angle of the mandible. Zone III is the area above the angle of the mandible. Zone I and III injuries are evaluated with angiography. Zone II injuries are evaluated by surgery. Therapy of Zone I and III is difficult and needs mandibulotomy or resection of the clavicle to gain exposure to the vessels. Penetrating wounds of the digestive tract are mostly diagnosed by the appearance of saliva. In most cases the wound can be closed primarily. If not it should be covered by strab muscles.			BOOTZ, F (corresponding author), UNIV TUBINGEN,HNO KLIN,SILCHERSTR 5,D-72076 TUBINGEN,GERMANY.							0	5	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0017-6192			HNO	HNO	NOV	1993	41	11					542	552					11	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	MJ875	WOS:A1993MJ87500011	8282581				2022-02-06	
J	STEIN, DG; GLASIER, MM; HOFFMAN, SW				STEIN, DG; GLASIER, MM; HOFFMAN, SW			CONCEPTUAL AND PRACTICAL ISSUES IN THE PHARMACOLOGICAL TREATMENT OF BRAIN INJURY	JOURNAL OF NEURAL TRANSPLANTATION & PLASTICITY			English	Article							NERVE GROWTH-FACTOR; GM1 GANGLIOSIDE TREATMENT; GINKGO-BILOBA EXTRACT; CHOLINE-ACETYLTRANSFERASE; RAT-BRAIN; FUNCTIONAL RECOVERY; BEHAVIORAL DEFICITS; TROPHIC FACTORS; DAMAGE; ADULT	It is only within the last ten years that research on treatment for central nervous system (CNS) recovery after injury has become more focused on the complexities involved in promoting recovery from brain injury when the CNS is viewed as an integrated and dynamic system. There have been major advances in research in recovery over the last decade, including new information on the mechanics and genetics of metabolism and chemical activity, the definition of excitotoxic effects and the discovery that the brain itself secretes complex proteins, peptides and hormones which are capable of directly stimulating the repair of damaged neurons or blocking some of the degenerative processes caused by the injury cascade. Many of these agents, plus other nontoxic naturally occurring substances, are being tested as treatment for brain injury. Further work is needed to determine appropriate combinations of treatments and optimum times of administration with respect to the time course of the CNS disorder. In order to understand the mechanisms that mediate traumatic brain injury and repair, there must be a merging of findings from neurochemical studies with data from intensive behavioral testing.			STEIN, DG (corresponding author), RUTGERS STATE UNIV,INST ANIM BEHAV,BRIAN RES LAB,NEWARK,NJ 07102, USA.		Stein, Donald/AAJ-5139-2020				ATTELLA MJ, 1992, BEHAV NEURAL BIOL, V57, P157, DOI 10.1016/0163-1047(92)90665-Q; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; ATTELLA MJ, 1989, EXP NEUROL, V105, P62, DOI 10.1016/0014-4886(89)90172-6; AUBURGER G, 1987, DEV BIOL, V120, P322, DOI 10.1016/0012-1606(87)90235-1; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARRES BA, 1991, J NEUROSCI, V11, P3685; BOAST CA, 1988, BRAIN RES, V442, P345, DOI 10.1016/0006-8993(88)91522-3; BRAILOWSKY S, 1991, RESTOR NEUROL NEUROS, V3, P267, DOI 10.3233/RNN-1991-3505; BRAUQET P, 1991, MED RES REV, V11, P295; BREDESEN DE, 1990, ANN NEUROL, V27, P205, DOI 10.1002/ana.410270218; BREMER EG, 1986, J BIOL CHEM, V261, P2434; BUTCHER LL, 1989, NEUROBIOL AGING, V10, P557, DOI 10.1016/0197-4580(89)90130-9; CHEN LS, 1991, J CELL BIOCHEM, V45, P252, DOI 10.1002/jcb.240450305; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; COTMAN CW, 1985, ANN NY ACAD SCI, V457, P83, DOI 10.1111/j.1749-6632.1985.tb20800.x; DEWEID D, 1966, P SOC EXP BIOL MED, V122, P28; DIPATRE PL, 1989, BRAIN RES, V480, P219, DOI 10.1016/0006-8993(89)91585-0; ELLIOTT PJ, 1989, NEUROSCIENCE, V31, P63, DOI 10.1016/0306-4522(89)90030-4; FADEN AI, 1989, SCIENCE, V244, P799; FAGAN AM, 1990, EXP NEUROL, V110, P105, DOI 10.1016/0014-4886(90)90055-W; FASS B, 1984, J NEUROSCI RES, V12, P445, DOI 10.1002/jnr.490120228; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FINGER S, 1982, BRAIN DAMAGE RECOVER, P153; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GAGE FH, 1991, TRENDS NEUROSCI, V14, P328, DOI 10.1016/0166-2236(91)90156-O; GOLDMAN H, 1992, J NEUROTRAUM, V9, P60; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Kandel E.R., 1991, PRINCIPLES NEURAL SC, V3rd ed.; KARPIAK SE, 1990, CRIT REV NEUROBIOL, V5, P221; KARPIAK SE, 1983, EXP NEUROL, V81, P330, DOI 10.1016/0014-4886(83)90267-4; KORSCHING S, 1986, TRENDS NEUROSCI, V9, P570, DOI 10.1016/0166-2236(86)90179-7; KROMER LF, 1987, ANN NY ACAD SCI, V495, P207, DOI 10.1111/j.1749-6632.1987.tb23676.x; LOY R, 1980, SCIENCE, V208, P1282, DOI 10.1126/science.7375941; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; OBERPICHLER H, 1990, J CEREBR BLOOD F MET, V10, P133, DOI 10.1038/jcbfm.1990.17; Olney J, 1978, KAINIC ACID TOOL NEU, P95; PHELPS CH, 1989, SCIENCE, V243, P11; RICHTERLANDSBER.C, 1987, NEUROSCI RES COMMUN, V1, P153; Roth J. R, 1986, BIOCH BASIS NEUROPHA; RSENBERG MB, 1988, SCIENCE, V242, P1575; SABEL BA, 1984, J NEUROSCI RES, V12, P429, DOI 10.1002/jnr.490120227; SABEL BA, 1987, NEUROSCI LETT, V77, P360, DOI 10.1016/0304-3940(87)90528-3; SABEL BA, 1984, SCIENCE, V225, P340, DOI 10.1126/science.6740316; SCHALLERT T, 1990, STROKE, V21, P143; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHENGRUND CL, 1990, BRAIN RES BULL, V24, P131, DOI 10.1016/0361-9230(90)90297-D; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; STRAND FL, 1989, PROG NEUROBIOL, V33, P45, DOI 10.1016/0301-0082(89)90035-X; TEICHBERG VI, 1991, FASEB J, V5, P3086, DOI 10.1096/fasebj.5.15.1660422; TYURIN VA, 1992, NEUROCHEM INT, V20, P401, DOI 10.1016/0197-0186(92)90055-V; WALSH TJ, 1989, BRAIN RES, V478, P24, DOI 10.1016/0006-8993(89)91473-X; WANHUA AY, 1982, BRAIN RES, V238, P404; WARNER MA, 1991, J CEREBR BLOOD F MET, V11, P600, DOI 10.1038/jcbfm.1991.110; WEIHMULLER FB, 1988, NEUROSCI LETT, V92, P207, DOI 10.1016/0304-3940(88)90062-6; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; WHITAKERAZMITIA PM, 1987, ANN NY ACAD SCI, V495, P10, DOI 10.1111/j.1749-6632.1987.tb23662.x; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; WOLTERINK G, 1990, BRAIN RES, V507, P109, DOI 10.1016/0006-8993(90)90528-J; ZIVIN JA, 1991, SCI AM, V265, P56, DOI 10.1038/scientificamerican0791-56; [No title captured]	66	5	5	0	0	FREUND PUBLISHING HOUSE	LONDON	STE 500, CHESHAM HOUSE, 150 REGENT ST, LONDON, ENGLAND W1R 5FA	0792-8483			J NEURAL TRANSP PLAS	J. Neural Transplant. Plast.	JUL-SEP	1993	4	3					227	237		10.1155/NP.1993.227			11	Neurosciences; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Transplantation	NG435	WOS:A1993NG43500006	8018754	gold, Green Published			2022-02-06	
J	KRAMER, TH; NELSON, DF; LI, PW				KRAMER, TH; NELSON, DF; LI, PW			AIDS KNOWLEDGE AND RISK BEHAVIORS AMONG TRAUMATIC BRAIN INJURY SURVIVORS WITH COEXISTING SUBSTANCE-ABUSE	BRAIN INJURY			English	Article							DRUG-ABUSE; SCREENING-TEST; HEAD-INJURY; ALCOHOL; CONDOM	An exploratory needs assessment for AIDS education and prevention was conducted at a traumatic brain injury (TBI) rehabilitation facility among 29 clients that also experience coexisting substance abuse disorders. The results suggest that the surveyed clients possessed a moderate level of information about AIDS. Their knowledge level was variable with a major source of misinformation surrounding the use of condoms. The sample members' knowledge was not related to the type or severity of substance abuse, nor was it associated with safer sexual practices. The present results are compared to earlier findings that used an identical survey with a dual disordered population of psychiatrically impaired substance abusers [1]. The results should help in developing an AIDS educations and prevention programme for clients with the dual diagnosis of TBI and substance abuse. Clients need up-to-date information that can be comprehended and used. Education will need to be coupled with approaches that present both behavioural and attitudinal change strategies that are best suited to these clients.	SUNY HLTH SCI CTR,DEPT PSYCHIAT,BROOKLYN,NY								Anderson G., 1990, COURAGE CARE RESPOND; BAER J, 1988, HOSPITAL COMMUNITY P, V41, P986; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; GINZBURG HM, 1984, PUBLIC HEALTH REP, V99, P206; GORDON SM, 1988, J SUBST ABUSE TREAT, V5, P99, DOI 10.1016/0740-5472(88)90019-0; HANSON M, 1992, AIDS EDUC PREV, V4, P41; KERR TA, 1971, BRIT J PREV SOC MED, V25, P179; KRAMER T H, 1992, Brain Injury, V6, P81, DOI 10.3109/02699059209008128; KRAMER TH, 1991, J SUBST ABUSE TREAT, V8, P241, DOI 10.1016/0740-5472(91)90045-C; KRAMER TH, 1992, INT J ADDICT, V27, P477, DOI 10.3109/10826089209068754; KRAMER TH, 1989, J SUBST ABUSE TREAT, V6, P83, DOI 10.1016/0740-5472(89)90034-2; LANGLEY MJ, BRAIN INJURY, V4, P77; MACGREGOR RR, 1986, JAMA-J AM MED ASSOC, V256, P1474, DOI 10.1001/jama.256.11.1474; Marlowe D., 1964, APPROVAL MOTIVE; MAUSSCLUM J, 1981, J NEUROSURGICAL NURS, V4, P165; MCCUSKER J, 1990, J ACQ IMMUN DEF SYND, V3, P729; Miller H. G., 1990, AIDS 2 DECADE; MOLGAARD CA, 1988, SOC SCI MED, V27, P1147, DOI 10.1016/0277-9536(88)90344-9; MURPHY DL, 1988, AIDS SUBSTANCE ABUSE, P89; OTTOMANELLI G, 1990, INT J ADDICT, V25, P291, DOI 10.3109/10826089009056212; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIMEL RW, 1982, NEUROSURGERY, V2, P65; ROSENTHAL M, 1987, REHABILITATION PSYCH; SCHLEIFER SJ, 1990, HOSP COMMUNITY PSYCH, V41, P248; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Skinner HA., 1984, ALCOHOL DEPENDENCE S; SKINNER HA, 1984, B SOC PSYCHOL ADDICT, V3, P21; STALEY D, 1990, ADDICT BEHAV, V15, P257, DOI 10.1016/0306-4603(90)90068-9; STALL R, 1986, HEALTH EDUC QUART, V13, P359, DOI 10.1177/109019818601300407; STLAWRENCE J, PROGR BEHAVIOR MOTIF, V24, P11; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; TOBIS JS, 1982, SCANDINAVIAN J REHAB, V14, P655; VANDEPERRE P, 1987, AIDS, V1, P49; VOELLER B, 1989, CONTRACEPTION, V39, P95, DOI 10.1016/0010-7824(89)90018-8; WINDLE M, 1989, J STUD ALCOHOL, V50, P503, DOI 10.15288/jsa.1989.50.503; 1988, NATIONAL HEAD INJUR; 1986, MORBIDITY MORTALITY, V35, P593; 1987, MORBIDITY MORTALITY, V36, P157; 1986, MORBIDITY MORTALITY, V35, P757; 1990, HIV AIDS SURVEILLANC	43	5	5	1	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1993	7	3					209	217		10.3109/02699059309029673			9	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MA170	WOS:A1993MA17000002	8508177				2022-02-06	
J	POVOLNY, MA; KAPLAN, SP				POVOLNY, MA; KAPLAN, SP			TRAUMATIC BRAIN INJURY OCCURRING WITH SPINAL-CORD INJURY - SIGNIFICANCE FOR REHABILITATION	JOURNAL OF REHABILITATION			English	Article							HEAD-INJURY; DEPRESSION; DEFICITS	Research indicates that traumatic brain injury (TBI) often occurs with traumatic spinal cord injury (SCI). However, the literature strongly suggests that TBI frequently remains undiagnosed in the presence of an SCI; a situation that may account for some rehabilitation failure and unusual affective stance seen in SCI individuals. Rehabilitation programming with people who incur SCI is intensive, and includes relearning daily living skills (ADLs), and communication and vocational skills; efforts requiring the injured person to adequately attend to and process information. Cognitive and emotional sequelae of TBI can adversely effect learning and skills acquisition and, therefore, must be assessed early in the rehabilitation process. We review literature concerning concomitance of TBI and SCI, and, we present specific instruments to assess the presence of TBI in motorically restricted individuals. Finally, we present factors which complicate the assessment of TBI in the SCI population, and provide implications for rehabilitation assessment and intervention procedures.	IIT, CHICAGO, IL 60616 USA		POVOLNY, MA (corresponding author), REHABIL INST CHICAGO, 448 E ONTARIO, CHICAGO, IL 60611 USA.						BUCHANAN L, 1987, SPINAL CORD INJURY C, P1; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P432; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DAVIDOFF GN, 1984, ARCH PHYSICAL MED RE, V66, P451; FISHER DG, 1986, INT J CLIN NEUROPSYC, V8, P14; FRANK RG, 1987, CLIN PSYCHOL REV, V7, P611, DOI 10.1016/0272-7358(87)90009-2; FRASER RT, 1988, CONT CHALLENGES REHA, P217; FRISBIE JHL, 1984, J AM PARAPLEGIC SOC, V7, P611; FULLERTON DT, 1981, ARCH GEN PSYCHIAT, V38, P1369; GOLDEN CJ, 1979, CLIN INTERPRETATION; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; HEVERN VW, 1980, CLIN NEUROPSYCHOLOGY, V2, P49; HOWELL T, 1981, PARAPLEGIA, V19, P284, DOI 10.1038/sc.1981.54; JENNETT B, 1972, SCANDINAVIAN J REHAB, V4; Jennett B, 1981, MANAGEMENT HEAD INJU; JUDD FK, 1986, PARAPLEGIA, V24, P358, DOI 10.1038/sc.1986.53; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Morris J, 1986, J HEAD TRAUMA REHAB, V1, P31; *NAT SPIN CORD INJ, 8 ANN REP; ODONNELL JJ, 1981, ALCOHOL HLTH RES WIN, P27; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; ROTH EJ, 1987, ARCH PHYSICAL MED RE, V8, P673; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; SOLOMON D, 1992, NEUROREHABILITATION, V2, P16; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Stutts M, 1991, NEUROREHABILITATION, V1; SWEENEY TT, 1982, INT J ADDICT, V17, P897, DOI 10.3109/10826088209056336; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; WOODBURY B, 1987, SPINAL CORD INJURY C, P187	40	5	5	0	1	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	1993	59	2					23	27					5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	LN427	WOS:A1993LN42700007					2022-02-06	
J	SANDEL, ME; ODELL, MW				SANDEL, ME; ODELL, MW			PERSISTENT FACIAL MYOCLONUS - A NEGATIVE PROGNOSTIC SIGN IN PATIENTS WITH SEVERE BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						COMA; HEAD INJURIES; MYOCLONUS; PROGNOSIS	TRAUMATIC COMA		UNIV CINCINNATI,DEPT PHYS MED & REHABIL,CINCINNATI,OH 45221		SANDEL, ME (corresponding author), MAGEE MEM REHABILITAT CTR,6 FRANKLIN PLAZA,PHILADELPHIA,PA 19102, USA.						BRESSMAN SB, 1990, NEUROL CLIN, V8, P51, DOI 10.1016/S0733-8619(18)30373-6; Dubinsky R M, 1988, Adv Neurol, V49, P263; Fahn S, 1986, Adv Neurol, V43, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HALLETT M, 1985, EPILEPSIA, V26, P567; JANKOVIC J, 1986, ARCH NEUROL-CHICAGO, V43, P1025, DOI 10.1001/archneur.1986.00520100039012; Klawans H L, 1986, Adv Neurol, V43, P251; Lapresle J, 1986, Adv Neurol, V43, P265; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; OBESO JA, 1985, BRAIN, V108, P193, DOI 10.1093/brain/108.1.193; PRANZATELLI MR, 1985, CLIN NEUROPHARMACOL, V8, P99, DOI 10.1097/00002826-198506000-00001; SANDEL ME, 1990, COMA EMERGING PATIEN, V4, P409; SHAVELSON RJ, 1988, STATISTICAL RESONING, P457; SWAIMAN KF, 1985, NEUROL CLIN, V3, P197, DOI 10.1016/S0733-8619(18)31063-6	14	5	5	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1993	74	4					411	415					5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KX398	WOS:A1993KX39800012	8466424				2022-02-06	
J	SEGAL, J; NARAYAN, RK; MUIZELAAR, JP				SEGAL, J; NARAYAN, RK; MUIZELAAR, JP			PROLONGED BARBITURATE THERAPY IN A PATIENT WITH CLOSED HEAD-INJURY AND JUGULAR VENOUS THROMBOSIS	NEUROSURGERY			English	Article						BARBITURATE COMA; CENTRAL VENOUS CATHETER; CLOSED HEAD INJURY; DEEP VENOUS THROMBOSIS; JUGULAR VEINS	TOTAL PARENTERAL-NUTRITION; SUBCLAVIAN VEIN-THROMBOSIS; LOW-DOSE HEPARIN; PULMONARY-EMBOLISM; UPPER EXTREMITY; NEUROSURGICAL PATIENTS; DEXTRAN 70; PROPHYLAXIS; CATHETERIZATION; COMPLICATIONS	THE CASE OF a patient who sustained a severe closed head injury complicated by jugular venous thrombosis is presented. Early problems with intracranial pressure were related to bifrontal intracerebral contusions. Jugular vein thrombosis became manifest clinically late in the patient's course and was verified by Doppler ultrasonography. Late problems with intracranial hypertension were presumed to be due to decreased cerebral outflow secondary to the thrombosis. The patient required 4 weeks of a high-dose regimen of pentobarbital to control his intracranial pressure. This is an exceptionally long period of time for a patient to be in barbiturate coma for a closed head injury and still make a satisfactory recovery. The incidence, etiology, prevention, and treatment of upper extremity and jugular venous thrombosis are discussed. The ramifications of jugular venous thrombosis in neurosurgical patients are discussed.									ADAMS JT, 1971, J TRAUM, V11, P923, DOI 10.1097/00005373-197111000-00006; ADAMS JT, 1965, ARCH SURG-CHICAGO, V91, P29; BARNETT HG, 1977, J NEUROSURG, V47, P27, DOI 10.3171/jns.1977.47.1.0027; BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744; BLACKETT RL, 1978, BRIT J SURG, V65, P393, DOI 10.1002/bjs.1800650607; BOZZETTI F, 1983, JPEN-PARENTER ENTER, V7, P560, DOI 10.1177/0148607183007006560; BRISMAR B, 1982, ARCH SURG-CHICAGO, V117, P1196; BRISMAR B, 1981, ANN SURG, V194, P779, DOI 10.1097/00000658-198112000-00021; BURT ME, 1981, CLIN RES, V29, pA264; CAMPBELL CB, 1977, SURGERY, V82, P816; CERRATO D, 1978, J NEUROSURG, V49, P378, DOI 10.3171/jns.1978.49.3.0378; CHASTRE J, 1982, NEW ENGL J MED, V306, P278, DOI 10.1056/NEJM198202043060506; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; COON WW, 1967, ARCH SURG-CHICAGO, V94, P657; COWAN F, 1983, ACTA PHYSIOL SCAND, V117, P131, DOI 10.1111/j.1748-1716.1983.tb07187.x; DEFALQUE RJ, 1988, JPEN-PARENTER ENTER, V12, P406, DOI 10.1177/0148607188012004406; DETAKATS G, 1950, JAMA-J AM MED ASSOC, V142, P527, DOI 10.1001/jama.1950.02910260001001; DICOSTANZO J, 1984, JPEN-PARENTER ENTER, V8, P293, DOI 10.1177/0148607184008003293; DONAYRE CE, 1986, AM J SURG, V152, P179, DOI 10.1016/0002-9610(86)90238-2; DRAPANAS T, 1966, J TRAUM, V6, P107, DOI 10.1097/00005373-196601000-00012; DRESSER LP, 1987, AM J SURG, V154, P220, DOI 10.1016/0002-9610(87)90185-1; EMERSON TE, 1975, CEREBRAL CIRCULATION, P10; FABRI PJ, 1982, SURG GYNECOL OBSTET, V155, P238; FISHER J, 1982, CIRCULATION, V65, P188, DOI 10.1161/01.CIR.65.1.188; GRUBER UF, 1980, BRIT MED J, V280, P69, DOI 10.1136/bmj.280.6207.69; Hughes ESR., 1949, INT ABSTR SURG, V88, P89; KAHN SE, 1985, AM HEART J, V110, P891, DOI 10.1016/0002-8703(85)90478-8; KAKKAR VV, 1980, LANCET, V1, P103; KLINE A, 1975, BRIT MED J, V2, P109, DOI 10.1136/bmj.2.5963.109; LADEFOGED K, 1978, BRIT MED J, V2, P262, DOI 10.1136/bmj.2.6132.262; LANGE HW, 1983, AM J CARDIOL, V52, P1108, DOI 10.1016/0002-9149(83)90542-8; LOKICH JJ, 1983, CANCER, V52, P1586, DOI 10.1002/1097-0142(19831101)52:9<1586::AID-CNCR2820520908>3.0.CO;2-4; LOKICH JJ, 1985, J CLIN ONCOL, V3, P710, DOI 10.1200/JCO.1985.3.5.710; MATAS R, 1934, AM J SURG, V24, P642; MCDONOUGH JJ, 1971, SURG GYNECOL OBSTETR, V133, P397; PADBERG FT, 1981, ANN SURG, V193, P264, DOI 10.1097/00000658-198103000-00002; PAINTER TD, 1984, ANGIOLOGY, V35, P743, DOI 10.1177/000331978403501110; POLLAK EW, 1980, SOUTHERN MED J, V73, P1503, DOI 10.1097/00007611-198011000-00025; Pottecher T, 1984, Eur J Anaesthesiol, V1, P361; POWERS SK, 1982, NEUROSURGERY, V10, P509, DOI 10.1227/00006123-198204000-00018; PRESCOTT SM, 1979, CIRCULATION, V59, P350, DOI 10.1161/01.CIR.59.2.350; RAISANEN H, 1979, NEW TESTAMENT STUD, V26, P101, DOI 10.1017/S0028688500008699; ROSS AHM, 1982, JPEN-PARENTER ENTER, V6, P61, DOI 10.1177/014860718200600161; RUSSELL JC, 1983, SURG GYNECOL OBSTET, V157, P89; RYAN JA, 1974, NEW ENGL J MED, V290, P757, DOI 10.1056/NEJM197404042901401; SINDOU M, 1980, NOUV PRESSE MED, V9, P439; SMITH VC, 1983, SOUTHERN MED J, V76, P603, DOI 10.1097/00007611-198305000-00018; SOTOVELASCO JM, 1984, CLEVELAND CLIN Q, V51, P159, DOI 10.3949/ccjm.51.1.159; STEPHENS PH, 1991, BRIT J ANAESTH, V67, P476, DOI 10.1093/bja/67.4.476; STONEY WS, 1976, ANN THORAC SURG, V22, P166, DOI 10.1016/S0003-4975(10)63980-X; SWINTON NW, 1968, CIRCULATION, V38, P737, DOI 10.1161/01.CIR.38.4.737; TILNEY NL, 1970, ARCH SURG-CHICAGO, V101, P792; TOUNG TJK, 1988, ANESTHESIOLOGY, V68, P53, DOI 10.1097/00000542-198801000-00009; VALERIO D, 1981, JPEN-PARENTER ENTER, V5, P240, DOI 10.1177/0148607181005003240; WARDEN GD, 1973, J TRAUMA, V13, P620, DOI 10.1097/00005373-197307000-00006	55	5	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	1993	32	3					468	472		10.1227/00006123-199303000-00023			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KT020	WOS:A1993KT02000023	8455776				2022-02-06	
J	LANG, W; OTT, R; HAAS, P; SCHWEIGER, H				LANG, W; OTT, R; HAAS, P; SCHWEIGER, H			POPLITEAL ARTERIOVENOUS-FISTULA AFTER CORRECTIVE UPPER TIBIAL OSTEOTOMY	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article								Injuries to the popliteal artery or vein are rare complications of knee arthroscopy or osteosynthesis at the distal femur or the proximal tibia. We report a case of iatrogenic arteriovenous fistula after proximal tibial osteotomy for varus deformity. A 71-year-old woman complained of pain and swelling of the foot 9 weeks after a corrective barrel-vault osteotomy of the left tibia. Angiography demonstrated an arteriovenous fistula between the popliteal vessels due to osteotomy of the tibial head. The fistula was separated and popliteal vessels closed by continuous suture and a small saphenous vein patch.	UNIV HOSP ERLANGEN,DEPT SURG,DIV VASC SURG,ERLANGEN,GERMANY; UNIV HOSP ERLANGEN,DEPT ORTHOPAED,ERLANGEN,GERMANY								JEFFRIES JT, 1987, J BONE JOINT SURG AM, V69A, P783, DOI 10.2106/00004623-198769050-00025; ROTH JH, 1988, J BONE JOINT SURG BR, V70, P840, DOI 10.1302/0301-620X.70B5.3192593; TAWES RL, 1988, AM J SURG, V156, P136, DOI 10.1016/S0002-9610(88)80374-X; WILLIAMSON DM, 1989, INJURY, V20, P310, DOI 10.1016/0020-1383(89)90181-2	4	5	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	FEB	1993	112	2					99	100		10.1007/BF00420266			2	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	KN848	WOS:A1993KN84800014	8457422				2022-02-06	
J	YUEN, HK; HARTWICK, JA				YUEN, HK; HARTWICK, JA			DIET MANIPULATION TO RESUME REGULAR FOOD-CONSUMPTION FOR AN ADULT WITH TRAUMATIC BRAIN INJURY	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						BRAIN DAMAGE, CHRONIC; DEGLUTITION DISORDERS; REHABILITATION			NEW MEDICO HIGHWATCH REHABIL CTR, CTR OSSIPEE, NH USA		YUEN, HK (corresponding author), ANDERSON MEM HOSP, REHABIL SERV, 800 N FANT ST, ANDERSON, SC 29621 USA.		yuen/AAB-6219-2021	yuen/0000-0001-5696-1845			ASHER I E, 1986, Occupational Therapy in Health Care, V3, P5, DOI 10.1080/J003v03n02_02; Cherney LR, 1989, J HEAD TRAUMA REHAB, V4, P42; HUTCHINS B, 1988, DYSPHAGIA INSTRUCTIO; HUTCHINS B, 1989, J HEAD TRAUMA REHAB, V4, P64; LANGLEY J, 1989, WORKING SWALLOWING D; Logemann JA, 1983, EVALUATION TREATMENT; SOBSEY R, 1983, MENTAL RETARDATION L, V11, P85; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; 1987, AM SPEECH LANGUAGE H, V29, P57	9	5	5	0	1	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	OCT	1992	46	10					943	945		10.5014/ajot.46.10.943			3	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	JP195	WOS:A1992JP19500010	1463067				2022-02-06	
J	GONSER, A				GONSER, A			PROGNOSIS, LONG-TERM CONSEQUENCES AND VOCATIONAL OUTCOME 2 TO 4 YEARS AFTER SEVERE BRAIN INJURY	NERVENARZT			German	Article							CLOSED HEAD-INJURY; FOLLOW-UP; REHABILITATION; SCALE	122 patients with severe head injuries were assessed in terms of their global outcome and social and vocational reintegration 2 to 4 years after trauma. Some patients were studied with regard to physical, psychological, psychosocial, and cognitive long-term consequences. Less than half of the patients (43%) were found to be without employment handicap, while the remainder showed various degrees of occupational difficulty. Most of the patients had significant long-term problems related to cognitive and psychosocial dysfunction. The cognitive disorder, physical handicap, age, and duration of unconsciousness are all important prognostic factors for vocational reintegration, neuropyschological impairment being the single most important factor.			GONSER, A (corresponding author), UNIV HOSP ZURICH,NEUROL KLIN,NEUROPSYCHOL ABT,FRAUENKLIN STR 26,CH-8091 ZURICH,SWITZERLAND.						ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2, P219; ANNONI JM, 1991, SCHWEIZ MED WSCHR, V121, P207; Bach-y-Rita P., 1980, RECOVERY FUNCTION TH; Benson D.F., 1986, FRONTAL LOBES; Brierley J. B., 1977, AMNESIA, P199; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROOKS N, 1984, CLOSED HEAD INJURY P; CHAPMAN JC, 1924, CHAPMAN COOK SPEED R; Corsi P.M., 1972, HUMAN MEMORY MEDIAL; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GONSER A, 1989, PROGNOSE REHABILITAT; HAGEL KH, 1982, UNFALLHEILKUNDE, V85, P192; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1981, MANAGEMENT HEAD INJU; JENNETT B, 1984, CLOSED HEAD INJURY P, P37; KRAMER J, 1970, KURZE ANLEITUNG INTE; LANDIS T, 1987, THER UMSCH, V44, P216; LASOGGA R, 1980, PROGNOSE REHABILITAT, pS109; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Levin HS, 1989, NEUROPSYCHOLOGY, V3, P243, DOI 10.1037//0894-4105.3.4.243; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; LUCKING CH, 1980, PROGNOSE REHABILITAT, pS77; McKinlay W W, 1987, Brain Inj, V1, P3, DOI 10.3109/02699058709034438; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Milner B., 1964, FRONTAL GRANULAR COR, P313; NEUNZIG HP, 1987, FORTSCHR NEUROL PSYC, V55, P223, DOI 10.1055/s-2007-1001824; ODDY M, 1984, CLOSED HEAD INJURY P, P108; PAMPUS I, 1980, PROGNOSE REHABILITAT, pS83; Perret E., 1973, GEHIRN VERHALTEN NEU; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; REY A, 1959, TEST COPY REPRODUCTI; ROSENTHAL M, 1983, REHABILITATION HEAD; RUCKERT RF, 1985, UNFALLCHIRURG, V88, P99; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SCHMIEDER F, 1980, PROGNOSE REHABILITAT, pS89; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE G, 1974, LANCET, V2, P81; THURSTONE LL, 1941, CHICAGO TESTS PRIMAR; TONNIS W, 1968, OGRANISATION BEHANDL; WECHSLER D, 1965, WECHSLER MEMORY SCAL; Wechsler D., 1964, MESSUNG INTELLIGENZ; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WUTHRICH P, 1987, THER UMSCH, V44, P176; Zazzo R., 1969, MANUEL EXAMEN PSYCHO, V3; 1979, INT KLASSIFIKATION K	55	5	9	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-2804			NERVENARZT	Nervenarzt	JUL	1992	63	7					426	433					8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JD549	WOS:A1992JD54900006	1501721				2022-02-06	
J	MAROON, JC; BAILES, JE; YATES, A; NORWIG, J				MAROON, JC; BAILES, JE; YATES, A; NORWIG, J			ASSESSING CLOSED HEAD-INJURIES	PHYSICIAN AND SPORTSMEDICINE			English	Article											MAROON, JC (corresponding author), MED COLL PENN,NEUROSURG,PHILADELPHIA,PA 19129, USA.							0	5	5	0	0	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	APR	1992	20	4					37	&					0	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	HL778	WOS:A1992HL77800002	27424636				2022-02-06	
J	FINSET, A				FINSET, A			SUBACUTE BRAIN INJURY REHABILITATION - A PROGRAM DESCRIPTION AND A STUDY OF STAFF PROGRAM-EVALUATION	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article								The concept of continuity of care is introduced and briefly discussed. Three aspects of subacute rehabilitation of patients with Traumatic Brain Injury (TBI) are discussed: the need for differentiated treatment programs, for team integration and emphasis on environmental or milieu factors to accomplish treatment success. The so called Wing Team Model at the TBI Unit at Sunnaas Rehabilitation Hospital is described. In our program the patients are divided in three groups: the North Wing Program, for slow to recover patients, the East Wing program for patients with severe sequelae after TBI and the South Wing Program for ambulatory patients mainly with cognitive sequelae. A questionnaire study of how staff members evaluate certain aspects of the program is presented. The study indicates that the staff members have in general a positive attitude towards the treatment model, but they wish an improved team coordination of the individual programs.			FINSET, A (corresponding author), SUNNAAS REHABIL HOSP,N-1450 NESODDTANGEN,NORWAY.							0	5	5	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1992				26			25	33					9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KG064	WOS:A1992KG06400003	1488638				2022-02-06	
J	SCHUTTABRAHAM, I; KNAUERKRAETZL, B; WORMUTH, HJ				SCHUTTABRAHAM, I; KNAUERKRAETZL, B; WORMUTH, HJ			OBSERVATIONS DURING CAPTIVE BOLT STUNNING OF RABBITS	BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT			German	Article						STUNNING; RABBITS; CAPTIVE BOLT APPARATUS		78 rabbits of mixed breed and about 3 kg live weight were stunned before slaughter with a commercial spring operated captive bolt apparatus designed for rabbits and water fowl. The following reaction patterns were observed: 1.) Immediate onset of tonic spasm, followed by weak to heavy clonic spasms and/or subsequent relaxation; irreversible loss of corneal reflex and cessation of respiration: effective and irreversible stun tantamount to killing 2.) Same reaction as before except that respiration restarted after 1/2 to 2 min: effective but only temporary stun 3.) Similar reaction as before, but respiration maintained: insufficient stun 4.) Immediate onset of weak tonic spasm; respiration and corneal reflex maintained: insufficient stun. According to this classification 56 rabbits (72 %) were killed outright and 18 (23 %) temporarily stunned while in 4 (5 %) the stun was ineffective. The captive bolt apparatus proved thus to be principally suited for the stunning resp. killing of slaughter rabbits. The best stunning results were obtained with shots into the parietal bone near the sagittal line but not hitting the bone sutures. To achieve this the apparatus has to be placed slightly paramedian on the front as close to the ears as possible. Insufficient stunning results could be blamed on deviating shooting positions. To avoid misses a good fixation of the animal including its head is necessary. Correct application provided the use of penetrating concussion stunners should be preferred to applying a blow to the neck for stunning rabbits.			SCHUTTABRAHAM, I (corresponding author), BUNDESGESUNDHEITSAMT,INST VET MED,POSTFACH 330013,W-1000 BERLIN 33,GERMANY.						AVMA, 1986, J AM VET MED ASSOC, V188, P252; DALY CC, 1989, RES VET SCI, V46, P406, DOI 10.1016/S0034-5288(18)31189-5; DICKEL H, 1976, ARCH TIERARZTLICHE F, V3; GEY K, 1978, ERGEBNISSE VERSUCHEN, V23, P92; GREGORY NG, 1990, VET REC, V126, P570; GREGORY NG, 1988, STUNNING LIVESTOCK; Ochakovskii V. S., 1976, Trudy, Vsesoyuznyi Nauchno-Issledovatel'skii Institut Myasnoi Promyshlennosti, V20, P21; Tholen V., 1987, Rundschau fur Fleischhygiene und Lebensmitteluberwachung, V39, P88; WORMUTH HJ, 1981, VET MED BERICHTE	9	5	5	0	4	BLACKWELL WISSENSCHAFTS-VERLAG GMBH	BERLIN	KURFURSTENDAMM 57, D-10707 BERLIN, GERMANY	0005-9366			BERL MUNCH TIERARZTL	Berliner Munchener Tierarztl. Wochenschr.	JAN 1	1992	105	1					10	15					6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	HA629	WOS:A1992HA62900003	1543476				2022-02-06	
J	ALTENMULLER, E; CORNELIUS, CP; UHL, H				ALTENMULLER, E; CORNELIUS, CP; UHL, H			FLASH-EVOKED VISUAL POTENTIALS IN THE EARLY DIAGNOSIS OF OPTIC-NERVE INJURY DUE TO CRANIOFACIAL FRACTURES	EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE			German	Article						FLASH EVOKED VISUAL POTENTIALS; VEP IN COMA; FLASH VEP IN CRANIOFACIAL FRACTURES	TRAUMA	Impairment or loss of vision due to optic nerve injury occurs in about 10% of patients with cranio-facial fractures. The assessment of optic nerve function is important for decisions regarding optic nerve decompression. But examination of vision and pupillary reflexes may be difficult, especially in uncooperative patients with reduced consciousness and primary disturbances of pupillary functions. In these cases, optic nerve function can be monitored by means of flash-evoked visual potentials elicited by use of a LED-goggle stimulator. VEPs were recorded in ten patients with head injuries comprising cranio-facial fractures and cerebral concussion with prolonged alteration of consciousness. Recordings were obtained in the acute phase upon admission. Visual acuity and visual fields were examined after regaining consciousness and the clinical findings correlated to the initial VEPs. Upon clinical examinations, four patients with initially normal VEPs had normal vision on both eyes. One patient initially revealed unilateral reduction of the VEP-amplitude of more than 50% and clinically showed a concentric visual field defect. Three patients with unilateral loss of potentials were amaurotic on this side. Perception of light was preserved in one patient in whom VEPs were absent. One patient with bilateral loss of potentials was blind when consciousness was regained. In general, pupillary light reflexes tested at admission corresponded to the VEP-findings. In two cases, however, pupillary reactivity was lost, but VEPs were still present. These patients had normal vision, but exhibited a lesion of the efferent pathways of pupillary reflexes. In two other patients, examination of pupillary reactivity could not be performed due to extreme edema of the eyelids. According to this results, investigations of flash-VEP in uncooperative, severely traumatized patients with cranio-facial fractures seems to be a valid parameter of optic nerve function with high prognostic significance. Since early diagnosis of optic nerve injury is crucial for successful surgical therapy, VEP-monitoring may by decisive for optic nerve decompression.	ZAHN MUND & KIEFERKLIN,TUBINGEN,GERMANY		ALTENMULLER, E (corresponding author), UNIV TUBINGEN,NEUROL KLIN,HOPPE SEYLER STR 3,W-7400 TUBINGEN 1,GERMANY.		Altenmuller, Eckart/AAB-9948-2021				ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; BRIHAYE J, 1901, CRANIAL NERVES, P116; CEDZICH C, 1987, NEUROSURGERY, V21, P709, DOI 10.1227/00006123-198711000-00018; CELESIA GC, 1987, ELECTROENCEPHALOGRAP, P773; CLIFFORDJONES RE, 1980, J NEUROL SCI, V46, P239, DOI 10.1016/0022-510X(80)90082-9; FEINSOD M, 1973, EUR NEUROL, V9, P56, DOI 10.1159/000114201; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; HALLIDAY AM, 1982, EVOKED POTENTIALS CL; HOLT GR, 1983, OTOLARYNG HEAD NECK, V91, P276, DOI 10.1177/019459988309100313; JACOBSON JH, 1958, ANN NY ACAD SCI, V74, P362, DOI 10.1111/j.1749-6632.1958.tb39557.x; KLINE LB, 1984, NEUROSURGERY, V14, P756, DOI 10.1227/00006123-198406000-00021; McDonald WI, 1977, VISUAL EVOKED POTENT, P427; NUWER MR, 1987, EVOKED POTENTIALS MO, P172; OSGUTHORPE JD, 1988, OTOLARYNG CLIN N AM, V21, P155; SHAKED A, 1982, ACTA NEUROCHIR, V62, P91, DOI 10.1007/BF01402214; Turner JWA, 1943, BRAIN, V66, P140	16	5	5	0	1	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0941-3790			EEG-EMG-Z ELEK ELEKT	EEG-EMG-Z. Elektroenz. Elektron. Geb.	DEC	1991	22	4					224	229					6	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	GZ048	WOS:A1991GZ04800006	1786783				2022-02-06	
J	LEE, JP				LEE, JP			INTRAPARENCHYMAL AND INTRAVENTRICULAR HEMORRHAGE WITHOUT MASS EFFECT IN TRAUMATIC COMA	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; COMPUTERIZED-TOMOGRAPHY; BRAIN-DAMAGE; CT SCAN; LESIONS	A group of 57-head injured patients showing computerized tomographic (CT) findings compatible with "diffuse brain injury" or of the so called "diffuse axonal injury" is analyzed. Thirty-four patients showed intraparenchymal hemorrhage in the CT scan study, 8 intraventricular hemorrhage and 15 patients had both intraparenchymal and intraventricular hemorrhage. Forty percent (23/57) of those with these findings had associated intracranial focal lesions. The deep nuclei are the most common location of intraparenchymal hemorrhage. Signs of brain stem hemorrhage were seen in 9 patients. Forty-nine percent of patients in this series had a good outcome. Old age (> 60), abnormal motor response, abnormal eye signs, associated with focal lesions, and evidence of brain stem hemorrhage are reliable prognostic parameters for a grave outcome.	CHANG GUNG MED COLL, DEPT SURG, DIV NEUROSURG, TAIPEI, TAIWAN; CHANG GUNG MEM HOSP, TAIPEI, TAIWAN								ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CROMPTON MR, 1971, LANCET, V1, P669; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GEORGE B, 1981, ACTA NEUROCHIR, V59, P35, DOI 10.1007/BF01411189; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; Holbourn AHS, 1943, LANCET, V2, P438; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; PAPO I, 1980, ACTA NEUROCHIR, V52, P249, DOI 10.1007/BF01402080; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; RICHARDS T, 1974, SURGERY, V75, P253; SAHUQUILLOBARRIS J, 1985, NEUROSURGERY, V17, P378; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P215, DOI 10.1136/jnnp.42.3.215; Stewart W A, 1973, Surg Neurol, V1, P303; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TEASDALE G, 1974, LANCET, V2, P81; TSAI FY, 1980, AM J NEURORADIOL, V1, P23; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZIMMERMAN RA, 1977, NEURAL TRAUMA, P253; [No title captured]	34	5	5	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	1991	18	4					458	462		10.1017/S0317167100032157			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT869	WOS:A1991GT86900003	1782610	Bronze			2022-02-06	
J	WANG, GL; ZHU, C				WANG, GL; ZHU, C			EFFECTS OF THYROTROPIN-RELEASING-HORMONE ON ACUTE EXPERIMENTAL TRAUMATIC HEAD-INJURY IN CATS	CHINESE MEDICAL JOURNAL			English	Article								The effects of thyrotropin-releasing hormone (TRH) on early acute traumatic head injury in cats were evaluated by continuous intravenous infusion of TRH (2 mg/kg/h) or saline (2 ml/kg/h) for four hours, beginning one hour after injury. The results showed that TRH, administered intravenously, significantly increased the mean arterial pressure and cerebral perfusion pressure, decreased intracranial pressure, alleviated brain edema, and reduced the mortality rate. These effects promoted the recovery of neurologic function following traumatic head injury. Because of the significant central action and the ability to antagonize many pathophysiological effects of endogenous opioids or exogenous opiates except their analgesic effects, TRH and its analogs have broad prospects in the treatment of patients with CNS injuries or shock.			WANG, GL (corresponding author), CHANG ZHENG HOSP, SECOND MIL MED UNIV, DEPT NEUROSURG, SHANGHAI 200003, PEOPLES R CHINA.						FADEN AI, 1983, TRENDS NEUROSCI, V6, P375, DOI 10.1016/0166-2236(83)90168-6; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1452, DOI 10.1001/jama.252.11.1452; ITO U, 1979, STROKE, V10, P542, DOI 10.1161/01.STR.10.5.542; MCINTOSH TK, 1988, AM J PHYSIOL, V254, P785; WANG GL, 1990, CHIN J ENDOCRINOL ME, V6, P105; WANG GL, 1990, CHIN J NEUROSURG, V6, P61; WANG GL, 1991, MED J CHIN PLA, V16, P127; WANG ZT, 1990, J MATER PROCESS TECH, V21, P275	8	5	6	0	0	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	NOV	1991	104	11					939	944					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ266	WOS:A1991GQ26600012	1800036				2022-02-06	
J	BERNAD, PG				BERNAD, PG			NEURODIAGNOSTIC TESTING IN PATIENTS WITH CLOSED HEAD-INJURY	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article						CLOSED HEAD INJURY, TYPE-1 AND TYPE-2; CONCUSSION; ELECTROENCEPHALOGRAPHY; ELECTRONYSTAGMOGRAPHY; EVOKED POTENTIALS; NEUROPSYCHOLOGICAL TESTING; POSTCONCUSSION SYNDROME	AUDITORY EVOKED-POTENTIALS; POST-CONCUSSION SYNDROME; DIZZINESS; RECOVERY; COMA				BERNAD, PG (corresponding author), NEURENTOX INT,2112 F ST NW,SUITE 303,WASHINGTON,DC 20037, USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; AHMED I, 1984, CLIN ELECTROENCEPHAL, V15, P110, DOI 10.1177/155005948401500208; ANDERSON FH, 1973, ARCH NEUROL-CHICAGO, V29, P437, DOI 10.1001/archneur.1973.00490300099015; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BENTAL E, 1968, ELECTROEN CLIN NEURO, V24, P192; BERNAD M, 1988, THESIS BOSTON U; BERNAD PG, 1988, CLIN ELECTROENCEPHAL, V19, P46; BERNAD PG, 1988, CLIN ELECTROENCEPHAL, V19, P174; BOLL TJ, 1982, HEAD INJURY; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CARROL C, 1986, J MUSCULOSKELETAL ME, V3, P57; CAVENESSW, 1977, TRAUMA, V27, P61; CONLIN FD, 1983, CONT ORTHO, V6, P79; DOW RS, 1945, AM J PSYCHIAT, V101, P174; DRAKE ME, 1986, NEUROLOGY, V36, P163; DRAKE ME, 1987, CLIN EVOKED POTENTIA, V5, P19; DRAKE ME, 1987, CLIN EV POT, V5, P26; FRANKOWSKI RAJ, 1985, DESCRIPTIVE EPIDEMIO; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GIBBS EL, 1982, CLIN ELECTROENCEPHAL, V13, P160; GIBBS FA, 1987, CLIN ELECTROENCEPHAL, V18, P10; Gibbs Frederic A., 1944, AMER JOUR PSYCHIATRY, V100, P738; GOSWASSER Z, 1987, SURG NEUROL, V27, P331; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HAUSER WA, 1982, NEW ENGL J MED, V307, P522, DOI 10.1056/NEJM198208263070903; HUGHES JR, 1982, EEG CLIN PRACTICE; HUGHES JR, 1983, EEG EVOKED POTENTIAL; JACOME DE, 1984, CLIN ELECTROENCEPHAL, V15, P214, DOI 10.1177/155005948401500406; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JERRETT B, 1983, ROYAL SOC MED INT C, V60, P49; JERRETT B, 1975, EPILEPSIA, V16, P251; JUNG R, 1953, HDB INNER MED, V1, P1206; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Mark VH., 1970, VIOLENCE BRAIN; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUSSELL WR, 1974, LANCET, V2, P1315; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, V44, P1181, DOI 10.1001/archneur.1987.00520230061015; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; TEASDALE G, 1974, LANCET, V2, P81; TOGLIA JU, 1976, NEUROLOGY, V26, P808, DOI 10.1212/WNL.26.9.808; Toglia JU, 1969, LATE EFFECTS HEAD IN, P72; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; [No title captured]; 1987, MAR MILD HEAD INJ C	49	5	5	0	0	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1991	22	4					203	210		10.1177/155005949102200408			8	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	GJ613	WOS:A1991GJ61300004	1934517				2022-02-06	
J	MAEDER, P; WIRSEN, A; BAJC, M; SCHALEN, W; SJOHOLM, H; SKEIDSVOLL, H; CRONQVIST, S; INGVAR, DH				MAEDER, P; WIRSEN, A; BAJC, M; SCHALEN, W; SJOHOLM, H; SKEIDSVOLL, H; CRONQVIST, S; INGVAR, DH			VOLUMES OF CHRONIC TRAUMATIC FRONTAL BRAIN-LESIONS MEASURED BY MR IMAGING AND CBF TOMOGRAPHY	ACTA RADIOLOGICA			English	Article						BRAIN, INJURIES; VOLUME; MR STUDIES; SPECT	SEVERE HEAD-INJURIES; COMPUTED-TOMOGRAPHY; LOBE; MILD	The volumes (ml) of chronic traumatic frontal brain lesions were compared measured "morphologically" with MR imaging (T1 and T2 weighted images) and "functionally" with a tomographic rCBF technique (SPECT with Xe-133 i.v.). The T1 volumes varied between 11 and 220 ml. The correlation between T1 and T2 volumes was 0.95, the T2 volumes being 33% larger than T1 volumes (p < 0.001). The functional SPECT volumes were considerably larger (range 16-324 ml) than the MR volumes. The mean volume difference was 81% between T1 and SPECT images (p < 0.001), and 35% between T2 and SPECT images (p < 0.001). Correlations between the MR and SPECT volumes were also higher for T2 than T1 volumes. The volume difference is most likely explained by a functional decrease in regions around the lesion in which no morphologic change visible on MR images had taken place. MR and SPECT volume measurements were positively related to persistent lack of energy and personality changes, but only moderately related to duration of impaired consciousness and neuropsychologic outcome.	UNIV LUND HOSP, DEPT CLIN NEUROPHYSIOL, S-22185 LUND, SWEDEN; UNIV LUND HOSP, DEPT NEURORADIOL, S-22185 LUND, SWEDEN; UNIV LUND HOSP, DEPT NEUROSURG, S-22185 LUND, SWEDEN								BRADVIK B, 1990, ACTA NEUROL SCAND, V81, P61; CANAVAN AGM, 1985, J NEUROL NEUROSUR PS, V48, P1049, DOI 10.1136/jnnp.48.10.1049; CELSIS P, 1981, J COMPUT ASSIST TOMO, V5, P641, DOI 10.1097/00004728-198110000-00006; ESCOURELLE R, 1979, MANUAL BASIC NEUROPA; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Hebb DO, 1940, ARCH NEURO PSYCHIATR, V44, P421, DOI 10.1001/archneurpsyc.1940.02280080181011; HEBB DO, 1945, ARCH NEURO PSYCHIATR, V54, P10, DOI 10.1001/archneurpsyc.1945.02300070020002; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KANNO I, 1979, J COMPUT ASSIST TOMO, V3, P71, DOI 10.1097/00004728-197902000-00012; KUHN MJ, 1988, RADIOLOGY, V168, P199, DOI 10.1148/radiology.168.1.3380957; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LASSEN NA, 1988, BASIC MECHANISMS HEA, P61; Levin HS, 1989, NEUROPSYCHOLOGY, V3, P243, DOI 10.1037//0894-4105.3.4.243; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; RISBERG J, 1986, EXPT TECHNIQUES HUMA, P514; Ruff R. M., 1989, NEUROPSY NEUROPSY BE, V2, P103; SHENKIN HA, 1961, ARCH NEUROL-CHICAGO, V4, P365, DOI 10.1001/archneur.1961.00450100013003; SKINHOJ E, 1965, ACTA NEUROL SCAND, VS 41, P161; TEASDALE G, 1974, LANCET, V2, P81; VAUGHN G, 1988, RADIOLOGY, V167, P517; Vogt C, 1920, J PSYCHOL NEUROL, V25, P279; von Monakow-Zunch C, 1910, J PSYCHOL NEUROL, V17, P185; WALKER AE, 1938, PRIMATE THALAMUS; Watts JW, 1950, PSYCHOSURGERY TREATM; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WIRSEN A, UNPUB DIFFUSE NEUROP; WIRSEN A, 1991, UNPUB NORMAL RCBF AC; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; Zimmerman RA, 1989, NEUROPSYCHOLOGY, V3, P191, DOI 10.1037/h0091791	35	5	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	JUL	1991	32	4					271	278					8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GB141	WOS:A1991GB14100002	1863498				2022-02-06	
J	IUVARABOMMELI, A; DETRIBOLET, N				IUVARABOMMELI, A; DETRIBOLET, N			DELAYED INTRACRANIAL HEMATOMA AFTER CRANIOCEREBRAL TRAUMA	SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT			German	Article							INTRACEREBRAL HEMATOMAS; CEREBRAL HEMATOMAS; HEMORRHAGE; ONSET	We present a retrospective study of 30 cases of delayed intracranial hematoma, of which 28 were intracerebral, 5 epidural and 2 subdural. Follow-up of the neurologic and radiologic evolution aimed at determining the risk factors capable of predicting the occurrence of delayed intracranial hematoma. 14 patients had a Glasgow score of 15 on admission. 11 patients were neurologically entirely normal and did not undergo an initial CT-scan. In the 19 cases where it was performed the initial CT-scan showed contusion in 9 cases, edema in 6 and epidural hematoma in 7. A skull fracture was diagnosed in 22 patients. The most significant prognostic factor was the level of the Glasgow score on admission. Of the 14 patients who had a score of 15, 7 made good recoveries, 4 had a minor handicap, 1 a severe handicap and 2 died. Delayed intracerebral hematomas are highly unpredictable and can occur in any age group, in patients who are fully conscious on admission, and in patients with a normal CT-scan, with or without fracture. Our current policy is the following: no concussion but normal neurological findings: discharge home; concussion but normal neurological findings on admission: plain skull films; if fracture, 24 hours' hospital supervision; if no fracture, discharge home; abnormal neurological findings on admission: CT-scan; repeat CT if there is secondary neurological deterioration, secondary rise in intracranial pressure, or lack of improvement after 24 hours, and in all sedated and hyperventilated patients after 24 hours.	CHU VAUDOIS,SERV NEUROCHIRURG,CH-1011 LAUSANNE,SWITZERLAND								BARATHAM G, 1972, J NEUROL NEUROSUR PS, V35, P698, DOI 10.1136/jnnp.35.5.698; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BRUNETTI J, 1979, NEURORADIOLOGY, V18, P43, DOI 10.1007/BF00346211; DEMIERRE B, 1987, NEUROCHIRURGIE, V33, P12; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; FANKHAUSER H, 1983, NEUROCHIRURGIE, V29, P255; Gentleman D, 1989, Br J Neurosurg, V3, P367, DOI 10.3109/02688698909002817; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; HIRSH LF, 1979, NEUROSURGERY, V5, P653, DOI 10.1227/00006123-197912000-00001; JENNETT B, 1975, LANCET, V1, P480; LIPPER MH, 1979, NEURORADIOLOGY, V133, P645; NINCHOJI T, 1984, ACTA NEUROCHIR, V71, P69, DOI 10.1007/BF01401152; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006	15	5	5	0	1	SCHWABE & CO AG VERLAG	MUTTENZ 1	FARNSBURGERSTRASSE 8, CH-4132 MUTTENZ 1, SWITZERLAND	0036-7672			SCHWEIZ MED WSCHR	Schweiz. Med. Wochenschr.	MAY 4	1991	121	18					646	652					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK881	WOS:A1991FK88100003	2047825				2022-02-06	
J	VINZ, H; FRANZ, R; KURZ, W; MEHNERT, P; WAHL, D				VINZ, H; FRANZ, R; KURZ, W; MEHNERT, P; WAHL, D			TREATMENT OF THE MONTEGGIA-FRACTURE IN CHILDHOOD	ZENTRALBLATT FUR CHIRURGIE			German	Article						MANAGEMENT OF FRACTURES IN CHILDREN; MONTEGGIA FRACTURE; OSTEOSYNTHESIS; RADIAL HEAD; DISLOCATION; ULNAR FRACTURE		Described in this paper is a therapeutic concept by which to cope with Monteggia's fracture in childhood. It is based on experience obtained from 72 cases with injuries of that kind and their evaluation in a group study. Therapeutic approach to the individual case was determined by the following criteria: age of infant, localisation and shape of ulnar fracture, reducibility of capitulum radii, and accompanying injuries requiring treatment on the same arm. The need for surgical stabilisation of ulnar fracture was found to increase along with growing age of the affected child. High-stability anatomic reduction of the ulnar fracture proved to be a prerequisite for safe stabilisation of the radial capitulum. Close reduction has proved to be sufficient in many instances. Open reduction and internal fixation were found to be necessary in cases in which an ulnar fracture was irreducible or unstable and/or a radial head was not reducible. Minimal osteosynthesis and plaster cast is considered to be an optional therapy for younger children, whereas ulnar stabilisation by means of plates is preferred for children in somewhat advanced age of childhood. The radial head may be fixed by transarticular Kirschner's wire (WITT) or primary reconstruction of the annular ligament, using a strip of biceps or triceps tendon, or adaptation around the collum radii and ulna of the proximal radio-ulnar joint by means of a sling of Dexon(R) or Vicryl(R) suture.			VINZ, H (corresponding author), KREISKRANKENHAUS,CHIRURG ABT,AUGUST BEBEL STR 55A,W-3270 BURG,GERMANY.							0	5	5	0	0	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-409X			ZBL CHIR	Zent.bl. Chir.		1991	116	3					143	150					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FH984	WOS:A1991FH98400001	2042406				2022-02-06	
J	MCCARROLL, JE; GUNDERSON, C				MCCARROLL, JE; GUNDERSON, C			5-YEAR STUDY OF INCIDENCE RATES OF HOSPITALIZED CASES OF HEAD-INJURIES IN THE UNITED-STATES-ARMY	NEUROEPIDEMIOLOGY			English	Article						EPIDEMIOLOGY; MILITARY MEDICINE; HEAD INJURY	POPULATION; TRAUMA	Incidence rates of hospitalized head injury cases in the US Army were calculated by age, race, and sex. Skull fractures and intracranial diagnoses were found almost exclusively in males. For concussion, white males were at about 1.5 times greater risk compared to black males, and white females were at about 2 to greater than 3 times the risk compared to black females. For other intracranial injury, males were at 1.25 to about 2 times increased risk compared to females, white males were at about 1.5 times risk compared to black males, and white females were at 1.5-2 times greater risk compared to black females. Ten percent of head injury cases had an alcohol-related additional diagnosis and 97% of these were found in males.	WALTER REED ARMY MED CTR,DEPT MIL PSYCHIAT,DIV NEUROPSYCHIAT,WASHINGTON,DC 20307; WALTER REED ARMY MED CTR,NEUROL SERV,WASHINGTON,DC 20307								FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; IVAN LP, 1984, CAN J NEUROL SCI, V11, P417, DOI 10.1017/S0317167100045935; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V8, P48, DOI 10.1159/000110165; Rothman K. J., 1986, MODERN EPIDEMIOLOGY, P23; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; 1975, MANUAL INT STATISTIC	8	5	5	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350			NEUROEPIDEMIOLOGY	Neuroepidemiology	NOV-DEC	1990	9	6					296	305		10.1159/000110792			10	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	FB394	WOS:A1990FB39400003	2096313				2022-02-06	
J	COLQUHOUN, IR; RAWLINSON, J				COLQUHOUN, IR; RAWLINSON, J			THE SIGNIFICANCE OF HEMATOMAS OF THE BASAL GANGLIA IN CLOSED HEAD-INJURY	CLINICAL RADIOLOGY			English	Article									SOUTHAMPTON GEN HOSP, DEPT NEURORADIOL, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND								ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1986, J NEUROL NEUROSUR PS, V49, P1039, DOI 10.1136/jnnp.49.9.1039; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; JENNETT B, 1975, LANCET, V1, P480; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	11	5	5	0	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0009-9260	1365-229X		CLIN RADIOL	Clin. Radiol.	NOV	1989	40	6					619	621		10.1016/S0009-9260(89)80324-1			3	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AY292	WOS:A1989AY29200018	2598589				2022-02-06	
J	SGANZERLA, EP; TOMEI, G; GUERRA, P; TIBERIO, F; RAMPINI, PM; GAINI, SM; VILLANI, RM				SGANZERLA, EP; TOMEI, G; GUERRA, P; TIBERIO, F; RAMPINI, PM; GAINI, SM; VILLANI, RM			CLINICORADIOLOGICAL AND THERAPEUTIC CONSIDERATIONS IN SEVERE DIFFUSE TRAUMATIC BRAIN INJURY IN CHILDREN	CHILDS NERVOUS SYSTEM			English	Article											SGANZERLA, EP (corresponding author), UNIV MILAN, INST NEUROCHIRURG, VIA F SFORZA 35, I-20122 MILAN, ITALY.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Convert J, 1988, Agressologie, V29, P273; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; JENNETT B, 1976, LANCET, V1, P1031; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; SGANZERLA EP, 1987, INT S NEUROTRAUMATOL, P43; SGANZERLA EP, 1987, ANEST RIANIM, V28, P123; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; Tomei G, 1988, Agressologie, V29, P267; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; WALKER ML, 1983, CONCEPTS PAEDIATRIC, V4, P243; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZIMMERMANN RA, 1983, PEDIATRIC HEAD TRAUM, P69	22	5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	1989	5	3					168	171		10.1007/BF00272121			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AB831	WOS:A1989AB83100012	2758431				2022-02-06	
J	SLATER, EJ				SLATER, EJ			DOES MILD MEAN MINOR - RECOVERY AFTER CLOSED HEAD-INJURY	JOURNAL OF ADOLESCENT HEALTH			English	Article											SLATER, EJ (corresponding author), UNIV MARYLAND,SCH MED,DEPT PEDIAT,DIV ADOLESCENT MED,22 S GREENE ST,BALTIMORE,MD 21201, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-240510] Funding Source: Medline		BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GOUVIER WD, 1986, AM PSYCHOL, V41, P484; Long C J, 1983, Psychiatr Med, V1, P35; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MODLIN HC, 1986, B MENNINGER CLIN, V50, P50; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; STERN JM, 1985, SCAND J REHAB MED S, V12, P36; Wechsler, 1997, WECHSLER ADULT INTEL	13	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	1054-139X			J ADOLESCENT HEALTH	J. Adolesc. Health	MAY	1989	10	3					237	240		10.1016/0197-0070(89)90240-4			4	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	U3638	WOS:A1989U363800012	2715099				2022-02-06	
J	Levin, HS; High, WM				Levin, Harvey S.; High, Walter M.			Contributions of Neuroimaging to Neuropsychological Research on Closed Head Injury	NEUROPSYCHOLOGY			English	Article						Neuroimaging; head injury; computed tomography; magnetic resonance imaging		This paper reviews the contributions of neuroimaging to research on neuropsychological outcome of closed head injury (CHI). Studies quantifying cerebral atrophy and investigations of focal brain lesions are discussed. Magnetic resonance imaging to characterize the location, size, and depth of focal brain lesions is reviewed. The disparities between the findings of computed tomography and MRI are discussed. Methodological issues are considered, as are directions for future research.	[Levin, Harvey S.] Univ Texas Med Branch, Div Neurosurg, Galveston, TX 77550 USA; [High, Walter M.] Laurelwood Hosp, Neurobehav Unit, Houston, TX USA		Levin, HS (corresponding author), Univ Texas Med Branch, Div Neurosurgery D 73, Galveston, TX 77550 USA.				 [NS-21889]	Research by the authors was supported by grant NS-21889.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALEXANDER MP, 1988, NEUROLOGY, V38, P802, DOI 10.1212/WNL.38.5.802; BOLLER FC, 1972, J NEUROL NEUROSUR PS, V35, P463, DOI 10.1136/jnnp.35.4.463; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; Eisenberg H. M., INITIAL CT IN PRESS; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; JENKINS A, 1986, LANCET, V2, P445; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1979, CORTEX, V15, P391, DOI 10.1016/S0010-9452(79)80066-0; VANDONGEN KJ, 1980, NEUROSURGERY, V7, P14, DOI 10.1227/00006123-198007000-00003	21	5	5	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology		1989	3	4					243	254		10.1037//0894-4105.3.4.243			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V44JW	WOS:000209746300004					2022-02-06	
J	ZARSKI, JJ; HALL, DE; DEPOMPEI, R				ZARSKI, JJ; HALL, DE; DEPOMPEI, R			CLOSED HEAD-INJURY PATIENTS - A FAMILY-THERAPY APPROACH TO THE REHABILITATION PROCESS	AMERICAN JOURNAL OF FAMILY THERAPY			English	Article											ZARSKI, JJ (corresponding author), UNIV AKRON, MARRIAGE & FAMILY THERAPY TRAINING PROGRAM, CARROLL HALL, AKRON, OH 44325 USA.						BICKNELL DJ, 1982, POSTGRAD MED J, V58, P597, DOI 10.1136/pgmj.58.684.597; BORDUIN CM, 1982, DELINQUENCY ADOLESCE, P205; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; FRISWELL J, 1982, COMMUNICATION; Goldenberg H., 1985, FAMILY THERAPY OVERV; GOLDSTEIN G, 1983, REHABILITATION BRAIN; HOFFMAN L, 1981, F FAMILY THERAPY; JACKSON D D, 1957, Psychiatr Q Suppl, V31, P79; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; McLaughlin A. M., 1985, COGNITIVE REHABILITA, V3, P14; MINUCHIN S, 1975, ARCH GEN PSYCHIAT, V32, P1031; Minuchin S., 1974, FAMILIES FAMILY THER; MINUCHIN S, 1978, PSYCHOSOMATIC FAMILI; RELLER J, 1984, PICKING PIECES; ROSENTHAL M, 1984, REHABILITATION HEAD; Watzlawick P., 1967, PRAGMATICS HUMAN COM	16	5	5	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0192-6187	1521-0383		AM J FAM THER	Am. J. Fam. Ther.	SPR	1987	15	1					62	68					7	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	G7237	WOS:A1987G723700008					2022-02-06	
J	ROTHKE, S; BLEIBERG, J; FREEDLAND, K				ROTHKE, S; BLEIBERG, J; FREEDLAND, K			NEUROPSYCHOLOGICAL TEST CORRELATES OF ANTICIPATORY BEHAVIOR DEFICIT IN CLOSED HEAD-INJURY	INTERNATIONAL JOURNAL OF CLINICAL NEUROPSYCHOLOGY			English	Article									NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611								ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; DAMASIO A, 1985, CLIN NEUROPSYCHOLOGY; FREEDMAN PE, IN PRESS J NEUROLOGY; Levin HS., 1982, NEUROBEHAVIORAL CONS; Luria A. R, 1969, HDB CLIN NEUROLOGY, V2; Luria A.R., 1973, WORKING BRAIN; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Reitan R, 1969, MANUAL ADM NEUROPSYC; Strub R. L., 1981, ORGANIC BRAIN SYNDRO; Wechsler D, 1981, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; [No title captured]	13	5	5	0	0	MELNIC PRESS INC	MADISON	PO BOX 6216, MADISON, WI 53716	0197-3681			INT J CLIN NEUROPSYC			1987	9	2					81	83					3	Psychology, Clinical; Neurosciences	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	H4965	WOS:A1987H496500007					2022-02-06	
J	UZZELL, BP; OBRIST, WD; DOLINSKAS, CA; LANGFITT, TW; WISER, RF				UZZELL, BP; OBRIST, WD; DOLINSKAS, CA; LANGFITT, TW; WISER, RF			RELATION OF VISUAL-FIELD DEFECTS TO NEUROPSYCHOLOGICAL OUTCOME AFTER CLOSED HEAD-INJURY	ACTA NEUROCHIRURGICA			English	Article									UNIV PENN,SCH MED,DIV NEUROSURG,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT RADIOL,PHILADELPHIA,PA 19104						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 08803] Funding Source: Medline		BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BASSO A, 1973, BRAIN, V96, P715, DOI 10.1093/brain/96.4.715; BENTON AL, 1962, INTERHEMISPHER RELAT, P253; BOORTZMARZ R, 1985, J NEUROSURG NURS, V17, P84; BOROD JC, 1982, CORTEX, V18, P199, DOI 10.1016/S0010-9452(82)80003-8; BROOKS D N, 1974, Cortex, V10, P224; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; DERENZI E, 1967, CORTEX, V3, P327; DOEHRING DG, 1961, J NERV MENT DIS, V132, P227, DOI 10.1097/00005053-196103000-00004; DOEHRING DG, 1961, ARCH NEUROL-CHICAGO, V5, P294, DOI 10.1001/archneur.1961.00450150060008; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; HUGHES B, 1962, B JOHNS HOPKINS HOSP, V111, P98; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1981, MANAGEMENT HEAD INJU, P77; KATAYAMA Y, 1985, SURG NEUROL, V24, P289, DOI 10.1016/0090-3019(85)90041-2; Klove H, 1972, Scand J Rehabil Med, V4, P55; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LAURSEN AB, 1971, ACTA OPHTHALMOL, V49, P134; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LURIA AR, 1973, WORKING BRAIN, P256; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILNER B, 1985, HUM NEUROBIOL, V4, P137; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NORRMAN B, 1964, ACTA PSYCHIAT SCAND, V37, P236; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OSTERBERG G., 1938, ACTA OPHTHALMOL [COPENHAGEN], V16, P466; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; REITAN RM, 1985, HALSTEAD REITAN NEUR, P15; ROWBOTHAM GF, 1964, ACUTE INJURIES HEAD, P410; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1983, NEUROPSYCHOLOGIA, V21, P235, DOI 10.1016/0028-3932(83)90040-4; TIBBS PA, 1979, J TRAUMA, V19, P129, DOI 10.1097/00005373-197902000-00013; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; Turner JWA, 1943, BRAIN, V66, P140; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; UZZELL BP, 1987, IN PRESS SURG NEUROL; UZZELL BP, 1986, INTRACRANIAL PRESSUR, V6, P687; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VRIES JK, 1973, J NEUROSURG, V39, P416, DOI 10.3171/jns.1973.39.3.0416; WALSH FB, 1969, CLIN NEURO OPHTH, V3, P2375; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433; WARD C, 1978, TERMINOLOGY EXTENT M, P1; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403; [No title captured]	55	5	5	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1987	86	1-2					18	24		10.1007/BF01419499			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	H6159	WOS:A1987H615900004	3618302				2022-02-06	
J	KIM, RC; FAGIN, K; CHOI, BH				KIM, RC; FAGIN, K; CHOI, BH			PROLONGED SURVIVAL AFTER SEVERE TRAUMATIC INJURY LIMITED TO THE BRAIN-STEM	SURGICAL NEUROLOGY			English	Article									UNIV CALIF IRVINE, CALIF COLL MED, DEPT PATHOL, IRVINE, CA 92717 USA; UNIV CALIF IRVINE, CALIF COLL MED, DEPT NEUROSURG, IRVINE, CA 92717 USA		KIM, RC (corresponding author), VET ADM MED CTR, LAB SERV 113, 5901 E 7TH ST, LONG BEACH, CA 90822 USA.				NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ES 02928] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES002928] Funding Source: NIH RePORTER		ADAMS H, 1972, SCI F NEUROLOGY, P478; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Adams JH, 1982, RECENT ADV NEUROPATH, P165; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; BRONSON R, 1978, HUM PATHOL, V9, P602, DOI 10.1016/S0046-8177(78)80143-9; CROMPTON MR, 1971, LANCET, V1, P669; FERINGA ER, 1983, NEUROLOGY, V33, P478, DOI 10.1212/WNL.33.4.478; HARDING B, 1981, J NEUROL NEUROSUR PS, V44, P1156, DOI 10.1136/jnnp.44.12.1156; Holmes G, 1909, BRAIN, V32, P1, DOI 10.1093/brain/32.1.1; Huhn B, 1970, Nervenarzt, V41, P326; KALIL K, 1975, BRAIN RES, V89, P15, DOI 10.1016/0006-8993(75)90130-4; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; MITCHELL DE, 1973, LANCET, V2, P215; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PILZ P, 1982, J NEUROL NEUROSUR PS, V45, P422, DOI 10.1136/jnnp.45.5.422; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; STRICH SJ, 1961, LANCET, V2, P443; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; ZOLTAN L, 1966, INT C SERIES, V110, P151	19	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		1985	23	5					525	528		10.1016/0090-3019(85)90250-2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AGD28	WOS:A1985AGD2800012	3983808				2022-02-06	
J	ROBERSON, MC; WICHETA, WE				ROBERSON, MC; WICHETA, WE			ENDOTHELIAL LOSS IN CORNEAL CONCUSSION INJURY	ANNALS OF OPHTHALMOLOGY			English	Article											ROBERSON, MC (corresponding author), UNIV ARKANSAS MED SCI,DEPT OPHTHALMOL,4301 W MARKHAM,LITTLE ROCK,AR 72205, USA.						BOURNE WM, 1976, T AM ACAD OPHTHALMOL, V81, P743; CIBIS GW, 1978, ARCH OPHTHALMOL-CHIC, V96, P485; DOUGHMAN DJ, 1976, ARCH OPHTHALMOL-CHIC, V94, P1791; DUKEELDER S, 1972, SYSTEM OPHTHALMOLOGY, V14, P80; FORSTOT SL, 1974, ARCH OPHTHALMOL-CHIC, V92, P527; MALONEY WF, 1979, ARCH OPHTHALMOL-CHIC, V97, P1647; SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041	7	5	5	0	0	AMER SOC CONTEMPORARY OPHTHALMOLOGY	SKOKIE	4711 GOLF RD, SUITE 408, SKOKIE, IL 60076-1242	0003-4886			ANN OPHTHALMOL	Ann. Ophthalmol.		1985	17	8					457	&					0	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	APR35	WOS:A1985APR3500002	4051377				2022-02-06	
J	OGAWA, N; TSUKAMOTO, S; MIZUNO, S; SHINDO, S; MORI, A				OGAWA, N; TSUKAMOTO, S; MIZUNO, S; SHINDO, S; MORI, A			EFFECTS OF CALCIUM HOPANTENATE ON CONCUSSION FOLLOWING HEAD-INJURY IN MICE	IRCS MEDICAL SCIENCE-BIOCHEMISTRY			English	Article											OGAWA, N (corresponding author), OKAYAMA UNIV,SCH MED,INST NEUROBIOL,DEPT NEUROCHEM,OKAYAMA 700,JAPAN.						BIRD ED, 1974, BRAIN, V97, P457, DOI 10.1093/brain/97.1.457; DANNO T, 1978, REPORTS TANABE SEIYA, P99; Guillemin R., 1977, RECENT PROGR HORMONE, V33, P1; HAMAMOTO E, 1966, P JPN ACAD, V42, P853, DOI 10.2183/pjab1945.42.853; MANAKA S, 1977, SAIGAI IGAKKAISHI, V25, P202; MANAKA S, 1977, IGAKU NO AYUMI, V102, P867; NISHIZAWA Y, 1968, J VITAMINOL, V14, P345, DOI 10.5925/jnsv1954.14.345; NISHIZAWA Y, 1968, J VITAMINOL, V14, P331, DOI 10.5925/jnsv1954.14.331; OKADA R, 1980, CLIN PSYCHIATR, V22, P89; Roberts E, 1972, Neurosci Res Program Bull, V10, P468; 1974, CLIN EVAL, V2, P335	11	5	5	0	2	ELSEVIER-IRCS LTD	LANCASTER	ST LEONARDS HOUSE ST LEONARDGATE, LANCASTER, LANCS, ENGLAND LA1 1PF				IRCS MED SCI-BIOCHEM			1982	10	7					512	513					2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NW855	WOS:A1982NW85500003					2022-02-06	
J	LAMBOOY, E; SPANJAARD, W; EIKELENBOOM, G				LAMBOOY, E; SPANJAARD, W; EIKELENBOOM, G			CONCUSSION STUNNING OF VEAL CALVES	FLEISCHWIRTSCHAFT			German	Article											LAMBOOY, E (corresponding author), INST TIERHALTUNG SCHOONOORD,DRIEBERGSEWEG 10 D,ZEIST,NETHERLANDS.							0	5	5	0	3	DEUTSCHER FACHVERLAG GMBH	FRANKFURT MAIN 1	MAINZER LANDSTRASSE 251 POSTFACH 10 06 06, W-6000 FRANKFURT MAIN 1, GERMANY	0015-363X			FLEISCHWIRTSCHAFT	Fleischwirtschaft		1981	61	1					128	130					3	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	KZ814	WOS:A1981KZ81400026					2022-02-06	
J	LOYD, DW; TSUANG, MT				LOYD, DW; TSUANG, MT			A SNAKE LADY - POST-CONCUSSION SYNDROME MANIFESTING VISUAL HALLUCINATIONS OF SNAKES	JOURNAL OF CLINICAL PSYCHIATRY			English	Article									UNIV IOWA,COLL MED,IOWA CITY,IA 52242								DAVIS SM, 1976, DRUG TREATMENT MENTA; GOODWIN DW, 1971, ARCH GEN PSYCHIAT, V24, P76; GRONWALL D, 1974, LANCET, V62, P605; LANCE JW, 1976, BRAIN, V99, P719; LIDVALL HE, 1974, ACTA NEUROL SCAND  S, V50, P56; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; SLATER E, 1969, CLIN PSYCHIATRY, P347; SLATER E, CLIN PSYCHIATRY, P401; 1977, BRIT MED J, V2, P147	11	5	5	0	0	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 240008, MEMPHIS, TN 38124	0160-6689			J CLIN PSYCHIAT	J. Clin. Psychiatry		1981	42	6					246	247					2	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Psychiatry	LT688	WOS:A1981LT68800007	7240106				2022-02-06	
J	PARSONS, LC; GUTHRIE, MD				PARSONS, LC; GUTHRIE, MD			NERVE-FIBER DEGENERATION FOLLOWING A SINGLE EXPERIMENTAL CEREBRAL CONCUSSION IN THE RAT	NEUROSCIENCE LETTERS			English	Article									UNIV VIRGINIA,SCH MED,DEPT PHYSIOL,CHARLOTTESVILLE,VA 22903; UNIV TEXAS,HLTH SCI CTR,SCH MED,DEPT ANAT,SAN ANTONIO,TX 78284		PARSONS, LC (corresponding author), UNIV VIRGINIA,SCH NURSING,CHARLOTTESVILLE,VA 22903, USA.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Cowan, 1970, CONT RES METHODS NEU, P217; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; GURDJIAN ES, 1975, IMPACT HEAD INJURY M, P181; NAUTA WJH, 1954, STAIN TECHNOL, V29, P91, DOI 10.3109/10520295409115448; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; PARSONS LC, 1967, PHYSIOLOGIST, V10, P273; PARSONS LC, 1980, NEUR ABSTR, V6, P12; PARSONS LC, 1968, THESIS U TEXAS GALVE; PARSONS LC, 1969, EXCERPTA MEDICA INT, V193, P70; PARSONS LC, 1979, VA J SCI, V30, P95; STRICH SJ, 1961, LANCET, V2, P443; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; ZEMLAN FP, 1978, EXP NEUROL, V62, P298, DOI 10.1016/0014-4886(78)90059-6	20	5	5	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.		1981	24	2					199	204		10.1016/0304-3940(81)90248-2			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LZ211	WOS:A1981LZ21100017	7254717				2022-02-06	
J	LIU, HC; LEE, JC; BAKAY, L				LIU, HC; LEE, JC; BAKAY, L			EXPERIMENTAL CEREBRAL CONCUSSION - HISTOCHEMICAL-STUDY	ACTA NEUROCHIRURGICA			English	Article									SUNY BUFFALO,CTR CLIN,DEPT NEUROSURG,BUFFALO,NY 14215								BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BROWN WJ, 1972, AM J PATHOL, V67, P41; BUTCHER RG, 1964, Q J MICROSC SCI, V105, P497; Duchesne P Y, 1968, Acta Neurol Psychiatr Belg, V68, P278; EGGER G, 1975, CYTOBIOLOGIE, V11, P110; ELBADAWI A, 1967, J HISTOCHEM CYTOCHEM, V15, P580, DOI 10.1177/15.10.580; FLUMERFELT BA, 1973, HISTOCHEM J, V5, P67, DOI 10.1007/BF01012046; GLYN DG, 1968, J COMP NEUROL, V133, P289; GOLDSTEIN GW, 1975, J NEUROCHEM, V25, P715, DOI 10.1111/j.1471-4159.1975.tb04395.x; Gomori G, 1952, MICROSCOPIC HISTOCHE; GOODMAN JH, 1976, J NEUROSURG, V44, P418, DOI 10.3171/jns.1976.44.4.0418; GREEN DE, 1968, BIOCHEM BIOPH RES CO, V31, P368, DOI 10.1016/0006-291X(68)90485-3; GRIFFITHS IR, 1974, J NEUROL SCI, V22, P291, DOI 10.1016/0022-510X(74)90002-1; Gurdjian E S, 1972, Clin Neurosurg, V19, P1; HAMBERGER A, 1966, J NEUROPATH EXP NEUR, V25, P68, DOI 10.1097/00005072-196601000-00004; HARDEBO J E, 1976, P233; HOUK EJ, 1976, J INSECT PHYSIOL, V22, P523, DOI 10.1016/0022-1910(76)90171-2; ITO T, 1978, J NEUROSURG, V48, P434, DOI 10.3171/jns.1978.48.3.0434; JOO F, 1967, HISTOCHEMISTRY, V9, P140, DOI 10.1007/BF00305858; JOO F, 1966, EXP BRAIN RES, V1, P147; KARCSU S, 1975, BRAIN RES, V95, P137, DOI 10.1016/0006-8993(75)90213-9; KARCSU S, 1977, BRAIN RES, V120, P146, DOI 10.1016/0006-8993(77)90505-4; LYNCH S, 1973, AM J PSYCHOL, V86, P643, DOI 10.2307/1421950; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420; PARSONS D. F., 1965, INT REV EXP PATHOL, V4, P1; RECHARDT L, 1972, HISTOCHEMISTRY, V30, P115, DOI 10.1007/BF01444058; RINDER L, 1968, ACTA NEUROPATHOL, V11, P201; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; SINGER SJ, 1975, CELL MEMBRANES BIOCH, P35; TERVO T, 1976, HISTOCHEMISTRY, V47, P133, DOI 10.1007/BF00492561; Van Gelder N M, 1968, Prog Brain Res, V29, P259; WISLOCKI GB, 1948, J COMP NEUROL, V88, P319, DOI 10.1002/cne.900880302	32	5	5	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1979	47	1-2					105	122		10.1007/BF01404667			18	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HC777	WOS:A1979HC77700009	224654				2022-02-06	
J	WEITBRECHT, WU; NOETZEL, H				WEITBRECHT, WU; NOETZEL, H			AUTORADIOGRAPHIC INVESTIGATIONS IN REPEATED EXPERIMENTAL BRAIN CONCUSSION	ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN			German	Article									UNIV FREIBURG,NEUROL KLIN,NEUROPHYSIOL ABT,D-7800 FREIBURG,FED REP GER; UNIV FREIBURG,ZENTRUM PATHOL,NEUROPATHOL ABT,D-7800 FREIBURG,FED REP GER								AUER L, 1975, NEUE ASPEKTE TRASYLO, P229; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BROWN WJ, 1972, AM J PATHOL, V67, P41; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; GOEDEKE R, 1974, NATURWISS RUNDSCH, V27, P4; HALLERVORDEN J, 1957, DEUT MED WOCHENSCHR, V82, P129, DOI 10.1055/s-0028-1114649; IBRAHIM MZM, 1970, AM J PATHOL, V60, P403; JEDLINSKI J, 1970, Polish Medical Journal (English Translation of Polskie Archiwum Medycyny Wewnetrznej), V9, P743; KAY DWK, 1971, LANCET, V2, P1052; LA CAVA G, 1949, Brux Med, V29, ppassim; LANG G, 1974, ZBL NEUROCHIR, V35, P215; LANGLOIS J, 1975, AGRESSOLOGIE, V16, P33; LORENZONI E, 1975, FORTSCHR NEUROL PSYC, V43, P155; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; NOETZEL H, 1968, ACTA NEUROPATHOL B S, V4, P134; NOETZEL H, 1965, DTSCH Z NERVENHEILK, V187, P637; NORDBY HK, 1975, ACTA NEUROCHIR, V32, P209, DOI 10.1007/BF01405454; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAMPUS F, 1956, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V194, P152, DOI 10.1007/BF00342839; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; PETERS G, 1959, VERHANDL DTSCH GES P, P103; Ricker G, 1919, VIRCHOWS ARCH A, V226, P180, DOI 10.1007/BF02039959; SCHERZER EB, 1975, FORTSCHR NEUROL PSYC, V43, P271; Spielmeyer W, 1922, HISTOPATHOLOGIE NERV; UNTERHARNSCHEID.D, 1970, TEX REP BIOL MED, V28, P421; UNTERHARNSCHEID.FJ, 1975, HDB CLIN NEUROLOGY, V23, P527; Wolter J, 1970, Arch Psychiatr Nervenkr (1970), V213, P46, DOI 10.1007/BF00342947; ZULCH VKJ, 1969, B SOC SCI MED GR DUC, V106, P153; [No title captured]; [No title captured]; [No title captured]	34	5	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0003-9373			ARCH PSYCHIAT NERVEN			1976	223	1					59	68		10.1007/BF00367453			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	CR085	WOS:A1976CR08500005	1016019				2022-02-06	
J	WHITE, RJ; ALBIN, MS; YASHON, D; DAKTERS, JG				WHITE, RJ; ALBIN, MS; YASHON, D; DAKTERS, JG			PROGRAMMED MANAGEMENT OF SEVERE CLOSED HEAD INJURIES	JOURNAL OF TRAUMA			English	Article																	LAZORTHES G, 1964, HYPOTHERMIA NEUROSUR, P175; MASPES PE, 1964, HYPOTHERMIA NEURO ED, P175; MCLAURIN RL, 1966, CLINICAL NEUROSURGER, V13, P143; SHILLITO J, 1966, CLINICAL NEUROSUR ED, V13, P143; WARD AA, 1966, CLINICAL NEUROSURGER, V13, P95; WHITE R J, 1962, Rocky Mt Med J, V59, P37; WHITE RJ, 1966, ANGIOLOGY, V17, P72, DOI 10.1177/000331976601700202	7	5	5	0	0							J TRAUM			1968	8	2					203	&		10.1097/00005373-196803000-00008			0	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	A8018	WOS:A1968A801800015	5645247				2022-02-06	
J	HAMBERGER, A; RINDER, L				HAMBERGER, A; RINDER, L			EXPERIMENTAL BRAIN CONCUSSION - EARLY EFFECT OF SUDDEN INCREASE IN INTRACTRANIAL PRESSURE ON SUCCINOXIDASE ACTIVITY OF ISOLATED NEURONS AND GLIAL CELLS FROM LATERAL VESTIBULAR NUCLEUS OF RABBIT	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article																	Brown DES, 1936, J CELL COMPAR PHYSL, V8, P141, DOI 10.1002/jcp.1030080203; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; EDSTROM J E, 1962, Sven Lakartidn, V59, P2353; GERMAN WJ, 1947, T AM NEUROL ASSOC, P86; HALLEN O, TO BE PUBLISHED; HALLERVORDEN J, 1941, ZBL NEUROCHIR, V6, P37; HAMBERGER A, 1964, J NEUROCHEM, V11, P687, DOI 10.1111/j.1471-4159.1964.tb06152.x; HYDEN H, 1958, J NEUROCHEM, V2, P304, DOI 10.1111/j.1471-4159.1958.tb12379.x; HYDEN H, 1960, J NEUROCHEM, V6, P57, DOI 10.1111/j.1471-4159.1960.tb13449.x; Ingvar S, 1923, ARCH NEURO PSYCHIATR, V10, P267, DOI 10.1001/archneurpsyc.1923.02190270002001; JAKOB A, 1913, ARB UBER GROSSHIRNRI, V5, P182; LINDQUIST JL, 1942, SURG GYNECOL OBSTET, V75, P28; LISSNER HR, 1960, 60WA273 AM SOC MECH; ROSENGREN BOH, 1959, ACTA RADIOL        S, P178; Unterharnscheidt F, 1963, GEDECKTEN SCHADEN GE; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WARD AA, 1958, J NEUROSURG, V15, P129, DOI 10.3171/jns.1958.15.2.0129; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; ZEUTHEN E, 1953, J EMBRYOL EXP MORPH, V1, P238	20	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.		1966	25	1					68	+		10.1097/00005072-196601000-00004			1	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	72147	WOS:A19667214700004					2022-02-06	
J	VORIS, HC				VORIS, HC			MILD HEAD INJURY (CONCUSSION)	AMERICAN JOURNAL OF SURGERY			English	Article																	Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; de Barenne JGD, 1939, J NEUROPHYSIOL, V2, P319, DOI 10.1152/jn.1939.2.4.319; Denny-Brown D, 1943, ANN INTERN MED, V19, P427, DOI 10.7326/0003-4819-19-3-427; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; FRIEDMAN AP, 1945, J NEUROSURG, V2, P36, DOI 10.3171/jns.1945.2.1.0036; Friedman AP, 1944, ARCH NEURO PSYCHIATR, V52, P126, DOI 10.1001/archneurpsyc.1944.02290320041005; FULTON JF, 1944, DIGEST NEUROL PSYCHI, V12, P315; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Gurdjian ES, 1944, J NEUROSURG, V1, P393, DOI 10.3171/jns.1944.1.6.0393; JASPER H, 1945, ASS RES NERV MENT DI, V24, P388; Jasper HH, 1940, ARCH NEURO PSYCHIATR, V44, P328, DOI 10.1001/archneurpsyc.1940.02280080088005; KESCHNER M, 1940, INJURIES SKULL BRAIN, P361; LYNN JG, 1945, A RES NERV MENT DIS, V24, P298; Malone JY, 1942, J AMER MED ASSOC, V119, P861, DOI 10.1001/jama.1942.02830280007002; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCKENZIE KG, 1943, SURG GYNECOL OBSTET, V77, P631; Munro D, 1943, ANN SURG, V117, P544, DOI 10.1097/00000658-194304000-00005; MURRAY SE, 1947, J MENT SC, V93, P303; Schaller WF, 1939, J AMER MED ASSOC, V113, P1779; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; SIRIS JH, 1944, US NAV M B, V42, P1357; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Walker AE, 1945, A RES NERV MENT DIS, V24, P437; WARD W, 1948, SCIENCE, V107, P49; WECHSLER JS, 1940, INJURIES BRAIN SKULL, P391; WHITE JC, 1943, ANN SURG, V118, P619; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1946, J NEUROSURG, V3, P157, DOI 10.3171/jns.1946.3.2.0157	29	5	5	0	1	CAHNERS PUBL CO	NEW YORK	249 WEST 17 STREET, NEW YORK, NY 10011	0002-9610			AM J SURG	Am. J. Surg.		1950	80	5					707	713		10.1016/0002-9610(50)90595-2			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UZ374	WOS:A1950UZ37400042	14790112				2022-02-06	
J	MEERLOO, AM				MEERLOO, AM			CEREBRAL CONCUSSION - A PSYCHOSOMATIC SURVEY	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article																	KAT, 1935, COMMOTIO CEREBRI; KATZENSTEIN, 1931, SCHWEIZ ARCH NEUROL; MEERLOO, 1939, SCHWEIZ ARCH NEUROL; STENVERS, 1926, ACTA OTOLARYNGOL; VANVALKENBURG, 1936, NEDERL TIJDDSCHR GEN	5	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.		1949	110	4					347	353		10.1097/00005053-194911040-00005			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	UU584	WOS:A1949UU58400005	15406695				2022-02-06	
J	ECHLIN, F				ECHLIN, F			SPREADING DEPRESSION OF ELECTRICAL ACTIVITY IN THE CEREBRAL CORTEX FOLLOWING LOCAL TRAUMA AND ITS POSSIBLE ROLE IN CONCUSSION	TRANSACTIONS OF THE AMERICAN NEUROLOGICAL ASSOCIATION			English	Article																		0	5	5	0	1	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, NEW YORK, NY 10036 USA	0065-9479			T AM NEUROL ASSOC			1948							199	202					4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XT773	WOS:A1948XT77300064	18111293				2022-02-06	
J	Goldstein, K				Goldstein, Kurt			Brain Concussion: Evaluation of the After Effects by Special Tests	DISEASES OF THE NERVOUS SYSTEM			English	Article									Tufts Med Sch, Boston, MA USA								BRUSSEL IA, 1942, PSYCHIAT QUART, V16, P706; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; Goldstein K, 1942, EFFECTS BRAIN INJURI; GOLDSTEIN K, 1931, NERVENARZT, V4, P460; GOLDSTEIN K, 1918, DTSCH Z NERVENH, V59, P199; GOLDSTEIN K, 1922, ARCH OPTHALMOLOGIE, V109, P387; GOLDSTEIN K, 1924, MONATSSCHR OHRENHEIL, V58; Munro D., 1939, SURG GYNECOL OBSTET, V68, P587; Scheerer M., 1941, PSYCHOL MONOGRAPHS, P53; STRAUSS J, 1934, ARCH NEU PSYCHIAT, V31, P893; Symonds C P, 1937, Proc R Soc Med, V30, P1081; SYMONDS CP, 1941, J ROY ARMY MED CORPS, V76, P320; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; [No title captured]	15	5	5	0	0	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 240008, MEMPHIS, TN 38124 USA	0012-3714			DIS NERV SYST	Dis. Nerv. Syst.	NOV	1943	4	11					325	334					10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V68PA	WOS:000204635800001					2022-02-06	
J	Paterson, JH				Paterson, JH			Some observations on the cerebrospinal fluid in closed head injuries	JOURNAL OF NEUROLOGY AND PSYCHIATRY			English	Article																	BAGLEY C, 1929, ARCH SURG-CHICAGO, V18, P1078; GREENFIELD JG, 1942, P ROY SOC MED, V35, P525; Jefferson Geoffrey, 1942, Glasgow Med J, V138, P77; McKissock W, 1941, LANCET, V1, P593; Merritt HH, 1937, CEREBROSPINAL FLUID; Rand CW, 1931, ARCH SURG-CHICAGO, V23, P357, DOI 10.1001/archsurg.1931.01160090002001; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Strauss I, 1932, ARCH NEUROL PSYCHIAT, V27, P1080; Turner IJA, 1941, BRIT MED J, V1941, P569, DOI 10.1136/bmj.2.4216.569	9	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0368-329X			J NEUROL PSYCHIATRY	J. Neurol. Psychiatry	JUL-OCT	1943	6	3/4					87	91		10.1136/jnnp.6.3-4.87			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V21BI	WOS:000201423000002	21611419	Green Published			2022-02-06	
J	Lhermitte, J				Lhermitte, J			Study of the marrow concussion	REVUE NEUROLOGIQUE			French	Article																		0	5	5	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787			REV NEUROL-FRANCE	Rev. Neurol.		1932	57		1				210	239					30	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V29VC	WOS:000202015200022					2022-02-06	
J	Master, CL; Katz, BP; Arbogast, KB; McCrea, MA; McAllister, TW; Pasquina, PF; Lapradd, M; Zhou, WX; Broglio, SP				Master, Christina L.; Katz, Barry P.; Arbogast, Kristy B.; McCrea, Michael A.; McAllister, Thomas W.; Pasquina, Paul F.; Lapradd, Michelle; Zhou, Wenxian; Broglio, Steven P.		CARE Consortium Investigators	Differences in sport-related concussion for female and male athletes in comparable collegiate sports: a study from the NCAA-DoD Concussion Assessment, Research and Education (CARE) Consortium	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						concussion; female; gender; male; sports analysis in different types of sports	SEX-DIFFERENCES; HIGH-SCHOOL; NEUROPSYCHOLOGICAL FUNCTION; RECOVERY TRAJECTORIES; GENDER-DIFFERENCES; BASE-LINE; SYMPTOMS; HISTORY; RATES; TIME	Objectives To examine sex differences in sport-related concussion (SRC) across comparable sports. Methods Prospective cohort of collegiate athletes enrolled between 2014 and 2017 in the Concussion Assessment, Research and Education Consortium study. Results Among 1071 concussions (females=615; 57.4%), there was no difference in recovery (median days to full return to play) (females=13.5 (IQR 9.0, 23.1) vs males=11.8 (IQR 8.1, 19.0), p=0.96). In subgroup analyses, female recovery was longer in contact (females=12.7 days (IQR 8.8, 21.4) vs males=11.0 days (IQR 7.9, 16.2), p=0.0021), while male recovery was longer in limited contact sports (males=16.9 days (IQR 9.7, 101.7) vs females=13.8 days (IQR 9.1, 22.0), p<0.0001). There was no overall difference in recovery among Division I schools (females=13.7 (IQR 9.0, 23.1) vs males=12.2 (IQR 8.2 19.7), p=0.5), but females had longer recovery at the Division II/III levels (females=13.0 (IQR 9.2, 22.7) vs males=10.6 (IQR 8.1, 13.9), p=0.0048). Conclusion Overall, no difference in recovery between sexes across comparable women's and men's sports in this collegiate cohort was found. However, females in contact and males in limited contact sports experienced longer recovery times, while females had longer recovery times at the Division II/III level. These disparate outcomes indicate that, while intrinsic biological sex differences in concussion recovery may exist, important, modifiable extrinsic factors may play a role in concussion outcomes.	[Master, Christina L.] Childrens Hosp Philadelphia, Pediat, Orthopaed & Sports Med, Philadelphia, PA 19104 USA; [Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Katz, Barry P.; Lapradd, Michelle; Zhou, Wenxian] Indiana Univ Sch Med, Biostat, Indianapolis, IN 46202 USA; [McCrea, Michael A.] Med Coll Wisconsin, Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Psychiat, Indianapolis, IN 46202 USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Phys Med & Rehabil, Bethesda, MD 20814 USA; [Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Broglio, Steven P.] Univ Michigan, Kinesiol, Ann Arbor, MI 48109 USA		Master, CL (corresponding author), Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Pediat,Orthopaed & Sports Med, Philadelphia, PA 19104 USA.	masterc@chop.edu		Master, Christina/0000-0002-6717-4270	Grand Alliance Concussion Assessment, Research and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, by support from the Grand Alliance Concussion Assessment, Research and Education (CARE) Consortium, funded by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The US Army Medical Research Acquisition Activity, Fort Detrick, MD is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award number W81XWH-14-2-0151.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Baugh CM, 2020, J ATHL TRAINING, V55, P580, DOI 10.4085/1062-6050-0517.19; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Li H., 2017, CLIN J SPORT MED, P1; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Pfaller AY, 2019, AM J SPORT MED, V47, P2294, DOI 10.1177/0363546519860120; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165	34	4	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2021	55	24					1387	1394		10.1136/bjsports-2020-103316			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XK9EU	WOS:000727760100004	33355211				2022-02-06	
J	DeMatteo, CA; Lin, CYA; Foster, G; Giglia, L; Thabane, L; Claridge, E; Noseworthy, MD; Hall, GB; Connolly, JF				DeMatteo, Carol A.; Lin, Chia-Yu A.; Foster, Gary; Giglia, Lucia; Thabane, Lehana; Claridge, Everett; Noseworthy, Michael D.; Hall, Geoffrey B.; Connolly, John F.			Evaluating Adherence to Return to School and Activity Protocols in Children After Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						child; youth; mild traumatic brain injury; adherence; concussion management	SPORTS-RELATED CONCUSSION; PLAY; ADOLESCENTS; GUIDELINES; RECOVERY; TIME	Objective: The need to have a pediatric-specific concussion management protocol on Return to School (RTS) and Return to Activity (RTA) after concussion has been recognized internationally. The first step to evaluate the protocol effectiveness is to establish whether children and youth are adhering to these recommendations. The objective of this study was to explore the prevalence and predictors of adherence to RTS and RTA concussion management protocols for children/youth. Design: A prospective cohort of children/youth with concussion. Setting: Childhood Disability Research Centre. Participants: One hundred thirty-nine children/youth aged 5 to 18 years, diagnosed with concussion and symptomatic upon enrollment, were followed for up to 6 months. Primary recruitment occurred from a Children's Hospital Emergency Department. Intervention: Provision of RTS/RTA guidelines. Main Outcome Measures: Measurement of adherence came from multiple sources, including the child's and parent's knowledge of protocols, research personnel evaluations, and self-reported stages of RTS/RTA and Post-Concussion Symptom Scale (PCSS) scores. Results: Spearman correlations and logistic regression were used, investigating the relationship between PCSS and progression of protocols and determining predictors of adherence. Significant negative associations between total PCSS score and stage of RTS/RTA protocols were found. Fifty-three percent and 56% of the participants adhered to the RTS and RTA protocols, respectively. Conclusions: Children's knowledge of protocols and total PCSS scores significantly predicted adherence to RTS/RTA and may be the most important factors in predicting adherence during recovery from concussion.	[DeMatteo, Carol A.; Claridge, Everett] McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 433, Hamilton, ON L8S 1C7, Canada; [DeMatteo, Carol A.; Lin, Chia-Yu A.; Claridge, Everett] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Lin, Chia-Yu A.; Connolly, John F.] McMaster Univ, Ctr Adv Res Expt & Appl Linguist, ARiEAL, Hamilton, ON, Canada; [Foster, Gary; Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Res Inst, Hamilton, ON, Canada; [Foster, Gary; Thabane, Lehana] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Giglia, Lucia] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Thabane, Lehana] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Noseworthy, Michael D.; Connolly, John F.] McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada; [Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Hall, Geoffrey B.; Connolly, John F.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Connolly, John F.] McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada		DeMatteo, CA (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 433, Hamilton, ON L8S 1C7, Canada.	dematteo@mcmaster.ca		Connolly, John/0000-0001-8869-5369; /0000-0002-3398-6692	Canadian Institutes for Health Research Operating GrantCanadian Institutes of Health Research (CIHR) [MOP-133527]	Supported by the Canadian Institutes for Health Research Operating Grant (MOP-133527).	Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DeMatteo C., 2013, ACTIVITY SUGGESTIONS; DeMatteo C., 2013, CONCUSSION MANAGEMEN; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2009, J HEAD TRAUMA REHAB, V24, P355, DOI 10.1097/HTR.0b013e3181b97a4e; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Jago R, 2005, AM J PREV MED, V28, P447, DOI 10.1016/j.amepre.2005.02.007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehmann A, 2014, INT J CLIN PHARM-NET, V36, P55, DOI 10.1007/s11096-013-9865-x; LEVENTHAL H, 1987, PATIENT EDUC COUNS, V10, P117, DOI 10.1016/0738-3991(87)90093-0; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFaull S, 2016, Health Promot Chronic Dis Prev Can, V36, P13; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Public Health Agency of Canada, 2016, HEAD INJ CHILDR YOUT; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Rapoff MA, 2010, ISSUES CLIN CHILD PS, P69, DOI 10.1007/978-1-4419-0570-3_4; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Walters-Salas T, 2012, BARIAT NURS SURG PAT, V7, P186, DOI 10.1089/bar.2012.9960; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152	25	4	5	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2021	31	6					E406	E413		10.1097/JSM.0000000000000800			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WM5NJ	WOS:000711131700017	31876794				2022-02-06	
J	Bezherano, I; Haider, MN; Willer, BS; Leddy, JJ				Bezherano, Itai; Haider, Mohammad N.; Willer, Barry S.; Leddy, John J.			Practical Management: Prescribing Subsymptom Threshold Aerobic Exercise for Sport-Related Concussion in the Outpatient Setting	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; sport-related concussion; exercise treatment; subsymptom threshold aerobic exercise; Buffalo Concussion Treadmill Test		Exercise intolerance is an objective biomarker of the physiological dysfunction after sport-related concussion (SRC). Several trials have established the safety and clinical efficacy of subsymptom threshold aerobic exercise prescribed within 1 week of injury as treatment for SRC. Clinicians, however, may not be comfortable prescribing aerobic exercise after SRC. This article presents 3 methods of exercise prescription for patients with SRC. The first requires a graded exertion test plus a home-based exercise program requiring a heart rate (HR) monitor. The second requires a graded exertion test but no HR monitor for home-based exercise. The third requires solely an HR monitor to safely progress through the home-based exercise prescription. Patients are encouraged to keep a symptom and exercise diary and return for re-evaluation every 1 to 2 weeks. Delayed recovery should prompt the clinician to evaluate for other potential symptom generators (eg, cervical, vestibular, oculomotor, mood, or migraine disorders).	[Bezherano, Itai; Haider, Mohammad N.; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthoped & Sports Med, Buffalo, NY 14260 USA; [Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, PhD Program Biomed Sci, Program Neurosci, Buffalo, NY 14260 USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthoped & Sports Med, Buffalo, NY 14260 USA.; Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, PhD Program Biomed Sci, Program Neurosci, Buffalo, NY 14260 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444 and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glass S., 2007, ACSMS METABOLIC CALC; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; PERES G, 1987, J SPORT MED PHYS FIT, V27, P205; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475	15	4	4	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					465	468		10.1097/JSM.0000000000000809			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400026	32058454				2022-02-06	
J	Bunt, SC; Didehbani, N; Tarkenton, T; Rossetti, H; Hicks, C; Vargas, B; Silver, C; Nakonezny, P; Bell, K; Batjer, H; Cullum, CM				Bunt, Stephen C.; Didehbani, Nyaz; Tarkenton, Tahnae; Rossetti, Heidi; Hicks, Cason; Vargas, Bert; Silver, Cheryl; Nakonezny, Paul; Bell, Kathleen; Batjer, Hunt; Cullum, C. Munro			Sex Differences and Reporting of SCAT-5 Concussion Symptoms in Adolescent Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; sports; symptoms; sex	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL-STUDENTS; STATES HIGH-SCHOOL; UNITED-STATES; POSTCONCUSSION SYNDROME; GENDER-DIFFERENCES; BASE-LINE; RECOVERY; EPIDEMIOLOGY; YOUTH	Objective: To elucidate specific symptoms that may differ between adolescent female and male athletes after a sports-related concussion (SRC) and identify symptoms that may require greater clinical attention by medical and athletic staff. Design: Prospective. Setting: This study is part of a larger research project conducted at clinics in the North Texas Concussion Network (ConTex) Registry. Participants: Subjects (N = 491) aged 12 to 18 years who sustained a diagnosed SRC within 30 days of clinic visit. Independent Variables: Sex (female vs male). Covariates included age, race, current mood (anxiety and depression), learning disability/ADHD, and time to clinic. Main Outcome Measures: Twenty-two individual postconcussion symptoms as measured by the Post-Concussion Symptom Scale from the Sport Concussion Assessment Tool-5 (SCAT-5). Results: Girls endorsed higher levels of anxiety and depression symptoms at initial clinic visit. analysis of covariance results revealed that girls had significantly greater symptom severity of headache, dizziness, sensitivity to light, sensitivity to noise, pressure in the head, feeling slowed down, fatigue, and drowsiness than boys. Ordinal logistic regression results also revealed that girls had significantly greater predicted odds of higher symptom severity on these 8 symptoms and in trouble concentrating than boys. Conclusions: Closer examination of specific symptoms with attention to patients' current levels of anxiety and depression symptoms may better inform medical and athletic staff to anticipate and address symptoms that may present greater challenges for adolescent girls than boys.	[Bunt, Stephen C.; Didehbani, Nyaz; Tarkenton, Tahnae; Rossetti, Heidi; Hicks, Cason; Silver, Cheryl; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Vargas, Bert; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Nakonezny, Paul] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Batjer, Hunt; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA		Bunt, SC (corresponding author), UT Southwestern Med Ctr, Div Psychol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	stephen.bunt@utsouthwestern.edu		Bunt, Stephen/0000-0002-3631-4648	Texas Institute for Brain Injury and Repair (TIBIR); Peter O'Donnell Jr.; Brain Institute at UT Southwestern Medical Center	Support for this study was provided by the Texas Institute for Brain Injury and Repair (TIBIR) and the Peter O'Donnell Jr. Brain Institute at UT Southwestern Medical Center.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Davies S, 2018, J ATHL TRAINING, V53, P873, DOI 10.4085/1062-6050-529-17; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dunne JA., 2017, J ATHL TRAINING, V52, pS171; Eaton DK, 2010, J ADOLESCENT HEALTH, V46, P399, DOI 10.1016/j.jadohealth.2009.10.011; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ozge A., 2017, HEADACHE COMORBIDITI, P1, DOI DOI 10.1007/978-3-319-54726-8; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; ter Wolbeek M, 2006, PEDIATRICS, V117, pE1078, DOI 10.1542/peds.2005-2575; Viner RM, 2008, ARCH PEDIAT ADOL MED, V162, P469, DOI 10.1001/archpedi.162.5.469; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	46	4	4	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					E229	E234		10.1097/JSM.0000000000000788			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400003	31985537				2022-02-06	
J	Iverson, GL; Kelshaw, PM; Cook, NE; Caswell, SV				Iverson, Grant L.; Kelshaw, Patricia M.; Cook, Nathan E.; Caswell, Shane, V			Middle School Children With Attention-Deficit/Hyperactivity Disorder Have a Greater Concussion History	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						adolescents; attention-deficit hyperactivity disorder; concussion; mild traumatic brain injury; surveillance	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; PSYCHIATRIC-ILLNESS; RISK-FACTOR; ADHD; SYMPTOMS; ADOLESCENTS; SCORES	Objective: Examine lifetime history of concussions in middle school student athletes who have attention-deficit/hyperactivity disorder (ADHD). Design: Cross-sectional study. Setting: Nine middle schools in Virginia, USA. Participants: A sample of 1037 middle school students (ages 11-14 years, M = 12.6, SD = 0.93; 45.8% girls) underwent baseline/preseason assessments during the 2017 to 2018 academic year and self-reported their health history, including whether or not they had been diagnosed with ADHD. Athletes were divided into 2 groups, those with ADHD (n = 71; 6.8%) and control subjects (n = 966). Independent Variables: Self-reported diagnosis of ADHD and self-identified sex. Main Outcome Measures: Self-reported concussion history. Results: In the total sample, boys were more likely to report a previous history of concussion than girls [chi(2)(1) = 10.81, P = 0.001; odds ratio (OR) = 1.92; 95% confidence interval (CI), 1.30-2.85]. The rate of previous concussion in children with ADHD (23.9%) was twice the rate of previous concussion among children without ADHD (11.4%) [chi(2)(1) = 9.70, P = 0.002; OR = 2.45; 95% CI, 1.37-4.38]. Approximately 1 in 4 boys with ADHD (24.5%) and 1 in 5 girls with ADHD (22.2%) reported having sustained one or more previous concussions. Conclusions: Attention-deficit/hyperactivity disorder is associated with a greater prevalence of previous concussion in middle school children. Further research is needed to understand the risk of sustaining concussion for young athletes with ADHD, as well as short- and long-term outcomes of concussion among young athletes with ADHD.	[Iverson, Grant L.; Cook, Nathan E.] Spaulding Rehabil Hosp, Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.; Cook, Nathan E.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.; Cook, Nathan E.] MassGen Hosp Children Sport Concuss Program, Boston, MA USA; [Kelshaw, Patricia M.] George Mason Univ, Coll Educ & Human Dev, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Athlet Training Educ Program, Manassas, VA USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 13th St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			ImPACT Applications, Inc; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc); National Football League; Louis V. Gerstner III Research Scholar Award; Potomac Health Foundation; Center for Disease Control and Virginia Department of Health	He has received research funding from several test publishing companies, including ImPACT Applications, Inc, CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc). He has received research funding as a principal investigator from the National Football League, and salary support as a collaborator from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. G. L. Iverson acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, Boston Bolts, and ImPACT Applications, Inc. N. E. Cook acknowledges support from the Louis V. Gerstner III Research Scholar Award. S. V. Caswell acknowledges unrestricted grant funding from the Potomac Health Foundation, the Center for Disease Control and Virginia Department of Health. The remaining author reports no conflicts of interest.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BIJUR PE, 1990, PEDIATRICS, V86, P337; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Herguner A, 2015, DENT TRAUMATOL, V31, P140, DOI 10.1111/edt.12153; Iverson GL, 2016, J ATTEN DISORD; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kaya A, 2008, J INT MED RES, V36, P9, DOI 10.1177/147323000803600102; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mota-Veloso I, 2016, INT J PAEDIATR DENT, V26, P471, DOI 10.1111/ipd.12222; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Russell AE, 2016, CHILD PSYCHIAT HUM D, V47, P440, DOI 10.1007/s10578-015-0578-3; Sabuncuoglu O, 2005, DENT TRAUMATOL, V21, P249, DOI 10.1111/j.1600-9657.2005.00317.x; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Shilon Y, 2012, CHILD CARE HLTH DEV, V38, P366, DOI 10.1111/j.1365-2214.2011.01278.x; Singh Gopal K, 2017, Int J MCH AIDS, V6, P139, DOI 10.21106/ijma.236; Swensen A., 2004, Journal of Adolescent Health, V35, P346, DOI 10.1016/S1054-139X(04)00055-2; Terry DP, 2018, CLIN J SPORT MED; The Aspen Institute: Project Play, 2017, STAT PLAY 2017 TREND; Thikkurissy S, 2012, PEDIATR DENT, V34, P28; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412	39	4	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2021	31	5					438	441		10.1097/JSM.0000000000000773			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3KG	WOS:000711670400021	32032165				2022-02-06	
J	Messa, I; Holcomb, M; Lichtenstein, JD; Tyson, BT; Roth, RM; Erdodi, LA				Messa, Isabelle; Holcomb, Matthew; Lichtenstein, Jonathan D.; Tyson, Brad T.; Roth, Robert M.; Erdodi, Laszlo A.			They are not destined to fail: a systematic examination of scores on embedded performance validity indicators in patients with intellectual disability	AUSTRALIAN JOURNAL OF FORENSIC SCIENCES			English	Article; Early Access						Intellectual disability; performance validity; embedded validity indicators; false positive rate; forensic assessment	ADULT INTELLIGENCE SCALE; CARD SORTING TEST; VERBAL-LEARNING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FORCED-CHOICE RECOGNITION; RELIABLE DIGIT SPAN; COMPLEX FIGURE TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY	This study was designed to determine the clinical utility of embedded performance validity indicators (EVIs) in adults with intellectual disability (ID) during neuropsychological assessment. Based on previous research, unacceptably high (>16%) base rates of failure (BRFail) were predicted on EVIs using on the method of threshold, but not on EVIs based on alternative detection methods. A comprehensive battery of neuropsychological tests was administered to 23 adults with ID (M-Age = 37.7 years, M-FSIQ = 64.9). BRFail were computed at two levels of cut-offs for 32 EVIs. Patients produced very high BRFail on 22 EVIs (18.2%-100%), indicating unacceptable levels of false positive errors. However, on the remaining ten EVIs BRFail was <16%. Moreover, six of the EVIs had a zero BRFail, indicating perfect specificity. Consistent with previous research, individuals with ID failed the majority of EVIs at high BRFail. However, they produced BRFail similar to cognitively higher functioning patients on select EVIs based on recognition memory and unusual patterns of performance, suggesting that the high BRFail reported in the literature may reflect instrumentation artefacts. The implications of these findings for clinical and forensic assessment are discussed.	[Messa, Isabelle; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Holcomb, Matthew] Jefferson Neurobehav Grp, New Orleans, LA USA; [Lichtenstein, Jonathan D.; Roth, Robert M.] Dartmouth Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03766 USA; [Tyson, Brad T.] EvergreenHlth Med Ctr, Neuropsychol Serv, Kirkland, WA USA		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	lerdodi@gmail.com		Tyson, Brad/0000-0002-5113-790X			Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Abramson DA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1774378; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Ashendorf L, 2019, CLIN NEUROPSYCHOL, V33, P1388, DOI 10.1080/13854046.2018.1543454; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barker A, 2014, APPL NEUROPSYCH-ADUL, V21, P51, DOI 10.1080/09084282.2012.726670; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bell-Sprinkel TL, 2013, CLIN NEUROPSYCHOL, V27, P516, DOI 10.1080/13854046.2012.744853; Bhasin Tanya Karapurkar, 2006, Morbidity and Mortality Weekly Report, V55, P1; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Boyle C A, 1996, MMWR CDC Surveill Summ, V45, P1; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Camp BW, 1998, EARLY HUM DEV, V50, P159, DOI 10.1016/S0378-3732(97)00034-9; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Chafetz MD, 2013, ARCH CLIN NEUROPSYCH, V28, P205, DOI 10.1093/arclin/act015; Chafetz MD, 2012, CLIN NEUROPSYCHOL, V26, P1358, DOI 10.1080/13854046.2012.730674; Chafetz MD, 2011, ARCH CLIN NEUROPSYCH, V26, P306, DOI 10.1093/arclin/acr030; Chafetz MD, 2010, CLIN NEUROPSYCHOL, V24, P1045, DOI 10.1080/13854046.2010.481637; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Dandachi-FitzGerald B, 2020, J INT NEUROPSYCH SOC, V26, P314, DOI 10.1017/S1355617719001139; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; DenBoer JW, 2007, CLIN NEUROPSYCHOL, V21, P943, DOI 10.1080/13854040601020783; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi LA., 2020, ASSESSMENT FEIGNED C, P218; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P1029, DOI 10.1080/13854046.2017.1323119; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Gligorovic M, 2013, J INTELLECT DEV DIS, V38, P134, DOI 10.3109/13668250.2013.772956; Graue LO, 2007, CLIN NEUROPSYCHOL, V21, P929, DOI 10.1080/13854040600932137; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Grossi LM, 2017, PSYCHOL ASSESSMENT, V29, P531, DOI 10.1037/pas0000364; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Holcomb MJ., 2018, J PEDIA NEUROPSYCHOL, V4, P83, DOI [10.1007/s40817-018-00062-y, DOI 10.1007/S40817-018-00062-Y]; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jodzio K, 2010, APPL NEUROPSYCHOL, V17, P267, DOI 10.1080/09084282.2010.525104; Johnstone L, 2003, BRIT J CLIN PSYCHOL, V42, P303, DOI 10.1348/01446650360703401; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Love CM, 2014, ASSESSMENT, V21, P618, DOI 10.1177/1073191114528028; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2020, ARCH CLIN NEUROPSYCH, V35, P717, DOI 10.1093/arclin/acaa017; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Millis SR., 2009, AM ACAD CLIN NEUROPS, P21; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morse CL, 2013, CLIN NEUROPSYCHOL, V27, P1395, DOI 10.1080/13854046.2013.832385; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson, 2009, ADV CLIN SOLUTIONS W; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Resch ZJ., 2020, APPL NEUROPSYCH-ADUL; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Salekin KL, 2009, APPL NEUROPSYCHOL, V16, P105, DOI 10.1080/09084280902864485; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Victor TL., 2007, ASSESSMENT FEIGNED C, P310, DOI [DOI 10.1076/JCEN.25.7.979.16481, 10.1076/jcen.25.7.979.16481]; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler, 1997, WECHSLER ADULT INTEL	133	4	4	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0045-0618	1834-562X		AUST J FORENSIC SCI	Aust. J. Forensic Sci.												10.1080/00450618.2020.1865457		AUG 2021	17	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	UE6WN	WOS:000688026300001					2022-02-06	
J	Dell'Aquila, M; Maiese, A; De Matteis, A; Viola, RV; Arcangeli, M; La Russa, R; Fineschi, V				Dell'Aquila, Massimiliano; Maiese, Aniello; De Matteis, Alessandra; Viola, Rocco Valerio; Arcangeli, Mauro; La Russa, Raffaele; Fineschi, Vittorio			Traumatic brain injury: Estimate of the age of the injury based on neuroinflammation, endothelial activation markers and adhesion molecules	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Traumatic brain injury; Age estimation; Immunohistochemistry; Brain; Pathology; Forensic science	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; BARRIER DISRUPTION; AXONAL INJURY; HEAD-INJURY; TIME-COURSE; PROTEIN; PATHOPHYSIOLOGY; ACCUMULATION; DAMAGE	Studies on traumatic brain injury (TBI) are applicable not only in the clinical context, but also in the forensic field. Over time, the literature has accumulated scientific evidence supporting the use of specific histopathological tests in dating traumatic brain injuries. In primary damage, cell death occurs by necrosis/apoptosis. In secondary injury, the underlying mechanisms are inflammation and ischemia. The inflammatory response of the central nervous system (CNS) follows the common steps of the innate response. In head injury, the blood brain barrier (BBB) undergoes both functional damage and, subsequently, finer structural changes. Scientific evidence has shown modifications of the junctional-endothelial system that favors the extravasation of immunocompetent cells. The histological evaluation of the subdural hematoma, of the cerebral contusions, of the diffuse axonal damage can certainly bring useful elements, with limitations, to the chronological evaluation of the lesions. Many markers have been used to better define the dating of the head injury. Several authors also analyzed the usefulness of secondary damage markers in brain tissue. The progress achieved with immunohistochemistry is significant compared to the use of routine staining. With immunohistochemistry it is possible to identify much narrower and more precise time intervals and, above all, with greater probative reliability. Recently attention has been paid to the modification of structural proteins and miRNAs. Future research is already started and entrusted to multidisciplinary teams that know how to combine their specific skills in search of a reproducible standard of known and sufficient accuracy.	[Dell'Aquila, Massimiliano; Maiese, Aniello; De Matteis, Alessandra; Viola, Rocco Valerio; La Russa, Raffaele; Fineschi, Vittorio] Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci, Viale Regina Elena 336, I-00161 Rome, Italy; [Maiese, Aniello; La Russa, Raffaele; Fineschi, Vittorio] IRCSS Neuromed Mediterranean Neurol Inst, Pozzilli, Italy; [Arcangeli, Mauro] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy		Fineschi, V (corresponding author), Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci, Viale Regina Elena 336, I-00161 Rome, Italy.	vittorio.fineschi@uniroma1.it					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bohnert S, 2020, INT J LEGAL MED, V134, P2167, DOI 10.1007/s00414-020-02384-z; Chmieliauskas S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012567; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; Dettmeyer R.B., 2018, FORENSIC HISTOPATHOL; DiMaio VJM, 2007, HDB FORENSIC PATHOLO; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Fineschi V, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6024959; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Hausmann Roland, 2006, Forensic Sci Med Pathol, V2, P85, DOI 10.1385/FSMP:2:2:85; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kobek M, 2014, Arch Med Sadowej Kryminol, V64, P268; Kobek M, 2016, FOLIA NEUROPATHOL, V54, P50, DOI 10.5114/fn.2016.58915; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; La Russa R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114148; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Liang Y, 2019, BRAIN RES BULL, V153, P289, DOI 10.1016/j.brainresbull.2019.09.004; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Man SM, 2009, J NEUROIMMUNOL, V210, P92, DOI 10.1016/j.jneuroim.2009.03.008; Michiue T, 2008, FORENSIC SCI INT, V178, P185, DOI 10.1016/j.forsciint.2008.03.019; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; O'Leary RA, 2018, J NEUROSURG SCI, V62, P542, DOI 10.23736/S0390-5616.18.04501-0; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Oehmichen M., 2009, Legal Medicine, V11, P118, DOI 10.1016/j.legalmed.2008.11.003; OEHMICHEN M, 1986, FORENSIC SCI INT, V30, P281, DOI 10.1016/0379-0738(86)90136-2; Olczak M, 2019, FOLIA NEUROPATHOL, V57, P51, DOI 10.5114/fn.2019.83831; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Oliver D, 2008, QUAL SAF HEALTH CARE, V17, P431, DOI 10.1136/qshc.2007.024703; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Pinchi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20699-1; Riezzo I, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-49; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Tirado MDR, 2018, AM J FOREN MED PATH, V39, P201, DOI 10.1097/PAF.0000000000000412; Ropper A.H., 2019, ADAMS VICTORS PRINCI, Veleventh; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Soares HD, 1995, J NEUROSCI, V15, P8223; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; STRASSMANN G, 1949, ARCH PATHOL, V47, P205; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Turowski P, 2005, CELL MOL NEUROBIOL, V25, P153, DOI 10.1007/s10571-004-1380-0; Walter Till, 2009, Leg Med (Tokyo), V11 Suppl 1, pS56, DOI 10.1016/j.legalmed.2009.01.112; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Wu Q, 2017, HISTOL HISTOPATHOL, V32, P551, DOI 10.14670/HH-11-841; Zaki M.K., 2011, EGYPT J FORENSIC SCI, V1, P87; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; [曾毅 ZENG Yi], 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P350; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	84	4	4	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	AUG	2021	36	8					795	806		10.14670/HH-18-319			12	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	XC2IV	WOS:000721844100001	33625724				2022-02-06	
J	Spindler, LRB; Luppi, AI; Adapa, RM; Craig, MM; Coppola, P; Peattie, ARD; Manktelow, AE; Finoia, P; Sahakian, BJ; Williams, GB; Allanson, J; Pickard, JD; Menon, DK; Stamatakis, EA				Spindler, Lennart R. B.; Luppi, Andrea, I; Adapa, Ram M.; Craig, Michael M.; Coppola, Peter; Peattie, Alexander R. D.; Manktelow, Anne E.; Finoia, Paola; Sahakian, Barbara J.; Williams, Guy B.; Allanson, Judith; Pickard, John D.; Menon, David K.; Stamatakis, Emmanuel A.			Dopaminergic brainstem disconnection is common to pharmacological and pathological consciousness	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						brainstem; consciousness; disorders of consciousness; dopamine; neurotransmitter	AREA INDUCES REANIMATION; ASCENDING AROUSAL SYSTEM; FUNCTIONAL CONNECTIVITY; GENERAL-ANESTHESIA; VEGETATIVE STATE; SEVERE DISORDERS; RECEPTORS; PROPOFOL; NETWORK; NEUROMODULATION	Clinical research into consciousness has long focused on cortical macroscopic networks and their disruption in pathological or pharmacological consciousness perturbation. Despite demonstrating diagnostic utility in disorders of consciousness (DoC) and monitoring anesthetic depth, these cortico-centric approaches have been unable to characterize which neurochemical systems may underpin consciousness alterations. Instead, preclinical experiments have long implicated the dopaminergic ventral tegmental area (VTA) in the brainstem. Despite dopaminergic agonist efficacy in DoC patients equally pointing to dopamine, the VTA has not been studied in human perturbed consciousness. To bridge this translational gap between preclinical subcortical and clinical cortico-centric perspectives, we assessed functional connectivity changes of a histologically characterized VTA using functional MRI recordings of pharmacologically (propofol sedation) and pathologically perturbed consciousness (DoC patients). Both cohorts demonstrated VTA disconnection from the precuneus and posterior cingulate (PCu/PCC), a main default mode network node widely implicated in consciousness. Strikingly, the stronger VTA- PCu/PCC connectivity was, the more the PCu/PCC functional connectome resembled its awake configuration, suggesting a possible neuromodulatory relationship. VTA-PCu/PCC connectivity increased toward healthy control levels only in DoC patients who behaviorally improved at follow-up assessment. To test whether VTA-PCu/PCC connectivity can be affected by a dopaminergic agonist, we demonstrated in a separate set of traumatic brain injury patients without DoC that methylphenidate significantly increased this connectivity. Together, our results characterize an in vivo dopaminergic connectivity deficit common to reversible and chronic consciousness perturbation. This noninvasive assessment of the dopaminergic system bridges preclinical and clinical work, associating dopaminergic VTA function with macroscopic network alterations, thereby elucidating a critical aspect of brainstem-cortical for consciousness.	[Spindler, Lennart R. B.; Luppi, Andrea, I; Adapa, Ram M.; Craig, Michael M.; Coppola, Peter; Peattie, Alexander R. D.; Manktelow, Anne E.; Finoia, Paola; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Univ Div Anaesthesia, Addenbrookes Hosp, Cambridge CB2 0SP, England; [Spindler, Lennart R. B.; Luppi, Andrea, I; Craig, Michael M.; Coppola, Peter; Peattie, Alexander R. D.; Williams, Guy B.; Allanson, Judith; Pickard, John D.; Stamatakis, Emmanuel A.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0SP, England; [Finoia, Paola; Pickard, John D.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Div Neurosurg, Cambridge CB2 0SP, England; [Sahakian, Barbara J.] Univ Cambridge, Sch Clin Med, Dept Psychiat, Cambridge CB2 0SZ, England; [Sahakian, Barbara J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Williams, Guy B.; Pickard, John D.; Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 0QQ, England; [Allanson, Judith] Cambridge Univ Hosp Natl Hlth Serv Fdn, Addenbrookes Hosp, Dept Neurosci, Cambridge CB2 0SP, England		Spindler, LRB; Stamatakis, EA (corresponding author), Univ Cambridge, Univ Div Anaesthesia, Addenbrookes Hosp, Cambridge CB2 0SP, England.; Spindler, LRB; Stamatakis, EA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0SP, England.	lrbs2@cam.ac.uk; eas46@cam.ac.uk	; Adapa, Ram/D-7925-2012	Williams, Guy/0000-0001-5223-6654; Adapa, Ram/0000-0002-9845-8532; Peattie, Alexander/0000-0003-2115-7640	Wellcome Trust: Clinical Research Training FellowshipWellcome Trust [083660/Z/07/Z]; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [U.1055.01.002.00001.01]; James S. McDonnell Foundation; Canadian Institute for Advanced ResearchCanadian Institute for Advanced Research (CIFAR); National Institute for Health Research (NIHR), Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Senior Investigator Awards; British Oxygen Professorship of the Royal College of Anaesthetists; Cambridge International Trust; Cambridge European Scholarship; Evelyn Trust, Cambridge; East of England Collaboration for Leadership in Applied Health Research and Care fellowship; Stephen Erskine Fellowship, Queens' College, University of Cambridge; Gates Cambridge Trust; NIHR Brain Injury Healthcare Technology Cooperative based at Cambridge University Hospitals National Health Service Foundation Trust; University of CambridgeUniversity of Cambridge; Medical Research Council research infrastructure Award [MR/M009041/1]	We thank Dr. Brian L. Edlow and Dr. Samuel B. Snider of Harvard University for their constructive comments on this work and for providing the HAAN atlas as an important research tool for this line of work. We would also like to thank Victoria Lupson and the staff in the Wolfson Brain Imaging Centre (WBIC) at Addenbrooke's Hospital for their assistance in scanning and all the participants, patients, and their carers for their con-tribution to this study. This work was supported by a grant from theWellcome Trust: Clinical Research Training Fellowship (to R.M.A.; contract Grant No. 083660/Z/07/Z) . The work was also supported by grants from the UK Medical Research Council (Grant No. U.1055.01.002.00001.01) to J.D.P.; the James S. McDonnell Foundation (to J.D.P.) ; the Canadian Institute for Advanced Research (to D.K.M. and E.A.S.) ; the National Institute for Health Research (NIHR) , Cambridge Biomedical Research Centre and NIHR Senior Investigator Awards (to J.D.P. and D.K.M.) ; the British Oxygen Professorship of the Royal College of Anaesthetists (to D.K.M.) ; the Cambridge Interna-tional Trust and the Cambridge European Scholarship (to L.R.B.S.) ; the Evelyn Trust, Cambridge and the East of England Collaboration for Leadership in Applied Health Research and Care fellowship (to J.A.) ; the Stephen Erskine Fellowship, Queens' College, University of Cambridge (to E.A.S.) ; and the Gates Cambridge Trust (to A.I.L.) . The research was also supported by the NIHR Brain Injury Healthcare Technology Cooperative based at Cambridge University Hospitals National Health Service Foundation Trust and University of Cambridge. Computing infrastructure at the WBIC High Performance Hub for Clinical Informatics was funded by Medical Research Council research infrastructure Award No. MR/M009041/1.	Adapa RM, 2014, HUM BRAIN MAPP, V35, P2935, DOI 10.1002/hbm.22375; Almgren H, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116435; Avery MC, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00108; Bar KJ, 2016, NEUROIMAGE, V134, P53, DOI 10.1016/j.neuroimage.2016.03.071; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bonhomme V, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00036; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Carhart-Harris RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00020; Chen SS, 2018, NEUROSCIENCE, V382, P115, DOI 10.1016/j.neuroscience.2018.04.039; Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Di Perri C, 2014, EPILEPSY BEHAV, V30, P28, DOI 10.1016/j.yebeh.2013.09.014; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Elsinga PH, 2006, CURR MED CHEM, V13, P2139, DOI 10.2174/092986706777935258; Fridman EA, 2019, BRAIN, V142, P1887, DOI 10.1093/brain/awz118; Fridman EA, 2014, CURR OPIN NEUROBIOL, V29, P172, DOI 10.1016/j.conb.2014.09.008; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Guldenmund P, 2017, BRIT J ANAESTH, V119, P674, DOI 10.1093/bja/aex257; Ishii T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189318; Kaller S, 2017, EUR J NUCL MED MOL I, V44, P1025, DOI 10.1007/s00259-017-3645-0; Kenny JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131914; Lehnerer S. M., 2017, BMJ CASE REP; Liu XY, 2015, NEUROPSYCH DIS TREAT, V11, P2573, DOI 10.2147/NDT.S88156; Luppi AI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12658-9; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Mashour GA, 2015, BRIT J ANAESTH, V115, P20, DOI 10.1093/bja/aev034; Mashour GA, 2018, TRENDS NEUROSCI, V41, P150, DOI 10.1016/j.tins.2018.01.003; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; Nagano-Saito A, 2017, SYNAPSE, V71, DOI 10.1002/syn.21993; Nir T, 2019, BRIT J ANAESTH, V123, P298, DOI 10.1016/j.bja.2019.05.038; Oishi Y, 2017, BRAIN STRUCT FUNCT, V222, P2907, DOI 10.1007/s00429-017-1365-7; Palmiter RD, 2011, NEUROSCIENCE, V198, P213, DOI 10.1016/j.neuroscience.2011.06.089; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Ruud X, 2016, J NEUROSCI, V36, P7865; Satpute AB, 2019, NEUROSCI LETT, V693, P19, DOI 10.1016/j.neulet.2018.01.042; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Sclocco R, 2018, NEUROIMAGE, V168, P412, DOI 10.1016/j.neuroimage.2017.02.052; Shine JM, 2019, NAT NEUROSCI, V22, P289, DOI 10.1038/s41593-018-0312-0; Shine JM, 2018, NETW NEUROSCI, V2, P381, DOI 10.1162/netn_a_00042; Solt K, 2014, ANESTHESIOLOGY, V121, P311, DOI 10.1097/ALN.0000000000000117; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Song AH, 2017, J NEUROSCI, V37, P6938, DOI 10.1523/JNEUROSCI.0446-17.2017; Spindler R. B., DOPAMINERGIC BRAINST; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Taylor NE, 2016, P NATL ACAD SCI USA, V113, P12826, DOI 10.1073/pnas.1614340113; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Tononi G, 2016, NAT REV NEUROSCI, V17, P450, DOI 10.1038/nrn.2016.44; Trutti AC, 2019, NEUROIMAGE, V191, P258, DOI 10.1016/j.neuroimage.2019.01.062; van den Brink RL, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00340; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Wang Y, 2016, AM J TRANSL RES, V8, P2301; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zhou XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138187	70	4	4	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	JUL 27	2021	118	30							e2026289118	10.1073/pnas.2026289118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA3CD	WOS:000685039000004	34301891	Green Published, hybrid			2022-02-06	
J	Ariyannur, PS; Xing, GQ; Barry, ES; Benford, B; Grunberg, NE; Sharma, P				Ariyannur, Prasanth S.; Xing, Guoqiang; Barry, Erin S.; Benford, Brandi; Grunberg, Neil E.; Sharma, Pushpa			Effects of Pyruvate Administration on Mitochondrial Enzymes, Neurological Behaviors, and Neurodegeneration after Traumatic Brain Injury	AGING AND DISEASE			English	Article						Fluid percussion; mTBI; mitochondrial enzyme; neurodegeneration; pyruvate	OXIDATIVE DAMAGE; ALZHEIMERS-DISEASE; HEMORRHAGIC-SHOCK; ETHYL PYRUVATE; HEAD-INJURY; RAT MODEL; MILD; TAU; DYSFUNCTION; MODERATE	Traumatic brain injury (TBI) is known to increase the susceptibility to various age-related neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). Although the role of damaged mitochondrial electron transport chain (ETC) in the progression of AD and PD has been identified, its relationship with altered expression of neurodegenerative proteins has not been examined before. This study aimed to investigate 1) how TBI could affect mitochondrial ETC and neurodegeneration in rat brain regions related to behavioral alteration, and 2) if administration of the key mitochondrial substrate pyruvate can improve the outcome of mild TBI (mTBI). In a rat lateral fluid percussion injury model of mTBI, sodium pyruvate in sterile distilled water (1 g/kg body weight) was administered orally daily for 7 days. The protein expression of mitochondrial ETC enzymes, and neurodegeneration proteins in the hippocampus and cerebral cortex and was assessed on Day 7. The hippocampal and cortical expressions of ETC complex I, III, IV, V were significantly and variably impaired following mTBI. Pyruvate treatment altered ETC complex expression, reduced the nitrosyl stress and the MBP expression in the injured brain area, but increased the expression of the glial fibrillary acidic protein ( GFAP) and Tau proteins. Pyruvate after mTBI augmented the Rotarod performance but decreased the horizontal and vertical open field locomotion activities and worsened neurobehavioural severity score, indicating a debilitating therapeutic effect on the acute phase of mTBI. These results suggest bidirectional neuroprotective and neurodegenerative modulating effects of pyruvate on TBI-induced alteration in mitochondrial activity and motor behavior. Pyruvate could potentially stimulate the proliferation of astrogliosis, and lactate acidosis, and caution should be exercised when used as a therapy in the acute phase of mTBI. More effective interventions targeted at multiple mechanisms are needed for the prevention and treatment of TBI-induced long-term neurodegeneration.	[Ariyannur, Prasanth S.; Xing, Guoqiang; Benford, Brandi; Sharma, Pushpa] Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA; [Xing, Guoqiang] North Sichuan Med Univ, Affiliated Hosp, Imaging Inst Rehabil & Dev Brain Funct, Nanchong Cent Hosp, Nanchong 637000, Peoples R China; [Xing, Guoqiang] North Sichuan Med Univ, Clin Med Coll 2, Nanchong Cent Hosp, Nanchong 637000, Peoples R China; [Ariyannur, Prasanth S.] Amrita Vishwa Vidyapeetham, Dept Biochem & Mol Biol, Amrita Inst Med Sci, Kochi 682041, Kerala, India; [Barry, Erin S.; Grunberg, Neil E.] Uniformed Serv Univ Hlth Sci, Mil & Emergency Med, Bethesda, MD 20814 USA		Sharma, P (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.; Xing, GQ (corresponding author), North Sichuan Med Univ, Affiliated Hosp, Nanchong, Peoples R China.; Xing, GQ (corresponding author), North Sichuan Med Univ, Clin Med Coll 2, Nanchong, Peoples R China.	gxing99@yahoo.com; pushpa.sharma@usuhs.edu	Ariyannur, Prasanth S./C-1280-2008; Sharma, Pushpa/AAY-8756-2020	Ariyannur, Prasanth S./0000-0003-0888-8094; 	DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W911NF 111005]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-1-0507]	This research was supported by the DARPA award W911NF 111005 and USAMRMC award W81XWH-10-1-0507 (Pushpa Sharma).	Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Ariyannur PS, 2010, J COMP NEUROL, V518, P2952, DOI 10.1002/cne.22373; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Franke H, 2014, NEUROSCI LETT, V565, P14, DOI 10.1016/j.neulet.2013.09.056; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Gash DM, 2008, ANN NEUROL, V63, P184, DOI 10.1002/ana.21288; Gil V, 2006, J NEUROPATH EXP NEUR, V65, P433, DOI 10.1097/01.jnen.0000222894.59293.98; Gill RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192801; Glancy B, 2021, J PHYSIOL-LONDON, V599, P863, DOI 10.1113/JP278930; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; GRUNBERG NE, 1985, PHARMACOL BIOCHEM BE, V23, P851, DOI 10.1016/0091-3057(85)90081-4; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Iglesias J, 2017, MOL NEUROBIOL, V54, P2518, DOI 10.1007/s12035-016-9833-2; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; Kovacs GG, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00096; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Li CY, 2015, NEUROCHEM INT, V83-84, P9, DOI 10.1016/j.neuint.2015.03.001; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lu PJ, 1999, NATURE, V399, P784; Lundblad M, 2003, J NEUROCHEM, V84, P1398, DOI 10.1046/j.1471-4159.2003.01632.x; Mailloux RJ, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060472; Marti M, 2005, J NEUROSCI, V25, P9591, DOI 10.1523/JNEUROSCI.2546-05.2005; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mongan PD, 2003, J SURG RES, V112, P180, DOI 10.1016/S0022-4804(03)00148-3; Morse DE, 1997, PHARMACOL BIOCHEM BE, V56, P221, DOI 10.1016/S0091-3057(96)00214-6; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rahman MA, 1997, PHARMACOL BIOCHEM BE, V56, P409, DOI 10.1016/S0091-3057(96)00222-5; Perea JR, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00442; Rustay NR, 2003, BEHAV BRAIN RES, V141, P237, DOI 10.1016/S0166-4328(02)00376-5; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sharma P, 2005, ANESTHESIOLOGY, V103, P65, DOI 10.1097/00000542-200507000-00013; Sharma P, 2003, BRAIN RES, V992, P104, DOI 10.1016/j.brainres.2003.08.043; Sharma P, 2010, SHOCK, V33, P532, DOI 10.1097/SHK.0b013e3181cc02b3; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tian JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095777; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Xing GQ, 2018, J NEUROTRAUM, V35, P2482, DOI 10.1089/neu.2017.5496; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Yarnell AM, 2016, CURR PROTOC NEUROSCI, V75; Yuan YM, 2012, BRIT J PHARMACOL, V166, P749, DOI 10.1111/j.1476-5381.2011.01804.x; Zilberter Y, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00017	72	4	4	5	5	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	JUL	2021	12	4					983	999		10.14336/AD.2020.1015			17	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	TD9PE	WOS:000669649700004	34221543	gold, Green Published			2022-02-06	
J	Wright, J; Sohlberg, MM				Wright, Jim; Sohlberg, McKay Moore			The Implementation of a Personalized Dynamic Approach for the Management of Prolonged Concussion Symptoms	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; REHABILITATION; CHILDREN; INTERVENTION; VETERANS; HISTORY; IMPACT	Purpose: This clinical focus article reviews the existing treatment literature on the management of prolonged concussion symptoms (PCS) for specifying treatment components that hold the most promise for effectively targeting functional goals that are disrupted due to cognitive impairments. Current evidence suggests the treatment ingredients of psychoeducation and cognitive strategy instruction can be effective for addressing changes in functioning due to perceived cognitive deficits in attention, working memory, and executive functioning. Based on the literature, we propose a personalized, dynamic approach to managing PCS that is tailored to the symptom profile of the individual client and consists of three phases, treatment setup, implementation of treatment, and discharge plan, in which the implementation phase consists of psychoeducation and strategy training. The unique aspect of this approach is the use of individualized status tracking measures on goal progress as well as strategy use and perceived strategy helpfulness to empirically guide treatment. Client performance directs clinical decisions, and the clinician adapts treatment components in order to facilitate functional change. Conclusion: We provide a case example of an adolescent client treated in our university clinic to demonstrate the implementation of the proposed personalized and dynamic approach to PCS management.	[Wright, Jim; Sohlberg, McKay Moore] Univ Oregon, Dept Commun Disorders & Sci, Eugene, OR 97403 USA		Wright, J (corresponding author), Univ Oregon, Dept Commun Disorders & Sci, Eugene, OR 97403 USA.	jwrigh16@uoregon.edu		Wright, Jim/0000-0003-3035-7003			American Speech-Language-Hearing Association, 2017, CLIN GUID COGN REH M CLIN GUID COGN REH M; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chesnutt JC, 2021, AM J SPEECH-LANG PAT, V30, P1592, DOI 10.1044/2021_AJSLP-20-00315; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Delis D.C., 2017, CALIFORNIA VERBAL LE, V3rd; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dutton M.A., 2008, J AGGRESS MALTREAT T, V17, P23, DOI DOI 10.1080/10926770802250942; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Foy K, 2009, BRIT J HOSP MED, V70, P440, DOI 10.12968/hmed.2009.70.8.43536; Gioia G. A., 2015, CAN J SCH PSYCHOL, V34, P73, DOI [10.1177/0829573518797762, DOI 10.1177/0829573518797762]; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P249, DOI 10.1016/j.rehab.2017.01.005; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Kucheria P, 2019, AM J SPEECH-LANG PAT, V28, P1257, DOI [10.1044/2019_AJSLP-18-0181, 10.1044/2019_AJLSP-18-0181]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Mashima P, 2019, TOP LANG DISORD, V39, P293, DOI 10.1097/TLD.0000000000000189; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Picon L. M., 2019, CONCUSSION E BOOK AS CONCUSSION E BOOK AS, P192; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Turkstra LS, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-15-0060; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Van Stan JH, 2019, ARCH PHYS MED REHAB, V100, P146, DOI 10.1016/j.apmr.2018.09.112; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wright J, 2020, TOP LANG DISORD, V40, P6, DOI 10.1097/TLD.0000000000000198; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	51	4	4	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JUL	2021	30	4					1611	1624		10.1044/2021_AJSLP-20-00306			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	TY1ZS	WOS:000683585400004	33914615				2022-02-06	
J	Jones, K; Quinn, T; Mazor, KM; Muehlschlegel, S				Jones, Kelsey; Quinn, Thomas; Mazor, Kathleen M.; Muehlschlegel, Susanne			Prognostic Uncertainty in Critically Ill Patients with Traumatic Brain Injury: A Multicenter Qualitative Study	NEUROCRITICAL CARE			English	Article						Shared decision-making; Traumatic brain injuries; Uncertainty; Intensive care units; Patient care planning; Communication barriers; Terminal care	DECISION-MAKERS PERSPECTIVES; FAMILY-MEMBERS; HEALTH-CARE; COMMUNICATION; CAREGIVERS; LIFE; END	Background Prognostic uncertainty is frequently cited as a barrier to communication between physicians and patients and is particularly burdensome for surrogate decision-makers, who must make choices on behalf of their incapacitated family members. The Conceptual Taxonomy of Uncertainty is one model through which physician and surrogate communication can be analyzed to identify strategies for reducing uncertainty in surrogate decision-making. Our objective was to examine themes of uncertainty in physician communication of prognosis and surrogate goals-of-care decision-making for critically ill patients with traumatic brain injury (TBI). Methods We performed a secondary analysis of a previous qualitative study that involved semistructured interviews of 16 surrogates of critically ill patients with TBI from two level 1 trauma centers and 20 TBI expert physicians from seven trauma centers. Open-ended questions about prognostic uncertainty were asked. We identified major themes with an inductive approach. The Conceptual Taxonomy of Uncertainty was applied to further characterize these themes as data-centered, system-centered, and patient-centered issues of uncertainty. Results Nearly all surrogates (15 of 16) and physicians (19 of 20) recognized the emotional burden of uncertainty in the decision-making process for surrogates. More than three quarters of surrogates (13 of 16) described instances in which a lack of information regarding their loved one's disease or prognosis created uncertainty in their decision-making process, identifying both positive and negative instances of prognostic communication by physicians. We found that physicians used one of three strategies to communicate prognostic uncertainty to surrogates: leaving no room for uncertainty, honesty about uncertainty, and range of possibilities. These strategies did not meet the communication preferences of the majority of surrogates, with more than a third of decision-makers (6 of 15) being frustrated by too much ambiguity about prognosis as well as the failure to acknowledge the existence of uncertainty. Conclusions We found that physician communication strategies rarely addressed surrogate needs regarding uncertainty adequately, suggesting an urgent need for future research into improved communication of prognostic uncertainty.	[Jones, Kelsey; Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01602 USA; [Quinn, Thomas] Harvard Univ, Harvard Med Sch, Dept Internal Med, Beth Israel Deacon ess Med Ctr, Boston, MA 02115 USA; [Mazor, Kathleen M.] Univ Massachusetts, Sch Med, Dept Internal Med, Worcester, MA USA; [Mazor, Kathleen M.] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Worcester, MA USA; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Anesthesiol Crit Care, Worcester, MA USA; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01602 USA.	Susanne.Muehlschlegel@umassmemorial.org		Jones, Kelsey/0000-0001-6440-159X	National Institutes of Health National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science - National Institutes of Health Clinical and Translational Science Award [UL1TR000161]	This study was funded by National Institutes of Health National Institute of Child Health and Human Development grant 5K23HD080971 (principal investigator: SM). This project was additionally supported by the University of Massachusetts Medical School Center for Clinical and Translational Science, which is funded by the National Institutes of Health Clinical and Translational Science Award to the University of Massachusetts Medical School (UL1TR000161).	Anderson RJ, 2020, PALLIATIVE MED, V34, P896, DOI 10.1177/0269216320910934; [Anonymous], GET FACTS TBI; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Bhise V, 2018, J GEN INTERN MED, V33, P103, DOI 10.1007/s11606-017-4164-1; Bomhof-Roordink H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031763; Brighton LJ, 2016, POSTGRAD MED J, V92, P466, DOI 10.1136/postgradmedj-2015-133368; Cameron JI, 2016, NEW ENGL J MED, V374, P1831, DOI 10.1056/NEJMoa1511160; Devnani R, 2017, J GEN INTERN MED, V32, P1285, DOI 10.1007/s11606-017-4158-z; Douglas SL, 2003, CHEST, V123, P1073, DOI 10.1378/chest.123.4.1073; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Farnan JM, 2008, QUAL SAF HEALTH CARE, V17, P122, DOI 10.1136/qshc.2007.023184; Hamui-Sutton A, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0459-2; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Harrison M, 2019, PATIENT EDUC COUNS, V102, P842, DOI 10.1016/j.pec.2018.12.009; Holloway RG, 2005, JAMA-J AM MED ASSOC, V294, P725; Holloway RG, 2013, NEUROLOGY, V80, P764, DOI 10.1212/WNL.0b013e318282509c; Kang J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234296; Kavalieratos D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1575-y; Krawczyk M, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0133-4; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Moreira T, 2011, SOC SCI MED, V72, P1333, DOI 10.1016/j.socscimed.2011.02.026; Quinn T, 2017, NEUROCRIT CARE, V27, P154, DOI 10.1007/s12028-017-0427-2; Sanders S, 2017, OMEGA-J DEATH DYING, V74, P329, DOI 10.1177/0030222815598912; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Simpkin AL, 2019, J GEN INTERN MED, V34, P2586, DOI 10.1007/s11606-019-04860-8; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232; Turnbull AE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211531; Wendlandt B, 2018, ANN AM THORAC SOC, V15, P1451, DOI 10.1513/AnnalsATS.201806-420OC; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012; Zahuranec DB, 2018, J PALLIAT MED, V21, P956, DOI 10.1089/jpm.2017.0604; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008	32	4	4	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	2					311	321		10.1007/s12028-021-01230-3		JUN 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	WU3OH	WOS:000657213800001	34080083				2022-02-06	
J	Van de Voorde, P; Turner, NM; Djakow, J; de Lucas, N; Martinez-Mejias, A; Biarent, D; Bingham, R; Brissaud, O; Hoffmann, F; Johannesdottir, GB; Lauritsen, T; Maconochie, I				Van de Voorde, Patrick; Turner, Nigel M.; Djakow, Jana; de Lucas, Nieves; Martinez-Mejias, Abel; Biarent, Dominique; Bingham, Robert; Brissaud, Olivier; Hoffmann, Florian; Johannesdottir, Groa Bjork; Lauritsen, Torsten; Maconochie, Ian			Paediatric Life Support European Resuscitation Council Guidelines 2021	NOTFALL & RETTUNGSMEDIZIN			German	Article						Resuscitation; Child; Infant; Paediatric; CPR; Basic life support; Advanced life support; Defibrillation; Pediatric; Respiratory failure; Circulatory failure; Shock; Oxygen; Cardiac arrest; Bag-mask ventilation	HOSPITAL CARDIAC-ARREST; CONVULSIVE STATUS EPILEPTICUS; POSITIVE AIRWAY PRESSURE; CRITICALLY-ILL CHILDREN; BYSTANDER CARDIOPULMONARY-RESUSCITATION; AUTOMATED EXTERNAL DEFIBRILLATORS; CHEST COMPRESSION QUALITY; TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT THORACOTOMY; ESTABLISHED STATUS EPILEPTICUS	The European Resuscitation Council (ERC) Paediatric Life Support (PLS) guidelines are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations of the International Liaison Committee on Resuscitation (ILCOR). This section provides guidelines on the management of critically ill or injured infants, children and adolescents before, during and after respiratory/cardiac arrest.	[Van de Voorde, Patrick] Ghent Univ Hosp, Fac Med UG, Dept Emergency Med, Ghent, Belgium; [Van de Voorde, Patrick] EMS Dispatch Ctr, Fed Dept Hlth, Brussels, Belgium; [Turner, Nigel M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Paediat Cardiac Anesthesiol, Utrecht, Netherlands; [Djakow, Jana] NH Hosp, Paediat Intens Care Unit, Horovice, Czech Republic; [Djakow, Jana] Masaryk Univ, Med Fac, Paediat Anaesthesiol & Intens Care Med, Univ Hosp Brno, Brno, Czech Republic; [de Lucas, Nieves] SAMUR Protecc Civil, Madrid, Spain; [Martinez-Mejias, Abel] Hosp Terassa, Dept Paediat & Emergency Med, Consorci Sanitari Terrassa, Barcelona, Spain; [Biarent, Dominique] Univ Libre Bruxelles, Hop Univ Enfants, Paediat Intens Care & Emergency Dept, Brussels, Belgium; [Bingham, Robert] Great Ormond St Hosp Sick Children, London, England; [Brissaud, Olivier] Univ Bordeaux, CHU Pellegrin, Reanimat & Surveillance Continue Pediat & Neonata, Hop Enfants Bordeaux, Bordeaux, France; [Hoffmann, Florian] Ludwig Maximilians Univ Munchen, Kinderklin & Kinderpoliklin Dr von Haunerschen Ki, Padiat Intens & Notfallmed, Munich, Germany; [Johannesdottir, Groa Bjork] Akureyri Hosp, Paediat Gastroenterol, Akureyri, Iceland; [Lauritsen, Torsten] Univ Hosp Copenhagen, Juliane Marie Ctr, Paediat Anaesthesia, Copenhagen, Denmark; [Maconochie, Ian] Imperial Coll Healthcare Trust NHS, Fac Med, Paediat Emergency Med, Imperial Coll, London, England		Van de Voorde, P (corresponding author), EMS Dispatch Ctr, Fed Dept Hlth, Brussels, Belgium.	florian.hoffmann@med.uni-muenchen.de		MARTINEZ-MEJIAS, ABEL/0000-0003-4437-4963			Abadesso C, 2012, PEDIATRIC REP, V4, P57, DOI [10.4081/pr.2012.e16, 10.4081/pr.2012.el6]; Abdelgadir IS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011413.pub2; Abraham MB, 2018, PEDIATR DIABETES, V19, P178, DOI 10.1111/pedi.12698; Abramo TJ, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.04.007; Abramo TJ, 1996, PEDIATR EMERG CARE, V12, P252, DOI 10.1097/00006565-199608000-00004; Abramo TJ, 1997, CRIT CARE MED, V25, P1242, DOI 10.1097/00003246-199707000-00029; Abramson Tiffany M, 2018, Clin Pract Cases Emerg Med, V2, P323, DOI 10.5811/cpcem.2018.8.38854; Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Adato B, 2016, EUR J PEDIATR, V175, P1249, DOI 10.1007/s00431-016-2751-5; Akam-Venkata J, 2019, CARDIOL YOUNG, V29, P263, DOI 10.1017/S1047951118002135; Al-Shibli A, 2020, PEDIATR EMERG CARE, V36, P39, DOI 10.1097/PEC.0000000000002019; Alam NH, 2020, ACTA PAEDIATR, V109, P1473, DOI 10.1111/apa.15134; Alangari AA, 2014, CHEST, V145, P772, DOI 10.1378/chest.13-2298; Alansari K, 2020, PEDIATR NEUROL, V109, P28, DOI 10.1016/j.pediatrneurol.2020.03.011; Albreiki M, 2018, EUR J TRAUMA EMERG S, V44, P191, DOI 10.1007/s00068-017-0862-y; Algie CM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011656.pub2; Allen CJ, 2015, J PEDIATR SURG, V50, P177, DOI 10.1016/j.jpedsurg.2014.10.042; Allen SG, 2017, RESP CARE, V62, P1166, DOI 10.4187/respcare.05368; Alqudah Z, 2020, RESUSCITATION, V149, P65, DOI 10.1016/j.resuscitation.2020.01.037; Alqudah Z, 2019, RESUSCITATION, V140, P127, DOI 10.1016/j.resuscitation.2019.05.020; Alqurashi W, 2017, J ALLER CL IMM-PRACT, V5, P1194, DOI 10.1016/j.jaip.2017.05.022; Alshehri A, 2017, ACAD EMERG MED, V24, P875, DOI 10.1111/acem.13190; AlSohime Fahad, 2018, Int J Pediatr Adolesc Med, V5, P116, DOI 10.1016/j.ijpam.2018.07.001; Amagasa S, 2019, RESUSCITATION, V137, P161, DOI 10.1016/j.resuscitation.2019.02.021; Amirnovin R, 2020, J INTENSIVE CARE MED, V35, P371, DOI 10.1177/0885066617752659; Anagnostou K, 2018, CURR PEDIATR REV, V14, P180, DOI 10.2174/1573396314666180507115115; Andersen L, 2015, JAMA-J AM MED ASSOC, V314, P802, DOI 10.1001/jama.2015.9678; Andrew E, 2018, PREHOSP EMERG CARE, V22, P445, DOI 10.1080/10903127.2017.1402110; [Anonymous], 2014, Emerg Med J, V31, P604, DOI 10.1136/emermed-2014-203947.1; [Anonymous], 2018, INF CHILDR AC MAN SE; Martin AMA, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012247.pub2; Anton-Martin P, 2020, CARDIOL YOUNG, V30, P607, DOI 10.1017/S1047951120000591; Arnholt AM, 2015, PEDIATR CRIT CARE ME, V16, pE224, DOI 10.1097/PCC.0000000000000497; Arulparithi CS, 2015, INDIAN J PEDIATR, V82, P328, DOI 10.1007/s12098-014-1498-0; Atanaskovic-Markovic M, 2019, PEDIAT ALLERG IMM-UK, V30, P269, DOI 10.1111/pai.13034; Atkinson SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112702; Au CC, 2017, J PEDIAT-BRAZIL, V93, P84, DOI 10.1016/j.jped.2017.08.004; Aubertin G, 2012, ARCH PEDIATRIE, V19, P528, DOI 10.1016/j.arcped.2012.02.016; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Austin AL, 2020, PEDIATR EMERG CARE, V36, pE79, DOI 10.1097/PEC.0000000000001312; Avau B, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013230; Balamuth F, 2019, ACAD EMERG MED, DOI 10.1111/acem.13815; Balamuth F, 2016, PEDIATR CRIT CARE ME, V17, P817, DOI 10.1097/PCC.0000000000000858; Balamuth F, 2015, ACAD EMERG MED, V22, P1298, DOI 10.1111/acem.12814; Balfour-Lynn RE, 2014, PAEDIATR RESPIR REV, V15, P181, DOI 10.1016/j.prrv.2014.02.002; Balhara KS, 2019, PREHOSP EMERG CARE, V23, P389, DOI 10.1080/10903127.2018.1513104; Balk DS, 2018, PEDIATR PULM, V53, P1130, DOI 10.1002/ppul.24020; Ballestero Y, 2018, J PEDIATR-US, V194, P204, DOI 10.1016/j.jpeds.2017.10.075; Bamber AR, 2015, FORENSIC SCI MED PAT, V11, P358, DOI 10.1007/s12024-015-9681-9; Barbaro RP, 2017, ASAIO J, V63, P456, DOI 10.1097/MAT.0000000000000603; Barboza CL, 2020, INDIAN J CRIT CARE M, V24, P128, DOI 10.5005/jp-journals-10071-23336; Barnard EBG, 2019, EMERG MED J, V36, P333, DOI 10.1136/emermed-2018-208165; Baruteau AE, 2016, EUR J PEDIATR, V175, P151, DOI 10.1007/s00431-015-2689-z; Bauman BD, 2021, PEDIATR EMERG CARE, V37, pE653, DOI 10.1097/PEC.0000000000001735; Becker HJ, 2020, PEDIATR EMERG CARE, V36, pE695, DOI 10.1097/PEC.0000000000001314; Bellamy D, 2019, PEDIATR CRIT CARE ME, V20, P262, DOI 10.1097/PCC.0000000000001847; Belsky J, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28144; Bennett M, 2007, PEDIATR EMERG CARE, V23, P267, DOI 10.1097/PEC.0b013e3180403088; Berce V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54499-y; Berg RA, 2018, RESUSCITATION, V133, P173, DOI 10.1016/j.resuscitation.2018.08.013; Berg RA, 2018, CIRCULATION, V137, P1784, DOI 10.1161/CIRCULATIONAHA.117.032270; Best RR, 2020, PEDIATR EMERG CARE, V36, P143, DOI 10.1097/PEC.0000000000001169; Bhalala US, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00107; Bhananker SM, 2007, ANESTH ANALG, V105, P344, DOI 10.1213/01.ane.0000268712.00756.dd; Bielski K, 2017, EUR J PEDIATR, V176, P865, DOI 10.1007/s00431-017-2922-z; Bilharz JR, 2018, RESP CARE, V63, P1079, DOI 10.4187/respcare.06021; Birbeck GL, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1766-2; Birkenes TS, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-40; Blacklock C, 2011, ARCH DIS CHILD, V96, P708, DOI 10.1136/adc.2010.206243; Boeschoten S, 2020, EUR J PEDIATR, V179, P455, DOI 10.1007/s00431-019-03502-9; Booth A, 2018, RESUSCITATION, V129, P70, DOI 10.1016/j.resuscitation.2018.03.029; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Borra V, 2019, CLIN TOXICOL, V57, P603, DOI 10.1080/15563650.2019.1574975; Bortcosh W, 2018, CURR OPIN PEDIATR, V30, P350, DOI 10.1097/MOP.0000000000000621; Bradley SM, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1653; Braga MS, 2009, PEDIATRICS, V124, pE69, DOI 10.1542/peds.2009-0153; Brauer CEL, 2016, J ALLER CL IMM-PRACT, V4, P1220, DOI 10.1016/j.jaip.2016.06.003; Brigo F, 2016, EPILEPSY BEHAV, V64, P29, DOI 10.1016/j.yebeh.2016.09.020; Brinck T, 2016, SCAND J SURG, V105, P109, DOI 10.1177/1457496915586650; Brindis SL, 2011, PEDIATR EMERG CARE, V27, P616, DOI 10.1097/PEC.0b013e31822255c9; Brissaud O, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0111-2; Britton PN, 2015, INTERN MED J, V45, P563, DOI 10.1111/imj.12749; Bronzetti G, 2018, INT J CARDIOL, V252, P106, DOI 10.1016/j.ijcard.2017.10.120; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brugada J, 2020, EUR HEART J, V41, P655, DOI 10.1093/eurheartj/ehz467; Brugada J, 2013, EUROPACE, V15, P1337, DOI 10.1093/europace/eut082; Brugger H, 2013, RESUSCITATION, V84, P539, DOI 10.1016/j.resuscitation.2012.10.020; Burman RJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00506; Caglar A, 2017, TURKISH J PEDIATR, V59, P642, DOI 10.24953/turkjped.2017.06.004; Cameron A, 2018, J TRAUMA ACUTE CARE, V84, P994, DOI 10.1097/TA.0000000000001886; Campbell M, 2017, EMERG MED J, V34, P58, DOI 10.1136/emermed-2016-206487.2; Campbell RL, 2014, ANN ALLERG ASTHMA IM, V113, P599, DOI 10.1016/j.anai.2014.10.007; Capizzani AR, 2010, J PEDIATR SURG, V45, P903, DOI 10.1016/j.jpedsurg.2010.02.014; Carapetis JR, 2014, CLIN INFECT DIS, V59, P358, DOI 10.1093/cid/ciu304; Carreiro S, 2020, CLIN TOXICOL, V58, P183, DOI 10.1080/15563650.2019.1634272; Carrillo E, 2016, PREHOSP EMERG CARE, V20, P239, DOI 10.3109/10903127.2015.1086843; CARRUTHERS DM, 1995, THORAX, V50, P186, DOI 10.1136/thx.50.2.186; Castelao EF, 2013, J CRIT CARE, V28, P504, DOI 10.1016/j.jcrc.2013.01.005; Cates Christopher J, 2013, Cochrane Database Syst Rev, pCD000052, DOI 10.1002/14651858.CD000052.pub3; Chamberlain DB, 2017, ANN EMERG MED, V69, P117, DOI 10.1016/j.annemergmed.2016.08.449; Chamberlain JM, 2020, LANCET, V395, P1217, DOI 10.1016/S0140-6736(20)30611-5; Chang R, 2016, SHOCK, V46, P17, DOI 10.1097/SHK.0000000000000577; Chao JY, 2020, J PEDIATR-US, V223, P14, DOI 10.1016/j.jpeds.2020.05.006; Chavez DE, 2013, RESUSCITATION, V84, P979, DOI 10.1016/j.resuscitation.2012.12.010; Chen DY, 2019, NEUROPSYCH DIS TREAT, V15, P905, DOI 10.2147/NDT.S188111; Cheng A, 2018, RESUSCITATION, V132, P33, DOI 10.1016/j.resuscitation.2018.08.021; Cheng A, 2015, RESUSCITATION, V97, P13, DOI 10.1016/j.resuscitation.2015.08.024; Cheng J, 2019, CLIN OTOLARYNGOL, V44, P235, DOI 10.1111/coa.13261; Cheong SA, 2015, EMERG MED AUSTRALAS, V27, P567, DOI 10.1111/1742-6723.12492; Chiarello D, 2020, SEIZURE-EUR J EPILEP, V78, P127, DOI 10.1016/j.seizure.2020.03.019; Chillag S, 2010, SOUTH MED J, V103, P147, DOI 10.1097/SMJ.0b013e3181c99140; Chime NO, 2015, PEDIATR CRIT CARE ME, V16, P404, DOI 10.1097/PCC.0000000000000384; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Choi YJ, 2019, ALLERGY ASTHMA IMMUN, V11, P529, DOI 10.4168/aair.2019.11.4.529; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; Chrysostomou C, 2013, CONGENIT HEART DIS, V8, P48, DOI 10.1111/j.1747-0803.2012.00669.x; Chu PY, 2015, EARLY HUM DEV, V91, P345, DOI 10.1016/j.earlhumdev.2015.04.001; Ciccone O, 2017, AFR J EMERG MED, V7, pS3, DOI 10.1016/j.afjem.2017.09.003; Clausen H, 2012, EMERG MED J, V29, P732, DOI 10.1136/emermed-2011-200242; Cohen N, 2018, ANN ALLERG ASTHMA IM, V121, P348, DOI 10.1016/j.anai.2018.06.033; Combret Y, 2017, MINERVA ANESTESIOL, V83, P624, DOI 10.23736/S0375-9393.17.11708-6; Considine J, 2020, RESUSCITATION, V146, P188, DOI 10.1016/j.resuscitation.2019.08.042; Conti G, 2016, CURR OPIN CRIT CARE, V22, P60, DOI 10.1097/MCC.0000000000000271; Conway JA, 2020, CRIT CARE MED, V48, pE489, DOI 10.1097/CCM.0000000000004314; Coolen E, 2019, EUR J PEDIATR, V178, P837, DOI 10.1007/s00431-019-03358-z; Cooney L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159965; Cooney L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153877; Cristiano LM, 2018, PREHOSP EMERG CARE, V22, P452, DOI 10.1080/10903127.2017.1399184; Crocker ME, 2020, LANCET GLOB HEALTH, V8, pE362, DOI 10.1016/S2214-109X(19)30543-1; Cronin JJ, 2016, ANN EMERG MED, V67, P593, DOI 10.1016/j.annemergmed.2015.08.001; Crulli B, 2016, PEDIATR PULM, V51, P165, DOI 10.1002/ppul.23223; Cundiff KM, 2018, PEDIATR EMERG CARE, V34, P385, DOI 10.1097/PEC.0000000000001163; Cunningham A, 2018, J TRAUMA ACUTE CARE, V85, P665, DOI 10.1097/TA.0000000000001839; Da Dalt L, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-017-0442-0; Daigle CH, 2020, CRIT CARE MED, V48, pE744, DOI 10.1097/CCM.0000000000004425; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; Davis AL, 2017, CRIT CARE MED, V45, P1061, DOI 10.1097/CCM.0000000000002425; Daw WJ, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000173; De Buck E, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013283.pub2; de Caen AR, 2015, CIRCULATION, V132, pS177, DOI 10.1161/CIR.0000000000000275; de Groot MG, 2020, J PEDIATR INTENSIVE, V9, P34, DOI 10.1055/s-0039-1697679; de la Grandville B, 2019, BRIT J ANAESTH, V122, P682, DOI 10.1016/j.bja.2019.01.036; De Maio VJ, 2012, PREHOSP EMERG CARE, V16, P230, DOI 10.3109/10903127.2011.640419; De Mul A, 2019, J PEDIATR INTENSIVE, V8, P57, DOI 10.1055/s-0038-1667012; Deakin CD, 2020, RESUSCITATION, V155, P24, DOI 10.1016/j.resuscitation.2020.06.008; Deasy C, 2012, RESUSCITATION, V83, P471, DOI 10.1016/j.resuscitation.2011.11.009; del Castillo J, 2014, RESUSCITATION, V85, P1380, DOI 10.1016/j.resuscitation.2014.06.024; Del Rossi G, 2014, PREHOSP EMERG CARE, V18, P539, DOI 10.3109/10903127.2014.916019; Delaloye NJ, 2020, J PATIENT SAF, V16, P73, DOI 10.1097/PTS.0000000000000359; DeLaroche AM, 2016, PEDIATR NEUROL, V65, P39, DOI 10.1016/j.pediatrneurol.2016.09.005; Depret F, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0509-8; Derkenne C, 2020, RESUSCITATION, V146, P34, DOI 10.1016/j.resuscitation.2019.10.038; Despins LA, 2017, J HEALTHC QUAL, V39, P322, DOI 10.1097/JHQ.0000000000000066; Dezfulian C, 2018, PEDIATR CRIT CARE ME, V19, P495, DOI 10.1097/PCC.0000000000001529; Diaz-Parra S, 2014, PEDIATR EMERG CARE, V30, P388, DOI 10.1097/PEC.0000000000000144; DiBrito SR, 2018, J PEDIATR SURG, V53, P1789, DOI 10.1016/j.jpedsurg.2017.12.027; Dittrich MHM, 2020, BURNS, V46, P1036, DOI 10.1016/j.burns.2020.02.003; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Donoghue A, 2009, PEDIATRICS, V124, P1541, DOI 10.1542/peds.2009-0727; Donoghue AJ, 2020, RESUSCITATION, V153, P37, DOI 10.1016/j.resuscitation.2020.05.026; Donoghue AJ, 2020, PEDIATR EMERG CARE, V36, P267, DOI 10.1097/PEC.0000000000002109; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Douvanas A, 2018, J MATERN-FETAL NEO M, V31, P805, DOI 10.1080/14767058.2017.1295953; Dubus JC, 2019, EUR J PEDIATR, V178, P69, DOI 10.1007/s00431-018-3246-3; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; Dunne B, 2014, HEART LUNG CIRC, V23, P1029, DOI 10.1016/j.hlc.2014.06.011; Dunne CL, 2020, RESUSCITATION, V153, P219, DOI 10.1016/j.resuscitation.2020.02.021; Dunning J, 2017, ANN THORAC SURG, V103, P1005, DOI 10.1016/j.athoracsur.2016.10.033; Dunning J, 2009, EUR J CARDIO-THORAC, V36, P3, DOI 10.1016/j.ejcts.2009.01.033; Durand P, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01926-2019; Duron V, 2014, J TRAUMA ACUTE CARE, V77, P422, DOI 10.1097/TA.0000000000000394; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Edmonds ML, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002308.pub2; Edwards-Jackson N, 2020, PAEDIATR INT CHILD H, V40, P11, DOI 10.1080/20469047.2019.1570443; Eisa L, 2015, ARCH DIS CHILD, V100, P684, DOI 10.1136/archdischild-2014-307868; El-Assaad I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-1903; El-Nawawy A, 2017, PEDIATR INFECT DIS J, V36, P155, DOI 10.1097/INF.0000000000001380; El-Nawawy AA, 2018, J TROP PEDIATRICS, V64, P132, DOI 10.1093/tropej/fmx061; Elkbuli A, 2020, J SURG RES, V247, P350, DOI 10.1016/j.jss.2019.10.009; Else SDN, 2020, ANESTH ANALG, V130, P831, DOI 10.1213/ANE.0000000000004403; Emami P, 2019, EUR J TRAUMA EMERG S, V45, P769, DOI 10.1007/s00068-018-01065-2; Emrath ET, 2017, CRIT CARE MED, V45, P1177, DOI 10.1097/CCM.0000000000002365; Engelhardt T, 2019, PEDIATR ANESTH, V29, P985, DOI 10.1111/pan.13716; Enriquez Diego, 2018, Arch. argent. pediatr., V116, pe730, DOI 10.5546/aap.2018.e730; Esangbedo ID, 2020, PEDIATR CRIT CARE ME, V21, pE934, DOI 10.1097/PCC.0000000000002373; Essouri S, 2014, INTENS CARE MED, V40, P84, DOI 10.1007/s00134-013-3129-z; Evans IVR, 2018, JAMA-J AM MED ASSOC, V320, P358, DOI 10.1001/jama.2018.9071; Eytan D, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00052; Fallat ME, 2014, PEDIATRICS, V133, pE1104, DOI 10.1542/peds.2014-0176; Farbman KS, 2016, CURR OPIN PEDIATR, V28, P294, DOI 10.1097/MOP.0000000000000340; Ferguson LP, 2020, CRIT CARE MED, V48, pE542, DOI 10.1097/CCM.0000000000004349; Fernandez A, 2017, J PEDIAT-BRAZIL, V93, P60, DOI 10.1016/j.jped.2017.07.002; Fernandez A, 2017, PEDIATR EMERG CARE, V33, P234, DOI 10.1097/PEC.0000000000000717; Fiadjoe J, 2020, PEDIATR ANESTH, V30, P257, DOI 10.1111/pan.13798; Fiadjoe JE, 2016, LANCET RESP MED, V4, P37, DOI 10.1016/S2213-2600(15)00508-1; Figueiredo S, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0420-8; Figueroa L, 2017, ARCH ARGENT PEDIATR, V115, P277, DOI [10.5546/aap.2017.eng.277, 10.5546/aap.2017.277]; Fleming JT, 2015, J ALLER CL IMM-PRACT, V3, P57, DOI 10.1016/j.jaip.2014.07.004; Fleming S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138155; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Flynn-O'Brien KT, 2016, J PEDIATR SURG, V51, P163, DOI 10.1016/j.jpedsurg.2015.10.034; Fraser J, 2014, LANCET, V384, P894, DOI 10.1016/S0140-6736(13)61089-2; Freire-Tellado M, 2017, RESUSCITATION, V115, P173, DOI 10.1016/j.resuscitation.2017.03.008; Fukuda T, 2020, RESUSCITATION, V150, P145, DOI 10.1016/j.resuscitation.2020.02.005; Fukuda T, 2018, EUR HEART J-CARD PHA, V4, P144, DOI 10.1093/ehjcvp/pvx023; Fukuda T, 2017, RESUSCITATION, V111, P1, DOI 10.1016/j.resuscitation.2016.11.010; Fukuda T, 2016, CIRCULATION, V134, P2060, DOI 10.1161/CIRCULATIONAHA.116.023831; Fukushima H, 2015, EMERG MED J, V32, P314, DOI 10.1136/emermed-2013-203112; Fusco Nicholas M, 2015, J Pediatr Pharmacol Ther, V20, P37, DOI 10.5863/1551-6776-20.1.37; Gabrielli S, 2019, J ALLER CL IMM-PRACT, V7, P2232, DOI 10.1016/j.jaip.2019.04.018; Gaensbauer JT, 2018, PEDIATR INFECT DIS J, V37, P1223, DOI 10.1097/INF.0000000000002002; Gallagher RA, 2014, ACAD EMERG MED, V21, P981, DOI 10.1111/acem.12460; Galvez JA, 2019, ANESTHESIOLOGY, V131, P830, DOI 10.1097/ALN.0000000000002847; Gamper G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub4; Garcia-Marcinkiewicz AG, 2020, ANESTH ANALG, V131, P469, DOI 10.1213/ANE.0000000000004393; Garcia-Salido A, 2020, PEDIATR CRIT CARE ME, V21, pE576, DOI 10.1097/PCC.0000000000002475; Garner AA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02865-y; Gausche-Hill M, 2014, PREHOSP EMERG CARE, V18, P520, DOI 10.3109/10903127.2014.912706; Gc VS, 2020, ARCH DIS CHILD, V105, P975, DOI 10.1136/archdischild-2019-318427; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Gilhooley Colin, 2019, J Intensive Care Soc, V20, P27, DOI 10.1177/1751143718764541; Gill Badar Ul Ahad, 2014, J Ayub Med Coll Abbottabad, V26, P29; Gill H, 2014, RESUSCITATION, V85, P1394, DOI 10.1016/j.resuscitation.2014.07.002; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Golden C, 2015, JAMA PEDIATR, V169, P186, DOI 10.1001/jamapediatrics.2014.2767; Gonzalez R, 2017, WORLD J PEDIATR, V13, P544, DOI 10.1007/s12519-017-0061-2; Goto T, 2016, WEST J EMERG MED, V17, P129, DOI 10.5811/westjem.2016.1.28685; Goto Y, 2016, CIRCULATION, V134, P2046, DOI 10.1161/CIRCULATIONAHA.116.023821; Goto Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003589; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Graff DM, 2019, PEDIATR PULM, V54, P1941, DOI 10.1002/ppul.24499; Granfeldt A, 2020, RESUSCITATION, V149, P150, DOI 10.1016/j.resuscitation.2020.02.025; Gravel CA, 2020, AM J EMERG MED, V38, P1, DOI 10.1016/j.ajem.2019.01.047; Gregson RK, 2017, ARCH DIS CHILD, V102, P403, DOI 10.1136/archdischild-2016-310691; Greif R, 2020, RESUSCITATION, V156, pA188, DOI 10.1016/j.resuscitation.2020.09.014; Grieco DL, 2019, AM J RESP CRIT CARE, V199, P728, DOI 10.1164/rccm.201806-1111OC; Griffis H, 2020, RESUSCITATION, V146, P126, DOI 10.1016/j.resuscitation.2019.09.038; Griffiths B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000060.pub2; Grimsley EA, 2021, PEDIATR EMERG CARE, V37, pE1122, DOI 10.1097/PEC.0000000000001923; Grunwell JR, 2017, PEDIATR CRIT CARE ME, V18, P741, DOI 10.1097/PCC.0000000000001175; Guedj R, 2015, ACAD EMERG MED, V22, P1290, DOI 10.1111/acem.12798; Gumer LB, 2014, PEDIATR EMERG CARE, V30, P660, DOI 10.1097/PEC.0000000000000218; Gupta A, 2018, PEDIATR ANESTH, V28, P1148, DOI 10.1111/pan.13524; Gupta P, 2014, RESUSCITATION, V85, P1473, DOI 10.1016/j.resuscitation.2014.07.016; Gurcharran K, 2019, SEIZURE-EUR J EPILEP, V68, P3, DOI 10.1016/j.seizure.2018.08.021; Hagedoorn NN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2653-9; Halbrich M, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0086-9; Haltmeier T, 2018, INJURY, V49, P62, DOI 10.1016/j.injury.2017.07.035; Hamed RK, 2013, J CLIN ANESTH, V25, P447, DOI 10.1016/j.jclinane.2013.03.013; Hamid MA, 2016, J PAK MED ASSOC, V66, P1015; Han M, 2017, SHOCK, V48, P29, DOI 10.1097/SHK.0000000000000833; Hansen M, 2018, CIRCULATION, V137, P2032, DOI 10.1161/CIRCULATIONAHA.117.033067; Hansen M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012259; Hansen M, 2015, RESUSCITATION, V90, P104, DOI 10.1016/j.resuscitation.2015.02.018; Hansen M, 2011, PEDIATR EMERG CARE, V27, P928, DOI 10.1097/PEC.0b013e3182307a2f; Hansmann A, 2017, AFR J EMERG MED, V7, pS10, DOI 10.1016/j.afjem.2017.10.001; Haque IU, 2008, RESUSCITATION, V79, P82, DOI 10.1016/j.resuscitation.2008.04.026; Haque IU, 2007, PEDIATR CRIT CARE ME, V8, P138, DOI 10.1097/01.PCC.0000257039.32593.DC; Harcke HT, 2020, PREHOSP EMERG CARE, V24, P665, DOI 10.1080/10903127.2019.1698682; Harel-Sterling M, 2019, J ULTRAS MED, V38, P407, DOI 10.1002/jum.14703; Harshman J, 2019, J BURN CARE RES, V40, P166, DOI 10.1093/jbcr/iry060; Health RCoPaC, 2012, HLTH RCOPAC MAJOR TR; Hebert A, 2017, PAED CHILD HEALT-CAN, V22, P13, DOI 10.1093/pch/pxw003; HEIMLICH HJ, 1990, POSTGRAD MED, V87, P38, DOI 10.1080/00325481.1990.11716329; Hernandez MC, 2018, J PEDIATR SURG, V53, P352, DOI 10.1016/j.jpedsurg.2017.10.004; Heschl S, 2018, INJURY, V49, P916, DOI 10.1016/j.injury.2018.02.013; Hilmo J, 2014, RESUSCITATION, V85, P1204, DOI 10.1016/j.resuscitation.2014.04.029; Hoffmann F, 2016, PREHOSP EMERG CARE, V20, P493, DOI 10.3109/10903127.2016.1139216; Holmberg MJ, 2020, RESUSCITATION, V152, P107, DOI 10.1016/j.resuscitation.2020.04.031; Holmberg MJ, 2020, RESUSCITATION, V149, P191, DOI 10.1016/j.resuscitation.2019.12.033; Holmberg MJ, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005580; Holmes JF, 2007, J PEDIATR SURG, V42, P1588, DOI 10.1016/j.jpedsurg.2007.04.023; Holmes JF, 2017, JAMA-J AM MED ASSOC, V317, P2290, DOI 10.1001/jama.2017.6322; Hon KLE, 2017, RECENT PATENTS INFLA, V11, P12, DOI 10.2174/1872213X11666170130143524; Horeczko T, 2013, J EMERG NURS, V39, P182, DOI 10.1016/j.jen.2011.12.020; Houston KA, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1356-z; Howard-Quijano KJ, 2010, ANESTHESIOLOGY, V112, P993, DOI 10.1097/ALN.0b013e3181d31fbe; Hoyme DB, 2020, RESUSCITATION, V153, P88, DOI 10.1016/j.resuscitation.2020.05.048; Hoyme DB, 2017, RESUSCITATION, V117, P18, DOI 10.1016/j.resuscitation.2017.05.023; Hoyt WJ, 2019, J CARDIOVASC ELECTR, V30, P2599, DOI 10.1111/jce.14125; Huang SC, 2012, RESUSCITATION, V83, P710, DOI 10.1016/j.resuscitation.2012.01.031; Huang Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009803.pub2; Hudgins JD, 2021, PEDIATR EMERG CARE, V37, P507, DOI 10.1097/PEC.0000000000001706; Hughes AL, 2014, JAMA OTOLARYNGOL, V140, P29, DOI 10.1001/jamaoto.2013.5550; Hunt EA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2643; Hurst V, 2007, RESUSCITATION, V73, P123, DOI 10.1016/j.resuscitation.2006.07.027; Hyldmo PK, 2016, ACTA ANAESTH SCAND, V60, P1003, DOI 10.1111/aas.12714; Hyldmo PK, 2017, AM J EMERG MED, V35, P1630, DOI 10.1016/j.ajem.2017.05.002; Hyldmo PK, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0143-x; Hyldmo PK, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0116-0; Incecik F, 2016, ANN INDIAN ACAD NEUR, V19, P79, DOI 10.4103/0972-2327.167702; Inwald DP, 2015, INTENS CARE MED, V41, P1457, DOI 10.1007/s00134-015-3905-z; Inwald DP, 2019, ARCH DIS CHILD, V104, P426, DOI 10.1136/archdischild-2018-314924; Iramain R, 2019, PEDIATR PULM, V54, P372, DOI 10.1002/ppul.24244; Iro MA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1006-1; Isayama K, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-2; Isguder R, 2016, J CHILD NEUROL, V31, P1120, DOI 10.1177/0883073816641187; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Jain P, 2016, EPILEPSY RES, V122, P47, DOI 10.1016/j.eplepsyres.2016.02.006; Jang HY, 2018, RESUSCITATION, V122, P36, DOI 10.1016/j.resuscitation.2017.11.044; Jardine DS, 2007, PEDIATR REV, V28, P249, DOI 10.1542/pir.28-7-249; Jat KR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009293.pub2; Jat KR, 2011, INDIAN J PEDIATR, V78, P211, DOI 10.1007/s12098-010-0276-x; Jiang J, 2015, AM J EMERG MED, V33, P531, DOI 10.1016/j.ajem.2015.01.025; Jo CH, 2017, PEDIATR EMERG CARE, V33, P462, DOI 10.1097/PEC.0000000000000833; Joffe AR, 2011, ARCH PEDIAT ADOL MED, V165, P419, DOI 10.1001/archpediatrics.2011.47; Johnson MA, 2014, RESUSCITATION, V85, P920, DOI 10.1016/j.resuscitation.2014.03.044; Johnson M, 2019, RESUSCITATION, V140, P50, DOI 10.1016/j.resuscitation.2019.04.039; Johnson M, 2016, AM SURGEON, V82, P876; Johnson PN, 2017, ANN PHARMACOTHER, V51, P656, DOI 10.1177/1060028017706522; Johnson SL, 2020, J NURS CARE QUAL, V35, P70, DOI 10.1097/NCQ.0000000000000407; Jones BP, 2016, J ASTHMA, V53, P607, DOI 10.3109/02770903.2015.1067323; Jones BP, 2016, CHEST, V150, P131, DOI 10.1016/j.chest.2016.02.643; Jones GAL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019253; Jones P, 2016, ARCH DIS CHILD, V101, P77, DOI 10.1136/archdischild-2014-308137; Jones P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086766; Jones P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057478; Jones SI, 2020, PEDIATR CRIT CARE ME, V21, pE592, DOI 10.1097/PCC.0000000000002345; Jousi M, 2019, EUR J EMERG MED, V26, P77, DOI 10.1097/MEJ.0000000000000569; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Julliand S, 2016, ARCH DIS CHILD, V101, P521, DOI 10.1136/archdischild-2015-308857; Jung JY, 2017, AM J EMERG MED, V35, P1303, DOI 10.1016/j.ajem.2017.04.003; Jung WJ, 2019, EUR J EMERG MED, V26, P261, DOI 10.1097/MEJ.0000000000000539; Kaestner M, 2016, HEART, V102, P57, DOI 10.1136/heartjnl-2015-307774; Kaji AH, 2020, ACAD EMERG MED, V27, P394, DOI 10.1111/acem.13869; Kalechstein S, 2012, J PEDIATR SURG, V47, P974, DOI 10.1016/j.jpedsurg.2012.01.055; Kandasamy J, 2019, ARCH DIS CHILD, V104, P793, DOI 10.1136/archdischild-2018-316576; Kao PC, 2009, PEDIATRICS, V124, P49, DOI 10.1542/peds.2008-2536; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Kapuscinski Christine A, 2020, J Pediatr Pharmacol Ther, V25, P314, DOI 10.5863/1551-6776-25.4.314; Katsunuma T, 2019, ALLERGOL INT, V68, P335, DOI 10.1016/j.alit.2019.02.001; Kayashima K, 2015, J ANESTH, V29, P944, DOI 10.1007/s00540-015-2045-5; Keeney GE, 2014, PEDIATRICS, V133, P493, DOI 10.1542/peds.2013-2273; KEMPER KJ, 1992, CLIN PEDIATR, V31, P405, DOI 10.1177/000992289203100705; Khajeh A, 2018, IRAN J CHILD NEUROL, V12, P85; Khera R, 2019, CIRCULATION, V140, P370, DOI 10.1161/CIRCULATIONAHA.118.039048; Kherbeche H, 2017, EUR J EMERG MED, V24, P262, DOI 10.1097/MEJ.0000000000000335; Khoury A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/762053; Kido T, 2020, RESUSCITATION, V148, P49, DOI 10.1016/j.resuscitation.2019.12.020; Kill C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127759; Kill C, 2014, CRIT CARE MED, V42, pE89, DOI 10.1097/CCM.0b013e3182a63fa0; Kim GJ, 2018, CHEST, V154, P77, DOI 10.1016/j.chest.2018.04.015; Kim JE, 2018, ACTA ANAESTH SCAND, V62, P312, DOI 10.1111/aas.13043; Kim JH, 2020, AM J EMERG MED, V38, P2291, DOI 10.1016/j.ajem.2019.10.018; Kim L, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-40; Kim MJ, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0118-y; Kim Se Young, 2015, Ann Pediatr Endocrinol Metab, V20, P179, DOI 10.6065/apem.2015.20.4.179; Kim YH, 2018, PEDIATR CRIT CARE ME, V19, pE1, DOI 10.1097/PCC.0000000000001369; Kim YS, 2016, J KOREAN MED SCI, V31, P997, DOI 10.3346/jkms.2016.31.6.997; Kjaergaard B, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0262-z; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Klugman D, 2016, PEDIATR CRIT CARE ME, V17, pS222, DOI 10.1097/PCC.0000000000000815; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kneyber MCJ, 2017, INTENS CARE MED, V43, P1764, DOI 10.1007/s00134-017-4920-z; Knightly R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003898.pub6; Knudson JD, 2013, PEDIATR CARDIOL, V34, P887, DOI 10.1007/s00246-012-0565-4; Kobayashi H, 2020, J HOSP INFECT, V106, P204, DOI 10.1016/j.jhin.2020.06.010; Kobayashi M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011135; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kojima T, 2018, PEDIATR CRIT CARE ME, V19, P528, DOI 10.1097/PCC.0000000000001531; Kojima T, 2018, PEDIATR CRIT CARE ME, V19, P106, DOI 10.1097/PCC.0000000000001373; Korang SK, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012067.pub2; Kortz TB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181160; Krage R, 2017, EMERG MED J, V34, P728, DOI 10.1136/emermed-2016-205754; Krishnan SG, 2020, ARCH DIS CHILD, V105, P533, DOI 10.1136/archdischild-2019-318043; Krmpotic K, 2019, J PEDIATR INTENSIVE, V8, P113, DOI 10.1055/s-0039-1683869; Kroll M, 2019, PREHOSP EMERG CARE, V23, P210, DOI 10.1080/10903127.2018.1489020; Kwon Ji-Won, 2020, Clin Exp Pediatr, V63, P3, DOI 10.3345/kjp.2019.00626; Kyo M, 2019, J CHEMOTHERAPY, V31, P388, DOI 10.1080/1120009X.2019.1623362; Ladner TR, 2015, STROKE, V46, P2328, DOI 10.1161/STROKEAHA.115.009961; Ladny JR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009386; Lammers RL, 2014, SIMUL HEALTHC, V9, P174, DOI 10.1097/SIH.0000000000000013; Lampin ME, 2012, ACTA PAEDIATR, V101, pe426, DOI 10.1111/j.1651-2227.2012.02725.x; Lane Roni D, 2020, Hosp Pediatr, V10, P311, DOI 10.1542/hpeds.2019-0250; Lane RD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4153; Langhan ML, 2018, PEDIATR CRIT CARE ME, V19, P98, DOI 10.1097/PCC.0000000000001372; Langhan ML, 2015, AM J EMERG MED, V33, P25, DOI 10.1016/j.ajem.2014.09.050; Langhan ML, 2011, PEDIATR EMERG CARE, V27, P394, DOI 10.1097/PEC.0b013e318217b538; Langhelle A, 2000, RESUSCITATION, V44, P105, DOI 10.1016/S0300-9572(00)00161-1; Lapid FM, 2020, PEDIATR ANESTH, V30, P462, DOI 10.1111/pan.13820; Larach MG, 1997, CLIN PEDIATR, V36, P9; Lasa JJ, 2019, PEDIATR CRIT CARE ME, V20, P1040, DOI 10.1097/PCC.0000000000002038; Latimer AJ, 2018, PREHOSP EMERG CARE, V22, P319, DOI 10.1080/10903127.2017.1392667; Laverriere EK, 2020, PEDIATR CRIT CARE ME, V21, P143, DOI 10.1097/PCC.0000000000002119; Lawton B, 2018, CURR OPIN PEDIATR, V30, P359, DOI 10.1097/MOP.0000000000000616; Le Conte P, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0584-x; Lee JH, 2019, PEDIATR CRIT CARE ME, V20, P1, DOI 10.1097/PCC.0000000000001782; Lee J, 2016, PEDIATR NEPHROL, V31, P2113, DOI 10.1007/s00467-016-3414-5; Lee JE, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017853; Lee JH, 2019, PEDIATR ANESTH, V29, P331, DOI 10.1111/pan.13594; Lee J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43020-0; Lee KH, 2013, RESUSCITATION, V84, P766, DOI 10.1016/j.resuscitation.2012.11.005; Lee SH, 2020, ANN EMERG MED, V75, P755, DOI 10.1016/j.annemergmed.2019.09.005; Lee SY, 2018, EUR J EMERG MED, V25, P372, DOI 10.1097/MEJ.0000000000000461; Lee SH, 2011, RESUSCITATION, V82, P1214, DOI 10.1016/j.resuscitation.2011.04.016; Lee SS, 2019, J PAEDIATR CHILD H, V55, P1361, DOI 10.1111/jpc.14422; Lee Yun-Jeong, 2016, Korean J Pediatr, V59, P35, DOI 10.3345/kjp.2016.59.1.35; Leonhard G, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0671-x; Levin M, 2019, LANCET RESP MED, V7, P581, DOI 10.1016/S2213-2600(19)30114-6; Lewis J, 2017, J PEDIATR-US, V181, P177, DOI 10.1016/j.jpeds.2016.10.051; Lewis SR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub7; Li LJ, 2020, SEIZURE-EUR J EPILEP, V78, P43, DOI 10.1016/j.seizure.2020.03.002; Li QY, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00623-19; Li S, 2018, PEDIATR CRIT CARE ME, V19, pE41, DOI 10.1097/PCC.0000000000001384; Li S, 2016, AM J MED QUAL, V31, P47, DOI 10.1177/1062860614547259; Lieberman P, 2015, ANN ALLERG ASTHMA IM, V115, P341, DOI 10.1016/j.anai.2015.07.019; Liedtke AG, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010071; Lim JS, 2013, EMERG MED J, V30, P139, DOI 10.1136/emermed-2011-200978; Lin CY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57320-y; Lin CH, 2013, RESUSCITATION, V84, P586, DOI 10.1016/j.resuscitation.2012.09.028; Lin CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126514; Lin MJ, 2016, PEDIATR CRIT CARE ME, V17, pE469, DOI 10.1097/PCC.0000000000000907; Lin YR, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00220; Lin YR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2391-z; Lin YR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003195; Lin YQ, 2018, RESUSCITATION, V130, P6, DOI 10.1016/j.resuscitation.2018.06.025; Lingappan K, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009975.pub3; Lipman GS, 2019, WILD ENVIRON MED, V30, pS33, DOI 10.1016/j.wem.2018.10.004; Lissaman C, 2019, ARCH DIS CHILD, V104, P12, DOI 10.1136/archdischild-2017-314496; Litman RS, 2003, ANESTHESIOLOGY, V98, P41, DOI 10.1097/00000542-200301000-00010; Liu XX, 2016, PEDIATR PULM, V51, P1414, DOI 10.1002/ppul.23482; Liyanage CK, 2017, EUR ANN ALLERGY CLIN, V49, P196, DOI 10.23822/EurAnnACI.1764-1489.15; Loaec M, 2020, RESUSCITATION, V152, P123, DOI 10.1016/j.resuscitation.2020.05.003; Long B, 2018, ANN EMERG MED, V71, P529, DOI 10.1016/j.annemergmed.2017.11.025; Long E, 2020, PEDIATR ANESTH, V30, P319, DOI 10.1111/pan.13784; Long E, 2019, J ULTRAS MED, V38, P1537, DOI 10.1002/jum.14842; Long E, 2018, PEDIATR CRIT CARE ME, V19, P513, DOI 10.1097/PCC.0000000000001534; Long E, 2017, SHOCK, V47, P550, DOI 10.1097/SHK.0000000000000801; Lopez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162185; Lopez-Herce J, 2018, PEDIATR CRIT CARE ME, V19, pE152, DOI 10.1097/PCC.0000000000001427; Lopez-Herce J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0607-9; Lopez-Herce J, 2014, REV ESP CARDIOL, V67, P189, DOI 10.1016/j.rec.2013.07.017; Lott C, 2021, RESUSCITATION, V161, P152, DOI 10.1016/j.resuscitation.2021.02.011; Lovrenski Jovan, 2016, Acta Med Acad, V45, P39, DOI 10.5644/ama2006-124.155; Lu CH, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0679-2; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Luo J, 2019, J PEDIATR-US, V215, P199, DOI 10.1016/j.jpeds.2019.07.059; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; Maa T, 2020, J ALLER CL IMM-PRACT, V8, P1239, DOI 10.1016/j.jaip.2019.11.013; Mackay MT, 2016, J PAEDIATR CHILD H, V52, P158, DOI 10.1111/jpc.13086; Maconochie IK, 2020, RESUSCITATION, V156, pA120, DOI 10.1016/j.resuscitation.2020.09.013; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Maeda T, 2018, PEDIATR CRIT CARE ME, V19, pE637, DOI 10.1097/PCC.0000000000001724; Maeda T, 2016, RESUSCITATION, V107, P80, DOI 10.1016/j.resuscitation.2016.08.010; Magoteaux SR, 2017, J PEDIATR SURG, V52, P979, DOI 10.1016/j.jpedsurg.2017.03.021; Maitland Kathryn, 1800, Wellcome Open Res, V2, P100, DOI 10.12688/wellcomeopenres.12747.1; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Male I, 2000, ARCH DIS CHILD, V83, P325, DOI 10.1136/adc.83.4.325; Mandelzweig K, 2018, J CRIT CARE, V47, P310, DOI 10.1016/j.jcrc.2018.01.007; Manrique G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63921-9; Marin JR, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0049-5; Marino BS, 2018, CIRCULATION, V137, pE691, DOI 10.1161/CIR.0000000000000524; Masarwa R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-016-1589-6; Matamoros M, 2015, PEDIATR EMERG CARE, V31, P31, DOI 10.1097/PEC.0000000000000323; Matettore A, 2019, PEDIATR CRIT CARE ME, V20, P518, DOI 10.1097/PCC.0000000000001923; Mathew JL, 2017, INDIAN PEDIATR, V54, P133, DOI 10.1007/s13312-017-1016-3; Matos RI, 2013, CIRCULATION, V127, P442, DOI 10.1161/CIRCULATIONAHA.112.125625; Matson Kelly L, 2017, J Pediatr Pharmacol Ther, V22, P81, DOI 10.5863/1551-6776-22.1.81; Matsui S, 2020, INT HEART J, V61, P254, DOI 10.1536/ihj.19-574; Maxien D, 2019, RESUSCITATION, V145, P1, DOI 10.1016/j.resuscitation.2019.09.028; Mayrand KP, 2015, WEST J EMERG MED, V16, P1135, DOI 10.5811/westjem.2015.9.28167; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; McTague A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001905.pub3; Medley TL, 2019, INT J STROKE, V14, P94, DOI 10.1177/1747493018799958; Meert K, 2018, RESUSCITATION, V124, P96, DOI 10.1016/j.resuscitation.2018.01.013; Melvan JN, 2020, WORLD J PEDIATR CONG, V11, P265, DOI 10.1177/2150135120902102; Mendelson J, 2018, EMERG MED CLIN N AM, V36, P427, DOI 10.1016/j.emc.2017.12.010; Mendler MR, 2017, NEONATOLOGY, V111, P100, DOI 10.1159/000447663; Mendler MR, 2015, NEONATOLOGY, V108, P73, DOI 10.1159/000381416; Menon K, 2015, SHOCK, V44, P402, DOI 10.1097/SHK.0000000000000355; Menon K, 2013, PEDIATR CRIT CARE ME, V14, P474, DOI 10.1097/PCC.0b013e31828a8125; Mentzelopoulos SD, 2021, ETHIK REANIMATION EN, DOI [10.1007/s10049- 021-00888- 8, DOI 10.1007/S10049-021-00888-8]; Mercier E, 2019, RESUSCITATION, V139, P241, DOI 10.1016/j.resuscitation.2019.04.028; Messer AF, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000225; Michel J, 2017, PEDIATR DRUGS, V19, P35, DOI 10.1007/s40272-016-0199-8; Michelson KA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2741; Michelson KA, 2015, J PEDIATR-US, V167, P719, DOI 10.1016/j.jpeds.2015.05.033; Miescier MJ, 2019, PEDIATR EMERG CARE, V35, P455, DOI 10.1097/PEC.0000000000000981; Mikalsen IB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0278-4; Miller KA, 2019, EMERG MED CLIN N AM, V37, P473, DOI 10.1016/j.emc.2019.03.006; Millin MG, 2020, RESUSCITATION, V148, P161, DOI 10.1016/j.resuscitation.2019.12.039; Mintegi S, 2019, PEDIATR EMERG CARE, V35, P50, DOI 10.1097/PEC.0000000000001031; Mintegi S, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0006; Misir A, 2018, CURR PEDIATR REV, V14, P9, DOI 10.2174/1573396313666170815101504; Mitani Y, 2013, EUROPACE, V15, P1259, DOI 10.1093/europace/eut053; Moffett BS, 2015, CARDIOL YOUNG, V25, P1080, DOI 10.1017/S1047951114001619; Mok YH, 2016, ANN ACAD MED SINGAP, V45, P534; Mokhateb-Rafii T, 2019, PEDIATR CRIT CARE ME, V20, P19, DOI 10.1097/PCC.0000000000001766; Momen AA, 2015, EUR J PAEDIATR NEURO, V19, P149, DOI 10.1016/j.ejpn.2014.11.007; Medeiros DNM, 2015, PEDIATR EMERG CARE, V31, pe11, DOI 10.1097/PEC.0000000000000601; Moore HB, 2016, J PEDIATR SURG, V51, P315, DOI 10.1016/j.jpedsurg.2015.10.040; Moore L, 2018, WORLD J SURG, V42, P1327, DOI 10.1007/s00268-017-4292-0; Morell E, 2020, PEDIATR CRIT CARE ME, V21, P256, DOI 10.1097/PCC.0000000000002127; Morello ML, 2018, PACE, V41, P472, DOI 10.1111/pace.13315; de la Rosa JSO, 2018, SEIZURE-EUR J EPILEP, V56, P34, DOI 10.1016/j.seizure.2018.01.014; Resuscitation AaNZCo, 1 AID MAN AN; Fernandez IS, 2019, SEIZURE-EUR J EPILEP, V68, P16, DOI 10.1016/j.seizure.2018.08.002; Fernandez IS, 2015, NEUROLOGY, V84, P2304, DOI 10.1212/WNL.0000000000001673; Fernandez IS, 2019, NEUROLOGY, V92, pE2339, DOI 10.1212/WNL.0000000000007503; Weston PJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011027.pub2; Morgan JK, 2018, ADDICT BEHAV, V80, P22, DOI 10.1016/j.addbeh.2018.01.002; Morgan RW, 2020, CRIT CARE MED, V48, P881, DOI 10.1097/CCM.0000000000004308; Morgan RW, 2020, PEDIATR CRIT CARE ME, V21, P305, DOI 10.1097/PCC.0000000000002187; Morgan RW, 2019, RESUSCITATION, V139, P1, DOI 10.1016/j.resuscitation.2019.03.032; Morgan RW, 2017, J CRIT CARE, V40, P128, DOI 10.1016/j.jcrc.2017.03.023; Mori T, 2020, J PAEDIATR CHILD H, V56, P1376, DOI 10.1111/jpc.14940; Mori T, 2019, J ULTRAS MED, V38, P2945, DOI 10.1002/jum.15000; Morin L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0545-4; Mortensen RB, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-16; Mortimer T, 2016, J PEDIATR INTENSIVE, V5, P28, DOI 10.1055/s-0035-1568149; Moses JM, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-20; Moskowitz EE, 2018, PEDIATR SURG INT, V34, P857, DOI 10.1007/s00383-018-4290-9; Muchao FP, 2016, PEDIATR PULM, V51, P1122, DOI 10.1002/ppul.23469; Mumma JM, 2018, HUM FACTORS, V60, P212, DOI 10.1177/0018720817744729; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Murphy KR, 2020, J ALLER CL IMM-PRACT, V8, P1815, DOI 10.1016/j.jaip.2020.01.042; Na JU, 2015, ACTA PAEDIATR, V104, pE70, DOI 10.1111/apa.12857; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nadler R, 2019, J TRAUMA ACUTE CARE, V87, P1315, DOI 10.1097/TA.0000000000002477; Nagata T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003481; Naim MY, 2017, JAMA PEDIATR, V171, P133, DOI 10.1001/jamapediatrics.2016.3643; Najaf-Zadeh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055270; Nasiri E, 2014, SAUDI J ANAESTH, V8, P30, DOI 10.4103/1658-354X.125923; Natsume J, 2017, BRAIN DEV-JPN, V39, P2, DOI 10.1016/j.braindev.2016.06.003; Navarro-Paton R, 2019, RESUSCITATION, V134, P104, DOI 10.1016/j.resuscitation.2018.10.030; Nehme Z, 2018, RESUSCITATION, V128, P43, DOI 10.1016/j.resuscitation.2018.04.030; Nelson P, 2014, ANESTH ANALG, V118, P369, DOI 10.1213/ANE.0b013e3182a8fad0; Neubrand TL, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000230; Nichols B, 2017, PEDIATR CRIT CARE ME, V18, pE406, DOI 10.1097/PCC.0000000000001237; Nijman RG, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4224; Niles DE, 2017, SIMUL HEALTHC, V12, P213, DOI 10.1097/SIH.0000000000000228; Ninchoji T, 2018, PEDIATR EMERG CARE, V34, pE64, DOI 10.1097/PEC.0000000000000691; Nishiyama M, 2018, BRAIN DEV-JPN, V40, P884, DOI 10.1016/j.braindev.2018.08.001; Noje C, 2019, PEDIATR CRIT CARE ME, V20, pE30, DOI 10.1097/PCC.0000000000001768; Nolan JP, 2020, RESUSCITATION, V153, P45, DOI 10.1016/j.resuscitation.2020.06.001; Noureen N, 2019, J CLIN NEUROL, V15, P468, DOI 10.3988/jcn.2019.15.4.468; Nuttall AGL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023216; O'Brien S, 2019, J PAEDIATR CHILD H, V55, P746, DOI 10.1111/jpc.14496; O'Connell KJ, 2019, RESUSCITATION, V145, P158, DOI 10.1016/j.resuscitation.2019.08.015; O'Leary F, 2015, ARCH DIS CHILD, V100, P733, DOI 10.1136/archdischild-2014-307401; O'Neil Erika R, 2020, Crit Care Explor, V2, pe0075, DOI 10.1097/CCE.0000000000000075; Oberender F, 2018, PEDIATR CRIT CARE ME, V19, P965, DOI 10.1097/PCC.0000000000001660; Oh JH, 2015, EMERG MED J, V32, P544, DOI 10.1136/emermed-2014-203932; Oh JH, 2015, EMERG MED AUSTRALAS, V27, P108, DOI 10.1111/1742-6723.12364; Ohchi F, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0982-y; Oksan D, 2013, INDIAN PEDIATR, V50, P689, DOI 10.1007/s13312-013-0192-z; Okubo M, 2020, RESUSCITATION, V153, P227, DOI 10.1016/j.resuscitation.2020.04.023; Okubo M, 2019, RESUSCITATION, V145, P175, DOI 10.1016/j.resuscitation.2019.09.007; Olasveengen TM, 2020, RESUSCITATION, V156, pA35, DOI 10.1016/j.resuscitation.2020.09.010; Opiyo N, 2011, ARCH DIS CHILD, V96, P1052, DOI 10.1136/adc.2010.186049; Oropeza AR, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0402-0; Orso D, 2020, J INTENSIVE CARE MED, V35, P354, DOI 10.1177/0885066617752308; Orso D, 2018, J ULTRASOUND, V21, P183, DOI 10.1007/s40477-018-0306-5; Oulego-Erroz I, 2016, J CRIT CARE, V35, P133, DOI 10.1016/j.jcrc.2016.05.010; Overmann KM, 2019, AM J EMERG MED, V37, P1416, DOI 10.1016/j.ajem.2018.10.030; Owattanapanich N, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0572-4; Ozdemir A, 2017, PEDIATR INT, V59, P209, DOI 10.1111/ped.13081; Ozkaya AK, 2019, AM J EMERG MED, V37, P2102, DOI 10.1016/j.ajem.2019.05.063; Paal P, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0303-7; Palatinus JA, 2015, J EMERG MED, V49, P159, DOI 10.1016/j.jemermed.2015.02.046; Paniagua N, 2017, J PEDIATR-US, V191, P190, DOI 10.1016/j.jpeds.2017.08.030; Park JW, 2019, PREHOSP EMERG CARE, V23, P74, DOI 10.1080/10903127.2018.1471559; Park M, 2018, PEDIATR CRIT CARE ME, V19, pE576, DOI 10.1097/PCC.0000000000001679; Park R, 2017, BRIT J ANAESTH, V119, P984, DOI 10.1093/bja/aex344; Parker Margaret M, 2017, Pediatr Crit Care Med, V18, P310, DOI 10.1097/PCC.0000000000001074; Parker MJ, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1689-2; Pasquier M, 2021, ANN THORAC SURG, V111, P1408, DOI 10.1016/j.athoracsur.2020.06.146; Pasquier M, 2018, RESUSCITATION, V126, P58, DOI 10.1016/j.resuscitation.2018.02.026; Patel B, 2019, PEDIATR PULM, V54, P970, DOI 10.1002/ppul.24329; Patel Jigar, 2017, Asian Cardiovasc Thorac Ann, V25, P118, DOI 10.1177/0218492316688416; Patel JK, 2018, RESUSCITATION, V127, P83, DOI 10.1016/j.resuscitation.2018.04.008; Patregnani JT, 2017, PEDIATR CRIT CARE ME, V18, pE378, DOI 10.1097/PCC.0000000000001230; Paul R, 2018, PEDIATR CLIN N AM, V65, P1107, DOI 10.1016/j.pcl.2018.07.012; Paul Raina, 2018, Pediatr Qual Saf, V3, pe051, DOI 10.1097/pq9.0000000000000051; Pearsall MF, 2014, ANESTH ANALG, V118, P776, DOI 10.1213/ANE.0000000000000148; Pelland-Marcotte MC, 2019, LANCET HAEMATOL, V6, pE144, DOI 10.1016/S2352-3026(18)30224-2; Pellegrino JL, 2019, ARCH DIS CHILD, V104, P530, DOI 10.1136/archdischild-2018-314893; Pepper DJ, 2018, ANN INTERN MED, V168, P610, DOI 10.7326/L18-0140; Perkins GD, 2021, RESUSCITATION, V161, P1, DOI 10.1016/j.resuscitation.2021.02.003; Perkins GD, 2017, RESUSCITATION, V121, P104, DOI 10.1016/j.resuscitation.2017.09.029; Peters MJ, 2018, INTENS CARE MED, V44, P1240, DOI 10.1007/s00134-018-5232-7; Phillips JS, 2017, RESP CARE, V62, P78, DOI 10.4187/respcare.05111; Phillips RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130327; Phillips R, 2020, J PEDIATR SURG, V55, P331, DOI 10.1016/j.jpedsurg.2019.10.008; Pifko EL, 2018, J PAEDIATR CHILD H, V54, P546, DOI 10.1111/jpc.13773; Polites SF, 2020, J TRAUMA ACUTE CARE, V89, P36, DOI 10.1097/TA.0000000000002702; Polites Stephanie F, 2018, J Trauma Acute Care Surg, V85, P108, DOI 10.1097/TA.0000000000001897; Portela JL, 2015, MED INTENSIVA, V39, P160, DOI 10.1016/j.medin.2014.04.003; Posner LS, 2017, DRUG HEALTHC PATIENT, V9, P9, DOI 10.2147/DHPS.S121733; Potes C, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1874-z; Potter SK, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.07.76; Pourmand A, 2018, AM J EMERG MED, V36, P1480, DOI 10.1016/j.ajem.2018.05.009; Pundi KN, 2015, HEART RHYTHM, V12, P776, DOI 10.1016/j.hrthm.2015.01.002; Puzio T, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000362; Qadori M, 2018, ACTA PAEDIATR, V107, P1455, DOI 10.1111/apa.14318; Quail MA, 2012, ARCH DIS CHILD, V97, P177, DOI 10.1136/archdischild-2011-301079; Quinn N, 2020, EMERG MED AUSTRALAS, V32, P117, DOI 10.1111/1742-6723.13392; Quintard H, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0483-1; Qureshi AU, 2012, JCPSP-J COLL PHYSICI, V22, P648, DOI 10.2012/JCPSP.648651; Ramaswamy KN, 2016, PEDIATR CRIT CARE ME, V17, pE502, DOI 10.1097/PCC.0000000000000954; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Ramgopal S, 2020, PREHOSP EMERG CARE, V24, P683, DOI 10.1080/10903127.2019.1699212; Ramnarayan P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2080-3; Ranjit S, 2018, INDIAN J CRIT CARE M, V22, P154, DOI 10.4103/ijccm.IJCCM_413_17; Ranjit S, 2016, INDIAN J CRIT CARE M, V20, P561, DOI 10.4103/0972-5229.192036; Rauf A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218155; Raymond TT, 2019, PEDIATR CRIT CARE ME, V20, P405, DOI 10.1097/PCC.0000000000001863; Raymond TT, 2015, RESUSCITATION, V89, P106, DOI 10.1016/j.resuscitation.2015.01.007; REDDING JS, 1979, CRIT CARE MED, V7, P475, DOI 10.1097/00003246-197910000-00008; Rehder KJ, 2017, RESP CARE, V62, P849, DOI 10.4187/respcare.05174; Rehn M, 2016, ACTA ANAESTH SCAND, V60, P852, DOI 10.1111/aas.12746; Remick K, 2017, PREHOSP EMERG CARE, V21, P216, DOI 10.1080/10903127.2016.1218979; Reuter-Rice K, 2015, ADV EMERG NURS J, V37, P301, DOI 10.1097/TME.0000000000000077; Ricci F, 2015, EUR HEART J-ACUTE CA, V4, P103, DOI 10.1177/2048872614553166; Richards M, 2020, J TROP PEDIATRICS, V66, P612, DOI 10.1093/tropej/fmaa024; Richardson C, 2017, PEDIATR DRUGS, V19, P539, DOI 10.1007/s40272-017-0254-0; Riskin A, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2043; Ristagno G, 2012, RESUSCITATION, V83, P755, DOI 10.1016/j.resuscitation.2011.12.010; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Robinson M, 2017, ANN ALLERG ASTHMA IM, V119, P164, DOI 10.1016/j.anai.2017.06.001; Rodriguez JJ, 2020, EMERG MED INT, V2020, DOI 10.1155/2020/7012508; Rodriguez SA, 2014, RESUSCITATION, V85, P119, DOI 10.1016/j.resuscitation.2013.09.003; Rodriguez-Ruiz E, 2019, MED INTENSIVA, V43, P346, DOI 10.1016/j.medin.2018.04.010; Rodriguez-Ruiz E, 2019, EUR J PEDIATR, V178, P1529, DOI 10.1007/s00431-019-03452-2; Roh YI, 2019, RESUSCITATION, V143, P100, DOI 10.1016/j.resuscitation.2019.08.022; Rosenberg H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0310-1; Rossano JW, 2015, PEDIATR EMERG CARE, V31, P526, DOI 10.1097/PEC.0000000000000490; Rostykus P, 2016, PREHOSP EMERG CARE, V20, P524, DOI 10.3109/10903127.2015.1128031; Rousseaux J, 2013, PEDIATR EMERG CARE, V29, P1055, DOI 10.1097/PEC.0b013e3182a5c99c; Saczkowski RS, 2018, RESUSCITATION, V127, P51, DOI 10.1016/j.resuscitation.2018.03.028; Salas N, 2007, RESUSCITATION, V74, P94, DOI 10.1016/j.resuscitation.2006.01.023; Salyer John W, 2003, Respir Care, V48, P386; Samransamruajkit R, 2018, INDIAN J CRIT CARE M, V22, P846, DOI 10.4103/ijccm.IJCCM_367_18; Santhanam I, 2017, ANN INDIAN ACAD NEUR, V20, P142, DOI 10.4103/aian.AIAN_369_16; Saunders R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013402; Schaller Stefan J, 2019, Ger Med Sci, V17, pDoc06, DOI 10.3205/000272; Schauer SG, 2020, J TRAUMA ACUTE CARE, V89, pS185, DOI 10.1097/TA.0000000000002590; Schauer SG, 2018, INJURY, V49, P911, DOI 10.1016/j.injury.2018.01.034; Schoneberg C, 2014, ZBL CHIR, V139, P584, DOI 10.1055/s-0032-1328645; Schreiber S, 2016, ACTA PAEDIATR, V105, P292, DOI 10.1111/apa.13282; Scott A, 2019, J PEDIATR INTENSIVE, V8, P117, DOI 10.1055/s-0039-1678552; Scott HF, 2017, JAMA PEDIATR, V171, P249, DOI 10.1001/jamapediatrics.2016.3681; Scott HF, 2016, J PEDIATR-US, V170, P149, DOI 10.1016/j.jpeds.2015.11.071; Scott HF, 2015, ACAD EMERG MED, V22, P381, DOI 10.1111/acem.12610; Scott HF, 2012, ACAD EMERG MED, V19, P1276, DOI 10.1111/acem.12014; Sepanski RJ, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00066; Sepehripour AH, 2013, INTERACT CARDIOV TH, V17, P564, DOI 10.1093/icvts/ivt208; Shah S, 2020, TROP DOCT, V50, P186, DOI 10.1177/0049475520914831; Shah SN, 2017, JAMA-J AM MED ASSOC, V318, P462, DOI 10.1001/jama.2017.9039; Shaker MS, 2020, J ALLERGY CLIN IMMUN, V145, P1082, DOI 10.1016/j.jaci.2020.01.017; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Shen J, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.928835; Sherman JM, 2020, PEDIATR EMERG CARE, V36, pE146, DOI 10.1097/PEC.0000000000001275; Sherr JL, 2016, DIABETES CARE, V39, P555, DOI 10.2337/dc15-1606; Shibahashi K, 2020, ANN EMERG MED, V75, P57, DOI 10.1016/j.annemergmed.2019.05.036; Shin Hong Ju, 2016, Korean J Thorac Cardiovasc Surg, V49, P151, DOI 10.5090/kjtcs.2016.49.3.151; Shtull-Leber E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173539; Sicherer SH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4006; Siddiqu NUR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011179; Sidhu N, 2016, PEDIATR EMERG CARE, V32, P508, DOI 10.1097/PEC.0000000000000864; Siegler J, 2017, PREHOSP EMERG CARE, V21, P74, DOI 10.1080/10903127.2016.1227003; Silbergleit R, 2019, LANCET, V393, P2101, DOI 10.1016/S0140-6736(19)30896-7; Silva Paula de Souza, 2015, Rev. bras. ter. intensiva, V27, P390, DOI 10.5935/0103-507X.20150065; Silverman EC, 2017, WEST J EMERG MED, V18, P419, DOI 10.5811/westjem.2016.12.32066; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Simons FER, 2015, J ALLERGY CLIN IMMUN, V135, P1125, DOI 10.1016/j.jaci.2014.09.014; Simons FER, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-9; Simons T, 2017, EUR J TRAUMA EMERG S, V43, P797, DOI 10.1007/s00068-016-0758-2; Singh K, 2018, J PEDIATR NEUROSCI, V13, P158, DOI 10.4103/jpn.JPN_126_17; Singh M, 2019, INDIAN J PEDIATR, V86, P1142, DOI 10.1007/s12098-019-03094-0; Singh Y, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2787-9; Singletary EM, 2020, RESUSCITATION, V156, pA240, DOI 10.1016/j.resuscitation.2020.09.016; Sinha R, 2019, J ANAESTH CLIN PHARM, V35, P509, DOI 10.4103/joacp.JOACP_106_18; Skellett S, 2020, RESUSCITATION, V155, P165, DOI 10.1016/j.resuscitation.2020.07.026; Skogvoll E, 2020, RESUSCITATION, V152, P116, DOI 10.1016/j.resuscitation.2020.05.013; Smallwood CD, 2019, RESP CARE, V64, P855, DOI 10.4187/respcare.07029; Smereka J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00159; Smereka J, 2017, AM J EMERG MED, V35, P1420, DOI 10.1016/j.ajem.2017.04.024; Smith DM, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040047; Soar J, 2021, RESUSCITATION, V161, P115, DOI 10.1016/j.resuscitation.2021.02.010; Soar J, 2019, RESUSCITATION, V145, P95, DOI 10.1016/j.resuscitation.2019.10.016; Soar J, 2019, RESUSCITATION, V134, P99, DOI 10.1016/j.resuscitation.2018.11.018; Sola C, 2017, ANAESTH CRIT CARE PA, V36, P267, DOI 10.1016/j.accpm.2016.10.005; Sole A, 2018, EUR J PEDIATR, V177, P1191, DOI 10.1007/s00431-018-3174-2; Soreide E, 2013, RESUSCITATION, V84, P1487, DOI 10.1016/j.resuscitation.2013.07.020; Spyres MB, 2019, J MED TOXICOL, V15, P228, DOI 10.1007/s13181-019-00736-9; Steensberg AT, 2017, RESUSCITATION, V115, P52, DOI 10.1016/j.resuscitation.2017.04.002; Stein ML, 2020, PEDIATR ANESTH, V30, P269, DOI 10.1111/pan.13814; Stine CN, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01871; Stinson HR, 2019, PEDIATR QUAL SAF, V4, DOI 10.1097/pq9.0000000000000197; Strapazzon G, 2017, EUR J EMERG MED, V24, P398, DOI 10.1097/MEJ.0000000000000390; Stredny CM, 2018, SEIZURE-EUR J EPILEP, V58, P133, DOI 10.1016/j.seizure.2018.04.011; Strutt J, 2019, PEDIATR EMERG CARE, V35, P132, DOI 10.1097/PEC.0000000000001733; Strzelczyk A, 2017, EPILEPSIA, V58, P933, DOI 10.1111/epi.13716; Stub D, 2012, RESUSCITATION, V83, P793, DOI 10.1016/j.resuscitation.2012.03.034; Sun F, 2017, J THORAC DIS, V9, P4599, DOI 10.21037/jtd.2017.10.79; Sun J, 2015, INT J CLIN EXP MED, V8, P16231; Sun Y, 2014, PEDIATR ANESTH, V24, P1056, DOI 10.1111/pan.12458; Sunde GA, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-52; Sutton RM, 2019, CRIT CARE MED, V47, P1627, DOI 10.1097/CCM.0000000000003898; Sutton RM, 2018, RESUSCITATION, V130, P159, DOI 10.1016/j.resuscitation.2018.07.015; Svendsen OS, 2017, ANN THORAC SURG, V103, P920, DOI 10.1016/j.athoracsur.2016.06.093; Swor R, 2013, RESUSCITATION, V84, P426, DOI 10.1016/j.resuscitation.2012.09.014; Szarpak L, 2020, PEDIATR EMERG CARE, V36, pE568, DOI 10.1097/PEC.0000000000001587; Tan BKK, 2013, MINERVA CHIR, V68, P241; Tan DY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171869; Tanno LK, 2019, CURR OPIN ALLERGY CL, V19, P393, DOI 10.1097/ACI.0000000000000539; Tasker RC, 2016, PEDIATR CRIT CARE ME, V17, P968, DOI 10.1097/PCC.0000000000000900; Tate Ramsey C, 2013, JEMS, V38, P36; Taylor KL, 2014, RESUSCITATION, V85, P1342, DOI 10.1016/j.resuscitation.2014.06.027; Terboven T, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0623-5; Theusinger OM, 2019, J EMERG MED, V57, P345, DOI 10.1016/j.jemermed.2019.05.036; Thomas-Jones E, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1210-z; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Tibballs J, 2011, PEDIATR CRIT CARE ME, V12, P14, DOI 10.1097/PCC.0b013e3181dbb4fc; Tibballs J, 2010, RESUSCITATION, V81, P671, DOI 10.1016/j.resuscitation.2010.01.030; Tiwari A, 2016, ANN THORAC MED, V11, P283, DOI 10.4103/1817-1737.191874; Tobin JM, 2020, PREHOSP DISASTER MED, V35, P141, DOI 10.1017/S1049023X20000060; Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP; Topal E, 2013, ALLERGY ASTHMA PROC, V34, P233, DOI 10.2500/aap.2013.34.3658; Topjian AA, 2019, RESUSCITATION, V141, P88, DOI 10.1016/j.resuscitation.2019.05.033; Topjian AA, 2019, RESUSCITATION, V141, P24, DOI 10.1016/j.resuscitation.2019.05.032; Topjian AA, 2018, JAMA PEDIATR, V172, P143, DOI 10.1001/jamapediatrics.2017.4043; Torres-Andres F, 2018, PEDIATR CRIT CARE ME, V19, P451, DOI 10.1097/PCC.0000000000001524; Tosif S, 2017, J TROP PEDIATRICS, V63, P402, DOI 10.1093/tropej/fmw100; Tran A, 2018, J TRAUMA ACUTE CARE, V84, P802, DOI 10.1097/TA.0000000000001816; Tran P, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa028; Trinka E, 2014, CNS DRUGS, V28, P623, DOI 10.1007/s40263-014-0167-1; Tripathi A, 2015, INDIAN PEDIATR, V52, P965, DOI 10.1007/s13312-015-0754-3; Tsou JY, 2020, EUR J EMERG MED, V27, P132, DOI 10.1097/MEJ.0000000000000631; Tsou PY, 2017, RESUSCITATION, V114, P92, DOI 10.1016/j.resuscitation.2017.02.021; Tsuda T, 2019, EUR J PEDIATR, V178, P1333, DOI 10.1007/s00431-019-03421-9; Tsung JW, 2009, RESUSCITATION, V80, P665, DOI 10.1016/j.resuscitation.2009.03.009; Turner PJ, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100066; Ulusoy E, 2019, SEIZURE-EUR J EPILEP, V71, P50, DOI 10.1016/j.seizure.2019.06.011; Uppal P, 2018, SEIZURE-EUR J EPILEP, V58, P147, DOI 10.1016/j.seizure.2018.04.005; Vadi MG, 2017, PEDIATR EMERG CARE, V33, P467, DOI 10.1097/PEC.0000000000000607; Vahlkvist S, 2020, EUR J PEDIATR, V179, P513, DOI 10.1007/s00431-019-03533-2; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; van der Valk JPM, 2018, ANN ALLERG ASTHMA IM, V120, P300, DOI 10.1016/j.anai.2017.08.018; van Paridon BM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1010-x; van Sambeeck SJ, 2019, EUR J PEDIATR, V178, P1219, DOI 10.1007/s00431-019-03395-8; van Vonderen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109049; Varallo FR, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/PharmPract.2019.1.1361, 10.18549/pharmpract.2019.1.1361]; Vassallo J, 2019, ARCH DIS CHILD, V104, P437, DOI 10.1136/archdischild-2018-314985; Ventura AMC, 2015, CRIT CARE MED, V43, P2292, DOI 10.1097/CCM.0000000000001260; Vezina K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010283.pub2; Vignesh V, 2020, INDIAN PEDIATR, V57, P222, DOI 10.1007/s13312-020-1755-4; Vilke Gary M, 2004, Prehosp Emerg Care, V8, P196; Vitaliti Giovanna, 2017, Respir Care, V62, P1036, DOI 10.4187/respcare.05384; von der Weid L, 2018, PAEDIATR INT CHILD H, V38, P113, DOI 10.1080/20469047.2017.1390828; Vonasek BJ, 2020, PAEDIATR INT CHILD H, V40, P148, DOI 10.1080/20469047.2020.1747003; Vukovic AA, 2019, AM J EMERG MED, V37, P27, DOI 10.1016/j.ajem.2018.04.039; Wall JJ, 2017, PEDIATR EMERG CARE, V33, P427, DOI 10.1097/PEC.0000000000001156; Walsh BM, 2017, J EMERG MED, V53, P467, DOI 10.1016/j.jemermed.2017.04.028; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; Wang EEL, 1996, PEDIATR PULM, V22, P23, DOI 10.1002/(SICI)1099-0496(199607)22:1<23::AID-PPUL4>3.0.CO;2-L; Wang TQ, 2020, SEIZURE-EUR J EPILEP, V80, P5, DOI 10.1016/j.seizure.2020.04.001; Wang YC, 2019, ALLERGY, V74, P1063, DOI 10.1111/all.13732; Wani G, 2019, J FAM MED PRIM CARE, V8, P3367, DOI 10.4103/jfmpc.jfmpc_750_19; Watts K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006100.pub2; Weber MW, 1997, ARCH DIS CHILD, V76, P310, DOI 10.1136/adc.76.4.310; Weberding NT, 2018, ANN EMERG MED, V71, P220, DOI 10.1016/j.annemergmed.2017.09.002; Wei JN, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00503; Weinstock P, 2008, PEDIATR CLIN N AM, V55, P1011, DOI 10.1016/j.pcl.2008.04.001; Weisfeldt Myron L, 2004, Trans Am Clin Climatol Assoc, V115, P115; Weiss SL, 2020, PEDIATR CRIT CARE ME, V21, pE52, DOI [10.1097/PCC.0000000000002198, 10.1007/s00134-019-05878-6]; Weiss SL, 2017, PEDIATR CRIT CARE ME, V18, P823, DOI 10.1097/PCC.0000000000001222; Weiss SL, 2017, J PEDIATR-US, V182, P304, DOI 10.1016/j.jpeds.2016.11.075; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; Welch RD, 2015, EPILEPSIA, V56, P254, DOI 10.1111/epi.12905; Wells M, 2017, RESUSCITATION, V121, P9, DOI 10.1016/j.resuscitation.2017.09.026; Wells M, 2017, INT J EMERG MED, V10, DOI 10.1186/s12245-017-0156-5; Wen LL, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-019-0768-x; Wieck MM, 2018, J TRAUMA ACUTE CARE, V85, P659, DOI 10.1097/TA.0000000000001908; Williams AM, 2011, INTENS CARE MED, V37, P1338, DOI 10.1007/s00134-011-2238-9; Williams DC, 2019, EXPERT REV RESP MED, V13, P327, DOI 10.1080/17476348.2019.1586536; Wisecup S, 2015, J ASTHMA, V52, P693, DOI 10.3109/02770903.2014.1002566; Wolfe HA, 2019, RESUSCITATION, V143, P57, DOI 10.1016/j.resuscitation.2019.08.006; Wollenek G, 2002, RESUSCITATION, V52, P255, DOI 10.1016/S0300-9572(01)00474-9; Wong HR, 2018, CRIT CARE MED, V46, pe242, DOI 10.1097/CCM.0000000000002932; Wong HR, 2016, CRIT CARE MED, V44, pE1000, DOI 10.1097/CCM.0000000000001833; Workman JK, 2020, ASAIO J, V66, P1152, DOI 10.1097/MAT.0000000000001147; Workman JK, 2016, PEDIATR CRIT CARE ME, V17, pE451, DOI 10.1097/PCC.0000000000000906; Writer Hilary, 2010, BMJ Clin Evid, V2010; Wu ET, 2009, RESUSCITATION, V80, P443, DOI 10.1016/j.resuscitation.2009.01.006; Wulff A, 2019, METHOD INFORM MED, V58, pe43, DOI 10.1055/s-0039-1695717; Xi B, 2016, CIRCULATION, V133, P398, DOI 10.1161/CIRCULATIONAHA.115.017936; Rojas-Reyes MX, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005975.pub3; Yan Hai-Peng, 2016, Zhongguo Dang Dai Er Ke Za Zhi, V18, P506; Yang D, 2019, PEDIATR CARDIOL, V40, P1217, DOI 10.1007/s00246-019-02135-x; Yang JT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9448; Yannopoulos Demetris, 2005, Respir Care, V50, P628; Yates AR, 2019, PEDIATR CRIT CARE ME, V20, P1126, DOI 10.1097/PCC.0000000000002088; Yock-Corrales A, 2011, ANN EMERG MED, V58, P156, DOI 10.1016/j.annemergmed.2010.10.013; Young KD, 2016, ANN EMERG MED, V68, P441, DOI 10.1016/j.annemergmed.2016.02.043; Youngquist S, 2007, PEDIATR EMERG CARE, V23, P250, DOI 10.1097/PEC.0b013e31803f7552; Yurtseven A, 2019, PEDIATR PULM, V54, P894, DOI 10.1002/ppul.24318; Zhan L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010134.pub2; Zhang Y, 2019, Zhonghua Yi Xue Za Zhi, V99, P3564, DOI 10.3760/cma.j.issn.0376-2491.2019.45.007; Zhao ZY, 2016, J CHILD NEUROL, V31, P1093, DOI 10.1177/0883073816638757; Zimmerman E, 2015, PEDIATRICS, V136, P905, DOI 10.1542/peds.2015-1858; Zwingmann J, 2015, RESUSCITATION, V96, P59, DOI 10.1016/j.resuscitation.2015.07.022; Zwingmann J, 2012, CRIT CARE, V16, DOI 10.1186/cc11410	806	4	4	10	10	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	JUN	2021	24	4			SI		650	719		10.1007/s10049-021-00887-9		JUN 2021	70	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SS7AF	WOS:000657231500001	34093080	Green Published, Bronze			2022-02-06	
J	Zhan, XH; Li, YH; Liu, YZ; Domel, AG; Alizadeh, HV; Raymond, SJ; Ruan, J; Barbat, S; Tiernan, S; Gevaert, O; Zeineh, MM; Grant, GA; Camarillo, DB				Zhan, Xianghao; Li, Yiheng; Liu, Yuzhe; Domel, August G.; Alizadeh, Hossein Vahid; Raymond, Samuel J.; Ruan, Jesse; Barbat, Saeed; Tiernan, Stephen; Gevaert, Olivier; Zeineh, Michael M.; Grant, Gerald A.; Camarillo, David B.			The relationship between brain injury criteria and brain strain across different types of head impacts can be different	JOURNAL OF THE ROYAL SOCIETY INTERFACE			English	Article						traumatic brain injury; brain injury criteria; brain strain; head impact	CONCUSSION; ACCELERATION; PREDICTORS; OUTCOMES	Multiple brain injury criteria (BIC) are developed to quickly quantify brain injury risks after head impacts. These BIC originated from different head impact types (e.g. sports and car crashes) are widely used in risk evaluation. However, the accuracy of using the BIC on brain injury risk estimation across head impact types has not been evaluated. Physiologically, brain strain is often considered the key parameter of brain injury. To evaluate the BIC's risk estimation accuracy across five datasets comprising different head impact types, linear regression was used to model 95% maximum principal strain, 95% maximum principal strain at the corpus callosum and cumulative strain damage (15%) on 18 BIC. The results show significantly different relationships between BIC and brain strain across datasets, indicating the same BIC value may suggest different brain strain across head impact types. The accuracy of brain strain regression is generally decreasing if the BIC regression models are fitted on a dataset with a different type of head impact rather than on the dataset with the same type. Given this finding, this study raises concerns for applying BIC to estimate the brain injury risks for head impacts different from the head impacts on which the BIC was developed.	[Zhan, Xianghao; Liu, Yuzhe; Domel, August G.; Alizadeh, Hossein Vahid; Raymond, Samuel J.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Li, Yiheng; Gevaert, Olivier] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ruan, Jesse; Barbat, Saeed] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Tiernan, Stephen] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Zeineh, Michael M.] Ford Motor Co, 3001 Miller Rd, Dearborn, MI 48120 USA; [Grant, Gerald A.] Technol Univ Dublin, Dublin, Ireland		Liu, YZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	yuzheliu@stanford.edu	Raymond, Samuel/AAV-5908-2021	Raymond, Samuel/0000-0003-2691-652X; Zhan, Xianghao/0000-0002-7058-2603	Pac-12 Conference's Student-Athlete Health and Well-Being Initiative; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24NS098518]; Taube Stanford Children's Concussion Initiative	This research was supported by the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative, the National Institutes of Health (R24NS098518) and Taube Stanford Children's Concussion Initiative.	Alizadeh HV, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4049155; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Corwin DJ, 2020, J EMERG MED, V59, P795, DOI 10.1016/j.jemermed.2020.09.017; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Domel AG., 2020, NEW OPEN ACCESS PLAT; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holbourn AHS, 1943, LANCET, V2, P438; Iwamoto M., 2002, P 2002 INT RES COUNC; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Liu, 2020, THEORETICAL NUMERICA; Liu Y., 2021, TIME WINDOW HEAD IMP; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Newman J.A., 2000, STAPP CAR CRASH J; Newman J.A., 1986, P INT IRCOBI C ZUR S; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts E. G., 2011, PAPER; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tiernan S, 2020, P I MECH ENG H, V234, P1472, DOI 10.1177/0954411920947850; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Yanaoka T, 2017, 25 INT TECHN C ENH S; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhan, 2021, CLASSIFICATION HEAD; Zhan X., 2021, PREDICTIVE FACTORS K; Zhan XH, 2021, IEEE T BIO-MED ENG, V68, P3424, DOI 10.1109/TBME.2021.3073380; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhou Z, 2021, J NEUROTRAUM, V38, P3260, DOI 10.1089/neu.2021.0195	59	4	4	7	8	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1742-5689	1742-5662		J R SOC INTERFACE	J. R. Soc. Interface	JUN 2	2021	18	179							20210260	10.1098/rsif.2021.0260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SO1XX	WOS:000658773400001	34062102	Green Submitted, Bronze			2022-02-06	
J	Howell, DR; Hunt, DL; Aaron, SE; Meehan, WP; Tan, CO				Howell, David R.; Hunt, Danielle L.; Aaron, Stacey E.; Meehan, William P., III; Tan, Can Ozan			Influence of Aerobic Exercise Volume on Postconcussion Symptoms	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; adolescent; treatment; rehabilitation; aerobic exercise; symptoms	CONCUSSION; CHILDREN; SAFETY	Background: Aerobic exercise has emerged as a useful treatment to improve outcomes among individuals who experience a concussion. However, compliance with exercise recommendations and the effect of exercise volume on symptom recovery require further investigation. Purpose: To examine (1) if an 8-week aerobic exercise prescription, provided within 2 weeks of concussion, affects symptom severity or exercise volume; (2) whether prescription adherence, rather than randomized group assignment, reflects the actual effect of aerobic exercise in postconcussion recovery; and (3) the optimal volume of exercise associated with symptom resolution after 1 month of study. Study Design: Cohort study; Level of evidence, 2. Methods: Individuals randomized to an exercise intervention (n = 17; mean age, 17.2 +/- 2.0 years; 41% female; initially tested a mean of 11.3 +/- 2.8 days after injury) or standard of care (n = 20; mean age, 16.8 +/- 2.2 years; 50% female; initially tested a mean of 10.7 +/- 3.2 days after injury) completed an aerobic exercise test within 14 days of injury. They returned for assessments 1 month and 2 months after the initial visit. The aerobic exercise group was instructed to exercise 5 d/wk, 20 min/d (100 min/wk), at a target heart rate based on an exercise test at the initial visit. Participants reported their exercise volume each week over the 8-week study period and reported symptoms at each study visit (initial, 1 month, 2 months). Because of low compliance in both groups, there was no difference in the volume of exercise between the 2 groups. Results: There were no significant symptom severity differences between the intervention and standard-of-care groups at the initial (median Post-Concussion Symptom Inventory, 15 [interquartile range = 10, 42] vs 20 [11, 35.5]; P = .26), 1-month (4 [0, 28] vs 5.5 [0.5, 21.5]; P = .96), or 2-month (6.5 [0, 27.5] vs 0 [0, 4]; P = .11) study visits. Exercise volume was similar between groups (median, 115 [54, 225] vs 88 [28, 230] min/wk for exercise intervention vs standard of care; P = .52). Regardless of group, those who exercised <100 min/wk reported significantly higher symptom severity at the 1-month evaluation compared with those who exercised >= 100 min/wk (median, 1.5 [0, 7.5] vs 12 [4, 28]; P = .03). Exercising >= 160 min/wk successfully discriminated between those with and those without symptoms 1 month after study commencement (classification accuracy, 81%; sensitivity, 90%; specificity, 78%). Conclusion: Greater exercise volume was associated with lower symptom burden after 1 month of study, and an exercise volume >160 min/wk in the first month of the study was the threshold associated with symptom resolution after the first month of the study. Because our observation on the association between exercise volume and symptom level is a retrospective and secondary outcome, it is possible that participants who were feeling better were more likely to exercise more, rather than the exercise itself driving the reduction in symptom severity.	[Howell, David R.; Hunt, Danielle L.; Aaron, Stacey E.; Meehan, William P., III; Tan, Can Ozan] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Howell, David R.; Hunt, Danielle L.; Aaron, Stacey E.; Meehan, William P., III; Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Cambridge, MA USA; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David R.; Hunt, Danielle L.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Aaron, Stacey E.; Tan, Can Ozan] Spaulding Rehabil Hosp, Cerebrovasc Res Lab, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthoped Surg, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Tan, Can Ozan] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Tan, Can Ozan] Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA USA		Howell, DR (corresponding author), Univ Colorado, Sports Med Ctr, Childrens Hosp Colorado, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	david.howell@cuanschutz.edu	Tan, Can Ozan/E-2598-2016	Tan, Can Ozan/0000-0001-9673-9907; Howell, David/0000-0002-2955-0191	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD094560] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03 NS106444, R43 NS108823, R01 NS100952] Funding Source: Medline		Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR., 2019, MED SCI SPORT EXER, V51, P613; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Langevin P, 2020, MED SCI SPORT EXER, V52, P2491, DOI 10.1249/MSS.0000000000002402; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller FL, 2014, MED SCI SPORT EXER, V46, P69, DOI 10.1249/MSS.0b013e3182a038b9; Nielsen RO, 2020, BRIT J SPORT MED, V54, P51, DOI 10.1136/bjsports-2019-100858; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Quatman-Yates CC, 2020, J ORTHOP SPORTS PHYS, V50; Root JM, 2019, CLIN PEDIATR, V58, P731, DOI 10.1177/0009922819839230; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; WHO. World Health Organization, 2011, GLOBAL RECOMMENDATIO; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	29	4	4	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2021	49	7					1912	1920		10.1177/03635465211005761			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	SN0FI	WOS:000657972800026	33856860				2022-02-06	
J	Karlander, M; Ljungqvist, J; Zelano, J				Karlander, Markus; Ljungqvist, Johan; Zelano, Johan			Post-traumatic epilepsy in adults: a nationwide register-based study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; SEIZURES; RISK; VALIDATION	Objective Traumatic brain injury (TBI) is a leading cause of epilepsy. Our aim was to characterise the risk of epilepsy in adults after hospitalisation for TBI. Methods Register-based cohort study. All individuals aged 18-100 with a first hospitalisation for TBI in the comprehensive national patient register in Sweden between 2000 and 2010 (n=111 947) and three controls per exposed (n=325 881), matched on age and sex were included. Exposed individuals were categorised according to TBI severity. Kaplan-Meier curves were used to estimate the risk of epilepsy and Cox regression to estimate the hazard in univariate or multivariate regression. Results The 10-year risk of epilepsy was 12.9% (95% CI 11.7% to 14.1%) for focal cerebral injuries, 8.1% (95% CI 7.5% to 8.7%) for diffuse cerebral injuries, 7.3% (95% CI 6.9% to 7.7%) for extracerebral injuries, 2.8% (95% CI 2.4% to 3.2%) for skull fractures and 2.6% (95% CI 2.4% to 2.8%) for mild TBI. The risk of epilepsy after any TBI was 4.0% (95% CI 3.8% to 4.2%). The corresponding 10-year risk for controls was 0.9% (95% CI 0.9% to 0.9%). The HR increased with a more severe injury, from 3.0 (95% CI 2.8 to 3.2) for mild injury to 16.0 (95% CI 14.5 to 17.5) for focal cerebral injury. Multivariable analyses identified central nervous system (CNS) comorbidities as risk factors, but TBI remained significant also after adjustment for these. Other identified risk factors were male sex, age, mechanical ventilation and seizure during index hospitalisation. Conclusion The risk of post-traumatic epilepsy is considerable, also with adjustments for CNS comorbidities.	[Karlander, Markus; Ljungqvist, Johan; Zelano, Johan] Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Gothenburg, Sweden; [Karlander, Markus] Sodra Alvsborgs Hosp Boras, Neurol, Boras, Sweden; [Ljungqvist, Johan] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Zelano, Johan] Sahlgrens Univ Hosp, Neurol, Gothenburg, Sweden; [Zelano, Johan] Gothenburg Univ, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden		Zelano, J (corresponding author), Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Gothenburg, Sweden.	zelano@neuro.gu.se		Zelano, Johan/0000-0001-9445-4545; Karlander, Markus/0000-0003-4262-3049	Swedish state under the ALF [ALFGBG-715781, ALFGBG-784921]; Swedish Society of Medicine [SLS-881501]; Swedish Society of Medical Research [S18-0040]; Linnea and Josef Carlsson foundation [90_20180321_048]; Promobilia foundation [18012]; Goteborg Medical Society [GLS-780651]; Magnus Bergvall foundation [2017-01990]	This study was funded by grants from the Swedish state under the ALF-agreement (ALFGBG-715781 and ALFGBG-784921), Swedish Society of Medicine(SLS-881501), Swedish Society of Medical Research (S18-0040), Linnea and Josef Carlsson foundation (90_20180321_048), The Promobilia foundation (18012), Goteborg Medical Society (GLS-780651), Magnus Bergvall foundation (2017-01990).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Galovic M, 2018, LANCET NEUROL, V17, P143, DOI 10.1016/S1474-4422(17)30404-0; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Sveinsson O, 2017, NEUROLOGY, V89, P170, DOI 10.1212/WNL.0000000000004094; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	11	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2021	92	6					617	621		10.1136/jnnp-2020-325382			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	SH6JS	WOS:000654242100010	33687971	Green Published, hybrid			2022-02-06	
J	Netteland, DF; Mejlaender-Evjensvold, M; Skaga, NO; Sandset, EC; Aarhus, M; Helseth, E				Netteland, Dag Ferner; Mejlaender-Evjensvold, Magnus; Skaga, Nils O.; Sandset, Else Charlotte; Aarhus, Mads; Helseth, Eirik			Cerebral venous thrombosis in traumatic brain injury: a cause of secondary insults and added mortality	JOURNAL OF NEUROSURGERY			English	Article						cerebral venous thrombosis; traumatic brain injury; complications; mortality; outcome	SINUS OCCLUSION; CLASSIFICATION	OBJECTIVE Cerebral venous thrombosis (CVT) is increasingly recognized in traumatic brain injury (TBI), but its complications and effect on outcome remain undetermined. In this study, the authors characterize the complications and outcome effect of CVT in TBI patients. METHODS In a retrospective, case-control study of patients included in the Oslo University Hospital trauma registry and radiology registry from 2008 to 2014, the authors identified TBI patients with CVT (cases) and without CVT (con- trols). The groups were matched regarding Abbreviated Injury Scale 1990, update 1998 (AIS'98) head region severity score 3-6. Cases were identified by AIS'98 or ICD-10 code for CVT and CT or MR venography findings confirmed to be positive for CVT, whereas controls had no AIS'98 or ICD-10 code for CVT and CT venography or MR venography findings confirmed to be negative for CVT. All images were reviewed by a neuroradiologist. Rates of complications due to CVT were recorded, and mortality was assessed both unadjusted and in a multivariable logistic regression analysis adjusting for initial Glasgow Coma Scale score, Rotterdam CT score, and Injury Severity Score. Complications and mortality were also assessed in prespecified subgroup analysis according to CVT location and degree of occlusion from CVT. Lastly, mortality was assessed in an exploratory subgroup analysis according to the presence of complications from CVT. RESULTS The CVT group (73 patients) and control group (120 patients) were well matched regarding baseline characteristics. In the CVT group, 18% developed venous infarction, 11% developed intracerebral hemorrhage, and 19% developed edema, all representing complications secondary to CVT. Unadjusted 30-day mortality was 16% in the CVT group and 4% in the no-CVT group (p = 0.004); however, the difference was no longer significant in the adjusted analysis (OR 2.24, 95% CI 0.63-8.03; p = 0.215). Subgroup analysis by CVT location showed an association between CVT location and rate of complications and an unadjusted 30-day mortality of 50% for midline or bilateral CVT and 8% for unilateral CVT compared with 4% for no CVT (p < 0.001). The adjusted analysis showed a significantly higher mortality in the mid- line/bilateral CVT group than in the no-CVT group (OR 8.41, 95% CI 1.56-45.25; p = 0.032). CONCLUSIONS There is a significant rate of complications from CVT in TBI patients, leading to secondary brain insults. The rate of complications is dependent on the anatomical location of the CVT, and midline and bilateral CVT is associated with an increased 30-day mortality in TBI patients.	[Netteland, Dag Ferner; Aarhus, Mads; Helseth, Eirik] Univ Oslo, Hosp Ulleval, Dept Neurosurg, Oslo, Norway; [Mejlaender-Evjensvold, Magnus] Univ Oslo, Hosp Ulleval, Dept Radiol & Nucl Med, Oslo, Norway; [Skaga, Nils O.] Univ Oslo, Hosp Ulleval, Dept Anesthesiol, Oslo, Norway; [Sandset, Else Charlotte] Univ Oslo, Hosp Ulleval, Dept Neurol, Oslo, Norway; [Netteland, Dag Ferner; Helseth, Eirik] Univ Oslo, Fac Med, Oslo, Norway; [Sandset, Else Charlotte] Norwegian Air Ambulance Fdn, Oslo, Norway		Netteland, DF (corresponding author), Oslo Univ Hosp, Oslo, Norway.	dagnetteland@gmail.com					Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; American Association of Anesthesiologists, ASA PHYS STAT CLASS; Association for the Advancement of Automotive Medicine, 1998, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Canhao PC, 2005, STROKE, V36, P1720, DOI 10.1161/01.STR.0000173152.84438.1c; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Giladi O, 2016, THROMB RES, V137, P26, DOI 10.1016/j.thromres.2015.11.035; Li J, 2015, NEUROL INDIA, V63, P881, DOI 10.4103/0028-3886.170067; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Rivkin MA, 2014, ACTA NEUROCHIR, V156, P999, DOI 10.1007/s00701-014-2025-9; Skaga NO, 2007, J TRAUMA, V63, P972, DOI 10.1097/TA.0b013e31804a571c; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; TEASDALE G, 1974, LANCET, V2, P81; World Health Organization, 1989, INT CLASSIFICATION D	14	4	4	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2021	134	6					1912	1920		10.3171/2020.4.JNS20511			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SP1YS	WOS:000659469900001	32707558	Bronze			2022-02-06	
J	Rosa, JM; Farre-Alins, V; Ortega, MC; Navarrete, M; Lopez-Rodriguez, AB; Palomino-Antolin, A; Fernandez-Lopez, E; Vila-del Sol, V; Decouty, C; Narros-Fernandez, P; Clemente, D; Egea, J				Rosa, Juliana M.; Farre-Alins, Victor; Ortega, Maria Cristina; Navarrete, Marta; Lopez-Rodriguez, Ana Belen; Palomino-Antolin, Alejandra; Fernandez-Lopez, Elena; Vila-del Sol, Virginia; Decouty, Celine; Narros-Fernandez, Paloma; Clemente, Diego; Egea, Javier			TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						astrocytes; BBB breakdown; microglia; infiltrated monocytes; synaptic remodelling; TLR4 antagonism; traumatic brain injury	MICROGLIA; TRANSCRIPTOME; PLASTICITY; PHENOTYPE; INTEGRITY; RECOVERY; DATABASE; NEURONS; CORTEX; DAMAGE	Background and Purpose Activation of astrocytes contributes to synaptic remodelling, tissue repair and neuronal survival following traumatic brain injury (TBI). The mechanisms by which these cells interact to resident/infiltrated inflammatory cells to rewire neuronal networks and repair brain functions remain poorly understood. Here, we explored how TLR4-induced astrocyte activation modified synapses and cerebrovascular integrity following TBI. Experimental Approach To determine how functional astrocyte alterations induced by activation of TLR4 pathway in inflammatory cells regulate synapses and neurovascular integrity after TBI, we used pharmacology, genetic approaches, live calcium imaging, immunofluorescence, flow cytometry, blood-brain barrier (BBB) integrity assessment and molecular and behavioural methods. Key Results Shortly after a TBI, there is a recruitment of excitable and reactive astrocytes mediated by TLR4 pathway activation with detrimental effects on post-synaptic density-95 (PSD-95)/vesicular glutamate transporter 1 (VGLUT1) synaptic puncta, BBB integrity and neurological outcome. Pharmacological blockage of the TLR4 pathway with resatorvid (TAK-242) partially reversed many of the observed effects. Synapses and BBB recovery after resatorvid administration were not observed in IP(3)R2(-/-) mice, indicating that effects of TLR4 inhibition depend on the subsequent astrocyte activation. In addition, TBI increased the astrocytic-protein thrombospondin-1 necessary to induce a synaptic recovery in a sub-acute phase. Conclusions and Implications Our data demonstrate that TLR4-mediated signalling, most probably through microglia and/or infiltrated monocyte-astrocyte communication, plays a crucial role in the TBI pathophysiology and that its inhibition prevents synaptic loss and BBB damage accelerating tissue recovery/repair, which might represent a therapeutic potential in CNS injuries and disorders.	[Rosa, Juliana M.; Fernandez-Lopez, Elena] Hosp Nacl Paraplejicos, Serv Salud Castilla La Mancha, SESCAM, Expt Neurophysiol & Neuronal Circuits Grp, Toledo, Spain; [Farre-Alins, Victor; Lopez-Rodriguez, Ana Belen; Palomino-Antolin, Alejandra; Decouty, Celine; Narros-Fernandez, Paloma; Egea, Javier] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Inst Teofilo Hernando, Madrid, Spain; [Ortega, Maria Cristina; Clemente, Diego] Hosp Nacl Paraplejicos, Serv Salud Castilla La Mancha, SESCAM, Neuroinmune Repair Grp, Toledo, Spain; [Navarrete, Marta] CSIC, Inst Cajal, Madrid, Spain; [Vila-del Sol, Virginia] Hosp Nacl Paraplejicos, Serv Salud Castilla La Mancha, SESCAM, Flow Cytometry Serv, Toledo, Spain; [Rosa, Juliana M.; Farre-Alins, Victor; Lopez-Rodriguez, Ana Belen; Palomino-Antolin, Alejandra; Decouty, Celine; Narros-Fernandez, Paloma; Egea, Javier] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IIS IP, Hosp Santa Cristina, Res Unit, Madrid, Spain		Rosa, JM (corresponding author), Hosp Nacl Paraplejicos, Res Unit, Finca La Peraleda S-N,Planta 1, Toledo 45071, Spain.; Egea, J (corresponding author), Hosp Santa Cristina, Res Unit, C Maestro Vives 2-3, Madrid 28009, Spain.	jmartinsd@sescam.jccm.es; javier.egea@inv.uam.es	Navarrete, Marta/E-9266-2013; Rosa, Juliana M/P-6969-2017; Lopez-Rodriguez, Ana Belen/H-3631-2017	Navarrete, Marta/0000-0003-2097-4788; Rosa, Juliana M/0000-0003-0857-3746; Vila-del Sol, Virginia/0000-0002-5606-2767; Fernandez Lopez, Elena/0000-0003-4402-4728; Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966	Instituto de Salud Carlos III (ISCIII) (Programa Miguel Servet II - FEDER - European Union 'Una manera de hacer Europa') [CPII19/00005, PI16/00735, PI19/00082, PI18/00357]; Fundacion Mutua MadrilenaInstituto de Salud Carlos III; Stop Fuga de Cerebros Roche Pharma; Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [RTI2018-094887-B-I00, RYC-2016-20414, RYC2019-026870-I]; European Union's Horizon 2020 research and innovation programme under the H2020 Marie Skodowska-Curie Actions grant [794926]	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) (Programa Miguel Servet II Grants CPII19/00005; PI16/00735; PI19/00082 to JE; and PI18/00357 to DC, partially funded by FEDER - European Union 'Una manera de hacer Europa') and Fundacion Mutua Madrilena to JE; European Union's Horizon 2020 research and innovation programme under the H2020 Marie Skodowska-Curie Actions grant agreement no. 794926 and Stop Fuga de Cerebros Roche Pharma to JMR; and Ministerio de Ciencia e Innovacion RTI2018-094887-B-I00 and RYC-2016-20414 to MN and RYC2019-026870-I to JMR. DC, MCO, VVS and EFL are hired by SESCAM. We also thank Dr. Ju Chen (University of California, San Diego, CA, USA) and Dr. Gertrudis Perea (Cajal Institute, Madrid, Spain) for kindly providing IP<INF>3</INF>R2<SUP>-/-</SUP> animals and Dr. Juan Aguilar (HNP, Toledo, Spain) for technical and scientific support.	Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS1, DOI 10.1111/bph.14747; Alexander SPH, 2018, BRIT J PHARMACOL, V175, P407, DOI 10.1111/bph.14112; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bechade C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00032; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clark AK, 2015, J NEUROSCI, V35, P4552, DOI 10.1523/JNEUROSCI.2061-14.2015; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1177/0271678X20943823]; Du SH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00409; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Holm TH, 2012, GLIA, V60, P630, DOI 10.1002/glia.22296; Ippolito D.M, 2010, JOVE-J VIS EXP, V45; Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959; Jiang HS, 2018, CELL MOL NEUROBIOL, V38, P1009, DOI 10.1007/s10571-017-0570-5; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kim SK, 2016, J CLIN INVEST, V126, P1983, DOI 10.1172/JCI82859; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178; Min H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0116-z; Mizee MR, 2014, ACTA NEUROPATHOL, V128, P691, DOI 10.1007/s00401-014-1335-6; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Navarrete M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10830-9; Nikolakopoulou AM, 2016, ASN NEURO, V8, DOI 10.1177/1759091416630220; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parada E, 2019, BRIT J PHARMACOL, V176, P2764, DOI 10.1111/bph.14703; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Paxinos G, 2019, PAXINOS FRANKLINS MO; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Rosa JM, 2016, NEURON, V90, P308, DOI 10.1016/j.neuron.2016.03.015; Rosa JM, 2015, ELIFE, V4, DOI 10.7554/eLife.09590; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Takatsuru Y, 2013, J NEUROSCI, V33, P4683, DOI 10.1523/JNEUROSCI.2657-12.2013; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	62	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	SEP	2021	178	17					3395	3413		10.1111/bph.15488		JUN 2021	19	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TW6WG	WOS:000656444700001	33830504	Green Published, hybrid, Green Submitted			2022-02-06	
J	Santamato, A; Facciorusso, S; Spina, S; Cinone, N; Avvantaggiato, C; Santoro, L; Ciritella, C; Smania, N; Picelli, A; Gasperini, G; Molteni, F; Baricich, A; Fiore, P				Santamato, Andrea; Facciorusso, Salvatore; Spina, Stefania; Cinone, Nicoletta; Avvantaggiato, Christian; Santoro, Luigi; Ciritella, Chiara; Smania, Nicola; Picelli, Alessandro; Gasperini, Giulio; Molteni, Franco; Baricich, Alessio; Fiore, Pietro			Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Muscle spasticity; COVID-19; Botulinum toxins; Surveys and questionnaires	UPPER-LIMB SPASTICITY; QUALITY-OF-LIFE; TOXIN TYPE-A; POSTSTROKE SPASTICITY; GOAL ATTAINMENT; ICF MODEL; THERAPY; PAIN; MANAGEMENT; INJECTIONS	BACKGROUND: The COVID-19 pandemic has affected health-care systems worldwide, including the outpatient spasticity care with botulinum neurotoxin toxin type A (BoNT-A). AIM: The aim of this study was to investigate the impact of discontinuation of BoNT-A treatment on patients living with spasticity during the COVID-19 quarantine. DESIGN: A multicentric cross-sectional study. SETTING: Outpatients setting. POPULATION : Patients with spasticity after stroke and traumatic brain injury treated with BoNT-A. METHODS: A phone-based survey was conducted from March to May, 2020. Based on the International Classification of Functioning, Disability and Health (ICF), an ad hoc questionnaire CORTO X (CORonavirus TO Xin survey) was developed to investigate patients' experiences following the discontinuation of their usual treatment for spasticity due to the lockdown and its implication on their health perception. It assessed patients' condition and explored different ICF domains related to spasticity: unpleasant sensations, mobility, self-care, facilitators and psychosocial factors. The sum of those represented the CORTO X score (Max 142). The questionnaire also collected data about the impact of COVID-19 on patients' wellbeing (mood, sleep, relationships, community life, motivation). RESULTS : A total of 151 participants completed the survey. Most participants (72.2%) experienced a worsening in perceived spasticity, 53% got worse in independence and 70.9% had a negative impact on quality of life. The mean CORTOX score was 52.85 +/- 27.25, reflecting a perceived worsening in all ICF domains investigated. Moderate to strong correlations were found between different sub-scores of the questionnaire and severity of spasticity (P<0.001). COVID-19 psychosocial related factors were associated with loss of independence (P<0.05) but only mood was associated with worsening of spasticity (P<0.001). The lack of rehabilitation therapy was significantly associated with the worsening of independence but not with the worsening of spasticity. Finally, respondents reported that BoNT-A was useful to their condition and should not be discontinued. CONCLUSIONS: The discontinuation of BoNT-A treatment was associated with worsening of activities and participation and perceived spasticity. COVID-19 related problems and rehabilitation showed an association with loss of independence. CLINICAL REHABILITATION IMPACT: This study will provide useful information in the field of spasticity management using a patient's centred approach, with consistent quantitative and qualitative information.	[Santamato, Andrea; Facciorusso, Salvatore; Spina, Stefania; Cinone, Nicoletta; Avvantaggiato, Christian; Santoro, Luigi; Ciritella, Chiara] Univ Foggia, Spast & Movement Disorders ReSTaRt Unit, Policlin Riuniti, Phys Med & Rehabil Sect, Foggia, Italy; [Santamato, Andrea] Fdn Turati, Rehabil Ctr, Foggia, Italy; [Smania, Nicola; Picelli, Alessandro] Univ Verona, Neuromotor & Cognit Rehabil Res Ctr, Dept Neurosci, Biomed & Movement Sci, Verona, Italy; [Gasperini, Giulio; Molteni, Franco] Valduce Hosp, Villa Beretta Rehabil Ctr, Costa Masnaga, Lecco, Italy; [Baricich, Alessio] Univ Piemonte Orientale, Maggiore Carita Univ Hosp, Dept Hlth Sci, Phys Med & Rehabil Unit, Novara, Italy; [Fiore, Pietro] IRCCS, Neurorehabil Unit, Inst Bari, Ist Clin Sci Maugeri, Bari, Italy		Santamato, A (corresponding author), Univ Foggia, Spast & Movement Disorders ReSTaRt Unit, Policlin Riuniti, Phys Med & Rehabil Sect, Foggia, Italy.	andrea.santamato@unifg.it	santamato, andrea/AAB-9751-2022	BARICICH, Alessio/0000-0001-8440-6283; Facciorusso, Salvatore/0000-0001-6748-9152; Spina, Stefania/0000-0002-7220-4016			Albany K, 1997, MUSCLE NERVE, pS221; Andrews JA, 2020, MUSCLE NERVE, V62, P182, DOI 10.1002/mus.26989; Aprile I, 2015, EUR J PHYS REHAB MED, V51, P725; Arroyo R, 2013, INT J NEUROSCI, V123, P850, DOI 10.3109/00207454.2013.812084; Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Ashford S, 2016, CLIN REHABIL, V30, P617, DOI 10.1177/0269215515593391; Baricich A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00719; Baricich A, 2016, FUNCT NEUROL, V31, P179; Barnes M, 2017, DISABIL REHABIL, V39, P1428, DOI 10.1080/09638288.2016.1198432; Bensmail Djamel, 2014, J Med Econ, V17, P618, DOI 10.3111/13696998.2014.925462; Bergfeldt U, 2006, J REHABIL MED, V38, P166, DOI 10.1080/16501970500415348; Bergfeldt U, 2009, J REHABIL MED, V41, P279, DOI 10.2340/16501977-0318; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Choi K, 2017, PHYSIOTHER CAN, V69, P113, DOI 10.3138/ptc.2016-25; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dijkers M, 2010, J SPINAL CORD MED, V33, P232, DOI 10.1080/10790268.2010.11689700; Eftekhar P, 2016, OCCUP THER INT, V23, P379, DOI 10.1002/oti.1440; Franceschini M, 2014, EUR J PHYS REHAB MED, V50, P525; Ghai Anju, 2013, Saudi J Anaesth, V7, P453, DOI 10.4103/1658-354X.121087; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Intiso D, 2020, TOXINS, V12, DOI 10.3390/toxins12050315; Mills PB, 2016, CLIN REHABIL, V30, P537, DOI 10.1177/0269215515593783; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Phadke CP, 2013, AM J PHYS MED REHAB, V92, P357, DOI 10.1097/PHM.0b013e31827d68a4; Pradon D, 2011, CLIN BIOMECH, V26, P867, DOI 10.1016/j.clinbiomech.2011.04.003; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Reebye R, 2020, CAN J NEUROL SCI, V47, P589, DOI 10.1017/cjn.2020.104; Royal College of Physicians, 2018, SPAST AD MAN US BOT; Santos J. R. A., 1999, J EXT, V37, P1, DOI DOI 10.1080/09500690802187025; Sheean GL, 2001, CURR OPIN NEUROL, V14, P771, DOI 10.1097/00019052-200112000-00015; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Stehr-green P., 2003, FOCUS FIELD EPIDEMIO, V2, P1; Steiner WA, 2002, PHYS THER, V82, P1098, DOI 10.1093/ptj/82.11.1098; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011157; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wassertheil S., 1970, STAT POWER ANAL BEHA; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; World Health Organization, 2003, ICF CHECKL VERS 2 1A	38	4	4	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2021	57	3					424	433		10.23736/S1973-9087.20.06478-3			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	TM7AB	WOS:000675699800013	33263248				2022-02-06	
J	Vaz, AR; Vizinha, D; Morais, H; Colaco, AR; Loch-Neckel, G; Barbosa, M; Brites, D				Vaz, Ana Rita; Vizinha, Daniela; Morais, Hermes; Colaco, Ana Rita; Loch-Neckel, Gecioni; Barbosa, Marta; Brites, Dora			Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						amyotrophic lateral sclerosis; inflamma-miRNAs; miR-124 modulation; motor neuron regeneration; motor neuron secretome; mSOD1 mice model; neuro-immune deregulation; paracrine signaling regulation; spinal microglia; spinal organotypic cultures	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD; ASTROCYTE DIFFERENTIATION; MITOCHONDRIAL FUSION; NEURITE OUTGROWTH; AXONAL-TRANSPORT; MURINE MICROGLIA; MICRORNAS; EXPRESSION	miRNA(miR)-124 is an important regulator of neurogenesis, but its upregulation in SOD1G93A motor neurons (mSOD1 MNs) was shown to associate with neurodegeneration and microglia activation. We used pre-miR-124 in wild-type (WT) MNs and anti-miR-124 in mSOD1 MNs to characterize the miR-124 pathological role. miR-124 overexpression in WT MNs produced a miRNA profile like that of mSOD1 MNs (high miR-125b; low miR-146a and miR-21), and similarly led to early apoptosis. Alterations in mSOD1 MNs were abrogated with anti-miR-124 and changes in their miRNAs mostly recapitulated by their secretome. Normalization of miR-124 levels in mSOD1 MNs prevented the dysregulation of neurite network, mitochondria dynamics, axonal transport, and synaptic signaling. Same alterations were observed in WT MNs after pre-miR-124 transfection. Secretome from mSOD1 MNs triggered spinal microglia activation, which was unno-ticed with that from anti-miR-124-modulated cells. Secretome from such modulated MNs, when added to SC organotypic cultures from mSOD1 mice in the early symptomatic stage, also coun-teracted the pathology associated to GFAP decrease, PSD-95 and CX3CL1-CX3CR1 signaling im-pairment, neuro-immune homeostatic imbalance, and enhanced miR-124 expression levels. Data suggest that miR-124 is implicated in MN degeneration and paracrine-mediated pathogenicity. We propose miR-124 as a new therapeutic target and a promising ALS biomarker in patient sub-populations.	[Vaz, Ana Rita; Vizinha, Daniela; Morais, Hermes; Colaco, Ana Rita; Loch-Neckel, Gecioni; Barbosa, Marta; Brites, Dora] Univ Lisbon, Res Inst Med iMed ULisboa, Neuroinflammat Signaling & Neuroregenerat Grp, P-1649003 Lisbon, Portugal; [Vaz, Ana Rita; Brites, Dora] Univ Lisbon, Dept Pharmaceut Sci & Med, Fac Pharm, P-1649003 Lisbon, Portugal		Vaz, AR; Brites, D (corresponding author), Univ Lisbon, Res Inst Med iMed ULisboa, Neuroinflammat Signaling & Neuroregenerat Grp, P-1649003 Lisbon, Portugal.; Vaz, AR; Brites, D (corresponding author), Univ Lisbon, Dept Pharmaceut Sci & Med, Fac Pharm, P-1649003 Lisbon, Portugal.	armvaz@ff.ulisboa.pt; daniela.vizinha@gmail.com; h.morais@campus.fct.unl.pt; anarac97@gmail.com; gneckel@hotmail.com; mbarbosa@ff.ulisboa.pt; dbrites@ff.ulisboa.pt	Brites, Dora/AAW-2001-2021; Brites, Dora/M-8293-2013; Vaz, Ana Rita/M-5149-2013	Brites, Dora/0000-0002-3024-9777; Brites, Dora/0000-0002-3024-9777; Barbosa, Marta/0000-0003-1735-3251; Vaz, Ana Rita/0000-0002-3418-3269	Fundacao para a Ciencia e a Tecnologia (FCT)Portuguese Foundation for Science and TechnologyEuropean Commission [PTDC/MED-NEU/31395/2017, UIDB/04138/2020, UIDP/04138/2020]; Programa Operacional Regional de Lisboa; Programa Operacional Competitividade e Internacionalizacao [LISBOA-01-0145-FEDER-031395]; Research Program in ALS from Santa Casa da Misericordia de Lisboa (SCML), Portugal [ELA-2015-002]; FCTPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BD/129586/2017]	This research was funded by Fundacao para a Ciencia e a Tecnologia (FCT), grant number PTDC/MED-NEU/31395/2017 (to D.B.) and UIDB/04138/2020 and UIDP/04138/2020 (to iMed.ULisboa), by Programa Operacional Regional de Lisboa and the Programa Operacional Competitividade e Internacionalizacao (LISBOA-01-0145-FEDER-031395, to D.B.) and by the Research Program in ALS from Santa Casa da Misericordia de Lisboa (SCML), Portugal (ELA-2015-002, to D.B.). Individual fellowship to M.B. (SFRH/BD/129586/2017) was also from FCT.	Alrafiah AR, 2018, IN VIVO, V32, P983, DOI 10.21873/invivo.11339; An FM, 2017, ONCOTARGET, V8, P114065, DOI 10.18632/oncotarget.23119; Barbosa M, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.634355; Bell E, 2017, COMPUT STRUCT BIOTEC, V15, P8, DOI 10.1016/j.csbj.2016.10.005; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Berthod F., 2012, AMYOTROPHIC LATERAL; Brites D, 2020, GLIA, V68, P1631, DOI 10.1002/glia.23846; Brites D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00117; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1056/NEJMc1710379]; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Caldeira C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00152; Campos-Melo D, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-26; Cavaliere F, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3540568; Cho GW, 2011, NEUROSCI LETT, V504, P107, DOI 10.1016/j.neulet.2011.09.008; Cunha C, 2018, MOL NEUROBIOL, V55, P4207, DOI 10.1007/s12035-017-0631-2; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; De Vos KJ, 2017, NEUROBIOL DIS, V105, P283, DOI 10.1016/j.nbd.2017.02.004; Delic V, 2018, J NEUROSCI RES, V96, P1353, DOI 10.1002/jnr.24249; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fernandes A, 2018, BIOCHIMIE, V155, P67, DOI 10.1016/j.biochi.2018.05.015; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Figueroa-Romero C, 2016, MOL CELL NEUROSCI, V71, P34, DOI 10.1016/j.mcn.2015.12.008; Foggin S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00578; Franklin TC, 2018, BIOL PSYCHIAT, V83, P50, DOI 10.1016/j.biopsych.2017.06.034; Gatto RG, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0122-z; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Genc B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41765; Ghafouri-Fard S, 2021, BIOMED PHARMACOTHER, V135, DOI 10.1016/j.biopha.2020.111198; Gomes C, 2020, EXP CELL RES, V395, DOI 10.1016/j.yexcr.2020.112209; Gomes C, 2019, MOL NEUROBIOL, V56, P2137, DOI 10.1007/s12035-018-1220-8; Gonzalez-Prieto M, 2021, GLIA, V69, P73, DOI 10.1002/glia.23885; Gugliandolo A, 2018, INFLAMMATION, V41, P93, DOI 10.1007/s10753-017-0667-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Guzman-Lenis MS, 2009, RESTOR NEUROL NEUROS, V27, P335, DOI 10.3233/RNN-2009-0482; Han D, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01555; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hawley ZCE, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00127; Hayden PJ, 2021, IN VITRO CELL DEV-AN, V57, P95, DOI 10.1007/s11626-020-00500-2; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Hou QM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10045; Joshi AU, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708166; Khalid SI, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00486; Kim KY, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00203-4; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liu K, 2017, J THORAC CARDIOV SUR, V154, P1498, DOI 10.1016/j.jtcvs.2017.05.046; Liu WT, 2013, CURR NEUROVASC RES, V10, P222, DOI 10.2174/15672026113109990060; Liu YJ, 2020, MECH AGEING DEV, V186, DOI 10.1016/j.mad.2020.111212; Lossi L, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00164; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; Marcuzzo S, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0095-0; Meyer K, 2017, BRAIN RES, V1656, P27, DOI 10.1016/j.brainres.2015.12.051; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Munoz-Lasso DC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020358; Nagata K, 2014, NEUROSCIENCE, V256, P426, DOI 10.1016/j.neuroscience.2013.10.055; Neo WH, 2014, J BIOL CHEM, V289, P20788, DOI 10.1074/jbc.M113.525493; Onesto E, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0316-5; Osking Z, 2019, ISCIENCE, V19, P448, DOI 10.1016/j.isci.2019.08.004; Parisi C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.491; Pinto S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00273; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Popko J, 2009, CYTOM PART A, V75A, P371, DOI 10.1002/cyto.a.20660; Qin Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00406; Quiroz JFD, 2014, DIS MODEL MECH, V7, P601, DOI 10.1242/dmm.014837; Ruangjaroon T, 2017, BIOCHEM BIOPH RES CO, V486, P652, DOI 10.1016/j.bbrc.2017.03.081; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Slota JA, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5020035; Sofroniew MV, 2020, TRENDS IMMUNOL, V41, P758, DOI 10.1016/j.it.2020.07.004; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sun Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00193; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Van Damme P, 2017, DIS MODEL MECH, V10, P537, DOI 10.1242/dmm.029058; Vaz AR, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01012; Vaz AR, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00109; Vaz AR, 2015, MOL NEUROBIOL, V51, P864, DOI 10.1007/s12035-014-8731-8; Veremeyko T, 2019, J NEUROSCI RES, V97, P162, DOI 10.1002/jnr.24344; Vuokila N, 2018, CELL MOL LIFE SCI, V75, P4557, DOI 10.1007/s00018-018-2911-z; Waller R, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00731; Wang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26697; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xue Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep26781; Yardeni T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17878-x; Yelick J, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113414; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zayia L.C., 2021, STATPEARLS INTERNET; Zhang JJ, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0138-4; Zhao Q, 2018, ONCOTARGET, V9, P1826, DOI 10.18632/oncotarget.22812; Zhou FH, 2018, J NEUROCHEM, V145, P51, DOI 10.1111/jnc.14229; Zullo J, 2015, PROSTAG OTH LIPID M, V120, P17, DOI 10.1016/j.prostaglandins.2015.03.012	96	4	4	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	11							6128	10.3390/ijms22116128			25	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SQ2TT	WOS:000660210700001	34200161	gold, Green Published			2022-02-06	
J	Zhang, J; Wang, RJ; Chen, M; Liu, XY; Ma, K; Xu, HY; Deng, WS; Ye, YC; Li, WX; Chen, XY; Sun, HT				Zhang, Jian; Wang, Ren-Jie; Chen, Miao; Liu, Xiao-Yin; Ma, Ke; Xu, Hui-You; Deng, Wu-Sheng; Ye, Yi-Chao; Li, Wei-Xin; Chen, Xu-Yi; Sun, Hong-Tao			Collagen/heparan sulfate porous scaffolds loaded with neural stem cells improve neurological function in a rat model of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						collagen; heparan sulfate; injury; neural stem cells; regeneration; repair; scaffold; traumatic brain injury; morris water maze; motor evoked potential; synapses; myelin sheaths	SPINAL-CORD; TRANSPLANTATION; RECOVERY; CANCER; BIOCOMPATIBILITY; DIFFERENTIATION; PROLIFERATION; NEURONS; REPAIR	One reason for the poor therapeutic effects of stem cell transplantation in traumatic brain injury is that exogenous neural stem cells cannot effectively migrate to the local injury site, resulting in poor adhesion and proliferation of neural stem cells at the injured area. To enhance the targeted delivery of exogenous stem cells to the injury site, cell therapy combined with neural tissue engineering technology is expected to become a new strategy for treating traumatic brain injury. Collagen/heparan sulfate porous scaffolds, prepared using a freeze-drying method, have stable physical and chemical properties. These scaffolds also have good cell biocompatibility because of their high porosity, which is suitable for the proliferation and migration of neural stem cells. In the present study, collagen/heparan sulfate porous scaffolds loaded with neural stem cells were used to treat a rat model of traumatic brain injury, which was established using the controlled cortical impact method. At 2 months after the implantation of collagen/heparan sulfate porous scaffolds loaded with neural stem cells, there was significantly improved regeneration of neurons, nerve fibers, synapses, and myelin sheaths in the injured brain tissue. Furthermore, brain edema and cell apoptosis were significantly reduced, and rat motor and cognitive functions were markedly recovered. These findings suggest that the novel collagen/heparan sulfate porous scaffold loaded with neural stem cells can improve neurological function in a rat model of traumatic brain injury.	[Zhang, Jian; Wang, Ren-Jie; Ma, Ke; Xu, Hui-You; Deng, Wu-Sheng; Ye, Yi-Chao; Chen, Xu-Yi; Sun, Hong-Tao] Chinese Peoples Armed Police Force, Characterist Med Ctr, Inst Traumat Brain Injury & Neurosci, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Zhang, Jian; Ma, Ke; Xu, Hui-You; Ye, Yi-Chao; Li, Wei-Xin] Logist Univ Peoples Armed Police Force, Grad Sch, Tianjin, Peoples R China; [Chen, Miao] Xinjiang Med Univ, Affiliated Hosp Tradit Chinese Med, Grad Sch, Urumqi, Xinjiang Uygur, Peoples R China; [Liu, Xiao-Yin] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China		Chen, XY; Sun, HT (corresponding author), Chinese Peoples Armed Police Force, Characterist Med Ctr, Inst Traumat Brain Injury & Neurosci, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China.	chenxuyi1979@126.com; zhangjian19237@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11672332, 11932013]; National Key Research and Development Plan of China [2016YFC1101500]; Key Science and Technology Support Foundation of Tianjin of China [17YFZCSY00620]	This work was supported by the National Natural Science Foundation of China, Nos. 11672332, 11932013 (both to XYC); the National Key Research and Development Plan of China, No. 2016YFC1101500 (to HTS); the Key Science and Technology Support Foundation of Tianjin of China, No. 17YFZCSY00620 (to HTS). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862; Echave MC, 2019, EXPERT OPIN BIOL TH, V19, P773, DOI 10.1080/14712598.2019.1610383; Chen C, 2017, J BIOMED MATER RES A, V105, P1324, DOI 10.1002/jbm.a.36011; Chen F, 2018, J COLLOID INTERF SCI, V521, P261, DOI 10.1016/j.jcis.2018.02.053; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chen YL, 2013, THROMB HAEMOSTASIS, V109, P1148, DOI 10.1160/TH12-12-0935; Cheng SX, 2018, NEUROTHERAPEUTICS, V15, P216, DOI 10.1007/s13311-017-0591-2; Clervius H, 2019, NEURAL REGEN RES, V14, P1699, DOI 10.4103/1673-5374.255620; Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893; Deryckere A, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.184861; Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; Hayashi N, 2004, NEUROSCI RES, V49, P19, DOI 10.1016/j.neures.2004.01.007; Hu K, 2019, ZHONGGUO ZUZHI GONGC, V23, P317; Jiang JP, 2020, NEURAL REGEN RES, V15, P959, DOI 10.4103/1673-5374.268974; Jiang JP, 2018, J NEUROSCI METH, V307, P95, DOI 10.1016/j.jneumeth.2018.06.025; Jin Y, 2016, NEUROSCIENCE, V320, P69, DOI 10.1016/j.neuroscience.2016.01.066; Karlsson J, 2000, NEUROREPORT, V11, P1665, DOI 10.1097/00001756-200006050-00014; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Khatoun A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00773; Kim HJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1372946; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Leong NL, 2015, J ORTHOP RES, V33, P229, DOI 10.1002/jor.22757; Leung GKK, 2012, METHOD ENZYMOL, V508, P177, DOI 10.1016/B978-0-12-391860-4.00009-4; Li FY, 2019, J CELL BIOCHEM, V120, P14899, DOI 10.1002/jcb.28751; Li F, 2007, KNEE SURG SPORT TR A, V15, P1219, DOI 10.1007/s00167-007-0385-x; Li ML, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5086297; Li SN, 2020, J ETHNOPHARMACOL, V261, DOI 10.1016/j.jep.2020.113061; Liu XL, 2013, MAT SCI ENG C-MATER, V33, P4144, DOI 10.1016/j.msec.2013.06.004; Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031; Luo ML, 2019, NEUROCHEM RES, V44, P2765, DOI 10.1007/s11064-019-02897-z; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Murakami K, 2015, NEUROSCIENCE, V300, P338, DOI 10.1016/j.neuroscience.2015.05.033; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Nurcombe V, 2007, CRIT REV EUKAR GENE, V17, P159, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.50; Ogle BM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad2304; Pang AL, 2017, CELL TRANSPLANT, V26, P1262, DOI 10.1177/0963689717715168; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2; Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013; Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043; Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Wang N, 2018, J TISSUE ENG REGEN M, V12, pE1154, DOI 10.1002/term.2450; Wen ZY, 2017, BRAIN RES, V1665, P88, DOI 10.1016/j.brainres.2017.04.001; Xing YJ, 2019, MOL MED REP, V20, P2403, DOI 10.3892/mmr.2019.10434; Yan F, 2019, NEURAL REGEN RES, V14, P1780, DOI 10.4103/1673-5374.257533; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015; Zeng SG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0138492, 10.1371/journal.pone.0128658]; Zhang QZ, 2019, ACTA BIOMATER, V88, P57, DOI 10.1016/j.actbio.2019.01.056; Zhang SX, 2020, ACS APPL MATER INTER, V12, P22066, DOI 10.1021/acsami.9b22258; Zhao SC, 2015, CARBOHYD RES, V401, P32, DOI 10.1016/j.carres.2014.10.019	61	4	4	16	47	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2021	16	6					1068	1077		10.4103/1673-5374.300458			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	PE8PL	WOS:000598623300010	33269752	gold, Green Published			2022-02-06	
J	Seven, ES; Seven, YB; Zhou, YQ; Poudel-Sharma, S; Diaz-Rucco, JJ; Cilingir, EK; Mitchell, GS; Van Dyken, JD; Leblanc, RM				Seven, Elif S.; Seven, Yasin B.; Zhou, Yiqun; Poudel-Sharma, Sijan; Diaz-Rucco, Juan J.; Kirbas Cilingir, Emel; Mitchell, Gordon S.; Van Dyken, J. David; Leblanc, Roger M.			Crossing the blood-brain barrier with carbon dots: uptake mechanism and in vivo cargo delivery	NANOSCALE ADVANCES			English	Article							FLUORESCENCE QUANTUM YIELDS; GLUCOSE TRANSPORTERS; SODIUM FLUORESCEIN; ZEBRAFISH; NANOMATERIALS; PERMEABILITY; EXPRESSION; CANCER; INJURY; MODEL	The blood-brain barrier (BBB) is a major obstacle for drug delivery to the central nervous system (CNS) such that most therapeutics lack efficacy against brain tumors or neurological disorders due to their inability to cross the BBB. Therefore, developing new drug delivery platforms to facilitate drug transport to the CNS and understanding their mechanism of transport are crucial for the efficacy of therapeutics. Here, we report (i) carbon dots prepared from glucose and conjugated to fluorescein (GluCD-F) cross the BBB in zebrafish and rats without the need of an additional targeting ligand and (ii) uptake mechanism of GluCDs is glucose transporter-dependent in budding yeast. Glucose transporter-negative strain of yeast showed undetectable GluCD accumulation unlike the glucose transporter-positive yeast, suggesting glucose-transporter-dependent GluCD uptake. We tested GluCDs' ability to cross the BBB using both zebrafish and rat models. Following the injection to the heart, wild-type zebrafish showed GluCD-F accumulation in the central canal consistent with the transport of GluCD-F across the BBB. In rats, following intravenous administration, GluCD-F was observed in the CNS. GluCD-F was localized in the gray matter (e.g. ventral horn, dorsal horn, and middle grey) of the cervical spinal cord consistent with neuronal accumulation. Therefore, neuron targeting GluCDs hold tremendous potential as a drug delivery platform in neurodegenerative disease, traumatic injury, and malignancies of the CNS.	[Seven, Elif S.; Zhou, Yiqun; Diaz-Rucco, Juan J.; Kirbas Cilingir, Emel; Leblanc, Roger M.] Univ Miami, Dept Chem, 1301 Mem Dr, Coral Gables, FL 33146 USA; [Seven, Yasin B.; Mitchell, Gordon S.] Univ Florida, Dept Phys Therapy, 101 Newell Dr, Gainesville, FL 32603 USA; [Seven, Yasin B.; Mitchell, Gordon S.] Univ Florida, McKnight Brain Inst, 1149 Newell Dr, Gainesville, FL 32610 USA; [Poudel-Sharma, Sijan; Van Dyken, J. David] Univ Miami, Dept Biol, 1301 Mem Dr, Coral Gables, FL 33146 USA		Leblanc, RM (corresponding author), Univ Miami, Dept Chem, 1301 Mem Dr, Coral Gables, FL 33146 USA.	rml@miami.edu		Kirbas Cilingir, Emel/0000-0001-8079-8080; Seven, Elif/0000-0002-4702-438X	National Science FoundationNational Science Foundation (NSF) [011298, 2041413]; University of Miami; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL147554, OT2OD023854]; University of Florida McKnight Institute (BSCIRTF)	RML gratefully acknowledges the support from the National Science Foundation (Grant #011298 and 2041413) and the University of Miami. GSM and YBS were supported by National Institute of Health (HL147554 and OT2OD023854) and the University of Florida McKnight Institute (BSCIRTF). We would like to thank Eckhard Boles for generously providing yeast EBY.VW 5000 strain.	Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Anraku Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00952-3; BABA M, 1988, N-S ARCH PHARMACOL, V337, P423; Baldrighi M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00250; Bhatta H, 2008, FEMS YEAST RES, V8, P81, DOI 10.1111/j.1567-1364.2007.00340.x; Bhattacharya K, 2016, NANOMED-NANOTECHNOL, V12, P333, DOI 10.1016/j.nano.2015.11.011; Cena V, 2018, NANOMEDICINE-UK, V13, P1513, DOI 10.2217/nnm-2018-0139; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Fery-Forgues S, 1999, J CHEM EDUC, V76, P1260, DOI 10.1021/ed076p1260; Halawa MI, 2020, J MATER CHEM B, V8, P3542, DOI 10.1039/c9tb02158b; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hettiarachchi SD, 2019, NANOSCALE, V11, P6192, DOI 10.1039/c8nr08970a; Kang ZH, 2019, NANOSCALE, V11, P19214, DOI 10.1039/c9nr05647e; Kozler P, 2003, PHYSIOL RES, V52, P607; Phan LMT, 2019, BIOMATER SCI-UK, V7, P5187, DOI 10.1039/c9bm01228a; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Li SH, 2016, COLLOID SURFACE B, V145, P251, DOI 10.1016/j.colsurfb.2016.05.007; Liu JJ, 2020, ACS CENTRAL SCI, V6, P2179, DOI 10.1021/acscentsci.0c01306; Liu ZJ, 2006, BIOCHEM BIOPH RES CO, V351, P424, DOI 10.1016/j.bbrc.2006.10.054; Liyanage PY, 2020, NANOSCALE, V12, P7927, DOI 10.1039/d0nr01647k; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Maslanka R, 2018, J MICROBIOL METH, V146, P55, DOI 10.1016/j.mimet.2018.01.017; Masserini Massimo, 2013, ISRN Biochem, V2013, P238428, DOI 10.1155/2013/238428; Mintz KJ, 2019, NANOSCALE, V11, P4634, DOI 10.1039/c8nr10059d; Mintz KJ, 2019, COLLOID SURFACE B, V176, P488, DOI 10.1016/j.colsurfb.2019.01.031; MOORE DW, 1961, J PHYS CHEM-US, V65, P224, DOI 10.1021/j100820a008; Moretti C, 2020, NAT PHOTONICS, V14, P361, DOI 10.1038/s41566-020-0612-2; Pardridge William M, 2005, NeuroRx, V2, P3; Peng ZL, 2017, NANOSCALE, V9, P17533, DOI 10.1039/c7nr05731h; Qin Y, 2010, J DRUG TARGET, V18, P536, DOI 10.3109/10611861003587235; Roy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121985; Seven ES, 2019, LANGMUIR, V35, P6708, DOI 10.1021/acs.langmuir.9b00920; Seven YB, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113067; Seven YB, 2018, J PHYSIOL-LONDON, V596, P1501, DOI 10.1113/JP275462; Seven YB, 2018, EXP NEUROL, V299, P148, DOI 10.1016/j.expneurol.2017.10.015; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Wang LQ, 2010, ANAL BIOANAL CHEM, V398, P1257, DOI 10.1007/s00216-010-4057-1; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xiao L, 2018, NANOSCALE HORIZ, V3, P565, DOI 10.1039/c8nh00106e; Xie FL, 2012, INT J NANOMED, V7, P163, DOI 10.2147/IJN.S23771; Ye D, 2021, NANOSCALE ADV, V3, P2488, DOI 10.1039/d0na00879f; Zhang MY, 2019, NANOSCALE ADV, V1, P3424, DOI [10.1039/c9na00334g, 10.1039/C9NA00334G]; ZHANG XL, 2009, MILITARY MED RES, V40, P829; Zhang ZT, 2020, NANOSCALE, V12, P13899, DOI 10.1039/d0nr03163a; Zheng M, 2015, ACS NANO, V9, P11455, DOI 10.1021/acsnano.5b05575; Zhou YQ, 2019, NANOSCALE, V11, P22387, DOI 10.1039/c9nr08194a; Zhou YQ, 2018, J CONTROL RELEASE, V270, P290, DOI 10.1016/j.jconrel.2017.12.015; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003	52	4	4	5	10	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2516-0230			NANOSCALE ADV	Nanoscale Adv.	JUL 7	2021	3	13					3942	3953		10.1039/d1na00145k		MAY 2021	12	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	TC0RM	WOS:000657796800001	34263140	gold, Green Published			2022-02-06	
J	Zhu, FZ; Liu, Y; Zeng, L; Wang, YL; Kong, XC; Yao, S; Chen, KF; Jing, XR; Yang, L; Guo, XD				Zhu, Fengzhao; Liu, Yuan; Zeng, Lian; Wang, Yulong; Kong, Xiangchuang; Yao, Sheng; Chen, Kaifang; Jing, Xirui; Yang, Lian; Guo, Xiaodong			Evaluating the Severity and Prognosis of Acute Traumatic Cervical Spinal Cord Injury A Novel Classification Using Diffusion Tensor Imaging and Diffusion Tensor Tractography	SPINE			English	Article						acute traumatic cervical spinal cord injury; anisotropy; classification; diffusion magnetic resonance imaging; diffusion tensor imaging; diffusion tensor tractography; magnetic resonance imaging; neck injuries; spinal injuries; white matter	RECOVERY; INSIGHTS; FEATURES; BRAIN	Study Design. Retrospective observational cohort study. Objective. We explored the relationship between diffusion tensor imaging (DTI) parameters and prognosis in patients with acute traumatic cervical spinal cord injury (ATCSCI). Summary of Background Data. DTI has been used to diagnose spinal cord injury; nevertheless, its role remains controversial. Methods. We analyzed retrospectively 24 patients with ATCSCI who were examined using conventional T2-weighted imaging and DTI. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were recorded at the injured site. Diffusion tensor tractography (DTT) was used to measure the spinal cord white matter fiber volume (MWFV). American Spinal Injury Association (ASIA) grades were recorded. Correlations between DTI parameters and ASIA scores were evaluated using Spearman correlation coefficients. Results. FA values at injured sites were significantly lower than those of the control group, whereas ADC values in injured and control groups were not significantly different. DTT revealed that ATCSCI could be divided into four types: Type A1-complete rupture of spinal cord white matter fiber (MWF); Type A2-partial rupture of MWF; Type B-most MWF retained with severe compression or abnormal fiber conduction direction; and Type C-MWF basically complete with slight compression. Preoperative physical examinations revealed complete injury (ASIA A) in patients with A1 (n = 4) and A2 (n = 4). The ASIA grades or scores of A2 were improved to varying degrees, whereas there was no significant improvement in A1. FA values and MWFV of ASIA B, C, and D were significantly higher than those of ASIA A. FA and MWFV were correlated with ASIA motor score preoperatively and at final follow-up. Conclusion. We propose a classification for the severity of ATCSCI based on DTI and DTT that may explain why some patients with ASIA A recover, whereas others do not.	[Zhu, Fengzhao; Zeng, Lian; Wang, Yulong; Yao, Sheng; Chen, Kaifang; Jing, Xirui; Guo, Xiaodong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Peoples R China; [Liu, Yuan; Kong, Xiangchuang; Yang, Lian] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China		Guo, XD (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, 1227 Jiefang Ave, Wuhan 430022, Peoples R China.	yanglian2003@163.com; xiaodongguo@hust.edu.cn	Kong, Xiangchuang/ABG-3857-2021	Wang, Yulong/0000-0002-0895-6010	National Key R&D Program of China [2016YFC1100100]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873999, 81672158]	National Key R&D Program of China (2016YFC1100100) and National Natural Science Foundation of China (81873999, 81672158) funds were received in support of this work.	Aarabi B, 2017, NEUROSURGERY, V80, P610, DOI 10.1093/neuros/nyw053; Alizadeh M, 2018, J NEUROTRAUM, V35, P452, DOI 10.1089/neu.2017.5174; [Anonymous], 2018, Neurosurgery, V82, P905, DOI 10.1093/neuros/nyy111; Asan Ziya., 2018, WORLD NEUROSURG, V114, P1147; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Bosma R. L., 2012, Critical Reviews in Biomedical Engineering, V40, P1, DOI 10.1615/CritRevBiomedEng.v40.i1.10; Cadotte DW, 2013, LANCET NEUROL, V12, P843, DOI 10.1016/S1474-4422(13)70157-1; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cohen Y, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3592; D'souza MM, 2017, INJURY, V48, P880, DOI 10.1016/j.injury.2017.02.016; David G, 2019, NAT REV NEUROL, V15, P718, DOI 10.1038/s41582-019-0270-5; Fehlings MG, 2017, GLOB SPINE J, V7, p231S, DOI 10.1177/2192568217701910; Freund P, 2019, LANCET NEUROL, V18, P1123, DOI 10.1016/S1474-4422(19)30138-3; Fujiyoshi K, 2013, EXP NEUROL, V242, P74, DOI 10.1016/j.expneurol.2012.07.015; Gelb DE, 2013, NEUROSURGERY, V72, P187, DOI 10.1227/NEU.0b013e318276f637; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kang Y, 2018, J NEURORESTORATOLOGY, V6, P1, DOI 10.2147/JN.S143236; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koskinen EA, 2014, SPINAL CORD, V52, P202, DOI 10.1038/sc.2013.163; Kulkarni M V, 1988, Radiographics, V8, P1059; Li XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12639; Maki S, 2017, EUR SPINE J, V26, P2459, DOI 10.1007/s00586-017-5191-7; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; Matsushita A, 2017, SPINE J, V17, P1319, DOI 10.1016/j.spinee.2017.05.009; Nouri A, 2017, NEUROSURGERY, V80, P121, DOI 10.1227/NEU.0000000000001420; Patel SP, 2016, J NEUROTRAUM, V33, P917, DOI 10.1089/neu.2015.4185; Rutman AM., 2017, CURR PROBL DIAGN RAD, V47, P824; Shanmuganathan K, 2017, J NEUROTRAUM, V34, P2964, DOI 10.1089/neu.2016.4901; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Telemacque D, 2018, J NEURORESTORATOLOGY, V6, P158, DOI 10.26599/JNR.2018.9040017; Tu TW, 2013, J NEUROSCIENCE NEURO, V2, P1; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; Vaccaro AR, 2016, EUR SPINE J, V25, P2173, DOI 10.1007/s00586-015-3831-3; Vedantam A, 2014, NEUROSURGERY, V74, P1, DOI 10.1227/NEU.0000000000000171; Zaninovich OA, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2019.1.FOCUS18591; Zhao C, 2016, NEURORADIOLOGY, V58, P607, DOI 10.1007/s00234-016-1660-7; Zhu FZ, 2019, EUR SPINE J, V28, P2275, DOI 10.1007/s00586-019-06091-1	39	4	4	4	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY 15	2021	46	10					687	694		10.1097/BRS.0000000000003923			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	SV3KP	WOS:000663721700014	33395024				2022-02-06	
J	Stenberg, J; Eikenes, L; Moen, KG; Vik, A; Hberg, AK; Skandsen, T				Stenberg, Jonas; Eikenes, Live; Moen, Kent Goran; Vik, Anne; Haberg, Asta K.; Skandsen, Toril			Acute Diffusion Tensor and Kurtosis Imaging and Outcome following Mild and Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; brain concussion; diffusion kurtosis imaging; diffusion tensor imaging; post-concussion syndrome	POST-CONCUSSION SYMPTOMS; WHITE-MATTER MICROSTRUCTURE; COGNITIVE RESERVE; ABNORMALITIES; MTBI; MRI	In this prospective cohort study, we investigated associations between acute diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI) metrics and persistent post-concussion symptoms (PPCS) 3 months after mild traumatic brain injury (mTBI). Adult patients with mTBI (n = 176) and community controls (n = 78) underwent 3 Tesla magnetic resonance imaging (MRI) within 72 h post-injury, estimation of cognitive reserve at 2 weeks, and PPCS assessment at 3 months. Eight DTI and DKI metrics were examined with Tract-Based Spatial Statistics. Analyses were performed in the total sample in uncomplicated mTBI only (i.e., without lesions on clinical MRI), and with cognitive reserve both controlled for and not. Patients with PPCS (n = 35) had lower fractional anisotropy (in 2.7% of all voxels) and kurtosis fractional anisotropy (in 6.9% of all voxels), and higher radial diffusivity (in 0.3% of all voxels), than patients without PPCS (n = 141). In uncomplicated mTBI, only fractional anisotropy was significantly lower in patients with PPCS. Compared with controls, patients with PPCS had widespread deviations in all diffusion metrics. When including cognitive reserve as a covariate, no significant differences in diffusion metrics between patients with and without PPCS were present, but patients with PPCS still had significantly higher mean, radial, and axial diffusivity than controls. In conclusion, patients who developed PPCS had poorer white matter microstructural integrity acutely after the injury, compared with patients who recovered and healthy controls. Differences became less pronounced when cognitive reserve was controlled for, suggesting that pre-existing individual differences in axonal integrity accounted for some of the observed differences.	[Stenberg, Jonas; Moen, Kent Goran; Vik, Anne; Haberg, Asta K.; Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Eikenes, Live] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Stenberg, Jonas; Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Moen, Kent Goran] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Radiol, Levanger, Norway		Skandsen, T (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Med & Hlth Sci, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no		Stenberg, Jonas/0000-0002-5769-7959	Liaison Committee [90157700, 46060918]; European Union's Horizon 2020 research and innovation programme, ERA-NET NEURON [811171]; Research Council of Norway (TAI-MRI project)Research Council of Norway [280282]	Supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (project numbers 90157700 and 46060918), the European Union's Horizon 2020 research and innovation programme, ERA-NET NEURON (grant agreement number 811171), and the Research Council of Norway (TAI-MRI project, project number 280282).	Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Husoy AK, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1028-6; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jiang J, 2017, J PSYCHIATR NEUROSCI, V42, P150, DOI 10.1503/jpn.150341; Karlsen RH, 2019, J NEUROSCI RES, V97, P568, DOI 10.1002/jnr.24383; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Muftuler LT, 2020, J NEUROTRAUM, V37, P2081, DOI 10.1089/neu.2020.6993; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Naess-Schmidt ET, 2018, BRAIN INJURY, V32, P91, DOI 10.1080/02699052.2017.1377352; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Navas-Sanchez FJ, 2014, HUM BRAIN MAPP, V35, P2619, DOI 10.1002/hbm.22355; Ohtani T, 2017, NEUROSCIENCE, V341, P52, DOI 10.1016/j.neuroscience.2016.11.002; Ohtani T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112691; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skandsen T., 2020, ARCH PHYS MED REHAB; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Stern Y, 2017, BRAIN IMAGING BEHAV, V11, P410, DOI 10.1007/s11682-016-9566-x; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Tamnes CK, 2010, HUM BRAIN MAPP, V31, P1609, DOI 10.1002/hbm.20962; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2007, WECHSLER ABBREVIATED; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wu YC, 2020, NEUROLOGY, V95, pE781, DOI 10.1212/WNL.0000000000009930; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	62	4	4	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2560	2571		10.1089/neu.2021.0074		MAY 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000648684800001	33858218	hybrid, Green Published, Green Submitted			2022-02-06	
J	Giudice, JS; Alshareef, A; Wu, TT; Knutsen, AK; Hiscox, LV; Johnson, CL; Panzer, MB				Giudice, J. Sebastian; Alshareef, Ahmed; Wu, Taotao; Knutsen, Andrew K.; Hiscox, Lucy, V; Johnson, Curtis L.; Panzer, Matthew B.			Calibration of a Heterogeneous Brain Model Using a Subject-Specific Inverse Finite Element Approach	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						traumatic brain injury; material properties; magneticresonance elastography; image registration; morphing	MAGNETIC-RESONANCE ELASTOGRAPHY; MAXIMUM PRINCIPAL STRAIN; MECHANICAL-PROPERTIES; TISSUE; SHEAR; BEHAVIOR; INJURY; HEAD; DEFORMATION; GRAY	Central to the investigation of the biomechanics of traumatic brain injury (TBI) and the assessment of injury risk from head impact are finite element (FE) models of the human brain. However, many existing FE human brain models have been developed with simplified representations of the parenchyma, which may limit their applicability as an injury prediction tool. Recent advances in neuroimaging techniques and brain biomechanics provide new and necessary experimental data that can improve the biofidelity of FE brain models. In this study, the CAB-20MSym template model was developed, calibrated, and extensively verified. To implement material heterogeneity, a magnetic resonance elastography (MRE) template image was leveraged to define the relative stiffness gradient of the brain model. A multi-stage inverse FE (iFE) approach was used to calibrate the material parameters that defined the underlying non-linear deviatoric response by minimizing the error between model-predicted brain displacements and experimental displacement data. This process involved calibrating the infinitesimal shear modulus of the material using low-severity, low-deformation impact cases and the material non-linearity using high-severity, high-deformation cases from a dataset of in situ brain displacements obtained from cadaveric specimens. To minimize the geometric discrepancy between the FE models used in the iFE calibration and the cadaveric specimens from which the experimental data were obtained, subject-specific models of these cadaveric brain specimens were developed and used in the calibration process. Finally, the calibrated material parameters were extensively verified using independent brain displacement data from 33 rotational head impacts, spanning multiple loading directions (sagittal, coronal, axial), magnitudes (20-40 rad/s), durations (30-60 ms), and severity. Overall, the heterogeneous CAB-20MSym template model demonstrated good biofidelity with a mean overall CORA score of 0.63 +/- 0.06 when compared to in situ brain displacement data. Strains predicted by the calibrated model under non-injurious rotational impacts in human volunteers (N = 6) also demonstrated similar biofidelity compared to in vivo measurements obtained from tagged magnetic resonance imaging studies. In addition to serving as an anatomically accurate model for further investigations of TBI biomechanics, the MRE-based framework for implementing material heterogeneity could serve as a foundation for incorporating subject-specific material properties in future models.	[Giudice, J. Sebastian; Wu, Taotao; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22904 USA; [Alshareef, Ahmed] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Knutsen, Andrew K.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Hiscox, Lucy, V; Johnson, Curtis L.] Univ Delaware, Dept Biomed Engn, Newark, DE USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22904 USA.	panzer@virginia.edu			Achievement Rewards for Collegiate Scientists (ARCS) Foundation; UVA Brain Institute	The authors gratefully acknowledge the Achievement Rewards for Collegiate Scientists (ARCS) Foundation and the UVA Brain Institute for supporting this research.	Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2020, BIOMED SIGNAL PROCES, V56, DOI 10.1016/j.bspc.2019.101691; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Brands D W, 2000, Stapp Car Crash J, V44, P249; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Dixit P, 2017, ARCH COMPUT METHOD E, V24, P979, DOI 10.1007/s11831-016-9196-x; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Fung Y. C., 1993, BIOMECHANICS MECH PR; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Garo A, 2007, BIORHEOLOGY, V44, P51; Gehre C., 2009, 21 INT TECHN C ENH S P 21 INT TECHN C ENH; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giudice JS, 2020, ANN BIOMED ENG, V48, P2412, DOI 10.1007/s10439-020-02584-z; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hiscox LV, 2020, HUM BRAIN MAPP, V41, P5282, DOI 10.1002/hbm.25192; Hiscox LV, 2018, NEUROBIOL AGING, V65, P158, DOI 10.1016/j.neurobiolaging.2018.01.010; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson CL, 2018, DEV COGN NEUROS-NETH, V33, P176, DOI 10.1016/j.dcn.2017.08.010; Johnson CL, 2016, HUM BRAIN MAPP, V37, P4221, DOI 10.1002/hbm.23314; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knutsen A. K., 2020, BRAIN MULTIPHYSICS, V1, DOI [10.1016/j.brain.2020.10001533870238, DOI 10.1016/J.BRAIN.2020.10001533870238]; Lippert SA, 2004, BIORHEOLOGY, V41, P681; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McGarry M, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/ab9a84; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; Murphy MC, 2019, NEUROIMAGE, V187, P176, DOI 10.1016/j.neuroimage.2017.10.008; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Reynier KA, 2020, ANN BIOMED ENG, V48, P2751, DOI 10.1007/s10439-020-02609-7; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Sack I, 2013, SOFT MATTER, V9, P5672, DOI 10.1039/c3sm50552a; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Smith DR, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046199; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Weaver JB, 2012, PHYS MED BIOL, V57, P7275, DOI 10.1088/0031-9155/57/22/7275; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Wu TT, 2021, J NEUROTRAUM, V38, P1879, DOI 10.1089/neu.2020.7445; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8	77	4	4	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	MAY 4	2021	9								664268	10.3389/fbioe.2021.664268			17	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	SD2UU	WOS:000651229200001	34017826	Green Published, gold			2022-02-06	
J	Aase, DM; Soble, JR; Shepard, P; Akagi, K; Schroth, C; Greenstein, JE; Proescher, E; Phan, KL				Aase, Darrin M.; Soble, Jason R.; Shepard, Paula; Akagi, Kouri; Schroth, Christopher; Greenstein, Justin E.; Proescher, Eric; Phan, K. Luan			Concordance of Embedded Performance and Symptom Validity Tests and Associations with Mild Traumatic Brain Injury and Posttraumatic Stress Disorder among Post-9/11 Veterans	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Head injury; Traumatic brain injury; Posttraumatic stress disorder	CROSS-VALIDATION; CLINICAL UTILITY; EXAGGERATION; PTSD; SCALE	Objective: The present study explored both embedded symptom (SVT) and performance (PVT) validity test scores within a post-9/11 veteran sample to elucidate the degree to which there is concordance between validity indicators, as well as how frequently one SVT and four PVT indicators were failed in screened mild traumatic brain injury (mTBI) and diagnosed posttraumatic stress disorder (PTSD). Method: A total of 114 post-9/11 veterans were evaluated utilizing the Neurobehavioral Symptom Inventory (NSI) Validity-10, four embedded PVTs, mTBI screening, and a diagnostic interview for PTSD. Results: While we found concordance between embedded PVTs and the NSI Validity-10 at select cutoffs (i.e., >= 13, >= 19), symptom and performance validity indicators were clinically dissociable in that only SVT significantly predicted diagnosed PTSD and screened mTBI. Conclusions: Dissociation between symptom and performance validity may be clinically useful when interpreting neuropsychological evaluation findings in post-9/11 veterans with a history of mTBI or PTSD.	[Aase, Darrin M.; Phan, K. Luan] Ohio State Univ, Dept Psychiat & Behav Hlth, Columbus, OH 43214 USA; [Soble, Jason R.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Soble, Jason R.] Univ Illinois, Dept Neurol, Chicago, IL USA; [Aase, Darrin M.; Shepard, Paula; Akagi, Kouri; Schroth, Christopher; Greenstein, Justin E.; Proescher, Eric] Jesse Brown VA Med Ctr, Mental Hlth Serv Line, Chicago, IL USA; [Schroth, Christopher] Edward Hines Jr VA Hosp, Cooperat Studies Program Coordinating Ctr, Hines, IL USA		Aase, DM (corresponding author), Ohio State Univ, Dept Psychiat & Behav Hlth, Wexner Med Ctr, 3650 Olentangy River Rd, Columbus, OH 43214 USA.	darrin.aase@osumc.edu			U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01CX000913]	This work was supported by the U.S. Department of Veterans Affairs [I01CX000913 to KLP].	Aase DM, 2018, PSYCHIAT RES, V268, P460, DOI 10.1016/j.psychres.2018.08.019; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Defense and Veterans Brain Injury Center, 2020, DOD WORLDW NUMB TBI DOD WORLDW NUMB TBI; Dismuke-Greer CE, 2018, BRAIN INJURY, V32, P1178, DOI 10.1080/02699052.2018.1482428; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Institute of Medicine of the National Academies, 2015, PSYCH TEST SERV DIS; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023	22	4	4	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2021	36	3					424	429		10.1093/arclin/acaa053			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TB2DI	WOS:000667754500013	32725113	Bronze			2022-02-06	
J	Cui, H; Yang, A; Zhou, H; Wang, Y; Luo, J; Zhou, J; Liu, T; Li, P; Zhou, J; Hu, E; He, Z; Hu, W; Tang, T				Cui, Hanjin; Yang, Ali; Zhou, Huajun; Wang, Yang; Luo, Jiekun; Zhou, Jun; Liu, Tao; Li, Pengfei; Zhou, Jing; Hu, En; He, Zehui; Hu, Wang; Tang, Tao			Thrombin-induced miRNA-24?1-5p upregulation promotes angiogenesis by targeting prolyl hydroxylase domain 1 in intracerebral hemorrhagic rats	JOURNAL OF NEUROSURGERY			English	Article						thrombin; microRNAs; angiogenesis; prolyl hydroxylase domain 1; intracerebral hemorrhage; vascular disorders	TRAUMATIC BRAIN-INJURY; ACTIVATION; EXPRESSION; TRANSCRIPTION; DEFICITS; MIR-24; PLASMA; GROWTH; MODEL	OBJECTIVE Thrombin is a unique factor that triggers post-intracerebral hemorrhage (ICH) angiogenesis by increasing hypoxia-inducible factor-1 alpha (HIF-1 alpha) at the protein level. However, HIF-1 alpha mRNA remains unchanged. MicroRNAs (miRNAs) mediate posttranscriptional regulation by suppressing protein translation from mRNAs. This study aimed to determine if miRNAs might be involved in thrombin-induced angiogenesis after ICH by targeting HIF-1 alpha or its upstream prolyl hydroxylase domains (PHDs). METHODS The study was divided into two parts. In part 1, rats received an injection of thrombin into the right globus pallidus. An miRNA array combined with miRNA target prediction, luciferase activity assay, and miRNA mimic/inhibitor transfection were used to identify candidate miRNAs and target genes. Part 2 included experiments 1 and 2. In experi- ment 1, rats were randomly divided into the sham group, ICH group, and ICH+hirudin-treated (thrombin inhibitor) group. In experiment 2, the rats were randomly divided into the sham group, ICH group, ICH+antagomir group, ICH+antagomircontrol group, and ICH+vehicle group. Western blotting and quantitative real-time polymerase chain reaction were used to determine the expression of protein and miRNA, respectively. The coexpression of miR-24-1-5p (abbreviated to miR24) and von Willebrand factor was detected by in situ hybridization and immunohistochemical analysis. The angiogenesis was evaluated by double-labeling immunofluorescence. Neurological function was evaluated by body weight, modified Neurological Severity Scores, and corner turn and foot-fault tests. RESULTS In part 1, it was shown that miR-24, which is predicted to target PHD1, was upregulated (fold-change of 1.83) after thrombin infusion, and that the miR-24 mimic transfection decreased luciferase activity and downregulated PHD1 expression (p < 0.05). miR-24 inhibitor transfection increased PHD1 expression (p < 0.05). In part 2, it was shown that miR-24 was expressed in endothelial cells. The HIF-1 alpha protein level and proliferating cell nuclear antigen-positive (PCNA+) nuclei in vessels were increased, while the PHD1 protein level was decreased after ICH, and these effects were reversed by hirudin (p < 0.05). The antagomiR-24-treated rats exhibited a markedly lower body weight and significantly poorer recovery from neurological deficit compared with those in ICH groups (p < 0.05). AntagomiR-24 intervention also led to lower miR-24 expression, a higher PHD1 protein level, and fewer PCNA+ nuclei in vessels compared with those in ICH groups (p < 0.05). CONCLUSIONS The present study suggests that thrombin reduces HIF-1 alpha degradation and initiates angiogenesis by increasing miR-24, which targets PHD1 after ICH. <comment>Superscript/Subscript Available</comment	[Cui, Hanjin; Wang, Yang; Luo, Jiekun; Liu, Tao; Li, Pengfei; Zhou, Jing; Hu, En; He, Zehui; Hu, Wang; Tang, Tao] Cent South Univ, Xiangya Hosp, Inst Integrat Med, Changsha, Hunan, Peoples R China; [Zhou, Jun] Cent South Univ, Xiangya Hosp, Inst Med Sci, Changsha, Peoples R China; [Yang, Ali] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China; [Zhou, Huajun] China Three Gorges Univ, Coll Clin Med Sci 1, Inst Neurol, Yichang, Hubei, Peoples R China		Tang, T (corresponding author), Cent South Univ, Xiangya Hosp, Inst Integrat Med, Changsha, Hunan, Peoples R China.	tangtaotay@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81904078, 81874425, 81603414, 81673719, 81973665]; Science Foundation for Young Scientists of Xiangya Hospital, Central South University [2016Q09]	This study was funded by grants from the National Natural Science Foundation of China (no. 81904078, to Hanjin Cui; no. 81874425, to Tao Tang; no. 81603414, to Ali Yang; and nos. 81673719 and 81973665, to Yang Wang) and from the Science Foundation for Young Scientists of Xiangya Hospital, Central South University (no. 2016Q09, to Hanjin Cui) .	al Taleb Z, 2016, J MOL MED, V94, P1153, DOI 10.1007/s00109-016-1439-7; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Bang C, 2012, MICROCIRCULATION, V19, P208, DOI 10.1111/j.1549-8719.2011.00153.x; Barbosa EH, 2016, J MOTOR BEHAV, V48, P5, DOI 10.1080/00222895.2015.1024824; Bernardo F, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104350; Blasiak J, 2019, J CELL MOL MED, V23, P8464, DOI 10.1111/jcmm.14731; Bogdanovski DA, 2017, J CRIT CARE, V42, P207, DOI 10.1016/j.jcrc.2017.07.029; Chen N, 2018, GENE, V678, P219, DOI 10.1016/j.gene.2018.08.012; Cheng BX, 2019, PEERJ, V7, DOI 10.7717/peerj.7716; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cui HJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0605-8; Cui HJ, 2018, CELL PHYSIOL BIOCHEM, V45, P1284, DOI 10.1159/000487464; Du YQ, 2018, MED SCI MONITOR, V24, P8870, DOI 10.12659/MSM.912051; Gao F, 2016, ACTA NEUROCHIR SUPPL, V121, P373, DOI 10.1007/978-3-319-18497-5_64; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Guo D, 2013, STROKE, V44, P1739, DOI 10.1161/STROKEAHA.111.000835; Hagg M, 2005, EXP CELL RES, V306, P180, DOI 10.1016/j.yexcr.2005.01.017; Hu E, 2019, BRAIN RES, V1708, P58, DOI 10.1016/j.brainres.2018.12.003; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lanigan SM, 2019, NEUROPHARMACOLOGY, V148, P117, DOI 10.1016/j.neuropharm.2018.12.021; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Li HT, 2018, TURK NEUROSURG, V28, P241, DOI 10.5137/1019-5149.JTN.18901-16.1; Liao XJ, 2016, BIOCHEM BIOPH RES CO, V469, P288, DOI 10.1016/j.bbrc.2015.11.102; Lin SC, 2010, ORAL ONCOL, V46, P204, DOI 10.1016/j.oraloncology.2009.12.005; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu R, 2015, ONCOTARGET, V6, P43831, DOI 10.18632/oncotarget.6257; Lynch SM, 2016, PROSTATE, V76, P637, DOI 10.1002/pros.23156; McBride DW, 2016, ACTA NEUROCHIR SUPPL, V121, P317, DOI 10.1007/978-3-319-18497-5_55; Omidkhoda N, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104516; Pan C, 2018, MOL NEUROBIOL, V55, P1556, DOI 10.1007/s12035-016-0363-8; Schreiber T, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0725-2; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Wu P, 2012, EXP THER MED, V3, P571, DOI 10.3892/etm.2012.452; Yang AL, 2012, J NEUROL SCI, V323, P141, DOI 10.1016/j.jns.2012.09.002; Yang XX, 2017, STROKE, V48, P1941, DOI 10.1161/STROKEAHA.117.017284; Yang Y, 2015, NEUROSCI LETT, V599, P133, DOI 10.1016/j.neulet.2015.05.049; Yin JY, 2014, INT J CLIN EXP PATHO, V7, P4261; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhou HJ, 2012, J NEUROSURG, V117, P920, DOI 10.3171/2012.8.JNS112152; Zhou HJ, 2017, J NEUROTRAUM, V34, P1658, DOI 10.1089/neu.2016.4711; Zhou JS, 2014, MOL MED REP, V10, P971, DOI 10.3892/mmr.2014.2245; Zhou J, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0113-2	45	4	4	7	15	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2021	134	5					1515	1526		10.3171/2020.2.JNS193069			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UC0DK	WOS:000686205900001	32413855	Bronze			2022-02-06	
J	Donders, J; Lefebre, N; Goldsworthy, R				Donders, Jacobus; Lefebre, Nathan; Goldsworthy, Rachael			Patterns of Performance and Symptom Validity Test Findings After Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity; Symptom validity; Assessment; Mild traumatic brain injury	TEST-RETEST RELIABILITY; VERBAL-LEARNING TEST; RESPONSE BIAS; CLASSIFICATION ACCURACY; MMPI-2-RF VALIDITY; TEST FAILURE; INDEXES; NEUROPSYCHOLOGY; ASSOCIATION; BELIEFS	Objective: The purpose of this study was to evaluate the presence of demographic, injury and neuropsychological correlates of distinct patterns of performance validity test and symptom validity test results in persons with mild traumatic brain injury (mTBI). Method: One hundred and seventy-eight persons with mTBI completed the Test of Memory Malingering (TOMM; performance validity) and the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF; symptom validity) within 1-12 months postinjury. Four groups were compared: (a) pass both TOMM and MMPI-2-RF validity criteria, (b) pass TOMM and fail MMPI-2-RF, (c) fail TOMM and pass MMPI-2-RF, and (d) fail both TOMM and MMPI-2-RF. Results: Compared to Group a, participants in combined Groups b-d were more than twice as likely to be engaged in financial compensation-seeking and about four times less likely to have neuroimaging evidence of an intracranial lesion. The average performance of Group d on an independent test of verbal learning was more than 1.5 standard deviations below that of Group a. Participants in Group b were more likely to have intracranial lesions on neuroimaging than participants in Group c. Conclusion: Performance and symptom validity tests provide complementary and non-redundant information in persons with mTBI. Whereas financial compensation-seeking is associated with increased risk of failure of either PVT or SVT, or both, the presence of intracranial findings on neuroimaging is associated with decreased risk of such.	[Donders, Jacobus; Goldsworthy, Rachael] Mary Free Bed Rehabil Hosp, Dept Psychol, Grand Rapids, MI 49503 USA; [Lefebre, Nathan] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	Jacobus.Donders@MaryFreeBed.com			Campbell Foundation [MFBJD2017]; Mary Free Bed Guild Fund [60]	Preparation of this manuscript was supported in parts by grants from the Campbell Foundation (MFBJD2017) and the Mary Free Bed Guild Fund (Project #60).	Aguerrevere LE, 2011, J CLIN EXP NEUROPSYC, V33, P497, DOI 10.1080/13803395.2010.535503; Alioto AG, 2017, CLIN NEUROPSYCHOL, V31, P1449, DOI 10.1080/13854046.2017.1310300; Armistead-Jehle P, 2018, ARCH CLIN NEUROPSYCH, V33, P120, DOI 10.1093/arclin/acx031; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bomyea J, 2018, APPL NEUROPSYCH-ADUL; Boone K. B, 2013, CLIN PRACTICE FORENS, P227; Brooks L, 2012, CLIN NEUROPSYCHOL, V26, P816, DOI 10.1080/13854046.2012.662999; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Copeland CT, 2016, ARCH CLIN NEUROPSYCH, V31, P18, DOI 10.1093/arclin/acv065; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Emhoff SM, 2018, DEV NEUROPSYCHOL, V43, P671, DOI 10.1080/87565641.2018.1525612; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Goldsworthy R, 2019, PSYCHOL ASSESSMENT, V31, P1145, DOI 10.1037/pas0000742; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, MEDICAL SYMPTOM VALI; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Grossi LM, 2017, PSYCHOL ASSESSMENT, V29, P531, DOI 10.1037/pas0000364; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kirk JW, 2014, ASSESSMENT, V21, P562, DOI 10.1177/1073191114520626; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Martin P. K, 2019, CLIN NEUROPSYCHOL; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McBride WF, 2013, BEHAV SCI LAW, V31, P779, DOI 10.1002/bsl.2083; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morin RT, 2017, CLIN NEUROPSYCHOL, V31, P1087, DOI 10.1080/13854046.2017.1341550; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rowland JA, 2017, ARCH CLIN NEUROPSYCH, V32, P306, DOI 10.1093/arclin/acw107; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Shura RD, 2017, PSYCHOL ASSESSMENT, V29, P1458, DOI 10.1037/pas0000436; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	45	4	4	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2021	36	3					394	402		10.1093/arclin/acz057			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TB2DI	WOS:000667754500010	31732733				2022-02-06	
J	Jeong, DU; Bae, S; Macks, C; Whitaker, J; Lynn, M; Webb, K; Lee, JS				Jeong, Da Un; Bae, Sooneon; Macks, Christian; Whitaker, Joseph; Lynn, Michael; Webb, Ken; Lee, Jeoung Soo			Hydrogel-mediated local delivery of dexamethasone reduces neuroinflammation after traumatic brain injury	BIOMEDICAL MATERIALS			English	Article						traumatic brain injury; PEG hydrogel; hyaluronic acid; dexamethasone; anti-inflammatory; motor functional recovery		Excessive and prolonged neuroinflammation leads to neuronal cell death and limits functional recovery after traumatic brain injury (TBI). Dexamethasone (DX) is a steroidal anti-inflammatory agent that is known to attenuate early expression of pro-inflammatory cytokines associated with activated microglia/macrophages. In this study, we investigated the effect of dexamethasone-conjugated hyaluronic acid (HA-DXM) incorporated in a hydrolytically degradable, photo-cross-linkable poly (ethylene) glycol-bis-(acryloyloxy acetate) (PEG-bis-AA) hydrogel on the inflammatory response, apoptosis, and functional recovery in a controlled cortical impact (CCI) rat TBI model. In vitro, DX release from PEG-bis-AA/HA-DXM hydrogel was slow in phosphate-buffered saline without enzymes, but significantly increased in the presence of hyauronidase/esterase enzymes. TBI was generated by a CCI device armed with a 3 mm tip (3.5 m s(-1), depth: 2 mm) and treated immediately with PEG-bis-AA/HA-DXM hydrogel. PEG-bis-AA/HA hydrogel without DX was used for comparison and untreated TBI group was used as a control. Significant reductions in cavity size, inflammatory response, and apoptosis were observed in animals treated with PEG-bis-AA/HA-DXM compared to those receiving PEG-bis-AA/HA and untreated. Animals receiving the PEG-bis-AA/HA-DXM hydrogel also exhibited higher neuronal cell survival and improved motor functional recovery compared to the other two groups.	[Jeong, Da Un; Macks, Christian; Whitaker, Joseph; Lee, Jeoung Soo] Clemson Univ, Dept Bioengn, Drug Design Dev & Delivery 4D Lab, Clemson, SC 29634 USA; [Bae, Sooneon; Webb, Ken] Clemson Univ, Dept Bioengn, Microenvironm Engn Lab, Clemson, SC USA; [Lynn, Michael] Prisma Hlth Syst, Dept Neurosurg, Greenville, SC USA; [Jeong, Da Un; Bae, Sooneon] Ewha Womans Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea		Lee, JS (corresponding author), Clemson Univ, Dept Bioengn, Drug Design Dev & Delivery 4D Lab, Clemson, SC 29634 USA.	jspia@clemson.edu		Lee, Jeoung Soo/0000-0001-6277-0922	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P20GM103444-07]; National Institute of Neurological Disorders and Strokes (NINDS) of the NIH [5R01 NS111037]	The authors would like to thank to Dr So Jung Gwak for her assistance with animal surgery and Dr Guzeliya Korneva in Bioengineering and Bioimaging Core, SC BioCRAFT for her technical assistance in performing HPLC. We also would like to thank Godley-Snell Research Center, especially Mr Travis Pruitt for his technical assistance with animal care. This work was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award number 5P20GM103444-07 and partly supported by the National Institute of Neurological Disorders and Strokes (NINDS) of the NIH under Grant Number 5R01 NS111037.	ARYA SK, 1984, J IMMUNOL, V133, P273; Bae S, 2015, BIOMACROMOLECULES, V16, P2757, DOI 10.1021/acs.biomac.5b00694; Bessler H, 1999, BIOL NEONATE, V75, P225, DOI 10.1159/000014099; Bratton S.L., 2007, J NEUROTRAUM, V24, pS, DOI [10.1089/neu.2007.9981, DOI 10.1089/NEU.2007.9981]; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cho E, 2009, J BIOMED MATER RES A, V90A, P1073, DOI 10.1002/jbm.a.32172; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Din BH, 2015, ACTA HAEMATOL-BASEL, V133, P124, DOI 10.1159/000362529; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012; Jensen G, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092113; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee HJ, 2015, ACTA BIOMATER, V14, P43, DOI 10.1016/j.actbio.2014.12.007; Lee IN, 2015, J NEUROSCI RES, V93, P178, DOI 10.1002/jnr.23454; LEW W, 1988, J IMMUNOL, V140, P1895; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Peng YZ, 2014, BRAIN RES, V1589, P68, DOI 10.1016/j.brainres.2014.09.073; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; WAAGE A, 1988, IMMUNOLOGY, V63, P299; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002	42	4	4	5	43	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-6041	1748-605X		BIOMED MATER	Biomed. Mater.	MAY 1	2021	16	3							035002	10.1088/1748-605X/abc7f1			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	QN2RH	WOS:000622313000001	33152711				2022-02-06	
J	Miller, GF; Daugherty, J; Waltzman, D; Sarmiento, K				Miller, Gabrielle F.; Daugherty, Jill; Waltzman, Dana; Sarmiento, Kelly			Predictors of traumatic brain injury morbidity and mortality: Examination of data from the national trauma data bank Predictors of TBI morbidity & mortality	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						TBI; Trauma; Mortality; Morbidity	LENGTH-OF-STAY; UNITED-STATES; RETROSPECTIVE ANALYSIS; ETHNIC DISPARITIES; INSURANCE STATUS; OLDER-ADULTS; LEVEL I; OUTCOMES; HEALTH; CARE	Background: There is evidence to suggest that traumatic brain injuries (TBI) are increasing in the United States. It is important to examine predictors of TBI outcomes to formulate better prevention and care strategies. Research design: National Trauma Data Bank (NTDB) data from 2016 were used to report the percentage of TBI by age, sex, race/ethnicity, health insurance status, intent/mechanism of injury, Glasgow Coma Scale (GCS), disposition at emergency department, and trauma center level. Logistic regression models were run to estimate the adjusted odds ratios of patient and facility characteristics on length of hospital stay and in-hospital mortality (analyzed in 2020). Results: There were 236,873 patients with TBI in the NTDB in 2016. Most patients with a TBI were male, non-Hispanic white, and had sustained a TBI due to an unintentional injury. After adjusting for other factors, individuals age 0-17, those who self-pay, and those with intentional injuries had increased odds of a shorter hospital stay. Older individuals, non-Hispanic black or Hispanic patients, those who had sustained an intentional injury, and those who were not seen in a Level I trauma center had higher odds of mortality following their TBI. Conclusions: Public health professionals' promotion of fall and other TBI prevention efforts and the development of strategies to improve access to Level I trauma centers, may decrease adverse TBI health outcomes. This may be especially important for older adults and other vulnerable populations. Published by Elsevier Ltd.	[Miller, Gabrielle F.; Daugherty, Jill; Waltzman, Dana; Sarmiento, Kelly] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop S106-08, Atlanta, GA 30341 USA		Miller, GF (corresponding author), CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop S106-08, Atlanta, GA 30341 USA.	ygm3@cdc.gov; xdul@cdc.gov; nmc3@cdc.gov; egz8@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Adzemovic T, 2019, J TRAUMA ACUTE CARE; Agency for Healthcare Research and Quality, 2016, EX HOSP QUAL MEAS CO; Al-Tawfiq JA, 2014, J INFECT PUBLIC HEAL, V7, P339, DOI 10.1016/j.jiph.2014.04.003; Alban RF, 2010, AM SURGEON, V76, P1108; American college of surgeons, 2010, ACS TRAUM QUAL IMPR; Anderson GF, 2007, HEALTH AFFAIR, V26, P780, DOI 10.1377/hlthaff.26.3.780; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bai GH, 2019, BRAIN RES, V1708, P93, DOI 10.1016/j.brainres.2018.12.018; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berwick D, 2016, BOARD HLTH SEL POP H; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Burns ER., 2015, CDC COMPENDIUM EFFEC; Carr BG, 2017, INJURY, V48, P332, DOI 10.1016/j.injury.2017.01.008; Centers for Disease Control and Prevention, 2019, STEADI STOPP ELD ACC; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Giner J., 2019, TRAUMATIC BRAIN INJU; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hedegaard Holly, 2016, Natl Health Stat Report, P1; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Missios S, 2016, INJURY, V47, P154, DOI 10.1016/j.injury.2015.06.037; Mitchell BG, 2016, J HOSP INFECT, V93, P92, DOI 10.1016/j.jhin.2016.01.012; Penman-Aguilar A, 2016, MMWR-MORBID MORTAL W, V65, P2, DOI 10.15585/mmwr.su6501a2; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Reid LD, 2017, AGENCY HEALTHC RES Q, V2020; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Roudsari B, 2008, INJURY PREV, V14, P96, DOI 10.1136/ip.2007.017129; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas KE, 2019, INT CLASSIFICATION D; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Zhao YD, 2001, WORLD J SURG, V25, P1202	57	4	4	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2021	52	5					1138	1144		10.1016/j.injury.2021.01.042			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RX4BJ	WOS:000647170200007	33551263				2022-02-06	
J	Patch, M; Farag, YMK; Anderson, JC; Perrin, N; Kelen, G; Campbell, JC				Patch, Michelle; Farag, Youssef M. K.; Anderson, Jocelyn C.; Perrin, Nancy; Kelen, Gabor; Campbell, Jacquelyn C.			UNITED STATES ED VISITS BY ADULT WOMEN FOR NONFATAL INTIMATE PARTNER STRANGULATION, 2006 TO 2014: PREVALENCE AND ASSOCIATED CHARACTERISTICS	JOURNAL OF EMERGENCY NURSING			English	Article						Strangulation; Intimate partner; Violence; Women's health; Prevalence	TRAUMATIC BRAIN-INJURY; SEXUAL ASSAULT; CAROTID-ARTERY; VIOLENCE; ACCURACY; IDENTIFICATION; DISSECTION; SYSTEM; ABUSE; CODES	Introduction: Nonfatal intimate partner strangulation poses significant acute and long-term morbidity risks and also heightens women's risk for future femicide. The lifetime prevalence of nonfatal intimate partner strangulation has been estimated to be approximately 10%, or 11 million women, in the general United States population. Given the potential for significant health risks and serious consequences of strangulation, this study adds to the limited literature by estimating prevalence and describing the associated characteristics of strangulation-related visits among United States ED visits by adult women after intimate partner violence. Methods: Prevalence estimation as well as simple and multi variable logistic regression analyses were completed using data from the Nationwide Emergency Department Sample spanning the years 2006 to 2014. Results: The prevalence of strangulation codes was estimated at 1.2% of all intimate partner violence visits. Adjusting for visits, hospital characteristics, and visit year, higher odds of strangulation were noted in younger women, metropolitan hos-pitals, level I/II trauma centers, and non-Northeast regions. In-creases in strangulation events among intimate partner violence-related visits in recent years were also observed. Discussion: A relatively low prevalence may reflect an under-estimate of true nonfatal intimate partner strangulation visits owing to coding or a very low rate of ED visits for this issue. Higher odds of strangulation among intimate partner violence visits by women in more recent years may be due to increased recognition and documentation by frontline clinicians and cod-ing teams. Continued research is needed to further inform clin-ical, postcare, and social policy efforts.	[Patch, Michelle; Campbell, Jacquelyn C.] Johns Hopkins Univ, Sch Nursing, 525 N Wolfe St,Room 460, Baltimore, MD 21205 USA; [Farag, Youssef M. K.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Anderson, Jocelyn C.] Penn State Univ, Coll Nursing, University Pk, PA 16802 USA; [Perrin, Nancy] Johns Hopkins Univ, Sch Nursing, Biostat & Methods Core, Baltimore, MD USA; [Kelen, Gabor] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA		Patch, M (corresponding author), Johns Hopkins Univ, Sch Nursing, 525 N Wolfe St,Room 460, Baltimore, MD 21205 USA.	mpatch1@jh.edu		Patch, Michelle/0000-0003-3639-6003	Emergency Nurses Association Foundation/Sigma Theta Tau International Nursing Research Grant; Jonas Nurse Leaders Scholar Program; National Center for Advancing Translational Sciences, a component of the National Institutes of Health [TL1 TR001078]; National Institutes of Health Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [1UL1TR001079]	The authors disclose the following funding sources:; 2017 Emergency Nurses Association Foundation/Sigma Theta Tau International Nursing Research Grant; Jonas Nurse Leaders Scholar Program; Johns Hopkins Institute for Clinical and Translational Research, funded in part by grant number TL1 TR001078 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health, and the National Institutes of Health Roadmap for Medical Research; Additional support for the statistical analysis was provided by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through grant number 1UL1TR001079.	Agency for Healthcare Research and Quality, 2014, INTR HCUP NAT EM DEP; Agency for Healthcare Research and Quality, HCUP QUAL CONTR PROC; [Anonymous], 2015, STATA14 VERS 14; Ballard ED, 2015, PEDIATR EMERG CARE, V31, P813, DOI 10.1097/PEC.0000000000000627; Barker-Collo S, 2016, NEUROEPIDEMIOLOGY, V47, P46, DOI 10.1159/000448403; Beydoun HA, 2017, J WOMENS HEALTH, V26, P141, DOI 10.1089/jwh.2016.5840; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Btoush R, 2008, J EMERG NURS, V34, P419, DOI 10.1016/j.jen.2007.10.015; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Clarot F, 2005, FORENSIC SCI INT, V149, P143, DOI 10.1016/j.forsciint.2004.06.009; Davidov DM, 2015, J EMERG MED, V48, P94, DOI 10.1016/j.jemermed.2014.07.053; DeKeseredy WS, 2008, ICPSR; Evans CS, 2017, J AM GERIATR SOC, V65, P91, DOI 10.1111/jgs.14480; Finfgeld-Connett D, 2015, ISSUES MENT HEALTH N, V36, P754, DOI 10.3109/01612840.2015.1047072; Furlan L, 2018, CLIN AUTON RES, V28, P577, DOI 10.1007/s10286-018-0509-z; George E, 2019, RADIOLOGY, V291, P61, DOI 10.1148/radiol.2019180801; Gilbert H., 2016, ENA TRAUMA COMMITTEE; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Green CA, 2017, PHARMACOEPIDEM DR S, V26, P509, DOI 10.1002/pds.4157; Hawley DA, 2001, J EMERG MED, V21, P317, DOI 10.1016/S0736-4679(01)00401-2; Holbrook DS, 2013, J FORENSIC NURS, V9, P140, DOI 10.1097/JFN.0b013e31829beb1e; Hooft AM, 2015, ACAD PEDIATR, V15, P444, DOI 10.1016/j.acap.2015.01.008; International Association of Forensic Nurses, NONF STRANG DOC TOOL; International Association of Forensic Nurses, MED BILL COD DEF; Jordan KS, 2020, ADV EMERG NURS J, V42, P186, DOI 10.1097/TME.0000000000000305; Joshi M, 2012, SOC WORK HEALTH CARE, V51, P798, DOI 10.1080/00981389.2012.692352; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Laughon K, 2008, JOGNN-J OBST GYN NEO, V37, P502, DOI 10.1111/j.1552-6909.2008.00268.x; Le Blanc-Louvry I, 2013, J FORENSIC SCI, V58, P1640, DOI 10.1111/1556-4029.12197; Malek AM, 2000, J NEUROSURG, V92, P481, DOI 10.3171/jns.2000.92.3.0481; Matusz EC, 2020, ANN EMERG MED, V75, P329, DOI 10.1016/j.annemergmed.2019.07.018; Mcquown C, 2016, AM J EMERG MED, V34, P1281, DOI 10.1016/j.ajem.2016.04.029; Medicode (Firm), 1996, ICD 9 CM INT CLASS D; Messing JT, 2018, WOMEN HEALTH ISS, V28, P104, DOI 10.1016/j.whi.2017.10.002; Messing JT, 2017, J ADV NURS, V73, P3220, DOI 10.1111/jan.13459; Messing JT, 2017, J INTERPERS VIOLENCE, V32, P205, DOI 10.1177/0886260515585540; Mittal M, 2018, VIOLENCE VICTIMS, V33, P1072, DOI 10.1891/0886-6708.33.6.1072; Nash Katherine R, 2009, J Forensic Nurs, V5, P31, DOI 10.1111/j.1939-3938.2009.01028.x; National Center for Health Statistics, INT CLASS DIS 10 REV; Patch M, 2018, J EMERG NURS, V44, P384, DOI 10.1016/j.jen.2017.12.001; Petrosky E, 2017, MMWR-MORBID MORTAL W, V66, P741, DOI 10.15585/mmwr.mm6628a1; Pritchard AJ, 2017, TRAUMA VIOLENCE ABUS, V18, P407, DOI 10.1177/1524838015622439; Robinson SR, TRAUMA VIOLENCE ABUS; Rudman WJ, CODING DOCUMENTATION; Samuel AM, 2015, J TRAUMA ACUTE CARE, V79, P622, DOI 10.1097/TA.0000000000000805; Scafide KN, 2020, J FORENSIC SCI, V65, P1191, DOI 10.1111/1556-4029.14294; Shields LBE, 2010, AM J FOREN MED PATH, V31, P320, DOI 10.1097/PAF.0b013e3181d3dc02; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Smock B, TRAINING I STRANGULA; Sorenson SB, 2014, AM J PUBLIC HEALTH, V104, pE54, DOI 10.2105/AJPH.2014.302191; Spencer CM, 2020, TRAUMA VIOLENCE ABUS, V21, P527, DOI 10.1177/1524838018781101; Stansfield R, J INTERPERS VIOLENCE, DOI 10.1177/; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Thomas KA, 2014, PSYCHOL WOMEN QUART, V38, P124, DOI 10.1177/0361684313488354; Training Institute on Strangulation Prevention, TRAIN I STRANG PREV; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Vella, 2013, COGNITIONS BEHAV STR; Vilke GM, 2011, J EMERG MED, V40, P355, DOI 10.1016/j.jemermed.2010.02.018; Zilkens RR, 2016, J FORENSIC LEG MED, V43, P1, DOI 10.1016/j.jflm.2016.06.005	59	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	MAY	2021	47	3					437	448		10.1016/j.jen.2021.01.008			12	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	SB0BE	WOS:000649666900014	33744016				2022-02-06	
J	Tucker, LB; Fu, AH; McCabe, JT				Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.			Hippocampal-Dependent Cognitive Dysfunction following Repeated Diffuse Rotational Brain Injury in Male and Female Mice	JOURNAL OF NEUROTRAUMA			English	Article						fear conditioning; hippocampus; learning; memory; Morris water maze; sex differences	HEAD IMPACT MODEL; CONTROLLED CORTICAL IMPACT; LONG-TERM DEPRESSION; DORSAL HIPPOCAMPUS; PARIETAL CORTEX; SEX-DIFFERENCES; SPATIAL INFORMATION; STRESS-RESPONSE; ACCELERATION; PROGESTERONE	Cognitive dysfunction is a common, often long-term complaint following acquired traumatic brain injury (TBI). Cognitive deficits suggest dysfunction in hippocampal circuits. The goal of the studies described here is to phenotype in both male and female mice the hippocampal-dependent learning and memory deficits resulting from TBI sustained by the Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA) device-a model that delivers both a contact-concussion injury as well as unrestrained rotational head movement. Mice sustained either sham procedures or four injuries (0.7 J, 24-h intervals). Spatial learning and memory skills assessed in the Morris water maze (MWM) approximately 3 weeks following injuries were significantly impaired by brain injuries; however, slower swimming speeds and poor performance on visible platform trials suggest that measurement of cognitive impairment with this test is confounded by injury-induced motor and/or visual impairments. A separate experiment confirmed hippocampal-dependent cognitive deficits with trace fear conditioning (TFC), a behavioral test less dependent on motor and visual function. Male mice had greater injury-induced deficits on both the MWM and TFC tests than female mice. Pathologically, the injury was characterized by white matter damage as observed by silver staining and glial fibrillary acidic protein (astrogliosis) in the optic tracts, with milder damage seen in the corpus callosum, and fimbria and brainstem (cerebral peduncles) of some animals. No changes in the density of GABAergic parvalbumin-expressing cells in the hippocampus, amygdala, or parietal cortex were found. This experiment confirmed significant sexually dimorphic cognitive impairments following a repeated, diffuse brain injury.	[Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	Center for Neuroscience and Regenerative Medicine (Department of Defense)United States Department of Defense [65310-309318-6.01, 65310-310185-6.01]	This work was supported by the Center for Neuroscience and Regenerative Medicine (Department of Defense), 65310-309318-6.01 and 65310-310185-6.01.	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Ausborn J., 2019, ELIFE, P8; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Besnard A, 2020, CELL REP, V30, P2360, DOI 10.1016/j.celrep.2020.01.055; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Broussard JI, 2020, J NEUROTRAUM, V37, P227, DOI 10.1089/neu.2019.6766; Bumber JR, 2021, J NEUROPATH EXP NEUR, V80, P2, DOI 10.1093/jnen/nlaa130; Carron SF, 2020, J COMP NEUROL, V528, P175, DOI 10.1002/cne.24746; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cross DJ, 2019, J ALZHEIMERS DIS, V67, P859, DOI 10.3233/JAD-180871; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Feyder M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.004.2007, 10.3389/neuro.08/004.2007]; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Franklin KBJ, 2013, PAXINOS FRANKLINS MO; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Griffiths BB, 2019, NEUROMOL MED, V21, P170, DOI 10.1007/s12017-019-08532-y; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kesner RP, 2009, NEUROBIOL LEARN MEM, V91, P197, DOI 10.1016/j.nlm.2008.09.004; Khan RS, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.1.8; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Krukowski K, 2020, J NEUROTRAUM, V37, P1370, DOI 10.1089/neu.2019.6827; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Lucas EK, 2018, BRAIN RES BULL, V141, P13, DOI 10.1016/j.brainresbull.2017.11.016; Lugo JN, 2014, JOVE-J VIS EXP, DOI 10.3791/51180; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Macheda T, 2020, J NEUROSCI METH, V343, DOI 10.1016/j.jneumeth.2020.108831; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCabe JT, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.541050; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McNamara EH, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113409; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Ognjanovski N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15039; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Povlishock J, 2016, METHODS MOL BIOL, V1462, P3, DOI 10.1007/978-1-4939-3816-2_1; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; Rogers JL, 2006, BEHAV NEUROSCI, V120, P852, DOI 10.1037/0735-7044.120.4.852; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Save E, 2009, NEUROBIOL LEARN MEM, V91, P172, DOI 10.1016/j.nlm.2008.08.005; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith CJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4411; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Tucker LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222153; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Tyagi E, 2014, EXP NEUROL, V253, P41, DOI 10.1016/j.expneurol.2013.12.004; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Vu PA, 2021, BRAIN RES, V1750, DOI 10.1016/j.brainres.2020.147147; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Weiss C, 2020, SHOCK, V53, P744, DOI 10.1097/SHK.0000000000001424; Wilson NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178013; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xia F, 2017, ELIFE, V6, DOI 10.7554/eLife.27868; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Zhang BL, 2018, NEURAL REGEN RES, V13, P1753, DOI 10.4103/1673-5374.238618; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	105	4	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1585	1606		10.1089/neu.2021.0025		APR 2021	22	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000645447700001	33622092	hybrid, Green Published			2022-02-06	
J	Wu, YX; Wu, HJ; Zeng, JX; Pluimer, B; Dong, SR; Xie, XC; Guo, XY; Ge, TH; Liang, XY; Feng, SD; Yan, YZ; Chen, JF; Maria, NS; Ma, QY; Gomez-Pinilla, F; Zhao, Z				Wu, Yingxi; Wu, Haijian; Zeng, Jianxiong; Pluimer, Brock; Dong, Shirley; Xie, Xiaochun; Guo, Xinying; Ge, Tenghuan; Liang, Xinyan; Feng, Sudi; Yan, Youzhen; Chen, Jian-Fu; Sta Maria, Naomi; Ma, Qingyi; Gomez-Pinilla, Fernando; Zhao, Zhen			Mild traumatic brain injury induces microvascular injury and accelerates Alzheimer-like pathogenesis in mice	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Alzheimer&#8217; s disease; Microvascular injury; Blood&#8211; brain barrier; &#946; -amyloid		Introduction Traumatic brain injury (TBI) is considered as the most robust environmental risk factor for Alzheimer's disease (AD). Besides direct neuronal injury and neuroinflammation, vascular impairment is also a hallmark event of the pathological cascade after TBI. However, the vascular connection between TBI and subsequent AD pathogenesis remains underexplored. Methods In a closed-head mild TBI (mTBI) model in mice with controlled cortical impact, we examined the time courses of microvascular injury, blood-brain barrier (BBB) dysfunction, gliosis and motor function impairment in wild type C57BL/6 mice. We also evaluated the BBB integrity, amyloid pathology as well as cognitive functions after mTBI in the 5xFAD mouse model of AD. Results mTBI induced microvascular injury with BBB breakdown, pericyte loss, basement membrane alteration and cerebral blood flow reduction in mice, in which BBB breakdown preceded gliosis. More importantly, mTBI accelerated BBB leakage, amyloid pathology and cognitive impairment in the 5xFAD mice. Discussion Our data demonstrated that microvascular injury plays a key role in the pathogenesis of AD after mTBI. Therefore, restoring vascular functions might be beneficial for patients with mTBI, and potentially reduce the risk of developing AD.	[Wu, Yingxi; Wu, Haijian; Zeng, Jianxiong; Pluimer, Brock; Dong, Shirley; Xie, Xiaochun; Guo, Xinying; Ge, Tenghuan; Liang, Xinyan; Feng, Sudi; Yan, Youzhen; Sta Maria, Naomi; Zhao, Zhen] Zilkha Neurogenet Inst, Ctr Neurodegenerat & Regenerat, Room 241,1501 San Pablo St, Los Angeles, CA 90033 USA; [Wu, Yingxi; Wu, Haijian; Zeng, Jianxiong; Pluimer, Brock; Dong, Shirley; Xie, Xiaochun; Guo, Xinying; Ge, Tenghuan; Liang, Xinyan; Feng, Sudi; Yan, Youzhen; Sta Maria, Naomi; Zhao, Zhen] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Wu, Haijian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China; [Pluimer, Brock; Liang, Xinyan; Zhao, Zhen] Univ Southern Calif, Keck Sch Med, Neurosci Grad Program, Los Angeles, CA 90033 USA; [Chen, Jian-Fu] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Ma, Qingyi] Loma Linda Univ, Lawrence D Longo MD Ctr Perinatal Biol, Div Pharmacol, Dept Basic Sci,Sch Med, Loma Linda, CA 92350 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Zhao, Z (corresponding author), Zilkha Neurogenet Inst, Ctr Neurodegenerat & Regenerat, Room 241,1501 San Pablo St, Los Angeles, CA 90033 USA.; Zhao, Z (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Zhao, Z (corresponding author), Univ Southern Calif, Keck Sch Med, Neurosci Grad Program, Los Angeles, CA 90033 USA.	zzhao@usc.edu	Ma, Qingyi/AAC-9203-2022; zhao, zhen/A-2080-2012	Ma, Qingyi/0000-0002-3499-0992; zhao, zhen/0000-0001-8967-5570	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS112404, RF1NS122060]; Alzheimer's AssociationAlzheimer's Association [NIRG-15-363387]; BrightFocus FoundationBrightFocus Foundation [A2019218S]	This work was partly supported by the National Institutes of Health (NIH) grant 1R01NS112404 to Q.M., NIH grant RF1NS122060, the Alzheimer's Association (NIRG-15-363387) and BrightFocus Foundation (A2019218S) to Z.Z.	Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Dinkins MB, 2015, J ALZHEIMERS DIS, V46, P55, DOI 10.3233/JAD-150088; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Hannocks MJ, 2018, J CEREBR BLOOD F MET, V38, P669, DOI 10.1177/0271678X17749689; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kenney K, 2018, JAMA NEUROL, V75, P1043, DOI 10.1001/jamaneurol.2018.0347; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lazic D, 2019, J EXP MED, V216, P279, DOI 10.1084/jem.20181035; Libbey JE, 2014, DISCOV MED, V18, P79; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Miao WY, 2020, J IMMUNOL, V204, P1486, DOI 10.4049/jimmunol.1900909; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Nikolakopoulou AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176225; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winship IR, 2014, METHODS MOL BIOL, V1135, P223, DOI 10.1007/978-1-4939-0320-7_19; Wu YX, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.01030; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	46	4	4	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 23	2021	9	1							74	10.1186/s40478-021-01178-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RR2DA	WOS:000642914400001	33892818	Green Published, gold			2022-02-06	
J	Sassetti, E; Clausen, MH; Laraia, L				Sassetti, Elisa; Clausen, Mads H.; Laraia, Luca			Small-Molecule Inhibitors of Reactive Oxygen Species Production	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HIGHLY SELECTIVE INHIBITOR; FREE-RADICAL SCAVENGER; TRAUMATIC BRAIN-INJURY; NADPH OXIDASE; MONOAMINE-OXIDASE; OXIDATIVE STRESS; IN-VITRO; GLUTATHIONE-PEROXIDASE; CHEMICAL-PROPERTIES	Reactive oxygen species (ROS) are involved in physiological cellular processes including differentiation, proliferation, and apoptosis by acting as signaling molecules or regulators of transcription factors. The maintenance of appropriate cellular ROS levels is termed redox homeostasis, a balance between their production and neutralization. High concentrations of ROS may contribute to severe pathological events including cancer, neuro-degenerative, and cardiovascular diseases. In recent years, approaches to target the sources of ROS production directly in order to develop tool compounds or potential therapeutics have been explored. Herein, we briefly outline the major sources of cellular ROS production and comprehensively review the targeting of these by small-molecule inhibitors. We critically assess the value of ROS inhibitors with different mechanisms-of-action, including their potency, mode-of-action, known off-target effects, and clinical or preclinical status, while suggesting future avenues of research in the field.	[Sassetti, Elisa; Clausen, Mads H.; Laraia, Luca] Tech Univ Denmark, Dept Chem, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark		Clausen, MH; Laraia, L (corresponding author), Tech Univ Denmark, Dept Chem, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark.	mhc@kemi.dtu.dk; luclar@kemi.dtu.dk	; Clausen, Mads Hartvig/A-9656-2015	Laraia, Luca/0000-0001-6692-3412; Clausen, Mads Hartvig/0000-0001-9649-1729	Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF19OC0055818, NNF17OC0028366, NNF19OC0058183]; Carlsberg FoundationCarlsberg Foundation [CF19-0072, CF19-0295]; DTU; Independent Research Fund Denmark [904100241B, 9041-00248B]	Work in the M.H.C. and L.L. laboratories is supported by the Novo Nordisk Foundation (NNF19OC0055818), the Carlsberg Foundation (CF19-0072), and DTU. L.L. also acknowledges the Independent Research Fund Denmark (904100241B and 9041-00248B), the Novo Nordisk Foundation (NNF17OC0028366 and NNF19OC0058183), and the Carlsberg Foundation (CF19-0295) for support.	Alderton WK, 2005, BRIT J PHARMACOL, V145, P301, DOI 10.1038/sj.bjp.0706168; Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Andrabi SS, 2020, PROTOPLASMA, V257, P335, DOI 10.1007/s00709-019-01439-2; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; Anvari E, 2015, FREE RADICAL RES, V49, P1308, DOI 10.3109/10715762.2015.1067697; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Arbogast S, 2010, ANTIOXID REDOX SIGN, V12, P893, DOI 10.1089/ars.2009.2890; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Augsburger F, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101272; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Banba A, 2019, J BIOL CHEM, V294, P6550, DOI 10.1074/jbc.RA119.007687; Battelli MG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3527579; Bautista-Aguilera OM, 2018, J MED CHEM, V61, P6937, DOI 10.1021/acs.jmedchem.8b00848; Bautista-Aguilera OM, 2017, ANGEW CHEM INT EDIT, V56, P12765, DOI 10.1002/anie.201706072; Becker MA, 2005, ARTHRITIS RHEUM, V52, P916, DOI 10.1002/art.20935; Beckhauser TF, 2016, J EXP NEUROSCI, V10, P23, DOI 10.4137/JEN.S39887; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belavgeni A, 2019, P NATL ACAD SCI USA, V116, P22269, DOI 10.1073/pnas.1912700116; Binda C, 2007, J MED CHEM, V50, P5848, DOI 10.1021/jm070677y; Binde CD, 2018, BRIT J CLIN PHARMACO, V84, P1917, DOI 10.1111/bcp.13651; BIRKMAYER W, 1983, ACTA NEUROL SCAND, V68, P103, DOI 10.1111/j.1600-0404.1983.tb01522.x; Blair HA, 2017, CNS DRUGS, V31, P169, DOI 10.1007/s40263-017-0408-1; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Bredemeier M, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0757-9; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Broom L, 2011, FREE RADICAL BIO MED, V50, P633, DOI 10.1016/j.freeradbiomed.2010.12.026; Cancela S, 2020, EUR J PHARMACOL, V871, DOI 10.1016/j.ejphar.2020.172926; Cattaneo C, 2003, CLIN NEUROPHARMACOL, V26, P213, DOI 10.1097/00002826-200307000-00012; CAVALLINI L, 1990, J MOL CELL CARDIOL, V22, P143, DOI 10.1016/0022-2828(90)91111-J; Cha JJ, 2017, LAB INVEST, V97, P419, DOI 10.1038/labinvest.2017.2; Chainy GBN, 2019, FREE RADICAL RES, DOI 10.1080/10715762.2019.1702656; Chatterjee PK, 2003, KIDNEY INT, V63, P853, DOI 10.1046/j.1523-1755.2003.00802.x; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Chatterjee Prabal K, 2003, Med Sci Monit, V9, pBR357; Chaube R, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00036; Chauvigne F, 2015, SCI REP-UK, V5, DOI 10.1038/srep07789; Chen XF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1580967; Chio IIC, 2017, TRENDS MOL MED, V23, P411, DOI 10.1016/j.molmed.2017.03.004; Chioua M, 2019, J MED CHEM, V62, P2184, DOI 10.1021/acs.jmedchem.8b01987; Chocry M, 2020, ANTIOXID REDOX SIGN, V33, P332, DOI 10.1089/ars.2019.7915; Choi HJ, 2015, MOL CELLS, V38, P918, DOI 10.14348/molcells.2015.0168; Cifuentes-Pagano E, 2013, MEDCHEMCOMM, V4, P1085, DOI 10.1039/c3md00061c; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Conrad M, 2019, NAT CHEM BIOL, V15, P1137, DOI 10.1038/s41589-019-0408-1; CRESTANELLO JA, 1995, J SURG RES, V59, P198, DOI 10.1006/jsre.1995.1154; CSALLANY A S, 1970, Lipids, V5, P63, DOI 10.1007/BF02531096; Cuzzocrea S, 2002, EUR J PHARMACOL, V453, P119, DOI 10.1016/S0014-2999(02)02338-5; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Das S, 2019, EXP EYE RES, V185, DOI 10.1016/j.exer.2019.107692; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Davey DD, 2007, J MED CHEM, V50, P1146, DOI 10.1021/jm061319i; Devisscher L, 2018, J MED CHEM, V61, P10126, DOI 10.1021/acs.jmedchem.8b01299; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dorotea D, 2018, PHARMACOLOGY, V102, P180, DOI 10.1159/000491398; Du K, 2017, ARCH TOXICOL, V91, P761, DOI 10.1007/s00204-016-1692-0; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Fakhruddin S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8379327; Ferreira E. I., 2017, NITRIC OXIDE SYNTHAS, P217, DOI [10.5772/67027., DOI 10.5772/67027]; Filip V, 1999, J PSYCHIATR NEUROSCI, V24, P234; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; FOX RM, 1970, SCIENCE, V168, P861, DOI 10.1126/science.168.3933.861; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Garcin ED, 2008, NAT CHEM BIOL, V4, P700, DOI 10.1038/nchembio.115; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gatto GJ, 2013, J ENZYM INHIB MED CH, V28, P95, DOI 10.3109/14756366.2011.636360; Gealageas R, 2018, J MED CHEM, V61, P7043, DOI 10.1021/acs.jmedchem.7b01588; Gottwald EM, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13667; Guan RQ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0487-4; Guay David R P, 2006, Am J Geriatr Pharmacother, V4, P330, DOI 10.1016/j.amjopharm.2006.12.001; Gurevich Eugenia V, 2014, Handb Exp Pharmacol, V219, P1, DOI 10.1007/978-3-642-41199-1_1; Gutteridge, 2015, FREE RADICALS BIOL M, DOI 10.1093/acprof:oso/9780198717478.001.0001; Hacis A., 2018, CHAPTER BOOK MELATON, P59, DOI DOI 10.5772/INTECHOPEN.79421; Haenen G. R. M. M., 2014, FRONT PHARMACOL, V5, P1; Hagmann WH, 2000, BIOORG MED CHEM LETT, V10, P1975, DOI 10.1016/S0960-894X(00)00389-9; Hariharan S, 2020, INFLAMMOPHARMACOLOGY, V28, P667, DOI 10.1007/s10787-020-00690-x; Hasegawa M, 1998, HETEROCYCLES, V47, P857, DOI 10.3987/COM-97-S(N)89; Hauser RA, 2017, J PARKINSON DIS, V7, P117, DOI 10.3233/JPD-160965; Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Hosoya T, 2017, CLIN RHEUMATOL, V36, P649, DOI 10.1007/s10067-016-3474-8; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Inokuchi Y, 2009, J PHARMACOL EXP THER, V329, P687, DOI 10.1124/jpet.108.148676; Jha J. C., 2019, MODULATION OXIDATIVE, P237, DOI [10.1007/ 978- 981- 13- 8946- 7_ 10, DOI 10.1007/978-981-13-8946-7_10]; Ji HT, 2010, J MED CHEM, V53, P7804, DOI 10.1021/jm100947x; Joo J. H., 2016, SCI REP-UK, V6, P1; Marchissio MJ, 2012, TOXICOL APPL PHARM, V264, P246, DOI 10.1016/j.taap.2012.08.005; Kaludercic N, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00012; Kaludercic N, 2014, ANTIOXID REDOX SIGN, V20, P267, DOI 10.1089/ars.2012.4616; Kawata A, 2018, IN VIVO, V32, P255, DOI 10.21873/invivo.11232; KELLEY WN, 1970, SCIENCE, V169, P388, DOI 10.1126/science.169.3943.388; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kilic E, 1999, J CEREBR BLOOD F MET, V19, P511, DOI 10.1097/00004647-199905000-00005; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kim KY, 2001, J BIOL CHEM, V276, P40591, DOI 10.1074/jbc.M100975200; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Korge P, 2017, J BIOL CHEM, V292, P9896, DOI 10.1074/jbc.M116.768325; Kuhn R, 1936, ANGEW CHEM-GER EDIT, V49, P0006, DOI 10.1002/ange.19360490103; Kumari S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918755391; Laforge M, 2020, NAT REV IMMUNOL, V20, P515, DOI 10.1038/s41577-020-0407-1; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Lecht Shimon, 2007, Ther Clin Risk Manag, V3, P467; Lee SG, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11090482; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Li Y, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101143; Lighezan R, 2016, CAN J PHYSIOL PHARM, V94, P1040, DOI 10.1139/cjpp-2015-0580; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967; Liu Z, 2017, J NEUROINTERV SURG, V9, P702, DOI 10.1136/neurintsurg-2016-012463; Locigno EJ, 2005, ORG BIOMOL CHEM, V3, P3220, DOI 10.1039/b507530k; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Ma XC, 2006, J PINEAL RES, V40, P343, DOI 10.1111/j.1600-079X.2006.00321.x; Maggiorani D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3017947; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Manzoor S, 2020, EUR J MED CHEM, V206, DOI 10.1016/j.ejmech.2020.112787; Marco-Contelles J, 2020, J MED CHEM, V63, P13413, DOI 10.1021/acs.jmedchem.0c00976; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Martinez GR, 2005, ENDOCRINE, V27, P111, DOI 10.1385/ENDO:27:2:111; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; Matsumoto K, 2011, J PHARMACOL EXP THER, V336, P95, DOI 10.1124/jpet.110.174540; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; MILLS GC, 1957, J BIOL CHEM, V229, P189; Minhas R, 2020, MED RES REV, V40, P823, DOI 10.1002/med.21636; Miotto G, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101328; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Morimoto K, 2012, J VASC SURG, V55, P1749, DOI 10.1016/j.jvs.2011.11.059; Mukherjee P, 2015, J MED CHEM, V58, P1067, DOI 10.1021/jm501719e; Mukherjee P, 2014, CHEM SOC REV, V43, P6814, DOI 10.1039/c3cs60467e; Muntean DM, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8254942; Nash KM, 2018, FREE RADICAL BIO MED, V115, P395, DOI 10.1016/j.freeradbiomed.2017.12.027; Ngarashi D, 2019, HYPERTENS RES, V42, P981, DOI 10.1038/s41440-019-0246-2; Nishino A, 2017, J OLEO SCI, V66, P77, DOI 10.5650/jos.ess16107; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/NCHEMBIO.1910, 10.1038/nchembio.1910]; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pallesen JS, 2018, J MED CHEM, V61, P8088, DOI 10.1021/acs.jmedchem.8b00358; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Panth N., 2016, ADV MED, V2016, P1, DOI DOI 10.1155/2016/9152732; Perez-Torres I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102098; Poon JF, 2020, J AM CHEM SOC, V142, P14331, DOI 10.1021/jacs.0c06379; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Quintana-Cabrera R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1722; Ramos E, 2017, FREE RADICAL BIO MED, V104, P32, DOI 10.1016/j.freeradbiomed.2017.01.005; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reczek CR, 2017, ANNU REV CANC BIOL, V1, P79, DOI 10.1146/annurev-cancerbio-041916-065808; Reis J, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101466; Reis J, 2018, J MED CHEM, V61, P4203, DOI 10.1021/acs.jmedchem.8b00357; Reis J, 2016, J MED CHEM, V59, P5879, DOI 10.1021/acs.jmedchem.6b00527; Revuelta M, 2019, MECH AGEING DEV, V183, DOI 10.1016/j.mad.2019.111147; ROBINS RK, 1956, J AM CHEM SOC, V78, P784, DOI 10.1021/ja01585a023; Ryu I, 2018, ONCOL REP, V40, P3869, DOI 10.3892/or.2018.6753; Sancho P, 2011, BIOCHEM PHARMACOL, V81, P917, DOI 10.1016/j.bcp.2011.01.007; Sato T, 2009, BIOORG MED CHEM LETT, V19, P6225, DOI 10.1016/j.bmcl.2009.08.091; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schildknecht S, 2014, CURR MED CHEM, V21, P365; Schramm M, 2014, EUR J IMMUNOL, V44, P728, DOI 10.1002/eji.201343940; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Selemidis S, 2019, RESPIROLOGY, V24, P15, DOI 10.1111/resp.13417; Shah R, 2017, ACS CHEM BIOL, V12, P2538, DOI 10.1021/acschembio.7b00730; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; SIERADZAN K, 1995, J CLIN PSYCHOPHARM, V15, pS51, DOI 10.1097/00004714-199508001-00010; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Sikora A, 2008, RADIAT PHYS CHEM, V77, P259, DOI 10.1016/j.radphyschem.2007.05.005; Sims NR, 2017, NEUROCHEM INT, V107, P88, DOI 10.1016/j.neuint.2016.12.016; Solbak SMO, 2020, J MED CHEM, V63, P1156, DOI 10.1021/acs.jmedchem.9b01492; Song SB, 2017, MOL CELLS, V40, P503, DOI 10.14348/molcells.2017.0081; Stalin J, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800265; Stanicka J, 2015, J BIOL CHEM, V290, P9348, DOI 10.1074/jbc.M113.510495; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Strub A, 2006, MOL PHARMACOL, V69, P328, DOI 10.1124/mol.105.017087; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; Sun QA, 2012, FREE RADICAL BIO MED, V52, P1897, DOI 10.1016/j.freeradbiomed.2012.02.046; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Swamy SMK, 2003, MOL CELL BIOCHEM, V245, P127, DOI 10.1023/A:1022807207948; Szilagyi JT, 2016, TOXICOL SCI, V151, P150, DOI 10.1093/toxsci/kfw031; Tabi T, 2020, J NEURAL TRANSM, V127, P831, DOI 10.1007/s00702-019-02082-0; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Tamma G, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1501847; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; To EE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00057-x; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Tzvetkov NT, 2014, J MED CHEM, V57, P6679, DOI 10.1021/jm500729a; Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013; Varma SD, 1998, FREE RADICAL RES, V28, P131, DOI 10.3109/10715769809065799; Vejrazka M, 2005, BBA-GEN SUBJECTS, V1722, P143, DOI 10.1016/j.bbagen.2004.12.008; Villamena FA, 2012, FUTURE MED CHEM, V4, P1171, DOI [10.4155/FMC.12.74, 10.4155/fmc.12.74]; Dao VTV, 2020, FREE RADICAL BIO MED, V148, P60, DOI 10.1016/j.freeradbiomed.2019.12.038; Vuohelainen V, 2015, INTERACT CARDIOV TH, V21, P441, DOI 10.1093/icvts/ivv175; Wang MW, 2020, NEUROCHEM RES, V45, P1097, DOI 10.1007/s11064-020-02987-3; Wang X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204271; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Wong HS, 2019, FREE RADICAL BIO MED, V143, P545, DOI 10.1016/j.freeradbiomed.2019.09.006; Xu YX, 2018, EUR J MED CHEM, V143, P33, DOI 10.1016/j.ejmech.2017.08.025; Yamamoto T, 2018, BIOL PHARM BULL, V41, P419, DOI 10.1248/bpb.b17-00804; Yamamoto Y, 1996, REDOX REP, V2, P333, DOI 10.1080/13510002.1996.11747069; Yamauchi R., 1997, FOOD SCI TECHNOL INT, V3, P301; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yauger YJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1430-7; Yoboue ED, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0033-4; Youdim MBH, 2001, CELL MOL NEUROBIOL, V21, P555, DOI 10.1023/A:1015131516649; Youdim MBH, 2018, J NEURAL TRANSM, V125, P1719, DOI 10.1007/s00702-018-1942-9; Yu X, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8364848; Zeng SY, 2019, BIOMED PHARMACOTHER, V109, P1907, DOI 10.1016/j.biopha.2018.11.077; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364; Zhao R, 2018, TROP J PHARM RES, V17, P1049, DOI 10.4314/tjpr.v17i6.10; Zheng JS, 2020, CELL METAB, V32, P920, DOI 10.1016/j.cmet.2020.10.011; Zheng SJ, 2012, ORG BIOMOL CHEM, V10, P2590, DOI 10.1039/c2ob25065a; Zhou YJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/374963; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	219	4	4	12	18	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-2623	1520-4804		J MED CHEM	J. Med. Chem.	MAY 13	2021	64	9					5252	5275		10.1021/acs.jmedchem.0c01914		APR 2021	24	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	SE0SP	WOS:000651785800004	33856791				2022-02-06	
J	Covington, NV; Duff, MC				Covington, Natalie, V; Duff, Melissa C.			Heterogeneity Is a Hallmark of Traumatic Brain Injury, Not a Limitation: A New Perspective on Study Design in Rehabilitation Research	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: In both basic science and intervention research in traumatic brain injury (TBI), heterogeneity in the patient population is frequently cited as a limitation and is often interpreted as a factor reducing certainty in the generalizability of research findings and as a source of conflicting findings across studies. Historically, much of TBI research in rehabilitation and cognition has relied upon case-control studies, with small to modest sample sizes. In this context, heterogeneity is indeed a significant limitation. Here, however, we argue that heterogeneity in patient profiles is a hallmark characteristic of TBI and therefore cannot be avoided or ignored. We argue that this inherent heterogeneity must be acknowledged and accounted for prior to study design. Fortunately, advances in statistical methods and computing power allow researchers to leverage heterogeneity, rather than be constrained by it. Method: In this article, we review sources of heterogeneity that contribute to challenges in TBI research, highlight methodological advances in statistical analysis and in other fields with high degrees of heterogeneity (e.g., psychiatry) that may be fruitfully applied to decomposing heterogeneity in TBI, and offer an example from our research group incorporating this approach. Conclusion: Only by adopting new methodological approaches can we advance the science of rehabilitation following TBI in ways that will impact clinical practice and inform decision making, allowing us to understand and respond to the range of individual differences that are a hallmark in this population.	[Covington, Natalie, V] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA; [Covington, Natalie, V; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA		Covington, NV (corresponding author), Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA.; Covington, NV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.	nvcoving@umn.edu		Covington, Natalie/0000-0002-0016-2654	ASHFoundation Clinical Research Grant; National Institute on Disability, Independent Living, and Rehabilitation Research Grant [90SFGE0012]	Work described in this article was funded by an ASHFoundation Clinical Research Grant awarded to N. V. C. and an National Institute on Disability, Independent Living, and Rehabilitation Research Grant 90SFGE0012 awarded to M. C. D. The authors thank the attendees of the International Cognitive-Communication Disorders Conference for discussions that prompted this article.	Ahmed AO, 2018, J PSYCHIATR RES, V97, P8, DOI 10.1016/j.jpsychires.2017.11.004; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Baron-Cohen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136521; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Brown J. D, 2014, LINEAR MODELS MATRIX, DOI [10.1007/978-3-319-11734-8_14, DOI 10.1007/978-3-319-11734-8_14]; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cooney MT, 2016, CLIN MED, V16, P109, DOI 10.7861/clinmedicine.16-2-109; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Covington N. V., 2018, PROSPERO INT PROSPEC; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Fellows LK, 2008, J COGNITIVE NEUROSCI, V20, P1107, DOI 10.1162/jocn.2008.20065; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Glisky E., 1993, COMMUNITY BASED EMPL, P3; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kent DM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4245; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kim-Kang G, 2008, Z PSYCHOL, V216, P49, DOI 10.1027/0044-3409.216.1.49; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Lah S, 2011, BRAIN INJURY, V25, P44, DOI 10.3109/02699052.2010.531693; Lombardo MV, 2019, MOL PSYCHIATR, V24, P1435, DOI 10.1038/s41380-018-0321-0; Lombardo MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35333; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marquand AF, 2019, MOL PSYCHIATR, V24, P1415, DOI 10.1038/s41380-019-0441-1; Marquand Andre F, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P433; Marquand AF, 2016, BIOL PSYCHIAT, V80, P552, DOI 10.1016/j.biopsych.2015.12.023; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Meeuws S, 2020, J NEUROTRAUM, V37, P1283, DOI 10.1089/neu.2019.6867; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Naggara O, 2011, AM J NEURORADIOL, V32, P633, DOI 10.3174/ajnr.A2442; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Robey RR, 1998, APHASIOLOGY, V12, P787, DOI 10.1080/02687039808249573; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saban KL, 2011, J WOMENS HEALTH, V20, P179, DOI 10.1089/jwh.2010.2334; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Stolwyk RJ, 2021, NEUROPSYCHOL REHABIL, V31, P316, DOI 10.1080/09602011.2019.1692672; Sysko R, 2010, J CONSULT CLIN PSYCH, V78, P681, DOI 10.1037/a0019735; Tate R., 2016, ARCH SCI PSYCHOL, V4, P10, DOI [DOI 10.1037/ARC0000027, 10.1037/arc0000027]; Tate RL, 2014, NEUROPSYCHOL REHABIL, V24, P315, DOI 10.1080/09602011.2013.875043; TEASDALE G, 1974, LANCET, V2, P81; Trivedi RB, 2015, CONTEMP CLIN TRIALS, V44, P20, DOI 10.1016/j.cct.2015.07.009; Turkstra LS, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00059; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2002, BRAIN COGNITION, V50, P304, DOI 10.1016/S0278-2626(02)00515-8; Van Rheenen TE, 2017, PSYCHOL MED, V47, P1848, DOI 10.1017/S0033291717000307; Verger K, 2000, BRAIN INJURY, V14, P495; Wang C, 2021, MULTIVAR BEHAV RES, V56, P459, DOI 10.1080/00273171.2020.1730739; Weiss D.J., 2011, J METHODS MEASUR SOC, V2, P80, DOI [10.2458/azu_jmmss_v2i2_weiss, DOI 10.2458/AZU_JMMSS_V2I2_WEISS]; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wolfers T, 2018, JAMA PSYCHIAT, V75, P1146, DOI 10.1001/jamapsychiatry.2018.2467; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhao YH, 2016, J CHILD PSYCHOL PSYC, V57, P421, DOI 10.1111/jcpp.12503	85	4	4	1	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		974	985		10.1044/2020_AJSLP-20-00081			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400010	33556261				2022-02-06	
J	ElGhamry, AN; Jayakumar, N; Youssef, M; Shumon, S; Mitchell, P				ElGhamry, Ahmed Nabil; Jayakumar, Nithish; Youssef, Mohamed; Shumon, Syed; Mitchell, Patrick			COVID-19 and Changes in Neurosurgical Workload in the United Kingdom	WORLD NEUROSURGERY			English	Article						COVID-19; Neurosurgery; Pandemics; Physicians' Practice Patterns; Referral and consultation; Workload		BACKGROUND: Cessation of elective procedures and lower bed capacity during the COVID-19 pandemic have led to a rise in the waiting lists for surgery, but it is unclear if workload has recovered sufficiently to account for this backlog. We describe the change in neurosurgical workload at a tertiary neurosciences center in the United Kingdom after the first pandemic wave in comparison with the months before and during the first wave. METHODS: A retrospective review of theatre records and electronic referrals-between December 1, 2019, and August 31, 2020-was performed. The months of December 2019-February 2020 were designated as pre-COVID months and March-May 2020 were designated as COVID months. The time period from June to August 2020 was designated as post-wave months. Statistical analyses were performed on SPSS v22 (IBM). RESULTS: Referrals declined from 572 in January to a nadir of 352 in April before a steady rise to August. Referral volumes for degenerative spinal disease and traumatic brain injuries showed a statistically significant change during the year. On average, 212 procedures per month were performed in the pre-COVID months, 167 procedures per month during COVID months, and 232 procedures per month in the post-wave months. The number of patients on the waiting list for scheduled operations rose from March (785 patients) onward to a peak of 997 patients in July. CONCLUSIONS: In the aftermath of COVID-19, higher referral volumes and operative procedures were apparent in the post-wave months as services returned to normal. With the expectation of a second wave of infections, it is unclear whether this will be sustainable.	[ElGhamry, Ahmed Nabil; Jayakumar, Nithish; Youssef, Mohamed; Shumon, Syed; Mitchell, Patrick] Newcastle Univ, Dept Neurosurg, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Mitchell, Patrick] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England		Jayakumar, N (corresponding author), Newcastle Univ, Dept Neurosurg, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England.	nithish.jayakumar90@gmail.com		Shumon, Syed/0000-0001-8598-1562			Agosti E, 2020, SPINAL CORD, V58, P726, DOI 10.1038/s41393-020-0480-0; [Anonymous], 2020, BBC NEWS; Bajunaid K, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106237; Brembilla C, 2020, NEUROSPINE, V17, P354, DOI 10.14245/ns.2040268.134; Cardwell M, EXPRESS STAR; Chaurasia B, 2020, NEUROSURGERY, V87, P854, DOI 10.1093/neuros/nyaa314; Cofano F, 2020, NEUROSURGERY, V87, pE211, DOI 10.1093/neuros/nyaa174; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; Deora H, 2020, WORLD NEUROSURG, V142, pE396, DOI 10.1016/j.wneu.2020.07.038; Grech V, EARLY HUM DEV, DOI [10.1016/j.earlhumdev.2020, DOI 10.1016/J.EARLHUMDEV.2020]; Grech Victor, 2020, Early Hum Dev, P105211, DOI 10.1016/j.earlhumdev.2020.105211; Ham CH, 2020, J KOREAN NEUROSURG S, V63, P407, DOI 10.3340/jkns.2020.0114; Jayakumar N, 2020, WORLD NEUROSURG, V144, pE414, DOI 10.1016/j.wneu.2020.08.162; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; July J, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105185; Mathiesen T, 2020, ACTA NEUROCHIR, V162, P2221, DOI 10.1007/s00701-020-04482-8; Mehta AI, 2020, SPINE, V45, P942, DOI 10.1097/BRS.0000000000003571; Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746; Newcastle Hospitals, TRUST PROFILE; NHS England, NHS ROADMAP SAFELY B; Patel PD, 2020, WORLD NEUROSURG, V142, pE183, DOI 10.1016/j.wneu.2020.06.176; Qureshi AI, 2020, ACCIDENT ANAL PREV, V146, DOI 10.1016/j.aap.2020.105747; Rojas J-PF, BUSINESS NEWS SKY NE; Royal College of Surgeons, RECOVERY SURG SERVIC; Sharif S, 2020, WORLD NEUROSURG, V140, pE401, DOI 10.1016/j.wneu.2020.06.007; Sivakanthan S, 2020, WORLD NEUROSURG, V143, pE561, DOI 10.1016/j.wneu.2020.08.028; Stewart H, 2020, GUARDIAN; The Royal College of Surgeons of England, COVID WRECKING BALLN; Venkataram T, 2020, NEUROL INDIA, V68, P595, DOI 10.4103/0028-3886.289004; Zali A, 2020, ASIA-PAC J PUBLIC HE, V32, P511, DOI 10.1177/1010539520957809	30	4	4	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E689	E694		10.1016/j.wneu.2021.01.094			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900079	33540092	Green Published, Bronze			2022-02-06	
J	Friedman-Levi, Y; Liraz-Zaltsman, S; Shemesh, C; Rosenblatt, K; Kesner, EL; Gincberg, G; Carmichael, ST; Silva, AJ; Shohami, E				Friedman-Levi, Yael; Liraz-Zaltsman, Sigal; Shemesh, Chen; Rosenblatt, Kinneret; Kesner, Efrat L.; Gincberg, Galit; Carmichael, S. Thomas; Silva, Alcino J.; Shohami, Esther			Pharmacological blockers of CCR5 and CXCR4 improve recovery after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						TBI; Treatment; Chemokine receptors; CCR5; CXC4; Plerixafor; Maraviroc; Mozobil; AMD3100; CHI	CLOSED-HEAD INJURY; CELL-PROLIFERATION; NMDA RECEPTORS; ADULT RATS; NEUROGENESIS; CHEMOKINE; NEURONS; MODEL; MICE; RISK	CCR5 and CXCR4 are structurally related chemokine receptors that belong to the superfamily of G-protein coupled receptors through which the HIV virus enters and infects cells. Both receptors are also related to HIV-associated neurocognitive disorders that include difficulties in concentration and memory, impaired executive functions, psychomotor slowing, depression and irritability, which are also hallmarks of the long-term sequelae of TBI. Moreover, A growing body of evidence attributes negative influences to CCR5 activation on cognition, particularly after stroke and traumatic brain injury (TBI). Here we investigated the effect of their blockage on motor and cognitive functions, on brain tissue loss and preservation and on some of the biochemical pathways involved. We examined the effect of maraviroc, a CCR5 antagonist used in HIV patients as a viral entry inhibitor, and of plerixafor (AMD3100), a CXCR4 antagonist used in cancer patients as an immune-modulator, on mice subjected to closed head injury (CHI). Mice were treated with maraviroc or plerixafor after CHI for the following 4 or 5 days, respectively. Neurobehavior was assessed according to the Neurological Severity Score; cognitive tests were performed by using the Y-maze, Barnes maze and the novel object recognition test; anxiety was evaluated with the open field test. The mice were sacrificed and brain tissues were collected for Western blot, pathological and immunohistochemical analyses. Both drugs enhanced tissue preservation in the cortex, hippocampus, periventricular areas, corpus callosum and striatum, and reduced astrogliosis)GFAP expression). They also increased the levels of synaptic cognition-related signaling molecules such as phosphorylated NR1 and CREB, and the synaptic plasticity protein PSD95. Both treatments also enhanced the expression of CCR5 and CXCR4 on different brain cell types. In summary, the beneficial effects of blocking CCR5 and CXCR4 after CHI suggest that the drugs used in this study, both FDA approved and in clinical use, should be considered for translational research in TBI patients.	[Friedman-Levi, Yael; Liraz-Zaltsman, Sigal; Kesner, Efrat L.; Gincberg, Galit; Shohami, Esther] Hebrew Univ Jerusalem, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel; [Liraz-Zaltsman, Sigal; Shemesh, Chen] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel; [Liraz-Zaltsman, Sigal] Ono Acad Coll, Inst Hlth & Med Profess, Dept Sports Therapy, Kiryat Ono, Israel; [Rosenblatt, Kinneret] Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel; [Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Silva, Alcino J.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Integrat Ctr Learning & Memory, Los Angeles, CA 90024 USA; [Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Friedman-Levi, Y (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Dept Pharmacol, Jerusalem, Israel.	yael.friedman-levi@mail.huji.ac.il; Sigal.lirazzaltsman@sheba.health.gov.il; Chen.Shemesh@sheba.health.gov.il; Kineret.Rosenblatt@sheba.health.gov.il; SCarmichael@mednet.ucla.edu; silvaa@mednet.ucla.edu; esty.shohami@mail.huji.ac.il	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558	Dr. Miriam and Sheldon Adelson Foundation (AMRF)	This study was supported by a grant from the Dr. Miriam and Sheldon Adelson Foundation (AMRF) to ES, STC and AJS.	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chiazza F, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0702-3; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Eggers C, 2017, J NEUROL, V264, P1715, DOI 10.1007/s00415-017-8503-2; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Gincberg G, 2018, CYTOTHERAPY, V20, P245, DOI 10.1016/j.jcyt.2017.11.008; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; Merino JJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020212; Lepinoux-Chambaud C, 2013, HISTOCHEM CELL BIOL, V140, P13, DOI 10.1007/s00418-013-1101-1; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Liraz-Zaltsman S, 2021, J NEUROTRAUM, V38, P2003, DOI 10.1089/neu.2020.7015; Luo J, 2014, NEUROSCI LETT, V578, P203, DOI 10.1016/j.neulet.2014.06.059; Middei S, 2012, LEARN MEMORY, V19, P330, DOI 10.1101/lm.025817.112; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Navarro D., 2015, LEARNING STAT R TUTO; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabinovich-Nikitin I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0587-6; Ru WJ, 2016, J NEUROIMMUNE PHARM, V11, P182, DOI 10.1007/s11481-015-9644-7; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Shaheen ZR, 2019, AM J PHYSIOL-REG I, V316, pR525, DOI 10.1152/ajpregu.00019.2019; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wang H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0095-0; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wei T., 2017, R PACKAGE CORRPLOT V; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P808, DOI 10.1016/j.bbamem.2006.10.002; Zhao SS, 2015, RESTOR NEUROL NEUROS, V33, P809, DOI 10.3233/RNN-150515; Zhou M, 2016, ELIFE, V5, DOI 10.7554/eLife.20985	46	4	4	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2021	338								113604	10.1016/j.expneurol.2021.113604			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QL2OR	WOS:000620920600011	33453212				2022-02-06	
J	Peterson, C; Xu, LK; Barnett, SBL				Peterson, Cora; Xu, Likang; Barnett, Sarah Beth L.			Average lost work productivity due to non-fatal injuries by type in the USA	INJURY PREVENTION			English	Article						public health; mechanism; barell matrix; costs	UNITED-STATES; ECONOMIC BURDEN; CARE UTILIZATION; INDIRECT COSTS	Objective To estimate the average lost work productivity due to non-fatal injuries in the USA comprehensively by injury type. Methods The attributable average number and value of lost work days in the year following non-fatal emergency department (ED)-treated injuries were estimated by injury mechanism (eg, fall) and body region (eg, head and neck) among individuals age 18-64 with employer health insurance injured 1 October 2014 through 30 September 2015 as reported in MarketScan medical claims and Health and Productivity Management databases. Workplace, short-term disability and workers' compensation absences were assessed. Multivariable regression models compared lost work days among injury patients and matched controls during the year following injured patients' ED visit, controlling for demographic, clinical and health insurance factors. Lost work days were valued using an average US daily market production estimate. Costs are 2015 USD. Results The 1-year per-person average number and value of lost work days due to all types of non-fatal injuries combined were approximately 11 days and US$1590. The range by injury mechanism was 1.5 days (US$210) for bites and stings to 44.1 days (US$6196) for motorcycle injuries. The range by body region was 4.0 days (US$567) for other head, face and neck injuries to 19.8 days (US$2787) for traumatic brain injuries. Conclusions and relevance Injuries are costly and preventable. Accurate estimates of attributable lost work productivity are important to monitor the economic burden of injuries and help to prioritise cost-effective public health prevention activities.	[Peterson, Cora; Xu, Likang; Barnett, Sarah Beth L.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Peterson, C (corresponding author), CDC Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA.	cora.peterson@cdc.hhs.gov	Peterson, Cora/AAU-2740-2021	Peterson, Cora/0000-0001-7955-0977			CDC National Center for Health Statistics, BARELL INJURY DIAGNO; Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1078, DOI 10.15585/mmwr.mm6438a5; Florence CS, 2016, MED CARE, V54, P901, DOI 10.1097/MLR.0000000000000625; Gilligan AM, 2018, J OCCUP ENVIRON MED, V60, P1120, DOI 10.1097/JOM.0000000000001450; Grosse SD, 2019, J MED ECON, V22, P501, DOI 10.1080/13696998.2018.1542520; Karve S, 2013, VACCINE, V31, P3370, DOI 10.1016/j.vaccine.2013.04.081; Luo FJ, 2017, MMWR-MORBID MORTAL W, V66, P1, DOI 10.15585/mmwr.mm6601a1; MarketScan Research Databases, 2016, MARKETSCAN USER GUID; Miller, 2014, MED WORK LOSS COST E; Monuteaux MC, 2017, J TRAUMA ACUTE CARE, V83, P310, DOI [10.1097/TA.0000000000001525, 10.1097/ta.0000000000001525]; National Center for Health Statistics, 2018, INT CLASSIFICATION D; National Center for Injury Prevention and Control, 2019, WEB BAS INJ STAT QUE; Peterson C, 2021, INJURY PREV, V27, P24, DOI 10.1136/injuryprev-2019-043544; Peterson C, 2018, CHILD ABUSE NEGLECT, V86, P178, DOI 10.1016/j.chiabu.2018.09.018; Peterson C, 2018, AM J PREV MED, V55, P433, DOI 10.1016/j.amepre.2018.04.049; Peterson C, 2017, AM J PREV MED, V52, P691, DOI 10.1016/j.amepre.2016.11.014; Social Security Administration, 2019, UND SUPPL SEC INC; Song X, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0925-x; US Bureau of Economic Analysis, 2019, TABLE 114 PRICE INDE; US Bureau of Economic Analysis, 2018, HLTH CAR SAT ACC BLE; US Centers for Disease Control and Prevention, 2010, REC FRAM E COD GROUP; Wang L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002348; Yu JS, 2016, LEUKEMIA LYMPHOMA, V57, P2636, DOI 10.3109/10428194.2016.1161187	23	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2021	27	2					111	117		10.1136/injuryprev-2019-043607			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	RF3UC	WOS:000634765600003	32366517	Green Accepted			2022-02-06	
J	Schon, SN; Skalicky, N; Sharma, N; Zumofen, DW; Thieringer, FM				Schon, Stephan N.; Skalicky, Nicolas; Sharma, Neha; Zumofen, Daniel W.; Thieringer, Florian M.			3D-Printer-Assisted Patient-Specific Polymethyl Methacrylate Cranioplasty: A Case Series of 16 Consecutive Patients	WORLD NEUROSURGERY			English	Article						3D-printing; Cranioplasty; Patient specific implant; PMMA		BACKGROUND: To develop a novel 3D-printer-assisted method to fabricate patient-specific implants for cranioplasty and to demonstrate its feasibility and its use in 16 consecutive cases. METHODS: We report on 16 consecutive patients who have undergone cranioplasty surgery for an extensive skull defect after decompressive surgery and in which the bone flap was not available. We present the workflow for the implant production using a 3D-printer-assisted molding technique. Preoperative, intraoperative, and postoperative data were analyzed/evaluated. RESULTS: Eleven out of our 16 patients (68.7%) presented with extensive hemispheric bone defects. Indication for initial craniotomy were traumatic brain injury (4; 25%), acute subdural hematoma (4; 25%), ischemic stroke (3; 18.8%), tumor (3; 18.8%), and ruptured aneurysm (2; 12.5%). Median (range) operation time was 121 (89e206) minutes. Median (range) intraoperative blood loss was 300 (100-3300) mL. The mean (range) follow-up period is 6 (0e21) months. Complications occurred in 7 out of our 16 patients (43.8%), in 6 (37.5%) of which a reoperation was required to evacuate an extra-axial hematoma (3; 50%), for shunting of an epidural fluid collection (1; 16.7%), or for skin flap necrosis (1; 16.7%). One patient (16.7%) developed a chronic asymptomatic subdural fluid collection that was stable over the followup period. CONCLUSIONS: Our workflow to intraoperatively produce patient-specific implants in a timely manner to cover cranial defects proved to be feasible. The results are cosmetically appealing, and postoperative CT scans show well-fitting implants. As implantable printable substrates are already available, we aim to advance and certify 3Dprinted patient-specific implants in the near future.	[Schon, Stephan N.] Univ Basel, Univ Hosp Basel, Dept Neurosurg & Spine Surg, Basel, Switzerland; [Skalicky, Nicolas] Univ Bern, Univ Hosp Bern, Dept Diagnost & Intervent Neuroradiol, Inselspital, Bern, Switzerland; [Zumofen, Daniel W.] SUNY Downstate Univ, Maimonides Med Ctr, Dept Neurol, Dept Surg, Brooklyn, NY USA; [Zumofen, Daniel W.] SUNY Downstate Univ, Maimonides Med Ctr, Dept Radiol, New York, NY USA; [Sharma, Neha; Thieringer, Florian M.] Univ Basel, Univ Hosp Basel, Dept Craniomaxillofacial Surg, Basel, Switzerland; [Sharma, Neha; Thieringer, Florian M.] Univ Basel, Univ Hosp Basel, 3D Print Lab, Basel, Switzerland; [Sharma, Neha; Thieringer, Florian M.] Univ Basel, Dept Biomed Engn, Med Addit Mfg Res Grp, Basel, Switzerland		Schon, SN (corresponding author), Univ Basel, Univ Hosp Basel, Dept Neurosurg & Spine Surg, Basel, Switzerland.		Thieringer, Florian M./H-7460-2019; Sharma, Neha/AAS-5267-2020	Thieringer, Florian M./0000-0003-3035-9308; Sharma, Neha/0000-0003-3299-0945			Chamo D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030832; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Fan MC, 2018, WORLD NEUROSURG, V109, pE853, DOI 10.1016/j.wneu.2017.10.112; Fischer CM, 2012, NEUROL RES, V34, P281, DOI 10.1179/1743132812Y.0000000007; Hay JA, 2017, WORLD NEUROSURG, V105, P971, DOI 10.1016/j.wneu.2017.05.007; Honigmann P, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4520636; Kim BJ, 2012, J KOREAN NEUROSURG S, V52, P541, DOI 10.3340/jkns.2012.52.6.541; Lemee JM, 2013, NEUROCHIRURGIE, V59, P60, DOI 10.1016/j.neuchi.2012.10.138; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; Manrique OJ, 2015, J CRANIOFAC SURG, V26, P663, DOI 10.1097/SCS.0000000000001443; Marbacher S, 2012, NEUROSURG REV, V35, P527, DOI 10.1007/s10143-012-0376-3; Morales-Gomez JA, 2019, J NEUROSURG, V130, P1721, DOI 10.3171/2017.12.JNS172574; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Msallem B, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001582; Poukens J, 2008, INT J MED ROBOT COMP, V4, P46, DOI 10.1002/rcs.171; Rotaru H, 2012, J ORAL MAXIL SURG, V70, pE169, DOI 10.1016/j.joms.2011.09.036; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shiban E, 2020, NEUROSURG REV, V43, P217, DOI 10.1007/s10143-018-1038-x; Tan ETW, 2016, J NEUROSURG, V124, P1531, DOI 10.3171/2015.5.JNS15119; Zheng WJ, 2019, WORLD NEUROSURG, V127, pE1166, DOI 10.1016/j.wneu.2019.04.079	20	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E356	E362		10.1016/j.wneu.2020.12.138			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900041	33418118	hybrid			2022-02-06	
J	Sorg, SF; Merritt, VC; Clark, AL; Werhane, ML; Holiday, KA; Schiehser, DM; Bondi, M; Delano-Wood, L				Sorg, Scott F.; Merritt, Victoria C.; Clark, Alexandra L.; Werhane, Madeleine L.; Holiday, Kelsey A.; Schiehser, Dawn M.; Bondi, Mark; Delano-Wood, Lisa			Elevated Intraindividual Variability in Executive Functions and Associations with White Matter Microstructure in Veterans with Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain concussion; TBI; Mild TBI; mTBI; Cognition; Assessment; Patient outcome; diffusion tensor imaging; Neuroimaging; Executive control		Objective: We examined whether intraindividual variability (IIV) across tests of executive functions (EF-IIV) is elevated in Veterans with a history of mild traumatic brain injury (mTBI) relative to military controls (MCs) without a history of mTBI. We also explored relationships among EF-IIV, white matter microstructure, and posttraumatic stress disorder (PTSD) symptoms. Method: A total of 77 Veterans (mTBI = 43, MCs = 34) completed neuropsychological testing, diffusion tensor imaging (DTI), and PTSD symptom ratings. EF-IIV was calculated as the standard deviation across six tests of EF, along with an EF-Mean composite. DSI Studio connectometry analysis identified white matter tracts significantly associated with EF-IIV according to generalized fractional anisotropy (GFA). Results: After adjusting for EF-Mean and PTSD symptoms, the mTBI group showed significantly higher EF-IIV than MCs. Groups did not differ on EF-Mean after adjusting for PTSD symptoms. Across groups, PTSD symptoms significantly negatively correlated with EF-Mean, but not with EF-IIV. EF-IIV significantly negatively correlated with GFA in multiple white matter pathways connecting frontal and more posterior regions. Conclusions: Veterans with mTBI demonstrated significantly greater IIV across EF tests compared to MCs, even after adjusting for mean group differences on those measures as well as PTSD severity. Findings suggest that, in contrast to analyses that explore effects of mean performance across tests, discrepancy analyses may capture unique variance in neuropsychological performance and more sensitively capture cognitive disruption in Veterans with mTBI histories. Importantly, findings show that EF-IIV is negatively associated with the microstructure of white matter pathways interconnecting cortical regions that mediate executive function and attentional processes.	[Sorg, Scott F.; Merritt, Victoria C.; Clark, Alexandra L.; Schiehser, Dawn M.; Bondi, Mark; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Psychol & Res Serv, San Diego, CA 92161 USA; [Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Werhane, Madeleine L.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Holiday, Kelsey A.] San Diego State Univ Univ Calif San Diego SDSU UC, San Diego, CA 92103 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst, 151B,3350 Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu		Merritt, Victoria/0000-0001-5683-4168	Veterans AffairsUS Department of Veterans Affairs [CDA-2-034-07F, CDA-2-065-10S, CX000842-01A2]; VA Clinical Science Research Development [CX001508]; VA Clinical Science Research & Development Service [IK2 CX001952]; Department of Defense Investigator-Initiated Research GrantUnited States Department of Defense [W81XWH10-2-0169]	The authors sincerely thank the OEF/OIF (Operation Enduring Freedom/Operation Iraqi Freedom) Veterans who volunteered to participate in this study. This work was supported by Veterans Affairs research grants including Career Development Awards to Drs. Delano-Wood (CDA-2-034-07F) and Schiehser (CDA-2-065-10S), a Veterans Affairs Merit Award to Dr. Delano-Wood (CX000842-01A2), and a Department of Defense Investigator-Initiated Research Grant awarded to Dr. Delano-Wood (W81XWH10-2-0169). This material was further supported by resources of the Veterans Affairs Center of Excellence for Stress and Mental Health. Dr. Sorg received salary support from a VA Clinical Science Research & Development funded Career Development Award (CX001508) during the preparation of this manuscript, and Dr. Merritt received salary support during this work from a Career Development Award (IK2 CX001952) from the VA Clinical Science Research & Development Service.	Bangen KJ, 2019, NEUROPSYCHOLOGY, V33, P599, DOI 10.1037/neu0000532; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Clouston Sean, 1800, Alzheimers Dement (N Y), V3, P593, DOI 10.1016/j.trci.2017.09.001; Cole WR, 2018, J INT NEUROPSYCH SOC, V24, P156, DOI 10.1017/S1355617717001187; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Hines LJ, 2016, BRAIN IMAGING BEHAV, V10, P640, DOI 10.1007/s11682-015-9441-1; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jones JD, 2018, NEUROPSYCHOLOGY, V32, P206, DOI 10.1037/neu0000390; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kongs K. S., 2000, WISCONSIN CARD SORTI; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Morgan EE, 2011, NEUROPSYCHOLOGY, V25, P645, DOI 10.1037/a0023792; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Tanner-Eggen C, 2015, ARCH CLIN NEUROPSYCH, V30, P217, DOI 10.1093/arclin/acv008; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Traumatic Brain Injury Task Force, 2009, REP SURG GEN TBI TAS; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers F, 1991, PTSD CHECKLIST MILIT, P42; Yeh FC, 2019, NEUROTHERAPEUTICS, V16, P52, DOI 10.1007/s13311-018-0663-y; Yeh FC, 2016, NEUROIMAGE, V125, P162, DOI 10.1016/j.neuroimage.2015.10.053; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2013, NEUROIMAGE-CLIN, V2, P912, DOI 10.1016/j.nicl.2013.06.014; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	52	4	4	1	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2021	27	4					305	314	PII S1355617720000879	10.1017/S1355617720000879			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	RI2QN	WOS:000636754200001	32967755	Green Accepted			2022-02-06	
J	Aamodt, AH; Hogestol, EA; Popperud, TH; Holter, JC; Dyrhol-Riise, AM; Tonby, K; Stiksrud, B; Quist-Paulsen, E; Berge, T; Barratt-Due, A; Aukrust, P; Heggelund, L; Blennow, K; Zetterberg, H; Harbo, HF				Aamodt, Anne Hege; Hogestol, Einar August; Popperud, Trine Haug; Holter, Jan Cato; Dyrhol-Riise, Anne Ma; Tonby, Kristian; Stiksrud, Birgitte; Quist-Paulsen, Else; Berge, Tone; Barratt-Due, Andreas; Aukrust, Pal; Heggelund, Lars; Blennow, Kaj; Zetterberg, Henrik; Harbo, Hanne Flinstad			Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19	JOURNAL OF NEUROLOGY			English	Article						SARS-CoV-2; COVID-19; Neurofilament light; Glial fibrillary acidic protein; Mortality	TRAUMATIC BRAIN-INJURY; BIOMARKER	Objective To test the hypotheses that blood biomarkers for nervous system injury, serum concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) can serve as biomarkers for disease severity in COVID-19 patients. Methods Forty-seven inpatients with confirmed COVID-19 had blood samples drawn on admission for assessing serum biomarkers of CNS injury by Single molecule array (Simoa), NfL and GFAp. Concentrations of NfL and GFAp were analyzed in relation to symptoms, clinical signs, inflammatory biomarkers and clinical outcomes. We used multivariate linear models to test for differences in biomarker concentrations in the subgroups, accounting for confounding effects. Results In total, 21% (n = 10) of the patients were admitted to an intensive care unit, and the overall mortality rate was 13% (n = 6). Non-survivors had higher serum concentrations of NfL (p < 0.001) upon admission than patients who were discharged alive both in adjusted analyses (p = 2.6 x 10(-7)) and unadjusted analyses (p = 0.001). The concentrations of NfL in non-survivors increased over repeated measurements; whereas, the concentrations in survivors were stable. The GFAp concentration was also significantly higher in non-survivors than survivors (p = 0.02). Conclusion Increased concentrations of NfL and GFAp in COVID-19 patients on admission may indicate increased mortality risk. Measurement of blood biomarkers for nervous system injury can be useful to detect and monitor CNS injury in COVID-19.	[Aamodt, Anne Hege; Hogestol, Einar August; Popperud, Trine Haug; Harbo, Hanne Flinstad] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Hogestol, Einar August; Holter, Jan Cato; Dyrhol-Riise, Anne Ma; Tonby, Kristian; Aukrust, Pal; Harbo, Hanne Flinstad] Univ Oslo, Inst Clin Med, Oslo, Norway; [Holter, Jan Cato; Quist-Paulsen, Else] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Dyrhol-Riise, Anne Ma; Tonby, Kristian; Stiksrud, Birgitte] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Berge, Tone] Oslo Metropolitan Univ, Dept Mech Elect & Chem Engn, Oslo, Norway; [Berge, Tone] Oslo Univ Hosp, Dept Res Innovat & Educ, Oslo, Norway; [Barratt-Due, Andreas] Oslo Univ Hosp, Div Emergencies & Crit Care, Rigshosp, Oslo, Norway; [Barratt-Due, Andreas; Aukrust, Pal] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Heggelund, Lars] Vestre Viken Hosp Trust, Drammen Hosp, Dept Internal Med, Drammen, Norway; [Heggelund, Lars] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Blennow, Kaj] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Aamodt, AH (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	a.h.aamodt@medisin.uio.no		Aamodt, Anne Hege/0000-0002-2824-2760	University of Oslo (Oslo University Hospital); Oslo University Hospital, Research Council of Norway [312780]	Open access funding provided by University of Oslo (incl Oslo University Hospital). Supported by Oslo University Hospital, Research Council of Norway Grant no. 312780, Vivaldi Invest A/S owned by Jon Stephenson von Tetzchner.	Aamodt AH., 2020, TIDSSKR LAEGEFOREN, V140, P89; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Deiner S, 2020, BRIT J ANAESTH, V125, P282, DOI 10.1016/j.bja.2020.04.085; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Ferrarese C, 2020, NEUROL SCI, V41, P1355, DOI 10.1007/s10072-020-04450-1; Frontera J, 2020, NEUROCRIT CARE, V33, P25, DOI 10.1007/s12028-020-00995-3; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gafson AR, 2020, BRAIN, V143, P1975, DOI 10.1093/brain/awaa098; Giovannoni G, 2018, BRAIN, V141, P2235, DOI 10.1093/brain/awy200; Heneka MT, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00640-3; Kanberg N, 2020, NEUROLOGY, V95, pE1754, DOI 10.1212/WNL.0000000000010111; Li X-L., 2020, THER ADV NEUROL DISO, V13, p1756286420917830, DOI DOI 10.1177/1756286420917830; Mao L., 2020, JAMA NEUROL, V77, P1, DOI DOI 10.1001/jamaneurol.2020.1127; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; R Core Team, 2017, R LANG ENV STAT COMP; Sutter R, 2021, ANN NEUROL, V89, P610, DOI 10.1002/ana.26004; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Verde F, 2019, J NEUROL NEUROSUR PS, V90, P157, DOI 10.1136/jnnp-2018-318704; Virhammar J, 2020, NEUROLOGY, V95, P445, DOI 10.1212/WNL.0000000000010250; Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065	26	4	4	1	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2021	268	10					3574	3583		10.1007/s00415-021-10517-6		MAR 2021	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU7HZ	WOS:000630854900002	33743046	hybrid, Green Published, Green Submitted			2022-02-06	
J	Ved, R; Sharouf, F; Harari, B; Muzaffar, M; Manivannan, S; Ormonde, C; Gray, WP; Zaben, M				Ved, R.; Sharouf, F.; Harari, B.; Muzaffar, M.; Manivannan, S.; Ormonde, C.; Gray, W. P.; Zaben, M.			Disulfide HMGB1 acts via TLR2/4 receptors to reduce the numbers of oligodendrocyte progenitor cells after traumatic injury in vitro	SCIENTIFIC REPORTS			English	Article								Traumatic brain injury (TBI) is associated with poor clinical outcomes; autopsy studies of TBI victims demonstrate significant oligodendrocyte progenitor cell (OPC) death post TBI; an observation, which may explain the lack of meaningful repair of injured axons. Whilst high-mobility group box-1 (HMGB1) and its key receptors TLR2/4 are identified as key initiators of neuroinflammation post-TBI, they have been identified as attractive targets for development of novel therapeutic approaches to improve post-TBI clinical outcomes. In this report we establish unequivocal evidence that HMGB1 released in vitro impairs OPC response to mechanical injury; an effect that is pharmacologically reversible. We show that needle scratch injury hyper-acutely induced microglial HMGB1 nucleus-to-cytoplasm translocation and subsequent release into culture medium. Application of injury-conditioned media resulted in significant decreases in OPC number through anti-proliferative effects. This effect was reversed by co-treatment with the TLR2/4 receptor antagonist BoxA. Furthermore, whilst injury conditioned medium drove OPCs towards an activated reactive morphology, this was also abolished after BoxA co-treatment. We conclude that HMGB1, through TLR2/4 dependant mechanisms, may be detrimental to OPC proliferation following injury in vitro, negatively affecting the potential for restoring a mature oligodendrocyte population, and subsequent axonal remyelination. Further study is required to assess how HMGB1-TLR signalling influences OPC maturation and myelination capacity.	[Ved, R.; Sharouf, F.; Harari, B.; Muzaffar, M.; Manivannan, S.; Ormonde, C.; Gray, W. P.; Zaben, M.] Neurosci & Mental Hlth Res Inst, Haydn Ellis Bldg, Cardiff CF24 4HQ, Wales; [Gray, W. P.; Zaben, M.] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci DPMCN, Cardiff CF24 4HQ, Wales		Zaben, M (corresponding author), Neurosci & Mental Hlth Res Inst, Haydn Ellis Bldg, Cardiff CF24 4HQ, Wales.; Zaben, M (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci DPMCN, Cardiff CF24 4HQ, Wales.	zabenm@cf.ac.uk		Gray, William/0000-0001-7595-8887	Royal College of Surgeons one-year clinical fellowship grant	This work was supported by a Royal College of Surgeons one-year clinical fellowship grant.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Back SA, 2004, SEMIN PERINATOL, V28, P405, DOI 10.1053/j.semperi.2004.10.010; Back SA, 1997, MENT RETARD DEV D R, V3, P96, DOI 10.1002/(SICI)1098-2779(1997)3:1<96::AID-MRDD12>3.0.CO;2-M; Barral-Moran MJ, 2003, J NEUROSCI RES, V72, P679, DOI 10.1002/jnr.10627; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buss A, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-32; Chen PH, 2008, BRAIN RES, V1243, P27, DOI 10.1016/j.brainres.2008.09.029; Chen XD, 2019, EXP NEUROL, V311, P1, DOI 10.1016/j.expneurol.2018.09.007; Choi JY, 2017, P NATL ACAD SCI USA, V114, pE4987, DOI 10.1073/pnas.1702035114; Choi JY, 2014, NEUROBIOL AGING, V35, P1643, DOI 10.1016/j.neurobiolaging.2014.01.146; Cummings Brian S, 2004, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1208s25; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Hackett AR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00199; Hayakawa K, 2016, J CEREBR BLOOD F MET, V36, P781, DOI 10.1177/0271678X15606148; Hayakawa K, 2013, J NEUROCHEM, V125, P273, DOI 10.1111/jnc.12120; Jin X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24385-0; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kerman BE, 2015, DEVELOPMENT, V142, P2213, DOI 10.1242/dev.116517; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lyons DA., 2019, OLIGODENDROCYTES MET, DOI [10.1007/978-1-4939-9072-6, DOI 10.1007/978-1-4939-9072-6]; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Manivannan S, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100760; Mattugini N, 2018, GLIA, V66, P1644, DOI 10.1002/glia.23329; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Michalski JP, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00310, 10.3389/fncel.2015.00340]; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Nielsen HM, 2014, ACTA NEUROPATHOL, V2, P1, DOI [10.1186/2051-5960-2-1, DOI 10.1186/2051-5960-2-1]; Nishiyama A, 1997, J NEUROSCI RES, V48, P299, DOI 10.1002/(SICI)1097-4547(19970515)48:4<299::AID-JNR2>3.0.CO;2-6; Parker TM, 2017, BRAIN INJURY, V31, P2, DOI 10.1080/02699052.2016.1217045; Parrish William, 2007, Methods Mol Biol, V361, P145; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Pereira PD, 2017, ONCOTARGET, V8, P40514, DOI 10.18632/oncotarget.17121; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Poon PY., 2017, J VIS EXP, V121, P55411; Reynolds R, 2001, Prog Brain Res, V132, P165; Richard SA., 2017, J BEHAV BRAIN SCI, V7, P50, DOI [10.4236/jbbs.2017.72006, DOI 10.4236/JBBS.2017.72006]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Stevens NE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06205-z; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Voskuhl RR, 2019, P NATL ACAD SCI USA, V116, P10130, DOI 10.1073/pnas.1821306116; Walker LE, 2017, J CLIN INVEST, V127, P2118, DOI 10.1172/JCI92001; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Weber MD, 2015, J NEUROSCI, V35, P316, DOI 10.1523/JNEUROSCI.3561-14.2015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu D, 2005, J NEUROCYTOL, V34, P459, DOI 10.1007/s11068-006-8998-4; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Yang LJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2532, DOI 10.1159/000489659; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108646; Zhang J, 2016, J NEUROPATH EXP NEUR, V75, P527, DOI 10.1093/jnen/nlw030	70	4	4	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 17	2021	11	1							6181	10.1038/s41598-021-84932-0			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ1RI	WOS:000630511700025	33731757	Green Accepted, gold, Green Published			2022-02-06	
J	Kawoos, U; Abutarboush, R; Gu, M; Chen, Y; Statz, JK; Goodrich, SY; Ahlers, ST				Kawoos, Usmah; Abutarboush, Rania; Gu, Ming; Chen, Ye; Statz, Jonathan K.; Goodrich, Samantha Y.; Ahlers, Stephen T.			Blast-induced temporal alterations in blood-brain barrier properties in a rodent model	SCIENTIFIC REPORTS			English	Article								The consequences of blast-induced traumatic brain injury (bTBI) on the blood-brain barrier (BBB) and components of the neurovascular unit are an area of active research. In this study we assessed the time course of BBB integrity in anesthetized rats exposed to a single blast overpressure of 130 kPa (18.9 PSI). BBB permeability was measured in vivo via intravital microscopy by imaging extravasation of fluorescently labeled tracers (40 kDa and 70 kDa molecular weight) through the pial microvasculature into brain parenchyma at 2-3 h, 1, 3, 14, or 28 days after the blast exposure. BBB structural changes were assessed by immunostaining and molecular assays. At 2-3 h and 1 day after blast exposure, significant increases in the extravasation of the 40 kDa but not the 70 kDa tracers were observed, along with differential reductions in the expression of tight junction proteins (occludin, claudin-5, zona occluden-1) and increase in the levels of the astrocytic water channel protein, AQP-4, and matrix metalloprotease, MMP-9. Nearly all of these measures were normalized by day 3 and maintained up to 28 days post exposure. These data demonstrate that blast-induced changes in BBB permeability are closely coupled to structural and functional components of the BBB.	[Kawoos, Usmah; Abutarboush, Rania; Gu, Ming; Chen, Ye; Statz, Jonathan K.; Goodrich, Samantha Y.; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Kawoos, Usmah; Abutarboush, Rania; Gu, Ming; Chen, Ye; Statz, Jonathan K.; Goodrich, Samantha Y.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA		Kawoos, U (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.; Kawoos, U (corresponding author), Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA.	Usmah.kawoos.ctr@mail.mil					Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; Abutarboush Rania, 2013, Curr Drug Discov Technol, V10, P315; Agimi Y, 2019, MIL MED, V184, pE233, DOI 10.1093/milmed/usy313; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1996, J TRAUMA, V40, pS148, DOI 10.1097/00005373-199603001-00032; Cernak I, 1991, Vojnosanit Pregl, V48, P507; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Crowley RW, 2008, DRUG DISCOV TODAY, V13, P254, DOI 10.1016/j.drudis.2007.11.010; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD WORLDW NUMB TBI; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Francesca B, 2010, CURR NEUROPHARMACOL, V8, P92, DOI 10.2174/157015910791233132; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Haorah J, 2005, ALCOHOL CLIN EXP RES, V29, P999, DOI 10.1097/01.ALC.0000166944.79914.0A; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Herold R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215393; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jiao XY, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/860120; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kawoos U, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00650; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Keep RF, 2018, J CEREBR BLOOD F MET, V38, P1255, DOI 10.1177/0271678X18774666; Keep RF, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-18; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Michinaga S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030571; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Miller F, 2012, VIRULENCE, V3, P222, DOI 10.4161/viru.19697; Min H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0116-z; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Moon-Massat Paula F, 2014, Curr Drug Discov Technol, V11, P220; Nadeau CA, 2019, TRANSL STROKE RES, V10, P287, DOI 10.1007/s12975-018-0636-9; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Neuschmelting V, 2009, ACTA NEUROCHIR, V151, P795, DOI 10.1007/s00701-009-0350-1; Ostrow LW, 2000, J CARDIOVASC PHARM, V36, pS274; Ostrow LW, 2011, BIOCHEM BIOPH RES CO, V410, P81, DOI 10.1016/j.bbrc.2011.05.109; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Price L., 2016, TRANSLATIONAL RES TR; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Reinhard SM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00280; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Thomsen MS, 2017, J CEREBR BLOOD F MET, V37, P3300, DOI 10.1177/0271678X17722436; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Wang HH, 2011, J CELL PHYSIOL, V226, P2244, DOI 10.1002/jcp.22560; Wang JM, 2016, CHIN J TRAUMATOL, V19, P125, DOI 10.1016/j.cjtee.2016.03.001; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Yamazaki Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091965; Yau B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113555; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; ZIV I, 1992, STROKE, V23, P1014, DOI 10.1161/01.STR.23.7.1014; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	95	4	4	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 15	2021	11	1							5906	10.1038/s41598-021-84730-8			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ1SR	WOS:000630515200011	33723300	Green Published, gold			2022-02-06	
J	Lindblad, C; Pin, E; Just, D; Al Nimer, F; Nilsson, P; Bellander, BM; Svensson, M; Piehl, F; Thelin, EP				Lindblad, Caroline; Pin, Elisa; Just, David; Al Nimer, Faiez; Nilsson, Peter; Bellander, Bo-Michael; Svensson, Mikael; Piehl, Fredrik; Thelin, Eric Peter			Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study	CRITICAL CARE			English	Article						Traumatic brain injury; Protein biomarkers; Proteomics; Neuroinflammation; Blood-brain barrier; Apolipoprotein E4; Glasgow Outcome Score; Human	VENTRICULAR CEREBROSPINAL-FLUID; MEMBRANE ATTACK COMPLEX; MULTIPLEX ASSESSMENT; DYSFUNCTION; BIOMARKERS; SYSTEM; ACTIVATION; INHIBITION; MANAGEMENT; BREAKDOWN	Background: Severe traumatic brain injury (TBI) is associated with blood-brain barrier (BBB) disruption and a subsequent neuroinflammatory process. We aimed to perform a multiplex screening of brain enriched and inflammatory proteins in blood and cerebrospinal fluid (CSF) in order to study their role in BBB disruption, neuroinflammation and long-term functional outcome in TBI patients and healthy controls. Methods: We conducted a prospective, observational study on 90 severe TBI patients and 15 control subjects. Clinical outcome data, Glasgow Outcome Score, was collected after 6-12 months. We utilized a suspension bead antibody array analyzed on a FlexMap 3D Luminex platform to characterize 177 unique proteins in matched CSF and serum samples. In addition, we assessed BBB disruption using the CSF-serum albumin quotient (Q(A)), and performed Apolipoprotein E-genotyping as the latter has been linked to BBB function in the absence of trauma. We employed pathway-, cluster-, and proportional odds regression analyses. Key findings were validated in blood samples from an independent TBI cohort. Results: TBI patients had an upregulation of structural CNS and neuroinflammatory pathways in both CSF and serum. In total, 114 proteins correlated with Q(A), among which the top-correlated proteins were complement proteins. A cluster analysis revealed protein levels to be strongly associated with BBB integrity, but not carriage of the Apolipoprotein E4-variant. Among cluster-derived proteins, innate immune pathways were upregulated. Forty unique proteins emanated as novel independent predictors of clinical outcome, that individually explained similar to 10% additional model variance. Among proteins significantly different between TBI patients with intact or disrupted BBB, complement C9 in CSF (p = 0.014, Delta R-2 = 7.4%) and complement factor B in serum (p = 0.003, Delta R-2 = 9.2%) were independent outcome predictors also following step-down modelling. Conclusions: This represents the largest concomitant CSF and serum proteomic profiling study so far reported in TBI, providing substantial support to the notion that neuroinflammatory markers, including complement activation, predicts BBB disruption and long-term outcome. Individual proteins identified here could potentially serve to refine current biomarker modelling or represent novel treatment targets in severe TBI.	[Lindblad, Caroline; Al Nimer, Faiez; Bellander, Bo-Michael; Svensson, Mikael; Piehl, Fredrik; Thelin, Eric Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Pin, Elisa; Just, David; Nilsson, Peter] KTH Royal Inst Technol, Div Affin Prote, Dept Prot Sci, SciLifeLab, Stockholm, Sweden; [Al Nimer, Faiez; Piehl, Fredrik] Stockholm Hlth Serv, Acad Specialist Ctr, Ctr Neurol, Stockholm, Sweden; [Bellander, Bo-Michael; Svensson, Mikael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Thelin, Eric Peter] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden		Lindblad, C (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	caroline.lindblad@ki.se	Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364; Al Nimer, Faiez/0000-0003-0937-5995	Karolinska InstituteKarolinska Institutet; Research Internship Program [K825715022, K825715052]; Swedish Brain Foundation [FO2019-0006]; Stockholm County ALF [20120560]; Karolinska Institute Funds Clinical Scientist Training Program	Open access funding provided by Karolinska Institute. We would like to acknowledge funders who enabled this work. CL received funding for this study through the Karolinska Institute Funds Clinical Scientist Training Program and Research Internship Program (grant numbers K825715022, K825715052). EPT received salary from the Swedish Society for Medical Research Post-Doctoral Scholarship (grant number N/A) and the Swedish Brain Foundation (grant number: FO2019-0006). BMB received grants from Stockholm County ALF (grant number 20120560). The funders did not participate in study design/conceptualization, data acquisition, data analysis/interpretation, manuscript compilation, or submission decision.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abu Hamdeh S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25060-0; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; [Anonymous], STEP BY STEP EXECUTI; [Anonymous], The human brain-The Human Protein Atlas; Auguie B., 2017, MISCELLANEOUS FUNCTI; Bao WX, 2018, EXPERT REV MOL DIAGN, V18, P761, DOI 10.1080/14737159.2018.1471985; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Brettschneider J, 2005, J NEUROL, V252, P1067, DOI 10.1007/s00415-005-0817-9; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Champely S, 2018, PWR BASIC FUNCTIONS; Chen H, 2018, VennDiagram: generate high-resolution Venn and Euler plots; Chen XN, 1999, GENOME RES, V9, P492; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cohen J., 2013, STAT POWER ANAL BEHA; Collaborators. HPA, 2005, HUMAN PROTEIN ATLAS; Connor David E Jr, 2017, Pathophysiology, V24, P169, DOI 10.1016/j.pathophys.2017.04.003; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Dinet V., 2019, FRONT NEUROSCI-SWITZ, V13, P1; Drobin Kimi, 2013, Methods Mol Biol, V1023, P137, DOI 10.1007/978-1-4614-7209-4_8; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Harrell FE, 2019, RMS REGRESSION MODEL; He XY., 2019, FRONT NEUROSCI-SWITZ, V13, P1; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; HOLM S, 1979, SCAND J STAT, V6, P65; HPA Collaborators, STMN4 PROT EXPR SUMM; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isung J., 2016, THESIS KAROLINSKA I; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Karolinska University Hospital Laboratory, ALB CSV S; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Krijthe J.H., 2015, RTSNE T DISTRIBUTED; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Lemarchant S, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P235, DOI 10.1016/B978-0-12-803196-4.00013-8; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lindblad C, 2020, J NEUROTRAUMA, V11, P1; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Montagne A, 2020, NATURE, V581, P70, DOI 10.1038/s41586-020-2247-3; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Murad H, 2003, AM STAT, V57, P155, DOI 10.1198/0003130031892; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakazawa T, 2005, BRAIN RES, V1061, P97, DOI 10.1016/j.brainres.2005.08.055; NeimanKungliaTekniskaHogskolan M, BEAD BASED PROTEIN P; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Neuwirth Erich, 2014, CRAN; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pin E, 2019, METHODS MOL BIOL, V2044, P303, DOI 10.1007/978-1-4939-9706-0_19; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramakrishnan S, 2014, J NEUROIMMUNE PHARM, V9, P142, DOI 10.1007/s11481-014-9531-7; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Schwenk JM, 2011, METHODS MOL BIOL, V723, P29, DOI 10.1007/978-1-61779-043-0_3; Shen WY, 2011, EUR J CELL BIOL, V90, P323, DOI 10.1016/j.ejcb.2010.10.013; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; Sjostedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130028; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Ulgen E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00858; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; WEISNER B, 1978, J NEUROL SCI, V37, P205, DOI 10.1016/0022-510X(78)90204-6; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wilke CO, COWPLOT STREAMLINED; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu BH, 2016, BRAIN RES, V1642, P344, DOI 10.1016/j.brainres.2016.04.008; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	103	4	5	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	MAR 12	2021	25	1							103	10.1186/s13054-021-03503-x			18	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV8KH	WOS:000628212800001	33712077	Green Submitted, gold, Green Published			2022-02-06	
J	Wu, LP; Gong, ZW				Wu, Liangpeng; Gong, Zaiwu			Can national carbon emission trading policy effectively recover GDP losses? A new linear programming-based three-step estimation approach	JOURNAL OF CLEANER PRODUCTION			English	Article						Carbon emission trading market; Carbon price; Carbon emission permit (CEP); CEP allocation Modes; GDP loss Recoveries	ABATEMENT COST; ENERGY EFFICIENCY; POTENTIAL GAINS; UNDESIRABLE OUTPUTS; QUOTA ALLOCATION; CO2 ABATEMENT; CHINA IRON; SCHEME; INDUSTRY; SAVINGS	With the implementation of China's national carbon trading market, concerns arose over how many gross domestic product (GDP) losses caused by carbon reduction could be recovered by trading carbon emissions. Accordingly, we proposed a new linear programming-based three-step estimation approach to systematically investigate four critical issues in carbon emissions trading. These are how to initially allocate carbon trading permits, set the carbon trading price, determine the amount of GDP loss recoveries that could be obtained from carbon trading, and how setting emission reduction targets. Our empirical results showed the following: (I) The allocation modes based on the sovereignty criterion and the ability-to-pay criterion resulted in the lowest (2.84%) and highest (24.56%) concussion impacts on GDP, respectively. (II) The optimal range of the carbon trading price was linked closely to the carbon emission reduction target. Specifically, when the reduction target was set at 10%, the estimated optimal carbon trading price was 256.2-394.8 Yuan/ton, which is higher than the price used in the carbon trading pilot market. (III) If the emission reduction target were set at more than 10%, China could recover at least 598.62 G Yuan of economic losses through the carbon trading market. (IV) From an economic perspective, the single allocation mode, the sovereignty-criterion-based allocation mode, was superior to the mixed allocation modes. We provide several suggestions for policymakers to implementing a carbon emissions trading market in China. (C) 2020 Elsevier Ltd. All rights reserved.	[Wu, Liangpeng; Gong, Zaiwu] Nanjing Univ Informat Sci & Technol, Coll Management Engn, Nanjing 210044, Peoples R China; [Wu, Liangpeng] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing 211106, Peoples R China		Wu, LP (corresponding author), Nanjing Univ Informat Sci & Technol, Coll Econ & Management, Nanjing 210016, Peoples R China.	1017379408@qq.com; 2748981325@qq.com			National Natural Science FundNational Natural Science Foundation of China (NSFC) [71273131, 71601096, 71871116]; Key Project of University Social Sciences Foundation of Jiangsu Province of China [2017ZDIXM083]; Postgraduate Research and Practice Innovation Programme of Jiangsu Province [KYCX18-0235]	Thanks are due to Dr. Liping Fang, Ginger K.Y, Haiyan Xu and Yuanqiao Li for their assistance with the writing and valuable discussion. This work is supported by grants from the National Natural Science Fund (71273131, 71601096 and 71871116), the Key Project of University Social Sciences Foundation of Jiangsu Province of China (2017ZDIXM083) and the Postgraduate Research and Practice Innovation Programme of Jiangsu Province (KYCX18-0235).	Bohringer C, 2005, EUR ECON REV, V49, P2041, DOI 10.1016/j.euroecorev.2004.06.006; Brannlund R., 2016, CEUR WORKSHOP PROC, V1621, P36, DOI [10.1023/A, DOI 10.1023/A]; Brannlund R, 2007, ENERG POLICY, V35, P4749, DOI 10.1016/j.enpol.2007.04.005; Clo S, 2010, ENERG POLICY, V38, P2420, DOI 10.1016/j.enpol.2009.12.035; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Dhamija AK, 2018, ENVIRON ECON POLICY, V20, P561, DOI 10.1007/s10018-017-0206-5; Fare R, 2014, RESOUR ENERGY ECON, V36, P99, DOI 10.1016/j.reseneeco.2013.11.004; Fare R, 2013, ENERG ECON, V40, P416, DOI 10.1016/j.eneco.2013.07.015; Feng CP, 2019, J OPER RES SOC, V70, P472, DOI 10.1080/01605682.2018.1447248; Gomes EG, 2008, J OPER RES SOC, V59, P616, DOI 10.1057/palgrave.jors.2602384; He WJ, 2018, ENERG ECON, V72, P62, DOI 10.1016/j.eneco.2018.03.025; Hepburn C, 2007, ANNU REV ENV RESOUR, V32, P375, DOI 10.1146/annurev.energy.32.053006.141203; Hubler M, 2014, ENERG POLICY, V75, P57, DOI 10.1016/j.enpol.2014.02.019; Jotzo F, 2014, ENERG POLICY, V75, P3, DOI 10.1016/j.enpol.2014.09.019; Lee CY, 2019, EUR J OPER RES, V273, P390, DOI 10.1016/j.ejor.2018.08.016; Lee JD, 2002, J ENVIRON MANAGE, V64, P365, DOI 10.1006/jema.2001.0480; Lee M, 2011, ENERG POLICY, V39, P6162, DOI 10.1016/j.enpol.2011.07.016; Li GY, 2017, APPL ENERG, V195, P837, DOI 10.1016/j.apenergy.2017.03.115; Li K, 2015, ENERG ECON, V48, P230, DOI 10.1016/j.eneco.2015.01.006; Li W, 2016, APPL ENERG, V174, P1, DOI 10.1016/j.apenergy.2016.04.086; Liu LW, 2016, APPL ENERG, V168, P594, DOI 10.1016/j.apenergy.2016.01.055; Reboredo JC, 2013, ENERG ECON, V36, P471, DOI 10.1016/j.eneco.2012.10.004; Song XN, 2018, ENERG POLICY, V118, P232, DOI 10.1016/j.enpol.2018.03.075; Sun JS, 2014, INT J PROD RES, V52, P419, DOI 10.1080/00207543.2013.829592; Tang L, 2015, ENERG POLICY, V81, P152, DOI 10.1016/j.enpol.2015.02.032; Wang K, 2018, EUR J OPER RES, V269, P35, DOI 10.1016/j.ejor.2017.04.053; Wang K, 2016, RENEW SUST ENERG REV, V65, P1005, DOI 10.1016/j.rser.2016.07.051; Wang K, 2016, OMEGA-INT J MANAGE S, V63, P48, DOI 10.1016/j.omega.2015.09.011; Wang K, 2014, APPL ENERG, V130, P617, DOI 10.1016/j.apenergy.2014.03.010; Wang QW, 2011, ENRGY PROCED, V5, P2316, DOI 10.1016/j.egypro.2011.03.398; Wang ZH, 2015, ENERG ECON, V49, P380, DOI 10.1016/j.eneco.2015.03.009; Wei YM, 2007, ENERGY, V32, P2262, DOI 10.1016/j.energy.2007.07.007; Weng QQ, 2018, RENEW SUST ENERG REV, V91, P613, DOI 10.1016/j.rser.2018.04.026; Wu LP, 2019, J CLEAN PROD, V207, P1007, DOI 10.1016/j.jclepro.2018.10.082; Wu LP, 2018, J CLEAN PROD, V198, P1431, DOI 10.1016/j.jclepro.2018.07.034; Wu LB, 2014, ENERG POLICY, V75, P22, DOI 10.1016/j.enpol.2014.04.022; Wu R, 2016, APPL ENERG, V184, P1114, DOI 10.1016/j.apenergy.2016.06.011; Yang L, 2016, ENERG POLICY, V98, P254, DOI 10.1016/j.enpol.2016.08.039; Yu YN, 2018, COMPUT ECON, V52, P1175, DOI 10.1007/s10614-017-9724-2; Zhang Jun, 2004, EC RES J, V50, P35; Zhang YJ, 2017, ANN OPER RES, V255, P117, DOI 10.1007/s10479-016-2232-2; Zhang YJ, 2017, ENERG POLICY, V100, P149, DOI 10.1016/j.enpol.2016.10.010; Zhang YJ, 2015, ENERG POLICY, V86, P176, DOI 10.1016/j.enpol.2015.07.004; Zhou P, 2016, ECOL ECON, V125, P47, DOI 10.1016/j.ecolecon.2016.03.001; Zhou P, 2013, APPL ENERG, V112, P1518, DOI 10.1016/j.apenergy.2013.04.013; Zhou X, 2015, ENERG POLICY, V77, P109, DOI 10.1016/j.enpol.2014.12.009; Zhu BZ, 2017, ENERG POLICY, V107, P309, DOI 10.1016/j.enpol.2017.04.051; Zhu L, 2017, ENERG ECON, V63, P332, DOI 10.1016/j.eneco.2017.02.004	48	4	4	13	30	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-6526	1879-1786		J CLEAN PROD	J. Clean Prod.	MAR 10	2021	287								125052	10.1016/j.jclepro.2020.125052			17	Green & Sustainable Science & Technology; Engineering, Environmental; Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics; Engineering; Environmental Sciences & Ecology	PY2QC	WOS:000611892400006					2022-02-06	
J	Jarrin, S; Cabre, S; Dowd, E				Jarrin, Sarah; Cabre, Silvia; Dowd, Eilis			The potential of biomaterials for central nervous system cellular repair	NEUROCHEMISTRY INTERNATIONAL			English	Article						Brain repair; Cell therapy; Biomaterials; Hydrogels		The central nervous system (CNS) can be injured or damaged through a variety of insults including traumatic injury, stroke, and neurodegenerative or demyelinating diseases, including Alzheimer?s disease, Parkinson?s disease and multiple sclerosis. Existing pharmacological and other therapeutics strategies are limited in their ability to repair or regenerate damaged CNS tissue meaning there are significant unmet clinical needs facing patients suffering CNS damage and/or degeneration. Through a variety of mechanisms including neuronal replacement, secretion of therapeutic factors, and stimulation of host brain plasticity, cell-based repair offers a potential mechanism to repair and heal the damaged CNS. However, over the decades of its evolution as a therapeutic strategy, cell-based CNS repair has faced significant hurdles that have prevented its translation to widespread clinical practice. In recent years, advances in cell technologies combined with advances in biomaterial-based regenerative medicine and tissue engineering have meant there is very real potential for many of these hurdles to be overcome. This review will provide an overview of the main CNS conditions that lend themselves to cellular repair and will then outline the potential of biomaterial-based approaches for improving the outcome of cellular repair in these conditions.	[Jarrin, Sarah; Cabre, Silvia; Dowd, Eilis] Natl Univ Ireland, Pharmacol & Therapeut, Galway, Ireland; [Jarrin, Sarah; Cabre, Silvia; Dowd, Eilis] Natl Univ Ireland, Galway Neurosci Ctr, Galway, Ireland; [Cabre, Silvia] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland		Dowd, E (corresponding author), Pharmacol & Therapeut Natl Univ Ireland, Galway, Ireland.	eilis.dowd@nuigalway.ie	Cabre, Silvia/AAE-5329-2021	Jarrin, Sarah/0000-0003-2990-3628	Michael J Foundation for Parkinson's Research [17244]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [19/FFP/6554]; European Union Horizon 2020 Programme (H2020-MSCA-ITN-2015) under the Marie Sklodowska-Curie Innovative Training Networks [676408]	Our research in this field is funded by the Michael J Foundation for Parkinson's Research (Grant Number: 17244), Science Foundation Ireland (Grant Number: 19/FFP/6554) and the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2015) under the Marie Sklodowska-Curie Innovative Training Networks (Grant Number: 676408).	Adil MM, 2017, BIOMATERIALS, V136, P1, DOI 10.1016/j.biomaterials.2017.05.008; Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Andre EM, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11100526; Assuncao-Silva RC, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/948040; Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013; Barker RA, 2019, NAT MED, V25, P1045, DOI 10.1038/s41591-019-0507-2; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004; Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085; Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Borlongan CV, 1998, EXP NEUROL, V151, P203, DOI 10.1006/exnr.1998.6790; Bruggeman KF, 2019, BRIT J PHARMACOL, V176, P355, DOI 10.1111/bph.14545; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Burdick JA, 2016, CELL STEM CELL, V18, P13, DOI 10.1016/j.stem.2015.12.004; Chau MJ, 2014, STEM CELLS, V32, P3075, DOI 10.1002/stem.1802; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Cherksey BD, 1996, NEUROSCIENCE, V75, P657, DOI 10.1016/0306-4522(96)00262-X; Chien HW, 2012, BIOMATERIALS, V33, P5706, DOI 10.1016/j.biomaterials.2012.04.031; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Cui GH, 2016, MOL NEUROBIOL, V53, P1108, DOI 10.1007/s12035-014-9069-y; Cummings Jeffrey, 2020, Alzheimers Dement (N Y), V6, pe12050, DOI 10.1002/trc2.12050; Curtis E, 2018, CELL STEM CELL, V22, P941, DOI 10.1016/j.stem.2018.05.014; Danielson P, 2002, P NATL ACAD SCI USA, V99, P7237, DOI 10.1073/pnas.082079899; Daviaud N, 2015, STEM CELL TRANSL MED, V4, P670, DOI 10.5966/sctm.2014-0139; Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Fan Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-019-0180-x; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Flores J, 2007, J NEUROPATH EXP NEUR, V66, P585, DOI 10.1097/nen.0b013e318093e53a; Fon D, 2014, ADV HEALTHC MATER, V3, P761, DOI 10.1002/adhm.201300287; Fuhrmann T, 2016, BIOMATERIALS, V83, P23, DOI 10.1016/j.biomaterials.2015.12.032; Garbayo E, 2011, J NEUROCHEM, V119, P972, DOI 10.1111/j.1471-4159.2011.07272.x; Goulao M, 2016, CURR STEM CELL RES T, V11, P321, DOI 10.2174/1574888X10666150723150059; Gross RE, 2011, LANCET NEUROL, V10, P509, DOI 10.1016/S1474-4422(11)70097-7; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Harmsen IE, 2020, BRAIN STIMUL, V13, P378, DOI 10.1016/j.brs.2019.11.008; Hennink WE, 2012, ADV DRUG DELIVER REV, V64, P223, DOI 10.1016/j.addr.2012.09.009; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Hinderer S, 2016, ADV DRUG DELIVER REV, V97, P260, DOI 10.1016/j.addr.2015.11.019; Hoban DB, 2013, BIOMATERIALS, V34, P9420, DOI 10.1016/j.biomaterials.2013.08.073; Ingall Timothy, 2004, J Insur Med, V36, P143; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x; Jgamadze D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030293; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011; Khan AR, 2017, J CONTROL RELEASE, V268, P364, DOI 10.1016/j.jconrel.2017.09.001; Koffler J, 2019, NAT MED, V25, P263, DOI 10.1038/s41591-018-0296-z; Krause M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00656; Lampe KJ, 2011, J BIOMED MATER RES A, V96A, P595, DOI 10.1002/jbm.a.33011; Langer R, 2016, J PEDIATR SURG, V51, P8, DOI 10.1016/j.jpedsurg.2015.10.022; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Li XR, 2013, BIOMATERIALS, V34, P5107, DOI 10.1016/j.biomaterials.2013.03.062; Liang GY, 2013, CELL RES, V23, P49, DOI 10.1038/cr.2012.175; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mansouri A, 2018, J NEUROSURG, V128, P1199, DOI 10.3171/2016.11.JNS16715; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; McAllister P, 2020, NEUROLOGY, V94; Mitrousis N, 2018, NAT REV MATER, V3, P441, DOI 10.1038/s41578-018-0057-0; Moriarty N, 2019, EUR J NEUROSCI, V49, P487, DOI 10.1111/ejn.14090; Moriarty N, 2018, NEURAL REGEN RES, V13, P1187, DOI 10.4103/1673-5374.235027; Moriarty N, 2019, EUR J NEUROSCI, V49, P472, DOI 10.1111/ejn.14051; Moriarty N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15970-w; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Newland B, 2016, DRUG DISCOV TODAY, V21, P1313, DOI 10.1016/j.drudis.2016.06.003; Niemczyk B, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aacbab; Nih LR, 2016, CURR OPIN BIOTECH, V40, P155, DOI 10.1016/j.copbio.2016.04.021; Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000; Nori S, 2018, STEM CELL REP, V11, P1433, DOI 10.1016/j.stemcr.2018.10.017; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; PAINO CL, 1991, EXP NEUROL, V114, P254, DOI 10.1016/0014-4886(91)90043-C; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Peng LL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012153; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159; Praet J, 2015, CELL TRANSPLANT, V24, P1481, DOI 10.3727/096368914X682800; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Quittet MS, 2015, ACTA BIOMATER, V15, P77, DOI 10.1016/j.actbio.2014.12.017; Rittchen S, 2015, BIOMATERIALS, V56, P78, DOI 10.1016/j.biomaterials.2015.03.044; Roitberg BZ, 2006, J NEUROSURG, V105, P96, DOI 10.3171/jns.2006.105.1.96; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502; Saporta S., 1997, MICROCARRIER ENHANCE; Schepici G, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56030137; Schweitzer JS, 2020, NEW ENGL J MED, V382, P1926, DOI 10.1056/NEJMoa1915872; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Subramanian T, 2002, CELL TRANSPLANT, V11, P207; Sugai K, 2015, J NEUROSCI RES, V93, P1826, DOI 10.1002/jnr.23636; Takahashi J, 2019, REGEN MED, V14, P93, DOI 10.2217/rme-2018-0158; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Tatard VM, 2007, BIOMATERIALS, V28, P1978, DOI 10.1016/j.biomaterials.2006.12.021; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tuladhar A, 2018, FRONT MATER, V5, DOI 10.3389/fmats.2018.00014; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Wang TY, 2016, BIOMATERIALS, V74, P89, DOI 10.1016/j.biomaterials.2015.09.039; Watts RL, 2003, J NEURAL TRANSM-SUPP, P215; Winner Beate, 2009, Ther Adv Neurol Disord, V2, P51, DOI 10.1177/1756285608100324; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yano A, 2005, J NEUROSURG, V103, P104, DOI 10.3171/jns.2005.103.1.0104; Yasuhara T, 2020, CNS NEUROSCI THER, V26, P595, DOI 10.1111/cns.13247; Yasuhara T, 2017, CELL TRANSPLANT, V26, P1551, DOI 10.1177/0963689717735411; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yun HM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.490; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088; Zustiak SP, 2013, TISSUE ENG PART B-RE, V19, P160, DOI 10.1089/ten.teb.2012.0458	122	4	4	9	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2021	144								104971	10.1016/j.neuint.2021.104971			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RH2TD	WOS:000636076900005	33515647	hybrid			2022-02-06	
J	Kroshus, E; Chrisman, SPD; Harmon, KG; Herring, SA; Broglio, SP; Master, CL; McGill, CA; Putukian, M; Register-Mihalik, JK; Rivara, FP				Kroshus, Emily; Chrisman, Sara P. D.; Harmon, Kimberly G.; Herring, Stanley A.; Broglio, Steven P.; Master, Christina L.; McGill, Catherine A.; Putukian, Margot; Register-Mihalik, Johna K.; Rivara, Frederick P.		Natl Delphi Panel Sports Concussio	What Do Parents Need to Know About Concussion? Developing Consensus Using the Delphi Method	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						Delphi panel; concussion; parent; shared decision-making; sport	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; SHARED DECISION-MAKING; YOUTH SPORTS; KNOWLEDGE; CHILDREN; PERCEPTIONS; ATTITUDES; FOOTBALL; PARTICIPATION	Objective: Many schools and sports leagues provide preseason concussion education to parents/guardians, and in some jurisdictions, it is required for interscholastic sports participation. However, directives about content are absent or vague. The purpose of this study was to obtain expert consensus about what parents/guardians need to know to about concussion. Design: A modified Delphi process with nationally recognized expert panel members was used to obtain consensus about parent/guardian behaviors relevant to concussion prevention, identification, and management and knowledge domains relevant to performance of those behaviors. Results: Sixteen parent/guardian behaviors and 24 knowledge domains were identified. However, consensus was not achieved regarding whether it is realistic to expect parents/guardians to perform approximately one-third of the behaviors that experts agreed mattered. This variability may reflect underlying uncertainty about the capacities of some parents/guardians to put knowledge into action or the belief that there are other barriers to action. Furthermore, for most knowledge domains, there was a lack of agreement about whether or not there could be a "correct" answer on the basis of current scientific knowledge. Conclusions: These findings raise practical and ethical questions: how can we expect parents/guardians to help prevent, identify, or manage concussion if they cannot have all the information required to engage in these behaviors due to lack of scientific consensus? This issue is not unique to concussion. Best practices for risk communication and shared decision-making can inform how we think about educating parents/guardians about concussion inside and outside of the health care setting.	[Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, 2001 8th Ave,Ste 400, Seattle, WA 98121 USA; [Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Harmon, Kimberly G.] Univ Washington, Dept Family Med, Seattle, WA 98121 USA; [Harmon, Kimberly G.; Herring, Stanley A.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98121 USA; [Herring, Stanley A.] Univ Washington, Dept Neurol Surg, Seattle, WA 98121 USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98121 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Broglio, Steven P.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Master, Christina L.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [McGill, Catherine A.] George Washington Univ, Sch Med, Washington, DC USA; [McGill, Catherine A.] Childrens Natl Hlth Syst, Washington, DC USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 8th Ave,Ste 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Chrisman, Sara/0000-0001-5373-7223			Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Coyne I, 2014, EUR J ONCOL NURS, V18, P273, DOI 10.1016/j.ejon.2014.01.006; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Dentro KN, 2014, J PHYS ACT HEALTH, V11, pS105, DOI 10.1123/jpah.2014-0184; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Garcia-Retamero R, 2013, CURR DIR PSYCHOL SCI, V22, P392, DOI 10.1177/0963721413491570; Gowda C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-509; HADDON W, 1970, AM J PUBLIC HEALTH N, V60, P2229, DOI 10.2105/AJPH.60.12.2229-b; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Hsu C., 2007, PRACTICAL ASSESSMENT, V12, P1, DOI DOI 10.1016/S0169-2070(99)00018-7; Kriebel D, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454986; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Love S, 2015, AM J SPORT MED, V43, P1260, DOI 10.1177/0363546514535187; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCaffery KJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S10; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; O'Hagan F, 2015, J EXERCI MOVE SPORT, V47, P108; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Romaine A, 2016, J CLIN SPORT PSYCHOL, V10, P253, DOI 10.1123/jcsp.2016-0018; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	40	4	4	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2021	31	2					139	144		10.1097/JSM.0000000000000702			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SL0TF	WOS:000656628200012	30475245	hybrid			2022-02-06	
J	Prins, JTH; Van Lieshout, EMM; Ali-Osman, F; Bauman, ZM; Caragounis, EC; Choi, J; Christie, DB; Cole, PA; Devoe, WB; Doben, AR; Eriksson, EA; Forrester, JD; Fraser, DR; Gontarz, B; Hardman, C; Hyatt, DG; Kaye, AJ; Ko, HJ; Leasia, KN; Leon, S; Marasco, SF; McNickle, AG; Nowack, T; Ogunleye, TD; Priya, P; Richman, AP; Schlanser, V; Semon, GR; Su, YH; Verhofstad, MHJ; Whitis, J; Pieracci, FM; Wijffels, MME				Prins, Jonne T. H.; Van Lieshout, Esther M. M.; Ali-Osman, Francis; Bauman, Zachary M.; Caragounis, Eva-Corina; Choi, Jeff; Christie, D. Benjamin, III; Cole, Peter A.; DeVoe, William B.; Doben, Andrew R.; Eriksson, Evert A.; Forrester, Joseph D.; Fraser, Douglas R.; Gontarz, Brendan; Hardman, Claire; Hyatt, Daniel G.; Kaye, Adam J.; Ko, Huan-Jang; Leasia, Kiara N.; Leon, Stuart; Marasco, Silvana F.; McNickle, Allison G.; Nowack, Timothy; Ogunleye, Temi D.; Priya, Prakash; Richman, Aaron P.; Schlanser, Victoria; Semon, Gregory R.; Su, Ying-Hao; Verhofstad, Michael H. J.; Whitis, Julie; Pieracci, Fredric M.; Wijffels, Mathieu M. E.			Outcome after surgical stabilization of rib fractures versus nonoperative treatment in patients with multiple rib fractures and moderate to severe traumatic brain injury (CWIS-TBI)	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Outcome; surgical stabilization of rib fractures; thoracic trauma; traumatic brain injury; rib fractures		BACKGROUND: Outcomes after surgical stabilization of rib fractures (SSRF) have not been studied in patients with multiple rib fractures and traumatic brain injury (TBI). We hypothesized that SSRF, as compared with nonoperative management, is associated with favorable outcomes in patients with TBI. METHODS: A multicenter, retrospective cohort study was performed in patients with rib fractures and TBI between January 2012 and July 2019. Patients who underwent SSRF were compared to those managed nonoperatively. The primary outcome was mechanical ventilation-free days. Secondary outcomes were intensive care unit length of stay and hospital length of stay, tracheostomy, occurrence of complications, neurologic outcome, and mortality. Patients were further stratified into moderate (GCS score, 9-12) and severe (GCS score, <= 8) TBI. RESULTS: The study cohort consisted of 456 patients of which 111 (24.3%) underwent SSRF. The SSRF was performed at a median of 3 days, and SSRF-related complication rate was 3.6%. In multivariable analyses, there was no difference in mechanical ventilation-free days between the SSRF and nonoperative groups. The odds of developing pneumonia (odds ratio [OR], 0.59; 95% confidence interval [95% CI], 0.38-0.98; p = 0.043) and 30-day mortality (OR, 0.32; 95% CI, 0.11-0.91; p = 0.032) were significantly lower in the SSRF group. Patients with moderate TBI had similar outcome in both groups. In patients with severe TBI, the odds of 30-day mortality was significantly lower after SSRF (OR, 0.19; 95% CI, 0.04-0.88; p = 0.034). CONCLUSION: In patients with multiple rib fractures and TBI, the mechanical ventilation-free days did not differ between the two treatment groups. In addition, SSRF was associated with a significantly lower risk of pneumonia and 30-day mortality. In patients with moderate TBI, outcome was similar. In patients with severe TBI a lower 30-day mortality was observed. There was a low SSRF-related complication risk. These data suggest a potential role for SSRF in select patients with TBI.	[Prins, Jonne T. H.; Van Lieshout, Esther M. M.; Verhofstad, Michael H. J.; Wijffels, Mathieu M. E.] Univ Med Ctr Rotterdam, Erasmus MC, Trauma Res Unit, Dept Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Ali-Osman, Francis] HonorHlth John C Lincoln Med Ctr, Dept Surg, Phoenix, AZ USA; [Bauman, Zachary M.] Univ Nebraska Med Ctr, Dept Surg, Div Trauma, Emergency Gen Surg,Crit Care Surg,Nebraska Med Ct, Omaha, NE USA; [Caragounis, Eva-Corina] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Surg, Gothenburg, Sweden; [Choi, Jeff; Forrester, Joseph D.] Stanford Univ, Dept Surg, Sect Acute Care Surg, Stanford, CA 94305 USA; [Christie, D. Benjamin, III; Nowack, Timothy] Mercer Univ, Sch Med, Med Ctr Navicent Hlth, Dept Trauma Surg Crit Care, Macon, GA 31207 USA; [Cole, Peter A.] HealthPartners Orthoped & Sports Med, Bloomington, IN USA; [Cole, Peter A.] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Cole, Peter A.] Reg Hosp, Dept Orthopaed Surg, St Paul, MN USA; [DeVoe, William B.; Hyatt, Daniel G.] Riverside Methodist Hosp, Dept Surg, Columbus, OH 43214 USA; [Doben, Andrew R.; Gontarz, Brendan] St Francis Hosp, Dept Surg, Hartfort, CT USA; [Eriksson, Evert A.; Leon, Stuart] Med Univ South Carolina, Dept Surg, Div Trauma & Crit Care, Charleston, SC 29425 USA; [Fraser, Douglas R.; McNickle, Allison G.] UNLV Sch Med, Dept Surg, Las Vegas, NV USA; [Hardman, Claire; Semon, Gregory R.] Wright State Univ, Miami Valley Hosp, Dept Surg, Div Trauma, Dayton, OH 45435 USA; [Kaye, Adam J.; Priya, Prakash] Overland Pk Reg Med Ctr, Dept Surg, Overland Pk, KS USA; [Ko, Huan-Jang; Su, Ying-Hao] Natl Taiwan Univ Hosp, Div Trauma Surg, Dept Surg, Hsinchu, Taiwan; [Leasia, Kiara N.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Marasco, Silvana F.] The Alfred, Dept Cardiothorac Surg, Melbourne, Vic, Australia; [Marasco, Silvana F.] Monash Univ, Dept Surg, Clayton, Vic, Australia; [Ogunleye, Temi D.] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Ogunleye, Temi D.] Reg Hosp, Dept Orthopaed Surg, St Paul, MN USA; [Richman, Aaron P.] Boston Univ, Sch Med, Dept Surg, Boston Med Ctr, Boston, MA 02118 USA; [Schlanser, Victoria] John H Stronger Hosp Cook Cty, Dept Trauma Burn, Chicago, IL USA; [Whitis, Julie] Univ Texas Rio Grande Valley, Dept Surg, Doctors Hosp Renaissance, Edinburg, TX USA; [Pieracci, Fredric M.] Univ Colorado, Sch Med, Dept Surg, Denver Hlth Med Ctr, Denver, CO USA		Wijffels, MME (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Trauma Res Unit, Dept Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.prins@erasmusmc.nl; e.vanlieshout@erasmusmc.nl; francisaliosman@gmail.com; zachary.bauman@unmc.edu; eva-corina.caragounis@gu.se; jc2226@stanford.edu; benjie_christie@yahoo.com; peter.a.cole@healthpartners.com; bidevoe@gmail.com; andrew.doben@trinityhealthofne.org; eriksson@musc.edu; jdf1@stanford.edu; douglas.fraser@unlv.edu; gontarz@uchc.edu; cehardman@premierhealth.com; daniel.hyatt@ohiohealth.com; adamjkaye@gmail.com; huanjangko@gmail.com; kiara.leasia@dhha.org; leon@musc.edu; s.marasco@alfred.org.au; allison.mcnickle@unlv.edu; nowack.timothy@navicenthealth.org; temi.ogunleye15@gmail.com; prakash.priya91@gmail.com; aaron.richman@bmc.org; victoria.schlanser@cookcountyhhs.org; grsemon@premierhealth.com; mdsuyinghao@gmail.com; m.verhofstad@erasmusmc.nl; jwhitis@gmail.com; fredric.pieracci@dhha.org; m.wijffels@erasmusmc.nl	Su, Ying-Hao/AAW-4502-2021	Su, Ying-Hao/0000-0003-1271-1179; Richman, Aaron/0000-0002-6826-7217			Althausen PL, 2011, J ORTHOP TRAUMA, V25, P641, DOI 10.1097/BOT.0b013e318234d479; [Anonymous], 2000, J Neurotrauma, V17, P563; Beks RB., 2018, EUR J TRAUMA EMERG S; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Bulger EM, J TRAUMA, V48, P6; Coary R., 2019, AGE AGEING; Dai D., 2013, PLOS ONE, V8; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DuBose J, 2012, J TRAUMA ACUTE CARE, V73, P752, DOI 10.1097/TA.0b013e31825c1616; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hofman M, 2020, EUR J TRAUMA EMERG S, V46, P11, DOI 10.1007/s00068-019-01179-1; Iqbal HJ, 2018, J BONE JOINT SURG AM, V100, P1298, DOI 10.2106/JBJS.17.01215; Kane ED, 2017, J TRAUMA ACUTE CARE, V83, P1047, DOI 10.1097/TA.0000000000001648; Kasotakis G, 2017, J TRAUMA ACUTE CARE, V82, P618, DOI [10.1097/TA.0000000000001350, 10.1097/TA.0000000000001389]; Lafferty PM, 2011, J BONE JOINT SURG AM, V93A, P97, DOI 10.2106/JBJS.I.00696; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; Cataneo AJM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009919.pub2; Michetti CP, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000288; de Campos JRM, 2018, J THORAC DIS, V10, pS951, DOI 10.21037/jtd.2018.04.69; O'Brien PJ, 2003, CAN J SURG, V46, P124; Otaka S, 2020, ANN THORAC SURG, V110, P988, DOI 10.1016/j.athoracsur.2020.03.084; Pieracci FM, 2018, INT ORTHOP, V42, P401, DOI 10.1007/s00264-017-3612-1; Pieracci FM, 2018, J TRAUMA ACUTE CARE, V84, P1, DOI 10.1097/TA.0000000000001729; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Prevention TCoDCa, 2018, PNEUM VENT ASS VAP N; Qiu MG, 2016, INDIAN J SURG, V78, P458, DOI 10.1007/s12262-015-1409-2; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	39	4	5	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2021	90	3					492	500		10.1097/TA.0000000000002994			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	QR7MW	WOS:000625400000015	33093293				2022-02-06	
J	Shanley, E; Thigpen, C; Kissenberth, M; Gilliland, RG; Thorpe, J; Nance, D; Register-Mihalik, JK; Tokish, J				Shanley, Ellen; Thigpen, Charles; Kissenberth, Michael; Gilliland, Robert Gil; Thorpe, John; Nance, Darryl; Register-Mihalik, Johna K.; Tokish, John			Heads Up Football Training Decreases Concussion Rates in High School Football Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; injury prevention; adolescents; football	AMERICAN MEDICAL SOCIETY; POSITION STATEMENT; INJURY; YOUTH; SPORTS; PREVENTION; ASSOCIATION; PROGRAM; RISK	Objective: The objective of this study was to determine whether football players receiving heads up (HU) training would display a lower rate of sport-related concussion (SRC) compared to those without HU training. Design: Prospective cohort. Setting: Scholastic football fields. Patients: Two thousand five hundred fourteen scholastic football players during the 2015 to 2016 football season were monitored throughout the football season. Interventions: Before the preseason, 1 coach from 14 schools received HU training from US football. These schools were matched with 10 control schools performing standard football training [non-heads up (NHU)]. Random monitoring for proper coaching instruction was performed during the season. School athletic trainers monitored injuries and return to sport over the season for all schools. Main Outcome Measures: The outcome measures of concussions and associated time loss were determined before data collection began. Injury incidence and rate ratios were calculated to determine program effectiveness. Results: During the season, football players sustained 117 concussions (HU = 75; NHU = 42). The HU players displayed a significantly lower concussion rate (4.1 vs 6.0/100 players) compared with NHU teams [rate ratio = 1.5; 95% confidence interval (CI), 1.1-5.4]. The HU group returned to full participation 27% faster than athletes in the NHU group [time loss: 18.2 days (95% CI, 15.8-20.6) vs 24.8 days (95% CI, 19.9-29.7)], respectively. Conclusions: This is the first study to evaluate the impact of the HU program on the incidence of SRC in high school football players. Our data demonstrated that the HU program reduced SRC rates by 33% supporting the use of US HU football training as an effective method to decrease the rate of SRCs in scholastic football.	[Shanley, Ellen; Thigpen, Charles] ATI Phys Therapy, Greenville, SC USA; [Shanley, Ellen; Thigpen, Charles; Kissenberth, Michael; Tokish, John] Univ South Carolina, SmartState Ctr, Ctr Effectiveness Res Orthoped, Greenville, SC 29615 USA; [Kissenberth, Michael; Gilliland, Robert Gil; Thorpe, John; Tokish, John] Greenville Hosp Syst, Steadman Hawkins Clin Carolinas, Greenville, SC USA; [Nance, Darryl] Greenville Cty Sch Syst, Greenville, SC USA; [Register-Mihalik, Johna K.] Univ N Carolina, Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Shanley, E (corresponding author), Univ South Carolina, Ctr Effectiveness Res Orthoped, 200 Patewood Rd Suite 100, Greenville, SC 29615 USA.	ellen.shanley@atipt.com					Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Frank BS, 2015, J SCI MED SPORT, V18, P400, DOI 10.1016/j.jsams.2014.06.008; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Merkel DL, 2013, OPEN ACCESS J SPORTS, V4, P151, DOI 10.2147/OAJSM.S33556; Padua DA, 2014, CLIN SPORT MED, V33, P615, DOI 10.1016/j.csm.2014.06.012; Participation statistics, NATL FED STAT HIGH S; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Ullrich-French S, 2012, RES Q EXERCISE SPORT, V83, P431	22	4	4	6	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2021	31	2					120	126		10.1097/JSM.0000000000000711			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SL0TF	WOS:000656628200009	30908329	Green Published			2022-02-06	
J	Martinez-Drudis, L; Amoros-Aguilar, L; Torras-Garcia, M; Serra-Elias, B; Costa-Miserachs, D; Portell-Cortes, I; Coll-Andreu, M				Martinez-Drudis, Laura; Amoros-Aguilar, Laura; Torras-Garcia, Meritxell; Serra-Elias, Bruna; Costa-Miserachs, David; Portell-Cortes, Isabel; Coll-Andreu, Margalida			Delayed voluntary physical exercise restores "when" and "where" object recognition memory after traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Physical exercise; Temporal order memory; Object location memory; Cytokines; Neurotrophins	MEDIAL PREFRONTAL CORTEX; CONTROLLED CORTICAL IMPACT; GROWTH-FACTOR-I; NEUROTROPHIC FACTOR; TREADMILL EXERCISE; TEMPORAL-ORDER; COGNITIVE DYSFUNCTION; SYNAPSIN-I; RECOVERY; HIPPOCAMPAL	Physical exercise has been associated with improved cognition and may even reduce memory deficits after brain injuries. The aims of this work were to: 1) assess whether voluntary physical exercise can reduce the deficits associated with traumatic brain injury (TBI) in two different components of episodic-like memory based on object recognition, temporal order memory ("when"), and object location memory ("where"); and 2) determine whether changes in levels of brain-derived neurotrophic factor (BDNF) in the hippocampus and prefrontal cortex, as well as alterations in hippocampal cytokines, insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF), may influence the effects exercise has on either or both tasks. The rats were distributed into a sham group, a TBI group that remained sedentary (TBI-sed), and a TBI group that had access to a running wheel for a 25-day period from post-injury day 11 (TBI-exe). The rats were sacrificed after the "where" memory task, at post-injury day 37. Physical exercise restored the "when" and "where" memories, which had been impaired by the TBI, and increased the concentration of BDNF in the hippocampus, but not the prefrontal cortex. Neither TBI nor exercise were found to significantly affect hippocampal cytokines, IGF-1 or VEGF at this time post-injury. BDNF levels showed significant positive correlations with exercise, and with "when" (but not "where") memory. These results indicate that post-injury physical exercise restores "when" and "where" object recognition memory tasks after TBI, and that increased BDNF seems to be involved in this effect, particularly with regard to "when" memory.	[Martinez-Drudis, Laura; Amoros-Aguilar, Laura; Torras-Garcia, Meritxell; Serra-Elias, Bruna; Costa-Miserachs, David; Portell-Cortes, Isabel; Coll-Andreu, Margalida] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psicobiol & Metodol Ciencies Salut, Barcelona, Spain; [Martinez-Drudis, Laura] Univ Laval, Fac Med, Dept Mol Med, CHU Quebec Res Ctr,Axe Neurosci, Quebec City, PQ, Canada		Coll-Andreu, M (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Psicobiol & Metodol Ciencies Salut, Barcelona, Spain.	Margalida.Coll@uab.es	Coll-Andreu, Margalida/C-9119-2011	Coll-Andreu, Margalida/0000-0003-4106-2606	Ministerio de Economia y competitividad (Spain) [IDPSI2014-55087-R]	This work was supported by Ministerio de Economia y competitividad (Spain; grant IDPSI2014-55087-R).; We thank Carlos Baldellou and Francisco Javier Carrasco for their support with brain dissections and biochemical analyses.	Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Amoros-Aguilar L, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113178; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Barker GRI, 2011, EUR J NEUROSCI, V33, P705, DOI 10.1111/j.1460-9568.2010.07555.x; Barker GRI, 2017, NAT NEUROSCI, V20, P242, DOI 10.1038/nn.4472; Barlow S, 2018, BRAIN RES BULL, V140, P212, DOI 10.1016/j.brainresbull.2018.05.012; Brown MW, 2012, NEUROPSYCHOLOGIA, V50, P3122, DOI 10.1016/j.neuropsychologia.2012.07.034; Cefis M, 2019, BRAIN STRUCT FUNCT, V224, P1975, DOI 10.1007/s00429-019-01889-7; Chao OY, 2017, NEUROBIOL LEARN MEM, V141, P72, DOI 10.1016/j.nlm.2017.03.019; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Cross L, 2013, LEARN MEMORY, V20, P41, DOI 10.1101/lm.028266.112; Darwish H, 2014, BRAIN INJURY, V28, P211, DOI 10.3109/02699052.2013.862737; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dong JT, 2018, NEUROL RES, V40, P68, DOI 10.1080/01616412.2017.1398389; Donzis EJ, 2014, NEUROBIOL LEARN MEM, V115, P68, DOI 10.1016/j.nlm.2014.08.008; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Morici JF, 2015, BEHAV BRAIN RES, V292, P241, DOI 10.1016/j.bbr.2015.06.030; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grace L, 2009, METAB BRAIN DIS, V24, P643, DOI 10.1007/s11011-009-9162-5; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Hunsaker MR, 2018, NEUROBIOL LEARN MEM, V147, P90, DOI 10.1016/j.nlm.2017.11.012; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morland C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15557; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; Morris TP, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00135; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Paterno R, 2018, J NEUROTRAUM, V35, P2117, DOI 10.1089/neu.2017.5170; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pinar C, 2020, BEHAV BRAIN RES, V387, DOI 10.1016/j.bbr.2020.112585; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; Prakash RS, 2015, ANNU REV PSYCHOL, V66, P769, DOI 10.1146/annurev-psych-010814-015249; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Shin MS, 2016, INT NEUROUROL J, V20, pS49, DOI 10.5213/inj.1632616.308; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Taylor JM, 2015, BRAIN RES, V1622, P414, DOI 10.1016/j.brainres.2015.07.009; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Warburton EC, 2015, BEHAV BRAIN RES, V285, P131, DOI 10.1016/j.bbr.2014.09.050; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Ya JC, 2015, MOL MED REP, V12, P6591, DOI 10.3892/mmr.2015.4292; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	73	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 26	2021	400								113048	10.1016/j.bbr.2020.113048			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	PT4SQ	WOS:000608605300002	33279639				2022-02-06	
J	McCarty, CA; Zatzick, DF; Marcynyszyn, LA; Wang, J; Hilt, R; Jinguji, T; Quitiquit, C; Chrisman, SPD; Rivara, FP				McCarty, Carolyn A.; Zatzick, Douglas F.; Marcynyszyn, Lyscha A.; Wang, Jin; Hilt, Robert; Jinguji, Thomas; Quitiquit, Celeste; Chrisman, Sara P. D.; Rivara, Frederick P.			Effect of Collaborative Care on Persistent Postconcussive Symptoms in Adolescents A Randomized Clinical Trial	JAMA NETWORK OPEN			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS; CHILDREN; INTERVENTION; PEDSQL(TM)-4.0; RELIABILITY; VALIDATION; CONCUSSION; PREVENTION; DISORDER	Question What is the effectiveness of collaborative care with cognitive behavioral therapy for treating adolescents with persistent postconcussive symptoms? Findings In this randomized clinical trial of 200 adolescents, those who received collaborative care reported fewer postconcussive symptoms at 3 and 12 months and higher health-related quality of life at 12 months compared with a control group receiving usual care. Meaning These findings suggest that collaborative care with cognitive behavioral therapy is a promising treatment to alleviate symptoms and improve functioning for adolescents with persistent postconcussive symptoms. Importance Despite the high level of impairment for adolescents with persistent postconcussive symptoms, few studies have tested whether such problems can be remediated. Objective To examine whether collaborative care treatment is associated with improvements in postconcussive, quality of life, anxiety, and depressive symptoms over 1 year, compared with usual care. Design, Setting, and Participants The Collaborative Care Model for Treatment of Persistent Symptoms After Concussion Among Youth II Trial was a randomized clinical trial conducted from March 2017 to May 2020 with follow-up assessments at 3, 6, and 12 months. Participants were recruited from pediatric primary care, sports medicine, neurology, and rehabilitation clinics in western Washington. Adolescents aged 11 to 18 years with a diagnosed sports-related or recreational-related concussion within the past 9 months and with at least 3 symptoms persisting at least 1 month after injury were eligible. Data analysis was performed from June to September 2020. Interventions The collaborative care intervention included cognitive behavioral therapy and care management, delivered mostly through telehealth, throughout the 6-month treatment period, with enhanced medication consultation when warranted. The comparator group was usual care provided in specialty clinics. Main Outcomes and Measures Primary outcomes were adolescents' reports of postconcussive, quality of life, anxiety, and depressive symptoms. Secondary outcomes were parent-reported symptoms. Results Of the 390 eligible adolescents, 201 (51.5%) agreed to participate, and 200 were enrolled (mean [SD] age, 14.7 [1.7] years; 124 girls [62.0%]), with 96% to 98% 3- to 12-month retention. Ninety-nine participants were randomized to usual care, and 101 were randomized to collaborative care. Adolescents who received collaborative care reported significant improvements in Health Behavior Inventory scores compared with usual care at 3 months (3.4 point decrease; 95% CI, -6.6 to -0.1 point decrease) and 12 months (4.1 point decrease; 95% CI, -7.7 to -0.4 point decrease). In addition, youth-reported Pediatric Quality of Life Inventory scores at 12 months improved by a mean of 4.7 points (95% CI, 0.05 to 9.3 points) in the intervention group compared with the control group. No differences emerged by group over time for adolescent depressive or anxiety symptoms or for parent-reported outcomes. Conclusions and Relevance Although both groups improved over time, youth receiving the collaborative care intervention had fewer symptoms and better quality of life over 1 year. Intervention delivery through telehealth broadens the reach of this treatment. This randomized clinical trial examines whether collaborative care treatment for adolescents with persistent postconcussive symptoms is associated with improvements in postconcussive, quality of life, anxiety, and depressive symptoms over 1 year, compared with usual care.	[McCarty, Carolyn A.; Marcynyszyn, Lyscha A.; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,Mailstop CW8-5, Seattle, WA 98145 USA; [McCarty, Carolyn A.; Jinguji, Thomas; Quitiquit, Celeste; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas F.; Hilt, Robert] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zatzick, Douglas F.; Wang, Jin; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Hilt, Robert] Univ Washington, Seattle Childrens Dept Psychiat & Behav Med, Seattle, WA USA; [Jinguji, Thomas; Quitiquit, Celeste] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA		McCarty, CA (corresponding author), Univ Washington, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,Mailstop CW8-5, Seattle, WA 98145 USA.	cari.mccarty@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD090230]	This work was supported by grant R01 HD090230 from the National Institute of Child Health and Human Development (Principal Investigators: McCarty, Rivara, and Zatzick).	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Copley M, 2020, J RACIAL ETHN HEALTH, V7, P571, DOI 10.1007/s40615-019-00686-6; Ebesutani C, 2012, PSYCHOL ASSESSMENT, V24, P833, DOI 10.1037/a0027283; Freed LH, 1998, J ADOLESCENT HEALTH, V22, P475, DOI 10.1016/S1054-139X(98)00002-0; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Goldstein L, 2019, SEMIN PEDIATR NEUROL, V30, P79, DOI 10.1016/j.spen.2019.03.012; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Mathyssek CM, 2013, INT J METH PSYCH RES, V22, P27, DOI 10.1002/mpr.1380; McCarty CA, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3662-3; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Olsson K, 2014, BRAIN IMPAIR, V15, P177, DOI 10.1017/BrImp.2014.22; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Richardson LP, 2012, PEDIATRICS, V130, pE1541, DOI 10.1542/peds.2012-0450; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Sufrinko AM, 2015, SLEEP MED, V16, P1204, DOI 10.1016/j.sleep.2015.07.002; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P298, DOI 10.1097/HTR.0000000000000532; Unutzer J, 2013, COLLABORATIVE CARE M; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	39	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	FEB 26	2021	4	2							e210207	10.1001/jamanetworkopen.2021.0207			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7KJ	WOS:000621953700002	33635325	gold, Green Published			2022-02-06	
J	Pingue, V; Mele, C; Nardone, A				Pingue, Valeria; Mele, Chiara; Nardone, Antonio			Post-traumatic seizures and antiepileptic therapy as predictors of the functional outcome in patients with traumatic brain injury	SCIENTIFIC REPORTS			English	Article								Post-traumatic seizures (PTS) are a common and debilitating complication of traumatic brain injury (TBI) and could have a harmful impact on the progress of patient rehabilitation. To assess the effect of PTS and relative therapy on outcome in the initial phase after TBI, during the rehabilitation process when neuroplasticity is at its highest, we retrospectively examined the clinical data of 341 adult patients undergoing rehabilitation for at least 6 months post-TBI in our neurorehabilitation unit between 2008 and 2019. We correlated through logistic regression the occurrence of seizures and use of anti-seizure medication (ASM) with neurological and functional outcomes, respectively assessed with the Glasgow Coma Scale (GCS) and the Functional Independence Measure (FIM). PTS were documented in 19.4% of patients: early PTS (EPTS) in 7.0%; late PTS (LPTS) in 9.4%; both types in 3.0%. Patients who developed EPTS had an increased risk of developing LPTS (OR=3.90, CI 95% 1.58-9.63, p=0.003). Patients with LPTS had a significantly higher risk of worse neurological (p<0.0001) and rehabilitation (p<0.05) outcome. Overall, 38.7% of patients underwent therapy with ASM; prophylactic therapy was prescribed in 24.0% of patients, of whom 14.6% subsequently developed seizures. Mortality was associated with a lower FIM and GCS score on admission but not significantly with PTS. The use of ASM was associated with a worse rehabilitation outcome, independently of the onset of epilepsy during treatment. LPTS appear to exert a negative impact on rehabilitation outcome and their occurrence is not reduced by prophylactic therapy, whereas EPTS do not influence outcome. Our findings caution against the generic use of prophylactic therapy to prevent post-traumatic epilepsy in patients with TBI.	[Pingue, Valeria; Nardone, Antonio] Ist Clin Sci Maugeri IRCCS, Neurorehabil & Spinal Unit, Inst Pavia, Via Maugeri 4, I-27100 Pavia, Italy; [Mele, Chiara; Nardone, Antonio] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy		Pingue, V (corresponding author), Ist Clin Sci Maugeri IRCCS, Neurorehabil & Spinal Unit, Inst Pavia, Via Maugeri 4, I-27100 Pavia, Italy.	valeria.pingue@icsmaugeri.it	pingue, valeria/AAC-1833-2020; Nardone, Antonio/J-8733-2016; Mele, Chiara/ABG-2902-2020	pingue, valeria/0000-0001-9376-4699; Nardone, Antonio/0000-0002-9547-1774; 	Ministry of Health, ItalyMinistry of Health, Italy	This work was partially supported by the "Ricerca Corrente" Funding scheme of the Ministry of Health, Italy.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Devanney NA, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113310; Dichter MA, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2008.02009.x; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Harris L, 2020, J NEUROL, V267, P1774, DOI 10.1007/s00415-020-09769-5; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Keret A, 2018, SEIZURE-EUR J EPILEP, V58, P29, DOI 10.1016/j.seizure.2018.03.018; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mackintosh S, 2009, AUST J PHYSIOTHER, V55, P65, DOI 10.1016/S0004-9514(09)70066-2; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rao VR, 2015, SEMIN NEUROL, V35, P57, DOI 10.1055/s-0035-1544239; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Strazzer S, 2016, PEDIATR DRUGS, V18, P235, DOI 10.1007/s40272-016-0167-3; TEASDALE G, 1978, ANESTHESIOLOGY, V49, P225, DOI 10.1097/00000542-197809000-00023; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wat R, 2019, WORLD NEUROSURG, V122, P433, DOI 10.1016/j.wneu.2018.11.076; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wilson CD, 2018, WORLD NEUROSURG, V110, pE901, DOI 10.1016/j.wneu.2017.11.116; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yang Y, 2016, CNS DRUGS, V30, P677, DOI 10.1007/s40263-016-0365-0; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	46	4	4	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 25	2021	11	1							4708	10.1038/s41598-021-84203-y			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5IS	WOS:000626621800068	33633297	Green Published, gold			2022-02-06	
J	Yang, J; Wang, KP; Hu, TM; Wang, G; Wang, WX; Zhang, JW				Yang, Jie; Wang, Kunpeng; Hu, Tiemin; Wang, Guang; Wang, Weixing; Zhang, Jiwei			Vitamin D3 Supplement Attenuates Blood-Brain Barrier Disruption and Cognitive Impairments in a Rat Model of Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article						Vitamin D3; Brain injuries; Cognitive deficits; Brain edema; Inflammation		This study was designed to study the effects of vitamin D3 supplementation on the cognitive dysfunction and neurological function of traumatic brain injury (TBI) and the possible underlying mechanisms. To this purpose, different doses of vitamin D3 were intraperitoneally injection to TBI rats for one week before TBI surgery and three consecutive weeks after TBI. Brain edema evaluation was conducted on the third day and Evans blue staining for blood-brain barrier (BBB) permeability on the seventh day after TBI. Rat behavior was assessed by evaluation of neurological scores and morris water maze. It was revealed that vitamin D levels increased in serum after the administration of vitamin D3 for one week. TBI led to neurological deficit, together with brain edema, BBB disruption and inflammation. Vitamin D3 supplement ameliorated neurological deficit and cognitive impairments induced by TBI. Vitamin D3 administration reduced brain edema and impairments of blood-brain barrier induced by TBI, as well as decreased inflammatory response in TBI rat brain. Our results showed that vitamin D3 administration alleviated neurobehavioral deficits and improved brain edema after TBI. Vitamin D3 inhibited inflammatory cytokines and decreased BBB disruption in TBI rats. Vitamin D3 may be used for the treatment of TBI as a protective intervention.	[Yang, Jie] Chengde Med Coll, Affiliated Hosp, Div Nutr, Chengde 067000, Hebei, Peoples R China; [Wang, Kunpeng; Hu, Tiemin; Wang, Guang; Wang, Weixing; Zhang, Jiwei] Chengde Med Coll, Affiliated Hosp, Div Neurosurg, Chengde 067000, Hebei, Peoples R China		Wang, KP (corresponding author), Chengde Med Coll, Affiliated Hosp, Div Neurosurg, Chengde 067000, Hebei, Peoples R China.	wkpyyayjabd@sina.com			Medical Science Research Project of Hebei Province [20190862]	This work was funded by Medical Science Research Project of Hebei Province in 2019 (Project Number: 20190862).	Annweiler C, 2016, J INTERN MED, V280, P300, DOI 10.1111/joim.12491; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Clelland JD, 2014, SCHIZOPHR RES, V156, P15, DOI 10.1016/j.schres.2014.03.017; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cui CM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9245702; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Dang RL, 2015, EUR NEUROPSYCHOPHARM, V25, P1239, DOI 10.1016/j.euroneuro.2015.04.028; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Finnie JW, 2014, VET RES COMMUN, V38, P297, DOI 10.1007/s11259-014-9616-z; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/BF02509538; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Imazeki I, 2006, BIOMED RES-TOKYO, V27, P1, DOI 10.2220/biomedres.27.1; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jorde R, 2015, J NEUROL SCI, V355, P155, DOI 10.1016/j.jns.2015.06.009; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Lee JM, 2019, WORLD NEUROSURG, V126, pE1421, DOI 10.1016/j.wneu.2019.02.244; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Miller JW, 2015, JAMA NEUROL, V72, P1295, DOI 10.1001/jamaneurol.2015.2115; Mokhtari-Zaer A, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117703; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Segaert S, 2000, BIOCHEM BIOPH RES CO, V279, P89, DOI 10.1006/bbrc.2000.3892; Sharma S, 2020, CLIN DRUG INVEST, V40, P327, DOI 10.1007/s40261-020-00896-5; Tang HL, 2015, BRAIN INJURY, V29, P1165, DOI 10.3109/02699052.2015.1035330; Thota C, 2013, REPROD SCI, V20, P463, DOI 10.1177/1933719112459225; Toffanello ED, 2014, NEUROLOGY, V83, P2292, DOI 10.1212/WNL.0000000000001080; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yan LJ, 2019, MED SCI MONITOR, V25, P4716, DOI 10.12659/MSM.915355; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423	38	4	4	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	DEC	2021	23	4					491	499		10.1007/s12017-021-08649-z		FEB 2021	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XC7YW	WOS:000620406800001	33616826				2022-02-06	
J	Galovski, TE; Werner, KB; Iverson, KM; Kaplan, S; Fortier, CB; Fonda, JR; Currao, A; Salat, D; McGlinchey, RE				Galovski, Tara E.; Werner, Kimberly B.; Iverson, Katherine M.; Kaplan, Stephanie; Fortier, Catherine B.; Fonda, Jennifer R.; Currao, Alyssa; Salat, David; McGlinchey, Regina E.			A Multi-Method Approach to a Comprehensive Examination of the Psychiatric and Neurological Consequences of Intimate Partner Violence in Women: A Methodology Protocol	FRONTIERS IN PSYCHIATRY			English	Article						intimate partner violence; traumatic brain injury; women; post-traumatic stress; concussion	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE IMPAIRMENT; MENTAL-DISORDERS; RISK-FACTORS; CHILD-ABUSE; OUTCOMES; HANDICAP; INVENTORY; INTERVIEW	The number of women in the United States that experience blows to the head during assaults by intimate partners is substantial. The number of head blows that result in a traumatic brain injury (TBI) is virtually unknown, but estimates far exceed numbers of TBI in parallel populations (e.g., blast exposure, accidents, sports) combined. Research on the impact of TBI on post-traumatic stress disorder (PTSD) in survivors of intimate partner violence (IPV) is sparse. This methodology paper describes the comprehensive, multi-method approach used by a multi-disciplinary team of investigators from several different fields of expertise to assess the interaction of psychiatric, cognitive, psychological, and physical conditions that result from IPV. Using state-of-the-art instruments, a comprehensive assessment of lifetime trauma exposure, lifetime history of TBI, psychiatric history, and a full assessment of current cognitive, neuropsychological and biomedical function was conducted with 51 female survivors of IPV who screened positive for PTSD. This multi-method assessment included clinician-administered diagnostic interviews modified to specifically assess the sequelae of IPV, standardized self-report surveys, neuropsychological tests, structural, diffusion, and functional neuroimaging and blood-based biomarkers. The specific details and full report of the results of the full study are beyond the scope of this methodology paper. Descriptive characteristics of the complex clinical presentation observed in this unique sample are described. The sample reported high rates of trauma exposure across the lifespan and 80% met full criteria for current PTSD. Women also reported high rates of lifetime subconcussive head injury (88.2%) and TBI (52.9%) from various etiologies (35.3% secondary to IPV). Descriptive findings from the methodological protocol described here have begun to reveal information that will advance our understanding of the impact of subconcussive head injury and TBI on recovery from mental injury among IPV survivors.	[Galovski, Tara E.; Iverson, Katherine M.] Vet Affairs Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr Posttraumat Stress Disorder, Boston, MA USA; [Galovski, Tara E.; Iverson, Katherine M.; Fonda, Jennifer R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Werner, Kimberly B.; Kaplan, Stephanie] VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA 02130 USA; [Fortier, Catherine B.; Fonda, Jennifer R.; Currao, Alyssa; Salat, David; McGlinchey, Regina E.] Vet Affairs Boston Healthcare Syst, Translat Res Ctr Traumat Brain Injury & Stress Di, Boston, MA USA; [Fortier, Catherine B.; Fonda, Jennifer R.; Currao, Alyssa; Salat, David; McGlinchey, Regina E.] Vet Affairs Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Fortier, Catherine B.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Cambridge, MA USA; [Salat, David] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA		Werner, KB (corresponding author), VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA 02130 USA.	wernerk@umsl.edu	Fortier, Catherine/AAS-2163-2021; Fonda, Jennifer R./ABG-2890-2021	Fortier, Catherine/0000-0002-8953-9904; Fonda, Jennifer R./0000-0001-9482-2918	National Center for PTSD, a VA Center for Excellence; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Research Center for Traumatic Brain Injury [B3001-C]	This research was supported by the National Center for PTSD, a VA Center for Excellence and, in part, by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development National Research Center for Traumatic Brain Injury (B3001-C).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson JC, 2015, J EMERG NURS, V41, P36, DOI 10.1016/j.jen.2014.01.015; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Blake DD., CLIN ADM PTSD SCALE; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Breiding MJ., 2015, INTIMATE PARTNER VIO; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caldwell JE, 2012, PSYCHOL VIOLENCE, V2, P42, DOI 10.1037/a0026296; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC., 2001, DELIS KAPLAN EXECUTI, P1; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Fortier C., 2020, J HEAD TRAUMA REHAB; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fritz Patti A, 2004, Violence Vict, V19, P3, DOI 10.1891/vivi.19.1.3.33236; Galovski TE, 2021, PSYCHOL TRAUMA-US, V13, P376, DOI 10.1037/tra0000976; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hegarty K, 1999, J FAM VIOLENCE, V14, P399, DOI 10.1023/A:1022834215681; Iverson K, 2019, LIFETIME TRAUMA INTE; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, J TRAUMA STRESS, V26, P767, DOI 10.1002/jts.21867; Iverson KM, 2013, PSYCHOL VIOLENCE, V3, P273, DOI 10.1037/a0030956; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lovibond SH., 1996, MANUAL DEPRESSION AN, DOI [10.1037/t01004-000, DOI 10.1037/T01004-000]; Maruish ME., 1999, USE PSYCHOL TESTING, P1277; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Niolon P. H., 2017, PREVENTING INTIMATE; Okuda M, 2011, PSYCHIAT SERV, V62, P959, DOI 10.1176/ps.62.8.pss6208_0959; Pattinson CL, 2019, J TRAUMA STRESS, V32, P546, DOI 10.1002/jts.22418; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Rasmusson AM, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0908-9; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; Smith P H, 1995, Womens Health, V1, P273; Smith S.G., 2017, NATL INTIMATE PARTNE; Spielberger CD., 1988, STATE TRAIT ANGER EX; Spitzer RL., 2015, STRUCTURED CLIN INTE, P1, DOI 10.1002/9781118625392.wbecp351; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Statements Qualifying., 2009, J REHABIL RES DEV, V46; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Sutherland CA, 2002, AM J COMMUN PSYCHOL, V30, P609, DOI 10.1023/A:1016317130710; Tolin DF, 2018, ASSESSMENT, V25, P3, DOI 10.1177/1073191116638410; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; WechslerD, 2001, WECHSLER TEST ADULT; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Widom CS, 2014, CHILD ABUSE NEGLECT, V38, P650, DOI 10.1016/j.chiabu.2013.11.004; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; Woods S J, 2000, Issues Ment Health Nurs, V21, P309, DOI 10.1080/016128400248112; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	93	4	4	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	FEB 19	2021	12								569335	10.3389/fpsyt.2021.569335			16	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	QS4ID	WOS:000625862700001	33679466	gold, Green Published			2022-02-06	
J	Bazarian, JJ; Elbin, RJ; Casa, DJ; Hotz, GA; Neville, C; Lopez, RM; Schnyer, DM; Yeargin, S; Covassin, T				Bazarian, Jeffrey J.; Elbin, Robert J.; Casa, Douglas J.; Hotz, Gillian A.; Neville, Christopher; Lopez, Rebecca M.; Schnyer, David M.; Yeargin, Susan; Covassin, Tracey			Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in Diagnosing Concussion Among Athletes	JAMA NETWORK OPEN			English	Article								IMPORTANCE An objective, reliable indicator of the presence and severity of concussive brain injury and of the readiness for the return to activity has the potential to reduce concussion-related disability. OBJECTIVE To validate the classification accuracy of a previously derived, machine learning, multimodal, brain electrical activity-based Concussion Index in an independent cohort of athletes with concussion. DESIGN, SETTING, AND PARTICIPANTS This prospective diagnostic cohort study was conducted at 10 clinical sites (ie, US universities and high schools) between February 4, 2017, and March 20, 2019. A cohort comprising a consecutive sample of 207 athletes aged 13 to 25 years with concussion and 373 matched athlete controls without concussion were assessed with electroencephalography, cognitive testing, and symptom inventories within 72 hours of injury, at return to play, and 45 days after return to play. Variables from the multimodal assessment were used to generate a Concussion Index at each time point. Athletes with concussion had experienced a witnessed head impact, were removed from play for 5 days or more, and had an initial Glasgow Coma Scale score of 13 to 15. Participants were excluded for known neurologic disease or history within the last year of traumatic brain injury. Athlete controls were matched to athletes with concussion for age, sex, and type of sport played. MAIN OUTCOMES AND MEASURES Classification accuracy of the Concussion Index at time of injury using a prespecified cutoff of 70 or less (total range, 0-100, where <= 70 indicates it is likely the individual has a concussion and >70 indicates it is likely the individual does not have a concussion). RESULTS Of 580 eligible participants with analyzable data, 207 had concussion (124 male participants [59.9%]; mean [SD] age, 19.4 [2.5] years), and 373 were athlete controls (187 male participants [50.1%]; mean [SD] age, 19.6 [2.2] years). The Concussion Index had a sensitivity of 86.0% (95% CI, 80.5%-90.4%), specificity of 70.8% (95% CI, 65.9%-75.4%), negative predictive value of 90.1% (95% CI, 86.1%-93.3%), positive predictive value of 62.0% (95% CI, 56.1%-67.7%), and area under receiver operator characteristic curve of 0.89. At day 0, the mean (SD) Concussion Index among athletes with concussion was significantly lower than among athletes without concussion (75.0 [14.0] vs 32.7 [27.2]; P < .001). Among athletes with concussion, there was a significant increase in the Concussion Index between day 0 and return to play, with a mean (SD) paired difference between these time points of -41.2 (27.0) (P < .001). CONCLUSIONS AND RELEVANCE These results suggest that the multimodal brain activity-based Concussion Index has high classification accuracy for identification of the likelihood of concussion at time of injury and may be associated with the return to control values at the time of recovery. The Concussion Index has the potential to aid in the clinical diagnosis of concussion and in the assessment of athletes' readiness to return to play.	[Bazarian, Jeffrey J.] Univ Rochester, Sch Med, Dept Emergency Med, New York, NY 14642 USA; [Elbin, Robert J.] Univ Arkansas, Off Sports Concuss Res, Fayetteville, AR 72701 USA; [Casa, Douglas J.] Univ Connecticut, Korey Stringer Inst, Storrs, CT USA; [Hotz, Gillian A.] Univ Miami, UHlth Concuss Program, Miami, FL USA; [Neville, Christopher] SUNY Upstate Med Univ, Dept Phys Therapy Educ, Syracuse, NY 13210 USA; [Lopez, Rebecca M.] Univ S Florida, Morsani Coll Med Orthoped & Sports Med, Tampa, FL 33620 USA; [Schnyer, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Yeargin, Susan] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Bazarian, JJ (corresponding author), Univ Rochester, Dept Emergency Med, 601 Elmwood Ave,POB 655c, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu	Schnyer, David/ABD-6372-2021	Schnyer, David/0000-0002-7472-2853	US Navy (Naval Health Research Center) [W911QY-14-C-0098]	The clinical studywas funded in part by contractW911QY-14-C-0098 to BrainScope Co Inc from the US Navy (Naval Health Research Center).	Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Balkan O, 2015, IEEE ENG MED BIO, P4053, DOI 10.1109/EMBC.2015.7319284; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; National Collegiate Athletic Association , CONC SAF BEST PRACT; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; O'Brien AM, 2018, APPL NEUROPSYCH-CHIL, V7, P208, DOI 10.1080/21622965.2017.1290529; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rawlins Michelle L Weber, 2020, J Clin Transl Res, V5, P186; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stork D.G., 2001, PATTERN CLASSIFICATI; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wilde EA, 2020, J NEUROTRAUM, V37, P2093, DOI 10.1089/neu.2018.6365; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	54	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	FEB 15	2021	4	2							e2037349	10.1001/jamanetworkopen.2020.37349			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QJ3QL	WOS:000619606600008	33587137	gold, Green Published			2022-02-06	
J	Du, DL; Tang, W; Zhou, C; Sun, XC; Wei, ZQ; Zhong, JJ; Huang, ZJ				Du, Donglin; Tang, Wei; Zhou, Chao; Sun, Xiaochuan; Wei, Zhengqiang; Zhong, Jianjun; Huang, Zhijian			Fecal Microbiota Transplantation Is a Promising Method to Restore Gut Microbiota Dysbiosis and Relieve Neurological Deficits after Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article								Background. Traumatic brain injury (TBI) can induce persistent fluctuation in the gut microbiota makeup and abundance. The present study is aimed at determining whether fecal microbiota transplantation (FMT) can rescue microbiota changes and ameliorate neurological deficits after TBI in rats. Methods. A controlled cortical impact (CCI) model was used to simulate TBI in male Sprague-Dawley rats, and FMT was performed for 7 consecutive days. 16S ribosomal RNA (rRNA) sequencing of fecal samples was performed to analyze the effects of FMT on gut microbiota. Modified neurological severity score and Morris water maze were used to evaluate neurobehavioral functions. Metabolomics was used to screen differential metabolites from the rat serum and ipsilateral brains. The oxidative stress indices were measured in the brain. Results. TBI induced significance changes in the gut microbiome, including the alpha- and beta-bacterial diversity, as well as the microbiome composition at 8 days after TBI. On the other hand, FMT could rescue these changes and relieve neurological deficits after TBI. Metabolomics results showed that the level of trimethylamine (TMA) in feces and the level of trimethylamine N-oxide (TMAO) in the ipsilateral brain and serum was increased after TBI, while FMT decreased TMA levels in the feces, and TMAO levels in the ipsilateral brain and serum. Antioxidant enzyme methionine sulfoxide reductase A (MsrA) in the ipsilateral hippocampus was decreased after TBI but increased after FMT. In addition, FMT elevated SOD and CAT activities and GSH/GSSG ratio and diminished ROS, GSSG, and MDA levels in the ipsilateral hippocampus after TBI. Conclusions. FMT can restore gut microbiota dysbiosis and relieve neurological deficits possibly through the TMA-TMAO-MsrA signaling pathway after TBI.	[Du, Donglin; Tang, Wei; Zhou, Chao; Sun, Xiaochuan; Zhong, Jianjun; Huang, Zhijian] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Wei, Zhengqiang] Chongqing Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Chongqing 400016, Peoples R China		Zhong, JJ; Huang, ZJ (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	jianjun@hospital.cqmu.edu.cn; zhijian@cqmu.edu.cn		Zhong, jianjun/0000-0002-9481-5088; Huang, Zhijian/0000-0002-8241-0761	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071397]; Youth Foundation of the National Natural Science Foundation of China [81801230]	We acknowledge the service provided by Chongqing Key Laboratory of Ophthalmology. This project was supported by grants from the National Natural Science Foundation of China (Grant No. 82071397) and Youth Foundation of the National Natural Science Foundation of China (Grant No. 81801230).	Benakis C, 2020, CURR OPIN NEUROBIOL, V61, P1, DOI 10.1016/j.conb.2019.11.009; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516; Brunt VE, 2021, GEROSCIENCE, V43, P377, DOI 10.1007/s11357-020-00257-2; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3; Del Rio D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101053; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001; Han YH, 2020, ANTICANCER RES, V40, P4491, DOI 10.21873/anticanres.14454; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; He Z, 2017, WORLD J GASTROENTERO, V23, P3565, DOI 10.3748/wjg.v23.i19.3565; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Huang YF, 2020, RHEUMATOLOGY, V59, P2960, DOI 10.1093/rheumatology/keaa018; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7; Kang YL, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1615-4; Kazi S, 2002, CHEM-BIOL INTERACT, V140, P121, DOI 10.1016/S0009-2797(02)00023-6; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; Khokhlova ON, 2017, J PHARMACOL TOX MET, V84, P11, DOI 10.1016/j.vascn.2016.10.005; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koopman N, 2019, ALIMENT PHARM THER, V50, P628, DOI 10.1111/apt.15416; Kuka J, 2014, LIFE SCI, V117, P84, DOI 10.1016/j.lfs.2014.09.028; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lee DH, 2017, ONCOTARGET, V8, P51096, DOI 10.18632/oncotarget.17002; Li D, 2018, AGING CELL, V17, DOI 10.1111/acel.12768; Li HS, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.926281; Li JW, 2019, PESTIC BIOCHEM PHYS, V159, P68, DOI 10.1016/j.pestbp.2019.05.018; Li KL, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/2058272; Li TJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00350; Li W, 2017, SCI CHINA LIFE SCI, V60, P1223, DOI 10.1007/s11427-016-9001-4; Li Y, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165764; Liao XY, 2019, EBIOMEDICINE, V44, P665, DOI 10.1016/j.ebiom.2019.03.057; Lin CH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1528-y; Liu TH, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0997-x; Louis P, 2012, DIGEST DIS SCI, V57, P1987, DOI 10.1007/s10620-012-2286-1; Lu L, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12777; Meng FQ, 2019, BEHAV BRAIN RES, V368, P94, DOI 10.1016/j.bbr.2019.111902; Mu CL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00345; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scheff SW, 2016, NEUROSCI LETT, V634, P126, DOI 10.1016/j.neulet.2016.10.016; Seldin MM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002767; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Spychala MS, 2018, ANN NEUROL, V84, P23, DOI 10.1002/ana.25250; Sun GP, 2017, BIOCHEM BIOPH RES CO, V493, P964, DOI 10.1016/j.bbrc.2017.09.108; Sun MF, 2018, BRAIN BEHAV IMMUN, V70, P48, DOI 10.1016/j.bbi.2018.02.005; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tu Q, 2016, MOL MED REP, V13, P753, DOI 10.3892/mmr.2015.4587; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vernetti L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42296; Vogt NM, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0451-2; Vuokila N, 2018, CELL MOL LIFE SCI, V75, P4557, DOI 10.1007/s00018-018-2911-z; Wang H, 2017, METALLOMICS, V9, P192, DOI [10.1039/c7mt00007c, 10.1039/C7MT00007C]; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang JP, 2014, BEHAV BRAIN RES, V265, P171, DOI 10.1016/j.bbr.2014.02.033; Wang XY, 2019, CELL RES, V29, P787, DOI 10.1038/s41422-019-0216-x; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu CJ, 2018, NEUROLOGY, V90, pE128, DOI 10.1212/WNL.0000000000005298; Xu FF, 2018, NEUROSCI BULL, V34, P1077, DOI 10.1007/s12264-018-0283-x; Xu WL, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00105; Xu X, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1655-x; Yuan XX, 2018, SCHIZOPHR RES, V201, P299, DOI 10.1016/j.schres.2018.05.017; Zhao L, 2019, NEUROCHEM RES, V44, P2506, DOI 10.1007/s11064-019-02868-4; Zheng JW, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00414; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	79	4	4	5	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	FEB 11	2021	2021								5816837	10.1155/2021/5816837			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	QM5ZS	WOS:000621857800003	33628361	Green Published, gold			2022-02-06	
J	Zhang, J; Liu, XY; Ma, K; Chen, M; Xu, HY; Niu, XG; Gu, HR; Wang, RJ; Chen, XY; Sun, HT				Zhang, Jian; Liu, Xiaoyin; Ma, Ke; Chen, Miao; Xu, Huiyou; Niu, Xuegang; Gu, Haoran; Wang, Renjie; Chen, Xuyi; Sun, HongTao			Collagen/heparin scaffold combined with vascular endothelial growth factor promotes the repair of neurological function in rats with traumatic brain injury	BIOMATERIALS SCIENCE			English	Article								The objective of this study was to evaluate the therapy effects of a novel biological scaffold containing heparin, collagen and vascular endothelial growth factor (VEGF) in treating traumatic brain injury (TBI). In our research, a functional composite scaffold constituted by collagen, heparin and vascular endothelial growth factor was used to stimulate angiogenesis and improve nerve-tissue regeneration in a rat model of TBI. The composite scaffold possessed excellent mechanical properties and good porosity, and could effectively control the release rate of VEGF. Motor and cognitive functions such as motor evoked potential, Morris water maze test and modified neurological severity score were evidently improved after the scaffold was grafted onto the injury site in the rat TBI model. There was clearly improved restoration of damaged nerve tissue at the injured site. Furthermore, brain edema and inflammatory reactions were significantly alleviated. Newly formed neurons with associated synaptic structures, nerve fibers, myelin sheaths and functional angiogenesis with intact endothelium at the injury site were observed. In conclusion, our data revealed that the collagen/heparin scaffold combined with VEGF could create excellent microenvironment stimuli for damaged nerve-tissue regeneration, providing a potential strategy for treating TBI.	[Zhang, Jian; Liu, Xiaoyin; Ma, Ke; Xu, Huiyou; Wang, Renjie; Chen, Xuyi; Sun, HongTao] Characterist Med Ctr Chinese Peoples Armed Police, Inst Thrumatir Brain Injury & Neurosci, Tianjin Key Lab Neurotraurna Repair, Chenglin Rd 220, Tianjin 300162, Peoples R China; [Zhang, Jian; Ma, Ke; Xu, Huiyou] Logist Univ Peoples Anned Police Force, Grad Sch, Tianjin, Peoples R China; [Liu, Xiaoyin] Sichuan Univ, West China Hosp, West China Med Sch, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Chen, Miao] Xinjiang Med Univ, Ajfiliated Hosp Tradit Chinese Med, Huanghe Rd 116, Urumqi 830000, Xinjiang, Peoples R China; [Niu, Xuegang] Tianjin 4th Cent Hosp, Tianjin 300140, Peoples R China; [Gu, Haoran] 947th Hosp Chinese Peoples Liberat Army, Kashgar 844000, Xinjiang, Peoples R China		Sun, HT (corresponding author), Characterist Med Ctr Chinese Peoples Armed Police, Inst Thrumatir Brain Injury & Neurosci, Tianjin Key Lab Neurotraurna Repair, Chenglin Rd 220, Tianjin 300162, Peoples R China.	zhangjian19237@163.com		Zhang, Jian/0000-0003-2076-3606	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [32070791, 11932013]; National Nature Scientific Fund of China [11672332]; National Key Research and Development Plan of China [2016YFC1101500]; Nature Scientific Fund of Tianjin [17YFZCSY00620, 15ZXLCSY00040]; Science and Technology Military-Civilian Integration Project of Tianjin [18ZXJMTG00260]	This work was supported by the National Natural Science Foundation of China (32070791), National Nature Scientific Fund of China (11672332), National Natural Science Foundation of China (11932013), National Key Research and Development Plan of China (2016YFC1101500), Nature Scientific Fund of Tianjin (17YFZCSY00620, 15ZXLCSY00040), and Science and Technology Military-Civilian Integration Project of Tianjin (18ZXJMTG00260).	Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; BAUTERS C, 1995, J VASC SURG, V21, P314, DOI 10.1016/S0741-5214(95)70272-5; Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Chen C, 2017, J BIOMED MATER RES A, V105, P1324, DOI 10.1002/jbm.a.36011; Chen YL, 2013, THROMB HAEMOSTASIS, V109, P1148, DOI 10.1160/TH12-12-0935; Chung YI, 2006, BIOMATERIALS, V27, P2621, DOI 10.1016/j.biomaterials.2005.11.043; Davies NH, 2012, TISSUE ENG PT A, V18, P26, DOI 10.1089/ten.tea.2011.0192; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097; Gao WW, 2018, EXP NEUROL, V307, P99, DOI 10.1016/j.expneurol.2018.06.001; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hiratsuka D, 2019, J NEUROIMMUNOL, V332, P176, DOI 10.1016/j.jneuroim.2019.04.016; Jiang J., 2018, J NEUROSCI METH; Jiang JP, 2020, NEURAL REGEN RES, V15, P959, DOI 10.4103/1673-5374.268974; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Ju SM, 2019, J ALZHEIMERS DIS, V68, P1687, DOI 10.3233/JAD-190063; Jung J, 2014, NEURAL REGEN RES, V9, P2119, DOI 10.4103/1673-5374.147940; Kim HJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1372946; Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074; Leung GKK, 2012, METHOD ENZYMOL, V508, P177, DOI 10.1016/B978-0-12-391860-4.00009-4; Li G, 2018, J BIOMED MATER RES A, V106, P2158, DOI 10.1002/jbm.a.36414; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P378, DOI 10.1055/s-0030-1254047; Liu K, 2020, NANOSCALE, V12, P18225, DOI 10.1039/d0nr04204h; Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031; Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571; Murakami K, 2015, NEUROSCIENCE, V300, P338, DOI 10.1016/j.neuroscience.2015.05.033; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Negah SS, 2019, ACTA BIOMATER, V92, P132, DOI 10.1016/j.actbio.2019.05.010; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Nillesen STM, 2006, J CONTROL RELEASE, V116, pE88, DOI 10.1016/j.jconrel.2006.09.065; Niu GG, 2014, BIOMATERIALS, V35, P4005, DOI 10.1016/j.biomaterials.2014.01.033; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schnieders J, 2011, J BIOMED MATER RES B, V99B, P391, DOI 10.1002/jbm.b.31910; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; SHIN DY, 1989, ARCH PHYS MED REHAB, V70, P189; Shin YJ, 2015, J HISTOCHEM CYTOCHEM, V63, P170, DOI 10.1369/0022155414564218; Shukla RP, 2020, BIOMATER SCI-UK, V8, P1298, DOI 10.1039/c9bm01246j; Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sun B, 2009, J BIOMED MATER RES B, V91B, P366, DOI 10.1002/jbm.b.31411; Sun Y, 2019, J BIOMED MATER RES A, V107, P1898, DOI 10.1002/jbm.a.36675; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Titus DJ, 2018, NEUROBIOL LEARN MEM, V148, P38, DOI 10.1016/j.nlm.2017.12.008; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Wen ZY, 2017, BRAIN RES, V1665, P88, DOI 10.1016/j.brainres.2017.04.001; Wu KW, 2015, NEUROSCIENCE, V298, P94, DOI 10.1016/j.neuroscience.2015.04.015; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu C, 2020, STEM CELLS DEV, V29, P222, DOI 10.1089/scd.2019.0173; Xu JY, 2003, NEUROSCIENCE, V118, P59, DOI 10.1016/S0306-4522(02)00948-X; Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhao WJ, 2012, BIOSCIENCE REP, V32, P71, DOI 10.1042/BSR20110077	61	4	4	10	15	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2047-4830	2047-4849		BIOMATER SCI-UK	Biomater. Sci.	FEB 7	2021	9	3					745	764		10.1039/c9bm01446b			20	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	QF1RO	WOS:000616677300010	33200759				2022-02-06	
J	Barkley, AS; Spece, LJ; Barros, LM; Bonow, RH; Ravanpay, A; Ellenbogen, R; Huoy, P; Thy, T; Sothea, S; Pak, S; LoGerfo, J; Lele, AV				Barkley, Ariana S.; Spece, Laura J.; Barros, Lia M.; Bonow, Robert H.; Ravanpay, Ali; Ellenbogen, Richard; Huoy, Phearum; Thy, Try; Sothea, Seang; Pak, Sopheak; LoGerfo, James; Lele, Abhijit V.			A mixed-methods needs assessment of traumatic brain injury care in a low- and middle-income country setting: building neurocritical care capacity at two major hospitals in Cambodia	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; neurocritical care; low-income countries; middle-income countries; needs assessment; mixed methods; capacity development; trauma	HEALTH	OBJECTIVE The high global burden of traumatic brain injury (TBI) disproportionately affects lowand middle-income countries (LMICs). These settings also have the greatest disparity in the availability of surgical care in general and neurosurgical care in particular. Recent focus has been placed on alleviating this surgical disparity. However, most capacity assessments are purely quantitative, and few focus on concomitantly assessing the complex healthcare system needs required to care for these patients. The objective of the present study was to use both quantitative and qualitative assessment data to establish a comprehensive approach to inform capacity-development initiatives for TBI care at two hospitals in an LMIC, Cambodia. METHODS This mixed-methods study used 3 quantitative assessment tools: the World Health Organization Personnel, Infrastructure, Procedures, Equipment, Supplies (WHO PIPES) checklist, the neurosurgery-specific PIPES (Neuro PIPES) checklist, and the Neurocritical Care (NCC) checklist at two hospitals in Phnom Penh, Cambodia. Descriptive statistics were obtained for quantitative results. Qualitative semistructured interviews of physicians, nurses, and health care administrators were conducted by a single interviewer. Responses were analyzed using a thematic content analysis approach and coded to allow categorization under the PIPES framework. RESULTS Of 35 healthcare providers approached, 29 (82.9%) participated in the surveys, including 19 physicians (65.5%) and 10 nurses (34.5%). The majority had fewer than 5 years of experience (51.7%), were male (n = 26, 89.7%), and were younger than 40 years of age (n = 25, 86.2%). For both hospitals, WHO PIPES scores were lowest in the equipment category. However, using the NCC checklist, both hospitals scored higher in equipment (81.2% and 62.7%) and infrastructure (78.6% and 69.6%; hospital 1 and 2, respectively) categories and lowest in the training/continuing education category (41.7% and 33.3%, hospital 1 and 2, respectively). Using the PIPES framework, analysis of the qualitative data obtained from interviews revealed a need for continuing educational initiatives for staff, increased surgical and critical care supplies and equipment, and infrastructure development. The analysis further elucidated barriers to care, such as challenges with time availability for experienced providers to educate incoming healthcare professionals, issues surrounding prehospital care, maintenance of donated supplies, and patient poverty. CONCLUSIONS This mixed-methods study identified areas in supplies, equipment, and educational/training initiatives as areas for capacity development for TBI care in an LMIC such as Cambodia. This first application of the NCC checklist in an LMIC setting demonstrated limitations in its use in this setting. Concomitant qualitative assessments provided insight into barriers otherwise undetected in quantitative assessments.	[Barkley, Ariana S.; Bonow, Robert H.; Ravanpay, Ali; Ellenbogen, Richard] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Spece, Laura J.; Barros, Lia M.] Univ Washington, Dept Med, Seattle, WA USA; [Spece, Laura J.] VA Puget Sound Hlth Care Syst, Dept Hlth Serv Res & Dev, Seattle, WA USA; [Ravanpay, Ali] VA Puget Sound Hlth Care Syst, Dept Neurol Surg, Seattle, WA USA; [Huoy, Phearum] Khmer Soviet Friendship Hosp, Dept Neurol Surg, Phnom Penh, Cambodia; [Thy, Try; Sothea, Seang] Univ Hlth Sci, Dept Neurol Surg, Phnom Penh, Cambodia; [Pak, Sopheak] Univ Hlth Sci, Tech Off, Phnom Penh, Cambodia; [LoGerfo, James] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA; [LoGerfo, James] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lele, Abhijit V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Barkley, AS (corresponding author), Univ Washington, Seattle, WA 98195 USA.	respub@uw.edu					Albert TJ, 2015, ANN AM THORAC SOC, V12, P491, DOI 10.1513/AnnalsATS.201412-557AR; [Anonymous], 2018, WORLD HLTH RANKINGS; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Groen RS, 2012, WORLD J SURG, V36, P1970, DOI 10.1007/s00268-012-1591-3; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Maguire M., 2017, AISHE J ALL IRELAND, V3, P3351; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Moheet AM, 2018, NEUROCRIT CARE, V29, P145, DOI 10.1007/s12028-018-0601-1; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Peeters S, 2017, WORLD NEUROSURG, V97, P580, DOI 10.1016/j.wneu.2016.09.127; Perry L, 2011, MED BIOL ENG COMPUT, V49, P719, DOI 10.1007/s11517-011-0786-3; Ploss B, 2017, WORLD NEUROSURG, V108, P844, DOI 10.1016/j.wneu.2017.08.045; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; United Nations Development Programme, 2009, CAP DEV UNDP PRIM; World Bank, 2017, CAMB GNI CURR US; World Health Organization, 2013, GLOB STAT REP ROAD S	21	4	4	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2021	134	1					244	250		10.3171/2019.10.JNS192118			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QF0IP	WOS:000616585200002	31860819	Green Accepted, Bronze			2022-02-06	
J	Elbogen, EB; Alsobrooks, A; Battles, S; Molloy, K; Dennis, PA; Beckham, JC; McLean, SA; Keith, JR; Russoniello, C				Elbogen, Eric B.; Alsobrooks, Amber; Battles, Sara; Molloy, Kiera; Dennis, Paul A.; Beckham, Jean C.; McLean, Samuel A.; Keith, Julian R.; Russoniello, Carmen			Mobile Neurofeedback for Pain Management in Veterans with TBI and PTSD	PAIN MEDICINE			English	Article						Chronic Pain; Neurofeedback; Traumatic Brain Injury; Post-traumatic Stress Disorder; Military Veterans		Objective. Chronic pain is common in military veterans with traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Neurofeedback, or electroencephalograph (EEG) biofeedback, has been associated with lower pain but requires frequent travel to a clinic. The current study examined feasibility and explored effectiveness of neurofeedback delivered with a portable EEG headset linked to an application on a mobile device. Design. Open-label, single-arm clinical trial. Setting. Home, outside of clinic. Subjects. N = 41 veterans with chronic pain, TBI, and PTSD. Method. Veterans were instructed to perform "mobile neurofeedback" on their own for three months. Clinical research staff conducted two home visits and two phone calls to provide technical assistance and troubleshoot difficulties. Results. N = 36 veterans returned for follow-up at three months (88% retention). During this time, subjects completed a mean of 33.09 neurofeedback sessions (10 minutes each). Analyses revealed that veterans reported lower pain intensity, pain interference, depression, PTSD symptoms, anger, sleep disturbance, and suicidal ideation after the three-month intervention compared with baseline. Comparing pain ratings before and after individual neurofeedback sessions, veterans reported reduced pain intensity 67% of the time immediately following mobile neurofeedback. There were no serious adverse events reported. Conclusions. This preliminary study found that veterans with chronic pain, TBI, and PTSD were able to use neurofeedback with mobile devices independently after modest training and support. While a double-blind randomized controlled trial is needed for confirmation, the results show promise of a portable, technology-based neuromodulatory approach for pain management with minimal side effects.	[Elbogen, Eric B.; Dennis, Paul A.; Beckham, Jean C.] Vet Affairs VA Midatlant Mental Illness Res Educ, Durham, NC USA; [Elbogen, Eric B.; Alsobrooks, Amber; Battles, Sara; Molloy, Kiera; Dennis, Paul A.; Beckham, Jean C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Box 2705, Durham, NC 27705 USA; [McLean, Samuel A.] Univ North Carolina Chapel Hill, Dept Anesthesiol, Sch Med, Chapel Hill, NC USA; [Keith, Julian R.] Univ North Carolina Wilmington, Dept Psychol, Wilmington, NC USA; [Russoniello, Carmen] East Carolina Univ, Ctr Appl Psychophysiol, Greenville, NC 27858 USA		Elbogen, EB (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Box 2705, Durham, NC 27705 USA.	eric.elbogen@duke.edu			National Center for Complementary and Integrative Health [R34 AT008399-0]; Department of DefenseUnited States Department of Defense [W81XWH-17-1-0591]; Clinical Sciences Research and Development Senior Research Career Scientist Award from the US Department of Veterans AffairsUS Department of Veterans Affairs [IK6CX001494]; Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC)	This work was supported by the National Center for Complementary and Integrative Health (Award#R34 AT008399-0), Department of Defense (Award#W81XWH-17-1-0591), a Clinical Sciences Research and Development Senior Research Career Scientist Award #IK6CX001494 (JCB) from the US Department of Veterans Affairs, and the Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC).	Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Bair MJ, 2009, PAIN MED, V10, P1280, DOI 10.1111/j.1526-4637.2009.00707.x; Banerjee A, 2018, PATIENT EDUC COUNS, V101, P767, DOI 10.1016/j.pec.2017.12.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Caro XJ, 2011, APPL PSYCHOPHYS BIOF, V36, P193, DOI 10.1007/s10484-011-9159-9; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; de Vries M, 2013, J PAIN RES, V6, P815, DOI 10.2147/JPR.S50919; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; Gallagher Rollin M, 2016, Anesthesiol Clin, V34, P357, DOI 10.1016/j.anclin.2016.01.003; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Hammond D.C., 2011, J NEUROTHER, V15, P305, DOI [10.1080/10874208.2011.623090, DOI 10.1080/10874208.2011.623090]; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Jensen MP, 2014, NAT REV NEUROL, V10, P167, DOI 10.1038/nrneurol.2014.12; Jensen MP, 2013, APPL PSYCHOPHYS BIOF, V38, P101, DOI 10.1007/s10484-013-9214-9; Johnstone SJ, 2012, CLIN EEG NEUROSCI, V43, P112, DOI 10.1177/1550059411435857; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Krebs EE, 2007, J GEN INTERN MED, V22, P1453, DOI 10.1007/s11606-007-0321-2; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Peake JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00743; Peniston E. G., 1991, MED PSYCHOTHERAPY, V4, P47, DOI DOI 10.1021/MA0483701; Prinsloo S, 2018, J PAIN SYMPTOM MANAG, V55, P1276, DOI 10.1016/j.jpainsymman.2018.01.010; Reiter K, 2016, J NERV MENT DIS, V204, P69, DOI 10.1097/NMD.0000000000000418; Rieiro H, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19122808; Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006; Rojas GM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00235; Ros T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01008; Schwartz MS, 2017, BIOFEEDBACK PRACTITI; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Searle SR, VARIANCE COMPONENTS; Sime A, 2004, J NEUROTHER, V8, P59, DOI [10.1300/j184v08n01_05, DOI 10.1300/J184V08N01_05, DOI 10.1300/J184V08N01_]; SKINNER BF, 1963, AM PSYCHOL, V18, P503, DOI 10.1037/h0045185; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stopczynski A, 2014, INT J PSYCHOPHYSIOL, V91, P54, DOI 10.1016/j.ijpsycho.2013.08.007; Thompson, 2003, NEUROFEEDBACK BOOK I; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; van der Kolk BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166752; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wetherell JL, 2011, PAIN, V152, P2098, DOI 10.1016/j.pain.2011.05.016; Wolfe F, 2003, J RHEUMATOL, V30, P369	47	4	4	4	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	FEB	2021	22	2					329	337		10.1093/pm/pnz269			9	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	RJ0VX	WOS:000637322800010	31697371	Green Published, hybrid			2022-02-06	
J	Islamov, RR; Bashirov, FV; Sokolov, ME; Izmailov, AA; Fadeev, FO; Markosyan, VA; Davleeva, MA; Zubkova, OV; Smarov, MM; Logunov, DY; Naroditskyi, BS; Salafutdinov, II; Rizvanov, AA; Turaev, RG				Islamov, Rustem R.; Bashirov, Farid, V; Sokolov, Mikhail E.; Izmailov, Andrei A.; Fadeev, Filip O.; Markosyan, Vage A.; Davleeva, Maria A.; Zubkova, Olga, V; Smarov, Maxim M.; Logunov, Denis Yu; Naroditskyi, Boris S.; Salafutdinov, Ilnur I.; Rizvanov, Albert A.; Turaev, Ramil G.			Gene-modified leucoconcentrate for personalized ex vivo gene therapy in a mini pig model of moderate spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article						chimeric Ad5/35F virus; enhanced green fluorescent protein; gene-modified leucoconcentrate; mini pig; peripheral blood; personalized ex vivo gene therapy; plastic blood bag; spinal cord injury	IN-VIVO; BLOOD-CELLS; ADENOVIRUS; DELIVERY; VECTOR; VITRO	We previously demonstrated that gene-modified umbilical cord blood mononuclear cells overexpressing a combination of recombinant neurotrophic factors are a promising therapeutic approach for cell-mediated gene therapy for neurodegenerative diseases, neurotrauma, and stroke. In this study, using a mini pig model of spinal cord injury, we proposed for the first time the use of gene-modified leucoconcentrate prepared from peripheral blood in the plastic blood bag for personalized ex vivo gene therapy. Leucoconcentrate obtained from mini pig peripheral blood was transduced with a chimeric adenoviral vector (Ad5/35F) that carried an enhanced green fluorescent protein (EGFP) reporter gene in the plastic blood bag. The day after blood donation, the mini pigs were subjected to moderate SCI and four hours post-surgery they were intravenously autoinfused with gene-modified leucoconcentrate. A week after gene-modified leucoconcentrate therapy, fluorescent microscopy revealed EGFP-expressing leucocytes in spinal cord at the site of contusion injury. In the spleen the groups of EGFP-positive cells located in the lymphoid follicles were observed. In vitro flow cytometry and fluorescent microscopy studies of the gene-modified leucoconcentrate samples also confirmed the production of EGFP by leucocytes. Thus, the efficacy of leucocytes transduction in the plastic blood bag and their migratory potential suggest their use for temporary production of recombinant biologically active molecules to correct certain pathological conditions. This paper presents a proof-of-concept of simple, safe and effective approach for personalized ex vivo gene therapy based on gene-modified leucoconcentrate autoinfusion.	[Islamov, Rustem R.; Bashirov, Farid, V; Sokolov, Mikhail E.; Izmailov, Andrei A.; Fadeev, Filip O.; Markosyan, Vage A.; Davleeva, Maria A.] Kazan State Med Univ, Kazan, Russia; [Zubkova, Olga, V; Smarov, Maxim M.; Logunov, Denis Yu; Naroditskyi, Boris S.] Gamaleya Res Inst Epidemiol & Microbiol, Moscow, Russia; [Salafutdinov, Ilnur I.; Rizvanov, Albert A.] Kazan Fed Univ, Kazan, Russia; [Turaev, Ramil G.] Minist Hlth Republ Tatarstan, Republican Blood Ctr, Kazan, Russia		Islamov, RR (corresponding author), Kazan State Med Univ, Kazan, Russia.; Rizvanov, AA (corresponding author), Kazan Fed Univ, Kazan, Russia.	rustem.islamov@gmail.com; rizvanov@gmail.com	Izmailov, Andrey/R-1143-2017; Markosyan, Vage/ABB-8925-2021; Rizvanov, Albert/H-4486-2013; Fadeev, Filip/U-9666-2019; Izmailov, Andrey/AAC-9451-2022; Logunov, Denis/E-8300-2014; Islamov, Rustem/A-3581-2019	Izmailov, Andrey/0000-0002-8128-4636; Markosyan, Vage/0000-0002-3789-0284; Rizvanov, Albert/0000-0002-9427-5739; Fadeev, Filip/0000-0002-8119-3136; Reis, AlessanRSS/0000-0001-8486-7469; Logunov, Denis/0000-0003-4035-6581; Islamov, Rustem/0000-0002-6632-4636	Russian Science FoundationRussian Science Foundation (RSF) [16-15-00010]; Russian Government Program of Competitive Growth of Kazan Federal University	This study was supported by the grant of Russian Science Foundation (No. 16-15-00010; to RRI). AAR was supported by the Russian Government Program of Competitive Growth of Kazan Federal University.	Adams WC, 2011, P NATL ACAD SCI USA, V108, P7499, DOI 10.1073/pnas.1017146108; Aiuti A, 2017, EMBO MOL MED, V9, P737, DOI 10.15252/emmm.201707573; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chellappan DK, 2018, BIOMED PHARMACOTHER, V108, P1188, DOI 10.1016/j.biopha.2018.09.138; Cheng H, 2002, J NEUROSCI RES, V69, P397, DOI 10.1002/jnr.10303; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Dalamagkas K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061776; Denby L, 2004, HUM GENE THER, V15, P1054, DOI 10.1089/1043034042431083; Ichim Thomas E, 2010, Int Arch Med, V3, P30, DOI 10.1186/1755-7682-3-30; Islamov RR, 2017, MOL NEUROBIOL, V54, P4756, DOI 10.1007/s12035-016-0017-x; Islamov RR, 2017, NEUROSCI LETT, V644, P67, DOI 10.1016/j.neulet.2017.02.034; Izmailov AA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00813; Jones CF, 2012, J NEUROSURG-SPINE, V16, P624, DOI 10.3171/2012.3.SPINE11970; Li Y, 2016, ADV EXP MED BIOL, V854, P549, DOI 10.1007/978-3-319-17121-0_73; Liu J, 2013, CYTOTHERAPY, V15, P185, DOI 10.1016/j.jcyt.2012.09.005; MAIZEL JV, 1968, VIROLOGY, V36, P126, DOI 10.1016/0042-6822(68)90122-0; Mooney R, 2017, ADV DRUG DELIVER REV, V118, P35, DOI 10.1016/j.addr.2017.09.003; Mukhamedshina YO, 2016, NEURAL REGEN RES, V11, P1420, DOI 10.4103/1673-5374.191213; Neirinckx V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0202-2; Nicklin SA, 2004, J GENE MED, V6, P300, DOI 10.1002/jgm.526; Papapetrou Eirini P, 2017, Adv Exp Med Biol, V1013, P219, DOI 10.1007/978-1-4939-7299-9_9; Qu Y, 2019, NEURAL REGEN RES, V14, P931, DOI 10.4103/1673-5374.250570; Rogozhin VN, 2011, ACTA NATURAE, V3, P100, DOI 10.32607/20758251-2011-3-3-100-106; Sokolov ME, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00111; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Yang WZ, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-75; Yao LQ, 2013, NEURAL REGEN RES, V8, P397, DOI 10.3969/j.issn.1673-5374.2013.05.002; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zheng PP, 2018, DRUG DISCOV TODAY, V23, P1175, DOI 10.1016/j.drudis.2018.02.012; Zhu H, 2016, CELL TRANSPLANT, V25, P1925, DOI 10.3727/096368916X691411	31	4	4	2	52	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2021	16	2					357	361	PMID 32859798	10.4103/1673-5374.290902			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NU5DI	WOS:000573661500033	32859798	Green Published, gold			2022-02-06	
J	Ord, AS; Lad, SS; Shura, RD; Rowland, JA; Taber, KH; Martindale, SL				Ord, Anna S.; Lad, Sagar S.; Shura, Robert D.; Rowland, Jared A.; Taber, Katherine H.; Martindale, Sarah L.			Pain Interference and Quality of Life in Combat Veterans: Examining the Roles of Posttraumatic Stress Disorder, Traumatic Brain Injury, and Sleep Quality	REHABILITATION PSYCHOLOGY			English	Article						pain; PTSD; TBI; sleep; veteran	COGNITIVE-BEHAVIORAL THERAPY; OPERATIONS ENDURING FREEDOM; AFFAIRS POLYTRAUMA SYSTEM; MALINGERED SYMPTOMATOLOGY; STRUCTURED INVENTORY; OIF/OEF VETERANS; CLINICAL-TRIAD; INSOMNIA; DISTURBANCES; ASSOCIATION	Objective: The goal of this study was to examine the associations among posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), sleep quality, pain interference, and quality of life in combat veterans. Method: Veterans (N = 289, 86.51% male) completed the Mid-Atlantic MIRECC Assessment of Traumatic Brain Injury, the Clinician-Administered PTSD Scale for DSM-5, and measures of sleep quality, pain interference, and quality of life. Results: Hierarchical linear regressions evaluated associations between PTSD severity, deployment TBI severity, sleep quality, and the outcomes of pain interference and quality of life after adjusting for demographic variables and the number of nondeployment TBIs. PTSD severity, B = 0.15, SE B = 0.04, deployment TBI severity, B = 3.98, SE B = 1.01, and sleep quality, B = 0.74, SE B = 0.13, were significantly associated with pain interference, p < .001. PTSD severity, B = -0.57, SE B = 0.07, and pain interference, B = -0.45, SE B = 0.11. were significantly. independently associated with quality of life, p < .001. However, pain interference, B = -0.24, SE B = 0.11, was no longer significantly associated with quality of life when sleep quality, B = -1.56, SE B = 0.25. was included in the model. There was no significant association between deployment TBI severity and quality of life. Interactions among the studied variables were not significant for either of the outcome variables. Conclusions: PTSD symptom severity, deployment TBI history, and sleep quality may be important to consider in treatment planning for veterans experiencing pain-related functional interference. For veterans with numerous conditions comorbid with pain, treatment plans may include interventions targeting sleep and PTSD to maximize quality of life improvements.	[Ord, Anna S.; Lad, Sagar S.; Rowland, Jared A.; Taber, Katherine H.; Martindale, Sarah L.] WG Bill Hefner VA Hlth Care Syst, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA; [Shura, Robert D.] WG Bill Hefner VA Hlth Care Syst, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Shura, Robert D.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA		Martindale, SL (corresponding author), WG Bill Hefner VA Hlth Care Syst, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Res & Acad Affairs Serv Line, 1601 Brenner Ave 11M, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Martindale, Sarah L/O-8553-2018; Rowland, Jared A./AAN-3030-2021	Martindale, Sarah L/0000-0002-0059-3454; Rowland, Jared A./0000-0002-3655-3411; Ord, Anna/0000-0003-3373-2016; Lad, PsyD, Sagar/0000-0002-1278-8355	Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	We thank the veterans and service members who participated in this research. We would also like to thank Mary Peoples, David J. Curry, Alana M. Higgins, Christine Sortino, and G. Melissa Evans for their contributions to this project. This work was supported by grant funding from Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. This work was also supported by resources of the Salisbury VA Medical Center, Mid-Atlantic Mental Illness Research, Education, and Clinical Center, and Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official U.S. Department of Veterans Affairs or U.S. Department of Defense position, policy, or decision, unless so designated by other official documentation. For a comprehensive list of publications from the present study, please contact Sarah L. Martindale.	Adams RS, 2019, J HEAD TRAUMA REHAB, V34, P167, DOI 10.1097/HTR.0000000000000481; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Asmundson GJG, 2004, EUR J PAIN, V8, P345, DOI 10.1016/j.ejpain.2003.10.008; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein DN, 2019, SPINE, V44, pE852, DOI 10.1097/BRS.0000000000002979; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Boonstra AM, 2013, QUAL LIFE RES, V22, P93, DOI 10.1007/s11136-012-0132-8; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Collins R. L., 2018, 2015 DEP DEFENSE HLT, DOI [10.7249/RR1695, DOI 10.7249/RR1695]; Cormier R. E., 1990, CLIN METHODS HIST PH, P398; Elliott JE, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz237; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Hoot MR, 2018, BRAIN INJURY, V32, P1169, DOI 10.1080/02699052.2018.1482427; Hughes M, 2019, J HEALTH PSYCHOL, V24, P1356, DOI 10.1177/1359105317750254; Kanady JC, 2018, J CLIN SLEEP MED, V14, P1193, DOI 10.5664/jcsm.7224; Kerr S, 2004, INTERN MED J, V34, P403, DOI 10.1111/j.1444-0903.2004.00627.x; Koffel E, 2016, PSYCHIAT ANN, V46, P173, DOI 10.3928/00485713-20160125-01; Koffel E, 2016, HEALTH PSYCHOL, V35, P41, DOI 10.1037/hea0000245; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Langerud AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199656; Lanteri-Minet M, 2005, PAIN, V118, P319, DOI 10.1016/j.pain.2005.09.010; Lew HL, 2013, J REHABIL RES DEV, V50, pXI, DOI 10.1682/JRRD.2013.09.0212; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Management of Concussion/mTBI Working Group, 2016, DOD CLIN PRACT GUID; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mills SEE, 2019, BRIT J ANAESTH, V123, pE273, DOI 10.1016/j.bja.2019.03.023; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Naylor JC, 2017, PAIN MED, V18, P1658, DOI 10.1093/pm/pnw308; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Siebern AT, 2011, PSYCHOL RES BEHAV MA, V4, P21, DOI 10.2147/PRBM.S10041; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Travaglini LE, 2019, PSYCHIATR REHABIL J, V42, P229, DOI 10.1037/prj0000358; Vogt D., 2012, MANUAL DEPLOYMENT RI; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wisdom NM, 2010, ARCH CLIN NEUROPSYCH, V25, P118, DOI 10.1093/arclin/acp110; Wu E, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000152; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	56	4	4	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2021	66	1					31	38		10.1037/rep0000333			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	QJ4MT	WOS:000619666700004	32378923	Green Accepted			2022-02-06	
J	Boltze, J; Aronowski, JA; Badaut, J; Buckwalter, MS; Caleo, M; Chopp, M; Dave, KR; Didwischus, N; Dijkhuizen, RM; Doeppner, TR; Dreier, JP; Fouad, K; Gelderblom, M; Gertz, K; Golubczyk, D; Gregson, BA; Hamel, E; Hanley, DF; Hartig, W; Hummel, FC; Ikhsan, M; Janowski, M; Jolkkonen, J; Karuppagounder, SS; Keep, RF; Koerte, IK; Kokaia, Z; Li, PY; Liu, FD; Lizasoain, I; Ludewig, P; Metz, GAS; Montagne, A; Obenaus, A; Palumbo, A; Pearl, M; Perez-Pinzon, M; Planas, AM; Plesnila, N; Raval, AP; Rueger, MA; Sansing, LH; Sohrabji, F; Stagg, CJ; Stetler, RA; Stowe, AM; Sun, DD; Taguchi, A; Tanter, M; Vay, SU; Vemuganti, R; Vivien, D; Walczak, P; Wang, J; Xiong, Y; Zille, M				Boltze, Johannes; Aronowski, Jaroslaw A.; Badaut, Jerome; Buckwalter, Marion S.; Caleo, Mateo; Chopp, Michael; Dave, Kunjan R.; Didwischus, Nadine; Dijkhuizen, Rick M.; Doeppner, Thorsten R.; Dreier, Jens P.; Fouad, Karim; Gelderblom, Mathias; Gertz, Karen; Golubczyk, Dominika; Gregson, Barbara A.; Hamel, Edith; Hanley, Daniel F.; Haertig, Wolfgang; Hummel, Friedhelm C.; Ikhsan, Maulana; Janowski, Miroslaw; Jolkkonen, Jukka; Karuppagounder, Saravanan S.; Keep, Richard F.; Koerte, Inga K.; Kokaia, Zaal; Li, Peiying; Liu, Fudong; Lizasoain, Ignacio; Ludewig, Peter; Metz, Gerlinde A. S.; Montagne, Axel; Obenaus, Andre; Palumbo, Alex; Pearl, Monica; Perez-Pinzon, Miguel; Planas, Anna M.; Plesnila, Nikolaus; Raval, Ami P.; Rueger, Maria A.; Sansing, Lauren H.; Sohrabji, Farida; Stagg, Charlotte J.; Stetler, R. Anne; Stowe, Ann M.; Sun, Dandan; Taguchi, Akihiko; Tanter, Mickael; Vay, Sabine U.; Vemuganti, Raghu; Vivien, Denis; Walczak, Piotr; Wang, Jian; Xiong, Ye; Zille, Marietta			New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases	FRONTIERS IN AGING NEUROSCIENCE			English	Article						cell therapies; dementia; experimental therapy; hemorrhage; neuroprotection; neurorehabilitation; stroke; translational research		The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovascular diseases as exemplified by the advent of thrombectomy in ischemic stroke, benefitting a steeply increasing number of stroke patients and potentially paving the way for a renaissance of neuroprotectants. Progress in basic science has been equally impressive. Based on a deeper understanding of pathomechanisms underlying cerebrovascular diseases, new therapeutic targets have been identified and novel treatment strategies such as pre- and post-conditioning methods were developed. Moreover, translationally relevant aspects are increasingly recognized in basic science studies, which is believed to increase their predictive value and the relevance of obtained findings for clinical application.This review reports key results from some of the most remarkable and encouraging achievements in neurovascular research that have been reported at the 10th International Symposium on Neuroprotection and Neurorepair. Basic science topics discussed herein focus on aspects such as neuroinflammation, extracellular vesicles, and the role of sex and age on stroke recovery. Translational reports highlighted endovascular techniques and targeted delivery methods, neurorehabilitation, advanced functional testing approaches for experimental studies, pre-and post-conditioning approaches as well as novel imaging and treatment strategies. Beyond ischemic stroke, particular emphasis was given on activities in the fields of traumatic brain injury and cerebral hemorrhage in which promising preclinical and clinical results have been reported. Although the number of neutral outcomes in clinical trials is still remarkably high when targeting cerebrovascular diseases, we begin to evidence stepwise but continuous progress towards novel treatment options. Advances in preclinical and translational research as reported herein are believed to have formed a solid foundation for this progress.	[Boltze, Johannes; Didwischus, Nadine] Univ Warwick, Sch Life Sci, Warwick, England; [Aronowski, Jaroslaw A.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Inst Stroke & Cerebrovasc Dis, Houston, TX 77030 USA; [Badaut, Jerome] Univ Bordeaux, NRS UMR 5287, Brain Mol Imaging Team, INCIA, Bordeaux, France; [Buckwalter, Marion S.] Stanford Sch Med, Wu Tsai Neurosci Inst, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Buckwalter, Marion S.] Stanford Sch Med, Wu Tsai Neurosci Inst, Dept Neurosurg, Stanford, CA 94305 USA; [Caleo, Mateo] CNR, Neurosci Inst, Pisa, Italy; [Caleo, Mateo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Dave, Kunjan R.; Perez-Pinzon, Miguel; Raval, Ami P.] Univ Miami, Miller Sch Med, Dept Neurol, Peritz Scheinberg Cerebral Vasc Dis Res Lab, Miami, FL 33136 USA; [Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Ctr Image Sci, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands; [Dijkhuizen, Rick M.] Univ Utrecht, Utrecht, Netherlands; [Doeppner, Thorsten R.] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Dreier, Jens P.; Gertz, Karen] Charite Univ Med Berlin, Dept Neurol, Ctr Stroke Res Berlin, Berlin, Germany; [Dreier, Jens P.] Charit Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Dreier, Jens P.] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Dreier, Jens P.] Einstein Ctr Neurosci Berlin, Berlin, Germany; [Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Fouad, Karim] Univ Alberta, Inst Neurosci & Mental Hlth, Edmonton, AB, Canada; [Gelderblom, Mathias; Ludewig, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Gertz, Karen] Berlin Inst Hlth, Berlin, Germany; [Golubczyk, Dominika] Univ Warmia & Mazury, Sch Med, Dept Neurosurg, Olsztyn, Poland; [Gregson, Barbara A.] Newcastle Univ, Inst Neurosci, Neurosurg Trials Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Hamel, Edith] McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, Montreal, PQ, Canada; [Hanley, Daniel F.] Johns Hopkins Univ, Div Brain Injury Outcomes, Baltimore, MD USA; [Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Hummel, Friedhelm C.] Swiss Fed Inst Technol Valais, Clin Romande Readaptat, Ctr Neuroprosthet, Clin Neuroengn, Sion, Switzerland; [Hummel, Friedhelm C.] Swiss Fed Inst Technol Valais, Clin Romande Readaptat, Brain Mind Inst, Sion, Switzerland; [Hummel, Friedhelm C.] Univ Geneva, Clin Neurosci, Med Sch, Geneva, Switzerland; [Ikhsan, Maulana; Palumbo, Alex; Zille, Marietta] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Lubeck, Germany; [Ikhsan, Maulana; Palumbo, Alex; Zille, Marietta] Fraunhofer Res Inst Marine Biotechnol & Cell Tech, Lubeck, Germany; [Ikhsan, Maulana; Palumbo, Alex; Zille, Marietta] Univ Lubeck, Inst Med & Marine Biotechnol, Lubeck, Germany; [Janowski, Miroslaw; Walczak, Piotr] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Jolkkonen, Jukka] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurol, Kuopio, Finland; [Karuppagounder, Saravanan S.] Burke Neurol Inst, White Plains, NY USA; [Karuppagounder, Saravanan S.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY USA; [Keep, Richard F.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI USA; [Koerte, Inga K.] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Koerte, Inga K.] Harvard Med Sch, Boston, MA 02115 USA; [Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Chili & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Kokaia, Zaal] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Li, Peiying] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Anesthesiol, Shanghai, Peoples R China; [Liu, Fudong] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, McGovern Med Sch, Houston, TX 77030 USA; [Lizasoain, Ignacio] Univ Complutense Madrid, Inst Univ Invest Neuroquim, Fac Med, Dept Farmacol & Toxicol,Unidad Invest Neurovasc, Madrid, Spain; [Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB, Canada; [Montagne, Axel] Univ Southern Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90007 USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Pearl, Monica] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Planas, Anna M.] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Area Neurociencies, Barcelona, Spain; [Planas, Anna M.] CSIC, Dept Isquemia Cerebral & Neurodegeneracio, Inst Invest Biomed Barcelona IIBB, Barcelona, Spain; [Plesnila, Nikolaus] Munich Univ Hosp, Inst Stroke & Dementia Res ISD, Munich, Germany; [Plesnila, Nikolaus] Munich Univ Hosp, Grad Sch Syst Neurosci GSN, Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany; [Rueger, Maria A.; Vay, Sabine U.] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany; [Rueger, Maria A.; Vay, Sabine U.] Univ Cologne, Univ Hosp, Dept Neurol, Cologne, Germany; [Sansing, Lauren H.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Sohrabji, Farida] Texas A&M Coll Med, Womens Hlth Neurosci Program, Neurosci & Expt Therapeut, Bryan, TX USA; [Stagg, Charlotte J.] Univ Oxford, Wellcome Ctr Integrat Neuroimaging, Nuffield Dept Clin Neurosci, Oxford, England; [Stagg, Charlotte J.] Univ Oxford, MRC Brain Network Dynam Unit, Oxford, England; [Stetler, R. Anne] Univ Pittsburgh, Dept Neurol, Pittsburgh Inst Brain Disorders & Recovery, Pittsburgh, PA 15260 USA; [Stowe, Ann M.] UT Southwestern Med Ctr, Peter ODonnell Jr Brain Inst, Dept Neurol & Neurotherapeut, Dallas, TX USA; [Sun, Dandan] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Disorders, Pittsburgh, PA 15260 USA; [Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med Res, Kobe, Hyogo, Japan; [Tanter, Mickael] PSL Univ, Inst Phys Med Paris, ESPCI Paris, INSERM U1273,CNRS FRE 2031, Paris, France; [Vemuganti, Raghu] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA; [Vivien, Denis] Normandy Univ, Physiopathol & Imaging Neurol Disorders PhIND, INSERM UMR S U1237, INSERM,UNICAEN, Caen, France; [Vivien, Denis] CHU Caen Cote Nacre, Clin Res Dept, CHU Caen, Caen, France; [Wang, Jian] Zhengzhou Univ, Coll Med Sci, Dept Human Anat, Zhengzhou, Peoples R China; [Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA		Boltze, J (corresponding author), Univ Warwick, Sch Life Sci, Warwick, England.	johannes.boltze@warwick.ac.uk	Palumbo, Alex/AAE-3115-2019; Mickael, Tanter/H-4657-2012; Zille, Marietta/P-1700-2018; Wang, Jian/I-4874-2019; Vay, Sabine Ulrike/AAP-3842-2020; Koerte, Inga Katharina/AAW-3031-2021; Walczak, Piotr/AAC-9101-2022; Planas, Anna/J-5991-2014	Palumbo, Alex/0000-0002-1631-785X; Mickael, Tanter/0000-0001-7739-8051; Zille, Marietta/0000-0002-0609-8956; Wang, Jian/0000-0003-2291-640X; Vay, Sabine Ulrike/0000-0002-3289-7807; Hanley, Daniel/0000-0002-9536-4258; Golubczyk, Dominika/0000-0001-5692-6329; Dijkhuizen, Rick/0000-0002-4623-4078; CALEO, MATTEO/0000-0002-4333-6378; Planas, Anna/0000-0002-6147-1880; Janowski, Miroslaw/0000-0001-5261-7975	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BO 3518/2-1]; International Society of Cerebral Blood Flow and Metabolism	We wish to express our gratitude to all institutions and people who supported the 10th ISN&N. First and foremost, we want to thank all meeting participants for their outstanding academic contributions. Moreover, we are particularly grateful to the Deutsche Forschungsgemeinschaft (grant number: BO 3518/2-1) and the International Society of Cerebral Blood Flow and Metabolism, both of which supported the meeting with generous grants. We further acknowledge all industrial sponsors and exhibitors for their academic and invaluable financial support.	Alawieh A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6459; Awad IA, 2019, NEUROSURGERY, V84, P1157, DOI 10.1093/neuros/nyz077; Balbi M, 2017, J CEREBR BLOOD F MET, V37, P178, DOI 10.1177/0271678X15621253; Balbil M, 2020, J CEREBR BLOOD F MET, V40, P1193, DOI 10.1177/0271678X19863021; Blicher JU, 2015, NEUROREHAB NEURAL RE, V29, P278, DOI 10.1177/1545968314543652; Boltze J, 2019, STROKE, V50, P3299, DOI 10.1161/STROKEAHA.119.025436; Boltze J, 2017, STEM CELLS, V35, P1141, DOI 10.1002/stem.2595; Boltze Johannes, 2012, Exp Transl Stroke Med, V4, P14; Boltze Johannes, 2011, Expert Rev Neurother, V11, P199, DOI 10.1586/ern.10.202; Bova A, 2019, JOVE-J VIS EXP, DOI 10.3791/59979; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Busato Alice, 2017, Curr Protoc Cell Biol, V75, DOI 10.1002/cpcb.23; Chang CF, 2018, J CLIN INVEST, V128, P607, DOI 10.1172/JCI95612; Choi H, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0316-1; Chu CY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00921; Cohan CH, 2017, J CEREBR BLOOD F MET, V37, P3774, DOI 10.1177/0271678X17712178; Coscia M, 2019, BRAIN, V142, P2182, DOI 10.1093/brain/awz181; Cui LL, 2019, ANN NEUROL, V86, P5, DOI 10.1002/ana.25493; d'Adesky ND, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051330; Dabrowska S, 2018, INT J NANOMED, V13, P1653, DOI 10.2147/IJN.S159404; DeFazio RA, 2009, J CEREBR BLOOD F MET, V29, P375, DOI 10.1038/jcbfm.2008.126; Demuth HU, 2017, RESTOR NEUROL NEUROS, V35, P87, DOI 10.3233/RNN-160690; Doeppner TR, 2017, MOL NEUROBIOL, V54, P6061, DOI 10.1007/s12035-016-0137-3; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; Dreier JP, 2018, NEUROPHARMACOLOGY, V134, P189, DOI 10.1016/j.neuropharm.2017.09.027; Egashira Y, 2016, ACTA NEUROCHIR SUPPL, V121, P131, DOI 10.1007/978-3-319-18497-5_23; Fenrich KK, 2015, BEHAV BRAIN RES, V281, P137, DOI 10.1016/j.bbr.2014.11.048; Fernandez G, 2018, MOL THER, V26, P2047, DOI 10.1016/j.ymthe.2018.05.019; Fouad K, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00085; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Garcia-Culebras A, 2019, STROKE, V50, P2922, DOI 10.1161/STROKEAHA.119.025085; Garcia-Culebras A, 2017, STROKE, V48, P1695, DOI 10.1161/STROKEAHA.116.015956; Gauberti M, 2018, THERANOSTICS, V8, P1195, DOI 10.7150/thno.22662; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Golubczyk D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74411-3; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Gulke E, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418774254; Guo DW, 2017, TRANSL STROKE RES, V8, P234, DOI 10.1007/s12975-016-0511-5; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hainsworth AH, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0793-9; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Herrmann AM, 2019, J CEREBR BLOOD F MET, V39, P375, DOI 10.1177/0271678X19827446; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Howard R, 2020, JAMA NEUROL, V77, P164, DOI 10.1001/jamaneurol.2019.3762; Huang HC, 2019, STROKE, V50, P1021, DOI 10.1161/STROKEAHA.118.024287; Iadecola C, 2018, CIRC RES, V123, P406, DOI 10.1161/CIRCRESAHA.118.313400; Jablonska A, 2016, MOL NEUROBIOL, V53, P6413, DOI 10.1007/s12035-015-9530-6; Ji X., 2019, CONDITION MED, V2, P225; Jy W, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00599; Kaiser D, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0169-8; Karuppagounder SS, 2018, ANN NEUROL, V84, P854, DOI 10.1002/ana.25356; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Khoury N, 2019, MOL NEUROBIOL, V56, P4549, DOI 10.1007/s12035-018-1380-6; Kim H, 2012, GLIA, V60, P1117, DOI 10.1002/glia.22339; Kim TH, 2015, CNS NEUROSCI THER, V21, P327, DOI 10.1111/cns.12346; Kirkland SW, 2012, J INTEGR NEUROSCI, V11, P33, DOI 10.1142/S0219635212500033; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Koch PJ, 2017, CURR OPIN NEUROL, V30, P388, DOI 10.1097/WCO.0000000000000462; Kolasinski J, 2019, J PHYSIOL-LONDON, V597, P271, DOI 10.1113/JP276626; Koronowski KB, 2017, STROKE, V48, P3117, DOI 10.1161/STROKEAHA.117.018562; Kronenberg G, 2018, ACTA NEUROPATHOL, V135, P551, DOI 10.1007/s00401-017-1795-6; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Laterza C, 2017, EXP NEUROL, V297, P129, DOI 10.1016/j.expneurol.2017.07.012; Li Q, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00581; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Liebeskind DS, 2018, STROKE, V49, P2241, DOI 10.1161/STROKEAHA.118.021424; Loera-Valencia R, 2019, J INTERN MED, V286, P398, DOI 10.1111/joim.12959; Ludewig P, 2017, ACS NANO, V11, P10480, DOI 10.1021/acsnano.7b05784; Luckl J, 2018, BRAIN, V141, P1734, DOI 10.1093/brain/awy102; Mantovani A, 2017, J AUTOIMMUN, V85, P1, DOI 10.1016/j.jaut.2017.10.007; Mao X, 2020, J NEUROTRAUM, V37, P1331, DOI 10.1089/neu.2019.6510; McCullough LD, 2016, AGING-US, V8, P1432, DOI 10.18632/aging.100997; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Miro-Mur F, 2016, BRAIN BEHAV IMMUN, V53, P18, DOI 10.1016/j.bbi.2015.08.010; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Morris-Blanco KC, 2019, STROKE, V50, P2513, DOI 10.1161/STROKEAHA.119.025665; Mu JW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00235; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Narayanan SV, 2015, STROKE, V46, P1626, DOI 10.1161/STROKEAHA.115.008921; Neumann JT, 2015, J CEREBR BLOOD F MET, V35, P121, DOI 10.1038/jcbfm.2014.185; O'Shea J, 2014, NEUROIMAGE, V85, P924, DOI 10.1016/j.neuroimage.2013.05.096; Panta A, 2019, BRAIN BEHAV IMMUN, V78, P31, DOI 10.1016/j.bbi.2019.01.003; Poinsatte K, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01055; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Potts MB, 2014, WORLD NEUROSURG, V82, P549, DOI 10.1016/j.wneu.2014.08.046; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Rabut C, 2019, NAT METHODS, V16, P994, DOI 10.1038/s41592-019-0572-y; Raffin E, 2018, NEUROSCIENTIST, V24, P400, DOI 10.1177/1073858417737486; Ramirez FD, 2017, CIRC RES, V120, P1916, DOI 10.1161/CIRCRESAHA.117.310628; Rehni AK, 2019, J CARDIOVASC PHARM T, V24, P474, DOI 10.1177/1074248419838512; Ritzel RM, 2018, ACTA NEUROPATHOL, V136, P89, DOI 10.1007/s00401-018-1859-2; Royea J, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104644; Ryait H, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000516; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Savitz SI, 2019, STROKE, V50, P1026, DOI 10.1161/STROKEAHA.118.023927; Schulz R, 2017, STROKE, V48, P2805, DOI 10.1161/STROKEAHA.117.016834; Selvamani A, 2017, NEUROCHEM INT, V107, P168, DOI 10.1016/j.neuint.2016.10.008; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Selvaraj UM, 2017, DISCOV MED, V24, P323; Sohrabji F, 2019, HORM BEHAV, V111, P87, DOI 10.1016/j.yhbeh.2018.10.010; Sohrabji F, 2019, NEUROCHEM INT, V127, P56, DOI 10.1016/j.neuint.2018.10.021; Spalletti C, 2017, ELIFE, V6, DOI 10.7554/eLife.28662; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Straathof M, 2019, J CEREBR BLOOD F MET, V39, P189, DOI 10.1177/0271678X18809547; Struys MMRF, 2016, ANESTH ANALG, V122, P56, DOI 10.1213/ANE.0000000000001008; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Trigiani LJ, 2019, FASEB J, V33, P13280, DOI 10.1096/fj.201901002R; Trigiani LJ, 2017, J CEREBR BLOOD F MET, V37, P2649, DOI 10.1177/0271678X17714655; Vaccari JPD, 2016, J NEUROCHEM, V136, P492, DOI 10.1111/jnc.13404; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vartanian KB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-140; Vay SU, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1261-y; Walczak P, 2017, J CEREBR BLOOD F MET, V37, P2346, DOI 10.1177/0271678X16665853; Wan YF, 2019, CNS NEUROSCI THER, V25, P1134, DOI 10.1111/cns.13203; Wang YC, 2015, EXP NEUROL, V272, P26, DOI 10.1016/j.expneurol.2015.04.009; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Xin HQ, 2017, STROKE, V48, P747, DOI 10.1161/STROKEAHA.116.015204; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Zaouter C, 2016, ANESTH ANALG, V123, P885, DOI 10.1213/ANE.0000000000001152; Zhang J, 2019, J CEREBR BLOOD F MET, V39, P1394, DOI 10.1177/0271678X18785480; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhao SC, 2017, ACTA PHARMACOL SIN, V38, P1425, DOI 10.1038/aps.2017.122; Zhao XR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00770-7; Zheng X, 2021, TRANSL STROKE RES, V12, P185, DOI 10.1007/s12975-020-00814-z; Zille M, 2019, CELL STRESS, V3, P330, DOI 10.15698/cst2019.11.203; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	134	4	5	5	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JAN 28	2021	13								623751	10.3389/fnagi.2021.623751			15	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	QF3MH	WOS:000616801600001	33584250	Green Published, gold			2022-02-06	
J	Chen, J; Wang, X; Hu, J; Du, JT; Dordoe, C; Zhou, QL; Huang, WT; Guo, RL; Han, FY; Guo, KM; Ye, SS; Lin, L; Li, XK				Chen, Jun; Wang, Xue; Hu, Jian; Du, Jingting; Dordoe, Confidence; Zhou, Qiulin; Huang, Wenting; Guo, Ruili; Han, Fanyi; Guo, Kaiming; Ye, Shasha; Lin, Li; Li, Xiaokun			FGF20 Protected Against BBB Disruption After Traumatic Brain Injury by Upregulating Junction Protein Expression and Inhibiting the Inflammatory Response	FRONTIERS IN PHARMACOLOGY			English	Article						Fgf20; traumatic brain injury; blood-brain barrier; tight junction protein; inflammatory response		Disruption of the blood-brain barrier (BBB) and the cerebral inflammatory response occurring after traumatic brain injury (TBI) facilitate further brain damage, which leads to long-term complications of TBI. Fibroblast growth factor 20 (FGF20), a neurotrophic factor, plays important roles in brain development and neuronal homeostasis. The aim of the current study was to assess the protective effects of FGF20 on TBI via BBB maintenance. In the present study, recombinant human FGF20 (rhFGF20) reduced neurofunctional deficits, brain edema, Evans blue extravasation and neuroinflammation in a TBI mouse model. In an in vitro TNF-alpha-induced human brain microvascular endothelial cell (HBMEC) model of BBB disruption, rhFGF20 reduced paracellular permeability and increased trans-endothelial electrical resistance (TEER). Both in the TBI mouse model and in vitro, rhFGF20 increased the expression of proteins composing in BBB-associated tight junctions (TJs) and adherens junctions (AJs), and decreased the inflammatory response, which protected the BBB integrity. Notably, rhFGF20 preserved BBB function by activating the AKT/GSK3 beta pathway and inhibited the inflammatory response by regulating the JNK/NF kappa B pathway. Thus, FGF20 is a potential candidate treatment for TBI that protects the BBB by upregulating junction protein expression and inhibiting the inflammatory response.	[Chen, Jun; Wang, Xue; Hu, Jian; Du, Jingting; Dordoe, Confidence; Zhou, Qiulin; Guo, Ruili; Han, Fanyi; Guo, Kaiming; Ye, Shasha; Lin, Li; Li, Xiaokun] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China; [Huang, Wenting] Wenzhou Med Univ, Sch First Clin Med Sci, Wenzhou, Peoples R China; [Li, Xiaokun] Chinese Acad Med Sci, Res Units Clin Translat Cell Growth Factors & Dis, Wenzhou, Peoples R China		Ye, SS; Lin, L; Li, XK (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China.; Li, XK (corresponding author), Chinese Acad Med Sci, Res Units Clin Translat Cell Growth Factors & Dis, Wenzhou, Peoples R China.	xiaokunli@wmu.edu.cn; linliwz@163.com; yeshasha0803@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971180]; Medical and Health Science and Technology Program of Zhejiang Province [2018KY505, WKJ-ZJ-2130]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LQ19H090012]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5-028]; Wenzhou Municipal Science and Technology Bureau [Y20170686]	This work was supported by the by the National Natural Science Foundation of China (No. 81971180), Medical and Health Science and Technology Program of Zhejiang Province (2018KY505, WKJ-ZJ-2130), Natural Science Foundation of Zhejiang Province (LQ19H090012), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-028), and Wenzhou Municipal Science and Technology Bureau (Y20170686).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Vigo MB, 2019, BIOCHEM PHARMACOL, V170, DOI 10.1016/j.bcp.2019.113662; Boshoff EL, 2018, NEUROPHARMACOLOGY, V137, P156, DOI 10.1016/j.neuropharm.2018.04.017; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen J., 2020, RES SQUARE, DOI [10.21203/rs.2.19529/v1, DOI 10.21203/RS.2.19529/V1]; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Citi S, 1998, BBA-MOL CELL RES, V1448, P1, DOI 10.1016/S0167-4889(98)00125-6; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Elwood E, 2017, BRAIN BEHAV IMMUN, V62, P35, DOI 10.1016/j.bbi.2016.10.020; Fletcher EJR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44803-1; Fouda AY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00277; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Graff CL, 2005, PHARM RES-DORDR, V22, P235, DOI 10.1007/s11095-004-1191-5; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Katoh M, 2005, ONCOL REP, V14, P287; Kim KA, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00182-8; Lan YL, 2019, INFLAMM RES, V68, P311, DOI 10.1007/s00011-019-01217-z; Lee MS, 2012, METABOLISM, V61, P1142, DOI 10.1016/j.metabol.2012.01.012; Li JY, 2012, ACTA PHARMACOL SIN, V33, P935, DOI 10.1038/aps.2012.46; Li L, 2015, ACS MED CHEM LETT, V6, P548, DOI 10.1021/acsmedchemlett.5b00044; Li XM, 2013, BRAIN RES BULL, V94, P49, DOI 10.1016/j.brainresbull.2013.02.004; Lin L, 2018, MOL NEUROBIOL, V55, P3131, DOI 10.1007/s12035-017-0544-0; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu S, 2019, J GINSENG RES, V43, P95, DOI 10.1016/j.jgr.2017.09.004; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Maiti P, 2019, J CELL MOL MED, V23, P5211, DOI 10.1111/jcmm.14396; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Narvaez M, 2020, NEUROPHARMACOLOGY, V170, DOI 10.1016/j.neuropharm.2020.108070; Niu JL, 2018, DRUG DELIV, V25, P1560, DOI 10.1080/10717544.2018.1482972; Odobasic D, 2019, J AM SOC NEPHROL, V30, P2140, DOI 10.1681/ASN.2019030236; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Rochfort KD, 2015, MICROVASC RES, V100, P48, DOI 10.1016/j.mvr.2015.04.010; Romero-Fernandez W, 2011, BIOCHEM BIOPH RES CO, V409, P764, DOI 10.1016/j.bbrc.2011.05.085; Schober ME, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112971; Shahror RA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6422; Sharma R, 2020, J CONTROL RELEASE, V323, P361, DOI 10.1016/j.jconrel.2020.04.036; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shimada H, 2009, J BIOSCI BIOENG, V107, P447, DOI 10.1016/j.jbiosc.2008.12.013; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Tang MM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00255; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Wang DX, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01921-2; Wang X, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00154; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Williams AM, 2020, J TRAUMA ACUTE CARE, V88, P207, DOI [10.109711-A.0000000000002563, 10.1097/TA.0000000000002563]; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wu FF, 2020, J CELL MOL MED, V24, P1220, DOI 10.1111/jcmm.14691; Xu WL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1620-3; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang LL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00801; Zhang X, 2018, BIOCHEM PHARMACOL, V156, P99, DOI 10.1016/j.bcp.2018.08.015; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao QC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1495-3; Zhou Y, 2019, J CELL MOL MED, V23, P3357, DOI 10.1111/jcmm.14226; Zhu L, 2019, J CELL MOL MED, V23, P3280, DOI 10.1111/jcmm.14214	75	4	4	4	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JAN 25	2021	11								590669	10.3389/fphar.2020.590669			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QD7WY	WOS:000615725800001	33568994	Green Published, gold			2022-02-06	
J	Vilimovsky, T; Chen, P; Hoidekrova, K; Petioky, J; Harsa, P				Vilimovsky, Tomas; Chen, Peii; Hoidekrova, Kristyna; Petioky, Jakub; Harsa, Pavel			Prism adaptation treatment to address spatial neglect in an intensive rehabilitation program: A randomized pilot and feasibility trial	PLOS ONE			English	Article							UNILATERAL NEGLECT; STROKE PATIENTS; SELF-CARE; HEMISPATIAL NEGLECT; RECOVERY; GUIDELINES; THERAPY; MOTOR	Spatial neglect (SN) is a common cognitive disorder after brain injury. Prism adaptation treatment (PAT) is one of the promising interventions for SN albeit inconsistent results from previous studies. We carried out a comparison intervention (PAT vs. Sham) and aimed to evaluate the efficacy of PAT on visuospatial symptoms of SN in an inpatient rehabilitation setting that offered a highly intensive comprehensive brain injury rehabilitation program. A total of 34 patients with moderate-to-severe SN secondary to stroke or traumatic brain injury were randomized to the PAT group and the Sham group (an active control group). Both groups received 10 sessions of treatment, over two weeks, in addition to the rehabilitation therapies provided by their rehabilitation care teams. Outcomes were measured using an ecological instrument (the Catherine Bergego Scale) and paper-and-pencil tests (the Bells Test, the Line Bisection Test and the Scene Copying Test). Patients were assessed at baseline, immediately after treatment, two weeks after treatment, and four weeks after treatment. 23 (67.6%) patients completed treatment and all the assessment sessions and were included in the final analyses using mixed linear modeling. While SN symptoms reduced in both groups, we found no difference between the two groups in the degree of improvement. In addition, the average SN recovery rates were 39.1% and 28.6% in the PAT and Sham groups, respectively, but this discrepancy did not reach statistical significance. Thus, the present study suggests that PAT may contribute little to SN care in the context of a highly intensive inpatient rehabilitation program. Further large-scale investigation is required to uncover the mechanisms underlying PAT and Sham in order to refine the treatment or create new interventions.	[Vilimovsky, Tomas; Harsa, Pavel] Charles Univ Prague, Fac Med 1, Dept Psychiat, Prague, Czech Republic; [Chen, Peii] Kessler Fdn, W Orange, NJ USA; [Chen, Peii] Rutgers State Univ, Dept Phys Med & Rehabil, Newark, NJ USA; [Hoidekrova, Kristyna] Charles Univ Prague, Fac Med 1, Dept Rehabil Med, Prague, Czech Republic; [Hoidekrova, Kristyna; Petioky, Jakub] Rehabil Ctr Kladruby, Kladruby, Czech Republic; [Hoidekrova, Kristyna] Charles Univ Prague, Fac Phys Educ & Sport, Dept Kinanthropol, Prague, Czech Republic; [Petioky, Jakub] Charles Univ Prague, Fac Med 3, Prague, Czech Republic		Vilimovsky, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Psychiat, Prague, Czech Republic.	tomas.vilimovsky@gmail.com		Petioky, Jakub/0000-0003-2619-765X; Hoidekrova, Kristyna/0000-0002-6981-5844	program PROGRES [Progres = C4 = 8D.Q 06/LF1 = 20]	TV: This study was supported by the program PROGRES (Progres = C4 = 8D.Q 06/LF1 = 20). The program had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-68; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 1996, NEUROPSYCHOL REHABIL, V6, P133, DOI 10.1080/713755501; Azouvi P, 2017, ANN PHYS REHABIL MED, V60, P191, DOI 10.1016/j.rehab.2016.10.006; Barrett AM, 2019, BRAIN COGNITION, V129, P16, DOI 10.1016/j.bandc.2018.11.013; Billingsley RL, 2002, DEV MED CHILD NEUROL, V44, P191, DOI 10.1017/S001216220100192X; Bowen A, 2016, ROYAL COLL PHYS 2016; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Carter AR, 2017, CORTEX, V88, P81, DOI 10.1016/j.cortex.2016.12.009; Champod AS, 2018, NEUROPSYCHOL REHABIL, V28, P491, DOI 10.1080/09602011.2016.1182032; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Chen P, 2014, KESSLER FDN NEGLECT; Chen P, 2020, HONG KONG J OCCUP TH, V33, P25, DOI 10.1177/1569186120921472; Chen P, 2018, DISABIL REHABIL, V40, P2677, DOI 10.1080/09638288.2017.1347720; Chen PI, 2014, BRAIN IMAGING BEHAV, V8, P346, DOI 10.1007/s11682-012-9200-5; Chen P, 2017, TOP STROKE REHABIL, V24, P24, DOI 10.1080/10749357.2016.1186373; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P869, DOI 10.1016/j.apmr.2014.10.023; Chen P, 2012, TOP STROKE REHABIL, V19, P423, DOI 10.1310/tsr1905-423; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Eldridge Sandra M, 2016, BMJ, V355, pi5239, DOI 10.1136/bmj.i5239; Fortis P, 2011, NEUROREPORT, V22, P700, DOI 10.1097/WNR.0b013e32834a3e20; Fortis P, 2010, NEUROPSYCHOLOGY, V24, P681, DOI 10.1037/a0019476; Frassinetti F, 2001, NEUROPSYCHOLOGIA, V39, P725, DOI 10.1016/S0028-3932(00)00156-1; GAINOTTI G, 1972, J NEUROL NEUROSUR PS, V35, P545, DOI 10.1136/jnnp.35.4.545; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Gillen G, 2015, AM J OCCUP THER, V69, P23, DOI 10.5014/ajot.2015.013409; Gillen R, 2005, ARCH PHYS MED REHAB, V86, P763, DOI 10.1016/j.apmr.2004.10.029; Goedert KM, 2020, NEUROPSYCHOL REHABIL, V30, P32, DOI 10.1080/09602011.2018.1448287; Goedert KM, 2014, NEUROREHAB NEURAL RE, V28, P483, DOI 10.1177/1545968313516872; Goedert KM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00211; Gossmann A, 2013, NEUROREHAB NEURAL RE, V27, P534, DOI 10.1177/1545968313478489; Gutierrez-Herrera M, 2020, NEUROPSYCHOL REHABIL, V30, P187, DOI 10.1080/09602011.2018.1454329; Hammerbeck U, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120374; HARRIS CS, 1963, SCIENCE, V140, P812, DOI 10.1126/science.140.3568.812; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; Heilman KM, 2000, SEMIN NEUROL, V20, P463, DOI 10.1055/s-2000-13179; Jehkonen M, 2006, RESTOR NEUROL NEUROS, V24, P209; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Kerkhoff G, 2012, NEUROPSYCHOLOGIA, V50, P1072, DOI 10.1016/j.neuropsychologia.2012.01.024; Mancuso M, 2012, EUR J PHYS REHAB MED, V48, P197; Mizuno K, 2011, NEUROREHAB NEURAL RE, V25, P711, DOI 10.1177/1545968311407516; Muth ER, 1996, J PSYCHOSOM RES, V40, P511, DOI 10.1016/0022-3999(95)00638-9; Nguyen J, 2013, NEUROLOGY, V80; Nijboer TCW, 2014, NEUROREPORT, V25, P307, DOI 10.1097/WNR.0000000000000088; Pandian JD, 2014, NEUROLOGY, V83, P1012, DOI 10.1212/WNL.0000000000000773; Panico F, 2020, CORTEX, V123, P57, DOI 10.1016/j.cortex.2019.10.003; Paolucci S, 2001, ARCH PHYS MED REHAB, V82, P743, DOI 10.1053/apmr.2001.23191; Parton A, 2004, J NEUROL NEUROSUR PS, V75, P13; Riestra Alonso R, 2013, Handb Clin Neurol, V110, P347, DOI 10.1016/B978-0-444-52901-5.00029-0; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Rode G, 2001, NEUROPSYCHOLOGIA, V39, P1250, DOI 10.1016/S0028-3932(01)00064-1; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Rundek T, 2000, NEUROLOGY, V55, P1180, DOI 10.1212/WNL.55.8.1180; Saevarsson S, 2011, APPL NEUROPSYCHOL, V18, P95, DOI 10.1080/09084282.2010.547774; Saj A, 2019, CORTEX, V119, P301, DOI 10.1016/j.cortex.2019.04.022; Sarri M, 2008, NEUROPSYCHOLOGIA, V46, P1069, DOI 10.1016/j.neuropsychologia.2007.11.005; Serino A, 2006, NEUROPSYCHOLOGIA, V44, P1068, DOI 10.1016/j.neuropsychologia.2005.10.024; Serino A, 2009, STROKE, V40, P1392, DOI 10.1161/STROKEAHA.108.530485; Shiraishi H, 2010, NEUROREHABILITATION, V27, P165, DOI 10.3233/NRE-2010-0593; Striemer CL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00334; Stroke Foundation, 2019, CLIN GUID STROK MAN; Ten Brink AF, 2017, NEUROREHAB NEURAL RE, V31, P1017, DOI 10.1177/1545968317744277; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Turton AJ, 2010, NEUROPSYCHOL REHABIL, V20, P180, DOI 10.1080/09602010903040683; Vaes N, 2018, NEUROPSYCHOL REHABIL, V28, P899, DOI 10.1080/09602011.2016.1208617; Wee JYM, 2008, AM J PHYS MED REHAB, V87, P910, DOI 10.1097/PHM.0b013e31818a58bd; Welfringer A, 2013, J INT NEUROPSYCH SS1, V19, P34; Wilson FC, 2003, NEUROPSYCHOL REHABIL, V13, P537, DOI 10.1080/09602010343000200; Wilson FC, 2000, RESTOR NEUROL NEUROS, V16, P1; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187	73	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245425	10.1371/journal.pone.0245425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	WOS:000612929300107	33481828	Green Published, gold			2022-02-06	
J	Karthigeyan, M; Dhandapani, S; Salunke, P; Sahoo, SK; Kataria, MS; Singh, A; Gendle, C; Panchal, C; Chhabra, R; Jain, K; Gupta, SK				Karthigeyan, Madhivanan; Dhandapani, Sivashanmugam; Salunke, Pravin; Sahoo, Sushanta K.; Kataria, Mandeep S.; Singh, Apinderpreet; Gendle, Chandrashekhar; Panchal, Chirag; Chhabra, Rajesh; Jain, Kajal; Gupta, Sunil K.			The collateral fallout of COVID19 lockdown on patients with head injury from north-west India	ACTA NEUROCHIRURGICA			English	Article						COVID; Head injury; Lockdown; Traumatic brain injury; Lower-middle income; Developing country; Neurotrauma		Background The COVID19 lockdown has altered the dynamics of living. Its collateral fallout on head injury care has not been studied in detail, especially from low- and middle-income countries, possibly overwhelmed more than developed nations. Here, we analyze the effects of COVID19 restrictions on head injury patients in a high-volume Indian referral trauma center. Methods From the prospective trauma registry, clinico-epidemiological and radiological parameters of patients managed during 190 days before and 190 days during COVID19 phases were studied. As an indicator of care, the inpatient mortality of patients with severe HI was also compared with appropriate statistical analyses. Results Of the total 3372 patients, there were 83 head injury admissions per week before COVID19 restrictions, which decreased to 33 every week (60% drop) during the lock phases and stabilized at 46 per week during the unlock phases. COVID19 restrictions caused a significant increase in the proportion of patients arriving directly without resuscitation at peripheral centers and later than 6 h of injury. Though the most common mechanism was vehicular, a relative increase in the proportion of assaults was noted during COVID19. There was no change in the distribution of mild, moderate, and severe injuries. Despite a decrease in the percentage of patients with systemic illnesses, severe head injury mortality was significantly more during the lock phases than before COVID19 (59% vs. 47%, p = 0.02). Conclusions COVID19 restrictions have amplified the already delayed admission among patients of head injury from north-west India. The severe head injury mortality was significantly greater during lock phases than before COVID19, highlighting the collateral fallout of lockdown. Pandemic control measures in the future should not ignore the concerns of trauma emergency care.	[Karthigeyan, Madhivanan; Dhandapani, Sivashanmugam; Salunke, Pravin; Sahoo, Sushanta K.; Kataria, Mandeep S.; Singh, Apinderpreet; Gendle, Chandrashekhar; Panchal, Chirag; Chhabra, Rajesh; Gupta, Sunil K.] Postgrad Inst Med Educ & Res PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India; [Jain, Kajal] Postgrad Inst Med Educ Res PGIMER, Dept Anesthesia, Sect 12, Chandigarh 160012, India		Dhandapani, S (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India.	ssdhandapani.neurosurg@gmail.com	Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255			Al-Shamsi HO, 2020, ONCOLOGIST, V25, pE936, DOI 10.1634/theoncologist.2020-0213; [Anonymous], 2020, COVID 19 STAT STAT; [Anonymous], 2020, MIN HLTH FAM WELF; Audi A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.567184; Bajunaid K, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106237; Bersano A, 2020, EUR J NEUROL, V27, P1794, DOI 10.1111/ene.14375; Bindu T S, 2017, Indian J Radiol Imaging, V27, P268, DOI 10.4103/ijri.IJRI_454_16; Devi Y, 2020, J NEUROSCI RURAL PRA, V11, P629, DOI 10.1055/s-0040-1716777; Dhandapani, 2015, SURG NEUROL INT, V6; Dhandapani Manju, 2020, Surg Neurol Int, V11, P441, DOI 10.25259/SNI_677_2020; Dhandapani M, 2021, INFECT DIS-NOR, V53, P145, DOI 10.1080/23744235.2020.1836390; Dhandapani S S, 2012, Asian J Neurosurg, V7, P17, DOI 10.4103/1793-5482.95690; Dhandapani S, 2018, STROKE, V49, P2890, DOI 10.1161/STROKEAHA.118.022865; Dhandapani S, 2018, NEUROSURG REV, V41, P513, DOI 10.1007/s10143-017-0880-6; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Engelbrecht FA, 2021, ONE HEALTH-AMSTERDAM, V12, DOI 10.1016/j.onehlt.2020.100202; Figueroa JM, 2021, WORLD NEUROSURG, V146, pe1, DOI 10.1016/j.wneu.2020.08.083; Franchini S, 2021, DISASTER MED PUBLIC, V15, pE33, DOI 10.1017/dmp.2020.265; GBD, 2016, LANCET NEUROL, V18, P56; Gupta P, 2020, NEUROL INDIA, V68, P246, DOI 10.4103/0028-3886.283130; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hecht N, 2020, ACTA NEUROCHIR, V162, P1795, DOI 10.1007/s00701-020-04437-z; Issac Alwin, 2020, J Prev Med Public Health, V53, P228, DOI 10.3961/jpmph.20.166; Jayakumar N, 2020, WORLD NEUROSURG, V144, pE414, DOI 10.1016/j.wneu.2020.08.162; Karthigeyan M, 2019, INDIAN J NEUROTRAUM, V16, P120, DOI 10.1055/s-0039-3402896; Krenzlin H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234956; Lara-Reyna J, 2020, WORLD NEUROSURG, V143, pE344, DOI 10.1016/j.wneu.2020.07.155; Looi MK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4113; Lubansu A, 2020, WORLD NEUROSURG, V144, pE380, DOI 10.1016/j.wneu.2020.08.168; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahak C, 2018, J NEUROSCI RURAL PRA, V9, P461, DOI 10.4103/jnrp.jnrp_25_18; Mathiesen T, 2020, ACTA NEUROCHIR, V162, P2221, DOI 10.1007/s00701-020-04482-8; Mukherjee KK, 2015, ACTA NEUROCHIR, V157, P305, DOI 10.1007/s00701-014-2296-1; Negrini S, 2020, EUR J PHYS REHAB MED, V56, P361, DOI 10.23736/S1973-9087.20.06361-3; Pinggera D, 2021, EUR J TRAUMA EMERG S, V47, P653, DOI 10.1007/s00068-020-01445-7; Rose DZ, 2020, NEUROHOSPITALIST, V10, P291, DOI 10.1177/1941874420929199; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sahoo Sushanta K, 2020, Neurosurg Focus, V49, pE7, DOI 10.3171/2020.9.FOCUS20705; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; Wong CKH, 2020, J MED INTERNET RES, V22, DOI 10.2196/19904	43	4	4	4	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2021	163	4					1053	1060		10.1007/s00701-021-04723-4		JAN 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QY0BL	WOS:000609322200004	33475830				2022-02-06	
J	Peng, F; Jeong, S; Gonzalez, G; Marks, H; Ho, A; Roussakis, E; Krauledat, PB; Hansen, P; Evans, CL				Peng, Fei; Jeong, Sinyoung; Gonzalez, German; Marks, Haley; Ho, Alexander; Roussakis, Emmanuel; Krauledat, Petra B.; Hansen, Peter; Evans, Conor L.			Assessment of Glial Fibrillary Acidic Protein Binding to the Surface of Leukocytes with Dark-Field Imaging and Computational Analysis	ADVANCED FUNCTIONAL MATERIALS			English	Article						dark-field imaging; glial fibrillary acidic proteins; gold nanoparticles; machine learning; traumatic brain injury		The glial fibrillary acidic protein (GFAP) is widely established as a traumatic brain injury (TBI) biomarker and can be used in early diagnosis. As essential primary human immune cells, leukocytes are recruited to injured cerebral sites during TBI response, where they can interact with and potentially bind to TBI biomarkers. To date, no studies have demonstrated ultra-low GFAP binding enumeration on leukocytes. Herein, a dark-field imaging technique coupled with computational analysis is introduced to quantify GFAP bound to peripheral blood mononuclear cells (PBMCs). Dark-field microscopy (DFM) with a custom-written image acquisition software is developed for rapid 3D PBMC imaging by utilizing specific antiGFAP monoclonal antibody functionalized gold nanoparticles (antiGFAP-AuNPs) as contrast-generating probes. Subsequently, the developed algorithm is utilized in processing thousands of acquired images for rapid visualization and enumeration of bound antiGFAP-AuNP on each leukocyte. The proposed method is demonstrates the specific binding of GFAP to the surface of PBMCs on a healthy donor blood. Thereafter, subpopulations of PBMCs with antiGFAP-AuNP binding are identified with the assistance of fluorescence imaging and DFM imaging, paving a new way to understanding the relationship between TBI and leukocyte classes. Hence, this study offers a rapid and ultra-sensitive strategy for biomarker assessment following TBI.	[Peng, Fei; Jeong, Sinyoung; Marks, Haley; Ho, Alexander; Roussakis, Emmanuel; Krauledat, Petra B.; Hansen, Peter; Evans, Conor L.] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, Charlestown, MA 02114 USA; [Gonzalez, German; Krauledat, Petra B.; Hansen, Peter] PNP Res Corp LLC, Drury, MA 01247 USA		Evans, CL (corresponding author), Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, Charlestown, MA 02114 USA.	evans.conor@mgh.harvard.edu		Peng, Fei/0000-0002-4965-7519; Ho, Alexander/0000-0001-5457-3611	Military Medical Photonics Program [FA9550-16-1-0479]	This work was supported by the Military Medical Photonics Program, FA9550-16-1-0479. The authors would also like to thank Raymond Lopez and Gayatri Joshi for their preliminary work on the GFAP project. The authors appreciate Dr. Mehdi Jorfi for providing the human astrocytes and Dr. Da Teng for performing the western blot assay.	Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Gonzalez G, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900004; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Kosaka PM, 2014, NAT NANOTECHNOL, V9, P1047, DOI [10.1038/nnano.2014.250, 10.1038/NNANO.2014.250]; Law WC, 2011, ACS NANO, V5, P4858, DOI 10.1021/nn2009485; Peng F, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202009229; Rezaii PG, 2019, J NEUROTRAUM, V36, P2407, DOI 10.1089/neu.2018.6053; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Rickard JJS, 2020, NAT BIOMED ENG, V4, P610, DOI 10.1038/s41551-019-0510-4; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sakamoto S, 2018, J NAT MED-TOKYO, V72, P32, DOI 10.1007/s11418-017-1144-z; Wang XL, 2015, ACS NANO, V9, P11924, DOI 10.1021/acsnano.5b04451; Zhang X.-D, ADV MAT, V28, P6872	17	4	4	3	18	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	MAR	2021	31	11							2009229	10.1002/adfm.202009229		JAN 2021	9	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	QV3RF	WOS:000608924700001					2022-02-06	
J	Subramaniam, DR; Unnikrishnan, G; Sundaramurthy, A; Rubio, JE; Kote, VB; Reifman, J				Subramaniam, Dhananjay Radhakrishnan; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Rubio, Jose E.; Kote, Vivek Bhaskar; Reifman, Jaques			The importance of modeling the human cerebral vasculature in blunt trauma	BIOMEDICAL ENGINEERING ONLINE			English	Article						Blunt impact; Traumatic brain injury; Finite element model; Human cerebral vasculature	FINITE-ELEMENT MODELS; BRAIN-INJURY; DYNAMIC-RESPONSE; IMPACT INJURY; UNITED-STATES; HEAD IMPACT; STRAIN-RATE; VALIDATION; SYSTEM; TISSUE	Background Multiple studies describing human head finite element (FE) models have established the importance of including the major cerebral vasculature to improve the accuracy of the model predictions. However, a more detailed network of cerebral vasculature, including the major veins and arteries as well as their branch vessels, can further enhance the model-predicted biomechanical responses and help identify correlates to observed blunt-induced brain injury. Methods We used an anatomically accurate three-dimensional geometry of a 50th percentile U.S. male head that included the skin, eyes, sinuses, spine, skull, brain, meninges, and a detailed network of cerebral vasculature to develop a high-fidelity model. We performed blunt trauma simulations and determined the intracranial pressure (ICP), the relative displacement (RD), the von Mises stress, and the maximum principal strain. We validated our detailed-vasculature model by comparing the model-predicted ICP and RD values with experimental measurements. To quantify the influence of including a more comprehensive network of brain vessels, we compared the biomechanical responses of our detailed-vasculature model with those of a reduced-vasculature model and a no-vasculature model. Results For an inclined frontal impact, the predicted ICP matched well with the experimental results in the fossa, frontal, parietal, and occipital lobes, with peak-pressure differences ranging from 2.4% to 9.4%. For a normal frontal impact, the predicted ICP matched the experimental results in the frontal lobe and lateral ventricle, with peak-pressure discrepancies equivalent to 1.9% and 22.3%, respectively. For an offset parietal impact, the model-predicted RD matched well with the experimental measurements, with peak RD differences of 27% and 24% in the right and left cerebral hemispheres, respectively. Incorporating the detailed cerebral vasculature did not influence the ICP but redistributed the brain-tissue stresses and strains by as much as 30%. In addition, our detailed-vasculature model predicted strain reductions by as much as 28% when compared to current reduced-vasculature FE models that only include the major cerebral vessels. Conclusions Our study highlights the importance of including a detailed representation of the cerebral vasculature in FE models to more accurately estimate the biomechanical responses of the human brain to blunt impact.	[Subramaniam, Dhananjay Radhakrishnan; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Rubio, Jose E.; Kote, Vivek Bhaskar; Reifman, Jaques] US Army, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Med Res & Dev Command,FCMR TT, 504 Scott St, Ft Detrick, MD 21702 USA; [Subramaniam, Dhananjay Radhakrishnan; Unnikrishnan, Ginu; Sundaramurthy, Aravind; Rubio, Jose E.; Kote, Vivek Bhaskar] Henry M Jackson Fdn Adv Mil Med Inc, 6720A Rockledge Dr, Bethesda, MD 20817 USA		Reifman, J (corresponding author), US Army, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Med Res & Dev Command,FCMR TT, 504 Scott St, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil	Lang, Steven/AAE-8102-2021; Rubio, Jose E./AAS-2201-2020; Subramaniam, Dhananjay Radhakrishnan/AAI-5686-2020	Lang, Steven/0000-0003-1669-9146; Rubio, Jose E./0000-0002-6320-2086; Subramaniam, Dhananjay Radhakrishnan/0000-0002-1037-4378; Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. DoD, Defense Health Program	The authors acknowledge support from the U.S. DoD, Defense Health Program, managed by the U.S. Army Military Operational Medicine Research Program (Ft. Detrick, MD).	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Barlow KM, 2013, HAND CLINIC, V112, P891, DOI 10.1016/B978-0-444-52910-7.00011-8; Begley DJ, 2003, PROG DRUG RES, V61, P39; Bernier M, 2018, HUM BRAIN MAPP, V39, P4962, DOI 10.1002/hbm.24337; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Cignoni Paolo, 2008, EUR IT CHAPT C EUR, DOI [10.2312/LocalChapterEvents/ItalChap/ItalianChapConf2008/129-136, DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136]; Claessens M, 1997, MODELING HUMAN HEAD; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; ESTES MS, 1970, MECH ENG, V92, P58; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Khanuja T, 2020, P I MECH ENG H, V234, P3, DOI 10.1177/0954411919881526; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kok S, 2014, INT J NUMER METH BIO, V30, P1460, DOI 10.1002/cnm.2667; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Levadnyi I, 2018, J MED BIOL ENG, V38, P587, DOI 10.1007/s40846-017-0324-3; Lozano-Minguez E, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2962; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Mobius Jan, 2012, Curves and Surfaces. 7th International Conference, Curves and Surfaces 2010. Revised Selected Papers, P488, DOI 10.1007/978-3-642-27413-8_31; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Ottenio M, 2015, J MECH BEHAV BIOMED, V41, P241, DOI 10.1016/j.jmbbm.2014.10.006; Piccinelli M, 2009, IEEE T MED IMAGING, V28, P1141, DOI 10.1109/TMI.2009.2021652; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sanchez C, 2018, MED BIOL ENG COMPUT, V56, P491, DOI 10.1007/s11517-017-1696-9; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Song C, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0500-x; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tan XG, 2019, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2018, VOL 3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teferra K, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3109; Trosseille X., 1992, DEV FEM HUMAN HEAD A; Trotta A, 2020, INT J MECH SCI, V173, DOI 10.1016/j.ijmecsci.2020.105448; Trotta A, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103381; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408278; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	68	4	4	3	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1475-925X		BIOMED ENG ONLINE	Biomed. Eng. Online	JAN 14	2021	20	1							11	10.1186/s12938-021-00847-x			19	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PW2SD	WOS:000610523400002	33446217	Green Published, gold			2022-02-06	
J	Cook, NE; Iverson, GL; Maxwell, B; Zafonte, R; Berkner, PD				Cook, Nathan E.; Iverson, Grant L.; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.			Adolescents With ADHD Do Not Take Longer to Recover From Concussion	FRONTIERS IN PEDIATRICS			English	Article						attention deficit hyperactivity disorder (ADHD); mild traumatic brain injury; injury surveillance; brain trauma; outcome research; prognosis	DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PREDICT PROTRACTED RECOVERY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; POSTCONCUSSION SYNDROME; TEST-PERFORMANCE; US CHILDREN; EFFECT SIZE; SYMPTOMS	The objective of this study was to determine whether adolescents with attention-deficit/hyperactivity disorder (ADHD) have prolonged return to school and sports following concussion compared to those without ADHD and whether medication status or concussion history is associated with recovery time. We hypothesized that having ADHD would not be associated with longer recovery time. This prospective observational cohort study, conducted between 2014 and 2019, examined concussion recovery among school sponsored athletics throughout Maine, USA. The sample included 623 adolescents, aged 14-19 years (mean = 16.3, standard deviation = 1.3 years), 43.8% girls, and 90 (14.4%) reported having ADHD. Concussions were identified by certified athletic trainers. We computed days to return to school (full time without accommodations) and days to return to sports (completed return to play protocol) following concussion. Adolescents with ADHD [median days = 7, interquartile range (IQR) = 3-13, range = 0-45] did not take longer than those without ADHD (median days = 7, IQR = 3-13, range = 0-231) to return to school (U = 22,642.0, p = 0.81, r = 0.01; log rank: chi(2)(1) = 0.059, p = 0.81). Adolescents with ADHD (median days = 14, IQR = 10-20, range = 2-80) did not take longer than those without ADHD (median days = 15, IQR = 10-21, range = 1-210) to return to sports (U = 20,295.0, p = 0.38, r = 0.04; log rank: chi(2)(1) = 0.511, p = 0.48). Medication status and concussion history were not associated with longer recovery times. Adolescents with ADHD did not take longer to functionally recover following concussion. Recovery times did not differ based on whether adolescents with ADHD reported taking medication to treat their ADHD or whether they reported a prior history of concussion.	[Cook, Nathan E.; Iverson, Grant L.; Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cook, Nathan E.; Iverson, Grant L.] Mass Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA; [Cook, Nathan E.; Iverson, Grant L.; Zafonte, Ross] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Iverson, Grant L.] Spaulding Res Inst, Discovery Ctr Brain Injury & Concuss Recovery, Charlestown, MA USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Berkner, Paul D.] Univ New England, Coll Osteopath Med, Biddeford, ME USA		Cook, NE (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Cook, NE (corresponding author), Mass Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA.; Cook, NE (corresponding author), Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.	necook@mgh.harvard.edu			National Football League; Goldfarb Center for Public Policy and Civic Engagement at Colby College; Bill and Joan Alfond Foundation; Louis V. Gerstner III Research Scholar Award	This study was funded in part by the National Football League for a program of research entitled The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects (PI: Iverson). This work was also funded in part by the Goldfarb Center for Public Policy and Civic Engagement at Colby College, and the Bill and Joan Alfond Foundation (PI: Berkner). NC acknowledges support from the Louis V. Gerstner III Research Scholar Award. GI acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, Boston Bolts, ImPACT (R) Applications, Inc., and the Spaulding Research Institute.	Aggarwal SS, 2019, APPL NEUROPSYCH-CHIL, V8, P50, DOI 10.1080/21622965.2017.1381099; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson LE, 2015, PEDIATRICS, V136, pE1178, DOI 10.1542/peds.2015-0807; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arnold LE, 2020, J ATTEN DISORD, V24, P73, DOI 10.1177/1087054714566076; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cook NE, 2019, J PEDIATR-US, V214, P168, DOI 10.1016/j.jpeds.2019.07.048; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; DuPaul GJ, 2013, J LEARN DISABIL-US, V46, P43, DOI 10.1177/0022219412464351; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Itriyeva Khalida, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2017-0070; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2021, CLIN J SPORT MED, V31, P438, DOI 10.1097/JSM.0000000000000773; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Larson K, 2011, PEDIATRICS, V127, P462, DOI 10.1542/peds.2010-0165; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Shilon Y, 2012, CHILD CARE HLTH DEV, V38, P366, DOI 10.1111/j.1365-2214.2011.01278.x; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	55	4	4	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	JAN 13	2021	8								606879	10.3389/fped.2020.606879			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	PY4CT	WOS:000611994200001	33520893	gold, Green Published			2022-02-06	
J	Halvachizadeh, S; Grobli, L; Berk, T; Jensen, KO; Hierholzer, C; Bischoff-Ferrari, HA; Pfeifer, R; Pape, HC				Halvachizadeh, Sascha; Grobli, Lea; Berk, Till; Jensen, Kai Oliver; Hierholzer, Christian; Bischoff-Ferrari, Heike A.; Pfeifer, Roman; Pape, Hans-Christoph			The effect of geriatric comanagement (GC) in geriatric trauma patients treated in a level 1 trauma setting: A comparison of data before and after the implementation of a certified geriatric trauma center	PLOS ONE			English	Article								Introduction Improvements in life expectancy imply that an increase of geriatric trauma patients occurs. These patients require special attention due to their multiple comorbidity issues. The aim of this study was to assess the impact of the implementation of geriatric comanagement (GC) on the allocation and clinical outcome of geriatric trauma patients. Methods This observational cohort study aims to compare the demographic development and the clinical outcome in geriatric trauma patients (aged 70 years and older) before and after implementation of a certified geriatric trauma center (GC). Geriatric trauma patients admitted between January 1, 2010 and December 31, 2010 were stratified to group pre-GC and admissions between January 1, 2018 and December 31, 2018 to Group post-GC. We excluded patients requiring end-of-life treatment and those who died within 24 h or due to severe traumatic brain injury. Outcome parameters included demographic changes, medical complexity (measured by American Society of Anaesthesiology Score (ASA) and Charlson Comorbidity Index (CCI)), in-hospital mortality and length of hospitalization. Results This study includes 626 patients in Group pre-GC (mean age 80.3 +/- 6.7 years) and 841 patients in Group post-GC (mean age 81.1 +/- 7.3 years). Group pre-GC included 244 (39.0%) males, group post-GC included 361 (42.9%) males. The mean CCI was 4.7 (+/- 1.8) points in pre-GC and 5.1 (+/- 2.0) points in post-GC (p < 0.001). In Group pre-GC, 100 patients (16.0%) were stratified as ASA 1 compared with 47 patients (5.6%) in Group post-GC (p < 0.001). Group pre-GC had significantly less patients stratified as ASA 3 or higher (n = 235, 37.5%) compared with Group post-GC (n = 389, 46.3%, p<0.001). Length of stay (LOS) decreased significantly from 10.4 (+/- 20.3) days in Group pre-GC to 7.9 (+/- 22.9) days in Group post-GC (p = 0.011). The 30-day mortality rate was comparable amongst these groups (pre-GC 8.8% vs. post-GC 8.9%). Conclusion This study appears to support the implementation of a geriatric trauma center, as certain improvements in the patient care were found: Despite a higher CCI and a higher number of patients with higher ASA classifications, Hospital LOS, complication rates and mortality did were not increased after implementation of the CG. The increase in the case numbers supports the fact that a higher degree of specialization leads to a response by admitting physicians, as it exceeded the expectable trend of demographic ageing. We feel that a larger data base, hopefully in a multi center set up should be undertaken to verify these results.	[Halvachizadeh, Sascha; Berk, Till; Jensen, Kai Oliver; Hierholzer, Christian; Pfeifer, Roman; Pape, Hans-Christoph] Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland; [Halvachizadeh, Sascha; Grobli, Lea; Hierholzer, Christian; Pfeifer, Roman; Pape, Hans-Christoph] Univ Zurich, Zurich, Switzerland; [Halvachizadeh, Sascha; Pfeifer, Roman; Pape, Hans-Christoph] Univ Hosp Zurich, Harald Tscherne Res Lab, Zurich, Switzerland; [Bischoff-Ferrari, Heike A.] Univ Hosp Zurich, Dept Geriatr Med, Zurich, Switzerland; [Bischoff-Ferrari, Heike A.] Univ Zurich, Ctr Aging & Mobil, Zurich, Switzerland; [Bischoff-Ferrari, Heike A.] Waid City Hosp Zurich, Zurich, Switzerland		Halvachizadeh, S (corresponding author), Univ Hosp Zurich, Dept Trauma, Zurich, Switzerland.; Halvachizadeh, S (corresponding author), Univ Zurich, Zurich, Switzerland.; Halvachizadeh, S (corresponding author), Univ Hosp Zurich, Harald Tscherne Res Lab, Zurich, Switzerland.	Sascha.Halvachizadeh@usz.ch		Pape, Hans-Christoph/0000-0002-2059-4980			Abrahamsen C, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1299-4; Ahmed N, 2020, AM J EMERG MED, V38, P2531, DOI 10.1016/j.ajem.2019.12.031; Atinga A, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170739; Ball JR, 2016, ANN INTERN MED, V164, P59, DOI 10.7326/M15-2256; Bhattacharya B, 2016, INJURY, V47, P1955, DOI 10.1016/j.injury.2016.06.019; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Boscart V, 2020, CLIN GERONTOLOGIST, DOI 10.1080/07317115.2019.1707339; Bureau USC, 2019, AGING NATION PROJECT; Calvo RY, 2019, AM J EMERG MED, V37, P1836, DOI 10.1016/j.ajem.2018.12.043; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; DiGiacomo JC, 2019, AGING CLIN EXP RES, V31, P1743, DOI 10.1007/s40520-019-01119-4; Eamer G, 2018, COCHRANE DATABASE SY, V1; Eglseer D, 2017, NUTRITION, V37, P104, DOI 10.1016/j.nut.2016.12.016; Eibinger N, REGISTER DGU, V10, P842, DOI [10.3390/brainsci10110842, DOI 10.3390/BRAINSCI10110842]; Fairfax LM, 2015, NEW ZEAL MED J, V128, P36; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/s0140-6736(18)31694-5, 10.1016/S0140-6736(18)31694-5]; Frohlich M, 2020, EUR J TRAUMA EMERG S, V46, P1463, DOI 10.1007/s00068-019-01285-0; Gallo V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001117; Garwe T, 2017, PREHOSP EMERG CARE, V21, P734, DOI 10.1080/10903127.2017.1332123; Halvachizadeh S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228082; Hammer PM, 2016, J TRAUMA ACUTE CARE, V81, P162, DOI 10.1097/TA.0000000000001063; HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360; Hung KKC, 2019, AM J EMERG MED, V37, P450, DOI 10.1016/j.ajem.2018.06.011; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Karlsson S, 2020, HOME HLTH CARE MAN P, V32, P53, DOI 10.1177/1084822319863308; Keller JM, 2012, J ORTHOP TRAUMA, V26, pE161, DOI 10.1097/BOT.0b013e3182324460; Knobe M, 2019, UNFALLCHIRURG, V122, P134, DOI 10.1007/s00113-018-0502-y; Knobe M, 2016, EUR J TRAUMA EMERG S, V42, P795, DOI 10.1007/s00068-016-0728-8; Knobe M, 2016, EUR J TRAUMA EMERG S, V42, P533, DOI 10.1007/s00068-016-0695-0; Korner M, 2010, CLIN REHABIL, V24, P745, DOI 10.1177/0269215510367538; Lowe JA, 2018, J ORTHOP TRAUMA, V32, P129, DOI 10.1097/BOT.0000000000001052; Mulvey HE, 2020, J SURG RES, V245, P13, DOI 10.1016/j.jss.2019.06.059; Office SFS, 2020, POPULATION YEARS 195; Olotu C, 2019, DTSCH ARZTEBL INT, V116, P63, DOI 10.3238/arztebl.2019.0063; Osterhoff G, 2019, J ORTHOP TRAUMA, V33, pE410, DOI 10.1097/BOT.0000000000001584; Pandya SR, 2011, J TRAUMA, V70, P1326, DOI 10.1097/TA.0b013e31820e327c; Pape HC, 2014, INJURY, V45, P1513, DOI 10.1016/j.injury.2014.08.006; Peterer L, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1380-z; Pfeifer R, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-9; Rollmann MF, 2019, GERIATR GERONTOL INT, V19, P24, DOI 10.1111/ggi.13558; Santhirapala R, 2020, ANAESTHESIA, V75, pE46, DOI 10.1111/anae.14910; Shipway David, 2018, Future Healthc J, V5, P108, DOI 10.7861/futurehosp.5-2-108; Singh S, 2020, J TRAUMA NURS, V27, P71, DOI 10.1097/JTN.0000000000000489; union SOotE Eurostat, 2019, ELDERLY POPULATION 6; University Hospital Zurich DoTaG, 2020, ORTHO GERIATRIC COMA; Wallace R, 2019, AGING CLIN EXP RES, V31, P273, DOI 10.1007/s40520-018-0952-7; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; Wong SP, 2020, J AM GERIATR SOC, V68, P859, DOI 10.1111/jgs.16315	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2021	16	1							e0244554	10.1371/journal.pone.0244554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4UJ	WOS:000630036100019	33428650	gold, Green Accepted, Green Published			2022-02-06	
J	Koshimizu, Y; Isa, K; Kobayashi, K; Isa, T				Koshimizu, Yoshinori; Isa, Kaoru; Kobayashi, Kenta; Isa, Tadashi			Double viral vector technology for selective manipulation of neural pathways with higher level of efficiency and safety	GENE THERAPY			English	Article							VENTRAL TEGMENTAL AREA; TRANSDUCTION EFFICIENCY; GENE-TRANSFER; CELL TROPISM; SEROTYPES 1; NEURONS; BRAIN; RECOVERY; MOUSE; RAT	Pathway-selective gene delivery would be critical for future gene therapy against neuropsychiatric disorders, traumatic neuronal injuries, or neurodegenerative diseases, because the impaired functions depend on neural circuits affected by the insults. Pathway-selective gene delivery can be achieved by double viral vector techniques, which combine an injection of a retrograde transport viral vector into the projection area of the target neurons and that of an anterograde viral vector into their somas. In this study, we tested the efficiency of gene delivery with different combinations of viral vectors to the pathway extending from the ventral tegmental area (VTA) to the cortical motor regions in rats, considered to be critical in the promotion of motor recovery from neural injuries. It was found that retrograde recombinant adeno-associated virus 2-retro (rAAV2reto) combined with anterograde AAVDJ (type2/type4/type5/type8/type9/avian/bovine/caprine chimera) exhibited the highest transduction efficiency in the short term (3-6 weeks) but high toxicity in the long term (3 months). In contrast, the same rAAV2reto combined with anterograde AAV5 displayed moderate transduction efficiency in the short term but low toxicity in the long term. These data suggest that the combination of anterograde AAV5 and retrograde rAAV2retro is suitable for safe and efficient gene delivery to the VTA-cortical pathway.	[Koshimizu, Yoshinori; Isa, Kaoru; Isa, Tadashi] Kyoto Univ, Div Physiol & Neurobiol, Dept Neurosci, Grad Sch Med, Kyoto, Japan; [Koshimizu, Yoshinori; Isa, Kaoru; Kobayashi, Kenta; Isa, Tadashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Tokyo, Japan; [Kobayashi, Kenta] Natl Inst Physiol Sci, Sect Viral Vector Dev, Okazaki, Aichi, Japan; [Kobayashi, Kenta] Grad Univ Adv Studies, SOKENDAI, Hayama, Kanagawa, Japan; [Isa, Tadashi] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Isa, Tadashi] Kyoto Univ, Inst Adv Study Human Biol WPI ASHBi, Kyoto, Japan		Isa, T (corresponding author), Kyoto Univ, Div Physiol & Neurobiol, Dept Neurosci, Grad Sch Med, Kyoto, Japan.; Isa, T (corresponding author), Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Tokyo, Japan.; Isa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan.; Isa, T (corresponding author), Kyoto Univ, Inst Adv Study Human Biol WPI ASHBi, Kyoto, Japan.	isa.tadashi.7u@kyoto-u.ac.jp		Isa, Tadashi/0000-0001-5652-4688	Core Research for Evolutionary Science and Technology (CREST) "Optobio" from Japan Science and Technology agency	This work was supported by the Core Research for Evolutionary Science and Technology (CREST) "Optobio" from Japan Science and Technology agency.	Albert K, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020063; Aransay A, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.7015.00059, 10.3389/fnana.2015.00059]; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Carvalho MM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00145; Chabrat A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01042-0; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Eban-Rothschild A, 2016, NAT NEUROSCI, V19, P1356, DOI 10.1038/nn.4377; Engelhard B, 2019, NATURE, V570, P509, DOI 10.1038/s41586-019-1261-9; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Gupta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172928; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hudry E, 2019, NEURON, V101, P839, DOI 10.1016/j.neuron.2019.02.017; Ingusci S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00724; Isa T, 2019, ANNU REV NEUROSCI, V42, P315, DOI 10.1146/annurev-neuro-070918-050436; Ishida A, 2016, J NEUROSCI, V36, P455, DOI 10.1523/JNEUROSCI.2399-15.2016; Katada Y, 2019, PEERJ, V7, DOI 10.7717/peerj.6317; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kobayashi K, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00065; Kobayashi K, 2016, NEUROSCI LETT, V630, P45, DOI 10.1016/j.neulet.2016.07.020; Koshimizu Y, 2008, EUR J NEUROSCI, V28, P2053, DOI 10.1111/j.1460-9568.2008.06502.x; Koshimizu Y, 2013, J COMP NEUROL, V521, P2125, DOI 10.1002/cne.23277; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Kunori N, 2014, J NEUROSCI, V34, P8894, DOI 10.1523/JNEUROSCI.5286-13.2014; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Mays LE, 2009, J IMMUNOL, V182, P6051, DOI 10.4049/jimmunol.0803965; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nishimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024854; Paxinos G., 2013, PAXINOS WATSONS RAT; Poulin JF, 2018, NAT NEUROSCI, V21, P1260, DOI 10.1038/s41593-018-0203-4; Sawada M, 2015, SCIENCE, V350, P98, DOI 10.1126/science.aab3825; Sooksawate T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00162; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; Vander Weele CM, 2018, NATURE, V563, P397, DOI 10.1038/s41586-018-0682-1; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Watakabe A, 2015, NEUROSCI RES, V93, P144, DOI 10.1016/j.neures.2014.09.002; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Zingg B, 2020, J NEUROSCI, V40, P3250, DOI 10.1523/JNEUROSCI.2158-19.2020; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045	46	4	4	4	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	JUN	2021	28	6					339	350		10.1038/s41434-020-00212-y		JAN 2021	12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	SX2RP	WOS:000607060900001	33432122	Green Published, hybrid			2022-02-06	
J	Sinke, MRT; Otte, WM; Meerwaldt, AE; Franx, BAA; Ali, MHM; Rakib, F; van der Toorn, A; van Heijningen, CL; Smeele, C; Ahmed, T; Blezer, ELA; Dijkhuizen, RM				Sinke, Michel R. T.; Otte, Willem M.; Meerwaldt, Anu E.; Franx, Bart A. A.; Ali, Mohamed H. M.; Rakib, Fazle; van der Toorn, Annette; van Heijningen, Caroline L.; Smeele, Christel; Ahmed, Tariq; Blezer, Erwin L. A.; Dijkhuizen, Rick M.			Imaging Markers for the Characterization of Gray and White Matter Changes from Acute to Chronic Stages after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; diffusion magnetic resonance imaging; histology; rats; traumatic brain injury	DIFFUSE AXONAL INJURY; FUNCTIONAL CONNECTIVITY; RADIAL DIFFUSIVITY; TENSOR; RAT; RECOVERY; MODEL; EPIDEMIOLOGY; ROBUST; REORGANIZATION	Despite clinical symptoms, a large majority of people with mild traumatic brain injury (TBI) have normal computed tomography (CT) and magnetic resonance imaging (MRI) scans. Therefore, present-day neuroimaging tools are insufficient to diagnose or classify low grades of TBI. Advanced neuroimaging techniques, such as diffusion-weighted and functional MRI, may yield novel biomarkers that may aid in the diagnosis of TBI. Therefore, the present study had two aims: first, to characterize the development of MRI-based measures of structural and functional changes in gray and white matter regions from acute to chronic stages after mild and moderate TBI; and second, to identify the imaging markers that can most accurately predict outcome after TBI. To these aims, 52 rats underwent serial functional (resting-state) and structural (T1-, T2-, and diffusion-weighted) MRI before and 1 h, 1 day, 1 week, 1 month and 3-4 months after mild or moderate experimental TBI. All rats underwent behavioral testing. Histology was performed in subgroups of rats at different time points. Early after moderate TBI, axial and radial diffusivities were increased, and fractional anisotropy was reduced in the corpus callosum and bilateral hippocampi, which normalized over time and was paralleled by recovery of sensorimotor function. Correspondingly, histology revealed decreased myelin staining early after TBI, which was not detected at chronic stages. No significant changes in individual outcome measures were detected after mild TBI. However, multivariate analysis showed a significant additive contribution of diffusion parameters in the distinction between control and different grades of TBI-affected brains. Therefore, combining multiple imaging markers may increase the sensitivity for TBI-related pathology.	[Sinke, Michel R. T.; Otte, Willem M.; Meerwaldt, Anu E.; Franx, Bart A. A.; van der Toorn, Annette; van Heijningen, Caroline L.; Smeele, Christel; Blezer, Erwin L. A.; Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Biomed MR Imaging & Spect Grp, Ctr Image Sci, Yalelaan 2, NL-3584 CM Utrecht, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Child Neurol, Utrecht, Netherlands; Univ Utrecht, Utrecht, Netherlands; [Ali, Mohamed H. M.; Ahmed, Tariq] Hamad Bin Khalifa Univ HBKU, Neurol Disorders Res Ctr, Qatar Biomed Res Inst QBRI, Doha, Qatar; [Rakib, Fazle] Qatar Univ, Dept Chem & Earth Sci, Coll Arts & Sci, Doha, Qatar		Sinke, MRT; Dijkhuizen, RM (corresponding author), Univ Med Ctr Utrecht, Biomed MR Imaging & Spect Grp, Ctr Image Sci, Yalelaan 2, NL-3584 CM Utrecht, Netherlands.	m.r.t.sinke@umcutrecht.nl; r.m.dijkhuizen@umcutrecht.nl		Franx, Bart/0000-0002-6410-3805; Dijkhuizen, Rick/0000-0002-4623-4078	Qatar National Research Fund (QNRF) [NPRP 7-1648-3-420]	This work was supported by Qatar National Research Fund (QNRF) grant no. NPRP 7-1648-3-420.	Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Blockx I, 2011, NEUROIMAGE, V58, P1006, DOI 10.1016/j.neuroimage.2011.07.007; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Heath F, 2018, DEV NEUROBIOL, V78, P136, DOI 10.1002/dneu.22552; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2017, NEURORADIOLOGY, V59, P1203, DOI 10.1007/s00234-017-1915-y; Li L, 2017, BRAIN RES, V1675, P61, DOI 10.1016/j.brainres.2017.09.007; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Louviere J.J., 2000, STATED CHOICE METHOD; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majka P, 2012, NEUROINFORMATICS, V10, P181, DOI 10.1007/s12021-011-9138-6; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mengler L, 2014, NEUROIMAGE, V84, P35, DOI 10.1016/j.neuroimage.2013.08.034; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Otte WM, 2015, BRAIN STRUCT FUNCT, V220, P27, DOI 10.1007/s00429-013-0633-4; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Reglodi D, 2003, BRAIN RES BULL, V59, P459, DOI 10.1016/S0361-9230(02)00962-0; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Tuor UI, 2014, NEUROIMAGE-CLIN, V6, P32, DOI 10.1016/j.nicl.2014.08.003; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Verhelst H, 2019, NEUROREHAB NEURAL RE, V33, P813, DOI 10.1177/1545968319868720; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	72	4	4	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1642	1653		10.1089/neu.2020.7151		JAN 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000607614000001	33198560				2022-02-06	
J	Chen, T; Liu, WB; Qian, X; Xie, KL; Wang, YH				Chen, Tao; Liu, Wen-Bo; Qian, Xiao; Xie, Ke-Liang; Wang, Yu-Hai			The AMPAR antagonist perampanel protects the neurovascular unit against traumatic injury via regulating Sirt3	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						AMPA receptor; neurovascular unit; perampanel; Sirt3; traumatic brain injury	BRAIN-INJURY; OXIDATIVE STRESS; RECEPTOR ANTAGONIST; CORTICAL-NEURONS; DOWN-REGULATION; CELL-DEATH; PERMEABILITY; INVOLVEMENT	Introduction: Perampanel is a highly selective and noncompetitive alpha-amino-3 -hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR) antagonist, which has been used as an orally administered antiepileptic drug in more than 55 countries. Recently, perampanel was shown to exert neuroprotective effects in hemorrhagic and ischemic stroke models via regulating blood-brain barrier (BBB) function. Aim: Here, the protective effects of perampanel were investigated in an in vitro neurovascular unit (NVU) system established using a triple cell co-culture model (neurons, astrocytes, and brain microvascular endothelial cells) and in an in vivo traumatic brain injury (TBI) model. Results: Neurons in the NVU system exhibit a more mature morphological phenotype compared with neurons cultured alone, and the co-culture system mimicked an impermeable barrier in vitro. Perampanel protects the NVU system against traumatic and excitotoxic injury, as evidenced by reduced lactate dehydrogenase (LDH) release and apoptotic rate. Treatment with perampanel attenuated lipid peroxidation and expression of inflammatory cytokines. In addition, perampanel increased Sirt3 protein expression, enhanced the activities of mitochondrial enzyme IDH2 and SOD2, and preserved BBB function in vitro. Knockdown of Sirt3 using specific siRNA (Si-Sirt3) partially reserved the effects of perampanel on neuronal injury and BBB function. Treatment with perampanel in vivo attenuated brain edema, preserved neurological function, inhibited apoptosis and microglia activation after TBI. Furthermore, perampanel increased the expression of Sirt3 and preserved BBB function after TBI. The effect of perampanel on BBB function and brain edema was abolished by knockdown of Sirt3 in vivo. Conclusion: Our results indicate that the noncompetitive AMPAR antagonist perampanel protects the NVU system and reduces brain damage after TBI via activating the Sirt3 cascades.	[Chen, Tao; Qian, Xiao; Wang, Yu-Hai] Anhui Med Univ, Med Sch, Hosp PLA 904, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China; [Chen, Tao; Liu, Wen-Bo; Xie, Ke-Liang] Weifang Med Univ, Coll Anesthesiol, Translat Res Inst Intens Care Med, Weifang, Peoples R China; [Xie, Ke-Liang] Tianjin Med Univ, Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Anesthesiol, Tianjin, Peoples R China; [Xie, Ke-Liang] Tianjin Med Univ, Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Crit Care Med, Tianjin, Peoples R China		Wang, YH (corresponding author), Anhui Med Univ, Med Sch, Hosp PLA 904, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China.; Xie, KL (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Crit Care Med, Tianjin, Peoples R China.; Xie, KL (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Res Inst Anesthesiol, Dept Anesthesiol,Dept Crit Care Med, Tianjin 300052, Peoples R China.	xiekeliang2009@hotmail.com; prof_wyh101@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701932, 81871589, 82072168]; Major Scientific Research Project of Wuxi Health Commission [Z202001]; Translational Medicine Research Major Project of Wuxi Health Commission [2019-ZZ001]; Clinical Medical Science and Technology Development Foundation of Jiangsu University [JLY20180028]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M651803]; Key Scientific Research Project of Jiangsu Health Commission [K2019018]; Logistics Scientific Research Project of PLA [CLB20J027]	This work was supported by the National Natural Science Foundation of China (No. 81701932, No. 81871589 and No. 82072168), the Major Scientific Research Project of Wuxi Health Commission (No. Z202001), the Translational Medicine Research Major Project of Wuxi Health Commission (No. 2019-ZZ001), Clinical Medical Science and Technology Development Foundation of Jiangsu University (No. JLY20180028), China Postdoctoral Science Foundation funded project (No. 2019M651803), the Key Scientific Research Project of Jiangsu Health Commission (No. K2019018) and the Logistics Scientific Research Project of PLA (No. CLB20J027).	Baker WB, 2019, J CEREBR BLOOD F MET, V39, P1469, DOI 10.1177/0271678X19846657; Basso M, 2019, CURR OPIN NEUROL, V32, P796, DOI 10.1097/WCO.0000000000000753; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Blochet C, 2020, J CEREBR BLOOD F MET, V40, P163, DOI 10.1177/0271678X18806893; Ceolin L, 2012, NEUROCHEM INT, V61, P517, DOI 10.1016/j.neuint.2012.02.035; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen T, 2018, REDOX BIOL, V14, P229, DOI 10.1016/j.redox.2017.09.016; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen YW, 2013, ECON POLIT STUD-EPS, V1, P3, DOI 10.1080/20954816.2013.11673857; Dai SH, 2014, INT J MOL SCI, V15, P14591, DOI 10.3390/ijms150814591; Dai SH, 2014, INT J MOL MED, V34, P1159, DOI 10.3892/ijmm.2014.1876; Dohare P, 2016, J NEUROSCI, V36, P3363, DOI 10.1523/JNEUROSCI.4329-15.2016; Forcione M, 2020, J CEREBR BLOOD F MET, V40, P1586, DOI 10.1177/0271678X20921973; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Hanada T, 2011, EPILEPSIA, V52, P1331, DOI 10.1111/j.1528-1167.2011.03109.x; Hibi S, 2012, J MED CHEM, V55, P10584, DOI 10.1021/jm301268u; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124744; Li Y, 2019, CNS NEUROSCI THER, V25, P1343, DOI 10.1111/cns.13260; Li Y, 2018, CNS NEUROSCI THER, V24, P1115, DOI 10.1111/cns.13081; Liu J, 2019, NEURAL REGEN RES, V14, P289, DOI 10.4103/1673-5374.244794; Liu LR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01024; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Lv JM, 2016, CELL MOL NEUROBIOL, V36, P745, DOI 10.1007/s10571-015-0257-8; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nakajima M, 2018, NEUROSCIENCE, V386, P256, DOI 10.1016/j.neuroscience.2018.06.043; Niu HX, 2018, CELL MOL NEUROBIOL, V38, P459, DOI 10.1007/s10571-017-0489-x; Patsalos PN, 2015, EPILEPSIA, V56, P12, DOI 10.1111/epi.12865; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Schulze-Bonhage A, 2015, PATIENT PREFER ADHER, V9, P1143, DOI 10.2147/PPA.S63951; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun ML, 2020, CNS NEUROSCI THER, V26, P815, DOI 10.1111/cns.13398; Tsai JJ, 2018, ACTA NEUROL SCAND, V137, P378, DOI 10.1111/ane.12879; Wang H, 2019, CNS NEUROSCI THER, V25, P476, DOI 10.1111/cns.13074; YAMAGUCHI S, 1993, EPILEPSY RES, V15, P179, DOI 10.1016/0920-1211(93)90054-B; Yang X, 2018, CNS NEUROSCI THER, V24, P775, DOI 10.1111/cns.12853; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang J, 2019, J CEREBR BLOOD F MET, V39, P1394, DOI 10.1177/0271678X18785480; Zhao JY, 2019, J CEREBR BLOOD F MET, V39, P1215, DOI 10.1177/0271678X18808174; Zhao Y, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105103	46	4	4	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JAN	2021	27	1			SI		134	144		10.1111/cns.13580		JAN 2021	11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	PR4BD	WOS:000606005200001	33421349	gold, Green Published			2022-02-06	
J	Abu Hamdeh, S; Ciuculete, DM; Sarkisyan, D; Bakalkin, G; Ingelsson, M; Schioth, HB; Marklund, N				Abu Hamdeh, Sami; Ciuculete, Diana-Maria; Sarkisyan, Daniil; Bakalkin, Georgy; Ingelsson, Martin; Schioth, Helgi B.; Marklund, Niklas			Differential DNA Methylation of the Genes for Amyloid Precursor Protein, Tau, and Neurofilaments in Human Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						amyloid beta precursor protein; DNA methylation; epigenome-wide association study tau; traumatic brain injury	HEAD-INJURY; ALZHEIMERS-DISEASE; AXONAL INJURY; MAPT GENE; ASSOCIATION; PATHOLOGY; RISK; HYPOMETHYLATION; MICRODIALYSIS; DEPOSITION	Traumatic brain injury (TBI) is an established risk factor for neurodegenerative disorders and dementias. Epigenetic modifications, such as DNA methylation, may alter the expression of genes without altering the DNA sequence in response to environmental factors. We hypothesized that DNA methylation changes may occur in the injured human brain and be implicated in the neurodegenerative aftermath of TBI. The DNA methylation status of genes related to neurodegeneration; for example, amyloid beta precursor protein (APP), microtubule associated protein tau (MAPT), neurofilament heavy (NEFH), neurofilament medium (NEFM), and neurofilament light (NEFL), was analyzed in fresh, surgically resected human brain tissue from 17 severe TBI patients and compared with brain biopsy samples from 19 patients with idiopathic normal pressure hydrocephalus (iNPH). We also performed an epigenome-wide association study (EWAS) comparing TBI patients with iNPH controls. Thirty-eight CpG sites in the APP, MAPT, NEFH, and NEFL genes were differentially methylated by TBI. Among the top 20 differentially methylated CpG sites, 11 were in the APP gene. In addition, the EWAS evaluating 828,888 CpG sites revealed 308 differentially methylated CpG sites in genes related to cellular/anatomical structure development, cell differentiation, and anatomical morphogenesis. These preliminary findings provide the first evidence of an altered DNA methylome in the injured human brain, and may have implications for the neurodegenerative disorders associated with TBI.	[Abu Hamdeh, Sami] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Ciuculete, Diana-Maria; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Div Pharmacol, Uppsala, Sweden; [Sarkisyan, Daniil; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Schioth, Helgi B.] Sechenov First Moscow State Med Univ, Inst Translat Med & Biotechnol, Moscow, Russia; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden		Marklund, N (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden.	niklas.marklund@med.lu.se			Swedish Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission [014-07550, 2018-0500]; Bissen Brain Walk; Selander Foundation	The study was supported by Swedish Brain Foundation, Swedish Research Council under the framework of EU-ERA-NET NEURON CnsAFlame (grant number 2014-07550), Bissen Brain Walk, and Selander Foundation, Swedish Research Council (grant number 2018-0500) (to N.M.).	Abu Hamdeh S., 2017, BRAIN PATHOL, V(Zurich, pSwitzerland; Abu Hamdeh S, 2019, J NEUROSURG, V130, P121, DOI 10.3171/2017.7.JNS171005; Abu Hamdeh S, 2018, BRAIN PATHOL, V28, P451, DOI 10.1111/bpa.12532; Abu Hamdeh S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25060-0; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; An R, 2015, AMYOTROPH LAT SCL FR, V16, P245, DOI 10.3109/21678421.2014.999790; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Bir SC, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16188; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Coupland KG, 2014, MOVEMENT DISORD, V29, P1606, DOI 10.1002/mds.25784; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; D'Orsi B, 2016, J NEUROSCI, V36, P4564, DOI 10.1523/JNEUROSCI.3780-15.2016; Deng M, 2013, NAT GENET, V45, P697, DOI 10.1038/ng.2627; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elobeid A, 2015, J NEUROPATH EXP NEUR, V74, P470, DOI 10.1097/NEN.0000000000000191; Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gasparoni G, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0211-3; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huin V, 2016, MOVEMENT DISORD, V31, P1883, DOI 10.1002/mds.26820; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2014, HUM MOL GENET, V23, P648, DOI 10.1093/hmg/ddt451; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones MJ, 2018, ANNU REV PSYCHOL, V69, P459, DOI 10.1146/annurev-psych-122414-033653; Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Karuppagounder SS, 2015, BRAIN RES, V1628, P273, DOI 10.1016/j.brainres.2015.07.030; Lin HC, 2009, NEUROTOXICOLOGY, V30, P622, DOI 10.1016/j.neuro.2009.03.011; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lundstrom Y, 2019, APPL IMMUNOHISTO M M, V27, P238, DOI 10.1097/PAI.0000000000000658; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Mansell G, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5761-7; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mateen BA, 2017, J NEUROTRAUM, V34, P2379, DOI 10.1089/neu.2017.5007; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mukherjee S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00002; Neal M, 2018, BBA-MOL BASIS DIS, V1864, P432, DOI 10.1016/j.bbadis.2017.11.004; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nishimura H, 2003, J NEUROCHEM, V85, P1216, DOI 10.1046/j.1471-4159.2003.01760.x; Ong ML, 2014, AGING CELL, V13, P142, DOI 10.1111/acel.12159; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Pisanu C, 2018, NEUROSCI LETT, V669, P24, DOI 10.1016/j.neulet.2016.06.045; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Policicchio S, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0752-7; Rizzardi LF, 2019, NAT NEUROSCI, V22, P307, DOI 10.1038/s41593-018-0297-8; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tirado-Magallanes R, 2017, ONCOTARGET, V8, P5629, DOI 10.18632/oncotarget.13562; Tohyama J, 2011, AM J MED GENET A, V155A, P130, DOI 10.1002/ajmg.a.33652; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhou ZW, 2019, EPIGENOMICS-UK, V11, P1089, DOI 10.2217/epi-2018-0204	75	4	4	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1679	1688		10.1089/neu.2020.7283		JAN 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000606620000001	33191850				2022-02-06	
J	Godoy, DA; Badenes, R; Pelosi, P; Robba, C				Godoy, Daniel Agustin; Badenes, Rafael; Pelosi, Paolo; Robba, Chiara			Ketamine in acute phase of severe traumatic brain injury "an old drug for new uses?"	CRITICAL CARE			English	Article						Ketamine; Traumatic brain injury; Sedation; Agitation; Secondary insult; Cooperative sedation; Neuroprotection		Maintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls.	[Godoy, Daniel Agustin] Sanatorio Pasteur, Neurointens Care Unit, Catamarca, Argentina; [Godoy, Daniel Agustin] Hosp Carlos Malbran, Intens Care Unit, Catamarca, Argentina; [Badenes, Rafael] Univ Clin Hosp, Anesthesiol & Surg Trauma Intens Care, Valencia, Spain; [Badenes, Rafael] Univ Valencia, Dept Surg, Valencia, Spain; [Badenes, Rafael] INCLIVA Res Med Inst, Valencia, Spain; [Pelosi, Paolo; Robba, Chiara] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anesthesia & Intens Care, Genoa, Italy; [Pelosi, Paolo; Robba, Chiara] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy		Robba, C (corresponding author), San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anesthesia & Intens Care, Genoa, Italy.	kiarobba@gmail.com		Badenes, Rafael/0000-0001-7017-0150			Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Akeju O, 2016, CLIN NEUROPHYSIOL, V127, P2414, DOI 10.1016/j.clinph.2016.03.005; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bell JD, 2017, ANESTH ANALG, V124, P1237, DOI 10.1213/ANE.0000000000001856; Bhaire Vishwanatha S, 2019, Anesth Essays Res, V13, P643, DOI 10.4103/aer.AER_119_19; Bhutta AT, 2012, PEDIATR CRIT CARE ME, V13, P328, DOI 10.1097/PCC.0b013e31822f18f9; Biegon A, 2018, CURR OPIN NEUROL, V31, P687, DOI 10.1097/WCO.0000000000000612; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; EVANS J, 1971, LANCET, V1, P40; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; GARDNER AE, 1971, ANESTHESIOLOGY, V35, P226, DOI 10.1097/00000542-197108000-00029; GIBBS JM, 1972, BRIT J ANAESTH, V44, P1298, DOI 10.1093/bja/44.12.1298; Green SM, 2015, ANN EMERG MED, V65, P52, DOI 10.1016/j.annemergmed.2014.08.025; Gregers MCT, 2020, NEUROCRIT CARE, V33, P273, DOI 10.1007/s12028-020-00975-7; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Hurth KP, 2020, CRIT CARE MED, V48, P899, DOI 10.1097/CCM.0000000000004335; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kamp J, 2020, ANESTHESIOLOGY, V133, P1192, DOI 10.1097/ALN.0000000000003577; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; LIST WF, 1972, ANESTHESIOLOGY, V36, P98, DOI 10.1097/00000542-197201000-00023; LOCKHART CH, 1972, ANESTHESIOLOGY, V37, P62; Loflin R, 2015, ANN EMERG MED, V65, P55, DOI 10.1016/j.annemergmed.2014.08.017; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mion G, 2013, CNS NEUROSCI THER, V19, P370, DOI 10.1111/cns.12099; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Opdenakker O, 2019, CURR OPIN CRIT CARE, V25, P97, DOI 10.1097/MCC.0000000000000592; Pfenninger E, 1997, ANAESTHESIST, V46, pS47, DOI 10.1007/PL00002465; Reinhart KM, 2018, EXP NEUROL, V305, P121, DOI 10.1016/j.expneurol.2018.04.007; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Sakai T, 2000, CAN J ANAESTH, V47, P1019, DOI 10.1007/BF03024876; Sanchez-Porras R, 2017, J CEREBR BLOOD F MET, V37, P1720, DOI 10.1177/0271678X16646586; SARI A, 1972, ANESTH ANAL CURR RES, V51, P560; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; TJADEN R J, 1969, Journal of the Canadian Association of Radiologists, V20, P155; Vincent JL, 2016, CRIT CARE MED, V44, pE450, DOI 10.1097/CCM.0000000000001597; Vlisides PE, 2017, ANESTHESIOLOGY, V127, P58, DOI 10.1097/ALN.0000000000001671; Wang X, 2014, J ANESTH, V28, P821, DOI 10.1007/s00540-014-1845-3; Zanos P, 2018, PHARMACOL REV, V70, P621, DOI 10.1124/pr.117.015198; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; Zheng JB, 2018, J THORAC DIS, V10, P190, DOI 10.21037/jtd.2017.11.129	50	4	4	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	JAN 6	2021	25	1							19	10.1186/s13054-020-03452-x			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PV7KA	WOS:000610161500011	33407737	Green Published, gold			2022-02-06	
